<SEC-DOCUMENT>0000064803-22-000029.txt : 20220803
<SEC-HEADER>0000064803-22-000029.hdr.sgml : 20220803
<ACCEPTANCE-DATETIME>20220803063556
ACCESSION NUMBER:		0000064803-22-000029
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		85
CONFORMED PERIOD OF REPORT:	20220630
FILED AS OF DATE:		20220803
DATE AS OF CHANGE:		20220803

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CVS HEALTH Corp
		CENTRAL INDEX KEY:			0000064803
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		IRS NUMBER:				050494040
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-01011
		FILM NUMBER:		221130832

	BUSINESS ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895
		BUSINESS PHONE:		4017651500

	MAIL ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CAREMARK CORP
		DATE OF NAME CHANGE:	20070509

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS/CAREMARK CORP
		DATE OF NAME CHANGE:	20070322

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CORP
		DATE OF NAME CHANGE:	19970128
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>cvs-20220630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:0140da76-e33c-4901-8b3b-5aa42426ab0a,g:ea97fc95-8028-4e4e-8a3a-2f9f67911aac,d:9cfc04c975ca4b3f87d2592f7def0c41--><html xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:srt="http://fasb.org/srt/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cvs="http://www.cvshealth.com/20220630" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cvs-20220630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80L2ZyYWc6ZDRkYWNiN2NjN2UwNDU5MmFhZGQyZTU0MTE4ZTZlODEvdGFibGU6ZWY1MTE3MjgyMjUxNDcyMmJkODI4Y2JmZmUxZDQ5MjIvdGFibGVyYW5nZTplZjUxMTcyODIyNTE0NzIyYmQ4MjhjYmZmZTFkNDkyMl8zLTEtMS0xLTEyMTc5Nw_8c7a169b-ece2-4d35-b0b6-50e072c69515">0000064803</ix:nonNumeric><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80L2ZyYWc6ZDRkYWNiN2NjN2UwNDU5MmFhZGQyZTU0MTE4ZTZlODEvdGFibGU6ZWY1MTE3MjgyMjUxNDcyMmJkODI4Y2JmZmUxZDQ5MjIvdGFibGVyYW5nZTplZjUxMTcyODIyNTE0NzIyYmQ4MjhjYmZmZTFkNDkyMl80LTEtMS0xLTEyMTc5Nw_3360de2e-abff-40ff-b038-2237e9f87469">12/31</ix:nonNumeric><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80L2ZyYWc6ZDRkYWNiN2NjN2UwNDU5MmFhZGQyZTU0MTE4ZTZlODEvdGFibGU6ZWY1MTE3MjgyMjUxNDcyMmJkODI4Y2JmZmUxZDQ5MjIvdGFibGVyYW5nZTplZjUxMTcyODIyNTE0NzIyYmQ4MjhjYmZmZTFkNDkyMl81LTEtMS0xLTEyMTc5Nw_d7fae05c-5b2a-419e-a252-b98eae1db792">2022</ix:nonNumeric><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80L2ZyYWc6ZDRkYWNiN2NjN2UwNDU5MmFhZGQyZTU0MTE4ZTZlODEvdGFibGU6ZWY1MTE3MjgyMjUxNDcyMmJkODI4Y2JmZmUxZDQ5MjIvdGFibGVyYW5nZTplZjUxMTcyODIyNTE0NzIyYmQ4MjhjYmZmZTFkNDkyMl82LTEtMS0xLTEyMTc5Nw_3676ec4a-781e-4582-a4d4-548c1d7d6696">Q2</ix:nonNumeric><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80L2ZyYWc6ZDRkYWNiN2NjN2UwNDU5MmFhZGQyZTU0MTE4ZTZlODEvdGFibGU6ZWY1MTE3MjgyMjUxNDcyMmJkODI4Y2JmZmUxZDQ5MjIvdGFibGVyYW5nZTplZjUxMTcyODIyNTE0NzIyYmQ4MjhjYmZmZTFkNDkyMl83LTEtMS0xLTEyMTc5Nw_d1d3eb0a-7765-4065-8d38-32a21add5ffe">false</ix:nonNumeric><ix:nonNumeric contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfOS0wLTEtMS0xMjE3OTc_160ea397-089c-4c69-9a75-1e41518644cc">http://fasb.org/us-gaap/2022#ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfOS0wLTEtMS0xMjE3OTc_20a62c90-3426-4729-933d-b5877901a94a">http://fasb.org/us-gaap/2022#ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfOS0wLTEtMS0xMjE3OTc_719a321b-4e2b-4d24-8046-f19cef0e0014">http://fasb.org/us-gaap/2022#ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfOS0wLTEtMS0xMjE3OTc_af9742cb-03e3-4e73-b493-02ef93572145">http://fasb.org/us-gaap/2022#ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="i497dd46327b4467f95cca59a81170078_I20220630" name="us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81Mi0wLTEtMS0xMzcyNzU_6dc679d2-e622-45de-819a-6f36bb88bc8b">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations</ix:nonNumeric><ix:nonNumeric contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" name="us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81Mi0wLTEtMS0xMzcyNzU_7cf3c139-629e-4185-b686-0b6e8760e74e">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cvs-20220630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19f7bb9164614f549fb4be76ce9dab1a_I20220727"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-07-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i735a87c60de044ac9f25eb3f0ab9e911_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ia15d386324864519875ee9e5e2fd30c5_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ideaba68ef44648c6b282b6f6679adf93_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdc339e14e1d455eaa0c9a2b8396f603_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i434909542d34451ea488689d9cca7066_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06f559cafd184fa0885076b8d71d4ab2_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2993c7eaedc041feab50da3fbcf43a01_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i363a5d855b604ba1a4087bcdf1601a77_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i497dd46327b4467f95cca59a81170078_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8af9eeada4aa4390a7aabb67f310e776_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1b37908bcec4675b7dd487bd3f7f745_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c91d440ca044d289daea52743e3cebd_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia48affe94b4f4604a40b1720a79d5db6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c088d53680e46f6baea92de14e2e4bd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if58f043854c54a53a5f1e35f8cb23492_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a1ac81823f94f75bab757497041c7f8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86d57bb206de43c4896717f849b4338e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaba8a997161f4500808bdfdae2e0492b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5700fd54dde54828b88be719d7275959_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i683b5a41864d461590fab401c4e35230_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42bd3a35f46d439da8e6e3e6a2da23e4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ae3518ddcc841158d875c2d6c95917a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i079d98ea4b47435d8f5a9eb08672f5a0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacd268c2c7e140009fb8bec3502a1e8c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fe1e1bc63a6493a915ac4598cb1bf1e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d0aa52dbadc483aad398f2459329f7b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffa3d985891f4ee4956e9a77643827ed_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b7f5b310ef64956895f542905a4622c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f2fc9063f2c489db3055478a06e568b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4175aff97fca4747940e80338e1c6b6b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47c09d87ce2542058a44638e0d3aee0e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b872d657c42459e8731fba04a499743_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9df87f1b15834003ab59b7fdaccda9a7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i902a60f937e94b7db75169a88a51ae87_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3779b6c8ef834637b29b6a1763d82299_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60699824f52b49fcb5663bfa26640e09_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4275461340524ac9a913007bb4256c99_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb80b8e269cf4f7cbdc40e28acc4636f_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9044e77680c543eab4fbb19765443084_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4478efe64a3489c931acebf3d633806_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf70211547034c07b67bbb782ef034de_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c407840d1534bd3a85610f6bc0f2a82_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65b5f26da4ed4d9f951f94da7cd00c3d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ebe896f6f5249aebd3596e8ae9c06e3_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91f59faea12744d3b7195336c1ca91cc_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f6f61f23dd44e0f9334dc0bfb9b4810_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d56c57b212d4a108b033b2948d0291b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7e372c5939d46a59aed59e0c12a2a5a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia55d0b5fcc284c1bb1843f6b3df18f68_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic10a47a61fb346eca4da1c6b4eb8f3e0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i152dc72ae8c845738b9dc7cb8c6f3c9f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40e08d0b5d454c76b137a0fcc9650921_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49bd9c3e375d4c40a91fc221c0821506_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad3da84ec0ac498db41f931fdcbc851b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31664a1f007d452f8f852aa3e9e14177_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9917e617b6b24457b71193960c36094b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee221d6eeb484991817f46c9fe0c087f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fdbb1c5a52d4721a5d3e754c65f8bc3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i561416f54ed14d4aa729dc31040c8e99_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46f6d2a9429541919bc596eed6bc6437_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i772325f7509041e3ae0b28f2fede65ec_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0eb4e5ad890414b9e6e3b2fbcd7a242_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8357bbbf6fe4f958f2b67dcfcf2a97b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24a096e6009a44be8a941b871322166f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if45457c84fd043c9b7d744c3fc83d3da_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica2f5f3fd6224895b0ce4b545dcbd6be_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1320581fe0074807a2a6f1646978f417_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98cd8c15279e490f8c5ece01fc0a2607_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9364eb9de5284648ba5dce23aaf45747_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2b899747e3a4cae8ea6928b46d7a6ef_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia657fbce9b4e48baa94aeb01df078a63_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i959322b91e4a46abaae950c149d362c1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4dd5a3fb4014191b1a23eef5aec7288_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64c81a1cfe4e4ed3a4d01a9a55628941_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e4dbea634eb411686fe24903cb97ba4_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i260f5a79243641bf898cd28e99b21a0f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i090190413d0546e98f4e006ce4c3c486_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7c5ecaffa7d41eb8fdfaa819f432922_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idaa5b59feb95483188ced67d5fbf4950_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48dfc02937744c869af28bd5454ce1e7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ce9ce9b48d54a45a210fb81622aa4dc_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a378f6ac4174a9c8b2c62fbb49af994_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i070d725cebd0413da9a910f72c7a5854_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d834339a4a64e8ab4f3498ba15b93ea_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe740c19bbce491b8bf0931a8ba2c65c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42940cbfec444379ba0dbd31dce09948_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e0ead3c67874e9c96bf47478f6e8f41_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="store"><xbrli:measure>cvs:store</xbrli:measure></xbrli:unit><xbrli:unit id="clinic"><xbrli:measure>cvs:clinic</xbrli:measure></xbrli:unit><xbrli:unit id="people"><xbrli:measure>cvs:people</xbrli:measure></xbrli:unit><xbrli:unit id="patient"><xbrli:measure>cvs:patient</xbrli:measure></xbrli:unit><xbrli:context id="i4313031902ce4be29cef2c3613a0b3a3_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>cvs:Segment</xbrli:measure></xbrli:unit><xbrli:context id="i1c0bcd0eebfa40769648a67be75183aa_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="state"><xbrli:measure>cvs:state</xbrli:measure></xbrli:unit><xbrli:context id="i52b2448e457a41c18f816cae8ba1b237_D20230101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i211b727efe674251b7af74e7c727f2f6_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ee2fa91c9e748c5bcd3a0dd4c42587d_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ad952d467934022a4d99fb585b701e3_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39657e3bd9404c6db2b0e8d4dfd62174_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia252187be8364a1dbaf93db9dc77a52d_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb6ae33774b44fb4995615218a58f912_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i925a067985ca40f48d352ec61580eefc_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75f41b5ed07e47ae8a0cbb4ad812d296_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0248b692278b4870a7c3ba3d7f66b90f_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d27d90709144b74bf478175cdb6010d_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0995d0ff3d504aba96c0fe94fe99a19d_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c12809aa193462b8677fc041a26a3c0_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f4852b5d8704ebdaab77950f88bb254_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13c0259435fc49c299d3a7dee2d7874f_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if133058117fb48ffa3c1f39f82db08b3_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i600c45cedb7847fe8e7f77de34c118c8_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71aab19dd48441a298119f6a243dc82c_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d8c6ba01e94480ca8cf278d517a9619_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5045314d03040549992e1b0d350c6f4_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61b1e59accbc4a6b9fdbbf4dd1e166d8_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i054a08a597154e34b91b50e36527b86c_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02a2e27009a64f7bb8e01545a97c8feb_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1040a72d0304a058af732ed3761a15a_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cb61ac775a7478680ac7295974da830_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia351ae656580421784396872e50f183f_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba21d41e0574453f9043075ca63b9071_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1005878849c5409b8747da25c2c3aaaa_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2a9323439d44a41bd807db01b403c2e_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0b0ed60026f4fadb0d2eedd77fc61e3_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9705f2eab1364f59a4310ba9e64be4f7_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66461e89f4cf4e2aa3f6185279aa73bb_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8548b563f1d944cca1d05b3dab4932ae_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5f9bf2f84f5424a8f4403ced4cdf313_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if91a5b69cd074ce79d4d34e004ebe4a9_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e8cf06c0bc54774a6be05b92ccb09f0_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id787a5341515453f9bca382ea7deede3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76cc779209494399b277155e37005f03_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69adb512452f407aa3bbe55a8fee69ec_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92d89a578ea644c4b4cf67268c64ef50_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i435b5e917ab045a4a02bf177f2b0e8b9_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7efacb33d756442cbe220b672cf09431_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36e853003adb424d944872c915ac6b0b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03a49e5738514a6bb26ab374104cee06_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6859cf97c16a4a5ebd938b85cb35957b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fab59a9eb31497ba179665fe456507e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61167828fdf24a1dbd6b7d94ab77ec42_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe16bcd19fa348eeb4e81dd6ad44410f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i507ba2e974e440f69b7567158be6571f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i438c350cb9734cbeb799f5b1892d664b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i623ff046ae5c485b878e5d00ab123314_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac24217ba0c74626b4bf25cec318c623_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if86bb61e4141479b9697828b3dc20cc6_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic44e989a3ada405d8425fbe65629dc23_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fa7e9e824974440a9373bee9896bb39_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4922155132bd45ada7189d0b3ef9fc3e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81adcf0d41fd450681c65b683fb1aba1_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1728c43ce0c146c3837ea3dca24f858d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0723aca048c948b09c4e21b76e36afcb_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief415c243f1342a49eed3ad3b8ccb6b3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0312c66cceb448a780815200255d58c0_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib88dd15d80484821a92bfc5cc6f71cec_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf0d9424f03a41f0bea7d15520ac11ae_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26d2adfcb7d047ac8b01711252305fdc_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib99bcbdff8fe401f90d46731f3dc1a6c_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6537cae612474b44bd681794d3356a66_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0782975245974b74b8eb5fc41883c74d_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16bcbe7065de4f5399be949b1c27cc7d_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2aff33ffc31447780863b02c8bd982b_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaefa8d0706ce4702b6fcfb8adb353dfe_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1255b4ef9e894adaba3c64f6d2612e0b_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52811493f7514547903b0812dc24ec85_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85c678a2a2f645898239a8ad884b0cf9_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9dba48c9530b483c8e2a19d59638a1be_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id28fa46920ee4b9f8a0fc63559c2e476_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d5d1a53ed80404d91555cf7ede4f1ac_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddb342e81917421abee497b130cc5997_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6df2f846eb984710b6afeb4efcea88b1_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74b2b424d482423984db3f523ee9fb5e_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c5104fe39a947b2bcd684db82b54e48_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1416df2f1ea4d3694000029e33ace71_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22caa8d1a08845c29d9104c92f002218_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96ab3a063aca414ead5f29a63f96b5ae_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia17daf1ddb80489bbdce4d94932efa21_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib89fad02b4b74e5cbffe8ec18de4bc64_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88782d759ab24dbd8db24d6e19ba64de_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8feac348d42b418da086e65a9b0801eb_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b2e6ca6c94b4ad5afd1d4f01f87431e_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b947bfa40dc4421923fa575beb49be8_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1b6035f28cb43a18932f1ea69845c67_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib62a0f8998684d1d9ba32dd07b1f9ff9_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c453fd49aa84dd8882ffc93c6c79248_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd9b5ab95c8b4a5685904bf985fd3749_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia84edce63c9740baa08e23d7f9537d75_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6303f55236d942fab6bbb1a2cba7ac53_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie437eecdbe674fc7ac7ace4c9417d023_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i450e973802ca4a89b066afe451cad627_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e8e4ca7275c41668b2c0d85eeb02748_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20c5541ab98a439d8cf5a822544191d2_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80a33a8e6a7646c2bf5b7c8f67ed21e0_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6228c1327ede4b82b91ec1ba1d6893a7_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e983c97388f434aa9ef46e937c90412_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i161127e00ea4498383d69d1be2d2c47a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1575b9d08b144d43981bd5eb802dd53f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a3ca1a8f9864d8899757bcfaed24e58_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30d7688d403b4e3ab22e76a11216efa3_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b47e1b909d4426aafc04538f0b5b755_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0048308c35140bb9969cdb4dd5440ee_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79ef86c1028641728228a2602b0b7d4c_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i528af9caa41c45da877206ed8fc66f8d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia07a38bcea214ce6a38514324ed4c87c_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ab215a9d2c44d37befa113efb740879_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92d3e64078334a22bfdeba1976be9fcb_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6a9e8a1a1b344cdb794e6a5f0c62ff6_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcf5af83ee0148b4935c83147cd82d02_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65583ca6502143fea8109266db45d395_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfa2cea5de8e43f9ba651607d9a10c30_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1d59b798de8427bb69d0f7d325309b7_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec432ef32c864c91b9106f3307398132_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bb38325fd294ffcb76280c930132208_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78f790a00f154949a940714ab7c599ca_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07c8c4b9dbbe4576a4bb2c9bf39072de_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a7ca95dd5c9433bb8e72e9c147bb27f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i659e7d4e49dd4140b46f05ec617268b7_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8e811dd702440d69beb3ddbac49f7c2_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i512aca10306b4c15a9e893f9f9a7fece_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6052c3c9f3814eb19317cbd04f0a8d6f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedfe0ee1cea245499d6a17e933ed0082_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cf77f9a3b234efcb511290bb7abcf0e_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80f415ea92fb4d01a514f6f8865f49a7_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvs:HeartlandHealthcareServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id743f37942444621831b2935b6d1e18a_D20220601-20220601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:PayflexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9647c5ab754d4d37a49e9ee3963f2e2c_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:PayflexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id829479219c245759e9e3ab39d4a09b9_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:PayflexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63fd0bfb9e4a43a58e4cfcab6009ac9e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:ThailandBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="member"><xbrli:measure>cvs:member</xbrli:measure></xbrli:unit><xbrli:context id="iac541484a57e442d8cefd6fa9441768c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:ThailandBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a80d23584cd49d89a6bb9a7bff4bdd5_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:ThailandBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icee03dec469e41edbf6c698fb0d48290_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:InternationalHealthCareRenewalRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i437d75cbaaca4357be7aed594234e4e6_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i973f5697b1474af9a8c7a8e70194ec8a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdbfd311e78b43f2b0104aa9cc8fb794_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13669c8a36c24e5d8272623034c20f84_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibadb7cc69aae4c759a42a17ef71ff248_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd6de90b616a4a0989fc988def9d4af9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib04a3967c8004f97aa14f769721b3a73_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e11998e647748a998ed3ae2000f65ec_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f3dc5b373774df58f1f755e836acc54_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i839c9086111641ffb78f678a49af4bfb_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b1da324447946a5a60e70cf44b0c827_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i312562153ede48bfb0ae6742085c849a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacd25bc0ddd1457bb0d369b53f596438_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27a2d69d05ce407693c56825032df2c6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f4295241da2454b9ca27744d8f494b2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic26d39b1909b4114abe91b81a22d3ca5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf2696db609145edadde7083bbfb8eac_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35a7089aaf074a29b807a8530fceab9c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a4d5943f3344b028b2021d88fb2d40d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57df9cc9e45b4dd8860db902aa9d7a4c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="security"><xbrli:measure>cvs:security</xbrli:measure></xbrli:unit><xbrli:context id="if33a8819dea14f63a14fc5b0024f0188_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if147f99b547041e7930b6068d7988826_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0aa8184ef83c4a40a3d80e580b517091_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92bb3a9ebd6340bbafee19e1a0961497_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i565890e50f664de28c6c98865dd484ac_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc6cfcaae9cd409daffba0639d13efcd_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfb24956f5d44b968d2715f9013c792b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b35d26a394f498ead4b8911f6b783f3_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice4289e5981f470c8348e6e0bd038770_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81ecba3177494484943b0150ef662927_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia42bbf3cad014282b14444e67b52efed_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb0ab983715d47e4adbbebc254ffa1e4_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i371c0520998941618ef7aea89496ed34_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if373bf37aea3458b912ce5c9dedfd404_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4edd43c72fa24ecb8eb03fa5e6bd17c0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33d8e2fa0f464eab934f3a3981276b03_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief7e32fbdcdc4b1db1c33985f1a1bfca_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46df26cf65e741a88308365f0fdce535_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fd18a6eac95471682e4f96b85733eb0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia13fa065e11f43c99f24e914e7606b15_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5eeda700ebc4f8eac3969546e289875_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia47b1c162c8a4dd19c3d46272804896b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i899578d869e54146a2dc8706728481b0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b60a590a9d846f38abc0bedd2f2462b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ec460be73364dbe9e6821a95e857a19_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c0db9ae3a654d1abcb624237ab2b056_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6513ccc2104b42fc9d1803cfa7134a7a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib744f76b72ec42598309a6e5c4e51b42_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i456084319dfe4263a992c645b2d706b2_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i861b819f6b654647b93791e8fbac82b7_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0fe0824d20a45ce92b02afde836c6e5_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a9fd2dddbfe44ff88021ac1f64666f6_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i740f5a3a2f9a435891769f604897c8bb_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0c41fd6ab6f49419e4feb0002f2d48f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief32efb6abac44468898f50592a29547_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i850b791bc3e2407da5747eebb4ab8c3f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38844338d2ce463798197e185e85f756_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if00cd26828534c21b6c33adb32cacfd7_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id743f9aa58344caf9f98f25c5d92b7de_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea202e1537584a368ceecede86271423_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62992d26f65645ff897bda2742cf86fb_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11c72ce8b8dc4d21aae7ff8290b67bec_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39b1269f49174087928bb212d8afc1d2_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d994fd5d397459d8367d852e8f5452f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb0affc8add2414ca8954a5991109f55_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4faa5bd0ec73475c94099ab518ccf4e3_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26d61f9963ea4196b8ba2d07d228e5bd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb3ebe7111bf41f584b98e07430377db_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i000af04ab3a34580abe06f0d79b475b9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37656451d6e54a6f87723c3c55ee7693_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id04cb4912f0c4add911f641b85b28d8d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a7a0277984b4d9292ccff484d447ce2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27decdd521e9427eb51858ecd5161a1c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0ab7e83123843f5995f6c913b85bc32_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib381c0925973492e9d3c59e35956766c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f517e0f803f424d9f8a281c67637d41_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5dabfedcb3446d79b9af20990e4475f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia44d0270c7fc4dab8d24ff7dd2185b17_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i787125a9fb1c4d2dae3f0091842a2905_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i533abaf939b14629802a0d1666202827_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0be6d49dea7a41c3b3be5025579b7f80_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic22d1b35d059439ba0cc5c6c6960921d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3530a0f47dac4ff1958936a41cb751d5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ad0cb156fab4fb6afd4533b759fba57_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib317e948955944578ea101ab7b8681bc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id27b20e03a0a420eb7c6b974de8faa01_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11c2cc84da31426aa9cf78264345c70d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i207775b0e52a46038a243f680c4bfe38_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic002c663bb55486dbea5fd9b8add8629_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i612e5e99ae014b8aab81d54d276d71a2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93420b43b370461b8eefc357152611ba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idde41fc6240949d2b00dd4bfaea668ce_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53f958f5f6f642d2b0e5a8f47b9be63e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a5ae34085d7468184ecc64dcf1815c3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib37a4b4576174adfbd328d6220e6446e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0218b9eeafa744cd976a2ee112999f4c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b71fc37bdcc4544ba59a680d2a845ad_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6410396dd3b049fc94d73ed03406a6f0_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb2b8ddb867c4af697afecf4d9a157e8_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41d8c374cbf548e987ad1657cdc38098_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib36aad3ac1484f6bbdaa4f1c0fc5b0b0_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e1b0b89b26a40c693ea4463c4d8593a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfac0b03d2274f43871a43aeb40a5ec2_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09b23468a180421fb01ec60b86dff5b1_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbcd8299564648c0b7ec0acfbd315e56_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b5bf1c54d1e4c2e9d9b2486e17e7e6f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fd8e5b0ac1842dca561465f4468b014_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4c795e51e0c4660990629bf4fd31005_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf069440948942608f8ec319d2ecfe5c_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05ef7a86b20148e5a32020bd5c7d5fd8_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ca2c256a7cf4284bfbeea2216a84437_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdee0bd923464f248a69eb92727cbc33_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e0d80e2d0a04bb8927a1bf01c58fd6a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68271d4af0dd46f9a15ba39a24443504_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib17cda40f9cf4d1a8490ee4268351419_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2537a5824e5c47d28dc9352ea4fb9b9a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b009077bf2641cfa4fee2b3ee3dc481_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc7e27d69ade4879bde348e70c0788ea_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5106c4aa67f4d928a1bc9439a50bfb2_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e7d19bf6cfd4b3b82ed5de057b0e6d8_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6777146f89994be2b6bcda5d10742ac8_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08f072e891b342e49c41b996818d9499_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a25737ed0924c969ac800d03eb71168_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a1482c6ec9f4cc8b0730cd66f43a3cc_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25ac6c0b47ec4e21b9505933348f0a1a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56d79a48fdda41359c90f5247d0eaa51_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fa48deca1e24bc0aec94bbb86efcea6_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i594d6d7e7e934f9cb1e27dbd9405aea9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcaa01a2d5a84178a364e0771d58f1d2_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15029ba66bfc4f258fcf28f87b20183a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i906410efac8d4de18248e766580b4e35_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i835c385fd6b04a3eb891ef6fc524b805_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0aaf81e8b9884bad80414c289699a57f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11805126295b4515b45903e544da225d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9e16c082be94460bfbbd4e151ba7e34_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i336d2e637e8649208863699c4fda08c2_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36599b795d654ff7b2fe314eced29657_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e0a0f734ebb45bdbb6cf4e33bdc5fb0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e86187a9ed44b89a6399da972fe5aa8_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i782d4ad0930949dea0a47084e41c4d26_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7299fe8524a4d5e9629da62ce398ea5_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75184f7f66bf420281dc428b61486c9c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a23ab37e1624317a3210888b909e6ad_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b4261e4da4b4593bd9444e957605d51_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5ac41f72364473b875a4f9f0cabfa01_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebbf8ae6ec4b4ac7ba59ec1bf20f58c1_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaebca4c2d3aa45788b5006d29248062c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26cda38200ea4757af8c3ae23320d2dc_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8407bc5011ab4df18368ae6456978998_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42bed7e3ca784f3ab32fc7ef56053fa3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i642c16a915674d7daa7f0a01f6634e62_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04e6dfc862dc4741bba4eb830bd1fe1a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2001a5cdcfe489587490f999c08e53d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb4d21f9607446baa96c4753b5ae4a2d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib778b8c5692f4a2f9ce7ecd3827265b2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b92e92046e3481c849127ba0d177b4f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b390fc483eb4bf1bf3c1e193419740f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80bffbb65d2b4070a225a033d6ea55b0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bac9c5f699d457884697fc93aadabad_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab74b3b8e454421c9d99fd0fea4f8b5d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12831131b4b347d28cc365b3e2b5d442_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04bb2995006a4a4f88bcd1f2ea901a73_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea75515a7ca440c2b48524fcb1053c9f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6de1349b73147148e1a6bc0dcb9232c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4cf155fcd064bd8b37cde3d0bf8a683_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52e238e983504ca6a0b5d0eca15be0f9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2d9b47f36c344a89eccfc77028e066b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9026e142a9d243c79099838b180bad0f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i223e616c479846e7bcfb1b323650c580_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i001fe54ef077469e82d46f274819777f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c084d4d05954ba4bad6546555d216b2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i904663f80f7d4ed8b9bdf80b571274b6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29352f2ba2bb430fb7edf1a52db0a767_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i305ff43cd2da42f5837673228114f047_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01d4fc3347b34e62bd298927db4d1507_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7455e34409e849e09720b15bdb39ef0b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i712137052e06498fbf764dbfba45c5cd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82307e5c20bb45bdbfe5652fb891c9ec_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09b4f7cbd578419a9e93e1f9baaea718_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i443a171c4d9046c6998ec0e711b34fb7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84d6ff7bcaf644209c3df2eae876d580_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8a0c11f7f38499ea3d96bb3423aa0f7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie480043139dd4ff799c6c90efb44c767_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1da882ac68a54dad9ccd7ec3d147e26a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6f883902b9f4d569180bdd25d7ac485_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie30f666179e54a5cb8e16248e2aa4dc6_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i509def96f3774f389ccb60611ef5b220_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i057d1d2e7dcf476caee443d101525a56_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e4863652a8d4786bda491af0f283e1f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf62033ec0a847bb91856b878b3b5184_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2abfa03cf0a34bb1a667090247c911ce_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0393895e099248fca624d76479d72f73_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icda51f2bbf534c3b99bd90ca2ff4fc4a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i950684090258490285b22303b8cbe92f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1998c1f186304330af3b39bac43d0a2f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc4896103e2847bfadabec9c0079aa36_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09642d3a548b46338b4bb3f615251a26_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9170e75144bb41cd9ee98de35d2f8127_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1401ca4c008547c2bac9543b488db12e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ac71f0b9bb14e4092be832d41e515a8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic46902baf4774da0b1d69a2251e4c766_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbbe45adfefe4948a1c89879ea88f003_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65512635d3f94fc399a6c13c4e5ca1a1_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i251231de7362453a940ab517a85970ae_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23f86f2cbd964ff2a810fd266595100f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i381f19e26d814d37904aee3ae800493b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i407ded4af3924d31952fb5d080084da1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id23c11799c424d598c0c1ae0ab2929ba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c8d2dc2b8704580a1a172c856d29530_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf81bb9d192d4f34906afe0ca3308cca_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i934c58db24df4f5b8e2df9a748e0ce3a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4c3e3b3b06443908af3ef65aa44ce1c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18c1dbf858274c46886b39848454543e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3eeede4806c04b8ca1b1515f91d2454f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3bcc189914f44dfbd6d8adba7da6648_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida1294c97533481bbb71cc59e1332b94_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61b3ccbd720b4118afa39412212dd864_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74971ce242444f5b8eca08207bb3fd01_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifde0481021814f2a9b9298bd03a46270_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7f7b435750440efa12f3876d71ad127_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if94bb34cac0e45b4b0a4cf53c05b0d13_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6df4f366580047d49b2e56046b8e7328_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b49cf8f22064d1c891ff76da09969c1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8a50f5f508f4a7b87e5542b0e6ffc42_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f56b0ef04ec4465adcf279a0c980a91_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a5e52e8002f439e863f471f508bd973_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03d9d5c763344a06ad0ba56859f58bcc_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b83284491314316be5282f5effb45cd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica5caded5b9f40868f9db05f17444835_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8454af9021ca47c98336dfba07097dc4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i824fe68acd534f1cb26fac7871f45022_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c50d4663e7046e988ba0a3d936e983d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1581ff2350a744a6b1f3e0be5835a1dd_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64773f23350843c69d9c79f2e715b95d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i856f8df36f55432cba11d2c1b2e7ba4e_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i633068dab92e4b98b0522d78e950565e_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:CorporateOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id563d585f536458ab16c7d10eb546a54_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:CorporateOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i701dfcde341042418a1230e58dfc107c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ib7e9c49d1afb41528f0c6f58ad82f91c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19ce665e627349488d7fdabbb5fd4f0c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9e4fce0f5914bc194df0543a8fb78c7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4945c0919f8a4b6fa67244e6df69a8e3_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79481fe5600c4d29829c7063ced8237b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33b68889734a4fe89dcb2fdde065e999_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a07ca981e96452699ccf6cc1296a094_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f28d0a871b74ccabed8651290f5df32_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJune2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b27b79528fa4d33895a9b7b0532c5a8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJune2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5743e3b67ba46fa843ceef9c280ed2d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i699c54fc3b714c6282acce7eaaac6c49_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29c21f5958d54c94a3300a81499e844e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.375DueAugust2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89b3c50e60c94e5287f35e0966dd4a3c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.375DueAugust2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34f2be9f895b466e96b08a69c1310ab7_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.625DueAugust2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57483b066e9f454b8904cd684a7f0427_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.625DueAugust2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic48a061167f048b8902603753dfa8e1d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueNovember2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51fd94c18b494791a8946f4cfd11cca6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueNovember2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5da825f37b64596bcfb8830bb18cb6c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4ce44f679934429824ee090659496ff_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idda7e364fedc4373a6c04d2aa621c990_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c3bc22603f14476908cfe99fc1875c6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9a0e60b49f44f1f9e50e8a2f21e126a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueJuly2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5609b04c209d4d23814975183321bf8d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueJuly2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29521c68c83d45fbafda3ca446e28ad6_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.875DueJune2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00f8ab37e94f47c5b959adc2fc05d1e4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.875DueJune2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i125e9ebb582747fc928d86e8183d5250_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3DueAugust2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if34ad8df01784ccd9c09e77e8c83abb0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3DueAugust2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c9846afea30440f955cec9041311ebb_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.625DueApril2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic44e6bc4ca52465abc641a71fd0e3162_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.625DueApril2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ef356dda5d1479b89006e9da3a6fafd_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.25DueJune2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1bfd120dbe14e73916b7c46067dcc30_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.25DueJune2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i200e92b399884866831aa7f66216c0b6_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes13DueAugust2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i725dc7730e3249c58e3e72c65a8ed7bd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes13DueAugust2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccf871c8fb35430d92796d1f0d0c146d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.3DueMarch2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf8670b729d642d49a6f047b3de3020e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.3DueMarch2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7257e80fe294cf89f6d21eb9a5a160b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.25DueAugust2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d68ec8cafb8440b922b87a639652d7d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.25DueAugust2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd128b7c8158440a960fc33fff1e4942_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.75DueApril2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icec9e0e991cc4516851d6f09627a471c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.75DueApril2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d97a719154d42e589f04dcc38484757_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes175DueAugust2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7df071c343834f33b524951050d6f51a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes175DueAugust2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdaae87a3e8b4e53973b84b8af214010_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1875DueFebruary2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9226a82fc64641d5afdd7ffa2c292e4c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1875DueFebruary2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie67b1016381d45dfb701cb39cb97655b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2125PercentDueSeptember2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2abdfe43d904e9b927694acb3cd4cf8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2125PercentDueSeptember2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i944da40b07b447d0a332880d0b588a20_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.875DueJuly2035Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i914306c1134948118679d384eef61fbd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.875DueJuly2035Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i643fea13573a45d8afeeb8de059866ed_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.625DueJune2036Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie286fcf256214324826f57573776deaf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.625DueJune2036Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie598796a91a246aaa0c09f9f30782bd0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.75DueDecember2037Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i361edf6919cf4676b09461ea7e67b84c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.75DueDecember2037Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65284b80f9764f99aa6e1e0c3d28922b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.78DueMarch2038Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i205b6c2b07564953a06f503cc5b37037_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.78DueMarch2038Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf399710257743edb37384ff227cd40d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.125DueSeptember2039Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5ed3b12e6eb4e059b0259b94de90f3d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.125DueSeptember2039Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id26f0bd9ad2d415ea77a3ab3ae626afc_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueApril2040Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56de23d883344a9a927ab5a974600a0b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueApril2040Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40305c3253a242ff97d2746b2a513a69_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes27DueAugust2040Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic138ff07b2f94c0cadf208f70bb6e79d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes27DueAugust2040Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icecf2da3a842413c965e457894528023_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.75DueMay2041Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i166e8b849a1145b5905209025edd018e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.75DueMay2041Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a7c0b54785745fe9adc93c9cf289db1_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.5DueMay2042Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i764dca86272443deb0bce7cb4b41e0e9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.5DueMay2042Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice00869200514840821cf7cc694e3133_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueNovember2042Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i614fbc67bf9144ee9a0deb06e9032f2e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueNovember2042Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdf41bb2bcd94610b70c6a62ce138649_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.3DueDecember2043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cae7a6a82104f61a0553383911b0094_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.3DueDecember2043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28e511837f134fd4a0d69cfe195fae71_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueMarch2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibae772bc2bae4e5ea9db4081c2e4001b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueMarch2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie084c2a7344c420c92ae9437d7ab6be3_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.125DueJuly2045Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia31d9e274a59413bb7895e1b77158660_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.125DueJuly2045Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd7eb609f3b14fac8983caa6c096c01d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueAugust2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3acd7c3b5f134957ac35694bfa158c39_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueAugust2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43811273ae184613adc9bb723848272a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.05DueMarch2048Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i959c954325ef4865add18451ad9d7a29_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.05DueMarch2048Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9bfff97b8b648908d79cc9a4159b298_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.25DueApril2050Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic19ab2f397f34a8585e736896e24aeed_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.25DueApril2050Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i015bc34a65a248e3a70847c5c7052cc6_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4d2a19a3df4491a9d4ada04059faf42_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b2cb684c3c54456b798887d44f26f18_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2a4890c67364387b34caac671f1ecb8_D20220501-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if35632f79478444b837b68f876c276d3_I20220815"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f8c724d4dc244c0b8cca96a9f405f4d_D20220815-20220815"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-15</xbrli:startDate><xbrli:endDate>2022-08-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide236c65d7b9413da75bda41de2407e0_I20220901"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd92c38e037f41c19fc207220bcc0c98_I20220901"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fbafbf9ebe841209a93040e930d5b09_D20220901-20220901"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-09-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6838b42fbf54414d9a3aa4b32a3784cc_D20220901-20220901"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-09-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2788e339558c49d4ad5e9a5ed3686ef7_I20211209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i973e6ae6f5664668812730f3574e2681_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf2ba7a1f37c43a2a329487ba4c8244a_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f0054d90f614171a2cdaff45560ffaa_I20220104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021AcceleratedRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:BarclaysBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id032d7a1b06a4edbb4e66d3c58ec984a_D20220104-20220104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021AcceleratedRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:BarclaysBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-04</xbrli:startDate><xbrli:endDate>2022-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9b2681d79b94d2f9857c1c1e9cd12d4_I20220104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021AcceleratedRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:BarclaysBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03eba332a9884f289cf2750b5c9cbf14_I20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021AcceleratedRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:BarclaysBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f44bafd8b514e13885650b83df2cba5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i672c8f5d9c8f451eb39619a46f51f47f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f9c15723eaf4a9eadcf03b852b70db2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i490d91efebc0468298a0da610cc516c9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7519dbaef94443449eecd8f162669ec1_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ca72ce1ba034c0c9c20ad0f3602947d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib125e54cf2b14e81ac89b10807680e76_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57a873f503fb43408df28140ea310d0d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95c7b68f19d34e799c2a2da632fc1a25_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0186d665a01a437290bd18c75323ee1e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d3ff99e11274317bfaa3db6aae0ba07_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbf36ad6ce3b471588e3a05013e799fe_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icef7877b29934f14b7831ab01b0e383a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib366b23034bd4459aada86fdb2dd3449_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i796acc4a7ae14fad88f553a72e53ed7b_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i882ca8d49b6a49d3b40dc01ce24b96ae_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b5b675fa53d484099873bf8055a89db_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i249b23ce7c4a4a9181faba8d0c98b9da_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4ad5ca1cf1345368ae93f7d409262d6_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92bca9f2f539472898cf0d31e92244c6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if26019edad134ef49f67621aae7d0881_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fb161b7e78242208da2fb60faed3211_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ebfa804cc314a5cbaa6c16091e1300b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5002b5c4b193406a82d57085bca7379c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17625cfa20f64405885913a70a548638_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b668c841c514504b89920b0f42c84fc_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8384d5359f84472ca5781e3a2d42ea0a_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if039d6d6983848a48803a4bc6f9a0ed1_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6968e95408a14a959a6cf1b5595b1562_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16a176b60bcf492c9d7596af5ec2d637_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie45bedb2b1594d3eb748dd76b2cab130_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60f2853c6a3842dd843c429de5b2337d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie59f2df1b9114d43b76163c7a171e5a4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6b9a02663b641188ebd9d833d0c8593_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2602b92305c04c68a196ab39ab51d7d1_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44bba003a74946ed87d9d0b98b2c950d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74776cd677844441a5cdd3bde68816e0_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f24cf7d8a01489c8b678a8a8c86ef3f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib24237470dfb4b14bdc3819e68f90af7_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8898a5dbc52c442fad3cc1e0d98f102c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a636d32fc2a454a89bd4991b0628853_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7a27b274c3a4d16b682c158f10c219e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6688966640734a61a1a460ea4b661770_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id86c8e524f224b00811843646316152e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5185ac0c651b4a17bd97c114f383805d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fdea86bdbcc429985d69c5258c861b8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cb8479c571d4f03bbc71c0d8f664eca_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:StockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd272e9bdea14242a207e8aff8e2266e_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:StockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ad6c128f57b4949a888c466705beca4_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:StockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i673355ef359540e592c71b0c9698de65_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:StockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id289f8fd821442c1a5d3cc80b9c40c2a_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1edca8cccef478fbae52ae8fb77dfee_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i597a5458b92444dda6db7761d84ee082_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic81654dd29534869be7ad8d23a454adb_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="lease"><xbrli:measure>cvs:lease</xbrli:measure></xbrli:unit><xbrli:context id="i068019055ff349b0ba2c43c7bdcad5a5_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:StateOfFloridaSettlementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i201d84873cdc44b8a00591a48c940e6a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:StateOfFloridaSettlementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if80d8dd79ebc4415ad936ec2eebc9a64_D20120101-20121231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2012-01-01</xbrli:startDate><xbrli:endDate>2012-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib401a332bf4543de8c13209d3b334652_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:RadcliffeAndFlaimVAetnaIncEtAlMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>cvs:claim</xbrli:measure></xbrli:unit><xbrli:context id="i3962c203da554375b32683c47219d427_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2694c12478b4def9c47ecb3ea71da60_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id75c1b3a512c4c79892d583882a1967c_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44edbe7ef7ad43448a3b2d7631217636_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3151b5f7456a43f18c1835c93c3d75af_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9187390af124c90962d0c6a2b195568_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd5001431c3443ff88087eb017ad54d3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21057757e50f4f2ea39ea7414498d440_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4ddbdc32c264c4891a21d2f9fcead1d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i755c9c59fb084cf0998fe64e0d197ec9_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i991ced4046224c589a965f12944e86a9_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id55fb76a33f24129b20ebde108e75c89_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bdb38f213f74f5ba49000631d9615b7_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28d06c947ab54421a9e15efa5f456726_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf6b44713106481ab0b80236ef727531_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ec2e1d871b94a40bc8202c2e78c4a16_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0f6137335b9496e89f147de3d2c0b66_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3203c39f39494e9b94ddb12984f8082f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4392ff7352894adabc22a650b7c08adb_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea76a931684f4ae5b894d9b3eac6dabf_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i904838b1ae43477cbccf8a6438f44ca8_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e5cd64cbc2d4ccabb220d0769a9469d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e0586238be64c3f99884eb8d13d76cb_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:StateOfFloridaSettlementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e046c9547cf4bf5b7545f9f74ee27f1_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:StateOfFloridaSettlementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9b86cad51db4e70bd972f1f3cf0a9ea_D20210601-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTItNS0xLTEtMTIxNzk3_686258d7-9a7b-45e9-9240-187605a59fdc id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfOS0yLTEtMS0xMjE3OTc_ba77f96c-eade-451e-8d3a-2eb2bda33475 id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTYtMi0xLTEtMTIxNzk3_154f1ad4-fca3-4f85-92d2-5a7635f0565d id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTItMi0xLTEtMTIxNzk3_1903b954-70cc-4787-accd-173691ab6baa id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTktMi0xLTEtMTIxNzk3_03bce8fe-e38d-4c1a-ba83-666579445e99 id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfOS01LTEtMS0xMjE3OTc_5f6533df-08ba-4e8e-8c9b-1267fa70c18f id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNS01LTEtMS0xMjE3OTc_3e47bdca-8b3c-4a9e-89e1-7a840174f8ce id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNS0yLTEtMS0xMjE3OTc_e1e5fa5f-7a8b-44b1-b10e-e547456d4b5f id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTYtNS0xLTEtMTIxNzk3_154e00c8-a541-4d98-accc-56eddbda1a6d id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTktNS0xLTEtMTIxNzk3_09c716ae-4201-4796-8206-a2ee1f58bb89" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfNDky_63589532-c838-4110-b767-3f81e3cda92d" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTItNC0xLTEtMTI3MDAz_bb526491-7c2b-4a52-9a48-cbbdf1fff5eb id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNS00LTEtMS0xMjcwMDM_54fa1447-121f-4df3-8c6b-e02c861e6ab3 id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfOC00LTEtMS0xMjcwMDM_8e4d2ad2-b399-4b6a-940c-a2e3e0d503e8 id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTUtNC0xLTEtMTI3MDAz_eeb6dd1a-454a-40c5-9b62-7871e942aac9 id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTktNC0xLTEtMTI3MDAz_da028d11-1181-47fb-8de2-1199b5addb2e" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMzI5ODUzNDg4NDU2MQ_057b7f4e-b885-4b2e-9da9-bf48cbe75bc8" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfOC00LTEtMS0xMjE3OTc_c0b1eebe-cd0a-4caa-87f2-58695294064f id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTUtNC0xLTEtMTIxNzk3_6c2747e3-dede-457b-8fb6-f18a11dd3d80 id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTItNC0xLTEtMTIxNzk3_dfa4649c-3f50-4e27-b8ac-8f10a789d3bb id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTktNC0xLTEtMTIxNzk3_987e90b2-e1f5-4dd2-b500-7e736e8766e7 id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNS00LTEtMS0xMjE3OTc_ffce7b07-c2e2-4a8b-9241-b8361898f9d8" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfNDkw_1003b8e3-dae8-4a27-82a0-29bb92e78bc3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTItNS0xLTEtMTI3MDAz_c33682a7-bcff-478e-bd70-3c9fde37f6fa id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfOS01LTEtMS0xMjcwMDM_9e0b0692-cefc-4172-8e83-11b20cc520d0 id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTItMi0xLTEtMTI3MDAz_911440fa-050b-488a-899d-429c516738f6 id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTktNS0xLTEtMTI3MDAz_b39331c3-41d8-444f-8ed9-c366fb0e90b8 id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTYtMi0xLTEtMTI3MDAz_9e1cc617-4617-4ca6-be10-e7d61fd3987b id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfOS0yLTEtMS0xMjcwMDM_e59e8c63-0c25-4211-a3f2-69398263ad87 id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNS01LTEtMS0xMjcwMDM_797349a6-d7bb-4e80-99b7-d08c78b967a4 id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTYtNS0xLTEtMTI3MDAz_691de804-9265-412f-bff6-1fbe6a8f3a9b id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNS0yLTEtMS0xMjcwMDM_4b69fe63-e272-4068-992d-1a5b471b8279 id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTktMi0xLTEtMTI3MDAz_01df612b-9071-4ff9-8baf-73b2748bcc51" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMzI5ODUzNDg4NDU2MA_e3676cc9-4075-4e41-88e3-205243fa39bd" order="1"></ix:relationship></ix:resources></ix:header></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_1"></div><div style="min-height:22.5pt;width:100%"><div style="padding-left:101.25pt;padding-right:101.25pt;text-align:center;text-indent:-184.5pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C.  20549</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGV4dHJlZ2lvbjo0M2E3NmE5ODFmMTA0Y2Q0YTZjY2MwNDU1NDU1NjBjMF84Ng_4d895fea-06ab-4a90-8439-b2fe63bb52b8">10-Q</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Mark One)</span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGV4dHJlZ2lvbjo0M2E3NmE5ODFmMTA0Y2Q0YTZjY2MwNDU1NDU1NjBjMF8yMDI5_06fb7716-0c86-4945-8bee-b91c395a5db0">&#9745;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGV4dHJlZ2lvbjo0M2E3NmE5ODFmMTA0Y2Q0YTZjY2MwNDU1NDU1NjBjMF8yMjQ_234c3b23-5126-4966-8bdd-d282662534a2">June&#160;30, 2022</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGV4dHJlZ2lvbjo0M2E3NmE5ODFmMTA0Y2Q0YTZjY2MwNDU1NDU1NjBjMF8yMDMy_d98ca8c8-7958-486d-b2f5-4b7efc20d79f">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the transition period from _________ to_________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGV4dHJlZ2lvbjo0M2E3NmE5ODFmMTA0Y2Q0YTZjY2MwNDU1NDU1NjBjMF8yMDMz_d1c87d39-e548-4f55-957c-e9f8817477ac">001-01011</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="cvs-20220630_g1.jpg" alt="cvs-20220630_g1.jpg" style="height:18px;margin-bottom:5pt;vertical-align:text-bottom;width:104px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGV4dHJlZ2lvbjo0M2E3NmE5ODFmMTA0Y2Q0YTZjY2MwNDU1NDU1NjBjMF8yMDMw_680f66c8-5d65-41d4-8863-0696e319dc8c">CVS HEALTH CORPORATION</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGFibGU6MDUyNWUzMzVmMWU3NGU4NGFhZjc5YmVjY2FmNmQ2Y2UvdGFibGVyYW5nZTowNTI1ZTMzNWYxZTc0ZTg0YWFmNzliZWNjYWY2ZDZjZV8wLTAtMS0xLTEyMTc5Nw_1b9ca4d3-942d-4cb8-a708-8cbdd222b694">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGFibGU6MDUyNWUzMzVmMWU3NGU4NGFhZjc5YmVjY2FmNmQ2Y2UvdGFibGVyYW5nZTowNTI1ZTMzNWYxZTc0ZTg0YWFmNzliZWNjYWY2ZDZjZV8wLTItMS0xLTEyMTc5Nw_5df63beb-259d-4818-9fa0-e2fc9938a6ed">05-0494040</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:4.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.165%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.460%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGFibGU6ZmIzMDQ2ZmRmNjhmNDZlNTg3YjVmNGVkNjJhYjFjNmEvdGFibGVyYW5nZTpmYjMwNDZmZGY2OGY0NmU1ODdiNWY0ZWQ2MmFiMWM2YV8wLTEtMS0xLTEyMTc5Nw_6f5b9494-6480-4e02-9499-d9c46bc82fdd">One CVS Drive,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGFibGU6ZmIzMDQ2ZmRmNjhmNDZlNTg3YjVmNGVkNjJhYjFjNmEvdGFibGVyYW5nZTpmYjMwNDZmZGY2OGY0NmU1ODdiNWY0ZWQ2MmFiMWM2YV8wLTItMS0xLTEyMTc5Nw_1bef4c20-2695-43ba-a8e2-cce29c27c2fb">Woonsocket,</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGFibGU6ZmIzMDQ2ZmRmNjhmNDZlNTg3YjVmNGVkNjJhYjFjNmEvdGFibGVyYW5nZTpmYjMwNDZmZGY2OGY0NmU1ODdiNWY0ZWQ2MmFiMWM2YV8wLTMtMS0xLTEyMTc5Nw_80667b9a-199a-414b-9355-6d02b0d193d7">Rhode Island</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGFibGU6ZmIzMDQ2ZmRmNjhmNDZlNTg3YjVmNGVkNjJhYjFjNmEvdGFibGVyYW5nZTpmYjMwNDZmZGY2OGY0NmU1ODdiNWY0ZWQ2MmFiMWM2YV8wLTUtMS0xLTEyMTc5Nw_f9a02857-042c-4ac1-8a0a-15bd529bf7f2">02895</ix:nonNumeric></span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;(Zip Code)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Registrant&#8217;s telephone number, including area code: &#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGFibGU6ZmIzMDQ2ZmRmNjhmNDZlNTg3YjVmNGVkNjJhYjFjNmEvdGFibGVyYW5nZTpmYjMwNDZmZGY2OGY0NmU1ODdiNWY0ZWQ2MmFiMWM2YV8zLTUtMS0xLTEyMTc5Nw_169e74e6-c974-4186-af60-7fd3dcb11558">(401)</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGFibGU6ZmIzMDQ2ZmRmNjhmNDZlNTg3YjVmNGVkNjJhYjFjNmEvdGFibGVyYW5nZTpmYjMwNDZmZGY2OGY0NmU1ODdiNWY0ZWQ2MmFiMWM2YV8zLTYtMS0xLTEyMTc5Nw_16061125-f437-457d-955c-e5993cf95002">765-1500</ix:nonNumeric></span></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Former name, former address and former fiscal year, if changed since last report:</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></div></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGFibGU6NTlhOWQxY2JkZmM5NGE3OGE0NmUxZmI3NDQ3MGQ1NjEvdGFibGVyYW5nZTo1OWE5ZDFjYmRmYzk0YTc4YTQ2ZTFmYjc0NDcwZDU2MV8xLTAtMS0xLTEyMTc5Nw_4f2aad97-cb1c-4bbf-a7d2-272c5f79aeb5">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGFibGU6NTlhOWQxY2JkZmM5NGE3OGE0NmUxZmI3NDQ3MGQ1NjEvdGFibGVyYW5nZTo1OWE5ZDFjYmRmYzk0YTc4YTQ2ZTFmYjc0NDcwZDU2MV8xLTEtMS0xLTEyMTc5Nw_2633d6cd-19e5-4315-b653-6af04dd27c28">CVS</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGFibGU6NTlhOWQxY2JkZmM5NGE3OGE0NmUxZmI3NDQ3MGQ1NjEvdGFibGVyYW5nZTo1OWE5ZDFjYmRmYzk0YTc4YTQ2ZTFmYjc0NDcwZDU2MV8xLTItMS0xLTEyMTc5Nw_2b14e193-9832-4742-8439-38161f2e89fb">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">                                                                            </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGV4dHJlZ2lvbjo0M2E3NmE5ODFmMTA0Y2Q0YTZjY2MwNDU1NDU1NjBjMF8yMDI3_cef0a268-ddc4-478f-81dd-3ab6bfc28ad4">Yes</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">     </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">                                                                                                               &#160;&#160;&#160;&#160;                  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGV4dHJlZ2lvbjo0M2E3NmE5ODFmMTA0Y2Q0YTZjY2MwNDU1NDU1NjBjMF8yMDI4_786f9a0c-c066-43ce-af68-b7e300d2390f">Yes</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;text-align:center;text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.555%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.624%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.175%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.146%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGFibGU6ZTliMDQzNjE3MDQxNDI0NTllMzViYjA0ZDZkNjcyMGUvdGFibGVyYW5nZTplOWIwNDM2MTcwNDE0MjQ1OWUzNWJiMDRkNmQ2NzIwZV8wLTAtMS0xLTEyMTc5Nw_ea915210-3387-4b03-995f-16263e37ac7c">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:2px 1pt 2px 97.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer                     </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt 2px 97.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company    </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGFibGU6ZTliMDQzNjE3MDQxNDI0NTllMzViYjA0ZDZkNjcyMGUvdGFibGVyYW5nZTplOWIwNDM2MTcwNDE0MjQ1OWUzNWJiMDRkNmQ2NzIwZV8xLTMtMS0xLTEyMTc5Nw_48789d26-472a-42ef-8d12-c3622ed0e42c">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 97.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company    </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGFibGU6ZTliMDQzNjE3MDQxNDI0NTllMzViYjA0ZDZkNjcyMGUvdGFibGVyYW5nZTplOWIwNDM2MTcwNDE0MjQ1OWUzNWJiMDRkNmQ2NzIwZV8yLTMtMS0xLTEyMTc5Nw_0d758d3d-2d6d-47f2-a868-6caec5a1d8e9">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">         </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGV4dHJlZ2lvbjo0M2E3NmE5ODFmMTA0Y2Q0YTZjY2MwNDU1NDU1NjBjMF8yMDMx_b8b0340c-7e4c-474b-88f3-1589a8ea2148">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Yes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">   </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of July&#160;27, 2022, the registrant had <ix:nonFraction unitRef="shares" contextRef="i19f7bb9164614f549fb4be76ce9dab1a_I20220727" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGV4dHJlZ2lvbjo0M2E3NmE5ODFmMTA0Y2Q0YTZjY2MwNDU1NDU1NjBjMF8xOTc5_d2a84149-e93f-417e-9cfe-734b0356047f">1,312,828,807</ix:nonFraction> shares of common stock issued and outstanding.</span></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.230%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TABLE OF CONTENTS</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part I</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Information</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_13">Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_13">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_73">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_73">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_106">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_106">60</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_109">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_109">60</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part II</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Information</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_115">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_115">60</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_118">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_118">60</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_121">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_121">61</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_124">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_124">62</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_127">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_127">62</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_130">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_130">62</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_133">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_133">63</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_136">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_136">64</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_7">Form 10-Q Table of Contents</a></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part I.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.25pt">Financial Information</span></div><div><span><br/></span></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_13"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.02pt">Financial Statements</span></div><div style="padding-left:27pt"><span><br/></span></div><div style="padding-left:3.37pt;padding-right:3.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Index to Condensed Consolidated Financial Statements</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Operations (Unaudited) for the three and six months ended June 30, 2022 and 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_19">2</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Comprehensive Income (Unaudited) for the three and six months ended June 30, 2022 and 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_22">3</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Balance Sheets (Unaudited) as of June 30, 2022 and December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_25">4</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Cash Flows (Unaudited) for the six months ended June 30, 2022 and 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_28">5</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Shareholders&#8217; Equity (Unaudited) for the three months ended June 30, 2022 and 2021 and the three months ended March 31, 2022 and 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_31">7</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_34">9</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Report of Independent Registered Public Accounting Firm</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_70">37</a></span></div></td></tr></table></div><div><span><br/></span></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_16"></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CVS Health Corporation </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except per share amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i735a87c60de044ac9f25eb3f0ab9e911_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMy0xLTEtMS0xMjE3OTc_8005d24d-b9c7-4659-991e-162b01907614">56,794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia15d386324864519875ee9e5e2fd30c5_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMy0zLTEtMS0xMjE3OTc_1ec13d74-9ef2-445c-8e84-4071b321007c">50,525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideaba68ef44648c6b282b6f6679adf93_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMy01LTEtMS0xMjE3OTc_116b1e04-5299-426b-86ff-cdbefd2e3e9e">109,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdc339e14e1d455eaa0c9a2b8396f603_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMy03LTEtMS0xMjE3OTc_7a63d5c8-ff32-42d9-8759-8ddac91c5d1a">97,912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNC0xLTEtMS0xMjE3OTc_17f68ac4-2cb7-47f1-a36f-1bab65edd180">21,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNC0zLTEtMS0xMjE3OTc_c3dd59b8-af04-4779-b03a-cb43be2231de">18,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNC01LTEtMS0xMjE3OTc_f2f91bbb-962b-4fc2-bc57-80d377dacfa0">42,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNC03LTEtMS0xMjE3OTc_8b0e82b2-3c44-4ea4-ab11-4070db438966">37,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i434909542d34451ea488689d9cca7066_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNS0xLTEtMS0xMjE3OTc_d5ca0b2f-51ca-47e0-87c3-5fc5527d6689">2,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06f559cafd184fa0885076b8d71d4ab2_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNS0zLTEtMS0xMjE3OTc_493eeea9-1080-4fb3-9222-1d6d3d48cadd">2,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2993c7eaedc041feab50da3fbcf43a01_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNS01LTEtMS0xMjE3OTc_75dfd8c4-2f67-4f49-9c5d-6e6712cf8344">4,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363a5d855b604ba1a4087bcdf1601a77_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNS03LTEtMS0xMjE3OTc_96b9bfd5-ea3c-441b-8aae-230e71f2999f">5,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNi0xLTEtMS0xMjE3OTc_31718c78-1efd-4078-bf44-3e1b497a3267">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNi0zLTEtMS0xMjE3OTc_36502afb-f958-4701-9722-3f0b7416f66a">289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNi01LTEtMS0xMjE3OTc_be07941a-c8de-473c-b4f0-27dbd4d791b3">314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNi03LTEtMS0xMjE3OTc_124ab4da-081a-4c6d-accf-5c48be5d4eb1">586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNy0xLTEtMS0xMjE3OTc_1b67120b-4080-4ebf-ad80-513e75000d88">80,636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNy0zLTEtMS0xMjE3OTc_62aba0a4-a333-449a-9db1-8986913e8847">72,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNy01LTEtMS0xMjE3OTc_4be644f4-bc46-4ea7-96a6-96c77998e023">157,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNy03LTEtMS0xMjE3OTc_7eff4f91-0b9f-498b-af76-fcc52e1dd88f">141,713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfOS0wLTEtMS0xMjE3OTc_160ea397-089c-4c69-9a75-1e41518644cc"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfOS0wLTEtMS0xMjE3OTc_20a62c90-3426-4729-933d-b5877901a94a"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfOS0wLTEtMS0xMjE3OTc_719a321b-4e2b-4d24-8046-f19cef0e0014"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfOS0wLTEtMS0xMjE3OTc_af9742cb-03e3-4e73-b493-02ef93572145">Cost of products sold</span></span></span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfOS0xLTEtMS0xMjE3OTc_f254d1a4-2173-4972-8e38-afc0f97cb527">49,290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfOS0zLTEtMS0xMjE3OTc_5257a9da-0cba-43e0-8b93-654dcf013cc2">43,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfOS01LTEtMS0xMjE3OTc_15cffdcc-0cba-430b-971f-95aac2bcc6a7">94,799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfOS03LTEtMS0xMjE3OTc_989c04f2-72fc-413f-b10d-047a96cebd15">84,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTAtMS0xLTEtMTIxNzk3_1f8b073a-45e3-4a6b-92f6-e3b5caf8c17e">17,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTAtMy0xLTEtMTIxNzk3_ac100ab0-aa51-42d8-9df5-baabeb507cfa">15,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTAtNS0xLTEtMTIxNzk3_335d853b-bf48-42f6-8269-1fd0d8e7adb2">35,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTAtNy0xLTEtMTIxNzk3_40ad683e-efd5-47d7-968e-3cfbb425731a">31,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTItMS0xLTEtMTIxNzk3_3b280f87-ca29-44f7-941b-3d0386267f90">9,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTItMy0xLTEtMTIxNzk3_1e8a5040-7e9b-4040-87fb-118cb0e37766">8,869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTItNS0xLTEtMTIxNzk3_b25dc1ba-5d02-430c-a62e-8aedeb363446">19,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTItNy0xLTEtMTIxNzk3_c4e70187-bfe4-4390-9e55-f2d32d461155">17,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTMtMS0xLTEtMTIxNzk3_8dfe6c20-d77f-44b2-8ba4-2354d76f1f70">76,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTMtMy0xLTEtMTIxNzk3_cf20f4ee-91d0-4883-99ff-1be3c4f66d6a">68,290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTMtNS0xLTEtMTIxNzk3_5e41b749-7c7a-41a5-8a1a-113a866d9bb9">149,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTMtNy0xLTEtMTIxNzk3_0e15d176-19f9-4542-8b6d-7a7a90332c5a">133,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTQtMS0xLTEtMTIxNzk3_db38508a-2e3d-4819-8c0b-aa1df7a87cfc">4,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTQtMy0xLTEtMTIxNzk3_b1820df7-684a-4403-aecd-78e7526ff1a7">4,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTQtNS0xLTEtMTIxNzk3_59dc4fd5-97f8-4745-9928-30012ff95d5e">8,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTQtNy0xLTEtMTIxNzk3_38d0b4b1-1370-4e0e-af64-5f9a3a25b5a9">7,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTUtMS0xLTEtMTIxNzk3_2ad1f24e-e98d-482a-b815-62e7fe93779a">583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTUtMy0xLTEtMTIxNzk3_835a43e7-6247-4a84-87a7-d124b2204ac7">636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTUtNS0xLTEtMTIxNzk3_fcd0b1d1-3c12-4912-a1c3-acfc7f7b2709">1,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTUtNy0xLTEtMTIxNzk3_10f48507-6ac8-4878-8767-f85abe8a1644">1,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTctMS0xLTEtMTIxNzk3_09c12506-ea7c-4bfe-86d4-95f45c378733">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTctMy0xLTEtMTIxNzk3_c31c73df-3b9e-4848-9204-b30d888a3ff5">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTctNS0xLTEtMTIxNzk3_1730b534-056a-4059-8973-74e682393cfb">85</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTctNy0xLTEtMTIxNzk3_4ce4d610-4f62-46af-91e0-e99d74008db4">95</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income tax provision</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTgtMS0xLTEtMTIxNzk3_a05767b9-839e-48a1-8f64-e422b49aa77d">4,029</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTgtMy0xLTEtMTIxNzk3_d9ddf656-8bc7-4944-b442-8cb3fb310f41">3,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTgtNS0xLTEtMTIxNzk3_b63be615-45a1-4d8e-a9fd-a4606608c25c">6,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTgtNy0xLTEtMTIxNzk3_6a90b9c5-204f-4d33-8aa9-f81cd28ccc35">6,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTktMS0xLTEtMTIxNzk3_f8f04699-d7ae-44ea-a510-8f7867614406">1,068</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTktMy0xLTEtMTIxNzk3_7402b16a-96a2-43bc-8fe8-638ad2a2f5bc">944</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTktNS0xLTEtMTIxNzk3_048b7ddb-c23d-4c65-bcab-3bd984d0ef42">1,701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTktNy0xLTEtMTIxNzk3_c6e884a4-15fc-4886-9e8e-45fc66f4a8ef">1,690</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjItMS0xLTEtMTIxNzk3_983be846-49f2-490f-98a1-b92cdc3102cc">2,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjItMy0xLTEtMTIxNzk3_ac43508d-a865-4f75-bec0-ee030cbfb9d2">2,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjItNS0xLTEtMTIxNzk3_af22c5b4-cc87-43fb-a555-be278fe41108">5,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjItNy0xLTEtMTIxNzk3_d9234a80-69d4-4c73-8b81-8c5627ce30b4">5,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjMtMS0xLTEtMTIxNzk3_277e9b9c-93ab-4946-beea-bae6b1c0a27c">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjMtMy0xLTEtMTIxNzk3_9deec45b-a6e8-43ee-897e-da209c8cc9b6">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjMtNS0xLTEtMTIxNzk3_18193c25-6910-4531-a4bb-1e50c4451eef">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjMtNy0xLTEtMTIxNzk3_903a8dfb-17fa-4a86-8160-95c18fac2ce5">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjQtMS0xLTEtMTIxNzk3_1aaabb70-bd86-44d7-a3e1-e218d993f612">2,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjQtMy0xLTEtMTIxNzk3_f464f0a5-c106-439b-986e-e82fae9db659">2,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjQtNS0xLTEtMTIxNzk3_d3186575-4aff-4b91-9f4a-1bf0cc273c41">5,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjQtNy0xLTEtMTIxNzk3_3f81e086-2261-4679-921f-bb3dafa033b4">5,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to CVS Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjctMS0xLTEtMTIxNzk3_d52eb521-4773-4a37-b6df-b48705e8bc49">2.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjctMy0xLTEtMTIxNzk3_da312616-83cc-429c-a550-ab0400a4a098">2.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjctNS0xLTEtMTIxNzk3_3d822908-2b1d-4a7c-849f-0d563281f381">4.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjctNy0xLTEtMTIxNzk3_670f11a0-b600-4143-b457-22526ade7c24">3.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjgtMS0xLTEtMTIxNzk3_3ded30a7-6d7b-4d90-9f1b-1a1982b26b50">2.23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjgtMy0xLTEtMTIxNzk3_9ff4f381-5f9f-4f37-a1a0-95734c904417">2.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjgtNS0xLTEtMTIxNzk3_8571bce3-331b-4aa4-a140-4cafa3f2af29">3.97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjgtNy0xLTEtMTIxNzk3_6c45191f-02aa-4f8b-8df8-1f103d8976a7">3.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMzAtMS0xLTEtMTIxNzk3_aa7e5b7a-698f-41b7-8429-73ff3ac5f8ad">1,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMzAtMy0xLTEtMTIxNzk3_a127c934-3b00-4ef7-ada4-75f14c09e95f">1,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMzAtNS0xLTEtMTIxNzk3_a8b5b78b-1833-49c5-a187-93d477a77329">1,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMzAtNy0xLTEtMTIxNzk3_32c654ca-f1ea-4573-aa98-fddc5982efd4">1,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMzEtMS0xLTEtMTIxNzk3_7691591e-a7cf-4b8c-986d-adc2d670cbf9">1,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMzEtMy0xLTEtMTIxNzk3_ff42000b-9383-4bb3-b247-1f884a4daa3b">1,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMzEtNS0xLTEtMTIxNzk3_52c4c58b-be70-4edd-b85c-47edc82c2a0d">1,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMzEtNy0xLTEtMTIxNzk3_b64c4cf2-9ddd-44da-bda1-d1d20d12a4e3">1,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNDItMS0xLTEtMTIxNzk3_f9759790-799b-491b-9959-2556e8b3ea33">0.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNDItMy0xLTEtMTIxNzk3_405efe83-2014-4203-81c8-41169ee11a3a">0.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNDItNS0xLTEtMTIxNzk3_43b10d4d-eb6a-44ca-b56d-c6f898290dbf">1.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNDItNy0xLTEtMTIxNzk3_2c7a49e7-806c-46af-aa2e-21f1a21d6352">1.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements (unaudited).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CVS Health Corporation </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Comprehensive Income</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfMi0xLTEtMS0xMjE3OTc_983be846-49f2-490f-98a1-b92cdc3102cc">2,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfMi0zLTEtMS0xMjE3OTc_ac43508d-a865-4f75-bec0-ee030cbfb9d2">2,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfMi01LTEtMS0xMjE3OTc_af22c5b4-cc87-43fb-a555-be278fe41108">5,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfMi03LTEtMS0xMjE3OTc_d9234a80-69d4-4c73-8b81-8c5627ce30b4">5,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized investment gains (losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNC0xLTEtMS0xMjE3OTc_90e17bbb-82e2-4072-b140-6ff7e446944d">813</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNC0zLTEtMS0xMjE3OTc_a2de8936-8ecc-4adf-a831-e2403a0425e7">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNC01LTEtMS0xMjE3OTc_40746b58-b29f-47c0-88c9-750684580763">1,968</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNC03LTEtMS0xMjE3OTc_2f4e15f6-c19d-4924-abc3-40fbffc9b329">237</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNS0xLTEtMS0xMjE3OTc_3a3fc48e-5b04-4ada-ba14-c4136903fc24">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNS0zLTEtMS0xMjE3OTc_4542449d-d901-4afa-a665-2494a1c04fce">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNS01LTEtMS0xMjE3OTc_a67bf679-7a14-4832-92da-d39f9f1bfc89">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNS03LTEtMS0xMjE3OTc_ebde053c-991c-4a85-9014-9dd8978b3352">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNi0xLTEtMS0xMjE3OTc_9eebd660-9164-4268-bf0b-85ee108ef34c">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNi0zLTEtMS0xMjE3OTc_d3f30f22-3dcb-4c4b-9f8e-db5facb990a3">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNi01LTEtMS0xMjE3OTc_7197054b-9e23-4a75-859f-7a2918a4099a">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNi03LTEtMS0xMjE3OTc_6e2cd8ee-8498-49a6-92e8-b40ed7a14e1a">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and other postretirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNy0xLTEtMS0xMjE3OTc_a3783c1d-1c7d-4dd9-b104-339735cdec56">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNy0zLTEtMS0xMjE3OTc_74f43e28-b00b-4116-90a8-7678922a5cf9">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNy01LTEtMS0xMjE3OTc_45c9c89a-3584-4bb0-9a91-b5989c082cf8">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNy03LTEtMS0xMjE3OTc_7cc2f951-6522-4982-b576-c046a6eabed1">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfOC0xLTEtMS0xMjE3OTc_aa440dec-1c5b-42ab-895f-0b8cc7126d5f">798</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfOC0zLTEtMS0xMjE3OTc_6ce9934b-1102-4f49-be00-09275310fc34">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfOC01LTEtMS0xMjE3OTc_642c2039-3a27-4b6a-8d27-178e8e0b8867">1,953</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfOC03LTEtMS0xMjE3OTc_35971b4a-e8b7-4fa8-9268-2c35b87963db">244</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfOS0xLTEtMS0xMjE3OTc_9e250154-3376-4ea9-8d23-978d4bee0bf6">2,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfOS0zLTEtMS0xMjE3OTc_eea96009-37d9-45bd-9f72-92030bf34d6d">2,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfOS01LTEtMS0xMjE3OTc_ed015c46-9a6c-4763-aad1-0f82a90b62ff">3,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfOS03LTEtMS0xMjE3OTc_c0f8b71a-6f05-4fe0-9a27-fd5ef110f9ca">4,771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfMTAtMS0xLTEtMTIxNzk3_277e9b9c-93ab-4946-beea-bae6b1c0a27c">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfMTAtMy0xLTEtMTIxNzk3_01fd8de4-130d-4a9e-9b1b-e723b23c3d70">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfMTAtNS0xLTEtMTIxNzk3_18193c25-6910-4531-a4bb-1e50c4451eef">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfMTAtNy0xLTEtMTIxNzk3_903a8dfb-17fa-4a86-8160-95c18fac2ce5">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to CVS Health</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfMTEtMS0xLTEtMTIxNzk3_7fc49a1e-7f69-467f-b4dd-9beacf2eee06">2,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfMTEtMy0xLTEtMTIxNzk3_d0c2b77b-b525-45fb-a1a8-9504dedf5fc4">2,931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfMTEtNS0xLTEtMTIxNzk3_03b97734-de05-40e4-9e98-0aa8c112ed2d">3,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfMTEtNy0xLTEtMTIxNzk3_30d6c5fe-2a31-4dfa-a3d4-f6e06b2d567d">4,762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements (unaudited).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_25"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">   CVS Health Corporation </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except per share amounts</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMi0xLTEtMS0xMjE3OTc_bc70507c-f3d5-4616-80fa-3dd379c11c54">12,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMi0zLTEtMS0xMjE3OTc_edb119ab-aa13-47e5-8aaf-c39508520fc0">9,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMy0xLTEtMS0xMjE3OTc_21f1a6d8-fe04-41b7-a830-1e4057a6f1db">2,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMy0zLTEtMS0xMjE3OTc_42338b03-2498-4432-90e0-affd34ab9d8e">3,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNC0xLTEtMS0xMjE3OTc_9ef1e9f9-c970-4142-b31e-7dcde016dc3c">27,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNC0zLTEtMS0xMjE3OTc_14f35731-29c5-4cd6-98c7-62805368272b">24,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNS0xLTEtMS0xMjE3OTc_2b52b9a5-8661-4d41-8c0d-1a044d94d353">17,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNS0zLTEtMS0xMjE3OTc_7f73cf11-6485-4ec2-9a02-d14f419b5d12">17,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNi0xLTEtMS0xMjE3OTc_83527418-3634-400c-b4b1-fae01717c787">2,541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNi0zLTEtMS0xMjE3OTc_7f91bec4-27af-4ca4-86c9-f5a04f12a2e7">5,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNy0xLTEtMS0xMjE3OTc_de19ed7c-c89e-4eee-be90-b13fcb16c2c1">62,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNy0zLTEtMS0xMjE3OTc_d14f32ab-de55-4e38-9211-2bb75cb560de">60,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfOC0xLTEtMS0xMjE3OTc_44f2585f-42c2-42fc-b985-f58f5d7e72dd">21,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfOC0zLTEtMS0xMjE3OTc_ec0fc9d4-3831-4762-a7cd-ee353ec8e1ab">23,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfOS0xLTEtMS0xMjE3OTc_3fc70635-e9fe-488d-bb37-9f5dc3e31fc7">12,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfOS0zLTEtMS0xMjE3OTc_29b0f59a-36b4-40b4-a926-5b08bf4c3543">12,896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTAtMS0xLTEtMTIxNzk3_8133ef92-c1e0-45ff-80fb-4d848732d02d">18,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTAtMy0xLTEtMTIxNzk3_d7847448-2b3a-488a-a14b-13466713e558">19,122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTEtMS0xLTEtMTIxNzk3_7ea6d280-0c29-46e5-b0f0-9754054d65a9">78,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTEtMy0xLTEtMTIxNzk3_8cb0cdf5-8ead-46ef-a229-40eb889d22ab">79,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTItMS0xLTEtMTIxNzk3_eae2bbb9-6613-45a4-8c9d-af33f9287632">28,135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTItMy0xLTEtMTIxNzk3_03cfd3fe-c259-4579-9637-045adb60feb1">29,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separate accounts assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTMtMS0xLTEtMTIxNzk3_79b5fd13-9219-4571-9858-fedcd3d0fa04">4,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTMtMy0xLTEtMTIxNzk3_e017503b-6363-4fd0-86ec-2f356d8ba577">5,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTQtMS0xLTEtMTIxNzk3_2db7310a-b964-4f14-98ae-4a7ef9d1844d">4,852</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTQtMy0xLTEtMTIxNzk3_29699511-a779-4751-a354-c3cff4820228">4,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTUtMS0xLTEtMTIxNzk3_d1fcee79-4e1b-41f1-b0c4-53a0365d6636">230,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTUtMy0xLTEtMTIxNzk3_1058ac0e-caac-4de3-b1fe-7057506baa5a">232,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTgtMS0xLTEtMTIxNzk3_c7e5cfdb-8aba-41b4-9383-bfde15a379db">13,238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTgtMy0xLTEtMTIxNzk3_79746230-03ad-46a4-94e1-88418179f58a">12,544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy claims and discounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="cvs:PharmacyClaimsandDiscountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTktMS0xLTEtMTIxNzk3_433105f4-3195-45ad-ba93-0514af1f9099">18,393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="cvs:PharmacyClaimsandDiscountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTktMy0xLTEtMTIxNzk3_2c150d6c-00e7-4290-bc6a-ff47dc59f10e">17,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjAtMS0xLTEtMTIxNzk3_66e5432b-8ae8-4d72-bad9-582af6b838c7">10,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjAtMy0xLTEtMTIxNzk3_b7b22819-e99a-4d29-8309-afc9655b7f78">8,808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Policyholders&#8217; funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:OtherPolicyholderFunds" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjEtMS0xLTEtMTIxNzk3_74e93b2c-51bf-4d21-97bd-2f9861ce2994">1,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:OtherPolicyholderFunds" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjEtMy0xLTEtMTIxNzk3_f370b173-9326-46b3-bd68-72961ffb7c6f">4,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjItMS0xLTEtMTIxNzk3_cc8d0760-e98f-4cbe-8923-69a4b89b79ef">17,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjItMy0xLTEtMTIxNzk3_264c06a9-0143-47ca-bb00-9cce72325dfc">17,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other insurance liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="cvs:OtherInsuranceLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjMtMS0xLTEtMTIxNzk3_cbe961b2-de8d-4e12-92bc-6ad259a61711">1,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="cvs:OtherInsuranceLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjMtMy0xLTEtMTIxNzk3_014063a6-49b1-4fa3-9f74-056166542b09">1,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjQtMS0xLTEtMTIxNzk3_f941f9fb-d7d3-4096-8021-24a4feb13c81">1,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjQtMy0xLTEtMTIxNzk3_19aeac77-36a8-437c-95fe-4858519f4b71">1,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjYtMS0xLTEtMTIxNzk3_3dc82706-e66a-4fd1-b0b4-731787c89666">4,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjYtMy0xLTEtMTIxNzk3_05cfee25-8f4a-4ea0-8bd1-4d68f86a832e">4,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjctMS0xLTEtMTIxNzk3_d98da68c-d599-4555-94f7-23bc60286bd6">68,457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjctMy0xLTEtMTIxNzk3_d2cf1172-06cb-4ea6-8d61-692da507be84">67,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjgtMS0xLTEtMTIxNzk3_41cdc8d5-d52e-4fba-84cf-cd3058292d95">17,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjgtMy0xLTEtMTIxNzk3_a55fdd05-8b61-4a91-932a-f162e21488e7">18,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjktMS0xLTEtMTIxNzk3_5ba32119-4680-43f2-b213-18f5ccc63162">50,797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjktMy0xLTEtMTIxNzk3_79a24104-e0f7-40dc-96cf-55941d6761c5">51,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzAtMS0xLTEtMTIxNzk3_1b4b549f-39bb-4444-a7bf-f1828c044a1d">5,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzAtMy0xLTEtMTIxNzk3_5bd78e5a-0060-4acc-b741-034437e71345">6,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separate accounts liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:SeparateAccountsLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzEtMS0xLTEtMTIxNzk3_99e333f3-e5f5-4fac-9483-a44b1b9b8b6e">4,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:SeparateAccountsLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzEtMy0xLTEtMTIxNzk3_545b3dbc-c53f-49e4-95e8-77eecbdb11af">5,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term insurance liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="cvs:OtherInsuranceLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzItMS0xLTEtMTIxNzk3_4f544bd5-cf9f-4953-b325-f39911b9e0fe">6,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="cvs:OtherInsuranceLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzItMy0xLTEtMTIxNzk3_71c4363a-55b0-41ca-8312-6d0d8f2eacfb">6,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzMtMS0xLTEtMTIxNzk3_45e2fc9d-9c38-4b6d-988b-3710846da519">2,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzMtMy0xLTEtMTIxNzk3_6993b0d5-cf2f-4644-b2ab-90f9f910b6d2">1,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzQtMS0xLTEtMTIxNzk3_d5b607da-1a11-4764-b4cd-932bc1c73381">154,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzQtMy0xLTEtMTIxNzk3_a2949ca3-bdb6-4630-aade-28b64acc5149">157,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzctMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MDVlNzJjZTgxNjJlNDA5N2E4Yjc5ZWVlZWQ3NjU4MmJfMzE_79616cf4-a2f8-4323-b8b4-0515e28f8baf"><ix:nonFraction unitRef="usdPerShare" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzctMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MDVlNzJjZTgxNjJlNDA5N2E4Yjc5ZWVlZWQ3NjU4MmJfMzE_8130af97-a1df-4ae0-83e1-43a8f0599074">0.01</ix:nonFraction></ix:nonFraction>: <ix:nonFraction unitRef="shares" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzctMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MDVlNzJjZTgxNjJlNDA5N2E4Yjc5ZWVlZWQ3NjU4MmJfMzU_279874f7-adce-41ef-9543-76d739ff9076"><ix:nonFraction unitRef="shares" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzctMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MDVlNzJjZTgxNjJlNDA5N2E4Yjc5ZWVlZWQ3NjU4MmJfMzU_e5398018-2450-4b35-a866-7cd627c652ef">0.1</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt-sec:numwordsen" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzctMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MDVlNzJjZTgxNjJlNDA5N2E4Yjc5ZWVlZWQ3NjU4MmJfNTc_13d79c1e-6519-453e-95da-c84481142782"><ix:nonFraction unitRef="shares" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt-sec:numwordsen" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzctMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MDVlNzJjZTgxNjJlNDA5N2E4Yjc5ZWVlZWQ3NjU4MmJfNTc_34706be3-5ba7-4ea6-af21-4888235036d7"><ix:nonFraction unitRef="shares" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt-sec:numwordsen" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzctMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MDVlNzJjZTgxNjJlNDA5N2E4Yjc5ZWVlZWQ3NjU4MmJfNTc_86208729-e4f6-457b-9045-a2beb39c48e6"><ix:nonFraction unitRef="shares" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt-sec:numwordsen" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzctMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MDVlNzJjZTgxNjJlNDA5N2E4Yjc5ZWVlZWQ3NjU4MmJfNTc_cf1b947a-496e-4ace-b18d-b426ec99550c">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>ne issued or outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzctMS0xLTEtMTIxNzk3_2a79bfad-de6e-45ec-a889-45cdc1a942a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzctMy0xLTEtMTIxNzk3_0e492b28-9c21-4606-88a6-86a8aef30201">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzgtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MmU2NTNlNjQzOTEzNDA5YTg2NWQ5M2E3NzA5NzYxNzlfMjg_1114199c-90a6-4dea-aced-69bfc50c9df6"><ix:nonFraction unitRef="usdPerShare" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzgtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MmU2NTNlNjQzOTEzNDA5YTg2NWQ5M2E3NzA5NzYxNzlfMjg_1c4bfc6c-a895-4e4e-9fe6-8673670d0140">0.01</ix:nonFraction></ix:nonFraction>: <ix:nonFraction unitRef="shares" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzgtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MmU2NTNlNjQzOTEzNDA5YTg2NWQ5M2E3NzA5NzYxNzlfMzI_551c7b51-09d6-429f-a1ee-010e47bcc925"><ix:nonFraction unitRef="shares" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzgtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MmU2NTNlNjQzOTEzNDA5YTg2NWQ5M2E3NzA5NzYxNzlfMzI_b6b5535f-dbef-4532-bf45-98bcb170dc6a">3,200</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzgtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MmU2NTNlNjQzOTEzNDA5YTg2NWQ5M2E3NzA5NzYxNzlfNTQ_1e1c62c1-73d9-4bc7-ae39-59950e1a17c4">1,755</ix:nonFraction> shares issued and <ix:nonFraction unitRef="shares" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzgtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MmU2NTNlNjQzOTEzNDA5YTg2NWQ5M2E3NzA5NzYxNzlfNzU_4a2cb899-9d49-4d35-b3ca-faed0cf47ac9">1,312</ix:nonFraction> shares outstanding at June&#160;30, 2022 and <ix:nonFraction unitRef="shares" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzgtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MmU2NTNlNjQzOTEzNDA5YTg2NWQ5M2E3NzA5NzYxNzlfMTA3_ee2521b1-a9ea-4ec0-a4a1-efeb6d3caaf0">1,744</ix:nonFraction> shares issued and <ix:nonFraction unitRef="shares" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzgtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MmU2NTNlNjQzOTEzNDA5YTg2NWQ5M2E3NzA5NzYxNzlfMTI4_11227be8-d86d-40fb-bfb0-e719f20a2e1c">1,322</ix:nonFraction> shares outstanding at December&#160;31, 2021 and capital surplus</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:CommonStocksIncludingAdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzgtMS0xLTEtMTIxNzk3_1ff8646f-8a4c-4113-a29c-2b89ae903ce2">47,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:CommonStocksIncludingAdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzgtMy0xLTEtMTIxNzk3_3abda348-bf3b-4538-8928-565c49d3b541">47,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost: <ix:nonFraction unitRef="shares" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzktMC0xLTEtMTIxNzk3L3RleHRyZWdpb246NzQwMWEwYWIwNWViNDkwZGJhZmYxMjJlMmMyZmE3ZjFfMjk_996f00b3-8c7c-4abd-81e9-955e5bde7939">443</ix:nonFraction> shares at June&#160;30, 2022 and <ix:nonFraction unitRef="shares" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzktMC0xLTEtMTIxNzk3L3RleHRyZWdpb246NzQwMWEwYWIwNWViNDkwZGJhZmYxMjJlMmMyZmE3ZjFfNDk_7e8819ca-4d4b-4309-9cd2-d8b8a02ac287">422</ix:nonFraction> shares at December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzktMS0xLTEtMTIxNzk3_db25bf46-f5aa-43c4-843b-797a878a0ed2">30,412</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzktMy0xLTEtMTIxNzk3_69ce047c-8b71-4fc1-8dc3-2c79a93240ae">28,173</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNDAtMS0xLTEtMTIxNzk3_13bbd494-9fb4-4a3b-be24-b90ebcd2fc61">58,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNDAtMy0xLTEtMTIxNzk3_c85cd752-1c59-435a-b914-d2acd2d4eeac">54,906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNDEtMS0xLTEtMTIxNzk3_0239cb9e-0a7d-451c-bded-9b231cc7d81d">988</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNDEtMy0xLTEtMTIxNzk3_9de5066f-d8ae-40af-adf6-4c55151ea1a3">965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total CVS Health shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNDItMS0xLTEtMTIxNzk3_2b56564e-f87d-438c-962b-0fb5bb510fd8">75,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNDItMy0xLTEtMTIxNzk3_2f9af450-a712-4b4a-87f5-bcd63a904dab">75,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNDMtMS0xLTEtMTIxNzk3_74a500be-124a-49ae-875d-a0b5794b6792">322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNDMtMy0xLTEtMTIxNzk3_332ccf28-597f-49dc-8345-a2d4eb17cc74">306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNDQtMS0xLTEtMTIxNzk3_afd3aafd-bcc1-4f31-b9ff-6ffcabedd81e">75,506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNDQtMy0xLTEtMTIxNzk3_dcbbd177-8554-4dbd-877b-1af3515e4876">75,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNDUtMS0xLTEtMTIxNzk3_1bb4f8ec-8ad7-48ec-8fe3-dfffb021e8ba">230,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNDUtMy0xLTEtMTIxNzk3_e340cc17-1a94-4350-a443-9071621cda64">232,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements (unaudited).</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CVS Health Corporation </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash receipts from customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:ProceedsFromCustomers" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMy0xLTEtMS0xMjE3OTc_cb1986a5-8b93-40b4-97a4-dd39cab2abc1">151,769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromCustomers" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMy0zLTEtMS0xMjE3OTc_f5b6bbad-1122-4fce-8e27-cf3ae8bca444">136,621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for inventory and prescriptions dispensed by retail network pharmacies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfNC0xLTEtMS0xMjE3OTc_45511d32-15a9-4608-ab99-0238fc4b44c1">90,887</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfNC0zLTEtMS0xMjE3OTc_5ac509af-5f89-4fd0-9dca-290c6fa35e68">79,316</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance benefits paid </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="cvs:PaymentsforInsuranceBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfNS0xLTEtMS0xMjE3OTc_8f68cdf3-8e70-4424-925a-652bfc38afd5">33,920</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="cvs:PaymentsforInsuranceBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfNS0zLTEtMS0xMjE3OTc_524c483a-e329-45d5-9953-3c0532932a77">31,245</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid to other suppliers and employees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:PaymentsToSuppliersAndEmployees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfNi0xLTEtMS0xMjE3OTc_40b00c94-92bc-48c1-a0a2-83f8494950a7">15,119</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsToSuppliersAndEmployees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfNi0zLTEtMS0xMjE3OTc_79e14ef2-56e7-4ffc-8ebc-780f23109890">14,900</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and investment income received</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:ProceedsFromInterestAndDividendsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfNy0xLTEtMS0xMjE3OTc_259548ca-77b6-4629-99ef-b65da8821a3d">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromInterestAndDividendsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfNy0zLTEtMS0xMjE3OTc_2e0d2566-a221-41aa-990c-16ee44c43397">394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfOC0xLTEtMS0xMjE3OTc_d274f54b-e903-4577-9386-c11d5666dc1e">1,150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfOC0zLTEtMS0xMjE3OTc_3f824f54-c304-4066-8b56-954bf3813414">1,263</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfOS0xLTEtMS0xMjE3OTc_8576b9a7-a27a-4a97-a3d7-c159f50ff50f">1,887</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfOS0zLTEtMS0xMjE3OTc_f0a5d897-aec4-4b12-b925-2b39a99bf3d1">1,552</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTAtMS0xLTEtMTIxNzk3_2300e934-f95c-45a0-8db7-fd7026af502f">9,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTAtMy0xLTEtMTIxNzk3_c84eb4d5-b539-4459-a625-2ce835c706d2">8,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales and maturities of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTMtMS0xLTEtMTIxNzk3_7ed9cfcf-70fd-4fff-99a6-8da80a4fac73">4,360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTMtMy0xLTEtMTIxNzk3_d4b7aeb0-63a4-4129-86a0-eb7264a7bf05">3,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTQtMS0xLTEtMTIxNzk3_b517f62b-28c8-4a88-8a73-980a26a00c25">5,010</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTQtMy0xLTEtMTIxNzk3_a95a3738-104c-4c4f-8e5b-28d1cb220388">5,570</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTUtMS0xLTEtMTIxNzk3_c511e387-3f60-4065-82a6-fddf94d29679">1,459</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTUtMy0xLTEtMTIxNzk3_c97e6654-bf7b-4846-a782-94ac0fa726f0">1,315</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions (net of cash acquired)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTYtMS0xLTEtMTIxNzk3_63b54a27-0163-48e4-94e9-af56d5909845">125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTYtMy0xLTEtMTIxNzk3_d064fd32-580c-4020-84ef-c3fc5ccf100d">108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of subsidiaries (net of cash and restricted cash sold of $<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:CashDivestedFromDeconsolidation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTctMC0xLTEtMTIxNzk3L3RleHRyZWdpb246NGViMjEyYmRhNjEzNDJkOWJlODlmODYyNWUzMjlkNTdfMzg0ODI5MDY5NzMxMg_b79e8bb4-f69e-48c7-9cb9-62660cb914d2">2,807</ix:nonFraction>)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTctMS0xLTEtMTIxNzk3_a5f15d73-ddcb-4dae-bfa5-dabcb7a69e6a">1,943</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTctMy0xLTEtMTIxNzk3_153a5435-d7d5-4d6f-849d-66d4924e0112">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTgtMS0xLTEtMTIxNzk3_2bac8b76-e7a1-4dda-938a-06ecd909937c">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTgtMy0xLTEtMTIxNzk3_76e8f612-34f1-4711-b09e-25614d295e51">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTktMS0xLTEtMTIxNzk3_9b9c5050-6d1a-48f9-9645-a93fef2dcfe3">4,123</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTktMy0xLTEtMTIxNzk3_23509902-8655-427f-9d34-7756dde8ed36">2,974</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMjQtMS0xLTEtMTIxNzk3_ebcdcd75-50c6-4b3a-bc5b-33e0c41d5edc">1,529</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMjQtMy0xLTEtMTIxNzk3_246863d2-1f66-483e-bb51-6c7ed3ab2d36">5,423</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMjUtMS0xLTEtMTIxNzk3_d0912635-174d-4d01-b460-eb452d3ae25e">2,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMjUtMy0xLTEtMTIxNzk3_7fe1aee3-08c8-4a80-b8a2-1f440c13d463">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMjctMS0xLTEtMTIxNzk3_974a7172-937a-4efc-a85e-b0c71307529c">1,462</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMjctMy0xLTEtMTIxNzk3_da1ae154-5f75-4761-a223-0c93b797ac78">1,306</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMjgtMS0xLTEtMTIxNzk3_c64a3e90-cb7a-43c8-a967-db68b8e63f1c">348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMjgtMy0xLTEtMTIxNzk3_7cc05dd6-57fe-49dc-9d07-5c051e2bc393">330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for taxes related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMjktMS0xLTEtMTIxNzk3_b765fa14-1d41-4d80-9d7d-bef55fb21d78">329</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMjktMy0xLTEtMTIxNzk3_ea998528-761b-46d4-b07b-282ef5d2f469">159</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMzAtMS0xLTEtMTIxNzk3_f750646f-23b2-49f1-b9ff-1b7c4a0182e9">139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMzAtMy0xLTEtMTIxNzk3_68f7596d-39b5-4253-8fe8-7d7b9973496a">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMzEtMS0xLTEtMTIxNzk3_4b60432e-2a5a-4219-a9ab-5e3252987881">5,111</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMzEtMy0xLTEtMTIxNzk3_53c2a35a-a522-4e1a-be59-b2dcd4fd9272">6,512</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net decrease in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMzItMS0xLTEtMTIxNzk3_02d098c7-5382-463f-a7b1-d82178dcfe1c">228</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMzItMy0xLTEtMTIxNzk3_3b8240f3-1756-4a57-9908-6593d76ad29b">747</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at the beginning of the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMzMtMS0xLTEtMTIxNzk3_30f1be7b-b5b5-421b-9b30-e1b190261cb9">12,691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1b37908bcec4675b7dd487bd3f7f745_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMzMtMy0xLTEtMTIxNzk3_b1fd4d29-65d2-4839-a7de-2624e27d7b8b">11,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at the end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMzQtMS0xLTEtMTIxNzk3_f8ee65da-cf86-4962-81b2-61f7f56d8de0">12,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c91d440ca044d289daea52743e3cebd_I20210630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMzQtMy0xLTEtMTIxNzk3_9a5f87b3-3b9a-4838-b9a4-2754455bbdad">10,296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CVS Health Corporation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation of net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMy0xLTEtMS0xMjE3OTc_af22c5b4-cc87-43fb-a555-be278fe41108">5,274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMy0zLTEtMS0xMjE3OTc_d9234a80-69d4-4c73-8b81-8c5627ce30b4">5,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments required to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfNS0xLTEtMS0xMjE3OTc_3a4c503c-a6e2-4639-9552-9aa8b6a9b8e3">2,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfNS0zLTEtMS0xMjE3OTc_4681b732-2c74-412d-a89e-9f46c52ed89b">2,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfNy0xLTEtMS0xMjE3OTc_0496fd8c-8a6f-4674-bea2-a699f8cc5c51">236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfNy0zLTEtMS0xMjE3OTc_73e2da9d-7a6a-4881-a609-72a927bc7e33">232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on sale of subsidiary</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfOC0xLTEtMS0xMjE3OTc_b0f97329-9a3f-4f07-94b5-92ceef770a86">225</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfOC0zLTEtMS0xMjE3OTc_ca6c3386-9274-4c6f-8471-8062e538ca24">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes and other noncash items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" sign="-" name="cvs:Deferredincometaxesandothernoncashitems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTAtMS0xLTEtMTIxNzk3_4ddf955c-b884-4b19-bd3f-b74d3a89512f">281</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" sign="-" name="cvs:Deferredincometaxesandothernoncashitems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTAtMy0xLTEtMTIxNzk3_8c9cf451-3c4a-45ba-89b9-2323f90a6f07">370</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in operating assets and liabilities, net of effects from acquisitions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTItMS0xLTEtMTIxNzk3_b8ed8c81-7199-48ed-905a-4462017670fb">2,687</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTItMy0xLTEtMTIxNzk3_d4279865-13b1-4964-872f-eddbfa1aca18">2,384</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTMtMS0xLTEtMTIxNzk3_4b4f4563-d43f-4a7a-a27c-982003bd6a80">469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTMtMy0xLTEtMTIxNzk3_c511fb9b-d359-4c2f-8f8e-3abb0efa3e4b">1,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTQtMS0xLTEtMTIxNzk3_56cfd0ff-4e25-4180-ba56-f7e0acc56443">325</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTQtMy0xLTEtMTIxNzk3_7cf9865b-7e57-47a5-a3b2-dca7efa43098">219</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and pharmacy claims and discounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTUtMS0xLTEtMTIxNzk3_9a14867c-ea5d-499a-9a1d-94c0e0afde91">2,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTUtMy0xLTEtMTIxNzk3_1778832a-a63c-43d0-b7d0-75543fa5fae2">1,702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable and other insurance liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTYtMS0xLTEtMTIxNzk3_45bfc26d-9bcb-4eba-ac9a-da7816d9508e">1,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTYtMy0xLTEtMTIxNzk3_b6a430d8-f102-4644-adb2-39054417f48d">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTctMS0xLTEtMTIxNzk3_f57f0e9c-1fbb-4896-8aa9-d4fd4d2c3069">903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTctMy0xLTEtMTIxNzk3_64846a31-6f9d-419f-a71d-198103339de0">879</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTgtMS0xLTEtMTIxNzk3_943e5d6c-6592-4fd0-9658-84fbe8cfdfcc">9,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTgtMy0xLTEtMTIxNzk3_edbfd6c5-5a3e-4b27-869d-180c523103de">8,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements (unaudited).</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CVS Health Corporation </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Shareholders&#8217; Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Attributable to CVS Health</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of shares<br/>outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Surplus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total <br/>CVS Health<br/>Shareholders&#8217;<br/>&#160;Equity</span></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Shareholders&#8217;<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Shares</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia48affe94b4f4604a40b1720a79d5db6_I20211231" decimals="-6" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNS0xLTEtMS0xMjE3OTc_c262cc0c-ceec-4c28-aecc-287c903a2dc6">1,744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2c088d53680e46f6baea92de14e2e4bd_I20211231" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNS0yLTEtMS0xMjE3OTc_e1e5fa5f-7a8b-44b1-b10e-e547456d4b5f">422</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if58f043854c54a53a5f1e35f8cb23492_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNS00LTEtMS0xMjE3OTc_ffce7b07-c2e2-4a8b-9241-b8361898f9d8">47,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c088d53680e46f6baea92de14e2e4bd_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNS01LTEtMS0xMjE3OTc_3e47bdca-8b3c-4a9e-89e1-7a840174f8ce">28,173</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a1ac81823f94f75bab757497041c7f8_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNS02LTEtMS0xMjE3OTc_f256586f-8201-4308-8a93-12eda4870bcf">54,906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86d57bb206de43c4896717f849b4338e_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNS03LTEtMS0xMjE3OTc_8881103c-40e8-4f39-aced-5967ea6c4cd1">965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba8a997161f4500808bdfdae2e0492b_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNS04LTEtMS0xMjE3OTc_684559cc-c9dd-4934-921a-679dec828288">75,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5700fd54dde54828b88be719d7275959_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNS05LTEtMS0xMjE3OTc_7d77a9bb-dfed-4b1d-81a3-e80b5a2b94d9">306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNS0xMC0xLTEtMTIxNzk3_ba1f5876-d388-433f-8dca-a2d318ae7750">75,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i683b5a41864d461590fab401c4e35230_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNi02LTEtMS0xMjE3OTc_91aa2e1f-2954-4b89-86b1-0bb1c4ba71d0">2,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42bd3a35f46d439da8e6e3e6a2da23e4_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNi04LTEtMS0xMjE3OTc_8cf790dd-f704-4854-be23-4bcd5d87d7c6">2,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ae3518ddcc841158d875c2d6c95917a_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNi05LTEtMS0xMjE3OTc_5719d1f4-97d4-4661-ad8c-fe631f9711cf">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i079d98ea4b47435d8f5a9eb08672f5a0_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNi0xMC0xLTEtMTIxNzk3_1f685ee6-4f5e-45d0-bd45-3855e44a531f">2,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iacd268c2c7e140009fb8bec3502a1e8c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNy03LTEtMS0xMjE3OTc_1b65f4c4-0ad2-4bf2-b086-e11a40edca80">1,155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42bd3a35f46d439da8e6e3e6a2da23e4_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNy04LTEtMS0xMjE3OTc_ca89e1ad-c844-4fdb-b05b-c8a4f0000e62">1,155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i079d98ea4b47435d8f5a9eb08672f5a0_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNy0xMC0xLTEtMTIxNzk3_525ca5fa-1e07-4d38-aa45-3456265b45dd">1,155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock option activity, stock awards and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4fe1e1bc63a6493a915ac4598cb1bf1e_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfOC0xLTEtMS0xMjE3OTc_a386e384-b46b-4ded-b630-5e8a4efe1341">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d0aa52dbadc483aad398f2459329f7b_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfOC00LTEtMS0xMjE3OTc_c0b1eebe-cd0a-4caa-87f2-58695294064f">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42bd3a35f46d439da8e6e3e6a2da23e4_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfOC04LTEtMS0xMjE3OTc_61559f25-638b-454f-940c-61bb9bf63ce8">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i079d98ea4b47435d8f5a9eb08672f5a0_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfOC0xMC0xLTEtMTIxNzk3_b7fdfe0f-fe93-4dce-a858-a55efe5745a3">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of treasury shares, net of ESPP issuances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iffa3d985891f4ee4956e9a77643827ed_D20220101-20220331" decimals="-6" name="cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfOS0yLTEtMS0xMjE3OTc_ba77f96c-eade-451e-8d3a-2eb2bda33475">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffa3d985891f4ee4956e9a77643827ed_D20220101-20220331" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfOS01LTEtMS0xMjE3OTc_5f6533df-08ba-4e8e-8c9b-1267fa70c18f">1,972</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42bd3a35f46d439da8e6e3e6a2da23e4_D20220101-20220331" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfOS04LTEtMS0xMjE3OTc_a13be57e-0152-4e64-a820-9c5b245c8f89">1,972</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i079d98ea4b47435d8f5a9eb08672f5a0_D20220101-20220331" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfOS0xMC0xLTEtMTIxNzk3_26c89e57-557a-4966-bae7-7b5cd9d506a3">1,972</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i683b5a41864d461590fab401c4e35230_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTAtNi0xLTEtMTIxNzk3_01192483-7532-4c4f-a4a1-607224dac70d">730</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42bd3a35f46d439da8e6e3e6a2da23e4_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTAtOC0xLTEtMTIxNzk3_91d60b07-e11c-43a5-827b-72f020f8ccec">730</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i079d98ea4b47435d8f5a9eb08672f5a0_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTAtMTAtMS0xLTEyMTc5Nw_530cf02f-dc5f-4553-8a93-c71c349cadb5">730</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other increases in noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ae3518ddcc841158d875c2d6c95917a_D20220101-20220331" decimals="-6" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTEtOS0xLTEtMTIxNzk3_805bd866-e7e4-4426-8e40-bfd25ce93cbc">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i079d98ea4b47435d8f5a9eb08672f5a0_D20220101-20220331" decimals="-6" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTEtMTAtMS0xLTEyMTc5Nw_bb672445-c7a2-4241-b79e-b9ae24666f59">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3b7f5b310ef64956895f542905a4622c_I20220331" decimals="-6" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTItMS0xLTEtMTIxNzk3_2b50e3c8-daae-4eff-881d-8db8340feac8">1,747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5f2fc9063f2c489db3055478a06e568b_I20220331" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTItMi0xLTEtMTIxNzk3_1903b954-70cc-4787-accd-173691ab6baa">441</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4175aff97fca4747940e80338e1c6b6b_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTItNC0xLTEtMTIxNzk3_dfa4649c-3f50-4e27-b8ac-8f10a789d3bb">47,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f2fc9063f2c489db3055478a06e568b_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTItNS0xLTEtMTIxNzk3_686258d7-9a7b-45e9-9240-187605a59fdc">30,145</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47c09d87ce2542058a44638e0d3aee0e_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTItNi0xLTEtMTIxNzk3_cf987f91-b54d-4166-8748-d9c752dfcb21">56,488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b872d657c42459e8731fba04a499743_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTItNy0xLTEtMTIxNzk3_03af1163-ecd2-483c-9942-43d25685f89e">190</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9df87f1b15834003ab59b7fdaccda9a7_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTItOC0xLTEtMTIxNzk3_7d32c90c-b917-407d-9e22-92297168bb29">73,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i902a60f937e94b7db75169a88a51ae87_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTItOS0xLTEtMTIxNzk3_aa34182c-45a8-41cc-b9e1-594c01d1f308">310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3779b6c8ef834637b29b6a1763d82299_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTItMTAtMS0xLTEyMTc5Nw_f1e2957c-010b-4879-b319-46e62e5e4a80">74,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60699824f52b49fcb5663bfa26640e09_D20220401-20220630" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTMtNi0xLTEtMTIxNzk3_690d9c7c-5133-4fc1-8b86-32d3f6a1798a">2,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4275461340524ac9a913007bb4256c99_D20220401-20220630" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTMtOC0xLTEtMTIxNzk3_7d1d6d71-ae30-4f83-8a05-be4fa292341c">2,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb80b8e269cf4f7cbdc40e28acc4636f_D20220401-20220630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTMtOS0xLTEtMTIxNzk3_49ac8c14-8f28-4a9a-83c8-72717dabd507">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTMtMTAtMS0xLTEyMTc5Nw_05f987a0-0b70-49f5-a0ce-0776d71fa68e">2,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss (Note 8)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9044e77680c543eab4fbb19765443084_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTQtNy0xLTEtMTIxNzk3_a3f60fc5-0a8d-46f2-8936-75e4bddaa444">798</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4275461340524ac9a913007bb4256c99_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTQtOC0xLTEtMTIxNzk3_18b9cdd9-af82-45d6-8312-b60a5cb5f488">798</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTQtMTAtMS0xLTEyMTc5Nw_1fda5fa2-56c7-4351-9a54-8b640cc2de23">798</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock option activity, stock awards and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia4478efe64a3489c931acebf3d633806_D20220401-20220630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTUtMS0xLTEtMTIxNzk3_3c819e17-4b2f-4c8b-8989-852d9485038f">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf70211547034c07b67bbb782ef034de_D20220401-20220630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTUtNC0xLTEtMTIxNzk3_6c2747e3-dede-457b-8fb6-f18a11dd3d80">197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4275461340524ac9a913007bb4256c99_D20220401-20220630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTUtOC0xLTEtMTIxNzk3_dd9ad66e-a722-48ac-acdf-4edc9dae5bba">197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTUtMTAtMS0xLTEyMTc5Nw_459737a9-e736-43e4-b58f-f895cf309a3a">197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of treasury shares, net of ESPP issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3c407840d1534bd3a85610f6bc0f2a82_D20220401-20220630" decimals="-6" name="cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTYtMi0xLTEtMTIxNzk3_154f1ad4-fca3-4f85-92d2-5a7635f0565d">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c407840d1534bd3a85610f6bc0f2a82_D20220401-20220630" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTYtNS0xLTEtMTIxNzk3_154e00c8-a541-4d98-accc-56eddbda1a6d">267</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4275461340524ac9a913007bb4256c99_D20220401-20220630" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTYtOC0xLTEtMTIxNzk3_3980c648-b7dc-4da2-8580-a2b0d6eab71f">267</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTYtMTAtMS0xLTEyMTc5Nw_f5e3ed1c-e688-4c63-918d-74dc53ba09ac">267</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i60699824f52b49fcb5663bfa26640e09_D20220401-20220630" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTctNi0xLTEtMTIxNzk3_0328278c-d48f-4faf-90f6-ff9d00853a07">729</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4275461340524ac9a913007bb4256c99_D20220401-20220630" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTctOC0xLTEtMTIxNzk3_967ed60d-080a-4cd9-80d5-003db4eda4eb">729</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTctMTAtMS0xLTEyMTc5Nw_eb93ce1f-431a-44e7-8e7a-b92748dd4e73">729</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other increases in noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb80b8e269cf4f7cbdc40e28acc4636f_D20220401-20220630" decimals="-6" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTgtOS0xLTEtMTIxNzk3_c16b37f1-f7dc-418c-a395-5ffea7dc6413">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTgtMTAtMS0xLTEyMTc5Nw_1c8dcf77-6bf5-462c-9b67-c45a3a7e3251">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i65b5f26da4ed4d9f951f94da7cd00c3d_I20220630" decimals="-6" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTktMS0xLTEtMTIxNzk3_5add3e46-74f9-4e2d-a5e7-32d8f2e8bc1d">1,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i4ebe896f6f5249aebd3596e8ae9c06e3_I20220630" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTktMi0xLTEtMTIxNzk3_03bce8fe-e38d-4c1a-ba83-666579445e99">443</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91f59faea12744d3b7195336c1ca91cc_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTktNC0xLTEtMTIxNzk3_987e90b2-e1f5-4dd2-b500-7e736e8766e7">47,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ebe896f6f5249aebd3596e8ae9c06e3_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTktNS0xLTEtMTIxNzk3_09c716ae-4201-4796-8206-a2ee1f58bb89">30,412</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6f61f23dd44e0f9334dc0bfb9b4810_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTktNi0xLTEtMTIxNzk3_a76f3777-8d7d-4f67-b8df-71b5cf509791">58,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d56c57b212d4a108b033b2948d0291b_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTktNy0xLTEtMTIxNzk3_bb307c98-f314-4731-b086-226228a2c4c1">988</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e372c5939d46a59aed59e0c12a2a5a_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTktOC0xLTEtMTIxNzk3_5e715efd-8165-4966-a0dc-7f811a4de7db">75,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia55d0b5fcc284c1bb1843f6b3df18f68_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTktOS0xLTEtMTIxNzk3_499d9cf3-b2ff-4e4a-9cf4-08f54b9416b4">322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTktMTAtMS0xLTEyMTc5Nw_cf917f62-f360-47b8-9123-abfb3d4bcd9a">75,506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfNDky_63589532-c838-4110-b767-3f81e3cda92d" footnoteRole="http://www.xbrl.org/2003/role/footnote">Treasury shares include <ix:nonFraction unitRef="shares" contextRef="i3779b6c8ef834637b29b6a1763d82299_I20220331" decimals="-6" name="cvs:TreasuryStockSharesHeldinTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMTcy_d00d5199-0aac-4e58-aeba-d5f762140f73"><ix:nonFraction unitRef="shares" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="cvs:TreasuryStockSharesHeldinTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMTcy_f2bba169-2673-477e-8c47-26b0ba6eae30"><ix:nonFraction unitRef="shares" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="cvs:TreasuryStockSharesHeldinTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMTcy_fbb06a2b-6db5-44d3-bc76-6f55a37286e7">1</ix:nonFraction></ix:nonFraction></ix:nonFraction> million shares held in trust and treasury stock includes $<ix:nonFraction unitRef="usd" contextRef="i3779b6c8ef834637b29b6a1763d82299_I20220331" decimals="-6" name="cvs:TreasuryStockValueSharesHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMjI0_be626d1b-cb08-4abb-a1c6-97ec4e5b604b"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="cvs:TreasuryStockValueSharesHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMjI0_da30be1e-ad71-41a1-b56b-4cf6433518e4"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="cvs:TreasuryStockValueSharesHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMjI0_ecbfc884-e47d-4eab-9a82-7d96df218bac">29</ix:nonFraction></ix:nonFraction></ix:nonFraction> million related to shares held in trust as of June&#160;30, 2022, March&#160;31, 2022 and December&#160;31, 2021.</ix:footnote></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfNDkw_1003b8e3-dae8-4a27-82a0-29bb92e78bc3" footnoteRole="http://www.xbrl.org/2003/role/footnote">Common stock and capital surplus includes the par value of common stock of $<ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMzY2_7ab51b95-5926-41b2-b5bf-1bc50e160f29">18</ix:nonFraction> million as of June&#160;30, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMTA5OTUxMTYyOTAzMg_0931fc27-1fc5-423b-a3a4-85c5abf2f94f"><ix:nonFraction unitRef="usd" contextRef="i3779b6c8ef834637b29b6a1763d82299_I20220331" decimals="-6" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMTA5OTUxMTYyOTAzMg_5b18a423-46a0-4b03-85bd-c0dd984f6915">17</ix:nonFraction></ix:nonFraction> million as of March&#160;31, 2022 and December&#160;31, 2021.</ix:footnote></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Attributable to CVS Health</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of shares<br/>outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Surplus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total <br/>CVS Health<br/>Shareholders&#8217;<br/>&#160;Equity</span></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Shareholders&#8217;<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Shares</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic10a47a61fb346eca4da1c6b4eb8f3e0_I20201231" decimals="-6" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNS0xLTEtMS0xMjcwMDM_0b480aa2-b1e1-4e32-9cd2-1c9e3748ec73">1,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i152dc72ae8c845738b9dc7cb8c6f3c9f_I20201231" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNS0yLTEtMS0xMjcwMDM_4b69fe63-e272-4068-992d-1a5b471b8279">423</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e08d0b5d454c76b137a0fcc9650921_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNS00LTEtMS0xMjcwMDM_54fa1447-121f-4df3-8c6b-e02c861e6ab3">46,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i152dc72ae8c845738b9dc7cb8c6f3c9f_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNS01LTEtMS0xMjcwMDM_797349a6-d7bb-4e80-99b7-d08c78b967a4">28,178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49bd9c3e375d4c40a91fc221c0821506_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNS02LTEtMS0xMjcwMDM_a8019749-4bab-4f5a-8aab-e30d4bce6342">49,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3da84ec0ac498db41f931fdcbc851b_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNS03LTEtMS0xMjcwMDM_8dc03ae3-708b-4528-8eda-53661e6acf25">1,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31664a1f007d452f8f852aa3e9e14177_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNS04LTEtMS0xMjcwMDM_e417b675-4d3f-4de4-8c04-6644ffbd48bb">69,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9917e617b6b24457b71193960c36094b_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNS05LTEtMS0xMjcwMDM_3601938e-fade-42f5-bd26-2c0e3aa08f1d">312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1b37908bcec4675b7dd487bd3f7f745_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNS0xMC0xLTEtMTI3MDAz_99ada50f-ec2a-41fb-8f19-f12130bf651f">69,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee221d6eeb484991817f46c9fe0c087f_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNi02LTEtMS0xMjcwMDM_9a4cbc09-8a61-41b7-a336-ac5ace52f6c4">2,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fdbb1c5a52d4721a5d3e754c65f8bc3_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNi04LTEtMS0xMjcwMDM_c9102396-e98d-4ac5-a974-67ba05a5b437">2,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561416f54ed14d4aa729dc31040c8e99_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNi05LTEtMS0xMjcwMDM_c7dbd971-c4bb-4f84-8bbb-636682e5fe87">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46f6d2a9429541919bc596eed6bc6437_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNi0xMC0xLTEtMTI3MDAz_a555fbe7-814b-405a-b77e-b51d3eb97787">2,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i772325f7509041e3ae0b28f2fede65ec_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNy03LTEtMS0xMjcwMDM_44ad32a0-9b6f-4c10-9ca6-caaecde350e8">392</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fdbb1c5a52d4721a5d3e754c65f8bc3_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNy04LTEtMS0xMjcwMDM_47a490b8-4876-44c2-837b-4ee2095a14cc">392</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46f6d2a9429541919bc596eed6bc6437_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNy0xMC0xLTEtMTI3MDAz_d88e8381-2607-4759-b346-9ec5b6a23b73">392</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock option activity, stock awards and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if0eb4e5ad890414b9e6e3b2fbcd7a242_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfOC0xLTEtMS0xMjcwMDM_09d63b2e-caa0-49bb-aee8-2482d8f5dadf">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8357bbbf6fe4f958f2b67dcfcf2a97b_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfOC00LTEtMS0xMjcwMDM_8e4d2ad2-b399-4b6a-940c-a2e3e0d503e8">214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fdbb1c5a52d4721a5d3e754c65f8bc3_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfOC04LTEtMS0xMjcwMDM_85a30975-8da6-4136-a273-5960954f5fe3">214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46f6d2a9429541919bc596eed6bc6437_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfOC0xMC0xLTEtMTI3MDAz_a61b1ffd-2925-4eb3-9bd2-551ce7b8c7b6">214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESPP issuances, net of purchase of treasury shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i24a096e6009a44be8a941b871322166f_D20210101-20210331" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfOS0yLTEtMS0xMjcwMDM_e59e8c63-0c25-4211-a3f2-69398263ad87">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24a096e6009a44be8a941b871322166f_D20210101-20210331" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfOS01LTEtMS0xMjcwMDM_9e0b0692-cefc-4172-8e83-11b20cc520d0">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fdbb1c5a52d4721a5d3e754c65f8bc3_D20210101-20210331" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfOS04LTEtMS0xMjcwMDM_7652c491-1d79-4ac8-9268-aebb58f918ac">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46f6d2a9429541919bc596eed6bc6437_D20210101-20210331" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfOS0xMC0xLTEtMTI3MDAz_1d759c7c-a7bf-459c-a440-321e86d29cfd">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee221d6eeb484991817f46c9fe0c087f_D20210101-20210331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTAtNi0xLTEtMTI3MDAz_f2e90576-2d68-46d5-818e-bad448e5fc9f">660</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fdbb1c5a52d4721a5d3e754c65f8bc3_D20210101-20210331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTAtOC0xLTEtMTI3MDAz_187e930c-e7c5-4b37-91dc-305d6f0b6351">660</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46f6d2a9429541919bc596eed6bc6437_D20210101-20210331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTAtMTAtMS0xLTEyNzAwMw_a28f92b0-8a21-4c90-b4d3-3c9af591ccec">660</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other increases in noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561416f54ed14d4aa729dc31040c8e99_D20210101-20210331" decimals="-6" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTEtOS0xLTEtMTI3MDAz_8b27b4d2-5841-418f-9c28-a8b41678186d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46f6d2a9429541919bc596eed6bc6437_D20210101-20210331" decimals="-6" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTEtMTAtMS0xLTEyNzAwMw_41d10884-e0f1-4a2e-a313-5a5b7e4b80ef">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if45457c84fd043c9b7d744c3fc83d3da_I20210331" decimals="-6" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTItMS0xLTEtMTI3MDAz_24fec2f4-42ce-4cd9-825a-1f7deb64787c">1,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ica2f5f3fd6224895b0ce4b545dcbd6be_I20210331" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTItMi0xLTEtMTI3MDAz_911440fa-050b-488a-899d-429c516738f6">422</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1320581fe0074807a2a6f1646978f417_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTItNC0xLTEtMTI3MDAz_bb526491-7c2b-4a52-9a48-cbbdf1fff5eb">46,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2f5f3fd6224895b0ce4b545dcbd6be_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTItNS0xLTEtMTI3MDAz_c33682a7-bcff-478e-bd70-3c9fde37f6fa">28,102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98cd8c15279e490f8c5ece01fc0a2607_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTItNi0xLTEtMTI3MDAz_53e159e9-3090-4322-a85e-02538a2f0db2">51,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9364eb9de5284648ba5dce23aaf45747_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTItNy0xLTEtMTI3MDAz_918aebaa-e7f4-49a4-a7a8-bd63987e8a52">1,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2b899747e3a4cae8ea6928b46d7a6ef_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTItOC0xLTEtMTI3MDAz_f8cf8848-9ec6-4781-94a5-03bf372fd01e">70,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia657fbce9b4e48baa94aeb01df078a63_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTItOS0xLTEtMTI3MDAz_f14c797f-28cb-45d5-9af7-ec2fb797722d">314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i959322b91e4a46abaae950c149d362c1_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTItMTAtMS0xLTEyNzAwMw_447a409c-3b58-4bcb-94b1-73b2c1ac4af9">71,164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4dd5a3fb4014191b1a23eef5aec7288_D20210401-20210630" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTMtNi0xLTEtMTI3MDAz_8fd738c0-18d6-4ea9-92f4-361af0593021">2,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64c81a1cfe4e4ed3a4d01a9a55628941_D20210401-20210630" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTMtOC0xLTEtMTI3MDAz_55940efa-c7cc-421e-99e1-eb75f50e90f7">2,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e4dbea634eb411686fe24903cb97ba4_D20210401-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTMtOS0xLTEtMTI3MDAz_2aa0278e-3302-4863-918b-7c2d6fab9740">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTMtMTAtMS0xLTEyNzAwMw_79d496fc-9708-48bf-a060-7a5e798397f5">2,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (Note 8)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i260f5a79243641bf898cd28e99b21a0f_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTQtNy0xLTEtMTI3MDAz_b9a71718-e1f4-41ec-8361-a2bd40ee1ba6">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64c81a1cfe4e4ed3a4d01a9a55628941_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTQtOC0xLTEtMTI3MDAz_b8e7f5ff-53fe-49c1-847a-d86678511c75">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTQtMTAtMS0xLTEyNzAwMw_3bb0d8ef-4973-432a-bc73-61618941dd4f">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock option activity, stock awards and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i090190413d0546e98f4e006ce4c3c486_D20210401-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTUtMS0xLTEtMTI3MDAz_730f2764-e71d-42f5-a819-6907a85875be">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7c5ecaffa7d41eb8fdfaa819f432922_D20210401-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTUtNC0xLTEtMTI3MDAz_eeb6dd1a-454a-40c5-9b62-7871e942aac9">268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64c81a1cfe4e4ed3a4d01a9a55628941_D20210401-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTUtOC0xLTEtMTI3MDAz_160e4d65-c45a-425d-8636-d90be1eed6dc">268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTUtMTAtMS0xLTEyNzAwMw_6152fe27-3893-4c66-9a3b-7fb19410be06">268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of treasury shares, net of ESPP issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="idaa5b59feb95483188ced67d5fbf4950_D20210401-20210630" decimals="-6" name="cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTYtMi0xLTEtMTI3MDAz_9e1cc617-4617-4ca6-be10-e7d61fd3987b">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idaa5b59feb95483188ced67d5fbf4950_D20210401-20210630" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTYtNS0xLTEtMTI3MDAz_691de804-9265-412f-bff6-1fbe6a8f3a9b">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64c81a1cfe4e4ed3a4d01a9a55628941_D20210401-20210630" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTYtOC0xLTEtMTI3MDAz_e6b1472a-f427-4d9c-9f30-1d822fc4108d">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTYtMTAtMS0xLTEyNzAwMw_8e531f18-1ef3-4568-8989-0d09680b19ae">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4dd5a3fb4014191b1a23eef5aec7288_D20210401-20210630" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTctNi0xLTEtMTI3MDAz_6579f989-c14f-46d2-9bb2-0229e912310f">655</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64c81a1cfe4e4ed3a4d01a9a55628941_D20210401-20210630" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTctOC0xLTEtMTI3MDAz_b9ba7b51-60c2-47b6-a6fa-180d4ea28d0e">655</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTctMTAtMS0xLTEyNzAwMw_6ffd9a2b-d350-4ae3-8cac-f9a8fc19dd25">655</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other decreases in noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e4dbea634eb411686fe24903cb97ba4_D20210401-20210630" decimals="-6" sign="-" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTgtOS0xLTEtMTI3MDAz_56554e8c-e8b8-4327-95e3-518c31862f3a">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" sign="-" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTgtMTAtMS0xLTEyNzAwMw_b1937e4b-0a1a-4744-8722-461637c183a8">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i48dfc02937744c869af28bd5454ce1e7_I20210630" decimals="-6" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTktMS0xLTEtMTI3MDAz_b9ead8e1-63b9-4492-9d0c-9c2874c7b972">1,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6ce9ce9b48d54a45a210fb81622aa4dc_I20210630" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTktMi0xLTEtMTI3MDAz_01df612b-9071-4ff9-8baf-73b2748bcc51">424</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a378f6ac4174a9c8b2c62fbb49af994_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTktNC0xLTEtMTI3MDAz_da028d11-1181-47fb-8de2-1199b5addb2e">46,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ce9ce9b48d54a45a210fb81622aa4dc_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTktNS0xLTEtMTI3MDAz_b39331c3-41d8-444f-8ed9-c366fb0e90b8">28,252</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i070d725cebd0413da9a910f72c7a5854_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTktNi0xLTEtMTI3MDAz_03699afd-95ef-42eb-ba61-effbf37d5585">53,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d834339a4a64e8ab4f3498ba15b93ea_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTktNy0xLTEtMTI3MDAz_8aa50288-51d7-4e76-8f8f-698d6f11cbe1">1,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe740c19bbce491b8bf0931a8ba2c65c_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTktOC0xLTEtMTI3MDAz_6d29af37-b808-423f-badc-3394f33c40c0">73,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42940cbfec444379ba0dbd31dce09948_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTktOS0xLTEtMTI3MDAz_1188f34f-86ae-4fa7-a432-ac334c729a51">321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c91d440ca044d289daea52743e3cebd_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTktMTAtMS0xLTEyNzAwMw_b4f47d0d-1b70-4b97-ab01-77a35ef65ee3">73,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMzI5ODUzNDg4NDU2MA_e3676cc9-4075-4e41-88e3-205243fa39bd" footnoteRole="http://www.xbrl.org/2003/role/footnote">Treasury shares include <ix:nonFraction unitRef="shares" contextRef="i9c91d440ca044d289daea52743e3cebd_I20210630" decimals="-6" name="cvs:TreasuryStockSharesHeldinTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMTA5OTUxMTYyODc1MQ_0f0054ab-8b30-42fa-ac96-62433e756172"><ix:nonFraction unitRef="shares" contextRef="id1b37908bcec4675b7dd487bd3f7f745_I20201231" decimals="-6" name="cvs:TreasuryStockSharesHeldinTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMTA5OTUxMTYyODc1MQ_bc1717d8-9278-4399-ba60-8e301d24e74b"><ix:nonFraction unitRef="shares" contextRef="i959322b91e4a46abaae950c149d362c1_I20210331" decimals="-6" name="cvs:TreasuryStockSharesHeldinTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMTA5OTUxMTYyODc1MQ_bdd312b9-2a36-47fd-87e2-2efae22ffecc">1</ix:nonFraction></ix:nonFraction></ix:nonFraction> million shares held in trust and treasury stock includes $<ix:nonFraction unitRef="usd" contextRef="i9c91d440ca044d289daea52743e3cebd_I20210630" decimals="-6" name="cvs:TreasuryStockValueSharesHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMTA5OTUxMTYyODc1Nw_0bd8908a-185f-49fd-a06a-8dfdc1f07bef"><ix:nonFraction unitRef="usd" contextRef="i959322b91e4a46abaae950c149d362c1_I20210331" decimals="-6" name="cvs:TreasuryStockValueSharesHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMTA5OTUxMTYyODc1Nw_778a89ff-0457-4645-aa69-5fb4626c1192"><ix:nonFraction unitRef="usd" contextRef="id1b37908bcec4675b7dd487bd3f7f745_I20201231" decimals="-6" name="cvs:TreasuryStockValueSharesHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMTA5OTUxMTYyODc1Nw_c1e8a0c7-e4b5-4dee-ac29-f5504a484772">29</ix:nonFraction></ix:nonFraction></ix:nonFraction> million related to shares held in trust as of June&#160;30, 2021, March 31, 2021 and December 31, 2020.</ix:footnote></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMzI5ODUzNDg4NDU2MQ_057b7f4e-b885-4b2e-9da9-bf48cbe75bc8" footnoteRole="http://www.xbrl.org/2003/role/footnote">Common stock and capital surplus includes the par value of common stock of $<ix:nonFraction unitRef="usd" contextRef="i959322b91e4a46abaae950c149d362c1_I20210331" decimals="-6" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMTA5OTUxMTYyODc2Mg_16888582-ee38-4cca-8075-b7042ee0094d"><ix:nonFraction unitRef="usd" contextRef="i9c91d440ca044d289daea52743e3cebd_I20210630" decimals="-6" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMTA5OTUxMTYyODc2Mg_3c52963c-2574-47ac-a5a3-6a8a78dce6c0"><ix:nonFraction unitRef="usd" contextRef="id1b37908bcec4675b7dd487bd3f7f745_I20201231" decimals="-6" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMTA5OTUxMTYyODc2Mg_f5141bc7-c959-4445-afce-921a1ed44038">17</ix:nonFraction></ix:nonFraction></ix:nonFraction> million as of June&#160;30, 2021, March 31, 2021 and December 31, 2020.</ix:footnote></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements (unaudited).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></div><div><span><br/></span></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_37"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTYxODI_222b3c15-a00e-4bed-95a5-1dd0a7b4492a" continuedAt="i0a3be81570d64bb6bf7844b3bea76f5c" escape="true">Significant Accounting Policies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i0a3be81570d64bb6bf7844b3bea76f5c" continuedAt="i45a4530b71a242b89c0560a6610f5782"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business&#160; </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation, together with its subsidiaries (collectively, &#8220;CVS Health&#8221; or the &#8220;Company&#8221;), has more than <ix:nonFraction unitRef="store" contextRef="i3e0ead3c67874e9c96bf47478f6e8f41_I20220630" decimals="-2" name="us-gaap:NumberOfStores" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTgy_626e618e-4b09-4362-bd8d-6bcbe7b46fab">9,000</ix:nonFraction> retail locations, more than <ix:nonFraction unitRef="clinic" contextRef="i3e0ead3c67874e9c96bf47478f6e8f41_I20220630" decimals="-2" name="cvs:NumberofWalkInMedicalClinics" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMjEz_3546db12-4ca2-4a89-86f2-0d4deedbf09e">1,100</ix:nonFraction> walk-in medical clinics, a leading pharmacy benefits manager with over <ix:nonFraction unitRef="people" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="cvs:NumberofPharmacyPlanMembers" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMjk2_8ff2831c-5f9a-46ac-a8b0-a80a24075b67">110</ix:nonFraction> million plan members with expanding specialty pharmacy solutions and a dedicated senior pharmacy care business serving more than <ix:nonFraction unitRef="patient" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="cvs:NumberofPatientsServedperYear" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfNDIw_76dd7f04-7080-459f-855c-272465d36875">one million</ix:nonFraction> patients per year. The Company also serves an estimated <ix:nonFraction unitRef="people" contextRef="i4313031902ce4be29cef2c3613a0b3a3_I20220630" decimals="-6" name="cvs:NumberOfPeopleServed" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfNDc5_a660b6ec-64fc-406f-aa31-1a294c072425">35</ix:nonFraction> million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#8220;PDP&#8221;). The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The coronavirus disease 2019 (&#8220;COVID-19&#8221;) and its emerging new variants continue to impact the economies of the U.S. and other countries around the world. The impact of COVID-19 on the Company&#8217;s businesses, operating results, cash flows and financial condition, as well as information regarding certain expected impacts of COVID-19 on the Company, is discussed throughout this Quarterly Report on Form 10-Q.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTYyMDQ_cb27d99c-df5c-4768-b0f9-fb1ffa4c4828" continuedAt="ieff73b0eb0e6452fb383084bde748e90" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="segment" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTI5Nw_409c8504-4ffb-4ce9-8506-357dea84e769">four</ix:nonFraction> reportable segments: Health Care Benefits, Pharmacy Services, Retail/LTC and Corporate/Other, which are described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment operates as one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology products and services. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221; In addition, effective January 2022, the Company entered the individual public health insurance exchanges (&#8220;Public Exchanges&#8221;) in <ix:nonFraction unitRef="state" contextRef="i1c0bcd0eebfa40769648a67be75183aa_D20220101-20220630" decimals="INF" name="cvs:IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMjg0Mw_f908f3d9-3b04-43dc-aea5-9cb52d9a128c">eight</ix:nonFraction> states through which it sells Insured plans directly to individual consumers. The Company has submitted regulatory filings to remain on the Public Exchanges in 2023 in each of those <ix:nonFraction unitRef="state" contextRef="i1c0bcd0eebfa40769648a67be75183aa_D20220101-20220630" decimals="INF" name="cvs:IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMzg0ODI5MDcxNzQ4MQ_f908f3d9-3b04-43dc-aea5-9cb52d9a128c">eight</ix:nonFraction> states, and has submitted regulatory filings to enter the Public Exchanges in <ix:nonFraction unitRef="state" contextRef="i52b2448e457a41c18f816cae8ba1b237_D20230101-20230131" decimals="INF" name="cvs:IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfAdditionalStates" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMzg0ODI5MDcxNzE5NA_bf3db026-f55c-4da9-b4dd-a3475c36b469">four</ix:nonFraction> additional states effective January 2023. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Pharmacy Services Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment provides a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services and mail order pharmacy. In addition, through the Pharmacy Services segment, the Company provides specialty pharmacy and infusion services, clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#8220;Covered Entities&#8221;). The Company operates a group purchasing organization that negotiates pricing for the purchase of pharmaceuticals and rebates with pharmaceutical manufacturers on behalf of its participants. The Company also provides various administrative, management and reporting services to pharmaceutical manufacturers. The Pharmacy Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on Public Exchanges and private health insurance exchanges, other sponsors of health benefit plans throughout the United States and Covered Entities. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, COVID-19 and shingles and conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of June&#160;30, 2022, the Retail/LTC segment operated more than <ix:nonFraction unitRef="store" contextRef="i3e0ead3c67874e9c96bf47478f6e8f41_I20220630" decimals="-2" name="us-gaap:NumberOfStores" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfNTAwNA_626e618e-4b09-4362-bd8d-6bcbe7b46fab">9,000</ix:nonFraction> retail </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i45a4530b71a242b89c0560a6610f5782" continuedAt="i131fa3f6d9b64e3386a3681263453026"><ix:continuation id="ieff73b0eb0e6452fb383084bde748e90"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">locations, more than <ix:nonFraction unitRef="clinic" contextRef="i3e0ead3c67874e9c96bf47478f6e8f41_I20220630" decimals="-2" name="cvs:NumberofWalkInMedicalClinics" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfNTAzNQ_3546db12-4ca2-4a89-86f2-0d4deedbf09e">1,100</ix:nonFraction> MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">locations as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate/Other Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTYxOTk_8959c64a-2091-4437-b8ed-be89769ae055" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) regarding interim financial reporting. In accordance with such rules and regulations, certain information and accompanying note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) have been omitted, although the Company believes the disclosures included herein are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2021 (the &#8220;2021 Form 10-K&#8221;).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Because of the influence of various factors on the Company&#8217;s operations, including business combinations, certain holidays and other seasonal influences, net income for any interim period may not be comparable to the same interim period in previous years or necessarily indicative of income for the full year.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTYxODU_22d02029-c745-4c5a-8ccf-e113567d7f2b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#8220;VIEs&#8221;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually evaluates its investments to determine if they represent variable interests in a VIE. If the Company determines that it has a variable interest in a VIE, the Company then evaluates if it is the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether the Company has the ability to direct the activities of a VIE that most significantly impact the entity&#8217;s economic performance. The Company consolidates a VIE if it is considered to be the primary beneficiary.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities of VIEs for which the Company is the primary beneficiary were not significant to the Company&#8217;s unaudited condensed consolidated financial statements. VIE creditors do not have recourse against the general credit of the Company.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTYxNDc_81098d99-2334-4ccf-b285-a7d3b44f7ad0" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform with the current year presentation.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i131fa3f6d9b64e3386a3681263453026" continuedAt="i2435dfc71ab44949a493c7477cf8b4f1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTYxOTE_bcbd4e27-74b6-4297-a4fc-dc74a624bbe2" continuedAt="i3a0993b519b84237bbccd1116d5ec647" escape="true">Restricted Cash</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3a0993b519b84237bbccd1116d5ec647">Restricted cash included in other current assets on the unaudited condensed consolidated balance sheets represents funds held on behalf of members, including health savings account funds associated with high deductible health plans. Restricted cash included in other assets on the unaudited condensed consolidated balance sheets represents amounts held in a trust in one of the Company&#8217;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits and money market funds.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTYxODY_dda7a3b7-6967-44e0-b044-e589b4e5cd42" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of cash and cash equivalents on the unaudited condensed consolidated balance sheets to total cash, cash equivalents and restricted cash on the unaudited condensed consolidated statements of cash flows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjU5NDY5NjEwOTYzYTRiNGI4YWNiMGYzM2UxODIxNzFmL3RhYmxlcmFuZ2U6NTk0Njk2MTA5NjNhNGI0YjhhY2IwZjMzZTE4MjE3MWZfMS0xLTEtMS0xMjE3OTc_bc70507c-f3d5-4616-80fa-3dd379c11c54">12,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjU5NDY5NjEwOTYzYTRiNGI4YWNiMGYzM2UxODIxNzFmL3RhYmxlcmFuZ2U6NTk0Njk2MTA5NjNhNGI0YjhhY2IwZjMzZTE4MjE3MWZfMS0zLTEtMS0xMjE3OTc_edb119ab-aa13-47e5-8aaf-c39508520fc0">9,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c91d440ca044d289daea52743e3cebd_I20210630" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjU5NDY5NjEwOTYzYTRiNGI4YWNiMGYzM2UxODIxNzFmL3RhYmxlcmFuZ2U6NTk0Njk2MTA5NjNhNGI0YjhhY2IwZjMzZTE4MjE3MWZfMS01LTEtMS0xMjE3OTc_6d864c8d-86bc-4ccf-9c11-c54e0ebbc9a0">7,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjU5NDY5NjEwOTYzYTRiNGI4YWNiMGYzM2UxODIxNzFmL3RhYmxlcmFuZ2U6NTk0Njk2MTA5NjNhNGI0YjhhY2IwZjMzZTE4MjE3MWZfMi0xLTEtMS0xMjE3OTc_73953fe3-63e5-4884-bf5c-f5fa3e82ad6f">131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:RestrictedCashCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjU5NDY5NjEwOTYzYTRiNGI4YWNiMGYzM2UxODIxNzFmL3RhYmxlcmFuZ2U6NTk0Njk2MTA5NjNhNGI0YjhhY2IwZjMzZTE4MjE3MWZfMi0zLTEtMS0xMjE3OTc_2399fab6-8462-4f35-a22d-c1f7f32d44c8">3,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c91d440ca044d289daea52743e3cebd_I20210630" decimals="-6" name="us-gaap:RestrictedCashCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjU5NDY5NjEwOTYzYTRiNGI4YWNiMGYzM2UxODIxNzFmL3RhYmxlcmFuZ2U6NTk0Njk2MTA5NjNhNGI0YjhhY2IwZjMzZTE4MjE3MWZfMi01LTEtMS0xMjE3OTc_2970c51b-ce35-44a6-b1ad-fb6f8fdfa2cc">2,959</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other assets)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjU5NDY5NjEwOTYzYTRiNGI4YWNiMGYzM2UxODIxNzFmL3RhYmxlcmFuZ2U6NTk0Njk2MTA5NjNhNGI0YjhhY2IwZjMzZTE4MjE3MWZfMy0xLTEtMS0xMjE3OTc_976be642-6584-413a-be28-007523e78be9">216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjU5NDY5NjEwOTYzYTRiNGI4YWNiMGYzM2UxODIxNzFmL3RhYmxlcmFuZ2U6NTk0Njk2MTA5NjNhNGI0YjhhY2IwZjMzZTE4MjE3MWZfMy0zLTEtMS0xMjE3OTc_1dc93548-9af9-4b00-b1f7-e399c5f542e9">218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c91d440ca044d289daea52743e3cebd_I20210630" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjU5NDY5NjEwOTYzYTRiNGI4YWNiMGYzM2UxODIxNzFmL3RhYmxlcmFuZ2U6NTk0Njk2MTA5NjNhNGI0YjhhY2IwZjMzZTE4MjE3MWZfMy01LTEtMS0xMjE3OTc_7d4371ac-121a-4d7f-85a7-e1a01f08c13a">218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash in the statements of cash flows</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjU5NDY5NjEwOTYzYTRiNGI4YWNiMGYzM2UxODIxNzFmL3RhYmxlcmFuZ2U6NTk0Njk2MTA5NjNhNGI0YjhhY2IwZjMzZTE4MjE3MWZfNC0xLTEtMS0xMjE3OTc_51e81291-7ef0-4ccc-bf41-30689547dadb">12,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjU5NDY5NjEwOTYzYTRiNGI4YWNiMGYzM2UxODIxNzFmL3RhYmxlcmFuZ2U6NTk0Njk2MTA5NjNhNGI0YjhhY2IwZjMzZTE4MjE3MWZfNC0zLTEtMS0xMjE3OTc_741d167f-3c45-4b79-95ff-5059f1f8d901">12,691</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c91d440ca044d289daea52743e3cebd_I20210630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjU5NDY5NjEwOTYzYTRiNGI4YWNiMGYzM2UxODIxNzFmL3RhYmxlcmFuZ2U6NTk0Njk2MTA5NjNhNGI0YjhhY2IwZjMzZTE4MjE3MWZfNC01LTEtMS0xMjE3OTc_5e48d43b-b104-4fa1-84ca-7d5e6a85fe3c">10,296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in restricted cash included in other current assets as of June&#160;30, 2022 compared to December&#160;31, 2021 was primarily due to a decrease in health savings account funds held on behalf of customers as a result of the sale of PayFlex Holdings, Inc. (&#8220;PayFlex&#8221;). See Note 2 &#8216;&#8216;Divestitures and Asset Sales&#8217;&#8217; for additional information on the Company&#8217;s sale of PayFlex.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTYxNDg_bb9e1371-b659-4805-b1ab-2ac9e635d497" continuedAt="i241e9b0589b14ccf8ca610922a39e988" escape="true">Accounts Receivable</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i241e9b0589b14ccf8ca610922a39e988">Accounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations</ix:continuation>. <ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTYxNTg_49d3ff2e-882a-4320-9e60-2d33e4392dd8" continuedAt="ic6685724f75e4391a541aab625ec9a8d" escape="true">Accounts receivable, net is composed of the following:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="ic6685724f75e4391a541aab625ec9a8d"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjQzMjM2YTIyYzM4YjRmZTZhNGE3YzgwMTBkOGIxYjg5L3RhYmxlcmFuZ2U6NDMyMzZhMjJjMzhiNGZlNmE0YTdjODAxMGQ4YjFiODlfMS0xLTEtMS0xMjE3OTc_ba31fbd8-8535-402c-b785-bffb17c6da7e">9,084</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjQzMjM2YTIyYzM4YjRmZTZhNGE3YzgwMTBkOGIxYjg5L3RhYmxlcmFuZ2U6NDMyMzZhMjJjMzhiNGZlNmE0YTdjODAxMGQ4YjFiODlfMS0zLTEtMS0xMjE3OTc_dc38c1fa-a272-4549-8ed3-de679298be34">7,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor and manufacturer receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="cvs:VendorandManufacturerReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjQzMjM2YTIyYzM4YjRmZTZhNGE3YzgwMTBkOGIxYjg5L3RhYmxlcmFuZ2U6NDMyMzZhMjJjMzhiNGZlNmE0YTdjODAxMGQ4YjFiODlfMi0xLTEtMS0xMjE3OTc_77a6cad7-3cb3-46ef-8801-9475352e5250">12,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="cvs:VendorandManufacturerReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjQzMjM2YTIyYzM4YjRmZTZhNGE3YzgwMTBkOGIxYjg5L3RhYmxlcmFuZ2U6NDMyMzZhMjJjMzhiNGZlNmE0YTdjODAxMGQ4YjFiODlfMi0zLTEtMS0xMjE3OTc_bbe47701-a684-44b4-917a-0084dfa828e3">10,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:PremiumsReceivableAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjQzMjM2YTIyYzM4YjRmZTZhNGE3YzgwMTBkOGIxYjg5L3RhYmxlcmFuZ2U6NDMyMzZhMjJjMzhiNGZlNmE0YTdjODAxMGQ4YjFiODlfMy0xLTEtMS0xMjE3OTc_1fe4b19f-def0-4973-af87-76a4efcd89d1">3,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:PremiumsReceivableAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjQzMjM2YTIyYzM4YjRmZTZhNGE3YzgwMTBkOGIxYjg5L3RhYmxlcmFuZ2U6NDMyMzZhMjJjMzhiNGZlNmE0YTdjODAxMGQ4YjFiODlfMy0zLTEtMS0xMjE3OTc_eed802a7-1f8e-4d0f-a0eb-a8eae4933fb4">2,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjQzMjM2YTIyYzM4YjRmZTZhNGE3YzgwMTBkOGIxYjg5L3RhYmxlcmFuZ2U6NDMyMzZhMjJjMzhiNGZlNmE0YTdjODAxMGQ4YjFiODlfNC0xLTEtMS0xMjE3OTc_524592a3-7ed0-4c91-8191-b2e1dcb0a226">2,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjQzMjM2YTIyYzM4YjRmZTZhNGE3YzgwMTBkOGIxYjg5L3RhYmxlcmFuZ2U6NDMyMzZhMjJjMzhiNGZlNmE0YTdjODAxMGQ4YjFiODlfNC0zLTEtMS0xMjE3OTc_16f0f2c8-0561-41b8-ade6-2972771c7d44">3,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total accounts receivable, net </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjQzMjM2YTIyYzM4YjRmZTZhNGE3YzgwMTBkOGIxYjg5L3RhYmxlcmFuZ2U6NDMyMzZhMjJjMzhiNGZlNmE0YTdjODAxMGQ4YjFiODlfNS0xLTEtMS0xMjE3OTc_94c2a9cd-3091-4454-9a2e-d69687550007">27,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjQzMjM2YTIyYzM4YjRmZTZhNGE3YzgwMTBkOGIxYjg5L3RhYmxlcmFuZ2U6NDMyMzZhMjJjMzhiNGZlNmE0YTdjODAxMGQ4YjFiODlfNS0zLTEtMS0xMjE3OTc_805e0e64-56f9-473c-b6ee-bc2e9a4c13db">24,431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s allowance for credit losses was $<ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfOTcwOQ_85473069-d827-439a-9fbc-40b9f96d2d7f">340</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfOTcxNg_a1f493f2-b8e7-421b-a872-033c9c919cf0">339</ix:nonFraction> million as of June&#160;30, 2022 and December&#160;31, 2021, respectively. <ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTYxNDI_2a4c4923-250e-4aa0-ab15-8e13d427bda5" escape="true">When developing an estimate of the Company&#8217;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#8217;s accounts receivable are short duration in nature and typically settle in less than 30 days.</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2435dfc71ab44949a493c7477cf8b4f1" continuedAt="i1ec7a037a8fb431f89856395b8d5801d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTYxOTU_2ba6b7ed-bd35-4019-ba9c-4c77bfe38308" continuedAt="i97bcf385b0ce4d5aa9ca415172d7f931" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables disaggregate the Company&#8217;s revenue by major source in each segment for the three and six months ended June 30, 2022 and 2021:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i211b727efe674251b7af74e7c727f2f6_D20220401-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMy0xLTEtMS0xMjE3OTc_86c113ae-7856-46a2-8eb0-673c801b0687">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ee2fa91c9e748c5bcd3a0dd4c42587d_D20220401-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMy0zLTEtMS0xMjE3OTc_dcf6ffa4-e9ff-427d-b2d6-e70fa7c37911">42,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad952d467934022a4d99fb585b701e3_D20220401-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMy01LTEtMS0xMjE3OTc_2600ee70-c0b9-4316-be77-013273cc21bf">20,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39657e3bd9404c6db2b0e8d4dfd62174_D20220401-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMy03LTEtMS0xMjE3OTc_099360d2-4d9d-4c94-a478-7d3401f5ad68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia252187be8364a1dbaf93db9dc77a52d_D20220401-20220630" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMy05LTEtMS0xMjE3OTc_4f7080d7-ae2f-43dd-8ef9-b81cba9f04c2">11,258</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb6ae33774b44fb4995615218a58f912_D20220401-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMy0xMS0xLTEtMTIxNzk3_3a2506fc-8dd3-41c0-ac9c-ebb333aae915">51,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a067985ca40f48d352ec61580eefc_D20220401-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNC0xLTEtMS0xMjE3OTc_f88af3a7-9637-46be-95fb-00f9f1d49a86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f41b5ed07e47ae8a0cbb4ad812d296_D20220401-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNC0zLTEtMS0xMjE3OTc_9a63acb4-1115-4762-9416-22d8d4f9059d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0248b692278b4870a7c3ba3d7f66b90f_D20220401-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNC01LTEtMS0xMjE3OTc_ba5964f5-21c1-4538-b429-ff529a059c74">5,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d27d90709144b74bf478175cdb6010d_D20220401-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNC03LTEtMS0xMjE3OTc_d6557057-055e-4ff8-b3ad-b9d6f419f0d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0995d0ff3d504aba96c0fe94fe99a19d_D20220401-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNC05LTEtMS0xMjE3OTc_57dc1273-c554-42b9-b487-ecdaa771e383">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c12809aa193462b8677fc041a26a3c0_D20220401-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNC0xMS0xLTEtMTIxNzk3_c2844fea-3a3f-4acf-bc34-2b7ffe633586">5,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f4852b5d8704ebdaab77950f88bb254_D20220401-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNS0xLTEtMS0xMjE3OTc_f09743d9-de3c-49bd-8256-078177cf236f">21,245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13c0259435fc49c299d3a7dee2d7874f_D20220401-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNS0zLTEtMS0xMjE3OTc_11b54350-af62-47d7-82a5-27cd876813a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if133058117fb48ffa3c1f39f82db08b3_D20220401-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNS01LTEtMS0xMjE3OTc_775575e2-89b0-4548-9267-3f824865819c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i600c45cedb7847fe8e7f77de34c118c8_D20220401-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNS03LTEtMS0xMjE3OTc_035ebf36-5f5e-4dd8-96e3-2b18c7816103">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71aab19dd48441a298119f6a243dc82c_D20220401-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNS05LTEtMS0xMjE3OTc_4c09df98-d65f-49bc-a623-90cf0f51a300">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d8c6ba01e94480ca8cf278d517a9619_D20220401-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNS0xMS0xLTEtMTIxNzk3_0a0cd2ce-d6d0-470d-97fe-74ac4766652d">21,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5045314d03040549992e1b0d350c6f4_D20220401-20220630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNi0xLTEtMS0xMjE3OTc_f18f10ed-9d0b-49a8-a7f1-05f22d3466a8">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61b1e59accbc4a6b9fdbbf4dd1e166d8_D20220401-20220630" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNi0zLTEtMS0xMjE3OTc_76f3fb83-1e6d-4889-9e52-d3894172ca7b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i054a08a597154e34b91b50e36527b86c_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNi01LTEtMS0xMjE3OTc_be6be382-c22f-4905-9416-bfb7005a96a9">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a2e27009a64f7bb8e01545a97c8feb_D20220401-20220630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNi03LTEtMS0xMjE3OTc_744c454b-f9c5-45a8-84ad-aad79f69f38f">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1040a72d0304a058af732ed3761a15a_D20220401-20220630" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNi05LTEtMS0xMjE3OTc_e96d0d16-c015-49f9-9282-4a445144814d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNi0xMS0xLTEtMTIxNzk3_50378b8c-d0b1-4d1b-af84-784a9b68617e">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb61ac775a7478680ac7295974da830_D20220401-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNy0xLTEtMS0xMjE3OTc_1a54ffd3-cfac-43e1-853d-5d3c84f3f1d2">1,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia351ae656580421784396872e50f183f_D20220401-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNy0zLTEtMS0xMjE3OTc_cde3b659-0794-4bab-b95f-f9b409141b13">245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba21d41e0574453f9043075ca63b9071_D20220401-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNy01LTEtMS0xMjE3OTc_3db7d23f-1ebe-42e7-8827-061ee5e6f78a">551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1005878849c5409b8747da25c2c3aaaa_D20220401-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNy03LTEtMS0xMjE3OTc_85780646-413d-43b1-8b2c-922311d8ec85">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2a9323439d44a41bd807db01b403c2e_D20220401-20220630" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNy05LTEtMS0xMjE3OTc_ef54f47b-1128-42d8-9c84-9cdd38607407">70</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0b0ed60026f4fadb0d2eedd77fc61e3_D20220401-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNy0xMS0xLTEtMTIxNzk3_4920e930-b272-42d3-9a86-0ed8c237d13c">2,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5045314d03040549992e1b0d350c6f4_D20220401-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfOC0xLTEtMS0xMjE3OTc_e4743c15-23cd-4071-9a70-9597f339c7f0">22,756</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61b1e59accbc4a6b9fdbbf4dd1e166d8_D20220401-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfOC0zLTEtMS0xMjE3OTc_a3a637b4-87eb-432d-8814-3192d80b6b8c">42,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i054a08a597154e34b91b50e36527b86c_D20220401-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfOC01LTEtMS0xMjE3OTc_3251c4b3-2ad6-47d8-88cb-4a591b42fdb5">26,286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a2e27009a64f7bb8e01545a97c8feb_D20220401-20220630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfOC03LTEtMS0xMjE3OTc_d5ced707-ad90-4563-a2f1-2d59fe3d5879">110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1040a72d0304a058af732ed3761a15a_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfOC05LTEtMS0xMjE3OTc_3f21011a-7144-4ad7-a035-631e4789642c">11,328</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfOC0xMS0xLTEtMTIxNzk3_55e7137f-6eaf-4627-89fc-4ac5da3f0060">80,636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9705f2eab1364f59a4310ba9e64be4f7_D20220401-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTEtMy0xLTEtMTIxNzk3_a0f36f23-633d-4f83-bf67-b8301e198020">24,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66461e89f4cf4e2aa3f6185279aa73bb_D20220401-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTItMy0xLTEtMTIxNzk3_432f368e-0cda-4e51-a4cf-fbd329629835">18,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8548b563f1d944cca1d05b3dab4932ae_D20220401-20220630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTMtMy0xLTEtMTIxNzk3_6795570d-2b4b-496e-9476-ce9bca371e9a">245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61b1e59accbc4a6b9fdbbf4dd1e166d8_D20220401-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTQtMy0xLTEtMTIxNzk3_5baca44a-be20-410a-9d99-6266c58ebe13">42,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5f9bf2f84f5424a8f4403ced4cdf313_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTgtMS0xLTEtMTIxNzk3_348ceeb1-064d-4f78-9fd4-c4504272e4b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if91a5b69cd074ce79d4d34e004ebe4a9_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTgtMy0xLTEtMTIxNzk3_7e90391e-fd11-4b29-b711-5dae290906bf">38,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e8cf06c0bc54774a6be05b92ccb09f0_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTgtNS0xLTEtMTIxNzk3_dc8f926d-1ff0-4143-8710-85fed82d0659">18,873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id787a5341515453f9bca382ea7deede3_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTgtNy0xLTEtMTIxNzk3_cb4901d0-2abd-4746-8740-54423bca52b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76cc779209494399b277155e37005f03_D20210401-20210630" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTgtOS0xLTEtMTIxNzk3_ad782389-119a-4df9-b6bc-7ef586b5eb85">11,094</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69adb512452f407aa3bbe55a8fee69ec_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTgtMTEtMS0xLTEyMTc5Nw_d5b095cb-da1a-4367-bf91-60d61d65f438">45,932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d89a578ea644c4b4cf67268c64ef50_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTktMS0xLTEtMTIxNzk3_c890d9be-aa42-457a-8235-bb8f69541efc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i435b5e917ab045a4a02bf177f2b0e8b9_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTktMy0xLTEtMTIxNzk3_f8882f5d-7b3a-4ce4-b7f5-72f8c64e8407">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7efacb33d756442cbe220b672cf09431_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTktNS0xLTEtMTIxNzk3_2e20d5e7-80bc-4a7a-bf87-9948ef080838">5,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36e853003adb424d944872c915ac6b0b_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTktNy0xLTEtMTIxNzk3_4f2c2b15-551c-4c0a-8fcb-b663517a17b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03a49e5738514a6bb26ab374104cee06_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTktOS0xLTEtMTIxNzk3_3acedfcf-d914-41d3-b34b-19c5d5505b5b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6859cf97c16a4a5ebd938b85cb35957b_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTktMTEtMS0xLTEyMTc5Nw_1ce4d58d-6cf0-4018-80a7-5f8962e12e2e">5,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fab59a9eb31497ba179665fe456507e_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjAtMS0xLTEtMTIxNzk3_91ea05cc-bf74-4313-94bd-9cfa3400b100">18,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61167828fdf24a1dbd6b7d94ab77ec42_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjAtMy0xLTEtMTIxNzk3_50f2b102-ba4c-41b4-b2e5-eeb45afff2d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe16bcd19fa348eeb4e81dd6ad44410f_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjAtNS0xLTEtMTIxNzk3_f8f65a22-4f93-4877-a68b-347b5aa05491">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507ba2e974e440f69b7567158be6571f_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjAtNy0xLTEtMTIxNzk3_214f03ce-c9ab-4ac1-9af2-2c3699f5b920">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i438c350cb9734cbeb799f5b1892d664b_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjAtOS0xLTEtMTIxNzk3_e037ed85-07b6-425a-884e-2281329f31a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i623ff046ae5c485b878e5d00ab123314_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjAtMTEtMS0xLTEyMTc5Nw_40142651-8e61-4351-9e18-08d75bc42be8">18,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24217ba0c74626b4bf25cec318c623_D20210401-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjEtMS0xLTEtMTIxNzk3_e14f0a89-c8ef-406f-8764-302d27316631">137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if86bb61e4141479b9697828b3dc20cc6_D20210401-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjEtMy0xLTEtMTIxNzk3_de653d12-cb14-4954-a5d9-ef47ff913c8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44e989a3ada405d8425fbe65629dc23_D20210401-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjEtNS0xLTEtMTIxNzk3_9626702d-2eb6-4bfc-b87c-2df6b43ecd42">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa7e9e824974440a9373bee9896bb39_D20210401-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjEtNy0xLTEtMTIxNzk3_4f3b693f-d0a8-424b-b0f6-0960fc9f78f3">152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4922155132bd45ada7189d0b3ef9fc3e_D20210401-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjEtOS0xLTEtMTIxNzk3_7743df0a-9576-4b4d-9f37-d4804bea7f81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjEtMTEtMS0xLTEyMTc5Nw_f97c2c4e-1850-477d-b920-cb86616f56f3">289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81adcf0d41fd450681c65b683fb1aba1_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjItMS0xLTEtMTIxNzk3_e056f634-84e7-4ef1-bc51-2be770bc74b4">1,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1728c43ce0c146c3837ea3dca24f858d_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjItMy0xLTEtMTIxNzk3_07a7a773-8b37-4258-a2ef-5b2cb885a949">161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0723aca048c948b09c4e21b76e36afcb_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjItNS0xLTEtMTIxNzk3_86d5766a-74cf-43de-8e35-81c6351d7f31">601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief415c243f1342a49eed3ad3b8ccb6b3_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjItNy0xLTEtMTIxNzk3_73418da3-6fd1-4bc0-953c-d8b77c9113d2">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0312c66cceb448a780815200255d58c0_D20210401-20210630" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjItOS0xLTEtMTIxNzk3_3fb16f10-11e0-4db2-99ed-6eaa1c2c7cb0">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib88dd15d80484821a92bfc5cc6f71cec_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjItMTEtMS0xLTEyMTc5Nw_175ca155-ca75-4e75-8156-80f0da921001">2,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24217ba0c74626b4bf25cec318c623_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjMtMS0xLTEtMTIxNzk3_7bc5c2fe-a649-4dab-8757-bd1f99c63bf9">20,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if86bb61e4141479b9697828b3dc20cc6_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjMtMy0xLTEtMTIxNzk3_a8429618-62e6-4de2-b8f6-a820f22032e7">38,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44e989a3ada405d8425fbe65629dc23_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjMtNS0xLTEtMTIxNzk3_61c9dffd-c944-484c-b2c2-6b92ff8b5716">24,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa7e9e824974440a9373bee9896bb39_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjMtNy0xLTEtMTIxNzk3_eede05f6-b7aa-4623-b4de-537f4338092e">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4922155132bd45ada7189d0b3ef9fc3e_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjMtOS0xLTEtMTIxNzk3_f8ade7e9-f012-4844-a36f-ebf2e11c4155">11,133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjMtMTEtMS0xLTEyMTc5Nw_bd5434a5-704f-4749-99ce-afe078b10bf0">72,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf0d9424f03a41f0bea7d15520ac11ae_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjYtMy0xLTEtMTIxNzk3_05255fcd-5b59-49ec-8b46-e05468899557">22,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26d2adfcb7d047ac8b01711252305fdc_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjctMy0xLTEtMTIxNzk3_757ad60d-3eec-46a1-83d3-a718daf9757a">15,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99bcbdff8fe401f90d46731f3dc1a6c_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjgtMy0xLTEtMTIxNzk3_17485250-4501-4776-910a-76e2f15e8666">161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if86bb61e4141479b9697828b3dc20cc6_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjktMy0xLTEtMTIxNzk3_3bf14e46-a8a6-4e74-a078-a5a69cdc2697">38,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1ec7a037a8fb431f89856395b8d5801d" continuedAt="i5723405d19d346208495c3017e74af91"><ix:continuation id="i97bcf385b0ce4d5aa9ca415172d7f931"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6537cae612474b44bd681794d3356a66_D20220101-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMy0xLTEtMS0xMjc0MzE_b25fc545-cec1-4571-9f3a-f46fed196fb4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0782975245974b74b8eb5fc41883c74d_D20220101-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMy0zLTEtMS0xMjc0Mzk_ba816f37-07da-4406-b25b-d6afa62805fa">81,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16bcbe7065de4f5399be949b1c27cc7d_D20220101-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMy01LTEtMS0xMjc0Mzk_392d701a-0087-468a-b11f-55cafa82db14">39,549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aff33ffc31447780863b02c8bd982b_D20220101-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMy03LTEtMS0xMjc0NTA_18cb742e-9276-4164-8b7d-9864877e51e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaefa8d0706ce4702b6fcfb8adb353dfe_D20220101-20220630" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMy05LTEtMS0xMjc0NTA_7513534e-4ebc-4c78-97ae-5ed98f5bb493">22,498</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1255b4ef9e894adaba3c64f6d2612e0b_D20220101-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMy0xMS0xLTEtMTI3NDUw_4c557be2-8e64-4281-a8d9-45840db5734d">98,816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52811493f7514547903b0812dc24ec85_D20220101-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNC0xLTEtMS0xMjc0MzE_cf2f078d-0d71-4c41-976a-c9b8e7a41664">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85c678a2a2f645898239a8ad884b0cf9_D20220101-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNC0zLTEtMS0xMjc0Mzk_4d6039f0-73d1-4b28-8cc0-0ca31abddeac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dba48c9530b483c8e2a19d59638a1be_D20220101-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNC01LTEtMS0xMjc0Mzk_da1f99c9-0e5a-4d86-b31e-e484ffce4b19">11,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id28fa46920ee4b9f8a0fc63559c2e476_D20220101-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNC03LTEtMS0xMjc0NTA_a89e18ca-775a-4b4a-b668-62449648b432">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d5d1a53ed80404d91555cf7ede4f1ac_D20220101-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNC05LTEtMS0xMjc0NTA_899bff1d-50cc-4db8-b651-9597ae4a40f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddb342e81917421abee497b130cc5997_D20220101-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNC0xMS0xLTEtMTI3NDUw_3cf62f82-631d-4572-b026-43ffde2025cd">11,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6df2f846eb984710b6afeb4efcea88b1_D20220101-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNS0xLTEtMS0xMjc0MzE_5d0c6f78-89ec-4b94-869c-3d8ed891b077">42,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74b2b424d482423984db3f523ee9fb5e_D20220101-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNS0zLTEtMS0xMjc0Mzk_98406e4d-f908-4677-bdb4-40ef811e112e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c5104fe39a947b2bcd684db82b54e48_D20220101-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNS01LTEtMS0xMjc0Mzk_3db2292d-9a5b-4593-be98-1c1af50d201c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1416df2f1ea4d3694000029e33ace71_D20220101-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNS03LTEtMS0xMjc0NTA_c7a74fef-ff3f-4663-879d-517a3e8c9629">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22caa8d1a08845c29d9104c92f002218_D20220101-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNS05LTEtMS0xMjc0NTA_fbc2363e-ba7c-443c-bb37-21423d1e92e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96ab3a063aca414ead5f29a63f96b5ae_D20220101-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNS0xMS0xLTEtMTI3NDUw_fbae69eb-679e-4589-97ea-940b9aec4b43">42,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia17daf1ddb80489bbdce4d94932efa21_D20220101-20220630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNi0xLTEtMS0xMjc0MzE_a78df943-370d-43b8-8299-e304d5bf5dda">177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib89fad02b4b74e5cbffe8ec18de4bc64_D20220101-20220630" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNi0zLTEtMS0xMjc0Mzk_068a07af-92ea-4118-bfec-c56805a153ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88782d759ab24dbd8db24d6e19ba64de_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNi01LTEtMS0xMjc0Mzk_e12fe267-f62f-4024-8acb-f9083bad674b">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8feac348d42b418da086e65a9b0801eb_D20220101-20220630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNi03LTEtMS0xMjc0NTA_ee8763f1-6703-4364-a4ab-1ed6e19379db">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b2e6ca6c94b4ad5afd1d4f01f87431e_D20220101-20220630" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNi05LTEtMS0xMjc0NTA_af2b02c7-0ac8-458d-a194-41d78a61fc2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNi0xMS0xLTEtMTI3NDUw_3a769233-6b6c-49d6-8671-909690afe89b">314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b947bfa40dc4421923fa575beb49be8_D20220101-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNy0xLTEtMS0xMjc0MzE_fe096c5d-562f-43bc-ad4f-1eb7113059b0">2,829</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b6035f28cb43a18932f1ea69845c67_D20220101-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNy0zLTEtMS0xMjc0Mzk_0de4d383-958b-470f-bcb1-ac878de906a6">508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib62a0f8998684d1d9ba32dd07b1f9ff9_D20220101-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNy01LTEtMS0xMjc0Mzk_e5a596a0-fd9a-4099-8e46-d7632333c19b">1,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c453fd49aa84dd8882ffc93c6c79248_D20220101-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNy03LTEtMS0xMjc0NTA_b6e111e6-7573-4559-9e84-d4bec1833544">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd9b5ab95c8b4a5685904bf985fd3749_D20220101-20220630" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNy05LTEtMS0xMjc0NTA_1fcdcc15-7fdc-4e14-bc65-7e07210e7ebe">118</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia84edce63c9740baa08e23d7f9537d75_D20220101-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNy0xMS0xLTEtMTI3NDUw_ae6fb3c8-1675-48d7-9137-ef39822a8e66">4,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia17daf1ddb80489bbdce4d94932efa21_D20220101-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfOC0xLTEtMS0xMjc0MzE_1262d4be-f5a5-46cc-acaa-79b423ba2530">45,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib89fad02b4b74e5cbffe8ec18de4bc64_D20220101-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfOC0zLTEtMS0xMjc0Mzk_056c5954-b195-4fff-9ac6-db6e0ac6ffc1">82,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88782d759ab24dbd8db24d6e19ba64de_D20220101-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfOC01LTEtMS0xMjc0Mzk_aaba5640-f2df-4fcf-8468-33f38cb75b9a">51,704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8feac348d42b418da086e65a9b0801eb_D20220101-20220630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfOC03LTEtMS0xMjc0NTA_4fd04846-314c-41c7-9ade-80c43ff54f99">236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b2e6ca6c94b4ad5afd1d4f01f87431e_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfOC05LTEtMS0xMjc0NTA_8b3faef2-1ac0-47d2-95ac-744283bdf7bd">22,616</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfOC0xMS0xLTEtMTI3NDUw_e906a771-1f8b-4ea5-9454-441c895f63a5">157,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6303f55236d942fab6bbb1a2cba7ac53_D20220101-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTEtMy0xLTEtMTI3NDU4_06e21abb-26e6-440f-983d-e77d0a7b1d73">47,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie437eecdbe674fc7ac7ace4c9417d023_D20220101-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTItMy0xLTEtMTI3NDU4_ba15b21f-8376-4d48-b7a0-661883225e80">34,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450e973802ca4a89b066afe451cad627_D20220101-20220630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTMtMy0xLTEtMTI3NDU4_da4f1ab4-b658-4aa8-89fa-835d0bd9aa5e">508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib89fad02b4b74e5cbffe8ec18de4bc64_D20220101-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTQtMy0xLTEtMTI3NDU4_1c60bc22-13ab-4c37-9004-3d3da54665ea">82,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021   </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e8e4ca7275c41668b2c0d85eeb02748_D20210101-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTgtMS0xLTEtMTI3MzQ1_0cabae7b-b27e-4e76-a94d-45ff1ce4d4ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20c5541ab98a439d8cf5a822544191d2_D20210101-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTgtMy0xLTEtMTI3MzQ1_c725a7dc-1c0e-413c-baaf-01f922c5f446">74,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80a33a8e6a7646c2bf5b7c8f67ed21e0_D20210101-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTgtNS0xLTEtMTI3MzQ1_9dc7f53d-9dab-4e5e-bbb9-9fecf94b9043">36,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6228c1327ede4b82b91ec1ba1d6893a7_D20210101-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTgtNy0xLTEtMTI3MzQ1_e7a963a9-1727-4fa7-a50f-56c76501b29d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e983c97388f434aa9ef46e937c90412_D20210101-20210630" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTgtOS0xLTEtMTI3MzQ1_8d5b19e4-fd76-4490-9949-c3d7e8798199">22,168</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i161127e00ea4498383d69d1be2d2c47a_D20210101-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTgtMTEtMS0xLTEyNzM0NQ_5c4c8e64-2102-4277-93f9-71752a76b374">88,884</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1575b9d08b144d43981bd5eb802dd53f_D20210101-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTktMS0xLTEtMTI3MzQ1_40cba9ba-3eea-4bf4-9da6-a12524befae6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a3ca1a8f9864d8899757bcfaed24e58_D20210101-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTktMy0xLTEtMTI3MzQ1_1db65f0f-d6b0-4b0f-aab9-80d3ef3767fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30d7688d403b4e3ab22e76a11216efa3_D20210101-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTktNS0xLTEtMTI3MzQ1_de75788c-20e3-4d61-a47b-e411402b01cd">9,896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b47e1b909d4426aafc04538f0b5b755_D20210101-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTktNy0xLTEtMTI3MzQ1_f2aefbd7-12c4-4749-a6b2-d5c7500db372">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0048308c35140bb9969cdb4dd5440ee_D20210101-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTktOS0xLTEtMTI3MzQ1_7138b0d9-023b-421d-8ac5-ac94d465d420">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79ef86c1028641728228a2602b0b7d4c_D20210101-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTktMTEtMS0xLTEyNzM0NQ_7f1dc46e-036f-42f9-b010-b3fb22404bd5">9,896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i528af9caa41c45da877206ed8fc66f8d_D20210101-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjAtMS0xLTEtMTI3MzQ1_6790e2b3-fde1-4fce-a979-4118debe3007">37,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07a38bcea214ce6a38514324ed4c87c_D20210101-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjAtMy0xLTEtMTI3MzQ1_7905a615-b5a6-45be-9d49-b6693d191a7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ab215a9d2c44d37befa113efb740879_D20210101-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjAtNS0xLTEtMTI3MzQ1_17ec875c-0309-4a4e-bbea-3e96312fd43c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d3e64078334a22bfdeba1976be9fcb_D20210101-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjAtNy0xLTEtMTI3MzQ1_c7edfee0-8c6e-46e9-8675-be72a4026b41">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6a9e8a1a1b344cdb794e6a5f0c62ff6_D20210101-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjAtOS0xLTEtMTI3MzQ1_aba62c1e-d50d-4eed-91a5-1c0c76708328">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf5af83ee0148b4935c83147cd82d02_D20210101-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjAtMTEtMS0xLTEyNzM0NQ_0876cf0c-0c99-459e-9a99-74b8f612053c">37,943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65583ca6502143fea8109266db45d395_D20210101-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjEtMS0xLTEtMTI3MzQ1_f439fc82-07c3-451f-86bc-3bab49c82b13">285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfa2cea5de8e43f9ba651607d9a10c30_D20210101-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjEtMy0xLTEtMTI3MzQ1_2bd9bca2-56e8-490d-b9af-c3ee7314ba51">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1d59b798de8427bb69d0f7d325309b7_D20210101-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjEtNS0xLTEtMTI3MzQ1_2080805e-e48a-4343-bd74-e0da788dbb92">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec432ef32c864c91b9106f3307398132_D20210101-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjEtNy0xLTEtMTI3MzQ1_00270083-6e25-45d0-9e0d-6303bb1c272c">255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bb38325fd294ffcb76280c930132208_D20210101-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjEtOS0xLTEtMTI3MzQ1_a37dd88e-5ac4-45cd-a06a-20415c701be2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjEtMTEtMS0xLTEyNzM0NQ_0a18584d-576b-49e8-ae26-317aca08dcf0">586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78f790a00f154949a940714ab7c599ca_D20210101-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjItMS0xLTEtMTI3MzQ1_d21749d1-681e-4c2d-aaaf-f4ec06973aa3">2,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07c8c4b9dbbe4576a4bb2c9bf39072de_D20210101-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjItMy0xLTEtMTI3MzQ1_0584150b-76fb-4d5b-9c43-be5b869a383e">341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a7ca95dd5c9433bb8e72e9c147bb27f_D20210101-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjItNS0xLTEtMTI3MzQ1_5508e3c0-a2e8-44ae-8590-387d461534c2">1,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i659e7d4e49dd4140b46f05ec617268b7_D20210101-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjItNy0xLTEtMTI3MzQ1_6cb6dc15-5d3c-4957-9792-cf0d40d50515">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8e811dd702440d69beb3ddbac49f7c2_D20210101-20210630" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjItOS0xLTEtMTI3MzQ1_e7492005-86a6-4250-9379-1194f971ccb0">81</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i512aca10306b4c15a9e893f9f9a7fece_D20210101-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjItMTEtMS0xLTEyNzM0NQ_20cfbfcd-2033-4ae1-b1d2-2acf5a6c29c1">4,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65583ca6502143fea8109266db45d395_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjMtMS0xLTEtMTI3MzQ1_7944741c-080d-4c34-b07e-f2b4f2429388">41,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfa2cea5de8e43f9ba651607d9a10c30_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjMtMy0xLTEtMTI3MzQ1_766b8e8a-b405-44e6-8fe8-996fad03b203">74,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1d59b798de8427bb69d0f7d325309b7_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjMtNS0xLTEtMTI3MzQ1_83adccb0-ab9f-4899-81e2-bb38ff69be20">48,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec432ef32c864c91b9106f3307398132_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjMtNy0xLTEtMTI3MzQ1_fad3777b-fedf-44ae-8879-6fc0975eda4e">317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bb38325fd294ffcb76280c930132208_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjMtOS0xLTEtMTI3MzQ1_1d73ddca-4b0c-415b-85b8-22a248e15642">22,249</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjMtMTEtMS0xLTEyNzM0NQ_44603aad-a471-4286-addc-a90cb2e4636a">141,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6052c3c9f3814eb19317cbd04f0a8d6f_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjYtMy0xLTEtMTI3MzQ4_888bd21e-cc1d-461f-ba2a-5bb72a48ebe5">44,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedfe0ee1cea245499d6a17e933ed0082_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjctMy0xLTEtMTI3MzQ4_db02dc8b-8e71-4073-bfce-0bbc501ef893">29,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cf77f9a3b234efcb511290bb7abcf0e_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjgtMy0xLTEtMTI3MzQ4_a90e4d1a-3bc9-43fa-bdbb-14803b3ed1eb">341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfa2cea5de8e43f9ba651607d9a10c30_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjktMy0xLTEtMTI3MzQ4_c0f589a2-e73d-4ca8-97d5-003ae30bd387">74,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS pharmacy retail store for the same price as mail order.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#8217;s retail pharmacies under the Maintenance Choice program.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTYxNTE_97c0cc43-f283-4ceb-8d42-a748d0878133" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily represent the Company&#8217;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTYxOTQ_22eafc1e-cbd8-4e9f-af97-04b21cc33acc" continuedAt="i62df78ccc05b4581b2b67f44233f1936" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about receivables and contract liabilities from contracts with customers:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.437%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.438%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables (included in accounts receivable, net)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjFjYWZmMDMyMjViMzRjMmZhYzEwMDg3MzAwZjUyYjFkL3RhYmxlcmFuZ2U6MWNhZmYwMzIyNWIzNGMyZmFjMTAwODczMDBmNTJiMWRfMS0xLTEtMS0xMjE3OTc_ba31fbd8-8535-402c-b785-bffb17c6da7e">9,084</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjFjYWZmMDMyMjViMzRjMmZhYzEwMDg3MzAwZjUyYjFkL3RhYmxlcmFuZ2U6MWNhZmYwMzIyNWIzNGMyZmFjMTAwODczMDBmNTJiMWRfMS0zLTEtMS0xMjE3OTc_a38bd33f-e133-496a-bd39-0334531e9bbd">7,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities (included in accrued expenses)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjFjYWZmMDMyMjViMzRjMmZhYzEwMDg3MzAwZjUyYjFkL3RhYmxlcmFuZ2U6MWNhZmYwMzIyNWIzNGMyZmFjMTAwODczMDBmNTJiMWRfMi0xLTEtMS0xMjE3OTc_3dd7c5af-abd3-4baf-8318-6aea21d43bff">80</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjFjYWZmMDMyMjViMzRjMmZhYzEwMDg3MzAwZjUyYjFkL3RhYmxlcmFuZ2U6MWNhZmYwMzIyNWIzNGMyZmFjMTAwODczMDBmNTJiMWRfMi0zLTEtMS0xMjE3OTc_5c6b828e-d22f-4322-abac-eeb86bae10bf">87</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5723405d19d346208495c3017e74af91"><ix:continuation id="i62df78ccc05b4581b2b67f44233f1936"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2022 and 2021, the contract liabilities balance includes increases related to customers&#8217; earnings in ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.437%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.438%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmQ1YjY4NTI4Y2RkMTQ5NTk5ZjRlMmYyZWE5NzhmOWE3L3RhYmxlcmFuZ2U6ZDViNjg1MjhjZGQxNDk1OTlmNGUyZjJlYTk3OGY5YTdfMi0xLTEtMS0xMjE3OTc_5c6b828e-d22f-4322-abac-eeb86bae10bf">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1b37908bcec4675b7dd487bd3f7f745_I20201231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmQ1YjY4NTI4Y2RkMTQ5NTk5ZjRlMmYyZWE5NzhmOWE3L3RhYmxlcmFuZ2U6ZDViNjg1MjhjZGQxNDk1OTlmNGUyZjJlYTk3OGY5YTdfMi0zLTEtMS0xMjE3OTc_d9167c73-fb84-4c33-9f1c-37ac533ea676">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rewards earnings and gift card issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmQ1YjY4NTI4Y2RkMTQ5NTk5ZjRlMmYyZWE5NzhmOWE3L3RhYmxlcmFuZ2U6ZDViNjg1MjhjZGQxNDk1OTlmNGUyZjJlYTk3OGY5YTdfMy0xLTEtMS0xMjE3OTc_707aef21-6b5f-436e-98d0-52d68018f722">175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmQ1YjY4NTI4Y2RkMTQ5NTk5ZjRlMmYyZWE5NzhmOWE3L3RhYmxlcmFuZ2U6ZDViNjg1MjhjZGQxNDk1OTlmNGUyZjJlYTk3OGY5YTdfMy0zLTEtMS0xMjE3OTc_1a9fd221-5c3b-489f-b821-48e3dee5bae7">183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and breakage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="cvs:ContractwithCustomerLiabilityRedemptionandBreakage" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmQ1YjY4NTI4Y2RkMTQ5NTk5ZjRlMmYyZWE5NzhmOWE3L3RhYmxlcmFuZ2U6ZDViNjg1MjhjZGQxNDk1OTlmNGUyZjJlYTk3OGY5YTdfNC0xLTEtMS0xMjE3OTc_a0801a20-21b4-408c-8b2a-34cb45fa0278">182</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="cvs:ContractwithCustomerLiabilityRedemptionandBreakage" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmQ1YjY4NTI4Y2RkMTQ5NTk5ZjRlMmYyZWE5NzhmOWE3L3RhYmxlcmFuZ2U6ZDViNjg1MjhjZGQxNDk1OTlmNGUyZjJlYTk3OGY5YTdfNC0zLTEtMS0xMjE3OTc_5255a06e-de02-4a35-a81f-d5b7200372e2">175</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmQ1YjY4NTI4Y2RkMTQ5NTk5ZjRlMmYyZWE5NzhmOWE3L3RhYmxlcmFuZ2U6ZDViNjg1MjhjZGQxNDk1OTlmNGUyZjJlYTk3OGY5YTdfNS0xLTEtMS0xMjE3OTc_3dd7c5af-abd3-4baf-8318-6aea21d43bff">80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c91d440ca044d289daea52743e3cebd_I20210630" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmQ1YjY4NTI4Y2RkMTQ5NTk5ZjRlMmYyZWE5NzhmOWE3L3RhYmxlcmFuZ2U6ZDViNjg1MjhjZGQxNDk1OTlmNGUyZjJlYTk3OGY5YTdfNS0zLTEtMS0xMjE3OTc_447476c6-8e90-4396-999a-4175e97473fb">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTYxMzc_3a5dcdca-1c54-48cd-a5d1-329b67ba6633" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in SureScripts, LLC (&#8220;SureScripts&#8221;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $<ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTI0OTI_716b7d01-ce61-43bf-82a1-355f5016b188">16</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTI0OTk_1ae1e135-f136-42c8-9ffd-ce15a9f3c218">10</ix:nonFraction> million in the three months ended June&#160;30, 2022 and 2021, respectively, and expensed fees for the use of this network of approximately $<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTA5OTUxMTY0NDA5NA_f6901326-1a3c-4456-80c3-9c36688fb568">31</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTA5OTUxMTY0NDEwNg_91cebb7b-6a00-4300-885a-aac5bf4d4293">19</ix:nonFraction> million in the six months ended June&#160;30, 2022 and 2021, respectively. The Company&#8217;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in Heartland Healthcare Services, LLC (&#8220;Heartland&#8221;). Heartland operates several LTC pharmacies in <ix:nonFraction unitRef="state" contextRef="i80f415ea92fb4d01a514f6f8865f49a7_I20220630" decimals="INF" name="us-gaap:NumberOfStatesInWhichEntityOperates" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTI4MDc_dd82318b-e444-4e6c-985e-b8e84b23bcb7">four</ix:nonFraction> states. Heartland paid the Company $<ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTI4NDU_6be13586-67e7-4571-9c85-b2cc33afec13">23</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTI4NTI_9820ff1c-89e2-459b-bb3b-03e31501179e">19</ix:nonFraction> million for pharmaceutical inventory purchases during the three months ended June&#160;30, 2022 and 2021, respectively, and $<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTA5OTUxMTY0NDMwMQ_51e99c7b-87a8-44b8-82e5-85250d7fd5e8">44</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTA5OTUxMTY0NDMwNw_fd77ebac-2172-4003-b169-a66bb0205fb3">37</ix:nonFraction> million for pharmaceutical inventory purchases during the six months ended June&#160;30, 2022 and 2021, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#8217;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTYxODk_2262c2c8-c9a0-41a4-9d87-180eff333b9c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Insurance Contracts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the Financial Accounting Standards Board issued Accounting Standards Update 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 944). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other comprehensive income. The rate used to discount the Company&#8217;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#8217;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#8217;s interim and annual financial statements. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company will adopt the new standard on January 1, 2023, using the modified retrospective transition method as of the earliest period presented for changes to the liability for future policy benefits and deferred acquisition costs. While the Company is still evaluating the impact of the new standard on its financial statements, the Company anticipates an increase to its liability for future policy benefits with a corresponding change in accumulated other comprehensive income as a result of updating the rate used to discount the liabilities to reflect the yield for an upper-medium grade fixed-income instrument compared to the Company&#8217;s expected investment yield under the existing guidance.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_1194"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMTk0L2ZyYWc6OWYwZDg0MzYxYTY0NDA1M2IwZjU3NTliN2FhNWMyZmUvdGV4dHJlZ2lvbjo5ZjBkODQzNjFhNjQ0MDUzYjBmNTc1OWI3YWE1YzJmZV8zMjk4NTM0ODg2NjE4_0c2e0412-76de-499c-acec-064a0acc025a" continuedAt="i83354ebde31045e498a2376bc65722fd" escape="true">Divestitures and Asset Sales</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i83354ebde31045e498a2376bc65722fd" continuedAt="i52228ddae40f40958dfa3044d679bb0f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestiture of PayFlex </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2022, the Company sold PayFlex for approximately $<ix:nonFraction unitRef="usd" contextRef="id743f37942444621831b2935b6d1e18a_D20220601-20220601" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMTk0L2ZyYWc6OWYwZDg0MzYxYTY0NDA1M2IwZjU3NTliN2FhNWMyZmUvdGV4dHJlZ2lvbjo5ZjBkODQzNjFhNjQ0MDUzYjBmNTc1OWI3YWE1YzJmZV8zODQ4MjkwNjk5Nzkz_08ace08c-0227-4f9e-a997-524b0c80c69b">775</ix:nonFraction>&#160;million. PayFlex provides services to employers, their employees, and their former employees in the areas of tax-advantaged account reimbursement administration (flexible spending, health reimbursement, health savings, transit and parking), Consolidated Omnibus Budget Reconciliation Act (&#8220;COBRA&#8221;) administration and special-member billing administration. The results of this business have historically been reported within the Health Care Benefits segment. The Company recorded a pre-tax gain on the divestiture of $<ix:nonFraction unitRef="usd" contextRef="i9647c5ab754d4d37a49e9ee3963f2e2c_D20220401-20220630" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMTk0L2ZyYWc6OWYwZDg0MzYxYTY0NDA1M2IwZjU3NTliN2FhNWMyZmUvdGV4dHJlZ2lvbjo5ZjBkODQzNjFhNjQ0MDUzYjBmNTc1OWI3YWE1YzJmZV8zODQ4MjkwNzAwOTMy_31481f9d-7958-4b99-b306-563c53c1b76b"><ix:nonFraction unitRef="usd" contextRef="id829479219c245759e9e3ab39d4a09b9_D20220101-20220630" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMTk0L2ZyYWc6OWYwZDg0MzYxYTY0NDA1M2IwZjU3NTliN2FhNWMyZmUvdGV4dHJlZ2lvbjo5ZjBkODQzNjFhNjQ0MDUzYjBmNTc1OWI3YWE1YzJmZV8zODQ4MjkwNzAwOTMy_5230ca33-b040-4100-b796-e282185171ef">225</ix:nonFraction></ix:nonFraction>&#160;million in the three and six months ended June&#160;30, 2022, which is reflected as a reduction in operating expenses in the Company&#8217;s unaudited condensed consolidated statements of operations within the Health Care Benefits segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestiture of Thailand Health Care Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the Company reached an agreement to sell its international health care business domiciled in Thailand (&#8220;Thailand business&#8221;), comprised of approximately <ix:nonFraction unitRef="member" contextRef="i63fd0bfb9e4a43a58e4cfcab6009ac9e_I20220331" decimals="-3" name="cvs:NumberOfMedicalMembers" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMTk0L2ZyYWc6OWYwZDg0MzYxYTY0NDA1M2IwZjU3NTliN2FhNWMyZmUvdGV4dHJlZ2lvbjo5ZjBkODQzNjFhNjQ0MDUzYjBmNTc1OWI3YWE1YzJmZV8zODQ4MjkwNzA3Njk3_00e6cfe1-8fcb-49ad-b1bb-a95bff557ce6">266,000</ix:nonFraction> medical members, which was included in the Commercial Business reporting unit within the Health Care Benefits segment. At that time, a portion of the Commercial Business goodwill was specifically allocated to the Thailand business. The net assets of the Thailand business were accounted for as assets held for sale at March 31, 2022. The carrying value of the Thailand business was determined to be greater than its fair value and, accordingly, the Company recorded a $<ix:nonFraction unitRef="usd" contextRef="iac541484a57e442d8cefd6fa9441768c_D20220101-20220331" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMTk0L2ZyYWc6OWYwZDg0MzYxYTY0NDA1M2IwZjU3NTliN2FhNWMyZmUvdGV4dHJlZ2lvbjo5ZjBkODQzNjFhNjQ0MDUzYjBmNTc1OWI3YWE1YzJmZV8zODQ4MjkwNzAwOTI0_391e178f-6bb2-4b7c-839a-455186066840"><ix:nonFraction unitRef="usd" contextRef="i2a80d23584cd49d89a6bb9a7bff4bdd5_D20220101-20220630" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMTk0L2ZyYWc6OWYwZDg0MzYxYTY0NDA1M2IwZjU3NTliN2FhNWMyZmUvdGV4dHJlZ2lvbjo5ZjBkODQzNjFhNjQ0MDUzYjBmNTc1OWI3YWE1YzJmZV8zODQ4MjkwNzAwOTI0_5f600211-67ba-42fc-b37b-fddcecff0221">41</ix:nonFraction></ix:nonFraction>&#160;million loss on assets held for sale within the Health Care Benefits segment during the first quarter of 2022. The sale closed in the second quarter of 2022, and the consideration received and ultimate loss on the sale were not material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International Health Care Benefits Renewal Rights Asset Sale</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i52228ddae40f40958dfa3044d679bb0f">In May 2022, the Company sold the renewal rights of approximately <ix:nonFraction unitRef="member" contextRef="icee03dec469e41edbf6c698fb0d48290_I20220531" decimals="-3" name="cvs:DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMTk0L2ZyYWc6OWYwZDg0MzYxYTY0NDA1M2IwZjU3NTliN2FhNWMyZmUvdGV4dHJlZ2lvbjo5ZjBkODQzNjFhNjQ0MDUzYjBmNTc1OWI3YWE1YzJmZV8yNzQ4Nzc5MDc0ODUw_8952c114-4847-4b7c-bfd2-7a0d0bbb2c0d">200,000</ix:nonFraction> international medical members outside of the Americas, Thailand and India in connection with an Asset Purchase Agreement. As part of this agreement, the Company will introduce and help migrate these existing international medical members to the purchaser upon renewal. The Company expects the migration process to occur over a <ix:nonNumeric contextRef="icee03dec469e41edbf6c698fb0d48290_I20220531" name="cvs:DisposalGroupNotDiscontinuedOperationMigrationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMTk0L2ZyYWc6OWYwZDg0MzYxYTY0NDA1M2IwZjU3NTliN2FhNWMyZmUvdGV4dHJlZ2lvbjo5ZjBkODQzNjFhNjQ0MDUzYjBmNTc1OWI3YWE1YzJmZV8yNzQ4Nzc5MDc0ODY2_73cd93db-ccd3-40c9-84bd-091e7e719ede">16-month</ix:nonNumeric> period between July 2022 and October 2023. The Company expects to cease writing any new or renewal business for international medical members outside of the Americas after October 31, 2022. The consideration received related to this agreement was not material.</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">  </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_40"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNTE1Mg_9456ae90-9043-4877-9d95-fc31adb23cc6" continuedAt="ic47a8ef8502d4c8c8d9b1049e6e4e70e" escape="true">Investments</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ic47a8ef8502d4c8c8d9b1049e6e4e70e" continuedAt="i63606f8139a6419ab76a947b9a93428a"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="cvs:TotalInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNTA2OA_88b5272e-9039-4743-82ea-36d9cc15d305" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total investments at June&#160;30, 2022 and December&#160;31, 2021 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.106%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.384%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities available for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i437d75cbaaca4357be7aed594234e4e6_I20220630" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfMi0xLTEtMS0xMjE3OTc_fd437331-e39d-4a12-a51b-cd19dce1462b">2,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i437d75cbaaca4357be7aed594234e4e6_I20220630" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfMi0zLTEtMS0xMjE3OTc_fd95b780-186e-40ee-a870-633f9c1c4d88">17,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i437d75cbaaca4357be7aed594234e4e6_I20220630" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfMi01LTEtMS0xMjE3OTc_f5a74085-8625-44ab-b4ef-22694f33bff0">20,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973f5697b1474af9a8c7a8e70194ec8a_I20211231" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfMi03LTEtMS0xMjE3OTc_4d706f94-6d6a-428c-adf9-d62b3b123c3c">3,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973f5697b1474af9a8c7a8e70194ec8a_I20211231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfMi05LTEtMS0xMjE3OTc_59748888-63bb-4186-894b-c2e98a7232b4">20,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973f5697b1474af9a8c7a8e70194ec8a_I20211231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfMi0xMS0xLTEtMTIxNzk3_b26aab60-30cc-491d-b8c4-a9d092ed754e">23,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdbfd311e78b43f2b0104aa9cc8fb794_I20220630" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfMy0xLTEtMS0xMjE3OTc_40a9252c-14d5-4d9a-b3d0-ffbfe2ba82fc">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdbfd311e78b43f2b0104aa9cc8fb794_I20220630" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfMy0zLTEtMS0xMjE3OTc_3c2fe39b-a438-43fb-8c4b-4aabd85f4bc8">905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdbfd311e78b43f2b0104aa9cc8fb794_I20220630" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfMy01LTEtMS0xMjE3OTc_8de585bb-8a75-4ba1-9877-9d2d27e3c2af">993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13669c8a36c24e5d8272623034c20f84_I20211231" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfMy03LTEtMS0xMjE3OTc_9a353999-f1ae-4352-b021-e143cdb1f211">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13669c8a36c24e5d8272623034c20f84_I20211231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfMy05LTEtMS0xMjE3OTc_5d3ec592-5f8d-4537-a307-b815f0f14a88">844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13669c8a36c24e5d8272623034c20f84_I20211231" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfMy0xMS0xLTEtMTIxNzk3_a28a4a17-5b41-4a84-8024-8d5a5bbb5e64">902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibadb7cc69aae4c759a42a17ef71ff248_I20220630" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfNC0xLTEtMS0xMjE3OTc_a6f91ced-fa75-44bd-a2fe-704c7e03209f">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibadb7cc69aae4c759a42a17ef71ff248_I20220630" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfNC0zLTEtMS0xMjE3OTc_248c993b-3b64-4005-bb52-81d63e2cc633">2,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibadb7cc69aae4c759a42a17ef71ff248_I20220630" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfNC01LTEtMS0xMjE3OTc_8744604f-25e5-4328-9984-9d1c88ae69cb">2,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd6de90b616a4a0989fc988def9d4af9_I20211231" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfNC03LTEtMS0xMjE3OTc_30ece811-e409-43ae-afab-245c940718fa">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd6de90b616a4a0989fc988def9d4af9_I20211231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfNC05LTEtMS0xMjE3OTc_1d51e974-234f-485f-bc69-d56f401ac663">1,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd6de90b616a4a0989fc988def9d4af9_I20211231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfNC0xMS0xLTEtMTIxNzk3_971d84fc-9bfa-4657-b0e9-ad88f859ec3f">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfNS0xLTEtMS0xMjE3OTc_c5fa43a5-80be-4fc2-b102-c5cfe53e1c64">2,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfNS0zLTEtMS0xMjE3OTc_6a1e4361-1770-4fe3-8304-71ea147cc290">21,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfNS01LTEtMS0xMjE3OTc_8d0115b8-7377-476f-a181-dd13aaaea261">24,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfNS03LTEtMS0xMjE3OTc_424085f6-7080-4617-95c3-9719f5fdd62d">3,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfNS05LTEtMS0xMjE3OTc_6d4a0637-2d40-4cdc-90d2-87e0d6f281d1">23,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfNS0xMS0xLTEtMTIxNzk3_ac29da68-162c-484b-b134-a6d15e04666d">26,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Securities</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNTExMA_3ebe11f7-0caa-4806-8493-4ded51a7c1ae" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities available for sale at June&#160;30, 2022 and December&#160;31, 2021 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.133%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.133%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.265%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Allowance<br/>for Credit<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMy0xLTEtMS0xMjE3OTc_da9721ab-7818-4db7-aeaa-b7c736f46ded">2,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMy0zLTEtMS0xMjE3OTc_e9870ff3-5f38-4771-984a-8e0b3d58622e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMy01LTEtMS0xMjE3OTc_97ab9024-9ea5-4147-ae76-218b5a5298f3">2,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMy03LTEtMS0xMjE3OTc_569fd9f7-2c47-4f41-b4a1-6e7b8148718e">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMy05LTEtMS0xMjE3OTc_a7b2864d-f2a9-4a68-9332-411d45ece77a">118</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMy0xMS0xLTEtMTIxNzk3_e4ec20b7-1394-451a-8e90-10e58c154cf6">2,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib04a3967c8004f97aa14f769721b3a73_I20220630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNC0xLTEtMS0xMjE3OTc_8a50b9c4-1bfa-4d53-a4d1-9c52b851598f">2,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib04a3967c8004f97aa14f769721b3a73_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNC0zLTEtMS0xMjE3OTc_714289b8-2f5d-45e7-85c9-e0542c208ee2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib04a3967c8004f97aa14f769721b3a73_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNC01LTEtMS0xMjE3OTc_4c1110ed-7101-4d21-917f-02bed687debe">2,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib04a3967c8004f97aa14f769721b3a73_I20220630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNC03LTEtMS0xMjE3OTc_0d581751-e41b-425a-88c1-d8fbb5d2c34b">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib04a3967c8004f97aa14f769721b3a73_I20220630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNC05LTEtMS0xMjE3OTc_6d2eb6c1-663a-48e4-9b93-829e3afd96cd">110</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib04a3967c8004f97aa14f769721b3a73_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNC0xMS0xLTEtMTIxNzk3_96a32812-c733-4e35-9c26-42d9e21a5599">2,373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNS0xLTEtMS0xMjE3OTc_237e388c-9030-4f30-8008-14375c78a576">9,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNS0zLTEtMS0xMjE3OTc_8480c7fe-1e5d-4177-bd74-177fdb08d342">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNS01LTEtMS0xMjE3OTc_9eee89e3-0ebf-4ff7-8c7f-cc82b137ec15">9,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNS03LTEtMS0xMjE3OTc_8a893d90-225f-48c2-93a1-7bd09a36f410">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNS05LTEtMS0xMjE3OTc_c4bd422f-c16d-4513-af12-3af20397201b">740</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNS0xMS0xLTEtMTIxNzk3_b13dc98f-57a4-403d-8530-40fcec65806b">9,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e11998e647748a998ed3ae2000f65ec_I20220630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNi0xLTEtMS0xMjE3OTc_e3850c99-bb4a-4dfe-abca-5d43a996e83a">2,857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e11998e647748a998ed3ae2000f65ec_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNi0zLTEtMS0xMjE3OTc_31b83536-1f60-45e3-af83-a393f5a5503b">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e11998e647748a998ed3ae2000f65ec_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNi01LTEtMS0xMjE3OTc_e28ffce8-8ef0-4767-8f0d-fb923cf2d83d">2,849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e11998e647748a998ed3ae2000f65ec_I20220630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNi03LTEtMS0xMjE3OTc_f10659ca-d1a8-444c-8193-eadea536e83d">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e11998e647748a998ed3ae2000f65ec_I20220630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNi05LTEtMS0xMjE3OTc_603a57e1-7052-42f4-911d-c5c187b3b93d">236</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e11998e647748a998ed3ae2000f65ec_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNi0xMS0xLTEtMTIxNzk3_89313aa5-4260-413a-af21-9d45a7d739af">2,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNy0xLTEtMS0xMjE3OTc_36ce35e7-4929-49e4-a349-c2c5808eba1d">808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNy0zLTEtMS0xMjE3OTc_dc6ce1e3-451a-4612-b737-9c889629b11f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNy01LTEtMS0xMjE3OTc_9dc47c04-b60a-4353-9ce0-e84d0e89923e">808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNy03LTEtMS0xMjE3OTc_c6117a1d-04c6-49e1-9e8d-9777b4e623ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNy05LTEtMS0xMjE3OTc_03e9118a-d645-43ac-bec7-9dd633f6bdcb">61</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNy0xMS0xLTEtMTIxNzk3_29869bf5-7f5d-4afc-a285-515f89d294f0">747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfOC0xLTEtMS0xMjE3OTc_53945b29-61f1-45e0-ac32-381e39bb3312">1,222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfOC0zLTEtMS0xMjE3OTc_ff398509-cc86-41bd-b3e9-584f96df64dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfOC01LTEtMS0xMjE3OTc_a18eb7c1-cc42-4848-b95c-b0110e728f1b">1,222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfOC03LTEtMS0xMjE3OTc_fbf96f95-beaa-4326-acfc-2820a6a61034">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfOC05LTEtMS0xMjE3OTc_8c24ca2b-eeb6-4c62-b94e-6e17438b4bf1">114</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfOC0xMS0xLTEtMTIxNzk3_7e4308b0-83eb-4da2-98b8-2f896b9e2446">1,108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfOS0xLTEtMS0xMjE3OTc_9f0f2274-8086-4577-ac12-3f9d46c7b4e5">2,721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfOS0zLTEtMS0xMjE3OTc_07e79219-1971-4f84-ae6b-9b477a31283d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfOS01LTEtMS0xMjE3OTc_20f9a2ae-872d-4b34-844d-29dde6219442">2,721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfOS03LTEtMS0xMjE3OTc_43ac9d13-6e0a-4df8-98c4-8ac0776b3e0b">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfOS05LTEtMS0xMjE3OTc_08f65fe2-7a20-49a7-a0fd-b33a302e1a5e">135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfOS0xMS0xLTEtMTIxNzk3_ed5a70ca-e8a2-470e-ade9-ff7130fb6394">2,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b1da324447946a5a60e70cf44b0c827_I20220630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTAtMS0xLTEtMTIxNzk3_d77b34d9-03b4-43c1-89b6-6fbbebccc9f4">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b1da324447946a5a60e70cf44b0c827_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTAtMy0xLTEtMTIxNzk3_2073cd0f-7c50-41e0-83f1-69630a64160f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b1da324447946a5a60e70cf44b0c827_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTAtNS0xLTEtMTIxNzk3_a5e94bdc-67f2-4aed-8e1f-ce0adb4b2d3c">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b1da324447946a5a60e70cf44b0c827_I20220630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTAtNy0xLTEtMTIxNzk3_7509c143-ca3e-4bb2-93c3-f5bdfbe6f36a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b1da324447946a5a60e70cf44b0c827_I20220630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTAtOS0xLTEtMTIxNzk3_3b22f17b-d9ed-4f5a-a429-bc7d704ab05a">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b1da324447946a5a60e70cf44b0c827_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTAtMTEtMS0xLTEyMTc5Nw_e623d2ca-abf5-4b25-81d3-0110f04d3cc1">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTEtMS0xLTEtMTIxNzk3_1c8ea210-fb42-40e0-b96b-b702a15508a0">22,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTEtMy0xLTEtMTIxNzk3_70b7f2ac-0fdb-4354-9803-fb6932d552a3">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTEtNS0xLTEtMTIxNzk3_61ab3b0a-e579-450a-803a-778245e6746a">22,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTEtNy0xLTEtMTIxNzk3_aa76ac88-a220-4e20-85a9-aae9211503cf">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTEtOS0xLTEtMTIxNzk3_1ddd6d64-be9c-42a8-89ff-d6208e1b88f5">1,515</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTEtMTEtMS0xLTEyMTc5Nw_a7dd3b8e-15da-497f-b592-79a269472038">20,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTUtMS0xLTEtMTIxNzk3_68f2aa30-90d4-4bbc-8b2f-658e205b1a1b">2,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTUtMy0xLTEtMTIxNzk3_b4acb7c9-037e-4055-9e3a-8177e93277d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTUtNS0xLTEtMTIxNzk3_6fbe3416-5296-46ae-80c4-73abe306439d">2,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTUtNy0xLTEtMTIxNzk3_4e3f73f0-1e9e-40bf-a674-d454d534190b">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTUtOS0xLTEtMTIxNzk3_98ff59c3-866d-46df-81ea-24de3ab134b1">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTUtMTEtMS0xLTEyMTc5Nw_49e20397-fe7c-4e5e-8f36-6d5ab1fde6c4">2,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i312562153ede48bfb0ae6742085c849a_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTYtMS0xLTEtMTIxNzk3_d7c29457-7680-4823-81d6-4e74fd8aa518">2,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i312562153ede48bfb0ae6742085c849a_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTYtMy0xLTEtMTIxNzk3_dacf3a48-068b-4924-bb6f-ab873c1d466c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i312562153ede48bfb0ae6742085c849a_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTYtNS0xLTEtMTIxNzk3_8d0344e5-b8aa-40c9-9167-94f8e58ace32">2,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i312562153ede48bfb0ae6742085c849a_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTYtNy0xLTEtMTIxNzk3_38abfe1b-7829-47d8-b752-b5ef5f010761">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i312562153ede48bfb0ae6742085c849a_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTYtOS0xLTEtMTIxNzk3_e9012b38-99b9-4fdc-9ab5-6da83446161b">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i312562153ede48bfb0ae6742085c849a_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTYtMTEtMS0xLTEyMTc5Nw_ff8e18dc-fa42-419d-9e16-4912183c6516">3,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacd25bc0ddd1457bb0d369b53f596438_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTctMS0xLTEtMTIxNzk3_a1656f5c-991e-4a50-b657-837607ab9e26">9,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacd25bc0ddd1457bb0d369b53f596438_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTctMy0xLTEtMTIxNzk3_a9a65fb9-99e6-4d02-9030-644bf31cd9ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacd25bc0ddd1457bb0d369b53f596438_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTctNS0xLTEtMTIxNzk3_d795dafa-f7a1-4d86-af72-4e5e35ae6a08">9,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacd25bc0ddd1457bb0d369b53f596438_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTctNy0xLTEtMTIxNzk3_66957df9-ba5f-472d-8eff-47c083b7d175">682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iacd25bc0ddd1457bb0d369b53f596438_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTctOS0xLTEtMTIxNzk3_5338fb06-c5e5-400f-a478-4262e72cacc4">40</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacd25bc0ddd1457bb0d369b53f596438_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTctMTEtMS0xLTEyMTc5Nw_18d938b7-6e64-4d5d-9c80-a7c140daac30">9,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27a2d69d05ce407693c56825032df2c6_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTgtMS0xLTEtMTIxNzk3_7698f536-eaea-46e8-bca5-4b2910772db5">2,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27a2d69d05ce407693c56825032df2c6_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTgtMy0xLTEtMTIxNzk3_319a6529-59a6-4b9b-9710-60b522a5739d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27a2d69d05ce407693c56825032df2c6_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTgtNS0xLTEtMTIxNzk3_2d3b5857-b49a-4068-a3ae-4dc87cb9216b">2,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27a2d69d05ce407693c56825032df2c6_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTgtNy0xLTEtMTIxNzk3_88769638-1765-46f7-9c8b-b9fd37b72ec4">196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27a2d69d05ce407693c56825032df2c6_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTgtOS0xLTEtMTIxNzk3_84d6fbb5-cce4-4b30-be9a-933e3ea73813">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27a2d69d05ce407693c56825032df2c6_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTgtMTEtMS0xLTEyMTc5Nw_3d5725de-0ae1-4d3b-8378-7e02784dd1f4">2,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f4295241da2454b9ca27744d8f494b2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTktMS0xLTEtMTIxNzk3_b5d81be1-709e-4594-9adb-daee1e9dfedb">870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f4295241da2454b9ca27744d8f494b2_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTktMy0xLTEtMTIxNzk3_ffb8a81d-22c5-4a14-b2a1-5ab9996891b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f4295241da2454b9ca27744d8f494b2_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTktNS0xLTEtMTIxNzk3_d1aafbbd-4e79-41c2-be95-dc4fd79c554d">870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f4295241da2454b9ca27744d8f494b2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTktNy0xLTEtMTIxNzk3_cba46b30-ccc4-4c2f-8e4c-03f0a3e23d17">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f4295241da2454b9ca27744d8f494b2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTktOS0xLTEtMTIxNzk3_28f220a1-c46f-4312-9af9-ccf89e4ec13e">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f4295241da2454b9ca27744d8f494b2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTktMTEtMS0xLTEyMTc5Nw_578fb97b-529c-4de7-a021-86d2e056002c">875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic26d39b1909b4114abe91b81a22d3ca5_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjAtMS0xLTEtMTIxNzk3_347fde55-610a-4cef-a5c8-3821dcf4bad3">1,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic26d39b1909b4114abe91b81a22d3ca5_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjAtMy0xLTEtMTIxNzk3_04d25799-a66f-4907-9cb9-75882ccf98bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic26d39b1909b4114abe91b81a22d3ca5_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjAtNS0xLTEtMTIxNzk3_bc2e9a43-d17c-489e-9375-c476dc78c3a8">1,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic26d39b1909b4114abe91b81a22d3ca5_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjAtNy0xLTEtMTIxNzk3_a282a6bb-19b1-44cd-9b97-ccece1bd8251">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic26d39b1909b4114abe91b81a22d3ca5_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjAtOS0xLTEtMTIxNzk3_b623d09e-c027-4eb8-a3ed-8fbdca1289ce">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic26d39b1909b4114abe91b81a22d3ca5_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjAtMTEtMS0xLTEyMTc5Nw_82818016-ade2-4200-b7cb-4e1bf082d1e3">1,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf2696db609145edadde7083bbfb8eac_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjEtMS0xLTEtMTIxNzk3_7acb9652-a882-426b-b504-86f2859bbc61">2,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf2696db609145edadde7083bbfb8eac_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjEtMy0xLTEtMTIxNzk3_76bb523a-d9e0-4b14-88eb-74af384a8dba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf2696db609145edadde7083bbfb8eac_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjEtNS0xLTEtMTIxNzk3_4aece58b-48d2-42e6-986c-1431167ef92d">2,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf2696db609145edadde7083bbfb8eac_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjEtNy0xLTEtMTIxNzk3_b766961c-a6cd-4b0c-9abb-384eb4b7e9b5">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf2696db609145edadde7083bbfb8eac_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjEtOS0xLTEtMTIxNzk3_e4a96079-ae0d-49c4-a1f9-dcdded32bf00">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf2696db609145edadde7083bbfb8eac_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjEtMTEtMS0xLTEyMTc5Nw_78c2c7b7-0660-428d-8b6e-fcef547f2bba">2,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35a7089aaf074a29b807a8530fceab9c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjItMS0xLTEtMTIxNzk3_21b0d449-5dd7-4b76-a38e-18ed6f0bd82d">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35a7089aaf074a29b807a8530fceab9c_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjItMy0xLTEtMTIxNzk3_e8bb30de-24f9-4b26-89a6-74626ddf09a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35a7089aaf074a29b807a8530fceab9c_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjItNS0xLTEtMTIxNzk3_ecbcd1b8-7b77-494e-b7de-2965860fcaec">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35a7089aaf074a29b807a8530fceab9c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjItNy0xLTEtMTIxNzk3_b4653053-e28c-403e-a035-6e3e70c6fdef">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35a7089aaf074a29b807a8530fceab9c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjItOS0xLTEtMTIxNzk3_fce2b872-bb00-40c2-8d30-5f3ec033fe7b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35a7089aaf074a29b807a8530fceab9c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjItMTEtMS0xLTEyMTc5Nw_fe63c404-9e61-45c4-82db-c8281c6e2d2d">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjMtMS0xLTEtMTIxNzk3_576de6e9-63b4-4275-990f-0e6b885f27ab">22,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjMtMy0xLTEtMTIxNzk3_9e234471-e675-498a-9e89-187f1de58006">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjMtNS0xLTEtMTIxNzk3_4d6274c4-2e1f-4c2b-a5d9-2df8045a9e40">22,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjMtNy0xLTEtMTIxNzk3_3c9dfcf4-5c44-49cb-b197-8f295cbfb841">1,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjMtOS0xLTEtMTIxNzk3_44ef5297-a6d7-4689-b41e-51f028d9f85b">106</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjMtMTEtMS0xLTEyMTc5Nw_a891c2b0-8e1d-4656-bdf4-c81b7f5f1a80">23,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Investment risks associated with the Company&#8217;s experience-rated products generally do not impact the Company&#8217;s consolidated operating results. At June&#160;30, 2022, debt securities with a fair value of $<ix:nonFraction unitRef="usd" contextRef="i4a4d5943f3344b028b2021d88fb2d40d_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNjk0_269b1aa8-2135-49e4-ba97-8a9e6edcefe6">658</ix:nonFraction> million, gross unrealized capital gains of $<ix:nonFraction unitRef="usd" contextRef="i4a4d5943f3344b028b2021d88fb2d40d_I20220630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNzMy_40203615-b610-4dc1-b325-ff945c979559">5</ix:nonFraction> million and gross unrealized capital losses of $<ix:nonFraction unitRef="usd" contextRef="i4a4d5943f3344b028b2021d88fb2d40d_I20220630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNzc0_20e7bec7-f8dc-416e-88af-dc17037d7a9f">39</ix:nonFraction> million and at December&#160;31, 2021, debt securities with a fair value of $<ix:nonFraction unitRef="usd" contextRef="i57df9cc9e45b4dd8860db902aa9d7a4c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfODI1_de21c2ec-2180-4956-903c-9472b6aa536b">864</ix:nonFraction> million, gross unrealized capital gains of $<ix:nonFraction unitRef="usd" contextRef="i57df9cc9e45b4dd8860db902aa9d7a4c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfODYz_7bbeffed-85bd-43ce-8f69-8717000915db">94</ix:nonFraction> million and gross unrealized capital losses of $<ix:nonFraction unitRef="usd" contextRef="i57df9cc9e45b4dd8860db902aa9d7a4c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfOTA1_c2426eaa-50d7-4d77-af66-ae8636c57195">2</ix:nonFraction> million were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income (loss).</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i63606f8139a6419ab76a947b9a93428a" continuedAt="ida40eb5780a84278918ae20705359557"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNTA4NQ_81c87043-5db5-4667-b273-21ebdf03e46c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net amortized cost and fair value of debt securities at June&#160;30, 2022 are shown below by contractual maturity.&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.690%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfMi0xLTEtMS0xMjE3OTc_286c246e-756b-4e71-9e35-836b86483dee">1,221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfMi0zLTEtMS0xMjE3OTc_dd0d0a56-7038-4009-93bc-b9e95096825d">1,221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfMy0xLTEtMS0xMjE3OTc_a3f0bfc2-1ec1-4848-aec6-825bbd118f9c">6,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfMy0zLTEtMS0xMjE3OTc_ba1abe61-b0db-4f9c-b02d-7efab1513c20">6,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfNC0xLTEtMS0xMjE3OTc_4c372457-b595-42ff-ba5d-96667c901239">5,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfNC0zLTEtMS0xMjE3OTc_b88df4bc-1ed0-40ae-b64c-47a53de2ea41">4,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfNS0xLTEtMS0xMjE3OTc_4d8ddd92-4f8b-41ae-a5b7-00744c86b15b">4,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfNS0zLTEtMS0xMjE3OTc_1884437e-c33e-4e05-a2b6-98e7e318d26a">4,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfNi0xLTEtMS0xMjE3OTc_800dbf75-12d8-40ea-891b-25ec497c3791">808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfNi0zLTEtMS0xMjE3OTc_cf2bc39e-2142-4f6f-9f1e-abe86b976c2f">747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfNy0xLTEtMS0xMjE3OTc_e7bc43e4-c24c-4f70-9d28-79332b99c297">1,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfNy0zLTEtMS0xMjE3OTc_d3ee445b-41e7-42e6-b0bc-d048b13f7bf7">1,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfOC0xLTEtMS0xMjE3OTc_47739b50-8cbd-48f1-9ff4-958923717827">2,721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfOC0zLTEtMS0xMjE3OTc_6a913724-d75a-418e-8515-d9786a83f9da">2,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfOS0xLTEtMS0xMjE3OTc_0d7a66ac-60ca-4bfc-a55e-5c71fa8e14fa">22,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfOS0zLTEtMS0xMjE3OTc_efa74701-2141-4d43-a341-6d0079c7c3f4">20,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ida40eb5780a84278918ae20705359557" continuedAt="i9b91bc3b2d5145a496cc42f1548e34a2"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNTE4Mg_944b28a5-a79b-4f7a-b41c-dcef42a32376" continuedAt="i99397a16baea4c51970d8017aab24bdd" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the debt securities the Company held at June&#160;30, 2022 and December&#160;31, 2021 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.244%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 12 months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except number of securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNC0xLTEtMS0xMjE3OTc_e24ce336-e539-4304-8ece-5ab97f048985">464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNC0zLTEtMS0xMjE3OTc_4e4de714-b255-4516-aacc-8dde00c6cbf7">1,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNC01LTEtMS0xMjE3OTc_26df099f-fb68-4ba7-ac21-1299eac84faa">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNC03LTEtMS0xMjE3OTc_acd9cf28-4938-4923-98d6-40fdba18e6ce">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNC05LTEtMS0xMjE3OTc_974583a7-dec9-4196-b1b0-cbf86be6ef22">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNC0xMS0xLTEtMTIxNzk3_0f15a7e4-6142-4a0d-b44a-814d4b91128f">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNC0xMy0xLTEtMTIxNzk3_629f810b-bcb2-4bec-ae5c-4e62c3399815">476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNC0xNS0xLTEtMTIxNzk3_68613ca8-83d5-4267-abea-4c28aedc4125">1,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNC0xNy0xLTEtMTIxNzk3_70497229-fd70-4a62-bc9a-e0e99f8d0b63">118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ib04a3967c8004f97aa14f769721b3a73_I20220630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNS0xLTEtMS0xMjE3OTc_8dd91f86-8656-4b9d-8aad-1f98ffe83037">875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib04a3967c8004f97aa14f769721b3a73_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNS0zLTEtMS0xMjE3OTc_613c3f87-4d1a-4155-960a-f70d5dadfe9e">1,372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib04a3967c8004f97aa14f769721b3a73_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNS01LTEtMS0xMjE3OTc_d0cd0f32-7f8e-47bb-9529-480f58d9bfb5">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ib04a3967c8004f97aa14f769721b3a73_I20220630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNS03LTEtMS0xMjE3OTc_1d7b6a4e-20be-42fa-b24b-53919f79ae06">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib04a3967c8004f97aa14f769721b3a73_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNS05LTEtMS0xMjE3OTc_ca0ad8e9-8e73-49c0-b0a0-3be1710d577e">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib04a3967c8004f97aa14f769721b3a73_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNS0xMS0xLTEtMTIxNzk3_95a18e6e-5ea0-4e42-ba55-872b8827778e">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ib04a3967c8004f97aa14f769721b3a73_I20220630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNS0xMy0xLTEtMTIxNzk3_b876ae35-e892-4ffa-b891-5b296dc02c05">902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib04a3967c8004f97aa14f769721b3a73_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNS0xNS0xLTEtMTIxNzk3_6cd4c4b5-8692-478d-8f10-53903c7e21ce">1,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib04a3967c8004f97aa14f769721b3a73_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNS0xNy0xLTEtMTIxNzk3_96acdbee-b7d1-40cd-afa1-08fc46476d89">110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNi0xLTEtMS0xMjE3OTc_96dfe061-89c7-49ac-b42c-43204f0ee432">5,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNi0zLTEtMS0xMjE3OTc_20303117-c7f2-46ac-99c2-01488de3fba9">6,989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNi01LTEtMS0xMjE3OTc_a81ba555-3b54-4e91-a849-0109782a0ae0">674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNi03LTEtMS0xMjE3OTc_fb8afcce-df54-4ab3-8cbd-510638e827c6">364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNi05LTEtMS0xMjE3OTc_06a975d2-4bd3-4103-bb90-fa014e928cc0">508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNi0xMS0xLTEtMTIxNzk3_6728fe2a-94fc-4212-a242-a24974424f0c">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNi0xMy0xLTEtMTIxNzk3_c280b6b0-ab55-424e-80b4-9999cd5ff339">5,947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNi0xNS0xLTEtMTIxNzk3_95d222c0-5167-474c-af4f-916abbf6dce8">7,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNi0xNy0xLTEtMTIxNzk3_1e11ac6d-c43f-47ea-8d7b-31958966fa2d">740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i2e11998e647748a998ed3ae2000f65ec_I20220630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNy0xLTEtMS0xMjE3OTc_300a4635-d60e-4f74-b7c8-53d684673fbc">1,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e11998e647748a998ed3ae2000f65ec_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNy0zLTEtMS0xMjE3OTc_5e5a462e-ecb8-43ae-898f-407a92fb20cd">1,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e11998e647748a998ed3ae2000f65ec_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNy01LTEtMS0xMjE3OTc_18c8db1f-3057-463a-9270-71f8559b3d0a">206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i2e11998e647748a998ed3ae2000f65ec_I20220630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNy03LTEtMS0xMjE3OTc_f2bf1be6-dd0a-414b-99cb-40c2d4e93d15">119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e11998e647748a998ed3ae2000f65ec_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNy05LTEtMS0xMjE3OTc_a8a0837d-5733-4d4f-828c-214845c798d3">172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e11998e647748a998ed3ae2000f65ec_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNy0xMS0xLTEtMTIxNzk3_55dab8a2-9d69-4528-b7dc-8401459e0757">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i2e11998e647748a998ed3ae2000f65ec_I20220630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNy0xMy0xLTEtMTIxNzk3_17a720fe-1095-4f64-b588-cc5b44099eb9">1,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e11998e647748a998ed3ae2000f65ec_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNy0xNS0xLTEtMTIxNzk3_66b012b0-01de-4ed5-b058-058f95d04d41">2,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e11998e647748a998ed3ae2000f65ec_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNy0xNy0xLTEtMTIxNzk3_b5ad83a6-bcce-453b-ad08-a68d38422502">236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOC0xLTEtMS0xMjE3OTc_2c9be325-2b25-431c-9426-08ebba312e6d">388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOC0zLTEtMS0xMjE3OTc_dccb406d-7909-4b70-9088-00f6f7122744">644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOC01LTEtMS0xMjE3OTc_84e2c822-1f0b-48e4-b353-feca3ca87777">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOC03LTEtMS0xMjE3OTc_b05d4005-59cc-4bff-9d79-6d8be68b881f">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOC05LTEtMS0xMjE3OTc_eca94e99-5d6e-4e8e-a9dd-cee4a6742cb3">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOC0xMS0xLTEtMTIxNzk3_1d46f84e-c9bb-4de1-b791-57e013da348f">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOC0xMy0xLTEtMTIxNzk3_d40b8e48-4441-4b0d-9213-5a1493fbb6bd">411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOC0xNS0xLTEtMTIxNzk3_7ef303b3-a57a-4f2c-9781-196784898574">709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOC0xNy0xLTEtMTIxNzk3_59923759-5074-420b-b265-b662fa660bb3">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOS0xLTEtMS0xMjE3OTc_4eff5858-482c-4a13-97fe-33d0bcebbc2e">436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOS0zLTEtMS0xMjE3OTc_c42af3e1-8a4b-483a-8f83-d2c81ba01dd1">955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOS01LTEtMS0xMjE3OTc_89de984f-c51b-428b-8fd6-3043a13799b9">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOS03LTEtMS0xMjE3OTc_d0badd97-bf06-4115-8982-1a55fad7ba81">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOS05LTEtMS0xMjE3OTc_3434741a-ec0b-4260-8724-b2a44eb1cc3d">118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOS0xMS0xLTEtMTIxNzk3_f3de2727-abff-44a6-aff0-0d2b8cf2347c">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOS0xMy0xLTEtMTIxNzk3_43d93b14-e04b-443c-8b53-6cc0f81fc043">489</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOS0xNS0xLTEtMTIxNzk3_3a9a011c-5660-47f9-baad-e7b19a254708">1,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOS0xNy0xLTEtMTIxNzk3_a044158e-c72c-43e8-aa9d-18c44789a210">114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTAtMS0xLTEtMTIxNzk3_46bd78f4-9434-4f47-97a5-ee8030b23bd6">1,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTAtMy0xLTEtMTIxNzk3_e911780f-8b06-48ae-90e7-3307ddeeba0c">2,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTAtNS0xLTEtMTIxNzk3_8ab43055-4253-41e4-b16b-5a64da660818">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTAtNy0xLTEtMTIxNzk3_1106b5c9-5eef-4af9-8849-d5e1c827cb1d">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTAtOS0xLTEtMTIxNzk3_bede8c1a-43e6-401c-b913-8dbd9909fd14">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTAtMTEtMS0xLTEyMTc5Nw_9525c9b1-324e-4220-b36d-b5a377fb115d">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTAtMTMtMS0xLTEyMTc5Nw_a8548c01-9612-42c3-9af3-f3f57c767be1">1,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTAtMTUtMS0xLTEyMTc5Nw_ce48515b-7540-475e-a68b-49c213abbfcb">2,472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTAtMTctMS0xLTEyMTc5Nw_902e664e-efd3-4eeb-aa8f-e4c1052520b6">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i7b1da324447946a5a60e70cf44b0c827_I20220630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTEtMS0xLTEtMTIxNzk3_ffb162b9-23a6-440d-80af-8873029d9488">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b1da324447946a5a60e70cf44b0c827_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTEtMy0xLTEtMTIxNzk3_adb52224-e270-44b0-aca3-c4541f4c2e72">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b1da324447946a5a60e70cf44b0c827_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTEtNS0xLTEtMTIxNzk3_75e7eaf6-80ea-471c-8475-713d60686073">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i7b1da324447946a5a60e70cf44b0c827_I20220630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTEtNy0xLTEtMTIxNzk3_833c9f07-d843-43fc-9478-21166bacbeda">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b1da324447946a5a60e70cf44b0c827_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTEtOS0xLTEtMTIxNzk3_2e3aaa56-11a9-4f15-bb89-6d01820ebf3f">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b1da324447946a5a60e70cf44b0c827_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTEtMTEtMS0xLTEyMTc5Nw_6c8de4ef-821e-4bb7-9ae7-80fa0f266855">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i7b1da324447946a5a60e70cf44b0c827_I20220630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTEtMTMtMS0xLTEyMTc5Nw_c2588a8f-28f3-42fe-92c6-11e7c9ac6296">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b1da324447946a5a60e70cf44b0c827_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTEtMTUtMS0xLTEyMTc5Nw_381d1d93-ef76-415a-82dc-c1fe550cd73c">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b1da324447946a5a60e70cf44b0c827_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTEtMTctMS0xLTEyMTc5Nw_fdd9a978-913d-4490-aed8-a5bb1f164f51">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTItMS0xLTEtMTIxNzk3_a2ca64f2-5802-466f-aeab-f091075e5456">10,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTItMy0xLTEtMTIxNzk3_54103767-8923-4c1c-bcfa-f1d3c1f9c082">15,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTItNS0xLTEtMTIxNzk3_cb98299f-dd52-473d-8392-3cbbc0430b89">1,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTItNy0xLTEtMTIxNzk3_118ba0c8-455d-44c3-a162-7aa332361dc8">690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTItOS0xLTEtMTIxNzk3_fee6ab7c-a07d-4b7d-8661-c9796f472fff">1,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTItMTEtMS0xLTEyMTc5Nw_fac09e69-25c0-4422-b977-37b599ea3ca5">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTItMTMtMS0xLTEyMTc5Nw_9aee9eca-cfa7-4285-9b2e-1705869f4b60">11,074</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTItMTUtMS0xLTEyMTc5Nw_8ea6c471-a536-4ff1-bcbc-309cd934a1a6">16,918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTItMTctMS0xLTEyMTc5Nw_b4599f36-7959-47ef-923e-e6b4d6f29c24">1,515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTYtMS0xLTEtMTIxNzk3_e46681f3-0a81-4fa9-a991-692b98ffae89">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTYtMy0xLTEtMTIxNzk3_8181a012-10e6-47ef-b09f-43ca81c6362b">242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTYtNS0xLTEtMTIxNzk3_e6056300-cacd-44f5-bc18-1b2ce1c30cb0">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTYtNy0xLTEtMTIxNzk3_85f86d40-814c-4470-9901-adcb778b582b">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTYtOS0xLTEtMTIxNzk3_7d0cec8f-36f5-4703-aaac-bafcea6e6591">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTYtMTEtMS0xLTEyMTc5Nw_2f771f85-f116-41ef-87f8-9431f583a8e8">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTYtMTMtMS0xLTEyMTc5Nw_dff772bc-c034-489c-81c7-0469dd254b5f">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTYtMTUtMS0xLTEyMTc5Nw_c05b8a38-c89f-4e6c-b44b-709be6845da5">282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTYtMTctMS0xLTEyMTc5Nw_8f52b691-81bd-4b27-bf21-43753f04dde3">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i312562153ede48bfb0ae6742085c849a_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTctMS0xLTEtMTIxNzk3_b7c799ef-78a9-4351-bff9-13579b2a9e37">233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i312562153ede48bfb0ae6742085c849a_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTctMy0xLTEtMTIxNzk3_ea39c89e-a988-4d36-956c-06962c4ca35e">428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i312562153ede48bfb0ae6742085c849a_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTctNS0xLTEtMTIxNzk3_d773f490-eb5e-4455-a2cd-5aa93a132cbb">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i312562153ede48bfb0ae6742085c849a_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTctNy0xLTEtMTIxNzk3_b547a157-5408-4437-98ac-5b3fb88d5770">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i312562153ede48bfb0ae6742085c849a_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTctOS0xLTEtMTIxNzk3_7493af38-17fe-4049-9028-c75b53ef50a8">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i312562153ede48bfb0ae6742085c849a_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTctMTEtMS0xLTEyMTc5Nw_bd10a4bb-6a12-46b7-9fd3-f190a56ceb1f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i312562153ede48bfb0ae6742085c849a_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTctMTMtMS0xLTEyMTc5Nw_66bef62f-b033-4567-a7fa-cdada019a701">246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i312562153ede48bfb0ae6742085c849a_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTctMTUtMS0xLTEyMTc5Nw_4b5feaa8-7356-47e3-b82c-84deb2b50bf7">461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i312562153ede48bfb0ae6742085c849a_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTctMTctMS0xLTEyMTc5Nw_7f985562-0767-423c-9e91-f30d22c824dd">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="iacd25bc0ddd1457bb0d369b53f596438_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTgtMS0xLTEtMTIxNzk3_82770779-9f48-4f11-96fc-30e4e7629deb">1,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacd25bc0ddd1457bb0d369b53f596438_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTgtMy0xLTEtMTIxNzk3_a3363389-886f-4bac-a77a-8af0c7525288">2,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacd25bc0ddd1457bb0d369b53f596438_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTgtNS0xLTEtMTIxNzk3_e7e1a418-e17c-43bc-854b-cc6c6e3085dd">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="iacd25bc0ddd1457bb0d369b53f596438_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTgtNy0xLTEtMTIxNzk3_a8e2463c-438a-48e0-bdd1-1071b2674a6e">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacd25bc0ddd1457bb0d369b53f596438_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTgtOS0xLTEtMTIxNzk3_39e08299-0f55-4b6f-ac93-da0857c915ab">238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacd25bc0ddd1457bb0d369b53f596438_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTgtMTEtMS0xLTEyMTc5Nw_10c04c1d-8e4a-4bb5-a537-b06ee4df84d2">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="iacd25bc0ddd1457bb0d369b53f596438_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTgtMTMtMS0xLTEyMTc5Nw_caa1ebae-37b0-4217-a96f-c331a9f2acc8">1,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacd25bc0ddd1457bb0d369b53f596438_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTgtMTUtMS0xLTEyMTc5Nw_04625ff8-013d-4b7f-8e2d-1c84ebade56b">2,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacd25bc0ddd1457bb0d369b53f596438_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTgtMTctMS0xLTEyMTc5Nw_f03f9549-80ca-428e-a58e-c3dde4d38364">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i27a2d69d05ce407693c56825032df2c6_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTktMS0xLTEtMTIxNzk3_89b5823c-5b5c-43f8-9f50-aef79ac9eea3">449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27a2d69d05ce407693c56825032df2c6_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTktMy0xLTEtMTIxNzk3_a6ec1262-ad83-40b7-911b-d44c09fa066e">747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27a2d69d05ce407693c56825032df2c6_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTktNS0xLTEtMTIxNzk3_6c947e79-d57e-4d35-a89d-36b337f890f1">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i27a2d69d05ce407693c56825032df2c6_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTktNy0xLTEtMTIxNzk3_ffcf3fb1-9b84-4ec4-afc0-0a61ebd35104">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27a2d69d05ce407693c56825032df2c6_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTktOS0xLTEtMTIxNzk3_3c2a23b0-1683-43cf-b7e1-03741006101b">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27a2d69d05ce407693c56825032df2c6_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTktMTEtMS0xLTEyMTc5Nw_275ac835-4b3e-4b23-a710-e1ff97c22299">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i27a2d69d05ce407693c56825032df2c6_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTktMTMtMS0xLTEyMTc5Nw_c22fd5c2-cac9-47a9-9ee9-618d969c095a">506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27a2d69d05ce407693c56825032df2c6_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTktMTUtMS0xLTEyMTc5Nw_306bdae6-a565-4785-af77-0438f35d1fef">838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27a2d69d05ce407693c56825032df2c6_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTktMTctMS0xLTEyMTc5Nw_df84682f-ca7d-4a62-9a8a-c36cbc2fe22e">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i5f4295241da2454b9ca27744d8f494b2_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjAtMS0xLTEtMTIxNzk3_6450450a-94a8-4c65-9e17-a7e4ceccf8c9">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f4295241da2454b9ca27744d8f494b2_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjAtMy0xLTEtMTIxNzk3_da774992-1195-4076-810d-635e2eaba951">593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f4295241da2454b9ca27744d8f494b2_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjAtNS0xLTEtMTIxNzk3_b25df978-d4e2-4ce0-81ee-04e2ac1c3b91">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i5f4295241da2454b9ca27744d8f494b2_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjAtNy0xLTEtMTIxNzk3_52fe5541-36d5-4fe4-96e6-ad4d71a3caa7">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f4295241da2454b9ca27744d8f494b2_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjAtOS0xLTEtMTIxNzk3_ed7d0a06-5ba3-4565-aac2-1beab0317adc">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f4295241da2454b9ca27744d8f494b2_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjAtMTEtMS0xLTEyMTc5Nw_e8dd4f07-810a-4fa0-957c-0926cb4ef912">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i5f4295241da2454b9ca27744d8f494b2_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjAtMTMtMS0xLTEyMTc5Nw_2d726668-fe44-45a7-9d81-2fef4bd24704">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f4295241da2454b9ca27744d8f494b2_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjAtMTUtMS0xLTEyMTc5Nw_3f72245a-8c9b-4465-be7b-67fcd01f9ea4">629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f4295241da2454b9ca27744d8f494b2_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjAtMTctMS0xLTEyMTc5Nw_cdacca2c-0a25-46f9-9673-7ce113f07155">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ic26d39b1909b4114abe91b81a22d3ca5_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjEtMS0xLTEtMTIxNzk3_8d425258-a5e0-4a15-895b-4d57b9357249">188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic26d39b1909b4114abe91b81a22d3ca5_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjEtMy0xLTEtMTIxNzk3_fdd20a87-fd0e-4568-9201-771d9a20aa54">462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic26d39b1909b4114abe91b81a22d3ca5_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjEtNS0xLTEtMTIxNzk3_4c786129-65a8-41f6-9045-7b7e640abe08">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ic26d39b1909b4114abe91b81a22d3ca5_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjEtNy0xLTEtMTIxNzk3_14bc7c6f-e5bd-4860-9ccc-c7979d6e498c">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic26d39b1909b4114abe91b81a22d3ca5_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjEtOS0xLTEtMTIxNzk3_e3230560-0646-4742-ad14-8aa0da5621d7">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic26d39b1909b4114abe91b81a22d3ca5_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjEtMTEtMS0xLTEyMTc5Nw_8d8897c0-31e1-4bfe-be28-988a68853fc4">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ic26d39b1909b4114abe91b81a22d3ca5_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjEtMTMtMS0xLTEyMTc5Nw_6dd24b44-a0c8-4865-ad2c-d951bf6c8fbc">223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic26d39b1909b4114abe91b81a22d3ca5_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjEtMTUtMS0xLTEyMTc5Nw_23622b31-71ef-4d17-80c1-f0b826876c72">574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic26d39b1909b4114abe91b81a22d3ca5_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjEtMTctMS0xLTEyMTc5Nw_284bb47c-84da-4912-b4d4-acda78de5881">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ibf2696db609145edadde7083bbfb8eac_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjItMS0xLTEtMTIxNzk3_6f2c44bb-3b40-4060-b984-8522ce66502a">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf2696db609145edadde7083bbfb8eac_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjItMy0xLTEtMTIxNzk3_f43cae44-949d-4aab-b21d-3d9c702d8c56">2,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf2696db609145edadde7083bbfb8eac_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjItNS0xLTEtMTIxNzk3_a5d1f4db-aeb5-4c90-8572-1fbbe5e2cc90">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ibf2696db609145edadde7083bbfb8eac_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjItNy0xLTEtMTIxNzk3_dd4e620a-6d1e-4a96-9f96-c151e17a78f9">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf2696db609145edadde7083bbfb8eac_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjItOS0xLTEtMTIxNzk3_b5cb2080-3b99-424b-932e-65a4fdce263b">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf2696db609145edadde7083bbfb8eac_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjItMTEtMS0xLTEyMTc5Nw_5ac92910-b75f-4a5c-b744-1e1ee66a8fbc">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ibf2696db609145edadde7083bbfb8eac_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjItMTMtMS0xLTEyMTc5Nw_0019e970-34b6-4978-b78e-bb638f47cb44">1,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf2696db609145edadde7083bbfb8eac_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjItMTUtMS0xLTEyMTc5Nw_ec9d766f-7de8-4cc4-972d-97c51004270d">2,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf2696db609145edadde7083bbfb8eac_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjItMTctMS0xLTEyMTc5Nw_d55d42c6-3237-45b2-b0c2-b4e8ae74fe65">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i35a7089aaf074a29b807a8530fceab9c_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjMtMS0xLTEtMTIxNzk3_37bad81a-ccd5-4118-a8a1-1c2a51b92f87">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35a7089aaf074a29b807a8530fceab9c_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjMtMy0xLTEtMTIxNzk3_3f320457-7da2-42f3-82d9-1b162f471640">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35a7089aaf074a29b807a8530fceab9c_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjMtNS0xLTEtMTIxNzk3_d8ba1b77-83f9-4748-85f5-ba1c86795586">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i35a7089aaf074a29b807a8530fceab9c_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjMtNy0xLTEtMTIxNzk3_a2797880-52ce-46c6-b507-190d40ce0bba">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35a7089aaf074a29b807a8530fceab9c_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjMtOS0xLTEtMTIxNzk3_a23b49fb-9537-433b-86dc-6fce57e57822">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35a7089aaf074a29b807a8530fceab9c_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjMtMTEtMS0xLTEyMTc5Nw_23262f51-1bb3-45a8-b269-2b8c398d67df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i35a7089aaf074a29b807a8530fceab9c_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjMtMTMtMS0xLTEyMTc5Nw_78202113-2b93-496f-8cdb-ddfb83513f05">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35a7089aaf074a29b807a8530fceab9c_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjMtMTUtMS0xLTEyMTc5Nw_84b691da-0d91-4f9a-953f-d8f1f3e4936d">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35a7089aaf074a29b807a8530fceab9c_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjMtMTctMS0xLTEyMTc5Nw_caeb2324-583d-421a-9f16-b2b227f00970">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjQtMS0xLTEtMTIxNzk3_0271636f-dea2-4219-8279-a11155298f7c">3,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjQtMy0xLTEtMTIxNzk3_e6b83c17-d806-44ea-b2ac-46a39fb1fc2a">6,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjQtNS0xLTEtMTIxNzk3_8621fc7c-68c8-43f0-a07d-bf00926f7e1d">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjQtNy0xLTEtMTIxNzk3_a9e02040-66c4-4ac1-b73c-40bd817653c4">317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjQtOS0xLTEtMTIxNzk3_9ce1066f-12b8-4ad3-88ca-44253523aae2">584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjQtMTEtMS0xLTEyMTc5Nw_6c2943c2-90fa-4c7e-986a-35660c24ceb5">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjQtMTMtMS0xLTEyMTc5Nw_1f18567b-975f-48f0-98d6-0a7383115f07">4,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjQtMTUtMS0xLTEyMTc5Nw_94ee6934-18e2-43cf-b5d0-292fb0ed0e59">7,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjQtMTctMS0xLTEyMTc5Nw_5c3fb2c7-e907-4018-b0b8-a55301968904">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviewed the securities in the table above and concluded that they are performing assets generating investment income to support the needs of the Company&#8217;s business.&#160;In performing this review, the Company considered factors such as the quality of the investment security based on research performed by the Company&#8217;s internal credit analysts and&#160;external rating agencies and the prospects of realizing the carrying value of the security based on the investment&#8217;s current prospects for recovery. Unrealized capital losses at June&#160;30, 2022 were generally caused by interest rate increases and not by unfavorable changes in the credit quality associated with these securities. As of June&#160;30, 2022, the Company did not intend to sell these securities, and did not believe it was more likely than not that it would be required to sell these securities prior to the anticipated recovery of their amortized cost basis.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i9b91bc3b2d5145a496cc42f1548e34a2" continuedAt="i6a3c133d86c349e1971cff71008e89e2"><ix:continuation id="i99397a16baea4c51970d8017aab24bdd"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity dates for debt securities in an unrealized capital loss position at June&#160;30, 2022 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.505%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.399%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.948%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting<br/>experience-rated products</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting <br/>remaining products</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a4d5943f3344b028b2021d88fb2d40d_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfMy0xLTEtMS0xMjE3OTc_b4384671-a0ec-47cc-908c-62b533c5edc5">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a4d5943f3344b028b2021d88fb2d40d_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfMy0zLTEtMS0xMjE3OTc_67a8d715-4c20-4986-a4d2-f9a9d925be5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if33a8819dea14f63a14fc5b0024f0188_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfMy01LTEtMS0xMjE3OTc_6843d0aa-12e2-49b8-bd9e-87e99e4f7a7b">438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if33a8819dea14f63a14fc5b0024f0188_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfMy03LTEtMS0xMjE3OTc_91de55c6-25bb-42e4-af6b-60d2a57b06f3">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfMy05LTEtMS0xMjE3OTc_b4b15cf0-6da0-459f-8618-682c09c60bc0">445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfMy0xMS0xLTEtMTIxNzk3_8b97a0e1-9da7-4146-8be1-bc67f65e7a3d">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a4d5943f3344b028b2021d88fb2d40d_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNC0xLTEtMS0xMjE3OTc_8abe90a8-5587-4cea-b6e0-d898a5c577ba">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a4d5943f3344b028b2021d88fb2d40d_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNC0zLTEtMS0xMjE3OTc_7f0850d7-7c45-4b75-9baf-71c7546d4507">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if33a8819dea14f63a14fc5b0024f0188_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNC01LTEtMS0xMjE3OTc_ac5756c3-e816-4ca2-88a6-e813ccb7cb1e">5,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if33a8819dea14f63a14fc5b0024f0188_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNC03LTEtMS0xMjE3OTc_62cb96da-8bcd-490b-8b50-9d0e954eec30">320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNC05LTEtMS0xMjE3OTc_61f28c08-d716-48f6-8b62-9e4b229645e2">5,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNC0xMS0xLTEtMTIxNzk3_d55c3ffc-074f-4469-bc59-5e55c0b67831">322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a4d5943f3344b028b2021d88fb2d40d_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNS0xLTEtMS0xMjE3OTc_f69f2159-86c3-4659-b847-c16cb52eb202">151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a4d5943f3344b028b2021d88fb2d40d_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNS0zLTEtMS0xMjE3OTc_091f1746-92d3-4d26-95c5-8c7df190016c">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if33a8819dea14f63a14fc5b0024f0188_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNS01LTEtMS0xMjE3OTc_c5aa8fbf-7df6-4e46-b0b9-351b4f97061e">3,713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if33a8819dea14f63a14fc5b0024f0188_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNS03LTEtMS0xMjE3OTc_df4048d3-050b-4b8c-b27b-3ac3bd3b8f2c">471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNS05LTEtMS0xMjE3OTc_57870bfb-1eef-4520-9312-ad3438762777">3,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNS0xMS0xLTEtMTIxNzk3_25bf65cf-920c-46c0-8ba4-6f6db992260a">486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a4d5943f3344b028b2021d88fb2d40d_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNi0xLTEtMS0xMjE3OTc_aa4a3399-71c3-43e4-ac4a-eb821d009a53">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a4d5943f3344b028b2021d88fb2d40d_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNi0zLTEtMS0xMjE3OTc_efd75079-4a93-4759-9dac-c980f2d29908">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if33a8819dea14f63a14fc5b0024f0188_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNi01LTEtMS0xMjE3OTc_5a29a0a8-7739-470e-833e-69427194ea8f">3,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if33a8819dea14f63a14fc5b0024f0188_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNi03LTEtMS0xMjE3OTc_fd9f6580-029b-400c-b64d-103aafd1855a">374</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNi05LTEtMS0xMjE3OTc_6dcb4301-abce-4af0-a162-105e3a84e6dc">3,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNi0xMS0xLTEtMTIxNzk3_0c9522db-5b59-4e46-849f-07fe6e77a0fa">392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if147f99b547041e7930b6068d7988826_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNy0xLTEtMS0xMjE3OTc_29c960ff-21fd-45ce-8b2f-0905572ddd40">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if147f99b547041e7930b6068d7988826_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNy0zLTEtMS0xMjE3OTc_88a5b015-f13b-42b8-ad88-84af86e7b129">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aa8184ef83c4a40a3d80e580b517091_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNy01LTEtMS0xMjE3OTc_f9538ef9-88af-49d1-8605-f56a5e7b5a0b">698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aa8184ef83c4a40a3d80e580b517091_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNy03LTEtMS0xMjE3OTc_05d76dd0-64f2-48d0-87d5-fb9678260289">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNy05LTEtMS0xMjE3OTc_cfdb060b-a5f2-49b2-97b1-92732f30307b">709</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNy0xMS0xLTEtMTIxNzk3_cd0efcec-e2db-430e-94b5-d9d14109737f">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92bb3a9ebd6340bbafee19e1a0961497_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfOC0xLTEtMS0xMjE3OTc_12dd0151-ee1a-46bd-8daf-1c90c1bacb73">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92bb3a9ebd6340bbafee19e1a0961497_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfOC0zLTEtMS0xMjE3OTc_c017ea02-6b3e-4c00-9ed9-2fd85f2b1fa6">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i565890e50f664de28c6c98865dd484ac_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfOC01LTEtMS0xMjE3OTc_fcb7f717-59b3-4090-9b24-14b0abdf44f4">1,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i565890e50f664de28c6c98865dd484ac_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfOC03LTEtMS0xMjE3OTc_548ff44a-bf1a-4a83-a04b-45ea1dfc94df">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfOC05LTEtMS0xMjE3OTc_ebc2fea8-eec1-4f2c-b9ea-bee0ea8a41e5">1,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfOC0xMS0xLTEtMTIxNzk3_213d1ef4-ce36-42fe-b0a1-6fab8e14060c">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc6cfcaae9cd409daffba0639d13efcd_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfOS0xLTEtMS0xMjE3OTc_361ea3d5-9107-4740-a694-a2f5742bfae4">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc6cfcaae9cd409daffba0639d13efcd_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfOS0zLTEtMS0xMjE3OTc_150dde76-1ef0-412c-b57c-3588db729533">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfb24956f5d44b968d2715f9013c792b_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfOS01LTEtMS0xMjE3OTc_8bb4dc47-392c-4efd-b8ea-a029110eadce">2,456</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfb24956f5d44b968d2715f9013c792b_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfOS03LTEtMS0xMjE3OTc_b7b2b985-a3bb-4fef-b7c1-ea674ee45ad7">134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfOS05LTEtMS0xMjE3OTc_e1f92f96-1f5e-4945-a073-994e1f97a7aa">2,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfOS0xMS0xLTEtMTIxNzk3_2a8a230b-76d6-4f13-9935-6a1a9301fe78">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a4d5943f3344b028b2021d88fb2d40d_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfMTAtMS0xLTEtMTIxNzk3_8d2372af-145b-4d19-bf47-4ff6b4603d4e">468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a4d5943f3344b028b2021d88fb2d40d_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfMTAtMy0xLTEtMTIxNzk3_5b124dd5-ca49-4094-9342-23264aeaf08c">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if33a8819dea14f63a14fc5b0024f0188_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfMTAtNS0xLTEtMTIxNzk3_e973b4ce-6267-46c3-9637-a909e3343ef0">16,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if33a8819dea14f63a14fc5b0024f0188_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfMTAtNy0xLTEtMTIxNzk3_ef48a83d-e00a-4028-9446-6057966626ec">1,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfMTAtOS0xLTEtMTIxNzk3_368dd331-baee-4359-b835-05aa981dbbd1">16,918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfMTAtMTEtMS0xLTEyMTc5Nw_53d4385a-ea2d-4505-9986-b0af1953ec0f">1,515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mortgage Loans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s mortgage loans are collateralized by commercial real estate.&#160;<ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="cvs:ActivityInMortgageLoanPortfolioTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNTE3Ng_fb1c942f-4609-45a7-9021-32a6a31b3755" continuedAt="i90c583c9b7734ecb9a8a99ef87653c0f" escape="true">During the three and six months ended June&#160;30, 2022 and 2021, the Company had the following activity in its mortgage loan portfolio:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i90c583c9b7734ecb9a8a99ef87653c0f"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.285%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New mortgage loans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b35d26a394f498ead4b8911f6b783f3_D20220401-20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateNewMortgageLoans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEwZjNmZjVhMDI0YzQ2ODNhYjUyMjE5MTEzZjYzNGJkL3RhYmxlcmFuZ2U6MTBmM2ZmNWEwMjRjNDY4M2FiNTIyMTkxMTNmNjM0YmRfMi0xLTEtMS0xMjE3OTc_6a722aef-cc3d-45c6-953f-3439e8aff01e">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice4289e5981f470c8348e6e0bd038770_D20210401-20210630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateNewMortgageLoans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEwZjNmZjVhMDI0YzQ2ODNhYjUyMjE5MTEzZjYzNGJkL3RhYmxlcmFuZ2U6MTBmM2ZmNWEwMjRjNDY4M2FiNTIyMTkxMTNmNjM0YmRfMi0zLTEtMS0xMjE3OTc_c1028a98-97fc-4440-b36c-5d2b1d47dc5c">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81ecba3177494484943b0150ef662927_D20220101-20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateNewMortgageLoans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEwZjNmZjVhMDI0YzQ2ODNhYjUyMjE5MTEzZjYzNGJkL3RhYmxlcmFuZ2U6MTBmM2ZmNWEwMjRjNDY4M2FiNTIyMTkxMTNmNjM0YmRfMi01LTEtMS0xMjE3OTc_cb199bf4-d249-4b61-9aaf-4bdf318a3cc3">180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia42bbf3cad014282b14444e67b52efed_D20210101-20210630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateNewMortgageLoans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEwZjNmZjVhMDI0YzQ2ODNhYjUyMjE5MTEzZjYzNGJkL3RhYmxlcmFuZ2U6MTBmM2ZmNWEwMjRjNDY4M2FiNTIyMTkxMTNmNjM0YmRfMi03LTEtMS0xMjE3OTc_99ef7ef3-5e46-4f18-8fbf-bc932be0f0ed">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans fully repaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b35d26a394f498ead4b8911f6b783f3_D20220401-20220630" decimals="-6" name="cvs:MortgageLoansOnRealEstateLoansFullyRepaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEwZjNmZjVhMDI0YzQ2ODNhYjUyMjE5MTEzZjYzNGJkL3RhYmxlcmFuZ2U6MTBmM2ZmNWEwMjRjNDY4M2FiNTIyMTkxMTNmNjM0YmRfMy0xLTEtMS0xMjE3OTc_ce3444da-ec0a-4230-8023-5961ddf99975">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice4289e5981f470c8348e6e0bd038770_D20210401-20210630" decimals="-6" name="cvs:MortgageLoansOnRealEstateLoansFullyRepaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEwZjNmZjVhMDI0YzQ2ODNhYjUyMjE5MTEzZjYzNGJkL3RhYmxlcmFuZ2U6MTBmM2ZmNWEwMjRjNDY4M2FiNTIyMTkxMTNmNjM0YmRfMy0zLTEtMS0xMjE3OTc_a1d7b057-8e44-4ead-9d01-429b9a7b7c30">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81ecba3177494484943b0150ef662927_D20220101-20220630" decimals="-6" name="cvs:MortgageLoansOnRealEstateLoansFullyRepaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEwZjNmZjVhMDI0YzQ2ODNhYjUyMjE5MTEzZjYzNGJkL3RhYmxlcmFuZ2U6MTBmM2ZmNWEwMjRjNDY4M2FiNTIyMTkxMTNmNjM0YmRfMy01LTEtMS0xMjE3OTc_6681b254-6d27-4de2-963b-2fc294a2e75b">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia42bbf3cad014282b14444e67b52efed_D20210101-20210630" decimals="-6" name="cvs:MortgageLoansOnRealEstateLoansFullyRepaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEwZjNmZjVhMDI0YzQ2ODNhYjUyMjE5MTEzZjYzNGJkL3RhYmxlcmFuZ2U6MTBmM2ZmNWEwMjRjNDY4M2FiNTIyMTkxMTNmNjM0YmRfMy03LTEtMS0xMjE3OTc_863d67dc-88fe-4394-b77b-04504f586a66">172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans foreclosed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b35d26a394f498ead4b8911f6b783f3_D20220401-20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateForeclosures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEwZjNmZjVhMDI0YzQ2ODNhYjUyMjE5MTEzZjYzNGJkL3RhYmxlcmFuZ2U6MTBmM2ZmNWEwMjRjNDY4M2FiNTIyMTkxMTNmNjM0YmRfNC0xLTEtMS0xMjE3OTc_c5b1a13e-28d1-4584-85b5-30197951b014">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice4289e5981f470c8348e6e0bd038770_D20210401-20210630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateForeclosures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEwZjNmZjVhMDI0YzQ2ODNhYjUyMjE5MTEzZjYzNGJkL3RhYmxlcmFuZ2U6MTBmM2ZmNWEwMjRjNDY4M2FiNTIyMTkxMTNmNjM0YmRfNC0zLTEtMS0xMjE3OTc_9aa68a6a-9d61-47d2-bb72-6d71ee9de6eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81ecba3177494484943b0150ef662927_D20220101-20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateForeclosures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEwZjNmZjVhMDI0YzQ2ODNhYjUyMjE5MTEzZjYzNGJkL3RhYmxlcmFuZ2U6MTBmM2ZmNWEwMjRjNDY4M2FiNTIyMTkxMTNmNjM0YmRfNC01LTEtMS0xMjE3OTc_450150d9-97cd-4ecd-9d56-a3833eb412f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia42bbf3cad014282b14444e67b52efed_D20210101-20210630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateForeclosures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEwZjNmZjVhMDI0YzQ2ODNhYjUyMjE5MTEzZjYzNGJkL3RhYmxlcmFuZ2U6MTBmM2ZmNWEwMjRjNDY4M2FiNTIyMTkxMTNmNjM0YmRfNC03LTEtMS0xMjE3OTc_e64059d4-7fe2-457a-ab41-5589449fd413">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses mortgage loans on a regular basis for credit impairments, and assigns a credit quality indicator to each loan.&#160;The Company&#8217;s credit quality indicator is internally developed and categorizes each loan in its portfolio on a scale from 1 to 7.&#160;These indicators are based upon several factors, including current loan-to-value ratios, current and future property cash flow, property condition, market trends, creditworthiness of the borrower and deal structure. </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 1 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Represents loans of superior quality.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 2 to 4 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Represent loans where credit risk is minimal to acceptable; however, these loans may display some susceptibility to economic changes.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 5 and 6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represent loans where credit risk is not substantial, but these loans warrant management&#8217;s close attention.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represents loans where collections are potentially at risk; if necessary, an impairment is recorded.</span></div></ix:continuation><div style="padding-left:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6a3c133d86c349e1971cff71008e89e2"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNTEwMg_c084d0f7-830b-42ef-95a0-a98430bd6ea2" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the Company&#8217;s assessments at June&#160;30, 2022 and December&#160;31, 2021, the amortized cost basis of the Company's mortgage loans within each credit quality indicator by year of origination was as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.997%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost Basis by Year of Origination</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except credit quality indicator</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb0ab983715d47e4adbbebc254ffa1e4_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMy0xLTEtMS0xMjE3OTc_956933cf-82d7-4e30-bedd-afb52b38f488">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371c0520998941618ef7aea89496ed34_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMy0zLTEtMS0xMjE3OTc_58207aa7-593a-4448-843d-ef2620930484">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if373bf37aea3458b912ce5c9dedfd404_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMy01LTEtMS0xMjE3OTc_218e7aa2-893f-4320-83d7-2592555dd42f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4edd43c72fa24ecb8eb03fa5e6bd17c0_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMy03LTEtMS0xMjE3OTc_0fc6b2c9-50d6-4146-91bd-e14162978f1d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33d8e2fa0f464eab934f3a3981276b03_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMy05LTEtMS0xMjE3OTc_0e54cb4e-42b8-44dc-a6ef-a51df7fe013b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief7e32fbdcdc4b1db1c33985f1a1bfca_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMy0xMS0xLTEtMTIxNzk3_ddcd1c30-67d8-4483-9226-17dd81ab7526">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46df26cf65e741a88308365f0fdce535_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMy0xMy0xLTEtMTIxNzk3_526ebedd-ad95-45c3-acd5-4de8831bf0cf">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fd18a6eac95471682e4f96b85733eb0_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNC0xLTEtMS0xMjE3OTc_455ad2aa-6beb-46ac-9032-64831ec99237">162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia13fa065e11f43c99f24e914e7606b15_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNC0zLTEtMS0xMjE3OTc_4f18a87e-64be-45f5-80e1-48954c38ff9b">250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5eeda700ebc4f8eac3969546e289875_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNC01LTEtMS0xMjE3OTc_8808b6ca-42fa-42ab-a517-33c304dc4319">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47b1c162c8a4dd19c3d46272804896b_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNC03LTEtMS0xMjE3OTc_e779ff60-aac5-4326-99bd-880483e85ca2">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i899578d869e54146a2dc8706728481b0_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNC05LTEtMS0xMjE3OTc_1a4eafa9-5d7d-4036-996a-e2ddd450f6e0">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b60a590a9d846f38abc0bedd2f2462b_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNC0xMS0xLTEtMTIxNzk3_14cf8f26-33a1-441e-bc63-8df458cd8efd">418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec460be73364dbe9e6821a95e857a19_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNC0xMy0xLTEtMTIxNzk3_14313cb4-df35-4dc0-a0ca-4c366c1de474">963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c0db9ae3a654d1abcb624237ab2b056_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNS0xLTEtMS0xMjE3OTc_3f79fb5b-86b2-426d-b5bf-a03cda5c89a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6513ccc2104b42fc9d1803cfa7134a7a_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNS0zLTEtMS0xMjE3OTc_bf5baf67-8115-4cd5-aa2f-ad8e87769c5b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib744f76b72ec42598309a6e5c4e51b42_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNS01LTEtMS0xMjE3OTc_fd26441d-a7b2-4073-b84f-0c9b27fec1f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i456084319dfe4263a992c645b2d706b2_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNS03LTEtMS0xMjE3OTc_0550c337-4a15-4a9c-98e0-c927a7ef7a04">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i861b819f6b654647b93791e8fbac82b7_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNS05LTEtMS0xMjE3OTc_f82cb4c9-e14c-413b-b8d6-a4995f1bbc62">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0fe0824d20a45ce92b02afde836c6e5_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNS0xMS0xLTEtMTIxNzk3_61bd2de1-e147-43aa-a60f-6c59a1e11bce">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a9fd2dddbfe44ff88021ac1f64666f6_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNS0xMy0xLTEtMTIxNzk3_6d83dfc6-5287-4271-9ecd-8a614623628a">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i740f5a3a2f9a435891769f604897c8bb_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNi0xLTEtMS0xMjE3OTc_4ddd858d-012c-4d98-9ba8-bf0ad23938ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c41fd6ab6f49419e4feb0002f2d48f_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNi0zLTEtMS0xMjE3OTc_58633822-4e6d-463b-9deb-0c33ec014006">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief32efb6abac44468898f50592a29547_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNi01LTEtMS0xMjE3OTc_8f934eea-2f95-4feb-96aa-25cd4521e2c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i850b791bc3e2407da5747eebb4ab8c3f_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNi03LTEtMS0xMjE3OTc_bae3e46b-9845-4c6a-af0d-e99e89fda6dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38844338d2ce463798197e185e85f756_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNi05LTEtMS0xMjE3OTc_f8ea1f1f-6ca1-4c17-8f94-bee405ce7bd1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if00cd26828534c21b6c33adb32cacfd7_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNi0xMS0xLTEtMTIxNzk3_e904b123-4a9e-434c-9687-329cc45d06df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id743f9aa58344caf9f98f25c5d92b7de_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNi0xMy0xLTEtMTIxNzk3_83fdcbfa-16d3-4429-b58e-6f311100f588">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea202e1537584a368ceecede86271423_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNy0xLTEtMS0xMjE3OTc_59bd1a5f-f78f-4754-9a0c-41db5f0b9199">162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62992d26f65645ff897bda2742cf86fb_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNy0zLTEtMS0xMjE3OTc_75378aae-b27c-4a2d-80b9-5e3a3bbb3da2">250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11c72ce8b8dc4d21aae7ff8290b67bec_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNy01LTEtMS0xMjE3OTc_e591e22d-b77b-428a-a5c3-85fd2f5610b9">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39b1269f49174087928bb212d8afc1d2_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNy03LTEtMS0xMjE3OTc_e049d871-b605-4146-a3bd-3371a87264bf">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d994fd5d397459d8367d852e8f5452f_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNy05LTEtMS0xMjE3OTc_89917e73-0d35-4586-b0ee-7865fa62364c">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb0affc8add2414ca8954a5991109f55_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNy0xMS0xLTEtMTIxNzk3_b637402b-2783-4263-b293-bcaeab23d879">445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4faa5bd0ec73475c94099ab518ccf4e3_I20220630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNy0xMy0xLTEtMTIxNzk3_d414dab8-49e3-4e12-b0fa-2416bf7acd44">993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26d61f9963ea4196b8ba2d07d228e5bd_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTAtMy0xLTEtMTIxNzk3_647831b3-05b9-43c0-a5eb-aab6f04e7295">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb3ebe7111bf41f584b98e07430377db_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTAtNS0xLTEtMTIxNzk3_c8b47685-317c-489c-8b92-c1dc0c495e3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i000af04ab3a34580abe06f0d79b475b9_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTAtNy0xLTEtMTIxNzk3_333f83de-7ca1-4a1c-8b63-1e9c06da155a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37656451d6e54a6f87723c3c55ee7693_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTAtOS0xLTEtMTIxNzk3_bedef4b2-cf0e-4cc0-a7d7-99be10ec85f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id04cb4912f0c4add911f641b85b28d8d_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTAtMTEtMS0xLTEyMTc5Nw_8ce735aa-3086-4876-bfa1-257e7daad517">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a7a0277984b4d9292ccff484d447ce2_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTAtMTMtMS0xLTEyMTc5Nw_b91c5254-d58b-41b2-be57-1a6ab55716d8">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27decdd521e9427eb51858ecd5161a1c_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTEtMy0xLTEtMTIxNzk3_3f7fa9d8-abdf-4c53-95c6-efab9547d296">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0ab7e83123843f5995f6c913b85bc32_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTEtNS0xLTEtMTIxNzk3_2500b290-85ee-4481-96c1-6935e855c006">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib381c0925973492e9d3c59e35956766c_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTEtNy0xLTEtMTIxNzk3_2ceee852-b38f-4e52-ada9-e0719c3387d0">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f517e0f803f424d9f8a281c67637d41_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTEtOS0xLTEtMTIxNzk3_95090e9a-e087-4320-ac34-f83f94dc3ca6">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5dabfedcb3446d79b9af20990e4475f_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTEtMTEtMS0xLTEyMTc5Nw_b226582e-39c0-4431-a30b-68ac4956e8f6">446</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia44d0270c7fc4dab8d24ff7dd2185b17_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTEtMTMtMS0xLTEyMTc5Nw_617e9a37-48c0-4bf0-91be-08be2d572882">861</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i787125a9fb1c4d2dae3f0091842a2905_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTItMy0xLTEtMTIxNzk3_c0d9f7d0-ccdb-4791-baa7-3e366d6e0563">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i533abaf939b14629802a0d1666202827_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTItNS0xLTEtMTIxNzk3_8da9c045-19f1-4307-b6b9-171f7de5a593">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0be6d49dea7a41c3b3be5025579b7f80_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTItNy0xLTEtMTIxNzk3_065d384a-5718-4713-9852-2fd376daeedc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic22d1b35d059439ba0cc5c6c6960921d_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTItOS0xLTEtMTIxNzk3_73aba20d-8456-407f-84a1-214909c2dd31">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3530a0f47dac4ff1958936a41cb751d5_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTItMTEtMS0xLTEyMTc5Nw_9ae44f95-cf6e-4b1d-8c83-798718b65d79">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad0cb156fab4fb6afd4533b759fba57_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTItMTMtMS0xLTEyMTc5Nw_dd076a2d-f8c4-422b-986d-d3cdadff32a4">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib317e948955944578ea101ab7b8681bc_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTMtMy0xLTEtMTIxNzk3_b33a2148-d508-4891-9664-dda6fbd41d6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id27b20e03a0a420eb7c6b974de8faa01_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTMtNS0xLTEtMTIxNzk3_0f106161-8df2-4dee-a8ae-5222c7fa4e2b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11c2cc84da31426aa9cf78264345c70d_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTMtNy0xLTEtMTIxNzk3_a16e83b2-b7fa-4734-b4ec-c85c0fc7713f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207775b0e52a46038a243f680c4bfe38_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTMtOS0xLTEtMTIxNzk3_58a4aee0-6339-4656-9c20-885e07153621">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic002c663bb55486dbea5fd9b8add8629_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTMtMTEtMS0xLTEyMTc5Nw_98b60afe-6906-447b-ab07-9491d5b26cbc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i612e5e99ae014b8aab81d54d276d71a2_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTMtMTMtMS0xLTEyMTc5Nw_e695165c-83f2-4859-9037-48ec48058ab6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93420b43b370461b8eefc357152611ba_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTQtMy0xLTEtMTIxNzk3_d70a40e0-1d4b-470d-8f2c-eefe62bca640">255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idde41fc6240949d2b00dd4bfaea668ce_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTQtNS0xLTEtMTIxNzk3_c5e8d3bf-3054-49c1-b440-886a742ca1d7">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53f958f5f6f642d2b0e5a8f47b9be63e_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTQtNy0xLTEtMTIxNzk3_7fc0f370-e4dc-4752-a703-d6af80f94fee">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a5ae34085d7468184ecc64dcf1815c3_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTQtOS0xLTEtMTIxNzk3_ef811277-d24f-4ac6-9753-8ccaa2ed37f6">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib37a4b4576174adfbd328d6220e6446e_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTQtMTEtMS0xLTEyMTc5Nw_e760f4b9-fc17-4e9c-b802-fdb1c37944b3">484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0218b9eeafa744cd976a2ee112999f4c_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTQtMTMtMS0xLTEyMTc5Nw_61e516fa-210e-4fe0-933a-455a1cb1d625">902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Income</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:InvestmentIncomeTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNTE1OA_ce9cf65a-b131-4088-9120-f4ff58a41f9a" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sources of net investment income for the three and six months ended June&#160;30, 2022 and 2021 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.625%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.283%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b71fc37bdcc4544ba59a680d2a845ad_D20220401-20220630" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfMi0xLTEtMS0xMjE3OTc_285e85ad-c494-4c28-9495-21333fdb3705">172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6410396dd3b049fc94d73ed03406a6f0_D20210401-20210630" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfMi0zLTEtMS0xMjE3OTc_a0e3b76c-e9c4-443a-8f53-42804b5344f2">160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb2b8ddb867c4af697afecf4d9a157e8_D20220101-20220630" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfMi01LTEtMS0xMjE3OTc_f4b3c5c3-e793-4c9a-a631-5466e5691b1a">336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41d8c374cbf548e987ad1657cdc38098_D20210101-20210630" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfMi03LTEtMS0xMjE3OTc_25003525-6890-42f9-acda-f1ad6a142a58">317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib36aad3ac1484f6bbdaa4f1c0fc5b0b0_D20220401-20220630" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfMy0xLTEtMS0xMjE3OTc_8a7f5187-c8a4-40d9-a28e-74c91a7bf888">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e1b0b89b26a40c693ea4463c4d8593a_D20210401-20210630" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfMy0zLTEtMS0xMjE3OTc_c7292402-06e3-426f-b568-78a7c14a3b93">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfac0b03d2274f43871a43aeb40a5ec2_D20220101-20220630" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfMy01LTEtMS0xMjE3OTc_014ba98f-e884-4d57-8391-31002d7c9a2d">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09b23468a180421fb01ec60b86dff5b1_D20210101-20210630" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfMy03LTEtMS0xMjE3OTc_ed6642f7-6a71-4866-9d18-49e5c16970a9">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbcd8299564648c0b7ec0acfbd315e56_D20220401-20220630" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNC0xLTEtMS0xMjE3OTc_564c25e1-5b9d-4823-96ae-ae5bdcd9f06b">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b5bf1c54d1e4c2e9d9b2486e17e7e6f_D20210401-20210630" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNC0zLTEtMS0xMjE3OTc_cef880d8-1194-4e60-bd14-5d7b26a9c914">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd8e5b0ac1842dca561465f4468b014_D20220101-20220630" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNC01LTEtMS0xMjE3OTc_f5eaed79-dc3c-423c-9996-f24bd075b0e0">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4c795e51e0c4660990629bf4fd31005_D20210101-20210630" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNC03LTEtMS0xMjE3OTc_347d6bb1-d387-473d-8d73-392626c446bd">198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross investment income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNS0xLTEtMS0xMjE3OTc_005ed880-50b4-4e4a-b414-7e5636a90a0f">253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNS0zLTEtMS0xMjE3OTc_098c436f-e503-44df-9228-45a5639c7492">285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNS01LTEtMS0xMjE3OTc_c95dba5b-02e6-4e7e-ac0d-308c554aa498">505</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNS03LTEtMS0xMjE3OTc_5a9298f1-10c2-41db-b4b3-38690e53cd21">543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNi0xLTEtMS0xMjE3OTc_da894542-54ea-4c49-bc44-4b1e5becbe9e">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNi0zLTEtMS0xMjE3OTc_14610c3f-b290-4afd-b846-891b2392f7b7">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNi01LTEtMS0xMjE3OTc_56f32de6-c9ab-4ed0-852f-9f3132ecfc1b">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNi03LTEtMS0xMjE3OTc_d8eb6293-bed6-44a1-933d-c16704767ed9">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (excluding net realized capital gains or losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="cvs:InvestmentIncomeExcludingCapitalGainsorLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNy0xLTEtMS0xMjE3OTc_d0e4fde3-0f28-4855-93b2-6885ce45e42f">244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="cvs:InvestmentIncomeExcludingCapitalGainsorLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNy0zLTEtMS0xMjE3OTc_6efd79f5-1e68-4cf2-bf06-52296148c922">276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="cvs:InvestmentIncomeExcludingCapitalGainsorLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNy01LTEtMS0xMjE3OTc_80233ed6-edcd-4a2e-a4f9-d1da1be4aebd">487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="cvs:InvestmentIncomeExcludingCapitalGainsorLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNy03LTEtMS0xMjE3OTc_d3df2281-4f4c-44f0-8b4f-580c68d0e28e">526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital gains (losses) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfOC0xLTEtMS0xMjE3OTc_2c52ae08-6790-4d3e-b9e3-e81258424c21">98</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfOC0zLTEtMS0xMjE3OTc_53dd0b77-c2ad-4b16-81a5-8e9336622fbe">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfOC01LTEtMS0xMjE3OTc_25b76ecc-545d-4e22-8b26-26063938af9e">173</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfOC03LTEtMS0xMjE3OTc_d90b7667-b7d5-4ba2-a6ab-a0e95d36b0d9">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfOS0xLTEtMS0xMjE3OTc_152c7406-f513-4d7d-a1d2-6cb1de2dd683">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfOS0zLTEtMS0xMjE3OTc_ffb0fe9a-a75f-4927-91a9-98b58bf0d3e6">289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfOS01LTEtMS0xMjE3OTc_8a63140c-9eda-48d3-8e94-97ded7febcc7">314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfOS03LTEtMS0xMjE3OTc_c9856144-0778-4495-be20-171c7fbf19b8">586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net realized capital losses include yield-related impairment losses on debt securities of $<ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfMzg0ODI5MDcwNDMxMw_95ec9acd-19d1-459f-bc42-c5c6ea21d9e0">30</ix:nonFraction> million and are shown net of the reversal of previously recorded credit-related impairment losses on debt securities of $<ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" sign="-" name="cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfMzg0ODI5MDcwNDUyMA_a0687a72-1e8d-40ca-b2a8-750f3ea2f665">22</ix:nonFraction> million in the three months ended June&#160;30, 2022. Net realized capital losses include credit-related and yield-related impairment losses on debt securities of $<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfMzg0ODI5MDcwNDUyOA_4214d3b5-99d4-4d46-96fb-25fa56ba0ee4">16</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfMTA5OTUxMTYzMzcyNQ_7b19cc52-524e-448d-8df7-6cf2b98bf20f">48</ix:nonFraction> million, respectively, in the six months ended June&#160;30, 2022. Net realized capital gains are net of yield-related impairment losses on debt securities of $<ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNDU2Nw_7dfd3f33-1519-46bd-bdd5-40628ef27898">2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfMTY0OTI2NzQ0NzAwNA_404b3d3d-7185-46a6-ab95-a6a99147bfee">32</ix:nonFraction> million, respectively, in the three and six months ended June&#160;30, 2021. There were <ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNDYxMQ_08988b42-607b-4af1-b96b-fe6fa83ab82d"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNDYxMQ_487008bc-4fcf-4e05-ae3f-86c244157fe0">no</ix:nonFraction></ix:nonFraction> credit-related losses on debt securities in the three and six months ended June&#160;30, 2021.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net investment income includes $<ix:nonFraction unitRef="usd" contextRef="iaf069440948942608f8ec319d2ecfe5c_D20220401-20220630" decimals="-6" name="us-gaap:InvestmentIncomeNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNDcyNg_1edf2451-9384-45ad-b3c8-d35be515625a">9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i05ef7a86b20148e5a32020bd5c7d5fd8_D20220101-20220630" decimals="-6" name="us-gaap:InvestmentIncomeNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfMTY0OTI2NzQ0NzE1Mw_ab0fc8f0-8d9b-4af2-8537-cacdf389adb0">18</ix:nonFraction> million for the three and six months ended June&#160;30, 2022, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i8ca2c256a7cf4284bfbeea2216a84437_D20210401-20210630" decimals="-6" name="us-gaap:InvestmentIncomeNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfMTY0OTI2NzQ0NzE2NA_2dd58999-8bdf-4fe6-a723-88773c5689b0">10</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifdee0bd923464f248a69eb92727cbc33_D20210101-20210630" decimals="-6" name="us-gaap:InvestmentIncomeNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfMTY0OTI2NzQ0NzE3Mw_5f0e18a7-fa2c-4e12-bc06-455e3af5a99d">19</ix:nonFraction> million for the three and six months ended June&#160;30, 2021, respectively, related to investments supporting experience-rated products.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNTA4Mg_4292183f-2b2f-4549-84fe-9d78c3f7e6cc" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding amounts related to experience-rated products, proceeds from the sale of available-for-sale debt securities and the related gross realized capital gains and losses for the three and six months ended June&#160;30, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjc3ZjEwNjJkZjFiZDRhYzhiY2JhYmIyM2JiYjJkZGJhL3RhYmxlcmFuZ2U6NzdmMTA2MmRmMWJkNGFjOGJjYmFiYjIzYmJiMmRkYmFfMi0xLTEtMS0xMjE3OTc_ba6d2510-ca2d-4c52-b70f-397c8a50eb8c">1,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjc3ZjEwNjJkZjFiZDRhYzhiY2JhYmIyM2JiYjJkZGJhL3RhYmxlcmFuZ2U6NzdmMTA2MmRmMWJkNGFjOGJjYmFiYjIzYmJiMmRkYmFfMi0zLTEtMS0xMjE3OTc_588aa7a1-e16f-4585-bf14-eece4ee6e9ff">919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjc3ZjEwNjJkZjFiZDRhYzhiY2JhYmIyM2JiYjJkZGJhL3RhYmxlcmFuZ2U6NzdmMTA2MmRmMWJkNGFjOGJjYmFiYjIzYmJiMmRkYmFfMi01LTEtMS0xMjE3OTc_da490376-e147-494a-8132-29c14ff9b035">2,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjc3ZjEwNjJkZjFiZDRhYzhiY2JhYmIyM2JiYjJkZGJhL3RhYmxlcmFuZ2U6NzdmMTA2MmRmMWJkNGFjOGJjYmFiYjIzYmJiMmRkYmFfMi03LTEtMS0xMjE3OTc_69c26597-40db-4f61-af77-6929a05c4c24">2,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjc3ZjEwNjJkZjFiZDRhYzhiY2JhYmIyM2JiYjJkZGJhL3RhYmxlcmFuZ2U6NzdmMTA2MmRmMWJkNGFjOGJjYmFiYjIzYmJiMmRkYmFfMy0xLTEtMS0xMjE3OTc_06bf177b-7a74-443e-9183-818947a516cc">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjc3ZjEwNjJkZjFiZDRhYzhiY2JhYmIyM2JiYjJkZGJhL3RhYmxlcmFuZ2U6NzdmMTA2MmRmMWJkNGFjOGJjYmFiYjIzYmJiMmRkYmFfMy0zLTEtMS0xMjE3OTc_02f4dc98-19bd-4943-88ca-04628b7c3bb4">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjc3ZjEwNjJkZjFiZDRhYzhiY2JhYmIyM2JiYjJkZGJhL3RhYmxlcmFuZ2U6NzdmMTA2MmRmMWJkNGFjOGJjYmFiYjIzYmJiMmRkYmFfMy01LTEtMS0xMjE3OTc_dc7b2a03-0b98-4d2d-89f2-cf6b36cbe56e">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjc3ZjEwNjJkZjFiZDRhYzhiY2JhYmIyM2JiYjJkZGJhL3RhYmxlcmFuZ2U6NzdmMTA2MmRmMWJkNGFjOGJjYmFiYjIzYmJiMmRkYmFfMy03LTEtMS0xMjE3OTc_89e3c269-da63-4153-85ff-8764d7acb476">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjc3ZjEwNjJkZjFiZDRhYzhiY2JhYmIyM2JiYjJkZGJhL3RhYmxlcmFuZ2U6NzdmMTA2MmRmMWJkNGFjOGJjYmFiYjIzYmJiMmRkYmFfNC0xLTEtMS0xMjE3OTc_9fd2bdcb-bdd5-4f00-a57e-a940e3ecd2f9">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjc3ZjEwNjJkZjFiZDRhYzhiY2JhYmIyM2JiYjJkZGJhL3RhYmxlcmFuZ2U6NzdmMTA2MmRmMWJkNGFjOGJjYmFiYjIzYmJiMmRkYmFfNC0zLTEtMS0xMjE3OTc_261b9bd3-a472-4edd-bd16-0d51f6b86d5a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjc3ZjEwNjJkZjFiZDRhYzhiY2JhYmIyM2JiYjJkZGJhL3RhYmxlcmFuZ2U6NzdmMTA2MmRmMWJkNGFjOGJjYmFiYjIzYmJiMmRkYmFfNC01LTEtMS0xMjE3OTc_cabffc6a-67e0-41e0-b21b-1b17b29aba41">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjc3ZjEwNjJkZjFiZDRhYzhiY2JhYmIyM2JiYjJkZGJhL3RhYmxlcmFuZ2U6NzdmMTA2MmRmMWJkNGFjOGJjYmFiYjIzYmJiMmRkYmFfNC03LTEtMS0xMjE3OTc_8f227899-c028-4f97-964f-ea7a56d52e9a">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_43"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RleHRyZWdpb246ODJhOGE1ZjBhNGQwNGFlZTg2Njc0MzRhZjFlMjBiNzVfMzEzNQ_fadea8c6-98c1-4f82-99be-5f62bbed4fcc" continuedAt="i02596a9159884ba2a0c3f1a12ace9db4" escape="true">Fair Value</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i02596a9159884ba2a0c3f1a12ace9db4" continuedAt="i554db407375b4bfbb6f73fe8cc9d03af"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company&#8217;s unaudited condensed consolidated financial statements in accordance with GAAP requires certain assets and liabilities to be reflected at their fair value and others to be reflected on another basis, such as an adjusted historical cost basis.&#160;The Company&#8217;s assets and liabilities carried at fair value have been classified within one of three levels of a hierarchy established by GAAP.&#160;The following are the levels of the hierarchy and a brief description of the type of valuation information (&#8220;valuation inputs&#8221;) that qualifies a financial asset or liability for each level:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; Unadjusted quoted prices for identical assets or liabilities in active markets.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; Valuation inputs other than Level 1 that are based on observable market data.&#160;&#160;These include: quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets, valuation inputs that are observable that are not prices (such as interest rates and credit risks) and valuation inputs that are derived from or corroborated by observable markets.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; Developed from unobservable data, reflecting the Company&#8217;s assumptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of the methods and assumptions that are used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument, see Note 4 &#8220;Fair Value&#8221; in the 2021 Form 10-K.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i554db407375b4bfbb6f73fe8cc9d03af" continuedAt="ic8f5072f0a9144efad9aace9bddabd90"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="i4e0d80e2d0a04bb8927a1bf01c58fd6a_I20220630" decimals="-6" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RleHRyZWdpb246ODJhOGE1ZjBhNGQwNGFlZTg2Njc0MzRhZjFlMjBiNzVfMTQzMw_58c5c6fb-3e4f-48db-b2a8-7868d637290a"><ix:nonFraction unitRef="usd" contextRef="i68271d4af0dd46f9a15ba39a24443504_I20211231" decimals="-6" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RleHRyZWdpb246ODJhOGE1ZjBhNGQwNGFlZTg2Njc0MzRhZjFlMjBiNzVfMTQzMw_6be40818-600e-491f-a3a9-e6b2951050cc">no</ix:nonFraction></ix:nonFraction> financial liabilities measured at fair value on a recurring basis on the unaudited condensed consolidated balance sheets at June&#160;30, 2022 or December&#160;31, 2021. <ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RleHRyZWdpb246ODJhOGE1ZjBhNGQwNGFlZTg2Njc0MzRhZjFlMjBiNzVfMzExMw_2b3981bb-0b7e-487a-95a0-feba1be2c28a" continuedAt="i6e3c881970144ad7a5b510a9c38dd36c" escape="true">Financial assets measured at fair value on a recurring basis on the unaudited condensed consolidated balance sheets at June&#160;30, 2022 and December&#160;31, 2021 were as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i6e3c881970144ad7a5b510a9c38dd36c"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17cda40f9cf4d1a8490ee4268351419_I20220630" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMi0xLTEtMS0xMjE3OTc_8fccbef1-12a4-4d1a-b6af-7fa8885dc398">7,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2537a5824e5c47d28dc9352ea4fb9b9a_I20220630" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMi0zLTEtMS0xMjE3OTc_a143495a-0f53-40e4-b285-0ff99b7ec1fe">4,781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b009077bf2641cfa4fee2b3ee3dc481_I20220630" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMi01LTEtMS0xMjE3OTc_44cc5d89-6163-44a3-9a7c-48e86f943de4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e0d80e2d0a04bb8927a1bf01c58fd6a_I20220630" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMi03LTEtMS0xMjE3OTc_84d365ed-bf84-42b3-afb2-f205bf9a205d">12,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc7e27d69ade4879bde348e70c0788ea_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNC0xLTEtMS0xMjE3OTc_fbc35e2c-1048-49f6-8f52-87912a26db54">2,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5106c4aa67f4d928a1bc9439a50bfb2_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNC0zLTEtMS0xMjE3OTc_cb38db53-8a3f-40c5-95fd-d40608cbc700">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e7d19bf6cfd4b3b82ed5de057b0e6d8_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNC01LTEtMS0xMjE3OTc_86623238-1783-42ec-bf83-bf9d82e37e10">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6777146f89994be2b6bcda5d10742ac8_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNC03LTEtMS0xMjE3OTc_7ac66591-9f0f-4f61-a279-f63b18072b16">2,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f072e891b342e49c41b996818d9499_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNS0xLTEtMS0xMjE3OTc_7a454223-13d1-472e-b79c-c216fa72ffa2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a25737ed0924c969ac800d03eb71168_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNS0zLTEtMS0xMjE3OTc_3d470049-3b68-42c7-bc08-c18cfe1759dc">2,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a1482c6ec9f4cc8b0730cd66f43a3cc_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNS01LTEtMS0xMjE3OTc_9a87df1e-79d6-4c2a-97ec-326c79a697f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25ac6c0b47ec4e21b9505933348f0a1a_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNS03LTEtMS0xMjE3OTc_e8e744bb-bc0c-412a-a989-faaa02ceecf6">2,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56d79a48fdda41359c90f5247d0eaa51_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNi0xLTEtMS0xMjE3OTc_4b4211dd-168b-4f60-87ba-4ac319f503f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fa48deca1e24bc0aec94bbb86efcea6_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNi0zLTEtMS0xMjE3OTc_f2c83ad3-9e5f-41f4-ac62-fa5310d5156f">9,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i594d6d7e7e934f9cb1e27dbd9405aea9_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNi01LTEtMS0xMjE3OTc_8fd53ffb-4100-4aa7-896c-689f13d3b82c">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcaa01a2d5a84178a364e0771d58f1d2_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNi03LTEtMS0xMjE3OTc_c44f6097-9da8-4e4e-8cd9-35e6558583ea">9,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15029ba66bfc4f258fcf28f87b20183a_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNy0xLTEtMS0xMjE3OTc_46e36d40-4308-4b41-8680-c36226144eca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i906410efac8d4de18248e766580b4e35_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNy0zLTEtMS0xMjE3OTc_e9b362ed-533b-4483-9612-989d6a235b18">2,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i835c385fd6b04a3eb891ef6fc524b805_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNy01LTEtMS0xMjE3OTc_23b0df61-e048-4005-9f47-bf52b1d4dfb7">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaf81e8b9884bad80414c289699a57f_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNy03LTEtMS0xMjE3OTc_4f1edc90-a861-4915-80a6-9c6903126a3e">2,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11805126295b4515b45903e544da225d_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfOC0xLTEtMS0xMjE3OTc_37055541-523a-431b-827b-b39a0c3d00bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9e16c082be94460bfbbd4e151ba7e34_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfOC0zLTEtMS0xMjE3OTc_85da8a88-0f67-4851-ba69-39e309f8a235">747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i336d2e637e8649208863699c4fda08c2_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfOC01LTEtMS0xMjE3OTc_462cef56-89f3-4706-aa24-72fc9de87949">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36599b795d654ff7b2fe314eced29657_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfOC03LTEtMS0xMjE3OTc_3857febc-3489-4d43-b2bf-3127852fedee">747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e0a0f734ebb45bdbb6cf4e33bdc5fb0_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfOS0xLTEtMS0xMjE3OTc_2f1369a2-f2cc-4ce5-ba65-772fc32a7b7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e86187a9ed44b89a6399da972fe5aa8_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfOS0zLTEtMS0xMjE3OTc_88cd285c-78a4-4f82-8b75-f9dfdfaec977">1,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i782d4ad0930949dea0a47084e41c4d26_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfOS01LTEtMS0xMjE3OTc_91e80580-1736-43a6-aca9-5365a6245847">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7299fe8524a4d5e9629da62ce398ea5_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfOS03LTEtMS0xMjE3OTc_2fa019de-5b48-4e35-aafe-257af9b5637a">1,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75184f7f66bf420281dc428b61486c9c_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTAtMS0xLTEtMTIxNzk3_d900edd6-8986-413e-bb5d-2b5a8ba21eb2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a23ab37e1624317a3210888b909e6ad_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTAtMy0xLTEtMTIxNzk3_c486f9f5-f409-4b35-8b3d-39dc1793efc3">2,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b4261e4da4b4593bd9444e957605d51_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTAtNS0xLTEtMTIxNzk3_c7d513b7-01db-4b13-9317-bcf58bbe43d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5ac41f72364473b875a4f9f0cabfa01_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTAtNy0xLTEtMTIxNzk3_fe7bf8f2-37ad-4216-8f8c-5157a9618217">2,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebbf8ae6ec4b4ac7ba59ec1bf20f58c1_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTEtMS0xLTEtMTIxNzk3_4c3a6899-f206-48be-9aea-5451fdf4ebcd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaebca4c2d3aa45788b5006d29248062c_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTEtMy0xLTEtMTIxNzk3_8b8d191d-38a5-4f81-b7de-3a87227679a2">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26cda38200ea4757af8c3ae23320d2dc_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTEtNS0xLTEtMTIxNzk3_2599278e-bcfa-461b-9fb3-be5efdd107d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8407bc5011ab4df18368ae6456978998_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTEtNy0xLTEtMTIxNzk3_5a5f2d30-8f22-4e43-aea5-85d64e0efd12">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17cda40f9cf4d1a8490ee4268351419_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTItMS0xLTEtMTIxNzk3_edd71221-7afb-4e39-b1bc-832abd8f5edc">2,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2537a5824e5c47d28dc9352ea4fb9b9a_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTItMy0xLTEtMTIxNzk3_653de171-d717-4f02-9299-601c4665f571">18,668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b009077bf2641cfa4fee2b3ee3dc481_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTItNS0xLTEtMTIxNzk3_48fee770-4a70-4ab2-9ba4-2ce6a3f7d5ea">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e0d80e2d0a04bb8927a1bf01c58fd6a_I20220630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTItNy0xLTEtMTIxNzk3_4fdf5514-bd87-440f-b4c6-38efd10ceb88">20,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17cda40f9cf4d1a8490ee4268351419_I20220630" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTMtMS0xLTEtMTIxNzk3_30b7c73d-ac53-440b-8e15-a86aef219c85">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2537a5824e5c47d28dc9352ea4fb9b9a_I20220630" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTMtMy0xLTEtMTIxNzk3_89e6b7e3-c1de-4af9-a63b-207f39db6df6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b009077bf2641cfa4fee2b3ee3dc481_I20220630" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTMtNS0xLTEtMTIxNzk3_8b77444e-6aba-4490-8b51-5515e97feed0">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e0d80e2d0a04bb8927a1bf01c58fd6a_I20220630" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTMtNy0xLTEtMTIxNzk3_c516f11d-745d-458d-ab02-994d92dda2a1">189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17cda40f9cf4d1a8490ee4268351419_I20220630" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTQtMS0xLTEtMTIxNzk3_41530072-28cc-4571-9fe5-2dbb845bb264">9,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2537a5824e5c47d28dc9352ea4fb9b9a_I20220630" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTQtMy0xLTEtMTIxNzk3_5cbc20b1-8b3e-44e0-9aa0-ebf4181ce440">23,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b009077bf2641cfa4fee2b3ee3dc481_I20220630" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTQtNS0xLTEtMTIxNzk3_5bf1a151-4f62-4765-9e44-348bf4b8c5c6">106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e0d80e2d0a04bb8927a1bf01c58fd6a_I20220630" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTQtNy0xLTEtMTIxNzk3_761da240-0fdf-45b0-94eb-6acd8f4f4263">33,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42bed7e3ca784f3ab32fc7ef56053fa3_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTctMS0xLTEtMTIxNzk3_d1609af7-4de3-421f-a9f4-05e13d482e60">4,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i642c16a915674d7daa7f0a01f6634e62_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTctMy0xLTEtMTIxNzk3_3dcea918-c366-4b12-8a56-0a7f6497c1b7">4,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04e6dfc862dc4741bba4eb830bd1fe1a_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTctNS0xLTEtMTIxNzk3_ff56a638-2341-4a22-9e3c-70079fe0a85d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68271d4af0dd46f9a15ba39a24443504_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTctNy0xLTEtMTIxNzk3_66dfc3b2-6e40-4e6d-a141-a972f2c368e6">9,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2001a5cdcfe489587490f999c08e53d_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTktMS0xLTEtMTIxNzk3_70d7a567-563d-41d2-9cb5-315be498341e">2,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb4d21f9607446baa96c4753b5ae4a2d_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTktMy0xLTEtMTIxNzk3_b5fae4f7-0b73-420a-bf5c-11c4350e30bb">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib778b8c5692f4a2f9ce7ecd3827265b2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTktNS0xLTEtMTIxNzk3_44a9a0ae-ae5c-46a1-9622-e846a7fd4aca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b92e92046e3481c849127ba0d177b4f_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTktNy0xLTEtMTIxNzk3_1dc659f9-8b65-4a1b-a509-60c296cfbedc">2,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b390fc483eb4bf1bf3c1e193419740f_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjAtMS0xLTEtMTIxNzk3_a7fcaf29-501d-45ea-8a5a-edcdbe738aa4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80bffbb65d2b4070a225a033d6ea55b0_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjAtMy0xLTEtMTIxNzk3_8d93df92-b791-441c-b10e-7d45d93011c5">3,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bac9c5f699d457884697fc93aadabad_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjAtNS0xLTEtMTIxNzk3_bb8233c5-d42c-43fd-9b17-0ac3b7896ed3">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab74b3b8e454421c9d99fd0fea4f8b5d_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjAtNy0xLTEtMTIxNzk3_14373c72-13fe-4d22-9935-644ddb224cd7">3,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12831131b4b347d28cc365b3e2b5d442_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjEtMS0xLTEtMTIxNzk3_75e60a9b-dd1e-4852-845c-8fb97d842045">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04bb2995006a4a4f88bcd1f2ea901a73_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjEtMy0xLTEtMTIxNzk3_01f81033-2c40-4534-99c6-73c805e3800f">9,697</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea75515a7ca440c2b48524fcb1053c9f_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjEtNS0xLTEtMTIxNzk3_270ddc5d-21de-4752-bd30-238165923142">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6de1349b73147148e1a6bc0dcb9232c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjEtNy0xLTEtMTIxNzk3_a6ff44b7-ff8a-4185-acc1-23c84e981b07">9,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4cf155fcd064bd8b37cde3d0bf8a683_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjItMS0xLTEtMTIxNzk3_b474b947-ec0d-4984-8d9a-b9778e173f30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52e238e983504ca6a0b5d0eca15be0f9_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjItMy0xLTEtMTIxNzk3_66e42b71-2fb5-4256-863a-3c648ddb337a">2,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2d9b47f36c344a89eccfc77028e066b_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjItNS0xLTEtMTIxNzk3_b5df7378-15cc-4727-9632-b5a7b55210e9">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9026e142a9d243c79099838b180bad0f_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjItNy0xLTEtMTIxNzk3_f2e6296c-74b4-4c67-ab5a-e39ff8a463a3">2,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223e616c479846e7bcfb1b323650c580_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjMtMS0xLTEtMTIxNzk3_44c2ee16-6aca-4046-845f-fafe39389645">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i001fe54ef077469e82d46f274819777f_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjMtMy0xLTEtMTIxNzk3_3289ebf6-8a6a-44a8-8f93-b5f8122f13d1">875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c084d4d05954ba4bad6546555d216b2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjMtNS0xLTEtMTIxNzk3_f1bfb67c-4989-44ee-8b72-01f5ccfc7043">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i904663f80f7d4ed8b9bdf80b571274b6_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjMtNy0xLTEtMTIxNzk3_3a0c4ca7-0692-447a-8724-1ca6954ae8c7">875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29352f2ba2bb430fb7edf1a52db0a767_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjQtMS0xLTEtMTIxNzk3_3b8f2f0a-6603-4bba-b28e-68d639ee98ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i305ff43cd2da42f5837673228114f047_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjQtMy0xLTEtMTIxNzk3_52eeba17-6327-4e27-a24e-007a9f4558be">1,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d4fc3347b34e62bd298927db4d1507_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjQtNS0xLTEtMTIxNzk3_5a90fc18-75c1-4341-8ae0-c09b0baac740">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7455e34409e849e09720b15bdb39ef0b_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjQtNy0xLTEtMTIxNzk3_8ac43f7c-d23f-4f0d-86af-c7db6220599e">1,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i712137052e06498fbf764dbfba45c5cd_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjUtMS0xLTEtMTIxNzk3_600c1662-4f43-40fb-889d-d3c941859f5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82307e5c20bb45bdbfe5652fb891c9ec_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjUtMy0xLTEtMTIxNzk3_2eb34626-7ba4-494f-88a8-406ef5e211ce">2,789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09b4f7cbd578419a9e93e1f9baaea718_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjUtNS0xLTEtMTIxNzk3_4e88ad30-0979-4572-a526-9218a1309dd1">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i443a171c4d9046c6998ec0e711b34fb7_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjUtNy0xLTEtMTIxNzk3_9cb79c12-1363-4e81-be80-07dcc6848081">2,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84d6ff7bcaf644209c3df2eae876d580_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjYtMS0xLTEtMTIxNzk3_497400b5-9099-4e20-81c9-b69ba57a7496">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8a0c11f7f38499ea3d96bb3423aa0f7_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjYtMy0xLTEtMTIxNzk3_3a3106fe-14b5-45cf-ab0b-e96871411ab1">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie480043139dd4ff799c6c90efb44c767_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjYtNS0xLTEtMTIxNzk3_ca63f165-b1a3-4481-8b23-b3d23611505a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1da882ac68a54dad9ccd7ec3d147e26a_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjYtNy0xLTEtMTIxNzk3_54342151-fca2-4c31-b556-11b3cf097dd6">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42bed7e3ca784f3ab32fc7ef56053fa3_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjctMS0xLTEtMTIxNzk3_bc06fe42-44ee-43f6-8e01-1700ba2d2f9f">2,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i642c16a915674d7daa7f0a01f6634e62_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjctMy0xLTEtMTIxNzk3_1c5a8e61-5184-41d6-b14a-e71b3260ef3a">20,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04e6dfc862dc4741bba4eb830bd1fe1a_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjctNS0xLTEtMTIxNzk3_9713f9d7-c156-4521-9a49-ae2b7cb80bd8">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68271d4af0dd46f9a15ba39a24443504_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjctNy0xLTEtMTIxNzk3_2947d018-35bb-4b4a-8ce6-5af32984570a">23,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42bed7e3ca784f3ab32fc7ef56053fa3_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjgtMS0xLTEtMTIxNzk3_6baddb2a-5fee-468e-b135-31af1bf5ed4b">114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i642c16a915674d7daa7f0a01f6634e62_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjgtMy0xLTEtMTIxNzk3_1b738491-c15b-4060-b255-1c59c3d0454d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04e6dfc862dc4741bba4eb830bd1fe1a_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjgtNS0xLTEtMTIxNzk3_1216b808-3f51-47c2-b6cf-b47703c5dd19">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68271d4af0dd46f9a15ba39a24443504_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjgtNy0xLTEtMTIxNzk3_e2338377-2d0a-4f85-bed7-2cb5c91ba804">169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42bed7e3ca784f3ab32fc7ef56053fa3_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjktMS0xLTEtMTIxNzk3_28486afb-e907-4521-876d-cef6901fa526">7,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i642c16a915674d7daa7f0a01f6634e62_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjktMy0xLTEtMTIxNzk3_e6e2fdb4-b683-43d2-8b45-276f38d38fcd">25,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04e6dfc862dc4741bba4eb830bd1fe1a_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjktNS0xLTEtMTIxNzk3_02f2c03e-04c1-45d7-ac6c-8728bc80ee1d">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68271d4af0dd46f9a15ba39a24443504_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjktNy0xLTEtMTIxNzk3_b207ed5e-bf68-47f4-ab41-d24c5da6a47e">32,817</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended June&#160;30, 2022 there were $<ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RleHRyZWdpb246ODJhOGE1ZjBhNGQwNGFlZTg2Njc0MzRhZjFlMjBiNzVfMjAzNA_453a602e-09bd-4a39-bb11-08812125b21b">26</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RleHRyZWdpb246ODJhOGE1ZjBhNGQwNGFlZTg2Njc0MzRhZjFlMjBiNzVfMTY0OTI2NzQ0NDg0Mg_4aa4545a-9b82-4f84-bd88-ef36d3a528fa">29</ix:nonFraction> million of transfers out of Level 3. During the three and six months ended June&#160;30, 2021, there were <ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RleHRyZWdpb246ODJhOGE1ZjBhNGQwNGFlZTg2Njc0MzRhZjFlMjBiNzVfMjA5NQ_338d79b4-18dd-41d8-853e-a72244ef2d56"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RleHRyZWdpb246ODJhOGE1ZjBhNGQwNGFlZTg2Njc0MzRhZjFlMjBiNzVfMjA5NQ_a888e03a-8702-48ba-b4e4-fda9947fd8c5"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RleHRyZWdpb246ODJhOGE1ZjBhNGQwNGFlZTg2Njc0MzRhZjFlMjBiNzVfMjA5NQ_dadfd571-3b1a-428d-a975-ba538d3d95a0"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RleHRyZWdpb246ODJhOGE1ZjBhNGQwNGFlZTg2Njc0MzRhZjFlMjBiNzVfMjA5NQ_e4765e96-5920-48cf-bb92-0ba143609388">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> transfers into or out of Level 3.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic8f5072f0a9144efad9aace9bddabd90"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RleHRyZWdpb246ODJhOGE1ZjBhNGQwNGFlZTg2Njc0MzRhZjFlMjBiNzVfMzExNA_d03355ee-3cb5-491d-941d-ee707a1d9db8" continuedAt="i3ef64f556377487f94f9a250bab57443" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the unaudited condensed consolidated balance sheets at adjusted cost or contract value at June&#160;30, 2022 and December&#160;31, 2021 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.284%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Estimated Fair Value</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f883902b9f4d569180bdd25d7ac485_I20220630" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfNC0xLTEtMS0xMjE3OTc_5d1404df-7c0d-4af8-9688-54a4108aff7f">993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie30f666179e54a5cb8e16248e2aa4dc6_I20220630" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfNC0zLTEtMS0xMjE3OTc_87434b32-ce01-47ea-993c-9c89a9708ad5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i509def96f3774f389ccb60611ef5b220_I20220630" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfNC01LTEtMS0xMjE3OTc_579e063f-fe92-4f2e-931a-d4d67729655a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057d1d2e7dcf476caee443d101525a56_I20220630" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfNC03LTEtMS0xMjE3OTc_8fa34794-bb37-4113-9ccc-21d44a4d445f">940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e4863652a8d4786bda491af0f283e1f_I20220630" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfNC05LTEtMS0xMjE3OTc_260355c0-2f34-4e30-b081-c84f42cad227">940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f883902b9f4d569180bdd25d7ac485_I20220630" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfNS0xLTEtMS0xMjE3OTc_e2b6dc50-e0c5-455c-813d-1e07ab301f3d">183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f883902b9f4d569180bdd25d7ac485_I20220630" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfOC0xLTEtMS0xMjE3OTc_e4f1bce2-d9a8-40b5-a74b-983f73dd29bb">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie30f666179e54a5cb8e16248e2aa4dc6_I20220630" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfOC0zLTEtMS0xMjE3OTc_517299d4-ecdf-4712-931c-bb74929b4c57">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i509def96f3774f389ccb60611ef5b220_I20220630" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfOC01LTEtMS0xMjE3OTc_37fc4485-a4b0-4443-87c5-e65fc74b1e92">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057d1d2e7dcf476caee443d101525a56_I20220630" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfOC03LTEtMS0xMjE3OTc_75712d46-d1e3-4c15-97fe-d5f7d993e327">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e4863652a8d4786bda491af0f283e1f_I20220630" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfOC05LTEtMS0xMjE3OTc_1abdf6b6-5429-4d88-b146-35417b94fd27">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f883902b9f4d569180bdd25d7ac485_I20220630" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfOS0xLTEtMS0xMjE3OTc_9226aeb1-e778-494d-81d3-f97ea731fe56">333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie30f666179e54a5cb8e16248e2aa4dc6_I20220630" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfOS0zLTEtMS0xMjE3OTc_82859617-ca9e-4531-bd0a-4774925a2fb2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i509def96f3774f389ccb60611ef5b220_I20220630" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfOS01LTEtMS0xMjE3OTc_44bd8bf8-896a-4b3f-aa65-004b49303d03">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057d1d2e7dcf476caee443d101525a56_I20220630" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfOS03LTEtMS0xMjE3OTc_1a293e99-6ba1-4f2a-9309-977e1cf5d1c6">317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e4863652a8d4786bda491af0f283e1f_I20220630" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfOS05LTEtMS0xMjE3OTc_0d3567ea-39c3-4633-baa4-027e6a18b18b">317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f883902b9f4d569180bdd25d7ac485_I20220630" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTAtMS0xLTEtMTIxNzk3_8ddc252c-ff86-45f3-add4-98d8d2b07af5">54,816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie30f666179e54a5cb8e16248e2aa4dc6_I20220630" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTAtMy0xLTEtMTIxNzk3_3e290d1f-ce17-400f-9e0e-1553e181f84a">51,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i509def96f3774f389ccb60611ef5b220_I20220630" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTAtNS0xLTEtMTIxNzk3_91202d7e-27c2-470a-acb0-d8a2c0dce77e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057d1d2e7dcf476caee443d101525a56_I20220630" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTAtNy0xLTEtMTIxNzk3_d0184478-31c2-46b2-919d-26262cf54b02">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e4863652a8d4786bda491af0f283e1f_I20220630" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTAtOS0xLTEtMTIxNzk3_9b6da564-09c5-4a0d-903d-fbd1c5bdbbc2">51,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf62033ec0a847bb91856b878b3b5184_I20211231" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTQtMS0xLTEtMTIxNzk3_773a5176-7882-4b8d-9a58-16eaa68341f8">902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2abfa03cf0a34bb1a667090247c911ce_I20211231" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTQtMy0xLTEtMTIxNzk3_a04509b9-73ed-437b-b7b5-dbd26f9c1fda">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0393895e099248fca624d76479d72f73_I20211231" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTQtNS0xLTEtMTIxNzk3_5970624b-9590-4184-957e-425c38aa1627">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icda51f2bbf534c3b99bd90ca2ff4fc4a_I20211231" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTQtNy0xLTEtMTIxNzk3_5f48130f-5ddd-424d-abf9-98840d9ec2a3">907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i950684090258490285b22303b8cbe92f_I20211231" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTQtOS0xLTEtMTIxNzk3_fca90ea0-fcaf-4c09-bc3d-8a790d3bd783">907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf62033ec0a847bb91856b878b3b5184_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTUtMS0xLTEtMTIxNzk3_c785377c-a9b0-41eb-b7be-d26f7f2fde90">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf62033ec0a847bb91856b878b3b5184_I20211231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTgtMS0xLTEtMTIxNzk3_805ba973-d19e-48d7-8445-301bca14759a">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2abfa03cf0a34bb1a667090247c911ce_I20211231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTgtMy0xLTEtMTIxNzk3_4d5a109a-a625-46df-a457-a9f54e9372d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0393895e099248fca624d76479d72f73_I20211231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTgtNS0xLTEtMTIxNzk3_5be9c48c-5d25-4080-a47e-9fd0dc5bd734">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icda51f2bbf534c3b99bd90ca2ff4fc4a_I20211231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTgtNy0xLTEtMTIxNzk3_0cde29c8-f620-44c0-9def-800bd26138ef">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i950684090258490285b22303b8cbe92f_I20211231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTgtOS0xLTEtMTIxNzk3_2ccfe8c9-b217-4174-8cad-5603467c44e8">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf62033ec0a847bb91856b878b3b5184_I20211231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTktMS0xLTEtMTIxNzk3_5414c4ca-7863-4820-8cd4-563fd2fdb164">336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2abfa03cf0a34bb1a667090247c911ce_I20211231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTktMy0xLTEtMTIxNzk3_c010fe92-4d19-4d29-8a76-e1098b9ff9c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0393895e099248fca624d76479d72f73_I20211231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTktNS0xLTEtMTIxNzk3_d435ef35-5ec8-417d-9358-9da473ec66ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icda51f2bbf534c3b99bd90ca2ff4fc4a_I20211231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTktNy0xLTEtMTIxNzk3_0500f4a7-9af9-4434-93f1-23551643c18d">373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i950684090258490285b22303b8cbe92f_I20211231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTktOS0xLTEtMTIxNzk3_99946eea-7ca2-48c9-93ab-b405fc16d6c4">373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf62033ec0a847bb91856b878b3b5184_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMjAtMS0xLTEtMTIxNzk3_f001a729-0d8c-4e48-b66f-b0b57c61ed9b">56,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2abfa03cf0a34bb1a667090247c911ce_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMjAtMy0xLTEtMTIxNzk3_e9ab7d99-392c-4e2b-aaf4-cc556a212b74">64,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0393895e099248fca624d76479d72f73_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMjAtNS0xLTEtMTIxNzk3_15bbce61-f3f3-43b9-bbcd-f8c4c010725b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icda51f2bbf534c3b99bd90ca2ff4fc4a_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMjAtNy0xLTEtMTIxNzk3_934c1714-96de-4c42-8184-71e8bf503e79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i950684090258490285b22303b8cbe92f_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMjAtOS0xLTEtMTIxNzk3_0667078f-3947-4cef-85f3-4605ec03c632">64,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div></ix:nonNumeric><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i3ef64f556377487f94f9a250bab57443" continuedAt="i7f3d97dc1df348ad88dece16928ecea4">(1)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="i7f3d97dc1df348ad88dece16928ecea4">It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets relate to the Company&#8217;s large case pensions products which represent funds maintained to meet specific objectives of contract holders.&#160;Since contract holders bear the investment risk of these assets, a corresponding Separate Accounts liability has been established equal to the assets.&#160;These assets and liabilities are carried at fair value.&#160;<ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RleHRyZWdpb246ODJhOGE1ZjBhNGQwNGFlZTg2Njc0MzRhZjFlMjBiNzVfMzExMQ_4d8ec71a-04a4-41db-a2e5-b1d44f5328ac" continuedAt="ic1f52096bee644c0a51e891b1db48239" escape="true">Separate Accounts financial assets as of June&#160;30, 2022 and December&#160;31, 2021 were as follows:</ix:nonNumeric></span></div><ix:continuation id="ic1f52096bee644c0a51e891b1db48239"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.408%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.243%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1998c1f186304330af3b39bac43d0a2f_I20220630" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMi0yLTEtMS0xMjE3OTc_f90a8eca-692f-45b3-ba9c-09c1b6bb78d7">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc4896103e2847bfadabec9c0079aa36_I20220630" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMi00LTEtMS0xMjE3OTc_7daf18cd-0b59-42fa-8202-7ca92e28de2c">178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09642d3a548b46338b4bb3f615251a26_I20220630" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMi02LTEtMS0xMjE3OTc_671fc745-52fb-4819-96f7-9767f1b72a50">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9170e75144bb41cd9ee98de35d2f8127_I20220630" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMi04LTEtMS0xMjE3OTc_48fd9d3d-b3e0-47d0-9c9f-e6ee7d23d301">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1401ca4c008547c2bac9543b488db12e_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMi0xMC0xLTEtMTIxNzk3_42d283ab-c6a0-4e3c-aea7-f9e33cd09643">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ac71f0b9bb14e4092be832d41e515a8_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMi0xMi0xLTEtMTIxNzk3_39961993-0bd8-46e6-afc7-92d7a0e04413">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic46902baf4774da0b1d69a2251e4c766_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMi0xNC0xLTEtMTIxNzk3_742b9bd5-8d76-4876-9d86-3c5e250f6618">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbbe45adfefe4948a1c89879ea88f003_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMi0xNi0xLTEtMTIxNzk3_431fe8f6-6841-40fb-84a4-36a41075e17c">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65512635d3f94fc399a6c13c4e5ca1a1_I20220630" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMy0yLTEtMS0xMjE3OTc_df625a54-9dd6-422f-bbbd-dea2cd62b5e6">913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i251231de7362453a940ab517a85970ae_I20220630" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMy00LTEtMS0xMjE3OTc_3ce17f78-89f4-4199-b851-6c77e42930e3">2,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23f86f2cbd964ff2a810fd266595100f_I20220630" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMy02LTEtMS0xMjE3OTc_248b3058-d703-481a-b03b-1982faf2bc42">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381f19e26d814d37904aee3ae800493b_I20220630" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMy04LTEtMS0xMjE3OTc_831124ad-ca9b-4936-a85d-6acd95bd893e">3,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i407ded4af3924d31952fb5d080084da1_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMy0xMC0xLTEtMTIxNzk3_80282477-085e-4efa-8fd6-c18286436917">1,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id23c11799c424d598c0c1ae0ab2929ba_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMy0xMi0xLTEtMTIxNzk3_bafe2a15-4e6f-4fe7-b089-203444290544">3,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c8d2dc2b8704580a1a172c856d29530_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMy0xNC0xLTEtMTIxNzk3_575d3e18-0801-418c-b676-7c790dfa5d71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf81bb9d192d4f34906afe0ca3308cca_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMy0xNi0xLTEtMTIxNzk3_7d8265a9-f176-48f7-af2b-e30ac92c0548">4,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i934c58db24df4f5b8e2df9a748e0ce3a_I20220630" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNC0yLTEtMS0xMjE3OTc_072bdc9f-243e-4b9d-be2c-3c23b0f2a1ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4c3e3b3b06443908af3ef65aa44ce1c_I20220630" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNC00LTEtMS0xMjE3OTc_787d20a2-a626-4cab-b1e3-99edd39b9a9f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c1dbf858274c46886b39848454543e_I20220630" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNC02LTEtMS0xMjE3OTc_37e0eb09-f4de-4371-8af6-4fbb0952058d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3eeede4806c04b8ca1b1515f91d2454f_I20220630" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNC04LTEtMS0xMjE3OTc_948ca431-464f-4386-9f06-b3b947d0737b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3bcc189914f44dfbd6d8adba7da6648_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNC0xMC0xLTEtMTIxNzk3_c7ac1d41-88b1-4471-9435-568b4aa19ce9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida1294c97533481bbb71cc59e1332b94_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNC0xMi0xLTEtMTIxNzk3_5a2fb73f-13f9-4977-8d54-67ccd767e270">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61b3ccbd720b4118afa39412212dd864_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNC0xNC0xLTEtMTIxNzk3_ec78de4d-c6a6-4824-a1e3-ab9b50681c31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74971ce242444f5b8eca08207bb3fd01_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNC0xNi0xLTEtMTIxNzk3_e2d3d2f2-ce95-451c-bb54-c080ed0b2c26">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common/collective trusts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifde0481021814f2a9b9298bd03a46270_I20220630" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNS0yLTEtMS0xMjE3OTc_a82c1af3-4008-4f42-bf87-da5b1c473787">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7f7b435750440efa12f3876d71ad127_I20220630" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNS00LTEtMS0xMjE3OTc_8b0fba2e-4a3f-49f2-b42a-05f683655599">421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if94bb34cac0e45b4b0a4cf53c05b0d13_I20220630" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNS02LTEtMS0xMjE3OTc_7f69e674-ac74-4769-9342-e6e8d9e9fb61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6df4f366580047d49b2e56046b8e7328_I20220630" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNS04LTEtMS0xMjE3OTc_9347f121-2cb5-4ba8-a2f3-e8dd3192ddd8">421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b49cf8f22064d1c891ff76da09969c1_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNS0xMC0xLTEtMTIxNzk3_b3756774-69ff-4d33-9d42-d70dfc9052b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8a50f5f508f4a7b87e5542b0e6ffc42_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNS0xMi0xLTEtMTIxNzk3_d406b7e2-1ec9-43f9-8a80-cc0de477e5d2">547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f56b0ef04ec4465adcf279a0c980a91_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNS0xNC0xLTEtMTIxNzk3_135eaa0b-75ed-47f1-8e8c-27af063787fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a5e52e8002f439e863f471f508bd973_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNS0xNi0xLTEtMTIxNzk3_95469a78-735a-4a34-b6bd-b8673965dbff">547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17cda40f9cf4d1a8490ee4268351419_I20220630" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNi0yLTEtMS0xMjE3OTc_93d5b95e-b9cd-4db9-8854-db7168cf1dbb">917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2537a5824e5c47d28dc9352ea4fb9b9a_I20220630" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNi00LTEtMS0xMjE3OTc_35b20670-928e-4a4b-824d-c5fdd4e45f01">3,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b009077bf2641cfa4fee2b3ee3dc481_I20220630" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNi02LTEtMS0xMjE3OTc_f33d917f-4f3e-4114-9958-98cde90ecb70">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e0d80e2d0a04bb8927a1bf01c58fd6a_I20220630" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNi04LTEtMS0xMjE3OTc_00010b0a-e0ea-4f52-83bf-30aa4c1d26b4">4,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42bed7e3ca784f3ab32fc7ef56053fa3_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNi0xMC0xLTEtMTIxNzk3_15c4d0f4-3d0b-4121-930a-77a45ffc8324">1,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i642c16a915674d7daa7f0a01f6634e62_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNi0xMi0xLTEtMTIxNzk3_8920c5ce-1680-4bc0-b5d5-fc8ef1095868">3,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04e6dfc862dc4741bba4eb830bd1fe1a_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNi0xNC0xLTEtMTIxNzk3_c5163da2-2d6c-4d6a-a15b-480fb03a1de9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68271d4af0dd46f9a15ba39a24443504_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNi0xNi0xLTEtMTIxNzk3_fe9b8cef-eb98-457b-8201-167a3e35bfcd">5,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $<ix:nonFraction unitRef="usd" contextRef="i03d9d5c763344a06ad0ba56859f58bcc_I20220630" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RleHRyZWdpb246ODJhOGE1ZjBhNGQwNGFlZTg2Njc0MzRhZjFlMjBiNzVfMzAzNw_a86b7302-1a77-4042-aa48-76f183b3f07c">88</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4b83284491314316be5282f5effb45cd_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RleHRyZWdpb246ODJhOGE1ZjBhNGQwNGFlZTg2Njc0MzRhZjFlMjBiNzVfMzA0NA_15db98d4-35cf-42b9-8fcd-0f0faa43cb1c">70</ix:nonFraction> million of other receivables at June&#160;30, 2022 and December&#160;31, 2021, respectively.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_46"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RleHRyZWdpb246YTY2NzhjYjEwZjM3NDYwMzk4YmRkMmYwMjY1OTFkZjlfMjA4NA_bbaac4cf-f6f4-4a77-97a3-5135947fed89" continuedAt="i6435b667aa6d43ba8f7e8e5dbab43972" escape="true">Health Care Costs Payable</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i6435b667aa6d43ba8f7e8e5dbab43972"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RleHRyZWdpb246YTY2NzhjYjEwZjM3NDYwMzk4YmRkMmYwMjY1OTFkZjlfMjA3NA_bebc7cd6-1a80-4552-80ed-9a5a2513ad5a" continuedAt="i715c44b50b0442af8df1d187bcbe230a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in health care costs payable during the six months ended June&#160;30, 2022 and 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica5caded5b9f40868f9db05f17444835_I20211231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMi0xLTEtMS0xMjE3OTc_a033e72d-b4ec-49aa-83a0-f16d2443ea21">8,808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8454af9021ca47c98336dfba07097dc4_I20201231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMi0zLTEtMS0xMjE3OTc_a98b4417-347f-4e1e-9fc4-044bd2de11a3">7,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica5caded5b9f40868f9db05f17444835_I20211231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMy0xLTEtMS0xMjE3OTc_3919a351-5eab-4f5f-87a1-e6152b15e3d8">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8454af9021ca47c98336dfba07097dc4_I20201231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMy0zLTEtMS0xMjE3OTc_b82605e8-0193-4d8c-86f4-da9f14294f0d">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of the period, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica5caded5b9f40868f9db05f17444835_I20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfNC0xLTEtMS0xMjE3OTc_a4faf8a6-bd87-4226-ab40-1ac9b9173806">8,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8454af9021ca47c98336dfba07097dc4_I20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfNC0zLTEtMS0xMjE3OTc_328c25fc-4c08-4253-8a9e-409c81a63661">7,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Components of incurred health care costs</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i824fe68acd534f1cb26fac7871f45022_D20220101-20220630" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfNy0xLTEtMS0xMjE3OTc_4745c6f9-1d4f-4e5f-a308-15bf96e22f4d">35,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c50d4663e7046e988ba0a3d936e983d_D20210101-20210630" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfNy0zLTEtMS0xMjE3OTc_3176c0b2-8bf4-49ad-a066-808abf2e50c8">32,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i824fe68acd534f1cb26fac7871f45022_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfOC0xLTEtMS0xMjE3OTc_4be84953-c128-4c69-b0d7-bcfc3ea417ce">666</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c50d4663e7046e988ba0a3d936e983d_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfOC0zLTEtMS0xMjE3OTc_7903e470-ba9d-4c7c-9975-ddf2c53e9448">709</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred health care costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i824fe68acd534f1cb26fac7871f45022_D20220101-20220630" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfOS0xLTEtMS0xMjE3OTc_837449ad-a339-41f0-9896-e6cee2bec780">35,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c50d4663e7046e988ba0a3d936e983d_D20210101-20210630" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfOS0zLTEtMS0xMjE3OTc_805859d4-ef09-43eb-ad45-c2a183f85ced">31,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Claims paid</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i824fe68acd534f1cb26fac7871f45022_D20220101-20220630" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMTEtMS0xLTEtMTIxNzk3_dc1b5546-6c14-4fce-9a02-87e605f80afb">26,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c50d4663e7046e988ba0a3d936e983d_D20210101-20210630" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMTEtMy0xLTEtMTIxNzk3_e9964b12-1b26-4ad7-8a42-1eebaaf57b5e">24,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i824fe68acd534f1cb26fac7871f45022_D20220101-20220630" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMTItMS0xLTEtMTIxNzk3_749d91a0-25d3-4a52-bfa0-822db2ad6945">6,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c50d4663e7046e988ba0a3d936e983d_D20210101-20210630" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMTItMy0xLTEtMTIxNzk3_87cb0b6c-ead0-425a-8e08-02cb2516492a">6,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total claims paid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i824fe68acd534f1cb26fac7871f45022_D20220101-20220630" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMTMtMS0xLTEtMTIxNzk3_95b5785b-8abd-4872-9703-8e19b99eff7c">33,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c50d4663e7046e988ba0a3d936e983d_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMTMtMy0xLTEtMTIxNzk3_96f3b4ca-8c49-4ad4-ac95-487e75e2fbf3">31,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Premium deficiency reserve</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1581ff2350a744a6b1f3e0be5835a1dd_I20220630" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMTQtMS0xLTEtMTIxNzk3_c85de03c-ca5d-4019-a31b-b9d6c47303ec">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64773f23350843c69d9c79f2e715b95d_I20210630" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMTQtMy0xLTEtMTIxNzk3_868e7180-67de-4246-a721-de11015e47de">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of the period, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1581ff2350a744a6b1f3e0be5835a1dd_I20220630" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMTYtMS0xLTEtMTIxNzk3_ee9a57a2-933a-4ecd-b03a-3ccb5bb6b23a">10,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64773f23350843c69d9c79f2e715b95d_I20210630" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMTYtMy0xLTEtMTIxNzk3_d8c10435-02a3-4cf2-b99b-7dba323df937">8,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1581ff2350a744a6b1f3e0be5835a1dd_I20220630" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMTctMS0xLTEtMTIxNzk3_0479f9b9-c0ac-4492-bc8f-5172846667a6">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64773f23350843c69d9c79f2e715b95d_I20210630" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMTctMy0xLTEtMTIxNzk3_720a1754-da3d-4ede-a2aa-31b4186f5f04">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1581ff2350a744a6b1f3e0be5835a1dd_I20220630" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMTgtMS0xLTEtMTIxNzk3_5062a5fd-a104-4ce0-8a8f-d951120e6709">10,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64773f23350843c69d9c79f2e715b95d_I20210630" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMTgtMy0xLTEtMTIxNzk3_049b8194-1b5d-432c-8de6-f333398154a8">8,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div></ix:nonNumeric><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i715c44b50b0442af8df1d187bcbe230a" continuedAt="i78bda43ceef740b1a2565e894e4ca4f4">(1)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="i78bda43ceef740b1a2565e894e4ca4f4">Total incurred health care costs for the six months ended June&#160;30, 2022 and 2021 in the table above exclude (i) $<ix:nonFraction unitRef="usd" contextRef="i1581ff2350a744a6b1f3e0be5835a1dd_I20220630" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RleHRyZWdpb246YTY2NzhjYjEwZjM3NDYwMzk4YmRkMmYwMjY1OTFkZjlfMjc2_c85de03c-ca5d-4019-a31b-b9d6c47303ec">5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i64773f23350843c69d9c79f2e715b95d_I20210630" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RleHRyZWdpb246YTY2NzhjYjEwZjM3NDYwMzk4YmRkMmYwMjY1OTFkZjlfMjgz_868e7180-67de-4246-a721-de11015e47de">5</ix:nonFraction> million, respectively, for premium deficiency reserves related to the Company&#8217;s Medicaid products, (ii) $<ix:nonFraction unitRef="usd" contextRef="i1c0bcd0eebfa40769648a67be75183aa_D20220101-20220630" decimals="-6" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RleHRyZWdpb246YTY2NzhjYjEwZjM3NDYwMzk4YmRkMmYwMjY1OTFkZjlfMzgz_1bb19cb6-2117-453d-95a3-1e09020c6360">37</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i856f8df36f55432cba11d2c1b2e7ba4e_D20210101-20210630" decimals="-6" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RleHRyZWdpb246YTY2NzhjYjEwZjM3NDYwMzk4YmRkMmYwMjY1OTFkZjlfMzkw_ba294fba-75d8-4a70-9efb-65526dbd4d08">27</ix:nonFraction> million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the unaudited condensed consolidated balance sheets and (iii) $<ix:nonFraction unitRef="usd" contextRef="i633068dab92e4b98b0522d78e950565e_D20220101-20220630" decimals="-6" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RleHRyZWdpb246YTY2NzhjYjEwZjM3NDYwMzk4YmRkMmYwMjY1OTFkZjlfNTg0_f1e63fef-9a62-4319-8b2c-5558185651a2">221</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id563d585f536458ab16c7d10eb546a54_D20210101-20210630" decimals="-6" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RleHRyZWdpb246YTY2NzhjYjEwZjM3NDYwMzk4YmRkMmYwMjY1OTFkZjlfNTkx_3a54c37b-2a5e-4ce7-b007-7bf4ae450482">99</ix:nonFraction> million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the unaudited condensed consolidated balance sheets.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimates of prior years&#8217; health care costs payable decreased by $<ix:nonFraction unitRef="usd" contextRef="i824fe68acd534f1cb26fac7871f45022_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RleHRyZWdpb246YTY2NzhjYjEwZjM3NDYwMzk4YmRkMmYwMjY1OTFkZjlfMTE1MQ_4be84953-c128-4c69-b0d7-bcfc3ea417ce">666</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2c50d4663e7046e988ba0a3d936e983d_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RleHRyZWdpb246YTY2NzhjYjEwZjM3NDYwMzk4YmRkMmYwMjY1OTFkZjlfMTE1OA_7903e470-ba9d-4c7c-9975-ddf2c53e9448">709</ix:nonFraction> million, respectively, in the six months ended June&#160;30, 2022 and 2021, because claims were settled for amounts less than originally estimated (i.e., the amount of claims incurred was lower than originally estimated), primarily due to lower health care cost trends as well as the actual claim submission time being faster than originally assumed (i.e., the Company&#8217;s completion factors were higher than originally assumed) in estimating health care costs payable at the end of the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022, the Company&#8217;s liabilities for the ultimate cost of (i) services rendered to the Company&#8217;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid (collectively, &#8220;IBNR&#8221;) plus expected development on reported claims totaled approximately $<ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-8" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RleHRyZWdpb246YTY2NzhjYjEwZjM3NDYwMzk4YmRkMmYwMjY1OTFkZjlfMTkzMQ_0f6c223c-7bd5-4df6-8c14-eb77f1e0b4d4">8.0</ix:nonFraction> billion. Substantially all of the Company&#8217;s liabilities for IBNR plus expected development on reported claims at June&#160;30, 2022 related to the current year.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_1204"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGV4dHJlZ2lvbjoxZTY4Y2QxYjk0NTk0MzY2YmY1YTdiY2EwM2I5ODVlOF8zMjk4NTM0ODg3ODcx_33c8f423-6dc4-4322-a716-c5d7188ba974" continuedAt="i97b70cc73bba42278dcf308d36bb086f" escape="true">Borrowings</ix:nonNumeric></span></div><div style="text-indent:-9pt"><span><br/></span></div><ix:continuation id="i97b70cc73bba42278dcf308d36bb086f" continuedAt="ibd8541cec2c64f6dba204ca48c866b2c"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGV4dHJlZ2lvbjoxZTY4Y2QxYjk0NTk0MzY2YmY1YTdiY2EwM2I5ODVlOF8zMjk4NTM0ODg3ODcy_28a5d297-7cdf-4d4b-8931-488b0efdccff" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s borrowings at June&#160;30, 2022 and December&#160;31, 2021: </span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.451%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i701dfcde341042418a1230e58dfc107c_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xMi0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjpmYWZjYzE0YmZiNzE0YTViOTY1ZjE1ZWNkMGNmZTM0NF8xMDk5NTExNjI3ODEw_516959f3-6ea7-4b2b-ad03-cb73f174c823">3.5</ix:nonFraction>% senior notes due July 2022</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i701dfcde341042418a1230e58dfc107c_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xMi0xLTEtMS0xMzcyNzU_2c3563f8-599b-47f0-b873-d51d8b577a6b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7e9c49d1afb41528f0c6f58ad82f91c_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xMi0zLTEtMS0xMzcyNzU_d32ac60c-42a9-4cc0-bc61-76f70d312552">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i19ce665e627349488d7fdabbb5fd4f0c_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xMy0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo0ZjAxNmNiM2UwOWE0NWVkOTAxNjhiMDg3ZDNlN2RiNF8xMDk5NTExNjI3ODIx_b14351f3-2aa2-4665-ba20-a1f5aa3b0c33">2.75</ix:nonFraction>% senior notes due November 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19ce665e627349488d7fdabbb5fd4f0c_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xMy0xLTEtMS0xMzcyNzU_45c7c7ee-8180-4f6c-bd0a-814ad8d6c9c7">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9e4fce0f5914bc194df0543a8fb78c7_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xMy0zLTEtMS0xMzcyNzU_5c553894-d754-4393-9cd6-63f4e122e473">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4945c0919f8a4b6fa67244e6df69a8e3_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xNC0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo1NjNkMmJhNjgyYzE0NTc3YmZkMmMzNzMxYWJlOWUxYl8xMDk5NTExNjI3ODIx_2eadc095-9dbe-412f-bca7-486aab93b69f">2.75</ix:nonFraction>% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4945c0919f8a4b6fa67244e6df69a8e3_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xNC0xLTEtMS0xMzcyNzU_385d272a-db1e-4b68-9d0d-b48019e0e148">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79481fe5600c4d29829c7063ced8237b_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xNC0zLTEtMS0xMzcyNzU_3c2c9cb0-f591-48c6-a14f-a3d05fd2dc8d">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i33b68889734a4fe89dcb2fdde065e999_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xNS0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo0MDg3NTNkMmQ3YWI0YmYyYjU0YTQ5OGNjZWE4MzE2YV8xMDk5NTExNjI3ODIx_9a557561-60c8-416a-9bb6-f7534b70c6f9">4.75</ix:nonFraction>% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33b68889734a4fe89dcb2fdde065e999_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xNS0xLTEtMS0xMzcyNzU_5561de0b-9a59-4303-a3a9-d19e5c1054a1">399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a07ca981e96452699ccf6cc1296a094_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xNS0zLTEtMS0xMzcyNzU_f4b69283-d375-441c-af06-b05a9c9ad14a">399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6f28d0a871b74ccabed8651290f5df32_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xNy0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo2YjI2N2RmOTU4MWI0MmYyODM5MDliZjk1NmZlZmJhNV8xMDk5NTExNjI3ODE1_45d24637-dee2-4e6d-b2a9-5dfff0572124">2.8</ix:nonFraction>% senior notes due June 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f28d0a871b74ccabed8651290f5df32_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xNy0xLTEtMS0xMzcyNzU_f95f0189-09e0-4aab-a3fc-b4b12b2fb628">1,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b27b79528fa4d33895a9b7b0532c5a8_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xNy0zLTEtMS0xMzcyNzU_fb3edcf0-f90e-4cc7-9220-52af52191e04">1,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if5743e3b67ba46fa843ceef9c280ed2d_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xOC0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjoxNWM3ZWM3Mzc2Y2M0ZTNhYTk3OGQ5ZmY1MWYwZmFhMl8xMDk5NTExNjI3ODE1_e3223a16-b592-4e4f-94fe-afdf23fe961e">4</ix:nonFraction>% senior notes due December 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5743e3b67ba46fa843ceef9c280ed2d_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xOC0xLTEtMS0xMzcyNzU_8239aadd-77a2-4c75-9cf7-a36bccf018f4">414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i699c54fc3b714c6282acce7eaaac6c49_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xOC0zLTEtMS0xMzcyNzU_2c96c516-e205-40c5-9781-57b5f82c9ac4">414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i29c21f5958d54c94a3300a81499e844e_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xOS0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo1OTI1ODZhMThkMjY0MjAwYmJhNTQyMjViOWMyZDI4YV8xMDk5NTExNjI3ODIx_14c7b651-41b7-4476-aa4b-d575b90e1cae">3.375</ix:nonFraction>% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29c21f5958d54c94a3300a81499e844e_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xOS0xLTEtMS0xMzcyNzU_540257fa-b88f-4878-a256-81d017114c27">650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89b3c50e60c94e5287f35e0966dd4a3c_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xOS0zLTEtMS0xMzcyNzU_5c16d1d1-bf05-41f2-8892-f640e714c090">650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i34f2be9f895b466e96b08a69c1310ab7_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yMC0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjpjZmYxMzlhZThhZjU0NDIwOWM0ZDM3ZjE5MmE1NDMwYV8xMDk5NTExNjI3ODIx_4d3595fe-eff7-4c1e-ad8d-d45ecae8a6fa">2.625</ix:nonFraction>% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34f2be9f895b466e96b08a69c1310ab7_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yMC0xLTEtMS0xMzcyNzU_091e5313-1582-4f01-934c-ff9a17b0a6f9">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57483b066e9f454b8904cd684a7f0427_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yMC0zLTEtMS0xMzcyNzU_8f5a8265-764b-414c-8747-70eae87e203b">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic48a061167f048b8902603753dfa8e1d_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yMS0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjoyNzNmN2NiMzA4MTY0NWI5OTA5NmZlNjZmZDFjMjJjYV8xMDk5NTExNjI3ODE5_f76ae7a1-b847-4afc-9b03-c4aac3708ed2">3.5</ix:nonFraction>% senior notes due November 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic48a061167f048b8902603753dfa8e1d_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yMS0xLTEtMS0xMzcyNzU_ee17e182-c303-4abb-8b62-2ff44b799444">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51fd94c18b494791a8946f4cfd11cca6_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yMS0zLTEtMS0xMzcyNzU_46dad562-96c7-4c99-ad0e-51f002017e1e">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id5da825f37b64596bcfb8830bb18cb6c_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yMi0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjowYWZiY2FiMDJhYTA0N2M0Yjk5NmVkZDk4NzgwNDQ5N18xMDk5NTExNjI3ODE1_2e6abeb0-67b3-429a-ab84-63ef502401c5">5</ix:nonFraction>% senior notes due December 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5da825f37b64596bcfb8830bb18cb6c_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yMi0xLTEtMS0xMzcyNzU_d4dc2494-3c5d-46ef-a94d-1e1a8b96bf80">299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4ce44f679934429824ee090659496ff_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yMi0zLTEtMS0xMzcyNzU_33f0c78a-64d2-4e29-890c-72edcafbfb01">299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idda7e364fedc4373a6c04d2aa621c990_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yMy0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjphNDIzNjFiYTc5MjI0MTk5YmM5YWJhZjFkODBmNDhkYV8xMDk5NTExNjI3ODE2_eab61242-1728-4a74-8a80-56cdd6018098">4.1</ix:nonFraction>% senior notes due March 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idda7e364fedc4373a6c04d2aa621c990_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yMy0xLTEtMS0xMzcyNzU_b8bd04e5-8fe1-424c-9417-9b7d7912b885">950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c3bc22603f14476908cfe99fc1875c6_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yMy0zLTEtMS0xMzcyNzU_cd40934e-6159-4b2c-bab9-2d809794bf0b">950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia9a0e60b49f44f1f9e50e8a2f21e126a_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yNC0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo2MzgyY2IyMWQ3MWM0NzFkOTY0OGQwZjdjMWZmNGFjNV8xMDk5NTExNjI3ODE5_a8fc5a21-94d3-4c74-99d7-0a706894e60d">3.875</ix:nonFraction>% senior notes due July 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9a0e60b49f44f1f9e50e8a2f21e126a_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yNC0xLTEtMS0xMzcyNzU_b3ce6f3a-3b8e-4a2c-b4a5-0974c375df9c">2,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5609b04c209d4d23814975183321bf8d_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yNC0zLTEtMS0xMzcyNzU_ee0e3f10-8c88-4198-aaf5-72c854d23e6f">2,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i29521c68c83d45fbafda3ca446e28ad6_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yNS0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo1NGE0MjY3ZjU0NWI0ZDEwYjc5ZmMyOGQ4MjVhNzg1Yl8xMDk5NTExNjI3ODE5_ead422cb-60f6-4c2a-b958-3cdec3d91c8f">2.875</ix:nonFraction>% senior notes due June 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29521c68c83d45fbafda3ca446e28ad6_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yNS0xLTEtMS0xMzcyNzU_39194eda-6f7e-4c6f-951d-09633dbd81a6">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00f8ab37e94f47c5b959adc2fc05d1e4_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yNS0zLTEtMS0xMzcyNzU_bd592f67-8872-4ec6-a2c8-375f757ed03f">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i125e9ebb582747fc928d86e8183d5250_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yNi0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjpmNDMxOWNjNWZjMDI0MTNkOWIxZmZkYzQ3MmMwZDIxOV8xMDk5NTExNjI3ODEz_044b7270-3f69-41b0-831e-9e704aa4711f">3</ix:nonFraction>% senior notes due August 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i125e9ebb582747fc928d86e8183d5250_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yNi0xLTEtMS0xMzcyNzU_b24b6fe2-b7d8-4ab2-a3a0-439ac967db1d">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if34ad8df01784ccd9c09e77e8c83abb0_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yNi0zLTEtMS0xMzcyNzU_9ad09597-4b6f-498f-a426-c8b2b6ebd691">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0c9846afea30440f955cec9041311ebb_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yNy0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo3MGM4ZmE2MmIyNDQ0NjU2YjRiYWY1YmJhOWI0MWMxOV8xMDk5NTExNjI3ODIw_e40139cb-b37a-4573-bac4-bef63f5ca105">3.625</ix:nonFraction>% senior notes due April 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c9846afea30440f955cec9041311ebb_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yNy0xLTEtMS0xMzcyNzU_869ebeb5-c28b-4ebf-ae0b-c5808d3076a4">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44e6bc4ca52465abc641a71fd0e3162_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yNy0zLTEtMS0xMzcyNzU_0b9ea5e9-eef7-47b9-b830-7ad3b77eafdb">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ef356dda5d1479b89006e9da3a6fafd_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yOC0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo4Yjg0ZmRmMDE1Mjk0ZjM1YjhmOWRiZThkZjQ2YTQyOF8xMDk5NTExNjI3ODE3_94dd9854-f418-47a8-9a84-2a55043fca9f">6.25</ix:nonFraction>% senior notes due June 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ef356dda5d1479b89006e9da3a6fafd_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yOC0xLTEtMS0xMzcyNzU_36c10a12-4744-4667-8b0f-e0942f6cfd14">372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1bfd120dbe14e73916b7c46067dcc30_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yOC0zLTEtMS0xMzcyNzU_7fb4fa3f-a186-43b6-b89e-cca1281cc8f6">372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i200e92b399884866831aa7f66216c0b6_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yOS0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo2MzU0NGZjOTlhN2Y0YmViOGFhNGExNzRhOTU3Y2UwNl8xMDk5NTExNjI3ODE3_daecb0b0-3459-403a-be1c-c76f6bd6444b">1.3</ix:nonFraction>% senior notes due August 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i200e92b399884866831aa7f66216c0b6_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yOS0xLTEtMS0xMzcyNzU_8406ebdd-3e15-43b5-8514-03dba1669424">2,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i725dc7730e3249c58e3e72c65a8ed7bd_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yOS0zLTEtMS0xMzcyNzU_3e7324e9-5b5e-4076-b66b-e5824c310b99">2,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iccf871c8fb35430d92796d1f0d0c146d_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zMC0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjpjYmQwZTQ1MDFkNWU0MTdkYjQzMGFlOWEzZTZmN2FiNV8xMDk5NTExNjI3ODE2_1ee5703d-c154-4378-bceb-4d0a6e3c0a78">4.3</ix:nonFraction>% senior notes due March 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccf871c8fb35430d92796d1f0d0c146d_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zMC0xLTEtMS0xMzcyNzU_7a1c8203-23f1-48bd-bf6e-b52fccfa47b5">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf8670b729d642d49a6f047b3de3020e_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zMC0zLTEtMS0xMzcyNzU_63616454-80c9-4fd1-b191-d622e2b62a05">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id7257e80fe294cf89f6d21eb9a5a160b_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zMS0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjowMTc1ODE4ZTQzNGE0YmRjYjU5YzU1NmJlYWI5YTQ4YV8xMDk5NTExNjI3ODE5_d15ce988-49ae-4860-92b9-6041db81a4cb">3.25</ix:nonFraction>% senior notes due August 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7257e80fe294cf89f6d21eb9a5a160b_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zMS0xLTEtMS0xMzcyNzU_f2a93238-ebc8-486b-879c-9061bb147a78">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d68ec8cafb8440b922b87a639652d7d_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zMS0zLTEtMS0xMzcyNzU_4e735268-03f1-43d9-a4b2-020073d93d10">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibd128b7c8158440a960fc33fff1e4942_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zMi0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjoyMTI0NTRjMjM2MjM0ZDc4ODRjZWRlOGNkYTc5NTQwYl8xMDk5NTExNjI3ODE4_f6334bf7-0dbe-417e-ad84-fa8967da4ff5">3.75</ix:nonFraction>% senior notes due April 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd128b7c8158440a960fc33fff1e4942_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zMi0xLTEtMS0xMzcyNzU_c678b724-ba6e-41df-a92d-422cea7d0bb8">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icec9e0e991cc4516851d6f09627a471c_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zMi0zLTEtMS0xMzcyNzU_cce3145e-180d-497d-a1bf-7badbcab285a">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8d97a719154d42e589f04dcc38484757_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zMy0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjplOGYzNTRjMWIyNDM0NjdlYWU4MzgxZWYzMWU0NDA3Nl8xMDk5NTExNjI3ODE5_22dac1ea-a46b-4a46-ace8-6f636c5fd3ac">1.75</ix:nonFraction>% senior notes due August 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d97a719154d42e589f04dcc38484757_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zMy0xLTEtMS0xMzcyNzU_831f4d90-4a1d-4b3a-a86a-f6ed94ad76f8">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7df071c343834f33b524951050d6f51a_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zMy0zLTEtMS0xMzcyNzU_b5005dd4-b5d7-4f52-81bf-adc2552503f7">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifdaae87a3e8b4e53973b84b8af214010_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zNC0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo2NWY4YmVhNjgxNDQ0YzNlOGMzNmU1NDk0NjAxMzQ3NV8xMDk5NTExNjI3ODIz_453b38c2-2448-40f8-802c-4345e54b6e06">1.875</ix:nonFraction>% senior notes due February 2031</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdaae87a3e8b4e53973b84b8af214010_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zNC0xLTEtMS0xMzcyNzU_7d6fe93f-e915-4724-a435-141c4690f2d8">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9226a82fc64641d5afdd7ffa2c292e4c_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zNC0zLTEtMS0xMzcyNzU_098dbc82-a325-4c87-9cbe-370f87074ab5">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie67b1016381d45dfb701cb39cb97655b_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zNS0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjpkY2RhMjYxMjllOTQ0YzQxYjgzZWY2MjQ0YWZhYzlhOV8xMDk5NTExNjI3ODI0_15caaba2-af03-4801-830b-e6c8cebb7525">2.125</ix:nonFraction>% senior notes due September 2031</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie67b1016381d45dfb701cb39cb97655b_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zNS0xLTEtMS0xMzcyNzU_21769282-6cac-4701-ac71-9420fabd55a0">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2abdfe43d904e9b927694acb3cd4cf8_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zNS0zLTEtMS0xMzcyNzU_a49b608f-6b84-4ce4-8632-baa895c05cc0">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i944da40b07b447d0a332880d0b588a20_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zNi0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjpmODgyNDM3ZDAxNGU0YzMwOGZjMTFlNGFjZTI0MzZiOF8xMDk5NTExNjI3ODE5_f76a26de-b9ed-4c43-a76f-a6982f123051">4.875</ix:nonFraction>% senior notes due July 2035</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i944da40b07b447d0a332880d0b588a20_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zNi0xLTEtMS0xMzcyNzU_6d736227-28ae-4afc-94ce-2f02c77e4c53">652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i914306c1134948118679d384eef61fbd_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zNi0zLTEtMS0xMzcyNzU_8d7eee0f-ddb3-4ff0-9ef0-5e57480423ae">652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i643fea13573a45d8afeeb8de059866ed_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zNy0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjphZTI5ODRhY2M2Yzc0ZjI0YTAxMzJkY2ViNzQ2MDIxNF8xMDk5NTExNjI3ODE5_c1546dfd-44e5-4cab-a67f-43b0e2ecbd47">6.625</ix:nonFraction>% senior notes due June 2036</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i643fea13573a45d8afeeb8de059866ed_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zNy0xLTEtMS0xMzcyNzU_8f8be4bf-8a74-47c8-b0e1-6b245b872ff2">771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie286fcf256214324826f57573776deaf_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zNy0zLTEtMS0xMzcyNzU_70c34dc0-0b97-4cea-af84-b044c13fb439">771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie598796a91a246aaa0c09f9f30782bd0_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zOC0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo5NTg1ZjJkZDExNDc0M2JhYjBiMDNjNDEwYzY0NGNiNF8xMDk5NTExNjI3ODIx_79eed786-5e5c-4bf1-9401-71d6911d456f">6.75</ix:nonFraction>% senior notes due December 2037</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie598796a91a246aaa0c09f9f30782bd0_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zOC0xLTEtMS0xMzcyNzU_558afcdc-0877-4d18-89c7-c20dea107584">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i361edf6919cf4676b09461ea7e67b84c_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zOC0zLTEtMS0xMzcyNzU_2e8da922-6303-4719-aff8-215f561b4747">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i65284b80f9764f99aa6e1e0c3d28922b_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zOS0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjozNmNkZDE2ODg3Mzg0OThhOWNlZTEwYzIxZWM2NWM4YV8xMDk5NTExNjI3ODE4_717f6949-d1bf-43c1-a967-02cb1ca84494">4.78</ix:nonFraction>% senior notes due March 2038</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65284b80f9764f99aa6e1e0c3d28922b_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zOS0xLTEtMS0xMzcyNzU_290c5322-cb35-4882-83b4-ad34c9008649">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i205b6c2b07564953a06f503cc5b37037_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zOS0zLTEtMS0xMzcyNzU_5c0ebd92-74f8-45c4-bfd0-4e421f8653ac">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idf399710257743edb37384ff227cd40d_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80MC0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjpjZjQ5MTU2MjFiY2Q0YTJlYjQxMGVmZGNiOTNhNjk0ZF8xMDk5NTExNjI3ODI2_a36c62cb-35d4-4351-95e5-7e25b224cccb">6.125</ix:nonFraction>% senior notes due September 2039</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf399710257743edb37384ff227cd40d_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80MC0xLTEtMS0xMzcyNzU_9ef60489-f72a-465d-b14e-e5b954da81ed">447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5ed3b12e6eb4e059b0259b94de90f3d_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80MC0zLTEtMS0xMzcyNzU_f30dfdea-ed9f-415b-8d51-6ebac1faebc7">447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id26f0bd9ad2d415ea77a3ab3ae626afc_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80MS0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo2ODgwNTI5NzZkNDE0Mzk1OTViMzViMmZhYTRhZmRmMF8xMDk5NTExNjI3ODIw_a1003cbb-73bf-47fe-bec8-41146de5d792">4.125</ix:nonFraction>% senior notes due April 2040</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id26f0bd9ad2d415ea77a3ab3ae626afc_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80MS0xLTEtMS0xMzcyNzU_aa0f391f-e5bd-498d-b501-747db88778d3">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56de23d883344a9a927ab5a974600a0b_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80MS0zLTEtMS0xMzcyNzU_422c3b4a-de84-41f0-b1d4-c4fa75276993">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i40305c3253a242ff97d2746b2a513a69_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80Mi0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjpmMTk4MDhhNjRlNWQ0ZWNkYjg4M2FlYzU5OTQ4YzM4NF8xMDk5NTExNjI3ODE3_e8cdbaa8-1ae3-45c1-beca-6a36d89bea7d">2.7</ix:nonFraction>% senior notes due August 2040</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40305c3253a242ff97d2746b2a513a69_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80Mi0xLTEtMS0xMzcyNzU_845b0fd1-45d7-416f-a962-c591e17e57a6">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic138ff07b2f94c0cadf208f70bb6e79d_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80Mi0zLTEtMS0xMzcyNzU_65fcfd06-8df8-4a5e-995e-e09d804ad8fd">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icecf2da3a842413c965e457894528023_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80My0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjpkYTdiZTVjOTc2ZGY0ZDgxYjBmNjkyMzU1YmVhYmY4ZV8xMDk5NTExNjI3ODE2_f4ab8e01-1076-4264-902a-39bb8e49141a">5.75</ix:nonFraction>% senior notes due May 2041</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icecf2da3a842413c965e457894528023_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80My0xLTEtMS0xMzcyNzU_e94e7fc0-c3c1-40fa-ba37-294f3a99abfb">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i166e8b849a1145b5905209025edd018e_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80My0zLTEtMS0xMzcyNzU_5b381f6a-b856-4c8f-afd0-c4a62713d00c">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0a7c0b54785745fe9adc93c9cf289db1_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80NC0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjpiMzllYzc4ODZjNGY0ZjE3YTY1MzZmNDJmOTBiNWQ5YV8xMDk5NTExNjI3ODE0_7899f4ca-29cc-4ad2-9468-60ce25ea7566">4.5</ix:nonFraction>% senior notes due May 2042</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a7c0b54785745fe9adc93c9cf289db1_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80NC0xLTEtMS0xMzcyNzU_b58dffb6-38a0-4c32-9c77-5ba1b9d38c2b">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i764dca86272443deb0bce7cb4b41e0e9_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80NC0zLTEtMS0xMzcyNzU_85256875-b850-410b-a7c7-b4d7d5eff19b">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ice00869200514840821cf7cc694e3133_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80NS0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjpmZDU0MWU1NWNiN2I0N2IyOWUzMTcxNzkxODM0NGQ2MF8xMDk5NTExNjI3ODIz_a14761be-4e8e-48c8-9c4b-96451bc284a7">4.125</ix:nonFraction>% senior notes due November 2042</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice00869200514840821cf7cc694e3133_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80NS0xLTEtMS0xMzcyNzU_05076aa1-893f-43be-8a2b-4cfc2fb160f5">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i614fbc67bf9144ee9a0deb06e9032f2e_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80NS0zLTEtMS0xMzcyNzU_ba17c043-8fb8-4fa4-a898-7b5948437b8e">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifdf41bb2bcd94610b70c6a62ce138649_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80Ni0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjpiNTEzOWJhY2E3NTY0NzdmYmYwYThjNGVmMDFjM2ZkOV8xMDk5NTExNjI3ODE5_3bdb1adf-6125-46b3-a4f0-9ee1d6a963db">5.3</ix:nonFraction>% senior notes due December 2043</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdf41bb2bcd94610b70c6a62ce138649_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80Ni0xLTEtMS0xMzcyNzU_315d046d-b40d-4213-b898-ce06285843d3">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cae7a6a82104f61a0553383911b0094_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80Ni0zLTEtMS0xMzcyNzU_49a46e59-5743-4a3d-9a20-7d99a57c96c1">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i28e511837f134fd4a0d69cfe195fae71_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80Ny0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo4NTU0OTkwZjFmOGY0YWVhOGQ5NTAzMTQzOGIwYjg5Nl8xMDk5NTExNjI3ODE4_986743f6-3aec-42f4-b988-1c0223c913ae">4.75</ix:nonFraction>% senior notes due March 2044</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28e511837f134fd4a0d69cfe195fae71_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80Ny0xLTEtMS0xMzcyNzU_0399e343-5e11-4dcc-b167-2a09f5d18826">375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibae772bc2bae4e5ea9db4081c2e4001b_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80Ny0zLTEtMS0xMzcyNzU_6359b51c-c56a-4108-ac6d-3f5cd555a7d4">375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie084c2a7344c420c92ae9437d7ab6be3_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80OC0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo2YjBhOGU5MDUxMDU0M2VkODgxZGM4Y2JhZTFlYjM2Nl8xMDk5NTExNjI3ODE5_89022144-2efa-4009-ba7a-6d868e8fca28">5.125</ix:nonFraction>% senior notes due July 2045</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie084c2a7344c420c92ae9437d7ab6be3_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80OC0xLTEtMS0xMzcyNzU_b2f906e2-54db-4602-b2d6-8a04c4a58c67">3,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31d9e274a59413bb7895e1b77158660_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80OC0zLTEtMS0xMzcyNzU_ef2be768-0366-480a-a6b6-7c836b785552">3,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibd7eb609f3b14fac8983caa6c096c01d_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80OS0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjpkMDQ0YWRhMDAzNGM0YzgyYWNkNDVhNTU4M2Y4ZmZhY18xMDk5NTExNjI3ODIx_6e7f9835-df44-462c-8f86-21196c77502b">3.875</ix:nonFraction>% senior notes due August 2047</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd7eb609f3b14fac8983caa6c096c01d_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80OS0xLTEtMS0xMzcyNzU_35f9393a-abdc-4428-8ab9-a5dab35d92ea">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3acd7c3b5f134957ac35694bfa158c39_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80OS0zLTEtMS0xMzcyNzU_37d7317a-6353-419c-934c-a94f353626b6">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i43811273ae184613adc9bb723848272a_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81MC0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjpjZmVmMjE2ZTc0MzA0N2U1YTNhYzI3NTJjNDgwMTA3Yl8xMDk5NTExNjI3ODE4_590efc8e-432f-40e3-8f0a-2de5cf661c56">5.05</ix:nonFraction>% senior notes due March 2048</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43811273ae184613adc9bb723848272a_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81MC0xLTEtMS0xMzcyNzU_093c717b-03b0-41ea-8409-e0e839e680b7">8,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i959c954325ef4865add18451ad9d7a29_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81MC0zLTEtMS0xMzcyNzU_636bd684-0293-4487-a92e-459a80ae2832">8,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie9bfff97b8b648908d79cc9a4159b298_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81MS0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo1ZDY1MDQ1MjY0Nzc0NzAwOGE4YjRhODc0NzQxOTEyZF8xMDk5NTExNjI3ODE4_fde571b8-e48f-4ac0-94b6-6e9448ada834">4.25</ix:nonFraction>% senior notes due April 2050</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9bfff97b8b648908d79cc9a4159b298_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81MS0xLTEtMS0xMzcyNzU_6a8895d1-af0a-4bf8-8dcc-799e1b799c9d">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic19ab2f397f34a8585e736896e24aeed_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81MS0zLTEtMS0xMzcyNzU_60bc1285-3331-4209-a323-4620e5e01513">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81Mi0wLTEtMS0xMzcyNzU_6dc679d2-e622-45de-819a-6f36bb88bc8b"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81Mi0wLTEtMS0xMzcyNzU_7cf3c139-629e-4185-b686-0b6e8760e74e">Finance lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81Mi0xLTEtMS0xMzcyNzU_5071bf57-ab68-4c78-ad4e-0aac900332e3">1,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81Mi0zLTEtMS0xMzcyNzU_7b9855be-2731-4b0a-95bf-017964778705">1,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i015bc34a65a248e3a70847c5c7052cc6_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81My0xLTEtMS0xMzcyNzU_c8f30a83-d9a0-441c-8d46-a5401edfa48c">316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4d2a19a3df4491a9d4ada04059faf42_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81My0zLTEtMS0xMzcyNzU_6e1c29b2-596b-411c-9385-996d4cb31806">320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt principal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="cvs:LongtermDebtGrossAndLeaseObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81NC0xLTEtMS0xMzcyNzU_87ef0334-d5f9-4b8a-90b2-b718eb2415a2">55,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="cvs:LongtermDebtGrossAndLeaseObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81NC0zLTEtMS0xMzcyNzU_8be68c84-17c9-49ae-8aa4-eff172fc032e">56,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81NS0xLTEtMS0xMzcyNzU_a0b1d525-fc1b-4406-8007-5407592c0c72">210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81NS0zLTEtMS0xMzcyNzU_67871774-150c-4391-880a-14f1188a441c">219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt discounts and deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81Ni0xLTEtMS0xMzcyNzU_cac1507e-9178-4565-a51f-68874f9a0592">740</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81Ni0zLTEtMS0xMzcyNzU_2e0c8615-1862-4b8b-898c-b85a7d90d461">786</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81Ny0xLTEtMS0xMzcyNzU_e4af97f3-a2f3-474d-a3d1-69089dc4458b">54,816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81Ny0zLTEtMS0xMzcyNzU_69a2a445-61a1-4644-a3eb-aa40c96a92a3">56,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV82MC0xLTEtMS0xMzcyNzU_69b55644-ba50-4619-8222-50c0c30f609d">4,019</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV82MC0zLTEtMS0xMzcyNzU_c6890c39-8662-4f67-8fe9-22da256fbe9a">4,205</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV82MS0xLTEtMS0xMzcyNzU_d0782b20-83f9-4fba-a0c8-19b555b08932">50,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV82MS0zLTEtMS0xMzcyNzU_4db575ba-083c-4712-aad2-745aea920635">51,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ibd8541cec2c64f6dba204ca48c866b2c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company exercised the par call option on its outstanding <ix:nonFraction unitRef="number" contextRef="i2b2cb684c3c54456b798887d44f26f18_I20220531" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGV4dHJlZ2lvbjoxZTY4Y2QxYjk0NTk0MzY2YmY1YTdiY2EwM2I5ODVlOF84MjQ2MzM3MjEzMTgw_2ee49ef1-6842-424f-b569-be872083c2be">3.5</ix:nonFraction>% senior notes due July 2022 and redeemed for cash on hand the entire $<ix:nonFraction unitRef="usd" contextRef="if2a4890c67364387b34caac671f1ecb8_D20220501-20220531" decimals="-8" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGV4dHJlZ2lvbjoxZTY4Y2QxYjk0NTk0MzY2YmY1YTdiY2EwM2I5ODVlOF84MjQ2MzM3MjEzMjE4_a4df868e-f3b6-48e1-8757-3964198f11a7">1.5</ix:nonFraction>&#160;billion aggregate principal amount. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 15, 2022, the Company announced that it will exercise the par call option on its outstanding <ix:nonFraction unitRef="number" contextRef="if35632f79478444b837b68f876c276d3_I20220815" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGV4dHJlZ2lvbjoxZTY4Y2QxYjk0NTk0MzY2YmY1YTdiY2EwM2I5ODVlOF8zODQ4MjkwNzAzNTUz_8879be95-f4d9-4b1b-8b56-a8f9b3850a38">2.75</ix:nonFraction>% senior notes due November 2022 (issued by Aetna Inc.) and will redeem for cash on hand the entire $<ix:nonFraction unitRef="usd" contextRef="i4f8c724d4dc244c0b8cca96a9f405f4d_D20220815-20220815" decimals="-8" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGV4dHJlZ2lvbjoxZTY4Y2QxYjk0NTk0MzY2YmY1YTdiY2EwM2I5ODVlOF82NTk3MDY5NzcyOTYx_b16ec0d7-0705-44f7-8aac-52191642bcac">1.0</ix:nonFraction>&#160;billion aggregate principal amount. The redemption is expected to occur on or about August 15, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 2, 2022, the Company announced that it will exercise the par call options on its outstanding <ix:nonFraction unitRef="number" contextRef="ide236c65d7b9413da75bda41de2407e0_I20220901" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGV4dHJlZ2lvbjoxZTY4Y2QxYjk0NTk0MzY2YmY1YTdiY2EwM2I5ODVlOF8zODQ4MjkwNzA0MzEw_7d781d65-f591-475d-b6af-b843dfad2968">2.75</ix:nonFraction>% senior notes due December 2022 and <ix:nonFraction unitRef="number" contextRef="ibd92c38e037f41c19fc207220bcc0c98_I20220901" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGV4dHJlZ2lvbjoxZTY4Y2QxYjk0NTk0MzY2YmY1YTdiY2EwM2I5ODVlOF8zODQ4MjkwNzA0MzE3_03473677-755a-4d50-987e-140e42350315">4.75</ix:nonFraction>% senior notes due December 2022 (including the unexchanged notes issued by Omnicare, Inc.) and will redeem for cash on hand the entire $<ix:nonFraction unitRef="usd" contextRef="i5fbafbf9ebe841209a93040e930d5b09_D20220901-20220901" decimals="-7" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGV4dHJlZ2lvbjoxZTY4Y2QxYjk0NTk0MzY2YmY1YTdiY2EwM2I5ODVlOF8zODQ4MjkwNzA0MzI0_276104c9-0a5e-4496-b5ff-7c7fe7919fae">1.25</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i6838b42fbf54414d9a3aa4b32a3784cc_D20220901-20220901" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGV4dHJlZ2lvbjoxZTY4Y2QxYjk0NTk0MzY2YmY1YTdiY2EwM2I5ODVlOF8zODQ4MjkwNzA0MzM5_edbfcea9-0dc5-448f-abc5-65e62af5969e">399</ix:nonFraction>&#160;million aggregate principal amounts, respectively. The redemptions are expected to occur on or about September 1, 2022.</span></div></ix:continuation><div><span><br/></span></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_49"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMjQ5Ng_9776bdf5-6ff2-4ab0-ada5-0eac480e8a2f" continuedAt="i4457c9c21a6d40a5a54e9f0609a98bd1" escape="true">Shareholders&#8217; Equity</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i4457c9c21a6d40a5a54e9f0609a98bd1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:ScheduleOfTreasuryStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMjQ4MA_5aaea866-7ade-4e4b-ad27-49b3835a6b7b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following share repurchase program has been authorized by CVS Health Corporation&#8217;s Board of Directors (the &#8220;Board&#8221;):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In billions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Authorization&#160;Date</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Authorized</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Remaining as of<br/>June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 9, 2021 (&#8220;2021 Repurchase Program&#8221;)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2788e339558c49d4ad5e9a5ed3686ef7_I20211209" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RhYmxlOjFhYzQzMTIyYzYxMDQ2NjI4Y2RiNDEzZjEyMDkxNWIyL3RhYmxlcmFuZ2U6MWFjNDMxMjJjNjEwNDY2MjhjZGI0MTNmMTIwOTE1YjJfMS0xLTEtMS0xMjE3OTc_5e60e603-f162-4c2a-af89-da9ae9ca1e6f">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973e6ae6f5664668812730f3574e2681_I20220630" decimals="-8" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RhYmxlOjFhYzQzMTIyYzYxMDQ2NjI4Y2RiNDEzZjEyMDkxNWIyL3RhYmxlcmFuZ2U6MWFjNDMxMjJjNjEwNDY2MjhjZGI0MTNmMTIwOTE1YjJfMS0zLTEtMS0xMjE3OTc_b687dffe-66ee-4f12-a193-c00b4ea94808">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Repurchase Program permits the Company to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase (&#8220;ASR&#8221;) transactions, and/or other derivative transactions. The 2021 Repurchase Program can be modified or terminated by the Board at any time.</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2022, the Company repurchased approximately <ix:nonFraction unitRef="shares" contextRef="ibf2ba7a1f37c43a2a329487ba4c8244a_D20220101-20220630" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfNTkx_315fd505-248e-4535-97e2-f37cd37d7ae1">19.1</ix:nonFraction> million shares of common stock for approximately $<ix:nonFraction unitRef="usd" contextRef="ibf2ba7a1f37c43a2a329487ba4c8244a_D20220101-20220630" decimals="-8" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfNjM1_fe743280-6b6d-4c21-a9e9-42428a6e9018">2.0</ix:nonFraction> billion pursuant to the 2021 Repurchase Program, including share repurchases under the ASR transaction described below. During the six months ended June&#160;30, 2021, the Company did <ix:nonFraction unitRef="shares" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfNzk3_b07794c8-e40d-49ff-9bce-a6b82eade611">no</ix:nonFraction>t repurchase any shares of its common stock. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the authorization under the 2021 Repurchase Program, the Company entered into a $<ix:nonFraction unitRef="usd" contextRef="i6f0054d90f614171a2cdaff45560ffaa_I20220104" decimals="-8" name="cvs:AcceleratedShareRepurchasesAgreementAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfOTM4_7c362552-58d4-4fa1-a468-c9f401e452d9">1.5</ix:nonFraction>&#160;billion fixed dollar ASR with Barclays Bank PLC (&#8220;Barclays&#8221;). Upon payment of the $<ix:nonFraction unitRef="usd" contextRef="id032d7a1b06a4edbb4e66d3c58ec984a_D20220104-20220104" decimals="-8" name="cvs:PaymentsForAcceleratedShareRepurchasesAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMTAxNQ_1adebeff-5656-4a03-8a05-b95be76e0721">1.5</ix:nonFraction>&#160;billion purchase price on January 4, 2022, the Company received a number of shares of CVS Health Corporation&#8217;s common stock equal to <ix:nonFraction unitRef="number" contextRef="i6f0054d90f614171a2cdaff45560ffaa_I20220104" decimals="2" name="cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMTE0Mw_1869cf48-19fe-4fc4-958c-bdd3ed8fdef4">80</ix:nonFraction>% of the $<ix:nonFraction unitRef="usd" contextRef="i6f0054d90f614171a2cdaff45560ffaa_I20220104" decimals="-8" name="cvs:AcceleratedShareRepurchasesAgreementAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMTE1Mw_ab98af33-9e05-4165-b921-963e9986f96f">1.5</ix:nonFraction>&#160;billion notional amount of the ASR or approximately <ix:nonFraction unitRef="shares" contextRef="i6f0054d90f614171a2cdaff45560ffaa_I20220104" decimals="-5" name="cvs:AcceleratedShareRepurchasesNumberOfSharesRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMTIwMA_58635991-de45-4d79-9285-c81ceda1a261">11.6</ix:nonFraction>&#160;million shares at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i6f0054d90f614171a2cdaff45560ffaa_I20220104" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMTIyNA_7c71a74a-327f-402d-8be7-8250adc18d94">103.34</ix:nonFraction> per share, which were placed into treasury stock in January 2022. The ASR was accounted for as an initial treasury stock transaction for $<ix:nonFraction unitRef="usd" contextRef="i6f0054d90f614171a2cdaff45560ffaa_I20220104" decimals="-8" name="cvs:TransferOfSharesToTreasuryStockValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMTM2NA_f922dea8-e6d4-41d4-931d-49bdd19f8e6c">1.2</ix:nonFraction>&#160;billion and a forward contract for $<ix:nonFraction unitRef="usd" contextRef="id9b2681d79b94d2f9857c1c1e9cd12d4_I20220104" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMTM5NA_d9504c9b-5b98-4cf8-bff8-45e25e0c18ea">0.3</ix:nonFraction>&#160;billion. The forward contract was classified as an equity instrument and was recorded within capital surplus. In February 2022, the Company received approximately <ix:nonFraction unitRef="shares" contextRef="i03eba332a9884f289cf2750b5c9cbf14_I20220228" decimals="-5" name="cvs:AcceleratedShareRepurchasesNumberOfSharesRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMTU1Mg_ec03059a-4fb6-4549-8917-e372effbf061">2.7</ix:nonFraction>&#160;million shares of CVS Health Corporation&#8217;s common stock, representing the remaining <ix:nonFraction unitRef="number" contextRef="i03eba332a9884f289cf2750b5c9cbf14_I20220228" decimals="2" name="cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMTYzMQ_2e8ad4e7-f778-45b1-8324-debf5347b07c">20</ix:nonFraction>% of the $<ix:nonFraction unitRef="usd" contextRef="i03eba332a9884f289cf2750b5c9cbf14_I20220228" decimals="-8" name="cvs:AcceleratedShareRepurchasesAgreementAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMTY0MQ_ae20ceda-f882-4b25-90eb-6446dc8352b4">1.5</ix:nonFraction>&#160;billion notional amount of the ASR, thereby concluding the ASR. These shares were placed into treasury stock and the forward contract was reclassified from capital surplus to treasury stock in February 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the time they were received, the initial and final receipt of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted average common shares outstanding for basic and diluted earnings per share.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The quarterly cash dividend declared by the Board was $<ix:nonFraction unitRef="usdPerShare" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMjE1MQ_32566879-3cbe-4150-8a0f-6fc8abc0572e">0.55</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMjE1OA_12f996a0-f75d-412c-9b13-8bdb03d4ba95">0.50</ix:nonFraction> per share in the three months ended June&#160;30, 2022 and 2021, respectively. Cash dividends declared by the Board were $<ix:nonFraction unitRef="usdPerShare" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMTY0OTI2NzQ0NDM1NQ_61c3aafe-5814-43fb-a060-4f4b01d634bc">1.10</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMTY0OTI2NzQ0NDM2Mg_aaa71b2c-267e-4f5f-8a6e-5b785881147e">1.00</ix:nonFraction> per share in the six months ended June&#160;30, 2022 and 2021, respectively. CVS Health Corporation has paid cash dividends every quarter since becoming a public company. Future dividend payments will depend on the Company&#8217;s earnings, capital requirements, financial condition and other factors considered relevant by the Board.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_52"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RleHRyZWdpb246MjkyZGE5MTM2NDRjNGU2MjkzMTkxY2VhZjJiNjk2OWNfNzk5_1ed7ca9e-6090-4a89-b844-10e565cc6521" continuedAt="i5f67f5a801d24759b492a9a44dc51725" escape="true">Other Comprehensive Income</ix:nonNumeric></span></div><ix:continuation id="i5f67f5a801d24759b492a9a44dc51725" continuedAt="i359b216564b042ad8685b05b92869ca1"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RleHRyZWdpb246MjkyZGE5MTM2NDRjNGU2MjkzMTkxY2VhZjJiNjk2OWNfNzg0_eae43be8-a5aa-4fc1-bdfa-343a133e3022" continuedAt="i0738626909344c3ba3ab9071e91b9ac7" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders&#8217; equity included the following activity in accumulated other comprehensive income (loss) for the three and six months ended June&#160;30, 2022 and 2021:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.161%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net unrealized investment gains (losses):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8f44bafd8b514e13885650b83df2cba5_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMy0xLTEtMS0xMjE3OTc_701921ea-5701-4901-8e41-f5a765ad24c2">377</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i672c8f5d9c8f451eb39619a46f51f47f_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMy0zLTEtMS0xMjE3OTc_e295de33-13de-49fb-a100-581d72a36ceb">828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f9c15723eaf4a9eadcf03b852b70db2_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMy01LTEtMS0xMjE3OTc_5cae2ac6-be64-4edb-b49d-9c21413ad007">778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i490d91efebc0468298a0da610cc516c9_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMy03LTEtMS0xMjE3OTc_4f1d4f23-4e6b-49c0-8a6e-983100677a1e">1,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="i7519dbaef94443449eecd8f162669ec1_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNC0wLTEtMS0xMjE3OTcvdGV4dHJlZ2lvbjplNzQ3MGQ2ZWFlMzI0MTEzOWI5ZjlmZWJjMDFiY2JkMl81NQ_7a77edc5-b8ca-45e0-b011-887840f3e160">1,105</ix:nonFraction>), $<ix:nonFraction unitRef="usd" contextRef="i8ca72ce1ba034c0c9c20ad0f3602947d_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNC0wLTEtMS0xMjE3OTcvdGV4dHJlZ2lvbjplNzQ3MGQ2ZWFlMzI0MTEzOWI5ZjlmZWJjMDFiY2JkMl82Mg_4048dfdc-4d2f-4d06-87a4-507a66d92556">214</ix:nonFraction>, $(<ix:nonFraction unitRef="usd" contextRef="ib125e54cf2b14e81ac89b10807680e76_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNC0wLTEtMS0xMjE3OTcvdGV4dHJlZ2lvbjplNzQ3MGQ2ZWFlMzI0MTEzOWI5ZjlmZWJjMDFiY2JkMl8xMDk5NTExNjI3ODUw_ef59801f-298c-4c91-87ca-76c7b3cd0187">2,510</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="i57a873f503fb43408df28140ea310d0d_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNC0wLTEtMS0xMjE3OTcvdGV4dHJlZ2lvbjplNzQ3MGQ2ZWFlMzI0MTEzOWI5ZjlmZWJjMDFiY2JkMl8xMDk5NTExNjI3ODU5_1da0b7d0-fa04-4621-aa6a-e6074c29f6a6">273</ix:nonFraction>) pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7519dbaef94443449eecd8f162669ec1_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNC0xLTEtMS0xMjE3OTc_57723e3e-abba-4fee-b9e2-b62307a69638">868</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ca72ce1ba034c0c9c20ad0f3602947d_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNC0zLTEtMS0xMjE3OTc_193605e9-a5c0-4d59-a902-e97f79489202">164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib125e54cf2b14e81ac89b10807680e76_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNC01LTEtMS0xMjE3OTc_ae5434b1-eb50-4b70-b5a5-a819eeba81a8">2,098</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i57a873f503fb43408df28140ea310d0d_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNC03LTEtMS0xMjE3OTc_c1232ec0-401d-4651-8f18-ba26b25371c1">236</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="i7519dbaef94443449eecd8f162669ec1_D20220401-20220630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNS0wLTEtMS0xMjE3OTcvdGV4dHJlZ2lvbjo2NDJmNzU1ZTE2YWU0MWM4YTQ1NmQ4YWU2YzU0NDdlNl83MA_1d277bfb-96b2-41d8-ba2b-915998952e5a">77</ix:nonFraction>, $(<ix:nonFraction unitRef="usd" contextRef="i8ca72ce1ba034c0c9c20ad0f3602947d_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNS0wLTEtMS0xMjE3OTcvdGV4dHJlZ2lvbjo2NDJmNzU1ZTE2YWU0MWM4YTQ1NmQ4YWU2YzU0NDdlNl83Nw_ac4dd25b-580c-4d4f-9685-6e1fc375696d">18</ix:nonFraction>), $<ix:nonFraction unitRef="usd" contextRef="ib125e54cf2b14e81ac89b10807680e76_D20220101-20220630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNS0wLTEtMS0xMjE3OTcvdGV4dHJlZ2lvbjo2NDJmNzU1ZTE2YWU0MWM4YTQ1NmQ4YWU2YzU0NDdlNl8xMDk5NTExNjI3ODc2_1e2c3601-4af7-4451-b1f0-76214806a37d">154</ix:nonFraction>, $(<ix:nonFraction unitRef="usd" contextRef="i57a873f503fb43408df28140ea310d0d_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNS0wLTEtMS0xMjE3OTcvdGV4dHJlZ2lvbjo2NDJmNzU1ZTE2YWU0MWM4YTQ1NmQ4YWU2YzU0NDdlNl8xMDk5NTExNjI3ODg1_5b478f02-2224-42eb-9fcb-b4d5fb5e12a2">1</ix:nonFraction>) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7519dbaef94443449eecd8f162669ec1_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNS0xLTEtMS0xMjE3OTc_20447903-374b-42be-a4b3-76abb92bef39">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ca72ce1ba034c0c9c20ad0f3602947d_D20210401-20210630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNS0zLTEtMS0xMjE3OTc_107832d4-8b0d-497d-baee-0fd2537f07ff">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib125e54cf2b14e81ac89b10807680e76_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNS01LTEtMS0xMjE3OTc_8c65ad56-4c34-41f6-a28d-a12c6256b903">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i57a873f503fb43408df28140ea310d0d_D20210101-20210630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNS03LTEtMS0xMjE3OTc_3c6604c5-82bb-4542-8303-9990d27e457a">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7519dbaef94443449eecd8f162669ec1_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNi0xLTEtMS0xMjE3OTc_b6e5c4b9-7f8c-467b-8113-9f36c158cf18">813</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ca72ce1ba034c0c9c20ad0f3602947d_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNi0zLTEtMS0xMjE3OTc_7996b2ce-864d-4a85-8b34-914f21f5a033">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib125e54cf2b14e81ac89b10807680e76_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNi01LTEtMS0xMjE3OTc_2c91e421-6d38-4da0-ba5c-5cd085f358ca">1,968</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i57a873f503fb43408df28140ea310d0d_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNi03LTEtMS0xMjE3OTc_861d7952-d0ea-41f1-b0c6-87c7a6b1f7bd">237</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95c7b68f19d34e799c2a2da632fc1a25_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNy0xLTEtMS0xMjE3OTc_fca2c61b-421b-4b0e-9585-02d4f47e2f92">1,190</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0186d665a01a437290bd18c75323ee1e_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNy0zLTEtMS0xMjE3OTc_30101620-99ed-4b9e-909a-35f5ce11d4a5">977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95c7b68f19d34e799c2a2da632fc1a25_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNy01LTEtMS0xMjE3OTc_aa6bbbbb-a99b-4ba6-9c27-7788ca9cd468">1,190</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0186d665a01a437290bd18c75323ee1e_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNy03LTEtMS0xMjE3OTc_24001a38-69d9-4a85-8f9e-2acb988147dd">977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d3ff99e11274317bfaa3db6aae0ba07_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTAtMS0xLTEtMTIxNzk3_85c830ba-2f36-4eaf-8337-e44b1fb03a0a">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbf36ad6ce3b471588e3a05013e799fe_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTAtMy0xLTEtMTIxNzk3_798d9d71-00ee-467c-9e12-b5c33ddd2be8">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icef7877b29934f14b7831ab01b0e383a_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTAtNS0xLTEtMTIxNzk3_ac97c6f0-ecd6-42fb-88b5-e625864b3727">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib366b23034bd4459aada86fdb2dd3449_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTAtNy0xLTEtMTIxNzk3_57908c77-0c79-4fd4-823b-6bc9d2788ac4">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i796acc4a7ae14fad88f553a72e53ed7b_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTEtMS0xLTEtMTIxNzk3_46b2ba90-3dd4-4ad9-a33b-0027eb5b3fee">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882ca8d49b6a49d3b40dc01ce24b96ae_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTEtMy0xLTEtMTIxNzk3_71ed74e9-1acf-41ec-88bb-0b24ac9845ec">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5b675fa53d484099873bf8055a89db_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTEtNS0xLTEtMTIxNzk3_9cda4eaf-1c40-44a9-925f-e11fe267e605">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i249b23ce7c4a4a9181faba8d0c98b9da_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTEtNy0xLTEtMTIxNzk3_8448675a-b47d-4481-9265-2436aa372725">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i796acc4a7ae14fad88f553a72e53ed7b_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTMtMS0xLTEtMTIxNzk3_530eb94b-55bb-443e-97ad-2ae0b03e42cf">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882ca8d49b6a49d3b40dc01ce24b96ae_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTMtMy0xLTEtMTIxNzk3_a9347e7d-f729-4768-8d28-530557a648ad">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5b675fa53d484099873bf8055a89db_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTMtNS0xLTEtMTIxNzk3_a53b2b3b-2155-4259-895b-92d46036e6e8">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i249b23ce7c4a4a9181faba8d0c98b9da_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTMtNy0xLTEtMTIxNzk3_f50a6c32-27ef-4677-a805-dc64da0d1ca7">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4ad5ca1cf1345368ae93f7d409262d6_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTQtMS0xLTEtMTIxNzk3_f2215750-91eb-4149-b560-1224c6bbdf4f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92bca9f2f539472898cf0d31e92244c6_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTQtMy0xLTEtMTIxNzk3_5b26f457-0266-4f29-a694-f0136ee4dbd0">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4ad5ca1cf1345368ae93f7d409262d6_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTQtNS0xLTEtMTIxNzk3_5b7e187d-a39c-42a0-8c04-ee433846d070">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92bca9f2f539472898cf0d31e92244c6_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTQtNy0xLTEtMTIxNzk3_f0aa0b0d-4819-47b2-b357-695f48638bc9">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if26019edad134ef49f67621aae7d0881_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTctMS0xLTEtMTIxNzk3_6ff3712d-f88a-40ef-b391-0cbf26e8a20c">219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fb161b7e78242208da2fb60faed3211_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTctMy0xLTEtMTIxNzk3_a0288fba-a998-41a7-94fb-fab0fad08f4a">244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ebfa804cc314a5cbaa6c16091e1300b_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTctNS0xLTEtMTIxNzk3_9eb31824-e939-4578-925b-78a7f884e54f">222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5002b5c4b193406a82d57085bca7379c_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTctNy0xLTEtMTIxNzk3_37cb3c1a-8a6f-4655-866b-01adc7653b5d">248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="i17625cfa20f64405885913a70a548638_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTgtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246OWFhNDEwODE2NzJmNGUxNzkwZDk4M2EwY2U0NGFiNDRfNjQ_d5723f60-14a0-46d5-b87d-6efa91b6203f">24</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i9b668c841c514504b89920b0f42c84fc_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTgtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246OWFhNDEwODE2NzJmNGUxNzkwZDk4M2EwY2U0NGFiNDRfMTA5OTUxMTYyNzg3NQ_64ca949d-814c-4c6c-9fab-83f41959a01f">0</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i8384d5359f84472ca5781e3a2d42ea0a_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTgtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246OWFhNDEwODE2NzJmNGUxNzkwZDk4M2EwY2U0NGFiNDRfNzE_1e2c74a5-2846-4062-b44b-a9af0f965bfa">24</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="if039d6d6983848a48803a4bc6f9a0ed1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTgtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246OWFhNDEwODE2NzJmNGUxNzkwZDk4M2EwY2U0NGFiNDRfMTA5OTUxMTYyNzg5MQ_41c23984-d344-4fd3-b6b6-a7fdd3b47d5c">0</ix:nonFraction> pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17625cfa20f64405885913a70a548638_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTgtMS0xLTEtMTIxNzk3_0d9c521d-d877-4fac-820a-7e7595e4024b">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b668c841c514504b89920b0f42c84fc_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTgtMy0xLTEtMTIxNzk3_af48cb9a-b296-4bf9-bc7a-4324a315c9b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8384d5359f84472ca5781e3a2d42ea0a_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTgtNS0xLTEtMTIxNzk3_a0477209-16fd-425e-aa89-ab14a22471e9">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if039d6d6983848a48803a4bc6f9a0ed1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTgtNy0xLTEtMTIxNzk3_dc3f9e93-bf0b-4340-8544-4b7a1838ada7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(<ix:nonFraction unitRef="usd" contextRef="i17625cfa20f64405885913a70a548638_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTktMC0xLTEtMTIxNzk3L3RleHRyZWdpb246ZjllNTA5ODZmZjc1NDM4MGI3MWM5MzAwNmMzMzkwODRfNzA_3d28b86d-4897-4172-b915-187fd9e2eb94">4</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="i9b668c841c514504b89920b0f42c84fc_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTktMC0xLTEtMTIxNzk3L3RleHRyZWdpb246ZjllNTA5ODZmZjc1NDM4MGI3MWM5MzAwNmMzMzkwODRfNzc_73fce5a3-4a98-4652-b0a1-74941d257907">4</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="i8384d5359f84472ca5781e3a2d42ea0a_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTktMC0xLTEtMTIxNzk3L3RleHRyZWdpb246ZjllNTA5ODZmZjc1NDM4MGI3MWM5MzAwNmMzMzkwODRfMTA5OTUxMTYyNzg3OA_d1df92e9-23a4-4220-a876-b04e4bf5e3b2">8</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="if039d6d6983848a48803a4bc6f9a0ed1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTktMC0xLTEtMTIxNzk3L3RleHRyZWdpb246ZjllNTA5ODZmZjc1NDM4MGI3MWM5MzAwNmMzMzkwODRfMTA5OTUxMTYyNzg4Nw_05ae8785-2788-402f-8f04-827415d6b987">9</ix:nonFraction>) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17625cfa20f64405885913a70a548638_D20220401-20220630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTktMS0xLTEtMTIxNzk3_ff1904a8-5357-476b-98c5-27b95fb03a0e">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b668c841c514504b89920b0f42c84fc_D20210401-20210630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTktMy0xLTEtMTIxNzk3_e5ae0ef7-7600-484a-b421-36ac2e829c88">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8384d5359f84472ca5781e3a2d42ea0a_D20220101-20220630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTktNS0xLTEtMTIxNzk3_3f40786b-22f8-4e52-bd8a-0ec6232c605e">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if039d6d6983848a48803a4bc6f9a0ed1_D20210101-20210630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTktNy0xLTEtMTIxNzk3_e6e73943-94ca-4b6e-8b06-bc9a3821f8ce">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17625cfa20f64405885913a70a548638_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjAtMS0xLTEtMTIxNzk3_d2d0207e-2c7b-43fe-b4f2-26307ba43322">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b668c841c514504b89920b0f42c84fc_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjAtMy0xLTEtMTIxNzk3_40005516-9258-42de-adc5-2e90d854104c">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8384d5359f84472ca5781e3a2d42ea0a_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjAtNS0xLTEtMTIxNzk3_92be235b-09f8-4850-838c-1514fa7fd5c7">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if039d6d6983848a48803a4bc6f9a0ed1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjAtNy0xLTEtMTIxNzk3_2cd9d02d-3ac2-43b9-9eea-e95baca02d6c">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6968e95408a14a959a6cf1b5595b1562_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjEtMS0xLTEtMTIxNzk3_e92e3b99-0cfb-447c-8856-c78042b7c961">234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16a176b60bcf492c9d7596af5ec2d637_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjEtMy0xLTEtMTIxNzk3_60fb6e05-2b9c-4e8d-a841-feb1615cf3cf">241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6968e95408a14a959a6cf1b5595b1562_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjEtNS0xLTEtMTIxNzk3_20cb42cf-f33a-4fdb-8a4a-7598723e048b">234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16a176b60bcf492c9d7596af5ec2d637_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjEtNy0xLTEtMTIxNzk3_93488376-2975-4b04-bbf7-e83d1513f9cc">241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension and other postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie45bedb2b1594d3eb748dd76b2cab130_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjQtMS0xLTEtMTIxNzk3_8959ec1d-a263-44e9-b0a4-ee9de84f50bd">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i60f2853c6a3842dd843c429de5b2337d_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjQtMy0xLTEtMTIxNzk3_a3e62b7d-fe1f-475d-af7f-9bcd6583c47e">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie59f2df1b9114d43b76163c7a171e5a4_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjQtNS0xLTEtMTIxNzk3_0bde0971-9e09-4710-9066-2d1aa9610e5a">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia6b9a02663b641188ebd9d833d0c8593_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjQtNy0xLTEtMTIxNzk3_03c15f34-5cd0-4bcd-bc62-83151df0b365">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="i2602b92305c04c68a196ab39ab51d7d1_D20220401-20220630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjYtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246YjEwNDllMDkxZTA0NGJhMWJjMWY3M2JhYmI3ZjJiOTJfNjg_e3b75a04-bd0e-4537-b348-03c9f838807b">1</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i44bba003a74946ed87d9d0b98b2c950d_D20210401-20210630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjYtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246YjEwNDllMDkxZTA0NGJhMWJjMWY3M2JhYmI3ZjJiOTJfNzI_ad4c8fc8-7adb-4aab-8288-900fe81ed6d2">1</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i74776cd677844441a5cdd3bde68816e0_D20220101-20220630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjYtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246YjEwNDllMDkxZTA0NGJhMWJjMWY3M2JhYmI3ZjJiOTJfNzY_3783a296-9684-4ec8-bb70-a311934255d1">1</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i4f24cf7d8a01489c8b678a8a8c86ef3f_D20210101-20210630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjYtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246YjEwNDllMDkxZTA0NGJhMWJjMWY3M2JhYmI3ZjJiOTJfODM_e7ee39e4-1a6d-4734-be6e-0774b6a71d1c">1</ix:nonFraction> pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2602b92305c04c68a196ab39ab51d7d1_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjYtMS0xLTEtMTIxNzk3_1239e674-515a-458c-b422-4bb42d2da4f2">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44bba003a74946ed87d9d0b98b2c950d_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjYtMy0xLTEtMTIxNzk3_14ecde1b-0daf-4ec5-9eb2-6ce3965c2b96">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74776cd677844441a5cdd3bde68816e0_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjYtNS0xLTEtMTIxNzk3_5b1c038c-f282-41b6-9baa-625ef22c8f26">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f24cf7d8a01489c8b678a8a8c86ef3f_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjYtNy0xLTEtMTIxNzk3_180b330b-7fee-4846-9008-345b52fae644">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2602b92305c04c68a196ab39ab51d7d1_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjctMS0xLTEtMTIxNzk3_fd26d51d-bba5-452e-844e-7cdd894c18e3">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44bba003a74946ed87d9d0b98b2c950d_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjctMy0xLTEtMTIxNzk3_de88e1ac-7ee2-41c2-8c7e-1a931a8d0ac9">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74776cd677844441a5cdd3bde68816e0_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjctNS0xLTEtMTIxNzk3_6c704e3d-a0dd-4a53-a872-9432b212d216">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f24cf7d8a01489c8b678a8a8c86ef3f_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjctNy0xLTEtMTIxNzk3_4673457f-9e45-4212-9da8-0d1e17639d4c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib24237470dfb4b14bdc3819e68f90af7_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjgtMS0xLTEtMTIxNzk3_1fa135c3-4687-466e-8539-e7a628030ce0">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8898a5dbc52c442fad3cc1e0d98f102c_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjgtMy0xLTEtMTIxNzk3_eec1af32-6231-40fa-97b2-85c4d787af30">54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib24237470dfb4b14bdc3819e68f90af7_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjgtNS0xLTEtMTIxNzk3_cdd83e13-4b4c-4d6b-a0b8-428e633bf7dc">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8898a5dbc52c442fad3cc1e0d98f102c_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjgtNy0xLTEtMTIxNzk3_638daa8b-3faa-4cea-8039-66974b1a5f59">54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total beginning of period accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a636d32fc2a454a89bd4991b0628853_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMzAtMS0xLTEtMTIxNzk3_83fe55a7-6088-4ca3-85a8-01839c08212b">190</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7a27b274c3a4d16b682c158f10c219e_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMzAtMy0xLTEtMTIxNzk3_8f6a2a66-80e8-4c65-9d6c-c368b0cee24b">1,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6688966640734a61a1a460ea4b661770_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMzAtNS0xLTEtMTIxNzk3_73c0a6c6-fac9-4e8f-90c6-7c06824b426a">965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id86c8e524f224b00811843646316152e_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMzAtNy0xLTEtMTIxNzk3_23eacba8-900b-4a36-acf0-ddff89589197">1,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMzEtMS0xLTEtMTIxNzk3_653898bc-44c6-49b9-b544-57a59aac62c1">798</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMzEtMy0xLTEtMTIxNzk3_36f31643-8faf-4d15-8845-c9bddc1e056d">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMzEtNS0xLTEtMTIxNzk3_971d7cf3-4406-43de-ace7-59c67fa29f6a">1,953</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMzEtNy0xLTEtMTIxNzk3_9c7129de-c9d0-4af1-ab47-7eb7faaf932f">244</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total end of period accumulated other comprehensive income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5185ac0c651b4a17bd97c114f383805d_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMzItMS0xLTEtMTIxNzk3_3f065ddf-7466-4a31-bed8-728c497c9a09">988</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdea86bdbcc429985d69c5258c861b8_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMzItMy0xLTEtMTIxNzk3_a8483bfb-822f-4d10-bda1-b4957b7d0cd9">1,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5185ac0c651b4a17bd97c114f383805d_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMzItNS0xLTEtMTIxNzk3_bbad81bf-5d67-4380-970f-a03b4cea6e39">988</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdea86bdbcc429985d69c5258c861b8_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMzItNy0xLTEtMTIxNzk3_1dfd7dea-8f55-485d-b4ee-f2f00731d50d">1,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income (loss) for specifically identified debt securities are included in net investment income in the unaudited condensed consolidated statements of operations.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included in interest expense in the unaudited condensed consolidated statements of operations. The Company expects to reclassify approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="i6968e95408a14a959a6cf1b5595b1562_I20220630" decimals="-6" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RleHRyZWdpb246MjkyZGE5MTM2NDRjNGU2MjkzMTkxY2VhZjJiNjk2OWNfNjc2_8fc1fa79-2fe0-4ce4-8b08-d343cb69906c">11</ix:nonFraction> million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.</span></div></ix:nonNumeric></ix:continuation><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i359b216564b042ad8685b05b92869ca1" continuedAt="i5736c576ddc043eea451dc231ae2abb0"><ix:continuation id="i0738626909344c3ba3ab9071e91b9ac7" continuedAt="id7a1b8b937ec454f824386de6214cc26">(3)</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="i5736c576ddc043eea451dc231ae2abb0"><ix:continuation id="id7a1b8b937ec454f824386de6214cc26">Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the unaudited condensed consolidated statements of operations.</ix:continuation></ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_55"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RleHRyZWdpb246YjE0YWFhZTJmZDI3NDE3YWFlNjQ5NmFkZjFhZmJkM2ZfNTY4_95e2eb1f-4adf-4f7b-a40b-2ae022d765f1" continuedAt="id8b7e45e987f4d22b1ada766a3c88eef" escape="true">Earnings Per Share</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="id8b7e45e987f4d22b1ada766a3c88eef"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share is computed using the treasury stock method. Stock options and stock appreciation rights to purchase <ix:nonFraction unitRef="shares" contextRef="i6cb8479c571d4f03bbc71c0d8f664eca_D20220401-20220630" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RleHRyZWdpb246YjE0YWFhZTJmZDI3NDE3YWFlNjQ5NmFkZjFhZmJkM2ZfMTQ2_63edd667-f6bd-4cde-b017-746f5f53741f">4</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="icd272e9bdea14242a207e8aff8e2266e_D20220101-20220630" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RleHRyZWdpb246YjE0YWFhZTJmZDI3NDE3YWFlNjQ5NmFkZjFhZmJkM2ZfMTA5OTUxMTYyODM5NA_793f9ce1-19b4-43f3-9c27-6e1e4a3196d5">3</ix:nonFraction> million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the three and six months ended June&#160;30, 2022, respectively, because their exercise prices were greater than the average market price of the common shares and, therefore, the effect would be antidilutive. For the same reason, stock options and stock appreciation rights to purchase <ix:nonFraction unitRef="shares" contextRef="i1ad6c128f57b4949a888c466705beca4_D20210401-20210630" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RleHRyZWdpb246YjE0YWFhZTJmZDI3NDE3YWFlNjQ5NmFkZjFhZmJkM2ZfMTA5OTUxMTYyODgzOA_b832e5a0-47f9-4510-9b2a-d835e9dd22a5">8</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i673355ef359540e592c71b0c9698de65_D20210101-20210630" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RleHRyZWdpb246YjE0YWFhZTJmZDI3NDE3YWFlNjQ5NmFkZjFhZmJkM2ZfMTA5OTUxMTYyODgwOQ_6c6a6514-f4c9-40ab-9e1f-ca4fe4d732dc">9</ix:nonFraction> million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the three and six months ended June&#160;30, 2021, respectively.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RleHRyZWdpb246YjE0YWFhZTJmZDI3NDE3YWFlNjQ5NmFkZjFhZmJkM2ZfNTY5_5f2e75c6-0cc4-4834-bef9-06f26efc1f7e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of basic and diluted earnings per share for the respective periods:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfNi0xLTEtMS0xMjE3OTc_3bdc60ce-2cd1-42d6-99ff-bd3c49b15a02">2,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfNi0zLTEtMS0xMjE3OTc_5e74afcc-0312-4940-9ed8-ffb823b26f00">2,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfNi01LTEtMS0xMjE3OTc_d29ee9c8-8bfd-47ee-874b-1db5b3d13295">5,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfNi03LTEtMS0xMjE3OTc_568cee06-eb5f-466a-9bd6-dcc6875379d4">5,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfOS0xLTEtMS0xMjE3OTc_aa7e5b7a-698f-41b7-8429-73ff3ac5f8ad">1,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfOS0zLTEtMS0xMjE3OTc_a127c934-3b00-4ef7-ada4-75f14c09e95f">1,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfOS01LTEtMS0xMjE3OTc_a8b5b78b-1833-49c5-a187-93d477a77329">1,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfOS03LTEtMS0xMjE3OTc_32c654ca-f1ea-4573-aa98-fddc5982efd4">1,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units and performance stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id289f8fd821442c1a5d3cc80b9c40c2a_D20220401-20220630" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTAtMS0xLTEtMTIxNzk3_ffd22bd1-fdfb-4764-a796-5e2f92fb852e">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia1edca8cccef478fbae52ae8fb77dfee_D20210401-20210630" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTAtMy0xLTEtMTIxNzk3_fca4bb6d-d497-42f8-b297-f470126b6340">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i597a5458b92444dda6db7761d84ee082_D20220101-20220630" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTAtNS0xLTEtMTI5NzY0_15bc5a9d-8372-45c4-b9a6-4865a67e84eb">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic81654dd29534869be7ad8d23a454adb_D20210101-20210630" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTAtNy0xLTEtMTI4MTA0_69e1eec2-a0e0-4685-a40f-3a302a6db10d">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and stock appreciation rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6cb8479c571d4f03bbc71c0d8f664eca_D20220401-20220630" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTEtMS0xLTEtMTIxNzk3_e16c6d0a-6c46-4750-9863-3ac67f8fc006">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1ad6c128f57b4949a888c466705beca4_D20210401-20210630" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTEtMy0xLTEtMTIxNzk3_15e61d57-b7f2-455e-ae07-404267383524">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icd272e9bdea14242a207e8aff8e2266e_D20220101-20220630" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTEtNS0xLTEtMTI5NzY0_8b0b7a20-6211-462f-b4dc-1a647699d6e2">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i673355ef359540e592c71b0c9698de65_D20210101-20210630" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTEtNy0xLTEtMTI4MTA0_0fdfd7d0-ccbd-41c4-a3b3-8fbd2c0ab1bb">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTItMS0xLTEtMTIxNzk3_7691591e-a7cf-4b8c-986d-adc2d670cbf9">1,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTItMy0xLTEtMTIxNzk3_ff42000b-9383-4bb3-b247-1f884a4daa3b">1,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTItNS0xLTEtMTIxNzk3_52c4c58b-be70-4edd-b85c-47edc82c2a0d">1,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTItNy0xLTEtMTIxNzk3_b64c4cf2-9ddd-44da-bda1-d1d20d12a4e3">1,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTUtMS0xLTEtMTIxNzk3_3f86a29a-7b50-4b94-aebf-c323f077c739">2.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTUtMy0xLTEtMTIxNzk3_d64ecfd8-e8fd-4d02-b036-43cb8e7cd4dc">2.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTUtNS0xLTEtMTIxNzk3_75f1b1ae-957c-40d5-b298-1b75038cec64">4.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTUtNy0xLTEtMTIxNzk3_a2bc2b45-c27d-4c43-9268-9953e86a0dd1">3.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTYtMS0xLTEtMTIxNzk3_aa04e6ef-b26f-489b-b71c-4a2e05acfb7f">2.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTYtMy0xLTEtMTIxNzk3_f33b3600-7a8f-49d6-ac62-af4f351645e0">2.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTYtNS0xLTEtMTIxNzk3_5fa4776b-f88d-4d65-9e1a-e7f1982c10d4">3.97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTYtNy0xLTEtMTIxNzk3_701b8a58-f96b-4a0f-bc69-c9a8592c7c20">3.78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_58"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81OC9mcmFnOmFlY2ZhYmMwMzg4ODRmNzQ4OThiZWY1OTM5NmY4Y2NmL3RleHRyZWdpb246YWVjZmFiYzAzODg4NGY3NDg5OGJlZjU5Mzk2ZjhjY2ZfMjg4NDU_56fb8bfa-fbba-4744-83f5-21bdb027b94e" continuedAt="i58db1579779e4ba3bed2d7d76b6600c3" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i58db1579779e4ba3bed2d7d76b6600c3" continuedAt="i16721aa720f24b32b6a6036fcbb9e5f2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to evolve. The Company believes COVID-19&#8217;s impact on its businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic; the pandemic&#8217;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns; and the timing, scope and impact of stimulus legislation as well as other federal, state and local governmental responses to the pandemic. Those primary drivers are beyond the Company&#8217;s knowledge and control. As a result, the impact COVID-19 will have on the Company&#8217;s businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. COVID-19 also may result in legal and regulatory proceedings, investigations and claims against the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lease Guarantees</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between 1995 and 1997, the Company sold or spun off a number of subsidiaries, including Bob&#8217;s Stores and Linens &#8216;n Things, each of which subsequently filed for bankruptcy, and Marshalls. In many cases, when a former subsidiary leased a store, the Company provided a guarantee of the former subsidiary&#8217;s lease obligations for the initial lease term and any extension thereof pursuant to a renewal option provided for in the lease prior to the time of the disposition. When the subsidiaries were disposed of and accounted for as discontinued operations, the Company&#8217;s guarantees remained in place, although each initial purchaser agreed to indemnify the Company for any lease obligations the Company was required to satisfy. If any of the purchasers or any of the former subsidiaries fail to make the required payments under a store lease, the Company could be required to satisfy those obligations, and any significant adverse impact of COVID-19 on such purchasers and/or former subsidiaries increases the risk that the Company will be required to satisfy those obligations. As of June&#160;30, 2022, the Company guaranteed <ix:nonFraction unitRef="lease" contextRef="i497dd46327b4467f95cca59a81170078_I20220630" decimals="INF" name="cvs:GuarantorObligationsNumberofLeases" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81OC9mcmFnOmFlY2ZhYmMwMzg4ODRmNzQ4OThiZWY1OTM5NmY4Y2NmL3RleHRyZWdpb246YWVjZmFiYzAzODg4NGY3NDg5OGJlZjU5Mzk2ZjhjY2ZfMjA1Mw_d8a803b8-162b-4e70-90b0-6cf1d10ac23f">68</ix:nonFraction> such store leases (excluding the lease guarantees related to Linens &#8216;n Things, which have been recorded as a liability on the unaudited condensed consolidated balance sheets), with the maximum remaining lease term extending through 2030. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i16721aa720f24b32b6a6036fcbb9e5f2" continuedAt="i4ae22d7a6baf476c89c24070ec8b2e49"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guaranty Fund Assessments, Market Stabilization and Other Non-Voluntary Risk Sharing Pools</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under guaranty fund laws existing in all states, insurers doing business in those states can be assessed (in most states up to prescribed limits) for certain obligations of insolvent insurance companies to policyholders and claimants. The life and health insurance guaranty associations in which the Company participates that operate under these laws respond to insolvencies of long-term care insurers and life insurers as well as health insurers. The Company&#8217;s assessments generally are based on a formula relating to the Company&#8217;s health care premiums in the state compared to the premiums of other insurers. Certain states allow assessments to be recovered over time as offsets to premium taxes. Some states have similar laws relating to HMOs and/or other payors such as not-for-profit consumer-governed health plans established under the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2009, the Pennsylvania Insurance Commissioner placed long-term care insurer Penn Treaty Network America Insurance Company and one of its subsidiaries (collectively, &#8220;Penn Treaty&#8221;) in rehabilitation, an intermediate action before insolvency, and subsequently petitioned a state court to convert the rehabilitation into a liquidation. Penn Treaty was placed in liquidation in March 2017. The Company has recorded a liability for its estimated share of future assessments by applicable life and health insurance guaranty associations. It is reasonably possible that in the future the Company may record a liability and expense relating to other insolvencies which could have a material adverse effect on the Company&#8217;s operating results, financial condition and cash flows, and the risk is heightened by any significant adverse impact of the COVID-19 pandemic on the solvency of other insurers, including long-term care and life insurers. While historically the Company has ultimately recovered more than half of guaranty fund assessments through statutorily permitted premium tax offsets, significant increases in assessments could lead to legislative and/or regulatory actions that limit future offsets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HMOs in certain states in which the Company does business are subject to assessments, including market stabilization and other risk-sharing pools, for which the Company is assessed charges based on incurred claims, demographic membership mix and other factors. The Company establishes liabilities for these assessments based on applicable laws and regulations. In certain states, the ultimate assessments the Company pays are dependent upon the Company&#8217;s experience relative to other entities subject to the assessment, and the ultimate liability is not known at the financial statement date. While the ultimate amount of the assessment is dependent upon the experience of all pool participants, the Company believes it has adequate reserves to cover such assessments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation and Regulatory Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been involved or is currently involved in numerous legal proceedings, including litigation, arbitration, government investigations, audits, reviews and claims. These include routine, regular and special investigations, audits and reviews by</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the U.S. Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;), state insurance and health and welfare departments, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the U.S. Department of Justice (the &#8220;DOJ&#8221;), </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">state attorneys general, the U.S. Drug Enforcement Administration (the &#8220;DEA&#8221;), the Federal Trade Commission (the &#8220;FTC&#8221;) and other governmental authorities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal proceedings, in general, and securities, class action and multi-district litigation, in particular, and governmental special investigations, audits and reviews can be expensive and disruptive. Some of the litigation matters may purport or be determined to be class actions and/or involve parties seeking large and/or indeterminate amounts, including punitive or exemplary damages, and may remain unresolved for several years. The Company also may be named from time to time in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> actions initiated by private third parties that could also be separately pursued by a governmental body. The results of legal proceedings, including government investigations, are often uncertain and difficult to predict, and the costs incurred in these matters can be substantial, regardless of the outcome.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred and the amount can be reasonably estimated. The Company evaluates, on a quarterly basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and reasonably estimable, the Company does not establish an accrued liability. None of the Company&#8217;s accruals for outstanding legal matters are material individually or in the aggregate to the Company&#8217;s financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise noted, the Company cannot predict with certainty the timing or outcome of the legal matters described below, and the Company is unable to reasonably estimate a possible loss or range of possible loss in excess of amounts already accrued for these matters. The Company believes that its defenses and assertions in pending legal proceedings have merit and does not believe that any of these pending matters, after consideration of applicable reserves and rights to indemnification, will </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4ae22d7a6baf476c89c24070ec8b2e49" continuedAt="i7e5ec960d59d44619f7beffbc93e838d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have a material adverse effect on the Company&#8217;s financial position. Substantial unanticipated verdicts, fines and rulings, however, do sometimes occur, which could result in judgments against the Company, entry into settlements or a revision to its expectations regarding the outcome of certain matters, and such developments could have a material adverse effect on its results of operations.  In addition, as a result of governmental investigations or proceedings, the Company may be subject to damages, civil or criminal fines or penalties, or other sanctions including possible suspension or loss of licensure and/or exclusion from participating in government programs. The outcome of such governmental investigations of proceedings could be material to the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Usual and Customary Pricing Litigation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and certain current and former directors and officers are named as a defendant in a number of lawsuits that allege that the Company&#8217;s retail pharmacies overcharged for prescription drugs by not submitting the correct usual and customary price during the claims adjudication process. These actions are brought by a number of different types of plaintiffs, including plan members, private payors, government payors, and shareholders based on different legal theories. Some of these cases are brought as putative class actions, and in some instances, classes have been certified. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PBM Litigation and Investigations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its PBM practices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is facing multiple lawsuits, including by a State Attorney General, governmental subdivisions and several putative class actions, regarding drug pricing and its rebate arrangements with drug manufacturers.  These complaints, brought by a number of different types of plaintiffs under a variety of legal theories, generally allege that rebate agreements between the drug manufacturers and PBMs caused inflated prices for certain drug products. The Company is defending itself against these claims.  The Company has also received subpoenas, civil investigative demands (&#8220;CIDs&#8221;) and other requests for documents and information from, and is being investigated by, the FTC and Attorneys General of several states and the District of Columbia regarding its PBM practices, including pricing and rebates. The Company has been providing documents and information in response to these subpoenas, CIDs and requests for information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Behnke v. CVS Caremark Corporation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. (U.S. District Court for the Eastern District of Pennsylvania). In April 2018, the Court unsealed a complaint filed in February 2014. The government has declined to intervene in this case. The relator alleges that the Company submitted, or caused to be submitted, to Part D of the Medicare program Prescription Drug Event data and/or Direct and Indirect Remuneration reports that misrepresented true prices paid by the Company&#8217;s PBM to pharmacies for drugs dispensed to Part D beneficiaries with prescription benefits administered by the Company&#8217;s PBM. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Controlled Substances Litigation, Audits and Subpoenas</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, the U.S. Judicial Panel on Multidistrict Litigation consolidated numerous cases filed against various defendants by plaintiffs such as counties, cities, hospitals, Indian tribes and third-party payors, alleging claims generally concerning the impacts of widespread prescription opioid abuse. The consolidated multidistrict litigation captioned In re National Prescription Opiate Litigation (MDL No. 2804) is pending in the U.S. District Court for the Northern District of Ohio. This multidistrict litigation presumptively includes hundreds of relevant federal court cases that name the Company as a defendant. A significant number of similar cases that name the Company as a defendant in some capacity are pending in state courts. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company has been named as a defendant in similar cases brought by certain state Attorneys General. The Company is defending itself against all such claims. Additionally, the Company has received subpoenas, CIDs and/or other requests for information regarding opioids from state Attorneys General and insurance and other regulators of several U.S. jurisdictions. The Company has been cooperating with the government with respect to these subpoenas, CIDs and other requests for information.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the Company was among the chain pharmacies found liable by a jury in a trial in federal court in Ohio; the remedy pursuant to that verdict has not been determined and the Company plans to appeal.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, CVS Health Corporation and CVS Pharmacy, Inc. entered into a settlement agreement with the State of Florida to resolve claims related to opioid medications dating back more than a decade. Under the terms of the settlement agreement, CVS Health Corporation settled all opioid claims against it and its subsidiaries by the State of Florida for $<ix:nonFraction unitRef="usd" contextRef="i068019055ff349b0ba2c43c7bdcad5a5_D20220301-20220331" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81OC9mcmFnOmFlY2ZhYmMwMzg4ODRmNzQ4OThiZWY1OTM5NmY4Y2NmL3RleHRyZWdpb246YWVjZmFiYzAzODg4NGY3NDg5OGJlZjU5Mzk2ZjhjY2ZfMTI5NDQ_2efb6893-875b-4950-bf0f-424c6c396452">484</ix:nonFraction>&#160;million, which is </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i7e5ec960d59d44619f7beffbc93e838d" continuedAt="if27390578890494f98cfe9a77bbcecaf"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to be paid over a period of <ix:nonNumeric contextRef="i201d84873cdc44b8a00591a48c940e6a_I20220331" name="cvs:LegalSettlementPeriodOfPayment" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81OC9mcmFnOmFlY2ZhYmMwMzg4ODRmNzQ4OThiZWY1OTM5NmY4Y2NmL3RleHRyZWdpb246YWVjZmFiYzAzODg4NGY3NDg5OGJlZjU5Mzk2ZjhjY2ZfMTI5ODU_c4682eff-ccd3-405c-9727-cf41f40d0309">18</ix:nonNumeric> years. During the three months ended March 31, 2022, the Company recorded a $<ix:nonFraction unitRef="usd" contextRef="i201d84873cdc44b8a00591a48c940e6a_I20220331" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81OC9mcmFnOmFlY2ZhYmMwMzg4ODRmNzQ4OThiZWY1OTM5NmY4Y2NmL3RleHRyZWdpb246YWVjZmFiYzAzODg4NGY3NDg5OGJlZjU5Mzk2ZjhjY2ZfMTMwNTg_61d7309f-d148-4666-9357-ed1eec898c4e">484</ix:nonFraction>&#160;million liability associated with this legal settlement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the DOJ served the Company with a DEA administrative subpoena. The subpoena seeks documents relating to practices with respect to prescription opioids and other controlled substances at CVS pharmacy locations concerning potential violations of the federal Controlled Substances Act and the federal False Claims Act. In January 2022, the DOJ served the Company with a CID regarding similar subjects. The Company is providing documents and information in response to these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Prescription Processing Litigation and Investigations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its prescription processing practices, including the following:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ex rel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Bassan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> v. Omnicare, Inc. and CVS Health Corp. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. District Court for the Southern District of New York). In December 2019, the U.S. Attorney&#8217;s Office for the Southern District of New York (the &#8220;SDNY&#8221;) filed a complaint-in-intervention in this previously sealed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case. The complaint alleges that for certain non-skilled nursing facilities, Omnicare improperly filled prescriptions beyond one year where a valid prescription did not exist and that these dispensing events violated the federal False Claims Act. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. ex rel. Gill et al. v. CVS Health Corp. et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (U.S. District Court for the Northern District of Illinois).  In July 2022, the Delaware Attorney General&#8217;s Office moved for partial intervention as to allegations under the Delaware false claims act related to not escheating alleged overpayments in this previously sealed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case.  The federal government and the remaining states declined to intervene on other additional theories in the relator&#8217;s complaint.  The Company is defending itself against all of the claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2017, the Company also received a subpoena from the California Department of Insurance requesting documents concerning the Company&#8217;s Omnicare pharmacies&#8217; cycle fill process for assisted living facilities. The Company has been cooperating with the California Department of Insurance and providing documents and information in response to this subpoena.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2016, the Company received a CID from the U.S. Attorney&#8217;s Office for the Northern District of New York requesting documents and information in connection with a federal False Claims Act investigation concerning whether the Company&#8217;s retail pharmacies improperly submitted certain insulin claims to Part D of the Medicare program rather than Part B of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Provider Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in purported class actions and individual lawsuits arising out of its practices related to the payment of claims for services rendered to its members by providers with whom the Company has a contract and with whom the Company does not have a contract (&#8220;out-of-network providers&#8221;). Among other things, these lawsuits allege that the Company paid too little to its health plan members and/or providers for out-of-network services (including COVID-19 testing) and/or otherwise allege that the Company failed to timely or appropriately pay or administer out-of-network claims and benefits (including the Company&#8217;s post payment audit and collection practices and reductions in payments to providers due to sequestration). Other major health insurers are the subject of similar litigation or have settled similar litigation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has received subpoenas and/or requests for documents and other information from, and been investigated by, state Attorneys General and other state and/or federal regulators, legislators and agencies relating to, and the Company is involved in other litigation regarding, its out-of-network benefit payment and administration practices. It is reasonably possible that others could initiate additional litigation or additional regulatory action against the Company with respect to its out-of-network benefit payment and/or administration practices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CMS Actions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS regularly audits the Company&#8217;s performance to determine its compliance with CMS&#8217;s regulations and its contracts with CMS and to assess the quality of services it provides to Medicare beneficiaries. CMS uses various payment mechanisms to allocate and adjust premium payments to the Company&#8217;s and other companies&#8217; Medicare plans by considering the applicable </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if27390578890494f98cfe9a77bbcecaf" continuedAt="ic69bbe1581024721af918ebd6ccb2d4f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">health status of Medicare members as supported by information prepared, maintained and provided by providers. The Company collects claim and encounter data from providers and generally relies on providers to appropriately code their submissions to the Company and document their medical records, including the diagnosis data submitted to the Company with claims. CMS pays increased premiums to Medicare Advantage plans and Medicare PDP plans for members who have certain medical conditions identified with specific diagnosis codes. Federal regulators review and audit the providers&#8217; medical records to determine whether those records support the related diagnosis codes that determine the members&#8217; health status and the resulting risk-adjusted premium payments to the Company. In that regard, CMS has instituted risk adjustment data validation (&#8220;RADV&#8221;) audits of various Medicare Advantage plans, including certain of the Company&#8217;s plans, to validate coding practices and supporting medical record documentation maintained by providers and the resulting risk-adjusted premium payments to the plans. CMS may require the Company to refund premium payments if the Company&#8217;s risk-adjusted premiums are not properly supported by medical record data. The Office of the Inspector General of the U.S. Department of Health and Human Services (&#8220;OIG&#8221;) also is auditing the Company&#8217;s risk adjustment-related data and that of other companies. The Company expects CMS and the OIG to continue these types of audits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2012, CMS revised its audit methodology for RADV audits to determine refunds payable by Medicare Advantage plans for contract year 2011 and forward. Under the revised methodology, among other things, CMS will extrapolate the error rate identified in the audit sample of approximately <ix:nonFraction unitRef="member" contextRef="if80d8dd79ebc4415ad936ec2eebc9a64_D20120101-20121231" decimals="-2" name="cvs:LossContingencyAuditMethodologySampleSize" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81OC9mcmFnOmFlY2ZhYmMwMzg4ODRmNzQ4OThiZWY1OTM5NmY4Y2NmL3RleHRyZWdpb246YWVjZmFiYzAzODg4NGY3NDg5OGJlZjU5Mzk2ZjhjY2ZfMTg4ODg_30497d15-108f-4529-b884-af0d0056c713">200</ix:nonFraction> members to all risk-adjusted premium payments made under the contract being audited. For contract years prior to 2011, CMS did not extrapolate sample error rates to the entire contract. As a result, the revised methodology may increase the Company&#8217;s exposure to premium refunds to CMS based on incomplete medical records maintained by providers. Since 2013, CMS has selected certain of the Company&#8217;s Medicare Advantage contracts for various contract years for RADV audit, and the number of RADV audits continues to increase. The Company is currently unable to predict which of its Medicare Advantage contracts will be selected for future audit, the amounts of any retroactive refunds of, or prospective adjustments to, Medicare Advantage premium payments made to the Company, the effect of any such refunds or adjustments on the actuarial soundness of the Company&#8217;s Medicare Advantage bids, or whether any RADV audit findings would require the Company to change its method of estimating future premium revenue in future bid submissions to CMS or compromise premium assumptions made in the Company&#8217;s bids for prior contract years, the current contract year or future contract years. Any premium or fee refunds or adjustments resulting from regulatory audits, whether as a result of RADV, Public Exchange related or other audits by CMS, the OIG or otherwise, including audits of the Company&#8217;s minimum medical loss ratio rebates, methodology and/or reports, could be material and could adversely affect the Company&#8217;s operating results, cash flows and/or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Medicare and Medicaid CIDs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has received CIDs from the Civil Division of the DOJ in connection with a current investigation of the Company&#8217;s patient chart review processes in connection with risk adjustment data submissions under Parts C and D of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to these CIDs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, the Company received a CID from the SDNY requesting documents and information concerning possible false claims submitted to Medicare in connection with reimbursements for prescription drugs under the Medicare Part D program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stockholder Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in February 2019, multiple class action complaints, as well as a derivative complaint, were filed by putative plaintiffs against the Company and certain current and former officers and directors. The plaintiffs in these cases assert a variety of causes of action under federal securities laws that are premised on allegations that the defendants made certain omissions and misrepresentations relating to the performance of the Company&#8217;s LTC business unit. The Company and its current and former officers and directors are defending themselves against these claims. Since filing, several of the cases have been consolidated, and the first-filed federal case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Miami Fire Fighters&#8217; and Police Officers&#8217; Retirement Trust, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anarkat</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), was dismissed with prejudice in February 2021. Plaintiffs have appealed that decision to the First Circuit after their motion for reconsideration was denied. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re CVS Health Corp. Securities Act Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Waterford</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re CVS Health Corp. Securities Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Warren</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Freundlich</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) have been stayed pending the outcome of the First Circuit appeal. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August and September 2020, <ix:nonFraction unitRef="claim" contextRef="ib401a332bf4543de8c13209d3b334652_I20200930" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81OC9mcmFnOmFlY2ZhYmMwMzg4ODRmNzQ4OThiZWY1OTM5NmY4Y2NmL3RleHRyZWdpb246YWVjZmFiYzAzODg4NGY3NDg5OGJlZjU5Mzk2ZjhjY2ZfMjI0NTA_7cf33a3a-4847-41da-bbc2-eb6d791c0b29">two</ix:nonFraction> class actions under the Employee Retirement Income Security Act of 1974 (&#8220;ERISA&#8221;)</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">were filed in the U.S. District Court for the District of Connecticut against CVS Health, Aetna Inc. (&#8220;Aetna&#8221;), and several current and former executives, directors and/or members of Aetna&#8217;s Compensation and Talent Management Committee: </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic69bbe1581024721af918ebd6ccb2d4f" continuedAt="id71ad4de3896488582941ae6c178efcf"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Radcliffe v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flaim v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. The plaintiffs in these cases assert a variety of causes of action premised on allegations that the defendants breached fiduciary duties and engaged in prohibited transactions relating to participants in the Aetna 401(k) Plan&#8217;s investment in company stock between December 3, 2017 and February 20, 2019, claiming losses related to the performance of the Company&#8217;s LTC business unit. The district court consolidated the actions, and in October 2021, dismissed the consolidated action without prejudice. Plaintiffs filed an amended consolidated complaint, which the Company has moved to dismiss. The Company also received a related document request pursuant to ERISA &#167; 104(b), to which the Company has responded. The Company and its current and former officers and directors are defending themselves against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company received a demand for inspection of books and records pursuant to Delaware Corporation Law Section 220 (the &#8220;Demand&#8221;). The Demand purports to be related to potential breaches of fiduciary duties by the Board in relation to certain matters concerning opioids.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Legal and Regulatory Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also a party to other legal proceedings and is subject to government investigations, inquiries and audits and has received and is cooperating with the government in response to CIDs, subpoenas or similar process from various governmental agencies requesting information. These other legal proceedings and government actions include claims of or relating to bad faith, medical or professional malpractice, breach of fiduciary duty, claims processing, dispensing of medications, non-compliance with state and federal regulatory regimes, marketing misconduct, denial of or failure to timely or appropriately pay or administer claims and benefits, provider network structure (including the use of performance-based networks and termination of provider contracts), rescission of insurance coverage, improper disclosure or use of personal information, anticompetitive practices, general contractual matters, product liability, intellectual property litigation and employment litigation. Some of these other legal proceedings are or are purported to be class actions or derivative claims. The Company is defending itself against the claims brought in these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards to the Company and others of certain government contracts, particularly Medicaid contracts and other contracts with government customers in the Company&#8217;s Health Care Benefits segment, frequently are subject to protests by unsuccessful bidders. These protests may result in awards to the Company being reversed, delayed or modified. The loss or delay in implementation of any government contract could adversely affect the Company&#8217;s operating results. The Company will continue to defend contract awards it receives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There also continues to be a heightened level of review and/or audit by regulatory authorities and legislators of, and increased litigation regarding, the Company&#8217;s and the rest of the health care and related benefits industry&#8217;s business and reporting practices, including premium rate increases, utilization management, development and application of medical policies, complaint, grievance and appeal processing, information privacy, provider network structure (including provider network adequacy, the use of performance-based networks and termination of provider contracts), provider directory accuracy, calculation of minimum medical loss ratios and/or payment of related rebates, delegated arrangements, rescission of insurance coverage, limited benefit health products, student health products, pharmacy benefit management practices (including manufacturers&#8217; rebates, pricing, the use of narrow networks and the placement of drugs in formulary tiers), sales practices, customer service practices, vendor oversight and claim payment practices (including payments to out-of-network providers).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a leading national health solutions company, the Company regularly is the subject of government actions of the types described above. These government actions may prevent or delay the Company from implementing planned premium rate increases and may result, and have resulted, in restrictions on the Company&#8217;s businesses, changes to or clarifications of the Company&#8217;s business practices, retroactive adjustments to premiums, refunds or other payments to members, beneficiaries, states or the federal government, withholding of premium payments to the Company by government agencies,&#160;assessments of damages, civil or criminal fines or penalties, or other sanctions, including the possible suspension or loss of licensure and/or suspension or exclusion from participation in government programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company can give no assurance that its businesses, financial condition, operating results and/or cash flows will not be materially adversely affected, or that the Company will not be required to materially change its business practices, based on: (i)&#160;future enactment of new health care or other laws or regulations; (ii)&#160;the interpretation or application of existing laws or regulations as they may relate to one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iii)&#160;pending or future federal or state government investigations of one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iv)&#160;pending or future government audits, investigations or enforcement actions against the Company; (v)&#160;adverse developments in any pending </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit against the Company, whether sealed or unsealed, or in any future </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><ix:continuation id="id71ad4de3896488582941ae6c178efcf"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit that may be filed against the Company; or (vi)&#160;adverse developments in pending or future legal proceedings against the Company or affecting one or more of the industries in which the Company competes and/or the health care industry generally.</span></ix:continuation></div><div><span><br/></span></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_61"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RleHRyZWdpb246OTBlMDJkZDRiODFjNGNiOTk3NGM2ODBmMTUxYzMzMDFfNDQ0MQ_f68bbf80-2549-40f6-ad4c-93e289a5ed91" continuedAt="i077f7d3c9e414ad284bbbba9a6d0afa2" escape="true">Segment Reporting</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i077f7d3c9e414ad284bbbba9a6d0afa2" continuedAt="i41d011945fb541639edf5a36a4539c00">The Company has <ix:nonFraction unitRef="segment" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RleHRyZWdpb246OTBlMDJkZDRiODFjNGNiOTk3NGM2ODBmMTUxYzMzMDFfNDE_49959d9f-3c39-47d0-83c3-1a3e248984f1">three</ix:nonFraction> operating segments, Health Care Benefits, Pharmacy Services and Retail/LTC, as well as a Corporate/Other segment. The Company&#8217;s segments maintain separate financial information, and the Company&#8217;s chief operating decision maker (the &#8220;CODM&#8221;) evaluates the segments&#8217; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#8217;s segments based on adjusted operating income, which is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#8217;s business nor reflect the Company&#8217;s underlying business performance. See the reconciliations of consolidated operating income (GAAP measure) to consolidated adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#8217;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP. </ix:continuation></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i41d011945fb541639edf5a36a4539c00" continuedAt="i83172d280f434725a2432e10f25e0cf4"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RleHRyZWdpb246OTBlMDJkZDRiODFjNGNiOTk3NGM2ODBmMTUxYzMzMDFfNDQ0OA_22dfae15-cc71-4a52-9259-b77885ddfed5" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of financial measures of the Company&#8217;s segments to the consolidated totals:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5045314d03040549992e1b0d350c6f4_D20220401-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMy0xLTEtMS0xMjE3OTc_97d3a4ce-8922-4f1d-b799-018aa8fb4355">22,645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61b1e59accbc4a6b9fdbbf4dd1e166d8_D20220401-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMy0zLTEtMS0xMjE3OTc_95c8d151-68d4-4d4a-9741-c9c1c31d5767">39,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i054a08a597154e34b91b50e36527b86c_D20220401-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMy01LTEtMS0xMjE3OTc_e4d00986-ab96-4b1a-83f5-8a9bc75b5af2">17,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a2e27009a64f7bb8e01545a97c8feb_D20220401-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMy03LTEtMS0xMjE3OTc_6ea85cac-eedd-4725-8e01-3f97fc814e7f">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMy0xMS0xLTEtMTIxNzk3_42bd8c5a-7a3c-4b58-a651-5b760eb542c7">80,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3962c203da554375b32683c47219d427_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNC0xLTEtMS0xMjE3OTc_2ade62fc-c5b6-4d42-8cd4-afd4e300c1d1">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2694c12478b4def9c47ecb3ea71da60_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNC0zLTEtMS0xMjE3OTc_830a9ed6-99a8-44e8-a10b-9ef4775cc549">2,953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id75c1b3a512c4c79892d583882a1967c_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNC01LTEtMS0xMjE3OTc_ba5a9676-a1e8-4fac-874f-086ed409470a">8,352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1040a72d0304a058af732ed3761a15a_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNC05LTEtMS0xMjE3OTc_5756750e-a66d-4039-bea4-b771b913e748">11,328</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5045314d03040549992e1b0d350c6f4_D20220401-20220630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNS0xLTEtMS0xMjE3OTc_f18f10ed-9d0b-49a8-a7f1-05f22d3466a8">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61b1e59accbc4a6b9fdbbf4dd1e166d8_D20220401-20220630" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNS0zLTEtMS0xMjE3OTc_76f3fb83-1e6d-4889-9e52-d3894172ca7b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i054a08a597154e34b91b50e36527b86c_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNS01LTEtMS0xMjE3OTc_be6be382-c22f-4905-9416-bfb7005a96a9">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a2e27009a64f7bb8e01545a97c8feb_D20220401-20220630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNS03LTEtMS0xMjE3OTc_744c454b-f9c5-45a8-84ad-aad79f69f38f">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1040a72d0304a058af732ed3761a15a_D20220401-20220630" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNS05LTEtMS0xMjE3OTc_e96d0d16-c015-49f9-9282-4a445144814d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNS0xMS0xLTEtMTIxNzk3_50378b8c-d0b1-4d1b-af84-784a9b68617e">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44edbe7ef7ad43448a3b2d7631217636_D20220401-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNi0xLTEtMS0xMjE3OTc_a1771858-7864-4f14-b849-65a10d466e78">22,756</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3151b5f7456a43f18c1835c93c3d75af_D20220401-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNi0zLTEtMS0xMjE3OTc_1fbd479c-31ec-41e0-a60f-051d5d2dec2f">42,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9187390af124c90962d0c6a2b195568_D20220401-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNi01LTEtMS0xMjE3OTc_3e641451-6228-4709-b38c-f22a955f3f0d">26,286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a2e27009a64f7bb8e01545a97c8feb_D20220401-20220630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNi03LTEtMS0xMjE3OTc_b19c5dd5-228b-4d5f-9b7b-304ba0fae445">110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1040a72d0304a058af732ed3761a15a_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNi05LTEtMS0xMjE3OTc_43c9d347-37e2-4c74-9353-0c8770ebdbb6">11,328</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNi0xMS0xLTEtMTIxNzk3_c3cddfa9-d691-4281-a5c5-9c47d07a8187">80,636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5045314d03040549992e1b0d350c6f4_D20220401-20220630" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNy0xLTEtMS0xMjE3OTc_741a0a57-fe72-4c85-8ae5-ed1d9f15528d">1,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61b1e59accbc4a6b9fdbbf4dd1e166d8_D20220401-20220630" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNy0zLTEtMS0xMjE3OTc_cbdd45a8-355d-42a6-9db6-5d2db3d6a17a">1,855</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i054a08a597154e34b91b50e36527b86c_D20220401-20220630" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNy01LTEtMS0xMjE3OTc_d82cf5cf-87de-423b-a374-1a12ada5abc2">1,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02a2e27009a64f7bb8e01545a97c8feb_D20220401-20220630" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNy03LTEtMS0xMjE3OTc_33529953-adbd-43b2-af54-3f55b9fe8fb6">555</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1040a72d0304a058af732ed3761a15a_D20220401-20220630" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNy05LTEtMS0xMjE3OTc_48893e07-532f-4874-8b4f-e4b87cb7a1ed">183</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNy0xMS0xLTEtMTIxNzk3_4df2f5d1-bc02-4416-a8df-f5423a71ca92">4,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24217ba0c74626b4bf25cec318c623_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTAtMS0xLTEtMTIxNzk3_b03fca31-871b-4e7c-a7eb-3d7bb6027800">20,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if86bb61e4141479b9697828b3dc20cc6_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTAtMy0xLTEtMTIxNzk3_facef4db-f85f-4a55-99b6-55e411141f81">35,745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44e989a3ada405d8425fbe65629dc23_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTAtNS0xLTEtMTIxNzk3_69277aff-feb7-40db-9d77-512e8fc0945c">16,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa7e9e824974440a9373bee9896bb39_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTAtNy0xLTEtMTIxNzk3_0dd8ad75-cafc-4156-bb17-a6effe6898a3">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTAtMTEtMS0xLTEyMTc5Nw_da40b270-7c26-4173-8dae-9353c51e901d">72,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd5001431c3443ff88087eb017ad54d3_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTEtMS0xLTEtMTIxNzk3_6b11ecef-5475-4c96-a3e1-8424230515d5">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21057757e50f4f2ea39ea7414498d440_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTEtMy0xLTEtMTIxNzk3_801ff96d-39cd-4bce-b70b-cd3054dcfc57">2,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4ddbdc32c264c4891a21d2f9fcead1d_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTEtNS0xLTEtMTIxNzk3_81a60a9b-d5cd-4af8-894b-233776951801">8,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4922155132bd45ada7189d0b3ef9fc3e_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTEtOS0xLTEtMTIxNzk3_bf27ca8a-fb68-4188-8bf6-884ecc2413d1">11,133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24217ba0c74626b4bf25cec318c623_D20210401-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTItMS0xLTEtMTIxNzk3_e14f0a89-c8ef-406f-8764-302d27316631">137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if86bb61e4141479b9697828b3dc20cc6_D20210401-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTItMy0xLTEtMTIxNzk3_de653d12-cb14-4954-a5d9-ef47ff913c8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44e989a3ada405d8425fbe65629dc23_D20210401-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTItNS0xLTEtMTIxNzk3_9626702d-2eb6-4bfc-b87c-2df6b43ecd42">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa7e9e824974440a9373bee9896bb39_D20210401-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTItNy0xLTEtMTIxNzk3_4f3b693f-d0a8-424b-b0f6-0960fc9f78f3">152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4922155132bd45ada7189d0b3ef9fc3e_D20210401-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTItOS0xLTEtMTIxNzk3_7743df0a-9576-4b4d-9f37-d4804bea7f81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTItMTEtMS0xLTEyMTc5Nw_36502afb-f958-4701-9722-3f0b7416f66a">289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i755c9c59fb084cf0998fe64e0d197ec9_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTMtMS0xLTEtMTIxNzk3_0bf01886-7861-4463-b217-1acbb0d51b16">20,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i991ced4046224c589a965f12944e86a9_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTMtMy0xLTEtMTIxNzk3_1beb055b-23b6-4838-8a72-68cd422a3ed7">38,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id55fb76a33f24129b20ebde108e75c89_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTMtNS0xLTEtMTIxNzk3_0cd65d73-a2e3-4707-97ee-9447a4d9ccf5">24,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa7e9e824974440a9373bee9896bb39_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTMtNy0xLTEtMTIxNzk3_162163f6-a637-4015-b29e-eeddd21c901a">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4922155132bd45ada7189d0b3ef9fc3e_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTMtOS0xLTEtMTIxNzk3_aa7c92e4-851e-4e66-bb28-9e18d0f65884">11,133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTMtMTEtMS0xLTEyMTc5Nw_065e31bf-fa6d-445b-93bd-5ecadfd05818">72,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac24217ba0c74626b4bf25cec318c623_D20210401-20210630" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTQtMS0xLTEtMTIxNzk3_a0ffc4b1-85b8-45f3-8311-2f1deaaa3f77">1,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if86bb61e4141479b9697828b3dc20cc6_D20210401-20210630" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTQtMy0xLTEtMTIxNzk3_3596e494-d8fc-420c-9d12-7566f6b4583b">1,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44e989a3ada405d8425fbe65629dc23_D20210401-20210630" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTQtNS0xLTEtMTIxNzk3_0a0030a0-1e69-4516-90c6-f4b95e36670e">2,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fa7e9e824974440a9373bee9896bb39_D20210401-20210630" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTQtNy0xLTEtMTIxNzk3_1ec86406-22f7-4476-ba2d-1231edae716c">369</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4922155132bd45ada7189d0b3ef9fc3e_D20210401-20210630" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTQtOS0xLTEtMTIxNzk3_7b14b470-264a-4a0e-85ac-81c05b1b8286">162</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTQtMTEtMS0xLTEyMTc5Nw_5a131d51-d833-432a-8b21-ebe5de6abb14">4,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia17daf1ddb80489bbdce4d94932efa21_D20220101-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTgtMS0xLTEtMTIxNzk3_d668d659-f42d-4c56-908f-419852d847a7">45,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib89fad02b4b74e5cbffe8ec18de4bc64_D20220101-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTgtMy0xLTEtMTIxNzk3_b7fb0972-f462-4285-a271-661577183d89">76,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88782d759ab24dbd8db24d6e19ba64de_D20220101-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTgtNS0xLTEtMTIxNzk3_8c3f79f0-1aef-44d5-9a4c-0b147d2fe501">35,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8feac348d42b418da086e65a9b0801eb_D20220101-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTgtNy0xLTEtMTIxNzk3_90b85ddf-242f-420f-881e-6cb5960d834e">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTgtMTEtMS0xLTEyMTc5Nw_acfe7a16-28a6-4b71-b884-c6e197bec38a">157,148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdb38f213f74f5ba49000631d9615b7_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTktMS0xLTEtMTIxNzk3_71eb2225-990c-45c7-8351-13aa720503ba">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28d06c947ab54421a9e15efa5f456726_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTktMy0xLTEtMTIxNzk3_d3f9d30b-a5fe-4804-83c7-cf54754be0f1">6,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf6b44713106481ab0b80236ef727531_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTktNS0xLTEtMTIxNzk3_a6c84a67-bf09-485f-be57-e19c1a850fd8">16,352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b2e6ca6c94b4ad5afd1d4f01f87431e_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTktOS0xLTEtMTIxNzk3_f3c4d6d5-ec55-4275-8cb2-d9eb4accf003">22,616</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia17daf1ddb80489bbdce4d94932efa21_D20220101-20220630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjAtMS0xLTEtMTIxNzk3_350c86a6-ec38-4c36-bc2e-e3e7065a9dea">177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib89fad02b4b74e5cbffe8ec18de4bc64_D20220101-20220630" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjAtMy0xLTEtMTIxNzk3_068a07af-92ea-4118-bfec-c56805a153ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88782d759ab24dbd8db24d6e19ba64de_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjAtNS0xLTEtMTIxNzk3_6d12b180-0399-4c0f-ae58-73aea321ef0b">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8feac348d42b418da086e65a9b0801eb_D20220101-20220630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjAtNy0xLTEtMTIxNzk3_78897e49-3cc8-47f7-a36d-dd0b6ffe506a">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b2e6ca6c94b4ad5afd1d4f01f87431e_D20220101-20220630" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjAtOS0xLTEtMTIxNzk3_af2b02c7-0ac8-458d-a194-41d78a61fc2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjAtMTEtMS0xLTEyMTc5Nw_be07941a-c8de-473c-b4f0-27dbd4d791b3">314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c0bcd0eebfa40769648a67be75183aa_D20220101-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjEtMS0xLTEtMTIxNzk3_1fe2db1b-6714-4731-86bd-3a593513e214">45,865</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ec2e1d871b94a40bc8202c2e78c4a16_D20220101-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjEtMy0xLTEtMTIxNzk3_86e7fa9b-5d14-406c-9a64-20dbf9e92fab">82,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0f6137335b9496e89f147de3d2c0b66_D20220101-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjEtNS0xLTEtMTIxNzk3_4aa0ccd4-a2ee-4f0d-ba19-9478180721d2">51,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8feac348d42b418da086e65a9b0801eb_D20220101-20220630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjEtNy0xLTEtMTIxNzk3_8317bfb2-82f0-409c-86c3-dd128ade6f57">236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b2e6ca6c94b4ad5afd1d4f01f87431e_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjEtOS0xLTEtMTIxNzk3_a24fbed6-3e52-4ce4-9fc1-5afd43764ca1">22,616</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjEtMTEtMS0xLTEyMTc5Nw_5c108b73-4c32-4ccd-8f7b-d763a64c422d">157,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia17daf1ddb80489bbdce4d94932efa21_D20220101-20220630" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjItMS0xLTEtMTIxNzk3_ed3ed027-23e3-411c-b49a-a0fd30ce2189">3,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib89fad02b4b74e5cbffe8ec18de4bc64_D20220101-20220630" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjItMy0xLTEtMTIxNzk3_a8abaa5e-5ba9-4909-9589-03c9e0fec407">3,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88782d759ab24dbd8db24d6e19ba64de_D20220101-20220630" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjItNS0xLTEtMTIxNzk3_b66729e7-330f-4876-b194-d68f91c4e547">3,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8feac348d42b418da086e65a9b0801eb_D20220101-20220630" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjItNy0xLTEtMTIxNzk3_b133ac2a-ea60-4118-af80-bbce82561860">860</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b2e6ca6c94b4ad5afd1d4f01f87431e_D20220101-20220630" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjItOS0xLTEtMTIxNzk3_59531d42-8bbd-4867-bc1c-cf0587be1f7a">387</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjItMTEtMS0xLTEyMTc5Nw_69e5f6c1-6f69-4fb1-a786-bf4d8e959631">9,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65583ca6502143fea8109266db45d395_D20210101-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjUtMS0xLTEtMTIxNzk3_386a5810-853d-4d44-ab6d-494eb7726cff">40,682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfa2cea5de8e43f9ba651607d9a10c30_D20210101-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjUtMy0xLTEtMTIxNzk3_1c70ffab-8b31-4764-87a9-6acecc0470b4">69,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1d59b798de8427bb69d0f7d325309b7_D20210101-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjUtNS0xLTEtMTIxNzk3_08530487-ae09-49f8-983c-9ae1e7c748ed">31,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec432ef32c864c91b9106f3307398132_D20210101-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjUtNy0xLTEtMTIxNzk3_50ba7339-6fa1-4e70-a6b9-da28d8851ef0">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjUtMTEtMS0xLTEyMTc5Nw_ebcf58a7-9135-43eb-84d4-96604e32807f">141,127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3203c39f39494e9b94ddb12984f8082f_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjYtMS0xLTEtMTIxNzk3_f9fcc1f6-7942-48f8-8271-08bf051e2d89">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4392ff7352894adabc22a650b7c08adb_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjYtMy0xLTEtMTIxNzk3_e3b23a6c-7527-4b12-a520-f14f82bf622e">5,577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea76a931684f4ae5b894d9b3eac6dabf_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjYtNS0xLTEtMTIxNzk3_87d62934-a267-40f4-a841-be648a69e3b5">16,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bb38325fd294ffcb76280c930132208_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjYtOS0xLTEtMTIxNzk3_a6e4345e-fbc2-4728-988b-1dfa947a153b">22,249</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65583ca6502143fea8109266db45d395_D20210101-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjctMS0xLTEtMTIxNzk3_26f647ae-9f32-41f3-8189-9d609ed58ec4">285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfa2cea5de8e43f9ba651607d9a10c30_D20210101-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjctMy0xLTEtMTIxNzk3_2bd9bca2-56e8-490d-b9af-c3ee7314ba51">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1d59b798de8427bb69d0f7d325309b7_D20210101-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjctNS0xLTEtMTIxNzk3_2080805e-e48a-4343-bd74-e0da788dbb92">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec432ef32c864c91b9106f3307398132_D20210101-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjctNy0xLTEtMTIxNzk3_00270083-6e25-45d0-9e0d-6303bb1c272c">255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bb38325fd294ffcb76280c930132208_D20210101-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjctOS0xLTEtMTIxNzk3_a37dd88e-5ac4-45cd-a06a-20415c701be2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjctMTEtMS0xLTEyMTc5Nw_124ab4da-081a-4c6d-accf-5c48be5d4eb1">586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i856f8df36f55432cba11d2c1b2e7ba4e_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjgtMS0xLTEtMTIxNzk3_e7a5bccc-17c6-47ed-b9f8-63185cfeb09e">41,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i904838b1ae43477cbccf8a6438f44ca8_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjgtMy0xLTEtMTIxNzk3_e7e23507-eebc-41c7-8a9b-094cd0494e9a">74,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e5cd64cbc2d4ccabb220d0769a9469d_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjgtNS0xLTEtMTIxNzk3_bc366b1d-bef9-4297-b2e5-97052427a963">48,002</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec432ef32c864c91b9106f3307398132_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjgtNy0xLTEtMTIxNzk3_7b0389e7-d575-4ac0-a85f-fc5ea5818b1f">317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bb38325fd294ffcb76280c930132208_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjgtOS0xLTEtMTIxNzk3_5faf80c5-973c-4eef-84eb-cf54e4a7cbe6">22,249</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjgtMTEtMS0xLTEyMTc5Nw_d4eaa068-d583-4961-afaf-4399dc61859f">141,713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65583ca6502143fea8109266db45d395_D20210101-20210630" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjktMS0xLTEtMTIxNzk3_c76716e4-b71a-4651-bf3b-b7735d653c52">3,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfa2cea5de8e43f9ba651607d9a10c30_D20210101-20210630" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjktMy0xLTEtMTIxNzk3_f72ab61b-afe5-47bb-aeb8-b773f9789a0c">3,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1d59b798de8427bb69d0f7d325309b7_D20210101-20210630" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjktNS0xLTEtMTIxNzk3_94c79ca9-9213-477e-9aec-2bf1c75dbcf0">3,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec432ef32c864c91b9106f3307398132_D20210101-20210630" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjktNy0xLTEtMTIxNzk3_c5bafb2a-f2d3-41c2-bb67-049a1bc6796e">672</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bb38325fd294ffcb76280c930132208_D20210101-20210630" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjktOS0xLTEtMTIxNzk3_c53b35f2-3bca-43db-ac93-b19938185245">337</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjktMTEtMS0xLTEyMTc5Nw_c53f07af-94fa-4053-b7e2-fd302747acf8">9,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total revenues of the Pharmacy Services segment include approximately $<ix:nonFraction unitRef="usd" contextRef="i61b1e59accbc4a6b9fdbbf4dd1e166d8_D20220401-20220630" decimals="-8" name="cvs:NetRevenuesRetailCoPayments" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RleHRyZWdpb246OTBlMDJkZDRiODFjNGNiOTk3NGM2ODBmMTUxYzMzMDFfMTczOA_b5135ee5-9ae7-40b9-82ac-1ea9941e60ed">3.1</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="if86bb61e4141479b9697828b3dc20cc6_D20210401-20210630" decimals="-8" name="cvs:NetRevenuesRetailCoPayments" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RleHRyZWdpb246OTBlMDJkZDRiODFjNGNiOTk3NGM2ODBmMTUxYzMzMDFfMTc0NQ_2a9e937b-a0e9-4192-b08b-5d56d67442f0">2.8</ix:nonFraction> billion of retail co-payments for the three months ended  June&#160;30, 2022 and 2021, respectively, and $<ix:nonFraction unitRef="usd" contextRef="ib89fad02b4b74e5cbffe8ec18de4bc64_D20220101-20220630" decimals="-8" name="cvs:NetRevenuesRetailCoPayments" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RleHRyZWdpb246OTBlMDJkZDRiODFjNGNiOTk3NGM2ODBmMTUxYzMzMDFfMTA5OTUxMTYzMjMxMQ_fac203fe-ed4e-4cba-933f-7a29c195752c">6.9</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ibfa2cea5de8e43f9ba651607d9a10c30_D20210101-20210630" decimals="-8" name="cvs:NetRevenuesRetailCoPayments" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RleHRyZWdpb246OTBlMDJkZDRiODFjNGNiOTk3NGM2ODBmMTUxYzMzMDFfMTA5OTUxMTYzMjMxOQ_befef6c1-dfb2-4d55-a79f-c42d60e23c5e">6.2</ix:nonFraction> billion of retail co-payments for the six months ended June&#160;30, 2022 and 2021, respectively.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Pharmacy Services segment, and/or the Retail/LTC segment. Intersegment adjusted operating income eliminations occur when members of Pharmacy Services Segment clients (&#8220;PSS members&#8221;) enrolled in Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> elect to pick up maintenance prescriptions at one of the Company&#8217;s retail pharmacies instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail/LTC segments record the adjusted operating income on a stand-alone basis.</span></div></ix:nonNumeric></ix:continuation><div style="padding-left:18pt"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i83172d280f434725a2432e10f25e0cf4" continuedAt="ie765f68113aa49f09383395747fad82a"><ix:nonNumeric contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" name="cvs:ReconciliationOfOperatingIncomeToAdjustedOperatingIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RleHRyZWdpb246OTBlMDJkZDRiODFjNGNiOTk3NGM2ODBmMTUxYzMzMDFfNDQzOA_f3d4c572-0689-41a0-bca3-acc2303b9e04" continuedAt="i5e491040539545fc9f4c4603f507ef7a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are reconciliations of consolidated operating income to adjusted operating income for the three and six months ended June&#160;30, 2022 and 2021:</span></div><div style="margin-bottom:0.3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfMi0xLTEtMS0xMjE3OTc_da982265-9d85-4055-9264-b61c44f6ccb9">4,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfMi0zLTEtMS0xMjE3OTc_b1820df7-684a-4403-aecd-78e7526ff1a7">4,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfMi01LTEtMS0xMjE3OTc_c0982b61-fc24-474a-987b-76846326d855">8,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfMi03LTEtMS0xMjE3OTc_38d0b4b1-1370-4e0e-af64-5f9a3a25b5a9">7,903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfMy0xLTEtMS0xMjE3OTc_0abd2c70-8d42-4bbf-a6ba-92e855f20879">466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfMy0zLTEtMS0xMjE3OTc_a59a8903-89d7-4c47-a414-a1ba52fe49af">582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfMy01LTEtMS0xMjE3OTc_617d5f6a-8619-480a-9289-f6a27df91f24">934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfMy03LTEtMS0xMjE3OTc_aa350532-c30a-4b5d-ae7c-92ce2bd940e3">1,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on divestiture of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNC0xLTEtMS0xMzY0NzU_4f1ac19a-b7dd-4e30-8556-688e5d32d96e">225</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNC0zLTEtMS0xMzY0Nzk_9e7999a2-e9d3-442d-88e8-9dacac6e2855">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNC01LTEtMS0xMzY0ODI_2c706547-7404-4716-b1c4-f767e991a455">225</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNC03LTEtMS0xMzY0ODY_37e40bcf-d605-4f44-bcd7-fe333bdd7bff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal settlement </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNC0xLTEtMS0xMjE3OTc_55dfff34-800f-4a7f-b077-c8f722ea0e2b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNC0zLTEtMS0xMjE3OTc_c05390b2-2a1f-4e6c-94ec-2c2b19f8d9ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNC01LTEtMS0xMjgyMDY_567a52e0-37b6-4ef4-a674-f683212ef4da">484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNC03LTEtMS0xMjk3Nzk_0c83104b-d79c-4b1f-9407-6601768ba42b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on assets held for sale </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNS0xLTEtMS0xMjE3OTc_916b7048-3757-4c6c-9238-48c5a412a36d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNS0zLTEtMS0xMjE3OTc_c0766bae-0567-486f-91b2-0e071247dfe5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNS01LTEtMS0xMjgyMDY_9241bbd9-df99-4f3f-9682-55a785b53786">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNS03LTEtMS0xMjk3Nzk_4c79060b-0eda-4113-992d-360b0c074c84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNi0xLTEtMS0xMjE3OTc_1e18ead1-f1cf-4b98-a18c-cb128803a652">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNi0zLTEtMS0xMjE3OTc_be8bd7e5-725e-4d92-87d9-54f4f90f2e25">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNi01LTEtMS0xMjE3OTc_664b6dac-3638-4d42-b934-a6f909ee14d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNi03LTEtMS0xMjE3OTc_049ac38d-b57b-427d-a44b-229a6cb97b45">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition purchase price adjustment outside of measurement period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNy0xLTEtMS0xMjE3OTc_42d88774-9a14-4cad-af29-42d41bf26602">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNy0zLTEtMS0xMjE3OTc_9534771a-8267-48d9-812f-edeee25290d5">61</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNy01LTEtMS0xMjE3OTc_5efc79e1-b163-43bf-9b46-d99cc5dba4f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNy03LTEtMS0xMjE3OTc_27280840-a340-48cc-a5a6-bef2ab529a68">61</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfMTAtMS0xLTEtMTIxNzk3_4df2f5d1-bc02-4416-a8df-f5423a71ca92">4,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfMTAtMy0xLTEtMTIxNzk3_5a131d51-d833-432a-8b21-ebe5de6abb14">4,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfMTAtNS0xLTEtMTIxNzk3_69e5f6c1-6f69-4fb1-a786-bf4d8e959631">9,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfMTAtNy0xLTEtMTIxNzk3_c53f07af-94fa-4053-b7e2-fd302747acf8">9,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the unaudited condensed consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three and six months ended June&#160;30, 2022, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of PayFlex, which the Company sold on June 1, 2022, for approximately $<ix:nonFraction unitRef="usd" contextRef="id743f37942444621831b2935b6d1e18a_D20220601-20220601" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RleHRyZWdpb246OTBlMDJkZDRiODFjNGNiOTk3NGM2ODBmMTUxYzMzMDFfMzg0ODI5MDcwNDExMA_08ace08c-0227-4f9e-a997-524b0c80c69b">775</ix:nonFraction>&#160;million. The gain on divestiture is reflected as a reduction in operating expenses in the Company&#8217;s unaudited condensed consolidated statements of operations within the Health Care Benefits segment.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the six months ended June&#160;30, 2022, the legal settlement relates to the agreement with the State of Florida, entered into in March 2022, to resolve claims dating back more than a decade related to opioid medications. Under this agreement, CVS Health Corporation settled all opioid claims against it and its subsidiaries by the State of Florida for $<ix:nonFraction unitRef="usd" contextRef="i2e0586238be64c3f99884eb8d13d76cb_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RleHRyZWdpb246OTBlMDJkZDRiODFjNGNiOTk3NGM2ODBmMTUxYzMzMDFfMzg0ODI5MDcwNTAwMQ_bbf98490-c167-4415-bd08-5843de85cec0">484</ix:nonFraction>&#160;million, inclusive of certain legal fees, to be paid over a period of <ix:nonNumeric contextRef="i8e046c9547cf4bf5b7545f9f74ee27f1_I20220630" name="cvs:LegalSettlementPeriodOfPayment" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RleHRyZWdpb246OTBlMDJkZDRiODFjNGNiOTk3NGM2ODBmMTUxYzMzMDFfMzAyNw_9058d580-7a3e-44ca-97da-c7b9d0dde6cc">18</ix:nonNumeric> years. The legal settlement is reflected in the unaudited condensed consolidated statement of operations in operating expenses within the Corporate/Other segment.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the six months ended June&#160;30, 2022, the loss on assets held for sale relates to the Commercial Business reporting unit within the Health Care Benefits segment. In March 2022, the Company reached an agreement to sell its Thailand business, which was included in the Commercial Business reporting unit. At that time, a portion of the Commercial Business goodwill was specifically allocated to the Thailand business. The net assets of the Thailand business were accounted for as assets held for sale at March 31, 2022. The carrying value of the Thailand business was determined to be greater than its fair value and a loss on assets held for sale was recorded during the first quarter of 2022. The sale closed in the second quarter of 2022, and the ultimate loss on the sale was not material. The loss on assets held for sale is reflected in the unaudited condensed consolidated statement of operations in operating expenses within the Health Care Benefits segment.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three and six months ended June&#160;30, 2021, acquisition-related integration costs relate to the acquisition of Aetna. The acquisition-related integration costs are reflected in the unaudited condensed consolidated statements of operations in operating expenses within the Corporate/Other segment. </span></div></ix:nonNumeric></ix:continuation><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="ie765f68113aa49f09383395747fad82a" continuedAt="ibffc3e7f0510493f8092ca4377601d86"><ix:continuation id="i5e491040539545fc9f4c4603f507ef7a" continuedAt="i63f8655ab26f42f2b8189d325d711510">(6)</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="ibffc3e7f0510493f8092ca4377601d86"><ix:continuation id="i63f8655ab26f42f2b8189d325d711510">In June 2021, the Company received $<ix:nonFraction unitRef="usd" contextRef="if9b86cad51db4e70bd972f1f3cf0a9ea_D20210601-20210630" decimals="-6" name="cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RleHRyZWdpb246OTBlMDJkZDRiODFjNGNiOTk3NGM2ODBmMTUxYzMzMDFfMzg0ODI5MDcwNDk4Mg_d5112f56-5e7a-4320-8d82-00f693d05cb5">61</ix:nonFraction> million related to a purchase price working capital adjustment for an acquisition completed during the first quarter of 2020. The resolution of this matter occurred subsequent to the acquisition accounting measurement period and is reflected in the Company&#8217;s unaudited condensed consolidated statements of operations for the three and six months ended June&#160;30, 2021 as a reduction of operating expenses within the Health Care Benefits segment.</ix:continuation></ix:continuation> </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_70"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of CVS Health Corporation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Review of Interim Financial Statements</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reviewed the accompanying condensed consolidated balance sheet of CVS Health Corporation (the Company) as of June&#160;30, 2022, the related condensed consolidated statements of operations and comprehensive income for the three-month and six-month periods ended June&#160;30, 2022 and 2021, the related condensed consolidated statements of shareholders&#8217; equity for the three-month periods ended March&#160;31, 2022 and 2021 and June&#160;30, 2022 and 2021, the related condensed consolidated statements of cash flows for the six-month periods ended June&#160;30, 2022 and 2021, and the related notes (collectively referred to as the &#8220;condensed consolidated interim financial statements&#8221;). Based on our reviews, we are not aware of any material modifications that should be made to the condensed consolidated interim financial statements for them to be in conformity with U.S. generally accepted accounting principles.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheet of the Company as of December&#160;31, 2021,  the related consolidated statements of operations, comprehensive income, shareholders&#8217; equity and cash flows for the year then ended, and the related notes (not presented herein); and in our report dated February 9, 2022, we expressed an unqualified audit opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December&#160;31, 2021, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Review Results</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company&#8217;s management. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the SEC and the PCAOB. We conducted our review in accordance with the standards of the PCAOB. A review of interim financial statements consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Ernst &amp; Young LLP</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston, Massachusetts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">August&#160;3, 2022</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_73"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_7">Form 10-Q Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (&#8220;MD&amp;A&#8221;)</span></div><div><span><br/></span></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_76"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation, together with its subsidiaries (collectively, &#8220;CVS Health,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our&#8221; or &#8220;us&#8221;), is a diversified health solutions company united around a common purpose of helping people on their path to better health. In an increasingly connected and digital world, we are meeting people wherever they are and changing health care to meet their needs. The Company has more than 9,000 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with over 110 million plan members with expanding specialty pharmacy solutions and a dedicated senior pharmacy care business serving more than one million patients per year. The Company also serves an estimated 35 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#8220;PDP&#8221;). The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has four reportable segments: Health Care Benefits, Pharmacy Services, Retail/LTC and Corporate/Other, which are described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of the Health Care Benefits Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment operates as one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services, and health information technology products and services. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221; In addition, effective January 2022, the Company entered the individual public health insurance exchanges (&#8220;Public Exchanges&#8221;) in eight states through which it sells Insured plans directly to individual consumers. The Company has submitted regulatory filings to remain on the Public Exchanges in 2023 in each of those eight states, and has submitted regulatory filings to enter the Public Exchanges in four additional states effective January 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Overview of the Pharmacy Services Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment provides a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services and mail order pharmacy. In addition, through the Pharmacy Services segment, the Company provides specialty pharmacy and infusion services, clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#8220;Covered Entities&#8221;). The Company operates a group purchasing organization that negotiates pricing for the purchase of pharmaceuticals and rebates with pharmaceutical manufacturers on behalf of its participants. The Company also provides various administrative, management and reporting services to pharmaceutical manufacturers. The Pharmacy Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on Public Exchanges and private health insurance exchanges, other sponsors of health benefit plans throughout the United States and Covered Entities. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of the Retail/LTC Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, coronavirus disease 2019 (&#8220;COVID-19&#8221;) and shingles and conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of June&#160;30, 2022, the Retail/LTC </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">segment operated more than 9,000 retail locations, more than 1,100 MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">locations as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of the Corporate/Other Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of Current Trends</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also face trends and uncertainties specific to our reportable segments, certain of which are summarized below and also discussed in the review of our segment results. For the remainder of the year, the Company believes you should consider the following important information:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Health Care Benefits segment is expected to continue to benefit from Medicare and Commercial membership growth, partially offset by the impact of the International Health Care Benefits Renewal Rights Asset sale as described in Note 2 &#8216;&#8216;Divestitures and Asset Sales&#8217;&#8217; to the unaudited condensed consolidated financial statements. We now expect the public health emergency to extend through the end of fiscal year 2022. The projected MBR is expected to decrease compared to 2021, reflecting pricing and a reduction in COVID-19 related medical costs. While the Company still expects a net negative impact from COVID-19 in 2022 within the Health Care Benefits segment, including the impact of the assumption that a fourth COVID-19 booster will be administered to adults aged 50 and older and to certain immunocompromised individuals as per the guidelines set forth by the CDC, the expectation is the impact will be less adverse than what was experienced in 2021. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Pharmacy Services segment is expected to continue to benefit from the Company&#8217;s ability to drive further improvements in purchasing economics and strong pharmacy network volume. These increases are expected to be partially offset by continued client price improvements, decreased contributions from pharmacy and/or other administrative services for Covered Entities and regulation of pharmacy pricing.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Retail/LTC segment is expected to continue to benefit from increased prescription volume and improved generic drug purchasing, partially offset by continued pharmacy reimbursement pressure and incremental operating expenses associated with the Company&#8217;s minimum wage investment. As noted above, the Company now expects the public health emergency to extend through the end of fiscal year 2022. The Company expects that COVID-19 vaccinations, including the impact of the assumption of a fourth COVID-19 booster as described above, and diagnostic testing will continue in 2022, albeit at lower levels than those experienced during 2021. The Company expects to see continued strength in front store sales, including sales of over-the-counter (&#8220;OTC&#8221;) test kits, in 2022. The extent of COVID-19 vaccinations, diagnostic testing and OTC test kit sales will be dependent upon various factors including vaccine hesitancy, the emergence of new variants, government testing initiatives and the availability and administration of pediatric and booster vaccinations.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company is expected to benefit from the continuation of its enterprise-wide cost savings initiatives, which aim to reduce the Company&#8217;s operating cost structure in a way that improves the consumer experience and is sustainable. Key drivers include:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Investments in digital, technology and analytics capabilities that will streamline processes and improve outcomes,  </span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Implementing workforce and workplace strategies, and</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Deploying vendor and procurement strategies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company expects changes to its business environment to continue as elected and other government officials at the national and state levels continue to propose and enact significant modifications to public policy and existing laws and regulations that govern or impact the Company&#8217;s businesses.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The COVID-19 pandemic continues to impact the economies of the U.S. and other countries around the world. The Company believes COVID-19&#8217;s impact on its businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic, as well as the pandemic&#8217;s impact on the U.S. and global economies, global supply chain, consumer behavior, and health care utilization patterns. In addition, as described in the &#8220;Government Regulation&#8221; section of the Company&#8217;s Annual Report on Form 10-K for the year ended </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2021 (the &#8220;2021 Form 10-K&#8221;), federal, state and local governmental policies and initiatives designed to reduce the transmission of COVID-19 and emerging new variants may not effectively combat the severity and/or duration of the COVID-19 pandemic, and have resulted in a myriad of impacts on the Company&#8217;s businesses. Those primary drivers are beyond the Company&#8217;s knowledge and control. As a result, the impact COVID-19 will have on the Company&#8217;s businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s current expectations described above are forward-looking statements. Please see the &#8220;Cautionary Statement Concerning Forward-Looking Statements&#8221; in this Form 10-Q for information regarding important factors that may cause the Company&#8217;s actual results to differ from those currently projected and/or otherwise materially affect the Company.</span></div><div><span><br/></span></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_79"></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Results</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion explains the material changes in the Company&#8217;s operating results for the three and six months ended June&#160;30, 2022 and 2021, and the significant developments affecting the Company&#8217;s financial condition since December&#160;31, 2021. We strongly recommend that you read our audited consolidated financial statements and notes thereto and Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, which are included in the 2021 Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Consolidated Financial Results</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.265%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,<br/>2022 vs 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,<br/>2022 vs 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">56,794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">50,525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">109,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">97,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">18,983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">42,891&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">37,943&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,948&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(383)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(331)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(49.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(272)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(46.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">80,636&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">72,616&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">157,462&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,713&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,020&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15,749&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">43,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">94,799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">84,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">31,605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,952&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">76,067&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">68,290&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">149,403&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">133,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,777&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15,593&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,569&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,326&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,059&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,903&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(124)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(9.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(95)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income tax provision</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,029&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,735&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,975&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,705&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">944&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,690&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,961&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,791&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,274&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,015&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(25.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(22.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,951&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,783&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,263&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,006&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Three Months Ended June&#160;30, 2022 vs. 2021 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $8.0 billion, or 11.0%, in the three months ended June&#160;30, 2022 compared to the prior year driven by growth across all segments. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this report for additional information about the revenues of the Company&#8217;s segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses increased $302 million, or 3.4%, in the three months ended June&#160;30, 2022 compared to the prior year. The increase in operating expenses was primarily due to incremental costs associated with growth in the business and the absence of the $137&#160;million gain from an anti-trust legal settlement, of which $125&#160;million was included in the Retail/LTC segment and $12&#160;million was included in the Pharmacy Services segment, recorded in the three months ended June&#160;30, 2021. These increases were partially offset by a $225 million pre-tax gain on the sale of PayFlex Holdings, Inc. (&#8220;PayFlex&#8221;), which was consummated on June 1, 2022.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues were 11.4% in the three months ended June&#160;30, 2022, a decrease of 80 basis points compared to the prior year. The decrease in operating expenses as a percentage of total revenues was primarily due to the increases in total revenues described above.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this report for additional information about the operating expenses of the Company&#8217;s segments.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating income increased $243 million, or 5.6%, in the three months ended June&#160;30, 2022 compared to the prior year primarily due to increases in the Health Care Benefits segment, including the $225 million pre-tax gain on the sale of PayFlex and a decrease in amortization of intangible assets compared to the prior year, as well as the Pharmacy Services segment, partially offset by declines in the Retail/LTC and Corporate/Other segments.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this report for additional information about the operating results of the Company&#8217;s segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Interest expense decreased $53 million, or 8.3%, in the three months ended June&#160;30, 2022 compared to the prior year due to lower debt in the three months ended June&#160;30, 2022. See &#8220;Liquidity and Capital Resources&#8221; later in this report for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income tax provision</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effective income tax rate was 26.5% for the three months ended June&#160;30, 2022 compared to 25.3% for the three months ended June&#160;30, 2021. The increase in the effective income tax rate was primarily due to basis differences on the sale of PayFlex in the three months ended June&#160;30, 2022. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Six Months Ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">June&#160;30, 2022 vs. 2021 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $15.7 billion, or 11.1%, in the six months ended June&#160;30, 2022 compared to the prior year driven by growth across all segments. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this report for additional information about the revenues of the Company&#8217;s segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses increased $1.3 billion, or 7.1%, in the six months ended June&#160;30, 2022 compared to the prior year. The increase in operating expenses was primarily due to a $484 million pretax ($370 million after-tax) legal settlement related to the agreement with the State of Florida to settle all opioid claims against the Company and incremental costs associated with growth in the business, partially offset by the $225 million pre-tax gain on the sale of PayFlex.  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues were 12.1% in the six months ended June&#160;30, 2022, a decrease of 50 basis points compared to the prior year. The decrease in operating expenses as a percentage of total revenues was primarily due to the increases in total revenues described above.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this report for additional information about the operating expenses of the Company&#8217;s segments.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating income increased $156 million, or 2.0%, in the six months ended June&#160;30, 2022 compared to the prior year primarily driven by increases in the Health Care Benefits segment, including the $225 million pre-tax gain on the sale of PayFlex and a decrease in amortization of intangible assets compared to the prior year, as well as the Pharmacy Services segment, partially offset by a decline in the Corporate/Other segment, including the legal settlement related to the Company&#8217;s agreement with the State of Florida described above. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this report for additional information about the operating results of the Company&#8217;s segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Interest expense decreased $124 million, or 9.6%, in the six months ended June&#160;30, 2022 compared to the prior year due to lower debt in the six months ended June&#160;30, 2022. See &#8220;Liquidity and Capital Resources&#8221; later in this report for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income tax provision</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effective income tax rate was 24.4% for the six months ended June&#160;30, 2022 compared to 25.2% for the six months ended June&#160;30, 2021. The decrease in the effective income tax rate was primarily due to the impact of certain discrete tax </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">items concluded in the first quarter of 2022, partially offset by basis differences on the sale of PayFlex in the six months ended June&#160;30, 2022. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_82"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Analysis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion of segment operating results is presented based on the Company&#8217;s reportable segments in accordance with the accounting guidance for segment reporting and is consistent with the segment disclosure in Note 11 &#8216;&#8216;Segment Reporting&#8217;&#8217; to the unaudited condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has three operating segments, Health Care Benefits, Pharmacy Services and Retail/LTC, as well as a Corporate/Other segment. The Company&#8217;s segments maintain separate financial information, and the Company&#8217;s chief operating decision maker (the &#8220;CODM&#8221;) evaluates the segments&#8217; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#8217;s segments based on adjusted operating income, which is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#8217;s business nor reflect the Company&#8217;s underlying business performance. See the reconciliations of operating income (GAAP measure) to adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#8217;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of financial measures of the Company&#8217;s segments to the consolidated totals:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.604%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,756&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,328)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,855&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,862&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(555)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,614&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,865&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,616)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(860)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(387)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,635&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,002&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,249)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,443&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(672)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(337)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total revenues of the Pharmacy Services segment include approximately $3.1 billion and $2.8 billion of retail co-payments for the three months ended  June&#160;30, 2022 and 2021, respectively, and $6.9 billion and $6.2 billion of retail co-payments for the six months ended June&#160;30, 2022 and 2021, respectively.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Pharmacy Services segment, and/or the Retail/LTC segment. Intersegment adjusted operating income eliminations occur when members of Pharmacy Services Segment clients (&#8220;PSS members&#8221;) enrolled in Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> elect to pick up maintenance prescriptions at one of the Company&#8217;s retail pharmacies instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail/LTC segments record the adjusted operating income on a stand-alone basis.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are reconciliations of consolidated operating income (GAAP measure) to consolidated adjusted operating income, as well as reconciliations of segment GAAP operating income to segment adjusted operating income:</span></div><div style="margin-bottom:0.3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.163%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,754&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,814&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,740&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(556)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,569&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on divestiture of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss) </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,831&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,855&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,862&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(555)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,810&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:0.3pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:31.792%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.179%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.213%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,273&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,919&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(409)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,326&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition purchase price adjustment outside of measurement period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,614&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,755&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,049&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,887&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.163%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,406&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,346)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(387)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,059&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on divestiture of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal settlement </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on assets held for sale </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss) </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,582&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,491&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,467&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(860)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(387)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,293&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:31.792%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.179%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.213%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,653&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,184&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(754)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(337)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,903&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">804&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition purchase price adjustment outside of measurement period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,396&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,262&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,443&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(672)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(337)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,092&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:0.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the unaudited condensed consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three and six months ended June&#160;30, 2022, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of PayFlex, which the Company sold on June 1, 2022, for approximately $775&#160;million. The gain on divestiture is reflected as a reduction in operating expenses in the Company&#8217;s unaudited condensed consolidated statements of operations within the Health Care Benefits segment.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three and six months ended June&#160;30, 2021, acquisition-related integration costs relate to the Company&#8217;s acquisition of Aetna Inc. The acquisition-related integration costs are reflected in the unaudited condensed consolidated statements of operations in operating expenses within the Corporate/Other segment. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In June 2021, the Company received $61 million related to a purchase price working capital adjustment for an acquisition completed during the first quarter of 2020. The resolution of this matter occurred subsequent to the acquisition accounting measurement period and is reflected in the Company&#8217;s unaudited condensed consolidated statements of operations for the three and six months ended June&#160;30, 2021 as a reduction of operating expenses within the Health Care Benefits segment. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the six months ended June&#160;30, 2022, the legal settlement relates to the agreement with the State of Florida, entered into in March 2022, to resolve claims dating back more than a decade related to opioid medications. Under this agreement, CVS Health Corporation settled all opioid claims against it and its subsidiaries by the State of Florida for $484 million, inclusive of certain legal fees, to be paid over a period of 18 years. The legal settlement is reflected in the unaudited condensed consolidated statement of operations in operating expenses within the Corporate/Other segment.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the six months ended June&#160;30, 2022, the loss on assets held for sale relates to the Commercial Business reporting unit within the Health Care Benefits segment. In March 2022, the Company reached an agreement to sell its international health care business domiciled in Thailand (&#8220;Thailand business&#8221;), which was included in the Commercial Business reporting unit. At that time, a portion of the Commercial Business goodwill was specifically allocated to the Thailand business. The net assets of the Thailand business were accounted for as assets held for sale at March 31, 2022. The carrying value of the Thailand business was determined to be greater than its fair value and a loss on assets held for sale was recorded during the first quarter of 2022. The sale closed in the second quarter of 2022, and the ultimate loss on the sale was not material. The loss on assets held for sale is reflected in the unaudited condensed consolidated statement of operations in operating expenses within the Health Care Benefits segment.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_85"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Care Benefits Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Health Care Benefits segment&#8217;s performance for the respective periods:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.949%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,<br/>2022 vs 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,<br/>2022 vs 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except percentages and basis points (&#8220;bps&#8221;)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,245</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,968</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,859</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,910</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,949&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,423</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,420</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,829</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,813</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,756</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,525</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,865</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,008</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,231&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,857&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,611</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,954</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,660</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,711</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,949&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MBR </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">bps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">bps</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,391</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,298</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,042</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,644</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,754</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,273</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,163</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,653</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,831</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,614</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,582</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,396</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium revenues (by business):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,751</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,897</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,946</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,814</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,494</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,071</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,913</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,096</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">817&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See &#8220;Segment Analysis&#8221; above in this report for a reconciliation of Health Care Benefits segment operating income (GAAP measure) to adjusted operating income, which represents the Company&#8217;s principal measure of segment performance.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Three Months Ended June&#160;30, 2022 vs. 2021</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $2.2 billion, or 10.9%, to $22.8 billion in the three months ended June&#160;30, 2022 compared to the prior year driven by growth across all product lines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Benefit Ratio (&#8220;MBR&#8221;)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical benefit ratio is calculated as benefit costs divided by premium revenues and represents the percentage of premium revenues spent on medical benefits for the Company&#8217;s Insured members. Management uses MBR to assess the underlying business performance and underwriting of its insurance products, understand variances between actual results and expected results and identify trends in period-over-period results. MBR provides management and investors with information useful in assessing the operating results of the Company&#8217;s Insured Health Care Benefits products. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The MBR decreased to 82.9% in the three months ended June&#160;30, 2022 compared to 84.1% in the prior year reflective of strong underlying performance, including higher favorable development of prior-periods&#8217; health care cost estimates in the three months ended June&#160;30, 2022 compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses in the Health Care Benefits segment include selling, general and administrative expenses and depreciation and amortization expenses.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses increased $93 million, or 2.8%, in the three months ended June&#160;30, 2022 compared to the prior year primarily driven by increased operating expenses to support the growth across all product lines described above, as well as incremental investments in the business, partially offset by the $225 million pre-tax gain on the sale of PayFlex.  </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues decreased to 14.9% in the three months ended June&#160;30, 2022 compared to 16.1% in the prior year. The decrease in operating expenses as a percentage of total revenues was primarily driven by the increases in total revenues described above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating income increased $217 million, or 13.4%, in the three months ended June&#160;30, 2022 compared to the prior year primarily driven by strong underlying performance, including higher favorable development of prior-periods&#8217; health care cost estimates in the three months ended June&#160;30, 2022 compared to the prior year, and membership growth across all product lines. These increases were partially offset by incremental investments to support growth in the business and net realized capital losses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Six Months Ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">June&#160;30, 2022 vs. 2021</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $4.9 billion, or 11.8%, to $45.9 billion in the six months ended June&#160;30, 2022 compared to the prior year driven by growth across all product lines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Benefit Ratio</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The MBR decreased slightly to 83.2% in the six months ended June&#160;30, 2022 compared to 83.6% in the prior year reflective of strong underlying performance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses increased $398 million, or 6.0%, in the six months ended June&#160;30, 2022 compared to the prior year primarily driven by increased operating expenses to support the growth across all product lines described above, as well as incremental investments in the business, partially offset by the $225 million pre-tax gain on the sale of PayFlex.    </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues decreased to 15.4% in the six months ended June&#160;30, 2022 compared to 16.2% in the prior year. The decrease in operating expenses as a percentage of total revenues was primarily driven by the increases in total revenues described above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating income increased $186 million, or 5.5%, in the six months ended June&#160;30, 2022 compared to the prior year primarily driven by the net favorable impact of COVID-19 compared to the prior year, membership growth across all product lines and strong underlying performance. These increases were partially offset by incremental investments to support growth in the business and net realized capital losses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Health Care Benefits segment&#8217;s medical membership for the respective periods:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.203%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insured</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insured</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insured</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insured</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Medical membership:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">13,835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">16,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3,285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">13,924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">17,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">13,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">16,788&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">13,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">16,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Medicare Advantage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3,216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3,216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,285&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Total medical membership</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">10,113&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">14,319&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">24,432&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">10,121&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">14,401&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">24,522&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">9,847&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">14,001&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">23,848&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">9,518&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">13,992&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">23,510&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Supplemental membership information: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Medicare Prescription Drug Plan (standalone)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">6,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">6,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5,777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Membership</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical membership represents the number of members covered by the Company&#8217;s Insured and ASC medical products and related services at a specified point in time. Management uses this metric to understand variances between actual medical membership and expected amounts as well as trends in period-over-period results. This metric provides management and investors with information useful in understanding the impact of medical membership on segment total revenues and operating results. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical membership as of June&#160;30, 2022 of 24.4 million decreased 90,000 members compared with March&#160;31, 2022, primarily due to the decrease of approximately 266,000 members in connection with the divestiture of the Company&#8217;s Thailand business during the second quarter of 2022. Excluding the impact of this divestiture, membership increased across all product lines compared with March&#160;31, 2022.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical membership as of June&#160;30, 2022 of 24.4 million increased 922,000 members compared with June&#160;30, 2021, reflecting increases across all product lines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicare Update</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 4, 2022, the U.S. Centers for Medicare &amp; Medicaid Services issued its final notice detailing final 2023 Medicare Advantage benchmark payment rates. Final 2023 Medicare Advantage rates resulted in an increase in industry benchmark rates of approximately 5.0%.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_88"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmacy Services Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Pharmacy Services segment&#8217;s performance for the respective periods:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.241%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,<br/>2022 vs 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,<br/>2022 vs 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except percentages</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,554</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,010</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,718</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,077</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,544&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">555</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,812</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,314</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,273</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,635</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,498&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,638&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,540</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,266</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,789</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">837</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,814</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,406</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,157</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,855</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,755</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,491</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,262</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues (by distribution channel): </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,537</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,918</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,361</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,811</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,235</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,404</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,483</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy claims processed: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,151.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,098.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">983.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">934.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generic dispensing rate: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See &#8220;Segment Analysis&#8221; above in this report for a reconciliation of Pharmacy Services segment operating income (GAAP measure) to adjusted operating income, which represents the Company&#8217;s principal measure of segment performance.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS pharmacy retail store for the same price as mail order.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#8217;s retail pharmacies under the Maintenance Choice program.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes an adjustment to convert 90-day prescriptions to the equivalent of three 30-day prescriptions. This adjustment reflects the fact that these prescriptions include approximately three times the amount of product days supplied compared to a normal prescription.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Three Months Ended June&#160;30, 2022 vs. 2021 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $4.5 billion, or 11.7%, to $42.8 billion in the three months ended June&#160;30, 2022 compared to the prior year primarily driven by increased pharmacy claims volume, growth in specialty pharmacy and brand inflation, partially offset by continued client price improvements.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses in the Pharmacy Services segment include selling, general and administrative expenses; depreciation and amortization expense; and expenses related to specialty retail pharmacies, which include administrative payroll, employee benefits and occupancy costs.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses increased $115 million, or 33.5%, in the three months ended June&#160;30, 2022 compared to the prior year primarily driven by increased restructuring and business integration costs in the three months ended June&#160;30, 2022 compared to the prior year.  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues remained relatively consistent at 1.1% and 0.9% in each of the three-month periods ended June&#160;30, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating income increased $100 million, or 5.7%, in the three months ended June&#160;30, 2022 compared to the prior year. The increase in adjusted operating income was primarily driven by improved purchasing economics, including increased contributions from the products and services of the Company&#8217;s group purchasing organization. These increases were partially offset by continued client price improvements, decreased contributions from pharmacy and/or other administrative services for Covered Entities and increased restructuring and business integration costs in the three months ended June&#160;30, 2022 compared to the prior year.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As you review the Pharmacy Services segment&#8217;s performance in this area, you should consider the following important information about the business:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s efforts to (i)&#160;retain existing clients, (ii)&#160;obtain new business and (iii)&#160;maintain or improve the rebates, fees and/or discounts the Company receives from manufacturers, wholesalers and retail pharmacies continue to have an impact on adjusted operating income. In particular, competitive pressures in the PBM industry have caused the Company and other PBMs to continue to share with clients a larger portion of rebates, fees and/or discounts received from pharmaceutical manufacturers. In addition, marketplace dynamics and regulatory changes have limited the Company&#8217;s ability to offer plan sponsors pricing that includes retail network &#8220;differential&#8221; or &#8220;spread,&#8221; and the Company expects these trends to continue. The &#8220;differential&#8221; or &#8220;spread&#8221; is any difference between the drug price charged to plan sponsors, including Medicare Part&#160;D plan sponsors, by a PBM and the price paid for the drug by the PBM to the dispensing provider. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy claims processed</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total pharmacy claims processed represents the number of prescription claims processed through our pharmacy benefits manager and dispensed by either our retail network pharmacies or our own mail and specialty pharmacies. Management uses this metric to understand variances between actual claims processed and expected amounts as well as trends in period-over-period results. This metric provides management and investors with information useful in understanding the impact of pharmacy claim volume on segment total revenues and operating results.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s pharmacy network claims processed on a 30-day equivalent basis increased 4.1% in the three months ended June&#160;30, 2022 compared to the prior year primarily driven by net new business, increased utilization and the impact of an extended cough, cold and flu season compared to the prior year, partially offset by decreased COVID-19 vaccinations.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s mail choice claims processed on a 30-day equivalent basis increased 2.8% in the three months ended June&#160;30, 2022 compared to the prior year primarily driven by net new business and the increased utilization of Maintenance Choice prescriptions.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Excluding the impact of COVID-19 vaccinations, total pharmacy claims processed increased 5.7% on a 30-day equivalent basis for the three months ended June&#160;30, 2022 compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Generic dispensing rate</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Generic dispensing rate is calculated by dividing the Pharmacy Services segment&#8217;s generic drug prescriptions processed or filled by its total prescriptions processed or filled. Management uses this metric to evaluate the effectiveness of the business at encouraging the use of generic drugs when they are available and clinically appropriate, which aids in decreasing costs for client members and retail customers. This metric provides management and investors with information useful in understanding trends in segment total revenues and operating results. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Pharmacy Services segment&#8217;s total generic dispensing rate increased to 88.0% in the three months ended June&#160;30, 2022 compared to 86.7% in the prior year. The increase in the segment&#8217;s generic dispensing rate was primarily driven by a decrease in brand prescriptions, largely attributable to decreased COVID-19 vaccinations in the three months ended June&#160;30, 2022 compared to the prior year. Excluding the impact of COVID-19 vaccinations, the segment&#8217;s total generic dispensing rate was 88.8% and 89.0% in the three months ended June&#160;30, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Six Months Ended June&#160;30, 2022 vs. 2021 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $7.6 billion, or 10.2%, to $82.3 billion in the six months ended June&#160;30, 2022 compared to the prior year primarily driven by increased pharmacy claims volume, growth in specialty pharmacy and brand inflation, partially offset by continued client price improvements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses increased $148 million, or 21.5%, in the six months ended June&#160;30, 2022 compared to the prior year primarily driven by increased restructuring and business integration costs in the six months ended June&#160;30, 2022 compared to the prior year.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues remained relatively consistent at 1.0% and 0.9% in the six-month periods ended June&#160;30, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating income increased $229 million, or 7.0%, in the six months ended June&#160;30, 2022 compared to the prior year. The increase in adjusted operating income was primarily driven by improved purchasing economics, including increased contributions from the products and services of the Company&#8217;s group purchasing organization. These increases were partially offset by continued client price improvements, decreased contributions from pharmacy and/or other administrative services for Covered Entities and increased restructuring and business integration costs in the six months ended June&#160;30, 2022 compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy claims processed</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s pharmacy network claims processed on a 30-day equivalent basis increased 5.2% in the six months ended June&#160;30, 2022 compared to the prior year primarily driven by net new business, increased utilization and the impact of a weaker cough, cold and flu season experienced in the prior year, partially offset by decreased COVID-19 vaccinations.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s mail choice claims processed on a 30-day equivalent basis increased 2.8% in the six months ended June&#160;30, 2022 compared to the prior year primarily driven by net new business and the increased utilization of Maintenance Choice prescriptions.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Excluding the impact of COVID-19 vaccinations, total pharmacy claims processed increased 5.6% on a 30-day equivalent basis for the six months ended June&#160;30, 2022 compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Generic dispensing rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Pharmacy Services segment&#8217;s total generic dispensing rate increased to 87.9% in the six months ended June&#160;30, 2022 compared to 87.4% in the prior year. The increase in the segment&#8217;s generic dispensing rate was primarily driven by a decrease in brand prescriptions, largely attributable to decreased COVID-19 vaccinations in the six months ended June&#160;30, 2022 compared to the prior year. Excluding the impact of COVID-19 vaccinations, the segment&#8217;s total generic dispensing rate was 88.8% and 89.0% in the six months ended June&#160;30, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_91"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retail/LTC Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Retail/LTC segment&#8217;s performance for the respective periods:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.242%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,<br/>2022 vs 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,<br/>2022 vs 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except percentages</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,528</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,609</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,133</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,003</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,919&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,119</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,953</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(348)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,286</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,728</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,704</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,002</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,558&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,702&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,554</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,952</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,319</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,994</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,992</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,857</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,162</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,824</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses as a % of total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,740</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,919</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,223</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,184</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,862</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,049</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,467</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,443</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(187)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues (by major goods/service lines):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,873</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,549</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,758</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,736</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,254</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,049</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,896</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,140</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,302</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescriptions filled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">795.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same store sales increase (decrease): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription volume </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generic dispensing rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See &#8220;Segment Analysis&#8221; above in this report for a reconciliation of Retail/LTC segment operating income (GAAP measure) to adjusted operating income, which represents the Company&#8217;s principal measure of segment performance.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes an adjustment to convert 90-day prescriptions to the equivalent of three 30-day prescriptions. This adjustment reflects the fact that these prescriptions include approximately three times the amount of product days supplied compared to a normal prescription.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Same store sales and prescription volume represent the change in revenues and prescriptions filled in the Company&#8217;s retail pharmacy stores that have been operating for greater than one year, expressed as a percentage that indicates the increase or decrease relative to the comparable prior period. Same store metrics exclude revenues from MinuteClinic, revenues and prescriptions from LTC operations. Management uses these metrics to evaluate the performance of existing stores on a comparable basis and to inform future decisions regarding existing stores and new locations. Same-store metrics provide management and investors with information useful&#160;in understanding the portion of current revenues and prescriptions resulting from organic growth in existing locations versus the portion resulting from opening new stores.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Three Months Ended June&#160;30, 2022 vs. 2021 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $1.6 billion, or 6.3%, to $26.3 billion in the three months ended June&#160;30, 2022 compared to the prior year primarily driven by increased prescription and front store volume, including the sale of COVID-19 OTC test kits and the impact of an extended cough, cold and flu season compared to the prior year, as well as pharmacy brand inflation. These increases were partially offset by decreased COVID-19 vaccinations and diagnostic testing, the impact of recent generic introductions and continued pharmacy reimbursement pressure.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pharmacy same store sales increased 7.6% in the three months ended June&#160;30, 2022 compared to the prior year. The increase was primarily driven by the 3.1% increase in pharmacy same store prescription volume on a 30-day equivalent basis, including the impact of an extended cough, cold and flu season compared to the prior year, and pharmacy brand inflation. These increases were partially offset by the impact of recent generic introductions and continued pharmacy reimbursement pressure. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Front store same store sales increased 9.4% in the three months ended June&#160;30, 2022 compared to the prior year. The increase was primarily due to strength in consumer health, including the sale of COVID-19 OTC test kits and the impact of an extended cough, cold and flu season compared to the prior year, in the three months ended June&#160;30, 2022. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other revenues decreased $50 million in the three months ended June&#160;30, 2022 compared to the prior year. The decrease was primarily due to decreased COVID-19 diagnostic testing in the three months ended June&#160;30, 2022 compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses in the Retail/LTC segment include store payroll, store employee benefits, store occupancy costs, selling expenses, advertising expenses, depreciation and amortization expense and certain administrative expenses. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses increased $135 million, or 2.8%, in the three months ended June&#160;30, 2022 compared to the prior year. The increase was primarily due to incremental costs associated with increased volume, increased investments in the segment&#8217;s operations and capabilities and the absence of the $125&#160;million gain from an anti-trust legal settlement recorded in the three months ended June&#160;30, 2021. These increases were partially offset by lower expenses associated with COVID-19 vaccination administration compared to the prior year.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues decreased to 19.0% in the three months ended June&#160;30, 2022 compared to 19.6% in the prior year. The decrease in operating expenses as a percentage of total revenues was primarily driven by the increases in total revenues described above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating income decreased $187 million, or 9.1% in the three months ended June&#160;30, 2022 compared to the prior year. The decrease in adjusted operating income was primarily driven by continued pharmacy reimbursement pressure, decreased COVID-19 vaccinations, increased investments in the segment&#8217;s operations and capabilities and the absence of the $125&#160;million gain from an anti-trust legal settlement recorded in the three months ended June&#160;30, 2021. These decreases were partially offset by the increased prescription and front store volume described above, improved generic drug purchasing and the favorable impact of business initiatives in the three months ended June&#160;30, 2022.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As you review the Retail/LTC segment&#8217;s performance in this area, you should consider the following important information about the business:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The segment&#8217;s adjusted operating income has been adversely affected by the efforts of managed care organizations, PBMs and governmental and other third-party payors to reduce their prescription drug costs, including the use of restrictive networks, as well as changes in the mix of business within the pharmacy portion of the Retail/LTC segment. If the pharmacy reimbursement pressure accelerates, the segment may not be able grow revenues, and its adjusted operating income could be adversely affected.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The increased use of generic drugs has positively impacted the segment&#8217;s adjusted operating income but has resulted in third-party payors augmenting their efforts to reduce reimbursement payments to retail pharmacies for prescriptions. This trend, which the Company expects to continue, reduces the benefit the segment realizes from brand to generic drug conversions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prescriptions filled</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prescriptions filled represents the number of prescriptions dispensed through the Retail/LTC segment&#8217;s pharmacies. Management uses this metric to understand variances between actual prescriptions dispensed and expected amounts as well as trends in period-over-period results. This metric provides management and investors with information useful in understanding the impact of prescription volume on segment total revenues and operating results.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prescriptions filled increased 1.6% on a 30-day equivalent basis in the three months ended June&#160;30, 2022 compared to the prior year primarily driven by increased utilization and the impact of an extended cough, cold and flu season compared to the prior year, partially offset by decreased COVID-19 vaccinations. Excluding the impact of COVID-19 vaccinations, prescriptions filled increased 4.6% on a 30-day equivalent basis for the three months ended June&#160;30, 2022 compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Generic dispensing rate</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Generic dispensing rate is calculated by dividing the Retail/LTC segment&#8217;s generic drug prescriptions filled by its total prescriptions filled. Management uses this metric to evaluate the effectiveness of the business at encouraging the use of generic drugs when they are available and clinically appropriate, which aids in decreasing costs for client members and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">retail customers. This metric provides management and investors with information useful in understanding trends in segment total revenues and operating results. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Retail/LTC segment&#8217;s generic dispensing rate increased to 88.5% in the three months ended June&#160;30, 2022 compared to 85.7% in the prior year. The increase in the segment&#8217;s generic dispensing rate was primarily driven by a decrease in brand prescriptions, largely attributable to decreased COVID-19 vaccinations in the three months ended June&#160;30, 2022 compared to the prior year. Excluding the impact of COVID-19 vaccinations, the segment&#8217;s total generic dispensing rate was 89.9% and 89.5% in the three months ended June&#160;30, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Six Months Ended June&#160;30, 2022 vs. 2021 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $3.7 billion, or 7.7%, to $51.7 billion in the six months ended June&#160;30, 2022 compared to the prior year primarily driven by increased prescription and front store volume, including the sale of COVID-19 OTC test kits and the impact of a weaker cough, cold and flu season experienced in the prior year, as well as pharmacy brand inflation. These increases were partially offset by decreased COVID-19 vaccinations and diagnostic testing, the impact of recent generic introductions and continued pharmacy reimbursement pressure.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pharmacy same store sales increased 8.8% in the six months ended June&#160;30, 2022 compared to the prior year. The increase was primarily driven by the 4.5% increase in pharmacy same store prescription volume on a 30-day equivalent basis, including the impact of a weaker cough, cold and flu season experienced in the prior year, and pharmacy brand inflation. These increases were partially offset by the impact of recent generic introductions and continued pharmacy reimbursement pressure. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Front store same store sales increased 11.2% in the six months ended June&#160;30, 2022 compared to the prior year. The increase was primarily due to strength in consumer health, including the sale of COVID-19 OTC test kits and the impact of a weaker cough, cold and flu season experienced in the prior year, in the six months ended June&#160;30, 2022. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other revenues decreased $162 million in the six months ended June&#160;30, 2022 compared to the prior year. The decrease was primarily due to decreased COVID-19 diagnostic testing in the six months ended June&#160;30, 2022 compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses increased $338 million, or 3.4%, in the six months ended June&#160;30, 2022 compared to the prior year. The increase was primarily due to incremental costs associated with increased volume, as well as increased investments in the segment&#8217;s operations and capabilities, partially offset by lower expenses associated with COVID-19 vaccination administration compared to the prior year.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues decreased to 19.7% in the six months ended June&#160;30, 2022 compared to 20.5% in the prior year. The decrease in operating expenses as a percentage of total revenues was primarily driven by the increases in total revenues described above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating income increased $24 million, or 0.7% in the six months ended June&#160;30, 2022 compared to the prior year. The increase in adjusted operating income was primarily driven by the increased prescription and front store volume described above, improved generic drug purchasing and the favorable impact of business initiatives in the six months ended June&#160;30, 2022. These increases were partially offset by continued pharmacy reimbursement pressure, decreased COVID-19 diagnostic testing and increased investments in the segment&#8217;s operations and capabilities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prescriptions filled</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prescriptions filled increased 3.3% on a 30-day equivalent basis in the six months ended June&#160;30, 2022 compared to the prior year primarily driven by increased utilization and the impact of a weaker cough, cold and flu season experienced in the prior year, partially offset by decreased COVID-19 vaccinations. Excluding the impact of COVID-19 vaccinations, prescriptions filled increased 5.1% on a 30-day equivalent basis for the six months ended June&#160;30, 2022 compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Generic dispensing rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Retail/LTC segment&#8217;s generic dispensing rate increased to 88.0% in the six months ended June&#160;30, 2022 compared to 86.5% in the prior year. The increase in the segment&#8217;s generic dispensing rate was primarily driven by a decrease in brand prescriptions, largely attributable to decreased COVID-19 vaccinations in the six months ended June&#160;30, 2022 compared to the prior year. Excluding the impact of COVID-19 vaccinations, the segment&#8217;s total generic dispensing rate was 89.9% and 89.6% in the six months ended June&#160;30, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_94"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate/Other Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Corporate/Other segment&#8217;s performance for the respective periods:</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.092%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,<br/>2022 vs 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,<br/>2022 vs 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except percentages</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">956&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(556)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(409)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,346)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(754)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(592)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(555)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(860)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(672)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See &#8220;Segment Analysis&#8221; above in this report for a reconciliation of Corporate/Other segment operating loss (GAAP measure) to adjusted operating loss, which represents the Company&#8217;s principal measure of segment performance.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Three Months Ended June&#160;30, 2022 vs. 2021 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues primarily relate to products for which the Company no longer solicits or accepts new customers, such as large case pensions and long-term care insurance products.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues decreased $72 million, or 39.6%, to $110 million in the three months ended June&#160;30, 2022 compared to the prior year primarily driven by lower net investment income from private equity investments and lower net realized capital gains in the three months ended June&#160;30, 2022 compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating loss </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating loss increased $186 million in the three months ended June&#160;30, 2022 compared to the prior year primarily driven by the strengthening of reserves in the Company&#8217;s long-term care insurance business and the decreases in net investment income described above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Six Months Ended June&#160;30, 2022 vs. 2021 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues decreased $81 million, or 25.6%, to $236 million in the six months ended June&#160;30, 2022 compared to the prior year primarily driven by lower net investment income from private equity investments and lower net realized capital gains in the six months ended June&#160;30, 2022 compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating loss </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating loss increased $188 million in the six months ended June&#160;30, 2022 compared to the prior year primarily driven by the strengthening of reserves in the Company&#8217;s long-term care insurance business and the decreases in net investment income described above.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_97"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a level of liquidity sufficient to allow it to meet its cash needs in the short-term. Over the long term, the Company manages its cash and capital structure to maximize shareholder return, maintain its financial condition and maintain flexibility for future strategic initiatives. The Company continuously assesses its regulatory capital requirements, working capital needs, debt and leverage levels, debt maturity schedule, capital expenditure requirements, dividend payouts, potential share repurchases and future investments or acquisitions. The Company believes its operating cash flows, commercial paper program, credit facilities, as well as any potential future borrowings, will be sufficient to fund these future payments and long-term initiatives. As of June&#160;30, 2022, the Company had approximately $12.1 billion in cash and cash equivalents, approximately $5.8 billion of which was held by the parent company or nonrestricted subsidiaries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net change in cash, cash equivalents and restricted cash during the six months ended June&#160;30, 2022 and 2021 was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.992%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except percentages</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,006&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,739&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,123)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,974)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,149)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,111)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,512)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net decrease in cash, cash equivalents and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(228)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(747)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Net cash provided by operating activities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increased by $267 million in the six months ended June&#160;30, 2022 compared to the prior year. The increase was primarily due to the timing of payments during the six months ended June&#160;30, 2022 compared to the prior year.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Net cash used in investing activities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increased by $1.1 billion in the six months ended June&#160;30, 2022 compared to the prior year primarily due to a reduction in restricted cash as a result of the sale of health savings account funds held on behalf of customers in conjunction with the sale of PayFlex, partially offset by lower net purchases of investments and the gross proceeds from the sale of PayFlex. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Net cash used in financing activities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">decreased to $5.1 billion in the six months ended June&#160;30, 2022 compared to $6.5 billion in the prior year. The decrease in cash used in financing activities primarily related to lower repayments of long-term debt during the six months ended June&#160;30, 2022 compared to the prior year, partially offset by share repurchases in the six months ended June&#160;30, 2022. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper and Back-up Credit Facilities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have any commercial paper outstanding as of June&#160;30, 2022. In connection with its commercial paper program, the Company maintains a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May&#160;16, 2025, a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 11, 2026, and a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 16, 2027. The credit facilities allow for borrowings at various rates that are dependent, in part, on the Company&#8217;s public debt ratings and require the Company to pay a weighted average quarterly facility fee of approximately 0.03%, regardless of usage. As of June&#160;30, 2022, there were no borrowings outstanding under any of the Company&#8217;s back-up credit facilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Home Loan Bank of Boston</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A subsidiary of the Company is a member of the Federal Home Loan Bank of Boston (the &#8220;FHLBB&#8221;). As a member, the subsidiary has the ability to obtain cash advances, subject to certain minimum collateral requirements. The maximum borrowing capacity available from the FHLBB as of June&#160;30, 2022 was approximately $930 million. As of June&#160;30, 2022, there were no outstanding advances from the FHLBB.</span></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company exercised the par call option on its outstanding 3.5% senior notes due July 2022 and redeemed for cash on hand the entire $1.5&#160;billion aggregate principal amount.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 15, 2022, the Company announced that it will exercise the par call option on its outstanding 2.75% senior notes due November 2022 (issued by Aetna Inc.) and will redeem for cash on hand the entire $1.0&#160;billion aggregate principal amount. The redemption is expected to occur on or about August 15, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 2, 2022, the Company announced that it will exercise the par call options on its outstanding 2.75% senior notes due December 2022 and 4.75% senior notes due December 2022 (including the unexchanged notes issued by Omnicare, Inc.) and will redeem for cash on hand the entire $1.25&#160;billion and $399&#160;million aggregate principal amounts, respectively. The redemptions are expected to occur on or about September 1, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Covenants</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s back-up revolving credit facilities and unsecured senior notes contain customary restrictive financial and operating covenants. These covenants do not include an acceleration of the Company&#8217;s debt maturities in the event of a downgrade in the Company&#8217;s credit ratings. The Company does not believe the restrictions contained in these covenants materially affect its financial or operating flexibility. As of June&#160;30, 2022, the Company was in compliance with all of its debt covenants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Ratings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, the Company&#8217;s long-term debt was rated &#8220;Baa2&#8221; by Moody&#8217;s Investor Service, Inc. (&#8220;Moody&#8217;s&#8221;) and &#8220;BBB&#8221; by Standard&#160;&amp; Poor&#8217;s Financial Services LLC (&#8220;S&amp;P&#8221;), and its commercial paper program was rated &#8220;P-2&#8221; by Moody&#8217;s and &#8220;A-2&#8221; by S&amp;P. The outlook on the Company&#8217;s long-term debt is &#8220;Stable&#8221; by Moody&#8217;s and &#8220;Positive&#8221; by S&amp;P. In assessing the Company&#8217;s credit strength, the Company believes that both Moody&#8217;s and S&amp;P considered, among other things, the Company&#8217;s capital structure and financial policies as well as its consolidated balance sheet, its historical acquisition activity and other financial information. Although the Company currently believes its long-term debt ratings will remain investment grade, it cannot guarantee the future actions of Moody&#8217;s and/or S&amp;P. The Company&#8217;s debt ratings have a direct impact on its future borrowing costs, access to capital markets and new store operating lease costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following share repurchase program has been authorized by CVS Health Corporation&#8217;s Board of Directors (the &#8220;Board&#8221;):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In billions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Authorization&#160;Date</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Authorized</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Remaining as of<br/>June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 9, 2021 (&#8220;2021 Repurchase Program&#8221;)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Repurchase Program permits the Company to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase (&#8220;ASR&#8221;) transactions, and/or other derivative transactions. The 2021 Repurchase Program can be modified or terminated by the Board at any time.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2022, the Company repurchased approximately 19.1 million shares of common stock for approximately $2.0 billion pursuant to the 2021 Repurchase Program, including share repurchases under the ASR transaction described below. During the six months ended June&#160;30, 2021, the Company did not repurchase any shares of its common stock. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the authorization under the 2021 Repurchase Program, the Company entered into a $1.5&#160;billion fixed dollar ASR with Barclays Bank PLC (&#8220;Barclays&#8221;). Upon payment of the $1.5&#160;billion purchase price on January 4, 2022, the Company received a number of shares of CVS Health Corporation&#8217;s common stock equal to 80% of the $1.5&#160;billion notional amount of the ASR or approximately 11.6&#160;million shares at a price of $103.34 per share, which were placed into treasury stock in January 2022. The ASR was accounted for as an initial treasury stock transaction for $1.2&#160;billion and a forward contract for $0.3&#160;billion. The forward contract was classified as an equity instrument and was recorded within capital surplus. In February 2022, the Company received approximately 2.7&#160;million shares of CVS Health Corporation&#8217;s common stock, representing the remaining 20% of the $1.5&#160;billion notional amount of the ASR, thereby concluding the ASR. These shares were placed into treasury stock and the forward contract was reclassified from capital surplus to treasury stock in February 2022.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the time they were received, the initial and final receipt of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted average common shares outstanding for basic and diluted earnings per share.</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company prepares the unaudited condensed consolidated financial statements in conformity with generally accepted accounting principles, which require management to make certain estimates and apply judgment. Estimates and judgments are based on historical experience, current trends and other factors that management believes to be important at the time the unaudited condensed consolidated financial statements are prepared. On a regular basis, the Company reviews its accounting policies and how they are applied and disclosed in the unaudited condensed consolidated financial statements. While the Company believes the historical experience, current trends and other factors considered by management support the preparation of the unaudited condensed consolidated financial statements in conformity with generally accepted accounting principles, actual results could differ from estimates, and such differences could be material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a full description of the Company&#8217;s critical accounting policies, see &#8220;Critical Accounting Policies&#8221; in Item 7 &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; of the 2021 Form 10-K.</span></div><div><span><br/></span></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_103"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Statement Concerning Forward-Looking Statements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Private Securities Litigation Reform Act of 1995 (the &#8220;Reform Act&#8221;) provides a &#8220;safe harbor&#8221; for forward-looking statements, so long as (1) those statements are identified as forward-looking and (2) the statements are accompanied by meaningful cautionary statements that identify important factors that could cause actual results to differ materially from those discussed in the statement. We want to take advantage of these safe harbor provisions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain information contained in this Quarterly Report on Form 10-Q (this &#8220;report&#8221;) is forward-looking within the meaning of the Reform Act or SEC rules. This information includes, but is not limited to the forward-looking information in Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations included in Part I, Item 2 of this report. In addition, throughout this report and our other reports and communications, we use the following words or variations or negatives of these words and similar expressions when we intend to identify forward-looking statements:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.354%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Anticipates</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Believes</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Can</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Continue</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Could</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Estimates</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Evaluate</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Expects</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Explore</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Forecast</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Guidance</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Intends</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Likely</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">May</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Might</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Outlook</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Potential</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Predict</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Probable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Projects</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Seeks</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Should</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">View</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Will</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">All statements addressing the future operating performance of CVS Health or any segment or any subsidiary and/or future events or developments, including statements relating to the projected impact of COVID-19 and its emerging new variants on the Company&#8217;s businesses, investment portfolio, operating results, cash flows and/or financial condition, statements relating to corporate strategy, statements relating to future revenue, operating income or adjusted operating income, earnings per share or adjusted earnings per share, Health Care Benefits segment business, sales results and/or trends, medical cost trends, medical membership, Medicare Part D membership, medical benefit ratios and/or operations, Pharmacy Services segment business, sales results and/or trends and/or operations, Retail/LTC segment business, sales results and/or trends and/or operations, incremental investment spending, interest expense, effective tax rate, weighted-average share count, cash flow from operations, net capital expenditures, cash available for debt repayment, integration synergies, net synergies, integration costs, enterprise modernization, transformation, leverage ratio, cash available for enhancing shareholder value, inventory reduction, turn rate and/or loss rate, debt ratings, the Company&#8217;s ability to attract or retain customers and clients, store development and/or relocations, new product development, and the impact of industry and regulatory developments as well as statements expressing optimism or pessimism about future operating results or events, are forward-looking statements within the meaning of the Reform Act.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forward-looking statements rely on a number of estimates, assumptions and projections concerning future events, and are subject to a number of significant risks and uncertainties and other factors that could cause actual results to differ materially from those statements. Many of these risks and uncertainties and other factors are outside our control. Certain of these risks and uncertainties and other factors are described under &#8220;Risk Factors&#8221; included in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2021 and under &#8220;Risk Factors&#8221; included in Part II, Item 1A of this report; these are not the only risks and uncertainties we face. There can be no assurance that the Company has identified all the risks </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_7">Form 10-Q Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">that affect it. Additional risks and uncertainties not presently known to the Company or that the Company currently believes to be immaterial also may adversely affect the Company&#8217;s businesses. If any of those risks or uncertainties develops into actual events, those events or circumstances could have a material adverse effect on the Company&#8217;s businesses, operating results, cash flows, financial condition and/or stock price, among other effects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should not put undue reliance on forward-looking statements. Any forward-looking statement speaks only as of the date of this report, and we disclaim any intention or obligation to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise.</span></div><div><span><br/></span></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_106"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:42.02pt">Quantitative and Qualitative Disclosures About Market Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not experienced any material changes in exposures to market risk since December 31, 2021. See the information contained in Part II, Item 7A &#8220;Quantitative and Qualitative Disclosures About Market Risk&#8221; of the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 for a discussion of the Company&#8217;s exposures to market risk. </span></div><div><span><br/></span></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_109"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:42.02pt">Controls and Procedures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of disclosure controls and procedures:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s Chief Executive Officer and Chief Financial Officer, after evaluating the effectiveness of the design and operation of the Company&#8217;s disclosure controls and procedures (as defined in Securities Exchange Act Rules&#160;13a&#8209;15(f) and 15d&#8209;15(f)) as of June&#160;30, 2022, have concluded that as of such date the Company&#8217;s disclosure controls and procedures were adequate and effective and designed to provide reasonable assurance that material information relating to the Company and its subsidiaries would be made known to such officers on a timely basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in internal control over financial reporting:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> There has been no change in the Company&#8217;s internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Rule 13a-15 or Rule 15d-15 that occurred in the three months ended&#160;June&#160;30, 2022 that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</span></div><div><span><br/></span></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_112"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part II.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:40.36pt">Other Information</span></div><div><span><br/></span></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_115"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:42.02pt">Legal Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information contained in Note 10 &#8216;&#8216;Commitments and Contingencies&#8217;&#8217; contained in &#8220;Notes to Condensed Consolidated Financial Statements (Unaudited)&#8221; in Part I, Item 1 of this Quarterly Report on Form 10-Q is incorporated by reference herein.</span></div><div><span><br/></span></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_118"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:34.8pt">Risk Factors</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to the &#8220;Risk Factors&#8221; disclosed in Part I, Item 1A of the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021. Those risk factors could adversely affect the Company&#8217;s businesses, operating results, cash flows and/or financial condition as well as the market price of CVS Health Corporation&#8217;s common shares.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_121"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_7">Form 10-Q Table of Contents</a></span></div></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:42.02pt">Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;Stock Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the total number of shares purchased in the three months ended June&#160;30, 2022, the average price paid per share and the approximate dollar value of shares that still could have been purchased at the end of the applicable fiscal period, pursuant to the share repurchase program authorized by CVS Health Corporation&#8217;s Board of Directors on December 9, 2021. See Note 7 &#8216;&#8216;Shareholders&#8217; Equity&#8217;&#8217; contained in &#8220;Notes to Condensed Consolidated Financial Statements (Unaudited)&#8221; in Part I, Item 1 of this Quarterly Report on Form&#160;10-Q for additional information.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.718%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Fiscal&#160;Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Total&#160;Number<br/>of&#160;Shares<br/>Purchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Average<br/>Price&#160;Paid&#160;per<br/>Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of&#160;Shares<br/>Purchased&#160;as&#160;Part&#160;of<br/>Publicly&#160;Announced<br/>Plans&#160;or&#160;Programs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Approximate&#160;Dollar<br/>Value&#160;of&#160;Shares&#160;that<br/>May&#160;Yet&#160;Be<br/>Purchased&#160;Under&#160;the<br/>Plans&#160;or&#160;Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 1, 2022 through April 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,000,000,137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 1, 2022 through May 31, 2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,000,000,137&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 1, 2022 through June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,000,000,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_124"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_7">Form 10-Q Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defaults Upon Senior Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_127"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Mine Safety Disclosures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div><span><br/></span></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_130"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_133"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_7">Form 10-Q Table of Contents</a></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.  Exhibits</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exhibits listed in this Item 6 are filed as part of this Quarterly Report on Form 10-Q. Exhibits marked with an asterisk (*) are management contracts or compensatory plans or arrangements. Exhibits other than those listed are omitted because they are not required to be listed or are not applicable. Pursuant to Item 601(b)(4)(iii) of Regulation S-K, the Registrant hereby agrees to furnish to the Securities and Exchange Commission a copy of any omitted instrument that is not required to be listed. </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO EXHIBITS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.091%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Material Contracts</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="a06302022ex101.htm">Five Year Credit Agreement dated as of May 16, 2022, by and among the Registrant, the lenders party thereto, and Bank of America, N.A., as Administrative Agent.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="a06302022ex102.htm">First Amendment to Five Year Credit Agreement dated as of May 16, 2022, to the Five Year Credit Agreement dated as of May 1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="a06302022ex102.htm">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="a06302022ex102.htm">, 2021, by and among the Registrant, the lenders party thereto and Bank of America, N.A., as Administrative Agent.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="a06302022ex103.htm">First Amendment to Five Year Credit Agreement dated as of May 16, 2022, to the Five Year Credit Agreement dated as of May 16, 2019, by and among the Registrant, the lenders party thereto and Bank of America, N.A., as Administrative Agent.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Letter re: unaudited interim financial information</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a06302022ex151.htm">Letter from Ernst &amp; Young LLP acknowledging awareness of the use of a report dated August 3, 2022 related to their reviews of interim financial information.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rule 13a-14(a)/15d-14(a) Certifications</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a06302022ex311.htm">Certification by the Chief Executive Officer.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a06302022ex312.htm">Certification by the Chief Financial Officer.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Section 1350 Certifications</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a06302022ex321.htm">Certification by the Chief Executive Officer.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a06302022ex322.htm">Certification by the Chief Financial Officer.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">101</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from the CVS Health Corporation Quarterly Report on Form 10-Q for the three and six months ended June 30, 2022 formatted in Inline XBRL: (i) the Condensed Consolidated Statements of Operations, (ii) the Condensed Consolidated Statements of Comprehensive Income, (iii) the Condensed Consolidated Balance Sheets, (iv) the Condensed Consolidated Statements of Cash Flows, (v) the Condensed Consolidated Statements of Shareholders&#8217; Equity and (vi) the related Notes to Condensed Consolidated Financial Statements. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File - The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended June&#160;30, 2022, formatted in Inline XBRL (included as Exhibit 101).</span></div></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><div id="i9cfc04c975ca4b3f87d2592f7def0c41_136"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9cfc04c975ca4b3f87d2592f7def0c41_7">Form 10-Q Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.854%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CVS HEALTH CORPORATION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.855%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Shawn M. Guertin</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shawn M. Guertin</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>a06302022ex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ifeec14c7a618494cb040e343e2bc92c6_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.1</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Execution Version</font></div></div><div style="padding-left:36pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Deal CUSIP&#58; 23242UAX1</font></div><div style="padding-left:36pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Facility CUSIP&#58; 23242UAY9</font></div><div style="margin-bottom:6pt;margin-top:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FIVE YEAR CREDIT AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">by and among</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CVS HEALTH CORPORATION,</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">THE LENDERS PARTY HERETO,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BARCLAYS BANK PLC and JPMORGAN CHASE BANK, N.A.,</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">as Co-Syndication Agents,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GOLDMAN SACHS BANK USA and</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WELLS FARGO BANK, NATIONAL ASSOCIATION,</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">as Co-Documentation Agents,</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">and</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BANK OF AMERICA, N.A.,</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">as Administrative Agent</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">______________________________</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Dated as of May 16, 2022</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">______________________________</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BOFA SECURITIES, INC.,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BARCLAYS BANK PLC, GOLDMAN SACHS BANK USA,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">JPMORGAN CHASE BANK, N.A.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">and</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WELLS FARGO SECURITIES, LLC,</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">as Joint Lead Arrangers and Joint Bookrunners</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:48pt;text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><div id="ifeec14c7a618494cb040e343e2bc92c6_4"></div><hr style="page-break-after:always"><div style="min-height:57.02pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TABLE OF CONTENTS</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:465.00pt"><tr><td style="width:1.0pt"></td><td style="width:22.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:31.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:366.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:37.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">DEFINITIONS AND PRINCIPLES OF CONSTRUCTION...............................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.12pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Definitions.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Principles of Construction.........................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AMOUNT AND TERMS OF LOANS.................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Revolving Credit Loans............................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Swing Line Loans.....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notice of Borrowing Revolving Credit Loans and Swing Line Loans.....................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Competitive Bid Loans and Procedure.....................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Use of Proceeds.........................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">28</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Termination, Reduction or Increase of Commitments..............................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">28</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Prepayments of Loans...............................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">30</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Letter of Credit Sub-facility......................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">30</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Letter of Credit Participation....................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">32</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Absolute Obligation with respect to Letter of Credit Payments...............................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">33</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notes..........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">33</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Extension of Commitment Termination Date...........................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">33</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.13</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Defaulting Lenders....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">34</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">PROCEEDS, PAYMENTS, CONVERSIONS, INTEREST, YIELD PROTECTION</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AND FEES.............................................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">37</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Disbursement of the Proceeds of the Loans..............................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">37</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Payments...................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">38</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Conversions&#59; Other Matters......................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">39</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Interest Rates and Payment Dates.............................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">40</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Indemnification for Loss...........................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">42</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Reimbursement for Costs, Etc..................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">43</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Illegality of Funding.................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">43</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Option to Fund&#59; Substituted Interest Rate.................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">44</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Certificates of Payment and Reimbursement............................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">46</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Taxes&#59; Net Payments................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">47</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Facility Fees..............................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">50</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Letter of Credit Participation Fee..............................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">51</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.13</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Replacement of Lender.............................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">51</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">REPRESENTATIONS AND WARRANTIES.....................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">52</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Existence and Power.................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">52</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Authority&#59; Affected Financial Institution..................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">52</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Binding Agreement...................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">52</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Litigation...................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">52</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No Conflicting Agreements......................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">53</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">53</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">53</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Governmental Regulations........................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">53</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Federal Reserve Regulations&#59; Use of Proceeds.........................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">53</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No Misrepresentation................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">53</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">54</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;..................................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">54</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.13</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Financial Statements.................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">54</font></td></tr></table></div><div style="height:61.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">i</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.02pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:465.00pt"><tr><td style="width:1.0pt"></td><td style="width:22.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:31.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:366.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:37.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.14</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.37pt;padding-right:1.37pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Anti-Corruption Laws and Sanctions........................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">54</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CONDITIONS TO EFFECTIVENESS................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">54</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Agreement.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">55</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notes.........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">55</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Corporate Action.......................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">55</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Opinion of Counsel to the Borrower.........................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">55</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Termination of Existing 2018 Credit Agreement.....................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">55</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No Default and Representations and Warranties......................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">55</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Fees...........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">56</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Due Diligence&#59; &#8220;Know Your Customer&#8221;..................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">56</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CONDITIONS OF LENDING - ALL LOANS AND LETTERS OF CREDIT..................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">56</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Compliance...............................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">56</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Requests....................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">56</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AFFIRMATIVE COVENANTS..........................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">57</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Legal Existence.........................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">57</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Taxes.........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">57</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">57</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">57</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">57</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Observance of Legal Requirements..........................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">57</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Financial Statements and Other Information............................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">58</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Records.....................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">59</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NEGATIVE COVENANTS.....................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">59</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">59</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Liens..........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">59</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Dispositions...............................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">60</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Merger or Consolidation, Etc....................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">60</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">61</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">61</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Limitation on Upstream Dividends by Subsidiaries..................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">61</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">61</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ratio of Consolidated Indebtedness to Total Capitalization.....................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">61</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">DEFAULT............................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">62</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Events of Default......................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">62</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Remedies...................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">64</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AGENT.................................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">65</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Appointment and Authority......................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">65</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Rights as a Lender.....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">65</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exculpatory Provisions.............................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">65</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Reliance by Administrative Agent............................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">66</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Delegation of Duties.................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">67</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Resignation of Administrative Agent.......................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">67</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Non-Reliance on Administrative Agent and Other Credit Parties............................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">68</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No Other Duties, Etc.................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">68</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Recovery of Erroneous Payments.............................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">68</font></td></tr></table></div><div style="height:61.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ii</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.02pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:465.00pt"><tr><td style="width:1.0pt"></td><td style="width:22.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:31.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:366.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:37.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">OTHER PROVISIONS.........................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">69</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Amendments, Waivers, Etc.......................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">69</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notices......................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">70</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No Waiver&#59; Cumulative Remedies................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">73</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Survival of Representations and Warranties..................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">73</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Payment of Expenses&#59; Indemnified Liabilities..............................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">73</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Lending Offices........................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">74</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Successors and Assigns..................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">74</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Counterparts&#59; Electronic Execution...............................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">80</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Set-off and Sharing of Payments..............................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">81</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Indemnity           .......................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">82</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Governing Law  .......................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">84</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Severability        .......................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">84</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.13</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Integration          .......................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">84</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.14</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Treatment of Certain Information.............................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">85</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.15</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Acknowledgments.....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">86</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.16</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Consent to Jurisdiction..............................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">86</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.17</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Service of Process.....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">86</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.18</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No Limitation on Service or Suit..............................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">86</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.19</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WAIVER OF TRIAL BY JURY..............................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">86</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.20</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Patriot Act Notice.....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">87</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.21</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No Fiduciary Duty....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">87</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.22</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Acknowledgement and Consent to Bail-In of Affected Financial</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Institutions     .............................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">87</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.23</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Certain ERISA Matters..............................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">87</font></td></tr></table></div><div><font><br></font></div><div style="height:61.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">iii</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.02pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EXHIBITS</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:344.25pt"><tr><td style="width:1.0pt"></td><td style="width:61.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:279.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit A</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">List of Commitments</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit B</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Note</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit C</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Borrowing Request</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit D-1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Opinion of Counsel to the Borrower</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit D-2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Opinion of Special Counsel to the Borrower</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit E</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Assignment and Assumption</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit F</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Competitive Bid Request</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit G</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Invitation to Bid</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit H</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Competitive Bid</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit I</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Competitive Bid Accept&#47;Reject Letter</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit J</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Letter of Credit Request</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit K</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Commitment Increase Supplement</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="height:61.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">iv</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><div id="ifeec14c7a618494cb040e343e2bc92c6_7"></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FIVE YEAR CREDIT AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, dated as of May 16, 2022, by and among </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">CVS HEALTH CORPORATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, a Delaware corporation (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Borrower&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), the lenders party hereto from time to time (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and, collectively, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Lenders&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">BARCLAYS BANK PLC </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Barclays&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">JPMORGAN CHASE BANK, N.A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;JPMC&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), as co-syndication agents (in such capacity, each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Co-Syndication Agent&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and, collectively, the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Co-Syndication Agents&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">GOLDMAN SACHS BANK USA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">GS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">WELLS FARGO BANK, NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Wells Fargo&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as codocumentation agents (in such capacity, each a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Co-Documentation Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and, collectively, the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Co-Documentation Agents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">BANK OF AMERICA, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as administrative agent for the Lenders (in  such capacity, together with its successors and assigns, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">DEFINITIONS AND PRINCIPLES OF CONSTRUCTION</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Definitions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">When used in any Loan Document (as defined below), each of the following terms shall have the meaning ascribed thereto unless the context otherwise specifically requires&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;ABR Advances&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Revolving Credit Loans (or any portions thereof) at such time as they (or  such portions) are made or are being maintained at a rate of interest based upon the Alternate Base Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Acquisition Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58;  any Indebtedness incurred by the Borrower or any of its Subsidiaries for the purpose of financing, in whole or in part, a Material Acquisition and any related transactions or series of related transactions (including for the purpose of refinancing or replacing all or a portion of any pre-existing Indebtedness of the Person(s) or assets to be acquired), which Indebtedness is redeemable or prepayable if such Material Acquisition is not consummated.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Accumulated Funding Deficiency&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in Section 304 of ERISA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Administrative Agent&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Administrative Agent&#8217;s Office</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the Administrative Agent&#8217;s address and, as appropriate, account   as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, or such other address or account as the Administrative Agent may from time to time notify to the Borrower and the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Administrative Questionnaire&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; an Administrative Questionnaire in a form supplied by the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Advances&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ABR Advances or Term SOFR Advances.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Affected Financial Institution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (a) any EEA Financial Institution or (b) any UK Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Affiliate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any Person at any time and from time to time, any other Person (other than a wholly-owned subsidiary of such Person) which, at such time (a) controls such Person, (b) is controlled by such Person or (c) is under common control with such Person. The term </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as used     in this definition with respect to any Person, means the power, whether direct or indirect through one or  more intermediaries, to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities or other interests, by contract or otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Agent Parties&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Aggregate Commitment Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time, the sum of the Commitment Amounts of the Lenders at such time under this Agreement. The Aggregate Commitment Amount on the Effective Date is $2,000,000,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Aggregate Credit Exposure&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time, the sum of (a) the aggregate Committed Credit  Exposure of the Lenders at such time and (b) the aggregate outstanding principal balance of all Competitive Bid Loans at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Aggregate Letter of Credit Commitment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">at any time, the sum of the Letter of Credit Commitments of the Issuers at such time. The Aggregate Letter of Credit Commitment on the Effective   Date is $150,000,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; this Five Year Credit Agreement, as the same may be amended, amended and restated, supplemented or otherwise modified from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Alternate Base Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; for any day, a fluctuating rate per annum equal to the highest of (a) the Federal Funds Effective Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 1&#47;2 of 1%, (b) the rate of interest in effect for such day as publicly announced from time to time by BofA as its &#8220;prime rate&#8221;, and (c) the One Month SOFR Rate in effect on such day </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 1.00%.  The &#8220;prime rate&#8221; is a rate set by BofA based upon various factors including BofA&#8217;s costs and desired return, general economic conditions and other factors, and is used as a reference point for pricing some loans, which may be priced at, above, or below such announced rate.  Any change in such prime rate announced by BofA shall take effect at the opening of business on the day specified in the public announcement of such change. If the Alternate Base Rate is being used as an alternate rate of interest pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> hereof, then the Alternate Base Rate shall be the greater of clauses (a) and (b) above and shall be determined without reference to clause (c) above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Anti-Corruption Laws&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; all laws, rules, and regulations of any jurisdiction applicable to the Borrower or the Subsidiaries from time to time concerning or relating to bribery or corruption.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Applicable Margin&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (i) with respect to the unpaid principal balance of ABR Advances, the applicable percentage set forth below in the column entitled &#8220;ABR Advances&#8221;, (ii)&#160;with respect to the   unpaid principal balance of Term SOFR Advances and Swing Line Loans bearing interest at the Term   SOFR Daily Floating Rate, the applicable percentage set forth below in the column entitled &#8220;Term SOFR Advances&#47;Swing Line Loans&#8221;, (iii) with respect to the Facility Fee, the applicable percentage set forth   below in the column entitled &#8220;Facility Fee&#8221;, (iv) with respect to the Letter of Credit Participation Fee  payable in respect of standby Letters of Credit, the applicable percentage set forth below in the column entitled &#8220;Participation Fee - Standby&#8221;, and (v) with respect to the Letter of Credit Participation Fee payable in respect of commercial Letters of Credit, the applicable percentage set forth below in the column entitled &#8220;Participation Fee - Commercial&#8221;, in each case opposite the applicable Pricing Level&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.305%"><tr><td style="width:1.0%"></td><td style="width:17.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.050%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Pricing Level</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ABR Advances</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Term SOFR Advances&#47; Swing Line Loans</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Facility Fee</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Participation Fee - Standby</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Participation Fee &#8211; Commercial</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pricing Level I</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.000%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.700%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.050%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.700%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.3500%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pricing Level II</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.000%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.815%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.060%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.815%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.4075%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pricing Level III</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.000%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.920%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.080%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.920%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.4600%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pricing Level IV</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.025%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.025%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.100%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.025%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.5125%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pricing Level V</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.125%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.125%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.125%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.125%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.5625%</font></td></tr></table></div><div><font><br></font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.305%"><tr><td style="width:1.0%"></td><td style="width:17.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.890%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pricing Level VI</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.275%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.275%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.225%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.275%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.6375%</font></td></tr></table></div><div style="margin-bottom:12pt;margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Decreases in the Applicable Margin resulting from a change in Pricing Level shall become effective upon  the delivery by the Borrower to the Administrative Agent of notice upon the Borrower becoming aware of any change in the applicability of a Pricing Level.  Increases in the Applicable Margin resulting from a change in Pricing Level shall become effective on the effective date of any downgrade or withdrawal in the rating by Moody&#8217;s or S&#38;P of the senior unsecured long term debt rating of the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Approved Fund&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any Person (other than a natural person) that is (or will be) engaged in making, purchasing, holding or otherwise investing in commercial loans and similar extensions of credit in the ordinary course of its business that is administered or managed by (a) a Lender, (b) an Affiliate of a Lender or (c) an entity or an Affiliate of an entity that administers or manages a Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Assignment and Assumption&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; an assignment and assumption entered into by a Lender and an assignee (with the consent of any party whose consent is required by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;11.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), and accepted by the Administrative Agent, substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit&#160;E</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or any other form (including electronic documentation generated by use of an electronic platform) approved by the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Authorized Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; (a) the chief executive officer, president, chief financial officer, treasurer, assistant treasurer or controller of the Borrower, (b) solely for purposes of the delivery of incumbency certificates pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the secretary or any assistant secretary of the Borrower, and (c) solely  for purposes of notices given pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, any other officer or employee of the  Borrower so designated by any of the foregoing officers in a notice to the Administrative Agent. Any document delivered hereunder that is signed by an Authorized Officer shall be conclusively presumed to have been authorized by all necessary corporate and&#47;or other action on the part of the Borrower and such Authorized Officer shall be conclusively presumed to have acted on behalf of the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Bail-In Action&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the exercise of any Write-Down and Conversion Powers by the applicable Resolution Authority in respect of any liability of an Affected Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Bail-In Legislation&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (a) with respect to any EEA Member Country implementing Article 55 of Directive 2014&#47;59&#47;EU of the European Parliament and of the Council of the European Union, the implementing law, rule, regulation or requirement for such EEA Member Country from time to time which  is described in the EU Bail-In Legislation Schedule, and (b) with respect to the United Kingdom, Part I of  the United Kingdom Banking Act 2009 (as amended from time to time) and any other law, regulation or   rule applicable in the United Kingdom relating to the resolution of unsound or failing banks, investment firms or other financial institutions or their affiliates (other than through liquidation, administration or other insolvency proceedings).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Barclays&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;BAS&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; BofA Securities, Inc.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Beneficial Ownership Certification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58;  a certification regarding beneficial ownership required by the Beneficial Ownership Regulation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Beneficial Ownership Regulation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58;  31 C.F.R. &#167; 1010.230.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Benefit Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.23(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;BofA&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; means Bank of America, N.A. and its successors.</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Borrower&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Borrower Materials&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Borrowing Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (i) in respect of Revolving Credit Loans, any Domestic Business Day on which the Lenders shall make Revolving Credit Loans pursuant to a Borrowing Request or pursuant to a  Mandatory Borrowing, (ii) in respect of Competitive Bid Loans, any Domestic Business Day on which a Lender shall make a Competitive Bid Loan pursuant to a Competitive Bid Request, (iii) in respect of Swing Line Loans, any Domestic Business Day on which the Swing Line Lender shall make a Swing Line Loan pursuant to a Borrowing Request and (iv) in respect of Letters of Credit, any Domestic Business Day on which an Issuer shall issue a Letter of Credit pursuant to a Letter of Credit Request.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Borrowing Request&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a request for Revolving Credit Loans or Swing Line Loans substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or such other form as may be approved by the Administrative Agent, including any form on an electronic platform or electronic transmission system as shall be approved by the Administrative Agent, appropriately completed and signed by an Authorized Officer of the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Change of Control&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any of the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:24.69pt">any Person or group (as such term is used in Section 13(d)(3) of the Securities Exchange Act of 1934, as amended), (a) shall have or acquire beneficial ownership of securities having 35% or more of the ordinary voting power of the Borrower or (b) shall possess, directly or indirectly, the power to direct or cause the direction of the management and policies of the  Borrower, whether through the ownership of voting securities, by contract or otherwise&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.36pt">the Continuing Directors shall cease for any reason to constitute a majority of the board of directors of the Borrower then in office.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;CME&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; CME Group Benchmark Administration Limited.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Co-Documentation Agent&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Co-Documentation Agents&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Co-Syndication Agent&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Co-Syndication Agents&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commercial Letter of Credit Commitment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time with respect to any Issuer, the commitment of such Issuer to issue commercial Letters of Credit in accordance with the terms hereof in an aggregate outstanding face amount not exceeding the lesser of (a) the amount set forth adjacent to such Issuer&#8217;s name under the heading &#8220;Commercial Letter of Credit Commitment&#8221; in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> at such time or,   if not listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the &#8220;Commercial Letter of Credit Commitment&#8221; which such Issuer shall have assumed from another Issuer in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> on or prior to such time, as the same may be adjusted from time to time pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, or (b) 6.0% of the Aggregate Commitment Amount as in effect at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commercial Letter of Credit Exposure&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time in respect of any Issuer, an amount equal to such Issuer&#8217;s Letter of Credit Exposure in respect of commercial Letters of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commitment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; in respect of any Lender, such Lender&#8217;s undertaking to make Revolving Credit Loans, subject to the terms and conditions hereof, in an aggregate outstanding principal amount not to  exceed the Commitment Amount of such Lender.</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commitment Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time and with respect to any Lender, the amount set forth adjacent to such Lender&#8217;s name under the heading </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Commitment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> at such time or, in the event that such Lender is not listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Commitment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> which such Lender shall have assumed from another Lender in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> on or prior to such time, as the same may     be adjusted from time to time pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commitment Increase Supplement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a Commitment Increase Supplement substantially in the  form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit K</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commitment Percentage&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time and with respect to any Lender, a fraction (expressed as a percentage carried out to the ninth decimal place) the numerator of which is such Lender&#8217;s Commitment Amount at such time, and the denominator of which is the Aggregate Commitment Amount at such time&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that in the event the Commitments shall have expired or otherwise terminated or been terminated, then Commitment Percentage shall be determined immediately prior thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commitment Period&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the period commencing on the Effective Date and ending on the Commitment Termination Date or on such earlier date as all of the Commitments shall have been terminated in accordance with the terms hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commitment Termination Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the earlier of (i) May 16, 2027 (subject to extension as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) and (ii) the date on which the Loans shall become due and payable in accordance with the terms hereof, whether by acceleration, notice of intention to prepay or otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Committed Credit Exposure&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any Lender at any time, the sum at such time of (a) the outstanding principal balance of such Lender&#8217;s Revolving Credit Loans, (b) the Swing Line Exposure    of such Lender and (c) the Letter of Credit Exposure of such Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Communication&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.8(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Compensatory Interest Payment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.4(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Competitive Bid&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; an offer by a Lender, substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit H</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to make one or  more Competitive Bid Loans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Competitive Bid Accept&#47;Reject Letter&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a notification made by the Borrower pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Competitive Bid Loan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Competitive Bid Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as to any Competitive Bid made by a Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,  the fixed rate of interest (which shall be expressed in the form of a decimal to no more than four decimal places) offered by such Lender with respect thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Competitive Bid Request&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a request by the Borrower, substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit F</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, for Competitive Bids.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Competitive Interest Period&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as to any Competitive Bid Loan, the period commencing on the   date of such Competitive Bid Loan and ending on the date requested in the Competitive Bid Request with respect thereto, which shall not be earlier than 3 days after the date of such Competitive Bid Loan or later than 180 days after the date of such Competitive Bid Loan&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that if any Competitive Interest Period would end on a day other than a Domestic Business Day, such Competitive Interest Period shall be extended </font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to the next succeeding Domestic Business Day, unless such next succeeding Domestic Business Day would be a date on or after the Commitment Termination Date, in which case such Competitive Interest Period  shall end on the next preceding Domestic Business Day. Interest shall accrue from and including the first  day of a Competitive Interest Period to but excluding the last day of such Competitive Interest Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Conforming Changes&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to the use, administration of or any conventions associated with SOFR or any proposed Successor Rate or Term SOFR, as applicable, any conforming changes to the definitions of &#8220;Alternate Base Rate&#8221;, &#8220;SOFR&#8221;, &#8220;Term SOFR&#8221;, &#8220;Term SOFR Daily Floating Rate&#8221;, &#8220;One Month SOFR Rate&#8221; and &#8220;Term SOFR Interest Period&#8221;, the timing and frequency of determining rates and making payments of interest and other technical, administrative or operational matters (including, for the avoidance of doubt, the definitions of &#8220;Domestic Business Day&#8221; and &#8220;U.S. Government Securities Business Day&#8221;, timing of borrowing requests or prepayment, conversion or continuation notices and length of lookback periods) as may be appropriate, in the discretion of the Administrative Agent, in consultation with the Borrower, to reflect the adoption and implementation of such applicable rate(s) and to permit the administration thereof by the Administrative Agent in a manner substantially consistent with market   practice (or, if the Administrative Agent, in consultation with the Borrower, determines that adoption of    any portion of such market practice is not administratively feasible or that no market practice for the administration of such rate exists, in such other manner of administration as the Administrative Agent, in consultation with the Borrower, determines is reasonably necessary in connection with the administration    of this Agreement and any other Loan Document).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Consolidated&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Borrower and the Subsidiaries on a consolidated basis in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Contingent Obligation&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as to any Person (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">secondary obligor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), any obligation of such secondary obligor (a) guaranteeing or in effect guaranteeing any return on any investment made by another Person, or (b) guaranteeing or in effect guaranteeing any Indebtedness, lease, dividend or other obligation (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">primary obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) of any other Person (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">primary obligor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) in any manner, whether directly or indirectly, including any obligation of such secondary obligor, whether or not contingent, (i) to purchase   any such primary obligation or any Property constituting direct or indirect security therefor, (ii) to advance  or supply funds (A) for the purchase or payment of any such primary obligation or (B) to maintain working capital or equity capital of the primary obligor or otherwise to maintain the net worth or solvency of the primary obligor, (iii) to purchase Property, securities or services primarily for the purpose of assuring the beneficiary of any such primary obligation of the ability of the primary obligor to make payment of such primary obligation, (iv) otherwise to assure or hold harmless the beneficiary of such primary obligation against loss in respect thereof, and (v) in respect of the Indebtedness of any partnership in which such secondary obligor is a general partner, except to the extent that such Indebtedness of such partnership is nonrecourse to such secondary obligor and its separate Property&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that the term </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Contingent Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall not include the indorsement of instruments for deposit or collection in the ordinary course of business.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Continuing Director&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any member of the board of directors of the Borrower (i) who is a member of that board of directors on the Effective Date, (ii) who was nominated for election by the board of directors a majority of whom were directors on the Effective Date, or (iii) whose election or nomination for election was approved by one or more of such directors.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Control Person&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Convert&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Conversion&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Converted&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; each, a reference to a conversion pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> of one Type of Revolving Credit Loan into the other Type of Revolving Credit Loan.</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Costs&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Credit Exposure&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any Lender at any time, the sum of (a) the Committed Credit Exposure of such Lender at such time and (b) the outstanding principal balance of all Competitive Bid  Loans of such Lender at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Credit Parties&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Administrative Agent, the Swing Line Lender, the Issuers and the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Daily Simple SOFR&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any applicable determination date, SOFR published on such date on the Federal Reserve Bank of New York&#8217;s website (or any successor source).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Default&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any of the events specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, whether or not any requirement for the giving of notice, the lapse of time, or both, or any other condition, has been satisfied.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Defaulting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any Lender, as reasonably determined by the Administrative Agent, that has (a) failed to fund any portion of its Loans or participations in Letters of Credit or Swing Line Loans within two Domestic Business Days of the date required to be funded by it hereunder, unless such Lender notifies the Administrative Agent and the Borrower in writing that such failure is the result of such Lender&#8217;s determination that one or more conditions precedent to funding (each of which conditions precedent,  together with any applicable default, shall be specifically identified in such writing) has not been satisfied, (b) notified the Borrower or any Credit Party in writing that it does not intend to comply with any of its funding obligations under this Agreement or has made a public statement to the effect that it does not intend to comply with its funding obligations under this Agreement or generally under other agreements in which   it commits to extend credit, unless such writing or public statement relates to such Lender&#8217;s obligation to fund a Loan hereunder and states that such position is based on such Lender&#8217;s determination that a condition precedent to funding (which condition precedent, together with any applicable default, shall be specifically identified in such writing or public statement) cannot be satisfied, (c) failed, two Domestic Business Days after written request by the Administrative Agent (based on the reasonable belief that it may not fulfill its funding obligation), to confirm that it will comply with the terms of this Agreement relating to its  obligations to fund prospective Loans and participations in then outstanding Letters of Credit and Swing  Line Loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such Lender shall cease to be a Defaulting Lender under this clause (c) upon receipt by the Administrative Agent of such confirmation, (d) otherwise failed to pay over to the Administrative Agent or any other Lender any other amount required to be paid by it hereunder within two Domestic Business Days of the date when due, unless the subject of a good faith dispute, or (e) (i) becomes or is insolvent or has a parent company that has become or is insolvent, (ii) becomes the subject of a bankruptcy or insolvency proceeding, or has had a receiver, interim receiver, receiver and manager, administrator, liquidator, conservator, trustee or custodian appointed for it, or has taken any action in furtherance of, or indicating its consent to, approval of or acquiescence in any such proceeding or appointment or has a parent company that has become the subject of a bankruptcy or insolvency proceeding, or has had a receiver, interim receiver, receiver and manager, administrator, liquidator, conservator, trustee  or custodian appointed for it, or has taken any action in furtherance of, or indicating its consent to, approval of or acquiescence in any such proceeding or appointment, or (iii) becomes, or has a parent company that becomes, the subject of a Bail-in Action&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that a Lender shall not qualify as a Defaulting Lender solely as a result of the acquisition or maintenance of an ownership interest in such Lender or its parent company, or of the exercise of control over such Lender or any Person controlling such Lender, by a Governmental Authority or instrumentality thereof so long as such ownership interest does not result in or provide such Lender with immunity from the jurisdiction of courts within the United States of America or from the enforcement of judgments or writs of attachment on its assets or permit such Lender (or such Governmental Authority) to reject, repudiate, disavow or disaffirm any agreements made by such Lender.</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Disposition&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any Person, any sale, assignment, transfer or other disposition by  such Person by any means, of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.7pt">the stock of, or other equity interests of, any other Person,</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.02pt">any business, operating entity, division or segment thereof, or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.7pt">any other Property of such Person, other than (i) the sale of inventory (other than    in connection with bulk transfers), (ii) the disposition of equipment and (iii) the sale of cash investments.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Disqualified Institutions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; those Persons that are (a) competitors of the Borrower or its Subsidiaries, identified in writing by the Borrower to the Administrative Agent and the Lenders from time   to time (by posting such notice to the Platform) not less than one (1) Domestic Business Day prior to the  date of determination (it being understood that, notwithstanding anything herein to the contrary, in no event shall a supplement apply retroactively to disqualify any Person that has previously acquired an assignment  or participation interest hereunder that is otherwise an Eligible Assignee, but upon the effectiveness of such designation, any such Person may not acquire any additional Commitments, Advances or participations),   (b) such other Persons identified in writing by the Borrower to the Administrative Agent prior to the Effective Date and (c) Affiliates of the Persons identified pursuant to clause (a) or (b) that are either clearly identifiable by name or identified in writing by the Borrower to the Administrative Agent&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that &#8220;Disqualified Institutions&#8221; shall exclude any Person that the Borrower has designated as no longer being a &#8220;Disqualified Institution&#8221; by written notice delivered to the Administrative Agent and the Lenders from   time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Dividend Restrictions&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Dollar&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;$&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; lawful currency of the United States of America.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Domestic Business Day&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any day other than a Saturday, Sunday or a day which in New York   City is a legal holiday or a day on which banking institutions are authorized or required by law or other governmental action to close.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;EEA Financial Institution&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (a) any credit institution or investment firm established in any EEA Member Country which is subject to the supervision of an EEA Resolution Authority, (b) any entity established in an EEA Member Country which is a parent of an institution described in clause (a) of this definition, or (c) any financial institution established in an EEA Member Country which is a subsidiary of   an institution described in clause (a) or (b) of this definition and is subject to consolidated supervision with its parent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;EEA Member Country&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any of the member states of the European Union, Iceland, Liechtenstein, and Norway.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;EEA Resolution Authority&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any public administrative authority or any person entrusted with public administrative authority of any EEA Member Country (including any delegee) having responsibility for the resolution of any EEA Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Effective Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Electronic Copy&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.8(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Electronic Record&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.8(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Electronic Signature&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.8(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Eligible Assignee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a Person that is a permitted assignee under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that has received  the consent of each party whose consent is required under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  For the avoidance of doubt, any Disqualified Institution is subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Employee Benefit Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; an employee benefit plan, within the meaning of Section&#160;3(3) of ERISA, maintained, sponsored or contributed to by the Borrower, any Subsidiary or any ERISA Affiliate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Environmental Laws&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; all laws, rules, regulations, codes, ordinances, orders, decrees, judgments, injunctions, notices or binding agreements issued, promulgated or entered into by any Governmental Authority, relating in any way to the environment, preservation or reclamation of natural resources, the management, release or threatened release of any Hazardous Material or, as such relate to exposure to Hazardous Materials, to health and safety matters.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Environmental Liability&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as to any Person, any statutory, common law or equitable liability, contingent or otherwise (including any liability for damages, costs of environmental investigation, sampling or remediation, fines, penalties or indemnities), of such Person directly or indirectly resulting from or based upon (i) violation of any Environmental Law, (ii) the generation, use, handling, transportation, storage, treatment, discharge or disposal of any Hazardous Materials, (iii) exposure to any Hazardous Materials, (iv) the release or threatened release of any Hazardous Materials into the environment or (v) any contract, agreement or other consensual arrangement pursuant to which liability is assumed or imposed with respect  to any of the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Equity Interests</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; shares of capital stock, partnership interests, membership interests, beneficial interests or other ownership interests, whether voting or nonvoting, in, or interests in the income or profits  of, a Person, and any warrants, options or other rights entitling the holder thereof to purchase or acquire    any of the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;ERISA&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Employee Retirement Income Security Act of 1974, as amended from time to time,   or any successor thereto, and the rules and regulations issued thereunder, as from time to time in effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;ERISA Affiliate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; when used with respect to an Employee Benefit Plan, ERISA, the PBGC or a provision of the Internal Revenue Code pertaining to employee benefit plans, any Person that is a member   of any group of organizations within the meaning of Sections 414(b) or (c) of the Internal Revenue Code    or, solely with respect to the applicable provisions of the Internal Revenue Code, Section 414(m) or (o) of the Internal Revenue Code, of which the Borrower or any Subsidiary is a member.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">ERISA Event&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (a) any &#8220;reportable event&#8221;, as defined in Section&#160;4043 of ERISA with respect to     a Pension Plan (other than an event for which the 30-day notice period is waived)&#59; (b) the determination    that any Pension Plan is considered an at-risk plan or a plan in endangered or critical status within the meaning of Sections&#160;430, 431 or 432 of the Internal Revenue Code or Sections&#160;303, 304 or 305 of ERISA&#59; (c) the filing pursuant to the Internal Revenue Code or ERISA of an application for a waiver of the minimum funding standard with respect to any Pension Plan&#59; (d) the incurrence by the Borrower, any Subsidiary or    an ERISA Affiliate of any liability under Title IV of ERISA with respect to the termination of any Pension Plan, other than for PBGC premiums due but not delinquent under Section 4007 of ERISA, upon the Borrower, any Subsidiary or an ERISA Affiliate&#59; (e) the receipt by the Borrower, any Subsidiary or an ERISA Affiliate from the PBGC or a plan administrator of any notice relating to an intention to terminate any Pension Plan or to appoint a trustee to administer any Pension Plan&#59; (f) the incurrence by the Borrower, </font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any Subsidiary or an ERISA Affiliate of any liability with respect to the withdrawal or partial withdrawal from any Pension Plan or Multiemployer Plan&#59; (g) any limits under Section 436 of the Internal Revenue Code become applicable&#59; or (h) any failure to make any payment required by Section 430(j) of the Internal Revenue Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;ESG&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.14(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;ESG Amendment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.14(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;ESG Applicable Margin Adjustments&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.14(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;ESG Pricing Provisions&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.14(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;EU Bail-In Legislation Schedule&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the EU Bail-In Legislation Schedule published by the Loan Market Association (or any successor person), as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Event of Default&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any of the events specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any requirement for   the giving of notice, the lapse of time, or both, or any other condition has been satisfied.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Excluded Taxes&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to the Administrative Agent, any Lender, any Issuer or any other recipient of any payment to be made by or on account of any obligation of the Borrower hereunder or any other Loan Document, (a)&#160;Taxes imposed on or measured by its net income (however denominated) or overall gross receipts, and franchise Taxes, in each case, (i) imposed on it by the jurisdiction (or any political subdivision thereof) under the laws of which it is organized or in which its principal office is located or, in the case of any Lender, in which its applicable lending office is located, or (ii) that are Other Connection Taxes, (b)&#160;any branch profits Taxes imposed by the United States of America or that are Other Connection Taxes, (c)&#160;in the case of a Lender, any withholding Tax that  is imposed on amounts payable to such Lender at the time such Lender becomes a party hereto (other than an assignee pursuant to a request by the Borrower under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) or designates a new lending office, except, in each case, to the extent that such Lender (or its assignor, if any) was entitled, at the time of designation of a new lending office (or assignment), to receive additional amounts from the Borrower with respect to such withholding Tax pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section  3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, (d) any Tax attributable to such recipient&#8217;s failure or inability to comply with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and (e) any Taxes imposed under FATCA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Existing Commitment Termination Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.12(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Existing 2018 Credit Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Five Year Credit Agreement, dated as of May 17, 2018,     by and among the Borrower, the lenders party thereto from time to time, Barclays and JPMC, as                  co-syndication agents, BofA, GS and Wells Fargo, as co-documentation agents, and The Bank of New York Mellon, as administrative agent, as amended by Amendment No. 1 to Five Year Credit Agreement, dated    as of May 16, 2019, and as the same may be amended, amended and restated, supplemented, replaced or otherwise modified from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Existing 2019 Credit Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Five Year Credit Agreement, dated as of May 16, 2019,     by and among the Borrower, the lenders party thereto from time to time, Barclays and JPMC, as                 co-syndication agents, GS and Wells Fargo, as co-documentation agents, and BofA, as administrative agent, as the same may be amended, amended and restated, supplemented, replaced or otherwise modified from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Existing 2021 Credit Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Five Year Credit Agreement, dated as of May 11, 2021,     by and among the Borrower, the lenders party thereto from time to time, Barclays and JPMC, as co-</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">syndication agents, GS and Wells Fargo, as co-documentation agents, and BofA, as administrative agent,    as the same may be amended, amended and restated, supplemented, replaced or otherwise modified from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Expiration Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the first date, occurring on or after the date the Commitments shall have terminated or been terminated in accordance herewith, upon which there shall be no Loans, Reimbursement Obligations or Letters of Credit outstanding.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Extension Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.12(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Extension Request&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.12(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Facility Fee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;FATCA&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; Sections 1471 through 1474 of the Internal Revenue Code, as of the date of this Agreement (or any amended or successor version that is substantively comparable and not materially more onerous to comply with), any current or future regulations or official interpretations thereof, any agreements entered into pursuant to Section 1471(b)(1) of the Internal Revenue Code, any applicable intergovernmental agreements with respect thereto, and any treaty, law, regulations, or other official guidance enacted in any other jurisdiction relating to such intergovernmental agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Federal Funds Effective Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;  for any day, the rate per annum calculated by the Federal Reserve Bank of New York based on such day&#8217;s federal funds transactions by depository institutions (as determined in such manner as the Federal Reserve Bank of New York shall set forth on its public website from time to time) and published on the next succeeding Domestic Business Day by the Federal Reserve Bank of New York as the federal funds effective rate&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if the Federal Funds Effective Rate as so determined would be less than zero, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Federal Funds Effective Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall be deemed to be zero for purposes of    this Agreement and the other Loan Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Fees&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.2(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Financial Statements&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Foreign Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any Lender or any Issuer that is not a United States person within the meaning  of Section 7701(a)(30) of the Internal Revenue Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;GAAP&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.2(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, generally accepted accounting principles set forth in the  opinions and pronouncements of the Accounting Principles Board and the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or such other principles as may be approved by a significant segment of the accounting profession, which are applicable to the circumstances as of the date of determination, consistently applied.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Governmental Authority&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any foreign, federal, state, municipal or other government, or any department, commission, board, bureau, agency, public authority or instrumentality thereof, or any court, arbitrator, regulatory body or central bank (including any supra-national bodies such as the European Union or the European Central Bank).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;GS&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Hazardous Materials&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; all ignitable, explosive, reactive, corrosive or radioactive substances or wastes and all hazardous or toxic materials, substances, chemicals, wastes or other pollutants, including but </font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">not limited to petroleum or petroleum distillates, asbestos or asbestos containing materials, polychlorinated biphenyls, radon gas, toxic mold, infectious or medical wastes, hazardous biological agents, hazardous pharmaceutical substances and all other materials, substances, chemicals, wastes, contaminants or    pollutants of any nature that are now or hereafter regulated pursuant to any Environmental Law, or are now or hereafter defined, listed or classified as a hazardous or toxic material, substance, chemical, waste, contaminant or pollutant in any Environmental Law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Highest Lawful Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as to any Lender, the maximum rate of interest, if any, which at any time   or from time to time may be contracted for, taken, charged or received on the Loans or the Notes or which may be owing to such Lender pursuant to this Agreement under the laws applicable to such Lender and this Agreement and the other Loan Documents. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Increasing Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Indebtedness&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as to any Person at a particular time, all items of such Person which constitute, without duplication, (a) indebtedness for borrowed money or the deferred purchase price of Property (other than trade payables and accrued expenses incurred in the ordinary course of business), (b) indebtedness evidenced by notes, bonds, debentures or similar instruments, (c) indebtedness with respect to any conditional sale or other title retention agreement, (d) indebtedness arising under acceptance facilities and  the amount available to be drawn under all letters of credit (excluding, for purposes of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, letters    of credit obtained in the ordinary course of business by the Borrower or any Subsidiary) issued for the account of such Person and, without duplication, all drafts drawn thereunder to the extent such Person shall not have reimbursed the issuer thereof in respect of such issuer&#8217;s payment of such drafts, (e) that portion of any obligation of such Person, as lessee, which in accordance with GAAP is required to be capitalized on      a balance sheet of such Person, (f) all indebtedness described in clauses (a) through (e) above secured by    any Lien on any Property owned by such Person even though such Person shall not have assumed or otherwise become liable for the payment thereof (other than carriers&#8217;, warehousemen&#8217;s, mechanics&#8217;, repairmen&#8217;s or other like non-consensual Liens arising in the ordinary course of business), and (g) Contingent Obligations in respect of any indebtedness described in clauses (a) through (f) above&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that, for purposes of this definition, Indebtedness shall not include Intercompany Debt and obligations in respect of interest rate caps, collars, exchanges, swaps or other, similar agreements.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Indebtedness for Borrowed Money&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as to any Person at a particular time, all items of such Person which constitute, without duplication, (a) indebtedness for borrowed money or the deferred purchase price  of Property (other than trade payables and accrued expenses incurred in the ordinary course of business),    (b) indebtedness evidenced by notes, bonds, debentures or similar instruments, (c) that portion of any obligation of such Person, as lessee, which in accordance with GAAP is required to be capitalized on a balance sheet of such Person, and (d) Contingent Obligations in respect of any indebtedness described in clauses (a) through (c) above&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that, for purposes of this definition, Indebtedness for Borrowed Money shall not include Intercompany Debt and obligations in respect of interest rate caps, collars, exchanges, swaps or other, similar agreements.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Indemnified Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Indemnified Liabilities&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.5(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Indemnified Person&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Indemnified Taxes&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (a) Taxes, other than Excluded Taxes, imposed on or with respect to any payment made by or on account of any obligation of the Borrower under any Loan Document and (b) to     the extent not otherwise described in clause (a), Other Taxes.</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Information&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.14(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Insurance Subsidiary&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any Subsidiary subject to regulation by the commissioner of insurance,   the commissioner of health or any equivalent Governmental Authority in any applicable jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Intangible Assets&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any date, the value, as shown on the most recent Consolidated balance sheet of the Borrower and the Subsidiaries as at the end of the fiscal quarter ending not more than 135 days prior  to such date, prepared in accordance with GAAP, of&#58; (i) all trade names, trademarks, licenses, patents, copyrights, service marks, goodwill and other like intangibles, (ii) organizational and development costs,  (iii) deferred charges (other than prepaid items, such as insurance, taxes, interest, commissions, rents, pensions, compensation and similar items and tangible assets being amortized), and (iv) unamortized debt discount and expense, less unamortized premium.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Intercompany Debt&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (i) Indebtedness of the Borrower to one or more of the Subsidiaries of the Borrower and (ii) Indebtedness of one or more of the Subsidiaries of the Borrower to the Borrower or any one or more of the other Subsidiaries of the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Interest Payment Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (i) as to any ABR Advance, the last day of each March, June, September and December, commencing on the first of such days to occur after such ABR Advance is made or any   Term SOFR Advance is converted to an ABR Advance, (ii) as to any Swing Line Loan, the day on which  the outstanding principal balance of such Swing Line Loan shall become due and payable in accordance  with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, (iii) as to any Term SOFR Advance in respect of which the Borrower has selected a Term SOFR Interest Period of one or three months, the last day of such Term SOFR Interest Period, (iv) as to any Competitive Bid Loan in respect of which the Borrower has selected a Competitive Interest Period    of 90 days or less, the last day of such Competitive Interest Period and (v) as to any Term SOFR Advance   or Competitive Bid Loan in respect of which the Borrower has selected an Interest Period greater than three months or 90 days, as the case may be, the last day of the third month or the 90th day, as the case may be,   of such Interest Period and the last day of such Interest Period.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Interest Period&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a Term SOFR Interest Period or a Competitive Interest Period, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Internal Revenue Code&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Internal Revenue Code of 1986, as amended from time to time, or any successor thereto, and the rules and regulations issued thereunder, as from time to time in effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;issue&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;issuance&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; when used with respect to a Letter of Credit, shall be deemed to include    any increase in the amount of such Letter of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Issuers&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; Barclays, BofA, GS, JPMC and Wells Fargo&#59; each an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Issuer&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Joint Lead Arrangers&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BAS, Barclays, GS, JPMC and WFS.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;JPMC&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;KPIs&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.14(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Lenders&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble&#59; such term to also include the Swing Line Lender and each Issuer where the context hereof requires or permits such inclusion.</font></div><div style="margin-bottom:15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Lender Party&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;10.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letters of Credit&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.8(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit Application&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; an application and agreement for the issuance or amendment of a Letter of Credit in the form from time to time in use by the applicable Issuer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit Commitment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time with respect to any Issuer, the commitment of such Issuer to issue Letters of Credit (which, for the avoidance of doubt, shall include all standby letters of credit and all commercial letters of credit issued by such Issuer) in accordance with the terms hereof in an aggregate outstanding face amount not exceeding the lesser of (a) the amount set forth adjacent to such Issuer&#8217;s name under the heading &#8220;Letter of Credit Commitment&#8221; in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> at such time or, if not listed   on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the &#8220;Letter of Credit Commitment&#8221; which such Issuer shall have assumed from another Issuer in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> on or prior to such time, as the same may be adjusted from time to time pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and (b) the amount equal to the Aggregate Commitment Amount  as in effect at such time multiplied by a percentage equal to a fraction, the numerator of which is one and   the denominator of which is five.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit Exposure&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time, (a) in respect of all Lenders, the sum, without duplication, of (i) the maximum aggregate amount which may be drawn under all unexpired Letters of Credit at such  time (whether or not the conditions for drawing thereunder have or may be satisfied), (ii) the aggregate amount, at such time, of all unpaid drafts (which have not been dishonored) drawn under all Letters of Credit, and (iii) the aggregate unpaid principal amount of the Reimbursement Obligations at such time, (b)  in respect of any Lender, an amount equal to such Lender&#8217;s Commitment Percentage at such time multiplied by the amount determined under clause (a) of this definition, and (c) in respect of any Issuer, the amount determined under clause (a) of this definition in respect of a Letter of Credit issued by such Issuer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit Participation Fee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit Request&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a request substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit J</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Lien&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any mortgage, pledge, hypothecation, assignment, lien, deposit arrangement, charge, encumbrance or other security arrangement or security interest of any kind, or the interest of a vendor or lessor under any conditional sale agreement, capital lease or other title retention agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that   in no event shall an operating lease or license of Intangible Assets be deemed to constitute a Lien.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Loan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a Revolving Credit Loan, a Competitive Bid Loan or a Swing Line Loan, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Loan Documents&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; this Agreement and, upon the execution and delivery thereof, the Notes, if   any, and the Reimbursement Agreements, if any.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Loans&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Revolving Credit Loans, the Competitive Bid Loans and the Swing Line Loans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Mandatory Borrowing&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Margin Stock&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">margin stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as said term is defined in Regulation U of the Board of Governors of the Federal Reserve System, as the same may be amended or supplemented from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Material Acquisition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any acquisition of (a) Equity Interests in any Person if, after giving effect thereto, such Person will become a Subsidiary or (b) assets comprising all or substantially all the assets of  (or all or substantially all the assets constituting a business unit, division, product line or line of business    of) any Person&#59; provided that the aggregate consideration therefor (including Indebtedness assumed in </font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">connection therewith, all obligations in respect of the deferred purchase price therefor (including    obligations under any purchase price adjustment but excluding earn-out or similar payments) and all other consideration payable in connection therewith (including payment obligations in respect of noncompetition agreements or other arrangements representing acquisition consideration)) equals or exceeds $500,000,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Material Adverse&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any change or effect, a material adverse change in, or effect   on, as the case may be, (i) the financial condition, operations, business, or Property of the Borrower and the Subsidiaries taken as a whole, (ii) the ability of the Borrower to perform its obligations under the Loan Documents, or (iii) the ability of the Administrative Agent, any Issuer or any Lender to enforce the Loan Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Material Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; a Subsidiary of the Borrower with respect to which (i) the Borrower&#8217;s and  its other Subsidiaries&#8217; investments in, and advances to, such Subsidiary exceed ten percent (10%) of the   total assets of the Borrower and its Consolidated Subsidiaries as of the end of the most recently completed fiscal year, (ii) the Borrower&#8217;s and its other Subsidiaries&#8217; proportionate share of the total assets (after intercompany eliminations) of such Subsidiary exceeds 10 percent (10%) of the total assets of the Borrower and its Consolidated Subsidiaries as of the end of the most recently completed fiscal year, or (iii) the Borrower&#8217;s and its other Subsidiaries&#8217; equity in the income from continuing operations before income taxes of such Subsidiary exclusive of amounts attributable to any non-controlling interests exceeds ten percent (10%) of such income of the Borrower and its Consolidated Subsidiaries for the most recently completed fiscal year.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Moody&#8217;s&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; Moody&#8217;s Investors Service, Inc., or any successor thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Multiemployer Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a Pension Plan which is a multiemployer plan as defined in Section 4001(a)(3) of ERISA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Negotiated Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; with respect to each Swing Line Loan, the rate per annum agreed to in writing  by the Borrower and the Swing Line Lender as the interest rate which such Swing Line Loan shall bear.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Net Tangible Assets&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any date, the total assets as shown on the most recent Consolidated balance sheet of the Borrower and the Subsidiaries as at the end of the fiscal quarter ending not more than 135 days prior to such date, prepared in accordance with GAAP, less, without duplication (i) all current liabilities (due within one year) as shown on such balance sheet and (ii) Intangible Assets and liabilities relating thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;New Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Non-Extending Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.12(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Note&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to each Lender that has requested one in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, a promissory note evidencing such Lender&#8217;s Loans payable to such Lender (or, if required by such Lender,     to such Lender and its registered assigns), substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;One Month SOFR Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; for any interest calculation with respect to an ABR Advance on any  date, the rate per annum equal to the Term SOFR Screen Rate with a term of one month commencing that day, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that in the event that the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">One Month SOFR Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> would otherwise be less than zero, such </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">One Month SOFR Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be deemed to be zero for purposes of this Agreement and the other Loan Documents.</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Other Connection Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to the Administrative Agent, any Lender, any Issuer or   any other recipient of any payment to be made by or on account of any obligation of the Borrower hereunder or any other Loan Document, Taxes imposed as a result of a present or former connection between such recipient and the jurisdiction imposing such Tax (other than connections arising from such recipient having executed, delivered, become a party to, performed its obligations under, received payments under, received or perfected a security interest under, engaged in any other transaction pursuant to, enforced any Loan Document, or sold or assigned an interest in any Loan or Loan Document).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Other Taxes&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; all present or future stamp, court or documentary Taxes or any other excise or property Taxes, charges or similar levies arising from any payment made hereunder or under any other   Loan Document or from the execution, delivery or enforcement of, or otherwise with respect to, this Agreement or any other Loan Document, except any such Taxes that are Other Connection Taxes imposed with respect to an assignment (other than an assignment made pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Participant&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Participant Register&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Patriot Act&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;PBGC&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Pension Benefit Guaranty Corporation established pursuant to Subtitle A of Title IV  of ERISA, or any Governmental Authority succeeding to the functions thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pension Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time, any Employee Benefit Plan (including a Multiemployer Plan) subject to Section 302 of ERISA or Section 412 of the Internal Revenue Code, the funding requirements of which are, or at any time within the six years immediately preceding the time in question were, in whole or in part, the responsibility of the Borrower, any Subsidiary or an ERISA Affiliate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Person&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any individual, firm, partnership, limited liability company, joint venture, corporation, association, business trust, joint stock company, unincorporated association, trust, Governmental Authority or any other entity, whether acting in an individual, fiduciary, or other capacity, and for the purpose of the definition of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ERISA Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, a trade or business.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Plan of Reorganization&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;11.7(h)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Platform&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pricing Level&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; Pricing Level I, Pricing Level II, Pricing Level III, Pricing Level IV, Pricing   Level V or Pricing Level VI, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pricing Level I&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any time when the senior unsecured long term debt rating of the Borrower by    (x) S&#38;P is A or higher or (y) Moody&#8217;s is A2 or higher.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pricing Level II&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any time when (i) the senior unsecured long term debt rating of the Borrower   by (x) S&#38;P is A- or higher or (y) Moody&#8217;s is A3 or higher and (ii) Pricing Level I does not apply.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pricing Level III&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any time when (i) the senior unsecured long term debt rating of the Borrower  by (x) S&#38;P is BBB+ or higher or (y) Moody&#8217;s is Baa1 or higher and (ii) neither Pricing Level I nor Pricing Level II applies.</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pricing Level IV&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any time when (i) the senior unsecured long term debt rating of the Borrower  by (x) S&#38;P is BBB or higher or (y) Moody&#8217;s is Baa2 or higher and (ii) none of Pricing Level I, Pricing  Level II or Pricing Level III applies.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pricing Level V&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any time when (i) the senior unsecured long term debt rating of the Borrower    by (x) S&#38;P is BBB- or higher or (y) Moody&#8217;s is Baa3 or higher and (ii) none of Pricing Level I, Pricing Level II, Pricing Level III or Pricing Level IV applies.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pricing Level VI&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any time when none of Pricing Level I, Pricing Level II, Pricing Level III, Pricing Level IV or Pricing Level V applies.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding each definition of Pricing Level set forth above, if at any time the senior unsecured long term debt ratings of the Borrower by S&#38;P and Moody&#8217;s differ by more than one equivalent rating level,   then the applicable Pricing Level shall be determined based upon the lower such rating adjusted upwards     to the next higher rating level.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Proceeding&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Prohibited Transaction&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a transaction that is prohibited under Section 4975 of the Internal Revenue Code or Section 406 of ERISA and not exempt under Section 4975 of the Internal Revenue Code, Section 408 of ERISA or any applicable administrative exemptions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Property&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; in respect of any Person, all types of real, personal or mixed property and all types of tangible or intangible property owned or leased by such Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;PTE&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.23(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Regulatory Change&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the occurrence, after the date hereof, of any of the following&#58; (a) the  adoption or taking effect of any law, rule, regulation or treaty, (b) any change in any law, rule, regulation     or treaty or in the administration, implementation, interpretation or application thereof by any   Governmental Authority or (c) the making or issuance of any request, guideline or directive (whether or    not having the force of law) by any Governmental Authority&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, notwithstanding anything   herein to the contrary, (i) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives thereunder or issued in connection therewith and (ii) all requests, rules, guidelines or directives promulgated by the Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case, pursuant to Basel III, in the case of each of clauses (i) and (ii), shall be deemed to  be a &#8220;Regulatory Change&#8221;, regardless of the date enacted, adopted or issued, but only if any such requirements are generally applicable to (and for which reimbursement is generally being sought by the Lenders in respect of) credit transactions similar to this transaction from similarly situated borrowers (which are parties to credit or loan documentation containing a provision similar to this definition), as determined  by the Lenders in their respective reasonable discretion.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Register&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Reimbursement Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.8(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and, as the context requires, shall  include the Letter of Credit Application related to the applicable Letter of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Reimbursement Obligations&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; all obligations and liabilities of the Borrower due and to become  due (a) under the Reimbursement Agreements and (b) hereunder in respect of Letters of Credit.</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Related Parties&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any specified Person, such Person&#8217;s Affiliates and the respective directors, officers, employees, agents and advisors of such Person and such Person&#8217;s Affiliates.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Replaced Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Replacement Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Required Lenders&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (a) at any time prior to the Commitment Termination Date or such earlier   date as all of the Commitments shall have terminated or been terminated in accordance herewith, Lenders having Commitment Amounts greater than 50% of the Aggregate Commitment Amount, and (b) at all other times, Lenders having Credit Exposure greater than 50% of the Aggregate Credit Exposure.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Rescindable Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.2(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Resolution Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; an EEA Resolution Authority or, with respect to any UK Financial Institution, a UK Resolution Authority.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Restrictive Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Revolving Credit Loan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Revolving Credit Loans&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;S&#38;P&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; Standard &#38; Poor&#8217;s Financial Services LLC, a subsidiary of S&#38;P Global Inc., or any successor thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Sanctioned Country&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time, a country or territory which is the subject or target of any Sanctions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Sanctioned Person&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time, (a) any Person listed in any Sanctions-related list of designated Persons maintained by the Office of Foreign Assets Control of the U.S. Department of the Treasury or the U.S. Department of State, (b) any Person operating, organized or resident in a Sanctioned Country or (c)   any Person controlled by any such Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Sanctions&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; economic or financial sanctions or trade embargoes imposed, administered or   enforced from time to time by the U.S. government, including those administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury or the U.S. Department of State.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Scheduled Unavailability Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(c)(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">SEC Reports</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the Borrower&#8217;s 2021 Annual Report on Form 10-K, the Borrower&#8217;s quarterly   report on Form 10-Q for the quarterly period ending March 31, 2022, and any 8-K filings made by the Borrower subsequent to March 31, 2022 and prior to the Effective Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Secured Overnight Financing Rate as administered by the Federal Reserve Bank of New York (or a successor administrator).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;SOFR Adjustment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> with respect to Daily Simple SOFR and any Term SOFR Interest Period, 0.10% (10.0 basis points).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Special Counsel&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; such counsel as the Administrative Agent may engage from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Subsidiary&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time and from time to time, any corporation, partnership, limited liability company, joint venture or other business entity of which the Borrower and&#47;or any Subsidiary of the </font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Borrower, directly or indirectly at such time, either (a) in respect of a corporation, owns or controls more than 50% of the outstanding stock having ordinary voting power to elect a majority of the board of directors or similar managing body, irrespective of whether a class or classes shall or might have voting power by reason of the happening of any contingency, or (b) in respect of a partnership, limited liability company,  joint venture or other business entity, is entitled to share in more than 50% of the profits and losses, however determined.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Successor Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Sustainability Coordinator&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; BofA Securities, Inc., in its capacity as the sustainability  coordinator.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Sustainability Linked Loan Principles&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Sustainability-Linked Loan Principles (as published  in March 2022 by the Loan Market Association, Asia Pacific Loan Market Association and Loan Syndications &#38; Trading Association).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Commitment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the commitment of the Swing Line Lender to make Swing Line Loans in accordance with the terms hereof in an aggregate outstanding principal amount not exceeding $100,000,000 (or, if less, the Aggregate Commitment Amount) at any time, as the same may be reduced pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Commitment Period&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the period from the Effective Date to, but excluding, the Swing Line Termination Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Exposure&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time, in respect of any Lender, an amount equal to the aggregate principal balance of such Lender&#8217;s Swing Line Participation Amount.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; BofA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Loan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Loans&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Maturity Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Participation Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Termination Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the date which is 7 Domestic Business Days prior to the Commitment Termination Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Taxes&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; all present or future taxes, levies, imposts, duties, deductions, withholdings, assessments, fees or other charges in the nature of a tax imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; for any Term SOFR Interest Period with respect to a Term SOFR Advance, the    rate per annum equal to the Term SOFR Screen Rate two U.S. Government Securities Business Days prior  to the commencement of such Term SOFR Interest Period with a term equivalent to such Term SOFR Interest Period&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if the rate is not published prior to 11&#58;00 A.M. on such determination date   then Term SOFR means the Term SOFR Screen Rate on the first U.S. Government Securities Business Day immediately prior thereto, in each case,</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the SOFR Adjustment for such Term SOFR Interest Period&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, further, that if Term SOFR determined pursuant to the above would be less than zero, Term SOFR shall be deemed zero for purposes of this Agreement and the other  Loan Documents.</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Term SOFR Advance&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a portion of the Revolving Credit Loans selected by the Borrower to bear interest during a Term SOFR Interest Period selected by the Borrower at a rate based upon Term SOFR, all pursuant to and in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Term SOFR Daily Floating Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; for any interest calculation with respect to a Term SOFR   Daily Floating Rate Loan on any date, a fluctuating rate of interest, which can change on each Domestic Business Day, equal to the Term SOFR Screen Rate, two U.S. Government Securities Business Days prior  to such day, with a term equivalent to one month beginning on that date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that if the rate is not published prior to 11&#58;00 A.M. on such determination date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">then the Term SOFR Daily Floating Rate means the Term SOFR Screen Rate on the first U.S. Government Securities Business Day immediately prior thereto, in each case, plus the SOFR Adjustment for Term SOFR for a one-month Interest Period&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that, (i) to the extent a comparable or successor rate is approved by the Swing Line Lender in connection herewith, the approved rate shall be applied in a manner consistent with market practice&#59; provided, further that to the extent such market practice is not administratively feasible for the Swing Line Lender, such approved rate shall be applied in a manner as otherwise reasonably determined by the Swing Line Lender in consultation with the Borrower, (ii) if the Term SOFR Daily Floating Rate determined pursuant to the above would be less than zero, such rate shall be deemed zero for purposes of this Agreement and the other Loan Documents, and (iii) if such rate is not available at such time for any reason, then the   rate will be determined by such alternate method as reasonably selected by the Swing Line Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Term SOFR Interest Period&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as to each Term SOFR Advance, the period commencing on the  date such Term SOFR Advance is disbursed or converted to or continued as a Term SOFR Advance and ending on the date one, three or six months thereafter, as selected by the Borrower in its Borrowing Request&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">any Term SOFR Interest Period that would otherwise end on a day that is not a Domestic Business Day shall be extended to the next succeeding Domestic Business Day unless  such Domestic Business Day falls in another calendar month, in which case such Term SOFR Interest Period shall end on the next preceding Domestic Business Day&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">any Term SOFR Interest Period that begins on the last Domestic Business Day of     a calendar month (or on a day for which there is no numerically corresponding day in the calendar month at the end of such Term SOFR Interest Period) shall end on the last Domestic Business Day  of the calendar month at the end of such Term SOFR Interest Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Term SOFR Replacement Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Term SOFR Screen Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the forward-looking SOFR term rate administered by CME (or any successor administrator reasonably satisfactory to the Administrative Agent) and published on the   applicable Reuters screen page (or such other commercially available source providing such quotations as may be designated by the Administrative Agent from time to time in its reasonable discretion).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Termination Event&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any Pension Plan, (a) an ERISA Event, (b) the termination    of a Pension Plan under Section 4041(c) of ERISA, or the filing of a notice of intent to terminate a Pension Plan under Section 4041(c) of ERISA, or the treatment of a Pension Plan amendment as a termination under Section 4041(e) of ERISA (except an amendment made after such Pension Plan satisfies the requirement    for a standard termination under Section 4041(b) of ERISA), (c) the institution of proceedings by the PBGC to terminate a Pension Plan under Section 4042 of ERISA, or (d) the appointment of a trustee to administer any Pension Plan under Section 4042 of ERISA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Threshold Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; $300,000,000.</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Total Capitalization&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any date, the sum of the Borrower&#8217;s Consolidated Indebtedness and shareholders&#8217; equity on such date, determined in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Trade Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Type&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any Revolving Credit Loan, the characteristic of such Loan as an ABR Advance or a Term SOFR Advance, each of which constitutes a Type of Revolving Credit Loan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">UK Financial Institution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any BRRD Undertaking (as such term is defined under the PRA Rulebook (as amended form time to time) promulgated by the United Kingdom Prudential Regulation Authority) or any person subject to IFPRU 11.6 of the FCA Handbook (as amended from time to time) promulgated by the United Kingdom Financial Conduct Authority, which includes certain credit institutions and investment firms, and certain affiliates of such credit institutions or investment firms.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">UK Resolution Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Bank of England or any other public administrative authority having responsibility for the resolution of any UK Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Unqualified Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.4(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Upstream Dividends&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;U.S. Government Securities Business Day&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any Domestic Business Day, except any Domestic Business Day on which any of the Securities Industry and Financial Markets Association, the New York Stock Exchange or the Federal Reserve Bank of New York is not open for business because such day is a legal holiday under the federal laws of the United States or the laws of the State of New York, as applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;U.S. Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;United States Tax Compliance Certificate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10(f)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Wells Fargo&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">WFS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; Wells Fargo Securities, LLC.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Write-Down and Conversion Powers&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (a) with respect to any EEA Resolution Authority, the write-down and conversion powers of such EEA Resolution Authority from time to time under the Bail-In Legislation for the applicable EEA Member Country, which write-down and conversion powers are described in the EU Bail-In Legislation Schedule, and (b) with respect to the United Kingdom, any powers  of the applicable Resolution Authority under the Bail-In Legislation to cancel, reduce, modify or change    the form of a liability of any UK Financial Institution or any contract or instrument under which that liability arises, to convert all or part of that liability into shares, securities or obligations of that person or any other person, to provide that any such contract or instrument is to have effect as if a right had been exercised  under it or to suspend any obligation in respect of that liability or any of the powers under that Bail-In Legislation that are related to or ancillary to any of those powers. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Principles of Construction</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">All capitalized terms defined in this Agreement shall have the meanings given to such capitalized terms herein when used in the other Loan Documents or in any certificate, opinion or other document made or delivered pursuant hereto or thereto, unless otherwise expressly   provided therein.</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Unless otherwise expressly provided herein, the word </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;fiscal&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> when used herein shall refer to the relevant fiscal period of the Borrower. As used in the Loan Documents and in any certificate, opinion or other document made or delivered pursuant thereto, accounting terms not defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and accounting terms partly defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the extent not defined, shall have the respective meanings given to them under GAAP as in effect from time to time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, if the Borrower notifies the Administrative Agent that the Borrower requests an amendment to any provision hereof to eliminate the effect of any change occurring after the date hereof in GAAP or in the application thereof on the operation of such provision (or if the Administrative Agent notifies the Borrower that the Required Lenders request an amendment to    any provision hereof for such purpose), regardless of whether any such notice is given before or  after such change in GAAP or in the application thereof, then such provision&#160;shall be interpreted    on the basis of, and any accounting term related thereto shall have the respective meaning given to   it under, GAAP as in effect and applied immediately before such change shall have become  effective until such notice shall have been withdrawn or such provision amended in accordance herewith.  Any lease that is characterized as an operating lease in accordance with GAAP after the Borrower&#8217;s adoption of ASC 842 (regardless of the date on which such lease has been entered into) shall not be a capital or finance lease, and any such lease shall be, for all purposes of this  Agreement, treated as though it were reflected on the Borrower&#8217;s consolidated financial statements  in the same manner as an operating lease would have been reflected prior to Borrower&#8217;s adoption    of ASC 842.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The words </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;hereof&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;herein&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;hereto&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;hereunder&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and similar words    when used in each Loan Document shall refer to such Loan Document as a whole and not to any particular provision of such Loan Document, and Section, schedule and exhibit references   contained therein shall refer to Sections thereof or schedules or exhibits thereto unless otherwise expressly provided therein.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">All references herein to a time of day shall mean the then-applicable time in New York, New York, unless otherwise expressly provided herein.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Section headings have been inserted in the Loan Documents for convenience only and shall not be construed to be a part thereof. Unless the context otherwise requires, words in the singular number include the plural, and words in the plural include the singular.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.02pt">Whenever in any Loan Document or in any certificate or other document made or delivered pursuant thereto, the terms thereof require that a Person sign or execute the same or refer  to the same as having been so signed or executed, such terms shall mean that the same shall be, or was, duly signed or executed by (i) in respect of any Person that is a corporation, any duly  authorized officer thereof, and (ii) in respect of any other Person (other than an individual), any analogous counterpart thereof.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">The words </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;include&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;including&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, when used in each Loan Document, shall mean that the same shall be included </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;without limitation&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, unless otherwise specifically provided.</font></div><div style="margin-bottom:147pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">All references to &#8220;knowledge&#8221; or &#8220;awareness&#8221; of the Borrower or any Subsidiary means the actual knowledge of an Authorized Officer of the Borrower or such Subsidiary.</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><div id="ifeec14c7a618494cb040e343e2bc92c6_308"></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">AMOUNT AND TERMS OF LOANS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Revolving Credit Loans</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Subject to the terms and conditions hereof, each Lender severally (and not jointly) agrees to make loans in Dollars under this Agreement (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Revolving Credit Loan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and, collectively with each other Revolving Credit Loan of such Lender and&#47;or with each Revolving Credit Loan of each other Lender, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Revolving Credit Loans&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) to the Borrower from time to   time during the Commitment Period, during which period the Borrower may borrow, prepay and reborrow in accordance with the provisions hereof. Immediately after making each Revolving   Credit Loan and after giving effect to all Swing Line Loans and Competitive Bid Loans repaid and all Reimbursement Obligations paid on the same date, the Aggregate Credit Exposure will not exceed the Aggregate Commitment Amount. With respect to each Lender, at the time of the making of any Revolving Credit Loan, the sum of (I) the principal amount of such Lender&#8217;s Revolving Credit Loan constituting a part of the Revolving Credit Loans to be made, (II) the aggregate  principal balance of all other Revolving Credit Loans (exclusive of Revolving Credit Loans which are repaid with the proceeds of, and simultaneously with the incurrence of, the Revolving Credit Loans to be made) then outstanding from such Lender and (III) the product of (A) such Lender&#8217;s Commitment Percentage and (B) the sum of (1) the aggregate principal balance of all Swing Line Loans (exclusive of Swing Line Loans which are repaid with the proceeds of, and simultaneously with the incurrence of, the Revolving Credit Loans to be made) then outstanding and (2) the Letter  of Credit Exposure of all Lenders, will not exceed the Commitment of such Lender at such time.     At the option of the Borrower, indicated in a Borrowing Request, Revolving Credit Loans may be made as ABR Advances or Term SOFR Advances.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">The aggregate outstanding principal balance of all Revolving Credit Loans shall     be due and payable on the Commitment Termination Date or on such earlier date upon which all     of the Commitments shall have been terminated in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Swing Line Loans</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Subject to the terms and conditions hereof and in reliance upon the agreements of the other Lenders set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Swing Line Lender agrees to make loans in  Dollars under this Agreement (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Loan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and, collectively, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Loans&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) to the Borrower from time to time during the Swing Line Commitment Period. Swing Line Loans (i) may be repaid and reborrowed in accordance with the provisions hereof, (ii) shall not, immediately after giving effect thereto, result in the Aggregate Credit Exposure exceeding the Aggregate Commitment Amount, and (iii) shall not, immediately after giving effect thereto, result   in the aggregate outstanding principal balance of all Swing Line Loans exceeding the Swing Line Commitment. The Swing Line Lender shall not be obligated to make any Swing Line Loan at a   time when any Lender is a Defaulting Lender unless the Swing Line Lender has entered into arrangements satisfactory to it and the Borrower to eliminate the Swing Line Lender&#8217;s risk with respect to such Defaulting Lender&#8217;s participation in such Swing Line Loan. The Swing Line Lender will not make a Swing Line Loan if the Administrative Agent or any Lender, by notice to the Swing Line Lender and the Borrower no later than one Domestic Business Day prior to the Borrowing   Date with respect to such Swing Line Loan, shall have determined that the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> have not been satisfied or waived and such conditions remain unsatisfied as of the requested time of the making of such Loan. Each Swing Line Loan shall be due and payable on the day (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Maturity Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) being the earliest of the tenth Domestic Business Day after such Swing Line Loan is made, the date on which the Swing Line Commitment shall have been terminated in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and the date on which the Loans shall become due and </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">payable pursuant to the provisions hereof, whether by acceleration or otherwise. Each Swing Line Loan shall bear interest at the Negotiated Rate (or, if the Negotiated Rate is not available, the Term SOFR Daily Floating Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Applicable Margin). The Swing Line Lender shall disburse the proceeds of Swing Line Loans at its office designated in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> by crediting such proceeds     to an account of the Borrower maintained with the Swing Line Lender.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">On any Domestic Business Day, the Swing Line Lender may, in its sole discretion, give notice to the Lenders and the Borrower that such outstanding Swing Line Loan shall be funded with a borrowing of Revolving Credit Loans (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such notice shall be deemed to have  been automatically given upon the occurrence of a Default or an Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), in which case a borrowing of Revolving Credit Loans made as ABR Advances (each such borrowing, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Mandatory Borrowing&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) shall be made by all Lenders </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> based on each such Lender&#8217;s Commitment Percentage on the Domestic Business Day immediately   succeeding the giving of such notice. The proceeds of each Mandatory Borrowing shall be remitted directly to the Swing Line Lender to repay such outstanding Swing Line Loan. Each Lender irrevocably agrees to make a Revolving Credit Loan pursuant to each Mandatory Borrowing in the amount and in the manner specified in the preceding sentence and on the date specified in writing   by the Swing Line Lender notwithstanding&#58; (i) whether the amount of such Mandatory Borrowing complies with the minimum amount for Loans otherwise required hereunder, (ii) whether any condition specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> is then unsatisfied, (iii) whether a Default then exists, (iv) the Borrowing Date of such Mandatory Borrowing, (v) the aggregate principal amount of all Loans   then outstanding, (vi) the Aggregate Credit Exposure at such time and (vii) the amount of the Commitments at such time.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Upon each receipt by a Lender of a notice from the Administrative Agent, such Lender shall purchase unconditionally, irrevocably, and severally (and not jointly) from the Swing Line Lender a participation in the outstanding Swing Line Loans (including accrued interest  thereon) in an amount equal to the product of its Commitment Percentage and the outstanding balance of the Swing Line Loans (each, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Participation Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">). Each Lender shall also be liable for an amount equal to the product of its Commitment Percentage and any amounts paid by the Borrower pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that are subsequently rescinded or avoided, or  must otherwise be restored or returned. Such liabilities shall be unconditional and without regard     to the occurrence of any Default or the compliance by the Borrower with any of its obligations   under the Loan Documents.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">In furtherance of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, upon each receipt by a Lender of a notice from     the Administrative Agent, such Lender shall promptly (and, in any event, no later than the Domestic Business Day immediately succeeding the giving of such notice) make available to the Administrative Agent for the account of the Swing Line Lender its Swing Line Participation  Amount at the office of the Administrative Agent specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, in Dollars and in immediately available funds. The Administrative Agent shall deliver the payments made by each Lender pursuant to the immediately preceding sentence to the Swing Line Lender promptly upon receipt thereof in like funds as received. Each Lender hereby indemnifies and agrees to hold harmless the Administrative Agent and the Swing Line Lender from and against any and all losses, liabilities (including liabilities for penalties), actions, suits, judgments, demands, costs and    expenses resulting from any failure on the part of such Lender to pay, or from any delay in paying, the Administrative Agent any amount such Lender is required by notice from the Administrative Agent to pay in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (except in respect of losses, liabilities or other obligations suffered by the Administrative Agent or the Swing Line Lender, as the case may be, resulting from the gross negligence or willful misconduct of the Administrative Agent or the Swing Line Lender, as the case may be), and such Lender shall pay interest to the Administrative Agent   </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">for the account of the Swing Line Lender from the date such amount was due until paid in full, on the unpaid portion thereof, at a rate of interest per annum, whether before or after judgment, equal   to (i) from the date such amount was due until the third day therefrom, the Federal Funds Effective Rate, and (ii) thereafter, the Federal Funds Effective Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 2%, payable upon demand by the Swing Line Lender. The Administrative Agent shall distribute such interest payments to the Swing Line Lender upon receipt thereof in like funds as received.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Whenever the Administrative Agent is reimbursed by the Borrower for the account of the Swing Line Lender for any payment in connection with Swing Line Loans and such payment relates to an amount previously paid by a Lender pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Administrative Agent will promptly remit such payment to such Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Notice of Borrowing Revolving Credit Loans and Swing Line Loans</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower agrees to notify the Administrative Agent (and with respect to a Swing Line Loan,    the Swing Line Lender), which notification shall be irrevocable, no later than (a) 2&#58;00 P.M., on the proposed Borrowing Date in the case of Swing Line Loans, (b) 12&#58;00 Noon on the proposed Borrowing Date in the case of Revolving Credit Loans to consist of ABR Advances and (c) 12&#58;00 Noon at least two Domestic Business Days prior to the proposed Borrowing Date in the case of Revolving Credit Loans to consist of Term SOFR Advances. Each such notice shall specify (i) the aggregate amount requested to be borrowed under the Commitments or the Swing Line Commitment, (ii) the proposed Borrowing Date, (iii) whether a borrowing of Revolving Credit Loans is to be made as an ABR Advance, one or more Term SOFR Advances, or both, and the amount of each thereof, (iv) the Term SOFR Interest Period for each such Term SOFR Advance and (v) the amount of each Swing Line Loan. Each such notice shall be promptly confirmed by delivery to the Administrative Agent (and, with respect to a Swing Line Loan, the Swing Line Lender)   of a Borrowing Request. Each Term SOFR Advance to be made on a Borrowing Date, when aggregated  with all amounts to be Converted to Term SOFR Advances on such date and having the same Interest Period as such Term SOFR Advance, shall equal no less than $10,000,000, or an integral multiple of $1,000,000    in excess thereof. Each ABR Advance made on each Borrowing Date shall equal no less than $5,000,000    or an integral multiple of $500,000 in excess thereof. Each Swing Line Loan made on each Borrowing Date shall equal no less than $1,000,000 or an integral multiple of $500,000 in excess thereof. The   Administrative Agent shall promptly notify each Lender (by telephone or otherwise, such notification to be confirmed by fax, email or other writing) of each such Borrowing Request. Subject to its receipt of each  such notice from the Administrative Agent and subject to the terms and conditions hereof, (A) each Lender shall make immediately available funds available to the Administrative Agent at the address therefor set  forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> not later than 1&#58;00 P.M. on each Borrowing Date in an amount equal to such Lender&#8217;s Commitment Percentage of the Revolving Credit Loans requested by the Borrower on such Borrowing Date and&#47;or (B) the Swing Line Lender shall make immediately available funds available to the Borrower on   such Borrowing Date in an amount equal to the Swing Line Loan requested by the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Competitive Bid Loans and Procedure</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Subject to the terms and conditions hereof, the Borrower may request competitive bid loans in Dollars under this Agreement (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Competitive Bid Loan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) during the   Commitment Period. In order to request Competitive Bids, the Borrower shall deliver by hand, fax  or email to the Administrative Agent a duly completed and executed Competitive Bid Request not later than 12&#58;00 Noon, one Domestic Business Day before the proposed Borrowing Date therefor.    A Competitive Bid Request that does not conform substantially to the format of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit F</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> may be rejected by the Administrative Agent in the Administrative Agent&#8217;s reasonable discretion, and the Administrative Agent shall promptly notify the Borrower of such rejection by fax or email and by telephone. Each Competitive Bid Request shall specify (x) the proposed Borrowing Date for the </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Competitive Bid Loans then being requested (which shall be a Domestic Business Day) and the aggregate principal amount thereof and (y) the Competitive Interest Period or Competitive Interest Periods (which shall not exceed ten different Interest Periods in a single Competitive Bid Request), with respect thereto (which may not end after the Domestic Business Day immediately preceding  the Commitment Termination Date). Promptly after its receipt of each Competitive Bid Request   that is not rejected as aforesaid, the Administrative Agent shall invite by fax or email (substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit G</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) the Lenders (other than any Defaulting Lender) to bid, on the terms and conditions of this Agreement, to make Competitive Bid Loans pursuant to such Competitive Bid Request.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Each Lender (other than any Defaulting Lender), in its sole and absolute discretion, may make one or more Competitive Bids to the Borrower responsive to a Competitive Bid Request. Each Competitive Bid by a Lender must be received by the Administrative Agent not later than 10&#58;00 A.M. on the proposed Borrowing Date for the relevant Competitive Bid Loan. Multiple bids will be accepted by the Administrative Agent. Bids to make Competitive Bid Loans that, in the reasonable judgment of the Administrative Agent, do not conform to the Competitive Bids solicited by the related Competitive Bid Request shall be rejected by the Administrative Agent. Competitive Bids that do not conform substantially to the format of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit H</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> may be rejected by the Administrative Agent after conferring with, and upon the instruction of, the Borrower, and the Administrative Agent shall notify the Lender making such nonconforming bid of such rejection as soon as practicable. Each Competitive Bid shall be irrevocable and shall specify (x) the principal amount (which (1) shall be in a minimum principal amount of $10,000,000 or an integral multiple  of $1,000,000 in excess thereof, and (2) may equal the entire principal amount requested by the Borrower) of the Competitive Bid Loan or Competitive Bid Loans that the Lender is willing to  make to the Borrower, (y) the Competitive Bid Rate or Competitive Bid Rates at which the Lender  is prepared to make such Competitive Bid Loan or Competitive Bid Loans, and (z) the Competitive Interest Period with respect to each such Competitive Bid Loan and the last day thereof. If any Lender shall elect not to make a Competitive Bid, such Lender shall so notify the Administrative Agent by fax or email not later than 10&#58;00 A.M. on the proposed Borrowing Date therefor&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that the failure by any Lender to give any such notice shall not obligate such Lender to make any Competitive Bid Loan in connection with the relevant Competitive Bid Request.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">With respect to each Competitive Bid Request, the Administrative Agent shall (i) notify the Borrower by fax or email by 11&#58;00 A.M. on the proposed Borrowing Date with respect thereto of each Competitive Bid made, the Competitive Bid Rate applicable thereto and the identity of the Lender that made such Competitive Bid, and (ii) send a list of all Competitive Bids to the Borrower for its records as soon as practicable after completion of the bidding process. Each notice and list sent by the Administrative Agent pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall list the Competitive Bids in ascending yield order.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">The Borrower may, in its sole and absolute discretion, subject only to the  provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, accept or reject any Competitive Bid made in accordance with the procedures set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and the Borrower shall notify the Administrative Agent by telephone, confirmed by fax or email in the form of a duly completed and executed Competitive   Bid Accept&#47;Reject Letter, whether and to what extent it has decided to accept or reject any or all of such Competitive Bids not later than 12&#58;00 Noon on the proposed Borrowing Date therefor&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the failure by the Borrower to give such notice shall be deemed to be a rejection of    all such Competitive Bids. In connection with each acceptance of one or more Competitive Bids    by the Borrower&#58;</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">the Borrower shall not accept a Competitive Bid of a given tenor made at    a particular Competitive Bid Rate if the Borrower has decided to reject a Competitive Bid having the same tenor made at a lower Competitive Bid Rate unless the acceptance of such Competitive Bid made at a lower Competitive Bid Rate would subject the Borrower to any requirement to withhold any taxes or deduct any amount from any amounts payable under the Loan Documents, in which case the Borrower may reject such Competitive Bid made    at a lower Competitive Bid Rate,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">the aggregate amount of the Competitive Bids accepted by the Borrower shall not exceed the principal amount specified in the Competitive Bid Request therefor,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">if the Borrower shall desire to accept a Competitive Bid made at a  particular Competitive Bid Rate, it must accept all other Competitive Bids at such Competitive Bid Rate, except for any such Competitive Bid the acceptance of which would subject the Borrower to any requirement to withhold any taxes or deduct any amount from any amounts payable under the Loan Documents&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if the acceptance of all   such other Competitive Bids would cause the aggregate amount of all such accepted Competitive Bids to exceed the amount requested, then such acceptance shall be made pro rata in accordance with the amount of each such Competitive Bid at such Competitive Bid Rate,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">except pursuant to clause (3) above, no Competitive Bid shall be accepted unless the Competitive Bid Loan with respect thereto shall be in a minimum principal amount of $10,000,000 or an integral multiple of $1,000,000 in excess thereof, and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">no Competitive Bid shall be accepted and no Competitive Bid Loan shall  be made, if immediately after giving effect thereto, the Aggregate Credit Exposure would exceed the Aggregate Commitment Amount.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Administrative Agent shall promptly fax or email to each bidding Lender   (with a copy to the Borrower) a Competitive Bid Accept&#47;Reject Letter advising such Lender  whether its Competitive Bid has been accepted (and if accepted, in what amount and at what Competitive Bid Rate), and each successful bidder so notified will thereupon become bound,  subject to the applicable conditions hereof, to make the Competitive Bid Loan in respect of which each of its Competitive Bids has been accepted by making immediately available funds available    to the Administrative Agent at its address set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> not later than 1&#58;00 P.M. on the Borrowing Date for such Competitive Bid Loan in the amount thereof.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.02pt">Anything herein to the contrary notwithstanding, if the Administrative Agent shall elect to submit a Competitive Bid in its capacity as a Lender, it shall submit such bid directly to the Borrower not later than 9&#58;30 A.M. on the relevant proposed Borrowing Date.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">All notices required by this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be given in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Each Competitive Bid Loan shall be due and payable on the last day of the Competitive Interest Period applicable thereto or on such earlier date upon which the Loans shall become due and payable pursuant to the provisions hereof, whether by acceleration or otherwise.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Use of Proceeds</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower agrees that the proceeds of the Loans and Letters of Credit shall be used solely for    its general corporate purposes, but not inconsistent with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or any other provision of this Agreement, including, without limitation, the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and not in contravention of any applicable law, rule or regulation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Termination, Reduction or Increase of Commitments</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Termination on Commitment Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Unless previously terminated, the Commitments and the Letter of Credit Commitment shall terminate on the Commitment  Termination Date and the Swing Line Commitment shall terminate on the Swing Line Termination Date.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Voluntary Termination or Reductions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. At the Borrower&#8217;s option in its sole and absolute discretion and upon at least one Domestic Business Day&#8217;s prior irrevocable notice to the Administrative Agent, the Borrower may (i) terminate the Commitments, the Swing Line Commitment and the Letter of Credit Commitment, at any time, or (ii) permanently reduce the Aggregate Commitment Amount, the Swing Line Commitment or the Letter of Credit   Commitment, in part at any time and from time to time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that (1) each such partial reduction shall be in an amount equal to at least $5,000,000 or an integral multiple of $1,000,000 in excess thereof and (2) immediately after giving effect to each such reduction, (A) the Aggregate Commitment Amount shall equal or exceed the Aggregate Credit Exposure, (B) the Swing Line Commitment shall equal or exceed the aggregate outstanding principal balance of all Swing Line Loans and (C) the Letter of Credit Commitment shall equal or exceed the Letter of Credit Exposure of all Lenders&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, notwithstanding the foregoing, a notice of termination of the Commitments, the Swing Line Commitment and the Letter of Credit Commitment delivered by the Borrower may state that such notice is conditioned upon the effectiveness of other credit facilities   or transactions (such notice to specify the proposed effective date), in which case such notice may  be revoked by the Borrower (by notice to the Administrative Agent on or prior to such specified effective date) if such condition is not satisfied and the Borrower shall indemnify the Lenders in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, if applicable.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each reduction of the Aggregate Commitment Amount shall be made  by reducing each Lender&#8217;s Commitment Amount by an amount equal to the product of such Lender&#8217;s Commitment Percentage and the amount of such reduction.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Increase in Aggregate Commitment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower may at any time and from time to time prior to the 90</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> day prior to the then-applicable Commitment Termination Date,  at its sole cost and expense, request any one or more of the Lenders having a Commitment to increase its Commitment Amount (the decision to increase the Commitment Amount of a Lender    to be within the sole and absolute discretion of such Lender), or any Eligible Assignee to provide     a new Commitment, by submitting to the Administrative Agent a Commitment Increase  Supplement, duly executed and delivered by the Borrower and each such Lender increasing its Commitment Amount or Eligible Assignee providing a new Commitment, as the case may be.   Upon receipt of any such Commitment Increase Supplement, the Administrative Agent, the Swing Line Lender and each Issuer shall promptly execute and deliver such Commitment Increase Supplement and the Administrative Agent shall deliver a copy thereof to the Borrower and each  such Lender or Eligible Assignee, as the case may be. Upon execution and delivery of such Commitment Increase Supplement by the Administrative Agent, the Swing Line Lender and each Issuer, (i) in the case of each such Lender increasing its Commitment Amount (an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Increasing </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), its Commitment Amount shall be increased to the amount set forth in such Commitment Increase Supplement, and (ii) in the case of each such Eligible Assignee providing a new Commitment (a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">New Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), such New Lender shall become a party hereto and have the rights and obligations of a Lender under the Loan Documents and its Commitment shall be as set forth in such Commitment Increase Supplement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">immediately after giving effect thereto, the sum of all increases in the Aggregate Commitment Amount made pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall not exceed $500,000,000&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">each such increase of the Aggregate Commitment Amount shall be in an amount not less than $25,000,000 or such amount plus an integral multiple of $5,000,000&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that an increase may be in a lesser amount if such increase is an increase of the entire remaining amount available under clause (1) above&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">no Default shall have occurred or be continuing on the effective date of    the increase&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">the representations and warranties contained in this Agreement shall be   true and correct in all material respects with the same effect as though such representations and warranties had been made on the effective date of such increase (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any representation and warranty that is qualified as to &#8220;materiality&#8221;, &#8220;Material Adverse&#8221; or similar language shall be true and correct (after giving effect to any qualification therein)    in all respects on such effective date), except those which are expressly specified to be  made as of an earlier date&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">in the case of each New Lender, the Commitment Amount assumed by  such New Lender shall not be less than $25,000,000&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">if Revolving Credit Loans would be outstanding immediately after giving effect to any such increase, then simultaneously with such increase (A) each such  Increasing Lender, each such New Lender and each other Lender shall be deemed to have entered into a master assignment and assumption, in form and substance substantially similar to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit E</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, pursuant to which each such other Lender shall have assigned to each such Increasing Lender and each such New Lender a portion of its Revolving Credit Loans necessary to reflect proportionately the Commitments as increased in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and (B) in connection with such assignment, each such Increasing Lender and each such New Lender shall pay to the Administrative Agent, for the account of each such other Lender, such amount as shall be necessary to reflect the assignment to it of such Revolving Credit Loans, and in connection with such master assignment each such other Lender may treat the assignment of Term SOFR Advances as a prepayment of such Term SOFR Advances for purposes of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">each such New Lender shall have delivered to the Administrative Agent    an Administrative Questionnaire and to the Administrative Agent and the Borrower all forms, if any, that are required to be delivered by such New Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(8)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">at least five Domestic Business Days prior to the effectiveness of such increase, if the Borrower qualifies as a &#8220;legal entity customer&#8221; under the Beneficial </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ownership Regulation, it shall have delivered, to each Lender that so requests, a Beneficial Ownership Certification&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(9)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">the Administrative Agent shall have received such other customary certificates, resolutions and opinions as the Administrative Agent shall have reasonably requested.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Prepayments of Loans</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Voluntary Prepayments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Borrower may, in its sole and absolute discretion, prepay Revolving Credit Loans, Competitive Bid Loans or Swing Line Loans, in whole or in part, without premium or penalty, but subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, at any time and from time to time, by notifying the Administrative Agent (which notice shall be in a form reasonably acceptable to the Administrative Agent) at least two Domestic Business Days, in the case of a prepayment of Term SOFR Advances, two Domestic Business Days, in the case of a prepayment of Competitive Bid Loans, or one Domestic Business Day, in the case of a prepayment of Swing Line Loans or ABR Advances, prior to the proposed prepayment date specifying (i) the Loans to be prepaid, (ii) the amount to be prepaid, and (iii) the date of prepayment. Upon receipt of each such notice, the Administrative Agent shall promptly notify each Lender thereof. Each such notice given by the Borrower pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be irrevocable, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, if a notice of prepayment  is given in connection with a conditional notice of termination of the Commitments, the Swing Line Commitment and the Letter of Credit Commitment as contemplated by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, then such   notice of prepayment may be revoked if such notice of termination is revoked in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and the Borrower shall indemnify the Lenders in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, if applicable. Each partial prepayment under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be (A) in the case of Term SOFR Advances, in a minimum amount of $5,000,000 or an integral multiple of $1,000,000 in excess thereof or the entire remaining amount of Term SOFR Advances, (B) in the case of ABR Advances, in a minimum amount of $1,000,000 or an integral multiple of $100,000 in excess thereof or the entire remaining amount of ABR Advances, (C) in the case of Swing Line Loans, in a minimum amount of $500,000 or an integral multiple of $100,000 in excess thereof or the entire remaining amount of Swing Line Loans, and (D) in the case of Competitive Bid Loans, in a minimum amount of $5,000,000 or an integral multiple of $1,000,000 in excess thereof or the entire remaining amount of Competitive Bid Loans.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Simultaneously with each prepayment hereunder, the Borrower shall prepay all accrued and unpaid interest on the amount prepaid through the date of prepayment and indemnify the Lenders in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, if applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Letter of Credit Sub-facility</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Subject to the terms and conditions hereof and the payment by the Borrower to   each Issuer of such fees as the Borrower and such Issuer shall have agreed in writing, each Issuer severally (and not jointly) agrees, in reliance on the agreement of the other Lenders set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to issue standby or commercial letters of credit (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and, collectively, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letters of Credit&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) during the Commitment Period for the account of the Borrower&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that immediately after the issuance of each Letter of Credit (i) the Letter of Credit Exposure of all Lenders shall not exceed the Aggregate Letter of Credit Commitment, (ii)   the Aggregate Credit Exposure shall not exceed the Aggregate Commitment Amount, (iii) the   Letter of Credit Exposure of such Issuer shall not exceed the Letter of Credit Commitment of such Issuer, and (iv) the Commercial Letter of Credit Exposure of such Issuer shall not exceed the Commercial Letter of Credit Commitment of such Issuer. Each Letter of Credit shall have an </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">expiration date which shall be not later than, in the case of standby Letters of Credit, the earlier to occur of one year from the date of issuance thereof or 5 days prior to the Commitment Termination Date and, in the case of commercial Letters of Credit, the earlier to occur of 180 days from the date of issuance thereof or 5 days prior to the Commitment Termination Date. No Letter of Credit shall be issued if the Administrative Agent, or any Lender by notice to the Administrative Agent, and    the proposed Issuer shall have determined, no later than 3&#58;00 P.M. one Domestic Business Day   prior to the requested date of issuance of such Letter of Credit, that the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> have not been satisfied or waived.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Each Letter of Credit shall be issued at the request of the Borrower in support of    an obligation of the Borrower or any Subsidiary in favor of a beneficiary who has requested the issuance of such Letter of Credit. The Borrower shall give the Administrative Agent a Letter of Credit Request for the issuance of each Letter of Credit by 12&#58;00 Noon at least two Domestic Business Days prior to the requested date of issuance. Such Letter of Credit Request shall specify   (i) whether such Letter of Credit is a standby or commercial Letter of Credit, (ii) the beneficiary of such Letter of Credit and the obligations of the Borrower or the Subsidiary in respect of which such Letter of Credit is to be issued, (iii) the Borrower&#8217;s proposal as to the conditions under which a drawing may be made under such Letter of Credit and the documentation to be required in respect thereof, (iv) the maximum amount to be available under such Letter of Credit, (v) the requested   date of issuance, and (vi) the name of the proposed Issuer thereof. Upon receipt of such Letter of Credit Request from the Borrower, the Administrative Agent shall promptly notify the applicable Issuer and each Lender thereof. Such Issuer shall, on the proposed date of issuance and subject to  the terms and conditions of this Agreement, issue the requested Letter of Credit&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that in   the event such Issuer fails to issue such Letter of Credit or is a Defaulting Lender, any other Issuer may (in its sole and absolute discretion, and notwithstanding that its Letter of Credit Exposure may exceed its Letter of Credit Commitment, but with (x) the consent of the Borrower and (y) notice to the Administrative Agent) issue such Letter of Credit otherwise in accordance with the terms  hereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that immediately after the issuance thereof (A) the Letter of Credit Exposure of all Lenders shall not exceed the Aggregate Letter of Credit Commitment, and (B) the Aggregate Credit Exposure shall not exceed the Aggregate Commitment Amount. Each Letter of Credit shall be in form and substance reasonably satisfactory to the Issuer thereof, with such provisions with respect to the conditions under which a drawing may be made thereunder and the documentation required in respect of such drawing as such Issuer shall reasonably require. Each Letter of Credit shall be used solely for the purposes described therein. Each Letter of Credit Request and each Letter of Credit shall be subject to the standard terms and conditions for letters    of credit of the Issuer thereof (each as amended, supplemented or replaced from time to time, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Reimbursement Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) executed by the Borrower and delivered to such Issuer.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Each payment by an Issuer of a drawing under a Letter of Credit issued thereby  shall give rise to the obligation of the Borrower to promptly (and in any event within one Domestic Business Day) reimburse such Issuer for the amount thereof (together with any interest). Such  Issuer shall promptly notify the Borrower of such payment by such Issuer of a drawing under a Letter of Credit. In lieu of such notice, if the Borrower has not made reimbursement prior to the   end of the Domestic Business Day following the day during which such Issuer made such payment of such drawing, the Borrower hereby authorizes such Issuer to deduct the amount of any such reimbursement from such account(s) as the Borrower may from time to time designate in writing    to such Issuer, upon which such Issuer shall apply the amount of such deduction to such reimbursement. If all or any portion of any Reimbursement Obligation in respect of a Letter of Credit shall not be paid on the date that the Issuer thereof shall have made payment of a drawing under such Letter of Credit, the amount of such Reimbursement Obligation shall bear interest, at a rate per annum equal to the Alternate Base Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Applicable Margin applicable to ABR </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Advances, from the date such Issuer made such payment of such drawing until the end of the Domestic Business Day following the day during which such Issuer made such payment of such drawing (whether at the stated maturity thereof, by acceleration or otherwise), and from and after such Domestic Business Day (whether at the stated maturity thereof, by acceleration or otherwise), such Reimbursement Obligation shall bear interest, payable upon demand, at a rate per annum equal to the Alternate Base Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Applicable Margin applicable to ABR Advances </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 2%, from such due date until paid in full (whether before or after the entry of a judgment thereon).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">In the event of any conflict between the terms hereof and the terms of any Reimbursement Agreement or Letter of Credit Application, the terms hereof shall control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Letter of Credit Participation</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Each Lender hereby unconditionally and irrevocably, severally (and not jointly) takes an undivided participating interest in the obligations of each Issuer under and in connection with each Letter of Credit issued thereby in an amount equal to such Lender&#8217;s Commitment Percentage (as in effect from time to time) of the amount of such Letter of Credit. Each Lender   shall be liable to each Issuer for its Commitment Percentage of the unreimbursed amount of any drawing honored under each Letter of Credit issued thereby. Each Lender shall also be liable for    an amount equal to the product of its Commitment Percentage and any amounts paid by the Borrower pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that are subsequently rescinded or avoided, or must otherwise be restored or returned. Such liabilities shall be unconditional and without regard to the occurrence of any Default or the compliance by the Borrower with any of its obligations under the Loan Documents.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Each Issuer shall promptly notify the Administrative Agent, and the    Administrative Agent shall promptly notify each Lender (which notice shall be promptly confirmed in writing), of the date and the amount of each drawing paid under each Letter of Credit issued by such Issuer with respect to which full reimbursement payment shall not have been made by the Borrower as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and forthwith upon receipt of such notice, such Lender   shall promptly make available to the Administrative Agent for the account of such Issuer its Commitment Percentage of the amount of such unreimbursed drawing at the office of the Administrative Agent specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> in Dollars and in immediately available funds. The Administrative Agent shall distribute the payments made by each Lender pursuant to the immediately preceding sentence to such Issuer promptly upon receipt thereof in like funds as received. Each Lender shall indemnify and hold harmless the Administrative Agent and each Issuer from and against any and all losses, liabilities (including liabilities for penalties), actions, suits, judgments, demands, costs and expenses (including, without limitation, reasonable attorneys&#8217; fees and expenses) resulting from any failure on the part of such Lender to provide, or from any delay    in providing, the Administrative Agent with such Lender&#8217;s Commitment Percentage of the amount of any payment made by such Issuer under a Letter of Credit issued by such Issuer in accordance with this clause (b) (except in respect of losses, liabilities or other obligations suffered by the Administrative Agent or such Issuer, as the case may be, resulting from the gross negligence or willful misconduct of the Administrative Agent or such Issuer, as the case may be). If a Lender   does not make available to the Administrative Agent when due an amount equal to such Lender&#8217;s Commitment Percentage of any unreimbursed payment made by an Issuer under a Letter of Credit issued thereby, such Lender shall be required to pay interest to the Administrative Agent for the account of such Issuer on the unpaid portion of such amount at a rate of interest per annum equal    to (i) from the date such Lender should have made such amount available until the third day therefrom, the Federal Funds Effective Rate, and (ii) thereafter, the Federal Funds Effective Rate </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 2%, in each case payable upon demand by such Issuer. The Administrative Agent shall distribute such interest payments to such Issuer upon receipt thereof in like funds as received.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Whenever the Administrative Agent is reimbursed by the Borrower, for the   account of an Issuer, for any payment under a Letter of Credit issued thereby and such payment relates to an amount previously paid by a Lender in respect of its Commitment Percentage of the amount of such payment under such Letter of Credit, the Administrative Agent (or such Issuer, if such payment by a Lender was paid by the Administrative Agent to such Issuer) will promptly pay over such payment to such Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Absolute Obligation with respect to Letter of Credit Payments</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower&#8217;s obligation to reimburse the Administrative Agent for the account of an Issuer for each payment under or in respect of each Letter of Credit issued thereby shall be absolute and unconditional under any and all circumstances and irrespective of any set-off, counterclaim or defense to payment which the Borrower may have or have had against the beneficiary of such Letter of Credit, the Administrative Agent, such Issuer, the Swing Line Lender, any Lender or any other Person, including, without limitation, any defense based on the failure of any drawing to conform to the terms of such Letter of Credit, any drawing document proving to be forged, fraudulent or invalid, or the legality, validity, regularity or enforceability of such Letter of Credit&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that, with respect to any Letter of Credit, the foregoing  shall not relieve the Issuer thereof of any liability it may have to the Borrower for any actual damages sustained by the Borrower arising from a wrongful payment (or failure to pay) under such Letter of Credit made as a result of such Issuer&#8217;s gross negligence or willful misconduct.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Notes</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any Lender may request that the Loans made by it be evidenced by a Note. In such event, the Borrower shall prepare, execute and deliver to such Lender a Note payable to such Person or, if requested  by such Person, such Person and its registered assigns.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Extension of Commitment Termination Date</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Request for Extension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Borrower may, in its sole and absolute discretion, by notice to the Administrative Agent (which shall promptly notify the Lenders) not more than 90   days and not less than 30 days prior to each of the first, second, third, fourth, fifth and, if the Borrower shall have exercised one such right to extend the Commitment Termination Date, sixth anniversary of the Effective Date (each such anniversary date, an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Extension Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), request (each, an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Extension Request</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) that the Lenders extend the Commitment Termination Date then in effect (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Existing Commitment Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) for an additional one-year period, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that  the Borrower may only effect two such extensions of the Commitment Termination Date.  Each Lender, acting in its sole discretion, shall, by notice to the Borrower and the Administrative Agent given not later than the 20th day (or such later day as shall be acceptable to the Borrower) following the date of the Borrower&#8217;s notice, advise the Borrower and the Administrative Agent whether or    not such Lender agrees to such extension&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any Lender (which includes each Issuer   and the Swing Line Lender) that does not so advise the Borrower and the Administrative Agent  shall be deemed to have rejected such Extension Request. The election of any Lender to agree to such extension shall not obligate any other Lender to so agree.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Replacement of Non-Extending Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Borrower shall have the right at any time on or prior to the relevant Extension Date to replace any Lender which has not consented to   the Extension Request (each, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Non-Extending Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Conditions to Effectiveness of Extension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding anything in this Agreement to the contrary, the extension of the Existing Commitment Termination Date on any Extension Date shall not be effective unless, immediately before and immediately after giving   effect to such extension on such Extension Date&#58; (i) no Default shall have occurred and be continuing on such Extension Date and the representations and warranties contained in this Agreement shall be true and correct in all material respects with the same effect as though such representations and warranties had been made on such Extension Date (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that any representation and warranty that is qualified as to &#8220;materiality&#8221;, &#8220;Material Adverse&#8221; or similar language shall be true and correct (after giving effect to any qualification therein) in all respects on such Extension Date), except those which are expressly specified to be made as of an earlier date, and the Administrative Agent shall have received a certificate, in form and substance reasonably satisfactory to the Administrative Agent, to such effect from an Authorized Officer of the Borrower (or such other financial officer reasonably acceptable to the Administrative Agent), and (ii) the Administrative Agent shall have received such other customary certificates, resolutions and  opinions as the Administrative Agent may reasonably request.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Effectiveness of Extension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If (and only if) the conditions specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">2.12(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall have been satisfied or waived with respect to the extension of the Existing  Commitment Termination Date on the applicable Extension Date, then, effective as of such Extension Date, the Commitment Termination Date, with respect to the Commitment of each  Lender that has agreed to so extend its Commitment and of each Replacement Lender that has assumed a Commitment of a Non-Extending Lender in connection with such Extension Request, shall be extended to the date falling one year after the Existing Commitment Termination Date (or,  if such date is not a Domestic Business Day, the immediately preceding Domestic Business Day), and each such Replacement Lender shall thereupon become a &#8220;Lender&#8221; for all purposes of this Agreement. Notwithstanding anything herein to the contrary, (i) with respect to any portion of the Commitment of any Non-Extending Lender that has not been fully assumed by one or more Replacement Lenders, the Commitment Termination Date for such Lender with respect to such   non-assumed portion of its Commitment shall remain unchanged, and (ii) with respect to any Loans of such Lender that have not been purchased by one or more Replacement Lenders, the applicable maturity date with respect to such non-purchased Loans shall remain unchanged and shall be repayable by the Borrower on such applicable maturity date without there being any requirement that any such repayment be shared with other Lenders. In addition, on the Extension Date, the Borrower agrees to pay all accrued and unpaid interest, fees and other amounts then due under this Agreement from the Borrower to each Lender consenting to the Extension Request, each            Non-Extending Lender and each Replacement Lender. Solely for the purpose of calculating break funding payments under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the assignment by any Non-Extending Lender of any Term SOFR Advance prior to the last day of the Interest Period applicable thereto in accordance with    this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be deemed to constitute a prepayment by the Borrower of such Term SOFR Advance.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Defaulting Lenders</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding any provision of this Agreement to the contrary, if any Lender becomes a Defaulting Lender, then the following provisions shall apply for so long as such Lender is a Defaulting Lender&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Facility Fees shall cease to accrue, and shall not be payable, on the unfunded  portion of the Commitment of such Defaulting Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">the Commitment and Credit Exposure of such Defaulting Lender shall not be included in determining whether all Lenders or the Required Lenders have taken or may take any action hereunder (including any consent to any amendment or waiver pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, notwithstanding the foregoing, any waiver, amendment or modification with respect to the following shall require the consent of such Defaulting Lender&#58; (i) any waiver, amendment or modification requiring the consent of all Lenders or each affected Lender which affects such Defaulting Lender in a manner that is materially adverse in comparison to the other affected Lenders, (ii) any waiver, amendment or modification increasing the Commitment of such  Defaulting Lender, (iii) any waiver, amendment or modification extending the Commitment Period with respect to such Defaulting Lender, (iv) any waiver, amendment or modification reducing the principal amount owed under the Loan Documents to such Defaulting Lender (other than by payment thereof), or (v) any waiver, amendment or modification extending the final maturity of sums owed to such Defaulting Lender, or (vi) a modification of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.13(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">if any Swing Line Exposure or Letter of Credit Exposure exists at the time a Lender becomes a Defaulting Lender then&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">all or any part of such Defaulting Lender&#8217;s Swing Line Exposure and   Letter of Credit Exposure shall be reallocated among the non-Defaulting Lenders in accordance with their respective Commitment Percentages but only to the extent that (A)  the sum of all non-Defaulting Lenders&#8217; Committed Credit Exposures </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, without duplication, the amount of such Defaulting Lender&#8217;s Swing Line Exposure and Letter of Credit Exposure reallocated to such non-Defaulting Lenders, does not exceed the total of   all non-Defaulting Lenders&#8217; Commitments and (B) with respect to each non-Defaulting Lender, the sum of such non-Defaulting Lender&#8217;s Committed Credit Exposure </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,   without duplication, the amount of such Defaulting Lender&#8217;s Swing Line Exposure and Letter of Credit Exposure reallocated to such non-Defaulting Lender, does not exceed such non-Defaulting Lender&#8217;s Commitment&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">if the reallocation described in clause (1) above cannot, or can only partially, be effected, the Borrower shall within one Domestic Business Day following notice by the Administrative Agent (A) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, prepay such Swing Line Exposure and (B) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, cash collateralize such Defaulting Lender&#8217;s Letter of Credit Exposure (after giving effect to any partial reallocation pursuant to clause (1) above) in a manner reasonably satisfactory to the Administrative Agent and the Issuers of the Letters of Credit of which shall be outstanding at such time for so long as such Letter of Credit Exposure is outstanding&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">if the Borrower cash collateralizes any portion of such Defaulting Lender&#8217;s Letter of Credit Exposure pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.13(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Borrower shall not be required to pay any Letter of Credit Participation Fees to such Defaulting Lender pursuant  to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> with respect to such Defaulting Lender&#8217;s Letter of Credit Exposure during the period such Defaulting Lender&#8217;s Letter of Credit Exposure is cash collateralized&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">if the Swing Line Exposure or Letter of Credit Exposure of such   Defaulting Lender is reallocated pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.13(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, then the fees payable to  the Lenders pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline"> Section 3.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be adjusted to give effect to  such reallocation, and the Administrative Agent shall promptly notify the Lenders of any reallocation described in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.13(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">so long as any Lender is a Defaulting Lender, the Swing Line Lender shall not be required to fund any Swing Line Loan and no Issuer shall be required to issue, amend, extend or increase any Letter of Credit, unless it is satisfied that the related exposure will be 100% covered   by the Commitments of the non-Defaulting Lenders and&#47;or cash collateral will be provided by the Borrower in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.13(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and participating interests in any such newly issued, amended, extended or increased Letter of Credit or newly funded Swing Line Loan shall be allocated among non-Defaulting Lenders in a manner consistent with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.13(c)(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (and Defaulting Lenders shall not participate therein)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">any amount payable to such Defaulting Lender hereunder (whether on account of principal, interest, fees or otherwise and including any amount that would otherwise be payable to such Defaulting Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> but excluding </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and other than any amount constituting Facilities Fees or Letter of Credit Participation Fees which are not payable to such Defaulting Lender in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 2.13(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">2.13(c)(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) shall, in lieu of being distributed to such Defaulting Lender, be retained by the Administrative Agent in a segregated account and, subject to any applicable requirements of law, be applied at such time or times as may be determined by the Administrative Agent (i) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment of any amounts owing by such Defaulting Lender to the Administrative Agent hereunder, (ii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, pro rata, to the payment of any amounts owing by such Defaulting Lender to the Issuers and the Swing Line Lender hereunder, (iii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">third</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, if so determined by the Administrative Agent and the Borrower or if requested by any Issuer or the Swing Line Lender, held in such account as cash collateral for future funding obligations of the Defaulting Lender in respect of any existing or future participating interest in any Swing Line Loan or Letter of Credit, (iv) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">fourth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the funding of any Revolving Credit Loan (including any Mandatory Borrowing) in respect of which such Defaulting Lender has failed to   fund its portion thereof as required by this Agreement, as determined by the Administrative Agent, (v) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">fifth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, if so determined by the Administrative Agent and the Borrower, held in such account as cash collateral for future funding obligations of the Defaulting Lender in respect of any Revolving Credit Loans (including any Mandatory Borrowings) under this Agreement, (vi) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">sixth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment of any amounts owing to the Lenders, the Issuers or the Swing Line Lender as a result of any final and non-appealable judgment of a court of competent jurisdiction obtained by any Lender, any Issuer or the Swing Line Lender against such Defaulting Lender as a result of such Defaulting Lender&#8217;s breach of its obligations under this Agreement, (vii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">seventh</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment of any amounts owing to the Borrower as a result of any final and non-appealable judgment of a court of competent jurisdiction obtained by the Borrower against such Defaulting Lender as a result of such Defaulting Lender&#8217;s breach of its obligations under this Agreement, and (viii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">eighth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to such Defaulting Lender or as otherwise directed by a court of competent jurisdiction&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if  such payment is (x) a prepayment of the principal amount of any Revolving Credit Loan (including any Mandatory Borrowing) or Reimbursement Obligations in respect of drawings under Letters of Credit paid by an Issuer with respect to which a Defaulting Lender has funded its participation obligations and (y) made at a time when the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> are satisfied or waived, such payment shall be applied solely to prepay the Revolving Credit Loans (including Mandatory Borrowings) of, and Reimbursement Obligations owed to, all non-Defaulting Lenders pro rata prior to being applied to the prepayment of any Loans, or Reimbursement Obligations owed to, any Defaulting Lender&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.02pt">the Borrower shall have the right at any time during which a Lender is a Defaulting Lender to replace such Defaulting Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, no reallocation pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.13(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall   constitute a waiver or release of any claim of any party hereunder against a Defaulting Lender </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">arising from a Lender having become a Defaulting Lender, including any claim of a non-Defaulting Lender as a result of such non-Defaulting Lender&#8217;s increased exposure following such reallocation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">ESG Adjustments</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Borrower, in consultation with the Sustainability Coordinator, shall be   entitled, in its sole discretion, to establish specified key performance indicators (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">KPIs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) with respect to certain environmental, social and governance (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">ESG</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) targets of the Borrower and its Subsidiaries.  The Sustainability Coordinator and the Borrower, with the consent of the Required Lenders, may amend this Agreement (such amendment, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">ESG Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) solely for the purpose of incorporating the KPIs and other related provisions (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">ESG Pricing Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) into this Agreement.  Upon the effectiveness of any such ESG Amendment, based on the Borrower&#8217;s performance against the KPIs, certain adjustments (increase, decrease or no adjustment) (such adjustments, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">ESG Applicable Margin Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) to the otherwise applicable Applicable Margin for Term SOFR Advances, ABR Advances, Letter of Credit Participation Fees, and the Facility Fee may be made&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the amount of such adjustments shall not exceed (i) in the case of the Applicable Margin for the Facility Fee, an increase and&#47;or decrease of 0.005% for any one KPI, or 0.01% in the aggregate for all KPIs and (ii) in the case of the Applicable Margin for Term SOFR Advances, ABR Advances, and Letter of Credit Participation Fees, an increase and&#47;or decrease of 0.02% for any one KPI, or 0.04% in the aggregate for all KPIs&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, in no event shall the Applicable Margin for Term SOFR Advances, ABR Advances, Letter of Credit Participation Fees, or the Facility Fee be less than zero.  The KPIs, the Borrower&#8217;s performance against the KPIs, and any related ESG Applicable Margin Adjustments resulting therefrom, will be determined based on certain certificates, reports and other documents, in each case, setting forth    the calculation and measurement of the KPIs in a manner that is aligned with the Sustainability Linked Loan Principles and to be mutually agreed between the Borrower and the Sustainability Coordinator (each acting reasonably).  Following the effectiveness of an ESG Amendment, any modification to the ESG Pricing Provisions shall be subject only to the consent of the Required Lenders so long as such modification does not have the effect of reducing the Applicable Margin   for Term SOFR Advances, ABR Advances, Letter of Credit Participation Fees, or the Facility Fee  to a level not otherwise permitted by this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.14(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">The Sustainability Coordinator will (i) assist the Borrower in determining the ESG Pricing Provisions in connection with the ESG Amendment and (ii) assist the Borrower in preparing informational materials focused on ESG to be used in connection with the ESG Amendment.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">This </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall supersede any provisions in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> to the contrary.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">PROCEEDS, PAYMENTS, CONVERSIONS, INTEREST, YIELD PROTECTION AND FEES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Disbursement of the Proceeds of the Loans</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall disburse the proceeds of the Loans (other than the Swing Line Loans) at its office specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> by crediting to the Borrower&#8217;s general deposit account with    the Administrative Agent the funds received from each Lender. Unless the Administrative Agent shall have received prior notice from a Lender (by telephone or otherwise, such notice to be confirmed by fax, email   or other writing) that such Lender will not make available to the Administrative Agent such Lender&#8217;s Commitment Percentage of the Revolving Credit Loans, or the amount of any Competitive Bid Loan, to be made by it on a Borrowing Date, the Administrative Agent may assume that such Lender has made such amount available to the Administrative Agent on such Borrowing Date in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, in the case of a Revolving Credit Loan, such Lender received notice thereof from the Administrative Agent in accordance with the terms hereof, and the Administrative Agent may, in reliance upon such assumption, make available to the Borrower on such Borrowing Date a corresponding amount.    If and to the extent that such Lender shall not have so made such amount available to the Administrative Agent, such Lender and the Borrower severally agree to pay to the Administrative Agent, forthwith on demand, such corresponding amount (to the extent not previously paid by the other), together with interest thereon for each day from the date such amount is made available to the Borrower until the date such  amount is paid to the Administrative Agent, at a rate per annum equal to, in the case of the Borrower, the applicable interest rate set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.4(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and, in the case of such Lender, the Federal Funds  Effective Rate from the date such payment is due until the third day after such date and, thereafter, at the Federal Funds Effective Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 2%. Any such payment by the Borrower shall be without prejudice to its rights against such Lender. If such Lender shall pay to the Administrative Agent such corresponding  amount, such amount so paid shall constitute such Lender&#8217;s Loan as part of such Loans for purposes of this Agreement, which Loan shall be deemed to have been made by such Lender on the Borrowing Date applicable to such Loans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Payments</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Each payment, including each prepayment, of principal and interest on the Loans and of the Facility Fee and the Letter of Credit Participation Fee (collectively, together with all of the other fees to be paid to the Administrative Agent, the Lenders, the Issuers and the Swing Line Lender in connection with, and pursuant to the terms of, the Loan Documents, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Fees&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), and of all of the other amounts to be paid to the Administrative Agent and the Lenders in connection with, and pursuant to the terms of, the Loan Documents (other than amounts payable to a Lender under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) shall be made by the Borrower to the Administrative Agent at its office specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> without condition, recoupment, defense, setoff, deduction or counterclaim in funds immediately available in New   York by 3&#58;00 P.M. on the due date for such payment. The failure of the Borrower to make any such payment by such time shall not constitute a default hereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such payment is made on such due date, but any such payment made after 3&#58;00 P.M. on such due date shall be deemed to have been made on the next Domestic Business Day for the purpose of calculating interest on amounts outstanding on the Loans. If the Borrower has not made any such payment prior to 3&#58;00 P.M., the Borrower hereby authorizes the Administrative Agent to deduct the amount of any such payment from such account(s) as the Borrower may from time to time designate in writing to the Administrative Agent, upon which the Administrative Agent shall apply the amount of such deduction to such payment. Promptly upon receipt thereof by the Administrative Agent, each payment of principal and interest on the&#58; (i) Revolving Credit Loans shall be remitted by the Administrative Agent in like funds as received to each Lender (a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, pro rata according to the amount of interest which is then due and payable to the Lenders, and (b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, pro rata according to the amount of principal which is then due and payable to the Lenders, (ii) Competitive Bid Loans shall be remitted by the Administrative Agent in like funds as received to each applicable Lender and (iii) Swing Line Loans shall be remitted by the Administrative Agent in like funds as received  to the Swing Line Lender. Each payment of the Facility Fee and the Letter of Credit Participation Fee payable to the Lenders shall be promptly transmitted by the Administrative Agent in like funds as received to each Lender pro rata according to such Lender&#8217;s Commitment Amount or, if the Commitments shall have terminated or been terminated, according to the outstanding principal amount of such Lender&#8217;s Revolving Credit Loans.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">If any payment hereunder or under the Loans shall be due and payable on a day which is not a Domestic Business Day the due date thereof (except as otherwise provided in the definition of Term SOFR Interest Period or Competitive Interest Period) shall be extended to the </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">next Domestic Business Day and (except with respect to payments in respect of the Facility Fee   and the Letter of Credit Participation Fee) interest shall be payable at the applicable rate specified herein during such extension.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Unless the Administrative Agent shall have received notice from the Borrower  prior to the date on which any payment is due to the Administrative Agent for the account of the Lenders or any of the Issuers hereunder that the Borrower will not make such payment, the Administrative Agent may assume that the Borrower has made such payment on such date in accordance herewith and may, in reliance upon such assumption, distribute to the applicable  Lenders or the applicable Issuers, as the case may be, the amount due.  With respect to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any payment that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Administrative Agent makes for the account of the Lenders or any of the Issuers hereunder as to which the Administrative Agent determines (which determination shall be conclusive absent manifest error) that any of the following applies (such payment referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Rescindable Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#58; (1) the Borrower has not in fact made such payment&#59; (2) the Administrative Agent has made a payment in excess of the amount so paid by the Borrower (whether or not then owed)&#59; or   (3) the Administrative Agent has for any reason otherwise erroneously made such payment&#59; then each of the Lenders or the applicable Issuers, as the case may be, severally agrees to repay to the Administrative Agent forthwith on demand the Rescindable Amount so distributed to such Lender  or such Issuer, in immediately available funds with interest thereon, for each day from and  including the date such amount is distributed to it to but excluding the date of payment to the Administrative Agent, at the greater of the Federal Funds Effective Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Conversions&#59; Other Matters</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Borrower may elect at any time and from time to time to Convert one or more Term SOFR Advances to an ABR Advance by giving the Administrative Agent at least one Domestic Business Day&#8217;s prior irrevocable notice of such election (in the form of a Borrowing Request), specifying the amount to be so Converted. In addition, the Borrower may elect at any   time and from time to time to Convert an ABR Advance to any one or more new Term SOFR Advances or to Convert any one or more existing Term SOFR Advances to any one or more new Term SOFR Advances by giving the Administrative Agent no later than 10&#58;00 A.M. at least two Domestic Business Days&#8217; prior irrevocable notice of such election (in the form of a Borrowing Request), specifying the amount to be so Converted and the initial Interest Period relating thereto&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any Conversion of an ABR Advance to an Term SOFR Advance shall only be made  on a Domestic Business Day&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, notwithstanding the foregoing, a Borrowing Request for a Conversion delivered by the Borrower may state that such Borrowing Request is conditioned upon the effectiveness of other credit facilities or transactions (such Borrowing   Request to specify the proposed effective date), in which case such Borrowing Request may be revoked by the Borrower (by notice to the Administrative Agent prior to the day specified for such Conversion in such Borrowing Request) if such condition is not satisfied and the Borrower shall indemnify the Lenders in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, if applicable. The Administrative Agent   shall promptly provide the Lenders with notice of each such election. Each Conversion of Loans shall be made pro rata according to the outstanding principal amount of the Loans of each Lender. ABR Advances and Term SOFR Advances may be Converted pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> in whole or in part&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the amount to be Converted to each Term SOFR Advance, when aggregated with any Term SOFR Advance to be made on such date in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and having the same Interest Period as such first Term SOFR Advance, shall equal no less than $10,000,000    or an integral multiple of $1,000,000 in excess thereof or the entire remaining amount of the Term SOFR Advances.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Notwithstanding anything in this Agreement to the contrary, the Borrower shall    not have the right to elect to Convert any existing ABR Advance to a Term SOFR Advance or to Convert any existing Term SOFR Advance to a new Term SOFR Advance if (i) a Default or an Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(h),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall then exist, or (ii) any other Event of Default shall then exist and the Administrative Agent   shall have notified the Borrower at the request of the Required Lenders that no ABR Advance or Term SOFR Advance may be Converted to a new Term SOFR Advance. In such event, such ABR Advance shall be automatically continued as an ABR Advance or such Term SOFR Advance shall be automatically Converted to an ABR Advance on the last day of the Interest Period applicable to such Term SOFR Advance. The foregoing shall not affect any other rights or remedies that the Administrative Agent or any Lender may have under this Agreement or any other Loan Document.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Each Conversion shall be effected by each Lender by applying the proceeds of   each new ABR Advance or Term SOFR Advance, as the case may be, to the existing ABR Advance or Term SOFR Advance (or portion thereof) being Converted (it being understood that such Conversion shall not constitute a borrowing for purposes of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Notwithstanding any other provision of any Loan Document&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">if the Borrower shall have failed to elect a Term SOFR Advance under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as the case may be, in connection with any borrowing of  new Revolving Credit Loans or expiration of an Interest Period with respect to any existing Term SOFR Advance, the amount of the Revolving Credit Loans subject to such borrowing or such existing Term SOFR Advance shall thereafter be an ABR Advance until such time, if any, as the Borrower shall elect a new Term SOFR Advance pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">the Borrower shall not be permitted to select a Term SOFR Advance the Interest Period in respect of which ends later than the Commitment Termination Date or such earlier date upon which all of the Commitments shall have been terminated in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">the Borrower shall not be permitted to have more than (x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">15 Term SOFR Advances and (y) 15 Competitive Bid Loans outstanding at any one time&#59; it being understood and agreed that each borrowing of Term SOFR Advances or Competitive Bid Loans pursuant to a single Borrowing Request or Competitive Bid Request, as the case   may be, shall constitute the making of one Term SOFR Advance or Competitive Bid Loan for the purpose of calculating such limitation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Interest Rates and Payment Dates.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Prior to Maturity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Except as otherwise provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.4(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">3.4(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Loans shall bear interest on the unpaid principal balance thereof at the applicable interest rate or rates per annum set forth below&#58;</font></div><div style="margin-bottom:0.12pt;text-align:justify;text-indent:0.36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.956%"><tr><td style="width:1.0%"></td><td style="width:36.809%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:60.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#d9d9d9;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">LOANS</font></td><td colspan="3" style="background-color:#d9d9d9;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">RATE</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Revolving Credit Loans constituting ABR Advances</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Alternate Base Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the Applicable Margin.</font></div></td></tr></table></div><div><font><br></font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.800%"><tr><td style="width:1.0%"></td><td style="width:36.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:61.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Revolving Credit Loans constituting Term SOFR Advances</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Term SOFR applicable thereto </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the Applicable Margin.</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Competitive Bid Loans</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Fixed rate of interest applicable thereto accepted by the Borrower pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.4(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Swing Line Loans</font></td><td colspan="3" style="border-bottom:0.5pt solid #000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Negotiated Rate applicable thereto as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.2(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (or if not available, the Term SOFR Daily Floating Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the Applicable Margin).</font></div></td></tr></table></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Late Payment Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Any payment of principal or interest on the Loans, Fees or  other amounts payable by the Borrower under the Loan Documents not paid on the date when due and payable shall, after the occurrence and during the continuance of an Event of Default pursuant  to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, bear interest, in the case of principal or interest on    a Loan, at the applicable interest rate on such Loan </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 2% per annum and, in the case of any Fees or other amounts, at the Alternate Base Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Applicable Margin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 2% per annum, in  each case from the due date thereof until the date such payment is made (whether before or after   the entry of any judgment thereon).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Highest Lawful Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding anything to the contrary contained in this Agreement, at no time shall the interest rate payable to any Lender on any of its Loans, together  with the Fees and all other amounts payable hereunder to such Lender to the extent the same constitute or are deemed to constitute interest, exceed the Highest Lawful Rate. If, in respect of any period during the term of this Agreement, any amount paid to any Lender hereunder, to the extent the same shall (but for the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) constitute or be deemed to constitute interest, would exceed the maximum amount of interest permitted by the Highest Lawful Rate during such period (such amount being hereinafter referred to as an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Unqualified Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), then  (i) such Unqualified Amount shall be applied or shall be deemed to have been applied as a prepayment of the Loans of such Lender, and (ii) if, in any subsequent period during the term of   this Agreement, all amounts payable hereunder to such Lender in respect of such period which constitute or shall be deemed to constitute interest shall be less than the maximum amount of  interest permitted by the Highest Lawful Rate during such period, then the Borrower shall pay to such Lender in respect of such period an amount (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Compensatory Interest Payment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) equal to the lesser of (x) a sum which, when added to all such amounts, would equal the maximum amount of interest permitted by the Highest Lawful Rate during such period, and (y) an amount equal to    the aggregate sum of all Unqualified Amounts </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">less</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> all other Compensatory Interest Payments.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Interest shall be payable in arrears on each Interest Payment Date, on the Commitment Termination Date, to the extent provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, upon each prepayment of the Loans and, to the extent provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.12(d), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">on the Extension Date. Any change in the interest rate on the Loans resulting from an increase or a decrease in the Alternate Base Rate or any reserve requirement shall become effective as of the opening of business on the day on which such change shall become effective.  Each determination by the Administrative Agent of the Alternate Base Rate, Term SOFR and the Competitive Bid Rate pursuant to this Agreement shall be conclusive and binding on the Borrower absent manifest error. The Borrower acknowledges that to the extent interest payable on the Loans is based on the Alternate Base Rate, such rate is only one   of the bases for computing interest on loans made by the Lenders, and by basing interest payable    on ABR Advances on the Alternate Base Rate, the Lenders have not committed to charge, and the Borrower has not in any way bargained for, interest based on a lower or the lowest rate at which    the Lenders may now or in the future make extensions of credit to other Persons. All interest (other </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">than interest calculated with reference to the Alternate Base Rate) shall be calculated on the basis   of a 360-day year for the actual number of days elapsed, and all interest determined with reference  to the Alternate Base Rate shall be calculated on the basis of a 365&#47;366-day year for the actual number of days elapsed.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">No Warranty</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> The Administrative Agent does not warrant, nor accept   responsibility for, nor shall the Administrative Agent have any liability with respect to, the administration, submission or any other matter related to any reference rate referred to herein or  with respect to any rate (including, for the avoidance of doubt, the selection of such rate and any related spread or other adjustment) that is an alternative or replacement for or successor to any such rate (including, without limitation, any Successor Rate) (or any component of any of the foregoing) or the effect of any of the foregoing, or of any Conforming Changes&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the foregoing shall not apply to any liability arising out of the bad faith, willful misconduct or gross negligence    of the Administrative Agent.  The Administrative Agent and its affiliates or other related entities may engage in transactions or other activities that affect any reference rate referred to herein, or   any alternative, successor or replacement rate (including, without limitation, any Successor Rate)  (or any component of any of the foregoing) or any related spread or other adjustments thereto, in each case, in a manner adverse to the Borrower.&#160; The Administrative Agent may select information sources or services in its reasonable discretion to ascertain any reference rate referred to herein or any alternative, successor or replacement rate (including, without limitation, any Successor Rate)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or any component of any of the foregoing), in each case pursuant to the terms of this Agreement, and shall have no liability to the Borrower, any Lender or any other person or entity for damages    of any kind, including direct or indirect, special, punitive, incidental or consequential damages, costs, losses or expenses (whether in tort, contract or otherwise and whether at law or in equity),    for any error or other action or omission related to or affecting the selection, determination, or calculation of any rate (or component thereof) provided by any such information source or service&#59; provided that the foregoing shall not apply to any liability arising out of the bad faith, willful misconduct or gross negligence of the Administrative Agent.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Indemnification for Loss</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding anything contained herein to the contrary, if&#58; (i) the Borrower shall fail to borrow   a Term SOFR Advance or if the Borrower shall fail to Convert all or any portion of any Revolving Credit Loan constituting an ABR Advance to a Term SOFR Advance after it shall have given notice to do so in which it shall have requested a Term SOFR Advance pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as the case   may be, (ii) the Borrower shall fail to borrow a Competitive Bid Loan after it shall have accepted any offer with respect thereto in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, (iii) a Term SOFR Advance or Competitive Bid Loan shall be terminated for any reason prior to the last day of the Interest Period applicable thereto, (iv) any repayment or prepayment of the principal amount of a Term SOFR Advance or Competitive Bid Loan is made for any reason on a date which is prior to the last day of the Interest Period applicable thereto, (v) the Borrower shall have revoked a notice of prepayment or notice of termination of the Commitments and the Letter of Credit Commitment that was conditioned upon the effectiveness of other credit facilities or transactions pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, or (vi) a Term SOFR Advance is assigned other than on the last day of the Interest Period applicable thereto as a result of an increase in the Aggregate Commitment Amount pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or a replacement of a Lender pursuant to clause (x) or (z) of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, then the Borrower agrees to indemnify each Lender against, and to pay on demand directly to such Lender the amount (calculated by such Lender using any method chosen by such Lender which is customarily used by such Lender for such purpose for borrowers similar to the Borrower) equal to any loss or expense suffered by such Lender as a result of such failure to borrow or Convert, or such termination, repayment, prepayment or revocation, including any loss, cost or expense suffered by such Lender in liquidating or employing deposits acquired to fund or maintain the funding of such Term SOFR Advance or Competitive </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Bid Loan, as the case may be, or redeploying funds prepaid or repaid, in amounts which correspond to such Term SOFR Advance or Competitive Bid Loan, as the case may be, and any reasonable internal processing charge customarily charged by such Lender in connection therewith for borrowers similar to the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Reimbursement for Costs, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If at any time or from time to time there shall occur a Regulatory Change and any Issuer or any Lender shall have reasonably determined that such Regulatory Change (i) shall have had or will thereafter have the effect of reducing (A) the rate of return on such Issuer&#8217;s or such Lender&#8217;s capital or liquidity or    the capital or liquidity of any Person directly or indirectly owning or controlling such Issuer or such Lender (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Control Person&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), or (B) the asset value (for capital or liquidity purposes) to such Issuer, such Lender or such Control Person, as applicable, of the Reimbursement Obligations, or any participation therein, or the Loans, or any participation therein, in any case to a level below that which such Issuer, such Lender or such Control Person could have achieved or would thereafter be able to achieve but for such Regulatory Change (after taking into account such Issuer&#8217;s, such Lender&#8217;s or such Control Person&#8217;s policies regarding capital or liquidity), (ii) will impose, modify or deem applicable any reserve, asset, special deposit or special assessment requirements on Term SOFR Advances, or (iii) will subject such Issuer, such Lender or such Control Person, as applicable, to any tax (documentary, stamp or otherwise) with respect to this Agreement, any Note, any Reimbursement Agreement or any other Loan Document (except, in the case of clause (iii) above, for any Indemnified Taxes, Excluded Taxes or Other Taxes), then, in each such case, within ten days after demand by such Issuer or such Lender, as applicable, the Borrower shall pay directly   to such Issuer, such Lender or such Control Person, as the case may be, such additional amount or amounts as shall be sufficient to compensate such Issuer, such Lender or such Control Person, as the case may be,   for any such reduction, reserve or other requirement, tax, loss, cost or expense (excluding general administrative and overhead costs) (collectively, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Costs&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) attributable to such Issuer&#8217;s, such Lender&#8217;s or such Control Person&#8217;s compliance during the term hereof with such Regulatory Change, but only if such Costs are generally applicable to (and for which reimbursement is generally being sought by such Issuer, such Lender or such Control Person, as applicable, in respect of) credit transactions similar to this transaction from similarly situated borrowers (which are parties to credit or loan documentation containing   a provision similar to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), as determined by such Issuer or such Lender, as applicable, in its reasonable discretion. Each Issuer and each Lender may make multiple requests for compensation under   this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, the Borrower will not be required to compensate any Issuer or any Lender for any Costs under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> arising prior to 45 days preceding the date of demand, unless   the applicable Regulatory Change giving rise to such Costs is imposed retroactively in which case the 45- day period referred to above shall be extended to include the period of retroactive effect thereof. In the case of retroactivity, such notice shall be provided to the Borrower not later than 45 days from the date that such Issuer or such Lender learned of such Regulatory Change. The Borrower&#8217;s obligation to compensate such Issuer or such Lender shall be contingent upon the provision of such timely notice (but any failure by such Issuer or such Lender to provide such timely notice shall not affect the Borrower&#8217;s obligations with respect to (i) Costs incurred from the date as of which such Regulatory Change became effective to the date that is 45 days after the date such Issuer or such Lender reasonably should have learned of such Regulatory Change and (ii) Costs incurred following the provision of such notice).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Illegality of Funding</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding any other provision hereof, if any Lender shall reasonably determine that any law, regulation, treaty or directive, or any change therein or in the interpretation or application thereof, shall  make it unlawful for such Lender to make or maintain Loans whose interest rates are based upon SOFR or Term SOFR, such Lender shall promptly notify the Borrower and the Administrative Agent thereof, and    </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a) the commitment of such Lender to make such Term SOFR Advances or to Convert ABR Advances to Term SOFR Advances shall forthwith be suspended, (b) such Lender shall fund its portion of each requested Term SOFR Advance as an ABR Advance, (c) such Lender&#8217;s Loans then outstanding as such Term SOFR Advances, if any, shall be Converted automatically to an ABR Advance on the last day of the then-current Interest Period applicable thereto or at such earlier time as may be required and (d) if such notice asserts    the illegality of such Lender making or maintaining ABR Advances the interest rate on which is determined by reference to One Month SOFR Rate, the interest rate on which ABR Advances of such Lender shall, if necessary to avoid such illegality, be determined by the Administrative Agent without reference to the One Month SOFR Rate component of the Alternate Base Rate.  If the commitment of any Lender with respect    to Term SOFR Advances is suspended pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and such Lender shall have obtained actual knowledge that it is once again legal for such Lender to make or maintain Term SOFR Advances, such Lender shall promptly notify the Administrative Agent and the Borrower thereof and, upon delivery     of such notice to each of the Administrative Agent and the Borrower, such Lender&#8217;s commitment to make    or maintain Term SOFR Advances shall be reinstated. If the commitment of any Lender with respect to Term SOFR Advances is suspended pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, such suspension shall not otherwise affect such Lender&#8217;s Commitment. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Option to Fund&#59; Substituted Interest Rate</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Each Lender has indicated that, if the Borrower requests a Term SOFR Advance    or a Competitive Bid Loan, such Lender may wish to purchase one or more deposits in order to   fund or maintain its funding of its Commitment Percentage of such Term SOFR Advance or Competitive Bid Loan during the Interest Period with respect thereto&#59; it being understood that the provisions of this Agreement relating to such funding are included only for the purpose of determining the rate of interest to be paid in respect of such Term SOFR Advance or Competitive Bid Loan and any amounts owing under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Each Lender shall be entitled to fund and maintain its funding of all or any part of each Term SOFR Advance and Competitive Bid Loan in any manner it sees fit, but all such determinations hereunder shall be made as if such Lender had actually funded and maintained its Commitment Percentage of each Term SOFR Advance or Competitive Bid Loan, as the case may be, during the applicable Interest Period through the purchase of deposits in an amount equal to the amount of its Commitment Percentage of such Term SOFR Advance or Competitive Bid Loan, as the case may be, and having a maturity corresponding to such Interest Period. Each Lender may fund its Advances from or for the account of any branch or office of such Lender as such Lender may choose from time to time, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">If in connection with any request for a Term SOFR Advance or a Conversion to or continuation thereof, as applicable, (i) the Administrative Agent determines (which determination shall be conclusive absent manifest error) that (A) no Successor Rate has been determined in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and the circumstances under clause (i) of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or the Scheduled Unavailability Date has occurred or (B) adequate and reasonable means do not otherwise exist for determining (1) Term SOFR for any requested Term SOFR Interest Period with respect to  a proposed Term SOFR Advance or (2) the One Month SOFR Rate in connection with an existing  or proposed ABR Advance or (ii) the Administrative Agent or the Required Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">determine that for any reason that (A) Term SOFR for any requested Term SOFR Interest Period with respect to     a proposed Term SOFR Advance or (B) the One Month SOFR Rate with respect to a proposed   ABR Advance, in any case, does not adequately and fairly reflect the cost to such Lenders of funding such Loan, the Administrative Agent will promptly so notify the Borrower and each  Lender.  Thereafter, (x)&#160;the obligation of the Lenders to make or maintain Term SOFR Advances    or to Convert ABR Advances to Term SOFR Advances shall be suspended (to the extent of the affected Term SOFR Advances or Term SOFR Interest Periods) and (y)&#160;in the event of a </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">determination described in the preceding sentence with respect to the One Month SOFR Rate component of the Alternate Base Rate, the utilization of the One Month SOFR Rate in determining the Alternate Base Rate shall be suspended, in each case, until the Administrative Agent (or, in the case of a determination by the Required Lenders described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">clause (ii</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(b</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), until the Administrative Agent upon instruction of the Required Lenders) revokes such notice.  Upon receipt of such notice, (i) the Borrower may revoke any pending request for a borrowing of, Conversion to or continuation of Term SOFR Advances (to the extent of the affected Term SOFR Advances or Term SOFR Interest Periods) or, failing that, will be deemed to have Converted such request into a request for a borrowing of ABR Advances in the amount specified therein and (ii)   any outstanding Term SOFR Advances shall be deemed to have been Converted to ABR Advances immediately at the end of their respective applicable Term SOFR Interest Period. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Notwithstanding anything to the contrary in this Agreement or any other Loan Documents, if the Administrative Agent and the Borrower determine (which determination shall    be conclusive absent manifest error), or the Borrower or the Required Lenders notify the Administrative Agent (with, in the case of the Required Lenders, a copy to the Borrower) that the Borrower or the Required Lenders (as applicable) have determined, that&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">adequate and reasonable means do not exist for ascertaining one month, three month and six month interest periods of Term SOFR, including, without limitation, because the Term SOFR Screen Rate is not available or published on a current basis and such circumstances are unlikely to be temporary&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">CME or any successor administrator of the Term SOFR Screen Rate or a Governmental Authority having jurisdiction over the Administrative Agent or such administrator with respect to its publication of Term SOFR, in each case acting in such capacity, has made a public statement identifying a specific date after which one month, three month and six month interest periods of Term SOFR or the Term SOFR Screen Rate shall or will no longer be made available, or permitted to be used for determining the  interest rate of Dollar denominated U.S. syndicated loans, or shall or will otherwise cease, provided that, at the time of such statement, there is no successor administrator that is satisfactory to the Administrative Agent, that will continue to provide such interest periods of Term SOFR after such specific date (the latest date on which one month, three month  and six month interest periods of Term SOFR or the Term SOFR Screen Rate are no longer available permanently or indefinitely, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Scheduled Unavailability Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">then, on a date and time determined by the Administrative Agent and the Borrower (any such date, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Term SOFR Replacement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), which date shall be at the end of a Term SOFR Interest Period or on the relevant interest payment date, as applicable, for interest calculated and, solely   with respect to clause (2) above, no later than the Scheduled Unavailability Date, Term SOFR will be replaced hereunder and under any Loan Document with Daily Simple SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the SOFR Adjustment for any payment period for interest calculated that can be determined by the Administrative Agent, in each case, without any amendment to, or further action or consent of any other party to, this Agreement or any other Loan Document (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Successor Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If the Successor Rate is Daily Simple SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the SOFR Adjustment, all interest payments will be payable on a quarterly basis.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding anything to the contrary herein, (i) if the Administrative Agent determines that Daily Simple SOFR is not available on or prior to the Term SOFR Replacement Date, or (ii) if the events or circumstances of the type described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(c)(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> have occurred with respect </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to the Successor Rate then in effect, then in each case, the Administrative Agent and the Borrower may amend this Agreement solely for the purpose of replacing Term SOFR or any then current Successor Rate in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> at the end of any Term SOFR Interest Period, relevant interest payment date or payment period for interest calculated, as applicable, with an alternative benchmark rate giving due consideration to any evolving or then existing convention    for similar Dollar denominated credit facilities syndicated and agented in the United States for such alternative benchmark. and, in each case, including any mathematical or other adjustments to such benchmark giving due consideration to any evolving or then existing convention for similar Dollar denominated credit facilities syndicated and agented in the United States for such benchmark,   which adjustment or method for calculating such adjustment shall be published on an information service as selected by the Administrative Agent from time to time in its reasonable discretion and may be periodically updated.  For the avoidance of doubt, any such proposed rate and adjustments, shall constitute a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Successor Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;.  Any such amendment shall become effective at 5&#58;00 p.m. on  the fifth Domestic Business Day after the Administrative Agent shall have posted such proposed amendment to all Lenders and the Borrower unless, prior to such time, Lenders comprising the Required Lenders have delivered to the Administrative Agent written notice that such Required Lenders object to such amendment.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent will promptly (in one or more notices) notify the Borrower and each Lender of the implementation of any Successor Rate.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any Successor Rate shall be applied in a manner consistent with market practice&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that to the extent such market practice is not administratively feasible for the Administrative Agent, such Successor Rate shall be applied in a manner as otherwise reasonably determined by the Administrative Agent (in consultation with the Borrower).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding anything else herein, if at any time any Successor Rate as so determined would otherwise be less than zero, the Successor Rate will be deemed to be zero for the purposes of this Agreement and the other Loan Documents.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In connection with the implementation of a Successor Rate, the Administrative Agent will have the right, in consultation with the Borrower, to make Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such Conforming Changes in the discretion of the Administrative Agent and in consultation with the Borrower will become effective without any further action or consent of any other party to this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, with respect to any such amendment effected, the Administrative Agent shall post each such amendment implementing such Conforming Changes to the Borrower and the Lenders promptly after such amendment becomes effective.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Certificates of Payment and Reimbursement</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each Issuer and each Lender agrees, in connection with any request by it for payment or reimbursement pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to provide the Borrower with a certificate, signed by an officer of such Issuer or such Lender, as the case may be, setting forth a description in reasonable detail of any such payment or reimbursement and the applicable Section of this Agreement pursuant to and in accordance with which such request is made. Each determination by such Issuer and such Lender of such payment or reimbursement shall be conclusive absent manifest error.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Taxes&#59; Net Payments</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Payments Free of Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Any and all payments by or on account of any obligation of the Borrower hereunder or under any other Loan Document shall be made free and clear of, and without reduction or withholding for, any Indemnified Taxes or Other Taxes&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if the Borrower shall be required by applicable law to deduct any Indemnified Taxes (including any Other Taxes) from such payments, then (i)&#160;the sum payable shall be increased as necessary so that after making all required deductions (including deductions applicable to additional sums payable under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) the Administrative Agent, the applicable Lender or the applicable Issuer, as the case may be, receives an amount equal to the sum it would have received had no such deductions  for Indemnified Taxes or Other Taxes been made, (ii)&#160;the Borrower shall make such deductions    and (iii)&#160;the Borrower shall timely pay the full amount deducted to the relevant Governmental Authority in accordance with applicable law. For purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the term &#8220;Lender&#8221; includes the Swing Line Lender and each Issuer and the term &#8220;applicable law&#8221; includes FATCA.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Payment of Other Taxes by the Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Without limiting the provisions of paragraph (a) above, the Borrower shall timely pay any Other Taxes to the relevant Governmental Authority in accordance with applicable law.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Indemnification by the Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Borrower shall indemnify the   Administrative Agent, each Lender and each Issuer, within 30 days after demand therefor, for the full amount of any Indemnified Taxes imposed on or with respect to, any payment made by, or on account of, any obligation of the Borrower under any Loan Document or Other Taxes (including Indemnified Taxes or Other Taxes imposed or asserted on or attributable to amounts payable under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) paid by the Administrative Agent, such Lender or such Issuer, as the case may   be, and, without duplication, any penalties, interest and reasonable and documented out-of-pocket expenses arising therefrom or with respect thereto (other than any penalties that result from the  gross negligence, bad faith or willful misconduct of the Administrative Agent, such Lender or such Issuer, as applicable, as determined by a final and non-appealable judgment of a court of competent jurisdiction)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if the Borrower reasonably believes that such Taxes were not correctly  or legally asserted, the Administrative Agent, such Lender or such Issuer, as applicable, will cooperate with the Borrower to obtain a refund of such Taxes so long as such efforts would not result in any additional costs or expenses not reimbursed by the Borrower and such cooperation would not, in the judgment of such Lender or such Issuer, as applicable, be materially disadvantageous to it.  A certificate as to the amount of such payment or liability that complies with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and is delivered to the Borrower by such Lender or such Issuer (with a copy to the Administrative Agent), or by the Administrative Agent on its own behalf or on behalf of such Lender or such Issuer, shall be conclusive absent manifest error. After any Lender or any Issuer (as the case may be) learns of the imposition of any Indemnified Taxes or Other Taxes, such Lender     or such Issuer (as the case may be) will as soon as reasonably practicable notify the Borrower thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the failure to provide the Borrower with such notice shall not release the Borrower from its indemnification obligations under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Notwithstanding anything   to the contrary contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Borrower shall not be required to indemnify the Administrative Agent or any Lender or Issuer pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> for any additional costs, such as penalties or interest, to the extent that such costs resulted from a failure of the Administrative Agent or such Lender or Issuer to notify the Borrower of such possible indemnification claim within 180 days after the Administrative Agent or such Lender or Issuer receives notice from the applicable taxing authority of the tax giving rise to such indemnification claim.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Evidence of Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. As soon as practicable after any payment of Indemnified Taxes or Other Taxes by the Borrower to a Governmental Authority, the Borrower shall deliver to the Administrative Agent the original or a certified copy of a receipt issued by such Governmental Authority evidencing such payment, a copy of the return reporting such payment or other evidence of such payment reasonably satisfactory to the Administrative Agent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Indemnification by the Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each Lender shall severally indemnify the Administrative Agent, within 10 days after demand therefor, for (i) any Indemnified Taxes attributable to such Lender (but only to the extent that the Borrower has not already indemnified   the Administrative Agent for such Indemnified Taxes and without limiting the obligation of the Borrower to do so), (ii) any Taxes attributable to such Lender&#8217;s failure to comply with the  provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> relating to the maintenance of a Participant Register, and (iii) any Excluded Taxes attributable to such Lender, in each case, that are payable or paid by the Administrative Agent in connection with any Loan Document, and any reasonable expenses arising therefrom or with respect thereto, whether or not such Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate as to the amount of such payment      or liability delivered to any Lender by the Administrative Agent shall be conclusive absent manifest error. Each Lender hereby authorizes the Administrative Agent to set off and apply any and all amounts at any time owing to such Lender under any Loan Document or otherwise payable by the Administrative Agent to the Lender from any other source against any amount due to the Administrative Agent under this paragraph (e).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.02pt;text-decoration:underline">Status of Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Any Lender that is entitled to an exemption from, or reduction  of, withholding Tax under the law of the jurisdiction in which the Borrower is resident for Tax purposes, or any treaty to which such jurisdiction is a party, with respect to payments hereunder or under any other Loan Document shall deliver to the Borrower (with a copy to the Administrative Agent), at the time or times prescribed by applicable law or reasonably requested by the Borrower  or the Administrative Agent, such properly completed and executed documentation prescribed by applicable law as will permit such payments to be made without withholding or at a reduced rate    of withholding. In addition, any Lender, if requested by the Borrower or the Administrative Agent, shall deliver such other documentation prescribed by applicable law or reasonably requested by the Borrower or the Administrative Agent as will enable the Borrower or the Administrative Agent to determine whether or not such Lender is subject to backup withholding or information reporting requirements.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Without limiting the generality of the foregoing, any Foreign Lender shall deliver to the Borrower and the Administrative Agent (in such number of copies as shall be requested by the recipient) on or prior to the date on which such Foreign Lender becomes a Lender under this Agreement (and from time to time thereafter (i) if such Foreign Lender shall determine that any applicable form or certification has expired or will then expire or has or will then become obsolete  or incorrect or that an event has occurred that requires or will then require a change in the most recent form or certification previously delivered by it to the Borrower and the Administrative Agent and (ii) upon the request of the Borrower or the Administrative Agent, but only if such Foreign Lender is legally entitled to do so), whichever of the following is applicable&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">duly completed copies of Internal Revenue Service Form W-8BEN or   Form W-8BEN-E claiming eligibility for benefits of an income Tax treaty to which the United States of America is a party,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.58pt">duly completed copies of Internal Revenue Service Form W-8ECI,</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.53pt">in the case of a Foreign Lender claiming the benefits of the exemption for portfolio interest under Section 881(c) of the Internal Revenue Code, (x) a certificate (a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;United States Tax Compliance Certificate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) to the effect that such Foreign Lender is not (A) a &#8220;bank&#8221; within the meaning of Section 881(c)(3)(A) of the Internal Revenue Code,   (B) a &#8220;10 percent shareholder&#8221; of the Borrower within the meaning of Section 881(c)(3)(B) of the Internal Revenue Code, (C) a &#8220;controlled foreign corporation&#8221; described in Section 881(c)(3)(C) of the Internal Revenue Code nor (D) engaged in the conduct of a trade or business within the United States to which the interest payment is effectively connected   and (y) duly completed copies of Internal Revenue Service Form W-8BEN or Form W- 8BEN-E,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.13pt">to the extent a Foreign Lender is not the beneficial owner (for example, where the Foreign Lender is a partnership or participating Lender granting a typical participation), a complete and executed Internal Revenue Service Form W-8IMY, accompanied by a Form W-8ECI, Form W-8BEN, Form W-8BEN-E, a United States Tax Compliance Certificate, Internal Revenue Service Form W-9 and&#47;or other certification documents from each beneficial owner, as applicable&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that, if the Foreign Lender  is a partnership (and not a participating Lender) and one or more partners of such Foreign Lender are claiming the portfolio interest exemption, such Foreign Lender shall provide a United States Tax Compliance Certificate, on behalf of such beneficial owner(s) in lieu of requiring each beneficial owner to provide its own certificate, or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">any other form prescribed by applicable law as a basis for claiming exemption from or a reduction in United States federal withholding Tax duly completed together with such supplementary documentation as may be prescribed by applicable law   to permit the Borrower to determine the withholding or deduction required to be made.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If a payment made to a Lender under any Loan Document would be subject to U.S. federal withholding Tax imposed by FATCA if such Lender were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472(b) of the Internal Revenue Code, as applicable), such Lender shall deliver to the Borrower and the Administrative Agent at the time or times prescribed by law and at such time or times reasonably requested by the Borrower or the Administrative Agent such documentation prescribed by  applicable law (including as prescribed by Section 1471(b)(3)(C) of the Internal Revenue Code)   and such additional documentation reasonably requested by the Borrower or the Administrative Agent as may be necessary for the Borrower and the Administrative Agent to comply with their obligations under FATCA and to determine that such Lender has complied with such Lender&#8217;s obligations under FATCA or to determine the amount to deduct and withhold from such payment. Solely for purposes of this clause, &#8220;FATCA&#8221; shall include any amendments made to FATCA after the date of this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Without limiting the foregoing, upon request of the Administrative Agent or the Borrower, each Lender and each Issuer that is a &#8220;United States person&#8221; within the meaning of Section 7701(a)(30) of the Internal Revenue Code that lends to the Borrower (each, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;U.S. Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) shall deliver to the Administrative Agent and the Borrower two duly signed, properly completed copies  of Internal Revenue Service Form W-9 on or prior to the Effective Date (or on or prior to the date    it becomes a party to this Agreement), certifying that such U.S. Lender is entitled to an exemption from United States backup withholding, or any successor form.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Treatment of Certain Refunds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If the Administrative Agent, a Lender or an Issuer determines, in its sole discretion exercised in good faith, that it has received a refund of any Taxes  </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or Other Taxes as to which it has been indemnified by the Borrower or with respect to which the Borrower has paid additional amounts pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, it shall promptly pay to the Borrower an amount equal to such refund (but only to the extent of indemnity payments made, or additional amounts paid, by the Borrower under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> with respect to the Taxes or Other Taxes giving rise to such refund), net of all reasonable and documented out-of-pocket expenses of the Administrative Agent, such Lender or such Issuer, as the case may be, and without interest  (other than any interest paid by the relevant Governmental Authority with respect to such refund), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the Borrower, upon the written request of the Administrative Agent, such Lender or such Issuer, agrees to repay the amount paid over to the Borrower (plus any penalties, interest or other charges imposed by the relevant Governmental Authority) to the Administrative Agent, such Lender or such Issuer in the event that the Administrative Agent, such Lender or such Issuer is required to repay such refund or Tax credit to such Governmental Authority. This paragraph shall not be construed to require the Administrative Agent, any Lender or any Issuer to make available   its Tax returns (or any other information relating to its Taxes that it deems confidential) to the Borrower or any other Person.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Designation of a Different Lending Office</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If any Lender requests compensation under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, or requires the Borrower to pay any additional amount to any Lender or any Governmental Authority for the account of any Lender pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, then such Lender shall use reasonable efforts to promptly designate a different lending office for funding or booking its Loans hereunder or to assign its rights and obligations hereunder to another of its  offices, branches or affiliates, if such designation or assignment (i)&#160;would eliminate or reduce amounts payable pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as the case may be, in the future and (ii)&#160;in the judgment of such Lender, would not subject such Lender to any unreimbursed cost or expense and would not otherwise be disadvantageous to such Lender. The Borrower hereby agrees to pay all reasonable and documented out-of-pocket costs and expenses incurred by any Lender in connection with any such designation or assignment.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each party&#8217;s obligations under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall survive the resignation or replacement of the Administrative Agent or any assignment of rights by, or the replacement of, a Lender, the termination of the Commitments and the repayment, satisfaction or discharge of all obligations under any Loan Document.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Facility Fees</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower agrees to pay to the Administrative Agent for the account of each Lender a fee (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Facility Fee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) during the period commencing on the Effective Date and ending on the Expiration Date, payable quarterly in arrears on the last day of each March, June, September and December of each year, commencing on the last day of the calendar quarter during which the Facility Fee shall commence to accrue, and on the Expiration Date, at a rate per annum equal to the Applicable Margin of (a) prior to the Commitment Termination Date or such earlier date upon which all of the Commitments shall have been terminated in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Commitment Amount of such Lender (whether used or unused), and (b) thereafter, the sum of (i) the outstanding principal balance of all Revolving Credit Loans   of such Lender, (ii) such Lender&#8217;s Swing Line Exposure and (iii) such Lender&#8217;s Letter of Credit Exposure. Notwithstanding anything to the contrary contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, on and after the Commitment Termination Date, the Facility Fee shall be payable upon demand. In addition, upon each reduction of the Aggregate Commitment Amount, the Borrower shall pay the Facility Fee accrued on the amount of such reduction through the date of such reduction. The Facility Fee shall be computed on the basis of a 360-day year for the actual number of days elapsed.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Letter of Credit Participation Fee</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower agrees to pay to the Administrative Agent for the pro rata account of each Lender a fee (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit Participation Fee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) with respect to the Letters of Credit during the period commencing on the Effective Date and ending on the Commitment Termination Date or, if later, the date when the Letter of Credit Exposure of all Lenders is $0, payable quarterly in arrears on the last day of each March, June, September and December of each year, commencing on the last day of the calendar quarter     in which the Effective Date shall have occurred, and on the last date of such period, at a rate per annum equal to (i) in the case of standby Letters of Credit, the Applicable Margin of the actual daily amount which may be drawn under all standby Letters of Credit during such period (whether or not the conditions for drawing thereunder have or may be satisfied) multiplied by such Lender&#8217;s Commitment Percentage, and    (ii) in the case of commercial Letters of Credit, the Applicable Margin of the actual daily amount which  may be drawn under all commercial Letters of Credit during such period (whether or not the conditions for drawing thereunder have or may be satisfied) multiplied by such Lender&#8217;s Commitment Percentage. The Letter of Credit Participation Fee shall be computed on the basis of a 360-day year for the actual number     of days elapsed.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Replacement of Lender</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If (w) the Borrower is obligated to pay to any Lender any amount under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Borrower shall have the right within 90 days thereafter, (x) any Lender shall be a Defaulting Lender, the Borrower shall have the right at any time during which such Lender shall remain a Defaulting Lender, (y) any Lender shall have not consented to an Extension Request or (z) any Lender shall not have approved any other consent, waiver or amendment that (A) requires the approval of all Lenders or all affected Lenders in accordance with the terms of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and (B) has been approved by the Required Lenders, the Borrower shall have the right at any time, in each case in accordance with the requirements of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and only if no Default shall exist, to replace such Lender (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Replaced Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) with   one or more Eligible Assignees (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Replacement Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that (i) at the time of any replacement pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Replacement Lender shall enter into one or more Assignment and Assumptions pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (with the processing and recordation fee referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> payable pursuant to said </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> to be paid by the Replacement Lender) pursuant to which the Replacement Lender shall acquire the Commitment, the outstanding Loans, the Swing Line Exposure and the Letter of Credit Exposure of the Replaced Lender and, in connection therewith, shall pay the following&#58; (a) to the Replaced Lender, an amount equal to the sum of (A) an amount equal to the principal of, and all accrued and unpaid interest on, all outstanding Loans and Swing Line Participation Amounts of the Replaced Lender, (B) an amount equal to all drawings on all Letters of Credit that have been funded by (and not reimbursed to) such Replaced Lender, together with all then unpaid interest with respect thereto at such time, and (C) an amount equal to all accrued, but unpaid, fees owing to the Replaced Lender, (b) to each Issuer, an amount equal to such Replaced Lender&#8217;s Commitment Percentage of all drawings on Letters of Credit issued by such Issuer (which at such time remain unpaid drawings) to the extent such amount was not funded by such Replaced Lender, (c) to the Swing Line Lender, an amount equal to such Replaced Lender&#8217;s Commitment Percentage of any Mandatory Borrowing to the extent such amount was not funded by such Replaced Lender, and (d) to the Administrative Agent an amount equal to all amounts owed by   such Replaced Lender to the Administrative Agent under this Agreement, including, without limitation, an amount equal to the principal of, and all accrued and unpaid interest on, all outstanding Loans of the Replaced Lender, a corresponding amount of which was made available by the Administrative Agent to the Borrower pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and which has not been repaid to the Administrative Agent by such Replaced Lender or the Borrower, and (ii) all obligations of the Borrower owing to the Replaced Lender (other than those specifically described in clause (i) above in respect of which the assignment purchase   price has been, or is concurrently being, paid) shall be paid in full to such Replaced Lender concurrently with such replacement. Upon the execution and delivery of the respective Assignment and Assumptions   </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and the payment of amounts referred to in clauses (i) and (ii) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Replacement Lender shall become a Lender hereunder and the Replaced Lender shall cease to constitute a Lender hereunder, except with respect to indemnification provisions under this Agreement that are intended to survive the termination of the Commitments and the repayment of the Loans which may be applicable to any such Replaced Lender prior to the date of its replacement. Solely for the purpose of calculating break funding payments under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the assignment by any Replaced Lender of any Term SOFR Advance prior to the last day of the Interest Period applicable thereto pursuant to clause (w) or (y) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall  be deemed to constitute a prepayment by the Borrower of such Term SOFR Advance.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">REPRESENTATIONS AND WARRANTIES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In order to induce the Administrative Agent, the Lenders and the Issuers to enter into this Agreement, the Lenders to make the Loans and the Issuers to issue Letters of Credit, the Borrower hereby makes the following representations and warranties to the Administrative Agent, the Lenders and the  Issuers&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Existence and Power</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower is duly organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation, has all requisite corporate power and authority to own its Property and to carry on its business as now conducted, and is qualified to do business as a foreign corporation and is in good standing in each jurisdiction in which it owns or leases real Property or in which the nature of its business requires it to be so qualified (except those jurisdictions where the failure to be so qualified or to    be in good standing could not reasonably be expected to have a Material Adverse effect).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Authority&#59; Affected Financial Institution</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower has full corporate power and authority to enter into, execute, deliver and perform the terms of the Loan Documents, all of which have been duly authorized by all proper and necessary corporate action and are not in contravention of&#58; (i) except as could not reasonably be expected to have a Material Adverse effect, any applicable law or (ii) the terms of its Certificate of Incorporation and By-Laws. No consent or approval of, or other action by, shareholders of the Borrower, any Governmental Authority, or any other Person (which has not already been obtained) is required to authorize in respect of the Borrower, or is required in connection with, the execution, delivery and performance by the Borrower of the Loan Documents or is required as a condition to the enforceability of the Loan Documents against the Borrower. The Borrower is not an Affected Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Binding Agreement</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Loan Documents constitute the valid and legally binding obligations of the Borrower, enforceable against the Borrower in accordance with their respective terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditors&#8217; rights generally and by equitable principles relating to the availability of specific performance as a remedy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Litigation</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of the Effective Date, there are no actions, suits, arbitration proceedings or claims (whether purportedly on behalf of the Borrower, any Material Subsidiary or otherwise) pending or, to the knowledge of the Borrower, threatened against the Borrower or any Material Subsidiary or any of their respective Properties, or maintained by the Borrower or any Material Subsidiary, at law or in equity, before any </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Governmental Authority which have not been disclosed in the SEC Reports that could reasonably be expected to have a Material Adverse effect. There are no proceedings pending or, to the knowledge of the Borrower, threatened against the Borrower or any Material Subsidiary (a) which call into question the validity or enforceability of any Loan Document, or otherwise seek to invalidate, any Loan Document, or  (b) which might, individually or in the aggregate, materially and adversely affect any of the transactions contemplated by any Loan Document.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">No Conflicting Agreements</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">&#91;Reserved&#93;.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">No provision of any existing material mortgage, material indenture, material contract or material agreement or of any existing statute, rule, regulation, judgment, decree or order binding on the Borrower or affecting the Property of the Borrower (i) conflicts with any Loan Document, (ii) requires any consent which has not already been obtained with respect to any Loan Document, or (iii) would in any way prevent the execution, delivery or performance by the  Borrower of the terms of any Loan Document, except in the case of provisions of any existing material mortgage, material indenture, material contract or material agreement, as could not reasonably be expected to have a Material Adverse effect. Neither the execution and delivery, nor the performance, by the Borrower of the terms of each Loan Document will constitute a default under, or result in the creation or imposition of, or obligation to create, any Lien upon the Property of the Borrower pursuant to the terms of any such mortgage, indenture, contract or agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Governmental Regulations</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower is not required to be registered as an &#8220;investment company&#8221; under the Investment Company Act of 1940, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Federal Reserve Regulations&#59; Use of Proceeds</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower is not engaged principally, or as one of its important activities, in the business of extending credit for the purpose of purchasing or carrying any Margin Stock. No part of the proceeds of the Loans or the Letters of Credit has been or will be used, directly or indirectly, and whether immediately, incidentally or ultimately, for a purpose which violates the provisions of Regulation T, U or X of the Board of Governors of the Federal Reserve System, as amended. Anything in this Agreement to the contrary notwithstanding, neither any Issuer nor any Lender shall be obligated to extend credit to, or on behalf of,   the Borrower in violation of any limitation or prohibition provided by any applicable law, regulation or statute, including said Regulation U. Following application of the proceeds of each Loan and the issuance   of each Letter of Credit, not more than 25% (or such greater or lesser percentage as is provided in the exclusions from the definition of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Indirectly Secured</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> contained in said Regulation U as in effect at the  time of the making of such Loan or issuance of such Letter of Credit) of the value of the assets of the Borrower and the Subsidiaries on a Consolidated basis that are subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> will be Margin Stock. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">No Misrepresentation</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No representation or warranty contained in any Loan Document and no certificate or written report furnished by the Borrower to the Administrative Agent or any Lender pursuant to any Loan Document </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">contains, as of its date, a misstatement of a material fact, or omits to state, as of its date, a material fact required to be stated in order to make the statements therein contained, when taken as a whole, not  materially misleading (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that any representation, warranty, statement or written report that is qualified as to &#8220;materiality&#8221;, &#8220;Material Adverse&#8221; or similar language shall be true and correct (after giving effect to any qualification therein) in all respects on such date) in the light of the circumstances under which made (after giving effect to all supplements and updates with respect thereto) (it being understood that the Borrower makes no representation or warranty hereunder with respect to any projections, other forward looking information, industry information or general economic information).  As of the Effective Date, the information included in any Beneficial Ownership Certification of the Borrower, if applicable, is true and correct in all respects.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Financial Statements</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower has heretofore delivered to the Lenders through the Administrative Agent copies of the audited Consolidated Balance Sheet of the Borrower and its Subsidiaries as of December 31, 2021, and the related Consolidated Statements of Income, Comprehensive Income, Shareholders&#8217; Equity and Cash Flows for the fiscal year then-ended. The financial statements referred to immediately above, including all related notes and schedules, are herein referred to collectively as the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Financial Statements&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Financial Statements fairly present, in all material respects, the Consolidated financial condition and results of the operations of the Borrower and the Subsidiaries as of the dates and for the periods indicated therein and, except as noted therein, have been prepared in conformity with GAAP as then in effect. Neither the Borrower nor any of the Subsidiaries has any material obligation or liability of any kind (whether fixed, accrued, contingent, unmatured or otherwise) which, in accordance with GAAP as then in effect, should have been disclosed in the Financial Statements and was not. During the period from January 1, 2022 to   and including the Effective Date, there was no Material Adverse change, including as a result of any change in law, in the Consolidated financial condition, operations, business or Property of the Borrower and the Subsidiaries taken as a whole that was not disclosed in the SEC Reports.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Anti-Corruption Laws and Sanctions</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower has implemented and maintains in effect policies and procedures designed to ensure compliance by the Borrower, the Subsidiaries and their respective directors, officers, employees and agents with Anti-Corruption Laws and applicable Sanctions, and the Borrower, the Subsidiaries and their  respective officers and employees and, to the knowledge of the Borrower, its directors are in compliance with Anti-Corruption Laws and applicable Sanctions in all material respects. None of (a) the Borrower, any Subsidiary or, to the knowledge of the Borrower or such Subsidiary, any of their respective directors, officers or employees, or (b) to the knowledge of the Borrower, any agent of the Borrower or any Subsidiary that will act in any capacity in connection with or benefit from the credit facility established hereby, is a Sanctioned Person. No Loan or Letter of Credit, use of proceeds or other transaction contemplated by this Agreement will violate Anti-Corruption Laws or applicable Sanctions.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">CONDITIONS TO EFFECTIVENESS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Agreement shall become effective on and as of the date (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Effective Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) that the following conditions shall have been satisfied or waived in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Agreement</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall have received counterparts of this Agreement executed by the Borrower, the Administrative Agent, each Issuer, the Swing Line Lender and each Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Notes</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall have received a Note, executed and delivered by the Borrower, for each Lender that shall have given at least three Domestic Business Days&#8217; prior written notice of its request for a Note.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Corporate Action</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall have received a certificate, dated the Effective Date, of the  Secretary or an Assistant Secretary of the Borrower (i) attaching a true and complete copy of the resolutions of its Board of Directors and of all documents evidencing all other necessary corporate action taken by the Borrower to authorize this Agreement, the other Loan Documents and the transactions contemplated hereby and thereby, (ii) attaching a true and complete copy of its Certificate of Incorporation and By-Laws, (iii) setting forth the incumbency of the officer or officers of the Borrower who may sign this Agreement and   the other Loan Documents, and any other certificates, requests, notices or other documents required hereunder or thereunder, and (iv) attaching a certificate of good standing of the Secretary of State of the State of Delaware.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Opinion of Counsel to the Borrower</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall have received (a) an opinion of Thomas Moffatt, assistant general counsel of the Borrower, dated the Effective Date, in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit D-1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and (b) an opinion of Shearman &#38; Sterling LLP, special counsel to the Borrower, dated the Effective Date, in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">D-2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Termination of Existing 2018 Credit Agreement </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">After giving effect to the application of the proceeds of the Loans on the Effective Date, the Indebtedness under the Existing 2018 Credit Agreement shall have been fully repaid, the commitments  under the Existing 2018 Credit Agreement shall have been canceled or terminated, and the Administrative Agent shall have received reasonably satisfactory evidence thereof.  In order to facilitate the termination of the commitments under the Existing 2018 Credit Agreement, the Borrower hereby gives notice that the Borrower wishes to terminate the commitments under the Existing 2018 Credit Agreement, effective as of the Effective Date.  Each Lender that is a party to the Existing 2018 Credit Agreement, by its execution and delivery hereof, waives any requirement of prior notice set forth therein as a condition to the right of the Borrower to terminate the commitments thereunder. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">No Default and Representations and Warranties</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall have received a certificate, dated the Effective Date, of the Senior Vice President and Treasurer of the Borrower certifying that there exists no Default and that the representations and warranties contained in this Agreement are true and correct in all material respects (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any representation and warranty that is qualified as to &#8220;materiality&#8221;, &#8220;Material Adverse&#8221; or similar language shall be true and correct (after giving effect to any qualification therein) in all respects on the Effective Date), except those which are expressly specified to be made as of an earlier date.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Fees</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall have received all fees and other amounts due and payable to it on  the Effective Date in respect of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Due Diligence&#59; &#8220;Know Your Customer&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a) Each Lender shall have received such documents and information as it may have requested in order to comply with &#8220;know-your-customer&#8221; and other applicable Sanctions, anti-terrorism, anti-money laundering and similar rules and regulations and related policies, to the extent the Borrower shall have received written requests therefor at least ten (10) Domestic Business Days prior to the Effective Date, and (b) at least five Domestic Business Days prior to the Effective Date, if the Borrower qualifies as a &#8220;legal entity customer&#8221; under the Beneficial Ownership Regulation, it shall have delivered to each Lender that so requests a Beneficial Ownership Certification.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Without limiting the generality of the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, for purposes of determining compliance with the conditions specified in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, each Lender that has signed this Agreement shall be deemed to have consented to, approved or accepted or to be satisfied with, each document or other matter required thereunder to be consented to or approved by or acceptable or satisfactory to a Lender unless the Administrative Agent shall have received notice from such Lender prior to the proposed Effective Date specifying its objection thereto.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">CONDITIONS OF LENDING - ALL LOANS AND LETTERS OF CREDIT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The obligation of each Lender on any Borrowing Date to make each Revolving Credit Loan (other than a Revolving Credit Loan constituting a Mandatory Borrowing), the Swing Line Lender to make each Swing Line Loan, each Issuer to issue each Letter of Credit and each Lender to make a Competitive Bid Loan are subject to the fulfillment (or waiver in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) of the following conditions precedent&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Compliance</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On each Borrowing Date, and after giving effect to the Loans to be made or the Letters of Credit     to be issued on such Borrowing Date, (a) there shall exist no Default, and (b) the representations and warranties contained in this Agreement shall be true and correct in all material respects with the same effect as though such representations and warranties had been made on such Borrowing Date (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that any representation and warranty that is qualified as to &#8220;materiality&#8221;, &#8220;Material Adverse&#8221; or similar language  shall be true and correct (after giving effect to any qualification therein) in all respects on such Borrowing Date), except those which are expressly specified to be made as of an earlier date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Requests</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall have timely received from the Borrower on or before such Borrowing Date, as applicable, a duly executed Borrowing Request (together with, in the case of a request for a Swing Line Loan that will bear interest at the Negotiated Rate, a duly executed agreement as to the Negotiated Rate with respect to such Swing Line Loan), Letter of Credit Request (together with a duly executed Reimbursement Agreement with respect to the Letter(s) of Credit requested thereby) and&#47;or Competitive Bid Request (together with a duly executed Competitive Bid Accept&#47;Reject Letter).</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">AFFIRMATIVE COVENANTS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower covenants and agrees that on and after the Effective Date and until the later to occur of (a) the Commitment Termination Date and (b) the payment in full of the Loans, the Reimbursement Obligations, the Fees and all other sums payable under the Loan Documents (other than contingent obligations for which no claim has been made), the Borrower will&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Legal Existence</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Except as may otherwise be permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, maintain, and cause each Material Subsidiary to maintain, its corporate existence in good standing in the jurisdiction of its incorporation or formation and in each other jurisdiction in which the failure so to do could reasonably be expected to have a Material Adverse effect, except that the corporate existence of Material Subsidiaries   may be terminated if (i) such Material Subsidiaries operate closing or discontinued operations or (ii) if the Borrower determines in good faith that such termination is in the best interests of the Borrower and is not materially disadvantageous to the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Taxes</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pay and discharge when due, and cause each Material Subsidiary so to do, all taxes, assessments, governmental charges, license fees and levies upon or with respect to the Borrower and such Material Subsidiary, and upon the income, profits and Property thereof unless, and only to the extent, that either   (i)(a) such taxes, assessments, governmental charges, license fees and levies shall be contested in good faith and by appropriate proceedings diligently conducted by the Borrower or such Material Subsidiary, and (b) such reserve or other appropriate provision as shall be required by GAAP shall have been made therefor,     or (ii) the failure to pay or discharge such taxes, assessments, governmental charges, license fees and levies could not reasonably be expected to have a Material Adverse effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Observance of Legal Requirements</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Observe and comply in all material respects, and cause each Material Subsidiary    so to do, with all laws, ordinances, orders, judgments, rules, regulations, certifications, franchises, permits, licenses, directions and requirements of all Governmental Authorities, which now or at   any time hereafter may be applicable to it or to such Material Subsidiary, except (i) where a violation of which could not reasonably be expected to have a Material Adverse effect, or (ii) to    the extent that such noncompliance is being contested in good faith and by appropriate proceedings diligently conducted by the Borrower or such Material Subsidiary.</font></div><div style="margin-bottom:15pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Maintain in effect and enforce policies and procedures designed to ensure compliance by the Borrower, the Subsidiaries and their respective directors, officers, employees   and agents with Anti-Corruption Laws and applicable Sanctions.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Financial Statements and Other Information</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Maintain, and cause each Subsidiary to maintain, a standard system of accounting in accordance with GAAP, and furnish to the Administrative Agent for distribution to the Lenders&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">As soon as available and, in any event, within 90 days after the close of each fiscal year, a copy of (x) the Borrower&#8217;s 10-K in respect of such fiscal year, and (y) (i) the Borrower&#8217;s Consolidated Balance Sheet as of the end of such fiscal year, and (ii) the related Consolidated Statements of Income, Comprehensive Income, Shareholders&#8217; Equity and Cash Flows, as of and through the end of such fiscal year, setting forth in each case in comparative form the corresponding figures in respect of the previous fiscal year, all in reasonable detail, and accompanied by a report   of the Borrower&#8217;s auditors, which report shall state that (A) such auditors audited such financial statements, (B) such audit was made in accordance with generally accepted auditing standards in effect at the time and provides a reasonable basis for such opinion, and (C) said financial statements have been prepared in accordance with GAAP&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">As soon as available, and in any event within 45 days after the end of each of the first three fiscal quarters of each fiscal year, a copy of (x) the Borrower&#8217;s 10-Q in respect of such fiscal quarter, and (y) (i) the Borrower&#8217;s condensed Consolidated Balance Sheet as of the end of such quarter and (ii) the related condensed Consolidated Statements of Income, Comprehensive Income, Shareholders&#8217; Equity and Cash Flows for (A) such quarter and (B) the period from the beginning of the then-current fiscal year to the end of such quarter, in each case in comparable form with the prior fiscal year, all in reasonable detail and prepared in accordance with GAAP (without footnotes and subject to year-end adjustments)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Simultaneously with the delivery of the financial statements required by clauses    (a) and (b) above, a certificate of the Chief Financial Officer or the Senior Vice President and Treasurer of the Borrower certifying that no Default shall have occurred or be continuing or, if so, specifying in such certificate all such Defaults, and setting forth computations in reasonable detail demonstrating compliance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:23.18pt">&#91;reserved&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">As soon as practicable after becoming available, copies of all regular or periodic reports (including current reports on Form 8-K) which the Borrower or any Subsidiary may now or hereafter be required to file with or deliver to the U.S. Securities and Exchange Commission, or   any other Governmental Authority succeeding to the functions thereof&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:25.02pt">&#91;reserved&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Prompt written notice of the occurrence of (i) each Default and (ii) each Event of Default&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:23.18pt">&#91;reserved&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">From time to time, such other information regarding the financial position or business of the Borrower and the Subsidiaries as the Administrative Agent, at the reasonable   request of any Lender, may reasonably request&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">Prompt written notice of such other information with documentation required by bank regulatory authorities under applicable &#8220;know your customer&#8221; and anti-money laundering  </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">laws, rules and regulations (including, without limitation, the Patriot Act and the Beneficial Ownership Regulation), as from time to time may be reasonably requested by the Administrative Agent or by any Issuer or any Lender (through the Administrative Agent).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Information required to be delivered pursuant to (x) this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be deemed to have been delivered if such information shall have been posted by the Administrative Agent on a Debtdomain, IntraLinks, Syndtrak or similar electronic system (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Platform&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) to which each Lender and each Issuer  has been granted access and (y) clauses (a), (b) and (e) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be deemed delivered to the Administrative Agent, the Issuers and the Lenders when available on the Borrower&#8217;s website at             </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">http&#58;&#47;&#47;www.cvshealth.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or the website of the U.S. Securities and Exchange Commission at                 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">http&#58;&#47;&#47;www.sec.gov</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Information delivered pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> may also be delivered by electronic communications pursuant to procedures approved by the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower hereby acknowledges that the Administrative Agent and&#47;or the Joint Lead Arrangers will make available to the Lenders materials and&#47;or information provided by or on behalf of the Borrower hereunder (collectively, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Borrower Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) by posting the Borrower Materials on the Platform.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Records</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Upon reasonable notice and during normal business hours after an Event of Default has occurred  and is continuing, permit representatives of the Administrative Agent and each Lender to visit the offices    of the Borrower and each Material Subsidiary, to examine the books and records (other than tax returns and work papers related to tax returns) thereof and auditors&#8217; reports relating thereto, to discuss the affairs of the Borrower and each Material Subsidiary with the respective officers thereof, and to meet and discuss the affairs of the Borrower and each Material Subsidiary with the Borrower&#8217;s auditors, except for information covered by an attorney-client or other legal privilege or to the extent the inspection would reasonably be expected to result in a violation or other breach of any third party confidentiality agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">NEGATIVE COVENANTS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower covenants and agrees that on and after the Effective Date and until the later to occur of (a) the Commitment Termination Date and (b) the payment in full of the Loans, the Reimbursement Obligations, the Fees and all other sums payable under the Loan Documents (other than contingent obligations for which no claim has been made), the Borrower will not&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Liens</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Create, incur, assume or suffer to exist any Lien against or on any Property now owned or hereafter acquired by the Borrower or any of the Subsidiaries, or permit any of the Subsidiaries so to do, except any one or more of the following types of Liens&#58; (a) Liens in connection with workers&#8217; compensation, unemployment insurance or other social security obligations (which phrase shall not be construed to refer    to ERISA or the minimum funding obligations under Section 412 of the Internal Revenue Code), (b) Liens  to secure the performance of bids, tenders, letters of credit, contracts (other than contracts for the payment  of Indebtedness), leases, statutory obligations, surety, customs, appeal, performance and payment bonds   and other obligations of like nature, or to qualify to do business, maintain insurance or obtain other benefits, in each such case arising in the ordinary course of business, (c) mechanics&#8217;, workmen&#8217;s, carriers&#8217;, warehousemen&#8217;s, materialmen&#8217;s, landlords&#8217; or other like Liens arising in the ordinary course of business with respect to obligations which are not due or which are being contested in good faith and by appropriate proceedings diligently conducted, (d) Liens for taxes, assessments, fees or governmental charges the </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">payment of which is not required under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, (e) easements, rights of way, restrictions, leases of Property to others, easements for installations of public utilities, title imperfections and restrictions, zoning ordinances and other similar encumbrances affecting Property which in the aggregate do not materially impair its use for the operation of the business of the Borrower or such Subsidiary, (f) Liens on Property of the Subsidiaries under capital leases and Liens on Property (including on the capital stock or other equity interests) of the Subsidiaries acquired (whether as a result of purchase, capital lease, merger or other acquisition) and either existing on such Property when acquired, or created contemporaneously with or within 12 months of such acquisition to secure the payment or financing of the purchase price of such Property (including the construction, development, substantial repair, alteration or improvement thereof), and any renewals thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such Liens attach only to the Property so purchased or acquired (including any such construction, development, substantial repair, alteration or improvement thereof)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the Indebtedness secured by such Liens is not otherwise prohibited hereunder, (g) statutory Liens in favor of lessors arising in connection with Property leased to the Borrower or any of the Subsidiaries, (h) Liens of attachments, judgments or awards against the Borrower or any of the Subsidiaries with respect to which an appeal or proceeding for review shall be pending or a stay of execution or bond shall have been obtained, or which are otherwise being contested in good faith and by appropriate proceedings diligently conducted, and in respect of which adequate reserves shall have been established in accordance with GAAP on the books of the Borrower or such Subsidiary, (i) Liens securing Indebtedness   of a Subsidiary to the Borrower or another Subsidiary, (j) Liens (other than Liens permitted by any of the foregoing clauses) arising in the ordinary course of its business which do not secure Indebtedness and do  not, in the aggregate, materially detract from the value of the business of the Borrower and its Subsidiaries, taken as a whole, (k) Liens in favor of the United States of America, or any state thereof, to secure partial, progress, advance or other payments pursuant to any contract or provisions of any statute, and (l) additional Liens securing Indebtedness of the Borrower and the Subsidiaries in an aggregate outstanding Consolidated principal amount not exceeding 15% of Net Tangible Assets.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Dispositions</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Make any Disposition (including by way of limited liability company division), or permit any of    its Subsidiaries so to do, of all or substantially all of the assets of the Borrower and the Subsidiaries on a Consolidated basis&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that (a) any Subsidiary may make Dispositions to the Borrower, and (b) so  long as no Default or Event of Default exists immediately prior to or immediately after giving effect thereto, (i) the Borrower may dispose of all or substantially all of its assets to a wholly-owned domestic Subsidiary that assumes all of the obligations of the Borrower under this Agreement and (ii) any Subsidiary may  dispose of all or substantially all of its assets to another Subsidiary&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if such Subsidiary is a wholly-owned Subsidiary, the transferee shall be a wholly-owned Subsidiary.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Merger or Consolidation, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Consolidate with, be acquired by, or merge into or with any Person unless (x) immediately after giving effect thereto, no Default shall or would exist and (y) either (i) the Borrower or (ii) a corporation organized and existing under the laws of one of the States of the United States of America or the District     of Columbia shall be the survivor of such consolidation or merger&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if the Borrower is not the survivor, the corporation which is the survivor shall expressly assume, pursuant to an instrument executed and delivered to the Administrative Agent, and in form and substance reasonably satisfactory to the Administrative Agent, all obligations of the Borrower under the Loan Documents and the Administrative Agent shall have received such documents, opinions and certificates as it shall have reasonably requested    in connection therewith.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Limitation on Upstream Dividends by Subsidiaries</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Permit or cause any of the Subsidiaries (other than any Insurance Subsidiary) to enter into or agree, or otherwise be or become subject, to any agreement, contract or other arrangement (other than this Agreement and the other Loan Documents) with any Person (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Restrictive Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) pursuant to the terms of which (a) such Subsidiary is or would be prohibited from declaring or paying any cash dividends on any class of its stock owned directly or indirectly by the Borrower or any of the other Subsidiaries or from making any other distribution on account of any class of any such stock (herein referred to as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Upstream Dividends&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), or (b) the declaration or payment of Upstream Dividends by a Subsidiary to the Borrower or another Subsidiary, on an annual or cumulative basis, is or would be otherwise limited or restricted (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Dividend Restrictions&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">). Notwithstanding the foregoing, nothing in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall prohibit&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Dividend Restrictions set forth in any Restrictive Agreement in effect on the date hereof and any extensions, refinancings, renewals or replacements thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that the Dividend Restrictions in any such extensions, refinancings, renewals or replacements are no less favorable in any material respect to the Lenders than those Dividend Restrictions that are then in effect and that are being extended, refinanced, renewed or replaced&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Dividend Restrictions existing with respect to any Person acquired by the   Borrower or any Subsidiary and existing at the time of such acquisition, which Dividend  Restrictions are not applicable to any Person or the property or assets of any Person other than such Person or its property or assets acquired, and any extensions, refinancings, renewals or   replacements of any of the foregoing&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the Dividend Restrictions in any such extensions, refinancings, renewals or replacements are no less favorable in any material respect to the Lenders than those Dividend Restrictions that are then in effect and that are being extended, refinanced, renewed or replaced&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Dividend Restrictions consisting of customary net worth, leverage and other financial covenants, customary covenants regarding the merger of or sale of stock or assets of a Subsidiary, customary restrictions on transactions with affiliates, and customary subordination provisions governing Indebtedness owed to the Borrower or any Subsidiary, in each case contained in, or required by, any agreement governing Indebtedness incurred by a Subsidiary in accordance with the terms of this Agreement&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Dividend Restrictions contained in any other credit agreement so long as such Dividend Restrictions are no more restrictive than those contained in this Agreement (including Dividend Restrictions contained in the Existing 2019 Credit Agreement and the Existing 2021  Credit Agreement).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Ratio of Consolidated Indebtedness to Total Capitalization</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Permit its ratio of Consolidated Indebtedness to Total Capitalization at the end of any fiscal quarter to exceed 0.60&#58;1.00&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that (i) upon the consummation of any Material Acquisition and the written election of the Borrower to the Administrative Agent no later than thirty days following the consummation </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of such Material Acquisition, the maximum permitted ratio of Consolidated Indebtedness to Total Capitalization shall be increased by 0.05&#58;1.00 above the otherwise-applicable maximum permitted ratio of Consolidated Indebtedness to Total Capitalization with respect to the last day of the fiscal quarter during which such Material Acquisition shall have been consummated and the last day of each of the immediately following three consecutive fiscal quarters, and (ii) between the signing of the definitive agreement (or   offer documentation, as applicable) for a Material Acquisition and the earlier of (x) the closing of such Material Acquisition and (y) thirty days following the termination of such definitive agreement (or offer documentation, as applicable) for such Material Acquisition, any Acquisition Debt incurred to finance such Material Acquisition shall be excluded for purposes of calculation the ratio of Consolidated Indebtedness    to Total Capitalization hereunder.  The Borrower shall only be permitted to make an election pursuant to   the proviso of the preceding sentence twice during the term of this Agreement, and there shall be at least  two consecutive fiscal quarters between such elections during which time no increase to the maximum permitted ratio of Consolidated Indebtedness to Total Capitalization shall be in effect.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">DEFAULT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Events of Default</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following shall each constitute an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Event of Default&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> hereunder&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The failure of the Borrower to make any payment of principal on any Loan or any reimbursement payment in respect of any Letter of Credit when due and payable&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">The failure of the Borrower to make any payment of interest on any Loan or of any Fee on any date when due and payable and such default shall continue unremedied for a period of    5 Domestic Business Days after the same shall be due and payable&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The failure of the Borrower to observe or perform any covenant or agreement contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (with respect to the Borrower only), or in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">The failure of the Borrower to observe or perform any other covenant or agreement contained in this Agreement, and such failure shall have continued unremedied for a period of 30 days after the Borrower shall have become aware of such failure&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">&#91;Reserved&#93;&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.02pt">Any representation or warranty of the Borrower (or of any of its officers on its behalf) made in any Loan Document, or made in any certificate or report or other document (other than an opinion of counsel) delivered on or after the date hereof in connection with any such Loan Document shall in any such case prove to have been incorrect or misleading (whether because of misstatement or omission) in any material respect when made&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">(i) Obligations in an aggregate Consolidated amount in excess of the Threshold Amount of the Borrower (other than its obligations hereunder and under the Notes) and the Material Subsidiaries, whether as principal, guarantor, surety or other obligor, for the payment of any Indebtedness for Borrowed Money or any net liability under interest rate swap, collar, exchange or cap agreements, (A) shall become or shall be declared to be due and payable prior to the expressed maturity thereof, or (B) shall not be paid when due or within any grace period for the payment thereof, or (ii) any holder of any such obligations shall have the right to declare the Indebtedness   for Borrowed Money evidenced thereby due and payable prior to its stated maturity&#59; or</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">An involuntary proceeding shall be commenced or an involuntary petition shall be filed seeking (i) liquidation, reorganization or other relief in respect of the Borrower or any Material Subsidiary or its debts, or of a substantial part of its assets, under any federal, state or foreign bankruptcy, insolvency, receivership or similar law now or hereafter in effect or (ii) the   appointment of a receiver, trustee, custodian, sequestrator, conservator or similar official for the Borrower or any Material Subsidiary or for a substantial part of its assets, and, in any such case,  such proceeding or petition shall continue undismissed for 60 days or an order or decree approving or ordering any of the foregoing shall be entered&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">The Borrower or any Material Subsidiary shall (i) voluntarily commence any proceeding or file any petition seeking liquidation, reorganization or other relief under any federal, state or foreign bankruptcy, insolvency, receivership or similar law now or hereafter in effect, (ii) consent to the institution of, or fail to contest in a timely and appropriate manner, any proceeding    or petition described in clause (h) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, (iii) apply for or consent to the appointment   of a receiver, trustee, custodian, sequestrator, conservator or similar official for the Borrower or   any Material Subsidiary or for a substantial part of its assets, (iv) file an answer admitting the material allegations of a petition filed against it in any such proceeding, (v) make a general assignment for the benefit of creditors or (vi) take any action for the purpose of effecting any of the foregoing&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">The Borrower or any Material Subsidiary shall (i) generally not be paying its debts as such debts become due or (ii) admit in writing its inability to pay its debts as they become due&#59;   or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Judgments or decrees in an aggregate Consolidated amount in excess of the Threshold Amount (to the extent not covered by independent third-party insurance or captive insurance as to which the insurer does not dispute coverage) against the Borrower and the Material Subsidiaries shall remain unpaid, unstayed on appeal, undischarged, unbonded or undismissed for    a period of 60 days during which execution shall not be effectively stayed, or any action shall be legally taken by a judgment creditor to attach or levy upon any assets of the Borrower or any Material Subsidiary to enforce any such judgment&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">After the Effective Date a Change of Control shall occur&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.13pt">Solely to the extent as would have a Material Adverse effect&#58;  (i) any Termination Event shall occur (x) with respect to any Pension Plan (other than a Multiemployer Plan) or (y)   with respect to any other retirement plan subject to Section 302 of ERISA or Section 412 of the Internal Revenue Code, which plan, during the five year period prior to such Termination Event,  was the responsibility in whole or in part of the Borrower, any Material Subsidiary or any ERISA Affiliate&#59; (ii) the failure to satisfy the minimum funding standards under Section 302 of ERISA or Section 412 of the Internal Revenue Code shall exist with respect to any Pension Plan for which    the Borrower has responsibility (other than that portion of a Multiemployer Plan&#8217;s Accumulated Funding Deficiency to the extent such Accumulated Funding Deficiency is attributable to   employers other than the Borrower)&#59; (iii) any Person shall engage in a Prohibited Transaction involving any Employee Benefit Plan in respect of which it is reasonably likely that liability will    be imposed upon the Borrower&#59; (iv) the Borrower shall fail to pay when due an amount which is payable by it to the PBGC or to a Pension Plan (including a Multiemployer Plan) under Title IV of ERISA&#59; (v) the imposition on the Borrower of any tax under Section 4980(B)(a) of the Internal Revenue Code&#59; or (vi) the assessment of a civil penalty on the Borrower with respect to any Employee Benefit Plan under Section 502(c) of ERISA.  In determining the Consolidated amount  for any purpose pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the liabilities, funding amounts, taxes and penalties </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">referenced in the foregoing clauses of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall include those of the Material Subsidiaries and ERISA Affiliates of the Borrower to the extent the Borrower is obligated to pay  any such liabilities, funding amounts, taxes and penalties.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">9.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Remedies</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Upon the occurrence of an Event of Default or at any time thereafter during the continuance of an Event of Default, the Administrative Agent, at the written request of the Required Lenders, shall notify the Borrower that the Commitments, the Swing Line Commitment and the Letter of Credit Commitment have been terminated and&#47;or that all of the Loans, the Notes and the Reimbursement Obligations and all accrued and unpaid interest on any thereof and all other  amounts owing under the Loan Documents have been declared immediately due and payable&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that upon the occurrence of an Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(h), (i) or (j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> with respect to the Borrower, the Commitments, the Swing Line Commitment and the Letter of Credit Commitment shall automatically terminate and all of the Loans, the Notes and the Reimbursement Obligations and all accrued and unpaid interest on any thereof and all other amounts owing under the Loan Documents shall become immediately due and payable without declaration or notice to   the Borrower. To the fullest extent not prohibited by law, except for the notice provided for in the preceding sentence, the Borrower expressly waives any presentment, demand, protest, notice of protest or other notice of any kind in connection with the Loan Documents and its obligations thereunder. To the fullest extent not prohibited by law, the Borrower further expressly waives and covenants not to assert any appraisement, valuation, stay, extension, redemption or similar law,   now or at any time hereafter in force which might delay, prevent or otherwise impede the performance or enforcement of the Loan Documents.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">In the event that the Commitments, the Swing Line Commitment and the Letter of Credit Commitment shall have been terminated or all of the Loans, the Notes and the Reimbursement Obligations shall have become or been declared to be due and payable pursuant to the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, (i) the Borrower shall forthwith deposit an amount equal to the Letter of Credit Exposure in a cash collateral account with and under the exclusive control of the Administrative Agent, and (ii) the Administrative Agent, the Issuers and the Lenders agree, among themselves, that any funds received from or on behalf of the Borrower under any Loan Document  by any Issuer or any Lender (except funds received by any Issuer or any Lender as a result of a purchase from such Issuer or such Lender, as the case may be, pursuant to the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.9(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) shall be remitted to the Administrative Agent, and shall be applied by the Administrative Agent in payment of the Loans, the Reimbursement Obligations and the other obligations of the Borrower under the Loan Documents in the following manner and order&#58; (1) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment    or reimbursement of the Administrative Agent, the Issuers and the Lenders, in that order, for any fees, expenses or amounts (other than the principal of and interest on the Reimbursement Obligations) due from the Borrower pursuant to the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and the Reimbursement Agreements, (2) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment of the Fees, (3) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">third</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment of   any other fees, expenses or amounts (other than the principal of and interest on the Loans and the Notes and the Reimbursement Obligations) payable by the Borrower to the Administrative Agent, any Issuer or any of the Lenders under the Loan Documents, (4) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">fourth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment, pro rata according to the outstanding principal balance of the Loans and the Letter of Credit Exposure of each Lender, of interest due on the Loans and the Reimbursement Obligations, (5) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">fifth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment, pro rata according to the sum of (A) the aggregate outstanding principal balance of the Loans of each Lender </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (B) the aggregate outstanding balance of the Reimbursement Obligations of each Lender, of the aggregate outstanding principal balance of the Loans and the aggregate outstanding balance of the Reimbursement Obligations, and (6) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">sixth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, any remaining funds shall be paid to whosoever shall be entitled thereto or as a court of competent jurisdiction shall direct.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">In the event that the Loans and the Notes and the Reimbursement Obligations shall have been declared due and payable pursuant to the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Administrative Agent, upon the written request of the Required Lenders, shall proceed to enforce  the Reimbursement Obligations and the rights of the holders of the Loans and the Notes by suit in equity, action at law and&#47;or other appropriate proceedings, whether for payment or the specific performance of any covenant or agreement contained in the Loan Documents. In the event that the Administrative Agent shall fail or refuse so to proceed, each Issuer and each Lender shall be entitled to take such action as the Required Lenders shall deem appropriate to enforce its rights under the Loan Documents.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">AGENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Appointment and Authority</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each Credit Party hereby irrevocably appoints BofA to act on its behalf as the Administrative Agent hereunder and under the other Loan Documents and authorizes the Administrative Agent to take such  actions on its behalf and to exercise such powers as are delegated to the Administrative Agent by the terms hereof or thereof, together with such actions and powers as are reasonably incidental thereto. The provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (other than </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) are solely for the benefit of the Administrative Agent and the Credit Parties and the Borrower shall have no rights as a third party beneficiary or otherwise of any of such provisions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Rights as a Lender</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Person serving as the Administrative Agent hereunder shall have the same rights and powers    in its capacity as a Lender (which includes Issuer) as any other Lender and may exercise the same as though it were not the Administrative Agent and the term &#8220;Lender&#8221; or &#8220;Lenders&#8221; shall, unless otherwise expressly indicated or unless the context otherwise requires, include the Person serving as the Administrative Agent hereunder in its individual capacity. Such Person and its Affiliates may accept deposits from, lend money   to, own securities of, act as the financial advisor or in any other advisory capacity for and generally engage in any kind of business with, the Borrower, any of its Subsidiaries or any other Affiliate thereof as if such Person were not the Administrative Agent hereunder and without any duty to account therefor to the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Exculpatory Provisions</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Administrative Agent shall not have any duties or obligations except those expressly set forth herein and in the other Loan Documents. Without limiting the generality of the foregoing, the Administrative Agent&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">shall not be subject to any fiduciary or other implied duties, regardless of whether a Default has occurred and is continuing&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">shall not have any duty to take any discretionary action or exercise any discretionary powers, except discretionary rights and powers expressly contemplated   hereby or by the other Loan Documents that the Administrative Agent is required to  exercise as directed in writing by the Required Lenders (or such other number or percentage of the Lenders as shall be expressly provided for herein or in the other Loan Documents)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the Administrative Agent shall not be required to take any action that, in its opinion or the opinion of its counsel, may expose the Administrative Agent to liability or that is contrary to any Loan Document or applicable law&#59; and</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">shall not, except as expressly set forth herein and in the other Loan Documents, have any duty to disclose, and shall not be liable for the failure to disclose,    any information relating to the Borrower, any of its Subsidiaries or any Affiliate thereof   that is communicated to or obtained by the Person serving as the Administrative Agent or any of its Affiliates in any capacity.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">The Administrative Agent shall not be liable for any action taken or not taken by     it (i)&#160;with the consent or at the request of the Required Lenders (or such other number or percentage of the Lenders as shall be necessary, or as the Administrative Agent shall believe in good faith shall be necessary, under the circumstances as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) or (ii)&#160;in the absence of its own gross negligence or willful misconduct. The Administrative Agent shall be deemed not to have knowledge of any Default unless and until written notice describing such Default is given to the Administrative Agent by the Borrower, a Lender or an Issuer.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Administrative Agent shall not be responsible for or have any duty to ascertain or inquire into (i) any statement, warranty or representation made in or in connection with this Agreement or any other Loan Document, (ii) the contents of any certificate, report or other document delivered hereunder or thereunder or in connection herewith or therewith, (iii) the performance or observance of any of the covenants, agreements or other terms or conditions set  forth herein or therein or the occurrence of any Default, (iv) the validity, enforceability, effectiveness or genuineness of this Agreement, any other Loan Document or any other agreement, instrument or document or (v) the satisfaction of any condition set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">    or elsewhere herein, other than to confirm receipt of items expressly required to be delivered to the Administrative Agent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">The Administrative Agent shall not be responsible or have any liability for, or have any duty to ascertain, inquire into, monitor or enforce, compliance with the provisions of this Agreement relating to Disqualified Institutions.  Without limiting the generality of the foregoing,  the Administrative Agent shall not (x) be obligated to ascertain, monitor or inquire as to whether  any Lender or prospective Lender is a Disqualified Institution or (y)&#160;have any liability with respect to or arising out of any assignment of Loans, or disclosure of confidential information, to any Disqualified Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Reliance by Administrative Agent</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall be entitled to rely upon, and shall not incur any liability for relying upon, any notice, request, certificate, consent, statement, instrument, document or other writing (including any electronic message, internet or intranet website posting or other distribution) believed by it to be  genuine and to have been signed, sent or otherwise authenticated by the proper Person. The Administrative Agent also may rely upon any statement made to it orally or by telephone and believed by it to have been made by the proper Person, and shall not incur any liability for relying thereon. In determining compliance with any condition hereunder to the making of a Loan or the issuance of a Letter of Credit that by its terms must be fulfilled to the satisfaction of a Lender or an Issuer, the Administrative Agent may presume that such condition is satisfactory to such Lender or such Issuer unless the Administrative Agent shall have received notice to the contrary from such Lender or such Issuer prior to the making of such Loan or the issuance of such Letter of Credit. The Administrative Agent may consult with legal counsel (who may be counsel for the Borrower), independent public accounting firms and other experts selected by it and shall  not be liable for any action taken or not taken by it in accordance with the advice of any such counsel, accounting firm or experts.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Delegation of Duties</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent may perform any and all of its duties and exercise its rights and powers hereunder or under any other Loan Document by or through any one or more sub-agents appointed by the Administrative Agent. The Administrative Agent and any such sub-agent may perform any and all of its duties and exercise its rights and powers by or through their respective Related Parties. The exculpatory provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall apply to any such sub-agent and to the Related Parties of the Administrative Agent and any such sub-agent, and shall apply to their respective activities in connection with the syndication of the credit facilities provided for herein as well as activities as the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Resignation of Administrative Agent</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Administrative Agent may at any time give notice of its resignation to the Credit Parties and the Borrower. Upon receipt of any such notice of resignation, the Required Lenders shall have the right, subject to, so long as no Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(h),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> has occurred and is continuing, the consent    of the Borrower (such consent not to be unreasonably withheld or delayed), to appoint a successor, which shall be a bank with an office in New York, New York, or an Affiliate of any such bank with an office in New York, New York. If no such successor shall have been so appointed by the Required Lenders and shall have accepted such appointment within 30&#160;days after the retiring Administrative Agent gives notice of its resignation, then the retiring Administrative Agent may    on behalf of the Credit Parties, appoint a successor Administrative Agent meeting the qualifications set forth above, subject to, so long as no Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(h),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> has occurred and is continuing, the consent of the Borrower (such consent not to be unreasonably withheld or delayed)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if the Administrative Agent shall notify the Borrower and the Credit Parties that no qualifying Person has accepted such appointment, then such resignation shall nonetheless become effective in accordance with such notice and the retiring Administrative Agent shall be discharged from its duties and obligations hereunder and under the other Loan Documents and all payments, communications and determinations provided to be made by, to or through the Administrative Agent shall instead be made by or to each Credit Party directly, until such time as the Required Lenders appoint a  successor Administrative Agent as provided for above in this Section. Upon the acceptance of a successor&#8217;s appointment as Administrative Agent hereunder, such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring (or retired) Administrative Agent, and the retiring Administrative Agent shall be discharged from all of its duties and obligations hereunder or under the other Loan Documents (if not already discharged therefrom as provided above in this Section). The fees payable by the Borrower to a successor Administrative Agent shall be the same as those payable to its predecessor unless otherwise agreed in writing between the Borrower and such successor. After the retiring Administrative Agent&#8217;s resignation hereunder and under the other Loan Documents, the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall continue in effect for the benefit of such retiring Administrative Agent, its       sub-agents and their respective Related Parties in respect of any actions taken or omitted to be taken by any of them while the retiring Administrative Agent was acting as Administrative Agent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Any resignation by BofA as Administrative Agent pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall also constitute its resignation as an Issuer and Swing Line Lender.  If BofA resigns as an Issuer, it shall, pending the issuance of letters of credit in substitution of the outstanding Letters of Credit in accordance with clause (iii) of the last sentence of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10.6(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and the return and cancellation of such outstanding Letters of Credit, retain all the rights, powers, privileges and duties of an Issuer hereunder with respect to all Letters of Credit outstanding as of the effective date of its </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">resignation as an Issuer and all Reimbursement Obligations with respect thereto, including the right to require the Lenders to make ABR Advances or fund risk participations pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.   If BofA resigns as Swing Line Lender, it shall retain all the rights of the Swing Line Lender provided for hereunder with respect to Swing Line Loans made by it and outstanding as of the effective date of such resignation, including the right to require the Lenders to make ABR Advances or fund risk participations in outstanding Swing Line Loans pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Upon the appointment by the Borrower of a successor Issuer or Swing Line Lender hereunder (which successor shall in all cases be a Lender other than a Defaulting Lender), (i) such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring Issuer or Swing Line Lender, as applicable, (ii) the retiring Issuer and Swing Line Lender shall be discharged from all of their respective duties and obligations hereunder or under the other Loan Documents (other than with respect to outstanding Swing Line Loans made by it and outstanding Letters of Credit issued by it), and (iii) the successor Issuer shall issue letters of credit in substitution for the Letters of Credit, if any, outstanding at the time of such succession or make other arrangements satisfactory to BofA and the Borrower to effectively assume the obligations of BofA with respect to such Letters of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Non-Reliance on Administrative Agent and Other Credit Parties</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each Credit Party acknowledges that it has, independently and without reliance upon the Administrative Agent or any other Credit Party or any of their Related Parties and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Agreement. Each Credit Party also acknowledges that it will, independently and without reliance upon the Administrative Agent or any other Credit Party or any of their Related Parties and based on such documents and information as it shall from time to time deem appropriate, continue to make its own decisions in taking or not taking action under or based upon this Agreement, any other Loan Document or any related  agreement or any document furnished hereunder or thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">No Other Duties, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Anything herein to the contrary notwithstanding, none of the Joint Lead Arrangers, the  Sustainability Coordinator, the Co-Documentation Agents or the Co-Syndication Agents shall have any powers, duties or responsibilities under this Agreement or any of the other Loan Documents, except in its capacity, as applicable, as the Administrative Agent, a Lender or an Issuer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Recovery of Erroneous Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Without limitation of any other provision in this Agreement, if at any time the Administrative Agent makes a payment hereunder in error to any Lender or any Issuer (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Lender Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), whether or not in respect of an obligation due and owing by the Borrower at such time, where such payment is a Rescindable Amount, then in any such event, each Lender Party receiving a Rescindable Amount severally agrees to repay to the Administrative Agent forthwith on demand the Rescindable Amount received by such Lender Party in immediately available funds in the currency so received, with interest thereon, for each day from and including the date such Rescindable Amount is received by it to but excluding the date of payment to  the Administrative Agent, at the greater of the Federal Funds Effective Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation.  Each Lender Party irrevocably waives any and all defenses, including any &#8220;discharge for value&#8221; (under which a creditor might otherwise claim a right to retain funds mistakenly paid by a third party in respect of a debt owed by another) or similar defense to its obligation to return any Rescindable Amount.&#160; The Administrative Agent shall inform each Lender Party promptly upon determining that any payment made to such Lender Party comprised, in whole or in part, a Rescindable Amount.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">OTHER PROVISIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Amendments, Waivers, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">With the written consent of the Required Lenders, the Administrative Agent and the Borrower may, from time to time, enter into written amendments, supplements or modifications of the Loan Documents (which, for the avoidance of doubt, shall require the prior written consent of the Borrower) and, with the written consent of the Required Lenders and the Borrower, the Administrative Agent on behalf of the Lenders may execute and deliver to any such parties a written instrument waiving or consenting to the departure from, on such terms and conditions as the Administrative Agent may specify in such instrument (which terms and conditions shall have been agreed to by the Borrower), any of the requirements of the  Loan Documents or any Default or any Event of Default and its consequences, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that no such amendment, supplement, modification, waiver or consent shall (i) increase the Commitment Amount of    any Lender without the consent of such Lender (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that no waiver of a Default or Event of Default shall be deemed to constitute such an increase), (ii) extend the Commitment Period without the consent of each Lender directly affected thereby, (iii) reduce the amount, or extend the time of payment, of the Fees without the consent of each Lender directly affected thereby, (iv) reduce the rate, or extend the time of payment of, interest on any Revolving Credit Loan, any Note or any Reimbursement Obligation (other than the applicability of any post-default increase in such rate of interest) without the consent of each Lender directly affected thereby, (v) reduce the amount of, or extend the time of payment of, any payment of any Reimbursement Obligation or principal on any Revolving Credit Loan or any Note without the consent of each Lender directly affected thereby, (vi) decrease or forgive the principal amount of any Revolving Credit Loan, any Note or any Reimbursement Obligation without the consent of each Lender directly affected thereby, (vii) consent to any assignment or delegation by the Borrower of any of its rights or obligations under any Loan Document without the consent of each Lender, (viii) change the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> without the consent of each Lender, (ix) change the definition of Required Lenders without the consent of each Lender, (x) change the several nature of the obligations of the Lenders without the consent of each Lender, (xi) change the sharing provisions among Lenders without the consent of each Lender directly affected thereby, or (xii) extend the expiration date of a Letter of Credit beyond the Commitment Termination Date without the consent of each Lender. Notwithstanding the foregoing, in addition to the receipt of the prior written consents of the Borrower and the Required Lenders, no such amendment, supplement, modification, waiver or consent shall (A) amend, modify or waive any provision of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or otherwise change any of the rights or obligations of the Administrative Agent, any Issuer or the Swing Line Lender under any Loan Document without the written consent of the Administrative Agent, such   Issuer or the Swing Line Lender, as the case may be, (B) change the Letter of Credit Commitment, change the amount or the time of payment of any Letter of Credit or any commission or fee payable to the Issuer thereof in connection therewith, or change any other term or provision which relates to the Letter of Credit Commitment of such Issuer or the Letters of Credit issued thereby without the written consent of such  Issuer, (C) change the Swing Line Commitment, change the amount or the time of payment of the Swing Line Loans or interest thereon or change any other term or provision which relates to the Swing Line Commitment or the Swing Line Loans without the written consent of the Swing Line Lender or (D) change the amount or the time of payment of any Competitive Bid Loan or interest thereon without the written consent of the Lender holding such Competitive Bid Loan. Any such amendment, supplement,   modification, waiver or consent shall apply equally to each of the Lenders and shall be binding upon the parties to the applicable Loan Document, the Lenders, the Issuers, the Administrative Agent and all future holders of the Loans, the Notes and the Reimbursement Obligations. In the case of any waiver, the  Borrower, the Lenders, the Issuers and the Administrative Agent shall be restored to their former position and rights under the Loan Documents, but any Default or Event of Default waived shall not extend to any subsequent or other Default or Event of Default, or impair any right consequent thereon. Notwithstanding anything to the contrary in this Agreement or in any other Loan Document, (1) the Administrative Agent  and the Borrower may make amendments contemplated by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> without the consent of any other </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Person party hereto, (2) in order to implement any ESG Amendment, this Agreement and the other Loan Documents may be amended in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> with only the consent of the Borrower, the Sustainability Coordinator and the Required Lenders (as and to the extent provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), (3) if the Administrative Agent and the Borrower shall have jointly identified an obvious error, ambiguity, defect, inconsistency, omission or any error or omission of a technical nature, in each case, in any provision of the Loan Documents, then the Administrative Agent and the Borrower shall be permitted to amend such provision, and, in each case, such amendment shall become effective without any further action or consent  of any party to any Loan Document (other than the Administrative Agent and the Borrower) if the same (x) does not adversely affect the rights of any Lender or (y) is not objected to in writing by the Required Lenders to the Administrative Agent within five Domestic Business Days following receipt of notice thereof, and   (4) this Agreement may be amended or amended and restated without the consent of any specific Lender  (but with the consent of the Borrower and the Administrative Agent) if, upon giving effect to such amendment or amendment and restatement, such Lender shall no longer be a party to this Agreement (as     so amended or amended and restated, as the case may be), the Commitments of such Lender shall have terminated, such Lender shall have no other commitment or other obligation hereunder and shall have been paid in full all principal, interest and other amounts owing to it or accrued for its account under this Agreement. Any amendment, waiver or consent effected in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be binding upon each Person that is at the time thereof a Lender and each Person that subsequently becomes a Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Notices</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Notices Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Except in the case of notices and other communications expressly permitted to be given by telephone, all notices and other communications provided for herein shall be in writing and shall be delivered by hand or overnight courier service, mailed by certified or registered mail or sent by facsimile or email, as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">If to the Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CVS Health Corporation</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1 CVS Drive</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">MC2340</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Woonsocket, Rhode Island 02895</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attention&#58;&#160;&#160;&#160;&#160;Carol A. DeNale</font></div><div style="padding-left:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Senior Vice President and Treasurer</font></div><div style="padding-left:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Facsimile&#58;&#160;&#160;&#160;&#160;(401) 770-5768</font></div><div style="padding-left:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Telephone&#58;&#160;&#160;&#160;&#160;(401) 770-4407</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Email&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;carol.denale&#64;cvshealth.com</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">with a copy, in the case of a notice of Default or Event of Default, to&#58;</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CVS Health Corporation</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1 CVS Drive</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Woonsocket, Rhode Island 02895</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attention&#58;&#160;&#160;&#160;&#160;Tom Moffatt</font></div><div style="padding-left:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Vice President, Assistant Secretary and Assistant General Counsel &#8211; Corporate Services</font></div><div style="padding-left:72pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Facsimile&#58;&#160;&#160;&#160;&#160;(401) 216-3758</font></div><div style="padding-left:72pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Telephone&#58;&#160;&#160;&#160;&#160;(401) 770-5409</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Email&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;thomas.moffatt&#64;cvshealth.com</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">with a copy (in the case of a notice of Default or Event of Default and which shall not constitute notice under this Agreement or any other Loan Document for any purpose) to&#58;</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Shearman &#38; Sterling LLP</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">599 Lexington Avenue</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">New York, New York 10022</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attention&#58;&#160;&#160;&#160;&#160;Gus M. Atiyah</font></div><div style="padding-left:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Facsimile&#58;&#160;&#160;&#160;&#160;(646) 848-5227</font></div><div style="padding-left:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Telephone&#58;&#160;&#160;&#160;&#160;(212) 848-5227</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Email&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;gus.atiyah&#64;shearman.com</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">If to the Administrative Agent, BofA as an Issuer or the Swing Line Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in the case of each Borrowing Request, each notice of prepayment under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, each Letter    of Credit Request, each Competitive Bid Request, each Competitive Bid, and each Competitive    Bid Accept&#47;Reject Letter&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Bank of America, N.A., as Administrative Agent</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">900 W. Trade St., 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Floor </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NC1-026-06-04</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Charlotte, NC 28255</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attention&#58;&#160; Kennedy Diggs</font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Tel&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">980-387-4805</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Facsimile&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">704-625-5608</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Email&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">kennedy.diggs&#64;bofa.com </font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Remittance Instructions- US Dollars</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Bank of America, N.A. </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">New York, NY</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ABA# </font><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">XXXXXXXXX</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Account No.&#58;  </font><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">XXXXXXXXXXXXX</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Account Name&#58; Wire Clearing Acct for Syn Loans-LIQ</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ref&#58;  CVS HEALTH CORPORATION </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in the case of each Letter of Credit Request&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Bank of America, N.A.</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Trade Operations</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1 Fleet Way</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Mail Code&#58; PA6-580-02-30</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Scranton, Pa. 18507</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attention&#58;  Trade Operations</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Tel&#58; 570-496-9619</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Facsimile&#58; 800-755-8740</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Email&#58; tradeclientserviceteamus&#64;bofa.com</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Remittance Instructions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Bank of America, N.A.</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">New York, NY</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ABA #&#58;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">XXX-XXX-XXX</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Account #&#58; </font><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">XXXXX-XXXXXX</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attn&#58; Scranton Standby&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ref&#58; CVS HEALTH CORPORATION </font></div><div style="padding-left:72pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and in all other cases&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Bank of America, N.A., as Administrative Agent</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">900 W. Trade St., 6th Floor </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NC1-026-06-03</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Charlotte, NC 28255</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attention&#58;  Kyle Harding</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Tel&#58; 980-275-6132</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Facsimile&#58; 704-719-5215</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Email&#58; kyle.d.harding&#64;bofa.com</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">If to any Lender or any other Issuer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; to it at its address (or facsimile number or email address) set forth in its Administrative Questionnaire.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Electronic Communications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notices and other communications to the Credit  Parties hereunder may be delivered or furnished by electronic communication (including email, FpML messaging and internet or intranet websites) pursuant to procedures approved by the Administrative Agent&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the foregoing shall not apply to notices to any Credit Party pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> if such Credit Party has notified the Administrative Agent that  it is incapable of receiving notices under such Sections by electronic communication. The Administrative Agent or the Borrower may, in its discretion, agree to accept notices and other communications to it hereunder by electronic communications pursuant to procedures approved by it&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that approval of such procedures may be limited to particular notices or communications.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Unless the Administrative Agent otherwise prescribes, (i)&#160;notices and other  communications sent to an email address shall be deemed received upon the sender&#8217;s receipt of an acknowledgement from the intended recipient (such as by the &#8220;return receipt requested&#8221; or &#8220;read requested&#8221; function, as available, return email or other written acknowledgement)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if such notice or other communication is not sent during the normal business hours of the recipient, such notice or communication shall be deemed to have been sent at the opening of business on the next Domestic Business Day for the recipient, and (ii)&#160;notices or communications posted to an internet or intranet website shall be deemed received upon the deemed receipt by the intended recipient at its email address as described in the foregoing clause&#160;(i) of notification that such notice or communication is available and identifying the website address therefor.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Change of Address</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Any party hereto may change its address, facsimile number or email address for notices and other communications hereunder by notice to the other parties hereto (or, in the case of any Lender or any Issuer, by notice to the Administrative Agent and the Borrower). Subject to the second paragraph of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, all notices and other communications given to any party hereto in accordance with the provisions of this Agreement   shall be deemed to have been given on the date of receipt&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any such notice or communication that is not received on a Domestic Business Day during the normal business hours  of the recipient shall be deemed received at the opening of business on the next Domestic Business Day.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">The Platform</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">THE PLATFORM IS PROVIDED &#8220;AS IS&#8221; AND &#8220;AS AVAILABLE.&#8221;  THE AGENT PARTIES (AS DEFINED BELOW) DO NOT WARRANT THE ACCURACY OR COMPLETENESS OF THE BORROWER MATERIALS OR THE  ADEQUACY OF THE PLATFORM, AND EXPRESSLY DISCLAIM LIABILITY FOR   ERRORS IN OR OMISSIONS FROM THE BORROWER MATERIALS.  NO WARRANTY OF ANY KIND, EXPRESS, IMPLIED OR STATUTORY, INCLUDING ANY WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT  OF THIRD PARTY RIGHTS OR FREEDOM FROM VIRUSES OR OTHER CODE DEFECTS,  IS MADE BY ANY AGENT PARTY IN CONNECTION WITH THE BORROWER  MATERIALS OR THE PLATFORM.  In no event shall the Administrative Agent or any of its Related Parties (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Agent Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) have any liability to the Borrower, any Lender, any Issuer or any other Person for losses, claims, damages, liabilities or expenses of any kind (whether in tort, contract or otherwise) arising out of the Borrower&#8217;s or the Administrative Agent&#8217;s transmission of Borrower Materials or notices through the Platform, any other electronic platform    or electronic messaging service, or through the Internet.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">No Waiver&#59; Cumulative Remedies</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No failure to exercise and no delay in exercising, on the part of the Administrative Agent, any Lender or any Issuer, any right, remedy, power or privilege under any Loan Document shall operate as a waiver thereof, nor shall any single or partial exercise of any right, remedy, power or privilege under any Loan Document preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege. The rights, remedies, powers and privileges under the Loan Documents are cumulative and not exclusive of any rights, remedies, powers and privileges provided by law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Survival of Representations and Warranties</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">All representations and warranties made in the Loan Documents and in any document, certificate    or statement delivered pursuant thereto or in connection therewith shall survive the execution and delivery  of the Loan Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Payment of Expenses&#59; Indemnified Liabilities</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Borrower agrees, as soon as practicable following presentation of a statement  or invoice therefor setting forth in reasonable detail the items thereof, and whether any Loan is  made or Letter of Credit is issued, (a) to pay or reimburse the Administrative Agent and its  Affiliates for all their reasonable and documented out-of-pocket costs and expenses actually  incurred in connection with the development, syndication, preparation and execution of, and any amendment, waiver, consent, supplement or modification to, the Loan Documents, any documents prepared in connection therewith and the consummation of the transactions contemplated thereby, whether such Loan Documents or any such amendment, waiver, consent, supplement or modification to the Loan Documents or any documents prepared in connection therewith are executed and whether the transactions contemplated thereby are consummated, including the reasonable and documented out-of-pocket fees and disbursements of Special Counsel, (b) to pay, indemnify, and hold the Administrative Agent, the Lenders and the Issuers harmless from any and all recording and filing fees and any and all liabilities and penalties with respect to, or resulting  from any delay (other than penalties to the extent attributable to the negligence of the  Administrative Agent, the Lenders or the Issuers, as the case may be, in failing to pay such fees, liabilities or penalties when due) which may be payable or determined to be payable in connection with the execution and delivery of, or consummation of any of the transactions contemplated by,    or any amendment, supplement or modification of, or any waiver or consent under or in respect of, </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Loan Documents or any documents prepared in connection therewith, and (c) to pay, reimburse, indemnify and hold each Indemnified Person harmless from and against any and all other liabilities, obligations, claims, losses, damages, penalties, actions, judgments, suits, costs, expenses and disbursements of any kind or nature whatsoever (including the reasonable and documented out-of-pocket fees and disbursements of one counsel (but excluding the allocated cost of internal counsel) representing all of the Indemnified Persons, taken as a whole, and, if reasonably necessary, of a single local counsel for each applicable jurisdiction (and, if reasonably necessary, one specialty counsel for each applicable specialty), representing all of the Indemnified Persons, taken as a whole (and, in the case of any actual or perceived conflict of interest where the Indemnified Person  affected by such conflict notifies the Borrower of the existence of such conflict and thereafter  retains its own counsel, of another firm of counsel (and, if reasonably necessary, a single local counsel for each applicable jurisdiction (which may include a single counsel acting in multiple jurisdictions) (and, if reasonably necessary, one specialty counsel for each applicable specialty),    for each such affected Indemnified Person))) actually incurred with respect to the enforcement, performance of, and preservation of rights under, the Loan Documents (all the foregoing, collectively, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Indemnified Liabilities&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) and, if and to the extent that the foregoing indemnity may be unenforceable for any reason, the Borrower agrees to make the maximum payment  permitted under applicable law. Notwithstanding anything to the contrary contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the foregoing payment, indemnification and reimbursement obligations will not, as to any Person identified in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, apply to any losses, claims, damages, liabilities and related expenses to the extent arising (A) from the willful misconduct, gross negligence, fraud or bad faith of such Person, (B) from a material breach of the obligations hereunder of such Person, (C) out of   or in connection with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, or (D) out of or in connection with any claim, litigation, investigation or proceeding that does not involve an act or omission of the Borrower or any of its Affiliates and that is brought by any such Person against any such other Person (other than the Administrative Agent, a Joint Lead Arranger, the Issuer or the Swing Line Lender, in each case, in its capacity as such), in each case under clauses (A) and (B), to the extent determined by a final and non-appealable judgment of a court of competent jurisdiction. The agreements in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall survive the termination of the Commitments and the payment of the Loans and the Notes and all other amounts payable under the Loan Documents.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Notwithstanding the above, the Borrower shall have no liability under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> to indemnify or hold harmless any Indemnified Person for any losses, claims, damages, liabilities and related expenses relating to income or withholding Taxes or any Tax in lieu of such Taxes. Notwithstanding the foregoing, any amounts claimed by an Indemnified Person under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall not be available to be claimed by such Indemnified Person under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, it being understood and agreed that the rights of an Indemnified Person under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall not be duplicative.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Lending Offices</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each Lender shall have the right at any time and from time to time to transfer any Loan to a different office of such Lender, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Successors and Assigns</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Successors and Assigns Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and  assigns permitted hereby, except that the Borrower may not assign or otherwise transfer any of its rights or obligations hereunder without the prior written consent of the Administrative Agent and each Lender and no Lender may assign or otherwise transfer any of its rights or obligations </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">hereunder except (i) to an assignee in accordance with the provisions of paragraph (b) of this  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, (ii) by way of participation in accordance with the provisions of paragraph (d) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or (iii) by way of pledge or assignment of a security interest subject to the restrictions of paragraph (f) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (and any other attempted assignment or transfer by any party hereto shall be null and void). Nothing in this Agreement, expressed or implied, shall be construed  to confer upon any Person (other than the parties hereto, their respective successors and assigns permitted hereby, the Participants to the extent provided in paragraph (d) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and,   to the extent expressly contemplated hereby, the Related Parties of each Credit Party) any legal or equitable right, remedy or claim under or by reason of this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Assignments by Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Any Lender may at any time assign to one or more assignees all or a portion of its rights and obligations under this Agreement (including all or a portion of its Commitment and the Loans and obligations in respect of its Letter of Credit Exposure and Swing Line Exposure at the time owing to it)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any such assignment shall be subject to the following conditions&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Minimum Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.74pt">in the case of an assignment of the entire remaining amount of the assigning Lender&#8217;s Commitment Amount or Swing Line Commitment and the Loans and obligations in respect of its Letter of Credit Exposure and Swing Line Exposure at the time owing to it or in the case of an assignment to a Lender, an Affiliate of a Lender or an Approved Fund, no minimum amount need be assigned&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.35pt">in any case not described in paragraph (b)(1)(A) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Commitment Amount or Swing Line Commitment (which for this   purpose includes the Loans of the assigning Lender outstanding thereunder and obligations in respect of its Letter of Credit Exposure and Swing Line Exposure at the time owing to it thereunder) or, if the Commitment or Swing Line Commitment of the assigning Lender is not then in effect, the principal outstanding balance of  the Loans and the Letter of Credit Exposure and Swing Line Exposure of the assigning Lender subject to each such assignment (determined as of the date the Assignment and Assumption with respect to such assignment is delivered to the Administrative Agent or, if a &#8220;Trade Date&#8221; is specified in the Assignment and Assumption, as of such &#8220;Trade Date&#8221;) shall not be less than $5,000,000, unless  each of the Administrative Agent and, so long as no Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(h),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> has occurred and is continuing, the Borrower otherwise consents (each such consent not to be unreasonably withheld or delayed).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Proportionate Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each partial assignment shall be made as an assignment of a proportionate part of all the assigning Lender&#8217;s rights and obligations under this Agreement with respect to the Loans, Letter of Credit Exposure and Swing Line Exposure or the Commitment assigned, except that this clause (2) shall not prohibit any Lender from assigning all or a portion of its rights and obligations in respect of Competitive Bid Loans on a non-pro rata basis.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Required Consents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. No consent shall be required for any assignment   except to the extent required by paragraph (b)(1)(B) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and, in addition&#58;</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.74pt">the consent of the Borrower (such consent not to be unreasonably withheld or delayed) shall be required unless (x) an Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(h),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> has occurred and is continuing at the time of such assignment or (y) such assignment is to a Lender, an Affiliate of a Lender or an Approved Fund (it being understood that it shall not be deemed unreasonable for the Borrower to withhold consent to any assignment if it reasonably believes that such assignment would result in the Borrower incurring increased costs pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">)&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.35pt">the consent of the Administrative Agent (such consent not to be unreasonably withheld, conditioned or delayed) shall be required for assignments   in respect of an unfunded or revolving facility hereunder if such assignment is to     a Person that is not a Lender with a Commitment in respect of such facility, an Affiliate of such Lender or an Approved Fund with respect to such Lender&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.35pt">the consent of each Issuer (such consent not to be unreasonably withheld, conditioned or delayed) shall be required for any assignment that increases the obligation of the assignee to participate in exposure under one or   more Letters of Credit (whether or not then outstanding) and the Swing Line  Lender (such consent not to be unreasonably withheld or delayed) shall be required for any assignment in respect of the revolving facility hereunder.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Assignment and Assumption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The parties to each assignment shall execute and deliver to the Administrative Agent an Assignment and Assumption, together with a processing and recordation fee of $4,500 ($7,500 in the case of an assignment by a Defaulting Lender) (which fee shall be paid by the assignor or the assignee and may be waived or reduced in the sole discretion of the Administrative Agent), and the assignee, if   it is not a Lender, shall deliver to the Administrative Agent an Administrative  Questionnaire.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">No Assignment to Certain Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. No such assignment shall be made to  (A) the Borrower, any of its Subsidiaries or any of their respective Affiliates or (B) any Defaulting Lender or any of its Subsidiaries or any Person who, upon becoming a Lender hereunder, would constitute any of the foregoing Persons described in this clause (B).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">No Assignment to Natural Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. No such assignment shall be made to    a natural person (or a holding company, investment vehicle or trust for, or owned and operated by or for the primary benefit of a natural person).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Certain Additional Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  In connection with any assignment of rights and obligations of any Defaulting Lender hereunder, no such assignment shall be effective unless and until, in addition to the other conditions thereto set forth herein, the parties to    the assignment shall make such additional payments to the Administrative Agent in an aggregate amount sufficient, upon distribution thereof as appropriate (which may be  outright payment, purchases by the assignee of participations or subparticipations, or other compensating actions, including funding, with the consent of the Borrower and the Administrative Agent, the applicable pro rata share of Loans previously requested but not funded by the Defaulting Lender, to each of which the applicable assignee and assignor hereby irrevocably consent), to (x) pay and satisfy in full all payment liabilities then owed by such Defaulting Lender to the Administrative Agent, any Issuer or any Lender   hereunder (and interest accrued thereon) and (y) acquire (and fund as appropriate) its full </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">pro rata share of all Loans and participations in Letters of Credit and Swing Line Loans in accordance with its Commitment Percentage. Notwithstanding the foregoing, in the event that any assignment of rights and obligations of any Defaulting Lender hereunder shall become effective under applicable law without compliance with the provisions of this  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">clause (7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, then the assignee of such interest shall be deemed to be a Defaulting Lender for all purposes of this Agreement until such compliance occurs.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Subject to acceptance and recording thereof by the Administrative Agent pursuant to paragraph (c) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, from and after the effective date specified in each Assignment  and Assumption, the assignee thereunder shall be a party to this Agreement and, to the extent of    the interest assigned by such Assignment and Assumption, have the rights and obligations of a Lender under this Agreement, and the assigning Lender thereunder shall, to the extent of the interest assigned by such Assignment and Assumption, be released from its obligations under this Agreement (and, in the case of an Assignment and Assumption covering all of the assigning Lender&#8217;s rights and obligations under this Agreement, such Lender shall cease to be a party hereto) but shall continue to be entitled to the benefits of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.6,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> with respect to facts and circumstances occurring prior to the effective date of such assignment. Any assignment or transfer by a Lender of rights or obligations under this Agreement that does not comply with this paragraph shall be treated for purposes of this Agreement as a sale by such Lender of a participation in such rights and obligations in accordance with paragraph (d) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Administrative Agent, acting solely for this purpose as an agent of  the Borrower, shall maintain at one of its offices in the United States of America a copy of each Assignment and Assumption delivered to it and a register for the recordation of the names and addresses of the Lenders, and the Commitments of, and principal amounts (and stated interest) of  the Loans owing to, each Lender pursuant to the terms hereof from time to time (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Register&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">). The entries in the Register shall be conclusive absent manifest error, and the Borrower, the Administrative Agent, the Issuers and the Lenders shall treat each Person whose name is recorded   in the Register pursuant to the terms hereof as a Lender hereunder for all purposes of this Agreement, notwithstanding notice to the contrary. The Register shall be available for inspection   by the Borrower, any Issuer and any Lender (but only, in the case of an Issuer or a Lender, at the Administrative Agent&#8217;s Office and with respect to any entry relating to such Lender&#8217;s  Commitments, Advances and other obligations pursuant to the terms hereof or such Issuer&#8217;s Letter of Credit Commitments and other obligations pursuant to the terms hereof, as applicable) at any reasonable time and from time to time upon reasonable prior notice.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Participations.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Any Lender may at any time, without the consent of, or notice to,   the Borrower or the Administrative Agent, sell participations to any Person (other than a natural person (or a holding company, investment vehicle or trust for, or owned and operated by or for the primary benefit of a natural person), the Borrower, any of its Subsidiaries or any of their respective Affiliates) (each, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) in all or a portion of such Lender&#8217;s rights and&#47;or obligations  under this Agreement (including all or a portion of its Commitment, Letter of Credit Exposure, Swing Line Exposure and&#47;or the Loans, Letter of Credit Exposure or Swing Line Exposure owing   to it)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that (i)&#160;all of such Lender&#8217;s obligations under this Agreement and the other Loan Documents shall remain in all respects unchanged, (ii)&#160;such Lender shall remain solely responsible to the other parties hereto for the performance of such obligations and (iii)&#160;the Borrower, the Administrative Agent and each Credit Party shall continue to deal solely and directly with such Lender in connection with such Lender&#8217;s rights and obligations under this Agreement. Any agreement or instrument pursuant to which a Lender sells such a participation shall provide that such Lender shall retain the sole right to enforce this Agreement and to approve any amendment, </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">modification or waiver of any provision of this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such agreement or instrument may provide that such Lender will not, without the consent of the Participant, agree to any amendment, modification or waiver which requires the consent of all Lenders or all affected Lenders that directly affects such Participant. Subject to paragraph (e) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Borrower agrees that each Participant shall be entitled to the benefits of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> to the same extent as if it were a Lender and had acquired its interest  by assignment pursuant to paragraph (b) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. To the extent permitted by law, each Participant also shall be entitled to the benefits of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;11.9(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as though it were a Lender&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such Participant agrees to be subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;11.9(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as though it were a Lender. Each Lender that sells a participation with respect to a Commitment or Loan shall, solely for the purposes of complying with the rules regarding registered form in the Internal Revenue Code, act   as a non-fiduciary agent of the Borrower, maintaining a register on which it enters the name and address of each Participant and the principal amounts (and stated interest amounts) of each Participant&#8217;s interest in the Commitment and&#47;or Loan (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Participant Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), and the entries in such Participant Register shall be conclusive, absent manifest error, and such Lender shall treat each Person whose name is recorded in the Participant Register as the owner of such participation for all purposes of this Agreement notwithstanding any notice to the contrary. No Lender shall be required to disclose the existence of, or any of the information contained in, any Participant Register maintained by it to the Borrower or any other Person unless requested in  writing by the Borrower, and only to the Internal Revenue Service to the extent such disclosure is required in order to comply with the rules requiring registered form pursuant to the Internal  Revenue Code.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Limitations upon Participant Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. A Participant shall not be entitled to receive any greater payment under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> than the applicable Lender would have been entitled to receive with respect to the participation sold to such Participant, unless the sale of the participation to such Participant is made with the Borrower&#8217;s prior written consent. A Participant shall not be entitled to the benefits of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> unless the Borrower is notified of the participation sold to such Participant and such Participant agrees, for the benefit of  the Borrower, to comply with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.10(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> as though it were a Lender.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.02pt;text-decoration:underline">Certain Pledges</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Any Lender may at any time pledge or assign a security interest    in all or any portion of its rights under this Agreement to secure obligations of such Lender, including any pledge or assignment to secure obligations to a Federal Reserve Bank or other central bank having jurisdiction over such Lender&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that no such pledge or assignment shall release such Lender from any of its obligations hereunder or substitute any such pledgee or assignee for such Lender as a party hereto.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Resignation as Issuer or Swing Line Lender after Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Notwithstanding anything to the contrary contained herein, if at any time any Issuer or the Swing Line Lender assigns all of its Commitment and Loans pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">clause (b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> above, such Issuer or Swing Line Lender may, (i) upon 30 days&#8217; notice to the Administrative Agent, the Borrower and the Lenders, resign     as an Issuer and&#47;or (ii) upon 30 days&#8217; notice to the Borrower, resign as Swing Line Lender.  In the event of any such resignation as an Issuer or Swing Line Lender, the Borrower shall be entitled to appoint from among the Lenders a successor Issuer or Swing Line Lender hereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that no failure by the Borrower to appoint any such successor shall affect the resignation  of the applicable Issuer or Swing Line Lender as an Issuer or Swing Line Lender, as the case may be.  If the applicable Issuer resigns as an Issuer, it shall retain all the rights, powers, privileges and duties of an Issuer hereunder with respect to all Letters of Credit issued by it and outstanding as of the effective date of its resignation as an Issuer and all Reimbursement Obligations with respect thereto (including the right to require the Lenders to make ABR Advances or fund risk  </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">participations in pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).  If the Swing Line Lender resigns as Swing Line Lender,  it shall retain all the rights of the Swing Line Lender provided for hereunder with respect to Swing Line Loans made by it and outstanding as of the effective date of such resignation, including the right to require the Lenders to make ABR Advances or fund risk participations in outstanding  Swing Line Loans pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Upon the appointment of a successor Issuer and&#47;or Swing Line Lender, (x) such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring Issuer or Swing Line Lender, as the case may be, and  (y) the successor Issuer shall issue letters of credit in substitution for the Letters of Credit, if any, outstanding at the time of such succession or make other arrangements satisfactory to the applicable retiring Issuer and the Borrower to effectively assume the obligations of the applicable retiring Issuer with respect to such Letters of Credit.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Disqualified Institutions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  (i)  No assignment shall be made to any Person that was   a Disqualified Institution as of the date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Trade Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) on which the applicable Lender entered into a binding agreement to sell and assign all or a portion of its rights and obligations under this Agreement to such Person (unless the Borrower has consented to  such assignment in writing as otherwise contemplated by this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, in which case such Person will not be considered a Disqualified Institution for the purpose of such assignment).  For the avoidance of doubt, with respect to any assignee that becomes a Disqualified Institution after the applicable Trade Date (including as a result of the delivery of a notice pursuant to, and&#47;or the expiration of the notice period referred to in, the  definition of &#8220;Disqualified Institution&#8221;), (x) such assignee shall not retroactively be disqualified from becoming a Lender and (y) the execution and delivery by the Borrower   of an Assignment and Assumption with respect to such assignee will not by itself result in such assignee no longer being considered a Disqualified Institution.  Any assignment in violation of this clause (h)(i) shall not be void, but the other provisions of this clause (h) shall apply.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;If any assignment is made to any Disqualified Institution without the Borrower&#8217;s prior consent in violation of clause (i) above, or if any Person becomes a Disqualified Institution after the applicable Trade Date, the Borrower may, at its sole expense and effort, upon notice to the applicable Disqualified Institution and the Administrative Agent, (A) terminate any Commitment of such Disqualified Institution and repay all obligations of the Borrower owing to such Disqualified Institution in connection with such Commitment, and&#47;or (B) require such Disqualified Institution to assign and delegate, without recourse (in accordance with and subject to the restrictions contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), all of its interest, rights and obligations under this Agreement and the other Loan Documents to an Eligible Assignee that shall assume such obligations at the lesser of (x) the principal amount thereof and (y) the amount that such Disqualified Institution paid to acquire such interests, rights and obligations, in each case plus accrued interest, accrued fees and all other amounts (other than principal amounts) payable to it hereunder and other the other Loan Documents.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary contained in this Agreement, Disqualified Institutions (A) will not (x) have the right to receive information, reports or other materials provided to Lenders by the Borrower, the Administrative Agent or any   other Lender, (y) attend or participate in meetings attended by the Lenders and the Administrative Agent, or (z) access any electronic site established for the Lenders or confidential communications from counsel to or financial advisors of the Administrative Agent or the Lenders and (B) (x) for purposes of any consent to any amendment, waiver     or modification of, or any action under, and for the purpose of any direction to the </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Administrative Agent or any Lender to undertake any action (or refrain from taking any action) under this Agreement or any other Loan Document, each Disqualified Institution  will be deemed to have consented in the same proportion as the Lenders that are not Disqualified Institutions consented to such matter, and (y) for purposes of voting on any plan of reorganization or plan of liquidation pursuant to any bankruptcy or insolvency laws (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Plan of Reorganization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), each Disqualified Institution party hereto hereby agrees (1) not to vote on such Plan of Reorganization, (2) if such Disqualified Institution does vote on  such Plan of Reorganization notwithstanding the restriction in the foregoing clause (1),   such vote will be deemed not to be in good faith and shall be &#8220;designated&#8221; pursuant to Section 1126(e) of the United States Bankruptcy Code (or any similar provision in any  other bankruptcy or insolvency laws), and such vote shall not be counted in determining whether the applicable class has accepted or rejected such Plan of Reorganization in accordance with Section 1126(c) of the United States Bankruptcy Code (or any similar provision in any other bankruptcy or insolvency laws) and (3) not to contest any request    by any party for a determination by the bankruptcy court (or other applicable court of competent jurisdiction) effectuating the foregoing clause (2).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Counterparts&#59; Electronic Execution </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each of the Loan Documents (other than the Notes) may be executed on any number of separate counterparts and all of said counterparts taken together shall be deemed to constitute one and the same agreement.  It shall not be necessary in making proof of any Loan Document to produce or account for more than one counterpart signed by the party to be charged.   A set of the copies of this Agreement signed by all of the parties hereto shall be lodged with each   of the Borrower and the Administrative Agent.  Delivery of an executed counterpart of a signature page of any Loan Document by fax or other electronic means (e.g., &#8220;.pdf&#8221; or &#8220;.tif&#8221;) shall be effective as delivery of a manually executed counterpart of such Loan Document.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Electronic Execution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This Agreement and any document, amendment, approval, assignment, consent, information, notice, certificate, request, statement, disclosure or authorization related to this Agreement (each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Communication</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), including Communications required to be in writing, may be in the form of an Electronic Record and may be executed using Electronic Signatures. Each party hereto hereby agrees that any Electronic Signature on, or associated with,  any Communication shall be valid and binding on such party to the same extent as a manual,  original signature, and that any Communication entered into by Electronic Signature, will constitute the legal, valid and binding obligation of such party enforceable against such party in accordance with the terms thereof to the same extent as if a manually executed original signature was delivered.   Any Communication may be executed in as many counterparts as necessary or convenient,  including both paper and electronic counterparts, but all such counterparts are one and the same Communication.  For the avoidance of doubt, the authorization under this paragraph may include, without limitation, use or acceptance by each party hereto of a manually signed paper Communication which has been converted into electronic form (such as scanned into PDF format), or an electronically signed Communication converted into another format, for transmission,   delivery and&#47;or retention. Each party hereto may, at its option, create one or more copies of any Communication in the form of an imaged Electronic Record (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Electronic Copy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), which shall be deemed created in the ordinary course of such Person&#8217;s business, and destroy the original paper document.  All Communications in the form of an Electronic Record, including an Electronic Copy, shall be considered an original for all purposes, and shall have the same legal effect, validity and enforceability as a paper record. Notwithstanding anything contained herein to the contrary, the Administrative Agent is under no obligation to accept an Electronic Signature in any form or in    any format unless expressly agreed to by the Administrative Agent pursuant to procedures approved </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">by it (it being acknowledged that the Administrative Agent will accept &#8220;.pdf&#8221; signatures).  Without limiting the foregoing sentence, (a) to the extent the Administrative Agent has agreed to accept   such Electronic Signature, the Administrative Agent and each of the Lenders shall be entitled to   rely on any such Electronic Signature purportedly given by or on behalf of the Borrower without further verification, and (b) upon the request of the Administrative Agent or any Lender hereto, any Electronic Signature shall be promptly (to the extent reasonably practicable at such time as reasonably determined by the Borrower) followed by such manually executed counterpart.  For purposes hereof, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Electronic Record</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Electronic Signature</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall have the meanings   assigned to them, respectively, by 15 USC &#167;7006, as it may be amended from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Set-off and Sharing of Payments.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">In addition to any rights and remedies of the Lenders and the Issuers provided by law, after the occurrence and during the continuance of an Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">     or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or upon the acceleration of the Loans, each Lender and each Issuer shall have the right, without prior notice to the Borrower, any such notice being expressly waived by the  Borrower, to set-off and apply against any indebtedness or other liability, whether matured or unmatured, of the Borrower to such Lender or such Issuer arising under the Loan Documents, any amount owing from such Lender or such Issuer to the Borrower. To the extent permitted by applicable law, the aforesaid right of set-off may be exercised by such Lender or such Issuer against the Borrower or against any trustee in bankruptcy, custodian, debtor in possession, assignee for the benefit of creditors, receiver, or execution, judgment or attachment creditor of the Borrower, or against anyone else claiming through or against the Borrower or such trustee in bankruptcy, custodian, debtor in possession, assignee for the benefit of creditors, receivers, or execution, judgment or attachment creditor, notwithstanding the fact that such right of set-off shall not have been exercised by such Lender or such Issuer prior to the making, filing or issuance of, service   upon such Lender or such Issuer of, or notice to such Lender or such Issuer of, any petition, assignment for the benefit of creditors, appointment or application for the appointment of a   receiver, or issuance of execution, subpoena, order or warrant. Each Lender and each Issuer agree promptly to notify the Borrower and the Administrative Agent after each such set-off and application made by such Lender or such Issuer, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the failure to give such notice shall not affect the validity of such set-off and application.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">If any Lender or any Issuer shall obtain any payment (whether voluntary, involuntary, through the exercise of any right of set-off, or otherwise) on account of its Loans or    its Notes or the Reimbursement Obligations in excess of its pro rata share (in accordance with the outstanding principal balance of all Loans or the Reimbursement Obligations) of payments then   due and payable on account of the Loans and Notes received by all the Lenders or the Reimbursement Obligations received by all Issuers, such Lender or such Issuer, as the case may    be, shall forthwith purchase, without recourse, for cash, from the other Lenders or Issuers, as the case may be, such participations in their Loans and Notes or the Reimbursement Obligations as  shall be necessary to cause such purchasing Lender or Issuer to share the excess payment with each of them according to their pro rata share (in accordance with the outstanding principal balance of   all Loans and the Reimbursement Obligations)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if all or any portion of such excess payment is thereafter recovered from such purchasing Lender or Issuer, such purchase from each Lender or Issuer shall be rescinded and each such Lender and Issuer shall repay to the purchasing Lender or Issuer the purchase price to the extent of such recovery, together with an amount equal     to such Lender&#8217;s or Issuer&#8217;s pro rata share (according to the proportion of (i) the amount of such Lender&#8217;s or Issuer&#8217;s required repayment to (ii) the total amount so recovered from the purchasing Lender or Issuer) of any interest or other amount paid or payable by the purchasing Lender or Issuer in respect of the total amount so recovered. The Borrower agrees, to the fullest extent permitted by </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">law, that any Lender or Issuer so purchasing a participation from another Lender or Issuer pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> may exercise such rights to payment (including the right of set-off) with respect to such participation as fully as if such Lender or Issuer were the direct creditor of the Borrower in the amount of such participation.  The provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall not be construed to   apply to (A) any payment made by or on behalf of the Borrower pursuant to, and in accordance  with, the express terms of this Agreement (including the application of funds arising from the existence of a Defaulting Lender or Disqualified Institution), (y) the application of cash collateral   as provided herein, or (z) any payment obtained by a Lender as consideration for the assignment of or sale of a participation in any of its Loans or subparticipations in Reimbursement Obligations or Swing Line Loans to any assignee or participant, other than an assignment to the Borrower or any Subsidiary thereof (as to which the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall apply).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Indemnity</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Borrower shall indemnify each Credit Party and each Related Party thereof (each such Person being called an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Indemnified Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) against, and hold each Indemnified Person harmless from, any and all losses, claims, damages, liabilities and related expenses,  including the reasonable and documented out-of-pocket fees and disbursements of one counsel (but excluding the allocated cost of internal counsel) representing all of the Indemnified Persons, taken  as a whole, and, if reasonably necessary, of a single local counsel for each applicable jurisdiction (which may include a single counsel acting in multiple jurisdictions) (and, if reasonably necessary, one specialty counsel for each applicable specialty), representing all of the Indemnified Persons, taken as a whole (and, in the case of any actual or perceived conflict of interest where the Indemnified Person affected by such conflict notifies the Borrower of the existence of such conflict and thereafter retains its own counsel, of another firm of counsel (and, if reasonably necessary, a single local counsel for each applicable jurisdiction (and, if reasonably necessary, one specialty counsel for each applicable specialty), for each such affected Indemnified Person)), actually  incurred by any Indemnified Person arising out of, in connection with, or as a result of (i) the execution or delivery of any Loan Document or any agreement or instrument contemplated thereby, the performance by the parties to the Loan Documents of their respective obligations thereunder or the consummation of the transactions contemplated hereby or any other transactions contemplated thereby, (ii) any Loan or Letter of Credit or the use of the proceeds thereof, (iii) any actual or  alleged presence or release of Hazardous Materials in, on, under or from any property owned or operated by the Borrower or any of the Subsidiaries, or any Environmental Liability related in any way to the Borrower or any of the Subsidiaries or (iv) any actual or prospective claim, litigation, investigation or proceeding relating to any of the foregoing, whether based on statute, contract, tort or any other theory and regardless of whether any Indemnified Person is a party thereto. Notwithstanding anything to the contrary contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the foregoing  indemnity will not, as to any Indemnified Person, apply to any losses, claims, damages, liabilities and related expenses to the extent arising (A) from the willful misconduct, gross negligence, fraud  or bad faith of such Indemnified Person, (B) from a material breach of the obligations hereunder of such Indemnified Person, (C) out of or in connection with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, or (D) out of or in connection with any claim, litigation, investigation or proceeding that does not involve an act or omission of the Borrower or any of its Affiliates and that is brought by an Indemnified Person against any other Indemnified Person (other than the Administrative Agent, a Joint Lead Arranger, the Issuer or the Swing Line Lender, in each case in its capacity as such), in each case under clauses (A) and (B), to the extent determined by a final and non-appealable judgment of a court of competent jurisdiction.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">To the extent that the Borrower fails to pay as soon as practicable any amount required to be paid by it to the Administrative Agent under subsection (a) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (the </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Indemnified Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), each Lender severally agrees to pay to the Administrative Agent an amount equal to the product of such unpaid amount </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (i) at any time when no Loans    are outstanding, its Commitment Percentage, and (ii) at any time when Loans are outstanding (x)     if the Commitments then exist, its Commitment Percentage or (y) if the Commitments have been terminated or otherwise no longer exist, the percentage equal to the fraction, (A) the numerator of which is the sum of such Lender&#8217;s Credit Exposure and (B) the denominator of which is the sum     of the Aggregate Credit Exposure (in each case determined as of the time that the applicable Indemnified Amount is sought)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the Indemnified Amount was payable to the Administrative Agent in its capacity as such.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The obligations of the Borrower and the Lenders under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall survive the termination of the Commitments and the payment of the Loans and the Notes and all other amounts payable under the Loan Documents.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">If any settlement of any investigation, litigation or proceeding to which the indemnity in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> applies (any of the foregoing, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Proceeding&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) is instituted or threatened against any Indemnified Person (or its Related Parties) in respect of which indemnity  may be sought hereunder, unless an Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(a),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> exists, the Borrower shall be entitled to assume the defense thereof with counsel selected by the Borrower (which counsel shall be reasonably satisfactory to such Indemnified Person) and after notice from the Borrower to such Indemnified Person of the Borrower&#8217;s election so to assume the defense thereof, the Borrower will not be liable to such Indemnified Person hereunder for any legal or other expenses subsequently incurred by such Indemnified Person in connection with the defense thereof, other than reasonable and documented out-of-pocket costs of investigation and such other reasonable and documented out-of-pocket expenses as have been approved in advance&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that (i) if counsel for such Indemnified Person determines in good faith that there is a conflict that requires separate representation for the Borrower and such Indemnified Person or that there may    be legal defenses available to such Indemnified Person which are different from, or in addition to, those available to the Borrower or (ii) the Borrower fails to assume or proceed in a timely and reasonable manner with the defense of such action or fails to employ counsel reasonably  satisfactory to such Indemnified Person in any such action, then in either such event, (A) such Indemnified Person shall be entitled to one primary counsel and, if necessary, one local counsel to represent such Indemnified Person and all other Indemnified Persons similarly situated (such counsels selected by the Administrative Agent), (B) the Borrower shall not, or shall not any longer, be entitled to assume the defense thereof on behalf of such Indemnified Person, and (C) such Indemnified Person shall be entitled to indemnification for the expenses (including fees and expenses of such counsel) to the extent provided in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding the foregoing, the Borrower shall not be liable for any settlement, compromise or consent to the entry   of any judgment in any action or Proceeding effected without the Borrower&#8217;s prior written consent (which consent shall not be unreasonably withheld, conditioned or delayed, it being understood and agreed that the withholding, conditioning or delaying of the Borrower&#8217;s consent in connection with  a settlement, compromise or consent to the entry of any judgment in any action or proceeding which does not include an unconditional release of the Borrower and the Subsidiaries from all liability or claims that are the subject matter of such Proceeding or which includes a statement as to any admission of fault by or on behalf of the Borrower or any Subsidiary shall not be deemed unreasonable), but if settled with the Borrower&#8217;s prior written consent or if there is a final judgment for the plaintiff in any such Proceeding, the Borrower agrees to indemnify and hold harmless each Indemnified Person from and against any and all losses, claims, damages, liabilities and expenses  by reason of such settlement, compromise or consent to the entry of any judgment in any action or Proceeding in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Borrower shall not, without the prior written consent of an Indemnified Person, effect any settlement of any pending or threatened Proceeding </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">against such Indemnified Person in respect of which indemnity could have been sought hereunder  by such Indemnified Person unless such settlement (x) includes an unconditional release of such Indemnified Person from all liability or claims that are the subject matter of such Proceeding, (y) does not include any statement as to any admission of fault by or on behalf of such Indemnified Person, and (z) contains customary confidentiality provisions with respect to the terms of such settlement. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Notwithstanding any provision in this Agreement to the contrary, none of the Borrower, the Administrative Agent, the Lenders or any Affiliate of any of the foregoing will be responsible or liable to any Person or entity, on any theory of liability, for any indirect, special, punitive or consequential damages that may be alleged as a result of the transactions contemplated hereby or by the other Loan Documents or any use or intended use of the proceeds of the Loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that nothing in this clause (e) shall limit the Borrower&#8217;s indemnity obligations set forth in this Agreement with respect to any indirect, punitive or consequential damages included in any   third party claim in connection with which an Indemnified Person is entitled to indemnification hereunder. In addition to, and without limiting the immediately foregoing sentence, and to the  extent permitted by applicable law, the Borrower shall not assert, and hereby waives, any claim against any Indemnified Person, on any theory of liability, for special, indirect, consequential or punitive damages (as opposed to direct and actual damages) arising out of, in connection with, or    as a result of, any Loan Document or any agreement, instrument or other document contemplated thereby, the transactions contemplated hereby or any Loan or any Letter of Credit or the use of the proceeds thereof.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.02pt">Notwithstanding the above, the Borrower shall have no liability under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> to indemnify or hold harmless any Indemnified Person for any losses, claims, damages, liabilities and related expenses relating to income or withholding Taxes or any Tax in lieu of such Taxes. Notwithstanding the foregoing, any amounts claimed by an Indemnified Person under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall not be available to be claimed by such Indemnified Person under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, it being understood and agreed that the rights of an Indemnified Person under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall not be duplicative.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Governing Law</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Loan Documents and the rights and obligations of the parties thereto shall be governed by, and construed and interpreted in accordance with, the laws of the State of New York.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Severability</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Every provision of the Loan Documents is intended to be severable, and if any term or provision thereof shall be invalid, illegal or unenforceable for any reason, the validity, legality and enforceability of  the remaining provisions thereof shall not be affected or impaired thereby, and any invalidity, illegality or unenforceability in any jurisdiction shall not affect the validity, legality or enforceability of any such term   or provision in any other jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Integration</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">All exhibits to the Loan Documents shall be deemed to be a part thereof. Each Loan Document embodies the entire agreement and understanding between or among the parties thereto with respect to the subject matter thereof and supersedes all prior agreements and understandings between or among the parties thereto with respect to the subject matter thereof.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Treatment of Certain Information</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Each Credit Party agrees to maintain the confidentiality of the Information (as defined below), except that Information may be disclosed (i) to its Affiliates and to its and its Affiliates&#8217; respective partners, directors, officers, employees, agents, advisors and other representatives (it being understood that the Persons to whom such disclosure is made will be informed of the confidential nature of such Information and instructed to keep such Information confidential)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that each Credit Party shall be responsible for its controlled Affiliates&#8217; compliance in keeping Information confidential, (ii) to the extent requested by any regulatory authority purporting to have jurisdiction over it (including any self-regulatory authority, such as    the National Association of Insurance Commissioners) (in which case such Person agrees (except with respect to any audit or examination conducted by bank accountants or any governmental regulatory authority exercising examination or regulatory authority) to use commercially   reasonable efforts to inform the Borrower promptly thereof prior to such disclosure to the extent practicable and not prohibited by law), (iii) to the extent required by applicable laws or regulations or by any subpoena or similar legal process (in which case such Person agrees to (except with respect to any audit or examination conducted by bank accountants or any governmental regulatory authority exercising examination or regulatory authority) to inform the Borrower promptly thereof prior to such disclosure to the extent practicable and not prohibited by law), (iv) to any other party hereto, (v) in connection with the exercise of any remedies hereunder or under any other Loan Document or any action or proceeding relating to this Agreement or any other Loan Document or the enforcement of rights hereunder or thereunder, (vi) subject to an agreement containing provisions substantially the same as those of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to (A) any assignee of or Participant in, or any prospective assignee of or Participant in, any of its rights or obligations under this Agreement or (B) any actual or prospective counterparty (or its advisors) to any swap or derivative transaction relating to the Borrower and its obligations, (vii) to Gold Sheets and other similar bank trade publications, such information to consist of deal terms and other information customarily found in such publications, (viii) with the prior written consent of the Borrower, (ix) to the extent such Information (1)&#160;becomes publicly available other than as a result of a breach of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or a breach of any other confidentiality obligation owing by such Credit Party to the Borrower or (2)&#160;becomes available to the Administrative Agent, any Credit Party or any of their respective Affiliates on a non-confidential basis from a source other than the Borrower not known to such Credit Party to be prohibited from disclosing such Information, and (x) on a confidential basis to   (1) any rating agency in connection with rating the Borrower or its Subsidiaries or the credit facilities provided hereunder or (2) the CUSIP Service Bureau or any similar agency in connection with the application, issuance, publishing and monitoring of CUSIP numbers of other market identifiers with respect to the credit facilities provided hereunder.  In addition, the Administrative Agent and the Lenders may disclose the existence of this Agreement and information about this Agreement to market data collectors, similar service providers to the lending industry and service providers to the Administrative Agent and the Lenders in connection with the administration of this Agreement, the other Loan Documents, and the Commitments.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">For purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Information&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> means all information received from the Borrower or any of its Subsidiaries relating to the Borrower or any of its Subsidiaries or any of their respective businesses, other than any such information that is available to the Administrative Agent or any other Credit Party on a non-confidential basis prior to disclosure by   the Borrower or any of its Subsidiaries.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Acknowledgments</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower acknowledges that (a) it has been advised by counsel in the negotiation, execution  and delivery of the Loan Documents, (b) by virtue of the Loan Documents, the relationship among the Administrative Agent, the Issuers and the Lenders, on the one hand, and the Borrower, on the other hand,    is solely that of debtor and creditor, and (c) by virtue of the Loan Documents, no joint venture exists among the Lenders or among the Borrower and the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Consent to Jurisdiction</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each of the parties hereto irrevocably submits to the exclusive jurisdiction of any New York State  or Federal Court sitting in the City of New York, Borough of Manhattan, over any suit, action, claim, counterclaim or proceeding arising out of or relating to the Loan Documents. EACH OF THE PARTIES HERETO IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY OBJECTION WHICH IT MAY NOW OR HEREAFTER HAVE TO THE LAYING OF THE VENUE OF ANY SUCH SUIT, ACTION, CLAIM, COUNTERCLAIM OR PROCEEDING BROUGHT IN SUCH A COURT AND ANY CLAIM THAT ANY SUCH SUIT, ACTION, CLAIM, COUNTERCLAIM OR PROCEEDING BROUGHT IN SUCH A COURT HAS BEEN BROUGHT IN AN INCONVENIENT FORUM.  Each of the parties hereto agrees that a final judgment in any such suit, action, claim, counterclaim or proceeding brought in such a court, after all appropriate appeals, shall be conclusive and binding upon it.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Service of Process</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each of the parties hereto agrees that process may be served against it in any suit, action or proceeding referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> by sending the same by first class mail, return receipt requested or  by overnight courier service, with receipt acknowledged, to the address of such party set forth or referred    to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each of the parties hereto agrees that any such service (i) shall be deemed in every  respect effective service of process upon it in any such suit, action, or proceeding, and (ii) shall to the fullest extent enforceable by law, be taken and held to be valid personal service upon and personal delivery to it.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">No Limitation on Service or Suit</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Nothing in the Loan Documents or any modification, waiver, or amendment thereto shall affect the right of the Administrative Agent, any Issuer or any Lender to serve process in any manner permitted by   law or limit the right of the Administrative Agent, any Issuer or any Lender to bring proceedings against    the Borrower in the courts of any jurisdiction or jurisdictions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">WAIVER OF TRIAL BY JURY</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EACH OF THE CREDIT PARTIES AND THE BORROWER KNOWINGLY, VOLUNTARILY AND INTENTIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION ARISING OUT OF, UNDER OR IN CONNECTION WITH THE LOAN DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED THEREBY. FURTHER, THE BORROWER HEREBY CERTIFIES THAT NO REPRESENTATIVE OR AGENT OF ANY OF THE CREDIT PARTIES, OR COUNSEL TO ANY OF THE CREDIT PARTIES, HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT ANY OF THE CREDIT PARTIES WOULD NOT, IN THE EVENT OF SUCH LITIGATION, SEEK TO ENFORCE THIS WAIVER OF RIGHT TO JURY TRIAL PROVISION. THE BORROWER ACKNOWLEDGES THAT THE CREDIT PARTIES HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">INTER ALIA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, THE PROVISIONS OF THIS </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">SECTION 11.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Patriot Act Notice</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each Lender and the Administrative Agent (for itself and not on behalf of any Lender) hereby notifies the Borrower that pursuant to the requirements of the USA PATRIOT Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001), as amended from time to time) (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Patriot Act&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), it is required to obtain, verify and record information that identifies the Borrower, which information includes the name and address of the Borrower and other information that will allow such Lender or the Administrative Agent, as applicable, to identify the Borrower in accordance with the Patriot Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">No Fiduciary Duty</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower agrees that in connection with all aspects of the transactions contemplated hereby   and any communications in connection therewith, the Borrower and its Subsidiaries, on the one hand, and the Credit Parties, the Joint Lead Arrangers, the Sustainability Coordinator, and their respective Affiliates, on the other hand, will have a business relationship that does not create, by implication or otherwise, any fiduciary duty on the part of the Credit Parties, such</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Joint Lead Arrangers or the Sustainability Coordinator, or their respective Affiliates, and no such duty will be deemed to have arisen in connection with any such transactions or communications.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Acknowledgement and Consent to Bail-In of Affected Financial Institutions</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding anything to the contrary in any Loan Document or in any other agreement, arrangement or understanding among any such parties, each party hereto acknowledges that any liability of any Lender that is an Affected Financial Institution arising under any Loan Document, to the extent such liability is unsecured, may be subject to the Write-Down and Conversion Powers of the applicable Resolution Authority and agrees and consents to, and acknowledges and agrees to be bound by&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">the application of any Write-Down and Conversion Powers by the applicable Resolution Authority to any such liabilities arising hereunder which may be payable to it by any Lender that is an Affected Financial Institution&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">the effects of any Bail-In Action on any such liability, including, if applicable&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.13pt">a reduction in full or in part or cancellation of any such liability&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.08pt">a conversion of all, or a portion of, such liability into shares or other instruments of ownership in such Affected Financial Institution, its parent entity, or a   bridge institution that may be issued to it or otherwise conferred on it, and that such shares or other instruments of ownership will be accepted by it in lieu of any rights with respect    to any such liability under this Agreement or any other Loan Document&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(viii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.03pt">the variation of the terms of such liability in connection with the exercise   of the Write-Down and Conversion Powers of the applicable Resolution Authority.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.23</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Certain ERISA Matters</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Each Lender (x) represents and warrants, as of the date such Person became a Lender party hereto, to, and (y) covenants, from the date such Person became a Lender party hereto to the date such Person ceases being a Lender party hereto, for the benefit of, the Administrative Agent and the Joint Lead Arrangers and not, for the avoidance of doubt, to or for the benefit of the Borrower, that at least one of the following is and will be true&#58;</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">such Lender is not using &#8220;plan assets&#8221; (within the meaning of    Section&#160;3(42) of ERISA or otherwise) of one or more Benefit Plans with respect to such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans,   the Letters of Credit, the Commitments or this Agreement,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.58pt">the transaction exemption set forth in one or more PTEs, such as PTE 84- 14 (a class exemption for certain transactions determined by independent qualified professional asset managers), PTE 95-60 (a class exemption for certain transactions involving insurance company general accounts), PTE 90-1 (a class exemption for certain transactions involving insurance company pooled separate accounts), PTE 91-38 (a class exemption for certain transactions involving bank collective investment funds) or PTE 96- 23 (a class exemption for certain transactions determined by in-house asset managers), is applicable with respect to such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.53pt">(A) such Lender is an investment fund managed by a &#8220;Qualified Professional Asset Manager&#8221; (within the meaning of Part VI of PTE 84-14), (B) such Qualified Professional Asset Manager made the investment decision on behalf of such Lender to enter into, participate in, administer and perform the Loans, the Letters of Credit, the Commitments and this Agreement, (C) the entrance into, participation in,   administration of and performance of the Loans, the Letters of Credit, the Commitments  and this Agreement satisfies the requirements of sub-sections (b) through (g) of Part I of PTE 84-14 and (D) to the best knowledge of such Lender, the requirements of subsection  (a) of Part I of PTE 84-14 are satisfied with respect to such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement, or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.13pt">such other representation, warranty and covenant as may be agreed in writing between the Administrative Agent, in its sole discretion, and such Lender.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">In addition, unless either (1) sub-clause (i) in the immediately preceding clause (a) is true with respect to a Lender or (2) a Lender has provided another representation, warranty and covenant in accordance with sub-clause (iv) in the immediately preceding clause (a), such Lender further (x) represents and warrants, as of the date such Person became a Lender party hereto, to,   and (y) covenants, from the date such Person became a Lender party hereto to the date such Person ceases being a Lender party hereto, for the benefit of, the Administrative Agent and the Joint Lead Arrangers and not, for the avoidance of doubt, to or for the benefit of the Borrower, that the Administrative Agent is not a fiduciary with respect to the assets of such Lender involved in such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement (including in connection with the reservation or exercise of any rights by the Administrative Agent under this Agreement, any Loan Document or any documents related hereto or thereto).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">For purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.23</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the following defined terms when used herein have the following meanings&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Benefit Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means any of (a) an &#8220;employee benefit plan&#8221; (as defined in ERISA) that is subject to Title I of ERISA, (b) a &#8220;plan&#8221; as defined in Section 4975 of the Internal Revenue Code or (c) any Person whose assets include (for purposes of ERISA Section  3(42) or otherwise for purposes of Title I of ERISA or Section 4975 of the Internal Revenue Code) the assets of any such &#8220;employee benefit plan&#8221; or &#8220;plan&#8221;.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">PTE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means a prohibited transaction class exemption issued by the U.S. Department of Labor, as any such exemption may be amended from time to time.</font></div><div style="margin-bottom:60pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;Balance of this Page is Intentionally Blank&#93;</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889946v5</font></div></div></div><div id="ifeec14c7a618494cb040e343e2bc92c6_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">AS EVIDENCE </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of the agreement by the parties hereto to the terms and conditions herein contained, each such party has caused this Agreement to be executed on its behalf.</font></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Carol A. DeNale                                                </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Carol A. DeNale</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Senior Vice President and Treasurer</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FIVE YEAR CREDIT AGREEMENT </font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BANK OF AMERICA, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as the Administrative Agent</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Kyle D. Harding                                                 </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Kyle D. Harding</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Vice President</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FIVE YEAR CREDIT AGREEMENT</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BANK OF AMERICA, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as an Issuer, the           Swing Line Lender and a Lender</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Joseph L. Corah                                              </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Joseph L. Corah</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Director</font></div><div style="margin-bottom:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FIVE YEAR CREDIT AGREEMENT</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BARCLAYS BANK PLC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as an Issuer and a            Lender </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Ritam Bhalla                                                       </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Ritam Bhalla</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Director</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FIVE YEAR CREDIT AGREEMENT</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GOLDMAN SACHS BANK USA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as an Issuer             and a Lender </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; William E. Briggs IV                                            </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  William E. Briggs IV</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Authorized Signatory</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FIVE YEAR CREDIT AGREEMENT</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">JPMORGAN CHASE BANK, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as an                 Issuer and a Lender </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; James Kyle O'Donnell                                           </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   James Kyle O'Donnell</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Vice President</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FIVE YEAR CREDIT AGREEMENT</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WELLS FARGO BANK, NATIONAL  ASSOCIATION, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as an issuer and a Lender </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Darin Mullis                                                      </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Darin Mullis</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Managing Director</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FIVE YEAR CREDIT AGREEMENT</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CITIBANK, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">      &#47;s&#47; Eugene Yermash                                             </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; Eugene Yermash</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;   Vice President</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FIVE YEAR CREDIT AGREEMENT</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CREDIT SUISSE AG, NEW YORK                 BRANCH</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">      &#47;s&#47; Judith Smith                                                       </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Judith Smith</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Authorized Signatory </font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">      &#47;s&#47; Jessica Gavarkos                                                </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Jessica Gavarkos </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Authorized Signatory</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FIVE YEAR CREDIT AGREEMENT</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">MIZUHO BANK, LTD.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">      &#47;s&#47; Tracy Rahn                                                     </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Tracy Rahn</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Executive Director</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FIVE YEAR CREDIT AGREEMENT</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ROYAL BANK OF CANADA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">      &#47;s&#47; Scott MacVicar                                                </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Scott MacVicar</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Authorized Signatory</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FIVE YEAR CREDIT AGREEMENT</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TRUIST BANK</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">      &#47;s&#47; Katie Lundin                                                     </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Katie Lundin</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Director</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FIVE YEAR CREDIT AGREEMENT</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">U.S. BANK NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as                   a Lender </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">      &#47;s&#47; Joyce P. Dorsett                                              </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Joyce P. Dorsett</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Senior Vice President </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FIVE YEAR CREDIT AGREEMENT</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FIFTH THIRD BANK, NATIONAL      ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">      &#47;s&#47; Todd Robinson                                                 </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Todd Robinson</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Managing Director, SVP</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FIVE YEAR CREDIT AGREEMENT</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">MORGAN STANLEY BANK N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">      &#47;s&#47; Michael King                                                      </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Michael King</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Authorized Signatory </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FIVE YEAR CREDIT AGREEMENT</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PNC BANK, NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">                   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">      &#47;s&#47; William P. Herold                                               </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  William P. Herold</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Vice President</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FIVE YEAR CREDIT AGREEMENT</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SUMITOMO MITSUI BANKING       CORPORATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">      &#47;s&#47; Rosa Pritsch                                                     </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; Rosa Pritsch</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;   Director</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FIVE YEAR CREDIT AGREEMENT</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">THE BANK OF NEW YORK MELLON</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a        Lender </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">      &#47;s&#47; Maurice Campbell                                           </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Maurice Campbell</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Director</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FIVE YEAR CREDIT AGREEMENT</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BANK OF CHINA, NEW YORK BRANCH</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">                 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">      &#47;s&#47; Raymond Qiao                                                     </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Raymond Qiao</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Executive Vice President</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FIVE YEAR CREDIT AGREEMENT</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">INDUSTRIAL AND COMMERCIAL BANK              OF CHINA LIMITED</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NEW YORK                BRANCH</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">      &#47;s&#47; Day Liu                                                          </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Dayi Liu</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Executive Director</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">      &#47;s&#47; Lindsay Du                                                    </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Lindsay Du</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Director</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FIVE YEAR CREDIT AGREEMENT</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">KEYBANK NATIONAL ASSOCIATION,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> as                  a Lender </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">      &#47;s&#47; Marianne T. Meil                                               </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Marianne T. Meil</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Sr. Vice President</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FIVE YEAR CREDIT AGREEMENT</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TD BANK, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">      &#47;s&#47; Bernadette Collins                                             </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Bernadette Collins</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Senior Vice President</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FIVE YEAR CREDIT AGREEMENT</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>a06302022ex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i1c633f90c64445bd8f80f3682fb52fae_1"></div><div style="min-height:63pt;width:100%"><div><font><br></font></div><div style="padding-left:324pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.2</font></div><div><font><br></font></div><div style="padding-left:324pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Execution Version</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">FIRST AMENDMENT TO FIVE YEAR CREDIT AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FIRST AMENDMENT TO FIVE YEAR CREDIT AGREEMENT (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), dated as of May 16, 2022, is entered into among CVS Health Corporation, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Lenders party hereto and Bank of America, N.A., as Administrative Agent. Except as otherwise provided herein, capitalized terms used herein which are not defined herein shall have the meanings set forth in the Credit Agreement (as defined below).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, the Borrower, the Lenders and the Administrative Agent entered into that certain Five Year Credit Agreement, dated as of May 11, 2021 (as amended, amended and restated, supplemented or otherwise modified from time to time prior to the date hereof, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#59; and </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, the Borrower has requested that the Lenders amend the Credit Agreement as set forth below. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration of the covenants, conditions and agreements hereinafter set forth, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, and pursuant to Section 11.1 of the Credit Agreement, the parties hereto hereby agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Amendments to the Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Credit Agreement is hereby amended as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Credit Agreement (but not the Exhibits thereto) is hereby amended and restated in its entirety to read as set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Annex A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> attached hereto.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Exhibit A (List of Commitments), Exhibit B (Form of Note) and Exhibit   C (Form of Borrowing Request) to the Credit Agreement are hereby amended and restated in their entirety to read as set forth on the corresponding exhibits attached hereto.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Conditions Precedents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This Amendment shall become effective on and as of the date hereof (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">First Amendment Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) upon satisfaction (or waiver in accordance with Section 11.1 of the Credit Agreement) of the conditions precedent set forth in this Section 2. Upon satisfaction (or waiver in accordance with Section 11.1 of the Credit Agreement) of the conditions precedents set forth in this Section 2, the Administrative Agent shall provide the Borrower and the Lenders with written confirmation that this Amendment has become effective.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Counterparts of this Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Receipt by the Administrative Agent of counterparts of this Amendment executed by the Borrower and the Lenders.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.&#160;&#160;&#160;&#160;The Administrative Agent shall have received all fees and other amounts due and payable to it on the First Amendment Effective Date, including the upfront fees payable to the Lenders, in respect of this Amendment.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Borrower hereby represents and warrants as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">The Borrower has taken all necessary corporate action to authorize the execution, delivery and performance of this Amendment. </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889347v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.58pt">This Amendment has been duly executed and delivered by the Borrower and constitutes the valid and legally binding obligations of the Borrower, enforceable against the Borrower in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditors&#8217; rights generally and by equitable principles relating to the availability of specific performance as a remedy.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.53pt">No consent or approval of, or other action by, shareholders of the Borrower, any Governmental Authority, or any other Person (which has not already been obtained) is required to authorize in respect of the Borrower, or is required in connection with, the execution, delivery, and performance by the Borrower of this Amendment or is required as a condition to the enforceability of this Amendment against the Borrower.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">The Borrower represents and warrants to the Lenders that the representations and warranties of the Borrower set forth in Section 4 of the Credit Agreement (as amended by this Amendment) are true and correct in all material respects  on the date hereof (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any representation and warranty that is qualified as to &#8220;materiality&#8221;, &#8220;Material Adverse&#8221; or similar language is true and correct (after giving effect to any qualification therein) in all respects on the date hereof), except those which are expressly specified to be made as of an earlier date.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">New Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Lender executing and delivering this Amendment as a &#8220;New Lender&#34;</font><font style="background-color:#ffffff;color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">New Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) (i) represents and warrants that (A) it has full power and authority, and has taken all action necessary, to execute and deliver this Amendment and to consummate the transactions contemplated hereby and to become a Lender under the Credit Agreement, (B) it meets the requirements to be an Eligible Assignee under Section 11.7 of the Credit Agreement, (C) it has received a copy of the Credit Agreement, and has received or has been accorded the opportunity to receive copies of the most recent financial statements delivered pursuant to Section 7.7 thereof, as applicable, and such other documents and information as it deems appropriate to make its own credit analysis and decision to enter into this Amendment, (D) it has, independently and without reliance upon the Administrative Agent or any other Lender and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Amendment, and (E) it is not and will not be (1) an employee benefit plan subject to Title   I of ERISA, (2) a plan or account subject to Section 4975 of the Internal Revenue Code,  (3) an entity deemed to hold &#8220;plan assets&#8221; of any such plans or accounts for purposes of ERISA or the Internal Revenue Code, or (4) a &#8220;governmental plan&#8221; within the meaning of ERISA&#59; and (ii) agrees that (A) it will, independently and without reliance on the Administrative Agent or any other Lender, and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit decisions in taking or not taking action under the Loan Documents, and (B) it will perform in accordance with their terms all of the obligations which by the terms of the Loan Documents are required   to be performed by it as a Lender.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">The Borrower agrees that, as of the First Amendment Effective Date, the New Lender shall (i) be a party to the Credit Agreement and the other Loan Documents,  (ii) be a &#8220;Lender&#8221; for all purposes of the Credit Agreement and the other Loan Documents, (iii) have the rights and obligations of a Lender under the Credit Agreement and the other Loan Documents, and (iv) have a Commitment in the amount set forth adjacent to the New </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889347v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Lender&#8217;s name under the heading </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Commitment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> in Exhibit A of the Credit Agreement (as amended hereby).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The applicable address, facsimile number and electronic mail address of the New Lender for purposes of Section 11.2 of the Credit Agreement are as set forth in  the New Lender&#8217;s Administrative Questionnaire delivered by the New Lender to the Administrative Agent on or before the First Amendment Effective Date or such other address, facsimile number and electronic mail address as shall be designated by the New Lender in a written notice to the Administrative Agent.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Except as expressly amended hereby, the Credit Agreement and the other Loan Documents shall remain in full force and effect. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">On and after the First Amendment Effective Date, each reference in the Credit Agreement to &#8220;this Agreement&#8221;, &#8220;hereunder&#8221;, &#8220;hereof&#8221; or words of like import referring to the Credit Agreement, and each reference in the other Loan Documents to &#8220;the Credit Agreement&#8221;, &#8220;thereunder&#8221;, &#8220;thereof&#8221; or words of like import referring to the Credit Agreement, shall mean and be a reference to the Credit Agreement as modified hereby. This Amendment shall constitute a Loan Document.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Subject to Section 11.18 of the Credit Agreement, this Amendment may  be in the form of an Electronic Record and may be executed using Electronic Signatures (including facsimile and .pdf) and shall be considered an original, and shall have the same legal effect, validity and enforceability as a paper record.&#160; This Amendment may be executed in as many counterparts as necessary or convenient, including both paper and electronic counterparts, but all such counterparts are one and the same agreement.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">This Amendment and the rights and obligations of the parties hereto shall be governed by, and construed and interpreted in accordance with, the laws of the State of New York.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;signature pages follow&#93;</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889347v5</font></div></div></div><div id="i1c633f90c64445bd8f80f3682fb52fae_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The parties have caused this Amendment to be duly executed as of the date first written above.</font></div><div style="margin-bottom:24pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Carol A. DeNale                                     </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Carol A. DeNale</font></div><div style="margin-bottom:24pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Senior Vice President and Treasurer</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2026 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BANK OF AMERICA, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as the Administrative Agent</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Kyle D Harding                                 </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Kyle D Harding</font></div><div style="margin-bottom:24pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Vice President</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2026 Facility&#93;</font></div><div><font><br></font></div></div></div><div id="i1c633f90c64445bd8f80f3682fb52fae_10"></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div style="margin-top:24pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BANK OF AMERICA, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as an Issuer, the Swing Line Lender and a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Joseph L. Corah                               </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Joseph L. Corah</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Director</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2026 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BARCLAYS BANK PLC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as an Issuer and a Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Ritam Bhalla                               </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Ritam Bhalla</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Director</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2026 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GOLDMAN SACHS BANK USA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as an Issuer and a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; William E. Briggs IV                          </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   William E. Briggs IV</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Authorized Signatory</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2026 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">JPMORGAN CHASE BANK, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as an Issuer and a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; James Kyle O'Donnell                  </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  James Kyle O'Donnell</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Vice President</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2026 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WELLS FARGO BANK, NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as an Issuer and a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Darin Mullis                                   </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Darin Mullis</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Managing Director</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2026 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CITIBANK, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Eugene Yermash                            </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Eugene Yermash</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Vice President</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2026 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CREDIT SUISSE AG, NEW YORK BRANCH</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Judith Smith                                      </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Judith Smith</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Authorized Signatory</font></div><div style="padding-left:252pt"><font><br></font></div><div style="padding-left:252pt"><font><br></font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Jessica Gavarkos                               </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Jessica Gavarkos</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Authorized Signatory</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2026 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">MIZUHO BANK, LTD.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> as a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Tracy Rahn                                       </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Tracy Rahn </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Executive Director</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2026 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ROYAL BANK OF CANADA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Scott MacVicar                                 </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Scott MacVicar</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Authorized Signatory</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2026 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TRUIST BANK</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Katie Lundin                                    </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Katie Lundin</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Director</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2026 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">U.S. BANK NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">         &#47;s&#47; Joyce P. Dorsett                                </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;    Joyce P. Dorsett</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;      Senior Vice President</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2026 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FIFTH THIRD BANK, NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Todd Robinson                               </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Todd Robinson</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Managing Director, SVP</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2026 Facility&#93;</font></div><div><font><br></font></div></div></div><div id="i1c633f90c64445bd8f80f3682fb52fae_13"></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div style="margin-top:24pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PNC BANK, NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; William P. Herold                               </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   William P. Herold</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Vice President</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2026 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SUMITOMO MITSUI BANKING CORPORATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Rosa Pritsch                                          </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Rosa Pritsch</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Director</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2026 Facility&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">THE BANK OF NEW YORK MELLON</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Maurice Campbell                              </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Maurice Campbell</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Director</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2026 Facility&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BANK OF CHINA, NEW YORK BRANCH</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Raymond Qiao                                    </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Raymond Qiao</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Executive Vice President</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2026 Facility&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">INDUSTRIAL AND COMMERCIAL BANK OF CHINA LIMITED, NEW YORK BRANCH</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Dayi Liu                                                </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Dayi Liu</font></div><div style="margin-bottom:9pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Executive Director</font></div><div style="padding-left:252pt"><font><br></font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Lindsay Du                                            </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Lindsay Du</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Director</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2026 Facility&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">KEYBANK NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Marianne T. Meil                                </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Marianne T. Meil</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Sr. Vice President</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2026 Facility&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TD BANK, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Bernadette Collins                             </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Bernadette Collins</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Senior Vice President</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2026 Facility&#93;</font></div></div></div><div id="i1c633f90c64445bd8f80f3682fb52fae_16"></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div style="margin-top:24pt;text-align:right"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:247.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:217.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NEW LENDER&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">MORGAN STANLEY BANK, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a New</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Lender</font></td></tr></table></div><div style="margin-top:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Michael King                                      </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Michael King</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Authorized Signatory</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2026 Facility&#93;</font></div><div><font><br></font></div></div></div><div id="i1c633f90c64445bd8f80f3682fb52fae_19"></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div style="margin-top:24pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">ANNEX A</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Amended Credit Agreement</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">See attached.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889347v5</font></div></div></div><div id="i1c633f90c64445bd8f80f3682fb52fae_219"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Deal CUSIP&#58; 23242UAV5</font></div><div style="padding-left:36pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Facility CUSIP&#58; 23242UAW3</font></div><div style="margin-bottom:6pt;margin-top:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FIVE YEAR CREDIT AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">by and among</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CVS HEALTH CORPORATION,</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">THE LENDERS PARTY HERETO,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BARCLAYS BANK PLC and JPMORGAN CHASE BANK, N.A.,</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">as Co-Syndication Agents,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GOLDMAN SACHS BANK USA and</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WELLS FARGO BANK, NATIONAL ASSOCIATION,</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">as Co-Documentation Agents,</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">and</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BANK OF AMERICA, N.A.,</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">as Administrative Agent</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">______________________________</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Dated as of May 11, 2021</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">______________________________</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BOFA SECURITIES, INC.,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BARCLAYS BANK PLC, GOLDMAN SACHS BANK USA,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">JPMORGAN CHASE BANK, N.A.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">and</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WELLS FARGO SECURITIES, LLC,</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">as Joint Lead Arrangers and Joint Bookrunners</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:48pt;text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1896389v2</font></div></div></div><div id="i1c633f90c64445bd8f80f3682fb52fae_231"></div><hr style="page-break-after:always"><div style="min-height:57.02pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TABLE OF CONTENTS</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:465.00pt"><tr><td style="width:1.0pt"></td><td style="width:22.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:31.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:366.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:37.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">DEFINITIONS AND PRINCIPLES OF CONSTRUCTION...............................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Definitions.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Principles of Construction.........................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">22</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AMOUNT AND TERMS OF LOANS.................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Revolving Credit Loans............................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Swing Line Loans.....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notice of Borrowing Revolving Credit Loans and Swing Line Loans.....................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Competitive Bid Loans and Procedure.....................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Use of Proceeds.........................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">28</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Termination, Reduction or Increase of Commitments..............................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">28</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Prepayments of Loans...............................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">30</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Letter of Credit Sub-facility......................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">31</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Letter of Credit Participation....................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">32</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Absolute Obligation with respect to Letter of Credit Payments...............................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">33</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notes..........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">33</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Extension of Commitment Termination Date...........................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">33</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.13</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Defaulting Lenders....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">35</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">PROCEEDS, PAYMENTS, CONVERSIONS, INTEREST, YIELD PROTECTION</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AND FEES.............................................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">38</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Disbursement of the Proceeds of the Loans..............................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">38</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Payments...................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">38</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Conversions&#59; Other Matters......................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">39</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Interest Rates and Payment Dates.............................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">41</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Indemnification for Loss...........................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">42</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Reimbursement for Costs, Etc..................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">43</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Illegality of Funding.................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">44</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Option to Fund&#59; Substituted Interest Rate.................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">44</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Certificates of Payment and Reimbursement............................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">47</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Taxes&#59; Net Payments................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">47</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Facility Fees..............................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">50</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Letter of Credit Participation Fee..............................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">51</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.13</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Replacement of Lender.............................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">51</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">REPRESENTATIONS AND WARRANTIES.....................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">52</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Existence and Power.................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">52</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Authority&#59; Affected Financial Institution..................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">52</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Binding Agreement...................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">52</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Litigation...................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">53</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No Conflicting Agreements......................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">53</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">53</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">53</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Governmental Regulations........................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">53</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Federal Reserve Regulations&#59; Use of Proceeds.........................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">53</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No Misrepresentation................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">54</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">54</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;..................................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">54</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.13</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Financial Statements.................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">54</font></td></tr></table></div><div style="height:61.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">i</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1896389v2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.02pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:465.00pt"><tr><td style="width:1.0pt"></td><td style="width:22.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:31.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:366.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:37.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.14</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.37pt;padding-right:1.37pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Anti-Corruption Laws and Sanctions........................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">54</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CONDITIONS TO EFFECTIVENESS................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">55</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Agreement.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">55</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notes.........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">55</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Corporate Action.......................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">55</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Opinion of Counsel to the Borrower.........................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">55</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Termination of Existing 2017 Credit Agreement.....................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">55</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No Default and Representations and Warranties......................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">56</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Fees...........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">56</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Due Diligence&#59; &#8220;Know Your Customer&#8221;..................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">56</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CONDITIONS OF LENDING - ALL LOANS AND LETTERS OF CREDIT..................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">56</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Compliance...............................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">56</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Requests....................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">57</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AFFIRMATIVE COVENANTS..........................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">57</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Legal Existence.........................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">57</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Taxes.........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">57</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">57</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">57</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">57</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Observance of Legal Requirements..........................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">57</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Financial Statements and Other Information............................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">58</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Records.....................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">59</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NEGATIVE COVENANTS.....................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">59</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">59</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Liens..........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">59</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Dispositions...............................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">60</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Merger or Consolidation, Etc....................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">60</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">61</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">61</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Limitation on Upstream Dividends by Subsidiaries..................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">61</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">62</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ratio of Consolidated Indebtedness to Total Capitalization.....................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">62</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">DEFAULT............................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">62</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Events of Default......................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">62</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Remedies...................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">64</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AGENT.................................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">65</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Appointment and Authority......................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">65</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Rights as a Lender.....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">65</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exculpatory Provisions.............................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">65</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Reliance by Administrative Agent............................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">66</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Delegation of Duties.................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">67</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Resignation of Administrative Agent.......................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">67</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Non-Reliance on Administrative Agent and Other Credit Parties............................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">68</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No Other Duties, Etc.................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">68</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Recovery of Erroneous Payments.............................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">68</font></td></tr></table></div><div style="height:61.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ii</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1896389v2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.02pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:465.00pt"><tr><td style="width:1.0pt"></td><td style="width:22.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:31.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:366.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:37.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">OTHER PROVISIONS.........................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">69</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Amendments, Waivers, Etc.......................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">69</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notices......................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">70</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No Waiver&#59; Cumulative Remedies................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">73</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Survival of Representations and Warranties..................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">73</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Payment of Expenses&#59; Indemnified Liabilities..............................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">73</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Lending Offices........................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">75</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Successors and Assigns..................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">75</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Counterparts&#59; Electronic Execution...............................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">80</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Set-off and Sharing of Payments..............................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">81</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Indemnity           .......................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">82</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Governing Law  .......................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">84</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Severability        .......................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">85</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.13</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Integration          .......................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">85</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.14</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Treatment of Certain Information.............................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">85</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.15</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Acknowledgments.....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">86</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.16</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Consent to Jurisdiction..............................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">86</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.17</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Service of Process.....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">86</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.18</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No Limitation on Service or Suit..............................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">86</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.19</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WAIVER OF TRIAL BY JURY..............................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">87</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.20</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Patriot Act Notice.....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">87</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.21</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No Fiduciary Duty....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">87</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.22</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Acknowledgement and Consent to Bail-In of Affected Financial</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Institutions     .............................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">87</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.23</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Certain ERISA Matters..............................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">88</font></td></tr></table></div><div><font><br></font></div><div style="height:61.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">iii</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1896389v2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.02pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EXHIBITS</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:344.25pt"><tr><td style="width:1.0pt"></td><td style="width:61.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:279.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit A</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">List of Commitments</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit B</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Note</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit C</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Borrowing Request</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit D-1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Opinion of Counsel to the Borrower</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit D-2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Opinion of Special Counsel to the Borrower</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit E</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Assignment and Assumption</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit F</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Competitive Bid Request</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit G</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Invitation to Bid</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit H</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Competitive Bid</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit I</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Competitive Bid Accept&#47;Reject Letter</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit J</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Letter of Credit Request</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit K</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Commitment Increase Supplement</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="height:61.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">iv</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1896389v2</font></div><div><font><br></font></div></div></div><div id="i1c633f90c64445bd8f80f3682fb52fae_241"></div><hr style="page-break-after:always"><div style="min-height:63.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FIVE YEAR CREDIT AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, dated as of May 11, 2021, by and among </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">CVS HEALTH CORPORATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, a Delaware corporation (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Borrower&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), the lenders party hereto from time to time (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and, collectively, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Lenders&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">BARCLAYS BANK PLC </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Barclays&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">JPMORGAN CHASE BANK, N.A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;JPMC&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), as co-syndication agents (in such capacity, each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Co-Syndication Agent&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and, collectively, the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Co-Syndication Agents&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">GOLDMAN SACHS BANK USA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">GS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">WELLS FARGO BANK, NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Wells Fargo&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as codocumentation agents (in such capacity, each a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Co-Documentation Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and, collectively, the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Co-Documentation Agents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">BANK OF AMERICA, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as administrative agent for the Lenders (in  such capacity, together with its successors and assigns, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">DEFINITIONS AND PRINCIPLES OF CONSTRUCTION</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Definitions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">When used in any Loan Document (as defined below), each of the following terms shall have the meaning ascribed thereto unless the context otherwise specifically requires&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;ABR Advances&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Revolving Credit Loans (or any portions thereof) at such time as they (or  such portions) are made or are being maintained at a rate of interest based upon the Alternate Base Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Acquisition Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58;  any Indebtedness incurred by the Borrower or any of its Subsidiaries for the purpose of financing, in whole or in part, a Material Acquisition and any related transactions or series of related transactions (including for the purpose of refinancing or replacing all or a portion of any pre-existing Indebtedness of the Person(s) or assets to be acquired), which Indebtedness is redeemable or prepayable if such Material Acquisition is not consummated.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Accumulated Funding Deficiency&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in Section 304 of ERISA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Administrative Agent&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Administrative Agent&#8217;s Office</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the Administrative Agent&#8217;s address and, as appropriate, account   as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, or such other address or account as the Administrative Agent may from time to time notify to the Borrower and the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Administrative Questionnaire&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; an Administrative Questionnaire in a form supplied by the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Advances&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ABR Advances or Term SOFR Advances.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Affected Financial Institution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (a) any EEA Financial Institution or (b) any UK Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Affiliate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any Person at any time and from time to time, any other Person (other than a wholly-owned subsidiary of such Person) which, at such time (a) controls such Person, (b) is controlled by such Person or (c) is under common control with such Person. The term </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as used     in this definition with respect to any Person, means the power, whether direct or indirect through one or  more intermediaries, to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities or other interests, by contract or otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Agent Parties&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1896389v2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Aggregate Commitment Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time, the sum of the Commitment Amounts of the Lenders at such time under this Agreement. The Aggregate Commitment Amount on the First Amendment Effective Date is $2,000,000,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Aggregate Credit Exposure&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time, the sum of (a) the aggregate Committed Credit  Exposure of the Lenders at such time and (b) the aggregate outstanding principal balance of all Competitive Bid Loans at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Aggregate Letter of Credit Commitment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">at any time, the sum of the Letter of Credit Commitments of the Issuers at such time. The Aggregate Letter of Credit Commitment on the First Amendment Effective Date is $250,000,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; this Five Year Credit Agreement, as the same may be amended, amended and restated, supplemented or otherwise modified from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Alternate Base Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; for any day, a fluctuating rate per annum equal to the highest of (a) the Federal Funds Effective Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 1&#47;2 of 1%, (b) the rate of interest in effect for such day as publicly announced from time to time by BofA as its &#8220;prime rate&#8221;, and (c) the One Month SOFR Rate in effect on such day </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 1.00%.  The &#8220;prime rate&#8221; is a rate set by BofA based upon various factors including BofA&#8217;s costs and desired return, general economic conditions and other factors, and is used as a reference point for pricing some loans, which may be priced at, above, or below such announced rate.  Any change in such prime rate announced by BofA shall take effect at the opening of business on the day specified in the public announcement of such change. If the Alternate Base Rate is being used as an alternate rate of interest pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> hereof, then the Alternate Base Rate shall be the greater of clauses (a) and (b) above and shall be determined without reference to clause (c) above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Anti-Corruption Laws&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; all laws, rules, and regulations of any jurisdiction applicable to the Borrower or the Subsidiaries from time to time concerning or relating to bribery or corruption.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Applicable Margin&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (i) with respect to the unpaid principal balance of ABR Advances, the applicable percentage set forth below in the column entitled &#8220;ABR Advances&#8221;, (ii)&#160;with respect to the   unpaid principal balance of Term SOFR Advances and Swing Line Loans bearing interest at the Term   SOFR Daily Floating Rate, the applicable percentage set forth below in the column entitled &#8220;Term SOFR Advances&#47;Swing Line Loans&#8221;, (iii) with respect to the Facility Fee, the applicable percentage set forth   below in the column entitled &#8220;Facility Fee&#8221;, (iv) with respect to the Letter of Credit Participation Fee  payable in respect of standby Letters of Credit, the applicable percentage set forth below in the column entitled &#8220;Participation Fee - Standby&#8221;, and (v) with respect to the Letter of Credit Participation Fee payable in respect of commercial Letters of Credit, the applicable percentage set forth below in the column entitled &#8220;Participation Fee - Commercial&#8221;, in each case opposite the applicable Pricing Level&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.305%"><tr><td style="width:1.0%"></td><td style="width:17.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.050%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Pricing Level</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ABR Advances</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Term SOFR Advances&#47; Swing Line Loans</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Facility Fee</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Participation Fee - Standby</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Participation Fee &#8211; Commercial</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pricing Level I</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.000%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.700%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.050%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.700%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.3500%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pricing Level II</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.000%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.815%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.060%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.815%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.4075%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pricing Level III</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.000%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.920%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.080%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.920%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.4600%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pricing Level IV</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.025%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.025%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.100%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.025%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.5125%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pricing Level V</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.125%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.125%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.125%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.125%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.5625%</font></td></tr></table></div><div><font><br></font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63.36pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.305%"><tr><td style="width:1.0%"></td><td style="width:17.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.890%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pricing Level VI</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.275%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.275%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.225%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.275%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.6375%</font></td></tr></table></div><div style="margin-bottom:12pt;margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Decreases in the Applicable Margin resulting from a change in Pricing Level shall become effective upon  the delivery by the Borrower to the Administrative Agent of notice upon the Borrower becoming aware of any change in the applicability of a Pricing Level.  Increases in the Applicable Margin resulting from a change in Pricing Level shall become effective on the effective date of any downgrade or withdrawal in the rating by Moody&#8217;s or S&#38;P of the senior unsecured long term debt rating of the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Approved Fund&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any Person (other than a natural person) that is (or will be) engaged in making, purchasing, holding or otherwise investing in commercial loans and similar extensions of credit in the ordinary course of its business that is administered or managed by (a) a Lender, (b) an Affiliate of a Lender or (c) an entity or an Affiliate of an entity that administers or manages a Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Assignment and Assumption&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; an assignment and assumption entered into by a Lender and an assignee (with the consent of any party whose consent is required by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;11.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), and accepted by the Administrative Agent, substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit&#160;E</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or any other form (including electronic documentation generated by use of an electronic platform) approved by the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Authorized Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; (a) the chief executive officer, president, chief financial officer, treasurer, assistant treasurer or controller of the Borrower, (b) solely for purposes of the delivery of incumbency certificates pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the secretary or any assistant secretary of the Borrower, and (c) solely  for purposes of notices given pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, any other officer or employee of the  Borrower so designated by any of the foregoing officers in a notice to the Administrative Agent. Any document delivered hereunder that is signed by an Authorized Officer shall be conclusively presumed to have been authorized by all necessary corporate and&#47;or other action on the part of the Borrower and such Authorized Officer shall be conclusively presumed to have acted on behalf of the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Bail-In Action&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the exercise of any Write-Down and Conversion Powers by the applicable Resolution Authority in respect of any liability of an Affected Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Bail-In Legislation&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (a) with respect to any EEA Member Country implementing Article 55 of Directive 2014&#47;59&#47;EU of the European Parliament and of the Council of the European Union, the implementing law, rule, regulation or requirement for such EEA Member Country from time to time which  is described in the EU Bail-In Legislation Schedule, and (b) with respect to the United Kingdom, Part I of  the United Kingdom Banking Act 2009 (as amended from time to time) and any other law, regulation or   rule applicable in the United Kingdom relating to the resolution of unsound or failing banks, investment firms or other financial institutions or their affiliates (other than through liquidation, administration or other insolvency proceedings).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Barclays&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;BAS&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; BofA Securities, Inc.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Beneficial Ownership Certification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58;  a certification regarding beneficial ownership required by the Beneficial Ownership Regulation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Beneficial Ownership Regulation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58;  31 C.F.R. &#167; 1010.230.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Benefit Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.23(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;BofA&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; means Bank of America, N.A. and its successors.</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Borrower&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Borrower Materials&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Borrowing Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (i) in respect of Revolving Credit Loans, any Domestic Business Day on which the Lenders shall make Revolving Credit Loans pursuant to a Borrowing Request or pursuant to a  Mandatory Borrowing, (ii) in respect of Competitive Bid Loans, any Domestic Business Day on which a Lender shall make a Competitive Bid Loan pursuant to a Competitive Bid Request, (iii) in respect of Swing Line Loans, any Domestic Business Day on which the Swing Line Lender shall make a Swing Line Loan pursuant to a Borrowing Request and (iv) in respect of Letters of Credit, any Domestic Business Day on which an Issuer shall issue a Letter of Credit pursuant to a Letter of Credit Request.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Borrowing Request&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a request for Revolving Credit Loans or Swing Line Loans substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or such other form as may be approved by the Administrative Agent, including any form on an electronic platform or electronic transmission system as shall be approved by the Administrative Agent, appropriately completed and signed by an Authorized Officer of the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Change of Control&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any of the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:24.69pt">any Person or group (as such term is used in Section 13(d)(3) of the Securities Exchange Act of 1934, as amended), (a) shall have or acquire beneficial ownership of securities having 35% or more of the ordinary voting power of the Borrower or (b) shall possess, directly or indirectly, the power to direct or cause the direction of the management and policies of the  Borrower, whether through the ownership of voting securities, by contract or otherwise&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.36pt">the Continuing Directors shall cease for any reason to constitute a majority of the board of directors of the Borrower then in office.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;CME&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; CME Group Benchmark Administration Limited.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Co-Documentation Agent&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Co-Documentation Agents&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Co-Syndication Agent&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Co-Syndication Agents&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commercial Letter of Credit Commitment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time with respect to any Issuer, the commitment of such Issuer to issue commercial Letters of Credit in accordance with the terms hereof in an aggregate outstanding face amount not exceeding the lesser of (a) the amount set forth adjacent to such Issuer&#8217;s name under the heading &#8220;Commercial Letter of Credit Commitment&#8221; in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> at such time or,   if not listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the &#8220;Commercial Letter of Credit Commitment&#8221; which such Issuer shall have assumed from another Issuer in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> on or prior to such time, as the same may be adjusted from time to time pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, or (b) 7.5% of the Aggregate Commitment Amount as in effect at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commercial Letter of Credit Exposure&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time in respect of any Issuer, an amount equal to such Issuer&#8217;s Letter of Credit Exposure in respect of commercial Letters of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commitment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; in respect of any Lender, such Lender&#8217;s undertaking to make Revolving Credit Loans, subject to the terms and conditions hereof, in an aggregate outstanding principal amount not to  exceed the Commitment Amount of such Lender.</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commitment Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time and with respect to any Lender, the amount set forth adjacent to such Lender&#8217;s name under the heading </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Commitment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> at such time or, in the event that such Lender is not listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Commitment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> which such Lender shall have assumed from another Lender in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> on or prior to such time, as the same may     be adjusted from time to time pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commitment Increase Supplement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a Commitment Increase Supplement substantially in the  form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit K</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commitment Percentage&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time and with respect to any Lender, a fraction (expressed as a percentage carried out to the ninth decimal place) the numerator of which is such Lender&#8217;s Commitment Amount at such time, and the denominator of which is the Aggregate Commitment Amount at such time&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that in the event the Commitments shall have expired or otherwise terminated or been terminated, then Commitment Percentage shall be determined immediately prior thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commitment Period&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the period commencing on the Effective Date and ending on the Commitment Termination Date or on such earlier date as all of the Commitments shall have been terminated in accordance with the terms hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commitment Termination Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the earlier of (i) May 11, 2026 (subject to extension as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) and (ii) the date on which the Loans shall become due and payable in accordance with the terms hereof, whether by acceleration, notice of intention to prepay or otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Committed Credit Exposure&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any Lender at any time, the sum at such time of (a) the outstanding principal balance of such Lender&#8217;s Revolving Credit Loans, (b) the Swing Line Exposure    of such Lender and (c) the Letter of Credit Exposure of such Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Communication&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.8(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Compensatory Interest Payment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.4(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Competitive Bid&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; an offer by a Lender, substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit H</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to make one or  more Competitive Bid Loans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Competitive Bid Accept&#47;Reject Letter&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a notification made by the Borrower pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Competitive Bid Loan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Competitive Bid Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as to any Competitive Bid made by a Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,  the fixed rate of interest (which shall be expressed in the form of a decimal to no more than four decimal places) offered by such Lender with respect thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Competitive Bid Request&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a request by the Borrower, substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit F</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, for Competitive Bids.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Competitive Interest Period&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as to any Competitive Bid Loan, the period commencing on the   date of such Competitive Bid Loan and ending on the date requested in the Competitive Bid Request with respect thereto, which shall not be earlier than 3 days after the date of such Competitive Bid Loan or later than 180 days after the date of such Competitive Bid Loan&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that if any Competitive Interest Period would end on a day other than a Domestic Business Day, such Competitive Interest Period shall be extended </font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to the next succeeding Domestic Business Day, unless such next succeeding Domestic Business Day would be a date on or after the Commitment Termination Date, in which case such Competitive Interest Period  shall end on the next preceding Domestic Business Day. Interest shall accrue from and including the first  day of a Competitive Interest Period to but excluding the last day of such Competitive Interest Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Conforming Changes&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to the use, administration of or any conventions associated with SOFR or any proposed Successor Rate or Term SOFR, as applicable, any conforming changes to the definitions of &#8220;Alternate Base Rate&#8221;, &#8220;SOFR&#8221;, &#8220;Term SOFR&#8221;, &#8220;Term SOFR Daily Floating Rate&#8221;, &#8220;One Month SOFR Rate&#8221; and &#8220;Term SOFR Interest Period&#8221;, the timing and frequency of determining rates and making payments of interest and other technical, administrative or operational matters (including, for the avoidance of doubt, the definitions of &#8220;Domestic Business Day&#8221; and &#8220;U.S. Government Securities Business Day&#8221;, timing of borrowing requests or prepayment, conversion or continuation notices and length of lookback periods) as may be appropriate, in the discretion of the Administrative Agent, in consultation with the Borrower, to reflect the adoption and implementation of such applicable rate(s) and to permit the administration thereof by the Administrative Agent in a manner substantially consistent with market   practice (or, if the Administrative Agent, in consultation with the Borrower, determines that adoption of    any portion of such market practice is not administratively feasible or that no market practice for the administration of such rate exists, in such other manner of administration as the Administrative Agent, in consultation with the Borrower, determines is reasonably necessary in connection with the administration    of this Agreement and any other Loan Document).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Consolidated&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Borrower and the Subsidiaries on a consolidated basis in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Contingent Obligation&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as to any Person (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">secondary obligor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), any obligation of such secondary obligor (a) guaranteeing or in effect guaranteeing any return on any investment made by another Person, or (b) guaranteeing or in effect guaranteeing any Indebtedness, lease, dividend or other obligation (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">primary obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) of any other Person (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">primary obligor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) in any manner, whether directly or indirectly, including any obligation of such secondary obligor, whether or not contingent, (i) to purchase   any such primary obligation or any Property constituting direct or indirect security therefor, (ii) to advance  or supply funds (A) for the purchase or payment of any such primary obligation or (B) to maintain working capital or equity capital of the primary obligor or otherwise to maintain the net worth or solvency of the primary obligor, (iii) to purchase Property, securities or services primarily for the purpose of assuring the beneficiary of any such primary obligation of the ability of the primary obligor to make payment of such primary obligation, (iv) otherwise to assure or hold harmless the beneficiary of such primary obligation against loss in respect thereof, and (v) in respect of the Indebtedness of any partnership in which such secondary obligor is a general partner, except to the extent that such Indebtedness of such partnership is nonrecourse to such secondary obligor and its separate Property&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that the term </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Contingent Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall not include the indorsement of instruments for deposit or collection in the ordinary course of business.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Continuing Director&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any member of the board of directors of the Borrower (i) who is a member of that board of directors on the First Amendment Effective Date, (ii) who was nominated for election by  the board of directors a majority of whom were directors on the First Amendment Effective Date, or (iii) whose election or nomination for election was approved by one or more of such directors.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Control Person&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Convert&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Conversion&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Converted&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; each, a reference to a conversion pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> of one Type of Revolving Credit Loan into the other Type of Revolving Credit Loan.</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Costs&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Credit Exposure&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any Lender at any time, the sum of (a) the Committed Credit Exposure of such Lender at such time and (b) the outstanding principal balance of all Competitive Bid  Loans of such Lender at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Credit Parties&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Administrative Agent, the Swing Line Lender, the Issuers and the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Daily Simple SOFR&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any applicable determination date, SOFR published on such date on the Federal Reserve Bank of New York&#8217;s website (or any successor source).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Default&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any of the events specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, whether or not any requirement for the giving of notice, the lapse of time, or both, or any other condition, has been satisfied.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Defaulting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any Lender, as reasonably determined by the Administrative Agent, that has (a) failed to fund any portion of its Loans or participations in Letters of Credit or Swing Line Loans within two Domestic Business Days of the date required to be funded by it hereunder, unless such Lender notifies the Administrative Agent and the Borrower in writing that such failure is the result of such Lender&#8217;s determination that one or more conditions precedent to funding (each of which conditions precedent,  together with any applicable default, shall be specifically identified in such writing) has not been satisfied, (b) notified the Borrower or any Credit Party in writing that it does not intend to comply with any of its funding obligations under this Agreement or has made a public statement to the effect that it does not intend to comply with its funding obligations under this Agreement or generally under other agreements in which   it commits to extend credit, unless such writing or public statement relates to such Lender&#8217;s obligation to fund a Loan hereunder and states that such position is based on such Lender&#8217;s determination that a condition precedent to funding (which condition precedent, together with any applicable default, shall be specifically identified in such writing or public statement) cannot be satisfied, (c) failed, two Domestic Business Days after written request by the Administrative Agent (based on the reasonable belief that it may not fulfill its funding obligation), to confirm that it will comply with the terms of this Agreement relating to its  obligations to fund prospective Loans and participations in then outstanding Letters of Credit and Swing  Line Loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such Lender shall cease to be a Defaulting Lender under this clause (c) upon receipt by the Administrative Agent of such confirmation, (d) otherwise failed to pay over to the Administrative Agent or any other Lender any other amount required to be paid by it hereunder within two Domestic Business Days of the date when due, unless the subject of a good faith dispute, or (e) (i) becomes or is insolvent or has a parent company that has become or is insolvent, (ii) becomes the subject of a bankruptcy or insolvency proceeding, or has had a receiver, interim receiver, receiver and manager, administrator, liquidator, conservator, trustee or custodian appointed for it, or has taken any action in furtherance of, or indicating its consent to, approval of or acquiescence in any such proceeding or appointment or has a parent company that has become the subject of a bankruptcy or insolvency proceeding, or has had a receiver, interim receiver, receiver and manager, administrator, liquidator, conservator, trustee  or custodian appointed for it, or has taken any action in furtherance of, or indicating its consent to, approval of or acquiescence in any such proceeding or appointment, or (iii) becomes, or has a parent company that becomes, the subject of a Bail-in Action&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that a Lender shall not qualify as a Defaulting Lender solely as a result of the acquisition or maintenance of an ownership interest in such Lender or its parent company, or of the exercise of control over such Lender or any Person controlling such Lender, by a Governmental Authority or instrumentality thereof so long as such ownership interest does not result in or provide such Lender with immunity from the jurisdiction of courts within the United States of America or from the enforcement of judgments or writs of attachment on its assets or permit such Lender (or such Governmental Authority) to reject, repudiate, disavow or disaffirm any agreements made by such Lender.</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Disposition&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any Person, any sale, assignment, transfer or other disposition by  such Person by any means, of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.7pt">the stock of, or other equity interests of, any other Person,</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.02pt">any business, operating entity, division or segment thereof, or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.7pt">any other Property of such Person, other than (i) the sale of inventory (other than    in connection with bulk transfers), (ii) the disposition of equipment and (iii) the sale of cash investments.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Disqualified Institutions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; those Persons that are (a) competitors of the Borrower or its Subsidiaries, identified in writing by the Borrower to the Administrative Agent and the Lenders from time   to time (by posting such notice to the Platform) not less than one (1) Domestic Business Day prior to the  date of determination (it being understood that, notwithstanding anything herein to the contrary, in no event shall a supplement apply retroactively to disqualify any Person that has previously acquired an assignment  or participation interest hereunder that is otherwise an Eligible Assignee, but upon the effectiveness of such designation, any such Person may not acquire any additional Commitments, Advances or participations),   (b) such other Persons identified in writing by the Borrower to the Administrative Agent prior to the First Amendment Effective Date and (c) Affiliates of the Persons identified pursuant to clause (a) or (b) that are either clearly identifiable by name or identified in writing by the Borrower to the Administrative Agent&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that &#8220;Disqualified Institutions&#8221; shall exclude any Person that the Borrower has designated as no longer being a &#8220;Disqualified Institution&#8221; by written notice delivered to the Administrative Agent and the Lenders from   time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Dividend Restrictions&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Dollar&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;$&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; lawful currency of the United States of America.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Domestic Business Day&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any day other than a Saturday, Sunday or a day which in New York   City is a legal holiday or a day on which banking institutions are authorized or required by law or other governmental action to close.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;EEA Financial Institution&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (a) any credit institution or investment firm established in any EEA Member Country which is subject to the supervision of an EEA Resolution Authority, (b) any entity established in an EEA Member Country which is a parent of an institution described in clause (a) of this definition, or (c) any financial institution established in an EEA Member Country which is a subsidiary of   an institution described in clause (a) or (b) of this definition and is subject to consolidated supervision with its parent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;EEA Member Country&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any of the member states of the European Union, Iceland, Liechtenstein, and Norway.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;EEA Resolution Authority&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any public administrative authority or any person entrusted with public administrative authority of any EEA Member Country (including any delegee) having responsibility for the resolution of any EEA Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Effective Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Electronic Copy&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.8(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Electronic Record&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.8(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Electronic Signature&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.8(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Eligible Assignee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a Person that is a permitted assignee under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that has received  the consent of each party whose consent is required under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  For the avoidance of doubt, any Disqualified Institution is subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Employee Benefit Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; an employee benefit plan, within the meaning of Section&#160;3(3) of ERISA, maintained, sponsored or contributed to by the Borrower, any Subsidiary or any ERISA Affiliate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Environmental Laws&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; all laws, rules, regulations, codes, ordinances, orders, decrees, judgments, injunctions, notices or binding agreements issued, promulgated or entered into by any Governmental Authority, relating in any way to the environment, preservation or reclamation of natural resources, the management, release or threatened release of any Hazardous Material or, as such relate to exposure to Hazardous Materials, to health and safety matters.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Environmental Liability&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as to any Person, any statutory, common law or equitable liability, contingent or otherwise (including any liability for damages, costs of environmental investigation, sampling or remediation, fines, penalties or indemnities), of such Person directly or indirectly resulting from or based upon (i) violation of any Environmental Law, (ii) the generation, use, handling, transportation, storage, treatment, discharge or disposal of any Hazardous Materials, (iii) exposure to any Hazardous Materials, (iv) the release or threatened release of any Hazardous Materials into the environment or (v) any contract, agreement or other consensual arrangement pursuant to which liability is assumed or imposed with respect  to any of the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Equity Interests</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; shares of capital stock, partnership interests, membership interests, beneficial interests or other ownership interests, whether voting or nonvoting, in, or interests in the income or profits  of, a Person, and any warrants, options or other rights entitling the holder thereof to purchase or acquire    any of the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;ERISA&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Employee Retirement Income Security Act of 1974, as amended from time to time,   or any successor thereto, and the rules and regulations issued thereunder, as from time to time in effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;ERISA Affiliate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; when used with respect to an Employee Benefit Plan, ERISA, the PBGC or a provision of the Internal Revenue Code pertaining to employee benefit plans, any Person that is a member   of any group of organizations within the meaning of Sections 414(b) or (c) of the Internal Revenue Code    or, solely with respect to the applicable provisions of the Internal Revenue Code, Section 414(m) or (o) of the Internal Revenue Code, of which the Borrower or any Subsidiary is a member.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">ERISA Event&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (a) any &#8220;reportable event&#8221;, as defined in Section&#160;4043 of ERISA with respect to     a Pension Plan (other than an event for which the 30-day notice period is waived)&#59; (b) the determination    that any Pension Plan is considered an at-risk plan or a plan in endangered or critical status within the meaning of Sections&#160;430, 431 or 432 of the Internal Revenue Code or Sections&#160;303, 304 or 305 of ERISA&#59; (c) the filing pursuant to the Internal Revenue Code or ERISA of an application for a waiver of the minimum funding standard with respect to any Pension Plan&#59; (d) the incurrence by the Borrower, any Subsidiary or    an ERISA Affiliate of any liability under Title IV of ERISA with respect to the termination of any Pension Plan, other than for PBGC premiums due but not delinquent under Section 4007 of ERISA, upon the Borrower, any Subsidiary or an ERISA Affiliate&#59; (e) the receipt by the Borrower, any Subsidiary or an ERISA Affiliate from the PBGC or a plan administrator of any notice relating to an intention to terminate any Pension Plan or to appoint a trustee to administer any Pension Plan&#59; (f) the incurrence by the Borrower, </font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any Subsidiary or an ERISA Affiliate of any liability with respect to the withdrawal or partial withdrawal from any Pension Plan or Multiemployer Plan&#59; (g) any limits under Section 436 of the Internal Revenue Code become applicable&#59; or (h) any failure to make any payment required by Section 430(j) of the Internal Revenue Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;ESG&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.14(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;ESG Amendment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.14(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;ESG Applicable Margin Adjustments&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.14(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;ESG Pricing Provisions&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.14(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;EU Bail-In Legislation Schedule&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the EU Bail-In Legislation Schedule published by the Loan Market Association (or any successor person), as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Event of Default&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any of the events specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any requirement for   the giving of notice, the lapse of time, or both, or any other condition has been satisfied.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Excluded Taxes&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to the Administrative Agent, any Lender, any Issuer or any other recipient of any payment to be made by or on account of any obligation of the Borrower hereunder or any other Loan Document, (a)&#160;Taxes imposed on or measured by its net income (however denominated) or overall gross receipts, and franchise Taxes, in each case, (i) imposed on it by the jurisdiction (or any political subdivision thereof) under the laws of which it is organized or in which its principal office is located or, in the case of any Lender, in which its applicable lending office is located, or (ii) that are Other Connection Taxes, (b)&#160;any branch profits Taxes imposed by the United States of America or that are Other Connection Taxes, (c)&#160;in the case of a Lender, any withholding Tax that  is imposed on amounts payable to such Lender at the time such Lender becomes a party hereto (other than an assignee pursuant to a request by the Borrower under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) or designates a new lending office, except, in each case, to the extent that such Lender (or its assignor, if any) was entitled, at the time of designation of a new lending office (or assignment), to receive additional amounts from the Borrower with respect to such withholding Tax pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section  3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, (d) any Tax attributable to such recipient&#8217;s failure or inability to comply with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and (e) any Taxes imposed under FATCA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Existing Commitment Termination Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.12(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Existing 2017 Credit Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Five Year Credit Agreement, dated as of May 18, 2017,     by and among the Borrower, the lenders party thereto from time to time, Barclays and JPMC, as                  co-syndication agents, BofA and Wells Fargo, as co-documentation agents, and The Bank of New York Mellon, as administrative agent, as amended by Amendment No. 1 to Five Year Credit Agreement, dated    as of December 15, 2017, and Amendment No. 2 to Five Year Credit Agreement, dated as of May 17, 2018, Amendment No. 3 to Five Year Credit Agreement, dated as of May 16, 2019.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Existing 2019 Credit Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Five Year Credit Agreement, dated as of May 16, 2019,     by and among the Borrower, the lenders party thereto from time to time, Barclays and JPMC, as                 co-syndication agents, GS and Wells Fargo, as co-documentation agents, and BofA, as administrative agent, as amended by that certain First Amendment to Five Year Credit Agreement, dated as of May &#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#93;, 2022,   as the same may be further amended, amended and restated, supplemented, replaced or otherwise modified from time to time.</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Existing 2022 Credit Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Five Year Credit Agreement, dated as of May &#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#93;, 2022,     by and among the Borrower, the lenders party thereto from time to time, Barclays and JPMC, as                  co-syndication agents, GS and Wells Fargo, as co-documentation agents, and BofA, as administrative agent,    as the same may be amended, amended and restated, supplemented, replaced or otherwise modified from time to time.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Existing 364-Day Credit Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the 364-Day Credit Agreement, dated as of May 13, 2020, by and among the Borrower, the lenders party thereto from time to time, Barclays and JPMC, as co-syndication agents, GS and Wells Fargo, as co-documentation agents, and BofA, as administrative agent.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Expiration Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the first date, occurring on or after the date the Commitments shall have terminated or been terminated in accordance herewith, upon which there shall be no Loans, Reimbursement Obligations or Letters of Credit outstanding.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Extension Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.12(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Extension Request&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.12(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Facility Fee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;FATCA&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; Sections 1471 through 1474 of the Internal Revenue Code, as of the date of this Agreement (or any amended or successor version that is substantively comparable and not materially more onerous to comply with), any current or future regulations or official interpretations thereof, any agreements entered into pursuant to Section 1471(b)(1) of the Internal Revenue Code, any applicable intergovernmental agreements with respect thereto, and any treaty, law, regulations, or other official guidance enacted in any other jurisdiction relating to such intergovernmental agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Federal Funds Effective Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;  for any day, the rate per annum calculated by the Federal Reserve Bank of New York based on such day&#8217;s federal funds transactions by depository institutions (as determined in such manner as the Federal Reserve Bank of New York shall set forth on its public website from time to time) and published on the next succeeding Domestic Business Day by the Federal Reserve Bank of New York as the federal funds effective rate&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if the Federal Funds Effective Rate as so determined would be less than zero, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Federal Funds Effective Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall be deemed to be zero for purposes of    this Agreement and the other Loan Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Fees&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.2(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Financial Statements&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;First Amendment Effective Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; May &#91;16&#93;, 2022.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Foreign Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any Lender or any Issuer that is not a United States person within the meaning  of Section 7701(a)(30) of the Internal Revenue Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;GAAP&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.2(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, generally accepted accounting principles set forth in the  opinions and pronouncements of the Accounting Principles Board and the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or such other principles as may be approved by a significant segment of the accounting profession, which are applicable to the circumstances as of the date of determination, consistently applied.</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Governmental Authority&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any foreign, federal, state, municipal or other government, or any department, commission, board, bureau, agency, public authority or instrumentality thereof, or any court, arbitrator, regulatory body or central bank (including any supra-national bodies such as the European Union or the European Central Bank).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;GS&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Hazardous Materials&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; all ignitable, explosive, reactive, corrosive or radioactive substances or wastes and all hazardous or toxic materials, substances, chemicals, wastes or other pollutants, including but not limited to petroleum or petroleum distillates, asbestos or asbestos containing materials, polychlorinated biphenyls, radon gas, toxic mold, infectious or medical wastes, hazardous biological agents, hazardous pharmaceutical substances and all other materials, substances, chemicals, wastes, contaminants or    pollutants of any nature that are now or hereafter regulated pursuant to any Environmental Law, or are now or hereafter defined, listed or classified as a hazardous or toxic material, substance, chemical, waste, contaminant or pollutant in any Environmental Law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Highest Lawful Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as to any Lender, the maximum rate of interest, if any, which at any time   or from time to time may be contracted for, taken, charged or received on the Loans or the Notes or which may be owing to such Lender pursuant to this Agreement under the laws applicable to such Lender and this Agreement and the other Loan Documents. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Increasing Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Indebtedness&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as to any Person at a particular time, all items of such Person which constitute, without duplication, (a) indebtedness for borrowed money or the deferred purchase price of Property (other than trade payables and accrued expenses incurred in the ordinary course of business), (b) indebtedness evidenced by notes, bonds, debentures or similar instruments, (c) indebtedness with respect to any conditional sale or other title retention agreement, (d) indebtedness arising under acceptance facilities and  the amount available to be drawn under all letters of credit (excluding, for purposes of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, letters    of credit obtained in the ordinary course of business by the Borrower or any Subsidiary) issued for the account of such Person and, without duplication, all drafts drawn thereunder to the extent such Person shall not have reimbursed the issuer thereof in respect of such issuer&#8217;s payment of such drafts, (e) that portion of any obligation of such Person, as lessee, which in accordance with GAAP is required to be capitalized on      a balance sheet of such Person, (f) all indebtedness described in clauses (a) through (e) above secured by    any Lien on any Property owned by such Person even though such Person shall not have assumed or otherwise become liable for the payment thereof (other than carriers&#8217;, warehousemen&#8217;s, mechanics&#8217;, repairmen&#8217;s or other like non-consensual Liens arising in the ordinary course of business), and (g) Contingent Obligations in respect of any indebtedness described in clauses (a) through (f) above&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that, for purposes of this definition, Indebtedness shall not include Intercompany Debt and obligations in respect of interest rate caps, collars, exchanges, swaps or other, similar agreements.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Indebtedness for Borrowed Money&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as to any Person at a particular time, all items of such Person which constitute, without duplication, (a) indebtedness for borrowed money or the deferred purchase price  of Property (other than trade payables and accrued expenses incurred in the ordinary course of business),    (b) indebtedness evidenced by notes, bonds, debentures or similar instruments, (c) that portion of any obligation of such Person, as lessee, which in accordance with GAAP is required to be capitalized on a balance sheet of such Person, and (d) Contingent Obligations in respect of any indebtedness described in clauses (a) through (c) above&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that, for purposes of this definition, Indebtedness for Borrowed Money shall not include Intercompany Debt and obligations in respect of interest rate caps, collars, exchanges, swaps or other, similar agreements.</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Indemnified Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Indemnified Liabilities&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.5(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Indemnified Person&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Indemnified Taxes&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (a) Taxes, other than Excluded Taxes, imposed on or with respect to any payment made by or on account of any obligation of the Borrower under any Loan Document and (b) to     the extent not otherwise described in clause (a), Other Taxes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Information&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.14(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Insurance Subsidiary&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any Subsidiary subject to regulation by the commissioner of insurance,   the commissioner of health or any equivalent Governmental Authority in any applicable jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Intangible Assets&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any date, the value, as shown on the most recent Consolidated balance sheet of the Borrower and the Subsidiaries as at the end of the fiscal quarter ending not more than 135 days prior  to such date, prepared in accordance with GAAP, of&#58; (i) all trade names, trademarks, licenses, patents, copyrights, service marks, goodwill and other like intangibles, (ii) organizational and development costs,  (iii) deferred charges (other than prepaid items, such as insurance, taxes, interest, commissions, rents, pensions, compensation and similar items and tangible assets being amortized), and (iv) unamortized debt discount and expense, less unamortized premium.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Intercompany Debt&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (i) Indebtedness of the Borrower to one or more of the Subsidiaries of the Borrower and (ii) Indebtedness of one or more of the Subsidiaries of the Borrower to the Borrower or any one or more of the other Subsidiaries of the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Interest Payment Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (i) as to any ABR Advance, the last day of each March, June, September and December, commencing on the first of such days to occur after such ABR Advance is made or any   Term SOFR Advance is converted to an ABR Advance, (ii) as to any Swing Line Loan, the day on which  the outstanding principal balance of such Swing Line Loan shall become due and payable in accordance  with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, (iii) as to any Term SOFR Advance in respect of which the Borrower has selected a Term SOFR Interest Period of one or three months, the last day of such Term SOFR Interest Period, (iv) as to any Competitive Bid Loan in respect of which the Borrower has selected a Competitive Interest Period    of 90 days or less, the last day of such Competitive Interest Period and (v) as to any Term SOFR Advance   or Competitive Bid Loan in respect of which the Borrower has selected an Interest Period greater than three months or 90 days, as the case may be, the last day of the third month or the 90th day, as the case may be,   of such Interest Period and the last day of such Interest Period.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Interest Period&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a Term SOFR Interest Period or a Competitive Interest Period, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Internal Revenue Code&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Internal Revenue Code of 1986, as amended from time to time, or any successor thereto, and the rules and regulations issued thereunder, as from time to time in effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;issue&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;issuance&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; when used with respect to a Letter of Credit, shall be deemed to include    any increase in the amount of such Letter of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Issuers&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; Barclays, BofA, GS, JPMC and Wells Fargo&#59; each an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Issuer&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Joint Lead Arrangers&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BAS, Barclays, GS, JPMC and WFS.</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;JPMC&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;KPIs&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.14(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Lenders&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble&#59; such term to also include the Swing Line Lender and each Issuer where the context hereof requires or permits such inclusion.</font></div><div style="margin-bottom:15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Lender Party&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;10.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letters of Credit&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.8(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit Application&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; an application and agreement for the issuance or amendment of a Letter of Credit in the form from time to time in use by the applicable Issuer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit Commitment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time with respect to any Issuer, the commitment of such Issuer to issue Letters of Credit (which, for the avoidance of doubt, shall include all standby letters of credit and all commercial letters of credit issued by such Issuer) in accordance with the terms hereof in an aggregate outstanding face amount not exceeding the lesser of (a) the amount set forth adjacent to such Issuer&#8217;s name under the heading &#8220;Letter of Credit Commitment&#8221; in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> at such time or, if not listed   on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the &#8220;Letter of Credit Commitment&#8221; which such Issuer shall have assumed from another Issuer in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> on or prior to such time, as the same may be adjusted from time to time pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and (b) the amount equal to the Aggregate Commitment Amount  as in effect at such time multiplied by a percentage equal to a fraction, the numerator of which is one and   the denominator of which is five.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit Exposure&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time, (a) in respect of all Lenders, the sum, without duplication, of (i) the maximum aggregate amount which may be drawn under all unexpired Letters of Credit at such  time (whether or not the conditions for drawing thereunder have or may be satisfied), (ii) the aggregate amount, at such time, of all unpaid drafts (which have not been dishonored) drawn under all Letters of Credit, and (iii) the aggregate unpaid principal amount of the Reimbursement Obligations at such time, (b)  in respect of any Lender, an amount equal to such Lender&#8217;s Commitment Percentage at such time multiplied by the amount determined under clause (a) of this definition, and (c) in respect of any Issuer, the amount determined under clause (a) of this definition in respect of a Letter of Credit issued by such Issuer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit Participation Fee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit Request&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a request substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit J</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Lien&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any mortgage, pledge, hypothecation, assignment, lien, deposit arrangement, charge, encumbrance or other security arrangement or security interest of any kind, or the interest of a vendor or lessor under any conditional sale agreement, capital lease or other title retention agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that   in no event shall an operating lease or license of Intangible Assets be deemed to constitute a Lien.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Loan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a Revolving Credit Loan, a Competitive Bid Loan or a Swing Line Loan, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Loan Documents&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; this Agreement and, upon the execution and delivery thereof, the Notes, if   any, and the Reimbursement Agreements, if any.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Loans&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Revolving Credit Loans, the Competitive Bid Loans and the Swing Line Loans.</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Mandatory Borrowing&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Margin Stock&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">margin stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as said term is defined in Regulation U of the Board of Governors of the Federal Reserve System, as the same may be amended or supplemented from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Material Acquisition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any acquisition of (a) Equity Interests in any Person if, after giving effect thereto, such Person will become a Subsidiary or (b) assets comprising all or substantially all the assets of  (or all or substantially all the assets constituting a business unit, division, product line or line of business    of) any Person&#59; provided that the aggregate consideration therefor (including Indebtedness assumed in connection therewith, all obligations in respect of the deferred purchase price therefor (including    obligations under any purchase price adjustment but excluding earn-out or similar payments) and all other consideration payable in connection therewith (including payment obligations in respect of noncompetition agreements or other arrangements representing acquisition consideration)) equals or exceeds $500,000,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Material Adverse&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any change or effect, a material adverse change in, or effect   on, as the case may be, (i) the financial condition, operations, business, or Property of the Borrower and the Subsidiaries taken as a whole, (ii) the ability of the Borrower to perform its obligations under the Loan Documents, or (iii) the ability of the Administrative Agent, any Issuer or any Lender to enforce the Loan Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Material Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; a Subsidiary of the Borrower with respect to which (i) the Borrower&#8217;s and  its other Subsidiaries&#8217; investments in, and advances to, such Subsidiary exceed ten percent (10%) of the   total assets of the Borrower and its Consolidated Subsidiaries as of the end of the most recently completed fiscal year, (ii) the Borrower&#8217;s and its other Subsidiaries&#8217; proportionate share of the total assets (after intercompany eliminations) of such Subsidiary exceeds 10 percent (10%) of the total assets of the Borrower and its Consolidated Subsidiaries as of the end of the most recently completed fiscal year, or (iii) the Borrower&#8217;s and its other Subsidiaries&#8217; equity in the income from continuing operations before income taxes of such Subsidiary exclusive of amounts attributable to any non-controlling interests exceeds ten percent (10%) of such income of the Borrower and its Consolidated Subsidiaries for the most recently completed fiscal year.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Moody&#8217;s&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; Moody&#8217;s Investors Service, Inc., or any successor thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Multiemployer Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a Pension Plan which is a multiemployer plan as defined in Section 4001(a)(3) of ERISA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Negotiated Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; with respect to each Swing Line Loan, the rate per annum agreed to in writing  by the Borrower and the Swing Line Lender as the interest rate which such Swing Line Loan shall bear.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Net Tangible Assets&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any date, the total assets as shown on the most recent Consolidated balance sheet of the Borrower and the Subsidiaries as at the end of the fiscal quarter ending not more than 135 days prior to such date, prepared in accordance with GAAP, less, without duplication (i) all current liabilities (due within one year) as shown on such balance sheet and (ii) Intangible Assets and liabilities relating thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;New Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Non-Extending Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.12(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Note&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to each Lender that has requested one in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, a promissory note evidencing such Lender&#8217;s Loans payable to such Lender (or, if required by such Lender,     to such Lender and its registered assigns), substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;One Month SOFR Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; for any interest calculation with respect to an ABR Advance on any  date, the rate per annum equal to the Term SOFR Screen Rate with a term of one month commencing that day, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that in the event that the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">One Month SOFR Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> would otherwise be less than zero, such </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">One Month SOFR Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be deemed to be zero for purposes of this Agreement and the other Loan Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Other Connection Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to the Administrative Agent, any Lender, any Issuer or   any other recipient of any payment to be made by or on account of any obligation of the Borrower hereunder or any other Loan Document, Taxes imposed as a result of a present or former connection between such recipient and the jurisdiction imposing such Tax (other than connections arising from such recipient having executed, delivered, become a party to, performed its obligations under, received payments under, received or perfected a security interest under, engaged in any other transaction pursuant to, enforced any Loan Document, or sold or assigned an interest in any Loan or Loan Document).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Other Taxes&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; all present or future stamp, court or documentary Taxes or any other excise or property Taxes, charges or similar levies arising from any payment made hereunder or under any other   Loan Document or from the execution, delivery or enforcement of, or otherwise with respect to, this Agreement or any other Loan Document, except any such Taxes that are Other Connection Taxes imposed with respect to an assignment (other than an assignment made pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Participant&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Participant Register&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Patriot Act&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;PBGC&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Pension Benefit Guaranty Corporation established pursuant to Subtitle A of Title IV  of ERISA, or any Governmental Authority succeeding to the functions thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pension Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time, any Employee Benefit Plan (including a Multiemployer Plan) subject to Section 302 of ERISA or Section 412 of the Internal Revenue Code, the funding requirements of which are, or at any time within the six years immediately preceding the time in question were, in whole or in part, the responsibility of the Borrower, any Subsidiary or an ERISA Affiliate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Person&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any individual, firm, partnership, limited liability company, joint venture, corporation, association, business trust, joint stock company, unincorporated association, trust, Governmental Authority or any other entity, whether acting in an individual, fiduciary, or other capacity, and for the purpose of the definition of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ERISA Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, a trade or business.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Plan of Reorganization&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;11.7(h)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Platform&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pricing Level&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; Pricing Level I, Pricing Level II, Pricing Level III, Pricing Level IV, Pricing   Level V or Pricing Level VI, as the case may be.</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pricing Level I&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any time when the senior unsecured long term debt rating of the Borrower by    (x) S&#38;P is A or higher or (y) Moody&#8217;s is A2 or higher.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pricing Level II&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any time when (i) the senior unsecured long term debt rating of the Borrower   by (x) S&#38;P is A- or higher or (y) Moody&#8217;s is A3 or higher and (ii) Pricing Level I does not apply.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pricing Level III&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any time when (i) the senior unsecured long term debt rating of the Borrower  by (x) S&#38;P is BBB+ or higher or (y) Moody&#8217;s is Baa1 or higher and (ii) neither Pricing Level I nor Pricing Level II applies.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pricing Level IV&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any time when (i) the senior unsecured long term debt rating of the Borrower  by (x) S&#38;P is BBB or higher or (y) Moody&#8217;s is Baa2 or higher and (ii) none of Pricing Level I, Pricing  Level II or Pricing Level III applies.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pricing Level V&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any time when (i) the senior unsecured long term debt rating of the Borrower    by (x) S&#38;P is BBB- or higher or (y) Moody&#8217;s is Baa3 or higher and (ii) none of Pricing Level I, Pricing Level II, Pricing Level III or Pricing Level IV applies.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pricing Level VI&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any time when none of Pricing Level I, Pricing Level II, Pricing Level III, Pricing Level IV or Pricing Level V applies.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding each definition of Pricing Level set forth above, if at any time the senior unsecured long term debt ratings of the Borrower by S&#38;P and Moody&#8217;s differ by more than one equivalent rating level,   then the applicable Pricing Level shall be determined based upon the lower such rating adjusted upwards     to the next higher rating level.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Proceeding&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Prohibited Transaction&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a transaction that is prohibited under Section 4975 of the Internal Revenue Code or Section 406 of ERISA and not exempt under Section 4975 of the Internal Revenue Code, Section 408 of ERISA or any applicable administrative exemptions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Property&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; in respect of any Person, all types of real, personal or mixed property and all types of tangible or intangible property owned or leased by such Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;PTE&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.23(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Regulatory Change&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the occurrence, after the date hereof, of any of the following&#58; (a) the  adoption or taking effect of any law, rule, regulation or treaty, (b) any change in any law, rule, regulation     or treaty or in the administration, implementation, interpretation or application thereof by any   Governmental Authority or (c) the making or issuance of any request, guideline or directive (whether or    not having the force of law) by any Governmental Authority&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, notwithstanding anything   herein to the contrary, (i) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives thereunder or issued in connection therewith and (ii) all requests, rules, guidelines or directives promulgated by the Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case, pursuant to Basel III, in the case of each of clauses (i) and (ii), shall be deemed to  be a &#8220;Regulatory Change&#8221;, regardless of the date enacted, adopted or issued, but only if any such requirements are generally applicable to (and for which reimbursement is generally being sought by the Lenders in respect of) credit transactions similar to this transaction from similarly situated borrowers (which </font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">are parties to credit or loan documentation containing a provision similar to this definition), as determined  by the Lenders in their respective reasonable discretion.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Register&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Reimbursement Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.8(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and, as the context requires, shall  include the Letter of Credit Application related to the applicable Letter of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Reimbursement Obligations&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; all obligations and liabilities of the Borrower due and to become  due (a) under the Reimbursement Agreements and (b) hereunder in respect of Letters of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Related Parties&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any specified Person, such Person&#8217;s Affiliates and the respective directors, officers, employees, agents and advisors of such Person and such Person&#8217;s Affiliates.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Replaced Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Replacement Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Required Lenders&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (a) at any time prior to the Commitment Termination Date or such earlier   date as all of the Commitments shall have terminated or been terminated in accordance herewith, Lenders having Commitment Amounts greater than 50% of the Aggregate Commitment Amount, and (b) at all other times, Lenders having Credit Exposure greater than 50% of the Aggregate Credit Exposure.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Rescindable Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.2(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Resolution Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; an EEA Resolution Authority or, with respect to any UK Financial Institution, a UK Resolution Authority.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Restrictive Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Revolving Credit Loan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Revolving Credit Loans&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;S&#38;P&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; Standard &#38; Poor&#8217;s Financial Services LLC, a subsidiary of S&#38;P Global Inc., or any successor thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Sanctioned Country&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time, a country or territory which is the subject or target of any Sanctions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Sanctioned Person&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time, (a) any Person listed in any Sanctions-related list of designated Persons maintained by the Office of Foreign Assets Control of the U.S. Department of the Treasury or the U.S. Department of State, (b) any Person operating, organized or resident in a Sanctioned Country or (c)   any Person controlled by any such Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Sanctions&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; economic or financial sanctions or trade embargoes imposed, administered or   enforced from time to time by the U.S. government, including those administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury or the U.S. Department of State.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Scheduled Unavailability Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(c)(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">SEC Reports</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the Borrower&#8217;s 2020 Annual Report on Form 10-K, the Borrower&#8217;s quarterly   report on Form 10-Q for the quarterly period ending March 31, 2021, and any 8-K filings made by the Borrower subsequent to March 31, 2021 and prior to the Effective Date.</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Secured Overnight Financing Rate as administered by the Federal Reserve Bank of New York (or a successor administrator).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;SOFR Adjustment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> with respect to Daily Simple SOFR and any Term SOFR Interest Period, 0.10% (10.0 basis points).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Special Counsel&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; such counsel as the Administrative Agent may engage from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Subsidiary&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time and from time to time, any corporation, partnership, limited liability company, joint venture or other business entity of which the Borrower and&#47;or any Subsidiary of the Borrower, directly or indirectly at such time, either (a) in respect of a corporation, owns or controls more than 50% of the outstanding stock having ordinary voting power to elect a majority of the board of directors or similar managing body, irrespective of whether a class or classes shall or might have voting power by reason of the happening of any contingency, or (b) in respect of a partnership, limited liability company,  joint venture or other business entity, is entitled to share in more than 50% of the profits and losses, however determined.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Successor Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Sustainability Coordinator&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; BofA Securities, Inc., in its capacity as the sustainability  coordinator.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Sustainability Linked Loan Principles&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Sustainability-Linked Loan Principles (as published  in March 2022 by the Loan Market Association, Asia Pacific Loan Market Association and Loan Syndications &#38; Trading Association).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Commitment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the commitment of the Swing Line Lender to make Swing Line Loans in accordance with the terms hereof in an aggregate outstanding principal amount not exceeding $100,000,000 (or, if less, the Aggregate Commitment Amount) at any time, as the same may be reduced pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Commitment Period&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the period from the Effective Date to, but excluding, the Swing Line Termination Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Exposure&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time, in respect of any Lender, an amount equal to the aggregate principal balance of such Lender&#8217;s Swing Line Participation Amount.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; BofA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Loan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Loans&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Maturity Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Participation Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Termination Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the date which is 7 Domestic Business Days prior to the Commitment Termination Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Taxes&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; all present or future taxes, levies, imposts, duties, deductions, withholdings, assessments, fees or other charges in the nature of a tax imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto.</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; for any Term SOFR Interest Period with respect to a Term SOFR Advance, the    rate per annum equal to the Term SOFR Screen Rate two U.S. Government Securities Business Days prior  to the commencement of such Term SOFR Interest Period with a term equivalent to such Term SOFR Interest Period&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if the rate is not published prior to 11&#58;00 A.M. on such determination date   then Term SOFR means the Term SOFR Screen Rate on the first U.S. Government Securities Business Day immediately prior thereto, in each case,</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the SOFR Adjustment for such Term SOFR Interest Period&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, further, that if Term SOFR determined pursuant to the above would be less than zero, Term SOFR shall be deemed zero for purposes of this Agreement and the other  Loan Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Term SOFR Advance&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a portion of the Revolving Credit Loans selected by the Borrower to bear interest during a Term SOFR Interest Period selected by the Borrower at a rate based upon Term SOFR, all pursuant to and in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Term SOFR Daily Floating Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; for any interest calculation with respect to a Term SOFR   Daily Floating Rate Loan on any date, a fluctuating rate of interest, which can change on each Domestic Business Day, equal to the Term SOFR Screen Rate, two U.S. Government Securities Business Days prior  to such day, with a term equivalent to one month beginning on that date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that if the rate is not published prior to 11&#58;00 A.M. on such determination date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">then the Term SOFR Daily Floating Rate means the Term SOFR Screen Rate on the first U.S. Government Securities Business Day immediately prior thereto, in each case, plus the SOFR Adjustment for Term SOFR for a one-month Interest Period&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that, (i) to the extent a comparable or successor rate is approved by the Swing Line Lender in connection herewith, the approved rate shall be applied in a manner consistent with market practice&#59; provided, further that to the extent such market practice is not administratively feasible for the Swing Line Lender, such approved rate shall be applied in a manner as otherwise reasonably determined by the Swing Line Lender in consultation with the Borrower, (ii) if the Term SOFR Daily Floating Rate determined pursuant to the above would be less than zero, such rate shall be deemed zero for purposes of this Agreement and the other Loan Documents, and (iii) if such rate is not available at such time for any reason, then the   rate will be determined by such alternate method as reasonably selected by the Swing Line Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Term SOFR Interest Period&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as to each Term SOFR Advance, the period commencing on the  date such Term SOFR Advance is disbursed or converted to or continued as a Term SOFR Advance and ending on the date one, three or six months thereafter, as selected by the Borrower in its Borrowing Request&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">any Term SOFR Interest Period that would otherwise end on a day that is not a Domestic Business Day shall be extended to the next succeeding Domestic Business Day unless  such Domestic Business Day falls in another calendar month, in which case such Term SOFR Interest Period shall end on the next preceding Domestic Business Day&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">any Term SOFR Interest Period that begins on the last Domestic Business Day of     a calendar month (or on a day for which there is no numerically corresponding day in the calendar month at the end of such Term SOFR Interest Period) shall end on the last Domestic Business Day  of the calendar month at the end of such Term SOFR Interest Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Term SOFR Replacement Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Term SOFR Screen Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the forward-looking SOFR term rate administered by CME (or any successor administrator reasonably satisfactory to the Administrative Agent) and published on the   applicable Reuters screen page (or such other commercially available source providing such quotations as may be designated by the Administrative Agent from time to time in its reasonable discretion).</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Termination Event&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any Pension Plan, (a) an ERISA Event, (b) the termination    of a Pension Plan under Section 4041(c) of ERISA, or the filing of a notice of intent to terminate a Pension Plan under Section 4041(c) of ERISA, or the treatment of a Pension Plan amendment as a termination under Section 4041(e) of ERISA (except an amendment made after such Pension Plan satisfies the requirement    for a standard termination under Section 4041(b) of ERISA), (c) the institution of proceedings by the PBGC to terminate a Pension Plan under Section 4042 of ERISA, or (d) the appointment of a trustee to administer any Pension Plan under Section 4042 of ERISA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Threshold Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; $300,000,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Total Capitalization&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any date, the sum of the Borrower&#8217;s Consolidated Indebtedness and shareholders&#8217; equity on such date, determined in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Trade Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Type&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any Revolving Credit Loan, the characteristic of such Loan as an ABR Advance or a Term SOFR Advance, each of which constitutes a Type of Revolving Credit Loan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">UK Financial Institution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any BRRD Undertaking (as such term is defined under the PRA Rulebook (as amended form time to time) promulgated by the United Kingdom Prudential Regulation Authority) or any person subject to IFPRU 11.6 of the FCA Handbook (as amended from time to time) promulgated by the United Kingdom Financial Conduct Authority, which includes certain credit institutions and investment firms, and certain affiliates of such credit institutions or investment firms.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">UK Resolution Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Bank of England or any other public administrative authority having responsibility for the resolution of any UK Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Unqualified Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.4(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Upstream Dividends&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;U.S. Government Securities Business Day&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any Domestic Business Day, except any Domestic Business Day on which any of the Securities Industry and Financial Markets Association, the New York Stock Exchange or the Federal Reserve Bank of New York is not open for business because such day is a legal holiday under the federal laws of the United States or the laws of the State of New York, as applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;U.S. Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;United States Tax Compliance Certificate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10(f)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Wells Fargo&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">WFS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; Wells Fargo Securities, LLC.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Write-Down and Conversion Powers&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (a) with respect to any EEA Resolution Authority, the write-down and conversion powers of such EEA Resolution Authority from time to time under the Bail-In Legislation for the applicable EEA Member Country, which write-down and conversion powers are described in the EU Bail-In Legislation Schedule, and (b) with respect to the United Kingdom, any powers  of the applicable Resolution Authority under the Bail-In Legislation to cancel, reduce, modify or change    the form of a liability of any UK Financial Institution or any contract or instrument under which that liability arises, to convert all or part of that liability into shares, securities or obligations of that person or any other </font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">person, to provide that any such contract or instrument is to have effect as if a right had been exercised  under it or to suspend any obligation in respect of that liability or any of the powers under that Bail-In Legislation that are related to or ancillary to any of those powers. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Principles of Construction</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">All capitalized terms defined in this Agreement shall have the meanings given to such capitalized terms herein when used in the other Loan Documents or in any certificate, opinion or other document made or delivered pursuant hereto or thereto, unless otherwise expressly   provided therein.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Unless otherwise expressly provided herein, the word </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;fiscal&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> when used herein shall refer to the relevant fiscal period of the Borrower. As used in the Loan Documents and in any certificate, opinion or other document made or delivered pursuant thereto, accounting terms not defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and accounting terms partly defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the extent not defined, shall have the respective meanings given to them under GAAP as in effect from time to time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, if the Borrower notifies the Administrative Agent that the Borrower requests an amendment to any provision hereof to eliminate the effect of any change occurring after the date hereof in GAAP or in the application thereof on the operation of such provision (or if the Administrative Agent notifies the Borrower that the Required Lenders request an amendment to    any provision hereof for such purpose), regardless of whether any such notice is given before or  after such change in GAAP or in the application thereof, then such provision&#160;shall be interpreted    on the basis of, and any accounting term related thereto shall have the respective meaning given to   it under, GAAP as in effect and applied immediately before such change shall have become  effective until such notice shall have been withdrawn or such provision amended in accordance herewith.  Any lease that is characterized as an operating lease in accordance with GAAP after the Borrower&#8217;s adoption of ASC 842 (regardless of the date on which such lease has been entered into) shall not be a capital or finance lease, and any such lease shall be, for all purposes of this  Agreement, treated as though it were reflected on the Borrower&#8217;s consolidated financial statements  in the same manner as an operating lease would have been reflected prior to Borrower&#8217;s adoption    of ASC 842.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The words </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;hereof&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;herein&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;hereto&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;hereunder&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and similar words    when used in each Loan Document shall refer to such Loan Document as a whole and not to any particular provision of such Loan Document, and Section, schedule and exhibit references   contained therein shall refer to Sections thereof or schedules or exhibits thereto unless otherwise expressly provided therein.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">All references herein to a time of day shall mean the then-applicable time in New York, New York, unless otherwise expressly provided herein.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Section headings have been inserted in the Loan Documents for convenience only and shall not be construed to be a part thereof. Unless the context otherwise requires, words in the singular number include the plural, and words in the plural include the singular.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.02pt">Whenever in any Loan Document or in any certificate or other document made or delivered pursuant thereto, the terms thereof require that a Person sign or execute the same or refer  to the same as having been so signed or executed, such terms shall mean that the same shall be, or was, duly signed or executed by (i) in respect of any Person that is a corporation, any duly  authorized officer thereof, and (ii) in respect of any other Person (other than an individual), any analogous counterpart thereof.</font></div><div style="height:62.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</font></div></div></div><div id="i1c633f90c64445bd8f80f3682fb52fae_337"></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">The words </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;include&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;including&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, when used in each Loan Document, shall mean that the same shall be included </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;without limitation&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, unless otherwise specifically provided.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">All references to &#8220;knowledge&#8221; or &#8220;awareness&#8221; of the Borrower or any Subsidiary means the actual knowledge of an Authorized Officer of the Borrower or such Subsidiary.</font></div><div id="i1c633f90c64445bd8f80f3682fb52fae_252"></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">AMOUNT AND TERMS OF LOANS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Revolving Credit Loans</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Subject to the terms and conditions hereof, each Lender severally (and not jointly) agrees to make loans in Dollars under this Agreement (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Revolving Credit Loan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and, collectively with each other Revolving Credit Loan of such Lender and&#47;or with each Revolving Credit Loan of each other Lender, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Revolving Credit Loans&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) to the Borrower from time to   time during the Commitment Period, during which period the Borrower may borrow, prepay and reborrow in accordance with the provisions hereof. Immediately after making each Revolving   Credit Loan and after giving effect to all Swing Line Loans and Competitive Bid Loans repaid and all Reimbursement Obligations paid on the same date, the Aggregate Credit Exposure will not exceed the Aggregate Commitment Amount. With respect to each Lender, at the time of the making of any Revolving Credit Loan, the sum of (I) the principal amount of such Lender&#8217;s Revolving Credit Loan constituting a part of the Revolving Credit Loans to be made, (II) the aggregate  principal balance of all other Revolving Credit Loans (exclusive of Revolving Credit Loans which are repaid with the proceeds of, and simultaneously with the incurrence of, the Revolving Credit Loans to be made) then outstanding from such Lender and (III) the product of (A) such Lender&#8217;s Commitment Percentage and (B) the sum of (1) the aggregate principal balance of all Swing Line Loans (exclusive of Swing Line Loans which are repaid with the proceeds of, and simultaneously with the incurrence of, the Revolving Credit Loans to be made) then outstanding and (2) the Letter  of Credit Exposure of all Lenders, will not exceed the Commitment of such Lender at such time.     At the option of the Borrower, indicated in a Borrowing Request, Revolving Credit Loans may be made as ABR Advances or Term SOFR Advances.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">The aggregate outstanding principal balance of all Revolving Credit Loans shall     be due and payable on the Commitment Termination Date or on such earlier date upon which all     of the Commitments shall have been terminated in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Swing Line Loans</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Subject to the terms and conditions hereof and in reliance upon the agreements of the other Lenders set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Swing Line Lender agrees to make loans in  Dollars under this Agreement (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Loan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and, collectively, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Loans&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) to the Borrower from time to time during the Swing Line Commitment Period. Swing Line Loans (i) may be repaid and reborrowed in accordance with the provisions hereof, (ii) shall not, immediately after giving effect thereto, result in the Aggregate Credit Exposure exceeding the Aggregate Commitment Amount, and (iii) shall not, immediately after giving effect thereto, result   in the aggregate outstanding principal balance of all Swing Line Loans exceeding the Swing Line Commitment. The Swing Line Lender shall not be obligated to make any Swing Line Loan at a   time when any Lender is a Defaulting Lender unless the Swing Line Lender has entered into arrangements satisfactory to it and the Borrower to eliminate the Swing Line Lender&#8217;s risk with respect to such Defaulting Lender&#8217;s participation in such Swing Line Loan. The Swing Line Lender will not make a Swing Line Loan if the Administrative Agent or any Lender, by notice to the Swing Line Lender and the Borrower no later than one Domestic Business Day prior to the Borrowing   </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Date with respect to such Swing Line Loan, shall have determined that the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> have not been satisfied or waived and such conditions remain unsatisfied as of the requested time of the making of such Loan. Each Swing Line Loan shall be due and payable on the day (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Maturity Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) being the earliest of the tenth Domestic Business Day after such Swing Line Loan is made, the date on which the Swing Line Commitment shall have been terminated in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and the date on which the Loans shall become due and payable pursuant to the provisions hereof, whether by acceleration or otherwise. Each Swing Line Loan shall bear interest at the Negotiated Rate (or, if the Negotiated Rate is not available, the Term SOFR Daily Floating Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Applicable Margin). The Swing Line Lender shall disburse the proceeds of Swing Line Loans at its office designated in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> by crediting such proceeds     to an account of the Borrower maintained with the Swing Line Lender.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">On any Domestic Business Day, the Swing Line Lender may, in its sole discretion, give notice to the Lenders and the Borrower that such outstanding Swing Line Loan shall be funded with a borrowing of Revolving Credit Loans (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such notice shall be deemed to have  been automatically given upon the occurrence of a Default or an Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), in which case a borrowing of Revolving Credit Loans made as ABR Advances (each such borrowing, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Mandatory Borrowing&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) shall be made by all Lenders </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> based on each such Lender&#8217;s Commitment Percentage on the Domestic Business Day immediately   succeeding the giving of such notice. The proceeds of each Mandatory Borrowing shall be remitted directly to the Swing Line Lender to repay such outstanding Swing Line Loan. Each Lender irrevocably agrees to make a Revolving Credit Loan pursuant to each Mandatory Borrowing in the amount and in the manner specified in the preceding sentence and on the date specified in writing   by the Swing Line Lender notwithstanding&#58; (i) whether the amount of such Mandatory Borrowing complies with the minimum amount for Loans otherwise required hereunder, (ii) whether any condition specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> is then unsatisfied, (iii) whether a Default then exists, (iv) the Borrowing Date of such Mandatory Borrowing, (v) the aggregate principal amount of all Loans   then outstanding, (vi) the Aggregate Credit Exposure at such time and (vii) the amount of the Commitments at such time.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Upon each receipt by a Lender of a notice from the Administrative Agent, such Lender shall purchase unconditionally, irrevocably, and severally (and not jointly) from the Swing Line Lender a participation in the outstanding Swing Line Loans (including accrued interest  thereon) in an amount equal to the product of its Commitment Percentage and the outstanding balance of the Swing Line Loans (each, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Participation Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">). Each Lender shall also be liable for an amount equal to the product of its Commitment Percentage and any amounts paid by the Borrower pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that are subsequently rescinded or avoided, or  must otherwise be restored or returned. Such liabilities shall be unconditional and without regard     to the occurrence of any Default or the compliance by the Borrower with any of its obligations   under the Loan Documents.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">In furtherance of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, upon each receipt by a Lender of a notice from     the Administrative Agent, such Lender shall promptly (and, in any event, no later than the Domestic Business Day immediately succeeding the giving of such notice) make available to the Administrative Agent for the account of the Swing Line Lender its Swing Line Participation  Amount at the office of the Administrative Agent specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, in Dollars and in immediately available funds. The Administrative Agent shall deliver the payments made by each Lender pursuant to the immediately preceding sentence to the Swing Line Lender promptly upon receipt thereof in like funds as received. Each Lender hereby indemnifies and agrees to hold harmless the Administrative Agent and the Swing Line Lender from and against any and all losses, liabilities (including liabilities for penalties), actions, suits, judgments, demands, costs and    </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">expenses resulting from any failure on the part of such Lender to pay, or from any delay in paying, the Administrative Agent any amount such Lender is required by notice from the Administrative Agent to pay in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (except in respect of losses, liabilities or other obligations suffered by the Administrative Agent or the Swing Line Lender, as the case may be, resulting from the gross negligence or willful misconduct of the Administrative Agent or the Swing Line Lender, as the case may be), and such Lender shall pay interest to the Administrative Agent   for the account of the Swing Line Lender from the date such amount was due until paid in full, on the unpaid portion thereof, at a rate of interest per annum, whether before or after judgment, equal   to (i) from the date such amount was due until the third day therefrom, the Federal Funds Effective Rate, and (ii) thereafter, the Federal Funds Effective Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 2%, payable upon demand by the Swing Line Lender. The Administrative Agent shall distribute such interest payments to the Swing Line Lender upon receipt thereof in like funds as received.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Whenever the Administrative Agent is reimbursed by the Borrower for the account of the Swing Line Lender for any payment in connection with Swing Line Loans and such payment relates to an amount previously paid by a Lender pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Administrative Agent will promptly remit such payment to such Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Notice of Borrowing Revolving Credit Loans and Swing Line Loans</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower agrees to notify the Administrative Agent (and with respect to a Swing Line Loan,    the Swing Line Lender), which notification shall be irrevocable, no later than (a) 2&#58;00 P.M., on the proposed Borrowing Date in the case of Swing Line Loans, (b) 12&#58;00 Noon on the proposed Borrowing Date in the case of Revolving Credit Loans to consist of ABR Advances and (c) 12&#58;00 Noon at least two Domestic Business Days prior to the proposed Borrowing Date in the case of Revolving Credit Loans to consist of Term SOFR Advances. Each such notice shall specify (i) the aggregate amount requested to be borrowed under the Commitments or the Swing Line Commitment, (ii) the proposed Borrowing Date, (iii) whether a borrowing of Revolving Credit Loans is to be made as an ABR Advance, one or more Term SOFR Advances, or both, and the amount of each thereof, (iv) the Term SOFR Interest Period for each such Term SOFR Advance and (v) the amount of each Swing Line Loan. Each such notice shall be promptly confirmed by delivery to the Administrative Agent (and, with respect to a Swing Line Loan, the Swing Line Lender)   of a Borrowing Request. Each Term SOFR Advance to be made on a Borrowing Date, when aggregated  with all amounts to be Converted to Term SOFR Advances on such date and having the same Interest Period as such Term SOFR Advance, shall equal no less than $10,000,000, or an integral multiple of $1,000,000    in excess thereof. Each ABR Advance made on each Borrowing Date shall equal no less than $5,000,000    or an integral multiple of $500,000 in excess thereof. Each Swing Line Loan made on each Borrowing Date shall equal no less than $1,000,000 or an integral multiple of $500,000 in excess thereof. The   Administrative Agent shall promptly notify each Lender (by telephone or otherwise, such notification to be confirmed by fax, email or other writing) of each such Borrowing Request. Subject to its receipt of each  such notice from the Administrative Agent and subject to the terms and conditions hereof, (A) each Lender shall make immediately available funds available to the Administrative Agent at the address therefor set  forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> not later than 1&#58;00 P.M. on each Borrowing Date in an amount equal to such Lender&#8217;s Commitment Percentage of the Revolving Credit Loans requested by the Borrower on such Borrowing Date and&#47;or (B) the Swing Line Lender shall make immediately available funds available to the Borrower on   such Borrowing Date in an amount equal to the Swing Line Loan requested by the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Competitive Bid Loans and Procedure</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Subject to the terms and conditions hereof, the Borrower may request competitive bid loans in Dollars under this Agreement (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Competitive Bid Loan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) during the   Commitment Period. In order to request Competitive Bids, the Borrower shall deliver by hand, fax  </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or email to the Administrative Agent a duly completed and executed Competitive Bid Request not later than 12&#58;00 Noon, one Domestic Business Day before the proposed Borrowing Date therefor.    A Competitive Bid Request that does not conform substantially to the format of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit F</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> may be rejected by the Administrative Agent in the Administrative Agent&#8217;s reasonable discretion, and the Administrative Agent shall promptly notify the Borrower of such rejection by fax or email and by telephone. Each Competitive Bid Request shall specify (x) the proposed Borrowing Date for the Competitive Bid Loans then being requested (which shall be a Domestic Business Day) and the aggregate principal amount thereof and (y) the Competitive Interest Period or Competitive Interest Periods (which shall not exceed ten different Interest Periods in a single Competitive Bid Request), with respect thereto (which may not end after the Domestic Business Day immediately preceding  the Commitment Termination Date). Promptly after its receipt of each Competitive Bid Request   that is not rejected as aforesaid, the Administrative Agent shall invite by fax or email (substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit G</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) the Lenders (other than any Defaulting Lender) to bid, on the terms and conditions of this Agreement, to make Competitive Bid Loans pursuant to such Competitive Bid Request.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Each Lender (other than any Defaulting Lender), in its sole and absolute discretion, may make one or more Competitive Bids to the Borrower responsive to a Competitive Bid Request. Each Competitive Bid by a Lender must be received by the Administrative Agent not later than 10&#58;00 A.M. on the proposed Borrowing Date for the relevant Competitive Bid Loan. Multiple bids will be accepted by the Administrative Agent. Bids to make Competitive Bid Loans that, in the reasonable judgment of the Administrative Agent, do not conform to the Competitive Bids solicited by the related Competitive Bid Request shall be rejected by the Administrative Agent. Competitive Bids that do not conform substantially to the format of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit H</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> may be rejected by the Administrative Agent after conferring with, and upon the instruction of, the Borrower, and the Administrative Agent shall notify the Lender making such nonconforming bid of such rejection as soon as practicable. Each Competitive Bid shall be irrevocable and shall specify (x) the principal amount (which (1) shall be in a minimum principal amount of $10,000,000 or an integral multiple  of $1,000,000 in excess thereof, and (2) may equal the entire principal amount requested by the Borrower) of the Competitive Bid Loan or Competitive Bid Loans that the Lender is willing to  make to the Borrower, (y) the Competitive Bid Rate or Competitive Bid Rates at which the Lender  is prepared to make such Competitive Bid Loan or Competitive Bid Loans, and (z) the Competitive Interest Period with respect to each such Competitive Bid Loan and the last day thereof. If any Lender shall elect not to make a Competitive Bid, such Lender shall so notify the Administrative Agent by fax or email not later than 10&#58;00 A.M. on the proposed Borrowing Date therefor&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that the failure by any Lender to give any such notice shall not obligate such Lender to make any Competitive Bid Loan in connection with the relevant Competitive Bid Request.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">With respect to each Competitive Bid Request, the Administrative Agent shall (i) notify the Borrower by fax or email by 11&#58;00 A.M. on the proposed Borrowing Date with respect thereto of each Competitive Bid made, the Competitive Bid Rate applicable thereto and the identity of the Lender that made such Competitive Bid, and (ii) send a list of all Competitive Bids to the Borrower for its records as soon as practicable after completion of the bidding process. Each notice and list sent by the Administrative Agent pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall list the Competitive Bids in ascending yield order.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">The Borrower may, in its sole and absolute discretion, subject only to the  provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, accept or reject any Competitive Bid made in accordance with the procedures set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and the Borrower shall notify the Administrative Agent by telephone, confirmed by fax or email in the form of a duly completed and executed Competitive   Bid Accept&#47;Reject Letter, whether and to what extent it has decided to accept or reject any or all of </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">such Competitive Bids not later than 12&#58;00 Noon on the proposed Borrowing Date therefor&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the failure by the Borrower to give such notice shall be deemed to be a rejection of    all such Competitive Bids. In connection with each acceptance of one or more Competitive Bids    by the Borrower&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">the Borrower shall not accept a Competitive Bid of a given tenor made at    a particular Competitive Bid Rate if the Borrower has decided to reject a Competitive Bid having the same tenor made at a lower Competitive Bid Rate unless the acceptance of such Competitive Bid made at a lower Competitive Bid Rate would subject the Borrower to any requirement to withhold any taxes or deduct any amount from any amounts payable under the Loan Documents, in which case the Borrower may reject such Competitive Bid made    at a lower Competitive Bid Rate,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">the aggregate amount of the Competitive Bids accepted by the Borrower shall not exceed the principal amount specified in the Competitive Bid Request therefor,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">if the Borrower shall desire to accept a Competitive Bid made at a  particular Competitive Bid Rate, it must accept all other Competitive Bids at such Competitive Bid Rate, except for any such Competitive Bid the acceptance of which would subject the Borrower to any requirement to withhold any taxes or deduct any amount from any amounts payable under the Loan Documents&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if the acceptance of all   such other Competitive Bids would cause the aggregate amount of all such accepted Competitive Bids to exceed the amount requested, then such acceptance shall be made pro rata in accordance with the amount of each such Competitive Bid at such Competitive Bid Rate,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">except pursuant to clause (3) above, no Competitive Bid shall be accepted unless the Competitive Bid Loan with respect thereto shall be in a minimum principal amount of $10,000,000 or an integral multiple of $1,000,000 in excess thereof, and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">no Competitive Bid shall be accepted and no Competitive Bid Loan shall  be made, if immediately after giving effect thereto, the Aggregate Credit Exposure would exceed the Aggregate Commitment Amount.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Administrative Agent shall promptly fax or email to each bidding Lender   (with a copy to the Borrower) a Competitive Bid Accept&#47;Reject Letter advising such Lender  whether its Competitive Bid has been accepted (and if accepted, in what amount and at what Competitive Bid Rate), and each successful bidder so notified will thereupon become bound,  subject to the applicable conditions hereof, to make the Competitive Bid Loan in respect of which each of its Competitive Bids has been accepted by making immediately available funds available    to the Administrative Agent at its address set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> not later than 1&#58;00 P.M. on the Borrowing Date for such Competitive Bid Loan in the amount thereof.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.02pt">Anything herein to the contrary notwithstanding, if the Administrative Agent shall elect to submit a Competitive Bid in its capacity as a Lender, it shall submit such bid directly to the Borrower not later than 9&#58;30 A.M. on the relevant proposed Borrowing Date.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">All notices required by this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be given in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Each Competitive Bid Loan shall be due and payable on the last day of the Competitive Interest Period applicable thereto or on such earlier date upon which the Loans shall become due and payable pursuant to the provisions hereof, whether by acceleration or otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Use of Proceeds</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower agrees that the proceeds of the Loans and Letters of Credit shall be used solely for    its general corporate purposes, but not inconsistent with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or any other provision of this Agreement, including, without limitation, the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and not in contravention of any applicable law, rule or regulation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Termination, Reduction or Increase of Commitments</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Termination on Commitment Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Unless previously terminated, the Commitments and the Letter of Credit Commitment shall terminate on the Commitment  Termination Date and the Swing Line Commitment shall terminate on the Swing Line Termination Date.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Voluntary Termination or Reductions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. At the Borrower&#8217;s option in its sole and absolute discretion and upon at least one Domestic Business Day&#8217;s prior irrevocable notice to the Administrative Agent, the Borrower may (i) terminate the Commitments, the Swing Line Commitment and the Letter of Credit Commitment, at any time, or (ii) permanently reduce the Aggregate Commitment Amount, the Swing Line Commitment or the Letter of Credit   Commitment, in part at any time and from time to time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that (1) each such partial reduction shall be in an amount equal to at least $5,000,000 or an integral multiple of $1,000,000 in excess thereof and (2) immediately after giving effect to each such reduction, (A) the Aggregate Commitment Amount shall equal or exceed the Aggregate Credit Exposure, (B) the Swing Line Commitment shall equal or exceed the aggregate outstanding principal balance of all Swing Line Loans and (C) the Letter of Credit Commitment shall equal or exceed the Letter of Credit Exposure of all Lenders&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, (x) notwithstanding the foregoing, a notice of termination of      the Commitments, the Swing Line Commitment and the Letter of Credit Commitment delivered by     the Borrower may state that such notice is conditioned upon the effectiveness of other credit facilities   or transactions (such notice to specify the proposed effective date), in which case such notice may  be revoked by the Borrower (by notice to the Administrative Agent on or prior to such specified effective date) if such condition is not satisfied and the Borrower shall indemnify the Lenders in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, if applicable and (y) the Administrative Agent and the Lenders who are a party to the Existing 364-Day Credit Agreement hereby (i) acknowledge and agree that the Existing 364-Day Credit Agreement shall be terminated and have no further force   and effect on and as of the Effective Date (other than those provisions which by their terms expressly survive the termination thereof), (ii) acknowledge and agree that the &#8220;Expiration Date&#8221; </font><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(as defined in the Existing 364-Day Credit Agreement) shall be deemed to have occurred on the Effective Date, (iii) acknowledge and agree that no Loans or other amounts are outstanding under the Existing 364-Day Credit Agreement, and (iv) waive any notice requirement pursuant to Section 2.6 of the Existing 364-Day Credit Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each reduction of the Aggregate Commitment Amount shall be made  by reducing each Lender&#8217;s Commitment Amount by an amount equal to the product of such Lender&#8217;s Commitment Percentage and the amount of such reduction.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Increase in Aggregate Commitment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower may at any time and from time to time prior to the 90</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> day prior to the then-applicable Commitment Termination Date,  </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">at its sole cost and expense, request any one or more of the Lenders having a Commitment to increase its Commitment Amount (the decision to increase the Commitment Amount of a Lender    to be within the sole and absolute discretion of such Lender), or any Eligible Assignee to provide     a new Commitment, by submitting to the Administrative Agent a Commitment Increase  Supplement, duly executed and delivered by the Borrower and each such Lender increasing its Commitment Amount or Eligible Assignee providing a new Commitment, as the case may be.   Upon receipt of any such Commitment Increase Supplement, the Administrative Agent, the Swing Line Lender and each Issuer shall promptly execute and deliver such Commitment Increase Supplement and the Administrative Agent shall deliver a copy thereof to the Borrower and each  such Lender or Eligible Assignee, as the case may be. Upon execution and delivery of such Commitment Increase Supplement by the Administrative Agent, the Swing Line Lender and each Issuer, (i) in the case of each such Lender increasing its Commitment Amount (an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Increasing Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), its Commitment Amount shall be increased to the amount set forth in such Commitment Increase Supplement, and (ii) in the case of each such Eligible Assignee providing a new Commitment (a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">New Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), such New Lender shall become a party hereto and have the rights and obligations of a Lender under the Loan Documents and its Commitment shall be as set forth in such Commitment Increase Supplement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">immediately after giving effect thereto, the sum of all increases in the Aggregate Commitment Amount made pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall not exceed $500,000,000&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">each such increase of the Aggregate Commitment Amount shall be in an amount not less than $25,000,000 or such amount plus an integral multiple of $5,000,000&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that an increase may be in a lesser amount if such increase is an increase of the entire remaining amount available under clause (1) above&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">no Default shall have occurred or be continuing on the effective date of    the increase&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">the representations and warranties contained in this Agreement shall be   true and correct in all material respects with the same effect as though such representations and warranties had been made on the effective date of such increase (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any representation and warranty that is qualified as to &#8220;materiality&#8221;, &#8220;Material Adverse&#8221; or similar language shall be true and correct (after giving effect to any qualification therein)    in all respects on such effective date), except those which are expressly specified to be  made as of an earlier date&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">in the case of each New Lender, the Commitment Amount assumed by  such New Lender shall not be less than $25,000,000&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">if Revolving Credit Loans would be outstanding immediately after giving effect to any such increase, then simultaneously with such increase (A) each such  Increasing Lender, each such New Lender and each other Lender shall be deemed to have entered into a master assignment and assumption, in form and substance substantially similar to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit E</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, pursuant to which each such other Lender shall have assigned to each such Increasing Lender and each such New Lender a portion of its Revolving Credit Loans necessary to reflect proportionately the Commitments as increased in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and (B) in connection with such assignment, each such Increasing Lender and each such New Lender shall pay to the Administrative Agent, for the account of each such other Lender, such amount as shall be necessary to reflect the assignment to it of such </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Revolving Credit Loans, and in connection with such master assignment each such other Lender may treat the assignment of Term SOFR Advances as a prepayment of such Term SOFR Advances for purposes of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">each such New Lender shall have delivered to the Administrative Agent    an Administrative Questionnaire and to the Administrative Agent and the Borrower all forms, if any, that are required to be delivered by such New Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(8)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">at least five Domestic Business Days prior to the effectiveness of such increase, if the Borrower qualifies as a &#8220;legal entity customer&#8221; under the Beneficial Ownership Regulation, it shall have delivered, to each Lender that so requests, a Beneficial Ownership Certification&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(9)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">the Administrative Agent shall have received such other customary certificates, resolutions and opinions as the Administrative Agent shall have reasonably requested.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Prepayments of Loans</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Voluntary Prepayments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Borrower may, in its sole and absolute discretion, prepay Revolving Credit Loans, Competitive Bid Loans or Swing Line Loans, in whole or in part, without premium or penalty, but subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, at any time and from time to time, by notifying the Administrative Agent (which notice shall be in a form reasonably acceptable to the Administrative Agent) at least two Domestic Business Days, in the case of a prepayment of Term SOFR Advances, two Domestic Business Days, in the case of a prepayment of Competitive Bid Loans, or one Domestic Business Day, in the case of a prepayment of Swing Line Loans or ABR Advances, prior to the proposed prepayment date specifying (i) the Loans to be prepaid, (ii) the amount to be prepaid, and (iii) the date of prepayment. Upon receipt of each such notice, the Administrative Agent shall promptly notify each Lender thereof. Each such notice given by the Borrower pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be irrevocable, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, if a notice of prepayment  is given in connection with a conditional notice of termination of the Commitments, the Swing Line Commitment and the Letter of Credit Commitment as contemplated by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, then such   notice of prepayment may be revoked if such notice of termination is revoked in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and the Borrower shall indemnify the Lenders in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, if applicable. Each partial prepayment under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be (A) in the case of Term SOFR Advances, in a minimum amount of $5,000,000 or an integral multiple of $1,000,000 in excess thereof or the entire remaining amount of Term SOFR Advances, (B) in the case of ABR Advances, in a minimum amount of $1,000,000 or an integral multiple of $100,000 in excess thereof or the entire remaining amount of ABR Advances, (C) in the case of Swing Line Loans, in a minimum amount of $500,000 or an integral multiple of $100,000 in excess thereof or the entire remaining amount of Swing Line Loans, and (D) in the case of Competitive Bid Loans, in a minimum amount of $5,000,000 or an integral multiple of $1,000,000 in excess thereof or the entire remaining amount of Competitive Bid Loans.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Simultaneously with each prepayment hereunder, the Borrower shall prepay all accrued and unpaid interest on the amount prepaid through the date of prepayment and indemnify the Lenders in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, if applicable.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Letter of Credit Sub-facility</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Subject to the terms and conditions hereof and the payment by the Borrower to   each Issuer of such fees as the Borrower and such Issuer shall have agreed in writing, each Issuer severally (and not jointly) agrees, in reliance on the agreement of the other Lenders set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to issue standby or commercial letters of credit (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and, collectively, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letters of Credit&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) during the Commitment Period for the account of the Borrower&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that immediately after the issuance of each Letter of Credit (i) the Letter of Credit Exposure of all Lenders shall not exceed the Aggregate Letter of Credit Commitment, (ii)   the Aggregate Credit Exposure shall not exceed the Aggregate Commitment Amount, (iii) the   Letter of Credit Exposure of such Issuer shall not exceed the Letter of Credit Commitment of such Issuer, and (iv) the Commercial Letter of Credit Exposure of such Issuer shall not exceed the Commercial Letter of Credit Commitment of such Issuer. Each Letter of Credit shall have an expiration date which shall be not later than, in the case of standby Letters of Credit, the earlier to occur of one year from the date of issuance thereof or 5 days prior to the Commitment Termination Date and, in the case of commercial Letters of Credit, the earlier to occur of 180 days from the date of issuance thereof or 5 days prior to the Commitment Termination Date. No Letter of Credit shall be issued if the Administrative Agent, or any Lender by notice to the Administrative Agent, and    the proposed Issuer shall have determined, no later than 3&#58;00 P.M. one Domestic Business Day   prior to the requested date of issuance of such Letter of Credit, that the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> have not been satisfied or waived.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Each Letter of Credit shall be issued at the request of the Borrower in support of    an obligation of the Borrower or any Subsidiary in favor of a beneficiary who has requested the issuance of such Letter of Credit. The Borrower shall give the Administrative Agent a Letter of Credit Request for the issuance of each Letter of Credit by 12&#58;00 Noon at least two Domestic Business Days prior to the requested date of issuance. Such Letter of Credit Request shall specify   (i) whether such Letter of Credit is a standby or commercial Letter of Credit, (ii) the beneficiary of such Letter of Credit and the obligations of the Borrower or the Subsidiary in respect of which such Letter of Credit is to be issued, (iii) the Borrower&#8217;s proposal as to the conditions under which a drawing may be made under such Letter of Credit and the documentation to be required in respect thereof, (iv) the maximum amount to be available under such Letter of Credit, (v) the requested   date of issuance, and (vi) the name of the proposed Issuer thereof. Upon receipt of such Letter of Credit Request from the Borrower, the Administrative Agent shall promptly notify the applicable Issuer and each Lender thereof. Such Issuer shall, on the proposed date of issuance and subject to  the terms and conditions of this Agreement, issue the requested Letter of Credit&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that in   the event such Issuer fails to issue such Letter of Credit or is a Defaulting Lender, any other Issuer may (in its sole and absolute discretion, and notwithstanding that its Letter of Credit Exposure may exceed its Letter of Credit Commitment, but with (x) the consent of the Borrower and (y) notice to the Administrative Agent) issue such Letter of Credit otherwise in accordance with the terms  hereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that immediately after the issuance thereof (A) the Letter of Credit Exposure of all Lenders shall not exceed the Aggregate Letter of Credit Commitment, and (B) the Aggregate Credit Exposure shall not exceed the Aggregate Commitment Amount. Each Letter of Credit shall be in form and substance reasonably satisfactory to the Issuer thereof, with such provisions with respect to the conditions under which a drawing may be made thereunder and the documentation required in respect of such drawing as such Issuer shall reasonably require. Each Letter of Credit shall be used solely for the purposes described therein. Each Letter of Credit Request and each Letter of Credit shall be subject to the standard terms and conditions for letters    of credit of the Issuer thereof (each as amended, supplemented or replaced from time to time, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Reimbursement Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) executed by the Borrower and delivered to such Issuer.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Each payment by an Issuer of a drawing under a Letter of Credit issued thereby  shall give rise to the obligation of the Borrower to promptly (and in any event within one Domestic Business Day) reimburse such Issuer for the amount thereof (together with any interest). Such  Issuer shall promptly notify the Borrower of such payment by such Issuer of a drawing under a Letter of Credit. In lieu of such notice, if the Borrower has not made reimbursement prior to the   end of the Domestic Business Day following the day during which such Issuer made such payment of such drawing, the Borrower hereby authorizes such Issuer to deduct the amount of any such reimbursement from such account(s) as the Borrower may from time to time designate in writing    to such Issuer, upon which such Issuer shall apply the amount of such deduction to such reimbursement. If all or any portion of any Reimbursement Obligation in respect of a Letter of Credit shall not be paid on the date that the Issuer thereof shall have made payment of a drawing under such Letter of Credit, the amount of such Reimbursement Obligation shall bear interest, at a rate per annum equal to the Alternate Base Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Applicable Margin applicable to ABR Advances, from the date such Issuer made such payment of such drawing until the end of the Domestic Business Day following the day during which such Issuer made such payment of such drawing (whether at the stated maturity thereof, by acceleration or otherwise), and from and after such Domestic Business Day (whether at the stated maturity thereof, by acceleration or otherwise), such Reimbursement Obligation shall bear interest, payable upon demand, at a rate per annum equal to the Alternate Base Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Applicable Margin applicable to ABR Advances </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 2%, from such due date until paid in full (whether before or after the entry of a judgment thereon).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">In the event of any conflict between the terms hereof and the terms of any Reimbursement Agreement or Letter of Credit Application, the terms hereof shall control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Letter of Credit Participation</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Each Lender hereby unconditionally and irrevocably, severally (and not jointly) takes an undivided participating interest in the obligations of each Issuer under and in connection with each Letter of Credit issued thereby in an amount equal to such Lender&#8217;s Commitment Percentage (as in effect from time to time) of the amount of such Letter of Credit. Each Lender   shall be liable to each Issuer for its Commitment Percentage of the unreimbursed amount of any drawing honored under each Letter of Credit issued thereby. Each Lender shall also be liable for    an amount equal to the product of its Commitment Percentage and any amounts paid by the Borrower pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that are subsequently rescinded or avoided, or must otherwise be restored or returned. Such liabilities shall be unconditional and without regard to the occurrence of any Default or the compliance by the Borrower with any of its obligations under the Loan Documents.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Each Issuer shall promptly notify the Administrative Agent, and the    Administrative Agent shall promptly notify each Lender (which notice shall be promptly confirmed in writing), of the date and the amount of each drawing paid under each Letter of Credit issued by such Issuer with respect to which full reimbursement payment shall not have been made by the Borrower as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and forthwith upon receipt of such notice, such Lender   shall promptly make available to the Administrative Agent for the account of such Issuer its Commitment Percentage of the amount of such unreimbursed drawing at the office of the Administrative Agent specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> in Dollars and in immediately available funds. The Administrative Agent shall distribute the payments made by each Lender pursuant to the immediately preceding sentence to such Issuer promptly upon receipt thereof in like funds as received. Each Lender shall indemnify and hold harmless the Administrative Agent and each Issuer from and against any and all losses, liabilities (including liabilities for penalties), actions, suits, judgments, demands, costs and expenses (including, without limitation, reasonable attorneys&#8217; fees </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and expenses) resulting from any failure on the part of such Lender to provide, or from any delay    in providing, the Administrative Agent with such Lender&#8217;s Commitment Percentage of the amount of any payment made by such Issuer under a Letter of Credit issued by such Issuer in accordance with this clause (b) (except in respect of losses, liabilities or other obligations suffered by the Administrative Agent or such Issuer, as the case may be, resulting from the gross negligence or willful misconduct of the Administrative Agent or such Issuer, as the case may be). If a Lender   does not make available to the Administrative Agent when due an amount equal to such Lender&#8217;s Commitment Percentage of any unreimbursed payment made by an Issuer under a Letter of Credit issued thereby, such Lender shall be required to pay interest to the Administrative Agent for the account of such Issuer on the unpaid portion of such amount at a rate of interest per annum equal    to (i) from the date such Lender should have made such amount available until the third day therefrom, the Federal Funds Effective Rate, and (ii) thereafter, the Federal Funds Effective Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 2%, in each case payable upon demand by such Issuer. The Administrative Agent shall distribute such interest payments to such Issuer upon receipt thereof in like funds as received.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Whenever the Administrative Agent is reimbursed by the Borrower, for the   account of an Issuer, for any payment under a Letter of Credit issued thereby and such payment relates to an amount previously paid by a Lender in respect of its Commitment Percentage of the amount of such payment under such Letter of Credit, the Administrative Agent (or such Issuer, if such payment by a Lender was paid by the Administrative Agent to such Issuer) will promptly pay over such payment to such Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Absolute Obligation with respect to Letter of Credit Payments</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower&#8217;s obligation to reimburse the Administrative Agent for the account of an Issuer for each payment under or in respect of each Letter of Credit issued thereby shall be absolute and unconditional under any and all circumstances and irrespective of any set-off, counterclaim or defense to payment which the Borrower may have or have had against the beneficiary of such Letter of Credit, the Administrative Agent, such Issuer, the Swing Line Lender, any Lender or any other Person, including, without limitation, any defense based on the failure of any drawing to conform to the terms of such Letter of Credit, any drawing document proving to be forged, fraudulent or invalid, or the legality, validity, regularity or enforceability of such Letter of Credit&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that, with respect to any Letter of Credit, the foregoing  shall not relieve the Issuer thereof of any liability it may have to the Borrower for any actual damages sustained by the Borrower arising from a wrongful payment (or failure to pay) under such Letter of Credit made as a result of such Issuer&#8217;s gross negligence or willful misconduct.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Notes</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any Lender may request that the Loans made by it be evidenced by a Note. In such event, the Borrower shall prepare, execute and deliver to such Lender a Note payable to such Person or, if requested  by such Person, such Person and its registered assigns.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Extension of Commitment Termination Date</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Request for Extension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Borrower may, in its sole and absolute discretion, by notice to the Administrative Agent (which shall promptly notify the Lenders) not more than 90   days and not less than 30 days prior to each of the first, second, third, fourth, fifth and, if the Borrower shall have exercised one such right to extend the Commitment Termination Date, sixth anniversary of the Effective Date (each such anniversary date, an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Extension Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), request (each, an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Extension Request</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) that the Lenders extend the Commitment Termination Date then in effect (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Existing Commitment Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) for an additional one-year period, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that  </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Borrower may only effect two such extensions of the Commitment Termination Date.  Each Lender, acting in its sole discretion, shall, by notice to the Borrower and the Administrative Agent given not later than the 20th day (or such later day as shall be acceptable to the Borrower) following the date of the Borrower&#8217;s notice, advise the Borrower and the Administrative Agent whether or    not such Lender agrees to such extension&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any Lender (which includes each Issuer   and the Swing Line Lender) that does not so advise the Borrower and the Administrative Agent  shall be deemed to have rejected such Extension Request. The election of any Lender to agree to such extension shall not obligate any other Lender to so agree.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Replacement of Non-Extending Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Borrower shall have the right at any time on or prior to the relevant Extension Date to replace any Lender which has not consented to   the Extension Request (each, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Non-Extending Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Conditions to Effectiveness of Extension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding anything in this Agreement to the contrary, the extension of the Existing Commitment Termination Date on any Extension Date shall not be effective unless, immediately before and immediately after giving   effect to such extension on such Extension Date&#58; (i) no Default shall have occurred and be continuing on such Extension Date and the representations and warranties contained in this Agreement shall be true and correct in all material respects with the same effect as though such representations and warranties had been made on such Extension Date (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that any representation and warranty that is qualified as to &#8220;materiality&#8221;, &#8220;Material Adverse&#8221; or similar language shall be true and correct (after giving effect to any qualification therein) in all respects on such Extension Date), except those which are expressly specified to be made as of an earlier date, and the Administrative Agent shall have received a certificate, in form and substance reasonably satisfactory to the Administrative Agent, to such effect from an Authorized Officer of the Borrower (or such other financial officer reasonably acceptable to the Administrative Agent), and (ii) the Administrative Agent shall have received such other customary certificates, resolutions and  opinions as the Administrative Agent may reasonably request.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Effectiveness of Extension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If (and only if) the conditions specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">2.12(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall have been satisfied or waived with respect to the extension of the Existing  Commitment Termination Date on the applicable Extension Date, then, effective as of such Extension Date, the Commitment Termination Date, with respect to the Commitment of each  Lender that has agreed to so extend its Commitment and of each Replacement Lender that has assumed a Commitment of a Non-Extending Lender in connection with such Extension Request, shall be extended to the date falling one year after the Existing Commitment Termination Date (or,  if such date is not a Domestic Business Day, the immediately preceding Domestic Business Day), and each such Replacement Lender shall thereupon become a &#8220;Lender&#8221; for all purposes of this Agreement. Notwithstanding anything herein to the contrary, (i) with respect to any portion of the Commitment of any Non-Extending Lender that has not been fully assumed by one or more Replacement Lenders, the Commitment Termination Date for such Lender with respect to such   non-assumed portion of its Commitment shall remain unchanged, and (ii) with respect to any Loans of such Lender that have not been purchased by one or more Replacement Lenders, the applicable maturity date with respect to such non-purchased Loans shall remain unchanged and shall be repayable by the Borrower on such applicable maturity date without there being any requirement that any such repayment be shared with other Lenders. In addition, on the Extension Date, the Borrower agrees to pay all accrued and unpaid interest, fees and other amounts then due under this Agreement from the Borrower to each Lender consenting to the Extension Request, each            Non-Extending Lender and each Replacement Lender. Solely for the purpose of calculating break funding payments under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the assignment by any Non-Extending Lender of any Term SOFR Advance prior to the last day of the Interest Period applicable thereto in accordance with    </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be deemed to constitute a prepayment by the Borrower of such Term SOFR Advance.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Defaulting Lenders</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding any provision of this Agreement to the contrary, if any Lender becomes a Defaulting Lender, then the following provisions shall apply for so long as such Lender is a Defaulting Lender&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Facility Fees shall cease to accrue, and shall not be payable, on the unfunded  portion of the Commitment of such Defaulting Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">the Commitment and Credit Exposure of such Defaulting Lender shall not be included in determining whether all Lenders or the Required Lenders have taken or may take any action hereunder (including any consent to any amendment or waiver pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, notwithstanding the foregoing, any waiver, amendment or modification with respect to the following shall require the consent of such Defaulting Lender&#58; (i) any waiver, amendment or modification requiring the consent of all Lenders or each affected Lender which affects such Defaulting Lender in a manner that is materially adverse in comparison to the other affected Lenders, (ii) any waiver, amendment or modification increasing the Commitment of such  Defaulting Lender, (iii) any waiver, amendment or modification extending the Commitment Period with respect to such Defaulting Lender, (iv) any waiver, amendment or modification reducing the principal amount owed under the Loan Documents to such Defaulting Lender (other than by payment thereof), or (v) any waiver, amendment or modification extending the final maturity of sums owed to such Defaulting Lender, or (vi) a modification of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.13(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">if any Swing Line Exposure or Letter of Credit Exposure exists at the time a Lender becomes a Defaulting Lender then&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">all or any part of such Defaulting Lender&#8217;s Swing Line Exposure and   Letter of Credit Exposure shall be reallocated among the non-Defaulting Lenders in accordance with their respective Commitment Percentages but only to the extent that (A)  the sum of all non-Defaulting Lenders&#8217; Committed Credit Exposures </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, without duplication, the amount of such Defaulting Lender&#8217;s Swing Line Exposure and Letter of Credit Exposure reallocated to such non-Defaulting Lenders, does not exceed the total of   all non-Defaulting Lenders&#8217; Commitments and (B) with respect to each non-Defaulting Lender, the sum of such non-Defaulting Lender&#8217;s Committed Credit Exposure </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,   without duplication, the amount of such Defaulting Lender&#8217;s Swing Line Exposure and Letter of Credit Exposure reallocated to such non-Defaulting Lender, does not exceed such non-Defaulting Lender&#8217;s Commitment&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">if the reallocation described in clause (1) above cannot, or can only partially, be effected, the Borrower shall within one Domestic Business Day following notice by the Administrative Agent (A) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, prepay such Swing Line Exposure and (B) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, cash collateralize such Defaulting Lender&#8217;s Letter of Credit Exposure (after giving effect to any partial reallocation pursuant to clause (1) above) in a manner reasonably satisfactory to the Administrative Agent and the Issuers of the Letters of Credit of which shall be outstanding at such time for so long as such Letter of Credit Exposure is outstanding&#59;</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">if the Borrower cash collateralizes any portion of such Defaulting Lender&#8217;s Letter of Credit Exposure pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.13(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Borrower shall not be required to pay any Letter of Credit Participation Fees to such Defaulting Lender pursuant  to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> with respect to such Defaulting Lender&#8217;s Letter of Credit Exposure during the period such Defaulting Lender&#8217;s Letter of Credit Exposure is cash collateralized&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">if the Swing Line Exposure or Letter of Credit Exposure of such   Defaulting Lender is reallocated pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.13(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, then the fees payable to  the Lenders pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline"> Section 3.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be adjusted to give effect to  such reallocation, and the Administrative Agent shall promptly notify the Lenders of any reallocation described in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.13(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">so long as any Lender is a Defaulting Lender, the Swing Line Lender shall not be required to fund any Swing Line Loan and no Issuer shall be required to issue, amend, extend or increase any Letter of Credit, unless it is satisfied that the related exposure will be 100% covered   by the Commitments of the non-Defaulting Lenders and&#47;or cash collateral will be provided by the Borrower in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.13(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and participating interests in any such newly issued, amended, extended or increased Letter of Credit or newly funded Swing Line Loan shall be allocated among non-Defaulting Lenders in a manner consistent with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.13(c)(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (and Defaulting Lenders shall not participate therein)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">any amount payable to such Defaulting Lender hereunder (whether on account of principal, interest, fees or otherwise and including any amount that would otherwise be payable to such Defaulting Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> but excluding </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and other than any amount constituting Facilities Fees or Letter of Credit Participation Fees which are not payable to such Defaulting Lender in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 2.13(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">2.13(c)(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) shall, in lieu of being distributed to such Defaulting Lender, be retained by the Administrative Agent in a segregated account and, subject to any applicable requirements of law, be applied at such time or times as may be determined by the Administrative Agent (i) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment of any amounts owing by such Defaulting Lender to the Administrative Agent hereunder, (ii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, pro rata, to the payment of any amounts owing by such Defaulting Lender to the Issuers and the Swing Line Lender hereunder, (iii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">third</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, if so determined by the Administrative Agent and the Borrower or if requested by any Issuer or the Swing Line Lender, held in such account as cash collateral for future funding obligations of the Defaulting Lender in respect of any existing or future participating interest in any Swing Line Loan or Letter of Credit, (iv) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">fourth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the funding of any Revolving Credit Loan (including any Mandatory Borrowing) in respect of which such Defaulting Lender has failed to   fund its portion thereof as required by this Agreement, as determined by the Administrative Agent, (v) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">fifth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, if so determined by the Administrative Agent and the Borrower, held in such account as cash collateral for future funding obligations of the Defaulting Lender in respect of any Revolving Credit Loans (including any Mandatory Borrowings) under this Agreement, (vi) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">sixth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment of any amounts owing to the Lenders, the Issuers or the Swing Line Lender as a result of any final and non-appealable judgment of a court of competent jurisdiction obtained by any Lender, any Issuer or the Swing Line Lender against such Defaulting Lender as a result of such Defaulting Lender&#8217;s breach of its obligations under this Agreement, (vii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">seventh</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment of any amounts owing to the Borrower as a result of any final and non-appealable judgment of a court of competent jurisdiction obtained by the Borrower against such Defaulting Lender as a result of such Defaulting Lender&#8217;s breach of its obligations under this Agreement, and (viii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">eighth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to such Defaulting Lender or as otherwise directed by a court of competent jurisdiction&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if  such payment is (x) a prepayment of the principal amount of any Revolving Credit Loan (including any Mandatory Borrowing) or Reimbursement Obligations in respect of drawings under Letters of Credit paid by an Issuer with respect to which a Defaulting Lender has funded its participation </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">obligations and (y) made at a time when the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> are satisfied or waived, such payment shall be applied solely to prepay the Revolving Credit Loans (including Mandatory Borrowings) of, and Reimbursement Obligations owed to, all non-Defaulting Lenders pro rata prior to being applied to the prepayment of any Loans, or Reimbursement Obligations owed to, any Defaulting Lender&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.02pt">the Borrower shall have the right at any time during which a Lender is a Defaulting Lender to replace such Defaulting Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, no reallocation pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.13(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall   constitute a waiver or release of any claim of any party hereunder against a Defaulting Lender arising from a Lender having become a Defaulting Lender, including any claim of a non-Defaulting Lender as a result of such non-Defaulting Lender&#8217;s increased exposure following such reallocation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">ESG Adjustments</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Borrower, in consultation with the Sustainability Coordinator, shall be   entitled, in its sole discretion, to establish specified key performance indicators (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">KPIs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) with respect to certain environmental, social and governance (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">ESG</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) targets of the Borrower and its Subsidiaries.  The Sustainability Coordinator and the Borrower, with the consent of the Required Lenders, may amend this Agreement (such amendment, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">ESG Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) solely for the purpose of incorporating the KPIs and other related provisions (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">ESG Pricing Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) into this Agreement.  Upon the effectiveness of any such ESG Amendment, based on the Borrower&#8217;s performance against the KPIs, certain adjustments (increase, decrease or no adjustment) (such adjustments, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">ESG Applicable Margin Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) to the otherwise applicable Applicable Margin for Term SOFR Advances, ABR Advances, Letter of Credit Participation Fees, and the Facility Fee may be made&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the amount of such adjustments shall not exceed (i) in the case of the Applicable Margin for the Facility Fee, an increase and&#47;or decrease of 0.005% for any one KPI, or 0.01% in the aggregate for all KPIs and (ii) in the case of the Applicable Margin for Term SOFR Advances, ABR Advances, and Letter of Credit Participation Fees, an increase and&#47;or decrease of 0.02% for any one KPI, or 0.04% in the aggregate for all KPIs&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, in no event shall the Applicable Margin for Term SOFR Advances, ABR Advances, Letter of Credit Participation Fees, or the Facility Fee be less than zero.  The KPIs, the Borrower&#8217;s performance against the KPIs, and any related ESG Applicable Margin Adjustments resulting therefrom, will be determined based on certain certificates, reports and other documents, in each case, setting forth    the calculation and measurement of the KPIs in a manner that is aligned with the Sustainability Linked Loan Principles and to be mutually agreed between the Borrower and the Sustainability Coordinator (each acting reasonably).  Following the effectiveness of an ESG Amendment, any modification to the ESG Pricing Provisions shall be subject only to the consent of the Required Lenders so long as such modification does not have the effect of reducing the Applicable Margin   for Term SOFR Advances, ABR Advances, Letter of Credit Participation Fees, or the Facility Fee  to a level not otherwise permitted by this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.14(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">The Sustainability Coordinator will (i) assist the Borrower in determining the ESG Pricing Provisions in connection with the ESG Amendment and (ii) assist the Borrower in preparing informational materials focused on ESG to be used in connection with the ESG Amendment.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">This </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall supersede any provisions in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> to the contrary.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">PROCEEDS, PAYMENTS, CONVERSIONS, INTEREST, YIELD PROTECTION AND FEES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Disbursement of the Proceeds of the Loans</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall disburse the proceeds of the Loans (other than the Swing Line Loans) at its office specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> by crediting to the Borrower&#8217;s general deposit account with    the Administrative Agent the funds received from each Lender. Unless the Administrative Agent shall have received prior notice from a Lender (by telephone or otherwise, such notice to be confirmed by fax, email   or other writing) that such Lender will not make available to the Administrative Agent such Lender&#8217;s Commitment Percentage of the Revolving Credit Loans, or the amount of any Competitive Bid Loan, to be made by it on a Borrowing Date, the Administrative Agent may assume that such Lender has made such amount available to the Administrative Agent on such Borrowing Date in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, in the case of a Revolving Credit Loan, such Lender received notice thereof from the Administrative Agent in accordance with the terms hereof, and the Administrative Agent may, in reliance upon such assumption, make available to the Borrower on such Borrowing Date a corresponding amount.    If and to the extent that such Lender shall not have so made such amount available to the Administrative Agent, such Lender and the Borrower severally agree to pay to the Administrative Agent, forthwith on demand, such corresponding amount (to the extent not previously paid by the other), together with interest thereon for each day from the date such amount is made available to the Borrower until the date such  amount is paid to the Administrative Agent, at a rate per annum equal to, in the case of the Borrower, the applicable interest rate set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.4(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and, in the case of such Lender, the Federal Funds  Effective Rate from the date such payment is due until the third day after such date and, thereafter, at the Federal Funds Effective Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 2%. Any such payment by the Borrower shall be without prejudice to its rights against such Lender. If such Lender shall pay to the Administrative Agent such corresponding  amount, such amount so paid shall constitute such Lender&#8217;s Loan as part of such Loans for purposes of this Agreement, which Loan shall be deemed to have been made by such Lender on the Borrowing Date applicable to such Loans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Payments</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Each payment, including each prepayment, of principal and interest on the Loans and of the Facility Fee and the Letter of Credit Participation Fee (collectively, together with all of the other fees to be paid to the Administrative Agent, the Lenders, the Issuers and the Swing Line Lender in connection with, and pursuant to the terms of, the Loan Documents, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Fees&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), and of all of the other amounts to be paid to the Administrative Agent and the Lenders in connection with, and pursuant to the terms of, the Loan Documents (other than amounts payable to a Lender under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) shall be made by the Borrower to the Administrative Agent at its office specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> without condition, recoupment, defense, setoff, deduction or counterclaim in funds immediately available in New   York by 3&#58;00 P.M. on the due date for such payment. The failure of the Borrower to make any such payment by such time shall not constitute a default hereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such payment is made on such due date, but any such payment made after 3&#58;00 P.M. on such due date shall be deemed to have been made on the next Domestic Business Day for the purpose of calculating interest on amounts outstanding on the Loans. If the Borrower has not made any such payment prior to 3&#58;00 P.M., the Borrower hereby authorizes the Administrative Agent to deduct the amount of any such payment from such account(s) as the Borrower may from time to time designate in writing to the Administrative Agent, upon which the Administrative Agent shall apply the amount of such deduction to such payment. Promptly upon receipt thereof by the Administrative Agent, each payment of principal and interest on the&#58; (i) Revolving Credit Loans shall be remitted by the Administrative Agent in like funds as received to each Lender (a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, pro rata according to the </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">amount of interest which is then due and payable to the Lenders, and (b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, pro rata according to the amount of principal which is then due and payable to the Lenders, (ii) Competitive Bid Loans shall be remitted by the Administrative Agent in like funds as received to each applicable Lender and (iii) Swing Line Loans shall be remitted by the Administrative Agent in like funds as received  to the Swing Line Lender. Each payment of the Facility Fee and the Letter of Credit Participation Fee payable to the Lenders shall be promptly transmitted by the Administrative Agent in like funds as received to each Lender pro rata according to such Lender&#8217;s Commitment Amount or, if the Commitments shall have terminated or been terminated, according to the outstanding principal amount of such Lender&#8217;s Revolving Credit Loans.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">If any payment hereunder or under the Loans shall be due and payable on a day which is not a Domestic Business Day the due date thereof (except as otherwise provided in the definition of Term SOFR Interest Period or Competitive Interest Period) shall be extended to the next Domestic Business Day and (except with respect to payments in respect of the Facility Fee   and the Letter of Credit Participation Fee) interest shall be payable at the applicable rate specified herein during such extension.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Unless the Administrative Agent shall have received notice from the Borrower  prior to the date on which any payment is due to the Administrative Agent for the account of the Lenders or any of the Issuers hereunder that the Borrower will not make such payment, the Administrative Agent may assume that the Borrower has made such payment on such date in accordance herewith and may, in reliance upon such assumption, distribute to the applicable  Lenders or the applicable Issuers, as the case may be, the amount due.  With respect to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any payment that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Administrative Agent makes for the account of the Lenders or any of the Issuers hereunder as to which the Administrative Agent determines (which determination shall be conclusive absent manifest error) that any of the following applies (such payment referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Rescindable Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#58; (1) the Borrower has not in fact made such payment&#59; (2) the Administrative Agent has made a payment in excess of the amount so paid by the Borrower (whether or not then owed)&#59; or   (3) the Administrative Agent has for any reason otherwise erroneously made such payment&#59; then each of the Lenders or the applicable Issuers, as the case may be, severally agrees to repay to the Administrative Agent forthwith on demand the Rescindable Amount so distributed to such Lender  or such Issuer, in immediately available funds with interest thereon, for each day from and  including the date such amount is distributed to it to but excluding the date of payment to the Administrative Agent, at the greater of the Federal Funds Effective Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Conversions&#59; Other Matters</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Borrower may elect at any time and from time to time to Convert one or more Term SOFR Advances to an ABR Advance by giving the Administrative Agent at least one Domestic Business Day&#8217;s prior irrevocable notice of such election (in the form of a Borrowing Request), specifying the amount to be so Converted. In addition, the Borrower may elect at any   time and from time to time to Convert an ABR Advance to any one or more new Term SOFR Advances or to Convert any one or more existing Term SOFR Advances to any one or more new Term SOFR Advances by giving the Administrative Agent no later than 10&#58;00 A.M. at least two Domestic Business Days&#8217; prior irrevocable notice of such election (in the form of a Borrowing Request), specifying the amount to be so Converted and the initial Interest Period relating thereto&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any Conversion of an ABR Advance to an Term SOFR Advance shall only be made  on a Domestic Business Day&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, notwithstanding the foregoing, a Borrowing Request for a Conversion delivered by the Borrower may state that such Borrowing Request is conditioned upon the effectiveness of other credit facilities or transactions (such Borrowing   </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Request to specify the proposed effective date), in which case such Borrowing Request may be revoked by the Borrower (by notice to the Administrative Agent prior to the day specified for such Conversion in such Borrowing Request) if such condition is not satisfied and the Borrower shall indemnify the Lenders in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, if applicable. The Administrative Agent   shall promptly provide the Lenders with notice of each such election. Each Conversion of Loans shall be made pro rata according to the outstanding principal amount of the Loans of each Lender. ABR Advances and Term SOFR Advances may be Converted pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> in whole or in part&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the amount to be Converted to each Term SOFR Advance, when aggregated with any Term SOFR Advance to be made on such date in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and having the same Interest Period as such first Term SOFR Advance, shall equal no less than $10,000,000    or an integral multiple of $1,000,000 in excess thereof or the entire remaining amount of the Term SOFR Advances.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Notwithstanding anything in this Agreement to the contrary, the Borrower shall    not have the right to elect to Convert any existing ABR Advance to a Term SOFR Advance or to Convert any existing Term SOFR Advance to a new Term SOFR Advance if (i) a Default or an Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(h),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall then exist, or (ii) any other Event of Default shall then exist and the Administrative Agent   shall have notified the Borrower at the request of the Required Lenders that no ABR Advance or Term SOFR Advance may be Converted to a new Term SOFR Advance. In such event, such ABR Advance shall be automatically continued as an ABR Advance or such Term SOFR Advance shall be automatically Converted to an ABR Advance on the last day of the Interest Period applicable to such Term SOFR Advance. The foregoing shall not affect any other rights or remedies that the Administrative Agent or any Lender may have under this Agreement or any other Loan Document.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Each Conversion shall be effected by each Lender by applying the proceeds of   each new ABR Advance or Term SOFR Advance, as the case may be, to the existing ABR Advance or Term SOFR Advance (or portion thereof) being Converted (it being understood that such Conversion shall not constitute a borrowing for purposes of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Notwithstanding any other provision of any Loan Document&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">if the Borrower shall have failed to elect a Term SOFR Advance under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as the case may be, in connection with any borrowing of  new Revolving Credit Loans or expiration of an Interest Period with respect to any existing Term SOFR Advance, the amount of the Revolving Credit Loans subject to such borrowing or such existing Term SOFR Advance shall thereafter be an ABR Advance until such time, if any, as the Borrower shall elect a new Term SOFR Advance pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">the Borrower shall not be permitted to select a Term SOFR Advance the Interest Period in respect of which ends later than the Commitment Termination Date or such earlier date upon which all of the Commitments shall have been terminated in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">the Borrower shall not be permitted to have more than (x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">15 Term SOFR Advances and (y) 15 Competitive Bid Loans outstanding at any one time&#59; it being understood and agreed that each borrowing of Term SOFR Advances or Competitive Bid Loans pursuant to a single Borrowing Request or Competitive Bid Request, as the case   may be, shall constitute the making of one Term SOFR Advance or Competitive Bid Loan for the purpose of calculating such limitation.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Interest Rates and Payment Dates.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Prior to Maturity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Except as otherwise provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.4(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">3.4(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Loans shall bear interest on the unpaid principal balance thereof at the applicable interest rate or rates per annum set forth below&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.800%"><tr><td style="width:1.0%"></td><td style="width:36.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:61.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#d9d9d9;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">LOANS</font></td><td colspan="3" style="background-color:#d9d9d9;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">RATE</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Revolving Credit Loans constituting ABR Advances</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Alternate Base Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the Applicable Margin.</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Revolving Credit Loans constituting Term SOFR Advances</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Term SOFR applicable thereto </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the Applicable Margin.</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Competitive Bid Loans</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Fixed rate of interest applicable thereto accepted by the Borrower pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.4(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Swing Line Loans</font></td><td colspan="3" style="border-bottom:0.5pt solid #000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Negotiated Rate applicable thereto as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.2(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (or if not available, the Term SOFR Daily Floating Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the Applicable Margin).</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Late Payment Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Any payment of principal or interest on the Loans, Fees or  other amounts payable by the Borrower under the Loan Documents not paid on the date when due and payable shall, after the occurrence and during the continuance of an Event of Default pursuant  to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, bear interest, in the case of principal or interest on    a Loan, at the applicable interest rate on such Loan </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 2% per annum and, in the case of any Fees or other amounts, at the Alternate Base Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Applicable Margin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 2% per annum, in  each case from the due date thereof until the date such payment is made (whether before or after   the entry of any judgment thereon).</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Highest Lawful Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding anything to the contrary contained in this Agreement, at no time shall the interest rate payable to any Lender on any of its Loans, together  with the Fees and all other amounts payable hereunder to such Lender to the extent the same constitute or are deemed to constitute interest, exceed the Highest Lawful Rate. If, in respect of any period during the term of this Agreement, any amount paid to any Lender hereunder, to the extent the same shall (but for the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) constitute or be deemed to constitute interest, would exceed the maximum amount of interest permitted by the Highest Lawful Rate during such period (such amount being hereinafter referred to as an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Unqualified Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), then  (i) such Unqualified Amount shall be applied or shall be deemed to have been applied as a prepayment of the Loans of such Lender, and (ii) if, in any subsequent period during the term of   this Agreement, all amounts payable hereunder to such Lender in respect of such period which constitute or shall be deemed to constitute interest shall be less than the maximum amount of  interest permitted by the Highest Lawful Rate during such period, then the Borrower shall pay to such Lender in respect of such period an amount (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Compensatory Interest Payment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) equal to the lesser of (x) a sum which, when added to all such amounts, would equal the maximum amount of interest permitted by the Highest Lawful Rate during such period, and (y) an amount equal to    the aggregate sum of all Unqualified Amounts </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">less</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> all other Compensatory Interest Payments.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Interest shall be payable in arrears on each Interest Payment Date, on the Commitment Termination Date, to the extent provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, upon each prepayment of </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Loans and, to the extent provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.12(d), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">on the Extension Date. Any change in the interest rate on the Loans resulting from an increase or a decrease in the Alternate Base Rate or any reserve requirement shall become effective as of the opening of business on the day on which such change shall become effective.  Each determination by the Administrative Agent of the Alternate Base Rate, Term SOFR and the Competitive Bid Rate pursuant to this Agreement shall be conclusive and binding on the Borrower absent manifest error. The Borrower acknowledges that to the extent interest payable on the Loans is based on the Alternate Base Rate, such rate is only one   of the bases for computing interest on loans made by the Lenders, and by basing interest payable    on ABR Advances on the Alternate Base Rate, the Lenders have not committed to charge, and the Borrower has not in any way bargained for, interest based on a lower or the lowest rate at which    the Lenders may now or in the future make extensions of credit to other Persons. All interest (other than interest calculated with reference to the Alternate Base Rate) shall be calculated on the basis   of a 360-day year for the actual number of days elapsed, and all interest determined with reference  to the Alternate Base Rate shall be calculated on the basis of a 365&#47;366-day year for the actual number of days elapsed.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">No Warranty</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> The Administrative Agent does not warrant, nor accept   responsibility for, nor shall the Administrative Agent have any liability with respect to, the administration, submission or any other matter related to any reference rate referred to herein or  with respect to any rate (including, for the avoidance of doubt, the selection of such rate and any related spread or other adjustment) that is an alternative or replacement for or successor to any such rate (including, without limitation, any Successor Rate) (or any component of any of the foregoing) or the effect of any of the foregoing, or of any Conforming Changes&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the foregoing shall not apply to any liability arising out of the bad faith, willful misconduct or gross negligence    of the Administrative Agent.  The Administrative Agent and its affiliates or other related entities may engage in transactions or other activities that affect any reference rate referred to herein, or   any alternative, successor or replacement rate (including, without limitation, any Successor Rate)  (or any component of any of the foregoing) or any related spread or other adjustments thereto, in each case, in a manner adverse to the Borrower.&#160; The Administrative Agent may select information sources or services in its reasonable discretion to ascertain any reference rate referred to herein or any alternative, successor or replacement rate (including, without limitation, any Successor Rate)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or any component of any of the foregoing), in each case pursuant to the terms of this Agreement, and shall have no liability to the Borrower, any Lender or any other person or entity for damages    of any kind, including direct or indirect, special, punitive, incidental or consequential damages, costs, losses or expenses (whether in tort, contract or otherwise and whether at law or in equity),    for any error or other action or omission related to or affecting the selection, determination, or calculation of any rate (or component thereof) provided by any such information source or service&#59; provided that the foregoing shall not apply to any liability arising out of the bad faith, willful misconduct or gross negligence of the Administrative Agent.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Indemnification for Loss</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding anything contained herein to the contrary, if&#58; (i) the Borrower shall fail to borrow   a Term SOFR Advance or if the Borrower shall fail to Convert all or any portion of any Revolving Credit Loan constituting an ABR Advance to a Term SOFR Advance after it shall have given notice to do so in which it shall have requested a Term SOFR Advance pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as the case   may be, (ii) the Borrower shall fail to borrow a Competitive Bid Loan after it shall have accepted any offer with respect thereto in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, (iii) a Term SOFR Advance or Competitive Bid Loan shall be terminated for any reason prior to the last day of the Interest Period applicable thereto, (iv) any repayment or prepayment of the principal amount of a Term SOFR Advance or Competitive Bid Loan is made for any reason on a date which is prior to the last day of the Interest Period applicable thereto, (v) the </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Borrower shall have revoked a notice of prepayment or notice of termination of the Commitments and the Letter of Credit Commitment that was conditioned upon the effectiveness of other credit facilities or transactions pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, or (vi) a Term SOFR Advance is assigned other than on the last day of the Interest Period applicable thereto as a result of an increase in the Aggregate Commitment Amount pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or a replacement of a Lender pursuant to clause (x) or (z) of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, then the Borrower agrees to indemnify each Lender against, and to pay on demand directly to such Lender the amount (calculated by such Lender using any method chosen by such Lender which is customarily used by such Lender for such purpose for borrowers similar to the Borrower) equal to any loss or expense suffered by such Lender as a result of such failure to borrow or Convert, or such termination, repayment, prepayment or revocation, including any loss, cost or expense suffered by such Lender in liquidating or employing deposits acquired to fund or maintain the funding of such Term SOFR Advance or Competitive Bid Loan, as the case may be, or redeploying funds prepaid or repaid, in amounts which correspond to such Term SOFR Advance or Competitive Bid Loan, as the case may be, and any reasonable internal processing charge customarily charged by such Lender in connection therewith for borrowers similar to the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Reimbursement for Costs, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If at any time or from time to time there shall occur a Regulatory Change and any Issuer or any Lender shall have reasonably determined that such Regulatory Change (i) shall have had or will thereafter have the effect of reducing (A) the rate of return on such Issuer&#8217;s or such Lender&#8217;s capital or liquidity or    the capital or liquidity of any Person directly or indirectly owning or controlling such Issuer or such Lender (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Control Person&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), or (B) the asset value (for capital or liquidity purposes) to such Issuer, such Lender or such Control Person, as applicable, of the Reimbursement Obligations, or any participation therein, or the Loans, or any participation therein, in any case to a level below that which such Issuer, such Lender or such Control Person could have achieved or would thereafter be able to achieve but for such Regulatory Change (after taking into account such Issuer&#8217;s, such Lender&#8217;s or such Control Person&#8217;s policies regarding capital or liquidity), (ii) will impose, modify or deem applicable any reserve, asset, special deposit or special assessment requirements on Term SOFR Advances, or (iii) will subject such Issuer, such Lender or such Control Person, as applicable, to any tax (documentary, stamp or otherwise) with respect to this Agreement, any Note, any Reimbursement Agreement or any other Loan Document (except, in the case of clause (iii) above, for any Indemnified Taxes, Excluded Taxes or Other Taxes), then, in each such case, within ten days after demand by such Issuer or such Lender, as applicable, the Borrower shall pay directly   to such Issuer, such Lender or such Control Person, as the case may be, such additional amount or amounts as shall be sufficient to compensate such Issuer, such Lender or such Control Person, as the case may be,   for any such reduction, reserve or other requirement, tax, loss, cost or expense (excluding general administrative and overhead costs) (collectively, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Costs&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) attributable to such Issuer&#8217;s, such Lender&#8217;s or such Control Person&#8217;s compliance during the term hereof with such Regulatory Change, but only if such Costs are generally applicable to (and for which reimbursement is generally being sought by such Issuer, such Lender or such Control Person, as applicable, in respect of) credit transactions similar to this transaction from similarly situated borrowers (which are parties to credit or loan documentation containing   a provision similar to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), as determined by such Issuer or such Lender, as applicable, in its reasonable discretion. Each Issuer and each Lender may make multiple requests for compensation under   this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, the Borrower will not be required to compensate any Issuer or any Lender for any Costs under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> arising prior to 45 days preceding the date of demand, unless   the applicable Regulatory Change giving rise to such Costs is imposed retroactively in which case the 45- day period referred to above shall be extended to include the period of retroactive effect thereof. In the case of retroactivity, such notice shall be provided to the Borrower not later than 45 days from the date that such Issuer or such Lender learned of such Regulatory Change. The Borrower&#8217;s obligation to compensate such Issuer or such Lender shall be contingent upon the provision of such timely notice (but any failure by such </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Issuer or such Lender to provide such timely notice shall not affect the Borrower&#8217;s obligations with respect to (i) Costs incurred from the date as of which such Regulatory Change became effective to the date that is 45 days after the date such Issuer or such Lender reasonably should have learned of such Regulatory Change and (ii) Costs incurred following the provision of such notice).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Illegality of Funding</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding any other provision hereof, if any Lender shall reasonably determine that any law, regulation, treaty or directive, or any change therein or in the interpretation or application thereof, shall  make it unlawful for such Lender to make or maintain Loans whose interest rates are based upon SOFR or Term SOFR, such Lender shall promptly notify the Borrower and the Administrative Agent thereof, and    (a) the commitment of such Lender to make such Term SOFR Advances or to Convert ABR Advances to Term SOFR Advances shall forthwith be suspended, (b) such Lender shall fund its portion of each requested Term SOFR Advance as an ABR Advance, (c) such Lender&#8217;s Loans then outstanding as such Term SOFR Advances, if any, shall be Converted automatically to an ABR Advance on the last day of the then-current Interest Period applicable thereto or at such earlier time as may be required and (d) if such notice asserts    the illegality of such Lender making or maintaining ABR Advances the interest rate on which is determined by reference to One Month SOFR Rate, the interest rate on which ABR Advances of such Lender shall, if necessary to avoid such illegality, be determined by the Administrative Agent without reference to the One Month SOFR Rate component of the Alternate Base Rate.  If the commitment of any Lender with respect    to Term SOFR Advances is suspended pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and such Lender shall have obtained actual knowledge that it is once again legal for such Lender to make or maintain Term SOFR Advances, such Lender shall promptly notify the Administrative Agent and the Borrower thereof and, upon delivery     of such notice to each of the Administrative Agent and the Borrower, such Lender&#8217;s commitment to make    or maintain Term SOFR Advances shall be reinstated. If the commitment of any Lender with respect to Term SOFR Advances is suspended pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, such suspension shall not otherwise affect such Lender&#8217;s Commitment. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Option to Fund&#59; Substituted Interest Rate</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Each Lender has indicated that, if the Borrower requests a Term SOFR Advance    or a Competitive Bid Loan, such Lender may wish to purchase one or more deposits in order to   fund or maintain its funding of its Commitment Percentage of such Term SOFR Advance or Competitive Bid Loan during the Interest Period with respect thereto&#59; it being understood that the provisions of this Agreement relating to such funding are included only for the purpose of determining the rate of interest to be paid in respect of such Term SOFR Advance or Competitive Bid Loan and any amounts owing under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Each Lender shall be entitled to fund and maintain its funding of all or any part of each Term SOFR Advance and Competitive Bid Loan in any manner it sees fit, but all such determinations hereunder shall be made as if such Lender had actually funded and maintained its Commitment Percentage of each Term SOFR Advance or Competitive Bid Loan, as the case may be, during the applicable Interest Period through the purchase of deposits in an amount equal to the amount of its Commitment Percentage of such Term SOFR Advance or Competitive Bid Loan, as the case may be, and having a maturity corresponding to such Interest Period. Each Lender may fund its Advances from or for the account of any branch or office of such Lender as such Lender may choose from time to time, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">If in connection with any request for a Term SOFR Advance or a Conversion to or continuation thereof, as applicable, (i) the Administrative Agent determines (which determination shall be conclusive absent manifest error) that (A) no Successor Rate has been determined in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and the circumstances under clause (i) of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or the </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Scheduled Unavailability Date has occurred or (B) adequate and reasonable means do not otherwise exist for determining (1) Term SOFR for any requested Term SOFR Interest Period with respect to  a proposed Term SOFR Advance or (2) the One Month SOFR Rate in connection with an existing  or proposed ABR Advance or (ii) the Administrative Agent or the Required Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">determine that for any reason that (A) Term SOFR for any requested Term SOFR Interest Period with respect to     a proposed Term SOFR Advance or (B) the One Month SOFR Rate with respect to a proposed   ABR Advance, in any case, does not adequately and fairly reflect the cost to such Lenders of funding such Loan, the Administrative Agent will promptly so notify the Borrower and each  Lender.  Thereafter, (x)&#160;the obligation of the Lenders to make or maintain Term SOFR Advances    or to Convert ABR Advances to Term SOFR Advances shall be suspended (to the extent of the affected Term SOFR Advances or Term SOFR Interest Periods) and (y)&#160;in the event of a determination described in the preceding sentence with respect to the One Month SOFR Rate component of the Alternate Base Rate, the utilization of the One Month SOFR Rate in determining the Alternate Base Rate shall be suspended, in each case, until the Administrative Agent (or, in the case of a determination by the Required Lenders described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">clause (ii</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(b</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), until the Administrative Agent upon instruction of the Required Lenders) revokes such notice.  Upon receipt of such notice, (i) the Borrower may revoke any pending request for a borrowing of, Conversion to or continuation of Term SOFR Advances (to the extent of the affected Term SOFR Advances or Term SOFR Interest Periods) or, failing that, will be deemed to have Converted such request into a request for a borrowing of ABR Advances in the amount specified therein and (ii)   any outstanding Term SOFR Advances shall be deemed to have been Converted to ABR Advances immediately at the end of their respective applicable Term SOFR Interest Period. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Notwithstanding anything to the contrary in this Agreement or any other Loan Documents, if the Administrative Agent and the Borrower determine (which determination shall    be conclusive absent manifest error), or the Borrower or the Required Lenders notify the Administrative Agent (with, in the case of the Required Lenders, a copy to the Borrower) that the Borrower or the Required Lenders (as applicable) have determined, that&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">adequate and reasonable means do not exist for ascertaining one month, three month and six month interest periods of Term SOFR, including, without limitation, because the Term SOFR Screen Rate is not available or published on a current basis and such circumstances are unlikely to be temporary&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">CME or any successor administrator of the Term SOFR Screen Rate or a Governmental Authority having jurisdiction over the Administrative Agent or such administrator with respect to its publication of Term SOFR, in each case acting in such capacity, has made a public statement identifying a specific date after which one month, three month and six month interest periods of Term SOFR or the Term SOFR Screen Rate shall or will no longer be made available, or permitted to be used for determining the  interest rate of Dollar denominated U.S. syndicated loans, or shall or will otherwise cease, provided that, at the time of such statement, there is no successor administrator that is satisfactory to the Administrative Agent, that will continue to provide such interest periods of Term SOFR after such specific date (the latest date on which one month, three month  and six month interest periods of Term SOFR or the Term SOFR Screen Rate are no longer available permanently or indefinitely, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Scheduled Unavailability Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">then, on a date and time determined by the Administrative Agent and the Borrower (any such date, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Term SOFR Replacement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), which date shall be at the end of a Term SOFR Interest Period or on the relevant interest payment date, as applicable, for interest calculated and, solely   with respect to clause (2) above, no later than the Scheduled Unavailability Date, Term SOFR will </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">be replaced hereunder and under any Loan Document with Daily Simple SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the SOFR Adjustment for any payment period for interest calculated that can be determined by the Administrative Agent, in each case, without any amendment to, or further action or consent of any other party to, this Agreement or any other Loan Document (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Successor Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If the Successor Rate is Daily Simple SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the SOFR Adjustment, all interest payments will be payable on a quarterly basis.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding anything to the contrary herein, (i) if the Administrative Agent determines that Daily Simple SOFR is not available on or prior to the Term SOFR Replacement Date, or (ii) if the events or circumstances of the type described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(c)(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> have occurred with respect to the Successor Rate then in effect, then in each case, the Administrative Agent and the Borrower may amend this Agreement solely for the purpose of replacing Term SOFR or any then current Successor Rate in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> at the end of any Term SOFR Interest Period, relevant interest payment date or payment period for interest calculated, as applicable, with an alternative benchmark rate giving due consideration to any evolving or then existing convention    for similar Dollar denominated credit facilities syndicated and agented in the United States for such alternative benchmark. and, in each case, including any mathematical or other adjustments to such benchmark giving due consideration to any evolving or then existing convention for similar Dollar denominated credit facilities syndicated and agented in the United States for such benchmark,   which adjustment or method for calculating such adjustment shall be published on an information service as selected by the Administrative Agent from time to time in its reasonable discretion and may be periodically updated.  For the avoidance of doubt, any such proposed rate and adjustments, shall constitute a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Successor Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;.  Any such amendment shall become effective at 5&#58;00 p.m. on  the fifth Domestic Business Day after the Administrative Agent shall have posted such proposed amendment to all Lenders and the Borrower unless, prior to such time, Lenders comprising the Required Lenders have delivered to the Administrative Agent written notice that such Required Lenders object to such amendment.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent will promptly (in one or more notices) notify the Borrower and each Lender of the implementation of any Successor Rate.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any Successor Rate shall be applied in a manner consistent with market practice&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that to the extent such market practice is not administratively feasible for the Administrative Agent, such Successor Rate shall be applied in a manner as otherwise reasonably determined by the Administrative Agent (in consultation with the Borrower).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding anything else herein, if at any time any Successor Rate as so determined would otherwise be less than zero, the Successor Rate will be deemed to be zero for the purposes of this Agreement and the other Loan Documents.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In connection with the implementation of a Successor Rate, the Administrative Agent will have the right, in consultation with the Borrower, to make Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such Conforming Changes in the discretion of the Administrative Agent and in consultation with the Borrower will become effective without any further action or consent of any other party to this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, with respect to any such amendment effected, the Administrative Agent shall post each such amendment implementing such Conforming Changes to the Borrower and the Lenders promptly after such amendment becomes effective.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Certificates of Payment and Reimbursement</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each Issuer and each Lender agrees, in connection with any request by it for payment or reimbursement pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to provide the Borrower with a certificate, signed by an officer of such Issuer or such Lender, as the case may be, setting forth a description in reasonable detail of any such payment or reimbursement and the applicable Section of this Agreement pursuant to and in accordance with which such request is made. Each determination by such Issuer and such Lender of such payment or reimbursement shall be conclusive absent manifest error.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Taxes&#59; Net Payments</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Payments Free of Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Any and all payments by or on account of any obligation of the Borrower hereunder or under any other Loan Document shall be made free and clear of, and without reduction or withholding for, any Indemnified Taxes or Other Taxes&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if the Borrower shall be required by applicable law to deduct any Indemnified Taxes (including any Other Taxes) from such payments, then (i)&#160;the sum payable shall be increased as necessary so that after making all required deductions (including deductions applicable to additional sums payable under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) the Administrative Agent, the applicable Lender or the applicable Issuer, as the case may be, receives an amount equal to the sum it would have received had no such deductions  for Indemnified Taxes or Other Taxes been made, (ii)&#160;the Borrower shall make such deductions    and (iii)&#160;the Borrower shall timely pay the full amount deducted to the relevant Governmental Authority in accordance with applicable law. For purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the term &#8220;Lender&#8221; includes the Swing Line Lender and each Issuer and the term &#8220;applicable law&#8221; includes FATCA.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Payment of Other Taxes by the Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Without limiting the provisions of paragraph (a) above, the Borrower shall timely pay any Other Taxes to the relevant Governmental Authority in accordance with applicable law.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Indemnification by the Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Borrower shall indemnify the   Administrative Agent, each Lender and each Issuer, within 30 days after demand therefor, for the full amount of any Indemnified Taxes imposed on or with respect to, any payment made by, or on account of, any obligation of the Borrower under any Loan Document or Other Taxes (including Indemnified Taxes or Other Taxes imposed or asserted on or attributable to amounts payable under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) paid by the Administrative Agent, such Lender or such Issuer, as the case may   be, and, without duplication, any penalties, interest and reasonable and documented out-of-pocket expenses arising therefrom or with respect thereto (other than any penalties that result from the  gross negligence, bad faith or willful misconduct of the Administrative Agent, such Lender or such Issuer, as applicable, as determined by a final and non-appealable judgment of a court of competent jurisdiction)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if the Borrower reasonably believes that such Taxes were not correctly  or legally asserted, the Administrative Agent, such Lender or such Issuer, as applicable, will cooperate with the Borrower to obtain a refund of such Taxes so long as such efforts would not result in any additional costs or expenses not reimbursed by the Borrower and such cooperation would not, in the judgment of such Lender or such Issuer, as applicable, be materially disadvantageous to it.  A certificate as to the amount of such payment or liability that complies with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and is delivered to the Borrower by such Lender or such Issuer (with a copy to the Administrative Agent), or by the Administrative Agent on its own behalf or on behalf of such Lender or such Issuer, shall be conclusive absent manifest error. After any Lender or any Issuer (as the case may be) learns of the imposition of any Indemnified Taxes or Other Taxes, such Lender     or such Issuer (as the case may be) will as soon as reasonably practicable notify the Borrower thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the failure to provide the Borrower with such notice shall not release the Borrower from its indemnification obligations under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Notwithstanding anything   </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to the contrary contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Borrower shall not be required to indemnify the Administrative Agent or any Lender or Issuer pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> for any additional costs, such as penalties or interest, to the extent that such costs resulted from a failure of the Administrative Agent or such Lender or Issuer to notify the Borrower of such possible indemnification claim within 180 days after the Administrative Agent or such Lender or Issuer receives notice from the applicable taxing authority of the tax giving rise to such indemnification claim.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Evidence of Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. As soon as practicable after any payment of Indemnified Taxes or Other Taxes by the Borrower to a Governmental Authority, the Borrower shall deliver to the Administrative Agent the original or a certified copy of a receipt issued by such Governmental Authority evidencing such payment, a copy of the return reporting such payment or other evidence of such payment reasonably satisfactory to the Administrative Agent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Indemnification by the Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each Lender shall severally indemnify the Administrative Agent, within 10 days after demand therefor, for (i) any Indemnified Taxes attributable to such Lender (but only to the extent that the Borrower has not already indemnified   the Administrative Agent for such Indemnified Taxes and without limiting the obligation of the Borrower to do so), (ii) any Taxes attributable to such Lender&#8217;s failure to comply with the  provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> relating to the maintenance of a Participant Register, and (iii) any Excluded Taxes attributable to such Lender, in each case, that are payable or paid by the Administrative Agent in connection with any Loan Document, and any reasonable expenses arising therefrom or with respect thereto, whether or not such Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate as to the amount of such payment      or liability delivered to any Lender by the Administrative Agent shall be conclusive absent manifest error. Each Lender hereby authorizes the Administrative Agent to set off and apply any and all amounts at any time owing to such Lender under any Loan Document or otherwise payable by the Administrative Agent to the Lender from any other source against any amount due to the Administrative Agent under this paragraph (e).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.02pt;text-decoration:underline">Status of Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Any Lender that is entitled to an exemption from, or reduction  of, withholding Tax under the law of the jurisdiction in which the Borrower is resident for Tax purposes, or any treaty to which such jurisdiction is a party, with respect to payments hereunder or under any other Loan Document shall deliver to the Borrower (with a copy to the Administrative Agent), at the time or times prescribed by applicable law or reasonably requested by the Borrower  or the Administrative Agent, such properly completed and executed documentation prescribed by applicable law as will permit such payments to be made without withholding or at a reduced rate    of withholding. In addition, any Lender, if requested by the Borrower or the Administrative Agent, shall deliver such other documentation prescribed by applicable law or reasonably requested by the Borrower or the Administrative Agent as will enable the Borrower or the Administrative Agent to determine whether or not such Lender is subject to backup withholding or information reporting requirements.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Without limiting the generality of the foregoing, any Foreign Lender shall deliver to the Borrower and the Administrative Agent (in such number of copies as shall be requested by the recipient) on or prior to the date on which such Foreign Lender becomes a Lender under this Agreement (and from time to time thereafter (i) if such Foreign Lender shall determine that any applicable form or certification has expired or will then expire or has or will then become obsolete  or incorrect or that an event has occurred that requires or will then require a change in the most recent form or certification previously delivered by it to the Borrower and the Administrative Agent </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and (ii) upon the request of the Borrower or the Administrative Agent, but only if such Foreign Lender is legally entitled to do so), whichever of the following is applicable&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">duly completed copies of Internal Revenue Service Form W-8BEN or   Form W-8BEN-E claiming eligibility for benefits of an income Tax treaty to which the United States of America is a party,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.58pt">duly completed copies of Internal Revenue Service Form W-8ECI,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.53pt">in the case of a Foreign Lender claiming the benefits of the exemption for portfolio interest under Section 881(c) of the Internal Revenue Code, (x) a certificate (a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;United States Tax Compliance Certificate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) to the effect that such Foreign Lender is not (A) a &#8220;bank&#8221; within the meaning of Section 881(c)(3)(A) of the Internal Revenue Code,   (B) a &#8220;10 percent shareholder&#8221; of the Borrower within the meaning of Section 881(c)(3)(B) of the Internal Revenue Code, (C) a &#8220;controlled foreign corporation&#8221; described in Section 881(c)(3)(C) of the Internal Revenue Code nor (D) engaged in the conduct of a trade or business within the United States to which the interest payment is effectively connected   and (y) duly completed copies of Internal Revenue Service Form W-8BEN or Form W- 8BEN-E,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.13pt">to the extent a Foreign Lender is not the beneficial owner (for example, where the Foreign Lender is a partnership or participating Lender granting a typical participation), a complete and executed Internal Revenue Service Form W-8IMY, accompanied by a Form W-8ECI, Form W-8BEN, Form W-8BEN-E, a United States Tax Compliance Certificate, Internal Revenue Service Form W-9 and&#47;or other certification documents from each beneficial owner, as applicable&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that, if the Foreign Lender  is a partnership (and not a participating Lender) and one or more partners of such Foreign Lender are claiming the portfolio interest exemption, such Foreign Lender shall provide a United States Tax Compliance Certificate, on behalf of such beneficial owner(s) in lieu of requiring each beneficial owner to provide its own certificate, or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">any other form prescribed by applicable law as a basis for claiming exemption from or a reduction in United States federal withholding Tax duly completed together with such supplementary documentation as may be prescribed by applicable law   to permit the Borrower to determine the withholding or deduction required to be made.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If a payment made to a Lender under any Loan Document would be subject to U.S. federal withholding Tax imposed by FATCA if such Lender were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472(b) of the Internal Revenue Code, as applicable), such Lender shall deliver to the Borrower and the Administrative Agent at the time or times prescribed by law and at such time or times reasonably requested by the Borrower or the Administrative Agent such documentation prescribed by  applicable law (including as prescribed by Section 1471(b)(3)(C) of the Internal Revenue Code)   and such additional documentation reasonably requested by the Borrower or the Administrative Agent as may be necessary for the Borrower and the Administrative Agent to comply with their obligations under FATCA and to determine that such Lender has complied with such Lender&#8217;s obligations under FATCA or to determine the amount to deduct and withhold from such payment. Solely for purposes of this clause, &#8220;FATCA&#8221; shall include any amendments made to FATCA after the date of this Agreement.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Without limiting the foregoing, upon request of the Administrative Agent or the Borrower, each Lender and each Issuer that is a &#8220;United States person&#8221; within the meaning of Section 7701(a)(30) of the Internal Revenue Code that lends to the Borrower (each, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;U.S. Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) shall deliver to the Administrative Agent and the Borrower two duly signed, properly completed copies  of Internal Revenue Service Form W-9 on or prior to the First Amendment Effective Date (or on    or prior to the date it becomes a party to this Agreement), certifying that such U.S. Lender is entitled to an exemption from United States backup withholding, or any successor form.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Treatment of Certain Refunds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If the Administrative Agent, a Lender or an Issuer determines, in its sole discretion exercised in good faith, that it has received a refund of any Taxes  or Other Taxes as to which it has been indemnified by the Borrower or with respect to which the Borrower has paid additional amounts pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, it shall promptly pay to the Borrower an amount equal to such refund (but only to the extent of indemnity payments made, or additional amounts paid, by the Borrower under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> with respect to the Taxes or Other Taxes giving rise to such refund), net of all reasonable and documented out-of-pocket expenses of the Administrative Agent, such Lender or such Issuer, as the case may be, and without interest  (other than any interest paid by the relevant Governmental Authority with respect to such refund), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the Borrower, upon the written request of the Administrative Agent, such Lender or such Issuer, agrees to repay the amount paid over to the Borrower (plus any penalties, interest or other charges imposed by the relevant Governmental Authority) to the Administrative Agent, such Lender or such Issuer in the event that the Administrative Agent, such Lender or such Issuer is required to repay such refund or Tax credit to such Governmental Authority. This paragraph shall not be construed to require the Administrative Agent, any Lender or any Issuer to make available   its Tax returns (or any other information relating to its Taxes that it deems confidential) to the Borrower or any other Person.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Designation of a Different Lending Office</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If any Lender requests compensation under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, or requires the Borrower to pay any additional amount to any Lender or any Governmental Authority for the account of any Lender pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, then such Lender shall use reasonable efforts to promptly designate a different lending office for funding or booking its Loans hereunder or to assign its rights and obligations hereunder to another of its  offices, branches or affiliates, if such designation or assignment (i)&#160;would eliminate or reduce amounts payable pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as the case may be, in the future and (ii)&#160;in the judgment of such Lender, would not subject such Lender to any unreimbursed cost or expense and would not otherwise be disadvantageous to such Lender. The Borrower hereby agrees to pay all reasonable and documented out-of-pocket costs and expenses incurred by any Lender in connection with any such designation or assignment.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each party&#8217;s obligations under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall survive the resignation or replacement of the Administrative Agent or any assignment of rights by, or the replacement of, a Lender, the termination of the Commitments and the repayment, satisfaction or discharge of all obligations under any Loan Document.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Facility Fees</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower agrees to pay to the Administrative Agent for the account of each Lender a fee (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Facility Fee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) during the period commencing on the Effective Date and ending on the Expiration Date, payable quarterly in arrears on the last day of each March, June, September and December of each year, commencing on the last day of the calendar quarter during which the Facility Fee shall commence to accrue, and on the Expiration Date, at a rate per annum equal to the Applicable Margin of (a) prior to the Commitment Termination Date or such earlier date upon which all of the Commitments shall have been </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">terminated in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Commitment Amount of such Lender (whether used or unused), and (b) thereafter, the sum of (i) the outstanding principal balance of all Revolving Credit Loans   of such Lender, (ii) such Lender&#8217;s Swing Line Exposure and (iii) such Lender&#8217;s Letter of Credit Exposure. Notwithstanding anything to the contrary contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, on and after the Commitment Termination Date, the Facility Fee shall be payable upon demand. In addition, upon each reduction of the Aggregate Commitment Amount, the Borrower shall pay the Facility Fee accrued on the amount of such reduction through the date of such reduction. The Facility Fee shall be computed on the basis of a 360-day year for the actual number of days elapsed.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Letter of Credit Participation Fee</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower agrees to pay to the Administrative Agent for the pro rata account of each Lender a fee (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit Participation Fee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) with respect to the Letters of Credit during the period commencing on the Effective Date and ending on the Commitment Termination Date or, if later, the date when the Letter of Credit Exposure of all Lenders is $0, payable quarterly in arrears on the last day of each March, June, September and December of each year, commencing on the last day of the calendar quarter     in which the Effective Date shall have occurred, and on the last date of such period, at a rate per annum equal to (i) in the case of standby Letters of Credit, the Applicable Margin of the actual daily amount which may be drawn under all standby Letters of Credit during such period (whether or not the conditions for drawing thereunder have or may be satisfied) multiplied by such Lender&#8217;s Commitment Percentage, and    (ii) in the case of commercial Letters of Credit, the Applicable Margin of the actual daily amount which  may be drawn under all commercial Letters of Credit during such period (whether or not the conditions for drawing thereunder have or may be satisfied) multiplied by such Lender&#8217;s Commitment Percentage. The Letter of Credit Participation Fee shall be computed on the basis of a 360-day year for the actual number     of days elapsed.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Replacement of Lender</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If (w) the Borrower is obligated to pay to any Lender any amount under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Borrower shall have the right within 90 days thereafter, (x) any Lender shall be a Defaulting Lender, the Borrower shall have the right at any time during which such Lender shall remain a Defaulting Lender, (y) any Lender shall have not consented to an Extension Request or (z) any Lender shall not have approved any other consent, waiver or amendment that (A) requires the approval of all Lenders or all affected Lenders in accordance with the terms of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and (B) has been approved by the Required Lenders, the Borrower shall have the right at any time, in each case in accordance with the requirements of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and only if no Default shall exist, to replace such Lender (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Replaced Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) with   one or more Eligible Assignees (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Replacement Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that (i) at the time of any replacement pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Replacement Lender shall enter into one or more Assignment and Assumptions pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (with the processing and recordation fee referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> payable pursuant to said </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> to be paid by the Replacement Lender) pursuant to which the Replacement Lender shall acquire the Commitment, the outstanding Loans, the Swing Line Exposure and the Letter of Credit Exposure of the Replaced Lender and, in connection therewith, shall pay the following&#58; (a) to the Replaced Lender, an amount equal to the sum of (A) an amount equal to the principal of, and all accrued and unpaid interest on, all outstanding Loans and Swing Line Participation Amounts of the Replaced Lender, (B) an amount equal to all drawings on all Letters of Credit that have been funded by (and not reimbursed to) such Replaced Lender, together with all then unpaid interest with respect thereto at such time, and (C) an amount equal to all accrued, but unpaid, fees owing to the Replaced Lender, (b) to each Issuer, an amount equal to such Replaced Lender&#8217;s Commitment Percentage of all drawings on Letters of Credit issued by such Issuer (which at such time remain unpaid drawings) to the extent such amount was not funded by such Replaced Lender, (c) to the Swing Line Lender, an amount equal to such Replaced Lender&#8217;s Commitment Percentage of any Mandatory Borrowing to the extent such amount was not funded </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">by such Replaced Lender, and (d) to the Administrative Agent an amount equal to all amounts owed by   such Replaced Lender to the Administrative Agent under this Agreement, including, without limitation, an amount equal to the principal of, and all accrued and unpaid interest on, all outstanding Loans of the Replaced Lender, a corresponding amount of which was made available by the Administrative Agent to the Borrower pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and which has not been repaid to the Administrative Agent by such Replaced Lender or the Borrower, and (ii) all obligations of the Borrower owing to the Replaced Lender (other than those specifically described in clause (i) above in respect of which the assignment purchase   price has been, or is concurrently being, paid) shall be paid in full to such Replaced Lender concurrently with such replacement. Upon the execution and delivery of the respective Assignment and Assumptions   and the payment of amounts referred to in clauses (i) and (ii) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Replacement Lender shall become a Lender hereunder and the Replaced Lender shall cease to constitute a Lender hereunder, except with respect to indemnification provisions under this Agreement that are intended to survive the termination of the Commitments and the repayment of the Loans which may be applicable to any such Replaced Lender prior to the date of its replacement. Solely for the purpose of calculating break funding payments under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the assignment by any Replaced Lender of any Term SOFR Advance prior to the last day of the Interest Period applicable thereto pursuant to clause (w) or (y) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall  be deemed to constitute a prepayment by the Borrower of such Term SOFR Advance.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">REPRESENTATIONS AND WARRANTIES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In order to induce the Administrative Agent, the Lenders and the Issuers to enter into this Agreement, the Lenders to make the Loans and the Issuers to issue Letters of Credit, the Borrower hereby makes the following representations and warranties to the Administrative Agent, the Lenders and the  Issuers&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Existence and Power</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower is duly organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation, has all requisite corporate power and authority to own its Property and to carry on its business as now conducted, and is qualified to do business as a foreign corporation and is in good standing in each jurisdiction in which it owns or leases real Property or in which the nature of its business requires it to be so qualified (except those jurisdictions where the failure to be so qualified or to    be in good standing could not reasonably be expected to have a Material Adverse effect).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Authority&#59; Affected Financial Institution</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower has full corporate power and authority to enter into, execute, deliver and perform the terms of the Loan Documents, all of which have been duly authorized by all proper and necessary corporate action and are not in contravention of&#58; (i) except as could not reasonably be expected to have a Material Adverse effect, any applicable law or (ii) the terms of its Certificate of Incorporation and By-Laws. No consent or approval of, or other action by, shareholders of the Borrower, any Governmental Authority, or any other Person (which has not already been obtained) is required to authorize in respect of the Borrower, or is required in connection with, the execution, delivery and performance by the Borrower of the Loan Documents or is required as a condition to the enforceability of the Loan Documents against the Borrower. The Borrower is not an Affected Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Binding Agreement</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Loan Documents constitute the valid and legally binding obligations of the Borrower, enforceable against the Borrower in accordance with their respective terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the enforcement of creditors&#8217; rights generally and by equitable principles relating to the availability of specific performance as a remedy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Litigation</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of the Effective Date, there are no actions, suits, arbitration proceedings or claims (whether purportedly on behalf of the Borrower, any Material Subsidiary or otherwise) pending or, to the knowledge of the Borrower, threatened against the Borrower or any Material Subsidiary or any of their respective Properties, or maintained by the Borrower or any Material Subsidiary, at law or in equity, before any Governmental Authority which have not been disclosed in the SEC Reports that could reasonably be expected to have a Material Adverse effect. There are no proceedings pending or, to the knowledge of the Borrower, threatened against the Borrower or any Material Subsidiary (a) which call into question the validity or enforceability of any Loan Document, or otherwise seek to invalidate, any Loan Document, or  (b) which might, individually or in the aggregate, materially and adversely affect any of the transactions contemplated by any Loan Document.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">No Conflicting Agreements</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">&#91;Reserved&#93;.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">No provision of any existing material mortgage, material indenture, material contract or material agreement or of any existing statute, rule, regulation, judgment, decree or order binding on the Borrower or affecting the Property of the Borrower (i) conflicts with any Loan Document, (ii) requires any consent which has not already been obtained with respect to any Loan Document, or (iii) would in any way prevent the execution, delivery or performance by the  Borrower of the terms of any Loan Document, except in the case of provisions of any existing material mortgage, material indenture, material contract or material agreement, as could not reasonably be expected to have a Material Adverse effect. Neither the execution and delivery, nor the performance, by the Borrower of the terms of each Loan Document will constitute a default under, or result in the creation or imposition of, or obligation to create, any Lien upon the Property of the Borrower pursuant to the terms of any such mortgage, indenture, contract or agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Governmental Regulations</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower is not required to be registered as an &#8220;investment company&#8221; under the Investment Company Act of 1940, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Federal Reserve Regulations&#59; Use of Proceeds</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower is not engaged principally, or as one of its important activities, in the business of extending credit for the purpose of purchasing or carrying any Margin Stock. No part of the proceeds of the Loans or the Letters of Credit has been or will be used, directly or indirectly, and whether immediately, incidentally or ultimately, for a purpose which violates the provisions of Regulation T, U or X of the Board of Governors of the Federal Reserve System, as amended. Anything in this Agreement to the contrary notwithstanding, neither any Issuer nor any Lender shall be obligated to extend credit to, or on behalf of,   the Borrower in violation of any limitation or prohibition provided by any applicable law, regulation or statute, including said Regulation U. Following application of the proceeds of each Loan and the issuance   </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of each Letter of Credit, not more than 25% (or such greater or lesser percentage as is provided in the exclusions from the definition of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Indirectly Secured</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> contained in said Regulation U as in effect at the  time of the making of such Loan or issuance of such Letter of Credit) of the value of the assets of the Borrower and the Subsidiaries on a Consolidated basis that are subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> will be Margin Stock. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">No Misrepresentation</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No representation or warranty contained in any Loan Document and no certificate or written report furnished by the Borrower to the Administrative Agent or any Lender pursuant to any Loan Document contains, as of its date, a misstatement of a material fact, or omits to state, as of its date, a material fact required to be stated in order to make the statements therein contained, when taken as a whole, not  materially misleading (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that any representation, warranty, statement or written report that is qualified as to &#8220;materiality&#8221;, &#8220;Material Adverse&#8221; or similar language shall be true and correct (after giving effect to any qualification therein) in all respects on such date) in the light of the circumstances under which made (after giving effect to all supplements and updates with respect thereto) (it being understood that the Borrower makes no representation or warranty hereunder with respect to any projections, other forward looking information, industry information or general economic information).  As of the Effective Date, the information included in any Beneficial Ownership Certification of the Borrower, if applicable, is true and correct in all respects.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Financial Statements</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower has heretofore delivered to the Lenders through the Administrative Agent copies of the audited Consolidated Balance Sheet of the Borrower and its Subsidiaries as of December 31, 2020, and the related Consolidated Statements of Income, Comprehensive Income, Shareholders&#8217; Equity and Cash Flows for the fiscal year then-ended. The financial statements referred to immediately above, including all related notes and schedules, are herein referred to collectively as the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Financial Statements&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Financial Statements fairly present, in all material respects, the Consolidated financial condition and results of the operations of the Borrower and the Subsidiaries as of the dates and for the periods indicated therein and, except as noted therein, have been prepared in conformity with GAAP as then in effect. Neither the Borrower nor any of the Subsidiaries has any material obligation or liability of any kind (whether fixed, accrued, contingent, unmatured or otherwise) which, in accordance with GAAP as then in effect, should have been disclosed in the Financial Statements and was not. During the period from January 1, 2021 to   and including the Effective Date, there was no Material Adverse change, including as a result of any change in law, in the Consolidated financial condition, operations, business or Property of the Borrower and the Subsidiaries taken as a whole that was not disclosed in the SEC Reports.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Anti-Corruption Laws and Sanctions</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower has implemented and maintains in effect policies and procedures designed to ensure compliance by the Borrower, the Subsidiaries and their respective directors, officers, employees and agents with Anti-Corruption Laws and applicable Sanctions, and the Borrower, the Subsidiaries and their  respective officers and employees and, to the knowledge of the Borrower, its directors are in compliance with Anti-Corruption Laws and applicable Sanctions in all material respects. None of (a) the Borrower, any Subsidiary or, to the knowledge of the Borrower or such Subsidiary, any of their respective directors, officers or employees, or (b) to the knowledge of the Borrower, any agent of the Borrower or any Subsidiary that will act in any capacity in connection with or benefit from the credit facility established hereby, is a </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Sanctioned Person. No Loan or Letter of Credit, use of proceeds or other transaction contemplated by this Agreement will violate Anti-Corruption Laws or applicable Sanctions.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">CONDITIONS TO EFFECTIVENESS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Agreement shall become effective on and as of the date (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Effective Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) that the following conditions shall have been satisfied or waived in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Agreement</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall have received counterparts of this Agreement executed by the Borrower, the Administrative Agent, each Issuer, the Swing Line Lender and each Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Notes</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall have received a Note, executed and delivered by the Borrower, for each Lender that shall have given at least three Domestic Business Days&#8217; prior written notice of its request for a Note.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Corporate Action</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall have received a certificate, dated the Effective Date, of the  Secretary or an Assistant Secretary of the Borrower (i) attaching a true and complete copy of the resolutions of its Board of Directors and of all documents evidencing all other necessary corporate action taken by the Borrower to authorize this Agreement, the other Loan Documents and the transactions contemplated hereby and thereby, (ii) attaching a true and complete copy of its Certificate of Incorporation and By-Laws, (iii) setting forth the incumbency of the officer or officers of the Borrower who may sign this Agreement and   the other Loan Documents, and any other certificates, requests, notices or other documents required hereunder or thereunder, and (iv) attaching a certificate of good standing of the Secretary of State of the State of Delaware.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Opinion of Counsel to the Borrower</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall have received (a) an opinion of Thomas Moffatt, assistant general counsel of the Borrower, dated the Effective Date, in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit D-1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and (b) an opinion of Shearman &#38; Sterling LLP, special counsel to the Borrower, dated the Effective Date, in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">D-2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Termination of Existing 2017 Credit Agreement </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">After giving effect to the application of the proceeds of the Loans on the Effective Date, the Indebtedness under the Existing 2017 Credit Agreement shall have been fully repaid, the commitments  under the Existing 2017 Credit Agreement shall have been canceled or terminated, and the Administrative Agent shall have received reasonably satisfactory evidence thereof.  In order to facilitate the termination of the commitments under the Existing 2017 Credit Agreement, the Borrower hereby gives notice that the Borrower wishes to terminate the commitments under the Existing 2017 Credit Agreement, effective as of the Effective Date.  Each Lender that is a party to the Existing 2017 Credit Agreement, by its execution hereof, waives any requirement of prior notice set forth therein as a condition to the right of the Borrower   to terminate the commitments thereunder. </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">No Default and Representations and Warranties</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall have received a certificate, dated the Effective Date, of the Senior Vice President and Treasurer of the Borrower certifying that there exists no Default and that the representations and warranties contained in this Agreement are true and correct in all material respects (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any representation and warranty that is qualified as to &#8220;materiality&#8221;, &#8220;Material Adverse&#8221; or similar language shall be true and correct (after giving effect to any qualification therein) in all respects on the Effective Date), except those which are expressly specified to be made as of an earlier date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Fees</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall have received all fees and other amounts due and payable to it on  the Effective Date in respect of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Due Diligence&#59; &#8220;Know Your Customer&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a) Each Lender shall have received such documents and information as it may have requested in order to comply with &#8220;know-your-customer&#8221; and other applicable Sanctions, anti-terrorism, anti-money laundering and similar rules and regulations and related policies, to the extent the Borrower shall have received written requests therefor at least ten (10) Domestic Business Days prior to the Effective Date, and (b) at least five Domestic Business Days prior to the Effective Date, if the Borrower qualifies as a &#8220;legal entity customer&#8221; under the Beneficial Ownership Regulation, it shall have delivered to each Lender that so requests a Beneficial Ownership Certification.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Without limiting the generality of the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, for purposes of determining compliance with the conditions specified in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, each Lender that has signed this Agreement shall be deemed to have consented to, approved or accepted or to be satisfied with, each document or other matter required thereunder to be consented to or approved by or acceptable or satisfactory to a Lender unless the Administrative Agent shall have received notice from such Lender prior to the proposed Effective Date specifying its objection thereto.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">CONDITIONS OF LENDING - ALL LOANS AND LETTERS OF CREDIT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The obligation of each Lender on any Borrowing Date to make each Revolving Credit Loan (other than a Revolving Credit Loan constituting a Mandatory Borrowing), the Swing Line Lender to make each Swing Line Loan, each Issuer to issue each Letter of Credit and each Lender to make a Competitive Bid Loan are subject to the fulfillment (or waiver in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) of the following conditions precedent&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Compliance</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On each Borrowing Date, and after giving effect to the Loans to be made or the Letters of Credit     to be issued on such Borrowing Date, (a) there shall exist no Default, and (b) the representations and warranties contained in this Agreement shall be true and correct in all material respects with the same effect as though such representations and warranties had been made on such Borrowing Date (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that any representation and warranty that is qualified as to &#8220;materiality&#8221;, &#8220;Material Adverse&#8221; or similar language  shall be true and correct (after giving effect to any qualification therein) in all respects on such Borrowing Date), except those which are expressly specified to be made as of an earlier date.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Requests</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall have timely received from the Borrower on or before such Borrowing Date, as applicable, a duly executed Borrowing Request (together with, in the case of a request for a Swing Line Loan that will bear interest at the Negotiated Rate, a duly executed agreement as to the Negotiated Rate with respect to such Swing Line Loan), Letter of Credit Request (together with a duly executed Reimbursement Agreement with respect to the Letter(s) of Credit requested thereby) and&#47;or Competitive Bid Request (together with a duly executed Competitive Bid Accept&#47;Reject Letter).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">AFFIRMATIVE COVENANTS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower covenants and agrees that on and after the Effective Date and until the later to occur of (a) the Commitment Termination Date and (b) the payment in full of the Loans, the Reimbursement Obligations, the Fees and all other sums payable under the Loan Documents (other than contingent obligations for which no claim has been made), the Borrower will&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Legal Existence</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Except as may otherwise be permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, maintain, and cause each Material Subsidiary to maintain, its corporate existence in good standing in the jurisdiction of its incorporation or formation and in each other jurisdiction in which the failure so to do could reasonably be expected to have a Material Adverse effect, except that the corporate existence of Material Subsidiaries   may be terminated if (i) such Material Subsidiaries operate closing or discontinued operations or (ii) if the Borrower determines in good faith that such termination is in the best interests of the Borrower and is not materially disadvantageous to the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Taxes</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pay and discharge when due, and cause each Material Subsidiary so to do, all taxes, assessments, governmental charges, license fees and levies upon or with respect to the Borrower and such Material Subsidiary, and upon the income, profits and Property thereof unless, and only to the extent, that either   (i)(a) such taxes, assessments, governmental charges, license fees and levies shall be contested in good faith and by appropriate proceedings diligently conducted by the Borrower or such Material Subsidiary, and (b) such reserve or other appropriate provision as shall be required by GAAP shall have been made therefor,     or (ii) the failure to pay or discharge such taxes, assessments, governmental charges, license fees and levies could not reasonably be expected to have a Material Adverse effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Observance of Legal Requirements</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Observe and comply in all material respects, and cause each Material Subsidiary    so to do, with all laws, ordinances, orders, judgments, rules, regulations, certifications, franchises, permits, licenses, directions and requirements of all Governmental Authorities, which now or at   any time hereafter may be applicable to it or to such Material Subsidiary, except (i) where a violation of which could not reasonably be expected to have a Material Adverse effect, or (ii) to    </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the extent that such noncompliance is being contested in good faith and by appropriate proceedings diligently conducted by the Borrower or such Material Subsidiary.</font></div><div style="margin-bottom:15pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Maintain in effect and enforce policies and procedures designed to ensure compliance by the Borrower, the Subsidiaries and their respective directors, officers, employees   and agents with Anti-Corruption Laws and applicable Sanctions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Financial Statements and Other Information</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Maintain, and cause each Subsidiary to maintain, a standard system of accounting in accordance with GAAP, and furnish to the Administrative Agent for distribution to the Lenders&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">As soon as available and, in any event, within 90 days after the close of each fiscal year, a copy of (x) the Borrower&#8217;s 10-K in respect of such fiscal year, and (y) (i) the Borrower&#8217;s Consolidated Balance Sheet as of the end of such fiscal year, and (ii) the related Consolidated Statements of Income, Comprehensive Income, Shareholders&#8217; Equity and Cash Flows, as of and through the end of such fiscal year, setting forth in each case in comparative form the corresponding figures in respect of the previous fiscal year, all in reasonable detail, and accompanied by a report   of the Borrower&#8217;s auditors, which report shall state that (A) such auditors audited such financial statements, (B) such audit was made in accordance with generally accepted auditing standards in effect at the time and provides a reasonable basis for such opinion, and (C) said financial statements have been prepared in accordance with GAAP&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">As soon as available, and in any event within 45 days after the end of each of the first three fiscal quarters of each fiscal year, a copy of (x) the Borrower&#8217;s 10-Q in respect of such fiscal quarter, and (y) (i) the Borrower&#8217;s condensed Consolidated Balance Sheet as of the end of such quarter and (ii) the related condensed Consolidated Statements of Income, Comprehensive Income, Shareholders&#8217; Equity and Cash Flows for (A) such quarter and (B) the period from the beginning of the then-current fiscal year to the end of such quarter, in each case in comparable form with the prior fiscal year, all in reasonable detail and prepared in accordance with GAAP (without footnotes and subject to year-end adjustments)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Simultaneously with the delivery of the financial statements required by clauses    (a) and (b) above, a certificate of the Chief Financial Officer or the Senior Vice President and Treasurer of the Borrower certifying that no Default shall have occurred or be continuing or, if so, specifying in such certificate all such Defaults, and setting forth computations in reasonable detail demonstrating compliance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:23.18pt">&#91;reserved&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">As soon as practicable after becoming available, copies of all regular or periodic reports (including current reports on Form 8-K) which the Borrower or any Subsidiary may now or hereafter be required to file with or deliver to the U.S. Securities and Exchange Commission, or   any other Governmental Authority succeeding to the functions thereof&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:25.02pt">&#91;reserved&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Prompt written notice of the occurrence of (i) each Default and (ii) each Event of Default&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:23.18pt">&#91;reserved&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">From time to time, such other information regarding the financial position or business of the Borrower and the Subsidiaries as the Administrative Agent, at the reasonable   request of any Lender, may reasonably request&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">Prompt written notice of such other information with documentation required by bank regulatory authorities under applicable &#8220;know your customer&#8221; and anti-money laundering  laws, rules and regulations (including, without limitation, the Patriot Act and the Beneficial Ownership Regulation), as from time to time may be reasonably requested by the Administrative Agent or by any Issuer or any Lender (through the Administrative Agent).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Information required to be delivered pursuant to (x) this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be deemed to have been delivered if such information shall have been posted by the Administrative Agent on a Debtdomain, IntraLinks, Syndtrak or similar electronic system (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Platform&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) to which each Lender and each Issuer  has been granted access and (y) clauses (a), (b) and (e) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be deemed delivered to the Administrative Agent, the Issuers and the Lenders when available on the Borrower&#8217;s website at             </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">http&#58;&#47;&#47;www.cvshealth.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or the website of the U.S. Securities and Exchange Commission at                 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">http&#58;&#47;&#47;www.sec.gov</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Information delivered pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> may also be delivered by electronic communications pursuant to procedures approved by the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower hereby acknowledges that the Administrative Agent and&#47;or the Joint Lead Arrangers will make available to the Lenders materials and&#47;or information provided by or on behalf of the Borrower hereunder (collectively, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Borrower Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) by posting the Borrower Materials on the Platform.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Records</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Upon reasonable notice and during normal business hours after an Event of Default has occurred  and is continuing, permit representatives of the Administrative Agent and each Lender to visit the offices    of the Borrower and each Material Subsidiary, to examine the books and records (other than tax returns and work papers related to tax returns) thereof and auditors&#8217; reports relating thereto, to discuss the affairs of the Borrower and each Material Subsidiary with the respective officers thereof, and to meet and discuss the affairs of the Borrower and each Material Subsidiary with the Borrower&#8217;s auditors, except for information covered by an attorney-client or other legal privilege or to the extent the inspection would reasonably be expected to result in a violation or other breach of any third party confidentiality agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">NEGATIVE COVENANTS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower covenants and agrees that on and after the Effective Date and until the later to occur of (a) the Commitment Termination Date and (b) the payment in full of the Loans, the Reimbursement Obligations, the Fees and all other sums payable under the Loan Documents (other than contingent obligations for which no claim has been made), the Borrower will not&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Liens</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Create, incur, assume or suffer to exist any Lien against or on any Property now owned or hereafter acquired by the Borrower or any of the Subsidiaries, or permit any of the Subsidiaries so to do, except any one or more of the following types of Liens&#58; (a) Liens in connection with workers&#8217; compensation, unemployment insurance or other social security obligations (which phrase shall not be construed to refer    to ERISA or the minimum funding obligations under Section 412 of the Internal Revenue Code), (b) Liens  to secure the performance of bids, tenders, letters of credit, contracts (other than contracts for the payment  </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of Indebtedness), leases, statutory obligations, surety, customs, appeal, performance and payment bonds   and other obligations of like nature, or to qualify to do business, maintain insurance or obtain other benefits, in each such case arising in the ordinary course of business, (c) mechanics&#8217;, workmen&#8217;s, carriers&#8217;, warehousemen&#8217;s, materialmen&#8217;s, landlords&#8217; or other like Liens arising in the ordinary course of business with respect to obligations which are not due or which are being contested in good faith and by appropriate proceedings diligently conducted, (d) Liens for taxes, assessments, fees or governmental charges the payment of which is not required under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, (e) easements, rights of way, restrictions, leases of Property to others, easements for installations of public utilities, title imperfections and restrictions, zoning ordinances and other similar encumbrances affecting Property which in the aggregate do not materially impair its use for the operation of the business of the Borrower or such Subsidiary, (f) Liens on Property of the Subsidiaries under capital leases and Liens on Property (including on the capital stock or other equity interests) of the Subsidiaries acquired (whether as a result of purchase, capital lease, merger or other acquisition) and either existing on such Property when acquired, or created contemporaneously with or within 12 months of such acquisition to secure the payment or financing of the purchase price of such Property (including the construction, development, substantial repair, alteration or improvement thereof), and any renewals thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such Liens attach only to the Property so purchased or acquired (including any such construction, development, substantial repair, alteration or improvement thereof)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the Indebtedness secured by such Liens is not otherwise prohibited hereunder, (g) statutory Liens in favor of lessors arising in connection with Property leased to the Borrower or any of the Subsidiaries, (h) Liens of attachments, judgments or awards against the Borrower or any of the Subsidiaries with respect to which an appeal or proceeding for review shall be pending or a stay of execution or bond shall have been obtained, or which are otherwise being contested in good faith and by appropriate proceedings diligently conducted, and in respect of which adequate reserves shall have been established in accordance with GAAP on the books of the Borrower or such Subsidiary, (i) Liens securing Indebtedness   of a Subsidiary to the Borrower or another Subsidiary, (j) Liens (other than Liens permitted by any of the foregoing clauses) arising in the ordinary course of its business which do not secure Indebtedness and do  not, in the aggregate, materially detract from the value of the business of the Borrower and its Subsidiaries, taken as a whole, (k) Liens in favor of the United States of America, or any state thereof, to secure partial, progress, advance or other payments pursuant to any contract or provisions of any statute, and (l) additional Liens securing Indebtedness of the Borrower and the Subsidiaries in an aggregate outstanding Consolidated principal amount not exceeding 15% of Net Tangible Assets.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Dispositions</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Make any Disposition (including by way of limited liability company division), or permit any of    its Subsidiaries so to do, of all or substantially all of the assets of the Borrower and the Subsidiaries on a Consolidated basis&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that (a) any Subsidiary may make Dispositions to the Borrower, and (b) so  long as no Default or Event of Default exists immediately prior to or immediately after giving effect thereto, (i) the Borrower may dispose of all or substantially all of its assets to a wholly-owned domestic Subsidiary that assumes all of the obligations of the Borrower under this Agreement and (ii) any Subsidiary may  dispose of all or substantially all of its assets to another Subsidiary&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if such Subsidiary is a wholly-owned Subsidiary, the transferee shall be a wholly-owned Subsidiary.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Merger or Consolidation, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Consolidate with, be acquired by, or merge into or with any Person unless (x) immediately after giving effect thereto, no Default shall or would exist and (y) either (i) the Borrower or (ii) a corporation organized and existing under the laws of one of the States of the United States of America or the District     of Columbia shall be the survivor of such consolidation or merger&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if the Borrower is not the survivor, the corporation which is the survivor shall expressly assume, pursuant to an instrument executed and delivered to the Administrative Agent, and in form and substance reasonably satisfactory to the </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Administrative Agent, all obligations of the Borrower under the Loan Documents and the Administrative Agent shall have received such documents, opinions and certificates as it shall have reasonably requested    in connection therewith.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Limitation on Upstream Dividends by Subsidiaries</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Permit or cause any of the Subsidiaries (other than any Insurance Subsidiary) to enter into or agree, or otherwise be or become subject, to any agreement, contract or other arrangement (other than this Agreement and the other Loan Documents) with any Person (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Restrictive Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) pursuant to the terms of which (a) such Subsidiary is or would be prohibited from declaring or paying any cash dividends on any class of its stock owned directly or indirectly by the Borrower or any of the other Subsidiaries or from making any other distribution on account of any class of any such stock (herein referred to as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Upstream Dividends&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), or (b) the declaration or payment of Upstream Dividends by a Subsidiary to the Borrower or another Subsidiary, on an annual or cumulative basis, is or would be otherwise limited or restricted (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Dividend Restrictions&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">). Notwithstanding the foregoing, nothing in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall prohibit&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Dividend Restrictions set forth in any Restrictive Agreement in effect on the date hereof and any extensions, refinancings, renewals or replacements thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that the Dividend Restrictions in any such extensions, refinancings, renewals or replacements are no less favorable in any material respect to the Lenders than those Dividend Restrictions that are then in effect and that are being extended, refinanced, renewed or replaced&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Dividend Restrictions existing with respect to any Person acquired by the   Borrower or any Subsidiary and existing at the time of such acquisition, which Dividend  Restrictions are not applicable to any Person or the property or assets of any Person other than such Person or its property or assets acquired, and any extensions, refinancings, renewals or   replacements of any of the foregoing&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the Dividend Restrictions in any such extensions, refinancings, renewals or replacements are no less favorable in any material respect to the Lenders than those Dividend Restrictions that are then in effect and that are being extended, refinanced, renewed or replaced&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Dividend Restrictions consisting of customary net worth, leverage and other financial covenants, customary covenants regarding the merger of or sale of stock or assets of a Subsidiary, customary restrictions on transactions with affiliates, and customary subordination provisions governing Indebtedness owed to the Borrower or any Subsidiary, in each case contained in, or required by, any agreement governing Indebtedness incurred by a Subsidiary in accordance with the terms of this Agreement&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Dividend Restrictions contained in any other credit agreement so long as such Dividend Restrictions are no more restrictive than those contained in this Agreement (including Dividend Restrictions contained in the Existing 2019 Credit Agreement and the Existing 2022  Credit Agreement).</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Ratio of Consolidated Indebtedness to Total Capitalization</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Permit its ratio of Consolidated Indebtedness to Total Capitalization at the end of any fiscal quarter to exceed 0.60&#58;1.00&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that (i) upon the consummation of any Material Acquisition and the written election of the Borrower to the Administrative Agent no later than thirty days following the consummation of such Material Acquisition, the maximum permitted ratio of Consolidated Indebtedness to Total Capitalization shall be increased by 0.05&#58;1.00 above the otherwise-applicable maximum permitted ratio of Consolidated Indebtedness to Total Capitalization with respect to the last day of the fiscal quarter during which such Material Acquisition shall have been consummated and the last day of each of the immediately following three consecutive fiscal quarters, and (ii) between the signing of the definitive agreement (or   offer documentation, as applicable) for a Material Acquisition and the earlier of (x) the closing of such Material Acquisition and (y) thirty days following the termination of such definitive agreement (or offer documentation, as applicable) for such Material Acquisition, any Acquisition Debt incurred to finance such Material Acquisition shall be excluded for purposes of calculation the ratio of Consolidated Indebtedness    to Total Capitalization hereunder.  The Borrower shall only be permitted to make an election pursuant to   the proviso of the preceding sentence twice during the term of this Agreement, and there shall be at least  two consecutive fiscal quarters between such elections during which time no increase to the maximum permitted ratio of Consolidated Indebtedness to Total Capitalization shall be in effect.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">DEFAULT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Events of Default</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following shall each constitute an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Event of Default&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> hereunder&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The failure of the Borrower to make any payment of principal on any Loan or any reimbursement payment in respect of any Letter of Credit when due and payable&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">The failure of the Borrower to make any payment of interest on any Loan or of any Fee on any date when due and payable and such default shall continue unremedied for a period of    5 Domestic Business Days after the same shall be due and payable&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The failure of the Borrower to observe or perform any covenant or agreement contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (with respect to the Borrower only), or in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">The failure of the Borrower to observe or perform any other covenant or agreement contained in this Agreement, and such failure shall have continued unremedied for a period of 30 days after the Borrower shall have become aware of such failure&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">&#91;Reserved&#93;&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.02pt">Any representation or warranty of the Borrower (or of any of its officers on its behalf) made in any Loan Document, or made in any certificate or report or other document (other than an opinion of counsel) delivered on or after the date hereof in connection with any such Loan Document shall in any such case prove to have been incorrect or misleading (whether because of misstatement or omission) in any material respect when made&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">(i) Obligations in an aggregate Consolidated amount in excess of the Threshold Amount of the Borrower (other than its obligations hereunder and under the Notes) and the Material </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Subsidiaries, whether as principal, guarantor, surety or other obligor, for the payment of any Indebtedness for Borrowed Money or any net liability under interest rate swap, collar, exchange or cap agreements, (A) shall become or shall be declared to be due and payable prior to the expressed maturity thereof, or (B) shall not be paid when due or within any grace period for the payment thereof, or (ii) any holder of any such obligations shall have the right to declare the Indebtedness   for Borrowed Money evidenced thereby due and payable prior to its stated maturity&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">An involuntary proceeding shall be commenced or an involuntary petition shall be filed seeking (i) liquidation, reorganization or other relief in respect of the Borrower or any Material Subsidiary or its debts, or of a substantial part of its assets, under any federal, state or foreign bankruptcy, insolvency, receivership or similar law now or hereafter in effect or (ii) the   appointment of a receiver, trustee, custodian, sequestrator, conservator or similar official for the Borrower or any Material Subsidiary or for a substantial part of its assets, and, in any such case,  such proceeding or petition shall continue undismissed for 60 days or an order or decree approving or ordering any of the foregoing shall be entered&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">The Borrower or any Material Subsidiary shall (i) voluntarily commence any proceeding or file any petition seeking liquidation, reorganization or other relief under any federal, state or foreign bankruptcy, insolvency, receivership or similar law now or hereafter in effect, (ii) consent to the institution of, or fail to contest in a timely and appropriate manner, any proceeding    or petition described in clause (h) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, (iii) apply for or consent to the appointment   of a receiver, trustee, custodian, sequestrator, conservator or similar official for the Borrower or   any Material Subsidiary or for a substantial part of its assets, (iv) file an answer admitting the material allegations of a petition filed against it in any such proceeding, (v) make a general assignment for the benefit of creditors or (vi) take any action for the purpose of effecting any of the foregoing&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">The Borrower or any Material Subsidiary shall (i) generally not be paying its debts as such debts become due or (ii) admit in writing its inability to pay its debts as they become due&#59;   or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Judgments or decrees in an aggregate Consolidated amount in excess of the Threshold Amount (to the extent not covered by independent third-party insurance or captive insurance as to which the insurer does not dispute coverage) against the Borrower and the Material Subsidiaries shall remain unpaid, unstayed on appeal, undischarged, unbonded or undismissed for    a period of 60 days during which execution shall not be effectively stayed, or any action shall be legally taken by a judgment creditor to attach or levy upon any assets of the Borrower or any Material Subsidiary to enforce any such judgment&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">After the Effective Date a Change of Control shall occur&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.13pt">Solely to the extent as would have a Material Adverse effect&#58;  (i) any Termination Event shall occur (x) with respect to any Pension Plan (other than a Multiemployer Plan) or (y)   with respect to any other retirement plan subject to Section 302 of ERISA or Section 412 of the Internal Revenue Code, which plan, during the five year period prior to such Termination Event,  was the responsibility in whole or in part of the Borrower, any Material Subsidiary or any ERISA Affiliate&#59; (ii) the failure to satisfy the minimum funding standards under Section 302 of ERISA or Section 412 of the Internal Revenue Code shall exist with respect to any Pension Plan for which    the Borrower has responsibility (other than that portion of a Multiemployer Plan&#8217;s Accumulated Funding Deficiency to the extent such Accumulated Funding Deficiency is attributable to   employers other than the Borrower)&#59; (iii) any Person shall engage in a Prohibited Transaction </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">involving any Employee Benefit Plan in respect of which it is reasonably likely that liability will    be imposed upon the Borrower&#59; (iv) the Borrower shall fail to pay when due an amount which is payable by it to the PBGC or to a Pension Plan (including a Multiemployer Plan) under Title IV of ERISA&#59; (v) the imposition on the Borrower of any tax under Section 4980(B)(a) of the Internal Revenue Code&#59; or (vi) the assessment of a civil penalty on the Borrower with respect to any Employee Benefit Plan under Section 502(c) of ERISA.  In determining the Consolidated amount  for any purpose pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the liabilities, funding amounts, taxes and penalties referenced in the foregoing clauses of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall include those of the Material Subsidiaries and ERISA Affiliates of the Borrower to the extent the Borrower is obligated to pay  any such liabilities, funding amounts, taxes and penalties.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">9.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Remedies</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Upon the occurrence of an Event of Default or at any time thereafter during the continuance of an Event of Default, the Administrative Agent, at the written request of the Required Lenders, shall notify the Borrower that the Commitments, the Swing Line Commitment and the Letter of Credit Commitment have been terminated and&#47;or that all of the Loans, the Notes and the Reimbursement Obligations and all accrued and unpaid interest on any thereof and all other  amounts owing under the Loan Documents have been declared immediately due and payable&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that upon the occurrence of an Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(h), (i) or (j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> with respect to the Borrower, the Commitments, the Swing Line Commitment and the Letter of Credit Commitment shall automatically terminate and all of the Loans, the Notes and the Reimbursement Obligations and all accrued and unpaid interest on any thereof and all other amounts owing under the Loan Documents shall become immediately due and payable without declaration or notice to   the Borrower. To the fullest extent not prohibited by law, except for the notice provided for in the preceding sentence, the Borrower expressly waives any presentment, demand, protest, notice of protest or other notice of any kind in connection with the Loan Documents and its obligations thereunder. To the fullest extent not prohibited by law, the Borrower further expressly waives and covenants not to assert any appraisement, valuation, stay, extension, redemption or similar law,   now or at any time hereafter in force which might delay, prevent or otherwise impede the performance or enforcement of the Loan Documents.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">In the event that the Commitments, the Swing Line Commitment and the Letter of Credit Commitment shall have been terminated or all of the Loans, the Notes and the Reimbursement Obligations shall have become or been declared to be due and payable pursuant to the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, (i) the Borrower shall forthwith deposit an amount equal to the Letter of Credit Exposure in a cash collateral account with and under the exclusive control of the Administrative Agent, and (ii) the Administrative Agent, the Issuers and the Lenders agree, among themselves, that any funds received from or on behalf of the Borrower under any Loan Document  by any Issuer or any Lender (except funds received by any Issuer or any Lender as a result of a purchase from such Issuer or such Lender, as the case may be, pursuant to the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.9(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) shall be remitted to the Administrative Agent, and shall be applied by the Administrative Agent in payment of the Loans, the Reimbursement Obligations and the other obligations of the Borrower under the Loan Documents in the following manner and order&#58; (1) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment    or reimbursement of the Administrative Agent, the Issuers and the Lenders, in that order, for any fees, expenses or amounts (other than the principal of and interest on the Reimbursement Obligations) due from the Borrower pursuant to the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and the Reimbursement Agreements, (2) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment of the Fees, (3) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">third</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment of   any other fees, expenses or amounts (other than the principal of and interest on the Loans and the Notes and the Reimbursement Obligations) payable by the Borrower to the Administrative Agent, any Issuer or any of the Lenders under the Loan Documents, (4) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">fourth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment, pro rata </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">according to the outstanding principal balance of the Loans and the Letter of Credit Exposure of each Lender, of interest due on the Loans and the Reimbursement Obligations, (5) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">fifth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment, pro rata according to the sum of (A) the aggregate outstanding principal balance of the Loans of each Lender </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (B) the aggregate outstanding balance of the Reimbursement Obligations of each Lender, of the aggregate outstanding principal balance of the Loans and the aggregate outstanding balance of the Reimbursement Obligations, and (6) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">sixth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, any remaining funds shall be paid to whosoever shall be entitled thereto or as a court of competent jurisdiction shall direct.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">In the event that the Loans and the Notes and the Reimbursement Obligations shall have been declared due and payable pursuant to the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Administrative Agent, upon the written request of the Required Lenders, shall proceed to enforce  the Reimbursement Obligations and the rights of the holders of the Loans and the Notes by suit in equity, action at law and&#47;or other appropriate proceedings, whether for payment or the specific performance of any covenant or agreement contained in the Loan Documents. In the event that the Administrative Agent shall fail or refuse so to proceed, each Issuer and each Lender shall be entitled to take such action as the Required Lenders shall deem appropriate to enforce its rights under the Loan Documents.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">AGENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Appointment and Authority</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each Credit Party hereby irrevocably appoints BofA to act on its behalf as the Administrative Agent hereunder and under the other Loan Documents and authorizes the Administrative Agent to take such  actions on its behalf and to exercise such powers as are delegated to the Administrative Agent by the terms hereof or thereof, together with such actions and powers as are reasonably incidental thereto. The provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (other than </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) are solely for the benefit of the Administrative Agent and the Credit Parties and the Borrower shall have no rights as a third party beneficiary or otherwise of any of such provisions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Rights as a Lender</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Person serving as the Administrative Agent hereunder shall have the same rights and powers    in its capacity as a Lender (which includes Issuer) as any other Lender and may exercise the same as though it were not the Administrative Agent and the term &#8220;Lender&#8221; or &#8220;Lenders&#8221; shall, unless otherwise expressly indicated or unless the context otherwise requires, include the Person serving as the Administrative Agent hereunder in its individual capacity. Such Person and its Affiliates may accept deposits from, lend money   to, own securities of, act as the financial advisor or in any other advisory capacity for and generally engage in any kind of business with, the Borrower, any of its Subsidiaries or any other Affiliate thereof as if such Person were not the Administrative Agent hereunder and without any duty to account therefor to the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Exculpatory Provisions</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Administrative Agent shall not have any duties or obligations except those expressly set forth herein and in the other Loan Documents. Without limiting the generality of the foregoing, the Administrative Agent&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">shall not be subject to any fiduciary or other implied duties, regardless of whether a Default has occurred and is continuing&#59;</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">shall not have any duty to take any discretionary action or exercise any discretionary powers, except discretionary rights and powers expressly contemplated   hereby or by the other Loan Documents that the Administrative Agent is required to  exercise as directed in writing by the Required Lenders (or such other number or percentage of the Lenders as shall be expressly provided for herein or in the other Loan Documents)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the Administrative Agent shall not be required to take any action that, in its opinion or the opinion of its counsel, may expose the Administrative Agent to liability or that is contrary to any Loan Document or applicable law&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">shall not, except as expressly set forth herein and in the other Loan Documents, have any duty to disclose, and shall not be liable for the failure to disclose,    any information relating to the Borrower, any of its Subsidiaries or any Affiliate thereof   that is communicated to or obtained by the Person serving as the Administrative Agent or any of its Affiliates in any capacity.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">The Administrative Agent shall not be liable for any action taken or not taken by     it (i)&#160;with the consent or at the request of the Required Lenders (or such other number or percentage of the Lenders as shall be necessary, or as the Administrative Agent shall believe in good faith shall be necessary, under the circumstances as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) or (ii)&#160;in the absence of its own gross negligence or willful misconduct. The Administrative Agent shall be deemed not to have knowledge of any Default unless and until written notice describing such Default is given to the Administrative Agent by the Borrower, a Lender or an Issuer.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Administrative Agent shall not be responsible for or have any duty to ascertain or inquire into (i) any statement, warranty or representation made in or in connection with this Agreement or any other Loan Document, (ii) the contents of any certificate, report or other document delivered hereunder or thereunder or in connection herewith or therewith, (iii) the performance or observance of any of the covenants, agreements or other terms or conditions set  forth herein or therein or the occurrence of any Default, (iv) the validity, enforceability, effectiveness or genuineness of this Agreement, any other Loan Document or any other agreement, instrument or document or (v) the satisfaction of any condition set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">    or elsewhere herein, other than to confirm receipt of items expressly required to be delivered to the Administrative Agent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">The Administrative Agent shall not be responsible or have any liability for, or have any duty to ascertain, inquire into, monitor or enforce, compliance with the provisions of this Agreement relating to Disqualified Institutions.  Without limiting the generality of the foregoing,  the Administrative Agent shall not (x) be obligated to ascertain, monitor or inquire as to whether  any Lender or prospective Lender is a Disqualified Institution or (y)&#160;have any liability with respect to or arising out of any assignment of Loans, or disclosure of confidential information, to any Disqualified Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Reliance by Administrative Agent</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall be entitled to rely upon, and shall not incur any liability for relying upon, any notice, request, certificate, consent, statement, instrument, document or other writing (including any electronic message, internet or intranet website posting or other distribution) believed by it to be  genuine and to have been signed, sent or otherwise authenticated by the proper Person. The Administrative Agent also may rely upon any statement made to it orally or by telephone and believed by it to have been made by the proper Person, and shall not incur any liability for relying thereon. In determining compliance with any condition hereunder to the making of a Loan or the issuance of a Letter of Credit that by its terms </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">must be fulfilled to the satisfaction of a Lender or an Issuer, the Administrative Agent may presume that such condition is satisfactory to such Lender or such Issuer unless the Administrative Agent shall have received notice to the contrary from such Lender or such Issuer prior to the making of such Loan or the issuance of such Letter of Credit. The Administrative Agent may consult with legal counsel (who may be counsel for the Borrower), independent public accounting firms and other experts selected by it and shall  not be liable for any action taken or not taken by it in accordance with the advice of any such counsel, accounting firm or experts.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Delegation of Duties</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent may perform any and all of its duties and exercise its rights and powers hereunder or under any other Loan Document by or through any one or more sub-agents appointed by the Administrative Agent. The Administrative Agent and any such sub-agent may perform any and all of its duties and exercise its rights and powers by or through their respective Related Parties. The exculpatory provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall apply to any such sub-agent and to the Related Parties of the Administrative Agent and any such sub-agent, and shall apply to their respective activities in connection with the syndication of the credit facilities provided for herein as well as activities as the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Resignation of Administrative Agent</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Administrative Agent may at any time give notice of its resignation to the Credit Parties and the Borrower. Upon receipt of any such notice of resignation, the Required Lenders shall have the right, subject to, so long as no Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(h),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> has occurred and is continuing, the consent    of the Borrower (such consent not to be unreasonably withheld or delayed), to appoint a successor, which shall be a bank with an office in New York, New York, or an Affiliate of any such bank with an office in New York, New York. If no such successor shall have been so appointed by the Required Lenders and shall have accepted such appointment within 30&#160;days after the retiring Administrative Agent gives notice of its resignation, then the retiring Administrative Agent may    on behalf of the Credit Parties, appoint a successor Administrative Agent meeting the qualifications set forth above, subject to, so long as no Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(h),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> has occurred and is continuing, the consent of the Borrower (such consent not to be unreasonably withheld or delayed)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if the Administrative Agent shall notify the Borrower and the Credit Parties that no qualifying Person has accepted such appointment, then such resignation shall nonetheless become effective in accordance with such notice and the retiring Administrative Agent shall be discharged from its duties and obligations hereunder and under the other Loan Documents and all payments, communications and determinations provided to be made by, to or through the Administrative Agent shall instead be made by or to each Credit Party directly, until such time as the Required Lenders appoint a  successor Administrative Agent as provided for above in this Section. Upon the acceptance of a successor&#8217;s appointment as Administrative Agent hereunder, such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring (or retired) Administrative Agent, and the retiring Administrative Agent shall be discharged from all of its duties and obligations hereunder or under the other Loan Documents (if not already discharged therefrom as provided above in this Section). The fees payable by the Borrower to a successor Administrative Agent shall be the same as those payable to its predecessor unless otherwise agreed in writing between the Borrower and such successor. After the retiring Administrative Agent&#8217;s resignation hereunder and under the other Loan Documents, the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall continue in effect for the benefit of such retiring Administrative Agent, its       </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">sub-agents and their respective Related Parties in respect of any actions taken or omitted to be taken by any of them while the retiring Administrative Agent was acting as Administrative Agent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Any resignation by BofA as Administrative Agent pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall also constitute its resignation as an Issuer and Swing Line Lender.  If BofA resigns as an Issuer, it shall, pending the issuance of letters of credit in substitution of the outstanding Letters of Credit in accordance with clause (iii) of the last sentence of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10.6(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and the return and cancellation of such outstanding Letters of Credit, retain all the rights, powers, privileges and duties of an Issuer hereunder with respect to all Letters of Credit outstanding as of the effective date of its resignation as an Issuer and all Reimbursement Obligations with respect thereto, including the right to require the Lenders to make ABR Advances or fund risk participations pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.   If BofA resigns as Swing Line Lender, it shall retain all the rights of the Swing Line Lender provided for hereunder with respect to Swing Line Loans made by it and outstanding as of the effective date of such resignation, including the right to require the Lenders to make ABR Advances or fund risk participations in outstanding Swing Line Loans pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Upon the appointment by the Borrower of a successor Issuer or Swing Line Lender hereunder (which successor shall in all cases be a Lender other than a Defaulting Lender), (i) such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring Issuer or Swing Line Lender, as applicable, (ii) the retiring Issuer and Swing Line Lender shall be discharged from all of their respective duties and obligations hereunder or under the other Loan Documents (other than with respect to outstanding Swing Line Loans made by it and outstanding Letters of Credit issued by it), and (iii) the successor Issuer shall issue letters of credit in substitution for the Letters of Credit, if any, outstanding at the time of such succession or make other arrangements satisfactory to BofA and the Borrower to effectively assume the obligations of BofA with respect to such Letters of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Non-Reliance on Administrative Agent and Other Credit Parties</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each Credit Party acknowledges that it has, independently and without reliance upon the Administrative Agent or any other Credit Party or any of their Related Parties and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Agreement. Each Credit Party also acknowledges that it will, independently and without reliance upon the Administrative Agent or any other Credit Party or any of their Related Parties and based on such documents and information as it shall from time to time deem appropriate, continue to make its own decisions in taking or not taking action under or based upon this Agreement, any other Loan Document or any related  agreement or any document furnished hereunder or thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">No Other Duties, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Anything herein to the contrary notwithstanding, none of the Joint Lead Arrangers, the  Sustainability Coordinator, the Co-Documentation Agents or the Co-Syndication Agents shall have any powers, duties or responsibilities under this Agreement or any of the other Loan Documents, except in its capacity, as applicable, as the Administrative Agent, a Lender or an Issuer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Recovery of Erroneous Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Without limitation of any other provision in this Agreement, if at any time the Administrative Agent makes a payment hereunder in error to any Lender or any Issuer (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Lender Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), whether or not in respect of an obligation due and owing by the Borrower at such time, where such payment is a Rescindable Amount, then in any such event, each Lender Party receiving a Rescindable Amount severally agrees to repay to the Administrative Agent forthwith on demand the Rescindable Amount received by such Lender </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Party in immediately available funds in the currency so received, with interest thereon, for each day from and including the date such Rescindable Amount is received by it to but excluding the date of payment to  the Administrative Agent, at the greater of the Federal Funds Effective Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation.  Each Lender Party irrevocably waives any and all defenses, including any &#8220;discharge for value&#8221; (under which a creditor might otherwise claim a right to retain funds mistakenly paid by a third party in respect of a debt owed by another) or similar defense to its obligation to return any Rescindable Amount.&#160; The Administrative Agent shall inform each Lender Party promptly upon determining that any payment made to such Lender Party comprised, in whole or in part, a Rescindable Amount.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">OTHER PROVISIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Amendments, Waivers, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">With the written consent of the Required Lenders, the Administrative Agent and the Borrower may, from time to time, enter into written amendments, supplements or modifications of the Loan Documents (which, for the avoidance of doubt, shall require the prior written consent of the Borrower) and, with the written consent of the Required Lenders and the Borrower, the Administrative Agent on behalf of the Lenders may execute and deliver to any such parties a written instrument waiving or consenting to the departure from, on such terms and conditions as the Administrative Agent may specify in such instrument (which terms and conditions shall have been agreed to by the Borrower), any of the requirements of the  Loan Documents or any Default or any Event of Default and its consequences, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that no such amendment, supplement, modification, waiver or consent shall (i) increase the Commitment Amount of    any Lender without the consent of such Lender (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that no waiver of a Default or Event of Default shall be deemed to constitute such an increase), (ii) extend the Commitment Period without the consent of each Lender directly affected thereby, (iii) reduce the amount, or extend the time of payment, of the Fees without the consent of each Lender directly affected thereby, (iv) reduce the rate, or extend the time of payment of, interest on any Revolving Credit Loan, any Note or any Reimbursement Obligation (other than the applicability of any post-default increase in such rate of interest) without the consent of each Lender directly affected thereby, (v) reduce the amount of, or extend the time of payment of, any payment of any Reimbursement Obligation or principal on any Revolving Credit Loan or any Note without the consent of each Lender directly affected thereby, (vi) decrease or forgive the principal amount of any Revolving Credit Loan, any Note or any Reimbursement Obligation without the consent of each Lender directly affected thereby, (vii) consent to any assignment or delegation by the Borrower of any of its rights or obligations under any Loan Document without the consent of each Lender, (viii) change the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> without the consent of each Lender, (ix) change the definition of Required Lenders without the consent of each Lender, (x) change the several nature of the obligations of the Lenders without the consent of each Lender, (xi) change the sharing provisions among Lenders without the consent of each Lender directly affected thereby, or (xii) extend the expiration date of a Letter of Credit beyond the Commitment Termination Date without the consent of each Lender. Notwithstanding the foregoing, in addition to the receipt of the prior written consents of the Borrower and the Required Lenders, no such amendment, supplement, modification, waiver or consent shall (A) amend, modify or waive any provision of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or otherwise change any of the rights or obligations of the Administrative Agent, any Issuer or the Swing Line Lender under any Loan Document without the written consent of the Administrative Agent, such   Issuer or the Swing Line Lender, as the case may be, (B) change the Letter of Credit Commitment, change the amount or the time of payment of any Letter of Credit or any commission or fee payable to the Issuer thereof in connection therewith, or change any other term or provision which relates to the Letter of Credit Commitment of such Issuer or the Letters of Credit issued thereby without the written consent of such  Issuer, (C) change the Swing Line Commitment, change the amount or the time of payment of the Swing Line Loans or interest thereon or change any other term or provision which relates to the Swing Line Commitment or the Swing Line Loans without the written consent of the Swing Line Lender or (D) change </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the amount or the time of payment of any Competitive Bid Loan or interest thereon without the written consent of the Lender holding such Competitive Bid Loan. Any such amendment, supplement,   modification, waiver or consent shall apply equally to each of the Lenders and shall be binding upon the parties to the applicable Loan Document, the Lenders, the Issuers, the Administrative Agent and all future holders of the Loans, the Notes and the Reimbursement Obligations. In the case of any waiver, the  Borrower, the Lenders, the Issuers and the Administrative Agent shall be restored to their former position and rights under the Loan Documents, but any Default or Event of Default waived shall not extend to any subsequent or other Default or Event of Default, or impair any right consequent thereon. Notwithstanding anything to the contrary in this Agreement or in any other Loan Document, (1) the Administrative Agent  and the Borrower may make amendments contemplated by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> without the consent of any other Person party hereto, (2) in order to implement any ESG Amendment, this Agreement and the other Loan Documents may be amended in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> with only the consent of the Borrower, the Sustainability Coordinator and the Required Lenders (as and to the extent provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), (3) if the Administrative Agent and the Borrower shall have jointly identified an obvious error, ambiguity, defect, inconsistency, omission or any error or omission of a technical nature, in each case, in any provision of the Loan Documents, then the Administrative Agent and the Borrower shall be permitted to amend such provision, and, in each case, such amendment shall become effective without any further action or consent  of any party to any Loan Document (other than the Administrative Agent and the Borrower) if the same (x) does not adversely affect the rights of any Lender or (y) is not objected to in writing by the Required Lenders to the Administrative Agent within five Domestic Business Days following receipt of notice thereof, and   (4) this Agreement may be amended or amended and restated without the consent of any specific Lender  (but with the consent of the Borrower and the Administrative Agent) if, upon giving effect to such amendment or amendment and restatement, such Lender shall no longer be a party to this Agreement (as     so amended or amended and restated, as the case may be), the Commitments of such Lender shall have terminated, such Lender shall have no other commitment or other obligation hereunder and shall have been paid in full all principal, interest and other amounts owing to it or accrued for its account under this Agreement. Any amendment, waiver or consent effected in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be binding upon each Person that is at the time thereof a Lender and each Person that subsequently becomes a Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Notices</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Notices Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Except in the case of notices and other communications expressly permitted to be given by telephone, all notices and other communications provided for herein shall be in writing and shall be delivered by hand or overnight courier service, mailed by certified or registered mail or sent by facsimile or email, as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">If to the Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CVS Health Corporation</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1 CVS Drive</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">MC2340</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Woonsocket, Rhode Island 02895</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attention&#58;&#160;&#160;&#160;&#160;Carol A. DeNale</font></div><div style="padding-left:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Senior Vice President and Treasurer</font></div><div style="padding-left:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Facsimile&#58;&#160;&#160;&#160;&#160;(401) 770-5768</font></div><div style="padding-left:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Telephone&#58;&#160;&#160;&#160;&#160;(401) 770-4407</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Email&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;carol.denale&#64;cvshealth.com</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">with a copy, in the case of a notice of Default or Event of Default, to&#58;</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CVS Health Corporation</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1 CVS Drive</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Woonsocket, Rhode Island 02895</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attention&#58;&#160;&#160;&#160;&#160;Tom Moffatt</font></div><div style="padding-left:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Vice President, Assistant Secretary and Assistant General Counsel &#8211; Corporate Services</font></div><div style="padding-left:72pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Facsimile&#58;&#160;&#160;&#160;&#160;(401) 216-3758</font></div><div style="padding-left:72pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Telephone&#58;&#160;&#160;&#160;&#160;(401) 770-5409</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Email&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;thomas.moffatt&#64;cvshealth.com</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">with a copy (in the case of a notice of Default or Event of Default and which shall not constitute notice under this Agreement or any other Loan Document for any purpose) to&#58;</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Shearman &#38; Sterling LLP</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">599 Lexington Avenue</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">New York, New York 10022</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attention&#58;&#160;&#160;&#160;&#160;Gus M. Atiyah</font></div><div style="padding-left:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Facsimile&#58;&#160;&#160;&#160;&#160;(646) 848-5227</font></div><div style="padding-left:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Telephone&#58;&#160;&#160;&#160;&#160;(212) 848-5227</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Email&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;gus.atiyah&#64;shearman.com</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">If to the Administrative Agent, BofA as an Issuer or the Swing Line Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in the case of each Borrowing Request, each notice of prepayment under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, each Letter    of Credit Request, each Competitive Bid Request, each Competitive Bid, and each Competitive    Bid Accept&#47;Reject Letter&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Bank of America, N.A., as Administrative Agent</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">900 W. Trade St., 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Floor </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NC1-026-06-04</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Charlotte, NC 28255</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attention&#58;&#160; Kennedy Diggs</font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Tel&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">980-387-4805</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Facsimile&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">704-625-5608</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Email&#58; kennedy.diggs&#64;bofa.com </font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Remittance Instructions- US Dollars</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Bank of America, N.A. </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">New York, NY</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ABA# </font><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">XXXXXXXXX</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Account No.&#58;  </font><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">XXXXXXXXXXXXX</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Account Name&#58; Wire Clearing Acct for Syn Loans-LIQ</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ref&#58;  CVS HEALTH CORPORATION </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in the case of each Letter of Credit Request&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Bank of America, N.A.</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Trade Operations</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1 Fleet Way</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Mail Code&#58; PA6-580-02-30</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Scranton, Pa. 18507</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attention&#58;  Trade Operations</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Tel&#58; 570-496-9619</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Facsimile&#58; 800-755-8740</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Email&#58; tradeclientserviceteamus&#64;bofa.com</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Remittance Instructions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Bank of America, N.A.</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">New York, NY</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ABA #&#58; </font><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">XXX-XXX-XXX</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Account #&#58; </font><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">XXXXX-XXXXXX</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attn&#58; Scranton Standby&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ref&#58; CVS HEALTH CORPORATION </font></div><div style="padding-left:72pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and in all other cases&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Bank of America, N.A., as Administrative Agent</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">900 W. Trade St., 6th Floor </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NC1-026-06-03</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Charlotte, NC 28255</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attention&#58;  Kyle Harding</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Tel&#58; 980-275-6132</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Facsimile&#58; 704-719-5215</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Email&#58; kyle.d.harding&#64;bofa.com</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">If to any Lender or any other Issuer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; to it at its address (or facsimile number or email address) set forth in its Administrative Questionnaire.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Electronic Communications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notices and other communications to the Credit  Parties hereunder may be delivered or furnished by electronic communication (including email, FpML messaging and internet or intranet websites) pursuant to procedures approved by the Administrative Agent&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the foregoing shall not apply to notices to any Credit Party pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> if such Credit Party has notified the Administrative Agent that  it is incapable of receiving notices under such Sections by electronic communication. The Administrative Agent or the Borrower may, in its discretion, agree to accept notices and other communications to it hereunder by electronic communications pursuant to procedures approved by it&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that approval of such procedures may be limited to particular notices or communications.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Unless the Administrative Agent otherwise prescribes, (i)&#160;notices and other  communications sent to an email address shall be deemed received upon the sender&#8217;s receipt of an acknowledgement from the intended recipient (such as by the &#8220;return receipt requested&#8221; or &#8220;read requested&#8221; function, as available, return email or other written acknowledgement)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if such notice or other communication is not sent during the normal business hours of the recipient, such notice or communication shall be deemed to have been sent at the opening of business on the next Domestic Business Day for the recipient, and (ii)&#160;notices or communications posted to an internet or intranet website shall be deemed received upon the deemed receipt by the intended recipient at its email address as described in the foregoing clause&#160;(i) of notification that such notice or communication is available and identifying the website address therefor.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Change of Address</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Any party hereto may change its address, facsimile number or email address for notices and other communications hereunder by notice to the other parties hereto (or, in the case of any Lender or any Issuer, by notice to the Administrative Agent and the Borrower). Subject to the second paragraph of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, all notices and other communications given to any party hereto in accordance with the provisions of this Agreement   shall be deemed to have been given on the date of receipt&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any such notice or communication that is not received on a Domestic Business Day during the normal business hours  of the recipient shall be deemed received at the opening of business on the next Domestic Business Day.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">The Platform</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">THE PLATFORM IS PROVIDED &#8220;AS IS&#8221; AND &#8220;AS AVAILABLE.&#8221;  THE AGENT PARTIES (AS DEFINED BELOW) DO NOT WARRANT THE ACCURACY OR COMPLETENESS OF THE BORROWER MATERIALS OR THE  ADEQUACY OF THE PLATFORM, AND EXPRESSLY DISCLAIM LIABILITY FOR   ERRORS IN OR OMISSIONS FROM THE BORROWER MATERIALS.  NO WARRANTY OF ANY KIND, EXPRESS, IMPLIED OR STATUTORY, INCLUDING ANY WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT  OF THIRD PARTY RIGHTS OR FREEDOM FROM VIRUSES OR OTHER CODE DEFECTS,  IS MADE BY ANY AGENT PARTY IN CONNECTION WITH THE BORROWER  MATERIALS OR THE PLATFORM.  In no event shall the Administrative Agent or any of its Related Parties (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Agent Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) have any liability to the Borrower, any Lender, any Issuer or any other Person for losses, claims, damages, liabilities or expenses of any kind (whether in tort, contract or otherwise) arising out of the Borrower&#8217;s or the Administrative Agent&#8217;s transmission of Borrower Materials or notices through the Platform, any other electronic platform    or electronic messaging service, or through the Internet.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">No Waiver&#59; Cumulative Remedies</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No failure to exercise and no delay in exercising, on the part of the Administrative Agent, any Lender or any Issuer, any right, remedy, power or privilege under any Loan Document shall operate as a waiver thereof, nor shall any single or partial exercise of any right, remedy, power or privilege under any Loan Document preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege. The rights, remedies, powers and privileges under the Loan Documents are cumulative and not exclusive of any rights, remedies, powers and privileges provided by law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Survival of Representations and Warranties</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">All representations and warranties made in the Loan Documents and in any document, certificate    or statement delivered pursuant thereto or in connection therewith shall survive the execution and delivery  of the Loan Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Payment of Expenses&#59; Indemnified Liabilities</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Borrower agrees, as soon as practicable following presentation of a statement  or invoice therefor setting forth in reasonable detail the items thereof, and whether any Loan is  made or Letter of Credit is issued, (a) to pay or reimburse the Administrative Agent and its  Affiliates for all their reasonable and documented out-of-pocket costs and expenses actually  incurred in connection with the development, syndication, preparation and execution of, and any amendment, waiver, consent, supplement or modification to, the Loan Documents, any documents prepared in connection therewith and the consummation of the transactions contemplated thereby, whether such Loan Documents or any such amendment, waiver, consent, supplement or </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">modification to the Loan Documents or any documents prepared in connection therewith are executed and whether the transactions contemplated thereby are consummated, including the reasonable and documented out-of-pocket fees and disbursements of Special Counsel, (b) to pay, indemnify, and hold the Administrative Agent, the Lenders and the Issuers harmless from any and all recording and filing fees and any and all liabilities and penalties with respect to, or resulting  from any delay (other than penalties to the extent attributable to the negligence of the  Administrative Agent, the Lenders or the Issuers, as the case may be, in failing to pay such fees, liabilities or penalties when due) which may be payable or determined to be payable in connection with the execution and delivery of, or consummation of any of the transactions contemplated by,    or any amendment, supplement or modification of, or any waiver or consent under or in respect of, the Loan Documents or any documents prepared in connection therewith, and (c) to pay, reimburse, indemnify and hold each Indemnified Person harmless from and against any and all other liabilities, obligations, claims, losses, damages, penalties, actions, judgments, suits, costs, expenses and disbursements of any kind or nature whatsoever (including the reasonable and documented out-of-pocket fees and disbursements of one counsel (but excluding the allocated cost of internal counsel) representing all of the Indemnified Persons, taken as a whole, and, if reasonably necessary, of a single local counsel for each applicable jurisdiction (and, if reasonably necessary, one specialty counsel for each applicable specialty), representing all of the Indemnified Persons, taken as a whole (and, in the case of any actual or perceived conflict of interest where the Indemnified Person  affected by such conflict notifies the Borrower of the existence of such conflict and thereafter  retains its own counsel, of another firm of counsel (and, if reasonably necessary, a single local counsel for each applicable jurisdiction (which may include a single counsel acting in multiple jurisdictions) (and, if reasonably necessary, one specialty counsel for each applicable specialty),    for each such affected Indemnified Person))) actually incurred with respect to the enforcement, performance of, and preservation of rights under, the Loan Documents (all the foregoing, collectively, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Indemnified Liabilities&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) and, if and to the extent that the foregoing indemnity may be unenforceable for any reason, the Borrower agrees to make the maximum payment  permitted under applicable law. Notwithstanding anything to the contrary contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the foregoing payment, indemnification and reimbursement obligations will not, as to any Person identified in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, apply to any losses, claims, damages, liabilities and related expenses to the extent arising (A) from the willful misconduct, gross negligence, fraud or bad faith of such Person, (B) from a material breach of the obligations hereunder of such Person, (C) out of   or in connection with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, or (D) out of or in connection with any claim, litigation, investigation or proceeding that does not involve an act or omission of the Borrower or any of its Affiliates and that is brought by any such Person against any such other Person (other than the Administrative Agent, a Joint Lead Arranger, the Issuer or the Swing Line Lender, in each case, in its capacity as such), in each case under clauses (A) and (B), to the extent determined by a final and non-appealable judgment of a court of competent jurisdiction. The agreements in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall survive the termination of the Commitments and the payment of the Loans and the Notes and all other amounts payable under the Loan Documents.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Notwithstanding the above, the Borrower shall have no liability under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> to indemnify or hold harmless any Indemnified Person for any losses, claims, damages, liabilities and related expenses relating to income or withholding Taxes or any Tax in lieu of such Taxes. Notwithstanding the foregoing, any amounts claimed by an Indemnified Person under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall not be available to be claimed by such Indemnified Person under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, it being understood and agreed that the rights of an Indemnified Person under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall not be duplicative.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Lending Offices</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each Lender shall have the right at any time and from time to time to transfer any Loan to a different office of such Lender, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Successors and Assigns</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Successors and Assigns Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and  assigns permitted hereby, except that the Borrower may not assign or otherwise transfer any of its rights or obligations hereunder without the prior written consent of the Administrative Agent and each Lender and no Lender may assign or otherwise transfer any of its rights or obligations hereunder except (i) to an assignee in accordance with the provisions of paragraph (b) of this  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, (ii) by way of participation in accordance with the provisions of paragraph (d) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or (iii) by way of pledge or assignment of a security interest subject to the restrictions of paragraph (f) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (and any other attempted assignment or transfer by any party hereto shall be null and void). Nothing in this Agreement, expressed or implied, shall be construed  to confer upon any Person (other than the parties hereto, their respective successors and assigns permitted hereby, the Participants to the extent provided in paragraph (d) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and,   to the extent expressly contemplated hereby, the Related Parties of each Credit Party) any legal or equitable right, remedy or claim under or by reason of this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Assignments by Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Any Lender may at any time assign to one or more assignees all or a portion of its rights and obligations under this Agreement (including all or a portion of its Commitment and the Loans and obligations in respect of its Letter of Credit Exposure and Swing Line Exposure at the time owing to it)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any such assignment shall be subject to the following conditions&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Minimum Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.74pt">in the case of an assignment of the entire remaining amount of the assigning Lender&#8217;s Commitment Amount or Swing Line Commitment and the Loans and obligations in respect of its Letter of Credit Exposure and Swing Line Exposure at the time owing to it or in the case of an assignment to a Lender, an Affiliate of a Lender or an Approved Fund, no minimum amount need be assigned&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.35pt">in any case not described in paragraph (b)(1)(A) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Commitment Amount or Swing Line Commitment (which for this   purpose includes the Loans of the assigning Lender outstanding thereunder and obligations in respect of its Letter of Credit Exposure and Swing Line Exposure at the time owing to it thereunder) or, if the Commitment or Swing Line Commitment of the assigning Lender is not then in effect, the principal outstanding balance of  the Loans and the Letter of Credit Exposure and Swing Line Exposure of the assigning Lender subject to each such assignment (determined as of the date the Assignment and Assumption with respect to such assignment is delivered to the Administrative Agent or, if a &#8220;Trade Date&#8221; is specified in the Assignment and Assumption, as of such &#8220;Trade Date&#8221;) shall not be less than $5,000,000, unless  each of the Administrative Agent and, so long as no Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(h),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> has occurred </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and is continuing, the Borrower otherwise consents (each such consent not to be unreasonably withheld or delayed).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Proportionate Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each partial assignment shall be made as an assignment of a proportionate part of all the assigning Lender&#8217;s rights and obligations under this Agreement with respect to the Loans, Letter of Credit Exposure and Swing Line Exposure or the Commitment assigned, except that this clause (2) shall not prohibit any Lender from assigning all or a portion of its rights and obligations in respect of Competitive Bid Loans on a non-pro rata basis.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Required Consents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. No consent shall be required for any assignment   except to the extent required by paragraph (b)(1)(B) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and, in addition&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.74pt">the consent of the Borrower (such consent not to be unreasonably withheld or delayed) shall be required unless (x) an Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(h),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> has occurred and is continuing at the time of such assignment or (y) such assignment is to a Lender, an Affiliate of a Lender or an Approved Fund (it being understood that it shall not be deemed unreasonable for the Borrower to withhold consent to any assignment if it reasonably believes that such assignment would result in the Borrower incurring increased costs pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">)&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.35pt">the consent of the Administrative Agent (such consent not to be unreasonably withheld, conditioned or delayed) shall be required for assignments   in respect of an unfunded or revolving facility hereunder if such assignment is to     a Person that is not a Lender with a Commitment in respect of such facility, an Affiliate of such Lender or an Approved Fund with respect to such Lender&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.35pt">the consent of each Issuer (such consent not to be unreasonably withheld, conditioned or delayed) shall be required for any assignment that increases the obligation of the assignee to participate in exposure under one or   more Letters of Credit (whether or not then outstanding) and the Swing Line  Lender (such consent not to be unreasonably withheld or delayed) shall be required for any assignment in respect of the revolving facility hereunder.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Assignment and Assumption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The parties to each assignment shall execute and deliver to the Administrative Agent an Assignment and Assumption, together with a processing and recordation fee of $4,500 ($7,500 in the case of an assignment by a Defaulting Lender) (which fee shall be paid by the assignor or the assignee and may be waived or reduced in the sole discretion of the Administrative Agent), and the assignee, if   it is not a Lender, shall deliver to the Administrative Agent an Administrative  Questionnaire.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">No Assignment to Certain Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. No such assignment shall be made to  (A) the Borrower, any of its Subsidiaries or any of their respective Affiliates or (B) any Defaulting Lender or any of its Subsidiaries or any Person who, upon becoming a Lender hereunder, would constitute any of the foregoing Persons described in this clause (B).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">No Assignment to Natural Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. No such assignment shall be made to    a natural person (or a holding company, investment vehicle or trust for, or owned and operated by or for the primary benefit of a natural person).</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Certain Additional Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  In connection with any assignment of rights and obligations of any Defaulting Lender hereunder, no such assignment shall be effective unless and until, in addition to the other conditions thereto set forth herein, the parties to    the assignment shall make such additional payments to the Administrative Agent in an aggregate amount sufficient, upon distribution thereof as appropriate (which may be  outright payment, purchases by the assignee of participations or subparticipations, or other compensating actions, including funding, with the consent of the Borrower and the Administrative Agent, the applicable pro rata share of Loans previously requested but not funded by the Defaulting Lender, to each of which the applicable assignee and assignor hereby irrevocably consent), to (x) pay and satisfy in full all payment liabilities then owed by such Defaulting Lender to the Administrative Agent, any Issuer or any Lender   hereunder (and interest accrued thereon) and (y) acquire (and fund as appropriate) its full pro rata share of all Loans and participations in Letters of Credit and Swing Line Loans in accordance with its Commitment Percentage. Notwithstanding the foregoing, in the event that any assignment of rights and obligations of any Defaulting Lender hereunder shall become effective under applicable law without compliance with the provisions of this  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">clause (7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, then the assignee of such interest shall be deemed to be a Defaulting Lender for all purposes of this Agreement until such compliance occurs.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Subject to acceptance and recording thereof by the Administrative Agent pursuant to paragraph (c) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, from and after the effective date specified in each Assignment  and Assumption, the assignee thereunder shall be a party to this Agreement and, to the extent of    the interest assigned by such Assignment and Assumption, have the rights and obligations of a Lender under this Agreement, and the assigning Lender thereunder shall, to the extent of the interest assigned by such Assignment and Assumption, be released from its obligations under this Agreement (and, in the case of an Assignment and Assumption covering all of the assigning Lender&#8217;s rights and obligations under this Agreement, such Lender shall cease to be a party hereto) but shall continue to be entitled to the benefits of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.6,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> with respect to facts and circumstances occurring prior to the effective date of such assignment. Any assignment or transfer by a Lender of rights or obligations under this Agreement that does not comply with this paragraph shall be treated for purposes of this Agreement as a sale by such Lender of a participation in such rights and obligations in accordance with paragraph (d) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Administrative Agent, acting solely for this purpose as an agent of  the Borrower, shall maintain at one of its offices in the United States of America a copy of each Assignment and Assumption delivered to it and a register for the recordation of the names and addresses of the Lenders, and the Commitments of, and principal amounts (and stated interest) of  the Loans owing to, each Lender pursuant to the terms hereof from time to time (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Register&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">). The entries in the Register shall be conclusive absent manifest error, and the Borrower, the Administrative Agent, the Issuers and the Lenders shall treat each Person whose name is recorded   in the Register pursuant to the terms hereof as a Lender hereunder for all purposes of this Agreement, notwithstanding notice to the contrary. The Register shall be available for inspection   by the Borrower, any Issuer and any Lender (but only, in the case of an Issuer or a Lender, at the Administrative Agent&#8217;s Office and with respect to any entry relating to such Lender&#8217;s  Commitments, Advances and other obligations pursuant to the terms hereof or such Issuer&#8217;s Letter of Credit Commitments and other obligations pursuant to the terms hereof, as applicable) at any reasonable time and from time to time upon reasonable prior notice.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Participations.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Any Lender may at any time, without the consent of, or notice to,   the Borrower or the Administrative Agent, sell participations to any Person (other than a natural </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">person (or a holding company, investment vehicle or trust for, or owned and operated by or for the primary benefit of a natural person), the Borrower, any of its Subsidiaries or any of their respective Affiliates) (each, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) in all or a portion of such Lender&#8217;s rights and&#47;or obligations  under this Agreement (including all or a portion of its Commitment, Letter of Credit Exposure, Swing Line Exposure and&#47;or the Loans, Letter of Credit Exposure or Swing Line Exposure owing   to it)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that (i)&#160;all of such Lender&#8217;s obligations under this Agreement and the other Loan Documents shall remain in all respects unchanged, (ii)&#160;such Lender shall remain solely responsible to the other parties hereto for the performance of such obligations and (iii)&#160;the Borrower, the Administrative Agent and each Credit Party shall continue to deal solely and directly with such Lender in connection with such Lender&#8217;s rights and obligations under this Agreement. Any agreement or instrument pursuant to which a Lender sells such a participation shall provide that  such Lender shall retain the sole right to enforce this Agreement and to approve any amendment, modification or waiver of any provision of this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such agreement or instrument may provide that such Lender will not, without the consent of the Participant, agree to any amendment, modification or waiver which requires the consent of all Lenders or all affected Lenders that directly affects such Participant. Subject to paragraph (e) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Borrower agrees that each Participant shall be entitled to the benefits of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> to the same extent as if it were a Lender and had acquired its interest  by assignment pursuant to paragraph (b) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. To the extent permitted by law, each Participant also shall be entitled to the benefits of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;11.9(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as though it were a Lender&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such Participant agrees to be subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;11.9(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as though it were a Lender. Each Lender that sells a participation with respect to a Commitment or Loan shall, solely for the purposes of complying with the rules regarding registered form in the Internal Revenue Code, act   as a non-fiduciary agent of the Borrower, maintaining a register on which it enters the name and address of each Participant and the principal amounts (and stated interest amounts) of each Participant&#8217;s interest in the Commitment and&#47;or Loan (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Participant Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), and the entries in such Participant Register shall be conclusive, absent manifest error, and such Lender shall treat each Person whose name is recorded in the Participant Register as the owner of such participation for all purposes of this Agreement notwithstanding any notice to the contrary. No Lender shall be required to disclose the existence of, or any of the information contained in, any Participant Register maintained by it to the Borrower or any other Person unless requested in  writing by the Borrower, and only to the Internal Revenue Service to the extent such disclosure is required in order to comply with the rules requiring registered form pursuant to the Internal  Revenue Code.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Limitations upon Participant Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. A Participant shall not be entitled to receive any greater payment under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> than the applicable Lender would have been entitled to receive with respect to the participation sold to such Participant, unless the sale of the participation to such Participant is made with the Borrower&#8217;s prior written consent. A Participant shall not be entitled to the benefits of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> unless the Borrower is notified of the participation sold to such Participant and such Participant agrees, for the benefit of  the Borrower, to comply with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.10(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> as though it were a Lender.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.02pt;text-decoration:underline">Certain Pledges</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Any Lender may at any time pledge or assign a security interest    in all or any portion of its rights under this Agreement to secure obligations of such Lender, including any pledge or assignment to secure obligations to a Federal Reserve Bank or other central bank having jurisdiction over such Lender&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that no such pledge or assignment shall release such Lender from any of its obligations hereunder or substitute any such pledgee or assignee for such Lender as a party hereto.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Resignation as Issuer or Swing Line Lender after Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Notwithstanding anything to the contrary contained herein, if at any time any Issuer or the Swing Line Lender assigns all of its Commitment and Loans pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">clause (b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> above, such Issuer or Swing Line Lender may, (i) upon 30 days&#8217; notice to the Administrative Agent, the Borrower and the Lenders, resign     as an Issuer and&#47;or (ii) upon 30 days&#8217; notice to the Borrower, resign as Swing Line Lender.  In the event of any such resignation as an Issuer or Swing Line Lender, the Borrower shall be entitled to appoint from among the Lenders a successor Issuer or Swing Line Lender hereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that no failure by the Borrower to appoint any such successor shall affect the resignation  of the applicable Issuer or Swing Line Lender as an Issuer or Swing Line Lender, as the case may be.  If the applicable Issuer resigns as an Issuer, it shall retain all the rights, powers, privileges and duties of an Issuer hereunder with respect to all Letters of Credit issued by it and outstanding as of the effective date of its resignation as an Issuer and all Reimbursement Obligations with respect thereto (including the right to require the Lenders to make ABR Advances or fund risk  participations in pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).  If the Swing Line Lender resigns as Swing Line Lender,  it shall retain all the rights of the Swing Line Lender provided for hereunder with respect to Swing Line Loans made by it and outstanding as of the effective date of such resignation, including the right to require the Lenders to make ABR Advances or fund risk participations in outstanding  Swing Line Loans pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Upon the appointment of a successor Issuer and&#47;or Swing Line Lender, (x) such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring Issuer or Swing Line Lender, as the case may be, and  (y) the successor Issuer shall issue letters of credit in substitution for the Letters of Credit, if any, outstanding at the time of such succession or make other arrangements satisfactory to the applicable retiring Issuer and the Borrower to effectively assume the obligations of the applicable retiring Issuer with respect to such Letters of Credit.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Disqualified Institutions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  (i)  No assignment shall be made to any Person that was   a Disqualified Institution as of the date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Trade Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) on which the applicable Lender entered into a binding agreement to sell and assign all or a portion of its rights and obligations under this Agreement to such Person (unless the Borrower has consented to  such assignment in writing as otherwise contemplated by this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, in which case such Person will not be considered a Disqualified Institution for the purpose of such assignment).  For the avoidance of doubt, with respect to any assignee that becomes a Disqualified Institution after the applicable Trade Date (including as a result of the delivery of a notice pursuant to, and&#47;or the expiration of the notice period referred to in, the  definition of &#8220;Disqualified Institution&#8221;), (x) such assignee shall not retroactively be disqualified from becoming a Lender and (y) the execution and delivery by the Borrower   of an Assignment and Assumption with respect to such assignee will not by itself result in such assignee no longer being considered a Disqualified Institution.  Any assignment in violation of this clause (h)(i) shall not be void, but the other provisions of this clause (h) shall apply.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;If any assignment is made to any Disqualified Institution without the Borrower&#8217;s prior consent in violation of clause (i) above, or if any Person becomes a Disqualified Institution after the applicable Trade Date, the Borrower may, at its sole expense and effort, upon notice to the applicable Disqualified Institution and the Administrative Agent, (A) terminate any Commitment of such Disqualified Institution and repay all obligations of the Borrower owing to such Disqualified Institution in connection with such Commitment, and&#47;or (B) require such Disqualified Institution to assign and delegate, without recourse (in accordance with and subject to the restrictions contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), all of its interest, rights and obligations under this Agreement and the other Loan Documents to an Eligible Assignee that shall assume such obligations at the </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">lesser of (x) the principal amount thereof and (y) the amount that such Disqualified Institution paid to acquire such interests, rights and obligations, in each case plus accrued interest, accrued fees and all other amounts (other than principal amounts) payable to it hereunder and other the other Loan Documents.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary contained in this Agreement, Disqualified Institutions (A) will not (x) have the right to receive information, reports or other materials provided to Lenders by the Borrower, the Administrative Agent or any   other Lender, (y) attend or participate in meetings attended by the Lenders and the Administrative Agent, or (z) access any electronic site established for the Lenders or confidential communications from counsel to or financial advisors of the Administrative Agent or the Lenders and (B) (x) for purposes of any consent to any amendment, waiver     or modification of, or any action under, and for the purpose of any direction to the Administrative Agent or any Lender to undertake any action (or refrain from taking any action) under this Agreement or any other Loan Document, each Disqualified Institution  will be deemed to have consented in the same proportion as the Lenders that are not Disqualified Institutions consented to such matter, and (y) for purposes of voting on any plan of reorganization or plan of liquidation pursuant to any bankruptcy or insolvency laws (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Plan of Reorganization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), each Disqualified Institution party hereto hereby agrees (1) not to vote on such Plan of Reorganization, (2) if such Disqualified Institution does vote on  such Plan of Reorganization notwithstanding the restriction in the foregoing clause (1),   such vote will be deemed not to be in good faith and shall be &#8220;designated&#8221; pursuant to Section 1126(e) of the United States Bankruptcy Code (or any similar provision in any  other bankruptcy or insolvency laws), and such vote shall not be counted in determining whether the applicable class has accepted or rejected such Plan of Reorganization in accordance with Section 1126(c) of the United States Bankruptcy Code (or any similar provision in any other bankruptcy or insolvency laws) and (3) not to contest any request    by any party for a determination by the bankruptcy court (or other applicable court of competent jurisdiction) effectuating the foregoing clause (2).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Counterparts&#59; Electronic Execution </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each of the Loan Documents (other than the Notes) may be executed on any number of separate counterparts and all of said counterparts taken together shall be deemed to constitute one and the same agreement.  It shall not be necessary in making proof of any Loan Document to produce or account for more than one counterpart signed by the party to be charged.   A set of the copies of this Agreement signed by all of the parties hereto shall be lodged with each   of the Borrower and the Administrative Agent.  Delivery of an executed counterpart of a signature page of any Loan Document by fax or other electronic means (e.g., &#8220;.pdf&#8221; or &#8220;.tif&#8221;) shall be effective as delivery of a manually executed counterpart of such Loan Document.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Electronic Execution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This Agreement and any document, amendment, approval, assignment, consent, information, notice, certificate, request, statement, disclosure or authorization related to this Agreement (each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Communication</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), including Communications required to be in writing, may be in the form of an Electronic Record and may be executed using Electronic Signatures. Each party hereto hereby agrees that any Electronic Signature on, or associated with,  any Communication shall be valid and binding on such party to the same extent as a manual,  original signature, and that any Communication entered into by Electronic Signature, will constitute the legal, valid and binding obligation of such party enforceable against such party in accordance with the terms thereof to the same extent as if a manually executed original signature was delivered.   Any Communication may be executed in as many counterparts as necessary or convenient,  </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">including both paper and electronic counterparts, but all such counterparts are one and the same Communication.  For the avoidance of doubt, the authorization under this paragraph may include, without limitation, use or acceptance by each party hereto of a manually signed paper Communication which has been converted into electronic form (such as scanned into PDF format), or an electronically signed Communication converted into another format, for transmission,   delivery and&#47;or retention. Each party hereto may, at its option, create one or more copies of any Communication in the form of an imaged Electronic Record (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Electronic Copy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), which shall be deemed created in the ordinary course of such Person&#8217;s business, and destroy the original paper document.  All Communications in the form of an Electronic Record, including an Electronic Copy, shall be considered an original for all purposes, and shall have the same legal effect, validity and enforceability as a paper record. Notwithstanding anything contained herein to the contrary, the Administrative Agent is under no obligation to accept an Electronic Signature in any form or in    any format unless expressly agreed to by the Administrative Agent pursuant to procedures approved by it (it being acknowledged that the Administrative Agent will accept &#8220;.pdf&#8221; signatures).  Without limiting the foregoing sentence, (a) to the extent the Administrative Agent has agreed to accept   such Electronic Signature, the Administrative Agent and each of the Lenders shall be entitled to   rely on any such Electronic Signature purportedly given by or on behalf of the Borrower without further verification, and (b) upon the request of the Administrative Agent or any Lender hereto, any Electronic Signature shall be promptly (to the extent reasonably practicable at such time as reasonably determined by the Borrower) followed by such manually executed counterpart.  For purposes hereof, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Electronic Record</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Electronic Signature</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall have the meanings   assigned to them, respectively, by 15 USC &#167;7006, as it may be amended from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Set-off and Sharing of Payments.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">In addition to any rights and remedies of the Lenders and the Issuers provided by law, after the occurrence and during the continuance of an Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">     or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or upon the acceleration of the Loans, each Lender and each Issuer shall have the right, without prior notice to the Borrower, any such notice being expressly waived by the  Borrower, to set-off and apply against any indebtedness or other liability, whether matured or unmatured, of the Borrower to such Lender or such Issuer arising under the Loan Documents, any amount owing from such Lender or such Issuer to the Borrower. To the extent permitted by applicable law, the aforesaid right of set-off may be exercised by such Lender or such Issuer against the Borrower or against any trustee in bankruptcy, custodian, debtor in possession, assignee for the benefit of creditors, receiver, or execution, judgment or attachment creditor of the Borrower, or against anyone else claiming through or against the Borrower or such trustee in bankruptcy, custodian, debtor in possession, assignee for the benefit of creditors, receivers, or execution, judgment or attachment creditor, notwithstanding the fact that such right of set-off shall not have been exercised by such Lender or such Issuer prior to the making, filing or issuance of, service   upon such Lender or such Issuer of, or notice to such Lender or such Issuer of, any petition, assignment for the benefit of creditors, appointment or application for the appointment of a   receiver, or issuance of execution, subpoena, order or warrant. Each Lender and each Issuer agree promptly to notify the Borrower and the Administrative Agent after each such set-off and application made by such Lender or such Issuer, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the failure to give such notice shall not affect the validity of such set-off and application.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">If any Lender or any Issuer shall obtain any payment (whether voluntary, involuntary, through the exercise of any right of set-off, or otherwise) on account of its Loans or    its Notes or the Reimbursement Obligations in excess of its pro rata share (in accordance with the outstanding principal balance of all Loans or the Reimbursement Obligations) of payments then   due and payable on account of the Loans and Notes received by all the Lenders or the </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Reimbursement Obligations received by all Issuers, such Lender or such Issuer, as the case may    be, shall forthwith purchase, without recourse, for cash, from the other Lenders or Issuers, as the case may be, such participations in their Loans and Notes or the Reimbursement Obligations as  shall be necessary to cause such purchasing Lender or Issuer to share the excess payment with each of them according to their pro rata share (in accordance with the outstanding principal balance of   all Loans and the Reimbursement Obligations)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if all or any portion of such excess payment is thereafter recovered from such purchasing Lender or Issuer, such purchase from each Lender or Issuer shall be rescinded and each such Lender and Issuer shall repay to the purchasing Lender or Issuer the purchase price to the extent of such recovery, together with an amount equal     to such Lender&#8217;s or Issuer&#8217;s pro rata share (according to the proportion of (i) the amount of such Lender&#8217;s or Issuer&#8217;s required repayment to (ii) the total amount so recovered from the purchasing Lender or Issuer) of any interest or other amount paid or payable by the purchasing Lender or Issuer in respect of the total amount so recovered. The Borrower agrees, to the fullest extent permitted by law, that any Lender or Issuer so purchasing a participation from another Lender or Issuer pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> may exercise such rights to payment (including the right of set-off) with respect to such participation as fully as if such Lender or Issuer were the direct creditor of the Borrower in the amount of such participation.  The provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall not be construed to   apply to (A) any payment made by or on behalf of the Borrower pursuant to, and in accordance  with, the express terms of this Agreement (including the application of funds arising from the existence of a Defaulting Lender or Disqualified Institution), (y) the application of cash collateral   as provided herein, or (z) any payment obtained by a Lender as consideration for the assignment of or sale of a participation in any of its Loans or subparticipations in Reimbursement Obligations or Swing Line Loans to any assignee or participant, other than an assignment to the Borrower or any Subsidiary thereof (as to which the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall apply).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Indemnity</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Borrower shall indemnify each Credit Party and each Related Party thereof (each such Person being called an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Indemnified Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) against, and hold each Indemnified Person harmless from, any and all losses, claims, damages, liabilities and related expenses,  including the reasonable and documented out-of-pocket fees and disbursements of one counsel (but excluding the allocated cost of internal counsel) representing all of the Indemnified Persons, taken  as a whole, and, if reasonably necessary, of a single local counsel for each applicable jurisdiction (which may include a single counsel acting in multiple jurisdictions) (and, if reasonably necessary, one specialty counsel for each applicable specialty), representing all of the Indemnified Persons, taken as a whole (and, in the case of any actual or perceived conflict of interest where the Indemnified Person affected by such conflict notifies the Borrower of the existence of such conflict and thereafter retains its own counsel, of another firm of counsel (and, if reasonably necessary, a single local counsel for each applicable jurisdiction (and, if reasonably necessary, one specialty counsel for each applicable specialty), for each such affected Indemnified Person)), actually  incurred by any Indemnified Person arising out of, in connection with, or as a result of (i) the execution or delivery of any Loan Document or any agreement or instrument contemplated thereby, the performance by the parties to the Loan Documents of their respective obligations thereunder or the consummation of the transactions contemplated hereby or any other transactions contemplated thereby, (ii) any Loan or Letter of Credit or the use of the proceeds thereof, (iii) any actual or  alleged presence or release of Hazardous Materials in, on, under or from any property owned or operated by the Borrower or any of the Subsidiaries, or any Environmental Liability related in any way to the Borrower or any of the Subsidiaries or (iv) any actual or prospective claim, litigation, investigation or proceeding relating to any of the foregoing, whether based on statute, contract, tort or any other theory and regardless of whether any Indemnified Person is a party thereto. Notwithstanding anything to the contrary contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the foregoing  </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">indemnity will not, as to any Indemnified Person, apply to any losses, claims, damages, liabilities and related expenses to the extent arising (A) from the willful misconduct, gross negligence, fraud  or bad faith of such Indemnified Person, (B) from a material breach of the obligations hereunder of such Indemnified Person, (C) out of or in connection with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, or (D) out of or in connection with any claim, litigation, investigation or proceeding that does not involve an act or omission of the Borrower or any of its Affiliates and that is brought by an Indemnified Person against any other Indemnified Person (other than the Administrative Agent, a Joint Lead Arranger, the Issuer or the Swing Line Lender, in each case in its capacity as such), in each case under clauses (A) and (B), to the extent determined by a final and non-appealable judgment of a court of competent jurisdiction.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">To the extent that the Borrower fails to pay as soon as practicable any amount required to be paid by it to the Administrative Agent under subsection (a) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Indemnified Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), each Lender severally agrees to pay to the Administrative Agent an amount equal to the product of such unpaid amount </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (i) at any time when no Loans    are outstanding, its Commitment Percentage, and (ii) at any time when Loans are outstanding (x)     if the Commitments then exist, its Commitment Percentage or (y) if the Commitments have been terminated or otherwise no longer exist, the percentage equal to the fraction, (A) the numerator of which is the sum of such Lender&#8217;s Credit Exposure and (B) the denominator of which is the sum     of the Aggregate Credit Exposure (in each case determined as of the time that the applicable Indemnified Amount is sought)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the Indemnified Amount was payable to the Administrative Agent in its capacity as such.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The obligations of the Borrower and the Lenders under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall survive the termination of the Commitments and the payment of the Loans and the Notes and all other amounts payable under the Loan Documents.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">If any settlement of any investigation, litigation or proceeding to which the indemnity in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> applies (any of the foregoing, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Proceeding&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) is instituted or threatened against any Indemnified Person (or its Related Parties) in respect of which indemnity  may be sought hereunder, unless an Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(a),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> exists, the Borrower shall be entitled to assume the defense thereof with counsel selected by the Borrower (which counsel shall be reasonably satisfactory to such Indemnified Person) and after notice from the Borrower to such Indemnified Person of the Borrower&#8217;s election so to assume the defense thereof, the Borrower will not be liable to such Indemnified Person hereunder for any legal or other expenses subsequently incurred by such Indemnified Person in connection with the defense thereof, other than reasonable and documented out-of-pocket costs of investigation and such other reasonable and documented out-of-pocket expenses as have been approved in advance&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that (i) if counsel for such Indemnified Person determines in good faith that there is a conflict that requires separate representation for the Borrower and such Indemnified Person or that there may    be legal defenses available to such Indemnified Person which are different from, or in addition to, those available to the Borrower or (ii) the Borrower fails to assume or proceed in a timely and reasonable manner with the defense of such action or fails to employ counsel reasonably  satisfactory to such Indemnified Person in any such action, then in either such event, (A) such Indemnified Person shall be entitled to one primary counsel and, if necessary, one local counsel to represent such Indemnified Person and all other Indemnified Persons similarly situated (such counsels selected by the Administrative Agent), (B) the Borrower shall not, or shall not any longer, be entitled to assume the defense thereof on behalf of such Indemnified Person, and (C) such Indemnified Person shall be entitled to indemnification for the expenses (including fees and expenses of such counsel) to the extent provided in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding the foregoing, the Borrower shall not be liable for any settlement, compromise or consent to the entry   </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of any judgment in any action or Proceeding effected without the Borrower&#8217;s prior written consent (which consent shall not be unreasonably withheld, conditioned or delayed, it being understood and agreed that the withholding, conditioning or delaying of the Borrower&#8217;s consent in connection with  a settlement, compromise or consent to the entry of any judgment in any action or proceeding which does not include an unconditional release of the Borrower and the Subsidiaries from all liability or claims that are the subject matter of such Proceeding or which includes a statement as to any admission of fault by or on behalf of the Borrower or any Subsidiary shall not be deemed unreasonable), but if settled with the Borrower&#8217;s prior written consent or if there is a final judgment for the plaintiff in any such Proceeding, the Borrower agrees to indemnify and hold harmless each Indemnified Person from and against any and all losses, claims, damages, liabilities and expenses  by reason of such settlement, compromise or consent to the entry of any judgment in any action or Proceeding in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Borrower shall not, without the prior written consent of an Indemnified Person, effect any settlement of any pending or threatened Proceeding against such Indemnified Person in respect of which indemnity could have been sought hereunder  by such Indemnified Person unless such settlement (x) includes an unconditional release of such Indemnified Person from all liability or claims that are the subject matter of such Proceeding, (y) does not include any statement as to any admission of fault by or on behalf of such Indemnified Person, and (z) contains customary confidentiality provisions with respect to the terms of such settlement. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Notwithstanding any provision in this Agreement to the contrary, none of the Borrower, the Administrative Agent, the Lenders or any Affiliate of any of the foregoing will be responsible or liable to any Person or entity, on any theory of liability, for any indirect, special, punitive or consequential damages that may be alleged as a result of the transactions contemplated hereby or by the other Loan Documents or any use or intended use of the proceeds of the Loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that nothing in this clause (e) shall limit the Borrower&#8217;s indemnity obligations set forth in this Agreement with respect to any indirect, punitive or consequential damages included in any   third party claim in connection with which an Indemnified Person is entitled to indemnification hereunder. In addition to, and without limiting the immediately foregoing sentence, and to the  extent permitted by applicable law, the Borrower shall not assert, and hereby waives, any claim against any Indemnified Person, on any theory of liability, for special, indirect, consequential or punitive damages (as opposed to direct and actual damages) arising out of, in connection with, or    as a result of, any Loan Document or any agreement, instrument or other document contemplated thereby, the transactions contemplated hereby or any Loan or any Letter of Credit or the use of the proceeds thereof.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.02pt">Notwithstanding the above, the Borrower shall have no liability under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> to indemnify or hold harmless any Indemnified Person for any losses, claims, damages, liabilities and related expenses relating to income or withholding Taxes or any Tax in lieu of such Taxes. Notwithstanding the foregoing, any amounts claimed by an Indemnified Person under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall not be available to be claimed by such Indemnified Person under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, it being understood and agreed that the rights of an Indemnified Person under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall not be duplicative.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Governing Law</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Loan Documents and the rights and obligations of the parties thereto shall be governed by, and construed and interpreted in accordance with, the laws of the State of New York.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Severability</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Every provision of the Loan Documents is intended to be severable, and if any term or provision thereof shall be invalid, illegal or unenforceable for any reason, the validity, legality and enforceability of  the remaining provisions thereof shall not be affected or impaired thereby, and any invalidity, illegality or unenforceability in any jurisdiction shall not affect the validity, legality or enforceability of any such term   or provision in any other jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Integration</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">All exhibits to the Loan Documents shall be deemed to be a part thereof. Each Loan Document embodies the entire agreement and understanding between or among the parties thereto with respect to the subject matter thereof and supersedes all prior agreements and understandings between or among the parties thereto with respect to the subject matter thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Treatment of Certain Information</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Each Credit Party agrees to maintain the confidentiality of the Information (as defined below), except that Information may be disclosed (i) to its Affiliates and to its and its Affiliates&#8217; respective partners, directors, officers, employees, agents, advisors and other representatives (it being understood that the Persons to whom such disclosure is made will be informed of the confidential nature of such Information and instructed to keep such Information confidential)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that each Credit Party shall be responsible for its controlled Affiliates&#8217; compliance in keeping Information confidential, (ii) to the extent requested by any regulatory authority purporting to have jurisdiction over it (including any self-regulatory authority, such as    the National Association of Insurance Commissioners) (in which case such Person agrees (except with respect to any audit or examination conducted by bank accountants or any governmental regulatory authority exercising examination or regulatory authority) to use commercially   reasonable efforts to inform the Borrower promptly thereof prior to such disclosure to the extent practicable and not prohibited by law), (iii) to the extent required by applicable laws or regulations or by any subpoena or similar legal process (in which case such Person agrees to (except with respect to any audit or examination conducted by bank accountants or any governmental regulatory authority exercising examination or regulatory authority) to inform the Borrower promptly thereof prior to such disclosure to the extent practicable and not prohibited by law), (iv) to any other party hereto, (v) in connection with the exercise of any remedies hereunder or under any other Loan Document or any action or proceeding relating to this Agreement or any other Loan Document or the enforcement of rights hereunder or thereunder, (vi) subject to an agreement containing provisions substantially the same as those of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to (A) any assignee of or Participant in, or any prospective assignee of or Participant in, any of its rights or obligations under this Agreement or (B) any actual or prospective counterparty (or its advisors) to any swap or derivative transaction relating to the Borrower and its obligations, (vii) to Gold Sheets and other similar bank trade publications, such information to consist of deal terms and other information customarily found in such publications, (viii) with the prior written consent of the Borrower, (ix) to the extent such Information (1)&#160;becomes publicly available other than as a result of a breach of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or a breach of any other confidentiality obligation owing by such Credit Party to the Borrower or (2)&#160;becomes available to the Administrative Agent, any Credit Party or any of their respective Affiliates on a non-confidential basis from a source other than the Borrower not known to such Credit Party to be prohibited from disclosing such Information, and (x) on a confidential basis to   (1) any rating agency in connection with rating the Borrower or its Subsidiaries or the credit facilities provided hereunder or (2) the CUSIP Service Bureau or any similar agency in connection with the application, issuance, publishing and monitoring of CUSIP numbers of other market </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">identifiers with respect to the credit facilities provided hereunder.  In addition, the Administrative Agent and the Lenders may disclose the existence of this Agreement and information about this Agreement to market data collectors, similar service providers to the lending industry and service providers to the Administrative Agent and the Lenders in connection with the administration of this Agreement, the other Loan Documents, and the Commitments.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">For purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Information&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> means all information received from the Borrower or any of its Subsidiaries relating to the Borrower or any of its Subsidiaries or any of their respective businesses, other than any such information that is available to the Administrative Agent or any other Credit Party on a non-confidential basis prior to disclosure by   the Borrower or any of its Subsidiaries.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Acknowledgments</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower acknowledges that (a) it has been advised by counsel in the negotiation, execution  and delivery of the Loan Documents, (b) by virtue of the Loan Documents, the relationship among the Administrative Agent, the Issuers and the Lenders, on the one hand, and the Borrower, on the other hand,    is solely that of debtor and creditor, and (c) by virtue of the Loan Documents, no joint venture exists among the Lenders or among the Borrower and the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Consent to Jurisdiction</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each of the parties hereto irrevocably submits to the exclusive jurisdiction of any New York State  or Federal Court sitting in the City of New York, Borough of Manhattan, over any suit, action, claim, counterclaim or proceeding arising out of or relating to the Loan Documents. EACH OF THE PARTIES HERETO IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY OBJECTION WHICH IT MAY NOW OR HEREAFTER HAVE TO THE LAYING OF THE VENUE OF ANY SUCH SUIT, ACTION, CLAIM, COUNTERCLAIM OR PROCEEDING BROUGHT IN SUCH A COURT AND ANY CLAIM THAT ANY SUCH SUIT, ACTION, CLAIM, COUNTERCLAIM OR PROCEEDING BROUGHT IN SUCH A COURT HAS BEEN BROUGHT IN AN INCONVENIENT FORUM.  Each of the parties hereto agrees that a final judgment in any such suit, action, claim, counterclaim or proceeding brought in such a court, after all appropriate appeals, shall be conclusive and binding upon it.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Service of Process</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each of the parties hereto agrees that process may be served against it in any suit, action or proceeding referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> by sending the same by first class mail, return receipt requested or  by overnight courier service, with receipt acknowledged, to the address of such party set forth or referred    to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each of the parties hereto agrees that any such service (i) shall be deemed in every  respect effective service of process upon it in any such suit, action, or proceeding, and (ii) shall to the fullest extent enforceable by law, be taken and held to be valid personal service upon and personal delivery to it.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">No Limitation on Service or Suit</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Nothing in the Loan Documents or any modification, waiver, or amendment thereto shall affect the right of the Administrative Agent, any Issuer or any Lender to serve process in any manner permitted by   law or limit the right of the Administrative Agent, any Issuer or any Lender to bring proceedings against    the Borrower in the courts of any jurisdiction or jurisdictions.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">WAIVER OF TRIAL BY JURY</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EACH OF THE CREDIT PARTIES AND THE BORROWER KNOWINGLY, VOLUNTARILY AND INTENTIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION ARISING OUT OF, UNDER OR IN CONNECTION WITH THE LOAN DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED THEREBY. FURTHER, THE BORROWER HEREBY CERTIFIES THAT NO REPRESENTATIVE OR AGENT OF ANY OF THE CREDIT PARTIES, OR COUNSEL TO ANY OF THE CREDIT PARTIES, HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT ANY OF THE CREDIT PARTIES WOULD NOT, IN THE EVENT OF SUCH LITIGATION, SEEK TO ENFORCE THIS WAIVER OF RIGHT TO JURY TRIAL PROVISION. THE BORROWER ACKNOWLEDGES THAT THE CREDIT PARTIES HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">INTER ALIA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, THE PROVISIONS OF THIS </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">SECTION 11.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Patriot Act Notice</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each Lender and the Administrative Agent (for itself and not on behalf of any Lender) hereby notifies the Borrower that pursuant to the requirements of the USA PATRIOT Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001), as amended from time to time) (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Patriot Act&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), it is required to obtain, verify and record information that identifies the Borrower, which information includes the name and address of the Borrower and other information that will allow such Lender or the Administrative Agent, as applicable, to identify the Borrower in accordance with the Patriot Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">No Fiduciary Duty</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower agrees that in connection with all aspects of the transactions contemplated hereby   and any communications in connection therewith, the Borrower and its Subsidiaries, on the one hand, and the Credit Parties, the Joint Lead Arrangers, the Sustainability Coordinator, and their respective Affiliates, on the other hand, will have a business relationship that does not create, by implication or otherwise, any fiduciary duty on the part of the Credit Parties, such</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Joint Lead Arrangers or the Sustainability Coordinator, or their respective Affiliates, and no such duty will be deemed to have arisen in connection with any such transactions or communications.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Acknowledgement and Consent to Bail-In of Affected Financial Institutions</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding anything to the contrary in any Loan Document or in any other agreement, arrangement or understanding among any such parties, each party hereto acknowledges that any liability of any Lender that is an Affected Financial Institution arising under any Loan Document, to the extent such liability is unsecured, may be subject to the Write-Down and Conversion Powers of the applicable Resolution Authority and agrees and consents to, and acknowledges and agrees to be bound by&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">the application of any Write-Down and Conversion Powers by the applicable Resolution Authority to any such liabilities arising hereunder which may be payable to it by any Lender that is an Affected Financial Institution&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">the effects of any Bail-In Action on any such liability, including, if applicable&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">a reduction in full or in part or cancellation of any such liability&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.58pt">a conversion of all, or a portion of, such liability into shares or other instruments of ownership in such Affected Financial Institution, its parent entity, or a   </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">bridge institution that may be issued to it or otherwise conferred on it, and that such shares or other instruments of ownership will be accepted by it in lieu of any rights with respect    to any such liability under this Agreement or any other Loan Document&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.53pt">the variation of the terms of such liability in connection with the exercise   of the Write-Down and Conversion Powers of the applicable Resolution Authority.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.23</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Certain ERISA Matters</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Each Lender (x) represents and warrants, as of the date such Person became a Lender party hereto, to, and (y) covenants, from the date such Person became a Lender party hereto to the date such Person ceases being a Lender party hereto, for the benefit of, the Administrative Agent and the Joint Lead Arrangers and not, for the avoidance of doubt, to or for the benefit of the Borrower, that at least one of the following is and will be true&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">such Lender is not using &#8220;plan assets&#8221; (within the meaning of    Section&#160;3(42) of ERISA or otherwise) of one or more Benefit Plans with respect to such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans,   the Letters of Credit, the Commitments or this Agreement,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.58pt">the transaction exemption set forth in one or more PTEs, such as PTE 84- 14 (a class exemption for certain transactions determined by independent qualified professional asset managers), PTE 95-60 (a class exemption for certain transactions involving insurance company general accounts), PTE 90-1 (a class exemption for certain transactions involving insurance company pooled separate accounts), PTE 91-38 (a class exemption for certain transactions involving bank collective investment funds) or PTE 96- 23 (a class exemption for certain transactions determined by in-house asset managers), is applicable with respect to such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.53pt">(A) such Lender is an investment fund managed by a &#8220;Qualified Professional Asset Manager&#8221; (within the meaning of Part VI of PTE 84-14), (B) such Qualified Professional Asset Manager made the investment decision on behalf of such Lender to enter into, participate in, administer and perform the Loans, the Letters of Credit, the Commitments and this Agreement, (C) the entrance into, participation in,   administration of and performance of the Loans, the Letters of Credit, the Commitments  and this Agreement satisfies the requirements of sub-sections (b) through (g) of Part I of PTE 84-14 and (D) to the best knowledge of such Lender, the requirements of subsection  (a) of Part I of PTE 84-14 are satisfied with respect to such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement, or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.13pt">such other representation, warranty and covenant as may be agreed in writing between the Administrative Agent, in its sole discretion, and such Lender.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">In addition, unless either (1) sub-clause (i) in the immediately preceding clause (a) is true with respect to a Lender or (2) a Lender has provided another representation, warranty and covenant in accordance with sub-clause (iv) in the immediately preceding clause (a), such Lender further (x) represents and warrants, as of the date such Person became a Lender party hereto, to,   and (y) covenants, from the date such Person became a Lender party hereto to the date such Person ceases being a Lender party hereto, for the benefit of, the Administrative Agent and the Joint Lead </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.28pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Arrangers and not, for the avoidance of doubt, to or for the benefit of the Borrower, that the Administrative Agent is not a fiduciary with respect to the assets of such Lender involved in such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement (including in connection with the reservation or exercise of any rights by the Administrative Agent under this Agreement, any Loan Document or any documents related hereto or thereto).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">For purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.23</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the following defined terms when used herein have the following meanings&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Benefit Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means any of (a) an &#8220;employee benefit plan&#8221; (as defined in ERISA) that is subject to Title I of ERISA, (b) a &#8220;plan&#8221; as defined in Section 4975 of the Internal Revenue Code or (c) any Person whose assets include (for purposes of ERISA Section  3(42) or otherwise for purposes of Title I of ERISA or Section 4975 of the Internal Revenue Code) the assets of any such &#8220;employee benefit plan&#8221; or &#8220;plan&#8221;.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">PTE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means a prohibited transaction class exemption issued by the U.S. Department of Labor, as any such exemption may be amended from time to time.</font></div><div style="margin-bottom:60pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;SIGNATURE PAGES OMITTED&#93;</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>a06302022ex103.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="iff8b9214df4549afa93ccc36670241b0_1"></div><div style="min-height:63pt;width:100%"><div style="padding-left:18pt;text-align:right"><font><br></font></div><div style="padding-left:324pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.3</font></div><div><font><br></font></div><div style="padding-left:324pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Execution Version</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">FIRST AMENDMENT TO FIVE YEAR CREDIT AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FIRST AMENDMENT TO FIVE YEAR CREDIT AGREEMENT (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), dated as of May 16, 2022, is entered into among CVS Health Corporation, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Lenders party hereto and Bank of America, N.A., as Administrative Agent. Except as otherwise provided herein, capitalized terms used herein which are not defined herein shall have the meanings set forth in the Credit Agreement (as defined below).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, the Borrower, the Lenders and the Administrative Agent entered into that certain Five Year Credit Agreement, dated as of May 16, 2019 (as amended, amended and restated, supplemented or otherwise modified from time to time prior to the date hereof, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#59; and </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, the Borrower has requested that the Lenders amend the Credit Agreement as set forth below. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration of the covenants, conditions and agreements hereinafter set forth, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, and pursuant to Section 11.1 of the Credit Agreement, the parties hereto hereby agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Amendments to the Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Credit Agreement is hereby amended as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Credit Agreement (but not the Exhibits thereto) is hereby amended  and restated in its entirety to read as set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Annex A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> attached hereto.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Exhibit A (List of Commitments), Exhibit B (Form of Note) and Exhibit   C (Form of Borrowing Request) to the Credit Agreement are hereby amended and    restated in their entirety to read as set forth on the corresponding exhibits attached hereto.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Conditions Precedents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This Amendment shall become effective on and as of the date hereof (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">First Amendment Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) upon satisfaction (or waiver in accordance with Section 11.1 of the Credit Agreement) of the conditions precedent set forth in this Section 2. Upon satisfaction (or waiver in accordance with Section 11.1 of the Credit Agreement) of the conditions precedent set forth in this Section 2, the Administrative Agent shall promptly provide the Borrower and the Lenders with written confirmation that this Amendment has become effective. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Counterparts of this Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Receipt by the Administrative Agent of counterparts of this Amendment executed by the Borrower and the Lenders</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Corporate Action</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Administrative Agent shall have received a certificate, dated the First Amendment Effective Date, of the Secretary or an Assistant Secretary of the Borrower (i) attaching a true and complete copy of the resolutions of its Board of Directors and of all documents evidencing all other necessary corporate action taken by the Borrower to authorize this Amendment, the other Loan Documents and the transactions contemplated hereby and thereby, (ii) attaching a true and complete copy of  its Certificate of Incorporation and By Laws, (iii) setting forth the incumbency of the officer or officers of the Borrower who may sign this Amendment and the other Loan Documents, and any other certificates, requests, notices or other documents required </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889343v4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">hereunder or thereunder, and (iv) attaching a certificate of good standing of the Secretary  of State of the State of Delaware.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Opinions of Counsel to the Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.   The Administrative Agent shall have received (i) an opinion of Thomas Moffatt, assistant general counsel of the Borrower, dated the First Amendment Effective Date, in a form reasonably satisfactory to the Administrative Agent, and (ii) an opinion of Shearman &#38; Sterling LLP, special counsel to the Borrower, dated the First Amendment Effective Date, in a form reasonably satisfactory to the Administrative Agent.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">No Default and Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Administrative Agent shall have received a certificate, dated the First Amendment Effective Date, of the Senior Vice President and Treasurer of the Borrower certifying that there exists no Default and that the representations and warranties contained in this Amendment are true and correct in all material respects (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any representation and warranty that is qualified as to &#8220;materiality&#8221;, &#8220;Material Adverse&#8221; or similar language shall be true and correct (after giving effect to any qualification therein) in all respects on the First Amendment Effective Date), except those which are expressly specified to be made as of an earlier date.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.&#160;&#160;&#160;&#160;The Administrative Agent shall have received all fees and other amounts due and payable to it on the First Amendment Effective Date, including the upfront fees payable to the Lenders, in respect of this Amendment.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.02pt;text-decoration:underline">Due Diligence&#59; &#8220;Know Your Customer&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.&#160;&#160;&#160;&#160;    (i) Each Lender shall have received such documents and information as it may have requested in order to comply with &#8220;know-your-customer&#8221; and other applicable Sanctions, anti-terrorism, anti-money laundering and similar rules and regulations and related policies, to the extent the Borrower shall have received written requests therefor at least ten (10) Domestic Business Days prior to the First Amendment Effective Date, and (ii) at least five Domestic Business Days prior to the First Amendment Effective Date, if the Borrower qualifies as a &#8220;legal entity customer&#8221; under the Beneficial Ownership Regulation, it shall have delivered to each Lender that so requests a Beneficial Ownership Certification.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Borrower hereby represents and warrants as follows&#58;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">The Borrower has taken all necessary corporate action to  authorize the execution, delivery and performance of this Amendment. </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.58pt">This Amendment has been duly executed and delivered by the Borrower and constitutes the valid and legally binding obligations of the Borrower, enforceable against the Borrower in accordance with its terms, except as such enforceability may be limited    by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditors&#8217; rights generally and by equitable principles relating to the availability    of specific performance as a remedy.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.53pt">No consent or approval of, or other action by, shareholders of the Borrower, any Governmental Authority, or any other Person (which has not already been obtained) is required to authorize in respect of the Borrower, or is required in connection with, the execution, </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889343v4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">delivery, and performance by the Borrower of this Amendment or is required as a condition to the enforceability of this Amendment against the Borrower.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">The Borrower represents and warrants to the Lenders that the representations and warranties of the Borrower set forth in Section 4 of the Credit Agreement (as amended by this Amendment) are true and correct in all material respects  on the date hereof (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any representation and warranty that is qualified as to &#8220;materiality&#8221;, &#8220;Material Adverse&#8221; or similar language is true and correct (after giving effect to any qualification therein) in all respects on the date hereof), except those which are expressly specified to be made as of an earlier date.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">New Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Lender executing and delivering this Amendment as a &#8220;New Lender&#34;</font><font style="background-color:#ffffff;color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">New Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) (i) represents and warrants that (A) it has full power and authority, and has taken all action necessary, to execute and deliver this Amendment and to consummate the transactions contemplated hereby and to become a Lender under the Credit Agreement, (B) it meets the requirements to be an Eligible Assignee under Section 11.7 of the Credit Agreement, (C) it has received a copy of the Credit Agreement, and has received or has been accorded the opportunity to receive copies of the most recent financial statements delivered pursuant to Section 7.7 thereof, as applicable, and such other documents and information as it deems appropriate to make its own credit analysis and decision to enter into this Amendment, (D) it has, independently and without reliance upon the Administrative Agent or any other Lender and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Amendment, and (E) it is not and will not be (1) an employee benefit plan subject to Title   I of ERISA, (2) a plan or account subject to Section 4975 of the Internal Revenue Code,  (3) an entity deemed to hold &#8220;plan assets&#8221; of any such plans or accounts for purposes of ERISA or the Internal Revenue Code, or (4) a &#8220;governmental plan&#8221; within the meaning of ERISA&#59; and (ii) agrees that (A) it will, independently and without reliance on the Administrative Agent or any other Lender, and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit decisions in taking or not taking action under the Loan Documents, and (B) it will perform in accordance with their terms all of the obligations which by the terms of the Loan Documents are required   to be performed by it as a Lender.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">The Borrower agrees that, as of the First Amendment Effective Date, the New Lender shall (i) be a party to the Credit Agreement and the other Loan Documents,  (ii) be a &#8220;Lender&#8221; for all purposes of the Credit Agreement and the other Loan Documents, (iii) have the rights and obligations of a Lender under the Credit Agreement and the other Loan Documents, and (iv) have a Commitment in the amount set forth adjacent to the New Lender&#8217;s name under the heading </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Commitment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> in Exhibit A of the Credit Agreement (as amended hereby).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The applicable address, facsimile number and electronic mail address of the New Lender for purposes of Section 11.2 of the Credit Agreement are as set forth in  the New Lender&#8217;s Administrative Questionnaire delivered by the New Lender to the Administrative Agent on or before the First Amendment Effective Date or such other address, facsimile number and electronic mail address as shall be designated by the New Lender in a written notice to the Administrative Agent.</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889343v4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Except as expressly amended hereby, the Credit Agreement and the other Loan Documents shall remain in full force and effect. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">On and after the First Amendment Effective Date, each reference in the Credit Agreement to &#8220;this Agreement&#8221;, &#8220;hereunder&#8221;, &#8220;hereof&#8221; or words of like import referring to the Credit Agreement, and each reference in the other Loan Documents to &#8220;the Credit Agreement&#8221;, &#8220;thereunder&#8221;, &#8220;thereof&#8221; or words of like import referring to the Credit Agreement, shall mean and be a reference to the Credit Agreement as modified hereby. This Amendment shall constitute a Loan Document.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Subject to Section 11.18 of the Credit Agreement, this Amendment may  be in the form of an Electronic Record and may be executed using Electronic Signatures (including facsimile and .pdf) and shall be considered an original, and shall have the same legal effect, validity and enforceability as a paper record.&#160; This Amendment may be executed in as many counterparts as necessary or convenient, including both paper and electronic counterparts, but all such counterparts are one and the same agreement.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">This Amendment and the rights and obligations of the parties hereto shall be governed by, and construed and interpreted in accordance with, the laws of the State of New York.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;signature pages follow&#93;</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889343v4</font></div></div></div><div id="iff8b9214df4549afa93ccc36670241b0_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The parties have caused this Amendment to be duly executed as of the date first written above.</font></div><div style="margin-bottom:24pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Carol A. DeNale                                         </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Carol A. DeNale</font></div><div style="margin-bottom:24pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Senior Vice President and Treasurer</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2025 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BANK OF AMERICA, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as Administrative Agent</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Kyle D Harding                                        </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Kyle D Harding</font></div><div style="margin-bottom:24pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Vice President</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2025 Facility&#93;</font></div><div><font><br></font></div></div></div><div id="iff8b9214df4549afa93ccc36670241b0_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BANK OF AMERICA, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as an Issuer, the Swing Line Lender and a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Joseph L. Corah                                     </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Joseph L. Corah</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Director</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2025 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BARCLAYS BANK PLC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as an Issuer and a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Ritam Bhalla                                        </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Ritam Bhalla</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Director</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2025 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GOLDMAN SACHS BANK USA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as an Issuer and a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; William E. Briggs IV                          </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   William E. Briggs IV</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Authorized Signatory</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2025 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">JPMORGAN CHASE BANK, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as an Issuer and a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; James Kyle O'Donnell                         </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   James Kyle O'Donnell</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Vice President</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2025 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WELLS FARGO BANK, NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as an Issuer and a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Darin Mullis                                    </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Darin Mullis</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Managing Director</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2025 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CITIBANK, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Eugene Yermash                               </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Eugene Yermash</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Vice President</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2025 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CREDIT SUISSE AG, NEW YORK BRANCH</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Judith Smith                                        </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Judith Smith </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Authorized Signatory</font></div><div style="padding-left:252pt"><font><br></font></div><div style="padding-left:252pt"><font><br></font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Jessica Gavarkovs                                </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Jessica Gavarkovs</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Authorized Signatory</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2025 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">MIZUHO BANK, LTD.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Tracy Rahn                                           </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Tracy Rahn</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Executive Director</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2025 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ROYAL BANK OF CANADA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Scott MacVicar                                   </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Scott MacVicar</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Authorized Signatory</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2025 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TRUIST BANK</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Katie Lundin                                    </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Katie Lundin</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Director</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2025 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">U.S. BANK NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">         &#47;s&#47; Joyce P. Dorsett                                   </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;    Joyce P. Dorsett</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;      Senior Vice President </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2025 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FIFTH THIRD BANK, NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">         &#47;s&#47; Todd Robinson                                  </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;    Todd Robinson</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;      Managing Director, SVP</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2025 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PNC BANK, NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; William P. Herold                             </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   William P. Herold</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Vice President</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2025 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SUMITOMO MITSUI BANKING CORPORATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Rosa Pritsch                                       </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Rosa Pritsch</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Director</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2025 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">THE BANK OF NEW YORK MELLON</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Maurice Campbell                                </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Maurice Campbell</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Director</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2025 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BANK OF CHINA, NEW YORK BRANCH</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Raymond Qiao                                   </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Raymond Qiao</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Executive Vice President</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2025 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">INDUSTRIAL AND COMMERCIAL BANK OF CHINA LIMITED, NEW YORK BRANCH</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Dayi Liu                                               </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Dayi Liu</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Executive Director</font></div><div style="padding-left:252pt"><font><br></font></div><div style="padding-left:252pt"><font><br></font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Lindsay Du                                           </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Lindsay Du</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Director</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2025 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">KEYBANK NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Marianne T. Meil                                </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Marianne T. Meil</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Sr. Vice President</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2025 Facility&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TD BANK, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Bernadette Collins                              </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Bernadette Collins</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Senior Vice President</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2025 Facility&#93;</font></div><div><font><br></font></div></div></div><div id="iff8b9214df4549afa93ccc36670241b0_13"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:247.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:217.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NEW LENDER&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">MORGAN STANLEY BANK, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a New</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Lender</font></td></tr></table></div><div style="margin-top:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">        &#47;s&#47; Michael King                                       </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Michael King</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Authorized Signatory</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;2025 Facility&#93;</font></div><div><font><br></font></div></div></div><div id="iff8b9214df4549afa93ccc36670241b0_165"></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">ANNEX A</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Amended Credit Agreement</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">See attached.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1889343v4</font></div></div></div><div id="iff8b9214df4549afa93ccc36670241b0_174"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Deal CUSIP&#58; 23242UAP8</font></div><div style="padding-left:36pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Facility CUSIP&#58; 23242UAQ6</font></div><div style="margin-bottom:6pt;margin-top:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FIVE YEAR CREDIT AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">by and among</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CVS HEALTH CORPORATION,</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">THE LENDERS PARTY HERETO,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BARCLAYS BANK PLC and JPMORGAN CHASE BANK, N.A.,</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">as Co-Syndication Agents,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GOLDMAN SACHS BANK USA and</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WELLS FARGO BANK, NATIONAL ASSOCIATION,</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">as Co-Documentation Agents,</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">and</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BANK OF AMERICA, N.A.,</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">as Administrative Agent</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">______________________________</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Dated as of May 16, 2019</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">______________________________</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BOFA SECURITIES, INC.,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BARCLAYS BANK PLC, GOLDMAN SACHS BANK USA,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">JPMORGAN CHASE BANK, N.A.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">and</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WELLS FARGO SECURITIES, LLC,</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">as Joint Lead Arrangers and Joint Bookrunners</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:48pt;text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1896388v2</font></div></div></div><div id="iff8b9214df4549afa93ccc36670241b0_181"></div><hr style="page-break-after:always"><div style="min-height:57.02pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TABLE OF CONTENTS</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:465.00pt"><tr><td style="width:1.0pt"></td><td style="width:22.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:31.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:366.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:37.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">DEFINITIONS AND PRINCIPLES OF CONSTRUCTION...............................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Definitions.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Principles of Construction.........................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">22</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AMOUNT AND TERMS OF LOANS.................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Revolving Credit Loans............................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Swing Line Loans.....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notice of Borrowing Revolving Credit Loans and Swing Line Loans.....................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Competitive Bid Loans and Procedure.....................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Use of Proceeds.........................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">28</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Termination, Reduction or Increase of Commitments..............................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">28</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Prepayments of Loans...............................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">30</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Letter of Credit Sub-facility......................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">30</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Letter of Credit Participation....................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">32</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Absolute Obligation with respect to Letter of Credit Payments...............................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">33</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notes..........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">33</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Extension of Commitment Termination Date...........................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">33</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.13</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Defaulting Lenders....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">34</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">PROCEEDS, PAYMENTS, CONVERSIONS, INTEREST, YIELD PROTECTION</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AND FEES.............................................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">37</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Disbursement of the Proceeds of the Loans..............................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">37</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Payments...................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">38</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Conversions&#59; Other Matters......................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">39</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Interest Rates and Payment Dates.............................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">40</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Indemnification for Loss...........................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">42</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Reimbursement for Costs, Etc..................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">43</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Illegality of Funding.................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">43</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Option to Fund&#59; Substituted Interest Rate.................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">44</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Certificates of Payment and Reimbursement............................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">46</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Taxes&#59; Net Payments................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">47</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Facility Fees..............................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">50</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Letter of Credit Participation Fee..............................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">51</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.13</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Replacement of Lender.............................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">51</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">REPRESENTATIONS AND WARRANTIES.....................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">52</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Existence and Power.................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">52</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Authority&#59; Affected Financial Institution..................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">52</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Binding Agreement...................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">52</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Litigation...................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">52</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No Conflicting Agreements......................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">53</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">53</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">53</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Governmental Regulations........................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">53</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Federal Reserve Regulations&#59; Use of Proceeds.........................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">53</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No Misrepresentation................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">53</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">54</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;..................................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">54</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.13</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Financial Statements.................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">54</font></td></tr></table></div><div style="height:61.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">i</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1896388v2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.02pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:465.00pt"><tr><td style="width:1.0pt"></td><td style="width:22.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:31.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:366.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:37.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.14</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.37pt;padding-right:1.37pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Anti-Corruption Laws and Sanctions........................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">54</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CONDITIONS TO EFFECTIVENESS................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">54</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Agreement.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">55</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notes.........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">55</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Corporate Action.......................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">55</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Opinion of Counsel to the Borrower.........................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">55</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Termination of Existing 2015 Credit Agreement.....................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">55</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No Default and Representations and Warranties......................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">55</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Fees...........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">56</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Due Diligence&#59; &#8220;Know Your Customer&#8221;..................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">56</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CONDITIONS OF LENDING - ALL LOANS AND LETTERS OF CREDIT..................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">56</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Compliance...............................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">56</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Requests....................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">56</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AFFIRMATIVE COVENANTS..........................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">57</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Legal Existence.........................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">57</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Taxes.........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">57</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">57</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">57</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">57</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Observance of Legal Requirements..........................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">57</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Financial Statements and Other Information............................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">58</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Records.....................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">59</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NEGATIVE COVENANTS.....................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">59</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">59</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Liens..........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">59</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Dispositions...............................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">60</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Merger or Consolidation, Etc....................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">60</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">61</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">61</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Limitation on Upstream Dividends by Subsidiaries..................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">61</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">61</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ratio of Consolidated Indebtedness to Total Capitalization.....................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">61</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">DEFAULT............................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">62</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Events of Default......................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">62</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Remedies...................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">64</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AGENT.................................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">65</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Appointment and Authority......................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">65</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Rights as a Lender.....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">65</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exculpatory Provisions.............................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">65</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Reliance by Administrative Agent............................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">66</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Delegation of Duties.................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">67</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Resignation of Administrative Agent.......................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">67</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Non-Reliance on Administrative Agent and Other Credit Parties............................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">68</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No Other Duties, Etc.................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">68</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Recovery of Erroneous Payments.............................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">68</font></td></tr></table></div><div style="height:61.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ii</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1896388v2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.02pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:465.00pt"><tr><td style="width:1.0pt"></td><td style="width:22.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:31.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:366.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:37.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">OTHER PROVISIONS.........................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">69</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Amendments, Waivers, Etc.......................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">69</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notices......................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">70</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No Waiver&#59; Cumulative Remedies................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">73</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Survival of Representations and Warranties..................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">73</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Payment of Expenses&#59; Indemnified Liabilities..............................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">73</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Lending Offices........................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">74</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Successors and Assigns..................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">74</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Counterparts&#59; Electronic Execution...............................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">80</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Set-off and Sharing of Payments..............................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">81</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Indemnity           .......................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">82</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Governing Law  .......................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">84</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Severability        .......................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">84</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.13</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Integration          .......................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">84</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.14</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Treatment of Certain Information.............................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">85</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.15</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Acknowledgments.....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">86</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.16</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Consent to Jurisdiction..............................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">86</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.17</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Service of Process.....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">86</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.18</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No Limitation on Service or Suit..............................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">86</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.19</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WAIVER OF TRIAL BY JURY..............................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">86</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.20</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Patriot Act Notice.....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">87</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.21</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No Fiduciary Duty....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">87</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.22</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Acknowledgement and Consent to Bail-In of Affected Financial</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Institutions     .............................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">87</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.23</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Certain ERISA Matters..............................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">87</font></td></tr></table></div><div><font><br></font></div><div style="height:61.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">iii</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1896388v2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.02pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EXHIBITS</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:344.25pt"><tr><td style="width:1.0pt"></td><td style="width:61.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:279.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit A</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">List of Commitments</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit B</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Note</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit C</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Borrowing Request</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit D-1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Opinion of Counsel to the Borrower</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit D-2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Opinion of Special Counsel to the Borrower</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit E</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Assignment and Assumption</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit F</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Competitive Bid Request</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit G</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Invitation to Bid</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit H</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Competitive Bid</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit I</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Competitive Bid Accept&#47;Reject Letter</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit J</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Letter of Credit Request</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit K</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Form of Commitment Increase Supplement</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="height:61.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">iv</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1896388v2</font></div></div></div><div id="iff8b9214df4549afa93ccc36670241b0_191"></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FIVE YEAR CREDIT AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, dated as of May 16, 2019, by and among </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">CVS HEALTH CORPORATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, a Delaware corporation (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Borrower&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), the lenders party hereto from time to time (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and, collectively, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Lenders&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">BARCLAYS BANK PLC </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Barclays&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">JPMORGAN CHASE BANK, N.A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;JPMC&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), as co-syndication agents (in such capacity, each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Co-Syndication Agent&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and, collectively, the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Co-Syndication Agents&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">GOLDMAN SACHS BANK USA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">GS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">WELLS FARGO BANK, NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Wells Fargo&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as codocumentation agents (in such capacity, each a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Co-Documentation Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and, collectively, the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Co-Documentation Agents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">BANK OF AMERICA, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as administrative agent for the Lenders (in  such capacity, together with its successors and assigns, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">DEFINITIONS AND PRINCIPLES OF CONSTRUCTION</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Definitions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">When used in any Loan Document (as defined below), each of the following terms shall have the meaning ascribed thereto unless the context otherwise specifically requires&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;ABR Advances&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Revolving Credit Loans (or any portions thereof) at such time as they (or  such portions) are made or are being maintained at a rate of interest based upon the Alternate Base Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Acquisition Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58;  any Indebtedness incurred by the Borrower or any of its Subsidiaries for the purpose of financing, in whole or in part, a Material Acquisition and any related transactions or series of related transactions (including for the purpose of refinancing or replacing all or a portion of any pre-existing Indebtedness of the Person(s) or assets to be acquired), which Indebtedness is redeemable or prepayable if such Material Acquisition is not consummated.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Accumulated Funding Deficiency&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in Section 304 of ERISA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Administrative Agent&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Administrative Agent&#8217;s Office</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the Administrative Agent&#8217;s address and, as appropriate, account   as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, or such other address or account as the Administrative Agent may from time to time notify to the Borrower and the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Administrative Questionnaire&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; an Administrative Questionnaire in a form supplied by the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Advances&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ABR Advances or Term SOFR Advances.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Affected Financial Institution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (a) any EEA Financial Institution or (b) any UK Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Affiliate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any Person at any time and from time to time, any other Person (other than a wholly-owned subsidiary of such Person) which, at such time (a) controls such Person, (b) is controlled by such Person or (c) is under common control with such Person. The term </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as used     in this definition with respect to any Person, means the power, whether direct or indirect through one or  more intermediaries, to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities or other interests, by contract or otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Agent Parties&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1896388v2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Aggregate Commitment Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time, the sum of the Commitment Amounts of the Lenders at such time under this Agreement. The Aggregate Commitment Amount on the First Amendment  Effective Date is $2,000,000,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Aggregate Credit Exposure&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time, the sum of (a) the aggregate Committed Credit  Exposure of the Lenders at such time and (b) the aggregate outstanding principal balance of all Competitive Bid Loans at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Aggregate Letter of Credit Commitment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">at any time, the sum of the Letter of Credit Commitments of the Issuers at such time. The Aggregate Letter of Credit Commitment on the First Amendment  Effective   Date is $250,000,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; this Five Year Credit Agreement, as the same may be amended, amended and restated, supplemented or otherwise modified from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Alternate Base Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; for any day, a fluctuating rate per annum equal to the highest of (a) the Federal Funds Effective Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 1&#47;2 of 1%, (b) the rate of interest in effect for such day as publicly announced from time to time by BofA as its &#8220;prime rate&#8221;, and (c) the One Month SOFR Rate in effect on such day </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 1.00%.  The &#8220;prime rate&#8221; is a rate set by BofA based upon various factors including BofA&#8217;s costs and desired return, general economic conditions and other factors, and is used as a reference point for pricing some loans, which may be priced at, above, or below such announced rate.  Any change in such prime rate announced by BofA shall take effect at the opening of business on the day specified in the public announcement of such change. If the Alternate Base Rate is being used as an alternate rate of interest pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> hereof, then the Alternate Base Rate shall be the greater of clauses (a) and (b) above and shall be determined without reference to clause (c) above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Anti-Corruption Laws&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; all laws, rules, and regulations of any jurisdiction applicable to the Borrower or the Subsidiaries from time to time concerning or relating to bribery or corruption.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Applicable Margin&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (i) with respect to the unpaid principal balance of ABR Advances, the applicable percentage set forth below in the column entitled &#8220;ABR Advances&#8221;, (ii)&#160;with respect to the   unpaid principal balance of Term SOFR Advances and Swing Line Loans bearing interest at the Term   SOFR Daily Floating Rate, the applicable percentage set forth below in the column entitled &#8220;Term SOFR Advances&#47;Swing Line Loans&#8221;, (iii) with respect to the Facility Fee, the applicable percentage set forth   below in the column entitled &#8220;Facility Fee&#8221;, (iv) with respect to the Letter of Credit Participation Fee  payable in respect of standby Letters of Credit, the applicable percentage set forth below in the column entitled &#8220;Participation Fee - Standby&#8221;, and (v) with respect to the Letter of Credit Participation Fee payable in respect of commercial Letters of Credit, the applicable percentage set forth below in the column entitled &#8220;Participation Fee - Commercial&#8221;, in each case opposite the applicable Pricing Level&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.305%"><tr><td style="width:1.0%"></td><td style="width:17.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.050%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Pricing Level</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ABR Advances</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Term SOFR Advances&#47; Swing Line Loans</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Facility Fee</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Participation Fee - Standby</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Participation Fee &#8211; Commercial</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pricing Level I</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.000%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.700%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.050%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.700%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.3500%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pricing Level II</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.000%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.815%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.060%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.815%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.4075%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pricing Level III</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.000%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.920%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.080%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.920%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.4600%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pricing Level IV</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.025%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.025%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.100%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.025%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.5125%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pricing Level V</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.125%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.125%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.125%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.125%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.5625%</font></td></tr></table></div><div><font><br></font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.305%"><tr><td style="width:1.0%"></td><td style="width:17.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.890%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pricing Level VI</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.275%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.275%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.225%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.275%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.6375%</font></td></tr></table></div><div style="margin-bottom:12pt;margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Decreases in the Applicable Margin resulting from a change in Pricing Level shall become effective upon  the delivery by the Borrower to the Administrative Agent of notice upon the Borrower becoming aware of any change in the applicability of a Pricing Level.  Increases in the Applicable Margin resulting from a change in Pricing Level shall become effective on the effective date of any downgrade or withdrawal in the rating by Moody&#8217;s or S&#38;P of the senior unsecured long term debt rating of the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Approved Fund&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any Person (other than a natural person) that is (or will be) engaged in making, purchasing, holding or otherwise investing in commercial loans and similar extensions of credit in the ordinary course of its business that is administered or managed by (a) a Lender, (b) an Affiliate of a Lender or (c) an entity or an Affiliate of an entity that administers or manages a Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Assignment and Assumption&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; an assignment and assumption entered into by a Lender and an assignee (with the consent of any party whose consent is required by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;11.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), and accepted by the Administrative Agent, substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit&#160;E</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or any other form (including electronic documentation generated by use of an electronic platform) approved by the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Authorized Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; (a) the chief executive officer, president, chief financial officer, treasurer, assistant treasurer or controller of the Borrower, (b) solely for purposes of the delivery of incumbency certificates pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the secretary or any assistant secretary of the Borrower, and (c) solely  for purposes of notices given pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, any other officer or employee of the  Borrower so designated by any of the foregoing officers in a notice to the Administrative Agent. Any document delivered hereunder that is signed by an Authorized Officer shall be conclusively presumed to have been authorized by all necessary corporate and&#47;or other action on the part of the Borrower and such Authorized Officer shall be conclusively presumed to have acted on behalf of the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Bail-In Action&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the exercise of any Write-Down and Conversion Powers by the applicable Resolution Authority in respect of any liability of an Affected Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Bail-In Legislation&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (a) with respect to any EEA Member Country implementing Article 55 of Directive 2014&#47;59&#47;EU of the European Parliament and of the Council of the European Union, the implementing law, rule, regulation or requirement for such EEA Member Country from time to time which  is described in the EU Bail-In Legislation Schedule, and (b) with respect to the United Kingdom, Part I of  the United Kingdom Banking Act 2009 (as amended from time to time) and any other law, regulation or   rule applicable in the United Kingdom relating to the resolution of unsound or failing banks, investment firms or other financial institutions or their affiliates (other than through liquidation, administration or other insolvency proceedings).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Barclays&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;BAS&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; BofA Securities, Inc.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Beneficial Ownership Certification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58;  a certification regarding beneficial ownership required by the Beneficial Ownership Regulation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Beneficial Ownership Regulation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58;  31 C.F.R. &#167; 1010.230.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Benefit Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.23(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;BofA&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; means Bank of America, N.A. and its successors.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Borrower&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Borrower Materials&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Borrowing Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (i) in respect of Revolving Credit Loans, any Domestic Business Day on which the Lenders shall make Revolving Credit Loans pursuant to a Borrowing Request or pursuant to a  Mandatory Borrowing, (ii) in respect of Competitive Bid Loans, any Domestic Business Day on which a Lender shall make a Competitive Bid Loan pursuant to a Competitive Bid Request, (iii) in respect of Swing Line Loans, any Domestic Business Day on which the Swing Line Lender shall make a Swing Line Loan pursuant to a Borrowing Request and (iv) in respect of Letters of Credit, any Domestic Business Day on which an Issuer shall issue a Letter of Credit pursuant to a Letter of Credit Request.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Borrowing Request&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a request for Revolving Credit Loans or Swing Line Loans substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or such other form as may be approved by the Administrative Agent, including any form on an electronic platform or electronic transmission system as shall be approved by the Administrative Agent, appropriately completed and signed by an Authorized Officer of the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Change of Control&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any of the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:24.69pt">any Person or group (as such term is used in Section 13(d)(3) of the Securities Exchange Act of 1934, as amended), (a) shall have or acquire beneficial ownership of securities having 35% or more of the ordinary voting power of the Borrower or (b) shall possess, directly or indirectly, the power to direct or cause the direction of the management and policies of the  Borrower, whether through the ownership of voting securities, by contract or otherwise&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.36pt">the Continuing Directors shall cease for any reason to constitute a majority of the board of directors of the Borrower then in office.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;CME&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; CME Group Benchmark Administration Limited.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Co-Documentation Agent&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Co-Documentation Agents&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Co-Syndication Agent&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Co-Syndication Agents&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commercial Letter of Credit Commitment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time with respect to any Issuer, the commitment of such Issuer to issue commercial Letters of Credit in accordance with the terms hereof in an aggregate outstanding face amount not exceeding the lesser of (a) the amount set forth adjacent to such Issuer&#8217;s name under the heading &#8220;Commercial Letter of Credit Commitment&#8221; in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> at such time or,   if not listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the &#8220;Commercial Letter of Credit Commitment&#8221; which such Issuer shall have assumed from another Issuer in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> on or prior to such time, as the same may be adjusted from time to time pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, or (b) 7.5% of the Aggregate Commitment Amount as in effect at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commercial Letter of Credit Exposure&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time in respect of any Issuer, an amount equal to such Issuer&#8217;s Letter of Credit Exposure in respect of commercial Letters of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commitment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; in respect of any Lender, such Lender&#8217;s undertaking to make Revolving Credit Loans, subject to the terms and conditions hereof, in an aggregate outstanding principal amount not to  exceed the Commitment Amount of such Lender.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commitment Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time and with respect to any Lender, the amount set forth adjacent to such Lender&#8217;s name under the heading </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Commitment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> at such time or, in the event that such Lender is not listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Commitment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> which such Lender shall have assumed from another Lender in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> on or prior to such time, as the same may     be adjusted from time to time pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commitment Increase Supplement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a Commitment Increase Supplement substantially in the  form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit K</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commitment Percentage&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time and with respect to any Lender, a fraction (expressed as a percentage carried out to the ninth decimal place) the numerator of which is such Lender&#8217;s Commitment Amount at such time, and the denominator of which is the Aggregate Commitment Amount at such time&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that in the event the Commitments shall have expired or otherwise terminated or been terminated, then Commitment Percentage shall be determined immediately prior thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commitment Period&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the period commencing on the Effective Date and ending on the Commitment Termination Date or on such earlier date as all of the Commitments shall have been terminated in accordance with the terms hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commitment Termination Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the earlier of (i) May 16, 2025 (subject to extension as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) and (ii) the date on which the Loans shall become due and payable in accordance with the terms hereof, whether by acceleration, notice of intention to prepay or otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Committed Credit Exposure&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any Lender at any time, the sum at such time of (a) the outstanding principal balance of such Lender&#8217;s Revolving Credit Loans, (b) the Swing Line Exposure    of such Lender and (c) the Letter of Credit Exposure of such Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Communication&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.8(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Compensatory Interest Payment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.4(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Competitive Bid&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; an offer by a Lender, substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit H</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to make one or  more Competitive Bid Loans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Competitive Bid Accept&#47;Reject Letter&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a notification made by the Borrower pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Competitive Bid Loan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Competitive Bid Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as to any Competitive Bid made by a Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,  the fixed rate of interest (which shall be expressed in the form of a decimal to no more than four decimal places) offered by such Lender with respect thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Competitive Bid Request&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a request by the Borrower, substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit F</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, for Competitive Bids.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Competitive Interest Period&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as to any Competitive Bid Loan, the period commencing on the   date of such Competitive Bid Loan and ending on the date requested in the Competitive Bid Request with respect thereto, which shall not be earlier than 3 days after the date of such Competitive Bid Loan or later than 180 days after the date of such Competitive Bid Loan&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that if any Competitive Interest Period would end on a day other than a Domestic Business Day, such Competitive Interest Period shall be extended </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to the next succeeding Domestic Business Day, unless such next succeeding Domestic Business Day would be a date on or after the Commitment Termination Date, in which case such Competitive Interest Period  shall end on the next preceding Domestic Business Day. Interest shall accrue from and including the first  day of a Competitive Interest Period to but excluding the last day of such Competitive Interest Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Conforming Changes&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to the use, administration of or any conventions associated with SOFR or any proposed Successor Rate or Term SOFR, as applicable, any conforming changes to the definitions of &#8220;Alternate Base Rate&#8221;, &#8220;SOFR&#8221;, &#8220;Term SOFR&#8221;, &#8220;Term SOFR Daily Floating Rate&#8221;, &#8220;One Month SOFR Rate&#8221; and &#8220;Term SOFR Interest Period&#8221;, the timing and frequency of determining rates and making payments of interest and other technical, administrative or operational matters (including, for the avoidance of doubt, the definitions of &#8220;Domestic Business Day&#8221; and &#8220;U.S. Government Securities Business Day&#8221;, timing of borrowing requests or prepayment, conversion or continuation notices and length of lookback periods) as may be appropriate, in the discretion of the Administrative Agent, in consultation with the Borrower, to reflect the adoption and implementation of such applicable rate(s) and to permit the administration thereof by the Administrative Agent in a manner substantially consistent with market   practice (or, if the Administrative Agent, in consultation with the Borrower, determines that adoption of    any portion of such market practice is not administratively feasible or that no market practice for the administration of such rate exists, in such other manner of administration as the Administrative Agent, in consultation with the Borrower, determines is reasonably necessary in connection with the administration    of this Agreement and any other Loan Document).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Consolidated&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Borrower and the Subsidiaries on a consolidated basis in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Contingent Obligation&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as to any Person (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">secondary obligor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), any obligation of such secondary obligor (a) guaranteeing or in effect guaranteeing any return on any investment made by another Person, or (b) guaranteeing or in effect guaranteeing any Indebtedness, lease, dividend or other obligation (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">primary obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) of any other Person (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">primary obligor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) in any manner, whether directly or indirectly, including any obligation of such secondary obligor, whether or not contingent, (i) to purchase   any such primary obligation or any Property constituting direct or indirect security therefor, (ii) to advance  or supply funds (A) for the purchase or payment of any such primary obligation or (B) to maintain working capital or equity capital of the primary obligor or otherwise to maintain the net worth or solvency of the primary obligor, (iii) to purchase Property, securities or services primarily for the purpose of assuring the beneficiary of any such primary obligation of the ability of the primary obligor to make payment of such primary obligation, (iv) otherwise to assure or hold harmless the beneficiary of such primary obligation against loss in respect thereof, and (v) in respect of the Indebtedness of any partnership in which such secondary obligor is a general partner, except to the extent that such Indebtedness of such partnership is nonrecourse to such secondary obligor and its separate Property&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that the term </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Contingent Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall not include the indorsement of instruments for deposit or collection in the ordinary course of business.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Continuing Director&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any member of the board of directors of the Borrower (i) who is a member of that board of directors on the First Amendment  Effective Date, (ii) who was nominated for election by the board of directors a majority of whom were directors on the First Amendment Effective Date, or (iii) whose election or nomination for election was approved by one or more of such directors.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Control Person&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Convert&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Conversion&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Converted&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; each, a reference to a conversion pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> of one Type of Revolving Credit Loan into the other Type of Revolving Credit Loan.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Costs&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Credit Exposure&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any Lender at any time, the sum of (a) the Committed Credit Exposure of such Lender at such time and (b) the outstanding principal balance of all Competitive Bid  Loans of such Lender at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Credit Parties&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Administrative Agent, the Swing Line Lender, the Issuers and the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Daily Simple SOFR&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any applicable determination date, SOFR published on such date on the Federal Reserve Bank of New York&#8217;s website (or any successor source).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Default&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any of the events specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, whether or not any requirement for the giving of notice, the lapse of time, or both, or any other condition, has been satisfied.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Defaulting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any Lender, as reasonably determined by the Administrative Agent, that has (a) failed to fund any portion of its Loans or participations in Letters of Credit or Swing Line Loans within two Domestic Business Days of the date required to be funded by it hereunder, unless such Lender notifies the Administrative Agent and the Borrower in writing that such failure is the result of such Lender&#8217;s determination that one or more conditions precedent to funding (each of which conditions precedent,  together with any applicable default, shall be specifically identified in such writing) has not been satisfied, (b) notified the Borrower or any Credit Party in writing that it does not intend to comply with any of its funding obligations under this Agreement or has made a public statement to the effect that it does not intend to comply with its funding obligations under this Agreement or generally under other agreements in which   it commits to extend credit, unless such writing or public statement relates to such Lender&#8217;s obligation to fund a Loan hereunder and states that such position is based on such Lender&#8217;s determination that a condition precedent to funding (which condition precedent, together with any applicable default, shall be specifically identified in such writing or public statement) cannot be satisfied, (c) failed, two Domestic Business Days after written request by the Administrative Agent (based on the reasonable belief that it may not fulfill its funding obligation), to confirm that it will comply with the terms of this Agreement relating to its  obligations to fund prospective Loans and participations in then outstanding Letters of Credit and Swing  Line Loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such Lender shall cease to be a Defaulting Lender under this clause (c) upon receipt by the Administrative Agent of such confirmation, (d) otherwise failed to pay over to the Administrative Agent or any other Lender any other amount required to be paid by it hereunder within two Domestic Business Days of the date when due, unless the subject of a good faith dispute, or (e) (i) becomes or is insolvent or has a parent company that has become or is insolvent, (ii) becomes the subject of a bankruptcy or insolvency proceeding, or has had a receiver, interim receiver, receiver and manager, administrator, liquidator, conservator, trustee or custodian appointed for it, or has taken any action in furtherance of, or indicating its consent to, approval of or acquiescence in any such proceeding or appointment or has a parent company that has become the subject of a bankruptcy or insolvency proceeding, or has had a receiver, interim receiver, receiver and manager, administrator, liquidator, conservator, trustee  or custodian appointed for it, or has taken any action in furtherance of, or indicating its consent to, approval of or acquiescence in any such proceeding or appointment, or (iii) becomes, or has a parent company that becomes, the subject of a Bail-in Action&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that a Lender shall not qualify as a Defaulting Lender solely as a result of the acquisition or maintenance of an ownership interest in such Lender or its parent company, or of the exercise of control over such Lender or any Person controlling such Lender, by a Governmental Authority or instrumentality thereof so long as such ownership interest does not result in or provide such Lender with immunity from the jurisdiction of courts within the United States of America or from the enforcement of judgments or writs of attachment on its assets or permit such Lender (or such Governmental Authority) to reject, repudiate, disavow or disaffirm any agreements made by such Lender.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Disposition&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any Person, any sale, assignment, transfer or other disposition by  such Person by any means, of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.7pt">the stock of, or other equity interests of, any other Person,</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.02pt">any business, operating entity, division or segment thereof, or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.7pt">any other Property of such Person, other than (i) the sale of inventory (other than    in connection with bulk transfers), (ii) the disposition of equipment and (iii) the sale of cash investments.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Disqualified Institutions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; those Persons that are (a) competitors of the Borrower or its Subsidiaries, identified in writing by the Borrower to the Administrative Agent and the Lenders from time   to time (by posting such notice to the Platform) not less than one (1) Domestic Business Day prior to the  date of determination (it being understood that, notwithstanding anything herein to the contrary, in no event shall a supplement apply retroactively to disqualify any Person that has previously acquired an assignment  or participation interest hereunder that is otherwise an Eligible Assignee, but upon the effectiveness of such designation, any such Person may not acquire any additional Commitments, Advances or participations),   (b) such other Persons identified in writing by the Borrower to the Administrative Agent prior to the First Amendment Effective Date and (c) Affiliates of the Persons identified pursuant to clause (a) or (b) that are either clearly identifiable by name or identified in writing by the Borrower to the Administrative Agent&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that &#8220;Disqualified Institutions&#8221; shall exclude any Person that the Borrower has designated as no longer being a &#8220;Disqualified Institution&#8221; by written notice delivered to the Administrative Agent and the Lenders from   time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Dividend Restrictions&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Dollar&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;$&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; lawful currency of the United States of America.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Domestic Business Day&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any day other than a Saturday, Sunday or a day which in New York   City is a legal holiday or a day on which banking institutions are authorized or required by law or other governmental action to close.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;EEA Financial Institution&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (a) any credit institution or investment firm established in any EEA Member Country which is subject to the supervision of an EEA Resolution Authority, (b) any entity established in an EEA Member Country which is a parent of an institution described in clause (a) of this definition, or (c) any financial institution established in an EEA Member Country which is a subsidiary of   an institution described in clause (a) or (b) of this definition and is subject to consolidated supervision with its parent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;EEA Member Country&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any of the member states of the European Union, Iceland, Liechtenstein, and Norway.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;EEA Resolution Authority&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any public administrative authority or any person entrusted with public administrative authority of any EEA Member Country (including any delegee) having responsibility for the resolution of any EEA Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Effective Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Electronic Copy&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.8(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Electronic Record&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.8(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Electronic Signature&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.8(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Eligible Assignee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a Person that is a permitted assignee under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that has received  the consent of each party whose consent is required under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  For the avoidance of doubt, any Disqualified Institution is subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Employee Benefit Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; an employee benefit plan, within the meaning of Section&#160;3(3) of ERISA, maintained, sponsored or contributed to by the Borrower, any Subsidiary or any ERISA Affiliate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Environmental Laws&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; all laws, rules, regulations, codes, ordinances, orders, decrees, judgments, injunctions, notices or binding agreements issued, promulgated or entered into by any Governmental Authority, relating in any way to the environment, preservation or reclamation of natural resources, the management, release or threatened release of any Hazardous Material or, as such relate to exposure to Hazardous Materials, to health and safety matters.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Environmental Liability&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as to any Person, any statutory, common law or equitable liability, contingent or otherwise (including any liability for damages, costs of environmental investigation, sampling or remediation, fines, penalties or indemnities), of such Person directly or indirectly resulting from or based upon (i) violation of any Environmental Law, (ii) the generation, use, handling, transportation, storage, treatment, discharge or disposal of any Hazardous Materials, (iii) exposure to any Hazardous Materials, (iv) the release or threatened release of any Hazardous Materials into the environment or (v) any contract, agreement or other consensual arrangement pursuant to which liability is assumed or imposed with respect  to any of the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Equity Interests</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; shares of capital stock, partnership interests, membership interests, beneficial interests or other ownership interests, whether voting or nonvoting, in, or interests in the income or profits  of, a Person, and any warrants, options or other rights entitling the holder thereof to purchase or acquire    any of the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;ERISA&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Employee Retirement Income Security Act of 1974, as amended from time to time,   or any successor thereto, and the rules and regulations issued thereunder, as from time to time in effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;ERISA Affiliate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; when used with respect to an Employee Benefit Plan, ERISA, the PBGC or a provision of the Internal Revenue Code pertaining to employee benefit plans, any Person that is a member   of any group of organizations within the meaning of Sections 414(b) or (c) of the Internal Revenue Code    or, solely with respect to the applicable provisions of the Internal Revenue Code, Section 414(m) or (o) of the Internal Revenue Code, of which the Borrower or any Subsidiary is a member.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">ERISA Event&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (a) any &#8220;reportable event&#8221;, as defined in Section&#160;4043 of ERISA with respect to     a Pension Plan (other than an event for which the 30-day notice period is waived)&#59; (b) the determination    that any Pension Plan is considered an at-risk plan or a plan in endangered or critical status within the meaning of Sections&#160;430, 431 or 432 of the Internal Revenue Code or Sections&#160;303, 304 or 305 of ERISA&#59; (c) the filing pursuant to the Internal Revenue Code or ERISA of an application for a waiver of the minimum funding standard with respect to any Pension Plan&#59; (d) the incurrence by the Borrower, any Subsidiary or    an ERISA Affiliate of any liability under Title IV of ERISA with respect to the termination of any Pension Plan, other than for PBGC premiums due but not delinquent under Section 4007 of ERISA, upon the Borrower, any Subsidiary or an ERISA Affiliate&#59; (e) the receipt by the Borrower, any Subsidiary or an ERISA Affiliate from the PBGC or a plan administrator of any notice relating to an intention to terminate any Pension Plan or to appoint a trustee to administer any Pension Plan&#59; (f) the incurrence by the Borrower, </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any Subsidiary or an ERISA Affiliate of any liability with respect to the withdrawal or partial withdrawal from any Pension Plan or Multiemployer Plan&#59; (g) any limits under Section 436 of the Internal Revenue Code become applicable&#59; or (h) any failure to make any payment required by Section 430(j) of the Internal Revenue Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;ESG&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.14(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;ESG Amendment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.14(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;ESG Applicable Margin Adjustments&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.14(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;ESG Pricing Provisions&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.14(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;EU Bail-In Legislation Schedule&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the EU Bail-In Legislation Schedule published by the Loan Market Association (or any successor person), as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Event of Default&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any of the events specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any requirement for   the giving of notice, the lapse of time, or both, or any other condition has been satisfied.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Excluded Taxes&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to the Administrative Agent, any Lender, any Issuer or any other recipient of any payment to be made by or on account of any obligation of the Borrower hereunder or any other Loan Document, (a)&#160;Taxes imposed on or measured by its net income (however denominated) or overall gross receipts, and franchise Taxes, in each case, (i) imposed on it by the jurisdiction (or any political subdivision thereof) under the laws of which it is organized or in which its principal office is located or, in the case of any Lender, in which its applicable lending office is located, or (ii) that are Other Connection Taxes, (b)&#160;any branch profits Taxes imposed by the United States of America or that are Other Connection Taxes, (c)&#160;in the case of a Lender, any withholding Tax that  is imposed on amounts payable to such Lender at the time such Lender becomes a party hereto (other than an assignee pursuant to a request by the Borrower under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) or designates a new lending office, except, in each case, to the extent that such Lender (or its assignor, if any) was entitled, at the time of designation of a new lending office (or assignment), to receive additional amounts from the Borrower with respect to such withholding Tax pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section  3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, (d) any Tax attributable to such recipient&#8217;s failure or inability to comply with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and (e) any Taxes imposed under FATCA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Existing Commitment Termination Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.12(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Existing 2015 Credit Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Credit Agreement, dated as of July 1, 2015, by and among the Borrower, the lenders party thereto from time to time, Barclays and JPMC, as co-syndication agents, BofA and Wells Fargo, as co-documentation agents, and The Bank of New York Mellon, as administrative agent, as amended by Amendment No. 1 to  Credit Agreement, dated   as of December 15, 2017, and Amendment No.2 to Credit Agreement, dated as of May 17, 2018.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Existing 2021 Credit Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Five Year Credit Agreement, dated as of May 11, 2021,     by and among the Borrower, the lenders party thereto from time to time, Barclays and JPMC, as                 co-syndication agents, GS and Wells Fargo, as co-documentation agents, and BofA, as administrative agent, as amended by that certain First Amendment to Five Year Credit Agreement, dated as of  May </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;16&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, 2022, and as the same may be further amended, amended and restated, supplemented, replaced or otherwise modified from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Existing 2022 Credit Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Five Year Credit Agreement, dated as of May </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;16&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, 2022,     by and among the Borrower, the lenders party thereto from time to time, Barclays and JPMC, as                 </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">co-syndication agents, GS and Wells Fargo, as co-documentation agents, and BofA, as administrative agent,    as the same may be amended, amended and restated, supplemented, replaced or otherwise modified from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Expiration Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the first date, occurring on or after the date the Commitments shall have terminated or been terminated in accordance herewith, upon which there shall be no Loans, Reimbursement Obligations or Letters of Credit outstanding.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Extension Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.12(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Extension Request&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.12(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Facility Fee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;FATCA&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; Sections 1471 through 1474 of the Internal Revenue Code, as of the date of this Agreement (or any amended or successor version that is substantively comparable and not materially more onerous to comply with), any current or future regulations or official interpretations thereof, any agreements entered into pursuant to Section 1471(b)(1) of the Internal Revenue Code, any applicable intergovernmental agreements with respect thereto, and any treaty, law, regulations, or other official guidance enacted in any other jurisdiction relating to such intergovernmental agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Federal Funds Effective Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;  for any day, the rate per annum calculated by the Federal Reserve Bank of New York based on such day&#8217;s federal funds transactions by depository institutions (as determined in such manner as the Federal Reserve Bank of New York shall set forth on its public website from time to time) and published on the next succeeding Domestic Business Day by the Federal Reserve Bank of New York as the federal funds effective rate&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if the Federal Funds Effective Rate as so determined would be less than zero, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Federal Funds Effective Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall be deemed to be zero for purposes of    this Agreement and the other Loan Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Fees&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.2(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Financial Statements&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;First Amendment Effective Date&#8221;&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> May &#91;16&#93;, 2022. </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Foreign Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any Lender or any Issuer that is not a United States person within the meaning  of Section 7701(a)(30) of the Internal Revenue Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;GAAP&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.2(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, generally accepted accounting principles set forth in the  opinions and pronouncements of the Accounting Principles Board and the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or such other principles as may be approved by a significant segment of the accounting profession, which are applicable to the circumstances as of the date of determination, consistently applied.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Governmental Authority&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any foreign, federal, state, municipal or other government, or any department, commission, board, bureau, agency, public authority or instrumentality thereof, or any court, arbitrator, regulatory body or central bank (including any supra-national bodies such as the European Union or the European Central Bank).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;GS&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Hazardous Materials&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; all ignitable, explosive, reactive, corrosive or radioactive substances or wastes and all hazardous or toxic materials, substances, chemicals, wastes or other pollutants, including but not limited to petroleum or petroleum distillates, asbestos or asbestos containing materials, polychlorinated biphenyls, radon gas, toxic mold, infectious or medical wastes, hazardous biological agents, hazardous pharmaceutical substances and all other materials, substances, chemicals, wastes, contaminants or    pollutants of any nature that are now or hereafter regulated pursuant to any Environmental Law, or are now or hereafter defined, listed or classified as a hazardous or toxic material, substance, chemical, waste, contaminant or pollutant in any Environmental Law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Highest Lawful Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as to any Lender, the maximum rate of interest, if any, which at any time   or from time to time may be contracted for, taken, charged or received on the Loans or the Notes or which may be owing to such Lender pursuant to this Agreement under the laws applicable to such Lender and this Agreement and the other Loan Documents. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Increasing Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Indebtedness&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as to any Person at a particular time, all items of such Person which constitute, without duplication, (a) indebtedness for borrowed money or the deferred purchase price of Property (other than trade payables and accrued expenses incurred in the ordinary course of business), (b) indebtedness evidenced by notes, bonds, debentures or similar instruments, (c) indebtedness with respect to any conditional sale or other title retention agreement, (d) indebtedness arising under acceptance facilities and  the amount available to be drawn under all letters of credit (excluding, for purposes of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, letters    of credit obtained in the ordinary course of business by the Borrower or any Subsidiary) issued for the account of such Person and, without duplication, all drafts drawn thereunder to the extent such Person shall not have reimbursed the issuer thereof in respect of such issuer&#8217;s payment of such drafts, (e) that portion of any obligation of such Person, as lessee, which in accordance with GAAP is required to be capitalized on      a balance sheet of such Person, (f) all indebtedness described in clauses (a) through (e) above secured by    any Lien on any Property owned by such Person even though such Person shall not have assumed or otherwise become liable for the payment thereof (other than carriers&#8217;, warehousemen&#8217;s, mechanics&#8217;, repairmen&#8217;s or other like non-consensual Liens arising in the ordinary course of business), and (g) Contingent Obligations in respect of any indebtedness described in clauses (a) through (f) above&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that, for purposes of this definition, Indebtedness shall not include Intercompany Debt and obligations in respect of interest rate caps, collars, exchanges, swaps or other, similar agreements.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Indebtedness for Borrowed Money&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as to any Person at a particular time, all items of such Person which constitute, without duplication, (a) indebtedness for borrowed money or the deferred purchase price  of Property (other than trade payables and accrued expenses incurred in the ordinary course of business),    (b) indebtedness evidenced by notes, bonds, debentures or similar instruments, (c) that portion of any obligation of such Person, as lessee, which in accordance with GAAP is required to be capitalized on a balance sheet of such Person, and (d) Contingent Obligations in respect of any indebtedness described in clauses (a) through (c) above&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that, for purposes of this definition, Indebtedness for Borrowed Money shall not include Intercompany Debt and obligations in respect of interest rate caps, collars, exchanges, swaps or other, similar agreements.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Indemnified Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Indemnified Liabilities&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.5(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Indemnified Person&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Indemnified Taxes&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (a) Taxes, other than Excluded Taxes, imposed on or with respect to any payment made by or on account of any obligation of the Borrower under any Loan Document and (b) to     the extent not otherwise described in clause (a), Other Taxes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Information&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.14(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Insurance Subsidiary&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any Subsidiary subject to regulation by the commissioner of insurance,   the commissioner of health or any equivalent Governmental Authority in any applicable jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Intangible Assets&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any date, the value, as shown on the most recent Consolidated balance sheet of the Borrower and the Subsidiaries as at the end of the fiscal quarter ending not more than 135 days prior  to such date, prepared in accordance with GAAP, of&#58; (i) all trade names, trademarks, licenses, patents, copyrights, service marks, goodwill and other like intangibles, (ii) organizational and development costs,  (iii) deferred charges (other than prepaid items, such as insurance, taxes, interest, commissions, rents, pensions, compensation and similar items and tangible assets being amortized), and (iv) unamortized debt discount and expense, less unamortized premium.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Intercompany Debt&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (i) Indebtedness of the Borrower to one or more of the Subsidiaries of the Borrower and (ii) Indebtedness of one or more of the Subsidiaries of the Borrower to the Borrower or any one or more of the other Subsidiaries of the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Interest Payment Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (i) as to any ABR Advance, the last day of each March, June, September and December, commencing on the first of such days to occur after such ABR Advance is made or any   Term SOFR Advance is converted to an ABR Advance, (ii) as to any Swing Line Loan, the day on which  the outstanding principal balance of such Swing Line Loan shall become due and payable in accordance  with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, (iii) as to any Term SOFR Advance in respect of which the Borrower has selected a Term SOFR Interest Period of one or three months, the last day of such Term SOFR Interest Period, (iv) as to any Competitive Bid Loan in respect of which the Borrower has selected a Competitive Interest Period    of 90 days or less, the last day of such Competitive Interest Period and (v) as to any Term SOFR Advance   or Competitive Bid Loan in respect of which the Borrower has selected an Interest Period greater than three months or 90 days, as the case may be, the last day of the third month or the 90th day, as the case may be,   of such Interest Period and the last day of such Interest Period.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Interest Period&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a Term SOFR Interest Period or a Competitive Interest Period, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Internal Revenue Code&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Internal Revenue Code of 1986, as amended from time to time, or any successor thereto, and the rules and regulations issued thereunder, as from time to time in effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;issue&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;issuance&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; when used with respect to a Letter of Credit, shall be deemed to include    any increase in the amount of such Letter of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Issuers&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; Barclays, BofA, GS, JPMC and Wells Fargo&#59; each an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Issuer&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Joint Lead Arrangers&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BAS, Barclays, GS, JPMC and WFS.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;JPMC&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;KPIs&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.14(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Lenders&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble&#59; such term to also include the Swing Line Lender and each Issuer where the context hereof requires or permits such inclusion.</font></div><div style="margin-bottom:15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Lender Party&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;10.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letters of Credit&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.8(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit Application&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; an application and agreement for the issuance or amendment of a Letter of Credit in the form from time to time in use by the applicable Issuer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit Commitment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time with respect to any Issuer, the commitment of such Issuer to issue Letters of Credit (which, for the avoidance of doubt, shall include all standby letters of credit and all commercial letters of credit issued by such Issuer) in accordance with the terms hereof in an aggregate outstanding face amount not exceeding the lesser of (a) the amount set forth adjacent to such Issuer&#8217;s name under the heading &#8220;Letter of Credit Commitment&#8221; in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> at such time or, if not listed   on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the &#8220;Letter of Credit Commitment&#8221; which such Issuer shall have assumed from another Issuer in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> on or prior to such time, as the same may be adjusted from time to time pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and (b) the amount equal to the Aggregate Commitment Amount  as in effect at such time multiplied by a percentage equal to a fraction, the numerator of which is one and   the denominator of which is five.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit Exposure&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time, (a) in respect of all Lenders, the sum, without duplication, of (i) the maximum aggregate amount which may be drawn under all unexpired Letters of Credit at such  time (whether or not the conditions for drawing thereunder have or may be satisfied), (ii) the aggregate amount, at such time, of all unpaid drafts (which have not been dishonored) drawn under all Letters of Credit, and (iii) the aggregate unpaid principal amount of the Reimbursement Obligations at such time, (b)  in respect of any Lender, an amount equal to such Lender&#8217;s Commitment Percentage at such time multiplied by the amount determined under clause (a) of this definition, and (c) in respect of any Issuer, the amount determined under clause (a) of this definition in respect of a Letter of Credit issued by such Issuer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit Participation Fee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit Request&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a request substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit J</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Lien&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any mortgage, pledge, hypothecation, assignment, lien, deposit arrangement, charge, encumbrance or other security arrangement or security interest of any kind, or the interest of a vendor or lessor under any conditional sale agreement, capital lease or other title retention agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that   in no event shall an operating lease or license of Intangible Assets be deemed to constitute a Lien.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Loan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a Revolving Credit Loan, a Competitive Bid Loan or a Swing Line Loan, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Loan Documents&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; this Agreement and, upon the execution and delivery thereof, the Notes, if   any, and the Reimbursement Agreements, if any.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Loans&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Revolving Credit Loans, the Competitive Bid Loans and the Swing Line Loans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Mandatory Borrowing&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Margin Stock&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">margin stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as said term is defined in Regulation U of the Board of Governors of the Federal Reserve System, as the same may be amended or supplemented from time to time.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Material Acquisition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any acquisition of (a) Equity Interests in any Person if, after giving effect thereto, such Person will become a Subsidiary or (b) assets comprising all or substantially all the assets of  (or all or substantially all the assets constituting a business unit, division, product line or line of business    of) any Person&#59; provided that the aggregate consideration therefor (including Indebtedness assumed in connection therewith, all obligations in respect of the deferred purchase price therefor (including    obligations under any purchase price adjustment but excluding earn-out or similar payments) and all other consideration payable in connection therewith (including payment obligations in respect of noncompetition agreements or other arrangements representing acquisition consideration)) equals or exceeds $500,000,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Material Adverse&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any change or effect, a material adverse change in, or effect   on, as the case may be, (i) the financial condition, operations, business, or Property of the Borrower and the Subsidiaries taken as a whole, (ii) the ability of the Borrower to perform its obligations under the Loan Documents, or (iii) the ability of the Administrative Agent, any Issuer or any Lender to enforce the Loan Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Material Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; a Subsidiary of the Borrower with respect to which (i) the Borrower&#8217;s and  its other Subsidiaries&#8217; investments in, and advances to, such Subsidiary exceed ten percent (10%) of the   total assets of the Borrower and its Consolidated Subsidiaries as of the end of the most recently completed fiscal year, (ii) the Borrower&#8217;s and its other Subsidiaries&#8217; proportionate share of the total assets (after intercompany eliminations) of such Subsidiary exceeds 10 percent (10%) of the total assets of the Borrower and its Consolidated Subsidiaries as of the end of the most recently completed fiscal year, or (iii) the Borrower&#8217;s and its other Subsidiaries&#8217; equity in the income from continuing operations before income taxes of such Subsidiary exclusive of amounts attributable to any non-controlling interests exceeds ten percent (10%) of such income of the Borrower and its Consolidated Subsidiaries for the most recently completed fiscal year.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Moody&#8217;s&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; Moody&#8217;s Investors Service, Inc., or any successor thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Multiemployer Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a Pension Plan which is a multiemployer plan as defined in Section 4001(a)(3) of ERISA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Negotiated Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; with respect to each Swing Line Loan, the rate per annum agreed to in writing  by the Borrower and the Swing Line Lender as the interest rate which such Swing Line Loan shall bear.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Net Tangible Assets&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any date, the total assets as shown on the most recent Consolidated balance sheet of the Borrower and the Subsidiaries as at the end of the fiscal quarter ending not more than 135 days prior to such date, prepared in accordance with GAAP, less, without duplication (i) all current liabilities (due within one year) as shown on such balance sheet and (ii) Intangible Assets and liabilities relating thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;New Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Non-Extending Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.12(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Note&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to each Lender that has requested one in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, a promissory note evidencing such Lender&#8217;s Loans payable to such Lender (or, if required by such Lender,     to such Lender and its registered assigns), substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;One Month SOFR Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; for any interest calculation with respect to an ABR Advance on any  date, the rate per annum equal to the Term SOFR Screen Rate with a term of one month commencing that day, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that in the event that the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">One Month SOFR Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> would otherwise be less than zero, such </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">One Month SOFR Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be deemed to be zero for purposes of this Agreement and the other Loan Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Other Connection Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to the Administrative Agent, any Lender, any Issuer or   any other recipient of any payment to be made by or on account of any obligation of the Borrower hereunder or any other Loan Document, Taxes imposed as a result of a present or former connection between such recipient and the jurisdiction imposing such Tax (other than connections arising from such recipient having executed, delivered, become a party to, performed its obligations under, received payments under, received or perfected a security interest under, engaged in any other transaction pursuant to, enforced any Loan Document, or sold or assigned an interest in any Loan or Loan Document).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Other Taxes&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; all present or future stamp, court or documentary Taxes or any other excise or property Taxes, charges or similar levies arising from any payment made hereunder or under any other   Loan Document or from the execution, delivery or enforcement of, or otherwise with respect to, this Agreement or any other Loan Document, except any such Taxes that are Other Connection Taxes imposed with respect to an assignment (other than an assignment made pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Participant&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Participant Register&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Patriot Act&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;PBGC&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Pension Benefit Guaranty Corporation established pursuant to Subtitle A of Title IV  of ERISA, or any Governmental Authority succeeding to the functions thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pension Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time, any Employee Benefit Plan (including a Multiemployer Plan) subject to Section 302 of ERISA or Section 412 of the Internal Revenue Code, the funding requirements of which are, or at any time within the six years immediately preceding the time in question were, in whole or in part, the responsibility of the Borrower, any Subsidiary or an ERISA Affiliate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Person&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any individual, firm, partnership, limited liability company, joint venture, corporation, association, business trust, joint stock company, unincorporated association, trust, Governmental Authority or any other entity, whether acting in an individual, fiduciary, or other capacity, and for the purpose of the definition of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ERISA Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, a trade or business.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Plan of Reorganization&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;11.7(h)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Platform&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pricing Level&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; Pricing Level I, Pricing Level II, Pricing Level III, Pricing Level IV, Pricing   Level V or Pricing Level VI, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pricing Level I&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any time when the senior unsecured long term debt rating of the Borrower by    (x) S&#38;P is A or higher or (y) Moody&#8217;s is A2 or higher.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pricing Level II&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any time when (i) the senior unsecured long term debt rating of the Borrower   by (x) S&#38;P is A- or higher or (y) Moody&#8217;s is A3 or higher and (ii) Pricing Level I does not apply.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pricing Level III&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any time when (i) the senior unsecured long term debt rating of the Borrower  by (x) S&#38;P is BBB+ or higher or (y) Moody&#8217;s is Baa1 or higher and (ii) neither Pricing Level I nor Pricing Level II applies.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pricing Level IV&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any time when (i) the senior unsecured long term debt rating of the Borrower  by (x) S&#38;P is BBB or higher or (y) Moody&#8217;s is Baa2 or higher and (ii) none of Pricing Level I, Pricing  Level II or Pricing Level III applies.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pricing Level V&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any time when (i) the senior unsecured long term debt rating of the Borrower    by (x) S&#38;P is BBB- or higher or (y) Moody&#8217;s is Baa3 or higher and (ii) none of Pricing Level I, Pricing Level II, Pricing Level III or Pricing Level IV applies.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pricing Level VI&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any time when none of Pricing Level I, Pricing Level II, Pricing Level III, Pricing Level IV or Pricing Level V applies.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding each definition of Pricing Level set forth above, if at any time the senior unsecured long term debt ratings of the Borrower by S&#38;P and Moody&#8217;s differ by more than one equivalent rating level,   then the applicable Pricing Level shall be determined based upon the lower such rating adjusted upwards     to the next higher rating level.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Proceeding&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Prohibited Transaction&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a transaction that is prohibited under Section 4975 of the Internal Revenue Code or Section 406 of ERISA and not exempt under Section 4975 of the Internal Revenue Code, Section 408 of ERISA or any applicable administrative exemptions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Property&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; in respect of any Person, all types of real, personal or mixed property and all types of tangible or intangible property owned or leased by such Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;PTE&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.23(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Regulatory Change&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the occurrence, after the date hereof, of any of the following&#58; (a) the  adoption or taking effect of any law, rule, regulation or treaty, (b) any change in any law, rule, regulation     or treaty or in the administration, implementation, interpretation or application thereof by any   Governmental Authority or (c) the making or issuance of any request, guideline or directive (whether or    not having the force of law) by any Governmental Authority&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, notwithstanding anything   herein to the contrary, (i) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives thereunder or issued in connection therewith and (ii) all requests, rules, guidelines or directives promulgated by the Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case, pursuant to Basel III, in the case of each of clauses (i) and (ii), shall be deemed to  be a &#8220;Regulatory Change&#8221;, regardless of the date enacted, adopted or issued, but only if any such requirements are generally applicable to (and for which reimbursement is generally being sought by the Lenders in respect of) credit transactions similar to this transaction from similarly situated borrowers (which are parties to credit or loan documentation containing a provision similar to this definition), as determined  by the Lenders in their respective reasonable discretion.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Register&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Reimbursement Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.8(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and, as the context requires, shall  include the Letter of Credit Application related to the applicable Letter of Credit.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Reimbursement Obligations&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; all obligations and liabilities of the Borrower due and to become  due (a) under the Reimbursement Agreements and (b) hereunder in respect of Letters of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Related Parties&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any specified Person, such Person&#8217;s Affiliates and the respective directors, officers, employees, agents and advisors of such Person and such Person&#8217;s Affiliates.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Replaced Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Replacement Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Required Lenders&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (a) at any time prior to the Commitment Termination Date or such earlier   date as all of the Commitments shall have terminated or been terminated in accordance herewith, Lenders having Commitment Amounts greater than 50% of the Aggregate Commitment Amount, and (b) at all other times, Lenders having Credit Exposure greater than 50% of the Aggregate Credit Exposure.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Rescindable Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.2(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Resolution Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; an EEA Resolution Authority or, with respect to any UK Financial Institution, a UK Resolution Authority.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Restrictive Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Revolving Credit Loan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Revolving Credit Loans&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;S&#38;P&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; Standard &#38; Poor&#8217;s Financial Services LLC, a subsidiary of S&#38;P Global Inc., or any successor thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Sanctioned Country&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time, a country or territory which is the subject or target of any Sanctions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Sanctioned Person&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time, (a) any Person listed in any Sanctions-related list of designated Persons maintained by the Office of Foreign Assets Control of the U.S. Department of the Treasury or the U.S. Department of State, (b) any Person operating, organized or resident in a Sanctioned Country or (c)   any Person controlled by any such Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Sanctions&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; economic or financial sanctions or trade embargoes imposed, administered or   enforced from time to time by the U.S. government, including those administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury or the U.S. Department of State.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Scheduled Unavailability Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(c)(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">SEC Reports</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the Borrower&#8217;s 2018 Annual Report on Form 10-K, the Borrower&#8217;s quarterly   report on Form 10-Q for the quarterly period ending March 31, 2019, and any 8-K filings made by the Borrower subsequent to March 31, 2019 and prior to the Effective Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Secured Overnight Financing Rate as administered by the Federal Reserve Bank of New York (or a successor administrator).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;SOFR Adjustment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> with respect to Daily Simple SOFR and any Term SOFR Interest Period, 0.10% (10.0 basis points).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Special Counsel&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; such counsel as the Administrative Agent may engage from time to time.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Subsidiary&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time and from time to time, any corporation, partnership, limited liability company, joint venture or other business entity of which the Borrower and&#47;or any Subsidiary of the Borrower, directly or indirectly at such time, either (a) in respect of a corporation, owns or controls more than 50% of the outstanding stock having ordinary voting power to elect a majority of the board of directors or similar managing body, irrespective of whether a class or classes shall or might have voting power by reason of the happening of any contingency, or (b) in respect of a partnership, limited liability company,  joint venture or other business entity, is entitled to share in more than 50% of the profits and losses, however determined.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Successor Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Sustainability Coordinator&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; BofA Securities, Inc., in its capacity as the sustainability  coordinator.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Sustainability Linked Loan Principles&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Sustainability-Linked Loan Principles (as published  in March 2022 by the Loan Market Association, Asia Pacific Loan Market Association and Loan Syndications &#38; Trading Association).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Commitment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the commitment of the Swing Line Lender to make Swing Line Loans in accordance with the terms hereof in an aggregate outstanding principal amount not exceeding $100,000,000 (or, if less, the Aggregate Commitment Amount) at any time, as the same may be reduced pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Commitment Period&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the period from the Effective Date to, but excluding, the Swing Line Termination Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Exposure&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time, in respect of any Lender, an amount equal to the aggregate principal balance of such Lender&#8217;s Swing Line Participation Amount.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; BofA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Loan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Loans&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Maturity Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Participation Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Termination Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the date which is 7 Domestic Business Days prior to the Commitment Termination Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Taxes&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; all present or future taxes, levies, imposts, duties, deductions, withholdings, assessments, fees or other charges in the nature of a tax imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; for any Term SOFR Interest Period with respect to a Term SOFR Advance, the    rate per annum equal to the Term SOFR Screen Rate two U.S. Government Securities Business Days prior  to the commencement of such Term SOFR Interest Period with a term equivalent to such Term SOFR Interest Period&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if the rate is not published prior to 11&#58;00 A.M. on such determination date   then Term SOFR means the Term SOFR Screen Rate on the first U.S. Government Securities Business Day immediately prior thereto, in each case,</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the SOFR Adjustment for such Term SOFR Interest Period&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, further, that if Term SOFR determined pursuant to the above would be less than zero, Term SOFR shall be deemed zero for purposes of this Agreement and the other  Loan Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Term SOFR Advance&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a portion of the Revolving Credit Loans selected by the Borrower to bear interest during a Term SOFR Interest Period selected by the Borrower at a rate based upon Term SOFR, all pursuant to and in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Term SOFR Daily Floating Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; for any interest calculation with respect to a Term SOFR   Daily Floating Rate Loan on any date, a fluctuating rate of interest, which can change on each Domestic Business Day, equal to the Term SOFR Screen Rate, two U.S. Government Securities Business Days prior  to such day, with a term equivalent to one month beginning on that date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that if the rate is not published prior to 11&#58;00 A.M. on such determination date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">then the Term SOFR Daily Floating Rate means the Term SOFR Screen Rate on the first U.S. Government Securities Business Day immediately prior thereto, in each case, plus the SOFR Adjustment for Term SOFR for a one-month Interest Period&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that, (i) to the extent a comparable or successor rate is approved by the Swing Line Lender in connection herewith, the approved rate shall be applied in a manner consistent with market practice&#59; provided, further that to the extent such market practice is not administratively feasible for the Swing Line Lender, such approved rate shall be applied in a manner as otherwise reasonably determined by the Swing Line Lender in consultation with the Borrower, (ii) if the Term SOFR Daily Floating Rate determined pursuant to the above would be less than zero, such rate shall be deemed zero for purposes of this Agreement and the other Loan Documents, and (iii) if such rate is not available at such time for any reason, then the   rate will be determined by such alternate method as reasonably selected by the Swing Line Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Term SOFR Interest Period&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as to each Term SOFR Advance, the period commencing on the  date such Term SOFR Advance is disbursed or converted to or continued as a Term SOFR Advance and ending on the date one, three or six months thereafter, as selected by the Borrower in its Borrowing Request&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">any Term SOFR Interest Period that would otherwise end on a day that is not a Domestic Business Day shall be extended to the next succeeding Domestic Business Day unless  such Domestic Business Day falls in another calendar month, in which case such Term SOFR Interest Period shall end on the next preceding Domestic Business Day&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">any Term SOFR Interest Period that begins on the last Domestic Business Day of     a calendar month (or on a day for which there is no numerically corresponding day in the calendar month at the end of such Term SOFR Interest Period) shall end on the last Domestic Business Day  of the calendar month at the end of such Term SOFR Interest Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Term SOFR Replacement Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Term SOFR Screen Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the forward-looking SOFR term rate administered by CME (or any successor administrator reasonably satisfactory to the Administrative Agent) and published on the   applicable Reuters screen page (or such other commercially available source providing such quotations as may be designated by the Administrative Agent from time to time in its reasonable discretion).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Termination Event&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any Pension Plan, (a) an ERISA Event, (b) the termination    of a Pension Plan under Section 4041(c) of ERISA, or the filing of a notice of intent to terminate a Pension Plan under Section 4041(c) of ERISA, or the treatment of a Pension Plan amendment as a termination under Section 4041(e) of ERISA (except an amendment made after such Pension Plan satisfies the requirement    for a standard termination under Section 4041(b) of ERISA), (c) the institution of proceedings by the PBGC </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to terminate a Pension Plan under Section 4042 of ERISA, or (d) the appointment of a trustee to administer any Pension Plan under Section 4042 of ERISA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Threshold Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; $300,000,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Total Capitalization&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any date, the sum of the Borrower&#8217;s Consolidated Indebtedness and shareholders&#8217; equity on such date, determined in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Trade Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Type&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any Revolving Credit Loan, the characteristic of such Loan as an ABR Advance or a Term SOFR Advance, each of which constitutes a Type of Revolving Credit Loan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">UK Financial Institution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any BRRD Undertaking (as such term is defined under the PRA Rulebook (as amended form time to time) promulgated by the United Kingdom Prudential Regulation Authority) or any person subject to IFPRU 11.6 of the FCA Handbook (as amended from time to time) promulgated by the United Kingdom Financial Conduct Authority, which includes certain credit institutions and investment firms, and certain affiliates of such credit institutions or investment firms.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">UK Resolution Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Bank of England or any other public administrative authority having responsibility for the resolution of any UK Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Unqualified Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.4(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Upstream Dividends&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;U.S. Government Securities Business Day&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any Domestic Business Day, except any Domestic Business Day on which any of the Securities Industry and Financial Markets Association, the New York Stock Exchange or the Federal Reserve Bank of New York is not open for business because such day is a legal holiday under the federal laws of the United States or the laws of the State of New York, as applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;U.S. Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;United States Tax Compliance Certificate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10(f)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Wells Fargo&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">WFS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; Wells Fargo Securities, LLC.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Write-Down and Conversion Powers&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (a) with respect to any EEA Resolution Authority, the write-down and conversion powers of such EEA Resolution Authority from time to time under the Bail-In Legislation for the applicable EEA Member Country, which write-down and conversion powers are described in the EU Bail-In Legislation Schedule, and (b) with respect to the United Kingdom, any powers  of the applicable Resolution Authority under the Bail-In Legislation to cancel, reduce, modify or change    the form of a liability of any UK Financial Institution or any contract or instrument under which that liability arises, to convert all or part of that liability into shares, securities or obligations of that person or any other person, to provide that any such contract or instrument is to have effect as if a right had been exercised  under it or to suspend any obligation in respect of that liability or any of the powers under that Bail-In Legislation that are related to or ancillary to any of those powers. </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:62.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Principles of Construction</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">All capitalized terms defined in this Agreement shall have the meanings given to such capitalized terms herein when used in the other Loan Documents or in any certificate, opinion or other document made or delivered pursuant hereto or thereto, unless otherwise expressly   provided therein.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Unless otherwise expressly provided herein, the word </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;fiscal&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> when used herein shall refer to the relevant fiscal period of the Borrower. As used in the Loan Documents and in any certificate, opinion or other document made or delivered pursuant thereto, accounting terms not defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and accounting terms partly defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the extent not defined, shall have the respective meanings given to them under GAAP as in effect from time to time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, if the Borrower notifies the Administrative Agent that the Borrower requests an amendment to any provision hereof to eliminate the effect of any change occurring after the date hereof in GAAP or in the application thereof on the operation of such provision (or if the Administrative Agent notifies the Borrower that the Required Lenders request an amendment to    any provision hereof for such purpose), regardless of whether any such notice is given before or  after such change in GAAP or in the application thereof, then such provision&#160;shall be interpreted    on the basis of, and any accounting term related thereto shall have the respective meaning given to   it under, GAAP as in effect and applied immediately before such change shall have become  effective until such notice shall have been withdrawn or such provision amended in accordance herewith.  Any lease that is characterized as an operating lease in accordance with GAAP after the Borrower&#8217;s adoption of ASC 842 (regardless of the date on which such lease has been entered into) shall not be a capital or finance lease, and any such lease shall be, for all purposes of this  Agreement, treated as though it were reflected on the Borrower&#8217;s consolidated financial statements  in the same manner as an operating lease would have been reflected prior to Borrower&#8217;s adoption    of ASC 842.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The words </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;hereof&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;herein&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;hereto&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;hereunder&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and similar words    when used in each Loan Document shall refer to such Loan Document as a whole and not to any particular provision of such Loan Document, and Section, schedule and exhibit references   contained therein shall refer to Sections thereof or schedules or exhibits thereto unless otherwise expressly provided therein.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">All references herein to a time of day shall mean the then-applicable time in New York, New York, unless otherwise expressly provided herein.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Section headings have been inserted in the Loan Documents for convenience only and shall not be construed to be a part thereof. Unless the context otherwise requires, words in the singular number include the plural, and words in the plural include the singular.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.02pt">Whenever in any Loan Document or in any certificate or other document made or delivered pursuant thereto, the terms thereof require that a Person sign or execute the same or refer  to the same as having been so signed or executed, such terms shall mean that the same shall be, or was, duly signed or executed by (i) in respect of any Person that is a corporation, any duly  authorized officer thereof, and (ii) in respect of any other Person (other than an individual), any analogous counterpart thereof.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">The words </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;include&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;including&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, when used in each Loan Document, shall mean that the same shall be included </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;without limitation&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, unless otherwise specifically provided.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</font></div><div><font><br></font></div></div></div><div id="iff8b9214df4549afa93ccc36670241b0_567"></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">All references to &#8220;knowledge&#8221; or &#8220;awareness&#8221; of the Borrower or any Subsidiary means the actual knowledge of an Authorized Officer of the Borrower or such Subsidiary. </font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div id="iff8b9214df4549afa93ccc36670241b0_202"></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">AMOUNT AND TERMS OF LOANS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Revolving Credit Loans</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Subject to the terms and conditions hereof, each Lender severally (and not jointly) agrees to make loans in Dollars under this Agreement (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Revolving Credit Loan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and, collectively with each other Revolving Credit Loan of such Lender and&#47;or with each Revolving Credit Loan of each other Lender, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Revolving Credit Loans&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) to the Borrower from time to   time during the Commitment Period, during which period the Borrower may borrow, prepay and reborrow in accordance with the provisions hereof. Immediately after making each Revolving   Credit Loan and after giving effect to all Swing Line Loans and Competitive Bid Loans repaid and all Reimbursement Obligations paid on the same date, the Aggregate Credit Exposure will not exceed the Aggregate Commitment Amount. With respect to each Lender, at the time of the making of any Revolving Credit Loan, the sum of (I) the principal amount of such Lender&#8217;s Revolving Credit Loan constituting a part of the Revolving Credit Loans to be made, (II) the aggregate  principal balance of all other Revolving Credit Loans (exclusive of Revolving Credit Loans which are repaid with the proceeds of, and simultaneously with the incurrence of, the Revolving Credit Loans to be made) then outstanding from such Lender and (III) the product of (A) such Lender&#8217;s Commitment Percentage and (B) the sum of (1) the aggregate principal balance of all Swing Line Loans (exclusive of Swing Line Loans which are repaid with the proceeds of, and simultaneously with the incurrence of, the Revolving Credit Loans to be made) then outstanding and (2) the Letter  of Credit Exposure of all Lenders, will not exceed the Commitment of such Lender at such time.     At the option of the Borrower, indicated in a Borrowing Request, Revolving Credit Loans may be made as ABR Advances or Term SOFR Advances.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">The aggregate outstanding principal balance of all Revolving Credit Loans shall     be due and payable on the Commitment Termination Date or on such earlier date upon which all     of the Commitments shall have been terminated in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Swing Line Loans</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Subject to the terms and conditions hereof and in reliance upon the agreements of the other Lenders set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Swing Line Lender agrees to make loans in  Dollars under this Agreement (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Loan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and, collectively, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Loans&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) to the Borrower from time to time during the Swing Line Commitment Period. Swing Line Loans (i) may be repaid and reborrowed in accordance with the provisions hereof, (ii) shall not, immediately after giving effect thereto, result in the Aggregate Credit Exposure exceeding the Aggregate Commitment Amount, and (iii) shall not, immediately after giving effect thereto, result   in the aggregate outstanding principal balance of all Swing Line Loans exceeding the Swing Line Commitment. The Swing Line Lender shall not be obligated to make any Swing Line Loan at a   time when any Lender is a Defaulting Lender unless the Swing Line Lender has entered into arrangements satisfactory to it and the Borrower to eliminate the Swing Line Lender&#8217;s risk with respect to such Defaulting Lender&#8217;s participation in such Swing Line Loan. The Swing Line Lender will not make a Swing Line Loan if the Administrative Agent or any Lender, by notice to the Swing Line Lender and the Borrower no later than one Domestic Business Day prior to the Borrowing   Date with respect to such Swing Line Loan, shall have determined that the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> have not been satisfied or waived and such conditions remain unsatisfied as of the requested time of the making of such Loan. Each Swing Line Loan shall be due and payable on the </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">day (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Maturity Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) being the earliest of the tenth Domestic Business Day after such Swing Line Loan is made, the date on which the Swing Line Commitment shall have been terminated in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and the date on which the Loans shall become due and payable pursuant to the provisions hereof, whether by acceleration or otherwise. Each Swing Line Loan shall bear interest at the Negotiated Rate (or, if the Negotiated Rate is not available, the Term SOFR Daily Floating Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Applicable Margin). The Swing Line Lender shall disburse the proceeds of Swing Line Loans at its office designated in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> by crediting such proceeds     to an account of the Borrower maintained with the Swing Line Lender.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">On any Domestic Business Day, the Swing Line Lender may, in its sole discretion, give notice to the Lenders and the Borrower that such outstanding Swing Line Loan shall be funded with a borrowing of Revolving Credit Loans (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such notice shall be deemed to have  been automatically given upon the occurrence of a Default or an Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), in which case a borrowing of Revolving Credit Loans made as ABR Advances (each such borrowing, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Mandatory Borrowing&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) shall be made by all Lenders </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> based on each such Lender&#8217;s Commitment Percentage on the Domestic Business Day immediately   succeeding the giving of such notice. The proceeds of each Mandatory Borrowing shall be remitted directly to the Swing Line Lender to repay such outstanding Swing Line Loan. Each Lender irrevocably agrees to make a Revolving Credit Loan pursuant to each Mandatory Borrowing in the amount and in the manner specified in the preceding sentence and on the date specified in writing   by the Swing Line Lender notwithstanding&#58; (i) whether the amount of such Mandatory Borrowing complies with the minimum amount for Loans otherwise required hereunder, (ii) whether any condition specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> is then unsatisfied, (iii) whether a Default then exists, (iv) the Borrowing Date of such Mandatory Borrowing, (v) the aggregate principal amount of all Loans   then outstanding, (vi) the Aggregate Credit Exposure at such time and (vii) the amount of the Commitments at such time.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Upon each receipt by a Lender of a notice from the Administrative Agent, such Lender shall purchase unconditionally, irrevocably, and severally (and not jointly) from the Swing Line Lender a participation in the outstanding Swing Line Loans (including accrued interest  thereon) in an amount equal to the product of its Commitment Percentage and the outstanding balance of the Swing Line Loans (each, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Participation Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">). Each Lender shall also be liable for an amount equal to the product of its Commitment Percentage and any amounts paid by the Borrower pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that are subsequently rescinded or avoided, or  must otherwise be restored or returned. Such liabilities shall be unconditional and without regard     to the occurrence of any Default or the compliance by the Borrower with any of its obligations   under the Loan Documents.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">In furtherance of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, upon each receipt by a Lender of a notice from     the Administrative Agent, such Lender shall promptly (and, in any event, no later than the Domestic Business Day immediately succeeding the giving of such notice) make available to the Administrative Agent for the account of the Swing Line Lender its Swing Line Participation  Amount at the office of the Administrative Agent specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, in Dollars and in immediately available funds. The Administrative Agent shall deliver the payments made by each Lender pursuant to the immediately preceding sentence to the Swing Line Lender promptly upon receipt thereof in like funds as received. Each Lender hereby indemnifies and agrees to hold harmless the Administrative Agent and the Swing Line Lender from and against any and all losses, liabilities (including liabilities for penalties), actions, suits, judgments, demands, costs and    expenses resulting from any failure on the part of such Lender to pay, or from any delay in paying, the Administrative Agent any amount such Lender is required by notice from the Administrative Agent to pay in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (except in respect of losses, liabilities or other </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">obligations suffered by the Administrative Agent or the Swing Line Lender, as the case may be, resulting from the gross negligence or willful misconduct of the Administrative Agent or the Swing Line Lender, as the case may be), and such Lender shall pay interest to the Administrative Agent   for the account of the Swing Line Lender from the date such amount was due until paid in full, on the unpaid portion thereof, at a rate of interest per annum, whether before or after judgment, equal   to (i) from the date such amount was due until the third day therefrom, the Federal Funds Effective Rate, and (ii) thereafter, the Federal Funds Effective Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 2%, payable upon demand by the Swing Line Lender. The Administrative Agent shall distribute such interest payments to the Swing Line Lender upon receipt thereof in like funds as received.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Whenever the Administrative Agent is reimbursed by the Borrower for the account of the Swing Line Lender for any payment in connection with Swing Line Loans and such payment relates to an amount previously paid by a Lender pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Administrative Agent will promptly remit such payment to such Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Notice of Borrowing Revolving Credit Loans and Swing Line Loans</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower agrees to notify the Administrative Agent (and with respect to a Swing Line Loan,    the Swing Line Lender), which notification shall be irrevocable, no later than (a) 2&#58;00 P.M., on the proposed Borrowing Date in the case of Swing Line Loans, (b) 12&#58;00 Noon on the proposed Borrowing Date in the case of Revolving Credit Loans to consist of ABR Advances and (c) 12&#58;00 Noon at least two Domestic Business Days prior to the proposed Borrowing Date in the case of Revolving Credit Loans to consist of Term SOFR Advances. Each such notice shall specify (i) the aggregate amount requested to be borrowed under the Commitments or the Swing Line Commitment, (ii) the proposed Borrowing Date, (iii) whether a borrowing of Revolving Credit Loans is to be made as an ABR Advance, one or more Term SOFR Advances, or both, and the amount of each thereof, (iv) the Term SOFR Interest Period for each such Term SOFR Advance and (v) the amount of each Swing Line Loan. Each such notice shall be promptly confirmed by delivery to the Administrative Agent (and, with respect to a Swing Line Loan, the Swing Line Lender)   of a Borrowing Request. Each Term SOFR Advance to be made on a Borrowing Date, when aggregated  with all amounts to be Converted to Term SOFR Advances on such date and having the same Interest Period as such Term SOFR Advance, shall equal no less than $10,000,000, or an integral multiple of $1,000,000    in excess thereof. Each ABR Advance made on each Borrowing Date shall equal no less than $5,000,000    or an integral multiple of $500,000 in excess thereof. Each Swing Line Loan made on each Borrowing Date shall equal no less than $1,000,000 or an integral multiple of $500,000 in excess thereof. The   Administrative Agent shall promptly notify each Lender (by telephone or otherwise, such notification to be confirmed by fax, email or other writing) of each such Borrowing Request. Subject to its receipt of each  such notice from the Administrative Agent and subject to the terms and conditions hereof, (A) each Lender shall make immediately available funds available to the Administrative Agent at the address therefor set  forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> not later than 1&#58;00 P.M. on each Borrowing Date in an amount equal to such Lender&#8217;s Commitment Percentage of the Revolving Credit Loans requested by the Borrower on such Borrowing Date and&#47;or (B) the Swing Line Lender shall make immediately available funds available to the Borrower on   such Borrowing Date in an amount equal to the Swing Line Loan requested by the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Competitive Bid Loans and Procedure</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Subject to the terms and conditions hereof, the Borrower may request competitive bid loans in Dollars under this Agreement (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Competitive Bid Loan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) during the   Commitment Period. In order to request Competitive Bids, the Borrower shall deliver by hand, fax  or email to the Administrative Agent a duly completed and executed Competitive Bid Request not later than 12&#58;00 Noon, one Domestic Business Day before the proposed Borrowing Date therefor.    A Competitive Bid Request that does not conform substantially to the format of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit F</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> may be </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">rejected by the Administrative Agent in the Administrative Agent&#8217;s reasonable discretion, and the Administrative Agent shall promptly notify the Borrower of such rejection by fax or email and by telephone. Each Competitive Bid Request shall specify (x) the proposed Borrowing Date for the Competitive Bid Loans then being requested (which shall be a Domestic Business Day) and the aggregate principal amount thereof and (y) the Competitive Interest Period or Competitive Interest Periods (which shall not exceed ten different Interest Periods in a single Competitive Bid Request), with respect thereto (which may not end after the Domestic Business Day immediately preceding  the Commitment Termination Date). Promptly after its receipt of each Competitive Bid Request   that is not rejected as aforesaid, the Administrative Agent shall invite by fax or email (substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit G</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) the Lenders (other than any Defaulting Lender) to bid, on the terms and conditions of this Agreement, to make Competitive Bid Loans pursuant to such Competitive Bid Request.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Each Lender (other than any Defaulting Lender), in its sole and absolute discretion, may make one or more Competitive Bids to the Borrower responsive to a Competitive Bid Request. Each Competitive Bid by a Lender must be received by the Administrative Agent not later than 10&#58;00 A.M. on the proposed Borrowing Date for the relevant Competitive Bid Loan. Multiple bids will be accepted by the Administrative Agent. Bids to make Competitive Bid Loans that, in the reasonable judgment of the Administrative Agent, do not conform to the Competitive Bids solicited by the related Competitive Bid Request shall be rejected by the Administrative Agent. Competitive Bids that do not conform substantially to the format of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit H</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> may be rejected by the Administrative Agent after conferring with, and upon the instruction of, the Borrower, and the Administrative Agent shall notify the Lender making such nonconforming bid of such rejection as soon as practicable. Each Competitive Bid shall be irrevocable and shall specify (x) the principal amount (which (1) shall be in a minimum principal amount of $10,000,000 or an integral multiple  of $1,000,000 in excess thereof, and (2) may equal the entire principal amount requested by the Borrower) of the Competitive Bid Loan or Competitive Bid Loans that the Lender is willing to  make to the Borrower, (y) the Competitive Bid Rate or Competitive Bid Rates at which the Lender  is prepared to make such Competitive Bid Loan or Competitive Bid Loans, and (z) the Competitive Interest Period with respect to each such Competitive Bid Loan and the last day thereof. If any Lender shall elect not to make a Competitive Bid, such Lender shall so notify the Administrative Agent by fax or email not later than 10&#58;00 A.M. on the proposed Borrowing Date therefor&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that the failure by any Lender to give any such notice shall not obligate such Lender to make any Competitive Bid Loan in connection with the relevant Competitive Bid Request.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">With respect to each Competitive Bid Request, the Administrative Agent shall (i) notify the Borrower by fax or email by 11&#58;00 A.M. on the proposed Borrowing Date with respect thereto of each Competitive Bid made, the Competitive Bid Rate applicable thereto and the identity of the Lender that made such Competitive Bid, and (ii) send a list of all Competitive Bids to the Borrower for its records as soon as practicable after completion of the bidding process. Each notice and list sent by the Administrative Agent pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall list the Competitive Bids in ascending yield order.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">The Borrower may, in its sole and absolute discretion, subject only to the  provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, accept or reject any Competitive Bid made in accordance with the procedures set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and the Borrower shall notify the Administrative Agent by telephone, confirmed by fax or email in the form of a duly completed and executed Competitive   Bid Accept&#47;Reject Letter, whether and to what extent it has decided to accept or reject any or all of such Competitive Bids not later than 12&#58;00 Noon on the proposed Borrowing Date therefor&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the failure by the Borrower to give such notice shall be deemed to be a rejection of    </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">all such Competitive Bids. In connection with each acceptance of one or more Competitive Bids    by the Borrower&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">the Borrower shall not accept a Competitive Bid of a given tenor made at    a particular Competitive Bid Rate if the Borrower has decided to reject a Competitive Bid having the same tenor made at a lower Competitive Bid Rate unless the acceptance of such Competitive Bid made at a lower Competitive Bid Rate would subject the Borrower to any requirement to withhold any taxes or deduct any amount from any amounts payable under the Loan Documents, in which case the Borrower may reject such Competitive Bid made    at a lower Competitive Bid Rate,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">the aggregate amount of the Competitive Bids accepted by the Borrower shall not exceed the principal amount specified in the Competitive Bid Request therefor,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">if the Borrower shall desire to accept a Competitive Bid made at a  particular Competitive Bid Rate, it must accept all other Competitive Bids at such Competitive Bid Rate, except for any such Competitive Bid the acceptance of which would subject the Borrower to any requirement to withhold any taxes or deduct any amount from any amounts payable under the Loan Documents&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if the acceptance of all   such other Competitive Bids would cause the aggregate amount of all such accepted Competitive Bids to exceed the amount requested, then such acceptance shall be made pro rata in accordance with the amount of each such Competitive Bid at such Competitive Bid Rate,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">except pursuant to clause (3) above, no Competitive Bid shall be accepted unless the Competitive Bid Loan with respect thereto shall be in a minimum principal amount of $10,000,000 or an integral multiple of $1,000,000 in excess thereof, and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">no Competitive Bid shall be accepted and no Competitive Bid Loan shall  be made, if immediately after giving effect thereto, the Aggregate Credit Exposure would exceed the Aggregate Commitment Amount.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Administrative Agent shall promptly fax or email to each bidding Lender   (with a copy to the Borrower) a Competitive Bid Accept&#47;Reject Letter advising such Lender  whether its Competitive Bid has been accepted (and if accepted, in what amount and at what Competitive Bid Rate), and each successful bidder so notified will thereupon become bound,  subject to the applicable conditions hereof, to make the Competitive Bid Loan in respect of which each of its Competitive Bids has been accepted by making immediately available funds available    to the Administrative Agent at its address set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> not later than 1&#58;00 P.M. on the Borrowing Date for such Competitive Bid Loan in the amount thereof.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.02pt">Anything herein to the contrary notwithstanding, if the Administrative Agent shall elect to submit a Competitive Bid in its capacity as a Lender, it shall submit such bid directly to the Borrower not later than 9&#58;30 A.M. on the relevant proposed Borrowing Date.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">All notices required by this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be given in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Each Competitive Bid Loan shall be due and payable on the last day of the Competitive Interest Period applicable thereto or on such earlier date upon which the Loans shall become due and payable pursuant to the provisions hereof, whether by acceleration or otherwise.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Use of Proceeds</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower agrees that the proceeds of the Loans and Letters of Credit shall be used solely for    its general corporate purposes, but not inconsistent with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or any other provision of this Agreement, including, without limitation, the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and not in contravention of any applicable law, rule or regulation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Termination, Reduction or Increase of Commitments</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Termination on Commitment Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Unless previously terminated, the Commitments and the Letter of Credit Commitment shall terminate on the Commitment  Termination Date and the Swing Line Commitment shall terminate on the Swing Line Termination Date.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Voluntary Termination or Reductions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. At the Borrower&#8217;s option in its sole and absolute discretion and upon at least one Domestic Business Day&#8217;s prior irrevocable notice to the Administrative Agent, the Borrower may (i) terminate the Commitments, the Swing Line Commitment and the Letter of Credit Commitment, at any time, or (ii) permanently reduce the Aggregate Commitment Amount, the Swing Line Commitment or the Letter of Credit   Commitment, in part at any time and from time to time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that (1) each such partial reduction shall be in an amount equal to at least $5,000,000 or an integral multiple of $1,000,000 in excess thereof and (2) immediately after giving effect to each such reduction, (A) the Aggregate Commitment Amount shall equal or exceed the Aggregate Credit Exposure, (B) the Swing Line Commitment shall equal or exceed the aggregate outstanding principal balance of all Swing Line Loans and (C) the Letter of Credit Commitment shall equal or exceed the Letter of Credit Exposure of all Lenders&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, notwithstanding the foregoing, a notice of termination of the Commitments, the Swing Line Commitment and the Letter of Credit Commitment delivered by the Borrower may state that such notice is conditioned upon the effectiveness of other credit facilities   or transactions (such notice to specify the proposed effective date), in which case such notice may  be revoked by the Borrower (by notice to the Administrative Agent on or prior to such specified effective date) if such condition is not satisfied and the Borrower shall indemnify the Lenders in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, if applicable.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each reduction of the Aggregate Commitment Amount shall be made  by reducing each Lender&#8217;s Commitment Amount by an amount equal to the product of such Lender&#8217;s Commitment Percentage and the amount of such reduction.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Increase in Aggregate Commitment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower may at any time and from time to time prior to the 90</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> day prior to the then-applicable Commitment Termination Date,  at its sole cost and expense, request any one or more of the Lenders having a Commitment to increase its Commitment Amount (the decision to increase the Commitment Amount of a Lender    to be within the sole and absolute discretion of such Lender), or any Eligible Assignee to provide     a new Commitment, by submitting to the Administrative Agent a Commitment Increase  Supplement, duly executed and delivered by the Borrower and each such Lender increasing its Commitment Amount or Eligible Assignee providing a new Commitment, as the case may be.   Upon receipt of any such Commitment Increase Supplement, the Administrative Agent, the Swing Line Lender and each Issuer shall promptly execute and deliver such Commitment Increase Supplement and the Administrative Agent shall deliver a copy thereof to the Borrower and each  such Lender or Eligible Assignee, as the case may be. Upon execution and delivery of such Commitment Increase Supplement by the Administrative Agent, the Swing Line Lender and each Issuer, (i) in the case of each such Lender increasing its Commitment Amount (an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Increasing </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), its Commitment Amount shall be increased to the amount set forth in such Commitment Increase Supplement, and (ii) in the case of each such Eligible Assignee providing a new Commitment (a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">New Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), such New Lender shall become a party hereto and have the rights and obligations of a Lender under the Loan Documents and its Commitment shall be as set forth in such Commitment Increase Supplement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">immediately after giving effect thereto, the sum of all increases in the Aggregate Commitment Amount made pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall not exceed $500,000,000&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">each such increase of the Aggregate Commitment Amount shall be in an amount not less than $25,000,000 or such amount plus an integral multiple of $5,000,000&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that an increase may be in a lesser amount if such increase is an increase of the entire remaining amount available under clause (1) above&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">no Default shall have occurred or be continuing on the effective date of    the increase&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">the representations and warranties contained in this Agreement shall be   true and correct in all material respects with the same effect as though such representations and warranties had been made on the effective date of such increase (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any representation and warranty that is qualified as to &#8220;materiality&#8221;, &#8220;Material Adverse&#8221; or similar language shall be true and correct (after giving effect to any qualification therein)    in all respects on such effective date), except those which are expressly specified to be  made as of an earlier date&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">in the case of each New Lender, the Commitment Amount assumed by  such New Lender shall not be less than $25,000,000&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">if Revolving Credit Loans would be outstanding immediately after giving effect to any such increase, then simultaneously with such increase (A) each such  Increasing Lender, each such New Lender and each other Lender shall be deemed to have entered into a master assignment and assumption, in form and substance substantially similar to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit E</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, pursuant to which each such other Lender shall have assigned to each such Increasing Lender and each such New Lender a portion of its Revolving Credit Loans necessary to reflect proportionately the Commitments as increased in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and (B) in connection with such assignment, each such Increasing Lender and each such New Lender shall pay to the Administrative Agent, for the account of each such other Lender, such amount as shall be necessary to reflect the assignment to it of such Revolving Credit Loans, and in connection with such master assignment each such other Lender may treat the assignment of Term SOFR Advances as a prepayment of such Term SOFR Advances for purposes of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">each such New Lender shall have delivered to the Administrative Agent    an Administrative Questionnaire and to the Administrative Agent and the Borrower all forms, if any, that are required to be delivered by such New Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(8)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">at least five Domestic Business Days prior to the effectiveness of such increase, if the Borrower qualifies as a &#8220;legal entity customer&#8221; under the Beneficial </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ownership Regulation, it shall have delivered, to each Lender that so requests, a Beneficial Ownership Certification&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(9)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">the Administrative Agent shall have received such other customary certificates, resolutions and opinions as the Administrative Agent shall have reasonably requested.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Prepayments of Loans</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Voluntary Prepayments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Borrower may, in its sole and absolute discretion, prepay Revolving Credit Loans, Competitive Bid Loans or Swing Line Loans, in whole or in part, without premium or penalty, but subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, at any time and from time to time, by notifying the Administrative Agent (which notice shall be in a form reasonably acceptable to the Administrative Agent) at least two Domestic Business Days, in the case of a prepayment of Term SOFR Advances, two Domestic Business Days, in the case of a prepayment of Competitive Bid Loans, or one Domestic Business Day, in the case of a prepayment of Swing Line Loans or ABR Advances, prior to the proposed prepayment date specifying (i) the Loans to be prepaid, (ii) the amount to be prepaid, and (iii) the date of prepayment. Upon receipt of each such notice, the Administrative Agent shall promptly notify each Lender thereof. Each such notice given by the Borrower pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be irrevocable, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, if a notice of prepayment  is given in connection with a conditional notice of termination of the Commitments, the Swing Line Commitment and the Letter of Credit Commitment as contemplated by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, then such   notice of prepayment may be revoked if such notice of termination is revoked in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and the Borrower shall indemnify the Lenders in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, if applicable. Each partial prepayment under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be (A) in the case of Term SOFR Advances, in a minimum amount of $5,000,000 or an integral multiple of $1,000,000 in excess thereof or the entire remaining amount of Term SOFR Advances, (B) in the case of ABR Advances, in a minimum amount of $1,000,000 or an integral multiple of $100,000 in excess thereof or the entire remaining amount of ABR Advances, (C) in the case of Swing Line Loans, in a minimum amount of $500,000 or an integral multiple of $100,000 in excess thereof or the entire remaining amount of Swing Line Loans, and (D) in the case of Competitive Bid Loans, in a minimum amount of $5,000,000 or an integral multiple of $1,000,000 in excess thereof or the entire remaining amount of Competitive Bid Loans.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Simultaneously with each prepayment hereunder, the Borrower shall prepay all accrued and unpaid interest on the amount prepaid through the date of prepayment and indemnify the Lenders in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, if applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Letter of Credit Sub-facility</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Subject to the terms and conditions hereof and the payment by the Borrower to   each Issuer of such fees as the Borrower and such Issuer shall have agreed in writing, each Issuer severally (and not jointly) agrees, in reliance on the agreement of the other Lenders set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to issue standby or commercial letters of credit (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and, collectively, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letters of Credit&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) during the Commitment Period for the account of the Borrower&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that immediately after the issuance of each Letter of Credit (i) the Letter of Credit Exposure of all Lenders shall not exceed the Aggregate Letter of Credit Commitment, (ii)   the Aggregate Credit Exposure shall not exceed the Aggregate Commitment Amount, (iii) the   Letter of Credit Exposure of such Issuer shall not exceed the Letter of Credit Commitment of such Issuer, and (iv) the Commercial Letter of Credit Exposure of such Issuer shall not exceed the Commercial Letter of Credit Commitment of such Issuer. Each Letter of Credit shall have an </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">expiration date which shall be not later than, in the case of standby Letters of Credit, the earlier to occur of one year from the date of issuance thereof or 5 days prior to the Commitment Termination Date and, in the case of commercial Letters of Credit, the earlier to occur of 180 days from the date of issuance thereof or 5 days prior to the Commitment Termination Date. No Letter of Credit shall be issued if the Administrative Agent, or any Lender by notice to the Administrative Agent, and    the proposed Issuer shall have determined, no later than 3&#58;00 P.M. one Domestic Business Day   prior to the requested date of issuance of such Letter of Credit, that the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> have not been satisfied or waived.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Each Letter of Credit shall be issued at the request of the Borrower in support of    an obligation of the Borrower or any Subsidiary in favor of a beneficiary who has requested the issuance of such Letter of Credit. The Borrower shall give the Administrative Agent a Letter of Credit Request for the issuance of each Letter of Credit by 12&#58;00 Noon at least two Domestic Business Days prior to the requested date of issuance. Such Letter of Credit Request shall specify   (i) whether such Letter of Credit is a standby or commercial Letter of Credit, (ii) the beneficiary of such Letter of Credit and the obligations of the Borrower or the Subsidiary in respect of which such Letter of Credit is to be issued, (iii) the Borrower&#8217;s proposal as to the conditions under which a drawing may be made under such Letter of Credit and the documentation to be required in respect thereof, (iv) the maximum amount to be available under such Letter of Credit, (v) the requested   date of issuance, and (vi) the name of the proposed Issuer thereof. Upon receipt of such Letter of Credit Request from the Borrower, the Administrative Agent shall promptly notify the applicable Issuer and each Lender thereof. Such Issuer shall, on the proposed date of issuance and subject to  the terms and conditions of this Agreement, issue the requested Letter of Credit&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that in   the event such Issuer fails to issue such Letter of Credit or is a Defaulting Lender, any other Issuer may (in its sole and absolute discretion, and notwithstanding that its Letter of Credit Exposure may exceed its Letter of Credit Commitment, but with (x) the consent of the Borrower and (y) notice to the Administrative Agent) issue such Letter of Credit otherwise in accordance with the terms  hereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that immediately after the issuance thereof (A) the Letter of Credit Exposure of all Lenders shall not exceed the Aggregate Letter of Credit Commitment, and (B) the Aggregate Credit Exposure shall not exceed the Aggregate Commitment Amount. Each Letter of Credit shall be in form and substance reasonably satisfactory to the Issuer thereof, with such provisions with respect to the conditions under which a drawing may be made thereunder and the documentation required in respect of such drawing as such Issuer shall reasonably require. Each Letter of Credit shall be used solely for the purposes described therein. Each Letter of Credit Request and each Letter of Credit shall be subject to the standard terms and conditions for letters    of credit of the Issuer thereof (each as amended, supplemented or replaced from time to time, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Reimbursement Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) executed by the Borrower and delivered to such Issuer.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Each payment by an Issuer of a drawing under a Letter of Credit issued thereby  shall give rise to the obligation of the Borrower to promptly (and in any event within one Domestic Business Day) reimburse such Issuer for the amount thereof (together with any interest). Such  Issuer shall promptly notify the Borrower of such payment by such Issuer of a drawing under a Letter of Credit. In lieu of such notice, if the Borrower has not made reimbursement prior to the   end of the Domestic Business Day following the day during which such Issuer made such payment of such drawing, the Borrower hereby authorizes such Issuer to deduct the amount of any such reimbursement from such account(s) as the Borrower may from time to time designate in writing    to such Issuer, upon which such Issuer shall apply the amount of such deduction to such reimbursement. If all or any portion of any Reimbursement Obligation in respect of a Letter of Credit shall not be paid on the date that the Issuer thereof shall have made payment of a drawing under such Letter of Credit, the amount of such Reimbursement Obligation shall bear interest, at a rate per annum equal to the Alternate Base Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Applicable Margin applicable to ABR </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Advances, from the date such Issuer made such payment of such drawing until the end of the Domestic Business Day following the day during which such Issuer made such payment of such drawing (whether at the stated maturity thereof, by acceleration or otherwise), and from and after such Domestic Business Day (whether at the stated maturity thereof, by acceleration or otherwise), such Reimbursement Obligation shall bear interest, payable upon demand, at a rate per annum equal to the Alternate Base Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Applicable Margin applicable to ABR Advances </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 2%, from such due date until paid in full (whether before or after the entry of a judgment thereon).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">In the event of any conflict between the terms hereof and the terms of any Reimbursement Agreement or Letter of Credit Application, the terms hereof shall control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Letter of Credit Participation</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Each Lender hereby unconditionally and irrevocably, severally (and not jointly) takes an undivided participating interest in the obligations of each Issuer under and in connection with each Letter of Credit issued thereby in an amount equal to such Lender&#8217;s Commitment Percentage (as in effect from time to time) of the amount of such Letter of Credit. Each Lender   shall be liable to each Issuer for its Commitment Percentage of the unreimbursed amount of any drawing honored under each Letter of Credit issued thereby. Each Lender shall also be liable for    an amount equal to the product of its Commitment Percentage and any amounts paid by the Borrower pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that are subsequently rescinded or avoided, or must otherwise be restored or returned. Such liabilities shall be unconditional and without regard to the occurrence of any Default or the compliance by the Borrower with any of its obligations under the Loan Documents.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Each Issuer shall promptly notify the Administrative Agent, and the    Administrative Agent shall promptly notify each Lender (which notice shall be promptly confirmed in writing), of the date and the amount of each drawing paid under each Letter of Credit issued by such Issuer with respect to which full reimbursement payment shall not have been made by the Borrower as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and forthwith upon receipt of such notice, such Lender   shall promptly make available to the Administrative Agent for the account of such Issuer its Commitment Percentage of the amount of such unreimbursed drawing at the office of the Administrative Agent specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> in Dollars and in immediately available funds. The Administrative Agent shall distribute the payments made by each Lender pursuant to the immediately preceding sentence to such Issuer promptly upon receipt thereof in like funds as received. Each Lender shall indemnify and hold harmless the Administrative Agent and each Issuer from and against any and all losses, liabilities (including liabilities for penalties), actions, suits, judgments, demands, costs and expenses (including, without limitation, reasonable attorneys&#8217; fees and expenses) resulting from any failure on the part of such Lender to provide, or from any delay    in providing, the Administrative Agent with such Lender&#8217;s Commitment Percentage of the amount of any payment made by such Issuer under a Letter of Credit issued by such Issuer in accordance with this clause (b) (except in respect of losses, liabilities or other obligations suffered by the Administrative Agent or such Issuer, as the case may be, resulting from the gross negligence or willful misconduct of the Administrative Agent or such Issuer, as the case may be). If a Lender   does not make available to the Administrative Agent when due an amount equal to such Lender&#8217;s Commitment Percentage of any unreimbursed payment made by an Issuer under a Letter of Credit issued thereby, such Lender shall be required to pay interest to the Administrative Agent for the account of such Issuer on the unpaid portion of such amount at a rate of interest per annum equal    to (i) from the date such Lender should have made such amount available until the third day therefrom, the Federal Funds Effective Rate, and (ii) thereafter, the Federal Funds Effective Rate </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 2%, in each case payable upon demand by such Issuer. The Administrative Agent shall distribute such interest payments to such Issuer upon receipt thereof in like funds as received.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Whenever the Administrative Agent is reimbursed by the Borrower, for the   account of an Issuer, for any payment under a Letter of Credit issued thereby and such payment relates to an amount previously paid by a Lender in respect of its Commitment Percentage of the amount of such payment under such Letter of Credit, the Administrative Agent (or such Issuer, if such payment by a Lender was paid by the Administrative Agent to such Issuer) will promptly pay over such payment to such Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Absolute Obligation with respect to Letter of Credit Payments</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower&#8217;s obligation to reimburse the Administrative Agent for the account of an Issuer for each payment under or in respect of each Letter of Credit issued thereby shall be absolute and unconditional under any and all circumstances and irrespective of any set-off, counterclaim or defense to payment which the Borrower may have or have had against the beneficiary of such Letter of Credit, the Administrative Agent, such Issuer, the Swing Line Lender, any Lender or any other Person, including, without limitation, any defense based on the failure of any drawing to conform to the terms of such Letter of Credit, any drawing document proving to be forged, fraudulent or invalid, or the legality, validity, regularity or enforceability of such Letter of Credit&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that, with respect to any Letter of Credit, the foregoing  shall not relieve the Issuer thereof of any liability it may have to the Borrower for any actual damages sustained by the Borrower arising from a wrongful payment (or failure to pay) under such Letter of Credit made as a result of such Issuer&#8217;s gross negligence or willful misconduct.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Notes</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any Lender may request that the Loans made by it be evidenced by a Note. In such event, the Borrower shall prepare, execute and deliver to such Lender a Note payable to such Person or, if requested  by such Person, such Person and its registered assigns.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Extension of Commitment Termination Date</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Request for Extension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Borrower may, in its sole and absolute discretion, by notice to the Administrative Agent (which shall promptly notify the Lenders) not more than 90   days and not less than 30 days prior to each of the first, second, third, fourth, fifth, sixth and, if the Borrower shall have exercised one such right to extend the Commitment Termination Date, seventh  anniversary of the Effective Date (each such anniversary date, an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Extension Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), request (each, an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Extension Request</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) that the Lenders extend the Commitment Termination Date then in effect (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Existing Commitment Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) for an additional one-year period, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that  the Borrower may only effect two such extensions of the Commitment Termination Date. Each Lender, acting in its sole discretion, shall, by notice to the Borrower and the Administrative Agent given not later than the 20th day (or such later day as shall be acceptable to the Borrower) following the date of the Borrower&#8217;s notice, advise the Borrower and the Administrative Agent whether or   not such Lender agrees to such extension&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any Lender (which includes each Issuer   and the Swing Line Lender) that does not so advise the Borrower and the Administrative Agent  shall be deemed to have rejected such Extension Request. The election of any Lender to agree to such extension shall not obligate any other Lender to so agree.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Replacement of Non-Extending Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Borrower shall have the right at any time on or prior to the relevant Extension Date to replace any Lender which has not consented to   the Extension Request (each, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Non-Extending Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Conditions to Effectiveness of Extension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding anything in this Agreement to the contrary, the extension of the Existing Commitment Termination Date on any Extension Date shall not be effective unless, immediately before and immediately after giving   effect to such extension on such Extension Date&#58; (i) no Default shall have occurred and be continuing on such Extension Date and the representations and warranties contained in this Agreement shall be true and correct in all material respects with the same effect as though such representations and warranties had been made on such Extension Date (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that any representation and warranty that is qualified as to &#8220;materiality&#8221;, &#8220;Material Adverse&#8221; or similar language shall be true and correct (after giving effect to any qualification therein) in all respects on such Extension Date), except those which are expressly specified to be made as of an earlier date, and the Administrative Agent shall have received a certificate, in form and substance reasonably satisfactory to the Administrative Agent, to such effect from an Authorized Officer of the Borrower (or such other financial officer reasonably acceptable to the Administrative Agent), and (ii) the Administrative Agent shall have received such other customary certificates, resolutions and  opinions as the Administrative Agent may reasonably request.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Effectiveness of Extension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If (and only if) the conditions specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">2.12(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall have been satisfied or waived with respect to the extension of the Existing  Commitment Termination Date on the applicable Extension Date, then, effective as of such Extension Date, the Commitment Termination Date, with respect to the Commitment of each  Lender that has agreed to so extend its Commitment and of each Replacement Lender that has assumed a Commitment of a Non-Extending Lender in connection with such Extension Request, shall be extended to the date falling one year after the Existing Commitment Termination Date (or,  if such date is not a Domestic Business Day, the immediately preceding Domestic Business Day), and each such Replacement Lender shall thereupon become a &#8220;Lender&#8221; for all purposes of this Agreement. Notwithstanding anything herein to the contrary, (i) with respect to any portion of the Commitment of any Non-Extending Lender that has not been fully assumed by one or more Replacement Lenders, the Commitment Termination Date for such Lender with respect to such   non-assumed portion of its Commitment shall remain unchanged, and (ii) with respect to any Loans of such Lender that have not been purchased by one or more Replacement Lenders, the applicable maturity date with respect to such non-purchased Loans shall remain unchanged and shall be repayable by the Borrower on such applicable maturity date without there being any requirement that any such repayment be shared with other Lenders. In addition, on the Extension Date, the Borrower agrees to pay all accrued and unpaid interest, fees and other amounts then due under this Agreement from the Borrower to each Lender consenting to the Extension Request, each            Non-Extending Lender and each Replacement Lender. Solely for the purpose of calculating break funding payments under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the assignment by any Non-Extending Lender of any Term SOFR Advance prior to the last day of the Interest Period applicable thereto in accordance with    this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be deemed to constitute a prepayment by the Borrower of such Term SOFR Advance.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Defaulting Lenders</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding any provision of this Agreement to the contrary, if any Lender becomes a Defaulting Lender, then the following provisions shall apply for so long as such Lender is a Defaulting Lender&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Facility Fees shall cease to accrue, and shall not be payable, on the unfunded  portion of the Commitment of such Defaulting Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">the Commitment and Credit Exposure of such Defaulting Lender shall not be included in determining whether all Lenders or the Required Lenders have taken or may take any action hereunder (including any consent to any amendment or waiver pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, notwithstanding the foregoing, any waiver, amendment or modification with respect to the following shall require the consent of such Defaulting Lender&#58; (i) any waiver, amendment or modification requiring the consent of all Lenders or each affected Lender which affects such Defaulting Lender in a manner that is materially adverse in comparison to the other affected Lenders, (ii) any waiver, amendment or modification increasing the Commitment of such  Defaulting Lender, (iii) any waiver, amendment or modification extending the Commitment Period with respect to such Defaulting Lender, (iv) any waiver, amendment or modification reducing the principal amount owed under the Loan Documents to such Defaulting Lender (other than by payment thereof), or (v) any waiver, amendment or modification extending the final maturity of sums owed to such Defaulting Lender, or (vi) a modification of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.13(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">if any Swing Line Exposure or Letter of Credit Exposure exists at the time a Lender becomes a Defaulting Lender then&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">all or any part of such Defaulting Lender&#8217;s Swing Line Exposure and   Letter of Credit Exposure shall be reallocated among the non-Defaulting Lenders in accordance with their respective Commitment Percentages but only to the extent that (A)  the sum of all non-Defaulting Lenders&#8217; Committed Credit Exposures </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, without duplication, the amount of such Defaulting Lender&#8217;s Swing Line Exposure and Letter of Credit Exposure reallocated to such non-Defaulting Lenders, does not exceed the total of   all non-Defaulting Lenders&#8217; Commitments and (B) with respect to each non-Defaulting Lender, the sum of such non-Defaulting Lender&#8217;s Committed Credit Exposure </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,   without duplication, the amount of such Defaulting Lender&#8217;s Swing Line Exposure and Letter of Credit Exposure reallocated to such non-Defaulting Lender, does not exceed such non-Defaulting Lender&#8217;s Commitment&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">if the reallocation described in clause (1) above cannot, or can only partially, be effected, the Borrower shall within one Domestic Business Day following notice by the Administrative Agent (A) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, prepay such Swing Line Exposure and (B) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, cash collateralize such Defaulting Lender&#8217;s Letter of Credit Exposure (after giving effect to any partial reallocation pursuant to clause (1) above) in a manner reasonably satisfactory to the Administrative Agent and the Issuers of the Letters of Credit of which shall be outstanding at such time for so long as such Letter of Credit Exposure is outstanding&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">if the Borrower cash collateralizes any portion of such Defaulting Lender&#8217;s Letter of Credit Exposure pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.13(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Borrower shall not be required to pay any Letter of Credit Participation Fees to such Defaulting Lender pursuant  to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> with respect to such Defaulting Lender&#8217;s Letter of Credit Exposure during the period such Defaulting Lender&#8217;s Letter of Credit Exposure is cash collateralized&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">if the Swing Line Exposure or Letter of Credit Exposure of such   Defaulting Lender is reallocated pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.13(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, then the fees payable to  the Lenders pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline"> Section 3.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be adjusted to give effect to  such reallocation, and the Administrative Agent shall promptly notify the Lenders of any reallocation described in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.13(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">so long as any Lender is a Defaulting Lender, the Swing Line Lender shall not be required to fund any Swing Line Loan and no Issuer shall be required to issue, amend, extend or increase any Letter of Credit, unless it is satisfied that the related exposure will be 100% covered   by the Commitments of the non-Defaulting Lenders and&#47;or cash collateral will be provided by the Borrower in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.13(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and participating interests in any such newly issued, amended, extended or increased Letter of Credit or newly funded Swing Line Loan shall be allocated among non-Defaulting Lenders in a manner consistent with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.13(c)(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (and Defaulting Lenders shall not participate therein)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">any amount payable to such Defaulting Lender hereunder (whether on account of principal, interest, fees or otherwise and including any amount that would otherwise be payable to such Defaulting Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> but excluding </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and other than any amount constituting Facilities Fees or Letter of Credit Participation Fees which are not payable to such Defaulting Lender in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 2.13(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">2.13(c)(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) shall, in lieu of being distributed to such Defaulting Lender, be retained by the Administrative Agent in a segregated account and, subject to any applicable requirements of law, be applied at such time or times as may be determined by the Administrative Agent (i) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment of any amounts owing by such Defaulting Lender to the Administrative Agent hereunder, (ii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, pro rata, to the payment of any amounts owing by such Defaulting Lender to the Issuers and the Swing Line Lender hereunder, (iii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">third</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, if so determined by the Administrative Agent and the Borrower or if requested by any Issuer or the Swing Line Lender, held in such account as cash collateral for future funding obligations of the Defaulting Lender in respect of any existing or future participating interest in any Swing Line Loan or Letter of Credit, (iv) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">fourth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the funding of any Revolving Credit Loan (including any Mandatory Borrowing) in respect of which such Defaulting Lender has failed to   fund its portion thereof as required by this Agreement, as determined by the Administrative Agent, (v) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">fifth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, if so determined by the Administrative Agent and the Borrower, held in such account as cash collateral for future funding obligations of the Defaulting Lender in respect of any Revolving Credit Loans (including any Mandatory Borrowings) under this Agreement, (vi) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">sixth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment of any amounts owing to the Lenders, the Issuers or the Swing Line Lender as a result of any final and non-appealable judgment of a court of competent jurisdiction obtained by any Lender, any Issuer or the Swing Line Lender against such Defaulting Lender as a result of such Defaulting Lender&#8217;s breach of its obligations under this Agreement, (vii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">seventh</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment of any amounts owing to the Borrower as a result of any final and non-appealable judgment of a court of competent jurisdiction obtained by the Borrower against such Defaulting Lender as a result of such Defaulting Lender&#8217;s breach of its obligations under this Agreement, and (viii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">eighth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to such Defaulting Lender or as otherwise directed by a court of competent jurisdiction&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if  such payment is (x) a prepayment of the principal amount of any Revolving Credit Loan (including any Mandatory Borrowing) or Reimbursement Obligations in respect of drawings under Letters of Credit paid by an Issuer with respect to which a Defaulting Lender has funded its participation obligations and (y) made at a time when the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> are satisfied or waived, such payment shall be applied solely to prepay the Revolving Credit Loans (including Mandatory Borrowings) of, and Reimbursement Obligations owed to, all non-Defaulting Lenders pro rata prior to being applied to the prepayment of any Loans, or Reimbursement Obligations owed to, any Defaulting Lender&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.02pt">the Borrower shall have the right at any time during which a Lender is a Defaulting Lender to replace such Defaulting Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, no reallocation pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.13(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall   constitute a waiver or release of any claim of any party hereunder against a Defaulting Lender </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">arising from a Lender having become a Defaulting Lender, including any claim of a non-Defaulting Lender as a result of such non-Defaulting Lender&#8217;s increased exposure following such reallocation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">ESG Adjustments</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Borrower, in consultation with the Sustainability Coordinator, shall be   entitled, in its sole discretion, to establish specified key performance indicators (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">KPIs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) with respect to certain environmental, social and governance (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">ESG</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) targets of the Borrower and its Subsidiaries.  The Sustainability Coordinator and the Borrower, with the consent of the Required Lenders, may amend this Agreement (such amendment, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">ESG Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) solely for the purpose of incorporating the KPIs and other related provisions (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">ESG Pricing Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) into this Agreement.  Upon the effectiveness of any such ESG Amendment, based on the Borrower&#8217;s performance against the KPIs, certain adjustments (increase, decrease or no adjustment) (such adjustments, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">ESG Applicable Margin Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) to the otherwise applicable Applicable Margin for Term SOFR Advances, ABR Advances, Letter of Credit Participation Fees, and the Facility Fee may be made&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the amount of such adjustments shall not exceed (i) in the case of the Applicable Margin for the Facility Fee, an increase and&#47;or decrease of 0.005% for any one KPI, or 0.01% in the aggregate for all KPIs and (ii) in the case of the Applicable Margin for Term SOFR Advances, ABR Advances, and Letter of Credit Participation Fees, an increase and&#47;or decrease of 0.02% for any one KPI, or 0.04% in the aggregate for all KPIs&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, in no event shall the Applicable Margin for Term SOFR Advances, ABR Advances, Letter of Credit Participation Fees, or the Facility Fee be less than zero.  The KPIs, the Borrower&#8217;s performance against the KPIs, and any related ESG Applicable Margin Adjustments resulting therefrom, will be determined based on certain certificates, reports and other documents, in each case, setting forth    the calculation and measurement of the KPIs in a manner that is aligned with the Sustainability Linked Loan Principles and to be mutually agreed between the Borrower and the Sustainability Coordinator (each acting reasonably).  Following the effectiveness of an ESG Amendment, any modification to the ESG Pricing Provisions shall be subject only to the consent of the Required Lenders so long as such modification does not have the effect of reducing the Applicable Margin   for Term SOFR Advances, ABR Advances, Letter of Credit Participation Fees, or the Facility Fee  to a level not otherwise permitted by this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.14(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">The Sustainability Coordinator will (i) assist the Borrower in determining the ESG Pricing Provisions in connection with the ESG Amendment and (ii) assist the Borrower in preparing informational materials focused on ESG to be used in connection with the ESG Amendment.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">This </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall supersede any provisions in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> to the contrary.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">PROCEEDS, PAYMENTS, CONVERSIONS, INTEREST, YIELD PROTECTION AND FEES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Disbursement of the Proceeds of the Loans</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall disburse the proceeds of the Loans (other than the Swing Line Loans) at its office specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> by crediting to the Borrower&#8217;s general deposit account with    the Administrative Agent the funds received from each Lender. Unless the Administrative Agent shall have received prior notice from a Lender (by telephone or otherwise, such notice to be confirmed by fax, email   or other writing) that such Lender will not make available to the Administrative Agent such Lender&#8217;s Commitment Percentage of the Revolving Credit Loans, or the amount of any Competitive Bid Loan, to be made by it on a Borrowing Date, the Administrative Agent may assume that such Lender has made such amount available to the Administrative Agent on such Borrowing Date in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, in the case of a Revolving Credit Loan, such Lender received notice thereof from the Administrative Agent in accordance with the terms hereof, and the Administrative Agent may, in reliance upon such assumption, make available to the Borrower on such Borrowing Date a corresponding amount.    If and to the extent that such Lender shall not have so made such amount available to the Administrative Agent, such Lender and the Borrower severally agree to pay to the Administrative Agent, forthwith on demand, such corresponding amount (to the extent not previously paid by the other), together with interest thereon for each day from the date such amount is made available to the Borrower until the date such  amount is paid to the Administrative Agent, at a rate per annum equal to, in the case of the Borrower, the applicable interest rate set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.4(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and, in the case of such Lender, the Federal Funds  Effective Rate from the date such payment is due until the third day after such date and, thereafter, at the Federal Funds Effective Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 2%. Any such payment by the Borrower shall be without prejudice to its rights against such Lender. If such Lender shall pay to the Administrative Agent such corresponding  amount, such amount so paid shall constitute such Lender&#8217;s Loan as part of such Loans for purposes of this Agreement, which Loan shall be deemed to have been made by such Lender on the Borrowing Date applicable to such Loans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Payments</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Each payment, including each prepayment, of principal and interest on the Loans and of the Facility Fee and the Letter of Credit Participation Fee (collectively, together with all of the other fees to be paid to the Administrative Agent, the Lenders, the Issuers and the Swing Line Lender in connection with, and pursuant to the terms of, the Loan Documents, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Fees&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), and of all of the other amounts to be paid to the Administrative Agent and the Lenders in connection with, and pursuant to the terms of, the Loan Documents (other than amounts payable to a Lender under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) shall be made by the Borrower to the Administrative Agent at its office specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> without condition, recoupment, defense, setoff, deduction or counterclaim in funds immediately available in New   York by 3&#58;00 P.M. on the due date for such payment. The failure of the Borrower to make any such payment by such time shall not constitute a default hereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such payment is made on such due date, but any such payment made after 3&#58;00 P.M. on such due date shall be deemed to have been made on the next Domestic Business Day for the purpose of calculating interest on amounts outstanding on the Loans. If the Borrower has not made any such payment prior to 3&#58;00 P.M., the Borrower hereby authorizes the Administrative Agent to deduct the amount of any such payment from such account(s) as the Borrower may from time to time designate in writing to the Administrative Agent, upon which the Administrative Agent shall apply the amount of such deduction to such payment. Promptly upon receipt thereof by the Administrative Agent, each payment of principal and interest on the&#58; (i) Revolving Credit Loans shall be remitted by the Administrative Agent in like funds as received to each Lender (a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, pro rata according to the amount of interest which is then due and payable to the Lenders, and (b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, pro rata according to the amount of principal which is then due and payable to the Lenders, (ii) Competitive Bid Loans shall be remitted by the Administrative Agent in like funds as received to each applicable Lender and (iii) Swing Line Loans shall be remitted by the Administrative Agent in like funds as received  to the Swing Line Lender. Each payment of the Facility Fee and the Letter of Credit Participation Fee payable to the Lenders shall be promptly transmitted by the Administrative Agent in like funds as received to each Lender pro rata according to such Lender&#8217;s Commitment Amount or, if the Commitments shall have terminated or been terminated, according to the outstanding principal amount of such Lender&#8217;s Revolving Credit Loans.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">If any payment hereunder or under the Loans shall be due and payable on a day which is not a Domestic Business Day the due date thereof (except as otherwise provided in the definition of Term SOFR Interest Period or Competitive Interest Period) shall be extended to the </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">next Domestic Business Day and (except with respect to payments in respect of the Facility Fee   and the Letter of Credit Participation Fee) interest shall be payable at the applicable rate specified herein during such extension.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Unless the Administrative Agent shall have received notice from the Borrower  prior to the date on which any payment is due to the Administrative Agent for the account of the Lenders or any of the Issuers hereunder that the Borrower will not make such payment, the Administrative Agent may assume that the Borrower has made such payment on such date in accordance herewith and may, in reliance upon such assumption, distribute to the applicable  Lenders or the applicable Issuers, as the case may be, the amount due.  With respect to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any payment that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Administrative Agent makes for the account of the Lenders or any of the Issuers hereunder as to which the Administrative Agent determines (which determination shall be conclusive absent manifest error) that any of the following applies (such payment referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Rescindable Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#58; (1) the Borrower has not in fact made such payment&#59; (2) the Administrative Agent has made a payment in excess of the amount so paid by the Borrower (whether or not then owed)&#59; or   (3) the Administrative Agent has for any reason otherwise erroneously made such payment&#59; then each of the Lenders or the applicable Issuers, as the case may be, severally agrees to repay to the Administrative Agent forthwith on demand the Rescindable Amount so distributed to such Lender  or such Issuer, in immediately available funds with interest thereon, for each day from and  including the date such amount is distributed to it to but excluding the date of payment to the Administrative Agent, at the greater of the Federal Funds Effective Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Conversions&#59; Other Matters</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Borrower may elect at any time and from time to time to Convert one or more Term SOFR Advances to an ABR Advance by giving the Administrative Agent at least one Domestic Business Day&#8217;s prior irrevocable notice of such election (in the form of a Borrowing Request), specifying the amount to be so Converted. In addition, the Borrower may elect at any   time and from time to time to Convert an ABR Advance to any one or more new Term SOFR Advances or to Convert any one or more existing Term SOFR Advances to any one or more new Term SOFR Advances by giving the Administrative Agent no later than 10&#58;00 A.M. at least two Domestic Business Days&#8217; prior irrevocable notice of such election (in the form of a Borrowing Request), specifying the amount to be so Converted and the initial Interest Period relating thereto&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any Conversion of an ABR Advance to an Term SOFR Advance shall only be made  on a Domestic Business Day&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, notwithstanding the foregoing, a Borrowing Request for a Conversion delivered by the Borrower may state that such Borrowing Request is conditioned upon the effectiveness of other credit facilities or transactions (such Borrowing   Request to specify the proposed effective date), in which case such Borrowing Request may be revoked by the Borrower (by notice to the Administrative Agent prior to the day specified for such Conversion in such Borrowing Request) if such condition is not satisfied and the Borrower shall indemnify the Lenders in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, if applicable. The Administrative Agent   shall promptly provide the Lenders with notice of each such election. Each Conversion of Loans shall be made pro rata according to the outstanding principal amount of the Loans of each Lender. ABR Advances and Term SOFR Advances may be Converted pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> in whole or in part&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the amount to be Converted to each Term SOFR Advance, when aggregated with any Term SOFR Advance to be made on such date in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and having the same Interest Period as such first Term SOFR Advance, shall equal no less than $10,000,000    or an integral multiple of $1,000,000 in excess thereof or the entire remaining amount of the Term SOFR Advances.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Notwithstanding anything in this Agreement to the contrary, the Borrower shall    not have the right to elect to Convert any existing ABR Advance to a Term SOFR Advance or to Convert any existing Term SOFR Advance to a new Term SOFR Advance if (i) a Default or an Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(h),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall then exist, or (ii) any other Event of Default shall then exist and the Administrative Agent   shall have notified the Borrower at the request of the Required Lenders that no ABR Advance or Term SOFR Advance may be Converted to a new Term SOFR Advance. In such event, such ABR Advance shall be automatically continued as an ABR Advance or such Term SOFR Advance shall be automatically Converted to an ABR Advance on the last day of the Interest Period applicable to such Term SOFR Advance. The foregoing shall not affect any other rights or remedies that the Administrative Agent or any Lender may have under this Agreement or any other Loan Document.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Each Conversion shall be effected by each Lender by applying the proceeds of   each new ABR Advance or Term SOFR Advance, as the case may be, to the existing ABR Advance or Term SOFR Advance (or portion thereof) being Converted (it being understood that such Conversion shall not constitute a borrowing for purposes of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Notwithstanding any other provision of any Loan Document&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">if the Borrower shall have failed to elect a Term SOFR Advance under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as the case may be, in connection with any borrowing of  new Revolving Credit Loans or expiration of an Interest Period with respect to any existing Term SOFR Advance, the amount of the Revolving Credit Loans subject to such borrowing or such existing Term SOFR Advance shall thereafter be an ABR Advance until such time, if any, as the Borrower shall elect a new Term SOFR Advance pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">the Borrower shall not be permitted to select a Term SOFR Advance the Interest Period in respect of which ends later than the Commitment Termination Date or such earlier date upon which all of the Commitments shall have been terminated in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">the Borrower shall not be permitted to have more than (x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">15 Term SOFR Advances and (y) 15 Competitive Bid Loans outstanding at any one time&#59; it being understood and agreed that each borrowing of Term SOFR Advances or Competitive Bid Loans pursuant to a single Borrowing Request or Competitive Bid Request, as the case   may be, shall constitute the making of one Term SOFR Advance or Competitive Bid Loan for the purpose of calculating such limitation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Interest Rates and Payment Dates.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Prior to Maturity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Except as otherwise provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.4(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">3.4(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Loans shall bear interest on the unpaid principal balance thereof at the applicable interest rate or rates per annum set forth below&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.956%"><tr><td style="width:1.0%"></td><td style="width:36.809%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:60.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#d9d9d9;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">LOANS</font></td><td colspan="3" style="background-color:#d9d9d9;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">RATE</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Revolving Credit Loans constituting ABR Advances</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Alternate Base Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the Applicable Margin.</font></div></td></tr></table></div><div><font><br></font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.800%"><tr><td style="width:1.0%"></td><td style="width:36.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:61.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Revolving Credit Loans constituting Term SOFR Advances</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Term SOFR applicable thereto </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the Applicable Margin.</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Competitive Bid Loans</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Fixed rate of interest applicable thereto accepted by the Borrower pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.4(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Swing Line Loans</font></td><td colspan="3" style="border-bottom:0.5pt solid #000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Negotiated Rate applicable thereto as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.2(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (or if not available, the Term SOFR Daily Floating Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the Applicable Margin).</font></div></td></tr></table></div><div style="margin-bottom:12pt;margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Late Payment Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Any payment of principal or interest on the Loans, Fees or  other amounts payable by the Borrower under the Loan Documents not paid on the date when due and payable shall, after the occurrence and during the continuance of an Event of Default pursuant  to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, bear interest, in the case of principal or interest on    a Loan, at the applicable interest rate on such Loan </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 2% per annum and, in the case of any Fees or other amounts, at the Alternate Base Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Applicable Margin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 2% per annum, in  each case from the due date thereof until the date such payment is made (whether before or after   the entry of any judgment thereon).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Highest Lawful Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding anything to the contrary contained in this Agreement, at no time shall the interest rate payable to any Lender on any of its Loans, together  with the Fees and all other amounts payable hereunder to such Lender to the extent the same constitute or are deemed to constitute interest, exceed the Highest Lawful Rate. If, in respect of any period during the term of this Agreement, any amount paid to any Lender hereunder, to the extent the same shall (but for the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) constitute or be deemed to constitute interest, would exceed the maximum amount of interest permitted by the Highest Lawful Rate during such period (such amount being hereinafter referred to as an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Unqualified Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), then  (i) such Unqualified Amount shall be applied or shall be deemed to have been applied as a prepayment of the Loans of such Lender, and (ii) if, in any subsequent period during the term of   this Agreement, all amounts payable hereunder to such Lender in respect of such period which constitute or shall be deemed to constitute interest shall be less than the maximum amount of  interest permitted by the Highest Lawful Rate during such period, then the Borrower shall pay to such Lender in respect of such period an amount (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Compensatory Interest Payment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) equal to the lesser of (x) a sum which, when added to all such amounts, would equal the maximum amount of interest permitted by the Highest Lawful Rate during such period, and (y) an amount equal to    the aggregate sum of all Unqualified Amounts </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">less</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> all other Compensatory Interest Payments.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Interest shall be payable in arrears on each Interest Payment Date, on the Commitment Termination Date, to the extent provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, upon each prepayment of the Loans and, to the extent provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.12(d), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">on the Extension Date. Any change in the interest rate on the Loans resulting from an increase or a decrease in the Alternate Base Rate or any reserve requirement shall become effective as of the opening of business on the day on which such change shall become effective.  Each determination by the Administrative Agent of the Alternate Base Rate, Term SOFR and the Competitive Bid Rate pursuant to this Agreement shall be conclusive and binding on the Borrower absent manifest error. The Borrower acknowledges that to the extent interest payable on the Loans is based on the Alternate Base Rate, such rate is only one   of the bases for computing interest on loans made by the Lenders, and by basing interest payable    on ABR Advances on the Alternate Base Rate, the Lenders have not committed to charge, and the Borrower has not in any way bargained for, interest based on a lower or the lowest rate at which    the Lenders may now or in the future make extensions of credit to other Persons. All interest (other </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">than interest calculated with reference to the Alternate Base Rate) shall be calculated on the basis   of a 360-day year for the actual number of days elapsed, and all interest determined with reference  to the Alternate Base Rate shall be calculated on the basis of a 365&#47;366-day year for the actual number of days elapsed.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">No Warranty</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> The Administrative Agent does not warrant, nor accept   responsibility for, nor shall the Administrative Agent have any liability with respect to, the administration, submission or any other matter related to any reference rate referred to herein or  with respect to any rate (including, for the avoidance of doubt, the selection of such rate and any related spread or other adjustment) that is an alternative or replacement for or successor to any such rate (including, without limitation, any Successor Rate) (or any component of any of the foregoing) or the effect of any of the foregoing, or of any Conforming Changes&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the foregoing shall not apply to any liability arising out of the bad faith, willful misconduct or gross negligence    of the Administrative Agent.  The Administrative Agent and its affiliates or other related entities may engage in transactions or other activities that affect any reference rate referred to herein, or   any alternative, successor or replacement rate (including, without limitation, any Successor Rate)  (or any component of any of the foregoing) or any related spread or other adjustments thereto, in each case, in a manner adverse to the Borrower.&#160; The Administrative Agent may select information sources or services in its reasonable discretion to ascertain any reference rate referred to herein or any alternative, successor or replacement rate (including, without limitation, any Successor Rate)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or any component of any of the foregoing), in each case pursuant to the terms of this Agreement, and shall have no liability to the Borrower, any Lender or any other person or entity for damages    of any kind, including direct or indirect, special, punitive, incidental or consequential damages, costs, losses or expenses (whether in tort, contract or otherwise and whether at law or in equity),    for any error or other action or omission related to or affecting the selection, determination, or calculation of any rate (or component thereof) provided by any such information source or service&#59; provided that the foregoing shall not apply to any liability arising out of the bad faith, willful misconduct or gross negligence of the Administrative Agent.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Indemnification for Loss</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding anything contained herein to the contrary, if&#58; (i) the Borrower shall fail to borrow   a Term SOFR Advance or if the Borrower shall fail to Convert all or any portion of any Revolving Credit Loan constituting an ABR Advance to a Term SOFR Advance after it shall have given notice to do so in which it shall have requested a Term SOFR Advance pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as the case   may be, (ii) the Borrower shall fail to borrow a Competitive Bid Loan after it shall have accepted any offer with respect thereto in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, (iii) a Term SOFR Advance or Competitive Bid Loan shall be terminated for any reason prior to the last day of the Interest Period applicable thereto, (iv) any repayment or prepayment of the principal amount of a Term SOFR Advance or Competitive Bid Loan is made for any reason on a date which is prior to the last day of the Interest Period applicable thereto, (v) the Borrower shall have revoked a notice of prepayment or notice of termination of the Commitments and the Letter of Credit Commitment that was conditioned upon the effectiveness of other credit facilities or transactions pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, or (vi) a Term SOFR Advance is assigned other than on the last day of the Interest Period applicable thereto as a result of an increase in the Aggregate Commitment Amount pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or a replacement of a Lender pursuant to clause (x) or (z) of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, then the Borrower agrees to indemnify each Lender against, and to pay on demand directly to such Lender the amount (calculated by such Lender using any method chosen by such Lender which is customarily used by such Lender for such purpose for borrowers similar to the Borrower) equal to any loss or expense suffered by such Lender as a result of such failure to borrow or Convert, or such termination, repayment, prepayment or revocation, including any loss, cost or expense suffered by such Lender in liquidating or employing deposits acquired to fund or maintain the funding of such Term SOFR Advance or Competitive </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Bid Loan, as the case may be, or redeploying funds prepaid or repaid, in amounts which correspond to such Term SOFR Advance or Competitive Bid Loan, as the case may be, and any reasonable internal processing charge customarily charged by such Lender in connection therewith for borrowers similar to the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Reimbursement for Costs, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If at any time or from time to time there shall occur a Regulatory Change and any Issuer or any Lender shall have reasonably determined that such Regulatory Change (i) shall have had or will thereafter have the effect of reducing (A) the rate of return on such Issuer&#8217;s or such Lender&#8217;s capital or liquidity or    the capital or liquidity of any Person directly or indirectly owning or controlling such Issuer or such Lender (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Control Person&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), or (B) the asset value (for capital or liquidity purposes) to such Issuer, such Lender or such Control Person, as applicable, of the Reimbursement Obligations, or any participation therein, or the Loans, or any participation therein, in any case to a level below that which such Issuer, such Lender or such Control Person could have achieved or would thereafter be able to achieve but for such Regulatory Change (after taking into account such Issuer&#8217;s, such Lender&#8217;s or such Control Person&#8217;s policies regarding capital or liquidity), (ii) will impose, modify or deem applicable any reserve, asset, special deposit or special assessment requirements on Term SOFR Advances, or (iii) will subject such Issuer, such Lender or such Control Person, as applicable, to any tax (documentary, stamp or otherwise) with respect to this Agreement, any Note, any Reimbursement Agreement or any other Loan Document (except, in the case of clause (iii) above, for any Indemnified Taxes, Excluded Taxes or Other Taxes), then, in each such case, within ten days after demand by such Issuer or such Lender, as applicable, the Borrower shall pay directly   to such Issuer, such Lender or such Control Person, as the case may be, such additional amount or amounts as shall be sufficient to compensate such Issuer, such Lender or such Control Person, as the case may be,   for any such reduction, reserve or other requirement, tax, loss, cost or expense (excluding general administrative and overhead costs) (collectively, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Costs&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) attributable to such Issuer&#8217;s, such Lender&#8217;s or such Control Person&#8217;s compliance during the term hereof with such Regulatory Change, but only if such Costs are generally applicable to (and for which reimbursement is generally being sought by such Issuer, such Lender or such Control Person, as applicable, in respect of) credit transactions similar to this transaction from similarly situated borrowers (which are parties to credit or loan documentation containing   a provision similar to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), as determined by such Issuer or such Lender, as applicable, in its reasonable discretion. Each Issuer and each Lender may make multiple requests for compensation under   this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, the Borrower will not be required to compensate any Issuer or any Lender for any Costs under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> arising prior to 45 days preceding the date of demand, unless   the applicable Regulatory Change giving rise to such Costs is imposed retroactively in which case the 45- day period referred to above shall be extended to include the period of retroactive effect thereof. In the case of retroactivity, such notice shall be provided to the Borrower not later than 45 days from the date that such Issuer or such Lender learned of such Regulatory Change. The Borrower&#8217;s obligation to compensate such Issuer or such Lender shall be contingent upon the provision of such timely notice (but any failure by such Issuer or such Lender to provide such timely notice shall not affect the Borrower&#8217;s obligations with respect to (i) Costs incurred from the date as of which such Regulatory Change became effective to the date that is 45 days after the date such Issuer or such Lender reasonably should have learned of such Regulatory Change and (ii) Costs incurred following the provision of such notice).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Illegality of Funding</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding any other provision hereof, if any Lender shall reasonably determine that any law, regulation, treaty or directive, or any change therein or in the interpretation or application thereof, shall  make it unlawful for such Lender to make or maintain Loans whose interest rates are based upon SOFR or Term SOFR, such Lender shall promptly notify the Borrower and the Administrative Agent thereof, and    </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a) the commitment of such Lender to make such Term SOFR Advances or to Convert ABR Advances to Term SOFR Advances shall forthwith be suspended, (b) such Lender shall fund its portion of each requested Term SOFR Advance as an ABR Advance, (c) such Lender&#8217;s Loans then outstanding as such Term SOFR Advances, if any, shall be Converted automatically to an ABR Advance on the last day of the then-current Interest Period applicable thereto or at such earlier time as may be required and (d) if such notice asserts    the illegality of such Lender making or maintaining ABR Advances the interest rate on which is determined by reference to One Month SOFR Rate, the interest rate on which ABR Advances of such Lender shall, if necessary to avoid such illegality, be determined by the Administrative Agent without reference to the One Month SOFR Rate component of the Alternate Base Rate.  If the commitment of any Lender with respect    to Term SOFR Advances is suspended pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and such Lender shall have obtained actual knowledge that it is once again legal for such Lender to make or maintain Term SOFR Advances, such Lender shall promptly notify the Administrative Agent and the Borrower thereof and, upon delivery     of such notice to each of the Administrative Agent and the Borrower, such Lender&#8217;s commitment to make    or maintain Term SOFR Advances shall be reinstated. If the commitment of any Lender with respect to Term SOFR Advances is suspended pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, such suspension shall not otherwise affect such Lender&#8217;s Commitment. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Option to Fund&#59; Substituted Interest Rate</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Each Lender has indicated that, if the Borrower requests a Term SOFR Advance    or a Competitive Bid Loan, such Lender may wish to purchase one or more deposits in order to   fund or maintain its funding of its Commitment Percentage of such Term SOFR Advance or Competitive Bid Loan during the Interest Period with respect thereto&#59; it being understood that the provisions of this Agreement relating to such funding are included only for the purpose of determining the rate of interest to be paid in respect of such Term SOFR Advance or Competitive Bid Loan and any amounts owing under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Each Lender shall be entitled to fund and maintain its funding of all or any part of each Term SOFR Advance and Competitive Bid Loan in any manner it sees fit, but all such determinations hereunder shall be made as if such Lender had actually funded and maintained its Commitment Percentage of each Term SOFR Advance or Competitive Bid Loan, as the case may be, during the applicable Interest Period through the purchase of deposits in an amount equal to the amount of its Commitment Percentage of such Term SOFR Advance or Competitive Bid Loan, as the case may be, and having a maturity corresponding to such Interest Period. Each Lender may fund its Advances from or for the account of any branch or office of such Lender as such Lender may choose from time to time, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">If in connection with any request for a Term SOFR Advance or a Conversion to or continuation thereof, as applicable, (i) the Administrative Agent determines (which determination shall be conclusive absent manifest error) that (A) no Successor Rate has been determined in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and the circumstances under clause (i) of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or the Scheduled Unavailability Date has occurred or (B) adequate and reasonable means do not otherwise exist for determining (1) Term SOFR for any requested Term SOFR Interest Period with respect to  a proposed Term SOFR Advance or (2) the One Month SOFR Rate in connection with an existing  or proposed ABR Advance or (ii) the Administrative Agent or the Required Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">determine that for any reason that (A) Term SOFR for any requested Term SOFR Interest Period with respect to     a proposed Term SOFR Advance or (B) the One Month SOFR Rate with respect to a proposed   ABR Advance, in any case, does not adequately and fairly reflect the cost to such Lenders of funding such Loan, the Administrative Agent will promptly so notify the Borrower and each  Lender.  Thereafter, (x)&#160;the obligation of the Lenders to make or maintain Term SOFR Advances    or to Convert ABR Advances to Term SOFR Advances shall be suspended (to the extent of the affected Term SOFR Advances or Term SOFR Interest Periods) and (y)&#160;in the event of a </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">determination described in the preceding sentence with respect to the One Month SOFR Rate component of the Alternate Base Rate, the utilization of the One Month SOFR Rate in determining the Alternate Base Rate shall be suspended, in each case, until the Administrative Agent (or, in the case of a determination by the Required Lenders described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">clause (ii</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(b</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), until the Administrative Agent upon instruction of the Required Lenders) revokes such notice.  Upon receipt of such notice, (i) the Borrower may revoke any pending request for a borrowing of, Conversion to or continuation of Term SOFR Advances (to the extent of the affected Term SOFR Advances or Term SOFR Interest Periods) or, failing that, will be deemed to have Converted such request into a request for a borrowing of ABR Advances in the amount specified therein and (ii)   any outstanding Term SOFR Advances shall be deemed to have been Converted to ABR Advances immediately at the end of their respective applicable Term SOFR Interest Period. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Notwithstanding anything to the contrary in this Agreement or any other Loan Documents, if the Administrative Agent and the Borrower determine (which determination shall    be conclusive absent manifest error), or the Borrower or the Required Lenders notify the Administrative Agent (with, in the case of the Required Lenders, a copy to the Borrower) that the Borrower or the Required Lenders (as applicable) have determined, that&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">adequate and reasonable means do not exist for ascertaining one month, three month and six month interest periods of Term SOFR, including, without limitation, because the Term SOFR Screen Rate is not available or published on a current basis and such circumstances are unlikely to be temporary&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">CME or any successor administrator of the Term SOFR Screen Rate or a Governmental Authority having jurisdiction over the Administrative Agent or such administrator with respect to its publication of Term SOFR, in each case acting in such capacity, has made a public statement identifying a specific date after which one month, three month and six month interest periods of Term SOFR or the Term SOFR Screen Rate shall or will no longer be made available, or permitted to be used for determining the  interest rate of Dollar denominated U.S. syndicated loans, or shall or will otherwise cease, provided that, at the time of such statement, there is no successor administrator that is satisfactory to the Administrative Agent, that will continue to provide such interest periods of Term SOFR after such specific date (the latest date on which one month, three month  and six month interest periods of Term SOFR or the Term SOFR Screen Rate are no longer available permanently or indefinitely, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Scheduled Unavailability Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">then, on a date and time determined by the Administrative Agent and the Borrower (any such date, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Term SOFR Replacement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), which date shall be at the end of a Term SOFR Interest Period or on the relevant interest payment date, as applicable, for interest calculated and, solely   with respect to clause (2) above, no later than the Scheduled Unavailability Date, Term SOFR will be replaced hereunder and under any Loan Document with Daily Simple SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the SOFR Adjustment for any payment period for interest calculated that can be determined by the Administrative Agent, in each case, without any amendment to, or further action or consent of any other party to, this Agreement or any other Loan Document (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Successor Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If the Successor Rate is Daily Simple SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the SOFR Adjustment, all interest payments will be payable on a quarterly basis.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding anything to the contrary herein, (i) if the Administrative Agent determines that Daily Simple SOFR is not available on or prior to the Term SOFR Replacement Date, or (ii) if the events or circumstances of the type described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(c)(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> have occurred with respect </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to the Successor Rate then in effect, then in each case, the Administrative Agent and the Borrower may amend this Agreement solely for the purpose of replacing Term SOFR or any then current Successor Rate in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> at the end of any Term SOFR Interest Period, relevant interest payment date or payment period for interest calculated, as applicable, with an alternative benchmark rate giving due consideration to any evolving or then existing convention    for similar Dollar denominated credit facilities syndicated and agented in the United States for such alternative benchmark. and, in each case, including any mathematical or other adjustments to such benchmark giving due consideration to any evolving or then existing convention for similar Dollar denominated credit facilities syndicated and agented in the United States for such benchmark,   which adjustment or method for calculating such adjustment shall be published on an information service as selected by the Administrative Agent from time to time in its reasonable discretion and may be periodically updated.  For the avoidance of doubt, any such proposed rate and adjustments, shall constitute a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Successor Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;.  Any such amendment shall become effective at 5&#58;00 p.m. on  the fifth Domestic Business Day after the Administrative Agent shall have posted such proposed amendment to all Lenders and the Borrower unless, prior to such time, Lenders comprising the Required Lenders have delivered to the Administrative Agent written notice that such Required Lenders object to such amendment.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent will promptly (in one or more notices) notify the Borrower and each Lender of the implementation of any Successor Rate.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any Successor Rate shall be applied in a manner consistent with market practice&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that to the extent such market practice is not administratively feasible for the Administrative Agent, such Successor Rate shall be applied in a manner as otherwise reasonably determined by the Administrative Agent (in consultation with the Borrower).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding anything else herein, if at any time any Successor Rate as so determined would otherwise be less than zero, the Successor Rate will be deemed to be zero for the purposes of this Agreement and the other Loan Documents.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In connection with the implementation of a Successor Rate, the Administrative Agent will have the right, in consultation with the Borrower, to make Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such Conforming Changes in the discretion of the Administrative Agent and in consultation with the Borrower will become effective without any further action or consent of any other party to this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, with respect to any such amendment effected, the Administrative Agent shall post each such amendment implementing such Conforming Changes to the Borrower and the Lenders promptly after such amendment becomes effective.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Certificates of Payment and Reimbursement</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each Issuer and each Lender agrees, in connection with any request by it for payment or reimbursement pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to provide the Borrower with a certificate, signed by an officer of such Issuer or such Lender, as the case may be, setting forth a description in reasonable detail of any such payment or reimbursement and the applicable Section of this Agreement pursuant to and in accordance with which such request is made. Each determination by such Issuer and such Lender of such payment or reimbursement shall be conclusive absent manifest error.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Taxes&#59; Net Payments</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Payments Free of Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Any and all payments by or on account of any obligation of the Borrower hereunder or under any other Loan Document shall be made free and clear of, and without reduction or withholding for, any Indemnified Taxes or Other Taxes&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if the Borrower shall be required by applicable law to deduct any Indemnified Taxes (including any Other Taxes) from such payments, then (i)&#160;the sum payable shall be increased as necessary so that after making all required deductions (including deductions applicable to additional sums payable under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) the Administrative Agent, the applicable Lender or the applicable Issuer, as the case may be, receives an amount equal to the sum it would have received had no such deductions  for Indemnified Taxes or Other Taxes been made, (ii)&#160;the Borrower shall make such deductions    and (iii)&#160;the Borrower shall timely pay the full amount deducted to the relevant Governmental Authority in accordance with applicable law. For purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the term &#8220;Lender&#8221; includes the Swing Line Lender and each Issuer and the term &#8220;applicable law&#8221; includes FATCA.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Payment of Other Taxes by the Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Without limiting the provisions of paragraph (a) above, the Borrower shall timely pay any Other Taxes to the relevant Governmental Authority in accordance with applicable law.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Indemnification by the Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Borrower shall indemnify the   Administrative Agent, each Lender and each Issuer, within 30 days after demand therefor, for the full amount of any Indemnified Taxes imposed on or with respect to, any payment made by, or on account of, any obligation of the Borrower under any Loan Document or Other Taxes (including Indemnified Taxes or Other Taxes imposed or asserted on or attributable to amounts payable under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) paid by the Administrative Agent, such Lender or such Issuer, as the case may   be, and, without duplication, any penalties, interest and reasonable and documented out-of-pocket expenses arising therefrom or with respect thereto (other than any penalties that result from the  gross negligence, bad faith or willful misconduct of the Administrative Agent, such Lender or such Issuer, as applicable, as determined by a final and non-appealable judgment of a court of competent jurisdiction)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if the Borrower reasonably believes that such Taxes were not correctly  or legally asserted, the Administrative Agent, such Lender or such Issuer, as applicable, will cooperate with the Borrower to obtain a refund of such Taxes so long as such efforts would not result in any additional costs or expenses not reimbursed by the Borrower and such cooperation would not, in the judgment of such Lender or such Issuer, as applicable, be materially disadvantageous to it.  A certificate as to the amount of such payment or liability that complies with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and is delivered to the Borrower by such Lender or such Issuer (with a copy to the Administrative Agent), or by the Administrative Agent on its own behalf or on behalf of such Lender or such Issuer, shall be conclusive absent manifest error. After any Lender or any Issuer (as the case may be) learns of the imposition of any Indemnified Taxes or Other Taxes, such Lender     or such Issuer (as the case may be) will as soon as reasonably practicable notify the Borrower thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the failure to provide the Borrower with such notice shall not release the Borrower from its indemnification obligations under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Notwithstanding anything   to the contrary contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Borrower shall not be required to indemnify the Administrative Agent or any Lender or Issuer pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> for any additional costs, such as penalties or interest, to the extent that such costs resulted from a failure of the Administrative Agent or such Lender or Issuer to notify the Borrower of such possible indemnification claim within 180 days after the Administrative Agent or such Lender or Issuer receives notice from the applicable taxing authority of the tax giving rise to such indemnification claim.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Evidence of Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. As soon as practicable after any payment of Indemnified Taxes or Other Taxes by the Borrower to a Governmental Authority, the Borrower shall deliver to the Administrative Agent the original or a certified copy of a receipt issued by such Governmental Authority evidencing such payment, a copy of the return reporting such payment or other evidence of such payment reasonably satisfactory to the Administrative Agent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Indemnification by the Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each Lender shall severally indemnify the Administrative Agent, within 10 days after demand therefor, for (i) any Indemnified Taxes attributable to such Lender (but only to the extent that the Borrower has not already indemnified   the Administrative Agent for such Indemnified Taxes and without limiting the obligation of the Borrower to do so), (ii) any Taxes attributable to such Lender&#8217;s failure to comply with the  provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> relating to the maintenance of a Participant Register, and (iii) any Excluded Taxes attributable to such Lender, in each case, that are payable or paid by the Administrative Agent in connection with any Loan Document, and any reasonable expenses arising therefrom or with respect thereto, whether or not such Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate as to the amount of such payment      or liability delivered to any Lender by the Administrative Agent shall be conclusive absent manifest error. Each Lender hereby authorizes the Administrative Agent to set off and apply any and all amounts at any time owing to such Lender under any Loan Document or otherwise payable by the Administrative Agent to the Lender from any other source against any amount due to the Administrative Agent under this paragraph (e).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.02pt;text-decoration:underline">Status of Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Any Lender that is entitled to an exemption from, or reduction  of, withholding Tax under the law of the jurisdiction in which the Borrower is resident for Tax purposes, or any treaty to which such jurisdiction is a party, with respect to payments hereunder or under any other Loan Document shall deliver to the Borrower (with a copy to the Administrative Agent), at the time or times prescribed by applicable law or reasonably requested by the Borrower  or the Administrative Agent, such properly completed and executed documentation prescribed by applicable law as will permit such payments to be made without withholding or at a reduced rate    of withholding. In addition, any Lender, if requested by the Borrower or the Administrative Agent, shall deliver such other documentation prescribed by applicable law or reasonably requested by the Borrower or the Administrative Agent as will enable the Borrower or the Administrative Agent to determine whether or not such Lender is subject to backup withholding or information reporting requirements.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Without limiting the generality of the foregoing, any Foreign Lender shall deliver to the Borrower and the Administrative Agent (in such number of copies as shall be requested by the recipient) on or prior to the date on which such Foreign Lender becomes a Lender under this Agreement (and from time to time thereafter (i) if such Foreign Lender shall determine that any applicable form or certification has expired or will then expire or has or will then become obsolete  or incorrect or that an event has occurred that requires or will then require a change in the most recent form or certification previously delivered by it to the Borrower and the Administrative Agent and (ii) upon the request of the Borrower or the Administrative Agent, but only if such Foreign Lender is legally entitled to do so), whichever of the following is applicable&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">duly completed copies of Internal Revenue Service Form W-8BEN or   Form W-8BEN-E claiming eligibility for benefits of an income Tax treaty to which the United States of America is a party,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.58pt">duly completed copies of Internal Revenue Service Form W-8ECI,</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.53pt">in the case of a Foreign Lender claiming the benefits of the exemption for portfolio interest under Section 881(c) of the Internal Revenue Code, (x) a certificate (a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;United States Tax Compliance Certificate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) to the effect that such Foreign Lender is not (A) a &#8220;bank&#8221; within the meaning of Section 881(c)(3)(A) of the Internal Revenue Code,   (B) a &#8220;10 percent shareholder&#8221; of the Borrower within the meaning of Section 881(c)(3)(B) of the Internal Revenue Code, (C) a &#8220;controlled foreign corporation&#8221; described in Section 881(c)(3)(C) of the Internal Revenue Code nor (D) engaged in the conduct of a trade or business within the United States to which the interest payment is effectively connected   and (y) duly completed copies of Internal Revenue Service Form W-8BEN or Form W- 8BEN-E,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.13pt">to the extent a Foreign Lender is not the beneficial owner (for example, where the Foreign Lender is a partnership or participating Lender granting a typical participation), a complete and executed Internal Revenue Service Form W-8IMY, accompanied by a Form W-8ECI, Form W-8BEN, Form W-8BEN-E, a United States Tax Compliance Certificate, Internal Revenue Service Form W-9 and&#47;or other certification documents from each beneficial owner, as applicable&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that, if the Foreign Lender  is a partnership (and not a participating Lender) and one or more partners of such Foreign Lender are claiming the portfolio interest exemption, such Foreign Lender shall provide a United States Tax Compliance Certificate, on behalf of such beneficial owner(s) in lieu of requiring each beneficial owner to provide its own certificate, or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">any other form prescribed by applicable law as a basis for claiming exemption from or a reduction in United States federal withholding Tax duly completed together with such supplementary documentation as may be prescribed by applicable law   to permit the Borrower to determine the withholding or deduction required to be made.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If a payment made to a Lender under any Loan Document would be subject to U.S. federal withholding Tax imposed by FATCA if such Lender were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472(b) of the Internal Revenue Code, as applicable), such Lender shall deliver to the Borrower and the Administrative Agent at the time or times prescribed by law and at such time or times reasonably requested by the Borrower or the Administrative Agent such documentation prescribed by  applicable law (including as prescribed by Section 1471(b)(3)(C) of the Internal Revenue Code)   and such additional documentation reasonably requested by the Borrower or the Administrative Agent as may be necessary for the Borrower and the Administrative Agent to comply with their obligations under FATCA and to determine that such Lender has complied with such Lender&#8217;s obligations under FATCA or to determine the amount to deduct and withhold from such payment. Solely for purposes of this clause, &#8220;FATCA&#8221; shall include any amendments made to FATCA after the date of this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Without limiting the foregoing, upon request of the Administrative Agent or the Borrower, each Lender and each Issuer that is a &#8220;United States person&#8221; within the meaning of Section 7701(a)(30) of the Internal Revenue Code that lends to the Borrower (each, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;U.S. Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) shall deliver to the Administrative Agent and the Borrower two duly signed, properly completed copies  of Internal Revenue Service Form W-9 on or prior to the First Amendment  Effective Date (or on   or prior to the date it becomes a party to this Agreement), certifying that such U.S. Lender is entitled to an exemption from United States backup withholding, or any successor form.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Treatment of Certain Refunds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If the Administrative Agent, a Lender or an Issuer determines, in its sole discretion exercised in good faith, that it has received a refund of any Taxes  </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or Other Taxes as to which it has been indemnified by the Borrower or with respect to which the Borrower has paid additional amounts pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, it shall promptly pay to the Borrower an amount equal to such refund (but only to the extent of indemnity payments made, or additional amounts paid, by the Borrower under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> with respect to the Taxes or Other Taxes giving rise to such refund), net of all reasonable and documented out-of-pocket expenses of the Administrative Agent, such Lender or such Issuer, as the case may be, and without interest  (other than any interest paid by the relevant Governmental Authority with respect to such refund), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the Borrower, upon the written request of the Administrative Agent, such Lender or such Issuer, agrees to repay the amount paid over to the Borrower (plus any penalties, interest or other charges imposed by the relevant Governmental Authority) to the Administrative Agent, such Lender or such Issuer in the event that the Administrative Agent, such Lender or such Issuer is required to repay such refund or Tax credit to such Governmental Authority. This paragraph shall not be construed to require the Administrative Agent, any Lender or any Issuer to make available   its Tax returns (or any other information relating to its Taxes that it deems confidential) to the Borrower or any other Person.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Designation of a Different Lending Office</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If any Lender requests compensation under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, or requires the Borrower to pay any additional amount to any Lender or any Governmental Authority for the account of any Lender pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, then such Lender shall use reasonable efforts to promptly designate a different lending office for funding or booking its Loans hereunder or to assign its rights and obligations hereunder to another of its  offices, branches or affiliates, if such designation or assignment (i)&#160;would eliminate or reduce amounts payable pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as the case may be, in the future and (ii)&#160;in the judgment of such Lender, would not subject such Lender to any unreimbursed cost or expense and would not otherwise be disadvantageous to such Lender. The Borrower hereby agrees to pay all reasonable and documented out-of-pocket costs and expenses incurred by any Lender in connection with any such designation or assignment.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each party&#8217;s obligations under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall survive the resignation or replacement of the Administrative Agent or any assignment of rights by, or the replacement of, a Lender, the termination of the Commitments and the repayment, satisfaction or discharge of all obligations under any Loan Document.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Facility Fees</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower agrees to pay to the Administrative Agent for the account of each Lender a fee (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Facility Fee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) during the period commencing on the Effective Date and ending on the Expiration Date, payable quarterly in arrears on the last day of each March, June, September and December of each year, commencing on the last day of the calendar quarter during which the Facility Fee shall commence to accrue, and on the Expiration Date, at a rate per annum equal to the Applicable Margin of (a) prior to the Commitment Termination Date or such earlier date upon which all of the Commitments shall have been terminated in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Commitment Amount of such Lender (whether used or unused), and (b) thereafter, the sum of (i) the outstanding principal balance of all Revolving Credit Loans   of such Lender, (ii) such Lender&#8217;s Swing Line Exposure and (iii) such Lender&#8217;s Letter of Credit Exposure. Notwithstanding anything to the contrary contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, on and after the Commitment Termination Date, the Facility Fee shall be payable upon demand. In addition, upon each reduction of the Aggregate Commitment Amount, the Borrower shall pay the Facility Fee accrued on the amount of such reduction through the date of such reduction. The Facility Fee shall be computed on the basis of a 360-day year for the actual number of days elapsed.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Letter of Credit Participation Fee</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower agrees to pay to the Administrative Agent for the pro rata account of each Lender a fee (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit Participation Fee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) with respect to the Letters of Credit during the period commencing on the Effective Date and ending on the Commitment Termination Date or, if later, the date when the Letter of Credit Exposure of all Lenders is $0, payable quarterly in arrears on the last day of each March, June, September and December of each year, commencing on the last day of the calendar quarter     in which the Effective Date shall have occurred, and on the last date of such period, at a rate per annum equal to (i) in the case of standby Letters of Credit, the Applicable Margin of the actual daily amount which may be drawn under all standby Letters of Credit during such period (whether or not the conditions for drawing thereunder have or may be satisfied) multiplied by such Lender&#8217;s Commitment Percentage, and    (ii) in the case of commercial Letters of Credit, the Applicable Margin of the actual daily amount which  may be drawn under all commercial Letters of Credit during such period (whether or not the conditions for drawing thereunder have or may be satisfied) multiplied by such Lender&#8217;s Commitment Percentage. The Letter of Credit Participation Fee shall be computed on the basis of a 360-day year for the actual number     of days elapsed.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Replacement of Lender</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If (w) the Borrower is obligated to pay to any Lender any amount under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Borrower shall have the right within 90 days thereafter, (x) any Lender shall be a Defaulting Lender, the Borrower shall have the right at any time during which such Lender shall remain a Defaulting Lender, (y) any Lender shall have not consented to an Extension Request or (z) any Lender shall not have approved any other consent, waiver or amendment that (A) requires the approval of all Lenders or all affected Lenders in accordance with the terms of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and (B) has been approved by the Required Lenders, the Borrower shall have the right at any time, in each case in accordance with the requirements of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and only if no Default shall exist, to replace such Lender (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Replaced Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) with   one or more Eligible Assignees (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Replacement Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that (i) at the time of any replacement pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Replacement Lender shall enter into one or more Assignment and Assumptions pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (with the processing and recordation fee referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> payable pursuant to said </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> to be paid by the Replacement Lender) pursuant to which the Replacement Lender shall acquire the Commitment, the outstanding Loans, the Swing Line Exposure and the Letter of Credit Exposure of the Replaced Lender and, in connection therewith, shall pay the following&#58; (a) to the Replaced Lender, an amount equal to the sum of (A) an amount equal to the principal of, and all accrued and unpaid interest on, all outstanding Loans and Swing Line Participation Amounts of the Replaced Lender, (B) an amount equal to all drawings on all Letters of Credit that have been funded by (and not reimbursed to) such Replaced Lender, together with all then unpaid interest with respect thereto at such time, and (C) an amount equal to all accrued, but unpaid, fees owing to the Replaced Lender, (b) to each Issuer, an amount equal to such Replaced Lender&#8217;s Commitment Percentage of all drawings on Letters of Credit issued by such Issuer (which at such time remain unpaid drawings) to the extent such amount was not funded by such Replaced Lender, (c) to the Swing Line Lender, an amount equal to such Replaced Lender&#8217;s Commitment Percentage of any Mandatory Borrowing to the extent such amount was not funded by such Replaced Lender, and (d) to the Administrative Agent an amount equal to all amounts owed by   such Replaced Lender to the Administrative Agent under this Agreement, including, without limitation, an amount equal to the principal of, and all accrued and unpaid interest on, all outstanding Loans of the Replaced Lender, a corresponding amount of which was made available by the Administrative Agent to the Borrower pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and which has not been repaid to the Administrative Agent by such Replaced Lender or the Borrower, and (ii) all obligations of the Borrower owing to the Replaced Lender (other than those specifically described in clause (i) above in respect of which the assignment purchase   price has been, or is concurrently being, paid) shall be paid in full to such Replaced Lender concurrently with such replacement. Upon the execution and delivery of the respective Assignment and Assumptions   </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and the payment of amounts referred to in clauses (i) and (ii) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Replacement Lender shall become a Lender hereunder and the Replaced Lender shall cease to constitute a Lender hereunder, except with respect to indemnification provisions under this Agreement that are intended to survive the termination of the Commitments and the repayment of the Loans which may be applicable to any such Replaced Lender prior to the date of its replacement. Solely for the purpose of calculating break funding payments under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the assignment by any Replaced Lender of any Term SOFR Advance prior to the last day of the Interest Period applicable thereto pursuant to clause (w) or (y) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall  be deemed to constitute a prepayment by the Borrower of such Term SOFR Advance.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">REPRESENTATIONS AND WARRANTIES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In order to induce the Administrative Agent, the Lenders and the Issuers to enter into this Agreement, the Lenders to make the Loans and the Issuers to issue Letters of Credit, the Borrower hereby makes the following representations and warranties to the Administrative Agent, the Lenders and the  Issuers&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Existence and Power</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower is duly organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation, has all requisite corporate power and authority to own its Property and to carry on its business as now conducted, and is qualified to do business as a foreign corporation and is in good standing in each jurisdiction in which it owns or leases real Property or in which the nature of its business requires it to be so qualified (except those jurisdictions where the failure to be so qualified or to    be in good standing could not reasonably be expected to have a Material Adverse effect).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Authority&#59; Affected Financial Institution</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower has full corporate power and authority to enter into, execute, deliver and perform the terms of the Loan Documents, all of which have been duly authorized by all proper and necessary corporate action and are not in contravention of&#58; (i) except as could not reasonably be expected to have a Material Adverse effect, any applicable law or (ii) the terms of its Certificate of Incorporation and By-Laws. No consent or approval of, or other action by, shareholders of the Borrower, any Governmental Authority, or any other Person (which has not already been obtained) is required to authorize in respect of the Borrower, or is required in connection with, the execution, delivery and performance by the Borrower of the Loan Documents or is required as a condition to the enforceability of the Loan Documents against the Borrower. The Borrower is not an Affected Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Binding Agreement</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Loan Documents constitute the valid and legally binding obligations of the Borrower, enforceable against the Borrower in accordance with their respective terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditors&#8217; rights generally and by equitable principles relating to the availability of specific performance as a remedy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Litigation</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of the Effective Date, there are no actions, suits, arbitration proceedings or claims (whether purportedly on behalf of the Borrower, any Material Subsidiary or otherwise) pending or, to the knowledge of the Borrower, threatened against the Borrower or any Material Subsidiary or any of their respective Properties, or maintained by the Borrower or any Material Subsidiary, at law or in equity, before any </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Governmental Authority which have not been disclosed in the SEC Reports that could reasonably be expected to have a Material Adverse effect. There are no proceedings pending or, to the knowledge of the Borrower, threatened against the Borrower or any Material Subsidiary (a) which call into question the validity or enforceability of any Loan Document, or otherwise seek to invalidate, any Loan Document, or  (b) which might, individually or in the aggregate, materially and adversely affect any of the transactions contemplated by any Loan Document.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">No Conflicting Agreements</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">&#91;Reserved&#93;.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">No provision of any existing material mortgage, material indenture, material contract or material agreement or of any existing statute, rule, regulation, judgment, decree or order binding on the Borrower or affecting the Property of the Borrower (i) conflicts with any Loan Document, (ii) requires any consent which has not already been obtained with respect to any Loan Document, or (iii) would in any way prevent the execution, delivery or performance by the  Borrower of the terms of any Loan Document, except in the case of provisions of any existing material mortgage, material indenture, material contract or material agreement, as could not reasonably be expected to have a Material Adverse effect. Neither the execution and delivery, nor the performance, by the Borrower of the terms of each Loan Document will constitute a default under, or result in the creation or imposition of, or obligation to create, any Lien upon the Property of the Borrower pursuant to the terms of any such mortgage, indenture, contract or agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Governmental Regulations</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower is not required to be registered as an &#8220;investment company&#8221; under the Investment Company Act of 1940, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Federal Reserve Regulations&#59; Use of Proceeds</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower is not engaged principally, or as one of its important activities, in the business of extending credit for the purpose of purchasing or carrying any Margin Stock. No part of the proceeds of the Loans or the Letters of Credit has been or will be used, directly or indirectly, and whether immediately, incidentally or ultimately, for a purpose which violates the provisions of Regulation T, U or X of the Board of Governors of the Federal Reserve System, as amended. Anything in this Agreement to the contrary notwithstanding, neither any Issuer nor any Lender shall be obligated to extend credit to, or on behalf of,   the Borrower in violation of any limitation or prohibition provided by any applicable law, regulation or statute, including said Regulation U. Following application of the proceeds of each Loan and the issuance   of each Letter of Credit, not more than 25% (or such greater or lesser percentage as is provided in the exclusions from the definition of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Indirectly Secured</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> contained in said Regulation U as in effect at the  time of the making of such Loan or issuance of such Letter of Credit) of the value of the assets of the Borrower and the Subsidiaries on a Consolidated basis that are subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> will be Margin Stock. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">No Misrepresentation</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No representation or warranty contained in any Loan Document and no certificate or written report furnished by the Borrower to the Administrative Agent or any Lender pursuant to any Loan Document </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">contains, as of its date, a misstatement of a material fact, or omits to state, as of its date, a material fact required to be stated in order to make the statements therein contained, when taken as a whole, not  materially misleading (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that any representation, warranty, statement or written report that is qualified as to &#8220;materiality&#8221;, &#8220;Material Adverse&#8221; or similar language shall be true and correct (after giving effect to any qualification therein) in all respects on such date) in the light of the circumstances under which made (after giving effect to all supplements and updates with respect thereto) (it being understood that the Borrower makes no representation or warranty hereunder with respect to any projections, other forward looking information, industry information or general economic information).  As of the Effective Date, the information included in any Beneficial Ownership Certification of the Borrower, if applicable, is true and correct in all respects.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Financial Statements</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower has heretofore delivered to the Lenders through the Administrative Agent copies of the audited Consolidated Balance Sheet of the Borrower and its Subsidiaries as of December 31, 2018,  and the related Consolidated Statements of Income, Comprehensive Income, Shareholders&#8217; Equity and Cash Flows for the fiscal year then ended. The financial statements referred to immediately above, including all related notes and schedules, are herein referred to collectively as the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Financial Statements&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Financial Statements fairly present, in all material respects, the Consolidated financial condition and results of the operations of the Borrower and the Subsidiaries as of the dates and for the periods indicated therein and, except as noted therein, have been prepared in conformity with GAAP as then in effect. Neither the Borrower nor any of the Subsidiaries has any material obligation or liability of any kind (whether fixed, accrued, contingent, unmatured or otherwise) which, in accordance with GAAP as then in effect, should have been disclosed in the Financial Statements and was not. During the period from January 1, 2019 to   and including the Effective Date, there was no Material Adverse change, including as a result of any change in law, in the Consolidated financial condition, operations, business or Property of the Borrower and the Subsidiaries taken as a whole that was not disclosed in the SEC Reports.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Anti-Corruption Laws and Sanctions</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower has implemented and maintains in effect policies and procedures designed to ensure compliance by the Borrower, the Subsidiaries and their respective directors, officers, employees and agents with Anti-Corruption Laws and applicable Sanctions, and the Borrower, the Subsidiaries and their  respective officers and employees and, to the knowledge of the Borrower, its directors are in compliance with Anti-Corruption Laws and applicable Sanctions in all material respects. None of (a) the Borrower, any Subsidiary or, to the knowledge of the Borrower or such Subsidiary, any of their respective directors, officers or employees, or (b) to the knowledge of the Borrower, any agent of the Borrower or any Subsidiary that will act in any capacity in connection with or benefit from the credit facility established hereby, is a Sanctioned Person. No Loan or Letter of Credit, use of proceeds or other transaction contemplated by this Agreement will violate Anti-Corruption Laws or applicable Sanctions.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">CONDITIONS TO EFFECTIVENESS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Agreement shall become effective on and as of the date (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Effective Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) that the following conditions shall have been satisfied or waived in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Agreement</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall have received counterparts of this Agreement executed by the Borrower, the Administrative Agent, each Issuer, the Swing Line Lender and each Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Notes</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall have received a Note, executed and delivered by the Borrower, for each Lender that shall have given at least three Domestic Business Days&#8217; prior written notice of its request for a Note.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Corporate Action</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall have received a certificate, dated the Effective Date, of the  Secretary or an Assistant Secretary of the Borrower (i) attaching a true and complete copy of the resolutions of its Board of Directors and of all documents evidencing all other necessary corporate action taken by the Borrower to authorize this Agreement, the other Loan Documents and the transactions contemplated hereby and thereby, (ii) attaching a true and complete copy of its Certificate of Incorporation and By-Laws, (iii) setting forth the incumbency of the officer or officers of the Borrower who may sign this Agreement and   the other Loan Documents, and any other certificates, requests, notices or other documents required hereunder or thereunder, and (iv) attaching a certificate of good standing of the Secretary of State of the State of Delaware.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Opinion of Counsel to the Borrower</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall have received (a) an opinion of Thomas Moffatt, assistant general counsel of the Borrower, dated the Effective Date, in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit D-1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and (b) an opinion of Shearman &#38; Sterling LLP, special counsel to the Borrower, dated the Effective Date, in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">D-2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Termination of Existing 2015 Credit Agreement </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">After giving effect to the application of the proceeds of the Loans on the Effective Date, the Indebtedness under the Existing 2015 Credit Agreement shall have been fully repaid, the commitments  under the Existing 2015 Credit Agreement shall have been canceled or terminated, and the Administrative Agent shall have received reasonably satisfactory evidence thereof.  In order to facilitate the termination of the commitments under the Existing 2015 Credit Agreement, the Borrower hereby gives notice that the Borrower wishes to terminate the commitments under the Existing 2015 Credit Agreement, effective as of the Effective Date.  Each Lender that is a party to the Existing 2015 Credit Agreement, by its execution  hereof, waives any requirement of prior notice set forth therein as a condition to the right of the Borrower   to terminate the commitments thereunder. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">No Default and Representations and Warranties</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall have received a certificate, dated the Effective Date, of the Senior Vice President and Treasurer of the Borrower certifying that there exists no Default and that the representations and warranties contained in this Agreement are true and correct in all material respects (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any representation and warranty that is qualified as to &#8220;materiality&#8221;, &#8220;Material Adverse&#8221; or similar language shall be true and correct (after giving effect to any qualification therein) in all respects on the Effective Date), except those which are expressly specified to be made as of an earlier date.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Fees</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall have received all fees and other amounts due and payable to it on  the Effective Date, including the upfront fees payable to the Lenders,  in respect of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Due Diligence&#59; &#8220;Know Your Customer&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a) Each Lender shall have received such documents and information as it may have requested in order to comply with &#8220;know-your-customer&#8221; and other applicable Sanctions, anti-terrorism, anti-money laundering and similar rules and regulations and related policies, to the extent the Borrower shall have received written requests therefor at least ten (10) Domestic Business Days prior to the Effective Date, and (b) at least five Domestic Business Days prior to the Effective Date, if the Borrower qualifies as a &#8220;legal entity customer&#8221; under the Beneficial Ownership Regulation, it shall have delivered to each Lender that so requests a Beneficial Ownership Certification.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Without limiting the generality of the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, for purposes of determining compliance with the conditions specified in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, each Lender that has signed this Agreement shall be deemed to have consented to, approved or accepted or to be satisfied with, each document or other matter required thereunder to be consented to or approved by or acceptable or satisfactory to a Lender unless the Administrative Agent shall have received notice from such Lender prior to the proposed Effective Date specifying its objection thereto.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">CONDITIONS OF LENDING - ALL LOANS AND LETTERS OF CREDIT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The obligation of each Lender on any Borrowing Date to make each Revolving Credit Loan (other than a Revolving Credit Loan constituting a Mandatory Borrowing), the Swing Line Lender to make each Swing Line Loan, each Issuer to issue each Letter of Credit and each Lender to make a Competitive Bid Loan are subject to the fulfillment (or waiver in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) of the following conditions precedent&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Compliance</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On each Borrowing Date, and after giving effect to the Loans to be made or the Letters of Credit     to be issued on such Borrowing Date, (a) there shall exist no Default, and (b) the representations and warranties contained in this Agreement shall be true and correct in all material respects with the same effect as though such representations and warranties had been made on such Borrowing Date (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that any representation and warranty that is qualified as to &#8220;materiality&#8221;, &#8220;Material Adverse&#8221; or similar language  shall be true and correct (after giving effect to any qualification therein) in all respects on such Borrowing Date), except those which are expressly specified to be made as of an earlier date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Requests</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall have timely received from the Borrower on or before such Borrowing Date, as applicable, a duly executed Borrowing Request (together with, in the case of a request for a Swing Line Loan that will bear interest at the Negotiated Rate, a duly executed agreement as to the Negotiated Rate with respect to such Swing Line Loan), Letter of Credit Request (together with a duly executed Reimbursement Agreement with respect to the Letter(s) of Credit requested thereby) and&#47;or Competitive Bid Request (together with a duly executed Competitive Bid Accept&#47;Reject Letter).</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">AFFIRMATIVE COVENANTS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower covenants and agrees that on and after the Effective Date and until the later to occur of (a) the Commitment Termination Date and (b) the payment in full of the Loans, the Reimbursement Obligations, the Fees and all other sums payable under the Loan Documents (other than contingent obligations for which no claim has been made), the Borrower will&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Legal Existence</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Except as may otherwise be permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, maintain, and cause each Material Subsidiary to maintain, its corporate existence in good standing in the jurisdiction of its incorporation or formation and in each other jurisdiction in which the failure so to do could reasonably be expected to have a Material Adverse effect, except that the corporate existence of Material Subsidiaries   may be terminated if (i) such Material Subsidiaries operate closing or discontinued operations or (ii) if the Borrower determines in good faith that such termination is in the best interests of the Borrower and is not materially disadvantageous to the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Taxes</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pay and discharge when due, and cause each Material Subsidiary so to do, all taxes, assessments, governmental charges, license fees and levies upon or with respect to the Borrower and such Material Subsidiary, and upon the income, profits and Property thereof unless, and only to the extent, that either   (i)(a) such taxes, assessments, governmental charges, license fees and levies shall be contested in good faith and by appropriate proceedings diligently conducted by the Borrower or such Material Subsidiary, and (b) such reserve or other appropriate provision as shall be required by GAAP shall have been made therefor,     or (ii) the failure to pay or discharge such taxes, assessments, governmental charges, license fees and levies could not reasonably be expected to have a Material Adverse effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Observance of Legal Requirements</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Observe and comply in all material respects, and cause each Material Subsidiary    so to do, with all laws, ordinances, orders, judgments, rules, regulations, certifications, franchises, permits, licenses, directions and requirements of all Governmental Authorities, which now or at   any time hereafter may be applicable to it or to such Material Subsidiary, except (i) where a violation of which could not reasonably be expected to have a Material Adverse effect, or (ii) to    the extent that such noncompliance is being contested in good faith and by appropriate proceedings diligently conducted by the Borrower or such Material Subsidiary.</font></div><div style="margin-bottom:15pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Maintain in effect and enforce policies and procedures designed to ensure compliance by the Borrower, the Subsidiaries and their respective directors, officers, employees   and agents with Anti-Corruption Laws and applicable Sanctions.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Financial Statements and Other Information</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Maintain, and cause each Subsidiary to maintain, a standard system of accounting in accordance with GAAP, and furnish to the Administrative Agent for distribution to the Lenders&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">As soon as available and, in any event, within 90 days after the close of each fiscal year, a copy of (x) the Borrower&#8217;s 10-K in respect of such fiscal year, and (y) (i) the Borrower&#8217;s Consolidated Balance Sheet as of the end of such fiscal year, and (ii) the related Consolidated Statements of Income, Comprehensive Income, Shareholders&#8217; Equity and Cash Flows, as of and through the end of such fiscal year, setting forth in each case in comparative form the corresponding figures in respect of the previous fiscal year, all in reasonable detail, and accompanied by a report   of the Borrower&#8217;s auditors, which report shall state that (A) such auditors audited such financial statements, (B) such audit was made in accordance with generally accepted auditing standards in effect at the time and provides a reasonable basis for such opinion, and (C) said financial statements have been prepared in accordance with GAAP&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">As soon as available, and in any event within 45 days after the end of each of the first three fiscal quarters of each fiscal year, a copy of (x) the Borrower&#8217;s 10-Q in respect of such fiscal quarter, and (y) (i) the Borrower&#8217;s condensed Consolidated Balance Sheet as of the end of such quarter and (ii) the related condensed Consolidated Statements of Income, Comprehensive Income, Shareholders&#8217; Equity and Cash Flows for (A) such quarter and (B) the period from the beginning of the then-current fiscal year to the end of such quarter, in each case in comparable form with the prior fiscal year, all in reasonable detail and prepared in accordance with GAAP (without footnotes and subject to year-end adjustments)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Simultaneously with the delivery of the financial statements required by clauses    (a) and (b) above, a certificate of the Chief Financial Officer or the Senior Vice President and Treasurer of the Borrower certifying that no Default shall have occurred or be continuing or, if so, specifying in such certificate all such Defaults, and setting forth computations in reasonable detail demonstrating compliance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:23.18pt">&#91;reserved&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">As soon as practicable after becoming available, copies of all regular or periodic reports (including current reports on Form 8-K) which the Borrower or any Subsidiary may now or hereafter be required to file with or deliver to the U.S. Securities and Exchange Commission, or   any other Governmental Authority succeeding to the functions thereof&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:25.02pt">&#91;reserved&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Prompt written notice of the occurrence of (i) each Default and (ii) each Event of Default&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:23.18pt">&#91;reserved&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">From time to time, such other information regarding the financial position or business of the Borrower and the Subsidiaries as the Administrative Agent, at the reasonable   request of any Lender, may reasonably request&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">Prompt written notice of such other information with documentation required by bank regulatory authorities under applicable &#8220;know your customer&#8221; and anti-money laundering  </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">laws, rules and regulations (including, without limitation, the Patriot Act and the Beneficial Ownership Regulation), as from time to time may be reasonably requested by the Administrative Agent or by any Issuer or any Lender (through the Administrative Agent).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Information required to be delivered pursuant to (x) this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be deemed to have been delivered if such information shall have been posted by the Administrative Agent on a Debtdomain, IntraLinks, Syndtrak or similar electronic system (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Platform&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) to which each Lender and each Issuer  has been granted access and (y) clauses (a), (b) and (e) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be deemed delivered to the Administrative Agent, the Issuers and the Lenders when available on the Borrower&#8217;s website at             </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">http&#58;&#47;&#47;www.cvshealth.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or the website of the U.S. Securities and Exchange Commission at                 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">http&#58;&#47;&#47;www.sec.gov</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Information delivered pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> may also be delivered by electronic communications pursuant to procedures approved by the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower hereby acknowledges that the Administrative Agent and&#47;or the Joint Lead Arrangers will make available to the Lenders materials and&#47;or information provided by or on behalf of the Borrower hereunder (collectively, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Borrower Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) by posting the Borrower Materials on the Platform.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Records</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Upon reasonable notice and during normal business hours after an Event of Default has occurred  and is continuing, permit representatives of the Administrative Agent and each Lender to visit the offices    of the Borrower and each Material Subsidiary, to examine the books and records (other than tax returns and work papers related to tax returns) thereof and auditors&#8217; reports relating thereto, to discuss the affairs of the Borrower and each Material Subsidiary with the respective officers thereof, and to meet and discuss the affairs of the Borrower and each Material Subsidiary with the Borrower&#8217;s auditors, except for information covered by an attorney-client or other legal privilege or to the extent the inspection would reasonably be expected to result in a violation or other breach of any third party confidentiality agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">NEGATIVE COVENANTS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower covenants and agrees that on and after the Effective Date and until the later to occur of (a) the Commitment Termination Date and (b) the payment in full of the Loans, the Reimbursement Obligations, the Fees and all other sums payable under the Loan Documents (other than contingent obligations for which no claim has been made), the Borrower will not&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Liens</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Create, incur, assume or suffer to exist any Lien against or on any Property now owned or hereafter acquired by the Borrower or any of the Subsidiaries, or permit any of the Subsidiaries so to do, except any one or more of the following types of Liens&#58; (a) Liens in connection with workers&#8217; compensation, unemployment insurance or other social security obligations (which phrase shall not be construed to refer    to ERISA or the minimum funding obligations under Section 412 of the Internal Revenue Code), (b) Liens  to secure the performance of bids, tenders, letters of credit, contracts (other than contracts for the payment  of Indebtedness), leases, statutory obligations, surety, customs, appeal, performance and payment bonds   and other obligations of like nature, or to qualify to do business, maintain insurance or obtain other benefits, in each such case arising in the ordinary course of business, (c) mechanics&#8217;, workmen&#8217;s, carriers&#8217;, warehousemen&#8217;s, materialmen&#8217;s, landlords&#8217; or other like Liens arising in the ordinary course of business with respect to obligations which are not due or which are being contested in good faith and by appropriate proceedings diligently conducted, (d) Liens for taxes, assessments, fees or governmental charges the </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">payment of which is not required under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, (e) easements, rights of way, restrictions, leases of Property to others, easements for installations of public utilities, title imperfections and restrictions, zoning ordinances and other similar encumbrances affecting Property which in the aggregate do not materially impair its use for the operation of the business of the Borrower or such Subsidiary, (f) Liens on Property of the Subsidiaries under capital leases and Liens on Property (including on the capital stock or other equity interests) of the Subsidiaries acquired (whether as a result of purchase, capital lease, merger or other acquisition) and either existing on such Property when acquired, or created contemporaneously with or within 12 months of such acquisition to secure the payment or financing of the purchase price of such Property (including the construction, development, substantial repair, alteration or improvement thereof), and any renewals thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such Liens attach only to the Property so purchased or acquired (including any such construction, development, substantial repair, alteration or improvement thereof)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the Indebtedness secured by such Liens is not otherwise prohibited hereunder, (g) statutory Liens in favor of lessors arising in connection with Property leased to the Borrower or any of the Subsidiaries, (h) Liens of attachments, judgments or awards against the Borrower or any of the Subsidiaries with respect to which an appeal or proceeding for review shall be pending or a stay of execution or bond shall have been obtained, or which are otherwise being contested in good faith and by appropriate proceedings diligently conducted, and in respect of which adequate reserves shall have been established in accordance with GAAP on the books of the Borrower or such Subsidiary, (i) Liens securing Indebtedness   of a Subsidiary to the Borrower or another Subsidiary, (j) Liens (other than Liens permitted by any of the foregoing clauses) arising in the ordinary course of its business which do not secure Indebtedness and do  not, in the aggregate, materially detract from the value of the business of the Borrower and its Subsidiaries, taken as a whole, (k) Liens in favor of the United States of America, or any state thereof, to secure partial, progress, advance or other payments pursuant to any contract or provisions of any statute, and (l) additional Liens securing Indebtedness of the Borrower and the Subsidiaries in an aggregate outstanding Consolidated principal amount not exceeding 15% of Net Tangible Assets.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Dispositions</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Make any Disposition (including by way of limited liability company division), or permit any of    its Subsidiaries so to do, of all or substantially all of the assets of the Borrower and the Subsidiaries on a Consolidated basis&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that (a) any Subsidiary may make Dispositions to the Borrower, and (b) so  long as no Default or Event of Default exists immediately prior to or immediately after giving effect thereto, (i) the Borrower may dispose of all or substantially all of its assets to a wholly-owned domestic Subsidiary that assumes all of the obligations of the Borrower under this Agreement and (ii) any Subsidiary may  dispose of all or substantially all of its assets to another Subsidiary&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if such Subsidiary is a wholly-owned Subsidiary, the transferee shall be a wholly-owned Subsidiary.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Merger or Consolidation, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Consolidate with, be acquired by, or merge into or with any Person unless (x) immediately after giving effect thereto, no Default shall or would exist and (y) either (i) the Borrower or (ii) a corporation organized and existing under the laws of one of the States of the United States of America or the District     of Columbia shall be the survivor of such consolidation or merger&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if the Borrower is not the survivor, the corporation which is the survivor shall expressly assume, pursuant to an instrument executed and delivered to the Administrative Agent, and in form and substance reasonably satisfactory to the Administrative Agent, all obligations of the Borrower under the Loan Documents and the Administrative Agent shall have received such documents, opinions and certificates as it shall have reasonably requested    in connection therewith.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Limitation on Upstream Dividends by Subsidiaries</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Permit or cause any of the Subsidiaries (other than any Insurance Subsidiary) to enter into or agree, or otherwise be or become subject, to any agreement, contract or other arrangement (other than this Agreement and the other Loan Documents) with any Person (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Restrictive Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) pursuant to the terms of which (a) such Subsidiary is or would be prohibited from declaring or paying any cash dividends on any class of its stock owned directly or indirectly by the Borrower or any of the other Subsidiaries or from making any other distribution on account of any class of any such stock (herein referred to as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Upstream Dividends&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), or (b) the declaration or payment of Upstream Dividends by a Subsidiary to the Borrower or another Subsidiary, on an annual or cumulative basis, is or would be otherwise limited or restricted (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Dividend Restrictions&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">). Notwithstanding the foregoing, nothing in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall prohibit&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Dividend Restrictions set forth in any Restrictive Agreement in effect on the date hereof and any extensions, refinancings, renewals or replacements thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that the Dividend Restrictions in any such extensions, refinancings, renewals or replacements are no less favorable in any material respect to the Lenders than those Dividend Restrictions that are then in effect and that are being extended, refinanced, renewed or replaced&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Dividend Restrictions existing with respect to any Person acquired by the   Borrower or any Subsidiary and existing at the time of such acquisition, which Dividend  Restrictions are not applicable to any Person or the property or assets of any Person other than such Person or its property or assets acquired, and any extensions, refinancings, renewals or   replacements of any of the foregoing&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the Dividend Restrictions in any such extensions, refinancings, renewals or replacements are no less favorable in any material respect to the Lenders than those Dividend Restrictions that are then in effect and that are being extended, refinanced, renewed or replaced&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Dividend Restrictions consisting of customary net worth, leverage and other financial covenants, customary covenants regarding the merger of or sale of stock or assets of a Subsidiary, customary restrictions on transactions with affiliates, and customary subordination provisions governing Indebtedness owed to the Borrower or any Subsidiary, in each case contained in, or required by, any agreement governing Indebtedness incurred by a Subsidiary in accordance with the terms of this Agreement&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Dividend Restrictions contained in any other credit agreement so long as such Dividend Restrictions are no more restrictive than those contained in this Agreement (including Dividend Restrictions contained in the Existing 2021 Credit Agreement and the Existing 2022  Credit Agreement).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Ratio of Consolidated Indebtedness to Total Capitalization</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Permit its ratio of Consolidated Indebtedness to Total Capitalization at the end of any fiscal quarter to exceed 0.60&#58;1.00&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that (i) upon the consummation of any Material Acquisition and the written election of the Borrower to the Administrative Agent no later than thirty days following the consummation </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of such Material Acquisition, the maximum permitted ratio of Consolidated Indebtedness to Total Capitalization shall be increased by 0.05&#58;1.00 above the otherwise-applicable maximum permitted ratio of Consolidated Indebtedness to Total Capitalization with respect to the last day of the fiscal quarter during which such Material Acquisition shall have been consummated and the last day of each of the immediately following three consecutive fiscal quarters, and (ii) between the signing of the definitive agreement (or   offer documentation, as applicable) for a Material Acquisition and the earlier of (x) the closing of such Material Acquisition and (y) thirty days following the termination of such definitive agreement (or offer documentation, as applicable) for such Material Acquisition, any Acquisition Debt incurred to finance such Material Acquisition shall be excluded for purposes of calculation the ratio of Consolidated Indebtedness    to Total Capitalization hereunder.  The Borrower shall only be permitted to make an election pursuant to   the proviso of the preceding sentence twice during the term of this Agreement, and there shall be at least  two consecutive fiscal quarters between such elections during which time no increase to the maximum permitted ratio of Consolidated Indebtedness to Total Capitalization shall be in effect.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">DEFAULT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Events of Default</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following shall each constitute an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Event of Default&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> hereunder&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The failure of the Borrower to make any payment of principal on any Loan or any reimbursement payment in respect of any Letter of Credit when due and payable&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">The failure of the Borrower to make any payment of interest on any Loan or of any Fee on any date when due and payable and such default shall continue unremedied for a period of    5 Domestic Business Days after the same shall be due and payable&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The failure of the Borrower to observe or perform any covenant or agreement contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (with respect to the Borrower only), or in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">The failure of the Borrower to observe or perform any other covenant or agreement contained in this Agreement, and such failure shall have continued unremedied for a period of 30 days after the Borrower shall have become aware of such failure&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">&#91;Reserved&#93;&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.02pt">Any representation or warranty of the Borrower (or of any of its officers on its behalf) made in any Loan Document, or made in any certificate or report or other document (other than an opinion of counsel) delivered on or after the date hereof in connection with any such Loan Document shall in any such case prove to have been incorrect or misleading (whether because of misstatement or omission) in any material respect when made&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">(i) Obligations in an aggregate Consolidated amount in excess of the Threshold Amount of the Borrower (other than its obligations hereunder and under the Notes) and the Material Subsidiaries, whether as principal, guarantor, surety or other obligor, for the payment of any Indebtedness for Borrowed Money or any net liability under interest rate swap, collar, exchange or cap agreements, (A) shall become or shall be declared to be due and payable prior to the expressed maturity thereof, or (B) shall not be paid when due or within any grace period for the payment thereof, or (ii) any holder of any such obligations shall have the right to declare the Indebtedness   for Borrowed Money evidenced thereby due and payable prior to its stated maturity&#59; or</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">An involuntary proceeding shall be commenced or an involuntary petition shall be filed seeking (i) liquidation, reorganization or other relief in respect of the Borrower or any Material Subsidiary or its debts, or of a substantial part of its assets, under any federal, state or foreign bankruptcy, insolvency, receivership or similar law now or hereafter in effect or (ii) the   appointment of a receiver, trustee, custodian, sequestrator, conservator or similar official for the Borrower or any Material Subsidiary or for a substantial part of its assets, and, in any such case,  such proceeding or petition shall continue undismissed for 60 days or an order or decree approving or ordering any of the foregoing shall be entered&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">The Borrower or any Material Subsidiary shall (i) voluntarily commence any proceeding or file any petition seeking liquidation, reorganization or other relief under any federal, state or foreign bankruptcy, insolvency, receivership or similar law now or hereafter in effect, (ii) consent to the institution of, or fail to contest in a timely and appropriate manner, any proceeding    or petition described in clause (h) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, (iii) apply for or consent to the appointment   of a receiver, trustee, custodian, sequestrator, conservator or similar official for the Borrower or   any Material Subsidiary or for a substantial part of its assets, (iv) file an answer admitting the material allegations of a petition filed against it in any such proceeding, (v) make a general assignment for the benefit of creditors or (vi) take any action for the purpose of effecting any of the foregoing&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">The Borrower or any Material Subsidiary shall (i) generally not be paying its debts as such debts become due or (ii) admit in writing its inability to pay its debts as they become due&#59;   or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Judgments or decrees in an aggregate Consolidated amount in excess of the Threshold Amount (to the extent not covered by independent third-party insurance or captive insurance as to which the insurer does not dispute coverage) against the Borrower and the Material Subsidiaries shall remain unpaid, unstayed on appeal, undischarged, unbonded or undismissed for    a period of 60 days during which execution shall not be effectively stayed, or any action shall be legally taken by a judgment creditor to attach or levy upon any assets of the Borrower or any Material Subsidiary to enforce any such judgment&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">After the Effective Date a Change of Control shall occur&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.13pt">Solely to the extent as would have a Material Adverse effect&#58;  (i) any Termination Event shall occur (x) with respect to any Pension Plan (other than a Multiemployer Plan) or (y)   with respect to any other retirement plan subject to Section 302 of ERISA or Section 412 of the Internal Revenue Code, which plan, during the five year period prior to such Termination Event,  was the responsibility in whole or in part of the Borrower, any Material Subsidiary or any ERISA Affiliate&#59; (ii) the failure to satisfy the minimum funding standards under Section 302 of ERISA or Section 412 of the Internal Revenue Code shall exist with respect to any Pension Plan for which    the Borrower has responsibility (other than that portion of a Multiemployer Plan&#8217;s Accumulated Funding Deficiency to the extent such Accumulated Funding Deficiency is attributable to   employers other than the Borrower)&#59; (iii) any Person shall engage in a Prohibited Transaction involving any Employee Benefit Plan in respect of which it is reasonably likely that liability will    be imposed upon the Borrower&#59; (iv) the Borrower shall fail to pay when due an amount which is payable by it to the PBGC or to a Pension Plan (including a Multiemployer Plan) under Title IV of ERISA&#59; (v) the imposition on the Borrower of any tax under Section 4980(B)(a) of the Internal Revenue Code&#59; or (vi) the assessment of a civil penalty on the Borrower with respect to any Employee Benefit Plan under Section 502(c) of ERISA.  In determining the Consolidated amount  for any purpose pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the liabilities, funding amounts, taxes and penalties </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">referenced in the foregoing clauses of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall include those of the Material Subsidiaries and ERISA Affiliates of the Borrower to the extent the Borrower is obligated to pay  any such liabilities, funding amounts, taxes and penalties.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">9.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt;text-decoration:underline">Remedies</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Upon the occurrence of an Event of Default or at any time thereafter during the continuance of an Event of Default, the Administrative Agent, at the written request of the Required Lenders, shall notify the Borrower that the Commitments, the Swing Line Commitment and the Letter of Credit Commitment have been terminated and&#47;or that all of the Loans, the Notes and the Reimbursement Obligations and all accrued and unpaid interest on any thereof and all other  amounts owing under the Loan Documents have been declared immediately due and payable&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that upon the occurrence of an Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(h), (i) or (j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> with respect to the Borrower, the Commitments, the Swing Line Commitment and the Letter of Credit Commitment shall automatically terminate and all of the Loans, the Notes and the Reimbursement Obligations and all accrued and unpaid interest on any thereof and all other amounts owing under the Loan Documents shall become immediately due and payable without declaration or notice to   the Borrower. To the fullest extent not prohibited by law, except for the notice provided for in the preceding sentence, the Borrower expressly waives any presentment, demand, protest, notice of protest or other notice of any kind in connection with the Loan Documents and its obligations thereunder. To the fullest extent not prohibited by law, the Borrower further expressly waives and covenants not to assert any appraisement, valuation, stay, extension, redemption or similar law,   now or at any time hereafter in force which might delay, prevent or otherwise impede the performance or enforcement of the Loan Documents.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">In the event that the Commitments, the Swing Line Commitment and the Letter of Credit Commitment shall have been terminated or all of the Loans, the Notes and the Reimbursement Obligations shall have become or been declared to be due and payable pursuant to the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, (i) the Borrower shall forthwith deposit an amount equal to the Letter of Credit Exposure in a cash collateral account with and under the exclusive control of the Administrative Agent, and (ii) the Administrative Agent, the Issuers and the Lenders agree, among themselves, that any funds received from or on behalf of the Borrower under any Loan Document  by any Issuer or any Lender (except funds received by any Issuer or any Lender as a result of a purchase from such Issuer or such Lender, as the case may be, pursuant to the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.9(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) shall be remitted to the Administrative Agent, and shall be applied by the Administrative Agent in payment of the Loans, the Reimbursement Obligations and the other obligations of the Borrower under the Loan Documents in the following manner and order&#58; (1) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment    or reimbursement of the Administrative Agent, the Issuers and the Lenders, in that order, for any fees, expenses or amounts (other than the principal of and interest on the Reimbursement Obligations) due from the Borrower pursuant to the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and the Reimbursement Agreements, (2) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment of the Fees, (3) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">third</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment of   any other fees, expenses or amounts (other than the principal of and interest on the Loans and the Notes and the Reimbursement Obligations) payable by the Borrower to the Administrative Agent, any Issuer or any of the Lenders under the Loan Documents, (4) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">fourth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment, pro rata according to the outstanding principal balance of the Loans and the Letter of Credit Exposure of each Lender, of interest due on the Loans and the Reimbursement Obligations, (5) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">fifth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment, pro rata according to the sum of (A) the aggregate outstanding principal balance of the Loans of each Lender </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (B) the aggregate outstanding balance of the Reimbursement Obligations of each Lender, of the aggregate outstanding principal balance of the Loans and the aggregate outstanding balance of the Reimbursement Obligations, and (6) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">sixth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, any remaining funds shall be paid to whosoever shall be entitled thereto or as a court of competent jurisdiction shall direct.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">In the event that the Loans and the Notes and the Reimbursement Obligations shall have been declared due and payable pursuant to the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Administrative Agent, upon the written request of the Required Lenders, shall proceed to enforce  the Reimbursement Obligations and the rights of the holders of the Loans and the Notes by suit in equity, action at law and&#47;or other appropriate proceedings, whether for payment or the specific performance of any covenant or agreement contained in the Loan Documents. In the event that the Administrative Agent shall fail or refuse so to proceed, each Issuer and each Lender shall be entitled to take such action as the Required Lenders shall deem appropriate to enforce its rights under the Loan Documents.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">AGENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Appointment and Authority</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each Credit Party hereby irrevocably appoints BofA to act on its behalf as the Administrative Agent hereunder and under the other Loan Documents and authorizes the Administrative Agent to take such  actions on its behalf and to exercise such powers as are delegated to the Administrative Agent by the terms hereof or thereof, together with such actions and powers as are reasonably incidental thereto. The provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (other than </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) are solely for the benefit of the Administrative Agent and the Credit Parties and the Borrower shall have no rights as a third party beneficiary or otherwise of any of such provisions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Rights as a Lender</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Person serving as the Administrative Agent hereunder shall have the same rights and powers    in its capacity as a Lender (which includes Issuer) as any other Lender and may exercise the same as though it were not the Administrative Agent and the term &#8220;Lender&#8221; or &#8220;Lenders&#8221; shall, unless otherwise expressly indicated or unless the context otherwise requires, include the Person serving as the Administrative Agent hereunder in its individual capacity. Such Person and its Affiliates may accept deposits from, lend money   to, own securities of, act as the financial advisor or in any other advisory capacity for and generally engage in any kind of business with, the Borrower, any of its Subsidiaries or any other Affiliate thereof as if such Person were not the Administrative Agent hereunder and without any duty to account therefor to the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Exculpatory Provisions</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Administrative Agent shall not have any duties or obligations except those expressly set forth herein and in the other Loan Documents. Without limiting the generality of the foregoing, the Administrative Agent&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">shall not be subject to any fiduciary or other implied duties, regardless of whether a Default has occurred and is continuing&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">shall not have any duty to take any discretionary action or exercise any discretionary powers, except discretionary rights and powers expressly contemplated   hereby or by the other Loan Documents that the Administrative Agent is required to  exercise as directed in writing by the Required Lenders (or such other number or percentage of the Lenders as shall be expressly provided for herein or in the other Loan Documents)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the Administrative Agent shall not be required to take any action that, in its opinion or the opinion of its counsel, may expose the Administrative Agent to liability or that is contrary to any Loan Document or applicable law&#59; and</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">shall not, except as expressly set forth herein and in the other Loan Documents, have any duty to disclose, and shall not be liable for the failure to disclose,    any information relating to the Borrower, any of its Subsidiaries or any Affiliate thereof   that is communicated to or obtained by the Person serving as the Administrative Agent or any of its Affiliates in any capacity.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">The Administrative Agent shall not be liable for any action taken or not taken by     it (i)&#160;with the consent or at the request of the Required Lenders (or such other number or percentage of the Lenders as shall be necessary, or as the Administrative Agent shall believe in good faith shall be necessary, under the circumstances as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) or (ii)&#160;in the absence of its own gross negligence or willful misconduct. The Administrative Agent shall be deemed not to have knowledge of any Default unless and until written notice describing such Default is given to the Administrative Agent by the Borrower, a Lender or an Issuer.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Administrative Agent shall not be responsible for or have any duty to ascertain or inquire into (i) any statement, warranty or representation made in or in connection with this Agreement or any other Loan Document, (ii) the contents of any certificate, report or other document delivered hereunder or thereunder or in connection herewith or therewith, (iii) the performance or observance of any of the covenants, agreements or other terms or conditions set  forth herein or therein or the occurrence of any Default, (iv) the validity, enforceability, effectiveness or genuineness of this Agreement, any other Loan Document or any other agreement, instrument or document or (v) the satisfaction of any condition set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">    or elsewhere herein, other than to confirm receipt of items expressly required to be delivered to the Administrative Agent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">The Administrative Agent shall not be responsible or have any liability for, or have any duty to ascertain, inquire into, monitor or enforce, compliance with the provisions of this Agreement relating to Disqualified Institutions.  Without limiting the generality of the foregoing,  the Administrative Agent shall not (x) be obligated to ascertain, monitor or inquire as to whether  any Lender or prospective Lender is a Disqualified Institution or (y)&#160;have any liability with respect to or arising out of any assignment of Loans, or disclosure of confidential information, to any Disqualified Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Reliance by Administrative Agent</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall be entitled to rely upon, and shall not incur any liability for relying upon, any notice, request, certificate, consent, statement, instrument, document or other writing (including any electronic message, internet or intranet website posting or other distribution) believed by it to be  genuine and to have been signed, sent or otherwise authenticated by the proper Person. The Administrative Agent also may rely upon any statement made to it orally or by telephone and believed by it to have been made by the proper Person, and shall not incur any liability for relying thereon. In determining compliance with any condition hereunder to the making of a Loan or the issuance of a Letter of Credit that by its terms must be fulfilled to the satisfaction of a Lender or an Issuer, the Administrative Agent may presume that such condition is satisfactory to such Lender or such Issuer unless the Administrative Agent shall have received notice to the contrary from such Lender or such Issuer prior to the making of such Loan or the issuance of such Letter of Credit. The Administrative Agent may consult with legal counsel (who may be counsel for the Borrower), independent public accounting firms and other experts selected by it and shall  not be liable for any action taken or not taken by it in accordance with the advice of any such counsel, accounting firm or experts.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Delegation of Duties</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent may perform any and all of its duties and exercise its rights and powers hereunder or under any other Loan Document by or through any one or more sub-agents appointed by the Administrative Agent. The Administrative Agent and any such sub-agent may perform any and all of its duties and exercise its rights and powers by or through their respective Related Parties. The exculpatory provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall apply to any such sub-agent and to the Related Parties of the Administrative Agent and any such sub-agent, and shall apply to their respective activities in connection with the syndication of the credit facilities provided for herein as well as activities as the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Resignation of Administrative Agent</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Administrative Agent may at any time give notice of its resignation to the Credit Parties and the Borrower. Upon receipt of any such notice of resignation, the Required Lenders shall have the right, subject to, so long as no Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(h),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> has occurred and is continuing, the consent    of the Borrower (such consent not to be unreasonably withheld or delayed), to appoint a successor, which shall be a bank with an office in New York, New York, or an Affiliate of any such bank with an office in New York, New York. If no such successor shall have been so appointed by the Required Lenders and shall have accepted such appointment within 30&#160;days after the retiring Administrative Agent gives notice of its resignation, then the retiring Administrative Agent may    on behalf of the Credit Parties, appoint a successor Administrative Agent meeting the qualifications set forth above, subject to, so long as no Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(h),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> has occurred and is continuing, the consent of the Borrower (such consent not to be unreasonably withheld or delayed)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if the Administrative Agent shall notify the Borrower and the Credit Parties that no qualifying Person has accepted such appointment, then such resignation shall nonetheless become effective in accordance with such notice and the retiring Administrative Agent shall be discharged from its duties and obligations hereunder and under the other Loan Documents and all payments, communications and determinations provided to be made by, to or through the Administrative Agent shall instead be made by or to each Credit Party directly, until such time as the Required Lenders appoint a  successor Administrative Agent as provided for above in this Section. Upon the acceptance of a successor&#8217;s appointment as Administrative Agent hereunder, such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring (or retired) Administrative Agent, and the retiring Administrative Agent shall be discharged from all of its duties and obligations hereunder or under the other Loan Documents (if not already discharged therefrom as provided above in this Section). The fees payable by the Borrower to a successor Administrative Agent shall be the same as those payable to its predecessor unless otherwise agreed in writing between the Borrower and such successor. After the retiring Administrative Agent&#8217;s resignation hereunder and under the other Loan Documents, the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall continue in effect for the benefit of such retiring Administrative Agent, its       sub-agents and their respective Related Parties in respect of any actions taken or omitted to be taken by any of them while the retiring Administrative Agent was acting as Administrative Agent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Any resignation by BofA as Administrative Agent pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall also constitute its resignation as an Issuer and Swing Line Lender.  If BofA resigns as an Issuer, it shall, pending the issuance of letters of credit in substitution of the outstanding Letters of Credit in accordance with clause (iii) of the last sentence of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10.6(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and the return and cancellation of such outstanding Letters of Credit, retain all the rights, powers, privileges and duties of an Issuer hereunder with respect to all Letters of Credit outstanding as of the effective date of its </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">resignation as an Issuer and all Reimbursement Obligations with respect thereto, including the right to require the Lenders to make ABR Advances or fund risk participations pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.   If BofA resigns as Swing Line Lender, it shall retain all the rights of the Swing Line Lender provided for hereunder with respect to Swing Line Loans made by it and outstanding as of the effective date of such resignation, including the right to require the Lenders to make ABR Advances or fund risk participations in outstanding Swing Line Loans pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Upon the appointment by the Borrower of a successor Issuer or Swing Line Lender hereunder (which successor shall in all cases be a Lender other than a Defaulting Lender), (i) such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring Issuer or Swing Line Lender, as applicable, (ii) the retiring Issuer and Swing Line Lender shall be discharged from all of their respective duties and obligations hereunder or under the other Loan Documents (other than with respect to outstanding Swing Line Loans made by it and outstanding Letters of Credit issued by it), and (iii) the successor Issuer shall issue letters of credit in substitution for the Letters of Credit, if any, outstanding at the time of such succession or make other arrangements satisfactory to BofA and the Borrower to effectively assume the obligations of BofA with respect to such Letters of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Non-Reliance on Administrative Agent and Other Credit Parties</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each Credit Party acknowledges that it has, independently and without reliance upon the Administrative Agent or any other Credit Party or any of their Related Parties and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Agreement. Each Credit Party also acknowledges that it will, independently and without reliance upon the Administrative Agent or any other Credit Party or any of their Related Parties and based on such documents and information as it shall from time to time deem appropriate, continue to make its own decisions in taking or not taking action under or based upon this Agreement, any other Loan Document or any related  agreement or any document furnished hereunder or thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">No Other Duties, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Anything herein to the contrary notwithstanding, none of the Joint Lead Arrangers, the  Sustainability Coordinator, the Co-Documentation Agents or the Co-Syndication Agents shall have any powers, duties or responsibilities under this Agreement or any of the other Loan Documents, except in its capacity, as applicable, as the Administrative Agent, a Lender or an Issuer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Recovery of Erroneous Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Without limitation of any other provision in this Agreement, if at any time the Administrative Agent makes a payment hereunder in error to any Lender or any Issuer (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Lender Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), whether or not in respect of an obligation due and owing by the Borrower at such time, where such payment is a Rescindable Amount, then in any such event, each Lender Party receiving a Rescindable Amount severally agrees to repay to the Administrative Agent forthwith on demand the Rescindable Amount received by such Lender Party in immediately available funds in the currency so received, with interest thereon, for each day from and including the date such Rescindable Amount is received by it to but excluding the date of payment to  the Administrative Agent, at the greater of the Federal Funds Effective Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation.  Each Lender Party irrevocably waives any and all defenses, including any &#8220;discharge for value&#8221; (under which a creditor might otherwise claim a right to retain funds mistakenly paid by a third party in respect of a debt owed by another) or similar defense to its obligation to return any Rescindable Amount.&#160; The Administrative Agent shall inform each Lender Party promptly upon determining that any payment made to such Lender Party comprised, in whole or in part, a Rescindable Amount.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">OTHER PROVISIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Amendments, Waivers, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">With the written consent of the Required Lenders, the Administrative Agent and the Borrower may, from time to time, enter into written amendments, supplements or modifications of the Loan Documents (which, for the avoidance of doubt, shall require the prior written consent of the Borrower) and, with the written consent of the Required Lenders and the Borrower, the Administrative Agent on behalf of the Lenders may execute and deliver to any such parties a written instrument waiving or consenting to the departure from, on such terms and conditions as the Administrative Agent may specify in such instrument (which terms and conditions shall have been agreed to by the Borrower), any of the requirements of the  Loan Documents or any Default or any Event of Default and its consequences, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that no such amendment, supplement, modification, waiver or consent shall (i) increase the Commitment Amount of    any Lender without the consent of such Lender (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that no waiver of a Default or Event of Default shall be deemed to constitute such an increase), (ii) extend the Commitment Period without the consent of each Lender directly affected thereby, (iii) reduce the amount, or extend the time of payment, of the Fees without the consent of each Lender directly affected thereby, (iv) reduce the rate, or extend the time of payment of, interest on any Revolving Credit Loan, any Note or any Reimbursement Obligation (other than the applicability of any post-default increase in such rate of interest) without the consent of each Lender directly affected thereby, (v) reduce the amount of, or extend the time of payment of, any payment of any Reimbursement Obligation or principal on any Revolving Credit Loan or any Note without the consent of each Lender directly affected thereby, (vi) decrease or forgive the principal amount of any Revolving Credit Loan, any Note or any Reimbursement Obligation without the consent of each Lender directly affected thereby, (vii) consent to any assignment or delegation by the Borrower of any of its rights or obligations under any Loan Document without the consent of each Lender, (viii) change the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> without the consent of each Lender, (ix) change the definition of Required Lenders without the consent of each Lender, (x) change the several nature of the obligations of the Lenders without the consent of each Lender, (xi) change the sharing provisions among Lenders without the consent of each Lender directly affected thereby, or (xii) extend the expiration date of a Letter of Credit beyond the Commitment Termination Date without the consent of each Lender. Notwithstanding the foregoing, in addition to the receipt of the prior written consents of the Borrower and the Required Lenders, no such amendment, supplement, modification, waiver or consent shall (A) amend, modify or waive any provision of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or otherwise change any of the rights or obligations of the Administrative Agent, any Issuer or the Swing Line Lender under any Loan Document without the written consent of the Administrative Agent, such   Issuer or the Swing Line Lender, as the case may be, (B) change the Letter of Credit Commitment, change the amount or the time of payment of any Letter of Credit or any commission or fee payable to the Issuer thereof in connection therewith, or change any other term or provision which relates to the Letter of Credit Commitment of such Issuer or the Letters of Credit issued thereby without the written consent of such  Issuer, (C) change the Swing Line Commitment, change the amount or the time of payment of the Swing Line Loans or interest thereon or change any other term or provision which relates to the Swing Line Commitment or the Swing Line Loans without the written consent of the Swing Line Lender or (D) change the amount or the time of payment of any Competitive Bid Loan or interest thereon without the written consent of the Lender holding such Competitive Bid Loan. Any such amendment, supplement,   modification, waiver or consent shall apply equally to each of the Lenders and shall be binding upon the parties to the applicable Loan Document, the Lenders, the Issuers, the Administrative Agent and all future holders of the Loans, the Notes and the Reimbursement Obligations. In the case of any waiver, the  Borrower, the Lenders, the Issuers and the Administrative Agent shall be restored to their former position and rights under the Loan Documents, but any Default or Event of Default waived shall not extend to any subsequent or other Default or Event of Default, or impair any right consequent thereon. Notwithstanding anything to the contrary in this Agreement or in any other Loan Document, (1) the Administrative Agent  and the Borrower may make amendments contemplated by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> without the consent of any other </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Person party hereto, (2) in order to implement any ESG Amendment, this Agreement and the other Loan Documents may be amended in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> with only the consent of the Borrower, the Sustainability Coordinator and the Required Lenders (as and to the extent provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), (3) if the Administrative Agent and the Borrower shall have jointly identified an obvious error, ambiguity, defect, inconsistency, omission or any error or omission of a technical nature, in each case, in any provision of the Loan Documents, then the Administrative Agent and the Borrower shall be permitted to amend such provision, and, in each case, such amendment shall become effective without any further action or consent  of any party to any Loan Document (other than the Administrative Agent and the Borrower) if the same (x) does not adversely affect the rights of any Lender or (y) is not objected to in writing by the Required Lenders to the Administrative Agent within five Domestic Business Days following receipt of notice thereof, and   (4) this Agreement may be amended or amended and restated without the consent of any specific Lender  (but with the consent of the Borrower and the Administrative Agent) if, upon giving effect to such amendment or amendment and restatement, such Lender shall no longer be a party to this Agreement (as     so amended or amended and restated, as the case may be), the Commitments of such Lender shall have terminated, such Lender shall have no other commitment or other obligation hereunder and shall have been paid in full all principal, interest and other amounts owing to it or accrued for its account under this Agreement. Any amendment, waiver or consent effected in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be binding upon each Person that is at the time thereof a Lender and each Person that subsequently becomes a Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Notices</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Notices Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Except in the case of notices and other communications expressly permitted to be given by telephone, all notices and other communications provided for herein shall be in writing and shall be delivered by hand or overnight courier service, mailed by certified or registered mail or sent by facsimile or email, as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">If to the Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CVS Health Corporation</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1 CVS Drive</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">MC2340</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Woonsocket, Rhode Island 02895</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attention&#58;&#160;&#160;&#160;&#160;Carol A. DeNale</font></div><div style="padding-left:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Senior Vice President and Treasurer</font></div><div style="padding-left:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Facsimile&#58;&#160;&#160;&#160;&#160;(401) 770-5768</font></div><div style="padding-left:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Telephone&#58;&#160;&#160;&#160;&#160;(401) 770-4407</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Email&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;carol.denale&#64;cvshealth.com</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">with a copy, in the case of a notice of Default or Event of Default, to&#58;</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CVS Health Corporation</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1 CVS Drive</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Woonsocket, Rhode Island 02895</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attention&#58;&#160;&#160;&#160;&#160;Tom Moffatt</font></div><div style="padding-left:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Vice President, Assistant Secretary and Assistant General Counsel &#8211; Corporate Services</font></div><div style="padding-left:72pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Facsimile&#58;&#160;&#160;&#160;&#160;(401) 216-3758</font></div><div style="padding-left:72pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Telephone&#58;&#160;&#160;&#160;&#160;(401) 770-5409</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Email&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;thomas.moffatt&#64;cvshealth.com</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">with a copy (in the case of a notice of Default or Event of Default and which shall not constitute notice under this Agreement or any other Loan Document for any purpose) to&#58;</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Shearman &#38; Sterling LLP</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">599 Lexington Avenue</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">New York, New York 10022</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attention&#58;&#160;&#160;&#160;&#160;Gus M. Atiyah</font></div><div style="padding-left:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Facsimile&#58;&#160;&#160;&#160;&#160;(646) 848-5227</font></div><div style="padding-left:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Telephone&#58;&#160;&#160;&#160;&#160;(212) 848-5227</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Email&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;gus.atiyah&#64;shearman.com</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">If to the Administrative Agent, BofA as an Issuer or the Swing Line Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in the case of each Borrowing Request, each notice of prepayment under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, each Letter    of Credit Request, each Competitive Bid Request, each Competitive Bid, and each Competitive    Bid Accept&#47;Reject Letter&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Bank of America, N.A., as Administrative Agent</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">900 W. Trade St., 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Floor </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NC1-026-06-04</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Charlotte, NC 28255</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attention&#58;&#160; Kennedy Diggs</font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Tel&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">980-387-4805</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Facsimile&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">704-625-5608</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Email&#58; kennedy.diggs&#64;bofa.com </font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Remittance Instructions- US Dollars</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Bank of America, N.A. </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">New York, NY</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ABA# </font><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">XXXXXXXXX</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Account No.&#58;  </font><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">XXXXXXXXXXXXX</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Account Name&#58; Wire Clearing Acct for Syn Loans-LIQ</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ref&#58;  CVS HEALTH CORPORATION </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in the case of each Letter of Credit Request&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Bank of America, N.A.</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Trade Operations</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1 Fleet Way</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Mail Code&#58; PA6-580-02-30</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Scranton, Pa. 18507</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attention&#58;  Trade Operations</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Tel&#58; 570-496-9619</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Facsimile&#58; 800-755-8740</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Email&#58; tradeclientserviceteamus&#64;bofa.com</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Remittance Instructions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Bank of America, N.A.</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">New York, NY</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ABA #&#58; </font><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">XXX-XXX-XXX</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Account #&#58; </font><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">XXXXX-XXXXXX</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attn&#58; Scranton Standby&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ref&#58; CVS HEALTH CORPORATION </font></div><div style="padding-left:72pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and in all other cases&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Bank of America, N.A., as Administrative Agent</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">900 W. Trade St., 6th Floor </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NC1-026-06-03</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Charlotte, NC 28255</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attention&#58;  Kyle Harding</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Tel&#58; 980-275-6132</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Facsimile&#58; 704-719-5215</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Email&#58; kyle.d.harding&#64;bofa.com</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">If to any Lender or any other Issuer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; to it at its address (or facsimile number or email address) set forth in its Administrative Questionnaire.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Electronic Communications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notices and other communications to the Credit  Parties hereunder may be delivered or furnished by electronic communication (including email, FpML messaging and internet or intranet websites) pursuant to procedures approved by the Administrative Agent&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the foregoing shall not apply to notices to any Credit Party pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> if such Credit Party has notified the Administrative Agent that  it is incapable of receiving notices under such Sections by electronic communication. The Administrative Agent or the Borrower may, in its discretion, agree to accept notices and other communications to it hereunder by electronic communications pursuant to procedures approved by it&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that approval of such procedures may be limited to particular notices or communications.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Unless the Administrative Agent otherwise prescribes, (i)&#160;notices and other  communications sent to an email address shall be deemed received upon the sender&#8217;s receipt of an acknowledgement from the intended recipient (such as by the &#8220;return receipt requested&#8221; or &#8220;read requested&#8221; function, as available, return email or other written acknowledgement)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if such notice or other communication is not sent during the normal business hours of the recipient, such notice or communication shall be deemed to have been sent at the opening of business on the next Domestic Business Day for the recipient, and (ii)&#160;notices or communications posted to an internet or intranet website shall be deemed received upon the deemed receipt by the intended recipient at its email address as described in the foregoing clause&#160;(i) of notification that such notice or communication is available and identifying the website address therefor.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Change of Address</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Any party hereto may change its address, facsimile number or email address for notices and other communications hereunder by notice to the other parties hereto (or, in the case of any Lender or any Issuer, by notice to the Administrative Agent and the Borrower). Subject to the second paragraph of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, all notices and other communications given to any party hereto in accordance with the provisions of this Agreement   shall be deemed to have been given on the date of receipt&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any such notice or communication that is not received on a Domestic Business Day during the normal business hours  of the recipient shall be deemed received at the opening of business on the next Domestic Business Day.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">The Platform</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">THE PLATFORM IS PROVIDED &#8220;AS IS&#8221; AND &#8220;AS AVAILABLE.&#8221;  THE AGENT PARTIES (AS DEFINED BELOW) DO NOT WARRANT THE ACCURACY OR COMPLETENESS OF THE BORROWER MATERIALS OR THE  ADEQUACY OF THE PLATFORM, AND EXPRESSLY DISCLAIM LIABILITY FOR   ERRORS IN OR OMISSIONS FROM THE BORROWER MATERIALS.  NO WARRANTY OF ANY KIND, EXPRESS, IMPLIED OR STATUTORY, INCLUDING ANY WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT  OF THIRD PARTY RIGHTS OR FREEDOM FROM VIRUSES OR OTHER CODE DEFECTS,  IS MADE BY ANY AGENT PARTY IN CONNECTION WITH THE BORROWER  MATERIALS OR THE PLATFORM.  In no event shall the Administrative Agent or any of its Related Parties (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Agent Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) have any liability to the Borrower, any Lender, any Issuer or any other Person for losses, claims, damages, liabilities or expenses of any kind (whether in tort, contract or otherwise) arising out of the Borrower&#8217;s or the Administrative Agent&#8217;s transmission of Borrower Materials or notices through the Platform, any other electronic platform    or electronic messaging service, or through the Internet.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">No Waiver&#59; Cumulative Remedies</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No failure to exercise and no delay in exercising, on the part of the Administrative Agent, any Lender or any Issuer, any right, remedy, power or privilege under any Loan Document shall operate as a waiver thereof, nor shall any single or partial exercise of any right, remedy, power or privilege under any Loan Document preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege. The rights, remedies, powers and privileges under the Loan Documents are cumulative and not exclusive of any rights, remedies, powers and privileges provided by law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Survival of Representations and Warranties</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">All representations and warranties made in the Loan Documents and in any document, certificate    or statement delivered pursuant thereto or in connection therewith shall survive the execution and delivery  of the Loan Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Payment of Expenses&#59; Indemnified Liabilities</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Borrower agrees, as soon as practicable following presentation of a statement  or invoice therefor setting forth in reasonable detail the items thereof, and whether any Loan is  made or Letter of Credit is issued, (a) to pay or reimburse the Administrative Agent and its  Affiliates for all their reasonable and documented out-of-pocket costs and expenses actually  incurred in connection with the development, syndication, preparation and execution of, and any amendment, waiver, consent, supplement or modification to, the Loan Documents, any documents prepared in connection therewith and the consummation of the transactions contemplated thereby, whether such Loan Documents or any such amendment, waiver, consent, supplement or modification to the Loan Documents or any documents prepared in connection therewith are executed and whether the transactions contemplated thereby are consummated, including the reasonable and documented out-of-pocket fees and disbursements of Special Counsel, (b) to pay, indemnify, and hold the Administrative Agent, the Lenders and the Issuers harmless from any and all recording and filing fees and any and all liabilities and penalties with respect to, or resulting  from any delay (other than penalties to the extent attributable to the negligence of the  Administrative Agent, the Lenders or the Issuers, as the case may be, in failing to pay such fees, liabilities or penalties when due) which may be payable or determined to be payable in connection with the execution and delivery of, or consummation of any of the transactions contemplated by,    or any amendment, supplement or modification of, or any waiver or consent under or in respect of, </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Loan Documents or any documents prepared in connection therewith, and (c) to pay, reimburse, indemnify and hold each Indemnified Person harmless from and against any and all other liabilities, obligations, claims, losses, damages, penalties, actions, judgments, suits, costs, expenses and disbursements of any kind or nature whatsoever (including the reasonable and documented out-of-pocket fees and disbursements of one counsel (but excluding the allocated cost of internal counsel) representing all of the Indemnified Persons, taken as a whole, and, if reasonably necessary, of a single local counsel for each applicable jurisdiction (and, if reasonably necessary, one specialty counsel for each applicable specialty), representing all of the Indemnified Persons, taken as a whole (and, in the case of any actual or perceived conflict of interest where the Indemnified Person  affected by such conflict notifies the Borrower of the existence of such conflict and thereafter  retains its own counsel, of another firm of counsel (and, if reasonably necessary, a single local counsel for each applicable jurisdiction (which may include a single counsel acting in multiple jurisdictions) (and, if reasonably necessary, one specialty counsel for each applicable specialty),    for each such affected Indemnified Person))) actually incurred with respect to the enforcement, performance of, and preservation of rights under, the Loan Documents (all the foregoing, collectively, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Indemnified Liabilities&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) and, if and to the extent that the foregoing indemnity may be unenforceable for any reason, the Borrower agrees to make the maximum payment  permitted under applicable law. Notwithstanding anything to the contrary contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the foregoing payment, indemnification and reimbursement obligations will not, as to any Person identified in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, apply to any losses, claims, damages, liabilities and related expenses to the extent arising (A) from the willful misconduct, gross negligence, fraud or bad faith of such Person, (B) from a material breach of the obligations hereunder of such Person, (C) out of   or in connection with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, or (D) out of or in connection with any claim, litigation, investigation or proceeding that does not involve an act or omission of the Borrower or any of its Affiliates and that is brought by any such Person against any such other Person (other than the Administrative Agent, a Joint Lead Arranger, the Issuer or the Swing Line Lender, in each case, in its capacity as such), in each case under clauses (A) and (B), to the extent determined by a final and non-appealable judgment of a court of competent jurisdiction. The agreements in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall survive the termination of the Commitments and the payment of the Loans and the Notes and all other amounts payable under the Loan Documents.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Notwithstanding the above, the Borrower shall have no liability under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> to indemnify or hold harmless any Indemnified Person for any losses, claims, damages, liabilities and related expenses relating to income or withholding Taxes or any Tax in lieu of such Taxes. Notwithstanding the foregoing, any amounts claimed by an Indemnified Person under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall not be available to be claimed by such Indemnified Person under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, it being understood and agreed that the rights of an Indemnified Person under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall not be duplicative.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Lending Offices</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each Lender shall have the right at any time and from time to time to transfer any Loan to a different office of such Lender, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Successors and Assigns</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Successors and Assigns Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and  assigns permitted hereby, except that the Borrower may not assign or otherwise transfer any of its rights or obligations hereunder without the prior written consent of the Administrative Agent and each Lender and no Lender may assign or otherwise transfer any of its rights or obligations </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">hereunder except (i) to an assignee in accordance with the provisions of paragraph (b) of this  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, (ii) by way of participation in accordance with the provisions of paragraph (d) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or (iii) by way of pledge or assignment of a security interest subject to the restrictions of paragraph (f) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (and any other attempted assignment or transfer by any party hereto shall be null and void). Nothing in this Agreement, expressed or implied, shall be construed  to confer upon any Person (other than the parties hereto, their respective successors and assigns permitted hereby, the Participants to the extent provided in paragraph (d) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and,   to the extent expressly contemplated hereby, the Related Parties of each Credit Party) any legal or equitable right, remedy or claim under or by reason of this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Assignments by Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Any Lender may at any time assign to one or more assignees all or a portion of its rights and obligations under this Agreement (including all or a portion of its Commitment and the Loans and obligations in respect of its Letter of Credit Exposure and Swing Line Exposure at the time owing to it)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any such assignment shall be subject to the following conditions&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Minimum Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.74pt">in the case of an assignment of the entire remaining amount of the assigning Lender&#8217;s Commitment Amount or Swing Line Commitment and the Loans and obligations in respect of its Letter of Credit Exposure and Swing Line Exposure at the time owing to it or in the case of an assignment to a Lender, an Affiliate of a Lender or an Approved Fund, no minimum amount need be assigned&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.35pt">in any case not described in paragraph (b)(1)(A) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Commitment Amount or Swing Line Commitment (which for this   purpose includes the Loans of the assigning Lender outstanding thereunder and obligations in respect of its Letter of Credit Exposure and Swing Line Exposure at the time owing to it thereunder) or, if the Commitment or Swing Line Commitment of the assigning Lender is not then in effect, the principal outstanding balance of  the Loans and the Letter of Credit Exposure and Swing Line Exposure of the assigning Lender subject to each such assignment (determined as of the date the Assignment and Assumption with respect to such assignment is delivered to the Administrative Agent or, if a &#8220;Trade Date&#8221; is specified in the Assignment and Assumption, as of such &#8220;Trade Date&#8221;) shall not be less than $5,000,000, unless  each of the Administrative Agent and, so long as no Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(h),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> has occurred and is continuing, the Borrower otherwise consents (each such consent not to be unreasonably withheld or delayed).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Proportionate Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each partial assignment shall be made as an assignment of a proportionate part of all the assigning Lender&#8217;s rights and obligations under this Agreement with respect to the Loans, Letter of Credit Exposure and Swing Line Exposure or the Commitment assigned, except that this clause (2) shall not prohibit any Lender from assigning all or a portion of its rights and obligations in respect of Competitive Bid Loans on a non-pro rata basis.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Required Consents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. No consent shall be required for any assignment   except to the extent required by paragraph (b)(1)(B) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and, in addition&#58;</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.74pt">the consent of the Borrower (such consent not to be unreasonably withheld or delayed) shall be required unless (x) an Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(h),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> has occurred and is continuing at the time of such assignment or (y) such assignment is to a Lender, an Affiliate of a Lender or an Approved Fund (it being understood that it shall not be deemed unreasonable for the Borrower to withhold consent to any assignment if it reasonably believes that such assignment would result in the Borrower incurring increased costs pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">)&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.35pt">the consent of the Administrative Agent (such consent not to be unreasonably withheld, conditioned or delayed) shall be required for assignments   in respect of an unfunded or revolving facility hereunder if such assignment is to     a Person that is not a Lender with a Commitment in respect of such facility, an Affiliate of such Lender or an Approved Fund with respect to such Lender&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.35pt">the consent of each Issuer (such consent not to be unreasonably withheld, conditioned or delayed) shall be required for any assignment that increases the obligation of the assignee to participate in exposure under one or   more Letters of Credit (whether or not then outstanding) and the Swing Line  Lender (such consent not to be unreasonably withheld or delayed) shall be required for any assignment in respect of the revolving facility hereunder.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Assignment and Assumption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The parties to each assignment shall execute and deliver to the Administrative Agent an Assignment and Assumption, together with a processing and recordation fee of $4,500 ($7,500 in the case of an assignment by a Defaulting Lender) (which fee shall be paid by the assignor or the assignee and may be waived or reduced in the sole discretion of the Administrative Agent), and the assignee, if   it is not a Lender, shall deliver to the Administrative Agent an Administrative  Questionnaire.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">No Assignment to Certain Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. No such assignment shall be made to  (A) the Borrower, any of its Subsidiaries or any of their respective Affiliates or (B) any Defaulting Lender or any of its Subsidiaries or any Person who, upon becoming a Lender hereunder, would constitute any of the foregoing Persons described in this clause (B).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">No Assignment to Natural Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. No such assignment shall be made to    a natural person (or a holding company, investment vehicle or trust for, or owned and operated by or for the primary benefit of a natural person).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Certain Additional Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  In connection with any assignment of rights and obligations of any Defaulting Lender hereunder, no such assignment shall be effective unless and until, in addition to the other conditions thereto set forth herein, the parties to    the assignment shall make such additional payments to the Administrative Agent in an aggregate amount sufficient, upon distribution thereof as appropriate (which may be  outright payment, purchases by the assignee of participations or subparticipations, or other compensating actions, including funding, with the consent of the Borrower and the Administrative Agent, the applicable pro rata share of Loans previously requested but not funded by the Defaulting Lender, to each of which the applicable assignee and assignor hereby irrevocably consent), to (x) pay and satisfy in full all payment liabilities then owed by such Defaulting Lender to the Administrative Agent, any Issuer or any Lender   hereunder (and interest accrued thereon) and (y) acquire (and fund as appropriate) its full </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">pro rata share of all Loans and participations in Letters of Credit and Swing Line Loans in accordance with its Commitment Percentage. Notwithstanding the foregoing, in the event that any assignment of rights and obligations of any Defaulting Lender hereunder shall become effective under applicable law without compliance with the provisions of this  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">clause (7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, then the assignee of such interest shall be deemed to be a Defaulting Lender for all purposes of this Agreement until such compliance occurs.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Subject to acceptance and recording thereof by the Administrative Agent pursuant to paragraph (c) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, from and after the effective date specified in each Assignment  and Assumption, the assignee thereunder shall be a party to this Agreement and, to the extent of    the interest assigned by such Assignment and Assumption, have the rights and obligations of a Lender under this Agreement, and the assigning Lender thereunder shall, to the extent of the interest assigned by such Assignment and Assumption, be released from its obligations under this Agreement (and, in the case of an Assignment and Assumption covering all of the assigning Lender&#8217;s rights and obligations under this Agreement, such Lender shall cease to be a party hereto) but shall continue to be entitled to the benefits of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.6,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> with respect to facts and circumstances occurring prior to the effective date of such assignment. Any assignment or transfer by a Lender of rights or obligations under this Agreement that does not comply with this paragraph shall be treated for purposes of this Agreement as a sale by such Lender of a participation in such rights and obligations in accordance with paragraph (d) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Administrative Agent, acting solely for this purpose as an agent of  the Borrower, shall maintain at one of its offices in the United States of America a copy of each Assignment and Assumption delivered to it and a register for the recordation of the names and addresses of the Lenders, and the Commitments of, and principal amounts (and stated interest) of  the Loans owing to, each Lender pursuant to the terms hereof from time to time (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Register&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">). The entries in the Register shall be conclusive absent manifest error, and the Borrower, the Administrative Agent, the Issuers and the Lenders shall treat each Person whose name is recorded   in the Register pursuant to the terms hereof as a Lender hereunder for all purposes of this Agreement, notwithstanding notice to the contrary. The Register shall be available for inspection   by the Borrower, any Issuer and any Lender (but only, in the case of an Issuer or a Lender, at the Administrative Agent&#8217;s Office and with respect to any entry relating to such Lender&#8217;s  Commitments, Advances and other obligations pursuant to the terms hereof or such Issuer&#8217;s Letter of Credit Commitments and other obligations pursuant to the terms hereof, as applicable) at any reasonable time and from time to time upon reasonable prior notice.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Participations.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Any Lender may at any time, without the consent of, or notice to,   the Borrower or the Administrative Agent, sell participations to any Person (other than a natural person (or a holding company, investment vehicle or trust for, or owned and operated by or for the primary benefit of a natural person), the Borrower, any of its Subsidiaries or any of their respective Affiliates) (each, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) in all or a portion of such Lender&#8217;s rights and&#47;or obligations  under this Agreement (including all or a portion of its Commitment, Letter of Credit Exposure, Swing Line Exposure and&#47;or the Loans, Letter of Credit Exposure or Swing Line Exposure owing   to it)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that (i)&#160;all of such Lender&#8217;s obligations under this Agreement and the other Loan Documents shall remain in all respects unchanged, (ii)&#160;such Lender shall remain solely responsible to the other parties hereto for the performance of such obligations and (iii)&#160;the Borrower, the Administrative Agent and each Credit Party shall continue to deal solely and directly with such Lender in connection with such Lender&#8217;s rights and obligations under this Agreement. Any agreement or instrument pursuant to which a Lender sells such a participation shall provide that such Lender shall retain the sole right to enforce this Agreement and to approve any amendment, </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">modification or waiver of any provision of this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such agreement or instrument may provide that such Lender will not, without the consent of the Participant, agree to any amendment, modification or waiver which requires the consent of all Lenders or all affected Lenders that directly affects such Participant. Subject to paragraph (e) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Borrower agrees that each Participant shall be entitled to the benefits of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> to the same extent as if it were a Lender and had acquired its interest  by assignment pursuant to paragraph (b) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. To the extent permitted by law, each Participant also shall be entitled to the benefits of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;11.9(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as though it were a Lender&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such Participant agrees to be subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;11.9(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as though it were a Lender. Each Lender that sells a participation with respect to a Commitment or Loan shall, solely for the purposes of complying with the rules regarding registered form in the Internal Revenue Code, act   as a non-fiduciary agent of the Borrower, maintaining a register on which it enters the name and address of each Participant and the principal amounts (and stated interest amounts) of each Participant&#8217;s interest in the Commitment and&#47;or Loan (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Participant Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), and the entries in such Participant Register shall be conclusive, absent manifest error, and such Lender shall treat each Person whose name is recorded in the Participant Register as the owner of such participation for all purposes of this Agreement notwithstanding any notice to the contrary. No Lender shall be required to disclose the existence of, or any of the information contained in, any Participant Register maintained by it to the Borrower or any other Person unless requested in  writing by the Borrower, and only to the Internal Revenue Service to the extent such disclosure is required in order to comply with the rules requiring registered form pursuant to the Internal  Revenue Code.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Limitations upon Participant Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. A Participant shall not be entitled to receive any greater payment under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> than the applicable Lender would have been entitled to receive with respect to the participation sold to such Participant, unless the sale of the participation to such Participant is made with the Borrower&#8217;s prior written consent. A Participant shall not be entitled to the benefits of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> unless the Borrower is notified of the participation sold to such Participant and such Participant agrees, for the benefit of  the Borrower, to comply with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.10(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> as though it were a Lender.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.02pt;text-decoration:underline">Certain Pledges</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Any Lender may at any time pledge or assign a security interest    in all or any portion of its rights under this Agreement to secure obligations of such Lender, including any pledge or assignment to secure obligations to a Federal Reserve Bank or other central bank having jurisdiction over such Lender&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that no such pledge or assignment shall release such Lender from any of its obligations hereunder or substitute any such pledgee or assignee for such Lender as a party hereto.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Resignation as Issuer or Swing Line Lender after Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Notwithstanding anything to the contrary contained herein, if at any time any Issuer or the Swing Line Lender assigns all of its Commitment and Loans pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">clause (b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> above, such Issuer or Swing Line Lender may, (i) upon 30 days&#8217; notice to the Administrative Agent, the Borrower and the Lenders, resign     as an Issuer and&#47;or (ii) upon 30 days&#8217; notice to the Borrower, resign as Swing Line Lender.  In the event of any such resignation as an Issuer or Swing Line Lender, the Borrower shall be entitled to appoint from among the Lenders a successor Issuer or Swing Line Lender hereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that no failure by the Borrower to appoint any such successor shall affect the resignation  of the applicable Issuer or Swing Line Lender as an Issuer or Swing Line Lender, as the case may be.  If the applicable Issuer resigns as an Issuer, it shall retain all the rights, powers, privileges and duties of an Issuer hereunder with respect to all Letters of Credit issued by it and outstanding as of the effective date of its resignation as an Issuer and all Reimbursement Obligations with respect thereto (including the right to require the Lenders to make ABR Advances or fund risk  </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">participations in pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).  If the Swing Line Lender resigns as Swing Line Lender,  it shall retain all the rights of the Swing Line Lender provided for hereunder with respect to Swing Line Loans made by it and outstanding as of the effective date of such resignation, including the right to require the Lenders to make ABR Advances or fund risk participations in outstanding  Swing Line Loans pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Upon the appointment of a successor Issuer and&#47;or Swing Line Lender, (x) such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring Issuer or Swing Line Lender, as the case may be, and  (y) the successor Issuer shall issue letters of credit in substitution for the Letters of Credit, if any, outstanding at the time of such succession or make other arrangements satisfactory to the applicable retiring Issuer and the Borrower to effectively assume the obligations of the applicable retiring Issuer with respect to such Letters of Credit.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Disqualified Institutions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  (i)  No assignment shall be made to any Person that was   a Disqualified Institution as of the date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Trade Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) on which the applicable Lender entered into a binding agreement to sell and assign all or a portion of its rights and obligations under this Agreement to such Person (unless the Borrower has consented to  such assignment in writing as otherwise contemplated by this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, in which case such Person will not be considered a Disqualified Institution for the purpose of such assignment).  For the avoidance of doubt, with respect to any assignee that becomes a Disqualified Institution after the applicable Trade Date (including as a result of the delivery of a notice pursuant to, and&#47;or the expiration of the notice period referred to in, the  definition of &#8220;Disqualified Institution&#8221;), (x) such assignee shall not retroactively be disqualified from becoming a Lender and (y) the execution and delivery by the Borrower   of an Assignment and Assumption with respect to such assignee will not by itself result in such assignee no longer being considered a Disqualified Institution.  Any assignment in violation of this clause (h)(i) shall not be void, but the other provisions of this clause (h) shall apply.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;If any assignment is made to any Disqualified Institution without the Borrower&#8217;s prior consent in violation of clause (i) above, or if any Person becomes a Disqualified Institution after the applicable Trade Date, the Borrower may, at its sole expense and effort, upon notice to the applicable Disqualified Institution and the Administrative Agent, (A) terminate any Commitment of such Disqualified Institution and repay all obligations of the Borrower owing to such Disqualified Institution in connection with such Commitment, and&#47;or (B) require such Disqualified Institution to assign and delegate, without recourse (in accordance with and subject to the restrictions contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), all of its interest, rights and obligations under this Agreement and the other Loan Documents to an Eligible Assignee that shall assume such obligations at the lesser of (x) the principal amount thereof and (y) the amount that such Disqualified Institution paid to acquire such interests, rights and obligations, in each case plus accrued interest, accrued fees and all other amounts (other than principal amounts) payable to it hereunder and other the other Loan Documents.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary contained in this Agreement, Disqualified Institutions (A) will not (x) have the right to receive information, reports or other materials provided to Lenders by the Borrower, the Administrative Agent or any   other Lender, (y) attend or participate in meetings attended by the Lenders and the Administrative Agent, or (z) access any electronic site established for the Lenders or confidential communications from counsel to or financial advisors of the Administrative Agent or the Lenders and (B) (x) for purposes of any consent to any amendment, waiver     or modification of, or any action under, and for the purpose of any direction to the </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Administrative Agent or any Lender to undertake any action (or refrain from taking any action) under this Agreement or any other Loan Document, each Disqualified Institution  will be deemed to have consented in the same proportion as the Lenders that are not Disqualified Institutions consented to such matter, and (y) for purposes of voting on any plan of reorganization or plan of liquidation pursuant to any bankruptcy or insolvency laws (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Plan of Reorganization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), each Disqualified Institution party hereto hereby agrees (1) not to vote on such Plan of Reorganization, (2) if such Disqualified Institution does vote on  such Plan of Reorganization notwithstanding the restriction in the foregoing clause (1),   such vote will be deemed not to be in good faith and shall be &#8220;designated&#8221; pursuant to Section 1126(e) of the United States Bankruptcy Code (or any similar provision in any  other bankruptcy or insolvency laws), and such vote shall not be counted in determining whether the applicable class has accepted or rejected such Plan of Reorganization in accordance with Section 1126(c) of the United States Bankruptcy Code (or any similar provision in any other bankruptcy or insolvency laws) and (3) not to contest any request    by any party for a determination by the bankruptcy court (or other applicable court of competent jurisdiction) effectuating the foregoing clause (2).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Counterparts&#59; Electronic Execution </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each of the Loan Documents (other than the Notes) may be executed on any number of separate counterparts and all of said counterparts taken together shall be deemed to constitute one and the same agreement.  It shall not be necessary in making proof of any Loan Document to produce or account for more than one counterpart signed by the party to be charged.   A set of the copies of this Agreement signed by all of the parties hereto shall be lodged with each   of the Borrower and the Administrative Agent.  Delivery of an executed counterpart of a signature page of any Loan Document by fax or other electronic means (e.g., &#8220;.pdf&#8221; or &#8220;.tif&#8221;) shall be effective as delivery of a manually executed counterpart of such Loan Document.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;text-decoration:underline">Electronic Execution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This Agreement and any document, amendment, approval, assignment, consent, information, notice, certificate, request, statement, disclosure or authorization related to this Agreement (each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Communication</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), including Communications required to be in writing, may be in the form of an Electronic Record and may be executed using Electronic Signatures. Each party hereto hereby agrees that any Electronic Signature on, or associated with,  any Communication shall be valid and binding on such party to the same extent as a manual,  original signature, and that any Communication entered into by Electronic Signature, will constitute the legal, valid and binding obligation of such party enforceable against such party in accordance with the terms thereof to the same extent as if a manually executed original signature was delivered.   Any Communication may be executed in as many counterparts as necessary or convenient,  including both paper and electronic counterparts, but all such counterparts are one and the same Communication.  For the avoidance of doubt, the authorization under this paragraph may include, without limitation, use or acceptance by each party hereto of a manually signed paper Communication which has been converted into electronic form (such as scanned into PDF format), or an electronically signed Communication converted into another format, for transmission,   delivery and&#47;or retention. Each party hereto may, at its option, create one or more copies of any Communication in the form of an imaged Electronic Record (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Electronic Copy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), which shall be deemed created in the ordinary course of such Person&#8217;s business, and destroy the original paper document.  All Communications in the form of an Electronic Record, including an Electronic Copy, shall be considered an original for all purposes, and shall have the same legal effect, validity and enforceability as a paper record. Notwithstanding anything contained herein to the contrary, the Administrative Agent is under no obligation to accept an Electronic Signature in any form or in    any format unless expressly agreed to by the Administrative Agent pursuant to procedures approved </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">by it (it being acknowledged that the Administrative Agent will accept &#8220;.pdf&#8221; signatures).  Without limiting the foregoing sentence, (a) to the extent the Administrative Agent has agreed to accept   such Electronic Signature, the Administrative Agent and each of the Lenders shall be entitled to   rely on any such Electronic Signature purportedly given by or on behalf of the Borrower without further verification, and (b) upon the request of the Administrative Agent or any Lender hereto, any Electronic Signature shall be promptly (to the extent reasonably practicable at such time as reasonably determined by the Borrower) followed by such manually executed counterpart.  For purposes hereof, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Electronic Record</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Electronic Signature</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall have the meanings   assigned to them, respectively, by 15 USC &#167;7006, as it may be amended from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt;text-decoration:underline">Set-off and Sharing of Payments.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">In addition to any rights and remedies of the Lenders and the Issuers provided by law, after the occurrence and during the continuance of an Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">     or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or upon the acceleration of the Loans, each Lender and each Issuer shall have the right, without prior notice to the Borrower, any such notice being expressly waived by the  Borrower, to set-off and apply against any indebtedness or other liability, whether matured or unmatured, of the Borrower to such Lender or such Issuer arising under the Loan Documents, any amount owing from such Lender or such Issuer to the Borrower. To the extent permitted by applicable law, the aforesaid right of set-off may be exercised by such Lender or such Issuer against the Borrower or against any trustee in bankruptcy, custodian, debtor in possession, assignee for the benefit of creditors, receiver, or execution, judgment or attachment creditor of the Borrower, or against anyone else claiming through or against the Borrower or such trustee in bankruptcy, custodian, debtor in possession, assignee for the benefit of creditors, receivers, or execution, judgment or attachment creditor, notwithstanding the fact that such right of set-off shall not have been exercised by such Lender or such Issuer prior to the making, filing or issuance of, service   upon such Lender or such Issuer of, or notice to such Lender or such Issuer of, any petition, assignment for the benefit of creditors, appointment or application for the appointment of a   receiver, or issuance of execution, subpoena, order or warrant. Each Lender and each Issuer agree promptly to notify the Borrower and the Administrative Agent after each such set-off and application made by such Lender or such Issuer, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the failure to give such notice shall not affect the validity of such set-off and application.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">If any Lender or any Issuer shall obtain any payment (whether voluntary, involuntary, through the exercise of any right of set-off, or otherwise) on account of its Loans or    its Notes or the Reimbursement Obligations in excess of its pro rata share (in accordance with the outstanding principal balance of all Loans or the Reimbursement Obligations) of payments then   due and payable on account of the Loans and Notes received by all the Lenders or the Reimbursement Obligations received by all Issuers, such Lender or such Issuer, as the case may    be, shall forthwith purchase, without recourse, for cash, from the other Lenders or Issuers, as the case may be, such participations in their Loans and Notes or the Reimbursement Obligations as  shall be necessary to cause such purchasing Lender or Issuer to share the excess payment with each of them according to their pro rata share (in accordance with the outstanding principal balance of   all Loans and the Reimbursement Obligations)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if all or any portion of such excess payment is thereafter recovered from such purchasing Lender or Issuer, such purchase from each Lender or Issuer shall be rescinded and each such Lender and Issuer shall repay to the purchasing Lender or Issuer the purchase price to the extent of such recovery, together with an amount equal     to such Lender&#8217;s or Issuer&#8217;s pro rata share (according to the proportion of (i) the amount of such Lender&#8217;s or Issuer&#8217;s required repayment to (ii) the total amount so recovered from the purchasing Lender or Issuer) of any interest or other amount paid or payable by the purchasing Lender or Issuer in respect of the total amount so recovered. The Borrower agrees, to the fullest extent permitted by </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">law, that any Lender or Issuer so purchasing a participation from another Lender or Issuer pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> may exercise such rights to payment (including the right of set-off) with respect to such participation as fully as if such Lender or Issuer were the direct creditor of the Borrower in the amount of such participation.  The provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall not be construed to   apply to (A) any payment made by or on behalf of the Borrower pursuant to, and in accordance  with, the express terms of this Agreement (including the application of funds arising from the existence of a Defaulting Lender or Disqualified Institution), (y) the application of cash collateral   as provided herein, or (z) any payment obtained by a Lender as consideration for the assignment of or sale of a participation in any of its Loans or subparticipations in Reimbursement Obligations or Swing Line Loans to any assignee or participant, other than an assignment to the Borrower or any Subsidiary thereof (as to which the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall apply).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Indemnity</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Borrower shall indemnify each Credit Party and each Related Party thereof (each such Person being called an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Indemnified Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) against, and hold each Indemnified Person harmless from, any and all losses, claims, damages, liabilities and related expenses,  including the reasonable and documented out-of-pocket fees and disbursements of one counsel (but excluding the allocated cost of internal counsel) representing all of the Indemnified Persons, taken  as a whole, and, if reasonably necessary, of a single local counsel for each applicable jurisdiction (which may include a single counsel acting in multiple jurisdictions) (and, if reasonably necessary, one specialty counsel for each applicable specialty), representing all of the Indemnified Persons, taken as a whole (and, in the case of any actual or perceived conflict of interest where the Indemnified Person affected by such conflict notifies the Borrower of the existence of such conflict and thereafter retains its own counsel, of another firm of counsel (and, if reasonably necessary, a single local counsel for each applicable jurisdiction (and, if reasonably necessary, one specialty counsel for each applicable specialty), for each such affected Indemnified Person)), actually  incurred by any Indemnified Person arising out of, in connection with, or as a result of (i) the execution or delivery of any Loan Document or any agreement or instrument contemplated thereby, the performance by the parties to the Loan Documents of their respective obligations thereunder or the consummation of the transactions contemplated hereby or any other transactions contemplated thereby, (ii) any Loan or Letter of Credit or the use of the proceeds thereof, (iii) any actual or  alleged presence or release of Hazardous Materials in, on, under or from any property owned or operated by the Borrower or any of the Subsidiaries, or any Environmental Liability related in any way to the Borrower or any of the Subsidiaries or (iv) any actual or prospective claim, litigation, investigation or proceeding relating to any of the foregoing, whether based on statute, contract, tort or any other theory and regardless of whether any Indemnified Person is a party thereto. Notwithstanding anything to the contrary contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the foregoing  indemnity will not, as to any Indemnified Person, apply to any losses, claims, damages, liabilities and related expenses to the extent arising (A) from the willful misconduct, gross negligence, fraud  or bad faith of such Indemnified Person, (B) from a material breach of the obligations hereunder of such Indemnified Person, (C) out of or in connection with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, or (D) out of or in connection with any claim, litigation, investigation or proceeding that does not involve an act or omission of the Borrower or any of its Affiliates and that is brought by an Indemnified Person against any other Indemnified Person (other than the Administrative Agent, a Joint Lead Arranger, the Issuer or the Swing Line Lender, in each case in its capacity as such), in each case under clauses (A) and (B), to the extent determined by a final and non-appealable judgment of a court of competent jurisdiction.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">To the extent that the Borrower fails to pay as soon as practicable any amount required to be paid by it to the Administrative Agent under subsection (a) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (the </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Indemnified Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), each Lender severally agrees to pay to the Administrative Agent an amount equal to the product of such unpaid amount </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (i) at any time when no Loans    are outstanding, its Commitment Percentage, and (ii) at any time when Loans are outstanding (x)     if the Commitments then exist, its Commitment Percentage or (y) if the Commitments have been terminated or otherwise no longer exist, the percentage equal to the fraction, (A) the numerator of which is the sum of such Lender&#8217;s Credit Exposure and (B) the denominator of which is the sum     of the Aggregate Credit Exposure (in each case determined as of the time that the applicable Indemnified Amount is sought)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the Indemnified Amount was payable to the Administrative Agent in its capacity as such.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The obligations of the Borrower and the Lenders under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall survive the termination of the Commitments and the payment of the Loans and the Notes and all other amounts payable under the Loan Documents.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">If any settlement of any investigation, litigation or proceeding to which the indemnity in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> applies (any of the foregoing, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Proceeding&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) is instituted or threatened against any Indemnified Person (or its Related Parties) in respect of which indemnity  may be sought hereunder, unless an Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(a),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> exists, the Borrower shall be entitled to assume the defense thereof with counsel selected by the Borrower (which counsel shall be reasonably satisfactory to such Indemnified Person) and after notice from the Borrower to such Indemnified Person of the Borrower&#8217;s election so to assume the defense thereof, the Borrower will not be liable to such Indemnified Person hereunder for any legal or other expenses subsequently incurred by such Indemnified Person in connection with the defense thereof, other than reasonable and documented out-of-pocket costs of investigation and such other reasonable and documented out-of-pocket expenses as have been approved in advance&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that (i) if counsel for such Indemnified Person determines in good faith that there is a conflict that requires separate representation for the Borrower and such Indemnified Person or that there may    be legal defenses available to such Indemnified Person which are different from, or in addition to, those available to the Borrower or (ii) the Borrower fails to assume or proceed in a timely and reasonable manner with the defense of such action or fails to employ counsel reasonably  satisfactory to such Indemnified Person in any such action, then in either such event, (A) such Indemnified Person shall be entitled to one primary counsel and, if necessary, one local counsel to represent such Indemnified Person and all other Indemnified Persons similarly situated (such counsels selected by the Administrative Agent), (B) the Borrower shall not, or shall not any longer, be entitled to assume the defense thereof on behalf of such Indemnified Person, and (C) such Indemnified Person shall be entitled to indemnification for the expenses (including fees and expenses of such counsel) to the extent provided in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding the foregoing, the Borrower shall not be liable for any settlement, compromise or consent to the entry   of any judgment in any action or Proceeding effected without the Borrower&#8217;s prior written consent (which consent shall not be unreasonably withheld, conditioned or delayed, it being understood and agreed that the withholding, conditioning or delaying of the Borrower&#8217;s consent in connection with  a settlement, compromise or consent to the entry of any judgment in any action or proceeding which does not include an unconditional release of the Borrower and the Subsidiaries from all liability or claims that are the subject matter of such Proceeding or which includes a statement as to any admission of fault by or on behalf of the Borrower or any Subsidiary shall not be deemed unreasonable), but if settled with the Borrower&#8217;s prior written consent or if there is a final judgment for the plaintiff in any such Proceeding, the Borrower agrees to indemnify and hold harmless each Indemnified Person from and against any and all losses, claims, damages, liabilities and expenses  by reason of such settlement, compromise or consent to the entry of any judgment in any action or Proceeding in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Borrower shall not, without the prior written consent of an Indemnified Person, effect any settlement of any pending or threatened Proceeding </font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">against such Indemnified Person in respect of which indemnity could have been sought hereunder  by such Indemnified Person unless such settlement (x) includes an unconditional release of such Indemnified Person from all liability or claims that are the subject matter of such Proceeding, (y) does not include any statement as to any admission of fault by or on behalf of such Indemnified Person, and (z) contains customary confidentiality provisions with respect to the terms of such settlement. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Notwithstanding any provision in this Agreement to the contrary, none of the Borrower, the Administrative Agent, the Lenders or any Affiliate of any of the foregoing will be responsible or liable to any Person or entity, on any theory of liability, for any indirect, special, punitive or consequential damages that may be alleged as a result of the transactions contemplated hereby or by the other Loan Documents or any use or intended use of the proceeds of the Loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that nothing in this clause (e) shall limit the Borrower&#8217;s indemnity obligations set forth in this Agreement with respect to any indirect, punitive or consequential damages included in any   third party claim in connection with which an Indemnified Person is entitled to indemnification hereunder. In addition to, and without limiting the immediately foregoing sentence, and to the  extent permitted by applicable law, the Borrower shall not assert, and hereby waives, any claim against any Indemnified Person, on any theory of liability, for special, indirect, consequential or punitive damages (as opposed to direct and actual damages) arising out of, in connection with, or    as a result of, any Loan Document or any agreement, instrument or other document contemplated thereby, the transactions contemplated hereby or any Loan or any Letter of Credit or the use of the proceeds thereof.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.02pt">Notwithstanding the above, the Borrower shall have no liability under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> to indemnify or hold harmless any Indemnified Person for any losses, claims, damages, liabilities and related expenses relating to income or withholding Taxes or any Tax in lieu of such Taxes. Notwithstanding the foregoing, any amounts claimed by an Indemnified Person under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall not be available to be claimed by such Indemnified Person under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, it being understood and agreed that the rights of an Indemnified Person under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall not be duplicative.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Governing Law</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Loan Documents and the rights and obligations of the parties thereto shall be governed by, and construed and interpreted in accordance with, the laws of the State of New York.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Severability</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Every provision of the Loan Documents is intended to be severable, and if any term or provision thereof shall be invalid, illegal or unenforceable for any reason, the validity, legality and enforceability of  the remaining provisions thereof shall not be affected or impaired thereby, and any invalidity, illegality or unenforceability in any jurisdiction shall not affect the validity, legality or enforceability of any such term   or provision in any other jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Integration</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">All exhibits to the Loan Documents shall be deemed to be a part thereof. Each Loan Document embodies the entire agreement and understanding between or among the parties thereto with respect to the subject matter thereof and supersedes all prior agreements and understandings between or among the parties thereto with respect to the subject matter thereof.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Treatment of Certain Information</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Each Credit Party agrees to maintain the confidentiality of the Information (as defined below), except that Information may be disclosed (i) to its Affiliates and to its and its Affiliates&#8217; respective partners, directors, officers, employees, agents, advisors and other representatives (it being understood that the Persons to whom such disclosure is made will be informed of the confidential nature of such Information and instructed to keep such Information confidential)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that each Credit Party shall be responsible for its controlled Affiliates&#8217; compliance in keeping Information confidential, (ii) to the extent requested by any regulatory authority purporting to have jurisdiction over it (including any self-regulatory authority, such as    the National Association of Insurance Commissioners) (in which case such Person agrees (except with respect to any audit or examination conducted by bank accountants or any governmental regulatory authority exercising examination or regulatory authority) to use commercially   reasonable efforts to inform the Borrower promptly thereof prior to such disclosure to the extent practicable and not prohibited by law), (iii) to the extent required by applicable laws or regulations or by any subpoena or similar legal process (in which case such Person agrees to (except with respect to any audit or examination conducted by bank accountants or any governmental regulatory authority exercising examination or regulatory authority) to inform the Borrower promptly thereof prior to such disclosure to the extent practicable and not prohibited by law), (iv) to any other party hereto, (v) in connection with the exercise of any remedies hereunder or under any other Loan Document or any action or proceeding relating to this Agreement or any other Loan Document or the enforcement of rights hereunder or thereunder, (vi) subject to an agreement containing provisions substantially the same as those of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to (A) any assignee of or Participant in, or any prospective assignee of or Participant in, any of its rights or obligations under this Agreement or (B) any actual or prospective counterparty (or its advisors) to any swap or derivative transaction relating to the Borrower and its obligations, (vii) to Gold Sheets and other similar bank trade publications, such information to consist of deal terms and other information customarily found in such publications, (viii) with the prior written consent of the Borrower, (ix) to the extent such Information (1)&#160;becomes publicly available other than as a result of a breach of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or a breach of any other confidentiality obligation owing by such Credit Party to the Borrower or (2)&#160;becomes available to the Administrative Agent, any Credit Party or any of their respective Affiliates on a non-confidential basis from a source other than the Borrower not known to such Credit Party to be prohibited from disclosing such Information, and (x) on a confidential basis to   (1) any rating agency in connection with rating the Borrower or its Subsidiaries or the credit facilities provided hereunder or (2) the CUSIP Service Bureau or any similar agency in connection with the application, issuance, publishing and monitoring of CUSIP numbers of other market identifiers with respect to the credit facilities provided hereunder.  In addition, the Administrative Agent and the Lenders may disclose the existence of this Agreement and information about this Agreement to market data collectors, similar service providers to the lending industry and service providers to the Administrative Agent and the Lenders in connection with the administration of this Agreement, the other Loan Documents, and the Commitments.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">For purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Information&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> means all information received from the Borrower or any of its Subsidiaries relating to the Borrower or any of its Subsidiaries or any of their respective businesses, other than any such information that is available to the Administrative Agent or any other Credit Party on a non-confidential basis prior to disclosure by   the Borrower or any of its Subsidiaries.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Acknowledgments</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower acknowledges that (a) it has been advised by counsel in the negotiation, execution  and delivery of the Loan Documents, (b) by virtue of the Loan Documents, the relationship among the Administrative Agent, the Issuers and the Lenders, on the one hand, and the Borrower, on the other hand,    is solely that of debtor and creditor, and (c) by virtue of the Loan Documents, no joint venture exists among the Lenders or among the Borrower and the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Consent to Jurisdiction</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each of the parties hereto irrevocably submits to the exclusive jurisdiction of any New York State  or Federal Court sitting in the City of New York, Borough of Manhattan, over any suit, action, claim, counterclaim or proceeding arising out of or relating to the Loan Documents. EACH OF THE PARTIES HERETO IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY OBJECTION WHICH IT MAY NOW OR HEREAFTER HAVE TO THE LAYING OF THE VENUE OF ANY SUCH SUIT, ACTION, CLAIM, COUNTERCLAIM OR PROCEEDING BROUGHT IN SUCH A COURT AND ANY CLAIM THAT ANY SUCH SUIT, ACTION, CLAIM, COUNTERCLAIM OR PROCEEDING BROUGHT IN SUCH A COURT HAS BEEN BROUGHT IN AN INCONVENIENT FORUM.  Each of the parties hereto agrees that a final judgment in any such suit, action, claim, counterclaim or proceeding brought in such a court, after all appropriate appeals, shall be conclusive and binding upon it.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Service of Process</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each of the parties hereto agrees that process may be served against it in any suit, action or proceeding referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> by sending the same by first class mail, return receipt requested or  by overnight courier service, with receipt acknowledged, to the address of such party set forth or referred    to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each of the parties hereto agrees that any such service (i) shall be deemed in every  respect effective service of process upon it in any such suit, action, or proceeding, and (ii) shall to the fullest extent enforceable by law, be taken and held to be valid personal service upon and personal delivery to it.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">No Limitation on Service or Suit</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Nothing in the Loan Documents or any modification, waiver, or amendment thereto shall affect the right of the Administrative Agent, any Issuer or any Lender to serve process in any manner permitted by   law or limit the right of the Administrative Agent, any Issuer or any Lender to bring proceedings against    the Borrower in the courts of any jurisdiction or jurisdictions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">WAIVER OF TRIAL BY JURY</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EACH OF THE CREDIT PARTIES AND THE BORROWER KNOWINGLY, VOLUNTARILY AND INTENTIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION ARISING OUT OF, UNDER OR IN CONNECTION WITH THE LOAN DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED THEREBY. FURTHER, THE BORROWER HEREBY CERTIFIES THAT NO REPRESENTATIVE OR AGENT OF ANY OF THE CREDIT PARTIES, OR COUNSEL TO ANY OF THE CREDIT PARTIES, HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT ANY OF THE CREDIT PARTIES WOULD NOT, IN THE EVENT OF SUCH LITIGATION, SEEK TO ENFORCE THIS WAIVER OF RIGHT TO JURY TRIAL PROVISION. THE BORROWER ACKNOWLEDGES THAT THE CREDIT PARTIES HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">INTER ALIA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, THE PROVISIONS OF THIS </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">SECTION 11.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Patriot Act Notice</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each Lender and the Administrative Agent (for itself and not on behalf of any Lender) hereby notifies the Borrower that pursuant to the requirements of the USA PATRIOT Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001), as amended from time to time) (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Patriot Act&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), it is required to obtain, verify and record information that identifies the Borrower, which information includes the name and address of the Borrower and other information that will allow such Lender or the Administrative Agent, as applicable, to identify the Borrower in accordance with the Patriot Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">No Fiduciary Duty</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower agrees that in connection with all aspects of the transactions contemplated hereby   and any communications in connection therewith, the Borrower and its Subsidiaries, on the one hand, and the Credit Parties, the Joint Lead Arrangers, the Sustainability Coordinator, and their respective Affiliates, on the other hand, will have a business relationship that does not create, by implication or otherwise, any fiduciary duty on the part of the Credit Parties, such</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Joint Lead Arrangers or the Sustainability Coordinator, or their respective Affiliates, and no such duty will be deemed to have arisen in connection with any such transactions or communications.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Acknowledgement and Consent to Bail-In of Affected Financial Institutions</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding anything to the contrary in any Loan Document or in any other agreement, arrangement or understanding among any such parties, each party hereto acknowledges that any liability of any Lender that is an Affected Financial Institution arising under any Loan Document, to the extent such liability is unsecured, may be subject to the Write-Down and Conversion Powers of the applicable Resolution Authority and agrees and consents to, and acknowledges and agrees to be bound by&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">the application of any Write-Down and Conversion Powers by the applicable Resolution Authority to any such liabilities arising hereunder which may be payable to it by any Lender that is an Affected Financial Institution&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">the effects of any Bail-In Action on any such liability, including, if applicable&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.13pt">a reduction in full or in part or cancellation of any such liability&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.08pt">a conversion of all, or a portion of, such liability into shares or other instruments of ownership in such Affected Financial Institution, its parent entity, or a   bridge institution that may be issued to it or otherwise conferred on it, and that such shares or other instruments of ownership will be accepted by it in lieu of any rights with respect    to any such liability under this Agreement or any other Loan Document&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(viii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.03pt">the variation of the terms of such liability in connection with the exercise   of the Write-Down and Conversion Powers of the applicable Resolution Authority.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.23</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.25pt;text-decoration:underline">Certain ERISA Matters</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Each Lender (x) represents and warrants, as of the date such Person became a Lender party hereto, to, and (y) covenants, from the date such Person became a Lender party hereto to the date such Person ceases being a Lender party hereto, for the benefit of, the Administrative Agent and the Joint Lead Arrangers and not, for the avoidance of doubt, to or for the benefit of the Borrower, that at least one of the following is and will be true&#58;</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">such Lender is not using &#8220;plan assets&#8221; (within the meaning of    Section&#160;3(42) of ERISA or otherwise) of one or more Benefit Plans with respect to such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans,   the Letters of Credit, the Commitments or this Agreement,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.58pt">the transaction exemption set forth in one or more PTEs, such as PTE 84- 14 (a class exemption for certain transactions determined by independent qualified professional asset managers), PTE 95-60 (a class exemption for certain transactions involving insurance company general accounts), PTE 90-1 (a class exemption for certain transactions involving insurance company pooled separate accounts), PTE 91-38 (a class exemption for certain transactions involving bank collective investment funds) or PTE 96- 23 (a class exemption for certain transactions determined by in-house asset managers), is applicable with respect to such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.53pt">(A) such Lender is an investment fund managed by a &#8220;Qualified Professional Asset Manager&#8221; (within the meaning of Part VI of PTE 84-14), (B) such Qualified Professional Asset Manager made the investment decision on behalf of such Lender to enter into, participate in, administer and perform the Loans, the Letters of Credit, the Commitments and this Agreement, (C) the entrance into, participation in,   administration of and performance of the Loans, the Letters of Credit, the Commitments  and this Agreement satisfies the requirements of sub-sections (b) through (g) of Part I of PTE 84-14 and (D) to the best knowledge of such Lender, the requirements of subsection  (a) of Part I of PTE 84-14 are satisfied with respect to such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement, or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.13pt">such other representation, warranty and covenant as may be agreed in writing between the Administrative Agent, in its sole discretion, and such Lender.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">In addition, unless either (1) sub-clause (i) in the immediately preceding clause (a) is true with respect to a Lender or (2) a Lender has provided another representation, warranty and covenant in accordance with sub-clause (iv) in the immediately preceding clause (a), such Lender further (x) represents and warrants, as of the date such Person became a Lender party hereto, to,   and (y) covenants, from the date such Person became a Lender party hereto to the date such Person ceases being a Lender party hereto, for the benefit of, the Administrative Agent and the Joint Lead Arrangers and not, for the avoidance of doubt, to or for the benefit of the Borrower, that the Administrative Agent is not a fiduciary with respect to the assets of such Lender involved in such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement (including in connection with the reservation or exercise of any rights by the Administrative Agent under this Agreement, any Loan Document or any documents related hereto or thereto).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">For purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.23</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the following defined terms when used herein have the following meanings&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Benefit Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means any of (a) an &#8220;employee benefit plan&#8221; (as defined in ERISA) that is subject to Title I of ERISA, (b) a &#8220;plan&#8221; as defined in Section 4975 of the Internal Revenue Code or (c) any Person whose assets include (for purposes of ERISA Section  3(42) or otherwise for purposes of Title I of ERISA or Section 4975 of the Internal Revenue Code) the assets of any such &#8220;employee benefit plan&#8221; or &#8220;plan&#8221;.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.84pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">PTE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means a prohibited transaction class exemption issued by the U.S. Department of Labor, as any such exemption may be amended from time to time.</font></div><div style="margin-bottom:60pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;SIGNATURE PAGES OMITTED&#93;</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-15.1
<SEQUENCE>5
<FILENAME>a06302022ex151.htm
<DESCRIPTION>EX-15.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i15fe1b5eaa3441358f7c0062e9ba93eb_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 15.1</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Letter re&#58; Unaudited Interim Financial Information</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">August&#160;3, 2022 </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of CVS Health Corporation</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">We are aware of the incorporation by reference in the Registration Statements (Form S-3ASR No. 333-238506 and Form S-8 Nos. 333-238507, 333-230035, 333-228622, 333-167746, 333-217853, 333-208805, 333-141481, 333-139470, 333-63664, 333-91253, 333-49407, 333-34927, and 333-28043) of CVS Health Corporation of our report dated August&#160;3, 2022, relating to the unaudited condensed consolidated interim financial statements of CVS Health Corporation that is included in its Form 10-Q for the quarter ended June&#160;30, 2022.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Ernst &#38; Young LLP</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Boston, Massachusetts</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>a06302022ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i9be1c334640244e9a3e5153322b3589c_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Karen S. Lynch, President and Chief Executive Officer of CVS Health Corporation, certify that&#58; </font></div><div><font><br></font></div><div style="margin-bottom:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this quarterly report on Form 10-Q of CVS Health Corporation&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. &#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:10pt;margin-top:8pt;padding-left:45pt;text-indent:-18pt"><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.121%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;&#160;&#160;&#160;&#160;&#160;KAREN S. LYNCH</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karen S. Lynch</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>a06302022ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ifa005e707cac44c1b4124fbef6ac2bb5_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Shawn M. Guertin, Executive Vice President and Chief Financial Officer of CVS Health Corporation, certify that&#58; </font></div><div><font><br></font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this quarterly report on Form 10-Q of CVS Health Corporation&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. &#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. &#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. &#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.121%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;&#160;&#160;&#160;&#160;&#160;SHAWN M. GUERTIN</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shawn M. Guertin</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Executive Vice President and Chief Financial Officer</font></td></tr></table></div><div style="margin-bottom:5pt;text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>a06302022ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ib133c4332def4c889ebd8149214a03b5_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The certification set forth below is being submitted in connection with the Quarterly Report of CVS Health Corporation (the &#8220;Company&#8221;) on Form 10-Q for the period ended June&#160;30, 2022 (the &#8220;Report&#8221;) solely for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Section 1350 of Chapter 63 of Title 18 of the United States Code. </font></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Karen S. Lynch, President and Chief Executive Officer of the Company, certify that, to the best of my knowledge&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.  the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.  the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:10pt;margin-top:5pt;padding-left:36pt;text-indent:-13.5pt"><font><br></font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.411%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;&#160;&#160;&#160;&#160;KAREN S. LYNCH</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karen S. Lynch</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>9
<FILENAME>a06302022ex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i8b7f9be98c9644daad97fd0dafc48042_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The certification set forth below is being submitted in connection with the Quarterly Report of CVS Health Corporation (the &#8220;Company&#8221;) on Form 10-Q for the period ended June&#160;30, 2022 (the &#8220;Report&#8221;) solely for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Section 1350 of Chapter 63 of Title 18 of the United States Code. </font></div><div style="margin-top:5pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Shawn M. Guertin, Executive Vice President and Chief Financial Officer of the Company, certify that, to the best of my knowledge&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.  the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.  the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-13.5pt"><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.895%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.049%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;&#160;&#160;&#160;&#160;SHAWN M. GUERTIN</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shawn M. Guertin</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Executive Vice President and Chief Financial&#160;Officer</font></td></tr></table></div><div style="margin-bottom:5pt;text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>cvs-20220630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:0140da76-e33c-4901-8b3b-5aa42426ab0a,g:ea97fc95-8028-4e4e-8a3a-2f9f67911aac-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cvs="http://www.cvshealth.com/20220630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cvshealth.com/20220630">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20220630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20220630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20220630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20220630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.cvshealth.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperationsUnaudited" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited">
        <link:definition>1001002 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited">
        <link:definition>1002003 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsUnaudited" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited">
        <link:definition>1003004 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsUnauditedParenthetical" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical">
        <link:definition>1004005 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsUnaudited" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsUnaudited_1" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsUnauditedParenthetical" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnauditedParenthetical">
        <link:definition>1406401 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofShareholdersEquityUnaudited" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited">
        <link:definition>1007007 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofShareholdersEquityParenthetical" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParenthetical">
        <link:definition>1008008 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://www.cvshealth.com/role/SignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesTables" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables">
        <link:definition>2303301 - Disclosure - Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2404402 - Disclosure - Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails">
        <link:definition>2405403 - Disclosure - Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesAccountsReceivableDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails">
        <link:definition>2406404 - Disclosure - Significant Accounting Policies - Accounts Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesDisaggregationofRevenueDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails">
        <link:definition>2407405 - Disclosure - Significant Accounting Policies - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesReceivablesandContractedBalancesDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails">
        <link:definition>2408406 - Disclosure - Significant Accounting Policies - Receivables and Contracted Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesContractBalancesDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails">
        <link:definition>2409407 - Disclosure - Significant Accounting Policies - Contract Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DivestituresandAssetSales" roleURI="http://www.cvshealth.com/role/DivestituresandAssetSales">
        <link:definition>2110102 - Disclosure - Divestitures and Asset Sales</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DivestituresandAssetSalesDetails" roleURI="http://www.cvshealth.com/role/DivestituresandAssetSalesDetails">
        <link:definition>2411408 - Disclosure - Divestitures and Asset Sales (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://www.cvshealth.com/role/Investments">
        <link:definition>2112103 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables" roleURI="http://www.cvshealth.com/role/InvestmentsTables">
        <link:definition>2313302 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTotalInvestmentScheduleDetails" roleURI="http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails">
        <link:definition>2414409 - Disclosure - Investments - Total Investment Schedule (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsDebtSecuritiesDetails" roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails">
        <link:definition>2415410 - Disclosure - Investments - Debt Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsDebtSecuritiesDetails_1" roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1">
        <link:definition>2415410 - Disclosure - Investments - Debt Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsDebtSecuritiesbyMaturityDetails" roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails">
        <link:definition>2416411 - Disclosure - Investments - Debt Securities by Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsUnrealizedLossPositionDetails" roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails">
        <link:definition>2417412 - Disclosure - Investments - Unrealized Loss Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsUnrealizedLossPositionMaturitiesDetails" roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails">
        <link:definition>2418413 - Disclosure - Investments - Unrealized Loss Position Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsMortgageLoansDetails" roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails">
        <link:definition>2419414 - Disclosure - Investments - Mortgage Loans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsMortgageLoansCreditRatingsIndicatorDetails" roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails">
        <link:definition>2420415 - Disclosure - Investments - Mortgage Loans Credit Ratings Indicator (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNetInvestmentIncomeDetails" roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails">
        <link:definition>2421416 - Disclosure - Investments - Net Investment Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsRealizedGainsDetails" roleURI="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails">
        <link:definition>2422417 - Disclosure - Investments - Realized Gains (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValue" roleURI="http://www.cvshealth.com/role/FairValue">
        <link:definition>2123104 - Disclosure - Fair Value</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueTables" roleURI="http://www.cvshealth.com/role/FairValueTables">
        <link:definition>2324303 - Disclosure - Fair Value (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementonaRecurringBasisDetails" roleURI="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails">
        <link:definition>2425418 - Disclosure - Fair Value - Measurement on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueNarrativeDetails" roleURI="http://www.cvshealth.com/role/FairValueNarrativeDetails">
        <link:definition>2426419 - Disclosure - Fair Value - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueCarryingValueandFairValueClassifiedbyLevelDetails" roleURI="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails">
        <link:definition>2427420 - Disclosure - Fair Value - Carrying Value and Fair Value Classified by Level (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueSeparateAccountsFairValueDetails" roleURI="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails">
        <link:definition>2428421 - Disclosure - Fair Value - Separate Accounts Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayable" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayable">
        <link:definition>2129105 - Disclosure - Health Care Costs Payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayableTables" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableTables">
        <link:definition>2330304 - Disclosure - Health Care Costs Payable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails">
        <link:definition>2431422 - Disclosure - Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayableNarrativeDetails" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails">
        <link:definition>2432423 - Disclosure - Health Care Costs Payable - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Borrowings" roleURI="http://www.cvshealth.com/role/Borrowings">
        <link:definition>2133106 - Disclosure - Borrowings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsTables" roleURI="http://www.cvshealth.com/role/BorrowingsTables">
        <link:definition>2334305 - Disclosure - Borrowings (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsScheduleofBorrowingsDetails" roleURI="http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails">
        <link:definition>2435424 - Disclosure - Borrowings - Schedule of Borrowings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsNarrativeDetails" roleURI="http://www.cvshealth.com/role/BorrowingsNarrativeDetails">
        <link:definition>2436425 - Disclosure - Borrowings - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquity" roleURI="http://www.cvshealth.com/role/ShareholdersEquity">
        <link:definition>2137107 - Disclosure - Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityTables" roleURI="http://www.cvshealth.com/role/ShareholdersEquityTables">
        <link:definition>2338306 - Disclosure - Shareholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityShareRepurchasesDetails" roleURI="http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails">
        <link:definition>2439426 - Disclosure - Shareholders' Equity - Share Repurchases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityAcceleratedShareRepurchasesDetails" roleURI="http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails">
        <link:definition>2440427 - Disclosure - Shareholders' Equity - Accelerated Share Repurchases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityDividendsDetails" roleURI="http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails">
        <link:definition>2441428 - Disclosure - Shareholders' Equity - Dividends (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveIncome" roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncome">
        <link:definition>2142108 - Disclosure - Other Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveIncomeTables" roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeTables">
        <link:definition>2343307 - Disclosure - Other Comprehensive Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveIncomeDetails" roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails">
        <link:definition>2444429 - Disclosure - Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.cvshealth.com/role/EarningsPerShare">
        <link:definition>2145109 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.cvshealth.com/role/EarningsPerShareTables">
        <link:definition>2346308 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareDetails" roleURI="http://www.cvshealth.com/role/EarningsPerShareDetails">
        <link:definition>2447430 - Disclosure - Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.cvshealth.com/role/CommitmentsandContingencies">
        <link:definition>2148110 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails">
        <link:definition>2449431 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.cvshealth.com/role/SegmentReporting">
        <link:definition>2150111 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.cvshealth.com/role/SegmentReportingTables">
        <link:definition>2351309 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingNarrativeDetails" roleURI="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails">
        <link:definition>2452432 - Disclosure - Segment Reporting - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails">
        <link:definition>2453433 - Disclosure - Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails" roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails">
        <link:definition>2454434 - Disclosure - Segment Reporting - Reconciliation of Consolidated Operating Income to Adjusted Operating Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="cvs_NumberofPharmacyPlanMembers" abstract="false" name="NumberofPharmacyPlanMembers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" abstract="false" name="LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes2.75DueNovember2022Member" abstract="true" name="SeniorNotes2.75DueNovember2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes2.875DueJune2026Member" abstract="true" name="SeniorNotes2.875DueJune2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.25DueAugust2029Member" abstract="true" name="SeniorNotes3.25DueAugust2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" abstract="true" name="MortgageLoansOnRealEstateCreditQualityIndicatorDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes13DueAugust2027Member" abstract="true" name="SeniorNotes13DueAugust2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" abstract="false" name="TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_TotalInvestmentsLineItems" abstract="true" name="TotalInvestmentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_Category7Member" abstract="true" name="Category7Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.5DueJuly2022Member" abstract="true" name="SeniorNotes3.5DueJuly2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" abstract="false" name="ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" abstract="false" name="InvestmentContractsWithFixedMaturityFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateLoansFullyRepaid" abstract="false" name="MortgageLoansOnRealEstateLoansFullyRepaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" abstract="false" name="ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_TreasuryStockValueSharesHeldInTrust" abstract="false" name="TreasuryStockValueSharesHeldInTrust" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_NetRevenuesRetailCoPayments" abstract="false" name="NetRevenuesRetailCoPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_BarclaysBankMember" abstract="true" name="BarclaysBankMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_TotalInvestmentsTable" abstract="true" name="TotalInvestmentsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_SeniorNotes4.3DueMarch2028Member" abstract="true" name="SeniorNotes4.3DueMarch2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ChangeinContractwithCustomerLiabilityRollForward" abstract="true" name="ChangeinContractwithCustomerLiabilityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_AcceleratedShareRepurchasesAgreementAmount" abstract="false" name="AcceleratedShareRepurchasesAgreementAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SalesChannelOtherMember" abstract="true" name="SalesChannelOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.1DueMarch2025Member" abstract="true" name="SeniorNotes4.1DueMarch2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes2125PercentDueSeptember2031Member" abstract="true" name="SeniorNotes2125PercentDueSeptember2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_OtherReceivablesMember" abstract="true" name="OtherReceivablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_InternationalHealthCareRenewalRightsMember" abstract="true" name="InternationalHealthCareRenewalRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SupportingRemainingProductsMember" abstract="true" name="SupportingRemainingProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.625DueApril2027Member" abstract="true" name="SeniorNotes3.625DueApril2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_RetailLongTermCareSegmentMember" abstract="true" name="RetailLongTermCareSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" abstract="false" name="ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_HealthCareBenefitsSegmentMember" abstract="true" name="HealthCareBenefitsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ActivityInMortgageLoanPortfolioTableTextBlock" abstract="false" name="ActivityInMortgageLoanPortfolioTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_NumberOfMedicalMembers" abstract="false" name="NumberOfMedicalMembers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_GuarantorObligationsNumberofLeases" abstract="false" name="GuarantorObligationsNumberofLeases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_SeniorNotes4.75DueMarch2044Member" abstract="true" name="SeniorNotes4.75DueMarch2044Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.78DueMarch2038Member" abstract="true" name="SeniorNotes4.78DueMarch2038Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_StateOfFloridaSettlementMember" abstract="true" name="StateOfFloridaSettlementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes1875DueFebruary2031Member" abstract="true" name="SeniorNotes1875DueFebruary2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" abstract="false" name="AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cvs_InvestmentIncomeExcludingCapitalGainsorLosses" abstract="false" name="InvestmentIncomeExcludingCapitalGainsorLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" abstract="false" name="DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_A2021RepurchaseProgramMember" abstract="true" name="A2021RepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.5DueMay2042Member" abstract="true" name="SeniorNotes4.5DueMay2042Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_TotalInvestmentsTableTextBlock" abstract="false" name="TotalInvestmentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_SeniorNotes5.75DueMay2041Member" abstract="true" name="SeniorNotes5.75DueMay2041Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.125DueNovember2042Member" abstract="true" name="SeniorNotes4.125DueNovember2042Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" abstract="false" name="BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_NumeratorForEarningsPerShareCalculationAbstract" abstract="true" name="NumeratorForEarningsPerShareCalculationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" abstract="true" name="MortgageLoansOnRealEstateCreditQualityIndicatorAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_Category2To4Member" abstract="true" name="Category2To4Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_TransferOfSharesToTreasuryStockValue" abstract="false" name="TransferOfSharesToTreasuryStockValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" abstract="false" name="TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_SeniorNotes27DueAugust2040Member" abstract="true" name="SeniorNotes27DueAugust2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.125DueApril2040Member" abstract="true" name="SeniorNotes4.125DueApril2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ReconciliationOfOperatingIncomeToAdjustedOperatingIncomeTableTextBlock" abstract="false" name="ReconciliationOfOperatingIncomeToAdjustedOperatingIncomeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_SeniorNotes6.25DueJune2027Member" abstract="true" name="SeniorNotes6.25DueJune2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.75DueApril2030Member" abstract="true" name="SeniorNotes3.75DueApril2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes5DueDecember2024Member" abstract="true" name="SeniorNotes5DueDecember2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DisposalGroupNotDiscontinuedOperationMigrationPeriod" abstract="false" name="DisposalGroupNotDiscontinuedOperationMigrationPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cvs_SeniorNotes5.125DueJuly2045Member" abstract="true" name="SeniorNotes5.125DueJuly2045Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodFiveMember" abstract="true" name="YearOfOriginationPeriodFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_TreasuryStockSharesHeldinTrust" abstract="false" name="TreasuryStockSharesHeldinTrust" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_PaymentsforInsuranceBenefits" abstract="false" name="PaymentsforInsuranceBenefits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfAdditionalStates" abstract="false" name="IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfAdditionalStates" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_SeniorNotes2.8DueJune2023Member" abstract="true" name="SeniorNotes2.8DueJune2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" abstract="false" name="AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cvs_SeniorNotes3.875DueJuly2025Member" abstract="true" name="SeniorNotes3.875DueJuly2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodThreeMember" abstract="true" name="YearOfOriginationPeriodThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_CommonAndCollectiveTrustsMember" abstract="true" name="CommonAndCollectiveTrustsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates" abstract="false" name="IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_Deferredincometaxesandothernoncashitems" abstract="false" name="Deferredincometaxesandothernoncashitems" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" abstract="false" name="PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" abstract="false" name="ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_HeartlandHealthcareServicesMember" abstract="true" name="HeartlandHealthcareServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_MortgageLoansMember" abstract="true" name="MortgageLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes2.75DueDecember2022Member" abstract="true" name="SeniorNotes2.75DueDecember2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" abstract="true" name="MortgageLoansOnRealEstateYearOfOriginationAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_YearOfOriginationPriorToPeriodFiveMember" abstract="true" name="YearOfOriginationPriorToPeriodFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodFourMember" abstract="true" name="YearOfOriginationPeriodFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" abstract="true" name="HealthCareandOtherInsuranceLiabilitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_Categories5and6Member" abstract="true" name="Categories5and6Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_OtherAssetBackedSecuritiesMember" abstract="true" name="OtherAssetBackedSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_TotalInvestmentsAxis" abstract="true" name="TotalInvestmentsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember" abstract="true" name="RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ContractwithCustomerLiabilityRedemptionandBreakage" abstract="false" name="ContractwithCustomerLiabilityRedemptionandBreakage" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_OtherInsuranceLiabilitiesNoncurrent" abstract="false" name="OtherInsuranceLiabilitiesNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes3.375DueAugust2024Member" abstract="true" name="SeniorNotes3.375DueAugust2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_StockOptionsAndStockAppreciationRightsMember" abstract="true" name="StockOptionsAndStockAppreciationRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_VendorandManufacturerReceivables" abstract="false" name="VendorandManufacturerReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_OtherInsuranceLiabilitiesCurrent" abstract="false" name="OtherInsuranceLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes4.25DueApril2050Member" abstract="true" name="SeniorNotes4.25DueApril2050Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes6.625DueJune2036Member" abstract="true" name="SeniorNotes6.625DueJune2036Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_TotalInvestmentsDomain" abstract="true" name="TotalInvestmentsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" abstract="false" name="CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_RadcliffeAndFlaimVAetnaIncEtAlMember" abstract="true" name="RadcliffeAndFlaimVAetnaIncEtAlMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes5.05DueMarch2048Member" abstract="true" name="SeniorNotes5.05DueMarch2048Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_A2021AcceleratedRepurchaseProgramMember" abstract="true" name="A2021AcceleratedRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.75DueDecember2022Member" abstract="true" name="SeniorNotes4.75DueDecember2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_Category1Member" abstract="true" name="Category1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ThailandBusinessMember" abstract="true" name="ThailandBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodOneMember" abstract="true" name="YearOfOriginationPeriodOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes2.625DueAugust2024Member" abstract="true" name="SeniorNotes2.625DueAugust2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PayflexMember" abstract="true" name="PayflexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.5DueNovember2024Member" abstract="true" name="SeniorNotes3.5DueNovember2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" abstract="false" name="ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_LegalSettlementPeriodOfPayment" abstract="false" name="LegalSettlementPeriodOfPayment" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cvs_NumberOfPeopleServed" abstract="false" name="NumberOfPeopleServed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_SeniorNotes6.125DueSeptember2039Member" abstract="true" name="SeniorNotes6.125DueSeptember2039Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PremiumDeficiencyReserveLiability" abstract="false" name="PremiumDeficiencyReserveLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_PharmacyRevenueMember" abstract="true" name="PharmacyRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes5.3DueDecember2043Member" abstract="true" name="SeniorNotes5.3DueDecember2043Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes6.75DueDecember2037Member" abstract="true" name="SeniorNotes6.75DueDecember2037Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodTwoMember" abstract="true" name="YearOfOriginationPeriodTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased" abstract="false" name="AcceleratedShareRepurchasesNumberOfSharesRepurchased" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_PaymentsForAcceleratedShareRepurchasesAmount" abstract="false" name="PaymentsForAcceleratedShareRepurchasesAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_LongtermDebtGrossAndLeaseObligation" abstract="false" name="LongtermDebtGrossAndLeaseObligation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes3DueAugust2026Member" abstract="true" name="SeniorNotes3DueAugust2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_NumberofWalkInMedicalClinics" abstract="false" name="NumberofWalkInMedicalClinics" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_SeniorNotes4DueDecember2023Member" abstract="true" name="SeniorNotes4DueDecember2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" abstract="false" name="NoncontrollinginterestOtherPeriodIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" abstract="true" name="ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_NumberofPatientsServedperYear" abstract="false" name="NumberofPatientsServedperYear" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_PharmacyClaimsandDiscountsPayableCurrent" abstract="false" name="PharmacyClaimsandDiscountsPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes4.875DueJuly2035Member" abstract="true" name="SeniorNotes4.875DueJuly2035Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PharmacyServicesSegmentMember" abstract="true" name="PharmacyServicesSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_FrontStoreRevenueMember" abstract="true" name="FrontStoreRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" abstract="false" name="PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DenominatorForEarningsPerShareCalculationAbstract" abstract="true" name="DenominatorForEarningsPerShareCalculationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" abstract="false" name="InvestmentContractsWithoutFixedMaturityFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_AdjustedOperatingIncomeLoss" abstract="false" name="AdjustedOperatingIncomeLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes175DueAugust2030Member" abstract="true" name="SeniorNotes175DueAugust2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SupportingExperienceRatedProductsMember" abstract="true" name="SupportingExperienceRatedProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LossContingencyAuditMethodologySampleSize" abstract="false" name="LossContingencyAuditMethodologySampleSize" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" abstract="false" name="YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" abstract="false" name="DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold" abstract="false" name="DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_DebtAndEquitySecuritiesAvailableForSaleMember" abstract="true" name="DebtAndEquitySecuritiesAvailableForSaleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" abstract="false" name="DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" abstract="true" name="MortgageLoansOnRealEstateYearOfOriginationDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.875DueAugust2047Member" abstract="true" name="SeniorNotes3.875DueAugust2047Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_EarningsPerShareBasicAndDilutedEPSAbstract" abstract="true" name="EarningsPerShareBasicAndDilutedEPSAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" abstract="true" name="DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_PremiumsMember" abstract="true" name="PremiumsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_CorporateOtherMember" abstract="true" name="CorporateOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>cvs-20220630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:0140da76-e33c-4901-8b3b-5aa42426ab0a,g:ea97fc95-8028-4e4e-8a3a-2f9f67911aac-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="cvs-20220630.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1a8140a9-277e-4c32-b930-7d89a5a84c81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9af81cbd-2208-4886-90a2-9e5b73c94157" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1a8140a9-277e-4c32-b930-7d89a5a84c81" xlink:to="loc_us-gaap_OperatingIncomeLoss_9af81cbd-2208-4886-90a2-9e5b73c94157" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_f0773e62-deb3-4582-a07c-5bc083dbbe12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1a8140a9-277e-4c32-b930-7d89a5a84c81" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_f0773e62-deb3-4582-a07c-5bc083dbbe12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_39446bd4-39e9-42ff-b21e-8bc2d66f517b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1a8140a9-277e-4c32-b930-7d89a5a84c81" xlink:to="loc_us-gaap_InterestExpense_39446bd4-39e9-42ff-b21e-8bc2d66f517b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3bddfde1-b760-42c6-a4bb-2a7fe611be5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2072abaa-0010-459b-b21d-4516ef57c004" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_3bddfde1-b760-42c6-a4bb-2a7fe611be5a" xlink:to="loc_us-gaap_ProfitLoss_2072abaa-0010-459b-b21d-4516ef57c004" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_257d9e2a-3ea1-4f8b-8ed3-a4a67584ddda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_3bddfde1-b760-42c6-a4bb-2a7fe611be5a" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_257d9e2a-3ea1-4f8b-8ed3-a4a67584ddda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_5676ea47-7a48-4bd0-ae77-da1f19ec42e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_2be5db61-085f-4b11-ab67-f69a94baa00c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_5676ea47-7a48-4bd0-ae77-da1f19ec42e2" xlink:to="loc_us-gaap_NetInvestmentIncome_2be5db61-085f-4b11-ab67-f69a94baa00c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_cba1db25-8970-4a14-9475-93b39e73f33e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_5676ea47-7a48-4bd0-ae77-da1f19ec42e2" xlink:to="loc_us-gaap_PremiumsEarnedNet_cba1db25-8970-4a14-9475-93b39e73f33e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d42bea56-c7b4-4ca9-ae07-5bf914d23908" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_5676ea47-7a48-4bd0-ae77-da1f19ec42e2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d42bea56-c7b4-4ca9-ae07-5bf914d23908" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7408ec4a-e607-4709-8f87-c032180df3b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d5e6e730-2682-4e8b-9281-a68fab36abbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_7408ec4a-e607-4709-8f87-c032180df3b3" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d5e6e730-2682-4e8b-9281-a68fab36abbc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e74b571c-0018-4d88-a3e6-90a0a5a8d5b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_7408ec4a-e607-4709-8f87-c032180df3b3" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e74b571c-0018-4d88-a3e6-90a0a5a8d5b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_95996989-5494-44cd-a4dd-980720614655" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_b5894c5e-da3d-49b2-a932-b079814f50bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_95996989-5494-44cd-a4dd-980720614655" xlink:to="loc_us-gaap_OperatingExpenses_b5894c5e-da3d-49b2-a932-b079814f50bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_b3c65a06-3c67-4a0c-bbba-c27328252b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_95996989-5494-44cd-a4dd-980720614655" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_b3c65a06-3c67-4a0c-bbba-c27328252b9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_51768cc8-aba7-480e-9280-0dcbd3038538" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_95996989-5494-44cd-a4dd-980720614655" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_51768cc8-aba7-480e-9280-0dcbd3038538" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ffe93cc3-83b6-4bb5-ad62-13868a0d9467" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_a4f8fc46-ac4a-4a9e-88c8-bad4e32aaa89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_ffe93cc3-83b6-4bb5-ad62-13868a0d9467" xlink:to="loc_us-gaap_CostsAndExpenses_a4f8fc46-ac4a-4a9e-88c8-bad4e32aaa89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_05e3ab3c-42ae-46a6-9aa4-cf11f5df6d89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_ffe93cc3-83b6-4bb5-ad62-13868a0d9467" xlink:to="loc_us-gaap_Revenues_05e3ab3c-42ae-46a6-9aa4-cf11f5df6d89" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="cvs-20220630.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cbaa2779-b61a-4f0f-8068-3e4a1832a3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_5ca1d75f-92ab-480f-82fc-00567f1cd0b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cbaa2779-b61a-4f0f-8068-3e4a1832a3c0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_5ca1d75f-92ab-480f-82fc-00567f1cd0b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_f9f608d3-fc36-44bd-a038-37c150e2b18f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cbaa2779-b61a-4f0f-8068-3e4a1832a3c0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_f9f608d3-fc36-44bd-a038-37c150e2b18f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_a9c92366-f859-4919-a715-3794afb057e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cbaa2779-b61a-4f0f-8068-3e4a1832a3c0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_a9c92366-f859-4919-a715-3794afb057e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_cad3be91-b20e-45f3-b046-d6fcb853bcd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cbaa2779-b61a-4f0f-8068-3e4a1832a3c0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_cad3be91-b20e-45f3-b046-d6fcb853bcd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_153aede7-f79a-4f38-a787-24f6db2f53f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_7dd68bbc-0625-49d4-86ef-01a1cfa0be17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_153aede7-f79a-4f38-a787-24f6db2f53f3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_7dd68bbc-0625-49d4-86ef-01a1cfa0be17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ca360132-796d-4184-b7a6-bceb6aa4ef87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_153aede7-f79a-4f38-a787-24f6db2f53f3" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ca360132-796d-4184-b7a6-bceb6aa4ef87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_f9234dcb-82b5-4adf-b2cf-066b630dd01a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2259f285-6c4d-4c8b-ba55-9556b60df799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_f9234dcb-82b5-4adf-b2cf-066b630dd01a" xlink:to="loc_us-gaap_ProfitLoss_2259f285-6c4d-4c8b-ba55-9556b60df799" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e37f3573-1b91-484e-910b-b05380210dde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_f9234dcb-82b5-4adf-b2cf-066b630dd01a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e37f3573-1b91-484e-910b-b05380210dde" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="cvs-20220630.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_0fe5144f-07be-4178-a684-e2c024e9c4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_e9efa8ab-a007-4f93-bd81-1fcfed78f6ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0fe5144f-07be-4178-a684-e2c024e9c4cd" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_e9efa8ab-a007-4f93-bd81-1fcfed78f6ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_8b2bc0cb-9b36-4d72-9e94-dde7b9fabc5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0fe5144f-07be-4178-a684-e2c024e9c4cd" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_8b2bc0cb-9b36-4d72-9e94-dde7b9fabc5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_83088c5d-6116-4c9e-8cad-0c1fa187cde2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0fe5144f-07be-4178-a684-e2c024e9c4cd" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_83088c5d-6116-4c9e-8cad-0c1fa187cde2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesCurrent_1a2de613-138b-4d11-906d-d8f6ad4d3b29" xlink:href="cvs-20220630.xsd#cvs_OtherInsuranceLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0fe5144f-07be-4178-a684-e2c024e9c4cd" xlink:to="loc_cvs_OtherInsuranceLiabilitiesCurrent_1a2de613-138b-4d11-906d-d8f6ad4d3b29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent_e13db3a3-5740-49e8-becc-4568bc2059b0" xlink:href="cvs-20220630.xsd#cvs_PharmacyClaimsandDiscountsPayableCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0fe5144f-07be-4178-a684-e2c024e9c4cd" xlink:to="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent_e13db3a3-5740-49e8-becc-4568bc2059b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_b8ab1e67-6c78-4b38-a297-a9c81afecd19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0fe5144f-07be-4178-a684-e2c024e9c4cd" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_b8ab1e67-6c78-4b38-a297-a9c81afecd19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPolicyholderFunds_bd568fc2-2d60-43dc-9b7b-cda04da027ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPolicyholderFunds"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0fe5144f-07be-4178-a684-e2c024e9c4cd" xlink:to="loc_us-gaap_OtherPolicyholderFunds_bd568fc2-2d60-43dc-9b7b-cda04da027ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_32af5e27-a7ce-465b-823f-a20caf967f83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0fe5144f-07be-4178-a684-e2c024e9c4cd" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_32af5e27-a7ce-465b-823f-a20caf967f83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_87e28ec9-dedc-4aa1-b48f-083305db3166" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_6c75bebb-15f9-4a4c-bebc-50b03fb32a79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_87e28ec9-dedc-4aa1-b48f-083305db3166" xlink:to="loc_us-gaap_PreferredStockValue_6c75bebb-15f9-4a4c-bebc-50b03fb32a79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_23c62107-fd67-425c-a661-966c5e3bff01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_87e28ec9-dedc-4aa1-b48f-083305db3166" xlink:to="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_23c62107-fd67-425c-a661-966c5e3bff01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_058370c2-1743-4281-be5d-afe4a7a76f08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_87e28ec9-dedc-4aa1-b48f-083305db3166" xlink:to="loc_us-gaap_TreasuryStockValue_058370c2-1743-4281-be5d-afe4a7a76f08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_bc77c1e9-8298-4b9c-aa05-ece346132a13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_87e28ec9-dedc-4aa1-b48f-083305db3166" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_bc77c1e9-8298-4b9c-aa05-ece346132a13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c517a7e0-833c-4834-b593-f6db7aa91199" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_87e28ec9-dedc-4aa1-b48f-083305db3166" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c517a7e0-833c-4834-b593-f6db7aa91199" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_11217489-7ded-4cf7-a61a-4cd8f671dbd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_df034a1e-6478-489f-bdd0-ed119ad5cdc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_11217489-7ded-4cf7-a61a-4cd8f671dbd4" xlink:to="loc_us-gaap_LongTermInvestments_df034a1e-6478-489f-bdd0-ed119ad5cdc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e2f5a57a-1e20-49b7-969a-e0b6cce775a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_11217489-7ded-4cf7-a61a-4cd8f671dbd4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_e2f5a57a-1e20-49b7-969a-e0b6cce775a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1514d1fc-a5c2-4058-a76c-6f1fcf6d5328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_11217489-7ded-4cf7-a61a-4cd8f671dbd4" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1514d1fc-a5c2-4058-a76c-6f1fcf6d5328" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f929d0d0-2256-4229-9dff-2c3ab20fe5a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_11217489-7ded-4cf7-a61a-4cd8f671dbd4" xlink:to="loc_us-gaap_Goodwill_f929d0d0-2256-4229-9dff-2c3ab20fe5a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4185b6ac-7efa-4297-81b7-a1df779e16ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_11217489-7ded-4cf7-a61a-4cd8f671dbd4" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4185b6ac-7efa-4297-81b7-a1df779e16ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_b0cf9c56-23c4-4a74-aa7e-6d4e7301c072" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_11217489-7ded-4cf7-a61a-4cd8f671dbd4" xlink:to="loc_us-gaap_SeparateAccountAssets_b0cf9c56-23c4-4a74-aa7e-6d4e7301c072" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_6d662f4e-c52e-4534-a08e-3d47d91a5d36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_11217489-7ded-4cf7-a61a-4cd8f671dbd4" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_6d662f4e-c52e-4534-a08e-3d47d91a5d36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_7767027b-ec46-43d0-87e7-aea8101652d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_11217489-7ded-4cf7-a61a-4cd8f671dbd4" xlink:to="loc_us-gaap_AssetsCurrent_7767027b-ec46-43d0-87e7-aea8101652d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_a447d63f-84bd-42d8-b6fa-724ad10824fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_45c7572e-dcc1-4cfa-8aa9-5c1edbb7613d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a447d63f-84bd-42d8-b6fa-724ad10824fe" xlink:to="loc_us-gaap_LiabilitiesCurrent_45c7572e-dcc1-4cfa-8aa9-5c1edbb7613d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_09941c6f-8561-4217-bc3e-81f73792cf36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a447d63f-84bd-42d8-b6fa-724ad10824fe" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_09941c6f-8561-4217-bc3e-81f73792cf36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e8a25a22-56b6-4b4f-91d3-8863b915b54e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a447d63f-84bd-42d8-b6fa-724ad10824fe" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e8a25a22-56b6-4b4f-91d3-8863b915b54e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_00338cc4-dd8b-4d94-90c8-b7cccbf4cff3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a447d63f-84bd-42d8-b6fa-724ad10824fe" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_00338cc4-dd8b-4d94-90c8-b7cccbf4cff3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_9708f358-f6cc-4206-8d4a-b5f45c2ef18b" xlink:href="cvs-20220630.xsd#cvs_OtherInsuranceLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a447d63f-84bd-42d8-b6fa-724ad10824fe" xlink:to="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_9708f358-f6cc-4206-8d4a-b5f45c2ef18b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_652e0417-ff65-4b81-9c58-718dca87ee50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a447d63f-84bd-42d8-b6fa-724ad10824fe" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_652e0417-ff65-4b81-9c58-718dca87ee50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability_e9bc8e69-f2d6-4ab1-9780-57301f7f8889" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a447d63f-84bd-42d8-b6fa-724ad10824fe" xlink:to="loc_us-gaap_SeparateAccountsLiability_e9bc8e69-f2d6-4ab1-9780-57301f7f8889" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_ec92bf6f-d5df-4ab3-916c-cabb787076aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_41c15f81-9a7f-4deb-8eb8-ed69d498f01a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ec92bf6f-d5df-4ab3-916c-cabb787076aa" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_41c15f81-9a7f-4deb-8eb8-ed69d498f01a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_69ba1678-3918-4ff5-9cac-c12b5a88ab81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ec92bf6f-d5df-4ab3-916c-cabb787076aa" xlink:to="loc_us-gaap_Liabilities_69ba1678-3918-4ff5-9cac-c12b5a88ab81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_303b8b78-7648-4eb2-ab22-a9712d993a32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_921ead68-0e55-452c-bbf4-35242166ed14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_303b8b78-7648-4eb2-ab22-a9712d993a32" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_921ead68-0e55-452c-bbf4-35242166ed14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_3864fb9d-81ec-485a-89c2-f0c5f85ba214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_303b8b78-7648-4eb2-ab22-a9712d993a32" xlink:to="loc_us-gaap_ShortTermInvestments_3864fb9d-81ec-485a-89c2-f0c5f85ba214" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_ebb911e0-8067-4130-8672-27b96d5d62f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_303b8b78-7648-4eb2-ab22-a9712d993a32" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_ebb911e0-8067-4130-8672-27b96d5d62f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_546fc4bc-d992-48de-80e7-73c8a48489af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_303b8b78-7648-4eb2-ab22-a9712d993a32" xlink:to="loc_us-gaap_InventoryNet_546fc4bc-d992-48de-80e7-73c8a48489af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_0a951422-24f3-4fd7-ac62-a4fc5c5dee5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_303b8b78-7648-4eb2-ab22-a9712d993a32" xlink:to="loc_us-gaap_OtherAssetsCurrent_0a951422-24f3-4fd7-ac62-a4fc5c5dee5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0d38f812-4a01-4951-8ac6-cfd356333553" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2cee924f-d001-423a-ae27-ab0fe7535d46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0d38f812-4a01-4951-8ac6-cfd356333553" xlink:to="loc_us-gaap_StockholdersEquity_2cee924f-d001-423a-ae27-ab0fe7535d46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_3322fdc6-cc36-4f58-bea3-4751ab439ac8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0d38f812-4a01-4951-8ac6-cfd356333553" xlink:to="loc_us-gaap_MinorityInterest_3322fdc6-cc36-4f58-bea3-4751ab439ac8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="cvs-20220630.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_457bb276-900f-4906-b385-7de975c51484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_e8b14854-a15a-4644-8830-6568df1097e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_457bb276-900f-4906-b385-7de975c51484" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_e8b14854-a15a-4644-8830-6568df1097e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_f6317b32-2b8d-44f1-8fd7-36833617c00d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_457bb276-900f-4906-b385-7de975c51484" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_f6317b32-2b8d-44f1-8fd7-36833617c00d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_c1321800-2d66-4141-9ff1-470b4c7ea2b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_457bb276-900f-4906-b385-7de975c51484" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_c1321800-2d66-4141-9ff1-470b4c7ea2b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_1f9f161b-bf27-47ab-84eb-de0cc8f6259e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_457bb276-900f-4906-b385-7de975c51484" xlink:to="loc_us-gaap_PaymentsOfDividends_1f9f161b-bf27-47ab-84eb-de0cc8f6259e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_3ca941aa-2a59-46a4-b59a-b72d53c9599c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_457bb276-900f-4906-b385-7de975c51484" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_3ca941aa-2a59-46a4-b59a-b72d53c9599c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_8c521808-14e8-4014-833e-b932a39d7a85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_457bb276-900f-4906-b385-7de975c51484" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_8c521808-14e8-4014-833e-b932a39d7a85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_92da1d18-61f9-45e5-831a-57339c448519" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_62f28588-f3c1-4a46-b38e-5a1dc462516d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_92da1d18-61f9-45e5-831a-57339c448519" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_62f28588-f3c1-4a46-b38e-5a1dc462516d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e9504706-c368-4fbf-95e0-ebee66f1e88f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_92da1d18-61f9-45e5-831a-57339c448519" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e9504706-c368-4fbf-95e0-ebee66f1e88f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_4d10841d-1a96-4cdc-87d5-450e7f45db0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_92da1d18-61f9-45e5-831a-57339c448519" xlink:to="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_4d10841d-1a96-4cdc-87d5-450e7f45db0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_d02b4518-2ca8-4b13-ac09-96544276b82b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_92da1d18-61f9-45e5-831a-57339c448519" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_d02b4518-2ca8-4b13-ac09-96544276b82b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Deferredincometaxesandothernoncashitems_699b9067-d4d7-4f8f-a839-4d10065ef781" xlink:href="cvs-20220630.xsd#cvs_Deferredincometaxesandothernoncashitems"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_92da1d18-61f9-45e5-831a-57339c448519" xlink:to="loc_cvs_Deferredincometaxesandothernoncashitems_699b9067-d4d7-4f8f-a839-4d10065ef781" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_a9270c7f-3060-45d4-a4a3-c583b090ee87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_92da1d18-61f9-45e5-831a-57339c448519" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_a9270c7f-3060-45d4-a4a3-c583b090ee87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_4a9d3928-f5cb-4d7e-adde-94b444137758" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_92da1d18-61f9-45e5-831a-57339c448519" xlink:to="loc_us-gaap_ShareBasedCompensation_4a9d3928-f5cb-4d7e-adde-94b444137758" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_abe99e5f-95b7-4a4d-a391-3857d86429ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_92da1d18-61f9-45e5-831a-57339c448519" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_abe99e5f-95b7-4a4d-a391-3857d86429ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_cccfdc02-1888-4516-8965-23f4c12000bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_92da1d18-61f9-45e5-831a-57339c448519" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_cccfdc02-1888-4516-8965-23f4c12000bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b6d2091d-269c-4039-ab4e-171911d4fbbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_92da1d18-61f9-45e5-831a-57339c448519" xlink:to="loc_us-gaap_ProfitLoss_b6d2091d-269c-4039-ab4e-171911d4fbbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_050ed0a9-1ca6-42fe-a8b6-a742e8359e79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_92da1d18-61f9-45e5-831a-57339c448519" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_050ed0a9-1ca6-42fe-a8b6-a742e8359e79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a539b5ec-f89f-4a77-a3f4-edcedbe8bef4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_50597369-4835-4c86-90b0-81e1de3e9903" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a539b5ec-f89f-4a77-a3f4-edcedbe8bef4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_50597369-4835-4c86-90b0-81e1de3e9903" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_73cef484-fc29-4159-b062-b1b2762dc1f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a539b5ec-f89f-4a77-a3f4-edcedbe8bef4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_73cef484-fc29-4159-b062-b1b2762dc1f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_50c12716-ad9c-490e-8e96-161a4a87da9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a539b5ec-f89f-4a77-a3f4-edcedbe8bef4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_50c12716-ad9c-490e-8e96-161a4a87da9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0d8b5189-811e-4f40-84f4-7ea7970427e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_7462377d-c1e0-4983-b4d8-47954126c476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0d8b5189-811e-4f40-84f4-7ea7970427e6" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_7462377d-c1e0-4983-b4d8-47954126c476" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_05e87fb4-4a03-4fd1-804b-510cc85567c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0d8b5189-811e-4f40-84f4-7ea7970427e6" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_05e87fb4-4a03-4fd1-804b-510cc85567c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_59e7d77c-e537-4eda-a0e0-70ac3c0c1181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0d8b5189-811e-4f40-84f4-7ea7970427e6" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_59e7d77c-e537-4eda-a0e0-70ac3c0c1181" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_75b7b079-be63-4fea-a881-05104ac6147b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0d8b5189-811e-4f40-84f4-7ea7970427e6" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_75b7b079-be63-4fea-a881-05104ac6147b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_45be5ba2-1fab-4542-9ff4-2ba93899921c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0d8b5189-811e-4f40-84f4-7ea7970427e6" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_45be5ba2-1fab-4542-9ff4-2ba93899921c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_27db1345-ea75-4adb-9344-63f5d1502cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0d8b5189-811e-4f40-84f4-7ea7970427e6" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_27db1345-ea75-4adb-9344-63f5d1502cc5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1" xlink:type="simple" xlink:href="cvs-20220630.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited_1"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_447a8376-0897-4220-aad2-df9df2f07e13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_363de8e9-e370-4bc2-848c-305495ce4c24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_447a8376-0897-4220-aad2-df9df2f07e13" xlink:to="loc_us-gaap_InterestPaidNet_363de8e9-e370-4bc2-848c-305495ce4c24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_f83f82cf-a32d-4d48-b6f1-686460297d15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromInterestAndDividendsReceived"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_447a8376-0897-4220-aad2-df9df2f07e13" xlink:to="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_f83f82cf-a32d-4d48-b6f1-686460297d15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_c3cbd619-c1bd-4a60-9814-0a1cdd2bd1e4" xlink:href="cvs-20220630.xsd#cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_447a8376-0897-4220-aad2-df9df2f07e13" xlink:to="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_c3cbd619-c1bd-4a60-9814-0a1cdd2bd1e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCustomers_0ae70e18-8084-40ad-9cf2-92ed6af00e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCustomers"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_447a8376-0897-4220-aad2-df9df2f07e13" xlink:to="loc_us-gaap_ProceedsFromCustomers_0ae70e18-8084-40ad-9cf2-92ed6af00e4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInsuranceBenefits_907c943c-8049-4e82-b24d-d91733f2abe7" xlink:href="cvs-20220630.xsd#cvs_PaymentsforInsuranceBenefits"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_447a8376-0897-4220-aad2-df9df2f07e13" xlink:to="loc_cvs_PaymentsforInsuranceBenefits_907c943c-8049-4e82-b24d-d91733f2abe7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_a7d058cb-7e80-4a2d-9046-85a51050f4f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_447a8376-0897-4220-aad2-df9df2f07e13" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_a7d058cb-7e80-4a2d-9046-85a51050f4f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToSuppliersAndEmployees_b7a2385b-9eae-4c69-91cc-bcccfa8192f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToSuppliersAndEmployees"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_447a8376-0897-4220-aad2-df9df2f07e13" xlink:to="loc_us-gaap_PaymentsToSuppliersAndEmployees_b7a2385b-9eae-4c69-91cc-bcccfa8192f6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f26a4053-1aca-46e7-b7ac-796a1a8cee48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0c355577-34ec-463f-bfbd-9e318af5f9b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f26a4053-1aca-46e7-b7ac-796a1a8cee48" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0c355577-34ec-463f-bfbd-9e318af5f9b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_93786715-e941-4025-9587-95456bc9203f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f26a4053-1aca-46e7-b7ac-796a1a8cee48" xlink:to="loc_us-gaap_RestrictedCashCurrent_93786715-e941-4025-9587-95456bc9203f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_b451dc4c-9040-43d8-9503-49174d540a53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f26a4053-1aca-46e7-b7ac-796a1a8cee48" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_b451dc4c-9040-43d8-9503-49174d540a53" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#SignificantAccountingPoliciesAccountsReceivableDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_44a90c52-4c90-4559-b846-189fff50879a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_3116e8f5-bd5f-4a15-8fe0-ab2ac415ff9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_44a90c52-4c90-4559-b846-189fff50879a" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_3116e8f5-bd5f-4a15-8fe0-ab2ac415ff9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VendorandManufacturerReceivables_e04c86fe-b070-4c30-9d08-1607ee710fac" xlink:href="cvs-20220630.xsd#cvs_VendorandManufacturerReceivables"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_44a90c52-4c90-4559-b846-189fff50879a" xlink:to="loc_cvs_VendorandManufacturerReceivables_e04c86fe-b070-4c30-9d08-1607ee710fac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_2044f7b3-4f6e-45b6-95c7-48d399aa2839" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_44a90c52-4c90-4559-b846-189fff50879a" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_2044f7b3-4f6e-45b6-95c7-48d399aa2839" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_68b36cd4-bd00-428f-b8cf-f3de54998e53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_44a90c52-4c90-4559-b846-189fff50879a" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_68b36cd4-bd00-428f-b8cf-f3de54998e53" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#InvestmentsTotalInvestmentScheduleDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_67244659-fd7c-4b8e-bef7-68e069819722" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_f9dff203-945f-4074-9a78-b2fe368274f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_67244659-fd7c-4b8e-bef7-68e069819722" xlink:to="loc_us-gaap_ShortTermInvestments_f9dff203-945f-4074-9a78-b2fe368274f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_cb519223-08d7-464f-8807-29bf20693f30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_67244659-fd7c-4b8e-bef7-68e069819722" xlink:to="loc_us-gaap_LongTermInvestments_cb519223-08d7-464f-8807-29bf20693f30" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#InvestmentsDebtSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_ddbab91e-541c-4283-910a-c9f0485b3af5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d063d00f-e9ea-4bd2-96af-1ef10ac83550" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_ddbab91e-541c-4283-910a-c9f0485b3af5" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d063d00f-e9ea-4bd2-96af-1ef10ac83550" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_bd64b049-9da5-434f-8b19-9d5be38095db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_ddbab91e-541c-4283-910a-c9f0485b3af5" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_bd64b049-9da5-434f-8b19-9d5be38095db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_191dd8c6-ecf3-48ee-a313-9d16422a95e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_ddbab91e-541c-4283-910a-c9f0485b3af5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_191dd8c6-ecf3-48ee-a313-9d16422a95e6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1" xlink:type="simple" xlink:href="cvs-20220630.xsd#InvestmentsDebtSecuritiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_333edb9c-981b-43e0-b97f-a1310ba12066" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_37b9cae8-c832-4a06-8dd6-6ddc10599a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_333edb9c-981b-43e0-b97f-a1310ba12066" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_37b9cae8-c832-4a06-8dd6-6ddc10599a6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_52ef207f-c8b5-4f51-acf6-6676ad41f12c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_333edb9c-981b-43e0-b97f-a1310ba12066" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_52ef207f-c8b5-4f51-acf6-6676ad41f12c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#InvestmentsDebtSecuritiesbyMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_b9b1cab6-11ce-49c5-85a2-1c2e965024f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_7380255f-6a19-4612-965c-d859bea9aacd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_b9b1cab6-11ce-49c5-85a2-1c2e965024f4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_7380255f-6a19-4612-965c-d859bea9aacd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_be5a6ddc-43f9-4e4e-946f-a00d740d05ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_b9b1cab6-11ce-49c5-85a2-1c2e965024f4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_be5a6ddc-43f9-4e4e-946f-a00d740d05ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_8bfd7113-0d5f-4fee-a9a3-05b290b62a32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_b9b1cab6-11ce-49c5-85a2-1c2e965024f4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_8bfd7113-0d5f-4fee-a9a3-05b290b62a32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_35a17187-6aba-4d6a-8a30-a39a9e317d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_b9b1cab6-11ce-49c5-85a2-1c2e965024f4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_35a17187-6aba-4d6a-8a30-a39a9e317d5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_d1a958a0-70b9-49fe-93e5-0a1f911036ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_b9b1cab6-11ce-49c5-85a2-1c2e965024f4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_d1a958a0-70b9-49fe-93e5-0a1f911036ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4c1c1766-3f46-4790-84ee-4a04a619770a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_9cd8715d-1946-413f-ac90-22d715af985e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4c1c1766-3f46-4790-84ee-4a04a619770a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_9cd8715d-1946-413f-ac90-22d715af985e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_e484ab19-c775-4f81-9cd0-fed483e9ee19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4c1c1766-3f46-4790-84ee-4a04a619770a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_e484ab19-c775-4f81-9cd0-fed483e9ee19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_0af66472-739f-44bc-bff3-91338dec1eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4c1c1766-3f46-4790-84ee-4a04a619770a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_0af66472-739f-44bc-bff3-91338dec1eb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_487df6b2-41ee-4787-9fc6-ec5ef9187b31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4c1c1766-3f46-4790-84ee-4a04a619770a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_487df6b2-41ee-4787-9fc6-ec5ef9187b31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_7a2b1d51-7b75-4115-ab00-b3ea977f2587" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4c1c1766-3f46-4790-84ee-4a04a619770a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_7a2b1d51-7b75-4115-ab00-b3ea977f2587" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#InvestmentsUnrealizedLossPositionDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_c8f11e33-f3d8-4d96-a738-3cf5e68567b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_12c0e539-4983-4edd-8078-9a82e349eb46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_c8f11e33-f3d8-4d96-a738-3cf5e68567b6" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_12c0e539-4983-4edd-8078-9a82e349eb46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_dcdb6ea4-5af5-4568-ae27-ba45f05cfdad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_c8f11e33-f3d8-4d96-a738-3cf5e68567b6" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_dcdb6ea4-5af5-4568-ae27-ba45f05cfdad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_a802f00f-a61b-4b9c-86c7-202eb0e2e1b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_72d480a6-b82a-470e-a013-f0312b6cc799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_a802f00f-a61b-4b9c-86c7-202eb0e2e1b4" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_72d480a6-b82a-470e-a013-f0312b6cc799" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_04c50946-7520-46f5-b022-1c01e73bc6c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_a802f00f-a61b-4b9c-86c7-202eb0e2e1b4" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_04c50946-7520-46f5-b022-1c01e73bc6c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_33ec2eee-6186-4cc8-ba7d-a254943ff4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_7e235b07-be03-4f7d-9894-df0657b66e16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_33ec2eee-6186-4cc8-ba7d-a254943ff4ed" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_7e235b07-be03-4f7d-9894-df0657b66e16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_89bab60d-884b-4fa6-970d-8cba47d66da3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_33ec2eee-6186-4cc8-ba7d-a254943ff4ed" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_89bab60d-884b-4fa6-970d-8cba47d66da3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#InvestmentsUnrealizedLossPositionMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_470fe3d2-d415-456e-ba97-5ec45d5e5ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_82e17bf5-2e76-4e66-abd1-4976558a2537" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_470fe3d2-d415-456e-ba97-5ec45d5e5ca9" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_82e17bf5-2e76-4e66-abd1-4976558a2537" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_38bf503a-acf3-4068-99b9-279b35569d65" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_470fe3d2-d415-456e-ba97-5ec45d5e5ca9" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_38bf503a-acf3-4068-99b9-279b35569d65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_0ac33423-dfd5-4a37-a243-5f6b84fc03e5" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_470fe3d2-d415-456e-ba97-5ec45d5e5ca9" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_0ac33423-dfd5-4a37-a243-5f6b84fc03e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_5682d3e1-d5ba-4d39-b327-f1dc1a1d3d6f" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_470fe3d2-d415-456e-ba97-5ec45d5e5ca9" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_5682d3e1-d5ba-4d39-b327-f1dc1a1d3d6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_b86a181b-3604-412a-b368-75287a2e1db3" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_470fe3d2-d415-456e-ba97-5ec45d5e5ca9" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_b86a181b-3604-412a-b368-75287a2e1db3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_ac98d242-752e-4220-92e5-bfcb7bc40216" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_55b7d215-43bf-4205-b04c-9c487efb71d4" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_ac98d242-752e-4220-92e5-bfcb7bc40216" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_55b7d215-43bf-4205-b04c-9c487efb71d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_c9e56778-1cbf-469e-8a5e-3dcb6501c62f" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_ac98d242-752e-4220-92e5-bfcb7bc40216" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_c9e56778-1cbf-469e-8a5e-3dcb6501c62f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_5dc84e09-649a-42b1-8b59-ca909c14b289" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_ac98d242-752e-4220-92e5-bfcb7bc40216" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_5dc84e09-649a-42b1-8b59-ca909c14b289" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_d8570f88-4a53-4857-9b69-7417329e2744" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_ac98d242-752e-4220-92e5-bfcb7bc40216" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_d8570f88-4a53-4857-9b69-7417329e2744" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_0cfbad80-af3c-447e-a818-fa8ac2ae4c07" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_ac98d242-752e-4220-92e5-bfcb7bc40216" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_0cfbad80-af3c-447e-a818-fa8ac2ae4c07" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#InvestmentsNetInvestmentIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_0f4375a0-fbfe-4a77-894c-f6f37d87a10b" xlink:href="cvs-20220630.xsd#cvs_InvestmentIncomeExcludingCapitalGainsorLosses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_2f6ac059-cc07-44e6-a089-51b24dd5f746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_0f4375a0-fbfe-4a77-894c-f6f37d87a10b" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_2f6ac059-cc07-44e6-a089-51b24dd5f746" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_bbd1dc6a-b0bb-4390-ab32-692ffaa5b63e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_0f4375a0-fbfe-4a77-894c-f6f37d87a10b" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_bbd1dc6a-b0bb-4390-ab32-692ffaa5b63e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_058b6452-cb94-405e-adb9-0bef2f5c8e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_7d0e239c-fbaa-408c-aa6b-ad15e0b8c147" xlink:href="cvs-20220630.xsd#cvs_InvestmentIncomeExcludingCapitalGainsorLosses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentIncomeNet_058b6452-cb94-405e-adb9-0bef2f5c8e9f" xlink:to="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_7d0e239c-fbaa-408c-aa6b-ad15e0b8c147" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_9c789ed2-7a72-4098-9426-2fcefadecf19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentIncomeNet_058b6452-cb94-405e-adb9-0bef2f5c8e9f" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_9c789ed2-7a72-4098-9426-2fcefadecf19" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#FairValueMeasurementonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_068ca224-efe7-4782-9536-0d59e131d223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_34b9a9b6-6980-4861-a849-d79a55fa6df4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_068ca224-efe7-4782-9536-0d59e131d223" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_34b9a9b6-6980-4861-a849-d79a55fa6df4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_299fe9f7-073c-4b7e-8e56-976fbda6bc98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_068ca224-efe7-4782-9536-0d59e131d223" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_299fe9f7-073c-4b7e-8e56-976fbda6bc98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_98cf4add-cc27-4b70-b542-165a593dd53f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_068ca224-efe7-4782-9536-0d59e131d223" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_98cf4add-cc27-4b70-b542-165a593dd53f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_a53efa21-2f9d-4831-aa40-0c16ca238070" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_49cffdbe-59f4-4daf-ac36-3e15e1141ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_a53efa21-2f9d-4831-aa40-0c16ca238070" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_49cffdbe-59f4-4daf-ac36-3e15e1141ef8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_484760e7-0b5b-44d0-9d34-62a4f4a445a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_a53efa21-2f9d-4831-aa40-0c16ca238070" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_484760e7-0b5b-44d0-9d34-62a4f4a445a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_d66ba8a5-7630-477f-a8c1-119ce0a1962f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_a119eca8-7e27-4967-ad0e-6c3975d09bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_d66ba8a5-7630-477f-a8c1-119ce0a1962f" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_a119eca8-7e27-4967-ad0e-6c3975d09bb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_9ff6dd9b-6838-47af-8943-dfeb6c8afdb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_d66ba8a5-7630-477f-a8c1-119ce0a1962f" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_9ff6dd9b-6838-47af-8943-dfeb6c8afdb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_f628f331-eda4-4006-8500-a732bfe31ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_dba55742-008c-42b3-ad51-27a673f331a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_f628f331-eda4-4006-8500-a732bfe31ce5" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_dba55742-008c-42b3-ad51-27a673f331a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_94098b37-8a01-42c7-9cf6-7c930aba8a23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_f628f331-eda4-4006-8500-a732bfe31ce5" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_94098b37-8a01-42c7-9cf6-7c930aba8a23" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#BorrowingsScheduleofBorrowingsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_f39951f1-304b-4006-89f9-f197bdd82243" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_be8b432c-b6c9-45fc-903f-b49dd7218adf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_f39951f1-304b-4006-89f9-f197bdd82243" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_be8b432c-b6c9-45fc-903f-b49dd7218adf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_2c182f5b-efcd-47f0-996e-208c81ccb674" xlink:href="cvs-20220630.xsd#cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_f39951f1-304b-4006-89f9-f197bdd82243" xlink:to="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_2c182f5b-efcd-47f0-996e-208c81ccb674" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongtermDebtGrossAndLeaseObligation_46216381-2cf7-4854-88af-1ea639b2691f" xlink:href="cvs-20220630.xsd#cvs_LongtermDebtGrossAndLeaseObligation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_f39951f1-304b-4006-89f9-f197bdd82243" xlink:to="loc_cvs_LongtermDebtGrossAndLeaseObligation_46216381-2cf7-4854-88af-1ea639b2691f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongtermDebtGrossAndLeaseObligation_c1dc3769-30cb-4869-8b45-6c1456d4fe30" xlink:href="cvs-20220630.xsd#cvs_LongtermDebtGrossAndLeaseObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_0db39dc1-96ff-462e-ae94-c1bccc14db8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LongtermDebtGrossAndLeaseObligation_c1dc3769-30cb-4869-8b45-6c1456d4fe30" xlink:to="loc_us-gaap_FinanceLeaseLiability_0db39dc1-96ff-462e-ae94-c1bccc14db8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_9ce502d1-c05e-4b7d-9377-ce943cd28db3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LongtermDebtGrossAndLeaseObligation_c1dc3769-30cb-4869-8b45-6c1456d4fe30" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_9ce502d1-c05e-4b7d-9377-ce943cd28db3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#OtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4d4d1e6f-1ab6-4df3-af45-e37bcef60334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_af7d80f8-f43f-4aaa-8b2d-023a26b4cd01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4d4d1e6f-1ab6-4df3-af45-e37bcef60334" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_af7d80f8-f43f-4aaa-8b2d-023a26b4cd01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_8ccefa74-d933-4b34-9f9a-8eb53d6da43a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4d4d1e6f-1ab6-4df3-af45-e37bcef60334" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_8ccefa74-d933-4b34-9f9a-8eb53d6da43a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#EarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_dbcea0e1-3db6-4f3a-8a13-e4bdc515e4d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_910ec955-c2cd-431d-800b-3f68fbacac80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_dbcea0e1-3db6-4f3a-8a13-e4bdc515e4d9" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_910ec955-c2cd-431d-800b-3f68fbacac80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_95a5c4dc-cba4-4759-a1b1-81b393b27c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_dbcea0e1-3db6-4f3a-8a13-e4bdc515e4d9" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_95a5c4dc-cba4-4759-a1b1-81b393b27c1b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_4a05fcda-03c2-4216-b72f-00531657a34f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_3c62d521-f68a-4fec-9ba0-b6f7be3d2eea" xlink:href="cvs-20220630.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_4a05fcda-03c2-4216-b72f-00531657a34f" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_3c62d521-f68a-4fec-9ba0-b6f7be3d2eea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5c12ec21-b3ea-4ae5-88ea-60cb48d4f936" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_4a05fcda-03c2-4216-b72f-00531657a34f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5c12ec21-b3ea-4ae5-88ea-60cb48d4f936" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_5993f1b4-ec9e-42f7-8249-e735f0132ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_4a05fcda-03c2-4216-b72f-00531657a34f" xlink:to="loc_us-gaap_NetInvestmentIncome_5993f1b4-ec9e-42f7-8249-e735f0132ef5" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>cvs-20220630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:0140da76-e33c-4901-8b3b-5aa42426ab0a,g:ea97fc95-8028-4e4e-8a3a-2f9f67911aac-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="cvs-20220630.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended" id="i3890ae3e24574652956b34807ae84585_CondensedConsolidatedStatementsofOperationsUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_a21bbf82-cfb4-4207-84e5-f62338309a98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:to="loc_us-gaap_RevenuesAbstract_a21bbf82-cfb4-4207-84e5-f62338309a98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2906aeeb-7d4b-479c-a539-9057baea8fba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_a21bbf82-cfb4-4207-84e5-f62338309a98" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2906aeeb-7d4b-479c-a539-9057baea8fba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_018af743-e1df-481b-815f-dd9314cc01be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_a21bbf82-cfb4-4207-84e5-f62338309a98" xlink:to="loc_us-gaap_PremiumsEarnedNet_018af743-e1df-481b-815f-dd9314cc01be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_b290a3da-976a-4248-bf3c-7aa18813cc7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_a21bbf82-cfb4-4207-84e5-f62338309a98" xlink:to="loc_us-gaap_NetInvestmentIncome_b290a3da-976a-4248-bf3c-7aa18813cc7d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_12a760e1-c7a6-408c-b180-7857c37811e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_a21bbf82-cfb4-4207-84e5-f62338309a98" xlink:to="loc_us-gaap_Revenues_12a760e1-c7a6-408c-b180-7857c37811e8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_2156d320-ef10-4fa2-bbe8-830c83b1cb61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:to="loc_us-gaap_OperatingExpensesAbstract_2156d320-ef10-4fa2-bbe8-830c83b1cb61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_bb1808b5-315d-45d4-9b02-65af28d0e1a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2156d320-ef10-4fa2-bbe8-830c83b1cb61" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_bb1808b5-315d-45d4-9b02-65af28d0e1a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_0a5efc34-7af2-41c3-adc4-d8d6a0d4d7a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2156d320-ef10-4fa2-bbe8-830c83b1cb61" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_0a5efc34-7af2-41c3-adc4-d8d6a0d4d7a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_8a59a1ef-0bd1-4dc6-8d4e-edae0a58b90a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2156d320-ef10-4fa2-bbe8-830c83b1cb61" xlink:to="loc_us-gaap_OperatingExpenses_8a59a1ef-0bd1-4dc6-8d4e-edae0a58b90a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_b9cd57a9-079b-4809-b27d-7bcbc49dfef0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2156d320-ef10-4fa2-bbe8-830c83b1cb61" xlink:to="loc_us-gaap_CostsAndExpenses_b9cd57a9-079b-4809-b27d-7bcbc49dfef0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_8d3d0c35-879e-4527-875d-f6c8628e0079" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:to="loc_us-gaap_OperatingIncomeLoss_8d3d0c35-879e-4527-875d-f6c8628e0079" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_b0202fd4-5ac2-4773-a7e3-f2a966a50cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:to="loc_us-gaap_InterestExpense_b0202fd4-5ac2-4773-a7e3-f2a966a50cb7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_8baa3b63-29f0-4fa5-b833-8cb8ad4f2d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_8baa3b63-29f0-4fa5-b833-8cb8ad4f2d4e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2671f260-ebdc-4128-9c22-6010971f8185" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2671f260-ebdc-4128-9c22-6010971f8185" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_63a55c6a-0fa4-46a1-8f1a-b9449190aa56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_63a55c6a-0fa4-46a1-8f1a-b9449190aa56" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2e8fe9a4-79f5-4224-a4f6-4d14471f6811" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:to="loc_us-gaap_ProfitLoss_2e8fe9a4-79f5-4224-a4f6-4d14471f6811" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9b7f4a04-1a6d-46a2-a240-b3d3735dab6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9b7f4a04-1a6d-46a2-a240-b3d3735dab6f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_879d2804-6c20-4fba-add0-8213c2d33b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:to="loc_us-gaap_NetIncomeLoss_879d2804-6c20-4fba-add0-8213c2d33b3c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e7516c79-992a-47f5-8be3-e33289c3c28c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:to="loc_us-gaap_EarningsPerShareAbstract_e7516c79-992a-47f5-8be3-e33289c3c28c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_514671b5-3969-4721-8363-a674a142dee6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e7516c79-992a-47f5-8be3-e33289c3c28c" xlink:to="loc_us-gaap_EarningsPerShareBasic_514671b5-3969-4721-8363-a674a142dee6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_97608436-699f-4d80-a6b5-e38ab1338384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e7516c79-992a-47f5-8be3-e33289c3c28c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_97608436-699f-4d80-a6b5-e38ab1338384" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f234f4e9-9b0d-4c5a-b045-d8b83760a9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f234f4e9-9b0d-4c5a-b045-d8b83760a9a4" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b9ad7628-47a1-4d62-ad34-080d18bba061" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f234f4e9-9b0d-4c5a-b045-d8b83760a9a4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b9ad7628-47a1-4d62-ad34-080d18bba061" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_984e8208-bde9-489c-8d02-800c8e9754a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f234f4e9-9b0d-4c5a-b045-d8b83760a9a4" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_984e8208-bde9-489c-8d02-800c8e9754a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_8581d130-afdc-4084-9e05-2b76b31c7615" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_8581d130-afdc-4084-9e05-2b76b31c7615" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_3297c470-aacf-45ce-ac68-e1c9d1fb0faf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:to="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_3297c470-aacf-45ce-ac68-e1c9d1fb0faf" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_84a6edcd-4cee-4fd7-aaf6-09dbef2bcfe1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:to="loc_us-gaap_StatementTable_84a6edcd-4cee-4fd7-aaf6-09dbef2bcfe1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f193ca32-8a0b-4de1-b62b-176f366bfc6e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_84a6edcd-4cee-4fd7-aaf6-09dbef2bcfe1" xlink:to="loc_srt_ProductOrServiceAxis_f193ca32-8a0b-4de1-b62b-176f366bfc6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f193ca32-8a0b-4de1-b62b-176f366bfc6e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_f193ca32-8a0b-4de1-b62b-176f366bfc6e" xlink:to="loc_srt_ProductsAndServicesDomain_f193ca32-8a0b-4de1-b62b-176f366bfc6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3566e73d-3049-4c7a-9265-c4db4e481cfa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_f193ca32-8a0b-4de1-b62b-176f366bfc6e" xlink:to="loc_srt_ProductsAndServicesDomain_3566e73d-3049-4c7a-9265-c4db4e481cfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_09502f1d-c75e-4c9f-bb84-83e33e9fc431" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3566e73d-3049-4c7a-9265-c4db4e481cfa" xlink:to="loc_us-gaap_ProductMember_09502f1d-c75e-4c9f-bb84-83e33e9fc431" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_5d12e57d-8f6b-4a50-9ee5-deb7bace7af5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3566e73d-3049-4c7a-9265-c4db4e481cfa" xlink:to="loc_us-gaap_ServiceMember_5d12e57d-8f6b-4a50-9ee5-deb7bace7af5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited" xlink:type="simple" xlink:href="cvs-20220630.xsd#CondensedConsolidatedStatementsofShareholdersEquityUnaudited"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited" xlink:type="extended" id="i375f41e93a314d06b37afa7a3aabd9ea_CondensedConsolidatedStatementsofShareholdersEquityUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_25f5b957-2caa-4643-a2e5-4dafc04a5984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_25f5b957-2caa-4643-a2e5-4dafc04a5984" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_97128ebd-cfd0-46b0-adcc-ed79649704d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:to="loc_us-gaap_SharesOutstanding_97128ebd-cfd0-46b0-adcc-ed79649704d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_d47a3cca-48dd-478a-a450-0579df5bddb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:to="loc_us-gaap_TreasuryStockCommonShares_d47a3cca-48dd-478a-a450-0579df5bddb7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d0e85cf5-7059-4256-b7f8-3f1de9199b69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d0e85cf5-7059-4256-b7f8-3f1de9199b69" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1a4faf17-afb9-4f05-b36c-5a8b712d1d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:to="loc_us-gaap_ProfitLoss_1a4faf17-afb9-4f05-b36c-5a8b712d1d9e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2b9f4ecb-9179-4a48-856c-65bbd302b629" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2b9f4ecb-9179-4a48-856c-65bbd302b629" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8df1f7fd-ffce-44e6-bcb1-435f075a19d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8df1f7fd-ffce-44e6-bcb1-435f075a19d7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_9366e7f2-09d4-45a3-8cb0-bf45fb6c5be8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_9366e7f2-09d4-45a3-8cb0-bf45fb6c5be8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_9b6a8d13-7b31-4e64-ae03-ab33d1c13c76" xlink:href="cvs-20220630.xsd#cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:to="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_9b6a8d13-7b31-4e64-ae03-ab33d1c13c76" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_ce828c88-2fb9-464c-b7b8-93649e5afd73" xlink:href="cvs-20220630.xsd#cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:to="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_ce828c88-2fb9-464c-b7b8-93649e5afd73" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_5998053c-299d-4c80-b979-79f7523d5cf7" xlink:href="cvs-20220630.xsd#cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:to="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_5998053c-299d-4c80-b979-79f7523d5cf7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_a53e680a-1b6f-4eb8-883f-5bbc4db0b431" xlink:href="cvs-20220630.xsd#cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:to="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_a53e680a-1b6f-4eb8-883f-5bbc4db0b431" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_faccf851-0044-4fae-836b-5ab15248ac8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:to="loc_us-gaap_DividendsCommonStock_faccf851-0044-4fae-836b-5ab15248ac8f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_eb4adee5-0e5b-4f1a-9d99-b97d9f6e9f16" xlink:href="cvs-20220630.xsd#cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:to="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_eb4adee5-0e5b-4f1a-9d99-b97d9f6e9f16" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_7eb37ecf-3e8e-46d5-9e47-7bdfd8b116ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_144115dd-a715-4dd8-a1af-593b42c036e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0ab4e05a-3e0d-4163-9cbb-77a5da341412" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_224c3900-2502-4619-b442-895585a50745" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_25f5b957-2caa-4643-a2e5-4dafc04a5984" xlink:to="loc_us-gaap_StatementTable_224c3900-2502-4619-b442-895585a50745" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2ac9f726-8b7a-4110-b659-ad1709ce14eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_224c3900-2502-4619-b442-895585a50745" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2ac9f726-8b7a-4110-b659-ad1709ce14eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2ac9f726-8b7a-4110-b659-ad1709ce14eb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2ac9f726-8b7a-4110-b659-ad1709ce14eb" xlink:to="loc_us-gaap_EquityComponentDomain_2ac9f726-8b7a-4110-b659-ad1709ce14eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_da066759-225d-4e5b-8ba8-4b729db55a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2ac9f726-8b7a-4110-b659-ad1709ce14eb" xlink:to="loc_us-gaap_EquityComponentDomain_da066759-225d-4e5b-8ba8-4b729db55a7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_d4077145-9805-4810-85bb-6e1aa7a4ceb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_da066759-225d-4e5b-8ba8-4b729db55a7d" xlink:to="loc_us-gaap_ParentMember_d4077145-9805-4810-85bb-6e1aa7a4ceb5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c7f7f8a1-56d0-4fd5-8348-4fa96cd34e27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_d4077145-9805-4810-85bb-6e1aa7a4ceb5" xlink:to="loc_us-gaap_CommonStockMember_c7f7f8a1-56d0-4fd5-8348-4fa96cd34e27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_0bcfef67-e2f1-4803-906f-2c18ac1837a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_d4077145-9805-4810-85bb-6e1aa7a4ceb5" xlink:to="loc_us-gaap_TreasuryStockCommonMember_0bcfef67-e2f1-4803-906f-2c18ac1837a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_62f8e603-c671-49f6-8991-7a04b108a1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_d4077145-9805-4810-85bb-6e1aa7a4ceb5" xlink:to="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_62f8e603-c671-49f6-8991-7a04b108a1fb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b780ad18-f257-4043-9740-0028249b4610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_d4077145-9805-4810-85bb-6e1aa7a4ceb5" xlink:to="loc_us-gaap_RetainedEarningsMember_b780ad18-f257-4043-9740-0028249b4610" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e48f63c8-4782-43ef-92ab-4d16c705e95c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_d4077145-9805-4810-85bb-6e1aa7a4ceb5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e48f63c8-4782-43ef-92ab-4d16c705e95c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_0fd9a30a-4054-425d-aadf-ff449e00f814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_da066759-225d-4e5b-8ba8-4b729db55a7d" xlink:to="loc_us-gaap_NoncontrollingInterestMember_0fd9a30a-4054-425d-aadf-ff449e00f814" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i4fc9aebc122346669710f2b1e5145bcd_SignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d6c422a2-aa77-48cb-8609-0c4e62f7a556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores_cc7654ff-e3d3-4e4a-9a27-c31aabdc4dca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfStores"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d6c422a2-aa77-48cb-8609-0c4e62f7a556" xlink:to="loc_us-gaap_NumberOfStores_cc7654ff-e3d3-4e4a-9a27-c31aabdc4dca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofWalkInMedicalClinics_26116672-1ce3-4b56-ad2a-052d28e50e91" xlink:href="cvs-20220630.xsd#cvs_NumberofWalkInMedicalClinics"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d6c422a2-aa77-48cb-8609-0c4e62f7a556" xlink:to="loc_cvs_NumberofWalkInMedicalClinics_26116672-1ce3-4b56-ad2a-052d28e50e91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPharmacyPlanMembers_9fc18869-f417-4642-b36c-0f9e0cc1282a" xlink:href="cvs-20220630.xsd#cvs_NumberofPharmacyPlanMembers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d6c422a2-aa77-48cb-8609-0c4e62f7a556" xlink:to="loc_cvs_NumberofPharmacyPlanMembers_9fc18869-f417-4642-b36c-0f9e0cc1282a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPatientsServedperYear_5f663670-d097-406c-8e85-af2ba74e9ede" xlink:href="cvs-20220630.xsd#cvs_NumberofPatientsServedperYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d6c422a2-aa77-48cb-8609-0c4e62f7a556" xlink:to="loc_cvs_NumberofPatientsServedperYear_5f663670-d097-406c-8e85-af2ba74e9ede" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPeopleServed_21703a69-3d16-4f3a-acf5-3b3498dd5de9" xlink:href="cvs-20220630.xsd#cvs_NumberOfPeopleServed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d6c422a2-aa77-48cb-8609-0c4e62f7a556" xlink:to="loc_cvs_NumberOfPeopleServed_21703a69-3d16-4f3a-acf5-3b3498dd5de9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_99b2d9a5-5b71-4165-bdde-d134aebf6bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d6c422a2-aa77-48cb-8609-0c4e62f7a556" xlink:to="loc_us-gaap_NumberOfReportableSegments_99b2d9a5-5b71-4165-bdde-d134aebf6bc1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates_73178378-ffbd-4438-90b0-b5211e123a57" xlink:href="cvs-20220630.xsd#cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d6c422a2-aa77-48cb-8609-0c4e62f7a556" xlink:to="loc_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates_73178378-ffbd-4438-90b0-b5211e123a57" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfAdditionalStates_fb575fb7-8a43-4a41-ba87-a304dd379e55" xlink:href="cvs-20220630.xsd#cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfAdditionalStates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d6c422a2-aa77-48cb-8609-0c4e62f7a556" xlink:to="loc_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfAdditionalStates_fb575fb7-8a43-4a41-ba87-a304dd379e55" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_83439d9a-404c-475b-be6e-8c179762c4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d6c422a2-aa77-48cb-8609-0c4e62f7a556" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_83439d9a-404c-475b-be6e-8c179762c4ef" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_593af524-ff71-4fff-ac94-67de38090932" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d6c422a2-aa77-48cb-8609-0c4e62f7a556" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_593af524-ff71-4fff-ac94-67de38090932" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_33fa7442-bb0a-497e-8d23-77750d761e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d6c422a2-aa77-48cb-8609-0c4e62f7a556" xlink:to="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_33fa7442-bb0a-497e-8d23-77750d761e1b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f179492d-bd74-40fd-a88a-2f6e27cf6f67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d6c422a2-aa77-48cb-8609-0c4e62f7a556" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f179492d-bd74-40fd-a88a-2f6e27cf6f67" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_72760657-4f08-4fa3-93ec-7fda6db4e83e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f179492d-bd74-40fd-a88a-2f6e27cf6f67" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_72760657-4f08-4fa3-93ec-7fda6db4e83e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_72760657-4f08-4fa3-93ec-7fda6db4e83e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_72760657-4f08-4fa3-93ec-7fda6db4e83e" xlink:to="loc_us-gaap_SegmentDomain_72760657-4f08-4fa3-93ec-7fda6db4e83e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5e96ecf2-38dd-4f99-9fb2-c0afc7a7087e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_72760657-4f08-4fa3-93ec-7fda6db4e83e" xlink:to="loc_us-gaap_SegmentDomain_5e96ecf2-38dd-4f99-9fb2-c0afc7a7087e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_25278772-3353-4819-b57b-a78a1c548543" xlink:href="cvs-20220630.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5e96ecf2-38dd-4f99-9fb2-c0afc7a7087e" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_25278772-3353-4819-b57b-a78a1c548543" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_6dc4458e-c655-497a-af8d-fc4d51265d3a" xlink:href="cvs-20220630.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5e96ecf2-38dd-4f99-9fb2-c0afc7a7087e" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_6dc4458e-c655-497a-af8d-fc4d51265d3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_fdecdea5-ea16-48ae-9370-f056041e76ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f179492d-bd74-40fd-a88a-2f6e27cf6f67" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_fdecdea5-ea16-48ae-9370-f056041e76ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_fdecdea5-ea16-48ae-9370-f056041e76ee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_fdecdea5-ea16-48ae-9370-f056041e76ee" xlink:to="loc_us-gaap_RelatedPartyDomain_fdecdea5-ea16-48ae-9370-f056041e76ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_b8b77535-548c-4a30-9a83-2d8e5c4640b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_fdecdea5-ea16-48ae-9370-f056041e76ee" xlink:to="loc_us-gaap_RelatedPartyDomain_b8b77535-548c-4a30-9a83-2d8e5c4640b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeartlandHealthcareServicesMember_2dff56fb-49d0-4b8c-bb8c-f50b9e485a77" xlink:href="cvs-20220630.xsd#cvs_HeartlandHealthcareServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_b8b77535-548c-4a30-9a83-2d8e5c4640b9" xlink:to="loc_cvs_HeartlandHealthcareServicesMember_2dff56fb-49d0-4b8c-bb8c-f50b9e485a77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_578ed20d-abe8-4756-9139-67092f089946" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f179492d-bd74-40fd-a88a-2f6e27cf6f67" xlink:to="loc_srt_StatementScenarioAxis_578ed20d-abe8-4756-9139-67092f089946" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_578ed20d-abe8-4756-9139-67092f089946_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_578ed20d-abe8-4756-9139-67092f089946" xlink:to="loc_srt_ScenarioUnspecifiedDomain_578ed20d-abe8-4756-9139-67092f089946_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_51aa0c00-670d-4b6c-a860-800ad93b4d47" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_578ed20d-abe8-4756-9139-67092f089946" xlink:to="loc_srt_ScenarioUnspecifiedDomain_51aa0c00-670d-4b6c-a860-800ad93b4d47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_4fb475ab-e771-4261-b8ba-ddbcf98befa4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_51aa0c00-670d-4b6c-a860-800ad93b4d47" xlink:to="loc_srt_ScenarioForecastMember_4fb475ab-e771-4261-b8ba-ddbcf98befa4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#SignificantAccountingPoliciesDisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="extended" id="i96d142f9e22d4880b0309a3d5d6d2db5_SignificantAccountingPoliciesDisaggregationofRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_64849fb4-3da0-4f50-ae3b-0c9fc505a6ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_315839f3-3560-4ac1-8308-e9e1587904e7" xlink:href="cvs-20220630.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_64849fb4-3da0-4f50-ae3b-0c9fc505a6ca" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_315839f3-3560-4ac1-8308-e9e1587904e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_8192e4bd-9c01-427d-b204-daa65473c859" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_64849fb4-3da0-4f50-ae3b-0c9fc505a6ca" xlink:to="loc_us-gaap_NetInvestmentIncome_8192e4bd-9c01-427d-b204-daa65473c859" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_e8aec3a1-bf0d-4aac-b038-41ce4800a146" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_64849fb4-3da0-4f50-ae3b-0c9fc505a6ca" xlink:to="loc_us-gaap_Revenues_e8aec3a1-bf0d-4aac-b038-41ce4800a146" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_f66be1fc-1a91-43b8-834d-a998571492c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_64849fb4-3da0-4f50-ae3b-0c9fc505a6ca" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_f66be1fc-1a91-43b8-834d-a998571492c7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_9d562725-337f-448e-a6a5-e2775c0c7ee9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f66be1fc-1a91-43b8-834d-a998571492c7" xlink:to="loc_srt_ConsolidationItemsAxis_9d562725-337f-448e-a6a5-e2775c0c7ee9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_9d562725-337f-448e-a6a5-e2775c0c7ee9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_9d562725-337f-448e-a6a5-e2775c0c7ee9" xlink:to="loc_srt_ConsolidationItemsDomain_9d562725-337f-448e-a6a5-e2775c0c7ee9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_3126dbb7-4d40-4049-946a-2430e4c87ea6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_9d562725-337f-448e-a6a5-e2775c0c7ee9" xlink:to="loc_srt_ConsolidationItemsDomain_3126dbb7-4d40-4049-946a-2430e4c87ea6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_69480515-1b65-4d83-868d-58710bfaf869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_3126dbb7-4d40-4049-946a-2430e4c87ea6" xlink:to="loc_us-gaap_OperatingSegmentsMember_69480515-1b65-4d83-868d-58710bfaf869" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_56123d7e-f779-4b37-96f4-2ded6b4e68f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_3126dbb7-4d40-4049-946a-2430e4c87ea6" xlink:to="loc_us-gaap_CorporateNonSegmentMember_56123d7e-f779-4b37-96f4-2ded6b4e68f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_6994e351-1a7f-405f-8701-d71b9887c565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_3126dbb7-4d40-4049-946a-2430e4c87ea6" xlink:to="loc_us-gaap_IntersegmentEliminationMember_6994e351-1a7f-405f-8701-d71b9887c565" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_03160412-9f0d-474c-9fe8-fc5dc087e155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f66be1fc-1a91-43b8-834d-a998571492c7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_03160412-9f0d-474c-9fe8-fc5dc087e155" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_03160412-9f0d-474c-9fe8-fc5dc087e155_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_03160412-9f0d-474c-9fe8-fc5dc087e155" xlink:to="loc_us-gaap_SegmentDomain_03160412-9f0d-474c-9fe8-fc5dc087e155_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_61a1d95b-1f76-4196-bca7-55dd4aa272f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_03160412-9f0d-474c-9fe8-fc5dc087e155" xlink:to="loc_us-gaap_SegmentDomain_61a1d95b-1f76-4196-bca7-55dd4aa272f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_71d4a71c-faf4-45d1-a36d-7499c9643cc8" xlink:href="cvs-20220630.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_61a1d95b-1f76-4196-bca7-55dd4aa272f8" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_71d4a71c-faf4-45d1-a36d-7499c9643cc8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_25914454-c692-491a-9955-8763c4a78a3e" xlink:href="cvs-20220630.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_61a1d95b-1f76-4196-bca7-55dd4aa272f8" xlink:to="loc_cvs_PharmacyServicesSegmentMember_25914454-c692-491a-9955-8763c4a78a3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_9ff88be1-64d5-4298-ab26-e7facef25e1d" xlink:href="cvs-20220630.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_61a1d95b-1f76-4196-bca7-55dd4aa272f8" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_9ff88be1-64d5-4298-ab26-e7facef25e1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_91544ce3-fda0-4e0b-b126-d874f17cffbd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f66be1fc-1a91-43b8-834d-a998571492c7" xlink:to="loc_srt_ProductOrServiceAxis_91544ce3-fda0-4e0b-b126-d874f17cffbd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_91544ce3-fda0-4e0b-b126-d874f17cffbd_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_91544ce3-fda0-4e0b-b126-d874f17cffbd" xlink:to="loc_srt_ProductsAndServicesDomain_91544ce3-fda0-4e0b-b126-d874f17cffbd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b3ff8e70-757e-4ed2-b3d4-0f5531e65635" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_91544ce3-fda0-4e0b-b126-d874f17cffbd" xlink:to="loc_srt_ProductsAndServicesDomain_b3ff8e70-757e-4ed2-b3d4-0f5531e65635" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRevenueMember_2d87d3ae-71d6-4d1a-a07d-dc1a4f71d6f9" xlink:href="cvs-20220630.xsd#cvs_PharmacyRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b3ff8e70-757e-4ed2-b3d4-0f5531e65635" xlink:to="loc_cvs_PharmacyRevenueMember_2d87d3ae-71d6-4d1a-a07d-dc1a4f71d6f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FrontStoreRevenueMember_e9e6db3e-65fb-4752-bd89-231a0ad3ae4b" xlink:href="cvs-20220630.xsd#cvs_FrontStoreRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b3ff8e70-757e-4ed2-b3d4-0f5531e65635" xlink:to="loc_cvs_FrontStoreRevenueMember_e9e6db3e-65fb-4752-bd89-231a0ad3ae4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsMember_ad509cac-55f2-4da3-9e9f-e9418497e023" xlink:href="cvs-20220630.xsd#cvs_PremiumsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b3ff8e70-757e-4ed2-b3d4-0f5531e65635" xlink:to="loc_cvs_PremiumsMember_ad509cac-55f2-4da3-9e9f-e9418497e023" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_11e22530-3e95-422d-a1e0-20e455c04c12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b3ff8e70-757e-4ed2-b3d4-0f5531e65635" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_11e22530-3e95-422d-a1e0-20e455c04c12" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_e7f80307-225b-46ca-bbc3-6489d8c8f000" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f66be1fc-1a91-43b8-834d-a998571492c7" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_e7f80307-225b-46ca-bbc3-6489d8c8f000" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_e7f80307-225b-46ca-bbc3-6489d8c8f000_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_e7f80307-225b-46ca-bbc3-6489d8c8f000" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_e7f80307-225b-46ca-bbc3-6489d8c8f000_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_849182f4-044a-4ce4-9b0a-1a0fb8463532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_e7f80307-225b-46ca-bbc3-6489d8c8f000" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_849182f4-044a-4ce4-9b0a-1a0fb8463532" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_6ffa7c9a-2c9c-4a53-a39f-3835befe0826" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_849182f4-044a-4ce4-9b0a-1a0fb8463532" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_6ffa7c9a-2c9c-4a53-a39f-3835befe0826" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_791a8a86-1e40-47ac-8cbe-341861edfca2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_849182f4-044a-4ce4-9b0a-1a0fb8463532" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_791a8a86-1e40-47ac-8cbe-341861edfca2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SalesChannelOtherMember_3eb7a321-c5ed-40ca-b0f2-f39547317e0c" xlink:href="cvs-20220630.xsd#cvs_SalesChannelOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_849182f4-044a-4ce4-9b0a-1a0fb8463532" xlink:to="loc_cvs_SalesChannelOtherMember_3eb7a321-c5ed-40ca-b0f2-f39547317e0c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/DivestituresandAssetSalesDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#DivestituresandAssetSalesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/DivestituresandAssetSalesDetails" xlink:type="extended" id="i205a1055b15347078f23ee84d8fb26f4_DivestituresandAssetSalesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_03e35244-3161-4ae8-b859-725d1f21ca0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_32bd0fc4-b261-47b9-a449-56c2b56950a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_03e35244-3161-4ae8-b859-725d1f21ca0c" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_32bd0fc4-b261-47b9-a449-56c2b56950a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_ba7d7511-25c3-43a5-94ed-643be8a836e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_03e35244-3161-4ae8-b859-725d1f21ca0c" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_ba7d7511-25c3-43a5-94ed-643be8a836e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfMedicalMembers_73ad3c7d-b4f2-45dc-8d32-fa2d2168bb25" xlink:href="cvs-20220630.xsd#cvs_NumberOfMedicalMembers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_03e35244-3161-4ae8-b859-725d1f21ca0c" xlink:to="loc_cvs_NumberOfMedicalMembers_73ad3c7d-b4f2-45dc-8d32-fa2d2168bb25" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_072691f0-63cd-45ab-bfd2-033506f68519" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_03e35244-3161-4ae8-b859-725d1f21ca0c" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_072691f0-63cd-45ab-bfd2-033506f68519" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold_c92f58aa-b441-4c08-97c8-ec4f3a084e5c" xlink:href="cvs-20220630.xsd#cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_03e35244-3161-4ae8-b859-725d1f21ca0c" xlink:to="loc_cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold_c92f58aa-b441-4c08-97c8-ec4f3a084e5c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DisposalGroupNotDiscontinuedOperationMigrationPeriod_cf06e755-8d78-4bb1-9d24-b92a37ca40aa" xlink:href="cvs-20220630.xsd#cvs_DisposalGroupNotDiscontinuedOperationMigrationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_03e35244-3161-4ae8-b859-725d1f21ca0c" xlink:to="loc_cvs_DisposalGroupNotDiscontinuedOperationMigrationPeriod_cf06e755-8d78-4bb1-9d24-b92a37ca40aa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_092bbfe2-7dc7-447f-9633-03a39fc5dda3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_03e35244-3161-4ae8-b859-725d1f21ca0c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_092bbfe2-7dc7-447f-9633-03a39fc5dda3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_1ed16c5a-0f3a-4134-8f4c-6a4931c053e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_092bbfe2-7dc7-447f-9633-03a39fc5dda3" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_1ed16c5a-0f3a-4134-8f4c-6a4931c053e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_1ed16c5a-0f3a-4134-8f4c-6a4931c053e6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1ed16c5a-0f3a-4134-8f4c-6a4931c053e6" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_1ed16c5a-0f3a-4134-8f4c-6a4931c053e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_3f8d8ffb-fb73-4240-84d2-00c4336ef2a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1ed16c5a-0f3a-4134-8f4c-6a4931c053e6" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_3f8d8ffb-fb73-4240-84d2-00c4336ef2a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_e8f4bbdc-cdf7-46e8-88a7-31161ba6e877" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_3f8d8ffb-fb73-4240-84d2-00c4336ef2a5" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_e8f4bbdc-cdf7-46e8-88a7-31161ba6e877" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a8c861f5-dab6-4e87-a512-9f8c026a6bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_092bbfe2-7dc7-447f-9633-03a39fc5dda3" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a8c861f5-dab6-4e87-a512-9f8c026a6bb5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a8c861f5-dab6-4e87-a512-9f8c026a6bb5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a8c861f5-dab6-4e87-a512-9f8c026a6bb5" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a8c861f5-dab6-4e87-a512-9f8c026a6bb5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_95d77867-58ed-41c2-928b-bbe1e8bae150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a8c861f5-dab6-4e87-a512-9f8c026a6bb5" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_95d77867-58ed-41c2-928b-bbe1e8bae150" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PayflexMember_2cf17126-bd89-4f4e-b812-384512bddcf9" xlink:href="cvs-20220630.xsd#cvs_PayflexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_95d77867-58ed-41c2-928b-bbe1e8bae150" xlink:to="loc_cvs_PayflexMember_2cf17126-bd89-4f4e-b812-384512bddcf9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ThailandBusinessMember_cebec18d-509d-48f6-baac-4272d7901eb1" xlink:href="cvs-20220630.xsd#cvs_ThailandBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_95d77867-58ed-41c2-928b-bbe1e8bae150" xlink:to="loc_cvs_ThailandBusinessMember_cebec18d-509d-48f6-baac-4272d7901eb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InternationalHealthCareRenewalRightsMember_e157abf9-e5af-493d-9ada-bff851382692" xlink:href="cvs-20220630.xsd#cvs_InternationalHealthCareRenewalRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_95d77867-58ed-41c2-928b-bbe1e8bae150" xlink:to="loc_cvs_InternationalHealthCareRenewalRightsMember_e157abf9-e5af-493d-9ada-bff851382692" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b2459a8a-a215-4941-937d-68535e321b60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_092bbfe2-7dc7-447f-9633-03a39fc5dda3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b2459a8a-a215-4941-937d-68535e321b60" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b2459a8a-a215-4941-937d-68535e321b60_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b2459a8a-a215-4941-937d-68535e321b60" xlink:to="loc_us-gaap_SegmentDomain_b2459a8a-a215-4941-937d-68535e321b60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d6f25289-e36e-4f12-a2f8-9c86d88debea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b2459a8a-a215-4941-937d-68535e321b60" xlink:to="loc_us-gaap_SegmentDomain_d6f25289-e36e-4f12-a2f8-9c86d88debea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_7f6a3853-498a-4241-8a31-c8c813cbe121" xlink:href="cvs-20220630.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d6f25289-e36e-4f12-a2f8-9c86d88debea" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_7f6a3853-498a-4241-8a31-c8c813cbe121" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#InvestmentsTotalInvestmentScheduleDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails" xlink:type="extended" id="iab5fd79cafba49b0a28b40c3d5b10aae_InvestmentsTotalInvestmentScheduleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsLineItems_e71e1a40-705c-45a4-a35a-585514cffe7d" xlink:href="cvs-20220630.xsd#cvs_TotalInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_71df1078-82c2-43e1-ad1e-98846d87e391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsLineItems_e71e1a40-705c-45a4-a35a-585514cffe7d" xlink:to="loc_us-gaap_ShortTermInvestments_71df1078-82c2-43e1-ad1e-98846d87e391" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_b89f93ba-cc43-4c91-9a32-7f7b40ed00c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsLineItems_e71e1a40-705c-45a4-a35a-585514cffe7d" xlink:to="loc_us-gaap_LongTermInvestments_b89f93ba-cc43-4c91-9a32-7f7b40ed00c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_35ea3b42-55a2-4ff1-8e7d-dc75e5b69ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsLineItems_e71e1a40-705c-45a4-a35a-585514cffe7d" xlink:to="loc_us-gaap_Investments_35ea3b42-55a2-4ff1-8e7d-dc75e5b69ac0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTable_5824c3ef-2d97-4781-8deb-656defc34124" xlink:href="cvs-20220630.xsd#cvs_TotalInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cvs_TotalInvestmentsLineItems_e71e1a40-705c-45a4-a35a-585514cffe7d" xlink:to="loc_cvs_TotalInvestmentsTable_5824c3ef-2d97-4781-8deb-656defc34124" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsAxis_76b10ac1-04f4-441c-a117-27c204e1d6c1" xlink:href="cvs-20220630.xsd#cvs_TotalInvestmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cvs_TotalInvestmentsTable_5824c3ef-2d97-4781-8deb-656defc34124" xlink:to="loc_cvs_TotalInvestmentsAxis_76b10ac1-04f4-441c-a117-27c204e1d6c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain_76b10ac1-04f4-441c-a117-27c204e1d6c1_default" xlink:href="cvs-20220630.xsd#cvs_TotalInvestmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cvs_TotalInvestmentsAxis_76b10ac1-04f4-441c-a117-27c204e1d6c1" xlink:to="loc_cvs_TotalInvestmentsDomain_76b10ac1-04f4-441c-a117-27c204e1d6c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain_1c44efe4-32cc-470e-9123-306bed81dd10" xlink:href="cvs-20220630.xsd#cvs_TotalInvestmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cvs_TotalInvestmentsAxis_76b10ac1-04f4-441c-a117-27c204e1d6c1" xlink:to="loc_cvs_TotalInvestmentsDomain_1c44efe4-32cc-470e-9123-306bed81dd10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_7ec6d97b-da90-432e-ac8b-b83ba6db9252" xlink:href="cvs-20220630.xsd#cvs_DebtAndEquitySecuritiesAvailableForSaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsDomain_1c44efe4-32cc-470e-9123-306bed81dd10" xlink:to="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_7ec6d97b-da90-432e-ac8b-b83ba6db9252" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_96951d0e-cc7a-42a8-a8c0-b78805ce793f" xlink:href="cvs-20220630.xsd#cvs_MortgageLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsDomain_1c44efe4-32cc-470e-9123-306bed81dd10" xlink:to="loc_cvs_MortgageLoansMember_96951d0e-cc7a-42a8-a8c0-b78805ce793f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_554162b9-608b-40fa-a6e5-f7dea8f2b7c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsDomain_1c44efe4-32cc-470e-9123-306bed81dd10" xlink:to="loc_us-gaap_OtherInvestmentsMember_554162b9-608b-40fa-a6e5-f7dea8f2b7c9" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#InvestmentsDebtSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="extended" id="iad0de1ec92ec427e8626c07cb8234c30_InvestmentsDebtSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ee4bfa42-b279-4363-b009-91f98ec02321" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7b7a8543-1d55-4f3d-8cbd-3b763f792461" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ee4bfa42-b279-4363-b009-91f98ec02321" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7b7a8543-1d55-4f3d-8cbd-3b763f792461" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_50ac071b-39f3-4245-8e9c-222ffa56cfd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ee4bfa42-b279-4363-b009-91f98ec02321" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_50ac071b-39f3-4245-8e9c-222ffa56cfd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_1dfd814f-06ae-43b5-817c-aced52a34de4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ee4bfa42-b279-4363-b009-91f98ec02321" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_1dfd814f-06ae-43b5-817c-aced52a34de4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_2cc0bc9c-7473-4811-a826-0039eaabeb77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ee4bfa42-b279-4363-b009-91f98ec02321" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_2cc0bc9c-7473-4811-a826-0039eaabeb77" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_12fce0ee-89fc-49ed-91cf-db7c52558f46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ee4bfa42-b279-4363-b009-91f98ec02321" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_12fce0ee-89fc-49ed-91cf-db7c52558f46" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_28652b9a-12f0-4035-8596-12c8ba29c613" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ee4bfa42-b279-4363-b009-91f98ec02321" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_28652b9a-12f0-4035-8596-12c8ba29c613" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0f7be6b7-80c6-45a2-b86d-2dcfe3a98eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ee4bfa42-b279-4363-b009-91f98ec02321" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0f7be6b7-80c6-45a2-b86d-2dcfe3a98eb8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_2ef92a05-d4f7-490c-a4f3-31c1e1c9b3f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0f7be6b7-80c6-45a2-b86d-2dcfe3a98eb8" xlink:to="loc_us-gaap_FinancialInstrumentAxis_2ef92a05-d4f7-490c-a4f3-31c1e1c9b3f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2ef92a05-d4f7-490c-a4f3-31c1e1c9b3f3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2ef92a05-d4f7-490c-a4f3-31c1e1c9b3f3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2ef92a05-d4f7-490c-a4f3-31c1e1c9b3f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_be7c0cd6-5f5c-4b62-b706-dba5b14c4ac4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2ef92a05-d4f7-490c-a4f3-31c1e1c9b3f3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_be7c0cd6-5f5c-4b62-b706-dba5b14c4ac4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_078210b3-7782-4541-9c0f-474a9f557f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_be7c0cd6-5f5c-4b62-b706-dba5b14c4ac4" xlink:to="loc_us-gaap_DebtSecuritiesMember_078210b3-7782-4541-9c0f-474a9f557f9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_aab78b54-e38d-4ab9-9292-de5c3fc416d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_078210b3-7782-4541-9c0f-474a9f557f9e" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_aab78b54-e38d-4ab9-9292-de5c3fc416d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_f7dfcc12-9cd4-4b2f-ac20-be7e3eafdb96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_078210b3-7782-4541-9c0f-474a9f557f9e" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_f7dfcc12-9cd4-4b2f-ac20-be7e3eafdb96" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_308f9361-6024-43f8-ace8-859d4de4129a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_078210b3-7782-4541-9c0f-474a9f557f9e" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_308f9361-6024-43f8-ace8-859d4de4129a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_1cbb235e-e7df-4e0a-bbc1-386510f0dddb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_078210b3-7782-4541-9c0f-474a9f557f9e" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_1cbb235e-e7df-4e0a-bbc1-386510f0dddb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_b14b4bc4-f6e9-46ed-8c16-015aaaef16a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_078210b3-7782-4541-9c0f-474a9f557f9e" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_b14b4bc4-f6e9-46ed-8c16-015aaaef16a2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_43ed25ff-ce03-4588-8962-32fdb75e236e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_078210b3-7782-4541-9c0f-474a9f557f9e" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_43ed25ff-ce03-4588-8962-32fdb75e236e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_cb020d79-70fc-48f7-9fce-a4049132df93" xlink:href="cvs-20220630.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_078210b3-7782-4541-9c0f-474a9f557f9e" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_cb020d79-70fc-48f7-9fce-a4049132df93" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_d91bce5c-c2a4-4691-9211-4ad341dfecf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_078210b3-7782-4541-9c0f-474a9f557f9e" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_d91bce5c-c2a4-4691-9211-4ad341dfecf4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_0fcef63b-9a51-4634-8af0-62140bcc2556" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0f7be6b7-80c6-45a2-b86d-2dcfe3a98eb8" xlink:to="loc_srt_ProductOrServiceAxis_0fcef63b-9a51-4634-8af0-62140bcc2556" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0fcef63b-9a51-4634-8af0-62140bcc2556_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_0fcef63b-9a51-4634-8af0-62140bcc2556" xlink:to="loc_srt_ProductsAndServicesDomain_0fcef63b-9a51-4634-8af0-62140bcc2556_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c53072f5-070e-417c-bfe5-287cc4a2242b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_0fcef63b-9a51-4634-8af0-62140bcc2556" xlink:to="loc_srt_ProductsAndServicesDomain_c53072f5-070e-417c-bfe5-287cc4a2242b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_b8ec5d4b-3b7a-4f0b-9fdd-dedc4ffce2bf" xlink:href="cvs-20220630.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c53072f5-070e-417c-bfe5-287cc4a2242b" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_b8ec5d4b-3b7a-4f0b-9fdd-dedc4ffce2bf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#InvestmentsDebtSecuritiesbyMaturityDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="extended" id="i7b7bc571b170411e88a174364254caf8_InvestmentsDebtSecuritiesbyMaturityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_3cfeee9a-6e75-4165-85da-16cf52da607c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_b3340472-ca03-436d-9ead-66646457a192" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_3cfeee9a-6e75-4165-85da-16cf52da607c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_b3340472-ca03-436d-9ead-66646457a192" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_327e15ad-c7d6-432f-b463-ad08b71d2d56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_b3340472-ca03-436d-9ead-66646457a192" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_327e15ad-c7d6-432f-b463-ad08b71d2d56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_946ec8c1-14aa-428e-bb9c-53bfde8fc872" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_b3340472-ca03-436d-9ead-66646457a192" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_946ec8c1-14aa-428e-bb9c-53bfde8fc872" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_b2357c95-1c13-4f5d-9830-6e805d77cc8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_b3340472-ca03-436d-9ead-66646457a192" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_b2357c95-1c13-4f5d-9830-6e805d77cc8e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_4d103086-7224-4b5a-b4c4-f1e5e8e61576" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_b3340472-ca03-436d-9ead-66646457a192" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_4d103086-7224-4b5a-b4c4-f1e5e8e61576" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_866d95c8-30a5-490d-a5b4-9cba61c9277b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_b3340472-ca03-436d-9ead-66646457a192" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_866d95c8-30a5-490d-a5b4-9cba61c9277b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_ded0ceb9-a4a0-4737-98fa-8b8193fb4aca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_b3340472-ca03-436d-9ead-66646457a192" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_ded0ceb9-a4a0-4737-98fa-8b8193fb4aca" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_ee38fc65-17b6-4dec-b87b-9ab4b1576489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_3cfeee9a-6e75-4165-85da-16cf52da607c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_ee38fc65-17b6-4dec-b87b-9ab4b1576489" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_f5219af8-07ad-42b1-aaf1-bd4e1650ece5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_ee38fc65-17b6-4dec-b87b-9ab4b1576489" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_f5219af8-07ad-42b1-aaf1-bd4e1650ece5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_05e0bba9-1017-4b97-bf77-c52429b14be3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_ee38fc65-17b6-4dec-b87b-9ab4b1576489" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_05e0bba9-1017-4b97-bf77-c52429b14be3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_a1618125-746d-4d64-970f-331fdc627e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_ee38fc65-17b6-4dec-b87b-9ab4b1576489" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_a1618125-746d-4d64-970f-331fdc627e3b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_7c328e69-5887-48af-98b9-ed2ee719d9f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_ee38fc65-17b6-4dec-b87b-9ab4b1576489" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_7c328e69-5887-48af-98b9-ed2ee719d9f4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_3e585d54-7270-4950-a7d0-b4d511a71a60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_ee38fc65-17b6-4dec-b87b-9ab4b1576489" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_3e585d54-7270-4950-a7d0-b4d511a71a60" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d432dcea-76a5-436c-a288-2a081ecf39f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_ee38fc65-17b6-4dec-b87b-9ab4b1576489" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d432dcea-76a5-436c-a288-2a081ecf39f5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e8075010-6ff1-49f0-a99b-5e553db29847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_3cfeee9a-6e75-4165-85da-16cf52da607c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e8075010-6ff1-49f0-a99b-5e553db29847" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_2f45fcbc-6194-4d9f-87bb-9c869d385a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e8075010-6ff1-49f0-a99b-5e553db29847" xlink:to="loc_us-gaap_FinancialInstrumentAxis_2f45fcbc-6194-4d9f-87bb-9c869d385a1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2f45fcbc-6194-4d9f-87bb-9c869d385a1e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2f45fcbc-6194-4d9f-87bb-9c869d385a1e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2f45fcbc-6194-4d9f-87bb-9c869d385a1e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_99bf0516-7fd6-4e87-9d23-438ddd98b4bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2f45fcbc-6194-4d9f-87bb-9c869d385a1e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_99bf0516-7fd6-4e87-9d23-438ddd98b4bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_6d470837-c46e-48ca-b354-6eb8c89d4d40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_99bf0516-7fd6-4e87-9d23-438ddd98b4bd" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_6d470837-c46e-48ca-b354-6eb8c89d4d40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_ec37fcdd-6f2f-47de-8db9-91f345ed197c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_99bf0516-7fd6-4e87-9d23-438ddd98b4bd" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_ec37fcdd-6f2f-47de-8db9-91f345ed197c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_fa79d2ea-63c1-48b7-a78d-e0c4959552e8" xlink:href="cvs-20220630.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_99bf0516-7fd6-4e87-9d23-438ddd98b4bd" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_fa79d2ea-63c1-48b7-a78d-e0c4959552e8" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#InvestmentsUnrealizedLossPositionDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="extended" id="ibd7eb26ca5e141219fac15faee8cc5b8_InvestmentsUnrealizedLossPositionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ec3adef5-b611-47a7-82cb-ec76c85e3aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_c7d37c91-3706-40cc-ae78-a8b4fd18ba83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ec3adef5-b611-47a7-82cb-ec76c85e3aa4" xlink:to="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_c7d37c91-3706-40cc-ae78-a8b4fd18ba83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_f55048d8-e583-4366-9d1d-ceaa36841c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_c7d37c91-3706-40cc-ae78-a8b4fd18ba83" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_f55048d8-e583-4366-9d1d-ceaa36841c2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_9041bc9b-27d9-40f4-9f5a-2d976b770f75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_c7d37c91-3706-40cc-ae78-a8b4fd18ba83" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_9041bc9b-27d9-40f4-9f5a-2d976b770f75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_029fccab-3329-4de5-8c00-451f60275d21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_c7d37c91-3706-40cc-ae78-a8b4fd18ba83" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_029fccab-3329-4de5-8c00-451f60275d21" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_d19ad300-9705-477d-a40c-2b3f9fd7a01b" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ec3adef5-b611-47a7-82cb-ec76c85e3aa4" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_d19ad300-9705-477d-a40c-2b3f9fd7a01b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_3e313b26-c3f6-4ad0-922a-8c71e67b7c06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_d19ad300-9705-477d-a40c-2b3f9fd7a01b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_3e313b26-c3f6-4ad0-922a-8c71e67b7c06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_7bee7437-89e8-478f-bd43-bb3994e7f323" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_d19ad300-9705-477d-a40c-2b3f9fd7a01b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_7bee7437-89e8-478f-bd43-bb3994e7f323" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_27d97f4d-6a3a-4a45-a3ea-cacd06f2e57c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_d19ad300-9705-477d-a40c-2b3f9fd7a01b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_27d97f4d-6a3a-4a45-a3ea-cacd06f2e57c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_85e4ee3f-f2f6-4be8-9e55-197091719b46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ec3adef5-b611-47a7-82cb-ec76c85e3aa4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_85e4ee3f-f2f6-4be8-9e55-197091719b46" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_10badb88-2c5f-494f-aa3d-5838fd5273da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_85e4ee3f-f2f6-4be8-9e55-197091719b46" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_10badb88-2c5f-494f-aa3d-5838fd5273da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_536bbb6e-b414-427d-913a-25b103565080" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_85e4ee3f-f2f6-4be8-9e55-197091719b46" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_536bbb6e-b414-427d-913a-25b103565080" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_603a7a8d-cfda-4a99-85ad-031d7ead2623" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_85e4ee3f-f2f6-4be8-9e55-197091719b46" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_603a7a8d-cfda-4a99-85ad-031d7ead2623" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_30ee2036-5e91-4081-b04e-7458be0074d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ec3adef5-b611-47a7-82cb-ec76c85e3aa4" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_30ee2036-5e91-4081-b04e-7458be0074d7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_3a339552-d726-4660-9c92-0fe7b362ab23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_30ee2036-5e91-4081-b04e-7458be0074d7" xlink:to="loc_us-gaap_FinancialInstrumentAxis_3a339552-d726-4660-9c92-0fe7b362ab23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3a339552-d726-4660-9c92-0fe7b362ab23_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_3a339552-d726-4660-9c92-0fe7b362ab23" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3a339552-d726-4660-9c92-0fe7b362ab23_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eae7f8f7-90b3-415b-8f9a-a1ae0dbb501a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_3a339552-d726-4660-9c92-0fe7b362ab23" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eae7f8f7-90b3-415b-8f9a-a1ae0dbb501a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_a6aa2e5e-0625-4a8a-a259-fa653c3754f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eae7f8f7-90b3-415b-8f9a-a1ae0dbb501a" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_a6aa2e5e-0625-4a8a-a259-fa653c3754f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_45605539-5985-49bd-a82b-793f89417cce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eae7f8f7-90b3-415b-8f9a-a1ae0dbb501a" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_45605539-5985-49bd-a82b-793f89417cce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_dbe9c5fe-7db2-43de-99c3-4c77ba8860d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eae7f8f7-90b3-415b-8f9a-a1ae0dbb501a" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_dbe9c5fe-7db2-43de-99c3-4c77ba8860d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_35d39f81-1e28-445c-82b7-6a34ae47b7be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eae7f8f7-90b3-415b-8f9a-a1ae0dbb501a" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_35d39f81-1e28-445c-82b7-6a34ae47b7be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_a1639190-cbb7-4886-8f2d-4361fe2f49d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eae7f8f7-90b3-415b-8f9a-a1ae0dbb501a" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_a1639190-cbb7-4886-8f2d-4361fe2f49d1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_19853f9a-56fc-4ef2-a880-2e95cac1ad06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eae7f8f7-90b3-415b-8f9a-a1ae0dbb501a" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_19853f9a-56fc-4ef2-a880-2e95cac1ad06" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_e570ba42-6b7c-4bff-b824-5da56e8e7881" xlink:href="cvs-20220630.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eae7f8f7-90b3-415b-8f9a-a1ae0dbb501a" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_e570ba42-6b7c-4bff-b824-5da56e8e7881" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_9f9dca76-4d1d-4660-bf2d-f5b93c067f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eae7f8f7-90b3-415b-8f9a-a1ae0dbb501a" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_9f9dca76-4d1d-4660-bf2d-f5b93c067f6e" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#InvestmentsUnrealizedLossPositionMaturitiesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="extended" id="i949f8bb6913b40ea86b262901a341bf2_InvestmentsUnrealizedLossPositionMaturitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e0e82d9b-7ada-43ec-bd98-feca60eaaff2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_2b462902-199e-4e84-9be5-59377bd4d45b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e0e82d9b-7ada-43ec-bd98-feca60eaaff2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_2b462902-199e-4e84-9be5-59377bd4d45b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_b77e5386-f2bf-4ef8-aed6-f42d005af050" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_2b462902-199e-4e84-9be5-59377bd4d45b" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_b77e5386-f2bf-4ef8-aed6-f42d005af050" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_1967055c-a178-4bee-8284-7cdc2c671123" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_2b462902-199e-4e84-9be5-59377bd4d45b" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_1967055c-a178-4bee-8284-7cdc2c671123" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_3de9313e-43a7-4f47-a33d-4a8644063c5a" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_2b462902-199e-4e84-9be5-59377bd4d45b" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_3de9313e-43a7-4f47-a33d-4a8644063c5a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_7cd7ad51-1416-4e05-9bf7-6738534c0c9d" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_2b462902-199e-4e84-9be5-59377bd4d45b" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_7cd7ad51-1416-4e05-9bf7-6738534c0c9d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_9f2c4491-238c-42e4-bd6b-d06013836ee9" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_2b462902-199e-4e84-9be5-59377bd4d45b" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_9f2c4491-238c-42e4-bd6b-d06013836ee9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_c53e55ec-d5ea-4c5e-b1df-48deabeccd2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_2b462902-199e-4e84-9be5-59377bd4d45b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_c53e55ec-d5ea-4c5e-b1df-48deabeccd2b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_d18cec7e-f7ae-4e14-a2bc-89695f00623e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e0e82d9b-7ada-43ec-bd98-feca60eaaff2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_d18cec7e-f7ae-4e14-a2bc-89695f00623e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_ca3a54a3-d525-40d3-b831-c79f3d8ce379" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_d18cec7e-f7ae-4e14-a2bc-89695f00623e" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_ca3a54a3-d525-40d3-b831-c79f3d8ce379" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_876e0142-19fd-489d-b7b6-bf05c0a44ea5" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_d18cec7e-f7ae-4e14-a2bc-89695f00623e" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_876e0142-19fd-489d-b7b6-bf05c0a44ea5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_db59a151-5d99-40ac-a12e-1c8fb31b4ab0" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_d18cec7e-f7ae-4e14-a2bc-89695f00623e" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_db59a151-5d99-40ac-a12e-1c8fb31b4ab0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_47041721-5d4f-432c-852a-023d6e1615b2" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_d18cec7e-f7ae-4e14-a2bc-89695f00623e" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_47041721-5d4f-432c-852a-023d6e1615b2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_4c9335fb-664b-4646-8a5b-c2b3f658c18b" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_d18cec7e-f7ae-4e14-a2bc-89695f00623e" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_4c9335fb-664b-4646-8a5b-c2b3f658c18b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_27f4200c-996b-4e9b-8924-97a7e31f3cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_d18cec7e-f7ae-4e14-a2bc-89695f00623e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_27f4200c-996b-4e9b-8924-97a7e31f3cb2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_baddb7f8-fa29-46ba-8be1-f5f4ecf2d615" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e0e82d9b-7ada-43ec-bd98-feca60eaaff2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_baddb7f8-fa29-46ba-8be1-f5f4ecf2d615" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9279aa46-d9ae-420a-8e0a-f0c91b83d22f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_baddb7f8-fa29-46ba-8be1-f5f4ecf2d615" xlink:to="loc_srt_ProductOrServiceAxis_9279aa46-d9ae-420a-8e0a-f0c91b83d22f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9279aa46-d9ae-420a-8e0a-f0c91b83d22f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_9279aa46-d9ae-420a-8e0a-f0c91b83d22f" xlink:to="loc_srt_ProductsAndServicesDomain_9279aa46-d9ae-420a-8e0a-f0c91b83d22f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_81a679b1-6b78-4b79-b431-741f5ccd53bb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_9279aa46-d9ae-420a-8e0a-f0c91b83d22f" xlink:to="loc_srt_ProductsAndServicesDomain_81a679b1-6b78-4b79-b431-741f5ccd53bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_3241ece0-7b4d-42cd-bfb4-ea441b941673" xlink:href="cvs-20220630.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_81a679b1-6b78-4b79-b431-741f5ccd53bb" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_3241ece0-7b4d-42cd-bfb4-ea441b941673" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingRemainingProductsMember_617cffe8-9f7a-40eb-9c93-2327aab1ddd9" xlink:href="cvs-20220630.xsd#cvs_SupportingRemainingProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_81a679b1-6b78-4b79-b431-741f5ccd53bb" xlink:to="loc_cvs_SupportingRemainingProductsMember_617cffe8-9f7a-40eb-9c93-2327aab1ddd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_de91405a-88c6-473f-92e2-b65948e08f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_baddb7f8-fa29-46ba-8be1-f5f4ecf2d615" xlink:to="loc_us-gaap_FinancialInstrumentAxis_de91405a-88c6-473f-92e2-b65948e08f8d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_de91405a-88c6-473f-92e2-b65948e08f8d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_de91405a-88c6-473f-92e2-b65948e08f8d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_de91405a-88c6-473f-92e2-b65948e08f8d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eaf92011-1889-4022-aa78-4f1724a67f71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_de91405a-88c6-473f-92e2-b65948e08f8d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eaf92011-1889-4022-aa78-4f1724a67f71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_6fbffc66-aa63-400e-b8af-30911335f188" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eaf92011-1889-4022-aa78-4f1724a67f71" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_6fbffc66-aa63-400e-b8af-30911335f188" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_6a8e8e48-4248-49ed-8bb9-4a4979549341" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eaf92011-1889-4022-aa78-4f1724a67f71" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_6a8e8e48-4248-49ed-8bb9-4a4979549341" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_da665e86-e902-427b-b28b-38dcac4a7fbd" xlink:href="cvs-20220630.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eaf92011-1889-4022-aa78-4f1724a67f71" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_da665e86-e902-427b-b28b-38dcac4a7fbd" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#InvestmentsMortgageLoansDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="extended" id="ic0694af33ddf4beaa9e09be7287581b0_InvestmentsMortgageLoansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_67b21f28-ccf2-4d47-bd7e-373f2bbf524c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_510061a5-04e9-4ca7-8be2-bcd9ac271edb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstateNewMortgageLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_67b21f28-ccf2-4d47-bd7e-373f2bbf524c" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_510061a5-04e9-4ca7-8be2-bcd9ac271edb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_1acfc0e5-925a-44ff-b07e-53683c66ddb6" xlink:href="cvs-20220630.xsd#cvs_MortgageLoansOnRealEstateLoansFullyRepaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_67b21f28-ccf2-4d47-bd7e-373f2bbf524c" xlink:to="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_1acfc0e5-925a-44ff-b07e-53683c66ddb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_22c211c4-5a3a-46cf-8ef6-8f2f39c4099e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstateForeclosures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_67b21f28-ccf2-4d47-bd7e-373f2bbf524c" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_22c211c4-5a3a-46cf-8ef6-8f2f39c4099e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_eb5ab3d6-8588-4c34-ab6a-863419e69a84" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_67b21f28-ccf2-4d47-bd7e-373f2bbf524c" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_eb5ab3d6-8588-4c34-ab6a-863419e69a84" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_d6c98ed2-944b-4ace-9eec-e171e64f4b0d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_eb5ab3d6-8588-4c34-ab6a-863419e69a84" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_d6c98ed2-944b-4ace-9eec-e171e64f4b0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d6c98ed2-944b-4ace-9eec-e171e64f4b0d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_d6c98ed2-944b-4ace-9eec-e171e64f4b0d" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d6c98ed2-944b-4ace-9eec-e171e64f4b0d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_3f000772-0fde-4eac-b9de-605ad3a6b323" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_d6c98ed2-944b-4ace-9eec-e171e64f4b0d" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_3f000772-0fde-4eac-b9de-605ad3a6b323" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_6142d4cb-2e48-4e34-a3e8-9cb6cfe58c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_3f000772-0fde-4eac-b9de-605ad3a6b323" xlink:to="loc_us-gaap_CommercialRealEstateMember_6142d4cb-2e48-4e34-a3e8-9cb6cfe58c9a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#InvestmentsMortgageLoansCreditRatingsIndicatorDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="extended" id="i2e86282ddb8e4566a79b0913fce984c0_InvestmentsMortgageLoansCreditRatingsIndicatorDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_f1d63295-6718-4aad-80f6-ac9872cf37ef" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstate_a46a63b3-1962-41f0-ae32-bf5ea1795db7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_f1d63295-6718-4aad-80f6-ac9872cf37ef" xlink:to="loc_us-gaap_MortgageLoansOnRealEstate_a46a63b3-1962-41f0-ae32-bf5ea1795db7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_8339ed18-0086-4a85-ad61-1dc98b80164e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_f1d63295-6718-4aad-80f6-ac9872cf37ef" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_8339ed18-0086-4a85-ad61-1dc98b80164e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_02b2cbd6-91c7-4e89-b637-55948da6a5ba" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_8339ed18-0086-4a85-ad61-1dc98b80164e" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_02b2cbd6-91c7-4e89-b637-55948da6a5ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_02b2cbd6-91c7-4e89-b637-55948da6a5ba_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_02b2cbd6-91c7-4e89-b637-55948da6a5ba" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_02b2cbd6-91c7-4e89-b637-55948da6a5ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_052df360-e715-4f9a-8ef1-8b637e439461" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_02b2cbd6-91c7-4e89-b637-55948da6a5ba" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_052df360-e715-4f9a-8ef1-8b637e439461" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_6ac7f154-4736-4b4a-9b62-9c0f5256db5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_052df360-e715-4f9a-8ef1-8b637e439461" xlink:to="loc_us-gaap_CommercialRealEstateMember_6ac7f154-4736-4b4a-9b62-9c0f5256db5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_0b4e9170-b923-410a-9160-6ff5ea0dcbc1" xlink:href="cvs-20220630.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_8339ed18-0086-4a85-ad61-1dc98b80164e" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_0b4e9170-b923-410a-9160-6ff5ea0dcbc1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_0b4e9170-b923-410a-9160-6ff5ea0dcbc1_default" xlink:href="cvs-20220630.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_0b4e9170-b923-410a-9160-6ff5ea0dcbc1" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_0b4e9170-b923-410a-9160-6ff5ea0dcbc1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_9d9133cb-6e6c-4fc7-8b69-65f1067d68ae" xlink:href="cvs-20220630.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_0b4e9170-b923-410a-9160-6ff5ea0dcbc1" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_9d9133cb-6e6c-4fc7-8b69-65f1067d68ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodOneMember_02c9ce35-ef52-4778-9ec8-1a9e953c8a8c" xlink:href="cvs-20220630.xsd#cvs_YearOfOriginationPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_9d9133cb-6e6c-4fc7-8b69-65f1067d68ae" xlink:to="loc_cvs_YearOfOriginationPeriodOneMember_02c9ce35-ef52-4778-9ec8-1a9e953c8a8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodTwoMember_ba3038f7-0d99-4138-8333-afe1aca478db" xlink:href="cvs-20220630.xsd#cvs_YearOfOriginationPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_9d9133cb-6e6c-4fc7-8b69-65f1067d68ae" xlink:to="loc_cvs_YearOfOriginationPeriodTwoMember_ba3038f7-0d99-4138-8333-afe1aca478db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodThreeMember_38d3346a-64fa-42e6-aa55-4825eb1e3be2" xlink:href="cvs-20220630.xsd#cvs_YearOfOriginationPeriodThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_9d9133cb-6e6c-4fc7-8b69-65f1067d68ae" xlink:to="loc_cvs_YearOfOriginationPeriodThreeMember_38d3346a-64fa-42e6-aa55-4825eb1e3be2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFourMember_ad299835-88f9-488e-96eb-b838cb9d1a3b" xlink:href="cvs-20220630.xsd#cvs_YearOfOriginationPeriodFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_9d9133cb-6e6c-4fc7-8b69-65f1067d68ae" xlink:to="loc_cvs_YearOfOriginationPeriodFourMember_ad299835-88f9-488e-96eb-b838cb9d1a3b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFiveMember_ce76fef5-1872-4834-ab40-f9ab1fab34a0" xlink:href="cvs-20220630.xsd#cvs_YearOfOriginationPeriodFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_9d9133cb-6e6c-4fc7-8b69-65f1067d68ae" xlink:to="loc_cvs_YearOfOriginationPeriodFiveMember_ce76fef5-1872-4834-ab40-f9ab1fab34a0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_d6f3d75e-07c5-4f65-84b0-572df47271bd" xlink:href="cvs-20220630.xsd#cvs_YearOfOriginationPriorToPeriodFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_9d9133cb-6e6c-4fc7-8b69-65f1067d68ae" xlink:to="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_d6f3d75e-07c5-4f65-84b0-572df47271bd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_291b1dd4-1886-4354-ab68-f0ffe2a02b4c" xlink:href="cvs-20220630.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_8339ed18-0086-4a85-ad61-1dc98b80164e" xlink:to="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_291b1dd4-1886-4354-ab68-f0ffe2a02b4c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_291b1dd4-1886-4354-ab68-f0ffe2a02b4c_default" xlink:href="cvs-20220630.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_291b1dd4-1886-4354-ab68-f0ffe2a02b4c" xlink:to="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_291b1dd4-1886-4354-ab68-f0ffe2a02b4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_5a0ba383-19cf-41e8-a0e6-e7d8681efb0a" xlink:href="cvs-20220630.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_291b1dd4-1886-4354-ab68-f0ffe2a02b4c" xlink:to="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_5a0ba383-19cf-41e8-a0e6-e7d8681efb0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category1Member_9e2ed3bb-7a7d-4f74-ba4d-a3e1ce6183c6" xlink:href="cvs-20220630.xsd#cvs_Category1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_5a0ba383-19cf-41e8-a0e6-e7d8681efb0a" xlink:to="loc_cvs_Category1Member_9e2ed3bb-7a7d-4f74-ba4d-a3e1ce6183c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category2To4Member_b72355de-c286-4d79-9e6f-738d4afdf79d" xlink:href="cvs-20220630.xsd#cvs_Category2To4Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_5a0ba383-19cf-41e8-a0e6-e7d8681efb0a" xlink:to="loc_cvs_Category2To4Member_b72355de-c286-4d79-9e6f-738d4afdf79d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Categories5and6Member_545607b7-c556-4f71-ab04-6857bb6e1c6a" xlink:href="cvs-20220630.xsd#cvs_Categories5and6Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_5a0ba383-19cf-41e8-a0e6-e7d8681efb0a" xlink:to="loc_cvs_Categories5and6Member_545607b7-c556-4f71-ab04-6857bb6e1c6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category7Member_01ba97ef-cc75-4b33-8d5b-d2762ff8e228" xlink:href="cvs-20220630.xsd#cvs_Category7Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_5a0ba383-19cf-41e8-a0e6-e7d8681efb0a" xlink:to="loc_cvs_Category7Member_01ba97ef-cc75-4b33-8d5b-d2762ff8e228" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#InvestmentsNetInvestmentIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="extended" id="i502a0ca8996143ab9290b5a7bc9a016c_InvestmentsNetInvestmentIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_4eeefc17-43f9-4536-acd8-57e36e6249e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_76b5a025-95b4-4ac2-804a-193ea4a19e56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_4eeefc17-43f9-4536-acd8-57e36e6249e8" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_76b5a025-95b4-4ac2-804a-193ea4a19e56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_d2795fa2-851a-4730-a6fc-558bb5ac4484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_4eeefc17-43f9-4536-acd8-57e36e6249e8" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_d2795fa2-851a-4730-a6fc-558bb5ac4484" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_8f61c9ea-2b1a-49b8-bc6d-acf3592b2f41" xlink:href="cvs-20220630.xsd#cvs_InvestmentIncomeExcludingCapitalGainsorLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_4eeefc17-43f9-4536-acd8-57e36e6249e8" xlink:to="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_8f61c9ea-2b1a-49b8-bc6d-acf3592b2f41" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_d56922e8-c50c-4513-800f-3e2768c680ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_4eeefc17-43f9-4536-acd8-57e36e6249e8" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_d56922e8-c50c-4513-800f-3e2768c680ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_89f20ac4-6f18-4f7c-9492-48384cbd8c82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_4eeefc17-43f9-4536-acd8-57e36e6249e8" xlink:to="loc_us-gaap_InvestmentIncomeNet_89f20ac4-6f18-4f7c-9492-48384cbd8c82" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_71bdef25-a464-4e12-a462-7cc1a648a22a" xlink:href="cvs-20220630.xsd#cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_4eeefc17-43f9-4536-acd8-57e36e6249e8" xlink:to="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_71bdef25-a464-4e12-a462-7cc1a648a22a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_09615cc6-534f-4222-9fbf-78b24e25c208" xlink:href="cvs-20220630.xsd#cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_4eeefc17-43f9-4536-acd8-57e36e6249e8" xlink:to="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_09615cc6-534f-4222-9fbf-78b24e25c208" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_eee9fbeb-7106-4621-876d-afd85bfdf4f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_4eeefc17-43f9-4536-acd8-57e36e6249e8" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_eee9fbeb-7106-4621-876d-afd85bfdf4f5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_c5f2646c-d7b3-4a91-8ad1-5241c0847306" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_eee9fbeb-7106-4621-876d-afd85bfdf4f5" xlink:to="loc_us-gaap_InvestmentTypeAxis_c5f2646c-d7b3-4a91-8ad1-5241c0847306" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_c5f2646c-d7b3-4a91-8ad1-5241c0847306_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_c5f2646c-d7b3-4a91-8ad1-5241c0847306" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_c5f2646c-d7b3-4a91-8ad1-5241c0847306_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_35ca3ad3-6572-43eb-be58-77442a98dd99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_c5f2646c-d7b3-4a91-8ad1-5241c0847306" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_35ca3ad3-6572-43eb-be58-77442a98dd99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_b6163d4e-5494-4ba0-830e-847f64d171d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_35ca3ad3-6572-43eb-be58-77442a98dd99" xlink:to="loc_us-gaap_DebtSecuritiesMember_b6163d4e-5494-4ba0-830e-847f64d171d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_9cf4dcce-67da-4e83-93b6-7c1ccc93d6fc" xlink:href="cvs-20220630.xsd#cvs_MortgageLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_35ca3ad3-6572-43eb-be58-77442a98dd99" xlink:to="loc_cvs_MortgageLoansMember_9cf4dcce-67da-4e83-93b6-7c1ccc93d6fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_a52601dd-8e20-4bda-ae62-16a7a7200a69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_35ca3ad3-6572-43eb-be58-77442a98dd99" xlink:to="loc_us-gaap_OtherInvestmentsMember_a52601dd-8e20-4bda-ae62-16a7a7200a69" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4b99bed9-154d-4e30-b2d2-fea7a31a6506" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_eee9fbeb-7106-4621-876d-afd85bfdf4f5" xlink:to="loc_srt_ProductOrServiceAxis_4b99bed9-154d-4e30-b2d2-fea7a31a6506" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4b99bed9-154d-4e30-b2d2-fea7a31a6506_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_4b99bed9-154d-4e30-b2d2-fea7a31a6506" xlink:to="loc_srt_ProductsAndServicesDomain_4b99bed9-154d-4e30-b2d2-fea7a31a6506_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7c8ef8b1-6e3e-438a-88d1-112367bcb29d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_4b99bed9-154d-4e30-b2d2-fea7a31a6506" xlink:to="loc_srt_ProductsAndServicesDomain_7c8ef8b1-6e3e-438a-88d1-112367bcb29d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_9e5edb2a-d50d-4419-93f6-d13c317a5e15" xlink:href="cvs-20220630.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7c8ef8b1-6e3e-438a-88d1-112367bcb29d" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_9e5edb2a-d50d-4419-93f6-d13c317a5e15" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#FairValueMeasurementonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails" xlink:type="extended" id="i7438ef9c4e564033ae55fd761f916ec1_FairValueMeasurementonaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_941439b4-eb48-46a7-a127-642db66c631a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_08f8a03a-18c4-4d77-bf1b-bd5b6febbaf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_941439b4-eb48-46a7-a127-642db66c631a" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_08f8a03a-18c4-4d77-bf1b-bd5b6febbaf7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_24e01892-2a70-4cd2-aff1-20849b57f741" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_941439b4-eb48-46a7-a127-642db66c631a" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_24e01892-2a70-4cd2-aff1-20849b57f741" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5c5ea725-20fb-4390-b156-574480e22f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_941439b4-eb48-46a7-a127-642db66c631a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5c5ea725-20fb-4390-b156-574480e22f6c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_2f6418f6-27e1-4c15-bbde-364a0617c0ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_941439b4-eb48-46a7-a127-642db66c631a" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_2f6418f6-27e1-4c15-bbde-364a0617c0ec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_d506f6a4-b93f-4303-9f8f-b8f672b07aee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_941439b4-eb48-46a7-a127-642db66c631a" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_d506f6a4-b93f-4303-9f8f-b8f672b07aee" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a8092797-5f0c-405a-bdc5-06311978dbcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_941439b4-eb48-46a7-a127-642db66c631a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a8092797-5f0c-405a-bdc5-06311978dbcf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_01f27125-0ede-47af-bd12-905ce898fec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a8092797-5f0c-405a-bdc5-06311978dbcf" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_01f27125-0ede-47af-bd12-905ce898fec2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_01f27125-0ede-47af-bd12-905ce898fec2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_01f27125-0ede-47af-bd12-905ce898fec2" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_01f27125-0ede-47af-bd12-905ce898fec2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f525185c-4e43-441e-9cac-6bdbb45139c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_01f27125-0ede-47af-bd12-905ce898fec2" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f525185c-4e43-441e-9cac-6bdbb45139c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_fee4186c-ec99-4007-89a6-a1525b03ee38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f525185c-4e43-441e-9cac-6bdbb45139c0" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_fee4186c-ec99-4007-89a6-a1525b03ee38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_8e260268-8f3e-4466-8040-fc21faba7da2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a8092797-5f0c-405a-bdc5-06311978dbcf" xlink:to="loc_us-gaap_FinancialInstrumentAxis_8e260268-8f3e-4466-8040-fc21faba7da2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e260268-8f3e-4466-8040-fc21faba7da2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8e260268-8f3e-4466-8040-fc21faba7da2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8e260268-8f3e-4466-8040-fc21faba7da2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d9056361-e9ae-4773-b03c-e4aef76528cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8e260268-8f3e-4466-8040-fc21faba7da2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d9056361-e9ae-4773-b03c-e4aef76528cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_0125f4c8-7521-4123-9988-746532eef616" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d9056361-e9ae-4773-b03c-e4aef76528cf" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_0125f4c8-7521-4123-9988-746532eef616" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_f169c86f-763c-4c06-94b4-b521ff80c50c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d9056361-e9ae-4773-b03c-e4aef76528cf" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_f169c86f-763c-4c06-94b4-b521ff80c50c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_80650f49-38d1-4fe1-8264-1eef38736b33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d9056361-e9ae-4773-b03c-e4aef76528cf" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_80650f49-38d1-4fe1-8264-1eef38736b33" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_60e3c55d-50a3-45ff-a882-c3bede6e6c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d9056361-e9ae-4773-b03c-e4aef76528cf" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_60e3c55d-50a3-45ff-a882-c3bede6e6c4d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_1155152a-72d3-43a5-a0f8-7916a8ca5450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d9056361-e9ae-4773-b03c-e4aef76528cf" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_1155152a-72d3-43a5-a0f8-7916a8ca5450" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_ec5284f8-a07c-43db-adb9-9e6c93681124" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d9056361-e9ae-4773-b03c-e4aef76528cf" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_ec5284f8-a07c-43db-adb9-9e6c93681124" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_874791e5-0805-4b52-8673-dc88d13a3567" xlink:href="cvs-20220630.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d9056361-e9ae-4773-b03c-e4aef76528cf" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_874791e5-0805-4b52-8673-dc88d13a3567" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_b73da221-1acc-4dfb-8038-98648474b9d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d9056361-e9ae-4773-b03c-e4aef76528cf" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_b73da221-1acc-4dfb-8038-98648474b9d6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f41319b4-bd9a-4d93-9dac-9a89f07845a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a8092797-5f0c-405a-bdc5-06311978dbcf" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f41319b4-bd9a-4d93-9dac-9a89f07845a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f41319b4-bd9a-4d93-9dac-9a89f07845a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f41319b4-bd9a-4d93-9dac-9a89f07845a1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f41319b4-bd9a-4d93-9dac-9a89f07845a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_808d28e1-24d7-48a8-8736-f8241837d89b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f41319b4-bd9a-4d93-9dac-9a89f07845a1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_808d28e1-24d7-48a8-8736-f8241837d89b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_fc0d87d8-d001-4f5f-939d-810862f119fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_808d28e1-24d7-48a8-8736-f8241837d89b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_fc0d87d8-d001-4f5f-939d-810862f119fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_283ec26c-05cb-4a9a-a41e-3984cf0bd40a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_808d28e1-24d7-48a8-8736-f8241837d89b" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_283ec26c-05cb-4a9a-a41e-3984cf0bd40a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_78e216b1-9510-4c61-80c6-3c1156922041" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_808d28e1-24d7-48a8-8736-f8241837d89b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_78e216b1-9510-4c61-80c6-3c1156922041" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#FairValueCarryingValueandFairValueClassifiedbyLevelDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="extended" id="if7ab64e78ca94252a4f77d3de312b63f_FairValueCarryingValueandFairValueClassifiedbyLevelDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_01274b58-4a85-4586-8411-d3f9ef4dec47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_04590e22-8187-4131-a823-7b925db5b000" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_01274b58-4a85-4586-8411-d3f9ef4dec47" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_04590e22-8187-4131-a823-7b925db5b000" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_a74d3d04-62cf-4a26-8a2e-78094eec9045" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgagesHeldForSaleFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_04590e22-8187-4131-a823-7b925db5b000" xlink:to="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_a74d3d04-62cf-4a26-8a2e-78094eec9045" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_094289e6-b61c-4931-bb18-fd91db91e276" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_04590e22-8187-4131-a823-7b925db5b000" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_094289e6-b61c-4931-bb18-fd91db91e276" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_fedf40c7-6e2c-4430-91d3-39d8e126ce91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_01274b58-4a85-4586-8411-d3f9ef4dec47" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_fedf40c7-6e2c-4430-91d3-39d8e126ce91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_da3064a7-15d7-447c-a71c-2df46d3facdb" xlink:href="cvs-20220630.xsd#cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_fedf40c7-6e2c-4430-91d3-39d8e126ce91" xlink:to="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_da3064a7-15d7-447c-a71c-2df46d3facdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_a858add7-cd96-4b52-9622-419689f18e2b" xlink:href="cvs-20220630.xsd#cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_fedf40c7-6e2c-4430-91d3-39d8e126ce91" xlink:to="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_a858add7-cd96-4b52-9622-419689f18e2b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_031388dc-0f51-4c87-8275-460f99b30c61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_fedf40c7-6e2c-4430-91d3-39d8e126ce91" xlink:to="loc_us-gaap_DebtInstrumentFairValue_031388dc-0f51-4c87-8275-460f99b30c61" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d95a2aea-d623-4d76-b2d8-495aadd5a4ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_01274b58-4a85-4586-8411-d3f9ef4dec47" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d95a2aea-d623-4d76-b2d8-495aadd5a4ab" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3d425c92-86e3-4527-be3a-608886638982" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d95a2aea-d623-4d76-b2d8-495aadd5a4ab" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3d425c92-86e3-4527-be3a-608886638982" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3d425c92-86e3-4527-be3a-608886638982_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3d425c92-86e3-4527-be3a-608886638982" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3d425c92-86e3-4527-be3a-608886638982_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_1667d458-720c-4472-b246-3258b912f155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3d425c92-86e3-4527-be3a-608886638982" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_1667d458-720c-4472-b246-3258b912f155" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_acce96e7-94bc-4534-bc01-60269f34cdde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_1667d458-720c-4472-b246-3258b912f155" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_acce96e7-94bc-4534-bc01-60269f34cdde" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7baa4474-ab6a-4879-ac30-b103a99266fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d95a2aea-d623-4d76-b2d8-495aadd5a4ab" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7baa4474-ab6a-4879-ac30-b103a99266fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7baa4474-ab6a-4879-ac30-b103a99266fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7baa4474-ab6a-4879-ac30-b103a99266fa" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7baa4474-ab6a-4879-ac30-b103a99266fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_157993fb-621c-4794-bdc3-07d46ec3f73c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7baa4474-ab6a-4879-ac30-b103a99266fa" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_157993fb-621c-4794-bdc3-07d46ec3f73c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_cac82b72-3132-428d-88a7-849db5d9f8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_157993fb-621c-4794-bdc3-07d46ec3f73c" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_cac82b72-3132-428d-88a7-849db5d9f8a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_aae336f7-331c-43c0-8307-c016dcddda00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_157993fb-621c-4794-bdc3-07d46ec3f73c" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_aae336f7-331c-43c0-8307-c016dcddda00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_8d3317bb-0257-48c0-9678-55be477787bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_157993fb-621c-4794-bdc3-07d46ec3f73c" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_8d3317bb-0257-48c0-9678-55be477787bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_e91fe224-f2a5-4673-9967-f419e36a38a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d95a2aea-d623-4d76-b2d8-495aadd5a4ab" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_e91fe224-f2a5-4673-9967-f419e36a38a4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_e91fe224-f2a5-4673-9967-f419e36a38a4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_e91fe224-f2a5-4673-9967-f419e36a38a4" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_e91fe224-f2a5-4673-9967-f419e36a38a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_015fdca0-3ab1-4cc6-a7c3-db85553f54da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_e91fe224-f2a5-4673-9967-f419e36a38a4" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_015fdca0-3ab1-4cc6-a7c3-db85553f54da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b50a8944-d9ca-4c76-9005-33aff842c0f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_015fdca0-3ab1-4cc6-a7c3-db85553f54da" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b50a8944-d9ca-4c76-9005-33aff842c0f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_f2758364-74be-4b7d-930f-31acfb4946a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b50a8944-d9ca-4c76-9005-33aff842c0f1" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_f2758364-74be-4b7d-930f-31acfb4946a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_aed31e50-11a4-429f-9e9c-fd55430fe87c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b50a8944-d9ca-4c76-9005-33aff842c0f1" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_aed31e50-11a4-429f-9e9c-fd55430fe87c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#FairValueSeparateAccountsFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="extended" id="i6da2211bee454db48c68c2f8509ef3de_FairValueSeparateAccountsFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_2939edfc-1778-4cd3-8665-24972149b888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_54960c8a-46d5-4fae-89b1-e022a03137c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_2939edfc-1778-4cd3-8665-24972149b888" xlink:to="loc_us-gaap_SeparateAccountAssets_54960c8a-46d5-4fae-89b1-e022a03137c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b8334f16-d4a2-45b6-b772-96cf9b564245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_2939edfc-1778-4cd3-8665-24972149b888" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b8334f16-d4a2-45b6-b772-96cf9b564245" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bc12aaf4-0122-4d18-99d3-0d223cc9093d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b8334f16-d4a2-45b6-b772-96cf9b564245" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bc12aaf4-0122-4d18-99d3-0d223cc9093d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_bc12aaf4-0122-4d18-99d3-0d223cc9093d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bc12aaf4-0122-4d18-99d3-0d223cc9093d" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_bc12aaf4-0122-4d18-99d3-0d223cc9093d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_5a6448a9-c468-4472-94f6-f6a69cbb7708" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bc12aaf4-0122-4d18-99d3-0d223cc9093d" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_5a6448a9-c468-4472-94f6-f6a69cbb7708" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_b2e3834f-79c1-4186-ad7b-ec1da1027b41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_5a6448a9-c468-4472-94f6-f6a69cbb7708" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_b2e3834f-79c1-4186-ad7b-ec1da1027b41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_869aa08e-8e3d-4e4e-b325-af9a8fe98e68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b8334f16-d4a2-45b6-b772-96cf9b564245" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_869aa08e-8e3d-4e4e-b325-af9a8fe98e68" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_869aa08e-8e3d-4e4e-b325-af9a8fe98e68_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_869aa08e-8e3d-4e4e-b325-af9a8fe98e68" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_869aa08e-8e3d-4e4e-b325-af9a8fe98e68_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c4fbb5cf-9be9-4c27-b29b-112ef088f665" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_869aa08e-8e3d-4e4e-b325-af9a8fe98e68" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c4fbb5cf-9be9-4c27-b29b-112ef088f665" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_60c597e6-7d8b-4678-93af-e839752da8b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c4fbb5cf-9be9-4c27-b29b-112ef088f665" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_60c597e6-7d8b-4678-93af-e839752da8b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f365ea8e-00de-492d-af10-00cd4cb99f19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c4fbb5cf-9be9-4c27-b29b-112ef088f665" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f365ea8e-00de-492d-af10-00cd4cb99f19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_95b3783f-ee7d-4c76-956b-59637a974492" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c4fbb5cf-9be9-4c27-b29b-112ef088f665" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_95b3783f-ee7d-4c76-956b-59637a974492" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_ea445f92-78aa-41bc-8cf0-3e332ab79c31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b8334f16-d4a2-45b6-b772-96cf9b564245" xlink:to="loc_us-gaap_InvestmentTypeAxis_ea445f92-78aa-41bc-8cf0-3e332ab79c31" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_ea445f92-78aa-41bc-8cf0-3e332ab79c31_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_ea445f92-78aa-41bc-8cf0-3e332ab79c31" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_ea445f92-78aa-41bc-8cf0-3e332ab79c31_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_93acf121-845b-467c-a974-3fb2918f53f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_ea445f92-78aa-41bc-8cf0-3e332ab79c31" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_93acf121-845b-467c-a974-3fb2918f53f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_2700709b-1aed-45e1-bd41-47acf558f3a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_93acf121-845b-467c-a974-3fb2918f53f0" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_2700709b-1aed-45e1-bd41-47acf558f3a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_81bca80e-7ea7-4c49-9e5e-eaba9de30668" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_93acf121-845b-467c-a974-3fb2918f53f0" xlink:to="loc_us-gaap_DebtSecuritiesMember_81bca80e-7ea7-4c49-9e5e-eaba9de30668" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_2fad13b5-dd1e-417a-968d-720afcfe8042" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_93acf121-845b-467c-a974-3fb2918f53f0" xlink:to="loc_us-gaap_EquitySecuritiesMember_2fad13b5-dd1e-417a-968d-720afcfe8042" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CommonAndCollectiveTrustsMember_72c6e51a-45ac-4d88-a52c-8721194f5529" xlink:href="cvs-20220630.xsd#cvs_CommonAndCollectiveTrustsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_93acf121-845b-467c-a974-3fb2918f53f0" xlink:to="loc_cvs_CommonAndCollectiveTrustsMember_72c6e51a-45ac-4d88-a52c-8721194f5529" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_8b10ce27-59f9-4be5-b197-26ac4178f8c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b8334f16-d4a2-45b6-b772-96cf9b564245" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_8b10ce27-59f9-4be5-b197-26ac4178f8c8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8b10ce27-59f9-4be5-b197-26ac4178f8c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8b10ce27-59f9-4be5-b197-26ac4178f8c8" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8b10ce27-59f9-4be5-b197-26ac4178f8c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_543e523b-dbd1-426e-acf4-3bf075681a20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8b10ce27-59f9-4be5-b197-26ac4178f8c8" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_543e523b-dbd1-426e-acf4-3bf075681a20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherReceivablesMember_c90408b4-7291-492a-9aa1-778172307dac" xlink:href="cvs-20220630.xsd#cvs_OtherReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_543e523b-dbd1-426e-acf4-3bf075681a20" xlink:to="loc_cvs_OtherReceivablesMember_c90408b4-7291-492a-9aa1-778172307dac" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="extended" id="i3941ae1a1f584053ab45d4947d8f92f5_HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_eca2a34e-8fbc-4e27-8a16-cbad58717a09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7c70827-00bd-443d-ac7b-b95dccf0916d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_eca2a34e-8fbc-4e27-8a16-cbad58717a09" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7c70827-00bd-443d-ac7b-b95dccf0916d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_551aace4-1a30-4d9c-b0cd-363008a51774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7c70827-00bd-443d-ac7b-b95dccf0916d" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_551aace4-1a30-4d9c-b0cd-363008a51774" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_93b0cfe2-eb25-4d79-a465-360eae277794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7c70827-00bd-443d-ac7b-b95dccf0916d" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_93b0cfe2-eb25-4d79-a465-360eae277794" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_385fbeb5-5624-48c9-a96e-00f76231ee16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7c70827-00bd-443d-ac7b-b95dccf0916d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_385fbeb5-5624-48c9-a96e-00f76231ee16" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_dffb523d-d10f-4c09-83c1-cc9201ecf9f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7c70827-00bd-443d-ac7b-b95dccf0916d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_dffb523d-d10f-4c09-83c1-cc9201ecf9f1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_fbf158bb-fbb4-4260-b5bd-704ff7da2c03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_dffb523d-d10f-4c09-83c1-cc9201ecf9f1" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_fbf158bb-fbb4-4260-b5bd-704ff7da2c03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_de5cfbf2-d569-4711-9cc0-1fd257cb3e04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_dffb523d-d10f-4c09-83c1-cc9201ecf9f1" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_de5cfbf2-d569-4711-9cc0-1fd257cb3e04" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_66acb8be-391d-4ffc-9e25-19d6021d747d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_dffb523d-d10f-4c09-83c1-cc9201ecf9f1" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_66acb8be-391d-4ffc-9e25-19d6021d747d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_860d57d1-a7c4-4559-9d06-dffc814cb007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7c70827-00bd-443d-ac7b-b95dccf0916d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_860d57d1-a7c4-4559-9d06-dffc814cb007" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_09039059-47ca-4398-befa-e6889bb63b08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_860d57d1-a7c4-4559-9d06-dffc814cb007" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_09039059-47ca-4398-befa-e6889bb63b08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_33ef4f22-6b51-4886-a0b6-53b616b60d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_860d57d1-a7c4-4559-9d06-dffc814cb007" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_33ef4f22-6b51-4886-a0b6-53b616b60d5d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_cb87913e-f37a-47ea-8b66-545ee4f2aa5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_860d57d1-a7c4-4559-9d06-dffc814cb007" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_cb87913e-f37a-47ea-8b66-545ee4f2aa5b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_aa78156b-e4d0-45a8-93b4-789241e5ae47" xlink:href="cvs-20220630.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7c70827-00bd-443d-ac7b-b95dccf0916d" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_aa78156b-e4d0-45a8-93b4-789241e5ae47" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_5d3843eb-e675-4ace-a584-e104e66431b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_168c6fbf-126a-4fc6-a543-b6dee837d59f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_10d67725-60dc-428e-a78b-e21ae2f16076" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_f71e27d5-71b6-430c-ba50-3c5fc98201c3" xlink:href="cvs-20220630.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_04f9fa89-c008-4ab2-951d-79eea6d592c2" xlink:href="cvs-20220630.xsd#cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_eca2a34e-8fbc-4e27-8a16-cbad58717a09" xlink:to="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_04f9fa89-c008-4ab2-951d-79eea6d592c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_cdf916c0-9dff-4722-9837-b9c3d3f9b444" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_eca2a34e-8fbc-4e27-8a16-cbad58717a09" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_cdf916c0-9dff-4722-9837-b9c3d3f9b444" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_25197209-e3d3-48d1-a494-b01367fafb3e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_cdf916c0-9dff-4722-9837-b9c3d3f9b444" xlink:to="loc_srt_ProductOrServiceAxis_25197209-e3d3-48d1-a494-b01367fafb3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_25197209-e3d3-48d1-a494-b01367fafb3e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_25197209-e3d3-48d1-a494-b01367fafb3e" xlink:to="loc_srt_ProductsAndServicesDomain_25197209-e3d3-48d1-a494-b01367fafb3e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0bcbf428-dae6-4253-9216-51fe89130c47" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_25197209-e3d3-48d1-a494-b01367fafb3e" xlink:to="loc_srt_ProductsAndServicesDomain_0bcbf428-dae6-4253-9216-51fe89130c47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_76f53107-3796-41e3-ac73-6d773f302669" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0bcbf428-dae6-4253-9216-51fe89130c47" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_76f53107-3796-41e3-ac73-6d773f302669" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3fe2e29a-c4b7-4c14-bd71-9d4fc2e757c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_cdf916c0-9dff-4722-9837-b9c3d3f9b444" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3fe2e29a-c4b7-4c14-bd71-9d4fc2e757c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3fe2e29a-c4b7-4c14-bd71-9d4fc2e757c1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3fe2e29a-c4b7-4c14-bd71-9d4fc2e757c1" xlink:to="loc_us-gaap_SegmentDomain_3fe2e29a-c4b7-4c14-bd71-9d4fc2e757c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6fbdac2d-a3fe-4126-9a62-7f5474a8154d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3fe2e29a-c4b7-4c14-bd71-9d4fc2e757c1" xlink:to="loc_us-gaap_SegmentDomain_6fbdac2d-a3fe-4126-9a62-7f5474a8154d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_49ac351f-c16c-4913-a90b-ce089ee7014d" xlink:href="cvs-20220630.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6fbdac2d-a3fe-4126-9a62-7f5474a8154d" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_49ac351f-c16c-4913-a90b-ce089ee7014d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CorporateOtherMember_f3e06a3b-e5f2-478a-8cf3-62c6efecd01b" xlink:href="cvs-20220630.xsd#cvs_CorporateOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6fbdac2d-a3fe-4126-9a62-7f5474a8154d" xlink:to="loc_cvs_CorporateOtherMember_f3e06a3b-e5f2-478a-8cf3-62c6efecd01b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#HealthCareCostsPayableNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="extended" id="ib17bb9ba3afd453c9a454ab7e6a37ee8_HealthCareCostsPayableNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_fbed5ad2-14b6-4371-863b-057245ba5857" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_eddddb30-d1c4-46fb-99b4-c53fecffb29a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_fbed5ad2-14b6-4371-863b-057245ba5857" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_eddddb30-d1c4-46fb-99b4-c53fecffb29a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_e4dc6ef2-c122-42b7-bd92-9f029344cc1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_fbed5ad2-14b6-4371-863b-057245ba5857" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_e4dc6ef2-c122-42b7-bd92-9f029344cc1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_235ce96b-4907-413e-8288-5800f027beab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_fbed5ad2-14b6-4371-863b-057245ba5857" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_235ce96b-4907-413e-8288-5800f027beab" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_df19edef-1009-4598-b594-2db68274537f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_235ce96b-4907-413e-8288-5800f027beab" xlink:to="loc_srt_ProductOrServiceAxis_df19edef-1009-4598-b594-2db68274537f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_df19edef-1009-4598-b594-2db68274537f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_df19edef-1009-4598-b594-2db68274537f" xlink:to="loc_srt_ProductsAndServicesDomain_df19edef-1009-4598-b594-2db68274537f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a93babc0-f3f7-43c7-8bce-c72b6428b1c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_df19edef-1009-4598-b594-2db68274537f" xlink:to="loc_srt_ProductsAndServicesDomain_a93babc0-f3f7-43c7-8bce-c72b6428b1c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_670ed1cf-4cf6-4871-9190-318226bd0982" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a93babc0-f3f7-43c7-8bce-c72b6428b1c3" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_670ed1cf-4cf6-4871-9190-318226bd0982" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#BorrowingsScheduleofBorrowingsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails" xlink:type="extended" id="ie785a88a45594dacae1684badefb86d9_BorrowingsScheduleofBorrowingsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2f611e9e-08ed-4a72-91fb-65d8a1ea0048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ebf08139-db50-4ca4-84c9-ae5a0618685f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f611e9e-08ed-4a72-91fb-65d8a1ea0048" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ebf08139-db50-4ca4-84c9-ae5a0618685f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_e7f92c36-8fe2-47e0-b9e9-4bc0dd85e8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f611e9e-08ed-4a72-91fb-65d8a1ea0048" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_e7f92c36-8fe2-47e0-b9e9-4bc0dd85e8a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_c1632703-e2bd-4b1d-a14b-153b9aaaddf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f611e9e-08ed-4a72-91fb-65d8a1ea0048" xlink:to="loc_us-gaap_FinanceLeaseLiability_c1632703-e2bd-4b1d-a14b-153b9aaaddf0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongtermDebtGrossAndLeaseObligation_f473c644-a0a1-47cc-9cbc-31066ebff787" xlink:href="cvs-20220630.xsd#cvs_LongtermDebtGrossAndLeaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f611e9e-08ed-4a72-91fb-65d8a1ea0048" xlink:to="loc_cvs_LongtermDebtGrossAndLeaseObligation_f473c644-a0a1-47cc-9cbc-31066ebff787" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_cd82dd09-2be7-428f-bd80-1d37fc5cc293" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f611e9e-08ed-4a72-91fb-65d8a1ea0048" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_cd82dd09-2be7-428f-bd80-1d37fc5cc293" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_53cf7f68-3bbc-4941-adb5-a31661f63cda" xlink:href="cvs-20220630.xsd#cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f611e9e-08ed-4a72-91fb-65d8a1ea0048" xlink:to="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_53cf7f68-3bbc-4941-adb5-a31661f63cda" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_380e1ce1-68a0-47e7-91c5-0181acb3f15a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f611e9e-08ed-4a72-91fb-65d8a1ea0048" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_380e1ce1-68a0-47e7-91c5-0181acb3f15a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_6701efff-936d-4e7b-b61b-c797ecc2ed59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f611e9e-08ed-4a72-91fb-65d8a1ea0048" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_6701efff-936d-4e7b-b61b-c797ecc2ed59" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_e94e6aab-a1de-479c-b92a-3adc1c7b99c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f611e9e-08ed-4a72-91fb-65d8a1ea0048" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_e94e6aab-a1de-479c-b92a-3adc1c7b99c2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_1276bce8-d9bb-43d3-89df-8dc1d256a0e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f611e9e-08ed-4a72-91fb-65d8a1ea0048" xlink:to="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_1276bce8-d9bb-43d3-89df-8dc1d256a0e2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9eef29aa-eeac-4212-b53e-7043fdfa34eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f611e9e-08ed-4a72-91fb-65d8a1ea0048" xlink:to="loc_us-gaap_DebtInstrumentTable_9eef29aa-eeac-4212-b53e-7043fdfa34eb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e768e407-7381-4c6f-ab5d-eb6cdcb6fce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9eef29aa-eeac-4212-b53e-7043fdfa34eb" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e768e407-7381-4c6f-ab5d-eb6cdcb6fce3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e768e407-7381-4c6f-ab5d-eb6cdcb6fce3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e768e407-7381-4c6f-ab5d-eb6cdcb6fce3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e768e407-7381-4c6f-ab5d-eb6cdcb6fce3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3554bbf7-c14f-4d51-b71b-c1bb433f88a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e768e407-7381-4c6f-ab5d-eb6cdcb6fce3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3554bbf7-c14f-4d51-b71b-c1bb433f88a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_9d93a01a-6345-4963-907b-f2ec0818f44d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3554bbf7-c14f-4d51-b71b-c1bb433f88a6" xlink:to="loc_us-gaap_SeniorNotesMember_9d93a01a-6345-4963-907b-f2ec0818f44d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_2e4971f1-911f-439c-8d32-3cd7bc1891e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3554bbf7-c14f-4d51-b71b-c1bb433f88a6" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_2e4971f1-911f-439c-8d32-3cd7bc1891e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7d151192-fd8e-4702-b900-c97ffb738371" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9eef29aa-eeac-4212-b53e-7043fdfa34eb" xlink:to="loc_us-gaap_DebtInstrumentAxis_7d151192-fd8e-4702-b900-c97ffb738371" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7d151192-fd8e-4702-b900-c97ffb738371_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_7d151192-fd8e-4702-b900-c97ffb738371" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7d151192-fd8e-4702-b900-c97ffb738371_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_7d151192-fd8e-4702-b900-c97ffb738371" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueJuly2022Member_3fc4e1f8-341a-4613-8965-9799132b7f9f" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes3.5DueJuly2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes3.5DueJuly2022Member_3fc4e1f8-341a-4613-8965-9799132b7f9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueNovember2022Member_79fba553-73e7-4a4d-bf5a-153552d4a094" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes2.75DueNovember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes2.75DueNovember2022Member_79fba553-73e7-4a4d-bf5a-153552d4a094" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueDecember2022Member_003cec4f-aad8-45a1-b7a9-4491b67b7ee6" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes2.75DueDecember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes2.75DueDecember2022Member_003cec4f-aad8-45a1-b7a9-4491b67b7ee6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueDecember2022Member_10483b0d-2f89-415e-9c62-f1a200db7d0c" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.75DueDecember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes4.75DueDecember2022Member_10483b0d-2f89-415e-9c62-f1a200db7d0c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.8DueJune2023Member_63e6c49f-8ca3-4f4f-9bfa-68fdc17e4eb8" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes2.8DueJune2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes2.8DueJune2023Member_63e6c49f-8ca3-4f4f-9bfa-68fdc17e4eb8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4DueDecember2023Member_d45095a7-43fb-47fe-a7c7-8fc6c4f31216" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4DueDecember2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes4DueDecember2023Member_d45095a7-43fb-47fe-a7c7-8fc6c4f31216" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.375DueAugust2024Member_488c4295-8595-4cd5-9bcc-e4a95078ee3e" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes3.375DueAugust2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes3.375DueAugust2024Member_488c4295-8595-4cd5-9bcc-e4a95078ee3e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.625DueAugust2024Member_2e1f828a-76c4-4dbb-a013-7bfa098262e1" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes2.625DueAugust2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes2.625DueAugust2024Member_2e1f828a-76c4-4dbb-a013-7bfa098262e1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueNovember2024Member_7a18c8ac-1a5d-4dd0-a716-eba53261142b" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes3.5DueNovember2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes3.5DueNovember2024Member_7a18c8ac-1a5d-4dd0-a716-eba53261142b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5DueDecember2024Member_c4689958-7b8f-42a2-9636-f80ca3ba6827" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes5DueDecember2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes5DueDecember2024Member_c4689958-7b8f-42a2-9636-f80ca3ba6827" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.1DueMarch2025Member_a3814584-fb89-4e33-bfc0-0ddbac786cae" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.1DueMarch2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes4.1DueMarch2025Member_a3814584-fb89-4e33-bfc0-0ddbac786cae" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueJuly2025Member_2041806f-d6fc-4493-9d60-30543d0dcc35" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes3.875DueJuly2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes3.875DueJuly2025Member_2041806f-d6fc-4493-9d60-30543d0dcc35" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.875DueJune2026Member_85b6068d-f5bf-45df-9f8f-e9973b644526" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes2.875DueJune2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes2.875DueJune2026Member_85b6068d-f5bf-45df-9f8f-e9973b644526" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3DueAugust2026Member_a2751fa7-cc20-478b-a2f1-2db87f3614da" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes3DueAugust2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes3DueAugust2026Member_a2751fa7-cc20-478b-a2f1-2db87f3614da" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.625DueApril2027Member_29f0a830-1aa9-4951-976e-fb337f4a24b4" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes3.625DueApril2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes3.625DueApril2027Member_29f0a830-1aa9-4951-976e-fb337f4a24b4" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.25DueJune2027Member_e317374e-091d-4b39-9eb0-7c4528ca5904" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes6.25DueJune2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes6.25DueJune2027Member_e317374e-091d-4b39-9eb0-7c4528ca5904" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes13DueAugust2027Member_ed3404b8-4fe9-4b02-8370-8386916f8f81" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes13DueAugust2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes13DueAugust2027Member_ed3404b8-4fe9-4b02-8370-8386916f8f81" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.3DueMarch2028Member_8e79b306-2fa6-41a5-bf92-31073ced44cf" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.3DueMarch2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes4.3DueMarch2028Member_8e79b306-2fa6-41a5-bf92-31073ced44cf" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.25DueAugust2029Member_13dd09cc-a0e1-4f52-a379-a6ee33126325" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes3.25DueAugust2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes3.25DueAugust2029Member_13dd09cc-a0e1-4f52-a379-a6ee33126325" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.75DueApril2030Member_92025c2b-853b-49e9-bf6f-c051103fa990" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes3.75DueApril2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes3.75DueApril2030Member_92025c2b-853b-49e9-bf6f-c051103fa990" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes175DueAugust2030Member_743f4e63-00d3-4054-b9ea-1eea6346ba4f" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes175DueAugust2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes175DueAugust2030Member_743f4e63-00d3-4054-b9ea-1eea6346ba4f" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1875DueFebruary2031Member_8e8df5ca-443d-4f73-a0d8-e8d4c2c28079" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes1875DueFebruary2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes1875DueFebruary2031Member_8e8df5ca-443d-4f73-a0d8-e8d4c2c28079" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2125PercentDueSeptember2031Member_a8564941-46c5-4baa-afc7-de3318e34348" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes2125PercentDueSeptember2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes2125PercentDueSeptember2031Member_a8564941-46c5-4baa-afc7-de3318e34348" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.875DueJuly2035Member_40866c9f-133e-445d-9443-c68e97103073" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.875DueJuly2035Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes4.875DueJuly2035Member_40866c9f-133e-445d-9443-c68e97103073" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.625DueJune2036Member_1f0d28ba-c78f-42ae-99e9-5d1ffcc5f3e7" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes6.625DueJune2036Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes6.625DueJune2036Member_1f0d28ba-c78f-42ae-99e9-5d1ffcc5f3e7" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.75DueDecember2037Member_26ec988e-c829-4685-87a1-90aeba899b39" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes6.75DueDecember2037Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes6.75DueDecember2037Member_26ec988e-c829-4685-87a1-90aeba899b39" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.78DueMarch2038Member_5b235457-d061-4719-b76e-9d4047fd5f42" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.78DueMarch2038Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes4.78DueMarch2038Member_5b235457-d061-4719-b76e-9d4047fd5f42" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.125DueSeptember2039Member_d4fc339c-d02c-4cbe-9f33-85e6392737d3" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes6.125DueSeptember2039Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes6.125DueSeptember2039Member_d4fc339c-d02c-4cbe-9f33-85e6392737d3" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueApril2040Member_96cf8cc9-a913-4d1d-8ec8-9f07252251cb" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.125DueApril2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes4.125DueApril2040Member_96cf8cc9-a913-4d1d-8ec8-9f07252251cb" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes27DueAugust2040Member_c9d280fc-04a5-4a61-a2ac-a4af078cfee1" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes27DueAugust2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes27DueAugust2040Member_c9d280fc-04a5-4a61-a2ac-a4af078cfee1" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.75DueMay2041Member_c2f1a47c-8a62-4acb-aed9-0968ead0b90c" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes5.75DueMay2041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes5.75DueMay2041Member_c2f1a47c-8a62-4acb-aed9-0968ead0b90c" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.5DueMay2042Member_e6fc234f-51e6-4f9d-b8eb-2ee4dd40e7e8" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.5DueMay2042Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes4.5DueMay2042Member_e6fc234f-51e6-4f9d-b8eb-2ee4dd40e7e8" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueNovember2042Member_4cc1943c-4458-433b-b023-937bc68dd078" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.125DueNovember2042Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes4.125DueNovember2042Member_4cc1943c-4458-433b-b023-937bc68dd078" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.3DueDecember2043Member_842df2f1-a979-4a51-b511-3da59ca62f17" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes5.3DueDecember2043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes5.3DueDecember2043Member_842df2f1-a979-4a51-b511-3da59ca62f17" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueMarch2044Member_a6e13315-5c2b-4b51-b982-c110365a0125" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.75DueMarch2044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes4.75DueMarch2044Member_a6e13315-5c2b-4b51-b982-c110365a0125" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.125DueJuly2045Member_c4e500da-b699-4d58-a60d-c0a7b285ab1a" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes5.125DueJuly2045Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes5.125DueJuly2045Member_c4e500da-b699-4d58-a60d-c0a7b285ab1a" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueAugust2047Member_c4e1e50c-f774-43ac-8580-781deadbf97c" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes3.875DueAugust2047Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes3.875DueAugust2047Member_c4e1e50c-f774-43ac-8580-781deadbf97c" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.05DueMarch2048Member_03e74013-63a2-4f0c-9cf1-cd515e7d2115" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes5.05DueMarch2048Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes5.05DueMarch2048Member_03e74013-63a2-4f0c-9cf1-cd515e7d2115" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.25DueApril2050Member_b2a76ae4-746d-4a68-818d-fdcc641b2372" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.25DueApril2050Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes4.25DueApril2050Member_b2a76ae4-746d-4a68-818d-fdcc641b2372" xlink:type="arc" order="38"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsNarrativeDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#BorrowingsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/BorrowingsNarrativeDetails" xlink:type="extended" id="idcf6e67286424777ac761b999c86123a_BorrowingsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_041500dc-3b71-434b-a30c-837aa0aa0c11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f9dd5258-885f-4e65-886f-1e3f6d7acc0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_041500dc-3b71-434b-a30c-837aa0aa0c11" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f9dd5258-885f-4e65-886f-1e3f6d7acc0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_6ca78326-bb0d-4734-bd1d-6114db2e97c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_041500dc-3b71-434b-a30c-837aa0aa0c11" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_6ca78326-bb0d-4734-bd1d-6114db2e97c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f0863845-f121-4605-9af4-77089a26cf26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_041500dc-3b71-434b-a30c-837aa0aa0c11" xlink:to="loc_us-gaap_DebtInstrumentTable_f0863845-f121-4605-9af4-77089a26cf26" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_07e2f3e8-8662-41a4-b8d2-542ecf925b03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f0863845-f121-4605-9af4-77089a26cf26" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_07e2f3e8-8662-41a4-b8d2-542ecf925b03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_07e2f3e8-8662-41a4-b8d2-542ecf925b03_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_07e2f3e8-8662-41a4-b8d2-542ecf925b03" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_07e2f3e8-8662-41a4-b8d2-542ecf925b03_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_de375e4a-d7cb-4ec5-896b-dbd9647f7a69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_07e2f3e8-8662-41a4-b8d2-542ecf925b03" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_de375e4a-d7cb-4ec5-896b-dbd9647f7a69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_13e13452-e472-475e-8609-04a7497fbcd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_de375e4a-d7cb-4ec5-896b-dbd9647f7a69" xlink:to="loc_us-gaap_SeniorNotesMember_13e13452-e472-475e-8609-04a7497fbcd2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_61848b16-9a4f-4ece-adfc-2f4516a8d4c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f0863845-f121-4605-9af4-77089a26cf26" xlink:to="loc_us-gaap_DebtInstrumentAxis_61848b16-9a4f-4ece-adfc-2f4516a8d4c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_61848b16-9a4f-4ece-adfc-2f4516a8d4c5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_61848b16-9a4f-4ece-adfc-2f4516a8d4c5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_61848b16-9a4f-4ece-adfc-2f4516a8d4c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_de663153-0e3c-4103-bfba-c7fe9866b485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_61848b16-9a4f-4ece-adfc-2f4516a8d4c5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_de663153-0e3c-4103-bfba-c7fe9866b485" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueJuly2022Member_5fdef935-ff12-4b9d-99fe-2111fb94d607" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes3.5DueJuly2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de663153-0e3c-4103-bfba-c7fe9866b485" xlink:to="loc_cvs_SeniorNotes3.5DueJuly2022Member_5fdef935-ff12-4b9d-99fe-2111fb94d607" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueNovember2022Member_07316c7b-e731-42fd-ad03-686c510e88c5" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes2.75DueNovember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de663153-0e3c-4103-bfba-c7fe9866b485" xlink:to="loc_cvs_SeniorNotes2.75DueNovember2022Member_07316c7b-e731-42fd-ad03-686c510e88c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueDecember2022Member_f741eafa-4b2e-45de-883a-a73a1fd5347b" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes2.75DueDecember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de663153-0e3c-4103-bfba-c7fe9866b485" xlink:to="loc_cvs_SeniorNotes2.75DueDecember2022Member_f741eafa-4b2e-45de-883a-a73a1fd5347b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueDecember2022Member_142d8a08-cbda-49de-aba4-06776d4816b3" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.75DueDecember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de663153-0e3c-4103-bfba-c7fe9866b485" xlink:to="loc_cvs_SeniorNotes4.75DueDecember2022Member_142d8a08-cbda-49de-aba4-06776d4816b3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2e5feee9-ba47-4578-a0a7-3552d8d9b6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f0863845-f121-4605-9af4-77089a26cf26" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2e5feee9-ba47-4578-a0a7-3552d8d9b6f3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2e5feee9-ba47-4578-a0a7-3552d8d9b6f3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2e5feee9-ba47-4578-a0a7-3552d8d9b6f3" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2e5feee9-ba47-4578-a0a7-3552d8d9b6f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_beb6b0ed-f75e-49bd-b389-ac8a65ea7af1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2e5feee9-ba47-4578-a0a7-3552d8d9b6f3" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_beb6b0ed-f75e-49bd-b389-ac8a65ea7af1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_f4000f6f-27ca-4206-9b8c-23611af930c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_beb6b0ed-f75e-49bd-b389-ac8a65ea7af1" xlink:to="loc_us-gaap_SubsequentEventMember_f4000f6f-27ca-4206-9b8c-23611af930c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_21c5564b-503d-451a-b6f8-0573694746ad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f0863845-f121-4605-9af4-77089a26cf26" xlink:to="loc_srt_StatementScenarioAxis_21c5564b-503d-451a-b6f8-0573694746ad" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_21c5564b-503d-451a-b6f8-0573694746ad_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_21c5564b-503d-451a-b6f8-0573694746ad" xlink:to="loc_srt_ScenarioUnspecifiedDomain_21c5564b-503d-451a-b6f8-0573694746ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_9562228a-e9c4-47aa-996d-66b56c0d156d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_21c5564b-503d-451a-b6f8-0573694746ad" xlink:to="loc_srt_ScenarioUnspecifiedDomain_9562228a-e9c4-47aa-996d-66b56c0d156d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_176e2ead-2dbc-4a3e-87e4-5d66327d6674" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_9562228a-e9c4-47aa-996d-66b56c0d156d" xlink:to="loc_srt_ScenarioForecastMember_176e2ead-2dbc-4a3e-87e4-5d66327d6674" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#ShareholdersEquityShareRepurchasesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails" xlink:type="extended" id="i15b4d31593fc4a51a3c5f028162e85df_ShareholdersEquityShareRepurchasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_90ed0f4b-feb4-4451-b1e5-4e1ed4271d62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_92c957a8-e124-4b00-bab6-cfb2eadcfb9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_90ed0f4b-feb4-4451-b1e5-4e1ed4271d62" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_92c957a8-e124-4b00-bab6-cfb2eadcfb9c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_1eade4c0-3e8b-4135-98c9-b1261ae433e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_90ed0f4b-feb4-4451-b1e5-4e1ed4271d62" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_1eade4c0-3e8b-4135-98c9-b1261ae433e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_2efca1ef-22fc-4d7e-b0a9-d478d56639c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_90ed0f4b-feb4-4451-b1e5-4e1ed4271d62" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_2efca1ef-22fc-4d7e-b0a9-d478d56639c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_ce814488-b61a-4470-a923-776c889f8f76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_90ed0f4b-feb4-4451-b1e5-4e1ed4271d62" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_ce814488-b61a-4470-a923-776c889f8f76" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_cb8f6886-fbf7-4ca9-b901-38948b34b351" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_90ed0f4b-feb4-4451-b1e5-4e1ed4271d62" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_cb8f6886-fbf7-4ca9-b901-38948b34b351" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_5f83bbf2-3486-4e10-a9e5-f1ef682e97eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_cb8f6886-fbf7-4ca9-b901-38948b34b351" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_5f83bbf2-3486-4e10-a9e5-f1ef682e97eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_5f83bbf2-3486-4e10-a9e5-f1ef682e97eb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_5f83bbf2-3486-4e10-a9e5-f1ef682e97eb" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_5f83bbf2-3486-4e10-a9e5-f1ef682e97eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_67ff3d5b-e437-4e40-888a-8003081b7914" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_5f83bbf2-3486-4e10-a9e5-f1ef682e97eb" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_67ff3d5b-e437-4e40-888a-8003081b7914" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2021RepurchaseProgramMember_2072b1e2-1725-4075-bf09-e6e22a45076e" xlink:href="cvs-20220630.xsd#cvs_A2021RepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_67ff3d5b-e437-4e40-888a-8003081b7914" xlink:to="loc_cvs_A2021RepurchaseProgramMember_2072b1e2-1725-4075-bf09-e6e22a45076e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#ShareholdersEquityAcceleratedShareRepurchasesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails" xlink:type="extended" id="i6370c0e498d54c41877fa0cfa2b146c5_ShareholdersEquityAcceleratedShareRepurchasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e0d2e52f-b914-44bb-b832-511d0f885293" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesAgreementAmount_0c810142-77eb-4e14-bd43-9a2e176c9061" xlink:href="cvs-20220630.xsd#cvs_AcceleratedShareRepurchasesAgreementAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e0d2e52f-b914-44bb-b832-511d0f885293" xlink:to="loc_cvs_AcceleratedShareRepurchasesAgreementAmount_0c810142-77eb-4e14-bd43-9a2e176c9061" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsForAcceleratedShareRepurchasesAmount_b8ecfd12-b204-4ea2-8083-50a1d7342812" xlink:href="cvs-20220630.xsd#cvs_PaymentsForAcceleratedShareRepurchasesAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e0d2e52f-b914-44bb-b832-511d0f885293" xlink:to="loc_cvs_PaymentsForAcceleratedShareRepurchasesAmount_b8ecfd12-b204-4ea2-8083-50a1d7342812" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares_332da8ca-eb51-47b6-be89-e6b7f38338fc" xlink:href="cvs-20220630.xsd#cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e0d2e52f-b914-44bb-b832-511d0f885293" xlink:to="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares_332da8ca-eb51-47b6-be89-e6b7f38338fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased_393c5e8e-1ce7-46e3-a144-f1016763cd79" xlink:href="cvs-20220630.xsd#cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e0d2e52f-b914-44bb-b832-511d0f885293" xlink:to="loc_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased_393c5e8e-1ce7-46e3-a144-f1016763cd79" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_d2e8baf9-b05f-43fc-8a6b-9aebee144a29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e0d2e52f-b914-44bb-b832-511d0f885293" xlink:to="loc_us-gaap_SharePrice_d2e8baf9-b05f-43fc-8a6b-9aebee144a29" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TransferOfSharesToTreasuryStockValue_faf66ae4-394c-4c9c-850b-405659cc38f2" xlink:href="cvs-20220630.xsd#cvs_TransferOfSharesToTreasuryStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e0d2e52f-b914-44bb-b832-511d0f885293" xlink:to="loc_cvs_TransferOfSharesToTreasuryStockValue_faf66ae4-394c-4c9c-850b-405659cc38f2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_c61c8752-8eb4-4232-a112-9cb1ce337d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e0d2e52f-b914-44bb-b832-511d0f885293" xlink:to="loc_us-gaap_DerivativeNotionalAmount_c61c8752-8eb4-4232-a112-9cb1ce337d3a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram_4071f885-6879-49ef-a05e-d2434182ae4b" xlink:href="cvs-20220630.xsd#cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e0d2e52f-b914-44bb-b832-511d0f885293" xlink:to="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram_4071f885-6879-49ef-a05e-d2434182ae4b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_171cc32a-915c-427f-854c-b6a7d1aedf61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e0d2e52f-b914-44bb-b832-511d0f885293" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_171cc32a-915c-427f-854c-b6a7d1aedf61" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_62a86d4e-0f4b-4b61-9e02-31ae5a91e792" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_171cc32a-915c-427f-854c-b6a7d1aedf61" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_62a86d4e-0f4b-4b61-9e02-31ae5a91e792" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_62a86d4e-0f4b-4b61-9e02-31ae5a91e792_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_62a86d4e-0f4b-4b61-9e02-31ae5a91e792" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_62a86d4e-0f4b-4b61-9e02-31ae5a91e792_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_e47e1f00-4e4b-4607-a06a-59510ee39a47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_62a86d4e-0f4b-4b61-9e02-31ae5a91e792" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_e47e1f00-4e4b-4607-a06a-59510ee39a47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2021AcceleratedRepurchaseProgramMember_a053dbc2-634d-4c20-bfe5-f3d5d5d41be6" xlink:href="cvs-20220630.xsd#cvs_A2021AcceleratedRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_e47e1f00-4e4b-4607-a06a-59510ee39a47" xlink:to="loc_cvs_A2021AcceleratedRepurchaseProgramMember_a053dbc2-634d-4c20-bfe5-f3d5d5d41be6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_bdf4ebe1-bf71-42e3-bd8f-e8c591ccbdaf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_171cc32a-915c-427f-854c-b6a7d1aedf61" xlink:to="loc_srt_CounterpartyNameAxis_bdf4ebe1-bf71-42e3-bd8f-e8c591ccbdaf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bdf4ebe1-bf71-42e3-bd8f-e8c591ccbdaf_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_bdf4ebe1-bf71-42e3-bd8f-e8c591ccbdaf" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bdf4ebe1-bf71-42e3-bd8f-e8c591ccbdaf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5e08c44e-7219-4592-897c-719159275976" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_bdf4ebe1-bf71-42e3-bd8f-e8c591ccbdaf" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5e08c44e-7219-4592-897c-719159275976" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BarclaysBankMember_ab663ca8-a98e-4874-9a58-0cef419bbb18" xlink:href="cvs-20220630.xsd#cvs_BarclaysBankMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5e08c44e-7219-4592-897c-719159275976" xlink:to="loc_cvs_BarclaysBankMember_ab663ca8-a98e-4874-9a58-0cef419bbb18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_d25ee5f9-56d0-40a2-b549-d4291ff00aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_171cc32a-915c-427f-854c-b6a7d1aedf61" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_d25ee5f9-56d0-40a2-b549-d4291ff00aa2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d25ee5f9-56d0-40a2-b549-d4291ff00aa2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d25ee5f9-56d0-40a2-b549-d4291ff00aa2" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d25ee5f9-56d0-40a2-b549-d4291ff00aa2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a67ca9aa-0fa9-44b8-b590-3fab01c7d3c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d25ee5f9-56d0-40a2-b549-d4291ff00aa2" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a67ca9aa-0fa9-44b8-b590-3fab01c7d3c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_2e42b8f0-e934-4b7f-b52a-5b6e9b603f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a67ca9aa-0fa9-44b8-b590-3fab01c7d3c8" xlink:to="loc_us-gaap_ForwardContractsMember_2e42b8f0-e934-4b7f-b52a-5b6e9b603f3b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#OtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="extended" id="i889a52e8c4864162a70d70b632f773b1_OtherComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_7d9a9c35-7776-498c-93fe-67a2f0064799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_bd356bd4-6fad-4e26-81bf-11c291d23c50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_7d9a9c35-7776-498c-93fe-67a2f0064799" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_bd356bd4-6fad-4e26-81bf-11c291d23c50" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_51098d01-637e-4cb3-bbf0-c715cb852de1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_bd356bd4-6fad-4e26-81bf-11c291d23c50" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_51098d01-637e-4cb3-bbf0-c715cb852de1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1b5a30a7-514e-4e2f-a6ed-5a8dbf62ed46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_bd356bd4-6fad-4e26-81bf-11c291d23c50" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1b5a30a7-514e-4e2f-a6ed-5a8dbf62ed46" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_20be8523-ca9b-4d20-a306-e082e5800f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_bd356bd4-6fad-4e26-81bf-11c291d23c50" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_20be8523-ca9b-4d20-a306-e082e5800f8e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e85bc6b3-85fd-4711-8911-26b64d0c00b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_bd356bd4-6fad-4e26-81bf-11c291d23c50" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e85bc6b3-85fd-4711-8911-26b64d0c00b2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4abddaa9-103c-4cc0-b7ab-3c0327511f46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_f62545ff-684b-4629-ad78-f07ec3178ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_7d9a9c35-7776-498c-93fe-67a2f0064799" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_f62545ff-684b-4629-ad78-f07ec3178ddd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_c58a2abe-bba9-4bb8-a8dc-c9ea4236aa36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_7d9a9c35-7776-498c-93fe-67a2f0064799" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_c58a2abe-bba9-4bb8-a8dc-c9ea4236aa36" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_75a1d3eb-1752-45fe-b5c0-66253234b8ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_7d9a9c35-7776-498c-93fe-67a2f0064799" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_75a1d3eb-1752-45fe-b5c0-66253234b8ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_006c1a35-d288-4bb7-b149-7406af407940" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_7d9a9c35-7776-498c-93fe-67a2f0064799" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_006c1a35-d288-4bb7-b149-7406af407940" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3920b785-87f6-43bf-ab8c-86b154ef971c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_006c1a35-d288-4bb7-b149-7406af407940" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3920b785-87f6-43bf-ab8c-86b154ef971c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3920b785-87f6-43bf-ab8c-86b154ef971c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3920b785-87f6-43bf-ab8c-86b154ef971c" xlink:to="loc_us-gaap_EquityComponentDomain_3920b785-87f6-43bf-ab8c-86b154ef971c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0a0c93fe-6bdd-47d7-81f7-2d1152990558" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3920b785-87f6-43bf-ab8c-86b154ef971c" xlink:to="loc_us-gaap_EquityComponentDomain_0a0c93fe-6bdd-47d7-81f7-2d1152990558" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_c4d0e31c-6aa2-4272-8ec1-9d699e5bfae9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0a0c93fe-6bdd-47d7-81f7-2d1152990558" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_c4d0e31c-6aa2-4272-8ec1-9d699e5bfae9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_28760662-bd57-48e3-a699-f6766663e0fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0a0c93fe-6bdd-47d7-81f7-2d1152990558" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_28760662-bd57-48e3-a699-f6766663e0fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_3d228144-10a7-47fb-9784-54efd36d461c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0a0c93fe-6bdd-47d7-81f7-2d1152990558" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_3d228144-10a7-47fb-9784-54efd36d461c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_b5f8d5b3-1b24-46f8-8f0b-5e3872e59974" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0a0c93fe-6bdd-47d7-81f7-2d1152990558" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_b5f8d5b3-1b24-46f8-8f0b-5e3872e59974" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_8db2a122-5193-465f-aafe-e597eb38dd86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0a0c93fe-6bdd-47d7-81f7-2d1152990558" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_8db2a122-5193-465f-aafe-e597eb38dd86" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#EarningsPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="extended" id="ie5d5149e97e84520905978ac83825bb8_EarningsPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b0900f95-6a20-4b15-a5f3-ff0eaba6bfc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_12951df1-ebf5-4ede-8a71-55405ad8e10a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b0900f95-6a20-4b15-a5f3-ff0eaba6bfc2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_12951df1-ebf5-4ede-8a71-55405ad8e10a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_767b92dc-fc77-4f3b-bf2b-60efd710c390" xlink:href="cvs-20220630.xsd#cvs_NumeratorForEarningsPerShareCalculationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b0900f95-6a20-4b15-a5f3-ff0eaba6bfc2" xlink:to="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_767b92dc-fc77-4f3b-bf2b-60efd710c390" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_a31725b4-c8bd-4413-a55e-550c99ae3c56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_767b92dc-fc77-4f3b-bf2b-60efd710c390" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_a31725b4-c8bd-4413-a55e-550c99ae3c56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_86ba4103-59ff-432a-b46e-abc68a7d6ffe" xlink:href="cvs-20220630.xsd#cvs_DenominatorForEarningsPerShareCalculationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b0900f95-6a20-4b15-a5f3-ff0eaba6bfc2" xlink:to="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_86ba4103-59ff-432a-b46e-abc68a7d6ffe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c3e8aea8-86e5-4e47-a339-09bebb268ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_86ba4103-59ff-432a-b46e-abc68a7d6ffe" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c3e8aea8-86e5-4e47-a339-09bebb268ddd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_9df875a2-0e40-4a74-8d0b-b24ea90e9cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_86ba4103-59ff-432a-b46e-abc68a7d6ffe" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_9df875a2-0e40-4a74-8d0b-b24ea90e9cf8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fe508048-25d0-40c0-a536-8e19a7da0b91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_86ba4103-59ff-432a-b46e-abc68a7d6ffe" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fe508048-25d0-40c0-a536-8e19a7da0b91" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_f54a5bc1-618c-4ca1-bbdc-724a1351de53" xlink:href="cvs-20220630.xsd#cvs_EarningsPerShareBasicAndDilutedEPSAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b0900f95-6a20-4b15-a5f3-ff0eaba6bfc2" xlink:to="loc_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_f54a5bc1-618c-4ca1-bbdc-724a1351de53" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_53183adb-0af7-4649-ae9a-1eb4cd66c53c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_f54a5bc1-618c-4ca1-bbdc-724a1351de53" xlink:to="loc_us-gaap_EarningsPerShareBasic_53183adb-0af7-4649-ae9a-1eb4cd66c53c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_b83538db-24e7-4904-acd8-5a5f9d718264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_f54a5bc1-618c-4ca1-bbdc-724a1351de53" xlink:to="loc_us-gaap_EarningsPerShareDiluted_b83538db-24e7-4904-acd8-5a5f9d718264" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_7ebb51d7-fc5e-47d6-8e4f-8661740325fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b0900f95-6a20-4b15-a5f3-ff0eaba6bfc2" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_7ebb51d7-fc5e-47d6-8e4f-8661740325fa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5c5f976c-87f0-41f7-9bf2-f1ac0af9ddde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_7ebb51d7-fc5e-47d6-8e4f-8661740325fa" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5c5f976c-87f0-41f7-9bf2-f1ac0af9ddde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5c5f976c-87f0-41f7-9bf2-f1ac0af9ddde_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5c5f976c-87f0-41f7-9bf2-f1ac0af9ddde" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5c5f976c-87f0-41f7-9bf2-f1ac0af9ddde_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a861e0c2-9d0d-4028-9609-7da821269288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5c5f976c-87f0-41f7-9bf2-f1ac0af9ddde" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a861e0c2-9d0d-4028-9609-7da821269288" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember_a0151c27-af1b-43eb-8b3c-399a2ac274d4" xlink:href="cvs-20220630.xsd#cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a861e0c2-9d0d-4028-9609-7da821269288" xlink:to="loc_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember_a0151c27-af1b-43eb-8b3c-399a2ac274d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StockOptionsAndStockAppreciationRightsMember_a4d2405b-1dd3-4f18-aa28-aa6f93e85508" xlink:href="cvs-20220630.xsd#cvs_StockOptionsAndStockAppreciationRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a861e0c2-9d0d-4028-9609-7da821269288" xlink:to="loc_cvs_StockOptionsAndStockAppreciationRightsMember_a4d2405b-1dd3-4f18-aa28-aa6f93e85508" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="ic304594bb11a4fa89c8f43cbf0813385_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_afd0e2a9-5dd6-44fa-9b7b-e353ce4cd167" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_31ce6694-0612-4633-b948-35ade41e2262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_afd0e2a9-5dd6-44fa-9b7b-e353ce4cd167" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_31ce6694-0612-4633-b948-35ade41e2262" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LegalSettlementPeriodOfPayment_dc9ea7c8-4fcb-4a70-8ede-3c405be4a01c" xlink:href="cvs-20220630.xsd#cvs_LegalSettlementPeriodOfPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_afd0e2a9-5dd6-44fa-9b7b-e353ce4cd167" xlink:to="loc_cvs_LegalSettlementPeriodOfPayment_dc9ea7c8-4fcb-4a70-8ede-3c405be4a01c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_e7ae0c45-f76c-4c64-bbdf-821c7cb0dd86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_afd0e2a9-5dd6-44fa-9b7b-e353ce4cd167" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_e7ae0c45-f76c-4c64-bbdf-821c7cb0dd86" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_e1ba46c9-f678-4cec-89a7-268d9577a7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_afd0e2a9-5dd6-44fa-9b7b-e353ce4cd167" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_e1ba46c9-f678-4cec-89a7-268d9577a7e6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_73877f38-bf34-4313-94e1-24e1644418c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_afd0e2a9-5dd6-44fa-9b7b-e353ce4cd167" xlink:to="loc_us-gaap_LossContingenciesTable_73877f38-bf34-4313-94e1-24e1644418c6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_7fcd2194-d05c-4004-8d60-0fec3cc0bd04" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_73877f38-bf34-4313-94e1-24e1644418c6" xlink:to="loc_srt_LitigationCaseAxis_7fcd2194-d05c-4004-8d60-0fec3cc0bd04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_7fcd2194-d05c-4004-8d60-0fec3cc0bd04_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_7fcd2194-d05c-4004-8d60-0fec3cc0bd04" xlink:to="loc_srt_LitigationCaseTypeDomain_7fcd2194-d05c-4004-8d60-0fec3cc0bd04_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_3bbd758d-1108-4697-bdcd-6c3cbd3f1232" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_7fcd2194-d05c-4004-8d60-0fec3cc0bd04" xlink:to="loc_srt_LitigationCaseTypeDomain_3bbd758d-1108-4697-bdcd-6c3cbd3f1232" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StateOfFloridaSettlementMember_cf059e8e-1d67-4055-adf8-0fbcba648348" xlink:href="cvs-20220630.xsd#cvs_StateOfFloridaSettlementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_3bbd758d-1108-4697-bdcd-6c3cbd3f1232" xlink:to="loc_cvs_StateOfFloridaSettlementMember_cf059e8e-1d67-4055-adf8-0fbcba648348" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember_7195c0df-843a-4304-bfe3-d4f2dadf9887" xlink:href="cvs-20220630.xsd#cvs_RadcliffeAndFlaimVAetnaIncEtAlMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_3bbd758d-1108-4697-bdcd-6c3cbd3f1232" xlink:to="loc_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember_7195c0df-843a-4304-bfe3-d4f2dadf9887" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_ae61710a-7be8-4017-afdf-5b65709f0ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_73877f38-bf34-4313-94e1-24e1644418c6" xlink:to="loc_us-gaap_LitigationStatusAxis_ae61710a-7be8-4017-afdf-5b65709f0ab8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_ae61710a-7be8-4017-afdf-5b65709f0ab8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_ae61710a-7be8-4017-afdf-5b65709f0ab8" xlink:to="loc_us-gaap_LitigationStatusDomain_ae61710a-7be8-4017-afdf-5b65709f0ab8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_4ab2688d-7048-4b65-8904-54a88fd2e8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_ae61710a-7be8-4017-afdf-5b65709f0ab8" xlink:to="loc_us-gaap_LitigationStatusDomain_4ab2688d-7048-4b65-8904-54a88fd2e8f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_301279af-75e1-4d39-9eb2-3557de51447f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_4ab2688d-7048-4b65-8904-54a88fd2e8f8" xlink:to="loc_us-gaap_PendingLitigationMember_301279af-75e1-4d39-9eb2-3557de51447f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="extended" id="i5391efc568024efd8b78a6986286a282_SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_9205ad78-3652-481e-a4f6-cce1f79be373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_2a74df8f-94fb-4948-87b1-8ec277a99bbd" xlink:href="cvs-20220630.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9205ad78-3652-481e-a4f6-cce1f79be373" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_2a74df8f-94fb-4948-87b1-8ec277a99bbd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b600dc4f-7d27-4866-a50b-aa103b302eba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9205ad78-3652-481e-a4f6-cce1f79be373" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b600dc4f-7d27-4866-a50b-aa103b302eba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_797bd2f3-4c2a-438f-b4ba-41a896648ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9205ad78-3652-481e-a4f6-cce1f79be373" xlink:to="loc_us-gaap_NetInvestmentIncome_797bd2f3-4c2a-438f-b4ba-41a896648ac9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_f2153414-7eeb-4c8a-b8fc-1ad9d7253f25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9205ad78-3652-481e-a4f6-cce1f79be373" xlink:to="loc_us-gaap_Revenues_f2153414-7eeb-4c8a-b8fc-1ad9d7253f25" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_10766622-6121-40cd-a2bf-2f48316edb98" xlink:href="cvs-20220630.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9205ad78-3652-481e-a4f6-cce1f79be373" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_10766622-6121-40cd-a2bf-2f48316edb98" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NetRevenuesRetailCoPayments_6a7003a7-1acd-486d-ab04-c8e7d9c00a31" xlink:href="cvs-20220630.xsd#cvs_NetRevenuesRetailCoPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9205ad78-3652-481e-a4f6-cce1f79be373" xlink:to="loc_cvs_NetRevenuesRetailCoPayments_6a7003a7-1acd-486d-ab04-c8e7d9c00a31" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_21549598-c795-4721-8ccf-23f9503653d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9205ad78-3652-481e-a4f6-cce1f79be373" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_21549598-c795-4721-8ccf-23f9503653d6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_1fa46c75-7eeb-4456-8546-ecb41e89fd91" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_21549598-c795-4721-8ccf-23f9503653d6" xlink:to="loc_srt_ConsolidationItemsAxis_1fa46c75-7eeb-4456-8546-ecb41e89fd91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_1fa46c75-7eeb-4456-8546-ecb41e89fd91_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_1fa46c75-7eeb-4456-8546-ecb41e89fd91" xlink:to="loc_srt_ConsolidationItemsDomain_1fa46c75-7eeb-4456-8546-ecb41e89fd91_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_9761433e-7f1f-45d6-b2b5-ae39ae2e8c96" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_1fa46c75-7eeb-4456-8546-ecb41e89fd91" xlink:to="loc_srt_ConsolidationItemsDomain_9761433e-7f1f-45d6-b2b5-ae39ae2e8c96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_f4889bc0-b61e-49bf-ad6d-cab9a1ba1e71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_9761433e-7f1f-45d6-b2b5-ae39ae2e8c96" xlink:to="loc_us-gaap_OperatingSegmentsMember_f4889bc0-b61e-49bf-ad6d-cab9a1ba1e71" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_844fc082-21d5-4af7-985f-d45fa9572138" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_9761433e-7f1f-45d6-b2b5-ae39ae2e8c96" xlink:to="loc_us-gaap_IntersegmentEliminationMember_844fc082-21d5-4af7-985f-d45fa9572138" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_c11f483e-3ec2-453c-84f3-5d9bb02f2b30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_9761433e-7f1f-45d6-b2b5-ae39ae2e8c96" xlink:to="loc_us-gaap_CorporateNonSegmentMember_c11f483e-3ec2-453c-84f3-5d9bb02f2b30" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_806ce060-2e0c-4913-aae2-5d4e5e2d2ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_21549598-c795-4721-8ccf-23f9503653d6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_806ce060-2e0c-4913-aae2-5d4e5e2d2ad2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_806ce060-2e0c-4913-aae2-5d4e5e2d2ad2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_806ce060-2e0c-4913-aae2-5d4e5e2d2ad2" xlink:to="loc_us-gaap_SegmentDomain_806ce060-2e0c-4913-aae2-5d4e5e2d2ad2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_187623f2-196d-4219-95f2-9aa5b1cd60d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_806ce060-2e0c-4913-aae2-5d4e5e2d2ad2" xlink:to="loc_us-gaap_SegmentDomain_187623f2-196d-4219-95f2-9aa5b1cd60d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_b88847f6-7a5a-4007-9000-a4c5206f2eb8" xlink:href="cvs-20220630.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_187623f2-196d-4219-95f2-9aa5b1cd60d0" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_b88847f6-7a5a-4007-9000-a4c5206f2eb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_fab3cc49-787e-4a6c-bb9e-e5d92ca959d7" xlink:href="cvs-20220630.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_187623f2-196d-4219-95f2-9aa5b1cd60d0" xlink:to="loc_cvs_PharmacyServicesSegmentMember_fab3cc49-787e-4a6c-bb9e-e5d92ca959d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_08798d33-478c-4e16-918c-bee1ce1afc87" xlink:href="cvs-20220630.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_187623f2-196d-4219-95f2-9aa5b1cd60d0" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_08798d33-478c-4e16-918c-bee1ce1afc87" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails" xlink:type="extended" id="i207a4abf0775471fac66d81ac1496a3d_SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_0cea689e-5e30-4495-95ab-92e96d371a47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ee027389-2de9-4daa-8d9b-c2c38ffacba9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_0cea689e-5e30-4495-95ab-92e96d371a47" xlink:to="loc_us-gaap_OperatingIncomeLoss_ee027389-2de9-4daa-8d9b-c2c38ffacba9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9ddce8e1-9a1b-4975-9975-7a7b678b8b05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_0cea689e-5e30-4495-95ab-92e96d371a47" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9ddce8e1-9a1b-4975-9975-7a7b678b8b05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_536c4677-7996-43ba-aca4-977f816c736d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_0cea689e-5e30-4495-95ab-92e96d371a47" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_536c4677-7996-43ba-aca4-977f816c736d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_c615accd-93db-4cb9-99b7-606462224497" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_0cea689e-5e30-4495-95ab-92e96d371a47" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_c615accd-93db-4cb9-99b7-606462224497" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_3f859a50-4cdd-4df9-ae84-815d2b5608a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_0cea689e-5e30-4495-95ab-92e96d371a47" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_3f859a50-4cdd-4df9-ae84-815d2b5608a4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_a782cfcc-577f-4141-a69f-4e231d17be4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_0cea689e-5e30-4495-95ab-92e96d371a47" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_a782cfcc-577f-4141-a69f-4e231d17be4c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_119a7cd5-0790-4551-af60-eb98156e9f65" xlink:href="cvs-20220630.xsd#cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_0cea689e-5e30-4495-95ab-92e96d371a47" xlink:to="loc_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_119a7cd5-0790-4551-af60-eb98156e9f65" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_769f840f-a3bc-456a-b747-97e6190142b1" xlink:href="cvs-20220630.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_0cea689e-5e30-4495-95ab-92e96d371a47" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_769f840f-a3bc-456a-b747-97e6190142b1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_a2f18176-f958-4a02-bbd9-9d79f3f05dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_0cea689e-5e30-4495-95ab-92e96d371a47" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_a2f18176-f958-4a02-bbd9-9d79f3f05dbd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LegalSettlementPeriodOfPayment_d1eb861d-2a0a-40d6-9a01-294bcaaa336a" xlink:href="cvs-20220630.xsd#cvs_LegalSettlementPeriodOfPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_0cea689e-5e30-4495-95ab-92e96d371a47" xlink:to="loc_cvs_LegalSettlementPeriodOfPayment_d1eb861d-2a0a-40d6-9a01-294bcaaa336a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_b7cc08e3-1052-466d-bd80-d9b77771266a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_0cea689e-5e30-4495-95ab-92e96d371a47" xlink:to="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_b7cc08e3-1052-466d-bd80-d9b77771266a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_a706665e-30a3-4985-b06d-5c6efc063553" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_b7cc08e3-1052-466d-bd80-d9b77771266a" xlink:to="loc_srt_LitigationCaseAxis_a706665e-30a3-4985-b06d-5c6efc063553" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_a706665e-30a3-4985-b06d-5c6efc063553_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_a706665e-30a3-4985-b06d-5c6efc063553" xlink:to="loc_srt_LitigationCaseTypeDomain_a706665e-30a3-4985-b06d-5c6efc063553_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_28d6e28e-550c-4e31-8833-b5e248ae8fc8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_a706665e-30a3-4985-b06d-5c6efc063553" xlink:to="loc_srt_LitigationCaseTypeDomain_28d6e28e-550c-4e31-8833-b5e248ae8fc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StateOfFloridaSettlementMember_99246058-0198-4266-9b79-61230bf41653" xlink:href="cvs-20220630.xsd#cvs_StateOfFloridaSettlementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_28d6e28e-550c-4e31-8833-b5e248ae8fc8" xlink:to="loc_cvs_StateOfFloridaSettlementMember_99246058-0198-4266-9b79-61230bf41653" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_2dfb0208-82e0-4e21-8c30-40828ed0a86b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_b7cc08e3-1052-466d-bd80-d9b77771266a" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_2dfb0208-82e0-4e21-8c30-40828ed0a86b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_2dfb0208-82e0-4e21-8c30-40828ed0a86b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_2dfb0208-82e0-4e21-8c30-40828ed0a86b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_2dfb0208-82e0-4e21-8c30-40828ed0a86b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_838a7938-fbc1-4f12-9421-0049ced4d87f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_2dfb0208-82e0-4e21-8c30-40828ed0a86b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_838a7938-fbc1-4f12-9421-0049ced4d87f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_acfcf87b-f513-44c2-92d8-ef9f64b4f927" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_838a7938-fbc1-4f12-9421-0049ced4d87f" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_acfcf87b-f513-44c2-92d8-ef9f64b4f927" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b9686a54-0e0b-47e6-a3d3-47cf3f9bcc62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_b7cc08e3-1052-466d-bd80-d9b77771266a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b9686a54-0e0b-47e6-a3d3-47cf3f9bcc62" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b9686a54-0e0b-47e6-a3d3-47cf3f9bcc62_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b9686a54-0e0b-47e6-a3d3-47cf3f9bcc62" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b9686a54-0e0b-47e6-a3d3-47cf3f9bcc62_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e1984530-d9f2-48a1-a169-71a810610551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b9686a54-0e0b-47e6-a3d3-47cf3f9bcc62" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e1984530-d9f2-48a1-a169-71a810610551" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PayflexMember_b7be983a-e4cb-433c-903d-8f8e544498af" xlink:href="cvs-20220630.xsd#cvs_PayflexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e1984530-d9f2-48a1-a169-71a810610551" xlink:to="loc_cvs_PayflexMember_b7be983a-e4cb-433c-903d-8f8e544498af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_72fda4ef-d7bc-4c50-98a0-d6440e7e6044" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_b7cc08e3-1052-466d-bd80-d9b77771266a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_72fda4ef-d7bc-4c50-98a0-d6440e7e6044" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_72fda4ef-d7bc-4c50-98a0-d6440e7e6044_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_72fda4ef-d7bc-4c50-98a0-d6440e7e6044" xlink:to="loc_us-gaap_SegmentDomain_72fda4ef-d7bc-4c50-98a0-d6440e7e6044_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b6dbda47-d6da-4555-86d3-636641d7ec6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_72fda4ef-d7bc-4c50-98a0-d6440e7e6044" xlink:to="loc_us-gaap_SegmentDomain_b6dbda47-d6da-4555-86d3-636641d7ec6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_61a99c56-c385-420e-8869-c7d9ba17e4a2" xlink:href="cvs-20220630.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b6dbda47-d6da-4555-86d3-636641d7ec6e" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_61a99c56-c385-420e-8869-c7d9ba17e4a2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>cvs-20220630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:0140da76-e33c-4901-8b3b-5aa42426ab0a,g:ea97fc95-8028-4e4e-8a3a-2f9f67911aac-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_2c9b35c8-7deb-4153-b3a3-4010992c5854_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c98fbcd3-e1d4-4e7f-b8f9-341d4c3bae86_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0f293bd9-3845-49a4-920a-8ee95b8f2d05_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherAssetBackedSecuritiesMember_00a61e69-744a-46da-bf09-2fa98f082d49_terseLabel_en-US" xlink:label="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other asset-backed securities</link:label>
    <link:label id="lab_cvs_OtherAssetBackedSecuritiesMember_label_en-US" xlink:label="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Asset-Backed Securities [Member]</link:label>
    <link:label id="lab_cvs_OtherAssetBackedSecuritiesMember_documentation_en-US" xlink:label="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities collateralized by a variety of assets such as automobile loans, credit card receivables, home equity loans, etc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember" xlink:href="cvs-20220630.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherAssetBackedSecuritiesMember" xlink:to="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_1c2ea8e1-989e-4357-a4d5-f59da63bef32_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_7201b1b6-27e6-477c-9ead-dfdf91d83db7_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_83db29e0-e765-4adc-a2be-5da661bfb4b7_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_b178472c-3b71-4314-b284-b38c84637c1b_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of claims</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_59dc89c4-8e7a-49ae-989f-c55d678055f6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_7fd71120-35ab-40d7-9ed3-53445755cb21_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_5b6e32e4-7bb8-4f59-95ac-ac67712a8974_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_36cee0a8-4133-4b78-b9a6-662780825494_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized investment gains (losses)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_f8c446ce-3099-42b6-910a-2def3caea46a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_7e6a40a6-45ee-471c-bc8a-07f4d246dc2a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_3f866b81-7c5a-4b29-b60e-a688fabe5a4d_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_1a4ce15a-d891-485c-884b-963e85891b09_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_19c1a6c5-2b72-448f-8fd6-5e682f66516c_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses from transactions with related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_6c00590d-aee2-4063-a391-dcdc51e92ea9_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_93f3da30-310e-492c-9ef3-eda2159e3934_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_2cab4a04-56ef-4a32-94d7-1f9bbfb41a80_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.05DueMarch2048Member_864b23f8-c42f-49e1-bcd9-b8e20b1e6eb7_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.05DueMarch2048Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.05% senior notes due March 2048</link:label>
    <link:label id="lab_cvs_SeniorNotes5.05DueMarch2048Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.05DueMarch2048Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.05%, Due March 2048 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.05DueMarch2048Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.05DueMarch2048Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.05%, Due March 2048 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.05DueMarch2048Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes5.05DueMarch2048Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.05DueMarch2048Member" xlink:to="lab_cvs_SeniorNotes5.05DueMarch2048Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_9283ddab-727c-4c2e-97c9-a79ad0d9fafd_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, beginning of the period</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_b7cf1896-eb39-4c5a-9199-750a0c5c1310_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, end of the period</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.5DueJuly2022Member_f94eacb8-0811-42c0-a4b6-6b956146e7d7_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueJuly2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.5% senior notes due July 2022</link:label>
    <link:label id="lab_cvs_SeniorNotes3.5DueJuly2022Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueJuly2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.5%, Due July 2022 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.5DueJuly2022Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueJuly2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.5%, Due July 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueJuly2022Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes3.5DueJuly2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.5DueJuly2022Member" xlink:to="lab_cvs_SeniorNotes3.5DueJuly2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_691ef7b6-df50-4b90-957f-47646e4c60d4_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_07c168b0-14b7-459e-b0f9-7fc0dc40a2ce_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a02ec383-2e44-41cd-8fb3-298b6da69986_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Category7Member_b6fa2ae0-dc1e-407b-a121-400ea77e3e5b_terseLabel_en-US" xlink:label="lab_cvs_Category7Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7</link:label>
    <link:label id="lab_cvs_Category7Member_label_en-US" xlink:label="lab_cvs_Category7Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 7 [Member]</link:label>
    <link:label id="lab_cvs_Category7Member_documentation_en-US" xlink:label="lab_cvs_Category7Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loan credit quality indicator - Category 7</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category7Member" xlink:href="cvs-20220630.xsd#cvs_Category7Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Category7Member" xlink:to="lab_cvs_Category7Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_7bc2b2d9-2434-47be-b28b-a4dfe38c94be_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ThailandBusinessMember_3e1654da-2573-4de7-9ad1-f5f66e95a86a_terseLabel_en-US" xlink:label="lab_cvs_ThailandBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thailand Business</link:label>
    <link:label id="lab_cvs_ThailandBusinessMember_label_en-US" xlink:label="lab_cvs_ThailandBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thailand Business [Member]</link:label>
    <link:label id="lab_cvs_ThailandBusinessMember_documentation_en-US" xlink:label="lab_cvs_ThailandBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thailand Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ThailandBusinessMember" xlink:href="cvs-20220630.xsd#cvs_ThailandBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ThailandBusinessMember" xlink:to="lab_cvs_ThailandBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e01b5623-cbd2-4591-af4d-9d0280af706a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option activity, stock awards and other (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_63e043da-914d-4f90-bdcb-67504b4e125b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_f7cbb8fb-c5b0-43a0-8bf3-6704abd6c0f3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales and maturities of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_c3a442f3-6056-4c98-82ba-9c12f0146c27_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Table]</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_afe0aefb-9aa0-45f5-bed9-0f7e9c63026b_terseLabel_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP issuances, net of purchase of treasury shares (in shares)</link:label>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_label_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Issuance, Net of Treasury Stock, Shares, Acquired, Cost Method</link:label>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_documentation_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Issuance, Net of Treasury Stock, Shares, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:href="cvs-20220630.xsd#cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:to="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_5f31e7b7-6200-4d8b-bf72-201baf6b2a11_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to CVS Health</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3f37020d-ae4c-418a-b5a1-b40dcbcb33b6_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a79b61b2-0e37-4409-b5ec-7636d08bb2a0_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of EPS (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_16a18c6d-bf8e-43b3-ab46-b92b7afb8e4a_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_96cd30ed-86f2-4593-914c-47ec17c6a2dd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesMember" xlink:to="lab_us-gaap_DebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_94fae80e-add5-4936-be3e-3080961c7dee_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RetailLongTermCareSegmentMember_b5164068-f8fa-473f-bb62-62c18e751e86_terseLabel_en-US" xlink:label="lab_cvs_RetailLongTermCareSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail/ LTC</link:label>
    <link:label id="lab_cvs_RetailLongTermCareSegmentMember_label_en-US" xlink:label="lab_cvs_RetailLongTermCareSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Long-Term Care Segment [Member]</link:label>
    <link:label id="lab_cvs_RetailLongTermCareSegmentMember_documentation_en-US" xlink:label="lab_cvs_RetailLongTermCareSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Long-Term Care Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember" xlink:href="cvs-20220630.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RetailLongTermCareSegmentMember" xlink:to="lab_cvs_RetailLongTermCareSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_4342a7a0-c5d6-4a95-b5b2-712ed8223e11_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_78b748fc-d4a8-4e2f-a051-460ba191b1bf_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states in which entity operates</link:label>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of States in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentIncome_c384c558-7376-48cb-adb0-5f90e667e816_verboseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income</link:label>
    <link:label id="lab_us-gaap_NetInvestmentIncome_7b7b1c27-df0f-4fb4-b3b9-232d0229a2ea_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income (loss)</link:label>
    <link:label id="lab_us-gaap_NetInvestmentIncome_label_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentIncome" xlink:to="lab_us-gaap_NetInvestmentIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_bf5bb6da-08db-447b-9448-c458f5d0815f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_1600846e-ba3b-4f46-bac0-0b502d367a93_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_be200886-c2d8-46cb-8b9d-71799dd20b7b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_bd305849-22a4-4423-8650-0a3208067fcf_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract_0ccd80b3-3d6b-4b81-bbc8-2f8065d8ec9c_terseLabel_en-US" xlink:label="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator for earnings per share calculation:</link:label>
    <link:label id="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract_label_en-US" xlink:label="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:label id="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract_documentation_en-US" xlink:label="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:href="cvs-20220630.xsd#cvs_NumeratorForEarningsPerShareCalculationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:to="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f33ea10c-0dc8-4da0-8312-cc8f1fb7b9ad_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_950020fc-78d1-41e8-bf0c-e2ab6c15d25c_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares_e44c7ecf-ba26-4f12-b373-30bd921be5cb_terseLabel_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR percent of notional amount received in shares</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares_label_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Percent of Notional Amount Received in Shares</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares_documentation_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Percent of Notional Amount Received in Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" xlink:href="cvs-20220630.xsd#cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" xlink:to="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.75DueDecember2022Member_17105f5f-f8a6-4037-85be-b03e90154f94_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% senior notes due December 2022</link:label>
    <link:label id="lab_cvs_SeniorNotes4.75DueDecember2022Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.75%, Due December 2022 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.75DueDecember2022Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.75%, Due December 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueDecember2022Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.75DueDecember2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.75DueDecember2022Member" xlink:to="lab_cvs_SeniorNotes4.75DueDecember2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterestAndDividend_72d6bb0d-367d-4b58-b7dc-43aed262aa15_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross investment income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterestAndDividend_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest and Dividend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterestAndDividend" xlink:to="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract_07fcd701-fba1-496b-abac-c9d0e7ed0be5_terseLabel_en-US" xlink:label="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator for earnings per share calculation:</link:label>
    <link:label id="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract_label_en-US" xlink:label="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:label id="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract_documentation_en-US" xlink:label="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:href="cvs-20220630.xsd#cvs_DenominatorForEarningsPerShareCalculationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:to="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes6.125DueSeptember2039Member_f72d6372-442e-44f5-80de-4a2a16535427_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.125% senior notes due September 2039</link:label>
    <link:label id="lab_cvs_SeniorNotes6.125DueSeptember2039Member_label_en-US" xlink:label="lab_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.125%, Due September 2039 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes6.125DueSeptember2039Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.125%, Due September 2039 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes6.125DueSeptember2039Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:to="lab_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.625DueApril2027Member_84d549d1-46cc-4e2f-bcf8-3801ed87ffcf_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.625DueApril2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.625% senior notes due April 2027</link:label>
    <link:label id="lab_cvs_SeniorNotes3.625DueApril2027Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.625DueApril2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.625%, Due April 2027 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.625DueApril2027Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.625DueApril2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.625%, Due April 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.625DueApril2027Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes3.625DueApril2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.625DueApril2027Member" xlink:to="lab_cvs_SeniorNotes3.625DueApril2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_acc76161-b225-4f76-b51b-4b91e1a2f072_terseLabel_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">States, municipalities and political subdivisions</link:label>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_label_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US States and Political Subdivisions Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:to="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_119a44d3-ac99-4c67-94b4-099f3c8e714c_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountsLiability_62db78ac-c98b-4103-90e2-aec1b48c963f_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountsLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate accounts liabilities</link:label>
    <link:label id="lab_us-gaap_SeparateAccountsLiability_label_en-US" xlink:label="lab_us-gaap_SeparateAccountsLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountsLiability" xlink:to="lab_us-gaap_SeparateAccountsLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b4af30c2-60eb-4caf-8d8f-ef7a719a217d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_fef2db31-3d70-48c9-8bdf-35276ffb46c5_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_dcd5a67e-a92a-4c7a-a000-19c57d789ffa_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_6c5e8a20-ac46-4c4d-8549-55610684d1d8_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt and lease obligation</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation, Including Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherReceivablesMember_ebbec3e9-48ed-4c8d-8407-7b344928d5ac_terseLabel_en-US" xlink:label="lab_cvs_OtherReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables</link:label>
    <link:label id="lab_cvs_OtherReceivablesMember_label_en-US" xlink:label="lab_cvs_OtherReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables [Member]</link:label>
    <link:label id="lab_cvs_OtherReceivablesMember_documentation_en-US" xlink:label="lab_cvs_OtherReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherReceivablesMember" xlink:href="cvs-20220630.xsd#cvs_OtherReceivablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherReceivablesMember" xlink:to="lab_cvs_OtherReceivablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_d6418d79-d7bf-42a0-88b3-1496aa2cd812_terseLabel_en-US" xlink:label="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment contracts liabilities without a fixed maturity</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_label_en-US" xlink:label="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts Without A Fixed Maturity, Fair Value Disclosure</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_documentation_en-US" xlink:label="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts Without A Fixed Maturity, Fair Value Disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:href="cvs-20220630.xsd#cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:to="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_6f8c173a-5286-467a-8f89-bb7de4ad2734_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_2d52177b-7a44-4a52-8e1b-a93a78b65d1f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesAgreementAmount_ee7cba52-5b7d-4e39-b872-ba707049884e_terseLabel_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesAgreementAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR agreement, amount</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesAgreementAmount_label_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesAgreementAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases Agreement, Amount</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesAgreementAmount_documentation_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesAgreementAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases Agreement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesAgreementAmount" xlink:href="cvs-20220630.xsd#cvs_AcceleratedShareRepurchasesAgreementAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AcceleratedShareRepurchasesAgreementAmount" xlink:to="lab_cvs_AcceleratedShareRepurchasesAgreementAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_2bf20a19-7b31-4389-98aa-63ac09c6f441_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember_4db64b5a-b24b-41ce-aeb3-dde854243c77_terseLabel_en-US" xlink:label="lab_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units and performance stock units</link:label>
    <link:label id="lab_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember_label_en-US" xlink:label="lab_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) [Member]</link:label>
    <link:label id="lab_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember_documentation_en-US" xlink:label="lab_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) and Performance Stock Units (PSUs)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember" xlink:href="cvs-20220630.xsd#cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember" xlink:to="lab_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_e2a35e87-a237-483c-95d5-5bbb45819ca9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_14dc708d-0c36-4d43-aa78-34e84edc73a6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_1faa65fe-ca04-4e88-89eb-b0db94107e61_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers out of Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_f3b4078f-26a4-400c-a880-d7e6ec402173_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_StockOptionsAndStockAppreciationRightsMember_66e7106c-bae9-4aaa-89db-7988da75990a_terseLabel_en-US" xlink:label="lab_cvs_StockOptionsAndStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and stock appreciation rights</link:label>
    <link:label id="lab_cvs_StockOptionsAndStockAppreciationRightsMember_label_en-US" xlink:label="lab_cvs_StockOptionsAndStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options and Stock Appreciation Rights [Member]</link:label>
    <link:label id="lab_cvs_StockOptionsAndStockAppreciationRightsMember_documentation_en-US" xlink:label="lab_cvs_StockOptionsAndStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options and Stock Appreciation Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StockOptionsAndStockAppreciationRightsMember" xlink:href="cvs-20220630.xsd#cvs_StockOptionsAndStockAppreciationRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_StockOptionsAndStockAppreciationRightsMember" xlink:to="lab_cvs_StockOptionsAndStockAppreciationRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_759c0f3f-e90a-4e53-915c-82d8aa6adbd5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_b878b04d-2aa5-49d9-8510-c9cceef23dc3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:to="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_57cc109c-7cb9-4c96-a3ef-f40ebbaf9ef8_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_10ff97dd-73a2-48d3-860f-42e077ee1524_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.01: 3,200 shares authorized; 1,755 shares issued and 1,312 shares outstanding at June&#160;30, 2022 and 1,744 shares issued and 1,322 shares outstanding at December&#160;31, 2021 and capital surplus</link:label>
    <link:label id="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stocks, Including Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:to="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e7bf67d1-187d-4be8-bdf7-ec2893d46615_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_3cd8fef2-5f0f-4dcd-b59e-1fde7680bd7f_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure_510f1f3e-561c-41f3-80e6-24db1f916eee_terseLabel_en-US" xlink:label="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans</link:label>
    <link:label id="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgages Held-for-sale, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgagesHeldForSaleFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:to="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_f7eb0d17-04d3-443d-893e-eed5ac2d1f55_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_cbfe1d9c-e58a-41e9-9ee6-ebb38787306a_terseLabel_en-US" xlink:label="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit-related impairment loss</link:label>
    <link:label id="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_label_en-US" xlink:label="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</link:label>
    <link:label id="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_documentation_en-US" xlink:label="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:href="cvs-20220630.xsd#cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:to="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_25b24800-a176-4697-9ef9-40a3da9e0e7d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Securities Available For Sale</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_443add1c-bc8d-4038-ad8f-8c9fc7051c6e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from divestiture of subsidiary</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Category2To4Member_c3339f13-a0fd-403d-83fe-e26df23b9037_terseLabel_en-US" xlink:label="lab_cvs_Category2To4Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2 to 4</link:label>
    <link:label id="lab_cvs_Category2To4Member_label_en-US" xlink:label="lab_cvs_Category2To4Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 2 to 4 [Member]</link:label>
    <link:label id="lab_cvs_Category2To4Member_documentation_en-US" xlink:label="lab_cvs_Category2To4Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan Credit Quality Indicator - Category 2 to 4 [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category2To4Member" xlink:href="cvs-20220630.xsd#cvs_Category2To4Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Category2To4Member" xlink:to="lab_cvs_Category2To4Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.3DueDecember2043Member_cec9b007-809b-4a7b-86f0-349d7b37fb4b_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.3DueDecember2043Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.3% senior notes due December 2043</link:label>
    <link:label id="lab_cvs_SeniorNotes5.3DueDecember2043Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.3DueDecember2043Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.3%, Due December 2043 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.3DueDecember2043Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.3DueDecember2043Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.3%, Due December 2043 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.3DueDecember2043Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes5.3DueDecember2043Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.3DueDecember2043Member" xlink:to="lab_cvs_SeniorNotes5.3DueDecember2043Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.25DueAugust2029Member_bb117ade-61a4-4646-9493-be5f434aac64_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.25DueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.25% senior notes due August 2029</link:label>
    <link:label id="lab_cvs_SeniorNotes3.25DueAugust2029Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.25DueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.25%, Due August 2029 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.25DueAugust2029Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.25DueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.25%, Due August 2029 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.25DueAugust2029Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes3.25DueAugust2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.25DueAugust2029Member" xlink:to="lab_cvs_SeniorNotes3.25DueAugust2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToSuppliersAndEmployees_5e9d852f-5af2-4093-b79b-3ef0e4905dd2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToSuppliersAndEmployees" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid to other suppliers and employees</link:label>
    <link:label id="lab_us-gaap_PaymentsToSuppliersAndEmployees_label_en-US" xlink:label="lab_us-gaap_PaymentsToSuppliersAndEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Suppliers and Employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToSuppliersAndEmployees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToSuppliersAndEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToSuppliersAndEmployees" xlink:to="lab_us-gaap_PaymentsToSuppliersAndEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_50068ccc-a34b-4769-89e5-aeb8f524507f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_2091214b-056c-4092-aa1c-09d4484a4f0a_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount expected to be reclassified</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5DueDecember2024Member_6f5b7727-35a4-4032-abac-1799053cd757_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5DueDecember2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5% senior notes due December 2024</link:label>
    <link:label id="lab_cvs_SeniorNotes5DueDecember2024Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5DueDecember2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5%, Due December 2024 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5DueDecember2024Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5DueDecember2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5%, Due December 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5DueDecember2024Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes5DueDecember2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5DueDecember2024Member" xlink:to="lab_cvs_SeniorNotes5DueDecember2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_70cee896-f00d-4c6b-98cf-d461273e9e70_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy network</link:label>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Through Intermediary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:to="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_12840f27-b55f-452d-8d1f-227806b32a57_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_A2021RepurchaseProgramMember_c51b4823-8195-405f-89ca-3f7d6aecc84b_terseLabel_en-US" xlink:label="lab_cvs_A2021RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Repurchase Program</link:label>
    <link:label id="lab_cvs_A2021RepurchaseProgramMember_label_en-US" xlink:label="lab_cvs_A2021RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Repurchase Program [Member]</link:label>
    <link:label id="lab_cvs_A2021RepurchaseProgramMember_documentation_en-US" xlink:label="lab_cvs_A2021RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2021RepurchaseProgramMember" xlink:href="cvs-20220630.xsd#cvs_A2021RepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_A2021RepurchaseProgramMember" xlink:to="lab_cvs_A2021RepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_f6195dd8-90de-4259-ad58-de3249af8d18_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2d6d8901-1549-41c4-822d-55c808c53067_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_f17da8cb-c707-4ce1-81b4-a3ed7e1b8ca0_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_47991935-00b1-40f0-9bdc-76c8d450c5f9_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate, Year Of Origination [Domain]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate, Year Of Origination [Domain]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Mortgage Loans On Real Estate, Year Of Origination [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:href="cvs-20220630.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:to="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_0e1a6d16-2fa8-4825-8388-fff626784cec_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_db182208-5f46-49b1-af5b-06796c5fe13b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_1f8ff06e-09a4-49be-a3c8-e47d80aa8eae_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_label_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:to="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_7f9a5f9a-8101-4623-b3c7-d3fe7938323d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Balances</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_4df26b93-d925-46c5-aad6-c0b34aa371c5_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_10830b87-6f53-474f-a68c-9036d6f421c0_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward_757da5d2-bc57-4a1a-993c-dcecbae6a0ce_terseLabel_en-US" xlink:label="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward_label_en-US" xlink:label="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward_documentation_en-US" xlink:label="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward" xlink:href="cvs-20220630.xsd#cvs_ChangeinContractwithCustomerLiabilityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward" xlink:to="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsDomain_a96c4895-ef63-4974-8fc4-64f02e246404_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Domain]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsDomain_label_en-US" xlink:label="lab_cvs_TotalInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain" xlink:href="cvs-20220630.xsd#cvs_TotalInvestmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsDomain" xlink:to="lab_cvs_TotalInvestmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_03bbcb37-2aaf-4e9a-bcd7-196c9c7aedf0_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date, fair value</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:to="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPriorToPeriodFiveMember_7bd9f74a-c00e-4bd8-8d1b-7ce9d4dfc7fc_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior</link:label>
    <link:label id="lab_cvs_YearOfOriginationPriorToPeriodFiveMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Prior To Period Five [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPriorToPeriodFiveMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Prior To Period Five [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:href="cvs-20220630.xsd#cvs_YearOfOriginationPriorToPeriodFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:to="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_5511869b-0524-4f55-aced-03ca0152b2fe_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Categories5and6Member_f15dfd29-f099-4d4b-815c-ec0acdd7fda7_terseLabel_en-US" xlink:label="lab_cvs_Categories5and6Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5 and 6</link:label>
    <link:label id="lab_cvs_Categories5and6Member_label_en-US" xlink:label="lab_cvs_Categories5and6Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Categories 5 and 6 [Member]</link:label>
    <link:label id="lab_cvs_Categories5and6Member_documentation_en-US" xlink:label="lab_cvs_Categories5and6Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loan credit quality indicator - Categories 5 and 6</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Categories5and6Member" xlink:href="cvs-20220630.xsd#cvs_Categories5and6Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Categories5and6Member" xlink:to="lab_cvs_Categories5and6Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_eb49f9bc-9660-4fbd-8eeb-e789be93393c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_7b5044c2-fd18-4e7a-95c6-36983c4db7af_negatedTerseLabel_en-US" xlink:label="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury shares, net of ESPP issuances (in shares)</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_label_en-US" xlink:label="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_documentation_en-US" xlink:label="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:href="cvs-20220630.xsd#cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:to="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashDivestedFromDeconsolidation_d3fd506b-974c-4540-bd00-d95c5813a1b1_terseLabel_en-US" xlink:label="lab_us-gaap_CashDivestedFromDeconsolidation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and restricted cash sold</link:label>
    <link:label id="lab_us-gaap_CashDivestedFromDeconsolidation_label_en-US" xlink:label="lab_us-gaap_CashDivestedFromDeconsolidation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Divested from Deconsolidation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDivestedFromDeconsolidation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashDivestedFromDeconsolidation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashDivestedFromDeconsolidation" xlink:to="lab_us-gaap_CashDivestedFromDeconsolidation" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_c85d47ad-20cc-46ac-b055-d4c2c2b34d00_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_b34d0d22-d5e9-4355-aa24-402c5487424e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flow hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_1120c521-3f49-49f5-b0dd-c9bdff85f097_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAbstract_60617e25-0c98-43cc-8381-a45f8446c522_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeTextBlock_d917950e-907f-42c6-bf14-7155637a13d3_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Investment Income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeTextBlock" xlink:to="lab_us-gaap_InvestmentIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_824ccae9-035b-489b-916c-7d8f686f23d5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investment Income, Reported Amounts, by Category [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Income [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:to="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3DueAugust2026Member_1d19ee0e-86a6-4b11-8e89-76ec9c47eb1d_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3DueAugust2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3% senior notes due August 2026</link:label>
    <link:label id="lab_cvs_SeniorNotes3DueAugust2026Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3DueAugust2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3%, Due August 2026 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3DueAugust2026Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3DueAugust2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3%, Due August 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3DueAugust2026Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes3DueAugust2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3DueAugust2026Member" xlink:to="lab_cvs_SeniorNotes3DueAugust2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.875DueJuly2035Member_5ce4c1ff-ba50-48a9-8278-64c8f48fa85c_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.875DueJuly2035Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.875% senior notes due July 2035</link:label>
    <link:label id="lab_cvs_SeniorNotes4.875DueJuly2035Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.875DueJuly2035Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.875%, Due July 2035 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.875DueJuly2035Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.875DueJuly2035Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.875%, Due July 2035 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.875DueJuly2035Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.875DueJuly2035Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.875DueJuly2035Member" xlink:to="lab_cvs_SeniorNotes4.875DueJuly2035Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_c165ac40-bd6f-49a9-8449-aadeec6ca045_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_4bb28e75-f351-4bd1-a974-4e74b2b44829_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_4d438cb9-0ef0-46dc-96e5-49842e37a272_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_509b3a49-a4ac-44b5-89b4-617073012038_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_5d50b8f0-3fa7-48d8-bd30-e1cf46841430_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of receivables and contract liabilities from contracts with customers</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_3e2bdea4-612e-4932-a6a2-28127bd16599_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes6.25DueJune2027Member_9462462b-e9b3-4d96-a88a-1b38fe9eae2b_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes6.25DueJune2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.25% senior notes due June 2027</link:label>
    <link:label id="lab_cvs_SeniorNotes6.25DueJune2027Member_label_en-US" xlink:label="lab_cvs_SeniorNotes6.25DueJune2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.25%, Due June 2027 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes6.25DueJune2027Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes6.25DueJune2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.25%, Due June 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.25DueJune2027Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes6.25DueJune2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes6.25DueJune2027Member" xlink:to="lab_cvs_SeniorNotes6.25DueJune2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInvestmentsMember_8803cd9a-10d2-4dec-8809-b225cc8e3cdb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investments</link:label>
    <link:label id="lab_us-gaap_OtherInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_OtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInvestmentsMember" xlink:to="lab_us-gaap_OtherInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.75DueApril2030Member_dc47094c-9016-4262-b862-33f68c629106_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.75DueApril2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.75% senior notes due April 2030</link:label>
    <link:label id="lab_cvs_SeniorNotes3.75DueApril2030Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.75DueApril2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.75%, Due April 2030 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.75DueApril2030Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.75DueApril2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.75%, Due April 2030 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.75DueApril2030Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes3.75DueApril2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.75DueApril2030Member" xlink:to="lab_cvs_SeniorNotes3.75DueApril2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_GuarantorObligationsNumberofLeases_4ccd2c03-f4b4-445c-b723-0830b6a41a44_terseLabel_en-US" xlink:label="lab_cvs_GuarantorObligationsNumberofLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor obligations, number of leases</link:label>
    <link:label id="lab_cvs_GuarantorObligationsNumberofLeases_label_en-US" xlink:label="lab_cvs_GuarantorObligationsNumberofLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Number of Leases</link:label>
    <link:label id="lab_cvs_GuarantorObligationsNumberofLeases_documentation_en-US" xlink:label="lab_cvs_GuarantorObligationsNumberofLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Number of Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_GuarantorObligationsNumberofLeases" xlink:href="cvs-20220630.xsd#cvs_GuarantorObligationsNumberofLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_GuarantorObligationsNumberofLeases" xlink:to="lab_cvs_GuarantorObligationsNumberofLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_436f0ef4-ede1-4648-b139-639a862740c2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountAssets_2f4f920d-519c-4531-95a2-4e1d49389196_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate accounts assets</link:label>
    <link:label id="lab_us-gaap_SeparateAccountAssets_label_en-US" xlink:label="lab_us-gaap_SeparateAccountAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountAssets" xlink:to="lab_us-gaap_SeparateAccountAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_06e7f934-484e-45d4-ac85-ac7e3e099da5_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Credit Quality Indicator [Axis]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Credit Quality Indicator [Axis]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Credit Quality Indicator [Axis].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" xlink:href="cvs-20220630.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" xlink:to="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_c1030d23-e14e-4178-bd99-b921c479c93e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_1a9a4418-8e5e-449a-bfb8-6893697cea13_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_f87e3ae3-5c37-42db-bce4-9f046652fe2b_totalLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total claims paid</link:label>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:to="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PharmacyRevenueMember_c0d83e34-32a7-4bfb-ac5f-b7e88ec5bbff_terseLabel_en-US" xlink:label="lab_cvs_PharmacyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy</link:label>
    <link:label id="lab_cvs_PharmacyRevenueMember_label_en-US" xlink:label="lab_cvs_PharmacyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Revenue [Member]</link:label>
    <link:label id="lab_cvs_PharmacyRevenueMember_documentation_en-US" xlink:label="lab_cvs_PharmacyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRevenueMember" xlink:href="cvs-20220630.xsd#cvs_PharmacyRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PharmacyRevenueMember" xlink:to="lab_cvs_PharmacyRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.125DueApril2040Member_d345dc09-d569-4412-8b56-0c087c9d2895_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueApril2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.125% senior notes due April 2040</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueApril2040Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueApril2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due April 2040 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueApril2040Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueApril2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due April 2040 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueApril2040Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.125DueApril2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.125DueApril2040Member" xlink:to="lab_cvs_SeniorNotes4.125DueApril2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_cc0a3372-59e5-4505-8cac-4243d36882bd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_eb9c504f-d2f5-4b9b-bcd3-c44bd2dcbdcc_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share attributable to CVS Health:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_0e7cb21a-5fdd-4a8b-aed3-b6273bff0d2f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt premiums</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e17af4e4-6d6e-46bc-9856-54e5b2d7a988_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_e83ab50e-3b09-4ba2-bdec-ffb37b240e6f_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_49682d68-739a-408b-8e68-879b94ad2390_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PharmacyServicesSegmentMember_36d901b1-8e0a-43c7-b0eb-2441051a36ae_terseLabel_en-US" xlink:label="lab_cvs_PharmacyServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Services</link:label>
    <link:label id="lab_cvs_PharmacyServicesSegmentMember_label_en-US" xlink:label="lab_cvs_PharmacyServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Services Segment [Member]</link:label>
    <link:label id="lab_cvs_PharmacyServicesSegmentMember_documentation_en-US" xlink:label="lab_cvs_PharmacyServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Services Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember" xlink:href="cvs-20220630.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PharmacyServicesSegmentMember" xlink:to="lab_cvs_PharmacyServicesSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_2a2c01ef-aeb4-470f-951c-5ae039d77b2c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FrontStoreRevenueMember_f065c57d-7199-43d0-9487-2abb324a5336_terseLabel_en-US" xlink:label="lab_cvs_FrontStoreRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Store</link:label>
    <link:label id="lab_cvs_FrontStoreRevenueMember_label_en-US" xlink:label="lab_cvs_FrontStoreRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Store Revenue [Member]</link:label>
    <link:label id="lab_cvs_FrontStoreRevenueMember_documentation_en-US" xlink:label="lab_cvs_FrontStoreRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Store Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FrontStoreRevenueMember" xlink:href="cvs-20220630.xsd#cvs_FrontStoreRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FrontStoreRevenueMember" xlink:to="lab_cvs_FrontStoreRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_d6576997-3fe4-4652-bada-df78d24bf8ac_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermInvestments_a9e56e2f-7985-42ea-af85-02a797445fb3_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_65154d57-2f3d-42d2-906a-090eb56da55b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_label_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermInvestments" xlink:to="lab_us-gaap_LongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_b8b32079-cde4-429d-9292-c653647a9727_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes27DueAugust2040Member_1337a4be-ddeb-4454-b86e-ce896fa32f8d_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes27DueAugust2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.7% senior notes due August 2040</link:label>
    <link:label id="lab_cvs_SeniorNotes27DueAugust2040Member_label_en-US" xlink:label="lab_cvs_SeniorNotes27DueAugust2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.7%, Due August 2040 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes27DueAugust2040Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes27DueAugust2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.7%, Due August 2040</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes27DueAugust2040Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes27DueAugust2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes27DueAugust2040Member" xlink:to="lab_cvs_SeniorNotes27DueAugust2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_3fa31f39-13ba-4f3c-90a2-256e47fa9d0d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of subsidiary</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_fb50a092-4d14-4f7e-9014-8612b3cc7e37_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on divestiture, pretax</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_888d2443-172a-40e9-9381-1232e23854a9_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of subsidiary</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_c8f855a3-0dc6-4d3b-9e9d-be8a1b0e6fb0_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_82bead91-dcac-4147-b087-d4c1169f8ef2_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_94dbefb9-8e03-4eee-9b13-68e93b534d3f_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_d288ee26-f7f9-4640-bfbe-169f456db7aa_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_7f5a7a50-64e3-4fce-bfa8-c746d76206df_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForwardContractsMember_7c474e20-26ce-4afd-8abf-e722c54dfd19_terseLabel_en-US" xlink:label="lab_us-gaap_ForwardContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward contract</link:label>
    <link:label id="lab_us-gaap_ForwardContractsMember_label_en-US" xlink:label="lab_us-gaap_ForwardContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForwardContractsMember" xlink:to="lab_us-gaap_ForwardContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_622b22c3-8034-471e-86d0-dc8cc2ad0087_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_89e193c3-3a29-4fcd-b9d8-d8389c61eb3b_periodStartLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Reinsurance recoverables</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_3757b93d-c99f-461e-b36c-91e5288ffc92_periodEndLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Reinsurance recoverables</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_label_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverable for Unpaid Claims and Claims Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:to="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SupportingExperienceRatedProductsMember_886c1d7d-e929-4472-a674-cae42aab2767_terseLabel_en-US" xlink:label="lab_cvs_SupportingExperienceRatedProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting experience-rated products</link:label>
    <link:label id="lab_cvs_SupportingExperienceRatedProductsMember_label_en-US" xlink:label="lab_cvs_SupportingExperienceRatedProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting Experience Rated Products [Member]</link:label>
    <link:label id="lab_cvs_SupportingExperienceRatedProductsMember_documentation_en-US" xlink:label="lab_cvs_SupportingExperienceRatedProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting discontinued and experience-rated products.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember" xlink:href="cvs-20220630.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SupportingExperienceRatedProductsMember" xlink:to="lab_cvs_SupportingExperienceRatedProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_a3e65632-7d77-4cd8-99b2-e3cf3cb752bd_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PaymentsforInsuranceBenefits_a1c6aff1-6ad1-4e6b-bf72-4b6fa3d90d9f_negatedTerseLabel_en-US" xlink:label="lab_cvs_PaymentsforInsuranceBenefits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance benefits paid</link:label>
    <link:label id="lab_cvs_PaymentsforInsuranceBenefits_label_en-US" xlink:label="lab_cvs_PaymentsforInsuranceBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Insurance Benefits</link:label>
    <link:label id="lab_cvs_PaymentsforInsuranceBenefits_documentation_en-US" xlink:label="lab_cvs_PaymentsforInsuranceBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Insurance Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInsuranceBenefits" xlink:href="cvs-20220630.xsd#cvs_PaymentsforInsuranceBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PaymentsforInsuranceBenefits" xlink:to="lab_cvs_PaymentsforInsuranceBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_fffffd90-878e-40d4-9ad9-ec5c8f64d67f_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember_b3191083-4f1a-4ee3-a827-697f854c5b63_terseLabel_en-US" xlink:label="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Residential mortgage-backed securities</link:label>
    <link:label id="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Residential Mortgage-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0d436f3d-9b26-41de-8230-961652bf1b6b_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_115f59d7-9240-4f80-9a78-59e0ac78f1e7_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_d1fc751e-beca-4ff3-9aa8-b4199b08ae6b_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_d526b3d9-5874-42ca-bbbf-22dd0fabd98e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_fffdc852-ea9b-4eb8-b6cf-c4a20111fddb_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_9936c20b-af7c-414d-b591-125a1ee9f6d6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_b7fd000b-1602-4df1-8e9a-ce6a1f207f4c_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCorporateDebtSecuritiesMember_04a31d84-24db-4255-aa5a-75064c0725b3_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign securities</link:label>
    <link:label id="lab_us-gaap_ForeignCorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security, Corporate, Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_771feb37-5935-4e69-a457-cc38b2fd65a6_negatedTerseLabel_en-US" xlink:label="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for inventory and prescriptions dispensed by retail network pharmacies</link:label>
    <link:label id="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_label_en-US" xlink:label="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Inventory and Prescriptions Dispensed by Retail Network Pharmacies</link:label>
    <link:label id="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_documentation_en-US" xlink:label="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Inventory and Prescriptions Dispensed by Retail Network Pharmacies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:href="cvs-20220630.xsd#cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:to="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_928e8a0e-64f5-45f4-965c-ab3204979c6a_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date, unrealized losses</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Amortized Cost</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:to="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_afd0010d-76d4-4bce-8a21-3ea0040cabb1_verboseLabel_en-US" xlink:label="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Proceeds and Related Gross Realized Capital Gains and Losses From the Sale of Debt Securities</link:label>
    <link:label id="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_label_en-US" xlink:label="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds And Related Gross Realized Capital Gains Losses From Sale Of Debt Securities [Table Text Block]</link:label>
    <link:label id="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_documentation_en-US" xlink:label="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item includes proceeds from the sale of debt securities and the related gross realized capital gains and losses, excluding amounts related to experience-rated and discontinued products.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:href="cvs-20220630.xsd#cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:to="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.875DueJune2026Member_57d46a13-7945-45c1-9726-61e932f3aab2_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.875DueJune2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% senior notes due June 2026</link:label>
    <link:label id="lab_cvs_SeniorNotes2.875DueJune2026Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.875DueJune2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.875%, Due June 2026 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.875DueJune2026Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.875DueJune2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.875%, Due June 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.875DueJune2026Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes2.875DueJune2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.875DueJune2026Member" xlink:to="lab_cvs_SeniorNotes2.875DueJune2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_f24c151e-5319-4b91-9003-93aaecccf2b1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialRealEstateMember_8c181518-577a-4374-a1c9-d4d284954775_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Real Estate</link:label>
    <link:label id="lab_us-gaap_CommercialRealEstateMember_label_en-US" xlink:label="lab_us-gaap_CommercialRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Real Estate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialRealEstateMember" xlink:to="lab_us-gaap_CommercialRealEstateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_4986089e-6a55-4672-a19e-a208729d9594_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_a361c877-2de4-4c79-9353-b7e8139c153e_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_0f24e350-c73a-4cb8-874a-a8f1651d0ab2_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incurred but not reported (IBNR) claims liability, net</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a7244fad-693f-4b39-8835-77cc703e09ea_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a0c197d5-9e22-409c-a758-ce1397d317cf_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_579cfb41-54b6-4b7b-bd8b-2e373e635b92_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_f2cb8693-0fd8-447e-b4ef-edd7d7ed58af_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_bc2556ad-a769-4cd4-8e05-be0d05279558_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_ad70ae4f-3cbb-4bb6-bfb7-a27ea02bfc86_terseLabel_en-US" xlink:label="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yield-related impairment loss</link:label>
    <link:label id="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_label_en-US" xlink:label="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yield-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</link:label>
    <link:label id="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_documentation_en-US" xlink:label="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yield-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:href="cvs-20220630.xsd#cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:to="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_859073b5-f202-491c-a667-ce25ec571157_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.3DueMarch2028Member_b1303844-c70f-41fa-9b80-ae34ec2101c9_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.3DueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.3% senior notes due March 2028</link:label>
    <link:label id="lab_cvs_SeniorNotes4.3DueMarch2028Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.3DueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.3%, Due March 2028 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.3DueMarch2028Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.3DueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.3%, Due March 2028 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.3DueMarch2028Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.3DueMarch2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.3DueMarch2028Member" xlink:to="lab_cvs_SeniorNotes4.3DueMarch2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_320fdb1e-b8f1-471b-9ebc-74055125f08d_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_8ae33a32-a93a-49a6-9193-1d157e04d568_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_f4ae1134-99d3-4ae9-a78e-d6745d07c03f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_a90053de-929a-4695-bd0e-dea5dd81e684_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_eb08094d-5e44-4b9e-9199-76337656a894_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3fa614f4-0af9-43db-8ead-6b7e801a0a27_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_fa39bd8d-b2b8-4b74-9900-adbf8859d799_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.875DueAugust2047Member_fb6b4b3e-b332-4107-91ca-f2ff431746d1_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueAugust2047Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.875% senior notes due August 2047</link:label>
    <link:label id="lab_cvs_SeniorNotes3.875DueAugust2047Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueAugust2047Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.875%, Due August 2047 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.875DueAugust2047Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueAugust2047Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.875%, Due August 2047 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueAugust2047Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes3.875DueAugust2047Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.875DueAugust2047Member" xlink:to="lab_cvs_SeniorNotes3.875DueAugust2047Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_9e3edc11-62a3-4b0e-98b4-6b95df9006e0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_0b79f015-71f5-48fe-be31-ee6c41c922db_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Accumulated Other Comprehensive Income (Loss) by Component</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_474e84f1-7371-4233-b613-e8c4a52f2b48_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_71bccb73-a91e-4f83-93fd-6ca4537efb6f_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_6df4ac34-498b-42d5-8400-3001ff719fda_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_b2aedf1c-7445-421a-b3db-9024ace386b3_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_a626bf3c-d8d6-4df7-b6ac-6412ddae8d61_terseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Costs Payable</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance and Deposit Contracts [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:to="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_df7b4453-3a4f-4d44-9370-3ccfc19074f3_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares outstanding, balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_f60e2671-4027-418a-bf94-9cd19d72fa10_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares outstanding, balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LongtermDebtGrossAndLeaseObligation_239084dd-8b26-4af9-b986-e4f9a23a2149_totalLabel_en-US" xlink:label="lab_cvs_LongtermDebtGrossAndLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt principal</link:label>
    <link:label id="lab_cvs_LongtermDebtGrossAndLeaseObligation_label_en-US" xlink:label="lab_cvs_LongtermDebtGrossAndLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross And Lease Obligation</link:label>
    <link:label id="lab_cvs_LongtermDebtGrossAndLeaseObligation_documentation_en-US" xlink:label="lab_cvs_LongtermDebtGrossAndLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross And Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongtermDebtGrossAndLeaseObligation" xlink:href="cvs-20220630.xsd#cvs_LongtermDebtGrossAndLeaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LongtermDebtGrossAndLeaseObligation" xlink:to="lab_cvs_LongtermDebtGrossAndLeaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_ff335eb8-87ef-416a-ba2b-637cad1c5779_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.125DueJuly2045Member_d0ed5c1a-a92d-492b-ba6b-f816fb7b9903_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.125DueJuly2045Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.125% senior notes due July 2045</link:label>
    <link:label id="lab_cvs_SeniorNotes5.125DueJuly2045Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.125DueJuly2045Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.125%, Due July 2045 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.125DueJuly2045Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.125DueJuly2045Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.125%, Due July 2045 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.125DueJuly2045Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes5.125DueJuly2045Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.125DueJuly2045Member" xlink:to="lab_cvs_SeniorNotes5.125DueJuly2045Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HealthCareBenefitsSegmentMember_a09a67ce-7c28-40cc-a4b5-2816e52c8f63_terseLabel_en-US" xlink:label="lab_cvs_HealthCareBenefitsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Benefits</link:label>
    <link:label id="lab_cvs_HealthCareBenefitsSegmentMember_label_en-US" xlink:label="lab_cvs_HealthCareBenefitsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Benefits Segment [Member]</link:label>
    <link:label id="lab_cvs_HealthCareBenefitsSegmentMember_documentation_en-US" xlink:label="lab_cvs_HealthCareBenefitsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Benefits Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember" xlink:href="cvs-20220630.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HealthCareBenefitsSegmentMember" xlink:to="lab_cvs_HealthCareBenefitsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_1646eee4-863b-411d-906a-6c9f2c3990ef_totalLabel_en-US" xlink:label="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income (excluding net realized capital gains or losses)</link:label>
    <link:label id="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_label_en-US" xlink:label="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Excluding Capital Gains or Losses</link:label>
    <link:label id="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_documentation_en-US" xlink:label="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Excluding Capital Gains or Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:href="cvs-20220630.xsd#cvs_InvestmentIncomeExcludingCapitalGainsorLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:to="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_724d894b-89f8-4097-a6f9-efaf7d57a9e7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investment Income, Reported Amounts, by Category [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:to="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_dcb3d291-4bc6-44ab-a4c9-62b8d2ef4331_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Deferredincometaxesandothernoncashitems_14b96856-9328-4a4b-9b7f-4158fec7d095_terseLabel_en-US" xlink:label="lab_cvs_Deferredincometaxesandothernoncashitems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes and other noncash items</link:label>
    <link:label id="lab_cvs_Deferredincometaxesandothernoncashitems_label_en-US" xlink:label="lab_cvs_Deferredincometaxesandothernoncashitems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes and other noncash items</link:label>
    <link:label id="lab_cvs_Deferredincometaxesandothernoncashitems_documentation_en-US" xlink:label="lab_cvs_Deferredincometaxesandothernoncashitems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of deferred income tax expense (benefit) and income tax credits and amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Deferredincometaxesandothernoncashitems" xlink:href="cvs-20220630.xsd#cvs_Deferredincometaxesandothernoncashitems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Deferredincometaxesandothernoncashitems" xlink:to="lab_cvs_Deferredincometaxesandothernoncashitems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_37324c8b-2bd7-4fc9-893b-feff1099d9c7_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_1cbb22ca-48dd-4af1-89f9-a5513f3306fc_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and pharmacy claims and discounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_9f5e0b54-fc99-45e8-b6a4-d4336308840a_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenues from transactions with related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Other Revenues from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberofPharmacyPlanMembers_31825c22-8328-4bb0-85bf-6472fe11fcfd_terseLabel_en-US" xlink:label="lab_cvs_NumberofPharmacyPlanMembers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of pharmacy plan members</link:label>
    <link:label id="lab_cvs_NumberofPharmacyPlanMembers_label_en-US" xlink:label="lab_cvs_NumberofPharmacyPlanMembers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Pharmacy Plan Members</link:label>
    <link:label id="lab_cvs_NumberofPharmacyPlanMembers_documentation_en-US" xlink:label="lab_cvs_NumberofPharmacyPlanMembers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Pharmacy Plan Members</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPharmacyPlanMembers" xlink:href="cvs-20220630.xsd#cvs_NumberofPharmacyPlanMembers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberofPharmacyPlanMembers" xlink:to="lab_cvs_NumberofPharmacyPlanMembers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_95471171-c695-4da4-9e64-50805e0e1683_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_7713168a-50ee-4b37-b4c2-e2c4ca6e9ddf_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_62bf3f09-b137-4b83-a6d3-c7e52865b567_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_78d0f0db-9a0e-4e77-9b78-5a48f9ac268f_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Other Significant Reconciling Item [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Other Significant Reconciling Item [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems" xlink:to="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_746d6fb5-ce82-4ac3-9f3a-9845a6c3b76f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities, Greater than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_f5735f9b-a6aa-4af0-b951-ac4ac75c6bce_totalLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNet" xlink:to="lab_us-gaap_InvestmentIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_ffc1eb56-a068-4f8b-a824-357afde2184e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes6.625DueJune2036Member_6afd5b1f-2d10-46d4-ad90-a75b020bc6f8_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes6.625DueJune2036Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.625% senior notes due June 2036</link:label>
    <link:label id="lab_cvs_SeniorNotes6.625DueJune2036Member_label_en-US" xlink:label="lab_cvs_SeniorNotes6.625DueJune2036Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.625%, Due June 2036 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes6.625DueJune2036Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes6.625DueJune2036Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.625%, Due June 2036 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.625DueJune2036Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes6.625DueJune2036Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes6.625DueJune2036Member" xlink:to="lab_cvs_SeniorNotes6.625DueJune2036Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CommonAndCollectiveTrustsMember_e17410d6-0295-45af-8a92-2db756a99b4b_terseLabel_en-US" xlink:label="lab_cvs_CommonAndCollectiveTrustsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common/collective trusts</link:label>
    <link:label id="lab_cvs_CommonAndCollectiveTrustsMember_label_en-US" xlink:label="lab_cvs_CommonAndCollectiveTrustsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common and Collective Trusts [Member]</link:label>
    <link:label id="lab_cvs_CommonAndCollectiveTrustsMember_documentation_en-US" xlink:label="lab_cvs_CommonAndCollectiveTrustsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The total amount of Common/Collective Trusts held by the company, primarily related to investment funds otherwise known as underlying funds.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CommonAndCollectiveTrustsMember" xlink:href="cvs-20220630.xsd#cvs_CommonAndCollectiveTrustsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CommonAndCollectiveTrustsMember" xlink:to="lab_cvs_CommonAndCollectiveTrustsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_b3ac7c1a-e059-4d4f-ace0-499ab4201f72_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Greater than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberOfMedicalMembers_6b7c0922-fa30-4591-8445-cad989d34c2e_terseLabel_en-US" xlink:label="lab_cvs_NumberOfMedicalMembers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of medical members</link:label>
    <link:label id="lab_cvs_NumberOfMedicalMembers_label_en-US" xlink:label="lab_cvs_NumberOfMedicalMembers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Medical Members</link:label>
    <link:label id="lab_cvs_NumberOfMedicalMembers_documentation_en-US" xlink:label="lab_cvs_NumberOfMedicalMembers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Medical Members</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfMedicalMembers" xlink:href="cvs-20220630.xsd#cvs_NumberOfMedicalMembers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberOfMedicalMembers" xlink:to="lab_cvs_NumberOfMedicalMembers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_9e18868e-af94-4d2a-b6ea-9f158c75d942_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_a4045234-4891-4db1-bdf5-b6f8bc87943e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_cf952c53-a4f5-4a1f-8707-dd7f4d6a5a5b_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_9c23d0f0-8c29-4407-b9d8-664bae348f32_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_c48f48fb-ac38-4f94-acbf-f3b87e5926fd_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockSharesHeldinTrust_cb261334-a02a-449c-bed2-a3cc5c8ac800_terseLabel_en-US" xlink:label="lab_cvs_TreasuryStockSharesHeldinTrust" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares held in trust (in shares)</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesHeldinTrust_label_en-US" xlink:label="lab_cvs_TreasuryStockSharesHeldinTrust" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Held in Trust</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesHeldinTrust_documentation_en-US" xlink:label="lab_cvs_TreasuryStockSharesHeldinTrust" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Held in Trust</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesHeldinTrust" xlink:href="cvs-20220630.xsd#cvs_TreasuryStockSharesHeldinTrust"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockSharesHeldinTrust" xlink:to="lab_cvs_TreasuryStockSharesHeldinTrust" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_f79f082b-9132-4f90-8196-da56d10ce8ed_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified, pre-tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_933981c9-9bb0-4de6-b91c-be19fcadee0f_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_7001a53d-668c-4dc3-932b-24e6a7916c0d_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate/ Other</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_e5c6298b-0943-4d5e-bc24-99ba5c08c1f9_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_6a42be46-c127-4682-9051-c9a7422f9c9c_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total CVS Health shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_9dccea7e-4fca-43d0-bdc1-102436547872_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStock_b66a31ea-db81-4585-b571-a97867670cbb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock dividends</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStock" xlink:to="lab_us-gaap_DividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_167ceed3-aa63-43eb-97fa-1085c0edca3c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_7f58a1ab-7294-4d06-b011-d714011f18e6_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialMortgageBackedSecuritiesMember_a79f97a9-84ff-40b7-a3b4-fe88a0d779aa_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial mortgage-backed securities</link:label>
    <link:label id="lab_us-gaap_CommercialMortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Mortgage-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_1a793e2d-f171-40bc-8324-ebc7db393b13_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_c23d4182-8871-455e-a270-096e2e25cf1c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_6df3fcdd-0892-4d1c-b563-56a5f0046985_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_21b7f993-9095-4013-af2a-d1e28b9f1578_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_d060c678-dbb3-4882-903f-3f5fce8fa9a4_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_8326d401-0efa-48e3-bff5-c82fdf58f246_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CorporateOtherMember_f1d45087-617f-44f9-9dc5-9e003725d400_terseLabel_en-US" xlink:label="lab_cvs_CorporateOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate / Other</link:label>
    <link:label id="lab_cvs_CorporateOtherMember_label_en-US" xlink:label="lab_cvs_CorporateOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate / Other [Member]</link:label>
    <link:label id="lab_cvs_CorporateOtherMember_documentation_en-US" xlink:label="lab_cvs_CorporateOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate / Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CorporateOtherMember" xlink:href="cvs-20220630.xsd#cvs_CorporateOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CorporateOtherMember" xlink:to="lab_cvs_CorporateOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_2a6d8e5e-08bd-470a-803d-ddf39c12b68b_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_4339cdb4-790d-43ce-add4-fb59fbf0ff4d_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal settlement</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_28b94268-8315-4d22-b1c0-c26bee95ff17_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_60402fad-2720-4cd8-ab0a-5e6cc1b58b5f_terseLabel_en-US" xlink:label="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_8cd2ce93-43a2-4eaa-8529-b39c4dbf7fe2_verboseLabel_en-US" xlink:label="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from external customers</link:label>
    <link:label id="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax</link:label>
    <link:label id="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_documentation_en-US" xlink:label="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="cvs-20220630.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_98305729-cbb4-420d-9bb8-001277d448ea_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Shares</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PaymentsForAcceleratedShareRepurchasesAmount_748698a5-6011-431c-9184-e8242a5030ad_terseLabel_en-US" xlink:label="lab_cvs_PaymentsForAcceleratedShareRepurchasesAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for ASR, amount</link:label>
    <link:label id="lab_cvs_PaymentsForAcceleratedShareRepurchasesAmount_label_en-US" xlink:label="lab_cvs_PaymentsForAcceleratedShareRepurchasesAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Accelerated Share Repurchases, Amount</link:label>
    <link:label id="lab_cvs_PaymentsForAcceleratedShareRepurchasesAmount_documentation_en-US" xlink:label="lab_cvs_PaymentsForAcceleratedShareRepurchasesAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Accelerated Share Repurchases, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsForAcceleratedShareRepurchasesAmount" xlink:href="cvs-20220630.xsd#cvs_PaymentsForAcceleratedShareRepurchasesAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PaymentsForAcceleratedShareRepurchasesAmount" xlink:to="lab_cvs_PaymentsForAcceleratedShareRepurchasesAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsReceivableAtCarryingValue_be8913e6-7b23-4536-974f-a1fca1c51759_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium receivables</link:label>
    <link:label id="lab_us-gaap_PremiumsReceivableAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsReceivableAtCarryingValue" xlink:to="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_be0bb983-684d-4552-a099-ddc24315e4a9_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_5f723c55-a7dd-494e-ba90-d1405cbdb7b6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_85b4f285-b3de-48a7-8211-6437b906d3b2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstate_6f0fd740-77f9-4579-8c7a-01b190cbccc2_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans</link:label>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstate_label_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoansOnRealEstate" xlink:to="lab_us-gaap_MortgageLoansOnRealEstate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_8ef4d812-1371-40cc-8b5c-bff9ba019c2f_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_cdb9907d-0859-4eca-8dad-bb0a8f4a6c33_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateLineItems_63f4cd07-a987-4fa4-8c53-6b8d0d069313_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate [Line Items]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateLineItems_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems" xlink:to="lab_srt_MortgageLoansOnRealEstateLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_d7b99bf0-79fc-468c-98c0-152ead22b033_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase programs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_3f5f515a-de7c-4c0c-9e3d-c2938f62b0e7_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6c0c9bd2-f929-4b33-8261-80fb1c08aef0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_f10abaa1-cf2d-4200-8197-4a7fa128987e_terseLabel_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_e1f9b031-4138-4e8b-ba41-c84d676c2054_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers into Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_d43a1c0b-060e-4c88-8849-05393f0c900f_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_b1904f6e-2d85-4501-877f-0a852737cbb9_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_71da3477-8ee7-4fb0-bc33-a33fc92b0098_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_7dc1bde6-66d8-49a1-9491-d53fe3756c1b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_1fca85a3-ea4f-4c66-adfc-e2f9297dc068_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_c1c3a4a6-c8e5-48bb-8c23-039fc0a093ee_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_3b3561a4-b2cc-41d0-ae54-01ee3bdff504_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_7eb44183-9b11-459f-906e-4a77a947d1a1_terseLabel_en-US" xlink:label="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities, net of effects from acquisitions:</link:label>
    <link:label id="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_label_en-US" xlink:label="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities, net of effects from acquisitions: [Abstract]</link:label>
    <link:label id="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_documentation_en-US" xlink:label="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities, net of effects from acquisitions: [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" xlink:href="cvs-20220630.xsd#cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" xlink:to="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_3a68738a-a08f-403f-9ae1-9e776ef8b1c2_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_7d5dde95-bac8-4917-a42b-50bbad9573d8_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_8240a806-a678-4345-b7b6-fa5ff419b70c_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_99b87a7d-7f36-4723-86f0-fd32c49d4f5b_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_f76d5597-e6db-43af-ba28-80a050ee15cf_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_41d616b3-b2f9-4ed6-9db8-ba12b25e5a2f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_036b28f4-3c78-4f5f-9e0e-df2ed0c5b51a_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_5506275f-8e7d-4178-b5ea-e966bdb346ae_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate, Year Of Origination [Axis]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate, Year Of Origination [Axis]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate, Year Of Origination [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:href="cvs-20220630.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:to="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_74ed2937-9a99-409d-a1f4-2d7a943bd92b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_ea4cdd58-75e7-4b1d-8221-c7eddfe5086e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_ab9d19fc-2852-4ffe-afaf-48274f557cdc_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_b6d7a10e-5a32-4ad4-854f-31f9d7de3636_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchased during period, value</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d0e96696-f628-41c5-ac20-470c48b78c12_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodThreeMember_0e8109b0-49cd-402e-8b61-38cf7613a472_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodThreeMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Three [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodThreeMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodThreeMember" xlink:href="cvs-20220630.xsd#cvs_YearOfOriginationPeriodThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodThreeMember" xlink:to="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_79b83a9a-001d-48ab-99dd-d03792f63f9a_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_c3e6327c-1600-414e-be41-7b2267ac462c_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.75DueNovember2022Member_4ba51b71-4116-4698-b31a-e3e417b043d8_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueNovember2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.75% senior notes due November 2022</link:label>
    <link:label id="lab_cvs_SeniorNotes2.75DueNovember2022Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueNovember2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.75%, Due November 2022 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.75DueNovember2022Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueNovember2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.75%, Due November 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueNovember2022Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes2.75DueNovember2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.75DueNovember2022Member" xlink:to="lab_cvs_SeniorNotes2.75DueNovember2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_aaf1704c-914b-456c-a730-ef71e27b817e_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_dc0bd986-e36e-4bbb-8451-54bee901207a_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_928a02b0-00ab-438f-ab1a-be9e1a94eec7_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_c447b1a6-6198-4a4e-a5a4-01a0d864180f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (GAAP measure)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_85ae00d5-2ff8-4ed6-aa05-6f91861f8f1e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_7421bcf0-93fe-4f95-a1ef-0f103a4a93cd_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_f48250f3-c779-4b10-b7d0-0e3dd69a2ac1_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPolicyholderFunds_e3500aa4-e366-4efe-bc37-2fe48ce4196f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPolicyholderFunds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholders&#8217; funds</link:label>
    <link:label id="lab_us-gaap_OtherPolicyholderFunds_label_en-US" xlink:label="lab_us-gaap_OtherPolicyholderFunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Policyholder Funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPolicyholderFunds" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPolicyholderFunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPolicyholderFunds" xlink:to="lab_us-gaap_OtherPolicyholderFunds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_74404b7a-4355-4100-8a33-3e7affc426c9_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_e3f3e6ad-a16c-4f95-a070-f3dbfe5e1776_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_0dbea603-2a03-406e-b9c0-9d8c7b2ecadc_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_a42064b7-319f-48fa-85e0-3d7bbc346868_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_93d7c75f-5486-4171-955f-0db4bfda3be8_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_d7da7681-876d-4b7e-9083-e12208442691_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchased during period (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_462cfc47-bd12-4029-bb5c-dae0f8fd54d9_terseLabel_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rewards earnings and gift card issuances</link:label>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_label_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer Liability Loyalty Program Earnings And Gift Card Issuance</link:label>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_documentation_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of increase (decrease) in contract liability recognized for loyalty program earnings and gift card issuance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:href="cvs-20220630.xsd#cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:to="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_6c9df323-c390-447c-9ace-07c1de8d60d8_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized investment gains (losses)</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c448abb7-e487-4915-90e1-6f252d4fca58_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments required to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_2057aaad-65d0-4b0a-a76e-23c0edada14b_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_96c760cc-4d07-4a86-be9a-7ab40ac871c2_terseLabel_en-US" xlink:label="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care and Other Insurance Liabilities [Abstract]</link:label>
    <link:label id="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_label_en-US" xlink:label="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care and Other Insurance Liabilities [Abstract]</link:label>
    <link:label id="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_documentation_en-US" xlink:label="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care and Other Insurance Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" xlink:href="cvs-20220630.xsd#cvs_HealthCareandOtherInsuranceLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" xlink:to="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_59af0f48-69fb-49b2-a828-929ec00e69d2_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_b91fec23-eadf-46d8-b36b-8db3c8ee3015_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_0de5bbe4-183b-40ce-8793-bf6bebc9dcd6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_72646a8e-e151-4011-96d7-bcd01dc924b9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_a9c158b0-260c-4261-8ded-1a51e838dbca_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_25b3c261-5bfc-4c0a-8ab7-032d7caab28b_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_4e5c2376-4545-44f1-8600-9140d2e9f733_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash (included in other assets)</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_507bad08-f449-4ebc-baef-c9fb15d345b9_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a5f26236-5dfe-4e68-a935-6eeb6cfa5b61_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3a992e15-d1fc-41b8-b170-08c0d2133e76_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average diluted shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberofPatientsServedperYear_96894adc-7fd0-4c70-8781-06c45542c283_terseLabel_en-US" xlink:label="lab_cvs_NumberofPatientsServedperYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patients served per year</link:label>
    <link:label id="lab_cvs_NumberofPatientsServedperYear_label_en-US" xlink:label="lab_cvs_NumberofPatientsServedperYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Patients Served per Year</link:label>
    <link:label id="lab_cvs_NumberofPatientsServedperYear_documentation_en-US" xlink:label="lab_cvs_NumberofPatientsServedperYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Patients Served per Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPatientsServedperYear" xlink:href="cvs-20220630.xsd#cvs_NumberofPatientsServedperYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberofPatientsServedperYear" xlink:to="lab_cvs_NumberofPatientsServedperYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_1cd30287-d1dd-4e0f-a303-20e3ad3f734a_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1286b6bf-71dd-4cde-845e-8b577ea82f67_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_37dfe503-9e50-4325-8a81-23ea923397e4_totalLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_438b135b-b9cd-4656-bbd1-37c3f7fceda0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_e49094a5-2b27-429d-b637-8621535fea5b_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_048d75ca-6c82-44b9-a276-e03bc40668bd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes1875DueFebruary2031Member_d19518fc-6754-4c6d-9932-d82080e96df8_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes1875DueFebruary2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.875% senior notes due February 2031</link:label>
    <link:label id="lab_cvs_SeniorNotes1875DueFebruary2031Member_label_en-US" xlink:label="lab_cvs_SeniorNotes1875DueFebruary2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.875%, Due February 2031 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes1875DueFebruary2031Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes1875DueFebruary2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.875%, Due February 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1875DueFebruary2031Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes1875DueFebruary2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes1875DueFebruary2031Member" xlink:to="lab_cvs_SeniorNotes1875DueFebruary2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4DueDecember2023Member_40b82a45-9b52-42fe-b7ee-79a5f5b77cee_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4DueDecember2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4% senior notes due December 2023</link:label>
    <link:label id="lab_cvs_SeniorNotes4DueDecember2023Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4DueDecember2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4%, Due December 2023 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4DueDecember2023Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4DueDecember2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4%, Due December 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4DueDecember2023Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4DueDecember2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4DueDecember2023Member" xlink:to="lab_cvs_SeniorNotes4DueDecember2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Category1Member_4f33e402-85ed-452c-98f0-d2dcf0dbae4a_terseLabel_en-US" xlink:label="lab_cvs_Category1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1</link:label>
    <link:label id="lab_cvs_Category1Member_label_en-US" xlink:label="lab_cvs_Category1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 1 [Member]</link:label>
    <link:label id="lab_cvs_Category1Member_documentation_en-US" xlink:label="lab_cvs_Category1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan Credit Quality Indicator - Category 1 [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category1Member" xlink:href="cvs-20220630.xsd#cvs_Category1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Category1Member" xlink:to="lab_cvs_Category1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_3c643c49-5c1e-4411-be84-85797865c170_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related integration costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_c36ef795-ec75-4cb4-b2b5-7a38337d9aaa_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_e0aec964-a641-4af8-adcb-a30ac93e0261_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New mortgage loans</link:label>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_label_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, New Mortgage Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstateNewMortgageLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:to="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_98b3b0a4-06e7-444e-bd0d-a39c2f68ba97_terseLabel_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized capital gains (losses)</link:label>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_label_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized Investment Gains (Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealizedInvestmentGainsLosses" xlink:to="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_674b5902-6e4c-4656-8205-ef486cdb8648_terseLabel_en-US" xlink:label="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit costs recorded in other insurance liabilities</link:label>
    <link:label id="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_label_en-US" xlink:label="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs</link:label>
    <link:label id="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_documentation_en-US" xlink:label="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:href="cvs-20220630.xsd#cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:to="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_06feca9d-e5a9-45c0-8eee-57ae35c44fa3_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mail choice</link:label>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Directly to Consumer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:to="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_42b46a3f-a9dc-405b-87bc-b044a1e0b49b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_f12bff45-a026-4165-9251-df3c92e62290_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_d658c7e7-f027-4b06-8dcf-0fedb4817992_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other postretirement benefits</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_5228dc9b-1c5b-43e6-9f7a-a66346542c8a_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram_300dc1ed-cafd-40e7-bb72-26b068fe9cd5_terseLabel_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR, shares to be received at the end of program as a percent of notional amount</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram_label_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Percent of Notional Amount in Shares to be Received at End of Program</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram_documentation_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Percent of Notional Amount in Shares to be Received at End of Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" xlink:href="cvs-20220630.xsd#cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" xlink:to="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ecb60908-c478-4cab-b092-e4903a6a5f4a_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at the beginning of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d234fec7-cd79-456a-9848-a9406a509066_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at the end of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8581b006-422d-445d-9ac2-93bf6264e956_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and restricted cash in the statements of cash flows</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_fcda9f97-7136-4942-b0c0-344bca3c3069_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0fb533c0-7394-4ea5-be5a-fab7d2805202_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_262cfc88-60ff-4f6d-b8c8-014d9a154303_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_bd0430c3-7912-4f75-9973-08d9a81cd84e_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.375DueAugust2024Member_33537c34-53aa-46c4-9b88-4c423f8e0fa1_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.375DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.375% senior notes due August 2024</link:label>
    <link:label id="lab_cvs_SeniorNotes3.375DueAugust2024Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.375DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.375%, Due August 2024 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.375DueAugust2024Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.375DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.375%, Due August 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.375DueAugust2024Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes3.375DueAugust2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.375DueAugust2024Member" xlink:to="lab_cvs_SeniorNotes3.375DueAugust2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_b0c896ba-23ca-4ccb-b783-2756299bb6da_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to CVS Health</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_11fae098-c08d-4f9a-94b8-6d57ec98737a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_542937cf-06ed-4aa0-8e2d-a758ca39f7fa_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes13DueAugust2027Member_0a9d9550-93d3-4ba3-9bc9-47d5e11c92e6_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes13DueAugust2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.3% senior notes due August 2027</link:label>
    <link:label id="lab_cvs_SeniorNotes13DueAugust2027Member_label_en-US" xlink:label="lab_cvs_SeniorNotes13DueAugust2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.3%, Due August 2027 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes13DueAugust2027Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes13DueAugust2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.3%, Due August 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes13DueAugust2027Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes13DueAugust2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes13DueAugust2027Member" xlink:to="lab_cvs_SeniorNotes13DueAugust2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_b70ccdfe-aa9e-4355-abbe-d46bb82f9829_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock and Capital Surplus</link:label>
    <link:label id="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Including Additional Paid in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_a0e3d878-b527-427b-9b14-7a3d90bfdf08_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities (included in accrued expenses)</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_d0a41754-2a67-43af-bae0-16d48e5ef709_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities, beginning of the period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_dbd29081-d9e1-418e-8059-aabda696c40d_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities, end of the period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.75DueMarch2044Member_d7e03fbb-99e1-418c-b3ec-0b18477a7e8c_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueMarch2044Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% senior notes due March 2044</link:label>
    <link:label id="lab_cvs_SeniorNotes4.75DueMarch2044Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueMarch2044Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.75%, Due March 2044 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.75DueMarch2044Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueMarch2044Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.75%, Due March 2044 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueMarch2044Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.75DueMarch2044Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.75DueMarch2044Member" xlink:to="lab_cvs_SeniorNotes4.75DueMarch2044Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_bf6b2824-25ac-47bd-8c9e-91413617b652_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Securities In An Unrealized Capital Loss Position</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_3b51a087-1222-4f60-816a-b392f9584db8_terseLabel_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP issuances, net of purchase of treasury shares</link:label>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Issuance, Net of Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_documentation_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Issuance, Net of Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:href="cvs-20220630.xsd#cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:to="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_19bc4c21-7e41-45fa-96f7-9d405c9c2685_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total CVS Health Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_5532f8fa-49db-4c83-ac03-ec8dd045f9b9_negatedTerseLabel_en-US" xlink:label="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt discounts and deferred financing costs</link:label>
    <link:label id="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_label_en-US" xlink:label="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount and Debt Issuance Costs, Net</link:label>
    <link:label id="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_documentation_en-US" xlink:label="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:href="cvs-20220630.xsd#cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:to="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9a144cb3-27fc-42d1-ba96-050134dc45e5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_526c81aa-5d48-4607-b2df-8c5575e6f859_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_c0c9537f-67cd-416a-9e07-d7c8c5b6f24e_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_48f77d1c-818a-4962-aa92-0ff86147e7e6_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_02641fe3-8c26-434d-996a-1b438b2cea90_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_9c983eb1-54d6-4d12-8dc5-449f703f25cb_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansMember_f1110c97-53a3-4dcd-a05a-8f5c34910de7_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans</link:label>
    <link:label id="lab_cvs_MortgageLoansMember_label_en-US" xlink:label="lab_cvs_MortgageLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans [Member]</link:label>
    <link:label id="lab_cvs_MortgageLoansMember_documentation_en-US" xlink:label="lab_cvs_MortgageLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents mortgage loans for the reporting period measured at carrying value. We carry the value of our mortgage loan investments on our balance sheet at the unpaid principal balance, net of impairment reserves.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember" xlink:href="cvs-20220630.xsd#cvs_MortgageLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansMember" xlink:to="lab_cvs_MortgageLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4988a67d-421a-47fc-bc67-82b16f87df97_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d71504c6-fef3-465c-a7be-b52a528ca2bd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_79f0ef71-a76a-4ceb-8eec-bc47cc73cdf7_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to CVS Health</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_0614ebe1-a5d1-4af7-8161-ee819e59b897_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AdjustedOperatingIncomeLoss_c76cd19b-8421-4cdf-b66e-d0757230581e_terseLabel_en-US" xlink:label="lab_cvs_AdjustedOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted operating income (loss)</link:label>
    <link:label id="lab_cvs_AdjustedOperatingIncomeLoss_06781dcf-d6e3-41b0-a58f-2c94260e9682_verboseLabel_en-US" xlink:label="lab_cvs_AdjustedOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted operating income</link:label>
    <link:label id="lab_cvs_AdjustedOperatingIncomeLoss_label_en-US" xlink:label="lab_cvs_AdjustedOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Operating Income (Loss)</link:label>
    <link:label id="lab_cvs_AdjustedOperatingIncomeLoss_documentation_en-US" xlink:label="lab_cvs_AdjustedOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss" xlink:href="cvs-20220630.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AdjustedOperatingIncomeLoss" xlink:to="lab_cvs_AdjustedOperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes175DueAugust2030Member_30104d36-b107-4d21-a3a6-67edf203abdd_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes175DueAugust2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.75% senior notes due August 2030</link:label>
    <link:label id="lab_cvs_SeniorNotes175DueAugust2030Member_label_en-US" xlink:label="lab_cvs_SeniorNotes175DueAugust2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.75%, Due August 2030 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes175DueAugust2030Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes175DueAugust2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.75%, Due August 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes175DueAugust2030Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes175DueAugust2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes175DueAugust2030Member" xlink:to="lab_cvs_SeniorNotes175DueAugust2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_790baf56-c799-406a-a5df-c56176115227_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summarized Financial Information Of Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_2cc84a81-2654-48b1-abe3-22c49dae4ab1_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_24bb9f2a-d296-45e8-9052-08922a7cbd9b_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on assets held for sale</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_2b3a4e34-80fa-4ab8-a11c-02bf25ec55cf_verboseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on assets held for sale</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets to be Disposed of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_128893ef-0709-4b19-a641-05cbb01c8337_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_1852df11-606b-4b3f-8615-95fadad4e722_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsLineItems_a6cfb514-fea7-41bc-812a-897427006988_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Line Items]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsLineItems_label_en-US" xlink:label="lab_cvs_TotalInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsLineItems" xlink:href="cvs-20220630.xsd#cvs_TotalInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsLineItems" xlink:to="lab_cvs_TotalInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_642dcc78-744a-449b-ad7c-b47e2874ebf3_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_dc0d9f06-8852-42ed-8d75-9839c7c0a19a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Claims paid</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_93b95377-a5a3-45d5-97bf-061d9c5f201e_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_9903d10e-4908-4c2d-820b-98e859ce1b18_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Line Items]</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_BarclaysBankMember_8c76df94-d461-4e0e-a2f1-7a3d11adde9a_terseLabel_en-US" xlink:label="lab_cvs_BarclaysBankMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays Bank</link:label>
    <link:label id="lab_cvs_BarclaysBankMember_label_en-US" xlink:label="lab_cvs_BarclaysBankMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays Bank [Member]</link:label>
    <link:label id="lab_cvs_BarclaysBankMember_documentation_en-US" xlink:label="lab_cvs_BarclaysBankMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays Bank</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BarclaysBankMember" xlink:href="cvs-20220630.xsd#cvs_BarclaysBankMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_BarclaysBankMember" xlink:to="lab_cvs_BarclaysBankMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_c38a3584-ff40-4e7a-821b-24de83644a0c_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_7b97434f-20b4-4956-8c14-af95ea3d239a_verboseLabel_en-US" xlink:label="lab_cvs_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share:</link:label>
    <link:label id="lab_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_label_en-US" xlink:label="lab_cvs_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted EPS [Abstract]</link:label>
    <link:label id="lab_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_documentation_en-US" xlink:label="lab_cvs_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted EPS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:href="cvs-20220630.xsd#cvs_EarningsPerShareBasicAndDilutedEPSAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:to="lab_cvs_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfAdditionalStates_f1801bc1-8a39-43b7-a7f9-f8e3ba359ecf_terseLabel_en-US" xlink:label="lab_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfAdditionalStates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional number of states in which the Company has entered the individual public health insurance exchange</link:label>
    <link:label id="lab_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfAdditionalStates_label_en-US" xlink:label="lab_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfAdditionalStates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Public Health Insurance Exchanges, Submitted Regulatory Filings, Number of Additional States</link:label>
    <link:label id="lab_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfAdditionalStates_documentation_en-US" xlink:label="lab_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfAdditionalStates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Public Health Insurance Exchanges, Submitted Regulatory Filings, Number of Additional States</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfAdditionalStates" xlink:href="cvs-20220630.xsd#cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfAdditionalStates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfAdditionalStates" xlink:to="lab_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfAdditionalStates" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_aabc85ae-0fc0-4634-ad03-91299550f50e_terseLabel_en-US" xlink:label="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other increases (decreases) in noncontrolling interests</link:label>
    <link:label id="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_label_en-US" xlink:label="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, Other Period Increase (Decrease)</link:label>
    <link:label id="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_documentation_en-US" xlink:label="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, Other Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:href="cvs-20220630.xsd#cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:to="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_860336c2-58ab-4eed-bd67-df5bafb65061_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities_11248611-1bbd-416f-ae02-3de7e5b62eee_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable and other insurance liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Insurance Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_VendorandManufacturerReceivables_b8d58a7e-7508-49e7-8e0b-c57ec6177b4c_terseLabel_en-US" xlink:label="lab_cvs_VendorandManufacturerReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor and manufacturer receivables</link:label>
    <link:label id="lab_cvs_VendorandManufacturerReceivables_label_en-US" xlink:label="lab_cvs_VendorandManufacturerReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor and Manufacturer Receivables</link:label>
    <link:label id="lab_cvs_VendorandManufacturerReceivables_documentation_en-US" xlink:label="lab_cvs_VendorandManufacturerReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor and Manufacturer Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VendorandManufacturerReceivables" xlink:href="cvs-20220630.xsd#cvs_VendorandManufacturerReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_VendorandManufacturerReceivables" xlink:to="lab_cvs_VendorandManufacturerReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_c05b2a45-521e-4487-8229-c2ca31d65e63_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities, Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_05058b67-ec55-476b-8863-fc6a613416c1_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_c1525ca8-3f70-4b48-9bdc-e1c73094d852_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_4054fc4e-3ec3-461b-95d4-707073f04114_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_da8725c1-7cfb-46a3-8b94-3f709b5433ce_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_78380107-22c5-436e-b515-1a947f7c514a_terseLabel_en-US" xlink:label="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities available for sale</link:label>
    <link:label id="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_label_en-US" xlink:label="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt And Equity Securities Available For Sale [Member]</link:label>
    <link:label id="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_documentation_en-US" xlink:label="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in debt and equity securities which are categorized neither as trading securities nor held-to-maturity securities. Such securities are reported at fair value; unrealized gains and losses related to Available-for-sale securities are excluded from earnings and reported in a separate component of shareholders' equity (other comprehensive income)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:href="cvs-20220630.xsd#cvs_DebtAndEquitySecuritiesAvailableForSaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:to="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateForeclosures_3fc0fad9-bd70-42e9-92eb-dfb33dae8ac7_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans foreclosed</link:label>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateForeclosures_label_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Foreclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstateForeclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:to="lab_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_0600ec89-e432-4dfe-8f36-6189d0a85485_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_5147657d-cb7c-4c9e-8625-a0a289862d02_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemed principal amount</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_5f001200-6e05-4f2a-ab10-4ecca4954c25_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost: 443 shares at June&#160;30, 2022 and 422 shares at December&#160;31, 2021</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_4b20927b-b72b-401c-a7a2-767823b3a30d_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Amortized Cost</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_abab8b75-e47e-467a-ae0d-8105a2836eb0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other postretirement benefits</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2125PercentDueSeptember2031Member_dbbc647d-865c-4d41-bc30-9b3fbf2d84cf_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2125PercentDueSeptember2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.125% senior notes due September 2031</link:label>
    <link:label id="lab_cvs_SeniorNotes2125PercentDueSeptember2031Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2125PercentDueSeptember2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.125 Percent, Due September 2031 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2125PercentDueSeptember2031Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2125PercentDueSeptember2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.125 Percent, Due September 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2125PercentDueSeptember2031Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes2125PercentDueSeptember2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2125PercentDueSeptember2031Member" xlink:to="lab_cvs_SeniorNotes2125PercentDueSeptember2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_d40fee6b-41b6-40f9-be51-4dff1b06a668_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option activity, stock awards and other</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_cee5e0a7-cbda-49c2-813a-5c380be75d79_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_57f09d5b-7e6d-40e2-a2f7-241afee63d55_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.625DueAugust2024Member_c4538fa6-40ee-484a-8bb8-6b73a8db0dd1_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.625DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.625% senior notes due August 2024</link:label>
    <link:label id="lab_cvs_SeniorNotes2.625DueAugust2024Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.625DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.625%, Due August 2024 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.625DueAugust2024Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.625DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.625%, Due August 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.625DueAugust2024Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes2.625DueAugust2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.625DueAugust2024Member" xlink:to="lab_cvs_SeniorNotes2.625DueAugust2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_00d73a4d-c637-4688-aaad-d1b971c06b76_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TransferOfSharesToTreasuryStockValue_8920d4fb-9d2c-4ff3-8ecd-945834645be1_terseLabel_en-US" xlink:label="lab_cvs_TransferOfSharesToTreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of shares to treasury stock value</link:label>
    <link:label id="lab_cvs_TransferOfSharesToTreasuryStockValue_label_en-US" xlink:label="lab_cvs_TransferOfSharesToTreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Shares to Treasury Stock Value</link:label>
    <link:label id="lab_cvs_TransferOfSharesToTreasuryStockValue_documentation_en-US" xlink:label="lab_cvs_TransferOfSharesToTreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Shares to Treasury Stock Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TransferOfSharesToTreasuryStockValue" xlink:href="cvs-20220630.xsd#cvs_TransferOfSharesToTreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TransferOfSharesToTreasuryStockValue" xlink:to="lab_cvs_TransferOfSharesToTreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_73587fc8-f235-46aa-9797-eb0f45548f36_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_88066f05-ad97-4533-8d53-a029ff4a4ec5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_128bf901-6f8e-4eff-80b1-3012ac35bb46_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_fb0a20e1-0085-4591-bcfb-18cfddff4485_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_acc992b8-8c2b-4f9b-99ac-17c2d62fe9cd_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold_4901f3b5-b487-4914-b898-f4379eca0069_terseLabel_en-US" xlink:label="lab_cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of international health care members, renewal rights sold</link:label>
    <link:label id="lab_cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold_label_en-US" xlink:label="lab_cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Number of International Health Care Members, Renewal Rights Sold</link:label>
    <link:label id="lab_cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold_documentation_en-US" xlink:label="lab_cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Number of International Health Care Members, Renewal Rights Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold" xlink:href="cvs-20220630.xsd#cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold" xlink:to="lab_cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_1ef9943f-3b10-430c-a330-f05a343ead7a_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes6.75DueDecember2037Member_84d069e0-194b-48f8-989d-ff54e396c395_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes6.75DueDecember2037Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.75% senior notes due December 2037</link:label>
    <link:label id="lab_cvs_SeniorNotes6.75DueDecember2037Member_label_en-US" xlink:label="lab_cvs_SeniorNotes6.75DueDecember2037Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.75%, Due December 2037 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes6.75DueDecember2037Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes6.75DueDecember2037Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.75%, Due December 2037 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.75DueDecember2037Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes6.75DueDecember2037Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes6.75DueDecember2037Member" xlink:to="lab_cvs_SeniorNotes6.75DueDecember2037Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_ae18ac96-a1b0-4f45-8ef3-b2305353d7ec_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.8DueJune2023Member_bec004c2-7237-4850-b8cc-ef6e7c9c449c_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.8DueJune2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.8% senior notes due June 2023</link:label>
    <link:label id="lab_cvs_SeniorNotes2.8DueJune2023Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.8DueJune2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.8%, Due June 2023 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.8DueJune2023Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.8DueJune2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.8%, Due June 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.8DueJune2023Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes2.8DueJune2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.8DueJune2023Member" xlink:to="lab_cvs_SeniorNotes2.8DueJune2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_3f63a4d8-8986-42b1-a060-7e24ea8c2bd4_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_40a59a61-7db9-48d2-a070-331c8a474c4f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_b0f68132-4ed8-49c1-b439-8795f0e2163c_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares outstanding, balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_4d96e2df-6d63-47af-af01-a44847b1015d_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares outstanding, balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LossContingencyAuditMethodologySampleSize_35da5d23-5748-41be-9cea-9887ff86d8c6_terseLabel_en-US" xlink:label="lab_cvs_LossContingencyAuditMethodologySampleSize" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sample size</link:label>
    <link:label id="lab_cvs_LossContingencyAuditMethodologySampleSize_label_en-US" xlink:label="lab_cvs_LossContingencyAuditMethodologySampleSize" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Audit Methodology Sample Size</link:label>
    <link:label id="lab_cvs_LossContingencyAuditMethodologySampleSize_documentation_en-US" xlink:label="lab_cvs_LossContingencyAuditMethodologySampleSize" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Audit Methodology Sample Size</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LossContingencyAuditMethodologySampleSize" xlink:href="cvs-20220630.xsd#cvs_LossContingencyAuditMethodologySampleSize"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LossContingencyAuditMethodologySampleSize" xlink:to="lab_cvs_LossContingencyAuditMethodologySampleSize" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_fb00ffa2-5d1b-4d2e-8977-d1cf9b84e690_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_f67bf9c3-a6cc-418a-a4e2-73f8b354fabd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_4ace7548-179c-4abf-91ec-67994239702e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_fcb6df1a-65ac-4de6-9da5-7269741788f6_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.875DueJuly2025Member_137f7f46-f2e2-41cf-aba9-91cbce680837_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueJuly2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.875% senior notes due July 2025</link:label>
    <link:label id="lab_cvs_SeniorNotes3.875DueJuly2025Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueJuly2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.875%, Due July 2025 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.875DueJuly2025Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueJuly2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.875%, Due July 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueJuly2025Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes3.875DueJuly2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.875DueJuly2025Member" xlink:to="lab_cvs_SeniorNotes3.875DueJuly2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_044cf18d-08fb-4782-92c7-75acfb285a1a_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums</link:label>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_label_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsEarnedNet" xlink:to="lab_us-gaap_PremiumsEarnedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCorporateDebtSecuritiesMember_adb54949-b53b-452a-b5f9-8040bcc32984_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. corporate securities</link:label>
    <link:label id="lab_us-gaap_DomesticCorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security, Corporate, US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_0beb3928-d138-405f-a4a9-6381c5f35d80_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_e5350bcc-c8dd-49cb-9bb2-0c0f325eb624_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans fully repaid</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Loans Fully Repaid</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pertains to amount of mortgage loans fully repaid.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:href="cvs-20220630.xsd#cvs_MortgageLoansOnRealEstateLoansFullyRepaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:to="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_c435175a-7568-4e88-91c4-cb6ed4b3c8e7_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemablePreferredStockMember_c68b5a8c-e8a5-4a32-b047-f554c94c45a6_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemablePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable preferred securities</link:label>
    <link:label id="lab_us-gaap_RedeemablePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_RedeemablePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemablePreferredStockMember" xlink:to="lab_us-gaap_RedeemablePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodFourMember_c9ffab6d-3cff-4458-ac50-dad5fadb424b_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFourMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Four [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFourMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFourMember" xlink:href="cvs-20220630.xsd#cvs_YearOfOriginationPeriodFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodFourMember" xlink:to="lab_cvs_YearOfOriginationPeriodFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfStores_1a085068-d517-45cf-ae2c-ad12501973d9_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfStores" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of retail locations (more than)</link:label>
    <link:label id="lab_us-gaap_NumberOfStores_label_en-US" xlink:label="lab_us-gaap_NumberOfStores" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Stores</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfStores"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfStores" xlink:to="lab_us-gaap_NumberOfStores" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_34b19281-0dc6-477a-b9fa-7056de0c8599_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_7a72de19-d660-4f04-917f-ca5c18006d2c_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased_1f2b9645-7e40-4088-ae7f-6752e6f1eaa5_terseLabel_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased under ASR agreement (in shares)</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased_label_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Number of Shares Repurchased</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased_documentation_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Number of Shares Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased" xlink:href="cvs-20220630.xsd#cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased" xlink:to="lab_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_8d299126-d9b9-4e83-8a62-8d86d829b584_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:to="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_17b9091e-1f0e-4757-a2e8-4025f23ac213_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Credit Quality Indicator [Domain]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Credit Quality Indicator [Domain]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Credit Quality Indicator [Domain].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" xlink:href="cvs-20220630.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" xlink:to="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage_b9597483-e09e-43f7-b633-094bd7062d7c_negatedTerseLabel_en-US" xlink:label="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption and breakage</link:label>
    <link:label id="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage_label_en-US" xlink:label="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer Liability Redemption and Breakage</link:label>
    <link:label id="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage_documentation_en-US" xlink:label="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer Liability Redemption and Breakage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractwithCustomerLiabilityRedemptionandBreakage" xlink:href="cvs-20220630.xsd#cvs_ContractwithCustomerLiabilityRedemptionandBreakage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ContractwithCustomerLiabilityRedemptionandBreakage" xlink:to="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberOfPeopleServed_f2ebb09c-7f90-4edc-b3f5-f05197e14d7c_terseLabel_en-US" xlink:label="lab_cvs_NumberOfPeopleServed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of people served</link:label>
    <link:label id="lab_cvs_NumberOfPeopleServed_label_en-US" xlink:label="lab_cvs_NumberOfPeopleServed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of People Served</link:label>
    <link:label id="lab_cvs_NumberOfPeopleServed_documentation_en-US" xlink:label="lab_cvs_NumberOfPeopleServed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of People Served</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPeopleServed" xlink:href="cvs-20220630.xsd#cvs_NumberOfPeopleServed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberOfPeopleServed" xlink:to="lab_cvs_NumberOfPeopleServed" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember_85f0980a-3aa4-45dc-b37f-05090625df59_terseLabel_en-US" xlink:label="lab_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Radcliffe and Flaim v. Aetna Inc., et al</link:label>
    <link:label id="lab_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember_label_en-US" xlink:label="lab_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Radcliffe and Flaim v. Aetna Inc., et al [Member]</link:label>
    <link:label id="lab_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember_documentation_en-US" xlink:label="lab_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Radcliffe and Flaim v. Aetna Inc., et al</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember" xlink:href="cvs-20220630.xsd#cvs_RadcliffeAndFlaimVAetnaIncEtAlMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember" xlink:to="lab_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_8580bd07-53fb-4184-9fb3-83dc8f4809e3_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_5689ecf9-d994-4ef3-b7b4-0fc0343fb0db_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_10e3a66c-bd56-4763-9bb6-4bc1241bf175_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_7234080b-63d0-44c7-958f-bfddff97a945_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_68c81564-8f5d-44ef-a718-0e9eaea8298b_terseLabel_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductAndServiceOtherMember" xlink:to="lab_us-gaap_ProductAndServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_dede3a13-65e7-4470-b4e3-a4993391e228_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of Separate Accounts by Major Category of Investment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_06570f78-c2ff-4285-a3b4-2739444abceb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateScheduleTable_4348045b-4d81-4385-9cbe-55edda8858a2_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateScheduleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate [Table]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateScheduleTable_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateScheduleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate Schedule [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable" xlink:to="lab_srt_MortgageLoansOnRealEstateScheduleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_d819b57b-62ce-4b2d-a397-90ac0e251ea4_terseLabel_en-US" xlink:label="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment contracts liabilities with a fixed maturity</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_label_en-US" xlink:label="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts With Fixed Maturity, Fair Value Disclosure</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_documentation_en-US" xlink:label="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts With Fixed Maturity, Fair Value Disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:href="cvs-20220630.xsd#cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:to="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_34c76e5a-aa86-46ac-b836-8da2952dc3cf_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses, Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.5DueNovember2024Member_a1bd3f80-4aa7-4155-8c18-9561deabf1be_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueNovember2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.5% senior notes due November 2024</link:label>
    <link:label id="lab_cvs_SeniorNotes3.5DueNovember2024Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueNovember2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.5%, Due November 2024 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.5DueNovember2024Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueNovember2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.5%, Due November 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueNovember2024Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes3.5DueNovember2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.5DueNovember2024Member" xlink:to="lab_cvs_SeniorNotes3.5DueNovember2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_eaed0dc2-bb12-487c-86be-b8373fb0ac68_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_71d6224a-fa36-42cf-b62d-c57137fa3f8e_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.1DueMarch2025Member_41f07b0a-c71f-4dbf-b922-6a3821b47a87_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.1DueMarch2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.1% senior notes due March 2025</link:label>
    <link:label id="lab_cvs_SeniorNotes4.1DueMarch2025Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.1DueMarch2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.1%, Due March 2025 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.1DueMarch2025Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.1DueMarch2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.1%, Due March 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.1DueMarch2025Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.1DueMarch2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.1DueMarch2025Member" xlink:to="lab_cvs_SeniorNotes4.1DueMarch2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_1bb9f30f-7b72-473d-8fa9-d5a3dc5888a5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses, Greater than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_A2021AcceleratedRepurchaseProgramMember_145fd588-1055-4076-bda7-d85cef3b7f40_terseLabel_en-US" xlink:label="lab_cvs_A2021AcceleratedRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 ASR</link:label>
    <link:label id="lab_cvs_A2021AcceleratedRepurchaseProgramMember_label_en-US" xlink:label="lab_cvs_A2021AcceleratedRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Accelerated Repurchase Program [Member]</link:label>
    <link:label id="lab_cvs_A2021AcceleratedRepurchaseProgramMember_documentation_en-US" xlink:label="lab_cvs_A2021AcceleratedRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Accelerated Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2021AcceleratedRepurchaseProgramMember" xlink:href="cvs-20220630.xsd#cvs_A2021AcceleratedRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_A2021AcceleratedRepurchaseProgramMember" xlink:to="lab_cvs_A2021AcceleratedRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_58d04650-cc39-4437-8278-e76f0b5fa157_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesCurrent_4309a674-096a-45e5-937f-b4cb28cc3670_terseLabel_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other insurance liabilities</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesCurrent_label_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Current</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesCurrent_documentation_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesCurrent" xlink:href="cvs-20220630.xsd#cvs_OtherInsuranceLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherInsuranceLiabilitiesCurrent" xlink:to="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.75DueDecember2022Member_b97a40ff-0b27-43e7-9758-7ae7c6bdc28b_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.75% senior notes due December 2022</link:label>
    <link:label id="lab_cvs_SeniorNotes2.75DueDecember2022Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.75%, Due December 2022 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.75DueDecember2022Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.75%, Due December 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueDecember2022Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes2.75DueDecember2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.75DueDecember2022Member" xlink:to="lab_cvs_SeniorNotes2.75DueDecember2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2d124d07-d15a-4fc7-9325-4edb4ca8c14f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_db172e12-e95c-458a-a064-731d472f6603_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_929ce309-9c97-480f-ad9c-b9819902ae7b_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_000cc624-1ff6-4716-8fdd-4e8a654025a3_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_8b659183-2004-4598-96c8-eb13d953be9c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_887e4544-5c32-4515-92ed-cb49e891769c_terseLabel_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Premium deficiency reserve</link:label>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_11c195a7-8d21-4085-908d-29f3bb5d88ab_verboseLabel_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium deficiency reserve</link:label>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_label_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Deficiency Reserve Liability</link:label>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_documentation_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of reserves related to expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), in excess of existing reserves plus anticipated future premiums and reinsurance recoveries.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability" xlink:href="cvs-20220630.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PremiumDeficiencyReserveLiability" xlink:to="lab_cvs_PremiumDeficiencyReserveLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_5a6bc342-3a2f-4394-9fba-8b15adff638a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_52900a67-451e-4f40-b199-002663503d53_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Amortized Cost and Fair Value of Debt Securities by Contractual Maturity</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_f0c55b5f-e264-4084-9b7d-b4900ccf3152_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_125071c5-0ea9-4678-aff8-77e892b5f729_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d2ac28e4-ccf6-494b-956a-5f604a4c8c0d_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f9d8487d-3021-4fc4-b358-94b9afb54470_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_bc108b61-df07-498a-828e-b328f0ef1603_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability recorded in association with legal settlement</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockValueSharesHeldInTrust_1c197157-d748-473b-89de-771293261088_terseLabel_en-US" xlink:label="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury share held in trust</link:label>
    <link:label id="lab_cvs_TreasuryStockValueSharesHeldInTrust_label_en-US" xlink:label="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Shares Held In Trust</link:label>
    <link:label id="lab_cvs_TreasuryStockValueSharesHeldInTrust_documentation_en-US" xlink:label="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Shares Held In Trust</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueSharesHeldInTrust" xlink:href="cvs-20220630.xsd#cvs_TreasuryStockValueSharesHeldInTrust"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockValueSharesHeldInTrust" xlink:to="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.125DueNovember2042Member_e53a4e51-a431-44b4-b21e-154ab8e21b48_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueNovember2042Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.125% senior notes due November 2042</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueNovember2042Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueNovember2042Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due November 2042 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueNovember2042Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueNovember2042Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item represents senior notes due 2042 with a coupon rate of 4.125%.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueNovember2042Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.125DueNovember2042Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.125DueNovember2042Member" xlink:to="lab_cvs_SeniorNotes4.125DueNovember2042Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_a29919b0-2047-4561-861f-5eaf45557118_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_6ae9a661-4f80-49a0-9380-8625dcbf40f0_negatedLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in prior years' healthcare costs payable</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NetRevenuesRetailCoPayments_a40b6f03-9b01-4859-87c7-f2ecb38aceac_terseLabel_en-US" xlink:label="lab_cvs_NetRevenuesRetailCoPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Copayments</link:label>
    <link:label id="lab_cvs_NetRevenuesRetailCoPayments_label_en-US" xlink:label="lab_cvs_NetRevenuesRetailCoPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenues, Retail CoPayments</link:label>
    <link:label id="lab_cvs_NetRevenuesRetailCoPayments_documentation_en-US" xlink:label="lab_cvs_NetRevenuesRetailCoPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenues, Retail CoPayments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NetRevenuesRetailCoPayments" xlink:href="cvs-20220630.xsd#cvs_NetRevenuesRetailCoPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NetRevenuesRetailCoPayments" xlink:to="lab_cvs_NetRevenuesRetailCoPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_11aea598-99d4-4e07-bf3b-4e1faf6eeaf8_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_184fb84c-eb47-4402-9489-3e4336adbd42_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward contract, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8837f40a-e895-43a3-b7f6-18efe96c463c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_c2d1ea54-9211-44c3-9692-f45396af702d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SalesChannelOtherMember_e0172649-ceb9-49ad-b898-d89916757d63_terseLabel_en-US" xlink:label="lab_cvs_SalesChannelOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_cvs_SalesChannelOtherMember_label_en-US" xlink:label="lab_cvs_SalesChannelOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Other [Member]</link:label>
    <link:label id="lab_cvs_SalesChannelOtherMember_documentation_en-US" xlink:label="lab_cvs_SalesChannelOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SalesChannelOtherMember" xlink:href="cvs-20220630.xsd#cvs_SalesChannelOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SalesChannelOtherMember" xlink:to="lab_cvs_SalesChannelOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_d3a137ff-f28c-4cf1-aa24-21ec29eeaad4_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash (included in other current assets)</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_a92f9e18-498c-46ec-b59c-55d8572fa9ae_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:to="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_1d91642f-f593-4a48-98b8-5f0fab8832af_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:to="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f4683272-86c0-46fe-8e65-d77eccd622e1_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ee43e305-56ba-4ccf-81d6-225eedc85bd5_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_b576fcd0-8a32-417d-9032-22718f7e16a8_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_a7013954-c4d8-46da-a230-2e79f23b7271_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_961c1c2f-dc74-46f6-afec-345779c2f101_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_466fabcc-e156-413f-9452-028e5a9fb40f_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_1434575e-7361-4904-a717-2951fced0fdb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_803f4c85-8790-489d-889c-5f0be7a2e82d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_12aa181c-617b-4302-a7ae-e77620ad95e2_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4b4c5d31-dd75-4687-a005-85ca9a3e1d1a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_933cf6df-f6b3-4689-9238-a6c653ac7710_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_1220bc60-9b4a-47c5-8fed-ffd4cae49d50_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_bf8061f9-ed1f-4bc4-9d45-eb835c1c364f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Components of incurred health care costs</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_78c4e8d7-05b0-48c2-8d29-841c61ed9de9_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_342c4253-c2e3-4b5a-ad4f-fd02edf8eefa_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.25DueApril2050Member_18d33432-1321-4b2f-ad17-a2e49b55fae1_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.25DueApril2050Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.25% senior notes due April 2050</link:label>
    <link:label id="lab_cvs_SeniorNotes4.25DueApril2050Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.25DueApril2050Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.25%, Due April 2050 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.25DueApril2050Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.25DueApril2050Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.25%, Due April 2050 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.25DueApril2050Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.25DueApril2050Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.25DueApril2050Member" xlink:to="lab_cvs_SeniorNotes4.25DueApril2050Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_c4b88598-1675-4828-bf2a-199755e9859d_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_111225e7-6c4f-4440-9256-9b8778ccb59b_negatedTerseLabel_en-US" xlink:label="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury shares, net of ESPP issuances</link:label>
    <link:label id="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_label_en-US" xlink:label="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:label id="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_documentation_en-US" xlink:label="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:href="cvs-20220630.xsd#cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:to="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_05c0a4b6-f401-4978-a2e7-dac7bf50d2f3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for taxes related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_f8412c4d-440a-47a5-bf02-ef03ae1216c4_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_4c5e3bc3-56be-4f92-bcc8-f008bf527092_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthInsuranceProductLineMember_3eba92dd-af51-496e-bea8-bf850bab59d0_terseLabel_en-US" xlink:label="lab_us-gaap_HealthInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurance Product Line</link:label>
    <link:label id="lab_us-gaap_HealthInsuranceProductLineMember_label_en-US" xlink:label="lab_us-gaap_HealthInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurance Product Line [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthInsuranceProductLineMember" xlink:to="lab_us-gaap_HealthInsuranceProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList_b4bb7041-16cd-4234-bc44-9b29796cea3a_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Product and Service [Extensible List]</link:label>
    <link:label id="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList_label_en-US" xlink:label="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Product and Service [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:to="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DisposalGroupNotDiscontinuedOperationMigrationPeriod_6def744e-6ce5-461c-b4b3-3c5a12fcb061_terseLabel_en-US" xlink:label="lab_cvs_DisposalGroupNotDiscontinuedOperationMigrationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Member migration period</link:label>
    <link:label id="lab_cvs_DisposalGroupNotDiscontinuedOperationMigrationPeriod_label_en-US" xlink:label="lab_cvs_DisposalGroupNotDiscontinuedOperationMigrationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Migration Period</link:label>
    <link:label id="lab_cvs_DisposalGroupNotDiscontinuedOperationMigrationPeriod_documentation_en-US" xlink:label="lab_cvs_DisposalGroupNotDiscontinuedOperationMigrationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Migration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DisposalGroupNotDiscontinuedOperationMigrationPeriod" xlink:href="cvs-20220630.xsd#cvs_DisposalGroupNotDiscontinuedOperationMigrationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DisposalGroupNotDiscontinuedOperationMigrationPeriod" xlink:to="lab_cvs_DisposalGroupNotDiscontinuedOperationMigrationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_fd19bc46-32d3-4391-8a71-b41f6ee57594_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_629aed27-9ebc-4a62-af63-8ac8a3ba4bbd_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent_f4100580-568a-4ecd-bea3-5fd91f20bd40_terseLabel_en-US" xlink:label="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy claims and discounts payable</link:label>
    <link:label id="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent_label_en-US" xlink:label="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Claims and Discounts Payable, Current</link:label>
    <link:label id="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent_documentation_en-US" xlink:label="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Claims and Discounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:href="cvs-20220630.xsd#cvs_PharmacyClaimsandDiscountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:to="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_7060737b-90a4-48c3-abc7-bbf7b9b16f97_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, remaining authorized repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_b0a35854-81fa-4322-afda-cba789ea3f92_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_aaf15903-657c-4864-97d1-6ecbfa1d9025_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_16e27853-839c-481a-b554-f8f4a1ef41f9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions (net of cash acquired)</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_fb032c08-f583-4d0e-9f64-ee82f5a16a16_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SupportingRemainingProductsMember_62368c20-9a6d-43a6-b715-bc9fe8cbdc7d_terseLabel_en-US" xlink:label="lab_cvs_SupportingRemainingProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting remaining products</link:label>
    <link:label id="lab_cvs_SupportingRemainingProductsMember_label_en-US" xlink:label="lab_cvs_SupportingRemainingProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting Remaining Products [Member]</link:label>
    <link:label id="lab_cvs_SupportingRemainingProductsMember_documentation_en-US" xlink:label="lab_cvs_SupportingRemainingProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities in an unrealized capital loss position supporting remaining products.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingRemainingProductsMember" xlink:href="cvs-20220630.xsd#cvs_SupportingRemainingProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SupportingRemainingProductsMember" xlink:to="lab_cvs_SupportingRemainingProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_f469d3dd-a99d-46fb-bb1e-1c851293a3bc_verboseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit costs</link:label>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_label_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Net, Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:to="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_a39be2e7-5e3f-4601-940c-71f05b89e249_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_06634a10-c2a2-417b-97e6-df9eb38d3c38_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates_6bb7fc4a-b0f2-4b3b-b697-576db124c000_terseLabel_en-US" xlink:label="lab_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states in which the Company has entered the individual public health insurance exchange</link:label>
    <link:label id="lab_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates_label_en-US" xlink:label="lab_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Public Health Insurance Exchanges, Submitted Regulatory Filings, Number of States</link:label>
    <link:label id="lab_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates_documentation_en-US" xlink:label="lab_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Public Health Insurance Exchanges, Submitted Regulatory Filings, Number of States</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates" xlink:href="cvs-20220630.xsd#cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates" xlink:to="lab_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_StateOfFloridaSettlementMember_144904e6-9ecd-4d2c-b124-a8161b190b2b_terseLabel_en-US" xlink:label="lab_cvs_StateOfFloridaSettlementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Florida Settlement</link:label>
    <link:label id="lab_cvs_StateOfFloridaSettlementMember_label_en-US" xlink:label="lab_cvs_StateOfFloridaSettlementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Florida Settlement [Member]</link:label>
    <link:label id="lab_cvs_StateOfFloridaSettlementMember_documentation_en-US" xlink:label="lab_cvs_StateOfFloridaSettlementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Florida Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StateOfFloridaSettlementMember" xlink:href="cvs-20220630.xsd#cvs_StateOfFloridaSettlementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_StateOfFloridaSettlementMember" xlink:to="lab_cvs_StateOfFloridaSettlementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_96050198-bc3e-4b56-992e-2bae9a3a93bc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross realized capital gains</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Realized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_3d92cbdf-8d33-4479-a5c2-8e6b51b7db16_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_cf7d2a62-0237-417e-90cb-e0c4c165bb5b_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_a3d1ebc7-e1d0-4c9f-bd39-c533e104f818_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_f1e1567e-53ad-4be9-a5ae-b6eb184c1ab8_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PremiumsMember_93187189-e5e2-4f98-96d1-3c27b2ba91c9_terseLabel_en-US" xlink:label="lab_cvs_PremiumsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums</link:label>
    <link:label id="lab_cvs_PremiumsMember_label_en-US" xlink:label="lab_cvs_PremiumsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums [Member]</link:label>
    <link:label id="lab_cvs_PremiumsMember_documentation_en-US" xlink:label="lab_cvs_PremiumsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsMember" xlink:href="cvs-20220630.xsd#cvs_PremiumsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PremiumsMember" xlink:to="lab_cvs_PremiumsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.75DueMay2041Member_33310b63-33cf-4bc2-b304-3687f1d46ac3_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.75DueMay2041Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.75% senior notes due May 2041</link:label>
    <link:label id="lab_cvs_SeniorNotes5.75DueMay2041Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.75DueMay2041Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.75%, Due May 2041 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.75DueMay2041Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.75DueMay2041Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.75%, Due May 2041 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.75DueMay2041Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes5.75DueMay2041Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.75DueMay2041Member" xlink:to="lab_cvs_SeniorNotes5.75DueMay2041Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodOneMember_63d5e14b-0315-4feb-b65b-3c8d90f9d796_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodOneMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period One [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodOneMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodOneMember" xlink:href="cvs-20220630.xsd#cvs_YearOfOriginationPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodOneMember" xlink:to="lab_cvs_YearOfOriginationPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_7961c485-299f-4c0f-9330-d48062c9e8b6_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_5270ced5-62d4-4d32-954f-4533a3bc16c9_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_321f980b-967c-4b12-bee1-12a36dad4969_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_8855f214-c6fa-4e11-8c44-bcdc16dbc238_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_bba130c7-0acf-487c-a56a-9150161a3d5b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_c6cd7a4f-024a-4755-a28c-cc6a6f98d109_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_07c5cc5c-9140-4c92-9df4-ed7437a884a1_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, beginning of the period, net</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_5222ab92-16b4-4e9b-9281-4a64a750c122_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, end of the period, net</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_82dcd746-30e1-48a3-8d11-09a09b228dcb_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_367587a4-e07b-4f92-8241-7af4a7d0b082_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestitures and Asset Sales</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_f9f059bc-bc05-4847-8fa3-a60c13e93c6e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInvestmentExpense_ed9e7003-62b6-4ba9-94e7-fc12ef509f67_negatedLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment expenses</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInvestmentExpense_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Investment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInvestmentExpense" xlink:to="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_203fff0b-305a-41a1-88fb-54acbfeb4463_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI before reclassifications, pre-tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_b854dcc2-4118-44f4-a7b3-c1e1c562a31d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_0e436358-36b5-4394-bd0e-bf6a6e5c107f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.78DueMarch2038Member_0bb3b949-6320-4363-99cf-928800e1730c_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.78DueMarch2038Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.78% senior notes due March 2038</link:label>
    <link:label id="lab_cvs_SeniorNotes4.78DueMarch2038Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.78DueMarch2038Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.78%, Due March 2038 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.78DueMarch2038Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.78DueMarch2038Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.78%, Due March 2038 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.78DueMarch2038Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.78DueMarch2038Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.78DueMarch2038Member" xlink:to="lab_cvs_SeniorNotes4.78DueMarch2038Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_e9af2881-0f37-4fc4-b6d5-1864055808c0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCustomers_1f5e909d-d13a-4345-83ca-10528b5cded2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash receipts from customers</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCustomers_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCustomers" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCustomers" xlink:to="lab_us-gaap_ProceedsFromCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_17baf812-228e-456a-9402-e7fa3919f2a5_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_5362ae38-5301-49fc-828b-e48773546b46_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:to="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_254894bc-a65d-4c48-a82b-523a77172682_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_79c13390-c8f8-4f0c-95bd-b9c15caa9b05_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_b681188b-7a5c-4b4a-93ae-0c31af72e79a_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total incurred health care costs</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_c75f0f96-93bb-4f18-a6ad-90a54fe9eb46_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_f5f8e83f-4e28-4680-a781-5c388b57c529_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_46323a1f-a511-4123-bb20-efba4d05c33b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_26e1c138-39f8-437c-9b51-3dc8dc080cd8_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsAxis_01875f34-07aa-4327-bc8d-cafd7d85a9a5_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Axis]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsAxis_label_en-US" xlink:label="lab_cvs_TotalInvestmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsAxis" xlink:href="cvs-20220630.xsd#cvs_TotalInvestmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsAxis" xlink:to="lab_cvs_TotalInvestmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_0dc8de00-18ac-488b-b5dc-a3ec0f8d9c72_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_453c19f9-6fa0-43b2-9932-5358c5b8ba3f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Company's Borrowings</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_e33f7931-78ab-4383-a595-ffe04ea3c562_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_3b122e7a-b7c5-4067-b06c-cfd2d32ffac4_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesNoncurrent_f7aaa3c1-806b-4643-90e4-9c129a347f09_terseLabel_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term insurance liabilities</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesNoncurrent_label_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Noncurrent</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesNoncurrent_documentation_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:href="cvs-20220630.xsd#cvs_OtherInsuranceLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:to="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_e36d9a10-2c47-48a2-884c-0cf3147236b0_verboseLabel_en-US" xlink:label="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Activity in Mortgage Loan Portfolio</link:label>
    <link:label id="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_label_en-US" xlink:label="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Activity in mortgage loan portfolio [Table Text Block]</link:label>
    <link:label id="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_documentation_en-US" xlink:label="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Table representing activities in mortgage loan portfolio during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:href="cvs-20220630.xsd#cvs_ActivityInMortgageLoanPortfolioTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:to="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_545f4342-dab3-4341-9654-c65ed70edb01_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_3580dd43-302c-4b48-9de0-eab21a38ad13_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_b8a65095-5173-421e-b49a-af205fc665d9_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_56cb17c9-6bb5-46a9-b120-cb9301b5e5fd_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_2cba6b01-e2cb-48e1-95d4-cb9d7afbd17a_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables (included in accounts receivable, net)</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberofWalkInMedicalClinics_cc3b923b-2791-4842-bf0a-3ea45177bb35_terseLabel_en-US" xlink:label="lab_cvs_NumberofWalkInMedicalClinics" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of walk in medical clinics</link:label>
    <link:label id="lab_cvs_NumberofWalkInMedicalClinics_label_en-US" xlink:label="lab_cvs_NumberofWalkInMedicalClinics" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Walk In Medical Clinics</link:label>
    <link:label id="lab_cvs_NumberofWalkInMedicalClinics_documentation_en-US" xlink:label="lab_cvs_NumberofWalkInMedicalClinics" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Walk In Medical Clinics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofWalkInMedicalClinics" xlink:href="cvs-20220630.xsd#cvs_NumberofWalkInMedicalClinics"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberofWalkInMedicalClinics" xlink:to="lab_cvs_NumberofWalkInMedicalClinics" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ab57dd25-43db-4862-9325-7c655a6e526b_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net decrease in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_800e3d59-83a5-4ac6-9e0c-7b0d96c99fe4_verboseLabel_en-US" xlink:label="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Mortgage Loan Amortized Cost and Credit Quality Indicator</link:label>
    <link:label id="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_label_en-US" xlink:label="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Mortgage Loan Internal Credit Ratings [Table Text Block]</link:label>
    <link:label id="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_documentation_en-US" xlink:label="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule detailing credit quality information related to financing receivables by credit quality indicator and by class of financing receivable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:href="cvs-20220630.xsd#cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:to="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_7267f004-181c-4149-b51f-0be20779dad0_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_b61d2147-8132-4c71-8d35-8260e140f7f2_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsTable_e916b177-1cc6-4e91-8ccf-92a52a867b68_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Table]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsTable_label_en-US" xlink:label="lab_cvs_TotalInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTable" xlink:href="cvs-20220630.xsd#cvs_TotalInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsTable" xlink:to="lab_cvs_TotalInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodTwoMember_b3231efb-ba33-43d7-9164-becc25dccd8d_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodTwoMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Two [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodTwoMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodTwoMember" xlink:href="cvs-20220630.xsd#cvs_YearOfOriginationPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodTwoMember" xlink:to="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_716d0300-fdf0-4ab7-94b3-6e57d318790d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsTableTextBlock_43c4e175-361c-42a7-9feb-ce66f9618364_verboseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Total Investments</link:label>
    <link:label id="lab_cvs_TotalInvestmentsTableTextBlock_label_en-US" xlink:label="lab_cvs_TotalInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Table Text Block]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsTableTextBlock_documentation_en-US" xlink:label="lab_cvs_TotalInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item includes total investments, both current and long-term.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTableTextBlock" xlink:href="cvs-20220630.xsd#cvs_TotalInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsTableTextBlock" xlink:to="lab_cvs_TotalInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LegalSettlementPeriodOfPayment_bb6d93be-020c-43c7-a48f-9614861aff17_terseLabel_en-US" xlink:label="lab_cvs_LegalSettlementPeriodOfPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal settlement, period of payment</link:label>
    <link:label id="lab_cvs_LegalSettlementPeriodOfPayment_label_en-US" xlink:label="lab_cvs_LegalSettlementPeriodOfPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Settlement, Period of Payment</link:label>
    <link:label id="lab_cvs_LegalSettlementPeriodOfPayment_documentation_en-US" xlink:label="lab_cvs_LegalSettlementPeriodOfPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Settlement, Period of Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LegalSettlementPeriodOfPayment" xlink:href="cvs-20220630.xsd#cvs_LegalSettlementPeriodOfPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LegalSettlementPeriodOfPayment" xlink:to="lab_cvs_LegalSettlementPeriodOfPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_651987a4-3184-49ff-8222-a48ec44788af_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities</link:label>
    <link:label id="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Number of Positions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:to="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_11b001f8-5578-48b6-90b8-e8c0536ae97f_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_8899d885-607a-4088-a72e-3f14b5be4a96_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_f9c55b96-465b-4ab0-ac8e-9642bca9d16f_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_22b75003-2a5a-43d3-8d94-f8dcc8044906_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt Obligations</link:label>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDebtSecuritiesMember" xlink:to="lab_us-gaap_OtherDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_b92c51ed-592c-4799-a0cf-d9caaf104feb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HeartlandHealthcareServicesMember_a4ed58e1-1c25-4880-97a2-bc58efc458a7_terseLabel_en-US" xlink:label="lab_cvs_HeartlandHealthcareServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heartland Healthcare Services</link:label>
    <link:label id="lab_cvs_HeartlandHealthcareServicesMember_label_en-US" xlink:label="lab_cvs_HeartlandHealthcareServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heartland Healthcare Services [Member]</link:label>
    <link:label id="lab_cvs_HeartlandHealthcareServicesMember_documentation_en-US" xlink:label="lab_cvs_HeartlandHealthcareServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heartland Healthcare Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeartlandHealthcareServicesMember" xlink:href="cvs-20220630.xsd#cvs_HeartlandHealthcareServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HeartlandHealthcareServicesMember" xlink:to="lab_cvs_HeartlandHealthcareServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_5b9bbe59-619d-4e78-b492-d56eed37f099_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.5DueMay2042Member_eb2ed4f7-4669-41cf-a551-349e9bd12f31_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.5DueMay2042Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.5% senior notes due May 2042</link:label>
    <link:label id="lab_cvs_SeniorNotes4.5DueMay2042Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.5DueMay2042Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.5%, Due May 2042 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.5DueMay2042Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.5DueMay2042Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.5%, Due May 2042 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.5DueMay2042Member" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.5DueMay2042Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.5DueMay2042Member" xlink:to="lab_cvs_SeniorNotes4.5DueMay2042Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0cf066b2-deaf-4f5a-8905-c27747f51290_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromInterestAndDividendsReceived_30289532-f15b-4104-8df4-dc5123a4bc93_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and investment income received</link:label>
    <link:label id="lab_us-gaap_ProceedsFromInterestAndDividendsReceived_label_en-US" xlink:label="lab_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Interest and Dividends Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromInterestAndDividendsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:to="lab_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_851f1b70-1498-49c3-b89c-e4e9e13f41b8_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial liabilities measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_92ce09ff-8614-49d3-bec1-84b5b4ee8a4c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_31fe96e0-a983-4bee-9330-e16bb0f3089d_negatedTerseLabel_en-US" xlink:label="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition purchase price adjustment outside of measurement period</link:label>
    <link:label id="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_label_en-US" xlink:label="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Purchase Price Adjustment, Outside of Measurement Period</link:label>
    <link:label id="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_documentation_en-US" xlink:label="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Purchase Price Adjustment, Outside of Measurement Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:href="cvs-20220630.xsd#cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:to="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_3bb13d53-f10e-47c3-ad55-f197c932b518_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_93f583c7-d0f3-45a5-afc2-24fc34b94396_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate, Type of Property [Axis]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate, Type of Property [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:to="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodFiveMember_a159d240-e4ed-4630-883d-879ebef350d4_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFiveMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Five [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFiveMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Five [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFiveMember" xlink:href="cvs-20220630.xsd#cvs_YearOfOriginationPeriodFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodFiveMember" xlink:to="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_4fdbb35f-8971-47e4-b580-4a356dafcd76_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_e989033e-d324-4b9a-b453-64b1dc927395_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_92852be1-c7dc-4892-8295-7076195d2d8b_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PayflexMember_22cf5111-279d-4a61-af87-294194fa1ebe_terseLabel_en-US" xlink:label="lab_cvs_PayflexMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payflex</link:label>
    <link:label id="lab_cvs_PayflexMember_label_en-US" xlink:label="lab_cvs_PayflexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payflex [Member]</link:label>
    <link:label id="lab_cvs_PayflexMember_documentation_en-US" xlink:label="lab_cvs_PayflexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payflex</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PayflexMember" xlink:href="cvs-20220630.xsd#cvs_PayflexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PayflexMember" xlink:to="lab_cvs_PayflexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f97ce81e-a927-4124-9925-291881996e51_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ReconciliationOfOperatingIncomeToAdjustedOperatingIncomeTableTextBlock_5620ece7-c454-4c48-9819-4f6e69d89029_terseLabel_en-US" xlink:label="lab_cvs_ReconciliationOfOperatingIncomeToAdjustedOperatingIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Consolidated Operating Income to Adjusted Operating Income</link:label>
    <link:label id="lab_cvs_ReconciliationOfOperatingIncomeToAdjustedOperatingIncomeTableTextBlock_label_en-US" xlink:label="lab_cvs_ReconciliationOfOperatingIncomeToAdjustedOperatingIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Income to Adjusted Operating Income [Table Text Block]</link:label>
    <link:label id="lab_cvs_ReconciliationOfOperatingIncomeToAdjustedOperatingIncomeTableTextBlock_documentation_en-US" xlink:label="lab_cvs_ReconciliationOfOperatingIncomeToAdjustedOperatingIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Income to Adjusted Operating Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ReconciliationOfOperatingIncomeToAdjustedOperatingIncomeTableTextBlock" xlink:href="cvs-20220630.xsd#cvs_ReconciliationOfOperatingIncomeToAdjustedOperatingIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ReconciliationOfOperatingIncomeToAdjustedOperatingIncomeTableTextBlock" xlink:to="lab_cvs_ReconciliationOfOperatingIncomeToAdjustedOperatingIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_b697b3d5-32e6-433b-a815-5cf5406e5be0_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_0b09b678-fa71-465c-8c27-824cb8d30c62_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of subsidiaries (net of cash and restricted cash sold of $2,807)</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses, Net of Cash Divested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3e9bff4e-e7b3-4c47-bedc-a87057212cfd_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_fafed04a-9317-43be-8475-17b5a6ad66d1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross realized capital losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Realized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InternationalHealthCareRenewalRightsMember_c30c0a99-accf-43bd-971a-a1bffc0f86de_terseLabel_en-US" xlink:label="lab_cvs_InternationalHealthCareRenewalRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Health Care Renewal Rights</link:label>
    <link:label id="lab_cvs_InternationalHealthCareRenewalRightsMember_label_en-US" xlink:label="lab_cvs_InternationalHealthCareRenewalRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Health Care Renewal Rights [Member]</link:label>
    <link:label id="lab_cvs_InternationalHealthCareRenewalRightsMember_documentation_en-US" xlink:label="lab_cvs_InternationalHealthCareRenewalRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Health Care Renewal Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InternationalHealthCareRenewalRightsMember" xlink:href="cvs-20220630.xsd#cvs_InternationalHealthCareRenewalRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InternationalHealthCareRenewalRightsMember" xlink:to="lab_cvs_InternationalHealthCareRenewalRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_4992de0c-7eca-42b3-b2df-5163a4da0341_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Domain]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:to="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_70275de1-7511-40de-9db4-a6209217f64e_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>cvs-20220630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:0140da76-e33c-4901-8b3b-5aa42426ab0a,g:ea97fc95-8028-4e4e-8a3a-2f9f67911aac-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cvshealth.com/role/CoverPage" xlink:type="simple" xlink:href="cvs-20220630.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_5c787e24-1f94-4d9d-8060-c295479bbaf6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_6bbcf245-1ee4-4680-9199-6d35762fcd62" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c787e24-1f94-4d9d-8060-c295479bbaf6" xlink:to="loc_dei_DocumentType_6bbcf245-1ee4-4680-9199-6d35762fcd62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_006561ee-5903-4f69-8095-77404e92a40c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c787e24-1f94-4d9d-8060-c295479bbaf6" xlink:to="loc_dei_DocumentQuarterlyReport_006561ee-5903-4f69-8095-77404e92a40c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_5bc4a1da-926a-4ff1-af49-db24d510ed22" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c787e24-1f94-4d9d-8060-c295479bbaf6" xlink:to="loc_dei_DocumentPeriodEndDate_5bc4a1da-926a-4ff1-af49-db24d510ed22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_9df66c3b-b064-45ce-9620-278cf4e7dc82" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c787e24-1f94-4d9d-8060-c295479bbaf6" xlink:to="loc_dei_DocumentTransitionReport_9df66c3b-b064-45ce-9620-278cf4e7dc82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_1f7604b4-401e-4826-b64b-698ea54c105c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c787e24-1f94-4d9d-8060-c295479bbaf6" xlink:to="loc_dei_EntityFileNumber_1f7604b4-401e-4826-b64b-698ea54c105c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_87e0ca25-b9d8-4506-ab37-64e477584988" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c787e24-1f94-4d9d-8060-c295479bbaf6" xlink:to="loc_dei_EntityRegistrantName_87e0ca25-b9d8-4506-ab37-64e477584988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_f87b9a57-59a2-458d-aba9-62e9caf08e96" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c787e24-1f94-4d9d-8060-c295479bbaf6" xlink:to="loc_dei_EntityIncorporationStateCountryCode_f87b9a57-59a2-458d-aba9-62e9caf08e96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_7f30d19b-460b-43d4-a6cf-6b5fc78fbad2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c787e24-1f94-4d9d-8060-c295479bbaf6" xlink:to="loc_dei_EntityTaxIdentificationNumber_7f30d19b-460b-43d4-a6cf-6b5fc78fbad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_b1ecadcd-b146-46e1-90e7-3312d9878919" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c787e24-1f94-4d9d-8060-c295479bbaf6" xlink:to="loc_dei_EntityAddressAddressLine1_b1ecadcd-b146-46e1-90e7-3312d9878919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_cf026021-84e4-4e4c-addf-3dd23799adb6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c787e24-1f94-4d9d-8060-c295479bbaf6" xlink:to="loc_dei_EntityAddressCityOrTown_cf026021-84e4-4e4c-addf-3dd23799adb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_084c38b3-7484-44a8-9693-72f5a598e9f9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c787e24-1f94-4d9d-8060-c295479bbaf6" xlink:to="loc_dei_EntityAddressStateOrProvince_084c38b3-7484-44a8-9693-72f5a598e9f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_4198ade5-9991-4d90-bdcf-d3d2ea1719e2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c787e24-1f94-4d9d-8060-c295479bbaf6" xlink:to="loc_dei_EntityAddressPostalZipCode_4198ade5-9991-4d90-bdcf-d3d2ea1719e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_458242cc-9fc0-4f53-955d-102b3b0a40d8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c787e24-1f94-4d9d-8060-c295479bbaf6" xlink:to="loc_dei_CityAreaCode_458242cc-9fc0-4f53-955d-102b3b0a40d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_00c35591-eada-4c3b-b707-dd3c4231e548" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c787e24-1f94-4d9d-8060-c295479bbaf6" xlink:to="loc_dei_LocalPhoneNumber_00c35591-eada-4c3b-b707-dd3c4231e548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_aa31d563-a185-4ad9-a5e5-6e97ecab056d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c787e24-1f94-4d9d-8060-c295479bbaf6" xlink:to="loc_dei_Security12bTitle_aa31d563-a185-4ad9-a5e5-6e97ecab056d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_9b34f97c-1a9a-4b88-a08b-32e7429d11d1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c787e24-1f94-4d9d-8060-c295479bbaf6" xlink:to="loc_dei_TradingSymbol_9b34f97c-1a9a-4b88-a08b-32e7429d11d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_36b3b2be-03ec-477f-bd76-c0165817e127" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c787e24-1f94-4d9d-8060-c295479bbaf6" xlink:to="loc_dei_SecurityExchangeName_36b3b2be-03ec-477f-bd76-c0165817e127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_7604885d-d6f8-486f-b5c6-d8bd98e1d3fd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c787e24-1f94-4d9d-8060-c295479bbaf6" xlink:to="loc_dei_EntityCurrentReportingStatus_7604885d-d6f8-486f-b5c6-d8bd98e1d3fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_8b63937f-7ba9-4023-9070-4c328a250939" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c787e24-1f94-4d9d-8060-c295479bbaf6" xlink:to="loc_dei_EntityInteractiveDataCurrent_8b63937f-7ba9-4023-9070-4c328a250939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_c8a42f7c-b674-499c-a13c-52a7bafcf46c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c787e24-1f94-4d9d-8060-c295479bbaf6" xlink:to="loc_dei_EntityFilerCategory_c8a42f7c-b674-499c-a13c-52a7bafcf46c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_09ad971c-2028-4b19-ba67-cc5ce058cf08" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c787e24-1f94-4d9d-8060-c295479bbaf6" xlink:to="loc_dei_EntitySmallBusiness_09ad971c-2028-4b19-ba67-cc5ce058cf08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_1cee550f-9a13-4692-91f2-1e957bda3a00" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c787e24-1f94-4d9d-8060-c295479bbaf6" xlink:to="loc_dei_EntityEmergingGrowthCompany_1cee550f-9a13-4692-91f2-1e957bda3a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_ab91d006-a7f1-4cc4-b959-e97026350c00" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c787e24-1f94-4d9d-8060-c295479bbaf6" xlink:to="loc_dei_EntityShellCompany_ab91d006-a7f1-4cc4-b959-e97026350c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_a4da9f41-6ffb-4c59-ac11-40506870a1dc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c787e24-1f94-4d9d-8060-c295479bbaf6" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_a4da9f41-6ffb-4c59-ac11-40506870a1dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_a6244ac0-8909-4aad-917a-dc233ac9586d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c787e24-1f94-4d9d-8060-c295479bbaf6" xlink:to="loc_dei_EntityCentralIndexKey_a6244ac0-8909-4aad-917a-dc233ac9586d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_36f116f5-f8e7-4f03-92cd-42a7ef0daee4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c787e24-1f94-4d9d-8060-c295479bbaf6" xlink:to="loc_dei_CurrentFiscalYearEndDate_36f116f5-f8e7-4f03-92cd-42a7ef0daee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_bf662382-0286-4056-9de9-67e60685cea7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c787e24-1f94-4d9d-8060-c295479bbaf6" xlink:to="loc_dei_DocumentFiscalYearFocus_bf662382-0286-4056-9de9-67e60685cea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_d8319989-ec70-4bbd-af41-1c6bd3848152" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c787e24-1f94-4d9d-8060-c295479bbaf6" xlink:to="loc_dei_DocumentFiscalPeriodFocus_d8319989-ec70-4bbd-af41-1c6bd3848152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_6ab38844-b5d3-42fa-9ade-7ce878a5aba8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c787e24-1f94-4d9d-8060-c295479bbaf6" xlink:to="loc_dei_AmendmentFlag_6ab38844-b5d3-42fa-9ade-7ce878a5aba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="cvs-20220630.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_b0207d6a-a861-4e86-8baa-baa92fe9c6e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_84a6edcd-4cee-4fd7-aaf6-09dbef2bcfe1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b0207d6a-a861-4e86-8baa-baa92fe9c6e4" xlink:to="loc_us-gaap_StatementTable_84a6edcd-4cee-4fd7-aaf6-09dbef2bcfe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f193ca32-8a0b-4de1-b62b-176f366bfc6e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_84a6edcd-4cee-4fd7-aaf6-09dbef2bcfe1" xlink:to="loc_srt_ProductOrServiceAxis_f193ca32-8a0b-4de1-b62b-176f366bfc6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3566e73d-3049-4c7a-9265-c4db4e481cfa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_f193ca32-8a0b-4de1-b62b-176f366bfc6e" xlink:to="loc_srt_ProductsAndServicesDomain_3566e73d-3049-4c7a-9265-c4db4e481cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_09502f1d-c75e-4c9f-bb84-83e33e9fc431" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3566e73d-3049-4c7a-9265-c4db4e481cfa" xlink:to="loc_us-gaap_ProductMember_09502f1d-c75e-4c9f-bb84-83e33e9fc431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_5d12e57d-8f6b-4a50-9ee5-deb7bace7af5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3566e73d-3049-4c7a-9265-c4db4e481cfa" xlink:to="loc_us-gaap_ServiceMember_5d12e57d-8f6b-4a50-9ee5-deb7bace7af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_84a6edcd-4cee-4fd7-aaf6-09dbef2bcfe1" xlink:to="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_a21bbf82-cfb4-4207-84e5-f62338309a98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:to="loc_us-gaap_RevenuesAbstract_a21bbf82-cfb4-4207-84e5-f62338309a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2906aeeb-7d4b-479c-a539-9057baea8fba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_a21bbf82-cfb4-4207-84e5-f62338309a98" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2906aeeb-7d4b-479c-a539-9057baea8fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_018af743-e1df-481b-815f-dd9314cc01be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_a21bbf82-cfb4-4207-84e5-f62338309a98" xlink:to="loc_us-gaap_PremiumsEarnedNet_018af743-e1df-481b-815f-dd9314cc01be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_b290a3da-976a-4248-bf3c-7aa18813cc7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_a21bbf82-cfb4-4207-84e5-f62338309a98" xlink:to="loc_us-gaap_NetInvestmentIncome_b290a3da-976a-4248-bf3c-7aa18813cc7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_12a760e1-c7a6-408c-b180-7857c37811e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_a21bbf82-cfb4-4207-84e5-f62338309a98" xlink:to="loc_us-gaap_Revenues_12a760e1-c7a6-408c-b180-7857c37811e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_2156d320-ef10-4fa2-bbe8-830c83b1cb61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:to="loc_us-gaap_OperatingExpensesAbstract_2156d320-ef10-4fa2-bbe8-830c83b1cb61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_bb1808b5-315d-45d4-9b02-65af28d0e1a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2156d320-ef10-4fa2-bbe8-830c83b1cb61" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_bb1808b5-315d-45d4-9b02-65af28d0e1a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_0a5efc34-7af2-41c3-adc4-d8d6a0d4d7a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2156d320-ef10-4fa2-bbe8-830c83b1cb61" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_0a5efc34-7af2-41c3-adc4-d8d6a0d4d7a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_8a59a1ef-0bd1-4dc6-8d4e-edae0a58b90a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2156d320-ef10-4fa2-bbe8-830c83b1cb61" xlink:to="loc_us-gaap_OperatingExpenses_8a59a1ef-0bd1-4dc6-8d4e-edae0a58b90a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_b9cd57a9-079b-4809-b27d-7bcbc49dfef0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2156d320-ef10-4fa2-bbe8-830c83b1cb61" xlink:to="loc_us-gaap_CostsAndExpenses_b9cd57a9-079b-4809-b27d-7bcbc49dfef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_8d3d0c35-879e-4527-875d-f6c8628e0079" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:to="loc_us-gaap_OperatingIncomeLoss_8d3d0c35-879e-4527-875d-f6c8628e0079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_b0202fd4-5ac2-4773-a7e3-f2a966a50cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:to="loc_us-gaap_InterestExpense_b0202fd4-5ac2-4773-a7e3-f2a966a50cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_8baa3b63-29f0-4fa5-b833-8cb8ad4f2d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_8baa3b63-29f0-4fa5-b833-8cb8ad4f2d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2671f260-ebdc-4128-9c22-6010971f8185" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2671f260-ebdc-4128-9c22-6010971f8185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_63a55c6a-0fa4-46a1-8f1a-b9449190aa56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_63a55c6a-0fa4-46a1-8f1a-b9449190aa56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2e8fe9a4-79f5-4224-a4f6-4d14471f6811" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:to="loc_us-gaap_ProfitLoss_2e8fe9a4-79f5-4224-a4f6-4d14471f6811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9b7f4a04-1a6d-46a2-a240-b3d3735dab6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9b7f4a04-1a6d-46a2-a240-b3d3735dab6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_879d2804-6c20-4fba-add0-8213c2d33b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:to="loc_us-gaap_NetIncomeLoss_879d2804-6c20-4fba-add0-8213c2d33b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e7516c79-992a-47f5-8be3-e33289c3c28c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:to="loc_us-gaap_EarningsPerShareAbstract_e7516c79-992a-47f5-8be3-e33289c3c28c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_514671b5-3969-4721-8363-a674a142dee6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e7516c79-992a-47f5-8be3-e33289c3c28c" xlink:to="loc_us-gaap_EarningsPerShareBasic_514671b5-3969-4721-8363-a674a142dee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_97608436-699f-4d80-a6b5-e38ab1338384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e7516c79-992a-47f5-8be3-e33289c3c28c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_97608436-699f-4d80-a6b5-e38ab1338384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f234f4e9-9b0d-4c5a-b045-d8b83760a9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f234f4e9-9b0d-4c5a-b045-d8b83760a9a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b9ad7628-47a1-4d62-ad34-080d18bba061" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f234f4e9-9b0d-4c5a-b045-d8b83760a9a4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b9ad7628-47a1-4d62-ad34-080d18bba061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_984e8208-bde9-489c-8d02-800c8e9754a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f234f4e9-9b0d-4c5a-b045-d8b83760a9a4" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_984e8208-bde9-489c-8d02-800c8e9754a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_8581d130-afdc-4084-9e05-2b76b31c7615" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_8581d130-afdc-4084-9e05-2b76b31c7615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_3297c470-aacf-45ce-ac68-e1c9d1fb0faf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_adb710e3-7c85-4da4-8e02-0b919eac20c9" xlink:to="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_3297c470-aacf-45ce-ac68-e1c9d1fb0faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="cvs-20220630.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f9dcd507-7c8b-4029-a9ed-7cb598737dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_61b72f1c-8ca4-443b-9b06-275683373d97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f9dcd507-7c8b-4029-a9ed-7cb598737dc9" xlink:to="loc_us-gaap_ProfitLoss_61b72f1c-8ca4-443b-9b06-275683373d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_701daea8-0d9f-4baf-9346-ef9a85c72fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f9dcd507-7c8b-4029-a9ed-7cb598737dc9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_701daea8-0d9f-4baf-9346-ef9a85c72fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_e4faa014-29c5-44e4-8403-6a5db25b2d83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_701daea8-0d9f-4baf-9346-ef9a85c72fb3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_e4faa014-29c5-44e4-8403-6a5db25b2d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_f4e45c5e-2f9e-4a3f-9a7a-0988395ad4f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_701daea8-0d9f-4baf-9346-ef9a85c72fb3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_f4e45c5e-2f9e-4a3f-9a7a-0988395ad4f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1fa80204-3942-4140-8449-defb102f10b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_701daea8-0d9f-4baf-9346-ef9a85c72fb3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1fa80204-3942-4140-8449-defb102f10b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_183ce73d-bf43-49a5-8517-56827a3c1375" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_701daea8-0d9f-4baf-9346-ef9a85c72fb3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_183ce73d-bf43-49a5-8517-56827a3c1375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_fdc564be-acda-45ce-8d9d-33ce78aa41fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_701daea8-0d9f-4baf-9346-ef9a85c72fb3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_fdc564be-acda-45ce-8d9d-33ce78aa41fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_0a2d81a3-8653-4d7a-9fa1-2c34ee9c1a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f9dcd507-7c8b-4029-a9ed-7cb598737dc9" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_0a2d81a3-8653-4d7a-9fa1-2c34ee9c1a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_cff6d506-3eb2-4c6f-95f0-f1d6df55bb75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f9dcd507-7c8b-4029-a9ed-7cb598737dc9" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_cff6d506-3eb2-4c6f-95f0-f1d6df55bb75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_bb560ab0-7d92-4e61-891e-0f5a6b255645" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f9dcd507-7c8b-4029-a9ed-7cb598737dc9" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_bb560ab0-7d92-4e61-891e-0f5a6b255645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="cvs-20220630.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_8ff80cdb-0340-4523-b954-cd81e3ea177b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_4383bfa0-c56b-4e1a-a327-1eae7519a616" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8ff80cdb-0340-4523-b954-cd81e3ea177b" xlink:to="loc_us-gaap_AssetsAbstract_4383bfa0-c56b-4e1a-a327-1eae7519a616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_18f27a18-7508-44bc-924f-e317903c9707" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4383bfa0-c56b-4e1a-a327-1eae7519a616" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_18f27a18-7508-44bc-924f-e317903c9707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_c57ae4fb-b3b2-48f6-abdf-a53c59634bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4383bfa0-c56b-4e1a-a327-1eae7519a616" xlink:to="loc_us-gaap_ShortTermInvestments_c57ae4fb-b3b2-48f6-abdf-a53c59634bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_13e257e0-2f03-40da-bd63-bb670de62eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4383bfa0-c56b-4e1a-a327-1eae7519a616" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_13e257e0-2f03-40da-bd63-bb670de62eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_1e0083b2-bb94-4a27-abf1-d64017eeb2d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4383bfa0-c56b-4e1a-a327-1eae7519a616" xlink:to="loc_us-gaap_InventoryNet_1e0083b2-bb94-4a27-abf1-d64017eeb2d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_836fdb4c-074e-4c91-b9a6-6ff063ecda84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4383bfa0-c56b-4e1a-a327-1eae7519a616" xlink:to="loc_us-gaap_OtherAssetsCurrent_836fdb4c-074e-4c91-b9a6-6ff063ecda84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_9863e65c-cb1e-42f0-a460-811a080c1507" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4383bfa0-c56b-4e1a-a327-1eae7519a616" xlink:to="loc_us-gaap_AssetsCurrent_9863e65c-cb1e-42f0-a460-811a080c1507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_44e9907d-0713-4bc3-bfce-a439213bc33d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4383bfa0-c56b-4e1a-a327-1eae7519a616" xlink:to="loc_us-gaap_LongTermInvestments_44e9907d-0713-4bc3-bfce-a439213bc33d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_45da82ac-cf88-444a-8dde-1e6b7cb12135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4383bfa0-c56b-4e1a-a327-1eae7519a616" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_45da82ac-cf88-444a-8dde-1e6b7cb12135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_606fbee5-4a90-47c0-8de5-325a126e9ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4383bfa0-c56b-4e1a-a327-1eae7519a616" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_606fbee5-4a90-47c0-8de5-325a126e9ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_688a776e-a421-4447-a310-818ce63abab4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4383bfa0-c56b-4e1a-a327-1eae7519a616" xlink:to="loc_us-gaap_Goodwill_688a776e-a421-4447-a310-818ce63abab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ad9ec900-dd76-432f-8fb8-9300db969116" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4383bfa0-c56b-4e1a-a327-1eae7519a616" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ad9ec900-dd76-432f-8fb8-9300db969116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_cbf02ecd-39df-4d9a-855c-21e1b12b91dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4383bfa0-c56b-4e1a-a327-1eae7519a616" xlink:to="loc_us-gaap_SeparateAccountAssets_cbf02ecd-39df-4d9a-855c-21e1b12b91dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_ddab919c-438a-4c87-a70f-d2952859d6ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4383bfa0-c56b-4e1a-a327-1eae7519a616" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_ddab919c-438a-4c87-a70f-d2952859d6ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_100953aa-0380-4c9e-a3ac-b863416adf6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4383bfa0-c56b-4e1a-a327-1eae7519a616" xlink:to="loc_us-gaap_Assets_100953aa-0380-4c9e-a3ac-b863416adf6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_fbe79112-c2a9-4035-856d-87b556683099" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8ff80cdb-0340-4523-b954-cd81e3ea177b" xlink:to="loc_us-gaap_LiabilitiesAbstract_fbe79112-c2a9-4035-856d-87b556683099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_6703f53c-2c91-4001-a36b-cce2240b634d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_fbe79112-c2a9-4035-856d-87b556683099" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_6703f53c-2c91-4001-a36b-cce2240b634d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent_dea22390-fa76-4f17-8e46-fe68d057ef0c" xlink:href="cvs-20220630.xsd#cvs_PharmacyClaimsandDiscountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_fbe79112-c2a9-4035-856d-87b556683099" xlink:to="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent_dea22390-fa76-4f17-8e46-fe68d057ef0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_54b12ffe-a01c-4b96-ba18-eea5cbb524e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_fbe79112-c2a9-4035-856d-87b556683099" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_54b12ffe-a01c-4b96-ba18-eea5cbb524e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPolicyholderFunds_6d34432c-e6a0-41b2-afd6-1a20f5e90670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPolicyholderFunds"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_fbe79112-c2a9-4035-856d-87b556683099" xlink:to="loc_us-gaap_OtherPolicyholderFunds_6d34432c-e6a0-41b2-afd6-1a20f5e90670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_d021da6c-fe29-47ce-ba92-fe3e8d414447" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_fbe79112-c2a9-4035-856d-87b556683099" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_d021da6c-fe29-47ce-ba92-fe3e8d414447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesCurrent_832a6bbf-453b-4479-b9e0-7da0e55a9dc2" xlink:href="cvs-20220630.xsd#cvs_OtherInsuranceLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_fbe79112-c2a9-4035-856d-87b556683099" xlink:to="loc_cvs_OtherInsuranceLiabilitiesCurrent_832a6bbf-453b-4479-b9e0-7da0e55a9dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_5850e060-083f-4ad6-b15b-a5f6c8538afd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_fbe79112-c2a9-4035-856d-87b556683099" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_5850e060-083f-4ad6-b15b-a5f6c8538afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_6f49b891-be54-48a0-9f30-7b3c26fb2f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_fbe79112-c2a9-4035-856d-87b556683099" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_6f49b891-be54-48a0-9f30-7b3c26fb2f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_dc3b87e7-20a6-444e-b308-519d24343b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_fbe79112-c2a9-4035-856d-87b556683099" xlink:to="loc_us-gaap_LiabilitiesCurrent_dc3b87e7-20a6-444e-b308-519d24343b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_36279024-5f0f-4af8-9a24-4ef089e18117" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_fbe79112-c2a9-4035-856d-87b556683099" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_36279024-5f0f-4af8-9a24-4ef089e18117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_ff87c7ab-6e26-4ffe-a2fa-2845904ba3aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_fbe79112-c2a9-4035-856d-87b556683099" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_ff87c7ab-6e26-4ffe-a2fa-2845904ba3aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2c3506f5-d446-43f1-b7a8-7864c55ca09e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_fbe79112-c2a9-4035-856d-87b556683099" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2c3506f5-d446-43f1-b7a8-7864c55ca09e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability_3166f71e-a336-486c-824d-cdcb2b59fcc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_fbe79112-c2a9-4035-856d-87b556683099" xlink:to="loc_us-gaap_SeparateAccountsLiability_3166f71e-a336-486c-824d-cdcb2b59fcc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_c3f01d48-9d1e-41d1-9bbc-d2213f459207" xlink:href="cvs-20220630.xsd#cvs_OtherInsuranceLiabilitiesNoncurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_fbe79112-c2a9-4035-856d-87b556683099" xlink:to="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_c3f01d48-9d1e-41d1-9bbc-d2213f459207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_38b94eea-24b7-4f9a-9dde-b74d5a2f6bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_fbe79112-c2a9-4035-856d-87b556683099" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_38b94eea-24b7-4f9a-9dde-b74d5a2f6bcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_a6c43501-144d-4163-b4f8-7a28588879b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_fbe79112-c2a9-4035-856d-87b556683099" xlink:to="loc_us-gaap_Liabilities_a6c43501-144d-4163-b4f8-7a28588879b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_f685f197-f825-43b6-832c-02331a2e6abf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8ff80cdb-0340-4523-b954-cd81e3ea177b" xlink:to="loc_us-gaap_StockholdersEquityAbstract_f685f197-f825-43b6-832c-02331a2e6abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_d8346671-7cf1-4df6-a916-daa4cb8b0ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f685f197-f825-43b6-832c-02331a2e6abf" xlink:to="loc_us-gaap_PreferredStockValue_d8346671-7cf1-4df6-a916-daa4cb8b0ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_4b981020-4589-4814-8abc-eb45530d2b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f685f197-f825-43b6-832c-02331a2e6abf" xlink:to="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_4b981020-4589-4814-8abc-eb45530d2b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_7f807438-0034-45f6-bb1d-12f105fc867d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f685f197-f825-43b6-832c-02331a2e6abf" xlink:to="loc_us-gaap_TreasuryStockValue_7f807438-0034-45f6-bb1d-12f105fc867d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6eb13e74-3641-4220-8024-cc4b6ab00542" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f685f197-f825-43b6-832c-02331a2e6abf" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6eb13e74-3641-4220-8024-cc4b6ab00542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a6a49e89-3332-4bf5-a94e-f235fd9ef4c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f685f197-f825-43b6-832c-02331a2e6abf" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a6a49e89-3332-4bf5-a94e-f235fd9ef4c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ca7c5416-b694-4111-9885-af43d23db88e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f685f197-f825-43b6-832c-02331a2e6abf" xlink:to="loc_us-gaap_StockholdersEquity_ca7c5416-b694-4111-9885-af43d23db88e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_8c32330e-ea27-4419-8854-11bd7deced02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8ff80cdb-0340-4523-b954-cd81e3ea177b" xlink:to="loc_us-gaap_MinorityInterest_8c32330e-ea27-4419-8854-11bd7deced02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f5e6f7ff-deaa-4b5b-bf4b-4df0f48de6bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8ff80cdb-0340-4523-b954-cd81e3ea177b" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f5e6f7ff-deaa-4b5b-bf4b-4df0f48de6bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_2118b3b1-e58e-4906-8c56-997f16fe7518" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8ff80cdb-0340-4523-b954-cd81e3ea177b" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_2118b3b1-e58e-4906-8c56-997f16fe7518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="cvs-20220630.xsd#CondensedConsolidatedBalanceSheetsUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_693e4c01-cbf2-474e-a95e-76ade1b835d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e87b92af-9615-41cb-b091-de58a36ebb73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_693e4c01-cbf2-474e-a95e-76ade1b835d9" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e87b92af-9615-41cb-b091-de58a36ebb73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_2790993d-fd6b-4355-a912-ef50f2b1a17d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_693e4c01-cbf2-474e-a95e-76ade1b835d9" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_2790993d-fd6b-4355-a912-ef50f2b1a17d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_63f38c65-c37d-4e0b-aabe-15dd43212a52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_693e4c01-cbf2-474e-a95e-76ade1b835d9" xlink:to="loc_us-gaap_PreferredStockSharesIssued_63f38c65-c37d-4e0b-aabe-15dd43212a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_f99f9515-a827-4a78-b5e5-924cd56639e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_693e4c01-cbf2-474e-a95e-76ade1b835d9" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_f99f9515-a827-4a78-b5e5-924cd56639e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_ca89398c-141e-4e2a-a5f6-28bbe9c0f18d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_693e4c01-cbf2-474e-a95e-76ade1b835d9" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_ca89398c-141e-4e2a-a5f6-28bbe9c0f18d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_9d751986-a267-4117-af27-fa9c8e7d6a34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_693e4c01-cbf2-474e-a95e-76ade1b835d9" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_9d751986-a267-4117-af27-fa9c8e7d6a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_545d9a1c-973f-49e1-bf12-36674f0fbfdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_693e4c01-cbf2-474e-a95e-76ade1b835d9" xlink:to="loc_us-gaap_CommonStockSharesIssued_545d9a1c-973f-49e1-bf12-36674f0fbfdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_33fd197f-c07d-481a-9bc9-8fb8aae47910" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_693e4c01-cbf2-474e-a95e-76ade1b835d9" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_33fd197f-c07d-481a-9bc9-8fb8aae47910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_f83b33f7-de8d-444b-b773-84ee613c1404" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_693e4c01-cbf2-474e-a95e-76ade1b835d9" xlink:to="loc_us-gaap_TreasuryStockShares_f83b33f7-de8d-444b-b773-84ee613c1404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="cvs-20220630.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_8e5853ae-8e92-434f-a837-f261d8b3938b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ac8345a8-18f1-4b44-86f5-b44688159367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8e5853ae-8e92-434f-a837-f261d8b3938b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ac8345a8-18f1-4b44-86f5-b44688159367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCustomers_c0d5a41d-f685-4b66-acae-bc394502588f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCustomers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ac8345a8-18f1-4b44-86f5-b44688159367" xlink:to="loc_us-gaap_ProceedsFromCustomers_c0d5a41d-f685-4b66-acae-bc394502588f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_d95935f3-a075-4921-9547-fffc08cbc25e" xlink:href="cvs-20220630.xsd#cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ac8345a8-18f1-4b44-86f5-b44688159367" xlink:to="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_d95935f3-a075-4921-9547-fffc08cbc25e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInsuranceBenefits_9693175e-9f46-45da-9285-210556282d8a" xlink:href="cvs-20220630.xsd#cvs_PaymentsforInsuranceBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ac8345a8-18f1-4b44-86f5-b44688159367" xlink:to="loc_cvs_PaymentsforInsuranceBenefits_9693175e-9f46-45da-9285-210556282d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToSuppliersAndEmployees_e8eddc77-f8af-4192-b561-ada48207e6a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToSuppliersAndEmployees"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ac8345a8-18f1-4b44-86f5-b44688159367" xlink:to="loc_us-gaap_PaymentsToSuppliersAndEmployees_e8eddc77-f8af-4192-b561-ada48207e6a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_f459097f-dcc4-41e8-a3ed-9a0fc495855b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromInterestAndDividendsReceived"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ac8345a8-18f1-4b44-86f5-b44688159367" xlink:to="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_f459097f-dcc4-41e8-a3ed-9a0fc495855b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_6bd55d55-d891-4eb1-8f44-0c23e5ea7c90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ac8345a8-18f1-4b44-86f5-b44688159367" xlink:to="loc_us-gaap_InterestPaidNet_6bd55d55-d891-4eb1-8f44-0c23e5ea7c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_9bcd8dc3-b224-4e5f-bc52-9269c67a49e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ac8345a8-18f1-4b44-86f5-b44688159367" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_9bcd8dc3-b224-4e5f-bc52-9269c67a49e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b8797592-efd5-484f-9e45-c1a4b2a57833" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ac8345a8-18f1-4b44-86f5-b44688159367" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b8797592-efd5-484f-9e45-c1a4b2a57833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5e0d8580-27c1-4d0a-a4d3-43590d6fd819" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8e5853ae-8e92-434f-a837-f261d8b3938b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5e0d8580-27c1-4d0a-a4d3-43590d6fd819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_d3b38d81-265e-48a9-ada0-3944cf67a426" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5e0d8580-27c1-4d0a-a4d3-43590d6fd819" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_d3b38d81-265e-48a9-ada0-3944cf67a426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_18ea3013-c19b-4224-ba92-aa67310db0c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5e0d8580-27c1-4d0a-a4d3-43590d6fd819" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_18ea3013-c19b-4224-ba92-aa67310db0c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7ee404bc-f1f0-4824-9919-ac7b31145f36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5e0d8580-27c1-4d0a-a4d3-43590d6fd819" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7ee404bc-f1f0-4824-9919-ac7b31145f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_68ffaa45-905c-42d7-b7be-4d001ce7b9b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5e0d8580-27c1-4d0a-a4d3-43590d6fd819" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_68ffaa45-905c-42d7-b7be-4d001ce7b9b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_d6dd6aca-bea8-4e60-a844-44be1974b6bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5e0d8580-27c1-4d0a-a4d3-43590d6fd819" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_d6dd6aca-bea8-4e60-a844-44be1974b6bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_b55f2903-3159-423a-97b1-c883f1470cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5e0d8580-27c1-4d0a-a4d3-43590d6fd819" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_b55f2903-3159-423a-97b1-c883f1470cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_06b5af2b-2715-43fe-a081-5cefca436b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5e0d8580-27c1-4d0a-a4d3-43590d6fd819" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_06b5af2b-2715-43fe-a081-5cefca436b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1b35d2e9-d36c-47ff-a31e-81a0427df9e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8e5853ae-8e92-434f-a837-f261d8b3938b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1b35d2e9-d36c-47ff-a31e-81a0427df9e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_2848d683-cff0-40b3-86c8-1a6e28eb3d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1b35d2e9-d36c-47ff-a31e-81a0427df9e2" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_2848d683-cff0-40b3-86c8-1a6e28eb3d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_38e8959d-af08-4889-a457-7e8f811b19a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1b35d2e9-d36c-47ff-a31e-81a0427df9e2" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_38e8959d-af08-4889-a457-7e8f811b19a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_2dd8f290-cd0f-4d09-8e53-9808f3f96dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1b35d2e9-d36c-47ff-a31e-81a0427df9e2" xlink:to="loc_us-gaap_PaymentsOfDividends_2dd8f290-cd0f-4d09-8e53-9808f3f96dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_08aeb65c-3049-4883-a387-35c7917ac85f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1b35d2e9-d36c-47ff-a31e-81a0427df9e2" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_08aeb65c-3049-4883-a387-35c7917ac85f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1f10f5f9-04a4-45a4-9c93-9f8f936c4580" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1b35d2e9-d36c-47ff-a31e-81a0427df9e2" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1f10f5f9-04a4-45a4-9c93-9f8f936c4580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_3f037df7-074c-4476-9222-8a8f90fa4359" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1b35d2e9-d36c-47ff-a31e-81a0427df9e2" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_3f037df7-074c-4476-9222-8a8f90fa4359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3c6432b8-eb09-4d37-8660-f1a9e554f271" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1b35d2e9-d36c-47ff-a31e-81a0427df9e2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3c6432b8-eb09-4d37-8660-f1a9e554f271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_67952519-cafd-45b6-8f49-b732ab1f3587" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8e5853ae-8e92-434f-a837-f261d8b3938b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_67952519-cafd-45b6-8f49-b732ab1f3587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_89f03102-23d0-407c-a596-b27bc5b80104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8e5853ae-8e92-434f-a837-f261d8b3938b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_89f03102-23d0-407c-a596-b27bc5b80104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_833a9da9-b627-43f1-a05b-47d562b7c6ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8e5853ae-8e92-434f-a837-f261d8b3938b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_833a9da9-b627-43f1-a05b-47d562b7c6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_e9c8ab95-2450-4391-b89b-c5e5e0312ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8e5853ae-8e92-434f-a837-f261d8b3938b" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_e9c8ab95-2450-4391-b89b-c5e5e0312ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1baa9595-2379-4b9c-b97b-28152b62857a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_e9c8ab95-2450-4391-b89b-c5e5e0312ed0" xlink:to="loc_us-gaap_ProfitLoss_1baa9595-2379-4b9c-b97b-28152b62857a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571c334b-0dfb-4c60-8563-26a4a854dfc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_e9c8ab95-2450-4391-b89b-c5e5e0312ed0" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571c334b-0dfb-4c60-8563-26a4a854dfc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_847ddaf6-2466-45e7-bb7e-6585b09ef07d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571c334b-0dfb-4c60-8563-26a4a854dfc7" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_847ddaf6-2466-45e7-bb7e-6585b09ef07d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_8da365dc-fd29-4f3c-933d-c840dad1ff4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571c334b-0dfb-4c60-8563-26a4a854dfc7" xlink:to="loc_us-gaap_ShareBasedCompensation_8da365dc-fd29-4f3c-933d-c840dad1ff4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_35de94fc-9f38-4659-b4e9-4d999970fc45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571c334b-0dfb-4c60-8563-26a4a854dfc7" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_35de94fc-9f38-4659-b4e9-4d999970fc45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Deferredincometaxesandothernoncashitems_20b52d38-1e5f-44ab-bc5d-83d92322e935" xlink:href="cvs-20220630.xsd#cvs_Deferredincometaxesandothernoncashitems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571c334b-0dfb-4c60-8563-26a4a854dfc7" xlink:to="loc_cvs_Deferredincometaxesandothernoncashitems_20b52d38-1e5f-44ab-bc5d-83d92322e935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_dc35f6e1-cfb3-43df-8422-32a3e21369cd" xlink:href="cvs-20220630.xsd#cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571c334b-0dfb-4c60-8563-26a4a854dfc7" xlink:to="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_dc35f6e1-cfb3-43df-8422-32a3e21369cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0fff948f-a9cf-4dc7-a32d-751114890323" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_dc35f6e1-cfb3-43df-8422-32a3e21369cd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0fff948f-a9cf-4dc7-a32d-751114890323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_b9b8f2c3-30d7-4bd5-a603-f74f6ec36b25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_dc35f6e1-cfb3-43df-8422-32a3e21369cd" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_b9b8f2c3-30d7-4bd5-a603-f74f6ec36b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_a5f966c7-d479-4995-b8c8-f1d3f5e0bbad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_dc35f6e1-cfb3-43df-8422-32a3e21369cd" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_a5f966c7-d479-4995-b8c8-f1d3f5e0bbad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_490e58ef-9d3a-459c-8126-bf13bee38e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_dc35f6e1-cfb3-43df-8422-32a3e21369cd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_490e58ef-9d3a-459c-8126-bf13bee38e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_4fb648da-94aa-4bc3-9120-dc4a01da3bae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_dc35f6e1-cfb3-43df-8422-32a3e21369cd" xlink:to="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_4fb648da-94aa-4bc3-9120-dc4a01da3bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_c7c19767-6b66-4eff-b172-75afdff0a888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_dc35f6e1-cfb3-43df-8422-32a3e21369cd" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_c7c19767-6b66-4eff-b172-75afdff0a888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_28e98c36-677e-4c2c-9295-949f9f5b6986" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_dc35f6e1-cfb3-43df-8422-32a3e21369cd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_28e98c36-677e-4c2c-9295-949f9f5b6986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1" xlink:type="simple" xlink:href="cvs-20220630.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited_1"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnauditedParenthetical" xlink:type="simple" xlink:href="cvs-20220630.xsd#CondensedConsolidatedStatementsofCashFlowsUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_c5662864-7573-435d-8562-1c003087c73c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDivestedFromDeconsolidation_18e00135-8fee-4037-bca2-69530c7ff7f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashDivestedFromDeconsolidation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c5662864-7573-435d-8562-1c003087c73c" xlink:to="loc_us-gaap_CashDivestedFromDeconsolidation_18e00135-8fee-4037-bca2-69530c7ff7f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited" xlink:type="simple" xlink:href="cvs-20220630.xsd#CondensedConsolidatedStatementsofShareholdersEquityUnaudited"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_865fcfc9-f756-4aa4-ad55-ccac0873a8c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_224c3900-2502-4619-b442-895585a50745" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_865fcfc9-f756-4aa4-ad55-ccac0873a8c5" xlink:to="loc_us-gaap_StatementTable_224c3900-2502-4619-b442-895585a50745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2ac9f726-8b7a-4110-b659-ad1709ce14eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_224c3900-2502-4619-b442-895585a50745" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2ac9f726-8b7a-4110-b659-ad1709ce14eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_da066759-225d-4e5b-8ba8-4b729db55a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2ac9f726-8b7a-4110-b659-ad1709ce14eb" xlink:to="loc_us-gaap_EquityComponentDomain_da066759-225d-4e5b-8ba8-4b729db55a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_d4077145-9805-4810-85bb-6e1aa7a4ceb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_da066759-225d-4e5b-8ba8-4b729db55a7d" xlink:to="loc_us-gaap_ParentMember_d4077145-9805-4810-85bb-6e1aa7a4ceb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c7f7f8a1-56d0-4fd5-8348-4fa96cd34e27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_d4077145-9805-4810-85bb-6e1aa7a4ceb5" xlink:to="loc_us-gaap_CommonStockMember_c7f7f8a1-56d0-4fd5-8348-4fa96cd34e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_0bcfef67-e2f1-4803-906f-2c18ac1837a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_d4077145-9805-4810-85bb-6e1aa7a4ceb5" xlink:to="loc_us-gaap_TreasuryStockCommonMember_0bcfef67-e2f1-4803-906f-2c18ac1837a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_62f8e603-c671-49f6-8991-7a04b108a1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_d4077145-9805-4810-85bb-6e1aa7a4ceb5" xlink:to="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_62f8e603-c671-49f6-8991-7a04b108a1fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b780ad18-f257-4043-9740-0028249b4610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_d4077145-9805-4810-85bb-6e1aa7a4ceb5" xlink:to="loc_us-gaap_RetainedEarningsMember_b780ad18-f257-4043-9740-0028249b4610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e48f63c8-4782-43ef-92ab-4d16c705e95c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_d4077145-9805-4810-85bb-6e1aa7a4ceb5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e48f63c8-4782-43ef-92ab-4d16c705e95c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_0fd9a30a-4054-425d-aadf-ff449e00f814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_da066759-225d-4e5b-8ba8-4b729db55a7d" xlink:to="loc_us-gaap_NoncontrollingInterestMember_0fd9a30a-4054-425d-aadf-ff449e00f814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_25f5b957-2caa-4643-a2e5-4dafc04a5984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_224c3900-2502-4619-b442-895585a50745" xlink:to="loc_us-gaap_StatementLineItems_25f5b957-2caa-4643-a2e5-4dafc04a5984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_25f5b957-2caa-4643-a2e5-4dafc04a5984" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_97128ebd-cfd0-46b0-adcc-ed79649704d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:to="loc_us-gaap_SharesOutstanding_97128ebd-cfd0-46b0-adcc-ed79649704d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_d47a3cca-48dd-478a-a450-0579df5bddb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:to="loc_us-gaap_TreasuryStockCommonShares_d47a3cca-48dd-478a-a450-0579df5bddb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d0e85cf5-7059-4256-b7f8-3f1de9199b69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d0e85cf5-7059-4256-b7f8-3f1de9199b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1a4faf17-afb9-4f05-b36c-5a8b712d1d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:to="loc_us-gaap_ProfitLoss_1a4faf17-afb9-4f05-b36c-5a8b712d1d9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2b9f4ecb-9179-4a48-856c-65bbd302b629" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2b9f4ecb-9179-4a48-856c-65bbd302b629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8df1f7fd-ffce-44e6-bcb1-435f075a19d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8df1f7fd-ffce-44e6-bcb1-435f075a19d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_9366e7f2-09d4-45a3-8cb0-bf45fb6c5be8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_9366e7f2-09d4-45a3-8cb0-bf45fb6c5be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_9b6a8d13-7b31-4e64-ae03-ab33d1c13c76" xlink:href="cvs-20220630.xsd#cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:to="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_9b6a8d13-7b31-4e64-ae03-ab33d1c13c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_ce828c88-2fb9-464c-b7b8-93649e5afd73" xlink:href="cvs-20220630.xsd#cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:to="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_ce828c88-2fb9-464c-b7b8-93649e5afd73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_5998053c-299d-4c80-b979-79f7523d5cf7" xlink:href="cvs-20220630.xsd#cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:to="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_5998053c-299d-4c80-b979-79f7523d5cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_a53e680a-1b6f-4eb8-883f-5bbc4db0b431" xlink:href="cvs-20220630.xsd#cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:to="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_a53e680a-1b6f-4eb8-883f-5bbc4db0b431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_faccf851-0044-4fae-836b-5ab15248ac8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:to="loc_us-gaap_DividendsCommonStock_faccf851-0044-4fae-836b-5ab15248ac8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_eb4adee5-0e5b-4f1a-9d99-b97d9f6e9f16" xlink:href="cvs-20220630.xsd#cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:to="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_eb4adee5-0e5b-4f1a-9d99-b97d9f6e9f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_7eb37ecf-3e8e-46d5-9e47-7bdfd8b116ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:to="loc_us-gaap_SharesOutstanding_7eb37ecf-3e8e-46d5-9e47-7bdfd8b116ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_144115dd-a715-4dd8-a1af-593b42c036e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:to="loc_us-gaap_TreasuryStockCommonShares_144115dd-a715-4dd8-a1af-593b42c036e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0ab4e05a-3e0d-4163-9cbb-77a5da341412" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bbc0ef2c-4629-4614-ac61-57d49fb750d0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0ab4e05a-3e0d-4163-9cbb-77a5da341412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParenthetical" xlink:type="simple" xlink:href="cvs-20220630.xsd#CondensedConsolidatedStatementsofShareholdersEquityParenthetical"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_e3a03544-d9f4-42d5-bae6-2948151cb8ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesHeldinTrust_00834218-ec22-4ca5-b7c4-3d8b00cc2d2d" xlink:href="cvs-20220630.xsd#cvs_TreasuryStockSharesHeldinTrust"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_e3a03544-d9f4-42d5-bae6-2948151cb8ae" xlink:to="loc_cvs_TreasuryStockSharesHeldinTrust_00834218-ec22-4ca5-b7c4-3d8b00cc2d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueSharesHeldInTrust_e4bf7cc8-9311-455e-a27b-cded930451fa" xlink:href="cvs-20220630.xsd#cvs_TreasuryStockValueSharesHeldInTrust"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_e3a03544-d9f4-42d5-bae6-2948151cb8ae" xlink:to="loc_cvs_TreasuryStockValueSharesHeldInTrust_e4bf7cc8-9311-455e-a27b-cded930451fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_deaa39c2-5385-48b0-b4de-33c5a9fa4b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_e3a03544-d9f4-42d5-bae6-2948151cb8ae" xlink:to="loc_us-gaap_CommonStockValue_deaa39c2-5385-48b0-b4de-33c5a9fa4b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="cvs-20220630.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e7bbb2c7-6092-40af-8071-a4d9e9748fae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_19ddddb5-326e-4301-8b77-f922ed2b4de7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e7bbb2c7-6092-40af-8071-a4d9e9748fae" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_19ddddb5-326e-4301-8b77-f922ed2b4de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="cvs-20220630.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_68ac9410-8ce1-423a-bd9b-cb23b9d52eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_2bc17235-d1b8-4b54-abf4-f5ec502d24f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_68ac9410-8ce1-423a-bd9b-cb23b9d52eb9" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_2bc17235-d1b8-4b54-abf4-f5ec502d24f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_bce390f4-dd98-40b0-8162-308d86b80f85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_68ac9410-8ce1-423a-bd9b-cb23b9d52eb9" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_bce390f4-dd98-40b0-8162-308d86b80f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_fbac1c14-bd6d-4cb5-9b91-98f7749336cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_68ac9410-8ce1-423a-bd9b-cb23b9d52eb9" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_fbac1c14-bd6d-4cb5-9b91-98f7749336cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_59919775-7cf5-4859-a21b-918c84003907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_68ac9410-8ce1-423a-bd9b-cb23b9d52eb9" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_59919775-7cf5-4859-a21b-918c84003907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_6d65869c-841a-4096-b0db-f97872504d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_68ac9410-8ce1-423a-bd9b-cb23b9d52eb9" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_6d65869c-841a-4096-b0db-f97872504d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_a9b282d7-cb37-49dd-a934-43ab430dc80a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_68ac9410-8ce1-423a-bd9b-cb23b9d52eb9" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_a9b282d7-cb37-49dd-a934-43ab430dc80a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_f5331c68-b33c-4fb3-b4e9-baf594b2a703" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_68ac9410-8ce1-423a-bd9b-cb23b9d52eb9" xlink:to="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_f5331c68-b33c-4fb3-b4e9-baf594b2a703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_ea37d641-816e-41b1-b0ce-f80c3a1d0711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_68ac9410-8ce1-423a-bd9b-cb23b9d52eb9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_ea37d641-816e-41b1-b0ce-f80c3a1d0711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_6e3c3641-448e-4c3d-a258-7682351d7c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_68ac9410-8ce1-423a-bd9b-cb23b9d52eb9" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_6e3c3641-448e-4c3d-a258-7682351d7c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a5cf1b48-8d1f-44c4-a6e1-2d8bf23f2dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_68ac9410-8ce1-423a-bd9b-cb23b9d52eb9" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a5cf1b48-8d1f-44c4-a6e1-2d8bf23f2dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="cvs-20220630.xsd#SignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_48de4227-ef28-41be-8a40-010e566b83ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_bae7446f-f3bf-48f5-be23-34abf2bcde9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_48de4227-ef28-41be-8a40-010e566b83ea" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_bae7446f-f3bf-48f5-be23-34abf2bcde9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_d908c4e8-57a5-416a-9f12-cdf53bd455b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_48de4227-ef28-41be-8a40-010e566b83ea" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_d908c4e8-57a5-416a-9f12-cdf53bd455b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_0b1cd0a5-2569-43b1-894d-de8c01ba1964" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_48de4227-ef28-41be-8a40-010e566b83ea" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_0b1cd0a5-2569-43b1-894d-de8c01ba1964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_ffaaef80-2664-43e0-ae92-d8b7adb2c5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_48de4227-ef28-41be-8a40-010e566b83ea" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_ffaaef80-2664-43e0-ae92-d8b7adb2c5c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_156802fc-f7da-4b04-ba92-989c6f59dcbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f179492d-bd74-40fd-a88a-2f6e27cf6f67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_156802fc-f7da-4b04-ba92-989c6f59dcbc" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f179492d-bd74-40fd-a88a-2f6e27cf6f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_72760657-4f08-4fa3-93ec-7fda6db4e83e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f179492d-bd74-40fd-a88a-2f6e27cf6f67" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_72760657-4f08-4fa3-93ec-7fda6db4e83e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5e96ecf2-38dd-4f99-9fb2-c0afc7a7087e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_72760657-4f08-4fa3-93ec-7fda6db4e83e" xlink:to="loc_us-gaap_SegmentDomain_5e96ecf2-38dd-4f99-9fb2-c0afc7a7087e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_25278772-3353-4819-b57b-a78a1c548543" xlink:href="cvs-20220630.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5e96ecf2-38dd-4f99-9fb2-c0afc7a7087e" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_25278772-3353-4819-b57b-a78a1c548543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_6dc4458e-c655-497a-af8d-fc4d51265d3a" xlink:href="cvs-20220630.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5e96ecf2-38dd-4f99-9fb2-c0afc7a7087e" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_6dc4458e-c655-497a-af8d-fc4d51265d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_fdecdea5-ea16-48ae-9370-f056041e76ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f179492d-bd74-40fd-a88a-2f6e27cf6f67" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_fdecdea5-ea16-48ae-9370-f056041e76ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_b8b77535-548c-4a30-9a83-2d8e5c4640b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_fdecdea5-ea16-48ae-9370-f056041e76ee" xlink:to="loc_us-gaap_RelatedPartyDomain_b8b77535-548c-4a30-9a83-2d8e5c4640b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeartlandHealthcareServicesMember_2dff56fb-49d0-4b8c-bb8c-f50b9e485a77" xlink:href="cvs-20220630.xsd#cvs_HeartlandHealthcareServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_b8b77535-548c-4a30-9a83-2d8e5c4640b9" xlink:to="loc_cvs_HeartlandHealthcareServicesMember_2dff56fb-49d0-4b8c-bb8c-f50b9e485a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_578ed20d-abe8-4756-9139-67092f089946" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f179492d-bd74-40fd-a88a-2f6e27cf6f67" xlink:to="loc_srt_StatementScenarioAxis_578ed20d-abe8-4756-9139-67092f089946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_51aa0c00-670d-4b6c-a860-800ad93b4d47" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_578ed20d-abe8-4756-9139-67092f089946" xlink:to="loc_srt_ScenarioUnspecifiedDomain_51aa0c00-670d-4b6c-a860-800ad93b4d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_4fb475ab-e771-4261-b8ba-ddbcf98befa4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_51aa0c00-670d-4b6c-a860-800ad93b4d47" xlink:to="loc_srt_ScenarioForecastMember_4fb475ab-e771-4261-b8ba-ddbcf98befa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d6c422a2-aa77-48cb-8609-0c4e62f7a556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f179492d-bd74-40fd-a88a-2f6e27cf6f67" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d6c422a2-aa77-48cb-8609-0c4e62f7a556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores_cc7654ff-e3d3-4e4a-9a27-c31aabdc4dca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfStores"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d6c422a2-aa77-48cb-8609-0c4e62f7a556" xlink:to="loc_us-gaap_NumberOfStores_cc7654ff-e3d3-4e4a-9a27-c31aabdc4dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofWalkInMedicalClinics_26116672-1ce3-4b56-ad2a-052d28e50e91" xlink:href="cvs-20220630.xsd#cvs_NumberofWalkInMedicalClinics"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d6c422a2-aa77-48cb-8609-0c4e62f7a556" xlink:to="loc_cvs_NumberofWalkInMedicalClinics_26116672-1ce3-4b56-ad2a-052d28e50e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPharmacyPlanMembers_9fc18869-f417-4642-b36c-0f9e0cc1282a" xlink:href="cvs-20220630.xsd#cvs_NumberofPharmacyPlanMembers"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d6c422a2-aa77-48cb-8609-0c4e62f7a556" xlink:to="loc_cvs_NumberofPharmacyPlanMembers_9fc18869-f417-4642-b36c-0f9e0cc1282a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPatientsServedperYear_5f663670-d097-406c-8e85-af2ba74e9ede" xlink:href="cvs-20220630.xsd#cvs_NumberofPatientsServedperYear"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d6c422a2-aa77-48cb-8609-0c4e62f7a556" xlink:to="loc_cvs_NumberofPatientsServedperYear_5f663670-d097-406c-8e85-af2ba74e9ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPeopleServed_21703a69-3d16-4f3a-acf5-3b3498dd5de9" xlink:href="cvs-20220630.xsd#cvs_NumberOfPeopleServed"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d6c422a2-aa77-48cb-8609-0c4e62f7a556" xlink:to="loc_cvs_NumberOfPeopleServed_21703a69-3d16-4f3a-acf5-3b3498dd5de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_99b2d9a5-5b71-4165-bdde-d134aebf6bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d6c422a2-aa77-48cb-8609-0c4e62f7a556" xlink:to="loc_us-gaap_NumberOfReportableSegments_99b2d9a5-5b71-4165-bdde-d134aebf6bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates_73178378-ffbd-4438-90b0-b5211e123a57" xlink:href="cvs-20220630.xsd#cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d6c422a2-aa77-48cb-8609-0c4e62f7a556" xlink:to="loc_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates_73178378-ffbd-4438-90b0-b5211e123a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfAdditionalStates_fb575fb7-8a43-4a41-ba87-a304dd379e55" xlink:href="cvs-20220630.xsd#cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfAdditionalStates"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d6c422a2-aa77-48cb-8609-0c4e62f7a556" xlink:to="loc_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfAdditionalStates_fb575fb7-8a43-4a41-ba87-a304dd379e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_83439d9a-404c-475b-be6e-8c179762c4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d6c422a2-aa77-48cb-8609-0c4e62f7a556" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_83439d9a-404c-475b-be6e-8c179762c4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_593af524-ff71-4fff-ac94-67de38090932" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d6c422a2-aa77-48cb-8609-0c4e62f7a556" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_593af524-ff71-4fff-ac94-67de38090932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_33fa7442-bb0a-497e-8d23-77750d761e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d6c422a2-aa77-48cb-8609-0c4e62f7a556" xlink:to="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_33fa7442-bb0a-497e-8d23-77750d761e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9b049a6e-f35c-4a73-9226-f9a5e9c06c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7f33e673-73be-4d91-ba33-1c940f42ef32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9b049a6e-f35c-4a73-9226-f9a5e9c06c2e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7f33e673-73be-4d91-ba33-1c940f42ef32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_4d8ecdc9-47dd-4fac-93d2-1da8ca921124" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9b049a6e-f35c-4a73-9226-f9a5e9c06c2e" xlink:to="loc_us-gaap_RestrictedCashCurrent_4d8ecdc9-47dd-4fac-93d2-1da8ca921124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_13621d68-6944-49fc-b34c-2267e388b236" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9b049a6e-f35c-4a73-9226-f9a5e9c06c2e" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_13621d68-6944-49fc-b34c-2267e388b236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_23ea0639-16b2-49e3-b084-babce52ad5b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9b049a6e-f35c-4a73-9226-f9a5e9c06c2e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_23ea0639-16b2-49e3-b084-babce52ad5b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#SignificantAccountingPoliciesAccountsReceivableDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6ecd70de-9957-41cb-ac91-927172841ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_d9826bf3-4f43-4cd6-b856-8f119d8e550e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6ecd70de-9957-41cb-ac91-927172841ed7" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_d9826bf3-4f43-4cd6-b856-8f119d8e550e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VendorandManufacturerReceivables_ea762c90-b274-4d84-a30e-a1f0d901d366" xlink:href="cvs-20220630.xsd#cvs_VendorandManufacturerReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6ecd70de-9957-41cb-ac91-927172841ed7" xlink:to="loc_cvs_VendorandManufacturerReceivables_ea762c90-b274-4d84-a30e-a1f0d901d366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_ad6e7d77-d8d6-43d4-9297-9c6a75892594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6ecd70de-9957-41cb-ac91-927172841ed7" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_ad6e7d77-d8d6-43d4-9297-9c6a75892594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_bf9df46a-e3dd-4039-aba1-64306b8cff9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6ecd70de-9957-41cb-ac91-927172841ed7" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_bf9df46a-e3dd-4039-aba1-64306b8cff9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_c390c1f5-38ed-4933-8bc2-cb062c3f6d51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6ecd70de-9957-41cb-ac91-927172841ed7" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_c390c1f5-38ed-4933-8bc2-cb062c3f6d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_3cc221f9-49a2-4599-8d8f-11daa740bd07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6ecd70de-9957-41cb-ac91-927172841ed7" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_3cc221f9-49a2-4599-8d8f-11daa740bd07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#SignificantAccountingPoliciesDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_465b6747-b0bd-47f8-be8d-79e6cf1a670d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_f66be1fc-1a91-43b8-834d-a998571492c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_465b6747-b0bd-47f8-be8d-79e6cf1a670d" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_f66be1fc-1a91-43b8-834d-a998571492c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_9d562725-337f-448e-a6a5-e2775c0c7ee9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f66be1fc-1a91-43b8-834d-a998571492c7" xlink:to="loc_srt_ConsolidationItemsAxis_9d562725-337f-448e-a6a5-e2775c0c7ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_3126dbb7-4d40-4049-946a-2430e4c87ea6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_9d562725-337f-448e-a6a5-e2775c0c7ee9" xlink:to="loc_srt_ConsolidationItemsDomain_3126dbb7-4d40-4049-946a-2430e4c87ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_69480515-1b65-4d83-868d-58710bfaf869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_3126dbb7-4d40-4049-946a-2430e4c87ea6" xlink:to="loc_us-gaap_OperatingSegmentsMember_69480515-1b65-4d83-868d-58710bfaf869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_56123d7e-f779-4b37-96f4-2ded6b4e68f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_3126dbb7-4d40-4049-946a-2430e4c87ea6" xlink:to="loc_us-gaap_CorporateNonSegmentMember_56123d7e-f779-4b37-96f4-2ded6b4e68f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_6994e351-1a7f-405f-8701-d71b9887c565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_3126dbb7-4d40-4049-946a-2430e4c87ea6" xlink:to="loc_us-gaap_IntersegmentEliminationMember_6994e351-1a7f-405f-8701-d71b9887c565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_03160412-9f0d-474c-9fe8-fc5dc087e155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f66be1fc-1a91-43b8-834d-a998571492c7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_03160412-9f0d-474c-9fe8-fc5dc087e155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_61a1d95b-1f76-4196-bca7-55dd4aa272f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_03160412-9f0d-474c-9fe8-fc5dc087e155" xlink:to="loc_us-gaap_SegmentDomain_61a1d95b-1f76-4196-bca7-55dd4aa272f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_71d4a71c-faf4-45d1-a36d-7499c9643cc8" xlink:href="cvs-20220630.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_61a1d95b-1f76-4196-bca7-55dd4aa272f8" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_71d4a71c-faf4-45d1-a36d-7499c9643cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_25914454-c692-491a-9955-8763c4a78a3e" xlink:href="cvs-20220630.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_61a1d95b-1f76-4196-bca7-55dd4aa272f8" xlink:to="loc_cvs_PharmacyServicesSegmentMember_25914454-c692-491a-9955-8763c4a78a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_9ff88be1-64d5-4298-ab26-e7facef25e1d" xlink:href="cvs-20220630.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_61a1d95b-1f76-4196-bca7-55dd4aa272f8" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_9ff88be1-64d5-4298-ab26-e7facef25e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_91544ce3-fda0-4e0b-b126-d874f17cffbd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f66be1fc-1a91-43b8-834d-a998571492c7" xlink:to="loc_srt_ProductOrServiceAxis_91544ce3-fda0-4e0b-b126-d874f17cffbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b3ff8e70-757e-4ed2-b3d4-0f5531e65635" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_91544ce3-fda0-4e0b-b126-d874f17cffbd" xlink:to="loc_srt_ProductsAndServicesDomain_b3ff8e70-757e-4ed2-b3d4-0f5531e65635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRevenueMember_2d87d3ae-71d6-4d1a-a07d-dc1a4f71d6f9" xlink:href="cvs-20220630.xsd#cvs_PharmacyRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b3ff8e70-757e-4ed2-b3d4-0f5531e65635" xlink:to="loc_cvs_PharmacyRevenueMember_2d87d3ae-71d6-4d1a-a07d-dc1a4f71d6f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FrontStoreRevenueMember_e9e6db3e-65fb-4752-bd89-231a0ad3ae4b" xlink:href="cvs-20220630.xsd#cvs_FrontStoreRevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b3ff8e70-757e-4ed2-b3d4-0f5531e65635" xlink:to="loc_cvs_FrontStoreRevenueMember_e9e6db3e-65fb-4752-bd89-231a0ad3ae4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsMember_ad509cac-55f2-4da3-9e9f-e9418497e023" xlink:href="cvs-20220630.xsd#cvs_PremiumsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b3ff8e70-757e-4ed2-b3d4-0f5531e65635" xlink:to="loc_cvs_PremiumsMember_ad509cac-55f2-4da3-9e9f-e9418497e023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_11e22530-3e95-422d-a1e0-20e455c04c12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b3ff8e70-757e-4ed2-b3d4-0f5531e65635" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_11e22530-3e95-422d-a1e0-20e455c04c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_e7f80307-225b-46ca-bbc3-6489d8c8f000" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f66be1fc-1a91-43b8-834d-a998571492c7" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_e7f80307-225b-46ca-bbc3-6489d8c8f000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_849182f4-044a-4ce4-9b0a-1a0fb8463532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_e7f80307-225b-46ca-bbc3-6489d8c8f000" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_849182f4-044a-4ce4-9b0a-1a0fb8463532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_6ffa7c9a-2c9c-4a53-a39f-3835befe0826" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_849182f4-044a-4ce4-9b0a-1a0fb8463532" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_6ffa7c9a-2c9c-4a53-a39f-3835befe0826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_791a8a86-1e40-47ac-8cbe-341861edfca2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_849182f4-044a-4ce4-9b0a-1a0fb8463532" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_791a8a86-1e40-47ac-8cbe-341861edfca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SalesChannelOtherMember_3eb7a321-c5ed-40ca-b0f2-f39547317e0c" xlink:href="cvs-20220630.xsd#cvs_SalesChannelOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_849182f4-044a-4ce4-9b0a-1a0fb8463532" xlink:to="loc_cvs_SalesChannelOtherMember_3eb7a321-c5ed-40ca-b0f2-f39547317e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_64849fb4-3da0-4f50-ae3b-0c9fc505a6ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f66be1fc-1a91-43b8-834d-a998571492c7" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_64849fb4-3da0-4f50-ae3b-0c9fc505a6ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_315839f3-3560-4ac1-8308-e9e1587904e7" xlink:href="cvs-20220630.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_64849fb4-3da0-4f50-ae3b-0c9fc505a6ca" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_315839f3-3560-4ac1-8308-e9e1587904e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_8192e4bd-9c01-427d-b204-daa65473c859" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_64849fb4-3da0-4f50-ae3b-0c9fc505a6ca" xlink:to="loc_us-gaap_NetInvestmentIncome_8192e4bd-9c01-427d-b204-daa65473c859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_e8aec3a1-bf0d-4aac-b038-41ce4800a146" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_64849fb4-3da0-4f50-ae3b-0c9fc505a6ca" xlink:to="loc_us-gaap_Revenues_e8aec3a1-bf0d-4aac-b038-41ce4800a146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#SignificantAccountingPoliciesReceivablesandContractedBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6a5f6e56-4026-435d-801f-f382b95c628b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_9b6a4527-c6ad-4711-82dc-f81f80fa53ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6a5f6e56-4026-435d-801f-f382b95c628b" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_9b6a4527-c6ad-4711-82dc-f81f80fa53ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_3d09f29f-1476-48b7-8ec1-c721c88264ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6a5f6e56-4026-435d-801f-f382b95c628b" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_3d09f29f-1476-48b7-8ec1-c721c88264ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#SignificantAccountingPoliciesContractBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_70411ebb-8593-47db-b9ad-a98767ed1e95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_4c68a168-e96b-49b8-b3bf-041c5eb475ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_70411ebb-8593-47db-b9ad-a98767ed1e95" xlink:to="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_4c68a168-e96b-49b8-b3bf-041c5eb475ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward_5a8ccd93-fe30-4a19-8571-428bcd626c8d" xlink:href="cvs-20220630.xsd#cvs_ChangeinContractwithCustomerLiabilityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_4c68a168-e96b-49b8-b3bf-041c5eb475ce" xlink:to="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward_5a8ccd93-fe30-4a19-8571-428bcd626c8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_deef5fb2-5ce3-4f40-bfd3-74448b092d15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward_5a8ccd93-fe30-4a19-8571-428bcd626c8d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_deef5fb2-5ce3-4f40-bfd3-74448b092d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_d1e20923-e0c0-4d97-919a-2575b8b0fba4" xlink:href="cvs-20220630.xsd#cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward_5a8ccd93-fe30-4a19-8571-428bcd626c8d" xlink:to="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_d1e20923-e0c0-4d97-919a-2575b8b0fba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractwithCustomerLiabilityRedemptionandBreakage_22f114eb-ed3c-4efe-a271-48ded6f5872d" xlink:href="cvs-20220630.xsd#cvs_ContractwithCustomerLiabilityRedemptionandBreakage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward_5a8ccd93-fe30-4a19-8571-428bcd626c8d" xlink:to="loc_cvs_ContractwithCustomerLiabilityRedemptionandBreakage_22f114eb-ed3c-4efe-a271-48ded6f5872d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_43384c99-a0b3-4e53-bec2-ed267e483a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward_5a8ccd93-fe30-4a19-8571-428bcd626c8d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_43384c99-a0b3-4e53-bec2-ed267e483a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/DivestituresandAssetSales" xlink:type="simple" xlink:href="cvs-20220630.xsd#DivestituresandAssetSales"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/DivestituresandAssetSales" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_e952162e-73aa-41b7-a4cd-a9592f03be9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_4fda888f-1842-4e8f-8aea-573f650a807d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_e952162e-73aa-41b7-a4cd-a9592f03be9a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_4fda888f-1842-4e8f-8aea-573f650a807d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/DivestituresandAssetSalesDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#DivestituresandAssetSalesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/DivestituresandAssetSalesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_b58bf280-b2ba-4e5e-8b86-77e32e367d56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_092bbfe2-7dc7-447f-9633-03a39fc5dda3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_b58bf280-b2ba-4e5e-8b86-77e32e367d56" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_092bbfe2-7dc7-447f-9633-03a39fc5dda3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_1ed16c5a-0f3a-4134-8f4c-6a4931c053e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_092bbfe2-7dc7-447f-9633-03a39fc5dda3" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_1ed16c5a-0f3a-4134-8f4c-6a4931c053e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_3f8d8ffb-fb73-4240-84d2-00c4336ef2a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1ed16c5a-0f3a-4134-8f4c-6a4931c053e6" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_3f8d8ffb-fb73-4240-84d2-00c4336ef2a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_e8f4bbdc-cdf7-46e8-88a7-31161ba6e877" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_3f8d8ffb-fb73-4240-84d2-00c4336ef2a5" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_e8f4bbdc-cdf7-46e8-88a7-31161ba6e877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a8c861f5-dab6-4e87-a512-9f8c026a6bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_092bbfe2-7dc7-447f-9633-03a39fc5dda3" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a8c861f5-dab6-4e87-a512-9f8c026a6bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_95d77867-58ed-41c2-928b-bbe1e8bae150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a8c861f5-dab6-4e87-a512-9f8c026a6bb5" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_95d77867-58ed-41c2-928b-bbe1e8bae150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PayflexMember_2cf17126-bd89-4f4e-b812-384512bddcf9" xlink:href="cvs-20220630.xsd#cvs_PayflexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_95d77867-58ed-41c2-928b-bbe1e8bae150" xlink:to="loc_cvs_PayflexMember_2cf17126-bd89-4f4e-b812-384512bddcf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ThailandBusinessMember_cebec18d-509d-48f6-baac-4272d7901eb1" xlink:href="cvs-20220630.xsd#cvs_ThailandBusinessMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_95d77867-58ed-41c2-928b-bbe1e8bae150" xlink:to="loc_cvs_ThailandBusinessMember_cebec18d-509d-48f6-baac-4272d7901eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InternationalHealthCareRenewalRightsMember_e157abf9-e5af-493d-9ada-bff851382692" xlink:href="cvs-20220630.xsd#cvs_InternationalHealthCareRenewalRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_95d77867-58ed-41c2-928b-bbe1e8bae150" xlink:to="loc_cvs_InternationalHealthCareRenewalRightsMember_e157abf9-e5af-493d-9ada-bff851382692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b2459a8a-a215-4941-937d-68535e321b60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_092bbfe2-7dc7-447f-9633-03a39fc5dda3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b2459a8a-a215-4941-937d-68535e321b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d6f25289-e36e-4f12-a2f8-9c86d88debea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b2459a8a-a215-4941-937d-68535e321b60" xlink:to="loc_us-gaap_SegmentDomain_d6f25289-e36e-4f12-a2f8-9c86d88debea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_7f6a3853-498a-4241-8a31-c8c813cbe121" xlink:href="cvs-20220630.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d6f25289-e36e-4f12-a2f8-9c86d88debea" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_7f6a3853-498a-4241-8a31-c8c813cbe121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_03e35244-3161-4ae8-b859-725d1f21ca0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_092bbfe2-7dc7-447f-9633-03a39fc5dda3" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_03e35244-3161-4ae8-b859-725d1f21ca0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_32bd0fc4-b261-47b9-a449-56c2b56950a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_03e35244-3161-4ae8-b859-725d1f21ca0c" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_32bd0fc4-b261-47b9-a449-56c2b56950a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_ba7d7511-25c3-43a5-94ed-643be8a836e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_03e35244-3161-4ae8-b859-725d1f21ca0c" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_ba7d7511-25c3-43a5-94ed-643be8a836e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfMedicalMembers_73ad3c7d-b4f2-45dc-8d32-fa2d2168bb25" xlink:href="cvs-20220630.xsd#cvs_NumberOfMedicalMembers"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_03e35244-3161-4ae8-b859-725d1f21ca0c" xlink:to="loc_cvs_NumberOfMedicalMembers_73ad3c7d-b4f2-45dc-8d32-fa2d2168bb25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_072691f0-63cd-45ab-bfd2-033506f68519" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_03e35244-3161-4ae8-b859-725d1f21ca0c" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_072691f0-63cd-45ab-bfd2-033506f68519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold_c92f58aa-b441-4c08-97c8-ec4f3a084e5c" xlink:href="cvs-20220630.xsd#cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_03e35244-3161-4ae8-b859-725d1f21ca0c" xlink:to="loc_cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold_c92f58aa-b441-4c08-97c8-ec4f3a084e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DisposalGroupNotDiscontinuedOperationMigrationPeriod_cf06e755-8d78-4bb1-9d24-b92a37ca40aa" xlink:href="cvs-20220630.xsd#cvs_DisposalGroupNotDiscontinuedOperationMigrationPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_03e35244-3161-4ae8-b859-725d1f21ca0c" xlink:to="loc_cvs_DisposalGroupNotDiscontinuedOperationMigrationPeriod_cf06e755-8d78-4bb1-9d24-b92a37ca40aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Investments" xlink:type="simple" xlink:href="cvs-20220630.xsd#Investments"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/Investments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_ed724863-5e63-4ec9-960e-512f1b4ed0cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_76de36f9-aa4a-4750-b5b9-97ee0da1d5f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_ed724863-5e63-4ec9-960e-512f1b4ed0cf" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_76de36f9-aa4a-4750-b5b9-97ee0da1d5f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsTables" xlink:type="simple" xlink:href="cvs-20220630.xsd#InvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_be1cc3ab-05a9-4ef7-b42b-01965b27eee0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTableTextBlock_7c70ae12-27b0-4af1-b73c-2d134cf370d3" xlink:href="cvs-20220630.xsd#cvs_TotalInvestmentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_be1cc3ab-05a9-4ef7-b42b-01965b27eee0" xlink:to="loc_cvs_TotalInvestmentsTableTextBlock_7c70ae12-27b0-4af1-b73c-2d134cf370d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_7bceb1ca-0a3f-4393-879b-22da999b8db3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_be1cc3ab-05a9-4ef7-b42b-01965b27eee0" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_7bceb1ca-0a3f-4393-879b-22da999b8db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_09414b81-2816-4ee5-882e-c0590d8bcbcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_be1cc3ab-05a9-4ef7-b42b-01965b27eee0" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_09414b81-2816-4ee5-882e-c0590d8bcbcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_37f0c1a2-39f6-4e82-bbc8-3a3b115d1455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_be1cc3ab-05a9-4ef7-b42b-01965b27eee0" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_37f0c1a2-39f6-4e82-bbc8-3a3b115d1455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_484630a5-5aa5-47a8-b75e-7c98f289d77f" xlink:href="cvs-20220630.xsd#cvs_ActivityInMortgageLoanPortfolioTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_be1cc3ab-05a9-4ef7-b42b-01965b27eee0" xlink:to="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_484630a5-5aa5-47a8-b75e-7c98f289d77f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_3e41a127-c4e9-4d17-b240-a04a6c884e08" xlink:href="cvs-20220630.xsd#cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_be1cc3ab-05a9-4ef7-b42b-01965b27eee0" xlink:to="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_3e41a127-c4e9-4d17-b240-a04a6c884e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeTextBlock_3973198d-1036-4a16-b9ff-28ecd01a545c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_be1cc3ab-05a9-4ef7-b42b-01965b27eee0" xlink:to="loc_us-gaap_InvestmentIncomeTextBlock_3973198d-1036-4a16-b9ff-28ecd01a545c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_d93f9dd2-b681-42d0-96fe-20516a6702e2" xlink:href="cvs-20220630.xsd#cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_be1cc3ab-05a9-4ef7-b42b-01965b27eee0" xlink:to="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_d93f9dd2-b681-42d0-96fe-20516a6702e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#InvestmentsTotalInvestmentScheduleDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_526b72ad-4910-487b-909e-9e45ebcf59c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTable_5824c3ef-2d97-4781-8deb-656defc34124" xlink:href="cvs-20220630.xsd#cvs_TotalInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_526b72ad-4910-487b-909e-9e45ebcf59c9" xlink:to="loc_cvs_TotalInvestmentsTable_5824c3ef-2d97-4781-8deb-656defc34124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsAxis_76b10ac1-04f4-441c-a117-27c204e1d6c1" xlink:href="cvs-20220630.xsd#cvs_TotalInvestmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsTable_5824c3ef-2d97-4781-8deb-656defc34124" xlink:to="loc_cvs_TotalInvestmentsAxis_76b10ac1-04f4-441c-a117-27c204e1d6c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain_1c44efe4-32cc-470e-9123-306bed81dd10" xlink:href="cvs-20220630.xsd#cvs_TotalInvestmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsAxis_76b10ac1-04f4-441c-a117-27c204e1d6c1" xlink:to="loc_cvs_TotalInvestmentsDomain_1c44efe4-32cc-470e-9123-306bed81dd10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_7ec6d97b-da90-432e-ac8b-b83ba6db9252" xlink:href="cvs-20220630.xsd#cvs_DebtAndEquitySecuritiesAvailableForSaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsDomain_1c44efe4-32cc-470e-9123-306bed81dd10" xlink:to="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_7ec6d97b-da90-432e-ac8b-b83ba6db9252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_96951d0e-cc7a-42a8-a8c0-b78805ce793f" xlink:href="cvs-20220630.xsd#cvs_MortgageLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsDomain_1c44efe4-32cc-470e-9123-306bed81dd10" xlink:to="loc_cvs_MortgageLoansMember_96951d0e-cc7a-42a8-a8c0-b78805ce793f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_554162b9-608b-40fa-a6e5-f7dea8f2b7c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsDomain_1c44efe4-32cc-470e-9123-306bed81dd10" xlink:to="loc_us-gaap_OtherInvestmentsMember_554162b9-608b-40fa-a6e5-f7dea8f2b7c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsLineItems_e71e1a40-705c-45a4-a35a-585514cffe7d" xlink:href="cvs-20220630.xsd#cvs_TotalInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsTable_5824c3ef-2d97-4781-8deb-656defc34124" xlink:to="loc_cvs_TotalInvestmentsLineItems_e71e1a40-705c-45a4-a35a-585514cffe7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_71df1078-82c2-43e1-ad1e-98846d87e391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsLineItems_e71e1a40-705c-45a4-a35a-585514cffe7d" xlink:to="loc_us-gaap_ShortTermInvestments_71df1078-82c2-43e1-ad1e-98846d87e391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_b89f93ba-cc43-4c91-9a32-7f7b40ed00c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsLineItems_e71e1a40-705c-45a4-a35a-585514cffe7d" xlink:to="loc_us-gaap_LongTermInvestments_b89f93ba-cc43-4c91-9a32-7f7b40ed00c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_35ea3b42-55a2-4ff1-8e7d-dc75e5b69ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsLineItems_e71e1a40-705c-45a4-a35a-585514cffe7d" xlink:to="loc_us-gaap_Investments_35ea3b42-55a2-4ff1-8e7d-dc75e5b69ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#InvestmentsDebtSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_06abccce-6df6-4710-b94c-a70087c55db6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0f7be6b7-80c6-45a2-b86d-2dcfe3a98eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_06abccce-6df6-4710-b94c-a70087c55db6" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0f7be6b7-80c6-45a2-b86d-2dcfe3a98eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_2ef92a05-d4f7-490c-a4f3-31c1e1c9b3f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0f7be6b7-80c6-45a2-b86d-2dcfe3a98eb8" xlink:to="loc_us-gaap_FinancialInstrumentAxis_2ef92a05-d4f7-490c-a4f3-31c1e1c9b3f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_be7c0cd6-5f5c-4b62-b706-dba5b14c4ac4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2ef92a05-d4f7-490c-a4f3-31c1e1c9b3f3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_be7c0cd6-5f5c-4b62-b706-dba5b14c4ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_078210b3-7782-4541-9c0f-474a9f557f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_be7c0cd6-5f5c-4b62-b706-dba5b14c4ac4" xlink:to="loc_us-gaap_DebtSecuritiesMember_078210b3-7782-4541-9c0f-474a9f557f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_aab78b54-e38d-4ab9-9292-de5c3fc416d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_078210b3-7782-4541-9c0f-474a9f557f9e" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_aab78b54-e38d-4ab9-9292-de5c3fc416d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_f7dfcc12-9cd4-4b2f-ac20-be7e3eafdb96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_078210b3-7782-4541-9c0f-474a9f557f9e" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_f7dfcc12-9cd4-4b2f-ac20-be7e3eafdb96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_308f9361-6024-43f8-ace8-859d4de4129a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_078210b3-7782-4541-9c0f-474a9f557f9e" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_308f9361-6024-43f8-ace8-859d4de4129a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_1cbb235e-e7df-4e0a-bbc1-386510f0dddb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_078210b3-7782-4541-9c0f-474a9f557f9e" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_1cbb235e-e7df-4e0a-bbc1-386510f0dddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_b14b4bc4-f6e9-46ed-8c16-015aaaef16a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_078210b3-7782-4541-9c0f-474a9f557f9e" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_b14b4bc4-f6e9-46ed-8c16-015aaaef16a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_43ed25ff-ce03-4588-8962-32fdb75e236e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_078210b3-7782-4541-9c0f-474a9f557f9e" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_43ed25ff-ce03-4588-8962-32fdb75e236e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_cb020d79-70fc-48f7-9fce-a4049132df93" xlink:href="cvs-20220630.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_078210b3-7782-4541-9c0f-474a9f557f9e" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_cb020d79-70fc-48f7-9fce-a4049132df93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_d91bce5c-c2a4-4691-9211-4ad341dfecf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_078210b3-7782-4541-9c0f-474a9f557f9e" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_d91bce5c-c2a4-4691-9211-4ad341dfecf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_0fcef63b-9a51-4634-8af0-62140bcc2556" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0f7be6b7-80c6-45a2-b86d-2dcfe3a98eb8" xlink:to="loc_srt_ProductOrServiceAxis_0fcef63b-9a51-4634-8af0-62140bcc2556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c53072f5-070e-417c-bfe5-287cc4a2242b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_0fcef63b-9a51-4634-8af0-62140bcc2556" xlink:to="loc_srt_ProductsAndServicesDomain_c53072f5-070e-417c-bfe5-287cc4a2242b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_b8ec5d4b-3b7a-4f0b-9fdd-dedc4ffce2bf" xlink:href="cvs-20220630.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c53072f5-070e-417c-bfe5-287cc4a2242b" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_b8ec5d4b-3b7a-4f0b-9fdd-dedc4ffce2bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ee4bfa42-b279-4363-b009-91f98ec02321" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0f7be6b7-80c6-45a2-b86d-2dcfe3a98eb8" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ee4bfa42-b279-4363-b009-91f98ec02321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7b7a8543-1d55-4f3d-8cbd-3b763f792461" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ee4bfa42-b279-4363-b009-91f98ec02321" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7b7a8543-1d55-4f3d-8cbd-3b763f792461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_50ac071b-39f3-4245-8e9c-222ffa56cfd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ee4bfa42-b279-4363-b009-91f98ec02321" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_50ac071b-39f3-4245-8e9c-222ffa56cfd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_1dfd814f-06ae-43b5-817c-aced52a34de4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ee4bfa42-b279-4363-b009-91f98ec02321" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_1dfd814f-06ae-43b5-817c-aced52a34de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_2cc0bc9c-7473-4811-a826-0039eaabeb77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ee4bfa42-b279-4363-b009-91f98ec02321" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_2cc0bc9c-7473-4811-a826-0039eaabeb77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_12fce0ee-89fc-49ed-91cf-db7c52558f46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ee4bfa42-b279-4363-b009-91f98ec02321" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_12fce0ee-89fc-49ed-91cf-db7c52558f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_28652b9a-12f0-4035-8596-12c8ba29c613" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ee4bfa42-b279-4363-b009-91f98ec02321" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_28652b9a-12f0-4035-8596-12c8ba29c613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1" xlink:type="simple" xlink:href="cvs-20220630.xsd#InvestmentsDebtSecuritiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#InvestmentsDebtSecuritiesbyMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_f9d3dec0-8108-49bb-837f-9670d7f08b25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e8075010-6ff1-49f0-a99b-5e553db29847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_f9d3dec0-8108-49bb-837f-9670d7f08b25" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e8075010-6ff1-49f0-a99b-5e553db29847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_2f45fcbc-6194-4d9f-87bb-9c869d385a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e8075010-6ff1-49f0-a99b-5e553db29847" xlink:to="loc_us-gaap_FinancialInstrumentAxis_2f45fcbc-6194-4d9f-87bb-9c869d385a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_99bf0516-7fd6-4e87-9d23-438ddd98b4bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2f45fcbc-6194-4d9f-87bb-9c869d385a1e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_99bf0516-7fd6-4e87-9d23-438ddd98b4bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_6d470837-c46e-48ca-b354-6eb8c89d4d40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_99bf0516-7fd6-4e87-9d23-438ddd98b4bd" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_6d470837-c46e-48ca-b354-6eb8c89d4d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_ec37fcdd-6f2f-47de-8db9-91f345ed197c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_99bf0516-7fd6-4e87-9d23-438ddd98b4bd" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_ec37fcdd-6f2f-47de-8db9-91f345ed197c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_fa79d2ea-63c1-48b7-a78d-e0c4959552e8" xlink:href="cvs-20220630.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_99bf0516-7fd6-4e87-9d23-438ddd98b4bd" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_fa79d2ea-63c1-48b7-a78d-e0c4959552e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_3cfeee9a-6e75-4165-85da-16cf52da607c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e8075010-6ff1-49f0-a99b-5e553db29847" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_3cfeee9a-6e75-4165-85da-16cf52da607c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_b3340472-ca03-436d-9ead-66646457a192" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_3cfeee9a-6e75-4165-85da-16cf52da607c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_b3340472-ca03-436d-9ead-66646457a192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_327e15ad-c7d6-432f-b463-ad08b71d2d56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_b3340472-ca03-436d-9ead-66646457a192" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_327e15ad-c7d6-432f-b463-ad08b71d2d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_946ec8c1-14aa-428e-bb9c-53bfde8fc872" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_b3340472-ca03-436d-9ead-66646457a192" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_946ec8c1-14aa-428e-bb9c-53bfde8fc872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_b2357c95-1c13-4f5d-9830-6e805d77cc8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_b3340472-ca03-436d-9ead-66646457a192" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_b2357c95-1c13-4f5d-9830-6e805d77cc8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_4d103086-7224-4b5a-b4c4-f1e5e8e61576" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_b3340472-ca03-436d-9ead-66646457a192" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_4d103086-7224-4b5a-b4c4-f1e5e8e61576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_866d95c8-30a5-490d-a5b4-9cba61c9277b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_b3340472-ca03-436d-9ead-66646457a192" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_866d95c8-30a5-490d-a5b4-9cba61c9277b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_ded0ceb9-a4a0-4737-98fa-8b8193fb4aca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_b3340472-ca03-436d-9ead-66646457a192" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_ded0ceb9-a4a0-4737-98fa-8b8193fb4aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_ee38fc65-17b6-4dec-b87b-9ab4b1576489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_3cfeee9a-6e75-4165-85da-16cf52da607c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_ee38fc65-17b6-4dec-b87b-9ab4b1576489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_f5219af8-07ad-42b1-aaf1-bd4e1650ece5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_ee38fc65-17b6-4dec-b87b-9ab4b1576489" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_f5219af8-07ad-42b1-aaf1-bd4e1650ece5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_05e0bba9-1017-4b97-bf77-c52429b14be3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_ee38fc65-17b6-4dec-b87b-9ab4b1576489" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_05e0bba9-1017-4b97-bf77-c52429b14be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_a1618125-746d-4d64-970f-331fdc627e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_ee38fc65-17b6-4dec-b87b-9ab4b1576489" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_a1618125-746d-4d64-970f-331fdc627e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_7c328e69-5887-48af-98b9-ed2ee719d9f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_ee38fc65-17b6-4dec-b87b-9ab4b1576489" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_7c328e69-5887-48af-98b9-ed2ee719d9f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_3e585d54-7270-4950-a7d0-b4d511a71a60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_ee38fc65-17b6-4dec-b87b-9ab4b1576489" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_3e585d54-7270-4950-a7d0-b4d511a71a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d432dcea-76a5-436c-a288-2a081ecf39f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_ee38fc65-17b6-4dec-b87b-9ab4b1576489" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d432dcea-76a5-436c-a288-2a081ecf39f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#InvestmentsUnrealizedLossPositionDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_37d0dbf4-8355-4146-8442-53deef6b3ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_30ee2036-5e91-4081-b04e-7458be0074d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_37d0dbf4-8355-4146-8442-53deef6b3ebe" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_30ee2036-5e91-4081-b04e-7458be0074d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_3a339552-d726-4660-9c92-0fe7b362ab23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_30ee2036-5e91-4081-b04e-7458be0074d7" xlink:to="loc_us-gaap_FinancialInstrumentAxis_3a339552-d726-4660-9c92-0fe7b362ab23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eae7f8f7-90b3-415b-8f9a-a1ae0dbb501a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_3a339552-d726-4660-9c92-0fe7b362ab23" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eae7f8f7-90b3-415b-8f9a-a1ae0dbb501a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_a6aa2e5e-0625-4a8a-a259-fa653c3754f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eae7f8f7-90b3-415b-8f9a-a1ae0dbb501a" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_a6aa2e5e-0625-4a8a-a259-fa653c3754f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_45605539-5985-49bd-a82b-793f89417cce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eae7f8f7-90b3-415b-8f9a-a1ae0dbb501a" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_45605539-5985-49bd-a82b-793f89417cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_dbe9c5fe-7db2-43de-99c3-4c77ba8860d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eae7f8f7-90b3-415b-8f9a-a1ae0dbb501a" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_dbe9c5fe-7db2-43de-99c3-4c77ba8860d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_35d39f81-1e28-445c-82b7-6a34ae47b7be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eae7f8f7-90b3-415b-8f9a-a1ae0dbb501a" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_35d39f81-1e28-445c-82b7-6a34ae47b7be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_a1639190-cbb7-4886-8f2d-4361fe2f49d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eae7f8f7-90b3-415b-8f9a-a1ae0dbb501a" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_a1639190-cbb7-4886-8f2d-4361fe2f49d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_19853f9a-56fc-4ef2-a880-2e95cac1ad06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eae7f8f7-90b3-415b-8f9a-a1ae0dbb501a" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_19853f9a-56fc-4ef2-a880-2e95cac1ad06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_e570ba42-6b7c-4bff-b824-5da56e8e7881" xlink:href="cvs-20220630.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eae7f8f7-90b3-415b-8f9a-a1ae0dbb501a" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_e570ba42-6b7c-4bff-b824-5da56e8e7881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_9f9dca76-4d1d-4660-bf2d-f5b93c067f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eae7f8f7-90b3-415b-8f9a-a1ae0dbb501a" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_9f9dca76-4d1d-4660-bf2d-f5b93c067f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ec3adef5-b611-47a7-82cb-ec76c85e3aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_30ee2036-5e91-4081-b04e-7458be0074d7" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ec3adef5-b611-47a7-82cb-ec76c85e3aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_c7d37c91-3706-40cc-ae78-a8b4fd18ba83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ec3adef5-b611-47a7-82cb-ec76c85e3aa4" xlink:to="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_c7d37c91-3706-40cc-ae78-a8b4fd18ba83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_f55048d8-e583-4366-9d1d-ceaa36841c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_c7d37c91-3706-40cc-ae78-a8b4fd18ba83" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_f55048d8-e583-4366-9d1d-ceaa36841c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_9041bc9b-27d9-40f4-9f5a-2d976b770f75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_c7d37c91-3706-40cc-ae78-a8b4fd18ba83" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_9041bc9b-27d9-40f4-9f5a-2d976b770f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_029fccab-3329-4de5-8c00-451f60275d21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_c7d37c91-3706-40cc-ae78-a8b4fd18ba83" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_029fccab-3329-4de5-8c00-451f60275d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_d19ad300-9705-477d-a40c-2b3f9fd7a01b" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ec3adef5-b611-47a7-82cb-ec76c85e3aa4" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_d19ad300-9705-477d-a40c-2b3f9fd7a01b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_3e313b26-c3f6-4ad0-922a-8c71e67b7c06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_d19ad300-9705-477d-a40c-2b3f9fd7a01b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_3e313b26-c3f6-4ad0-922a-8c71e67b7c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_7bee7437-89e8-478f-bd43-bb3994e7f323" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_d19ad300-9705-477d-a40c-2b3f9fd7a01b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_7bee7437-89e8-478f-bd43-bb3994e7f323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_27d97f4d-6a3a-4a45-a3ea-cacd06f2e57c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_d19ad300-9705-477d-a40c-2b3f9fd7a01b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_27d97f4d-6a3a-4a45-a3ea-cacd06f2e57c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_85e4ee3f-f2f6-4be8-9e55-197091719b46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ec3adef5-b611-47a7-82cb-ec76c85e3aa4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_85e4ee3f-f2f6-4be8-9e55-197091719b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_10badb88-2c5f-494f-aa3d-5838fd5273da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_85e4ee3f-f2f6-4be8-9e55-197091719b46" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_10badb88-2c5f-494f-aa3d-5838fd5273da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_536bbb6e-b414-427d-913a-25b103565080" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_85e4ee3f-f2f6-4be8-9e55-197091719b46" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_536bbb6e-b414-427d-913a-25b103565080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_603a7a8d-cfda-4a99-85ad-031d7ead2623" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_85e4ee3f-f2f6-4be8-9e55-197091719b46" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_603a7a8d-cfda-4a99-85ad-031d7ead2623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#InvestmentsUnrealizedLossPositionMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_b38e8ecc-6112-4820-8bf0-4a9f70eea2ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_baddb7f8-fa29-46ba-8be1-f5f4ecf2d615" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_b38e8ecc-6112-4820-8bf0-4a9f70eea2ea" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_baddb7f8-fa29-46ba-8be1-f5f4ecf2d615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9279aa46-d9ae-420a-8e0a-f0c91b83d22f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_baddb7f8-fa29-46ba-8be1-f5f4ecf2d615" xlink:to="loc_srt_ProductOrServiceAxis_9279aa46-d9ae-420a-8e0a-f0c91b83d22f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_81a679b1-6b78-4b79-b431-741f5ccd53bb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_9279aa46-d9ae-420a-8e0a-f0c91b83d22f" xlink:to="loc_srt_ProductsAndServicesDomain_81a679b1-6b78-4b79-b431-741f5ccd53bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_3241ece0-7b4d-42cd-bfb4-ea441b941673" xlink:href="cvs-20220630.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_81a679b1-6b78-4b79-b431-741f5ccd53bb" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_3241ece0-7b4d-42cd-bfb4-ea441b941673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingRemainingProductsMember_617cffe8-9f7a-40eb-9c93-2327aab1ddd9" xlink:href="cvs-20220630.xsd#cvs_SupportingRemainingProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_81a679b1-6b78-4b79-b431-741f5ccd53bb" xlink:to="loc_cvs_SupportingRemainingProductsMember_617cffe8-9f7a-40eb-9c93-2327aab1ddd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_de91405a-88c6-473f-92e2-b65948e08f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_baddb7f8-fa29-46ba-8be1-f5f4ecf2d615" xlink:to="loc_us-gaap_FinancialInstrumentAxis_de91405a-88c6-473f-92e2-b65948e08f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eaf92011-1889-4022-aa78-4f1724a67f71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_de91405a-88c6-473f-92e2-b65948e08f8d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eaf92011-1889-4022-aa78-4f1724a67f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_6fbffc66-aa63-400e-b8af-30911335f188" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eaf92011-1889-4022-aa78-4f1724a67f71" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_6fbffc66-aa63-400e-b8af-30911335f188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_6a8e8e48-4248-49ed-8bb9-4a4979549341" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eaf92011-1889-4022-aa78-4f1724a67f71" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_6a8e8e48-4248-49ed-8bb9-4a4979549341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_da665e86-e902-427b-b28b-38dcac4a7fbd" xlink:href="cvs-20220630.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eaf92011-1889-4022-aa78-4f1724a67f71" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_da665e86-e902-427b-b28b-38dcac4a7fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e0e82d9b-7ada-43ec-bd98-feca60eaaff2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_baddb7f8-fa29-46ba-8be1-f5f4ecf2d615" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e0e82d9b-7ada-43ec-bd98-feca60eaaff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_2b462902-199e-4e84-9be5-59377bd4d45b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e0e82d9b-7ada-43ec-bd98-feca60eaaff2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_2b462902-199e-4e84-9be5-59377bd4d45b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_b77e5386-f2bf-4ef8-aed6-f42d005af050" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_2b462902-199e-4e84-9be5-59377bd4d45b" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_b77e5386-f2bf-4ef8-aed6-f42d005af050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_1967055c-a178-4bee-8284-7cdc2c671123" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_2b462902-199e-4e84-9be5-59377bd4d45b" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_1967055c-a178-4bee-8284-7cdc2c671123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_3de9313e-43a7-4f47-a33d-4a8644063c5a" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_2b462902-199e-4e84-9be5-59377bd4d45b" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_3de9313e-43a7-4f47-a33d-4a8644063c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_7cd7ad51-1416-4e05-9bf7-6738534c0c9d" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_2b462902-199e-4e84-9be5-59377bd4d45b" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_7cd7ad51-1416-4e05-9bf7-6738534c0c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_9f2c4491-238c-42e4-bd6b-d06013836ee9" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_2b462902-199e-4e84-9be5-59377bd4d45b" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_9f2c4491-238c-42e4-bd6b-d06013836ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_c53e55ec-d5ea-4c5e-b1df-48deabeccd2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_2b462902-199e-4e84-9be5-59377bd4d45b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_c53e55ec-d5ea-4c5e-b1df-48deabeccd2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_d18cec7e-f7ae-4e14-a2bc-89695f00623e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e0e82d9b-7ada-43ec-bd98-feca60eaaff2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_d18cec7e-f7ae-4e14-a2bc-89695f00623e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_ca3a54a3-d525-40d3-b831-c79f3d8ce379" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_d18cec7e-f7ae-4e14-a2bc-89695f00623e" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_ca3a54a3-d525-40d3-b831-c79f3d8ce379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_876e0142-19fd-489d-b7b6-bf05c0a44ea5" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_d18cec7e-f7ae-4e14-a2bc-89695f00623e" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_876e0142-19fd-489d-b7b6-bf05c0a44ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_db59a151-5d99-40ac-a12e-1c8fb31b4ab0" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_d18cec7e-f7ae-4e14-a2bc-89695f00623e" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_db59a151-5d99-40ac-a12e-1c8fb31b4ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_47041721-5d4f-432c-852a-023d6e1615b2" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_d18cec7e-f7ae-4e14-a2bc-89695f00623e" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_47041721-5d4f-432c-852a-023d6e1615b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_4c9335fb-664b-4646-8a5b-c2b3f658c18b" xlink:href="cvs-20220630.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_d18cec7e-f7ae-4e14-a2bc-89695f00623e" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_4c9335fb-664b-4646-8a5b-c2b3f658c18b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_27f4200c-996b-4e9b-8924-97a7e31f3cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_d18cec7e-f7ae-4e14-a2bc-89695f00623e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_27f4200c-996b-4e9b-8924-97a7e31f3cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#InvestmentsMortgageLoansDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_bf4e4295-06fd-41c2-b4b2-42d5ebca8fce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_eb5ab3d6-8588-4c34-ab6a-863419e69a84" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_bf4e4295-06fd-41c2-b4b2-42d5ebca8fce" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_eb5ab3d6-8588-4c34-ab6a-863419e69a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_d6c98ed2-944b-4ace-9eec-e171e64f4b0d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_eb5ab3d6-8588-4c34-ab6a-863419e69a84" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_d6c98ed2-944b-4ace-9eec-e171e64f4b0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_3f000772-0fde-4eac-b9de-605ad3a6b323" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_d6c98ed2-944b-4ace-9eec-e171e64f4b0d" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_3f000772-0fde-4eac-b9de-605ad3a6b323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_6142d4cb-2e48-4e34-a3e8-9cb6cfe58c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_3f000772-0fde-4eac-b9de-605ad3a6b323" xlink:to="loc_us-gaap_CommercialRealEstateMember_6142d4cb-2e48-4e34-a3e8-9cb6cfe58c9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_67b21f28-ccf2-4d47-bd7e-373f2bbf524c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_eb5ab3d6-8588-4c34-ab6a-863419e69a84" xlink:to="loc_srt_MortgageLoansOnRealEstateLineItems_67b21f28-ccf2-4d47-bd7e-373f2bbf524c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_510061a5-04e9-4ca7-8be2-bcd9ac271edb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstateNewMortgageLoans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_67b21f28-ccf2-4d47-bd7e-373f2bbf524c" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_510061a5-04e9-4ca7-8be2-bcd9ac271edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_1acfc0e5-925a-44ff-b07e-53683c66ddb6" xlink:href="cvs-20220630.xsd#cvs_MortgageLoansOnRealEstateLoansFullyRepaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_67b21f28-ccf2-4d47-bd7e-373f2bbf524c" xlink:to="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_1acfc0e5-925a-44ff-b07e-53683c66ddb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_22c211c4-5a3a-46cf-8ef6-8f2f39c4099e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstateForeclosures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_67b21f28-ccf2-4d47-bd7e-373f2bbf524c" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_22c211c4-5a3a-46cf-8ef6-8f2f39c4099e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#InvestmentsMortgageLoansCreditRatingsIndicatorDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_1948698b-704d-4b5d-953d-a00a3d8aa0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_8339ed18-0086-4a85-ad61-1dc98b80164e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_1948698b-704d-4b5d-953d-a00a3d8aa0a8" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_8339ed18-0086-4a85-ad61-1dc98b80164e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_02b2cbd6-91c7-4e89-b637-55948da6a5ba" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_8339ed18-0086-4a85-ad61-1dc98b80164e" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_02b2cbd6-91c7-4e89-b637-55948da6a5ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_052df360-e715-4f9a-8ef1-8b637e439461" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_02b2cbd6-91c7-4e89-b637-55948da6a5ba" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_052df360-e715-4f9a-8ef1-8b637e439461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_6ac7f154-4736-4b4a-9b62-9c0f5256db5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_052df360-e715-4f9a-8ef1-8b637e439461" xlink:to="loc_us-gaap_CommercialRealEstateMember_6ac7f154-4736-4b4a-9b62-9c0f5256db5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_0b4e9170-b923-410a-9160-6ff5ea0dcbc1" xlink:href="cvs-20220630.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_8339ed18-0086-4a85-ad61-1dc98b80164e" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_0b4e9170-b923-410a-9160-6ff5ea0dcbc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_9d9133cb-6e6c-4fc7-8b69-65f1067d68ae" xlink:href="cvs-20220630.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_0b4e9170-b923-410a-9160-6ff5ea0dcbc1" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_9d9133cb-6e6c-4fc7-8b69-65f1067d68ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodOneMember_02c9ce35-ef52-4778-9ec8-1a9e953c8a8c" xlink:href="cvs-20220630.xsd#cvs_YearOfOriginationPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_9d9133cb-6e6c-4fc7-8b69-65f1067d68ae" xlink:to="loc_cvs_YearOfOriginationPeriodOneMember_02c9ce35-ef52-4778-9ec8-1a9e953c8a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodTwoMember_ba3038f7-0d99-4138-8333-afe1aca478db" xlink:href="cvs-20220630.xsd#cvs_YearOfOriginationPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_9d9133cb-6e6c-4fc7-8b69-65f1067d68ae" xlink:to="loc_cvs_YearOfOriginationPeriodTwoMember_ba3038f7-0d99-4138-8333-afe1aca478db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodThreeMember_38d3346a-64fa-42e6-aa55-4825eb1e3be2" xlink:href="cvs-20220630.xsd#cvs_YearOfOriginationPeriodThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_9d9133cb-6e6c-4fc7-8b69-65f1067d68ae" xlink:to="loc_cvs_YearOfOriginationPeriodThreeMember_38d3346a-64fa-42e6-aa55-4825eb1e3be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFourMember_ad299835-88f9-488e-96eb-b838cb9d1a3b" xlink:href="cvs-20220630.xsd#cvs_YearOfOriginationPeriodFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_9d9133cb-6e6c-4fc7-8b69-65f1067d68ae" xlink:to="loc_cvs_YearOfOriginationPeriodFourMember_ad299835-88f9-488e-96eb-b838cb9d1a3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFiveMember_ce76fef5-1872-4834-ab40-f9ab1fab34a0" xlink:href="cvs-20220630.xsd#cvs_YearOfOriginationPeriodFiveMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_9d9133cb-6e6c-4fc7-8b69-65f1067d68ae" xlink:to="loc_cvs_YearOfOriginationPeriodFiveMember_ce76fef5-1872-4834-ab40-f9ab1fab34a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_d6f3d75e-07c5-4f65-84b0-572df47271bd" xlink:href="cvs-20220630.xsd#cvs_YearOfOriginationPriorToPeriodFiveMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_9d9133cb-6e6c-4fc7-8b69-65f1067d68ae" xlink:to="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_d6f3d75e-07c5-4f65-84b0-572df47271bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_291b1dd4-1886-4354-ab68-f0ffe2a02b4c" xlink:href="cvs-20220630.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_8339ed18-0086-4a85-ad61-1dc98b80164e" xlink:to="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_291b1dd4-1886-4354-ab68-f0ffe2a02b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_5a0ba383-19cf-41e8-a0e6-e7d8681efb0a" xlink:href="cvs-20220630.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_291b1dd4-1886-4354-ab68-f0ffe2a02b4c" xlink:to="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_5a0ba383-19cf-41e8-a0e6-e7d8681efb0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category1Member_9e2ed3bb-7a7d-4f74-ba4d-a3e1ce6183c6" xlink:href="cvs-20220630.xsd#cvs_Category1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_5a0ba383-19cf-41e8-a0e6-e7d8681efb0a" xlink:to="loc_cvs_Category1Member_9e2ed3bb-7a7d-4f74-ba4d-a3e1ce6183c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category2To4Member_b72355de-c286-4d79-9e6f-738d4afdf79d" xlink:href="cvs-20220630.xsd#cvs_Category2To4Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_5a0ba383-19cf-41e8-a0e6-e7d8681efb0a" xlink:to="loc_cvs_Category2To4Member_b72355de-c286-4d79-9e6f-738d4afdf79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Categories5and6Member_545607b7-c556-4f71-ab04-6857bb6e1c6a" xlink:href="cvs-20220630.xsd#cvs_Categories5and6Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_5a0ba383-19cf-41e8-a0e6-e7d8681efb0a" xlink:to="loc_cvs_Categories5and6Member_545607b7-c556-4f71-ab04-6857bb6e1c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category7Member_01ba97ef-cc75-4b33-8d5b-d2762ff8e228" xlink:href="cvs-20220630.xsd#cvs_Category7Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_5a0ba383-19cf-41e8-a0e6-e7d8681efb0a" xlink:to="loc_cvs_Category7Member_01ba97ef-cc75-4b33-8d5b-d2762ff8e228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_f1d63295-6718-4aad-80f6-ac9872cf37ef" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_8339ed18-0086-4a85-ad61-1dc98b80164e" xlink:to="loc_srt_MortgageLoansOnRealEstateLineItems_f1d63295-6718-4aad-80f6-ac9872cf37ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstate_a46a63b3-1962-41f0-ae32-bf5ea1795db7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_f1d63295-6718-4aad-80f6-ac9872cf37ef" xlink:to="loc_us-gaap_MortgageLoansOnRealEstate_a46a63b3-1962-41f0-ae32-bf5ea1795db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#InvestmentsNetInvestmentIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_7bb7bb57-95b9-4a8d-aeee-97fd5c34fcb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_eee9fbeb-7106-4621-876d-afd85bfdf4f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_7bb7bb57-95b9-4a8d-aeee-97fd5c34fcb8" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_eee9fbeb-7106-4621-876d-afd85bfdf4f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_c5f2646c-d7b3-4a91-8ad1-5241c0847306" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_eee9fbeb-7106-4621-876d-afd85bfdf4f5" xlink:to="loc_us-gaap_InvestmentTypeAxis_c5f2646c-d7b3-4a91-8ad1-5241c0847306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_35ca3ad3-6572-43eb-be58-77442a98dd99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_c5f2646c-d7b3-4a91-8ad1-5241c0847306" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_35ca3ad3-6572-43eb-be58-77442a98dd99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_b6163d4e-5494-4ba0-830e-847f64d171d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_35ca3ad3-6572-43eb-be58-77442a98dd99" xlink:to="loc_us-gaap_DebtSecuritiesMember_b6163d4e-5494-4ba0-830e-847f64d171d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_9cf4dcce-67da-4e83-93b6-7c1ccc93d6fc" xlink:href="cvs-20220630.xsd#cvs_MortgageLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_35ca3ad3-6572-43eb-be58-77442a98dd99" xlink:to="loc_cvs_MortgageLoansMember_9cf4dcce-67da-4e83-93b6-7c1ccc93d6fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_a52601dd-8e20-4bda-ae62-16a7a7200a69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_35ca3ad3-6572-43eb-be58-77442a98dd99" xlink:to="loc_us-gaap_OtherInvestmentsMember_a52601dd-8e20-4bda-ae62-16a7a7200a69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4b99bed9-154d-4e30-b2d2-fea7a31a6506" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_eee9fbeb-7106-4621-876d-afd85bfdf4f5" xlink:to="loc_srt_ProductOrServiceAxis_4b99bed9-154d-4e30-b2d2-fea7a31a6506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7c8ef8b1-6e3e-438a-88d1-112367bcb29d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_4b99bed9-154d-4e30-b2d2-fea7a31a6506" xlink:to="loc_srt_ProductsAndServicesDomain_7c8ef8b1-6e3e-438a-88d1-112367bcb29d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_9e5edb2a-d50d-4419-93f6-d13c317a5e15" xlink:href="cvs-20220630.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7c8ef8b1-6e3e-438a-88d1-112367bcb29d" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_9e5edb2a-d50d-4419-93f6-d13c317a5e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_4eeefc17-43f9-4536-acd8-57e36e6249e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_eee9fbeb-7106-4621-876d-afd85bfdf4f5" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_4eeefc17-43f9-4536-acd8-57e36e6249e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_76b5a025-95b4-4ac2-804a-193ea4a19e56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_4eeefc17-43f9-4536-acd8-57e36e6249e8" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_76b5a025-95b4-4ac2-804a-193ea4a19e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_d2795fa2-851a-4730-a6fc-558bb5ac4484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_4eeefc17-43f9-4536-acd8-57e36e6249e8" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_d2795fa2-851a-4730-a6fc-558bb5ac4484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_8f61c9ea-2b1a-49b8-bc6d-acf3592b2f41" xlink:href="cvs-20220630.xsd#cvs_InvestmentIncomeExcludingCapitalGainsorLosses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_4eeefc17-43f9-4536-acd8-57e36e6249e8" xlink:to="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_8f61c9ea-2b1a-49b8-bc6d-acf3592b2f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_d56922e8-c50c-4513-800f-3e2768c680ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_4eeefc17-43f9-4536-acd8-57e36e6249e8" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_d56922e8-c50c-4513-800f-3e2768c680ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_89f20ac4-6f18-4f7c-9492-48384cbd8c82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_4eeefc17-43f9-4536-acd8-57e36e6249e8" xlink:to="loc_us-gaap_InvestmentIncomeNet_89f20ac4-6f18-4f7c-9492-48384cbd8c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_71bdef25-a464-4e12-a462-7cc1a648a22a" xlink:href="cvs-20220630.xsd#cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_4eeefc17-43f9-4536-acd8-57e36e6249e8" xlink:to="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_71bdef25-a464-4e12-a462-7cc1a648a22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_09615cc6-534f-4222-9fbf-78b24e25c208" xlink:href="cvs-20220630.xsd#cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_4eeefc17-43f9-4536-acd8-57e36e6249e8" xlink:to="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_09615cc6-534f-4222-9fbf-78b24e25c208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#InvestmentsRealizedGainsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_72ba6022-7a64-4653-8bab-92737fc2a9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_a599acef-f74b-45ae-8f4a-1a73aeeb26ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_72ba6022-7a64-4653-8bab-92737fc2a9e6" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_a599acef-f74b-45ae-8f4a-1a73aeeb26ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_f9fa91b2-3d34-4eed-8019-b486b70f3f57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_72ba6022-7a64-4653-8bab-92737fc2a9e6" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_f9fa91b2-3d34-4eed-8019-b486b70f3f57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_f125118a-5d19-4161-9a31-9d9a52f67956" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_72ba6022-7a64-4653-8bab-92737fc2a9e6" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_f125118a-5d19-4161-9a31-9d9a52f67956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValue" xlink:type="simple" xlink:href="cvs-20220630.xsd#FairValue"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1a7a2fa8-8f33-4dae-a4a8-c943cb6098fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_358233bc-8b48-4109-9220-7076a790579a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1a7a2fa8-8f33-4dae-a4a8-c943cb6098fe" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_358233bc-8b48-4109-9220-7076a790579a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueTables" xlink:type="simple" xlink:href="cvs-20220630.xsd#FairValueTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_dfe1942c-b86d-4799-a056-109c1ad82582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_1c89e88e-2091-45c6-9f07-7704cad522ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_dfe1942c-b86d-4799-a056-109c1ad82582" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_1c89e88e-2091-45c6-9f07-7704cad522ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_682a63f1-de38-40dd-a1d8-b76be4d13dea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_dfe1942c-b86d-4799-a056-109c1ad82582" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_682a63f1-de38-40dd-a1d8-b76be4d13dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_17e593fb-60bd-4904-9907-2c8dc9ffbcbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_dfe1942c-b86d-4799-a056-109c1ad82582" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_17e593fb-60bd-4904-9907-2c8dc9ffbcbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#FairValueMeasurementonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3b861939-eb28-425c-8082-1a04531094b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a8092797-5f0c-405a-bdc5-06311978dbcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3b861939-eb28-425c-8082-1a04531094b7" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a8092797-5f0c-405a-bdc5-06311978dbcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_01f27125-0ede-47af-bd12-905ce898fec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a8092797-5f0c-405a-bdc5-06311978dbcf" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_01f27125-0ede-47af-bd12-905ce898fec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f525185c-4e43-441e-9cac-6bdbb45139c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_01f27125-0ede-47af-bd12-905ce898fec2" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f525185c-4e43-441e-9cac-6bdbb45139c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_fee4186c-ec99-4007-89a6-a1525b03ee38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f525185c-4e43-441e-9cac-6bdbb45139c0" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_fee4186c-ec99-4007-89a6-a1525b03ee38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_8e260268-8f3e-4466-8040-fc21faba7da2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a8092797-5f0c-405a-bdc5-06311978dbcf" xlink:to="loc_us-gaap_FinancialInstrumentAxis_8e260268-8f3e-4466-8040-fc21faba7da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d9056361-e9ae-4773-b03c-e4aef76528cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8e260268-8f3e-4466-8040-fc21faba7da2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d9056361-e9ae-4773-b03c-e4aef76528cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_0125f4c8-7521-4123-9988-746532eef616" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d9056361-e9ae-4773-b03c-e4aef76528cf" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_0125f4c8-7521-4123-9988-746532eef616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_f169c86f-763c-4c06-94b4-b521ff80c50c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d9056361-e9ae-4773-b03c-e4aef76528cf" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_f169c86f-763c-4c06-94b4-b521ff80c50c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_80650f49-38d1-4fe1-8264-1eef38736b33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d9056361-e9ae-4773-b03c-e4aef76528cf" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_80650f49-38d1-4fe1-8264-1eef38736b33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_60e3c55d-50a3-45ff-a882-c3bede6e6c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d9056361-e9ae-4773-b03c-e4aef76528cf" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_60e3c55d-50a3-45ff-a882-c3bede6e6c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_1155152a-72d3-43a5-a0f8-7916a8ca5450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d9056361-e9ae-4773-b03c-e4aef76528cf" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_1155152a-72d3-43a5-a0f8-7916a8ca5450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_ec5284f8-a07c-43db-adb9-9e6c93681124" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d9056361-e9ae-4773-b03c-e4aef76528cf" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_ec5284f8-a07c-43db-adb9-9e6c93681124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_874791e5-0805-4b52-8673-dc88d13a3567" xlink:href="cvs-20220630.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d9056361-e9ae-4773-b03c-e4aef76528cf" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_874791e5-0805-4b52-8673-dc88d13a3567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_b73da221-1acc-4dfb-8038-98648474b9d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d9056361-e9ae-4773-b03c-e4aef76528cf" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_b73da221-1acc-4dfb-8038-98648474b9d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f41319b4-bd9a-4d93-9dac-9a89f07845a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a8092797-5f0c-405a-bdc5-06311978dbcf" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f41319b4-bd9a-4d93-9dac-9a89f07845a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_808d28e1-24d7-48a8-8736-f8241837d89b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f41319b4-bd9a-4d93-9dac-9a89f07845a1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_808d28e1-24d7-48a8-8736-f8241837d89b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_fc0d87d8-d001-4f5f-939d-810862f119fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_808d28e1-24d7-48a8-8736-f8241837d89b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_fc0d87d8-d001-4f5f-939d-810862f119fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_283ec26c-05cb-4a9a-a41e-3984cf0bd40a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_808d28e1-24d7-48a8-8736-f8241837d89b" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_283ec26c-05cb-4a9a-a41e-3984cf0bd40a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_78e216b1-9510-4c61-80c6-3c1156922041" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_808d28e1-24d7-48a8-8736-f8241837d89b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_78e216b1-9510-4c61-80c6-3c1156922041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_941439b4-eb48-46a7-a127-642db66c631a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a8092797-5f0c-405a-bdc5-06311978dbcf" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_941439b4-eb48-46a7-a127-642db66c631a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_08f8a03a-18c4-4d77-bf1b-bd5b6febbaf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_941439b4-eb48-46a7-a127-642db66c631a" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_08f8a03a-18c4-4d77-bf1b-bd5b6febbaf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_24e01892-2a70-4cd2-aff1-20849b57f741" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_941439b4-eb48-46a7-a127-642db66c631a" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_24e01892-2a70-4cd2-aff1-20849b57f741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5c5ea725-20fb-4390-b156-574480e22f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_941439b4-eb48-46a7-a127-642db66c631a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5c5ea725-20fb-4390-b156-574480e22f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_2f6418f6-27e1-4c15-bbde-364a0617c0ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_941439b4-eb48-46a7-a127-642db66c631a" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_2f6418f6-27e1-4c15-bbde-364a0617c0ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_d506f6a4-b93f-4303-9f8f-b8f672b07aee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_941439b4-eb48-46a7-a127-642db66c631a" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_d506f6a4-b93f-4303-9f8f-b8f672b07aee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueNarrativeDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#FairValueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3eeffcce-ad64-46d2-a922-cc9f02662c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_d946bb5c-990c-4e04-b241-1a4f4afb2fda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3eeffcce-ad64-46d2-a922-cc9f02662c7d" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_d946bb5c-990c-4e04-b241-1a4f4afb2fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_e6b946da-29c5-4e49-8284-c7bc25902c42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3eeffcce-ad64-46d2-a922-cc9f02662c7d" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_e6b946da-29c5-4e49-8284-c7bc25902c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#FairValueCarryingValueandFairValueClassifiedbyLevelDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_96ac2a0b-91be-4dce-bf94-043dbb22ee19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d95a2aea-d623-4d76-b2d8-495aadd5a4ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_96ac2a0b-91be-4dce-bf94-043dbb22ee19" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d95a2aea-d623-4d76-b2d8-495aadd5a4ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3d425c92-86e3-4527-be3a-608886638982" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d95a2aea-d623-4d76-b2d8-495aadd5a4ab" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3d425c92-86e3-4527-be3a-608886638982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_1667d458-720c-4472-b246-3258b912f155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3d425c92-86e3-4527-be3a-608886638982" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_1667d458-720c-4472-b246-3258b912f155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_acce96e7-94bc-4534-bc01-60269f34cdde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_1667d458-720c-4472-b246-3258b912f155" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_acce96e7-94bc-4534-bc01-60269f34cdde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7baa4474-ab6a-4879-ac30-b103a99266fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d95a2aea-d623-4d76-b2d8-495aadd5a4ab" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7baa4474-ab6a-4879-ac30-b103a99266fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_157993fb-621c-4794-bdc3-07d46ec3f73c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7baa4474-ab6a-4879-ac30-b103a99266fa" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_157993fb-621c-4794-bdc3-07d46ec3f73c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_cac82b72-3132-428d-88a7-849db5d9f8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_157993fb-621c-4794-bdc3-07d46ec3f73c" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_cac82b72-3132-428d-88a7-849db5d9f8a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_aae336f7-331c-43c0-8307-c016dcddda00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_157993fb-621c-4794-bdc3-07d46ec3f73c" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_aae336f7-331c-43c0-8307-c016dcddda00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_8d3317bb-0257-48c0-9678-55be477787bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_157993fb-621c-4794-bdc3-07d46ec3f73c" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_8d3317bb-0257-48c0-9678-55be477787bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_e91fe224-f2a5-4673-9967-f419e36a38a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d95a2aea-d623-4d76-b2d8-495aadd5a4ab" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_e91fe224-f2a5-4673-9967-f419e36a38a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_015fdca0-3ab1-4cc6-a7c3-db85553f54da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_e91fe224-f2a5-4673-9967-f419e36a38a4" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_015fdca0-3ab1-4cc6-a7c3-db85553f54da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b50a8944-d9ca-4c76-9005-33aff842c0f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_015fdca0-3ab1-4cc6-a7c3-db85553f54da" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b50a8944-d9ca-4c76-9005-33aff842c0f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_f2758364-74be-4b7d-930f-31acfb4946a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b50a8944-d9ca-4c76-9005-33aff842c0f1" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_f2758364-74be-4b7d-930f-31acfb4946a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_aed31e50-11a4-429f-9e9c-fd55430fe87c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b50a8944-d9ca-4c76-9005-33aff842c0f1" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_aed31e50-11a4-429f-9e9c-fd55430fe87c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_01274b58-4a85-4586-8411-d3f9ef4dec47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d95a2aea-d623-4d76-b2d8-495aadd5a4ab" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_01274b58-4a85-4586-8411-d3f9ef4dec47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_04590e22-8187-4131-a823-7b925db5b000" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_01274b58-4a85-4586-8411-d3f9ef4dec47" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_04590e22-8187-4131-a823-7b925db5b000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_a74d3d04-62cf-4a26-8a2e-78094eec9045" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgagesHeldForSaleFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_04590e22-8187-4131-a823-7b925db5b000" xlink:to="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_a74d3d04-62cf-4a26-8a2e-78094eec9045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_094289e6-b61c-4931-bb18-fd91db91e276" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_04590e22-8187-4131-a823-7b925db5b000" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_094289e6-b61c-4931-bb18-fd91db91e276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_fedf40c7-6e2c-4430-91d3-39d8e126ce91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_01274b58-4a85-4586-8411-d3f9ef4dec47" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_fedf40c7-6e2c-4430-91d3-39d8e126ce91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_da3064a7-15d7-447c-a71c-2df46d3facdb" xlink:href="cvs-20220630.xsd#cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_fedf40c7-6e2c-4430-91d3-39d8e126ce91" xlink:to="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_da3064a7-15d7-447c-a71c-2df46d3facdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_a858add7-cd96-4b52-9622-419689f18e2b" xlink:href="cvs-20220630.xsd#cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_fedf40c7-6e2c-4430-91d3-39d8e126ce91" xlink:to="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_a858add7-cd96-4b52-9622-419689f18e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_031388dc-0f51-4c87-8275-460f99b30c61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_fedf40c7-6e2c-4430-91d3-39d8e126ce91" xlink:to="loc_us-gaap_DebtInstrumentFairValue_031388dc-0f51-4c87-8275-460f99b30c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#FairValueSeparateAccountsFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_fd23f125-b606-43bd-b9a7-42e88fb05ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b8334f16-d4a2-45b6-b772-96cf9b564245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_fd23f125-b606-43bd-b9a7-42e88fb05ce7" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b8334f16-d4a2-45b6-b772-96cf9b564245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bc12aaf4-0122-4d18-99d3-0d223cc9093d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b8334f16-d4a2-45b6-b772-96cf9b564245" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bc12aaf4-0122-4d18-99d3-0d223cc9093d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_5a6448a9-c468-4472-94f6-f6a69cbb7708" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bc12aaf4-0122-4d18-99d3-0d223cc9093d" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_5a6448a9-c468-4472-94f6-f6a69cbb7708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_b2e3834f-79c1-4186-ad7b-ec1da1027b41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_5a6448a9-c468-4472-94f6-f6a69cbb7708" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_b2e3834f-79c1-4186-ad7b-ec1da1027b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_869aa08e-8e3d-4e4e-b325-af9a8fe98e68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b8334f16-d4a2-45b6-b772-96cf9b564245" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_869aa08e-8e3d-4e4e-b325-af9a8fe98e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c4fbb5cf-9be9-4c27-b29b-112ef088f665" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_869aa08e-8e3d-4e4e-b325-af9a8fe98e68" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c4fbb5cf-9be9-4c27-b29b-112ef088f665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_60c597e6-7d8b-4678-93af-e839752da8b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c4fbb5cf-9be9-4c27-b29b-112ef088f665" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_60c597e6-7d8b-4678-93af-e839752da8b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f365ea8e-00de-492d-af10-00cd4cb99f19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c4fbb5cf-9be9-4c27-b29b-112ef088f665" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f365ea8e-00de-492d-af10-00cd4cb99f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_95b3783f-ee7d-4c76-956b-59637a974492" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c4fbb5cf-9be9-4c27-b29b-112ef088f665" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_95b3783f-ee7d-4c76-956b-59637a974492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_ea445f92-78aa-41bc-8cf0-3e332ab79c31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b8334f16-d4a2-45b6-b772-96cf9b564245" xlink:to="loc_us-gaap_InvestmentTypeAxis_ea445f92-78aa-41bc-8cf0-3e332ab79c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_93acf121-845b-467c-a974-3fb2918f53f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_ea445f92-78aa-41bc-8cf0-3e332ab79c31" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_93acf121-845b-467c-a974-3fb2918f53f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_2700709b-1aed-45e1-bd41-47acf558f3a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_93acf121-845b-467c-a974-3fb2918f53f0" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_2700709b-1aed-45e1-bd41-47acf558f3a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_81bca80e-7ea7-4c49-9e5e-eaba9de30668" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_93acf121-845b-467c-a974-3fb2918f53f0" xlink:to="loc_us-gaap_DebtSecuritiesMember_81bca80e-7ea7-4c49-9e5e-eaba9de30668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_2fad13b5-dd1e-417a-968d-720afcfe8042" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_93acf121-845b-467c-a974-3fb2918f53f0" xlink:to="loc_us-gaap_EquitySecuritiesMember_2fad13b5-dd1e-417a-968d-720afcfe8042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CommonAndCollectiveTrustsMember_72c6e51a-45ac-4d88-a52c-8721194f5529" xlink:href="cvs-20220630.xsd#cvs_CommonAndCollectiveTrustsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_93acf121-845b-467c-a974-3fb2918f53f0" xlink:to="loc_cvs_CommonAndCollectiveTrustsMember_72c6e51a-45ac-4d88-a52c-8721194f5529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_8b10ce27-59f9-4be5-b197-26ac4178f8c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b8334f16-d4a2-45b6-b772-96cf9b564245" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_8b10ce27-59f9-4be5-b197-26ac4178f8c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_543e523b-dbd1-426e-acf4-3bf075681a20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8b10ce27-59f9-4be5-b197-26ac4178f8c8" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_543e523b-dbd1-426e-acf4-3bf075681a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherReceivablesMember_c90408b4-7291-492a-9aa1-778172307dac" xlink:href="cvs-20220630.xsd#cvs_OtherReceivablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_543e523b-dbd1-426e-acf4-3bf075681a20" xlink:to="loc_cvs_OtherReceivablesMember_c90408b4-7291-492a-9aa1-778172307dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_2939edfc-1778-4cd3-8665-24972149b888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b8334f16-d4a2-45b6-b772-96cf9b564245" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_2939edfc-1778-4cd3-8665-24972149b888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_54960c8a-46d5-4fae-89b1-e022a03137c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_2939edfc-1778-4cd3-8665-24972149b888" xlink:to="loc_us-gaap_SeparateAccountAssets_54960c8a-46d5-4fae-89b1-e022a03137c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayable" xlink:type="simple" xlink:href="cvs-20220630.xsd#HealthCareCostsPayable"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_4a622ce9-3946-4537-8e82-694035f479f1" xlink:href="cvs-20220630.xsd#cvs_HealthCareandOtherInsuranceLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_8b0178cd-57b4-4b0d-acb1-3769e6169dec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_4a622ce9-3946-4537-8e82-694035f479f1" xlink:to="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_8b0178cd-57b4-4b0d-acb1-3769e6169dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableTables" xlink:type="simple" xlink:href="cvs-20220630.xsd#HealthCareCostsPayableTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_4fb78b72-97f7-4fae-b7ef-56de849d1f23" xlink:href="cvs-20220630.xsd#cvs_HealthCareandOtherInsuranceLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_83d1d0a2-16bd-4f67-b6c5-a3950287aef0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_4fb78b72-97f7-4fae-b7ef-56de849d1f23" xlink:to="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_83d1d0a2-16bd-4f67-b6c5-a3950287aef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_aeb77f3c-5455-484d-ae1b-b36f24e69561" xlink:href="cvs-20220630.xsd#cvs_HealthCareandOtherInsuranceLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_cdf916c0-9dff-4722-9837-b9c3d3f9b444" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_aeb77f3c-5455-484d-ae1b-b36f24e69561" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_cdf916c0-9dff-4722-9837-b9c3d3f9b444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_25197209-e3d3-48d1-a494-b01367fafb3e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_cdf916c0-9dff-4722-9837-b9c3d3f9b444" xlink:to="loc_srt_ProductOrServiceAxis_25197209-e3d3-48d1-a494-b01367fafb3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0bcbf428-dae6-4253-9216-51fe89130c47" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_25197209-e3d3-48d1-a494-b01367fafb3e" xlink:to="loc_srt_ProductsAndServicesDomain_0bcbf428-dae6-4253-9216-51fe89130c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_76f53107-3796-41e3-ac73-6d773f302669" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0bcbf428-dae6-4253-9216-51fe89130c47" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_76f53107-3796-41e3-ac73-6d773f302669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3fe2e29a-c4b7-4c14-bd71-9d4fc2e757c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_cdf916c0-9dff-4722-9837-b9c3d3f9b444" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3fe2e29a-c4b7-4c14-bd71-9d4fc2e757c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6fbdac2d-a3fe-4126-9a62-7f5474a8154d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3fe2e29a-c4b7-4c14-bd71-9d4fc2e757c1" xlink:to="loc_us-gaap_SegmentDomain_6fbdac2d-a3fe-4126-9a62-7f5474a8154d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_49ac351f-c16c-4913-a90b-ce089ee7014d" xlink:href="cvs-20220630.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6fbdac2d-a3fe-4126-9a62-7f5474a8154d" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_49ac351f-c16c-4913-a90b-ce089ee7014d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CorporateOtherMember_f3e06a3b-e5f2-478a-8cf3-62c6efecd01b" xlink:href="cvs-20220630.xsd#cvs_CorporateOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6fbdac2d-a3fe-4126-9a62-7f5474a8154d" xlink:to="loc_cvs_CorporateOtherMember_f3e06a3b-e5f2-478a-8cf3-62c6efecd01b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_eca2a34e-8fbc-4e27-8a16-cbad58717a09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_cdf916c0-9dff-4722-9837-b9c3d3f9b444" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_eca2a34e-8fbc-4e27-8a16-cbad58717a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7c70827-00bd-443d-ac7b-b95dccf0916d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_eca2a34e-8fbc-4e27-8a16-cbad58717a09" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7c70827-00bd-443d-ac7b-b95dccf0916d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_551aace4-1a30-4d9c-b0cd-363008a51774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7c70827-00bd-443d-ac7b-b95dccf0916d" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_551aace4-1a30-4d9c-b0cd-363008a51774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_93b0cfe2-eb25-4d79-a465-360eae277794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7c70827-00bd-443d-ac7b-b95dccf0916d" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_93b0cfe2-eb25-4d79-a465-360eae277794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_385fbeb5-5624-48c9-a96e-00f76231ee16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7c70827-00bd-443d-ac7b-b95dccf0916d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_385fbeb5-5624-48c9-a96e-00f76231ee16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_dffb523d-d10f-4c09-83c1-cc9201ecf9f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7c70827-00bd-443d-ac7b-b95dccf0916d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_dffb523d-d10f-4c09-83c1-cc9201ecf9f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_fbf158bb-fbb4-4260-b5bd-704ff7da2c03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_dffb523d-d10f-4c09-83c1-cc9201ecf9f1" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_fbf158bb-fbb4-4260-b5bd-704ff7da2c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_de5cfbf2-d569-4711-9cc0-1fd257cb3e04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_dffb523d-d10f-4c09-83c1-cc9201ecf9f1" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_de5cfbf2-d569-4711-9cc0-1fd257cb3e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_66acb8be-391d-4ffc-9e25-19d6021d747d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_dffb523d-d10f-4c09-83c1-cc9201ecf9f1" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_66acb8be-391d-4ffc-9e25-19d6021d747d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_860d57d1-a7c4-4559-9d06-dffc814cb007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7c70827-00bd-443d-ac7b-b95dccf0916d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_860d57d1-a7c4-4559-9d06-dffc814cb007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_09039059-47ca-4398-befa-e6889bb63b08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_860d57d1-a7c4-4559-9d06-dffc814cb007" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_09039059-47ca-4398-befa-e6889bb63b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_33ef4f22-6b51-4886-a0b6-53b616b60d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_860d57d1-a7c4-4559-9d06-dffc814cb007" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_33ef4f22-6b51-4886-a0b6-53b616b60d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_cb87913e-f37a-47ea-8b66-545ee4f2aa5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_860d57d1-a7c4-4559-9d06-dffc814cb007" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_cb87913e-f37a-47ea-8b66-545ee4f2aa5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_aa78156b-e4d0-45a8-93b4-789241e5ae47" xlink:href="cvs-20220630.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7c70827-00bd-443d-ac7b-b95dccf0916d" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_aa78156b-e4d0-45a8-93b4-789241e5ae47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_5d3843eb-e675-4ace-a584-e104e66431b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7c70827-00bd-443d-ac7b-b95dccf0916d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_5d3843eb-e675-4ace-a584-e104e66431b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_168c6fbf-126a-4fc6-a543-b6dee837d59f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7c70827-00bd-443d-ac7b-b95dccf0916d" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_168c6fbf-126a-4fc6-a543-b6dee837d59f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_10d67725-60dc-428e-a78b-e21ae2f16076" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7c70827-00bd-443d-ac7b-b95dccf0916d" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_10d67725-60dc-428e-a78b-e21ae2f16076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_f71e27d5-71b6-430c-ba50-3c5fc98201c3" xlink:href="cvs-20220630.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_eca2a34e-8fbc-4e27-8a16-cbad58717a09" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_f71e27d5-71b6-430c-ba50-3c5fc98201c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_04f9fa89-c008-4ab2-951d-79eea6d592c2" xlink:href="cvs-20220630.xsd#cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_eca2a34e-8fbc-4e27-8a16-cbad58717a09" xlink:to="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_04f9fa89-c008-4ab2-951d-79eea6d592c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#HealthCareCostsPayableNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_65160fc9-4d8d-4e03-a9e9-c0c027ccf98f" xlink:href="cvs-20220630.xsd#cvs_HealthCareandOtherInsuranceLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_235ce96b-4907-413e-8288-5800f027beab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_65160fc9-4d8d-4e03-a9e9-c0c027ccf98f" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_235ce96b-4907-413e-8288-5800f027beab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_df19edef-1009-4598-b594-2db68274537f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_235ce96b-4907-413e-8288-5800f027beab" xlink:to="loc_srt_ProductOrServiceAxis_df19edef-1009-4598-b594-2db68274537f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a93babc0-f3f7-43c7-8bce-c72b6428b1c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_df19edef-1009-4598-b594-2db68274537f" xlink:to="loc_srt_ProductsAndServicesDomain_a93babc0-f3f7-43c7-8bce-c72b6428b1c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_670ed1cf-4cf6-4871-9190-318226bd0982" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a93babc0-f3f7-43c7-8bce-c72b6428b1c3" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_670ed1cf-4cf6-4871-9190-318226bd0982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_fbed5ad2-14b6-4371-863b-057245ba5857" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_235ce96b-4907-413e-8288-5800f027beab" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_fbed5ad2-14b6-4371-863b-057245ba5857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_eddddb30-d1c4-46fb-99b4-c53fecffb29a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_fbed5ad2-14b6-4371-863b-057245ba5857" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_eddddb30-d1c4-46fb-99b4-c53fecffb29a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_e4dc6ef2-c122-42b7-bd92-9f029344cc1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_fbed5ad2-14b6-4371-863b-057245ba5857" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_e4dc6ef2-c122-42b7-bd92-9f029344cc1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Borrowings" xlink:type="simple" xlink:href="cvs-20220630.xsd#Borrowings"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/Borrowings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_7b55590e-cea3-41bf-b1c4-b460809daa93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_64ecd941-342f-468e-85d5-bb550fa2ea2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_7b55590e-cea3-41bf-b1c4-b460809daa93" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_64ecd941-342f-468e-85d5-bb550fa2ea2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsTables" xlink:type="simple" xlink:href="cvs-20220630.xsd#BorrowingsTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/BorrowingsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_211324b2-b913-4938-a865-910b4bc3ba74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_9244027d-e9b6-4cbf-a093-5590f9b039eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_211324b2-b913-4938-a865-910b4bc3ba74" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_9244027d-e9b6-4cbf-a093-5590f9b039eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#BorrowingsScheduleofBorrowingsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_785a432e-e83e-47e3-9597-efdb295ec556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9eef29aa-eeac-4212-b53e-7043fdfa34eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_785a432e-e83e-47e3-9597-efdb295ec556" xlink:to="loc_us-gaap_DebtInstrumentTable_9eef29aa-eeac-4212-b53e-7043fdfa34eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e768e407-7381-4c6f-ab5d-eb6cdcb6fce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9eef29aa-eeac-4212-b53e-7043fdfa34eb" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e768e407-7381-4c6f-ab5d-eb6cdcb6fce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3554bbf7-c14f-4d51-b71b-c1bb433f88a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e768e407-7381-4c6f-ab5d-eb6cdcb6fce3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3554bbf7-c14f-4d51-b71b-c1bb433f88a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_9d93a01a-6345-4963-907b-f2ec0818f44d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3554bbf7-c14f-4d51-b71b-c1bb433f88a6" xlink:to="loc_us-gaap_SeniorNotesMember_9d93a01a-6345-4963-907b-f2ec0818f44d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_2e4971f1-911f-439c-8d32-3cd7bc1891e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3554bbf7-c14f-4d51-b71b-c1bb433f88a6" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_2e4971f1-911f-439c-8d32-3cd7bc1891e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7d151192-fd8e-4702-b900-c97ffb738371" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9eef29aa-eeac-4212-b53e-7043fdfa34eb" xlink:to="loc_us-gaap_DebtInstrumentAxis_7d151192-fd8e-4702-b900-c97ffb738371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_7d151192-fd8e-4702-b900-c97ffb738371" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueJuly2022Member_3fc4e1f8-341a-4613-8965-9799132b7f9f" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes3.5DueJuly2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes3.5DueJuly2022Member_3fc4e1f8-341a-4613-8965-9799132b7f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueNovember2022Member_79fba553-73e7-4a4d-bf5a-153552d4a094" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes2.75DueNovember2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes2.75DueNovember2022Member_79fba553-73e7-4a4d-bf5a-153552d4a094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueDecember2022Member_003cec4f-aad8-45a1-b7a9-4491b67b7ee6" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes2.75DueDecember2022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes2.75DueDecember2022Member_003cec4f-aad8-45a1-b7a9-4491b67b7ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueDecember2022Member_10483b0d-2f89-415e-9c62-f1a200db7d0c" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.75DueDecember2022Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes4.75DueDecember2022Member_10483b0d-2f89-415e-9c62-f1a200db7d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.8DueJune2023Member_63e6c49f-8ca3-4f4f-9bfa-68fdc17e4eb8" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes2.8DueJune2023Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes2.8DueJune2023Member_63e6c49f-8ca3-4f4f-9bfa-68fdc17e4eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4DueDecember2023Member_d45095a7-43fb-47fe-a7c7-8fc6c4f31216" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4DueDecember2023Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes4DueDecember2023Member_d45095a7-43fb-47fe-a7c7-8fc6c4f31216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.375DueAugust2024Member_488c4295-8595-4cd5-9bcc-e4a95078ee3e" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes3.375DueAugust2024Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes3.375DueAugust2024Member_488c4295-8595-4cd5-9bcc-e4a95078ee3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.625DueAugust2024Member_2e1f828a-76c4-4dbb-a013-7bfa098262e1" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes2.625DueAugust2024Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes2.625DueAugust2024Member_2e1f828a-76c4-4dbb-a013-7bfa098262e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueNovember2024Member_7a18c8ac-1a5d-4dd0-a716-eba53261142b" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes3.5DueNovember2024Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes3.5DueNovember2024Member_7a18c8ac-1a5d-4dd0-a716-eba53261142b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5DueDecember2024Member_c4689958-7b8f-42a2-9636-f80ca3ba6827" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes5DueDecember2024Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes5DueDecember2024Member_c4689958-7b8f-42a2-9636-f80ca3ba6827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.1DueMarch2025Member_a3814584-fb89-4e33-bfc0-0ddbac786cae" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.1DueMarch2025Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes4.1DueMarch2025Member_a3814584-fb89-4e33-bfc0-0ddbac786cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueJuly2025Member_2041806f-d6fc-4493-9d60-30543d0dcc35" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes3.875DueJuly2025Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes3.875DueJuly2025Member_2041806f-d6fc-4493-9d60-30543d0dcc35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.875DueJune2026Member_85b6068d-f5bf-45df-9f8f-e9973b644526" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes2.875DueJune2026Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes2.875DueJune2026Member_85b6068d-f5bf-45df-9f8f-e9973b644526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3DueAugust2026Member_a2751fa7-cc20-478b-a2f1-2db87f3614da" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes3DueAugust2026Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes3DueAugust2026Member_a2751fa7-cc20-478b-a2f1-2db87f3614da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.625DueApril2027Member_29f0a830-1aa9-4951-976e-fb337f4a24b4" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes3.625DueApril2027Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes3.625DueApril2027Member_29f0a830-1aa9-4951-976e-fb337f4a24b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.25DueJune2027Member_e317374e-091d-4b39-9eb0-7c4528ca5904" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes6.25DueJune2027Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes6.25DueJune2027Member_e317374e-091d-4b39-9eb0-7c4528ca5904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes13DueAugust2027Member_ed3404b8-4fe9-4b02-8370-8386916f8f81" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes13DueAugust2027Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes13DueAugust2027Member_ed3404b8-4fe9-4b02-8370-8386916f8f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.3DueMarch2028Member_8e79b306-2fa6-41a5-bf92-31073ced44cf" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.3DueMarch2028Member"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes4.3DueMarch2028Member_8e79b306-2fa6-41a5-bf92-31073ced44cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.25DueAugust2029Member_13dd09cc-a0e1-4f52-a379-a6ee33126325" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes3.25DueAugust2029Member"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes3.25DueAugust2029Member_13dd09cc-a0e1-4f52-a379-a6ee33126325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.75DueApril2030Member_92025c2b-853b-49e9-bf6f-c051103fa990" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes3.75DueApril2030Member"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes3.75DueApril2030Member_92025c2b-853b-49e9-bf6f-c051103fa990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes175DueAugust2030Member_743f4e63-00d3-4054-b9ea-1eea6346ba4f" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes175DueAugust2030Member"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes175DueAugust2030Member_743f4e63-00d3-4054-b9ea-1eea6346ba4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1875DueFebruary2031Member_8e8df5ca-443d-4f73-a0d8-e8d4c2c28079" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes1875DueFebruary2031Member"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes1875DueFebruary2031Member_8e8df5ca-443d-4f73-a0d8-e8d4c2c28079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2125PercentDueSeptember2031Member_a8564941-46c5-4baa-afc7-de3318e34348" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes2125PercentDueSeptember2031Member"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes2125PercentDueSeptember2031Member_a8564941-46c5-4baa-afc7-de3318e34348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.875DueJuly2035Member_40866c9f-133e-445d-9443-c68e97103073" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.875DueJuly2035Member"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes4.875DueJuly2035Member_40866c9f-133e-445d-9443-c68e97103073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.625DueJune2036Member_1f0d28ba-c78f-42ae-99e9-5d1ffcc5f3e7" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes6.625DueJune2036Member"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes6.625DueJune2036Member_1f0d28ba-c78f-42ae-99e9-5d1ffcc5f3e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.75DueDecember2037Member_26ec988e-c829-4685-87a1-90aeba899b39" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes6.75DueDecember2037Member"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes6.75DueDecember2037Member_26ec988e-c829-4685-87a1-90aeba899b39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.78DueMarch2038Member_5b235457-d061-4719-b76e-9d4047fd5f42" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.78DueMarch2038Member"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes4.78DueMarch2038Member_5b235457-d061-4719-b76e-9d4047fd5f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.125DueSeptember2039Member_d4fc339c-d02c-4cbe-9f33-85e6392737d3" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes6.125DueSeptember2039Member"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes6.125DueSeptember2039Member_d4fc339c-d02c-4cbe-9f33-85e6392737d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueApril2040Member_96cf8cc9-a913-4d1d-8ec8-9f07252251cb" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.125DueApril2040Member"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes4.125DueApril2040Member_96cf8cc9-a913-4d1d-8ec8-9f07252251cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes27DueAugust2040Member_c9d280fc-04a5-4a61-a2ac-a4af078cfee1" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes27DueAugust2040Member"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes27DueAugust2040Member_c9d280fc-04a5-4a61-a2ac-a4af078cfee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.75DueMay2041Member_c2f1a47c-8a62-4acb-aed9-0968ead0b90c" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes5.75DueMay2041Member"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes5.75DueMay2041Member_c2f1a47c-8a62-4acb-aed9-0968ead0b90c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.5DueMay2042Member_e6fc234f-51e6-4f9d-b8eb-2ee4dd40e7e8" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.5DueMay2042Member"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes4.5DueMay2042Member_e6fc234f-51e6-4f9d-b8eb-2ee4dd40e7e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueNovember2042Member_4cc1943c-4458-433b-b023-937bc68dd078" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.125DueNovember2042Member"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes4.125DueNovember2042Member_4cc1943c-4458-433b-b023-937bc68dd078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.3DueDecember2043Member_842df2f1-a979-4a51-b511-3da59ca62f17" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes5.3DueDecember2043Member"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes5.3DueDecember2043Member_842df2f1-a979-4a51-b511-3da59ca62f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueMarch2044Member_a6e13315-5c2b-4b51-b982-c110365a0125" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.75DueMarch2044Member"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes4.75DueMarch2044Member_a6e13315-5c2b-4b51-b982-c110365a0125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.125DueJuly2045Member_c4e500da-b699-4d58-a60d-c0a7b285ab1a" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes5.125DueJuly2045Member"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes5.125DueJuly2045Member_c4e500da-b699-4d58-a60d-c0a7b285ab1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueAugust2047Member_c4e1e50c-f774-43ac-8580-781deadbf97c" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes3.875DueAugust2047Member"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes3.875DueAugust2047Member_c4e1e50c-f774-43ac-8580-781deadbf97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.05DueMarch2048Member_03e74013-63a2-4f0c-9cf1-cd515e7d2115" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes5.05DueMarch2048Member"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes5.05DueMarch2048Member_03e74013-63a2-4f0c-9cf1-cd515e7d2115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.25DueApril2050Member_b2a76ae4-746d-4a68-818d-fdcc641b2372" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.25DueApril2050Member"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_83dd21e0-7ba9-4967-939c-f0459fe0e88a" xlink:to="loc_cvs_SeniorNotes4.25DueApril2050Member_b2a76ae4-746d-4a68-818d-fdcc641b2372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2f611e9e-08ed-4a72-91fb-65d8a1ea0048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9eef29aa-eeac-4212-b53e-7043fdfa34eb" xlink:to="loc_us-gaap_DebtInstrumentLineItems_2f611e9e-08ed-4a72-91fb-65d8a1ea0048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ebf08139-db50-4ca4-84c9-ae5a0618685f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f611e9e-08ed-4a72-91fb-65d8a1ea0048" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ebf08139-db50-4ca4-84c9-ae5a0618685f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_e7f92c36-8fe2-47e0-b9e9-4bc0dd85e8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f611e9e-08ed-4a72-91fb-65d8a1ea0048" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_e7f92c36-8fe2-47e0-b9e9-4bc0dd85e8a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_c1632703-e2bd-4b1d-a14b-153b9aaaddf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f611e9e-08ed-4a72-91fb-65d8a1ea0048" xlink:to="loc_us-gaap_FinanceLeaseLiability_c1632703-e2bd-4b1d-a14b-153b9aaaddf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongtermDebtGrossAndLeaseObligation_f473c644-a0a1-47cc-9cbc-31066ebff787" xlink:href="cvs-20220630.xsd#cvs_LongtermDebtGrossAndLeaseObligation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f611e9e-08ed-4a72-91fb-65d8a1ea0048" xlink:to="loc_cvs_LongtermDebtGrossAndLeaseObligation_f473c644-a0a1-47cc-9cbc-31066ebff787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_cd82dd09-2be7-428f-bd80-1d37fc5cc293" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f611e9e-08ed-4a72-91fb-65d8a1ea0048" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_cd82dd09-2be7-428f-bd80-1d37fc5cc293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_53cf7f68-3bbc-4941-adb5-a31661f63cda" xlink:href="cvs-20220630.xsd#cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f611e9e-08ed-4a72-91fb-65d8a1ea0048" xlink:to="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_53cf7f68-3bbc-4941-adb5-a31661f63cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_380e1ce1-68a0-47e7-91c5-0181acb3f15a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f611e9e-08ed-4a72-91fb-65d8a1ea0048" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_380e1ce1-68a0-47e7-91c5-0181acb3f15a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_6701efff-936d-4e7b-b61b-c797ecc2ed59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f611e9e-08ed-4a72-91fb-65d8a1ea0048" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_6701efff-936d-4e7b-b61b-c797ecc2ed59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_e94e6aab-a1de-479c-b92a-3adc1c7b99c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f611e9e-08ed-4a72-91fb-65d8a1ea0048" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_e94e6aab-a1de-479c-b92a-3adc1c7b99c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_1276bce8-d9bb-43d3-89df-8dc1d256a0e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f611e9e-08ed-4a72-91fb-65d8a1ea0048" xlink:to="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_1276bce8-d9bb-43d3-89df-8dc1d256a0e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsNarrativeDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#BorrowingsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/BorrowingsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e44c9d52-f430-4796-ac14-a2e2d03f48fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f0863845-f121-4605-9af4-77089a26cf26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e44c9d52-f430-4796-ac14-a2e2d03f48fe" xlink:to="loc_us-gaap_DebtInstrumentTable_f0863845-f121-4605-9af4-77089a26cf26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_07e2f3e8-8662-41a4-b8d2-542ecf925b03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f0863845-f121-4605-9af4-77089a26cf26" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_07e2f3e8-8662-41a4-b8d2-542ecf925b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_de375e4a-d7cb-4ec5-896b-dbd9647f7a69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_07e2f3e8-8662-41a4-b8d2-542ecf925b03" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_de375e4a-d7cb-4ec5-896b-dbd9647f7a69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_13e13452-e472-475e-8609-04a7497fbcd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_de375e4a-d7cb-4ec5-896b-dbd9647f7a69" xlink:to="loc_us-gaap_SeniorNotesMember_13e13452-e472-475e-8609-04a7497fbcd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_61848b16-9a4f-4ece-adfc-2f4516a8d4c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f0863845-f121-4605-9af4-77089a26cf26" xlink:to="loc_us-gaap_DebtInstrumentAxis_61848b16-9a4f-4ece-adfc-2f4516a8d4c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_de663153-0e3c-4103-bfba-c7fe9866b485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_61848b16-9a4f-4ece-adfc-2f4516a8d4c5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_de663153-0e3c-4103-bfba-c7fe9866b485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueJuly2022Member_5fdef935-ff12-4b9d-99fe-2111fb94d607" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes3.5DueJuly2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de663153-0e3c-4103-bfba-c7fe9866b485" xlink:to="loc_cvs_SeniorNotes3.5DueJuly2022Member_5fdef935-ff12-4b9d-99fe-2111fb94d607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueNovember2022Member_07316c7b-e731-42fd-ad03-686c510e88c5" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes2.75DueNovember2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de663153-0e3c-4103-bfba-c7fe9866b485" xlink:to="loc_cvs_SeniorNotes2.75DueNovember2022Member_07316c7b-e731-42fd-ad03-686c510e88c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueDecember2022Member_f741eafa-4b2e-45de-883a-a73a1fd5347b" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes2.75DueDecember2022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de663153-0e3c-4103-bfba-c7fe9866b485" xlink:to="loc_cvs_SeniorNotes2.75DueDecember2022Member_f741eafa-4b2e-45de-883a-a73a1fd5347b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueDecember2022Member_142d8a08-cbda-49de-aba4-06776d4816b3" xlink:href="cvs-20220630.xsd#cvs_SeniorNotes4.75DueDecember2022Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de663153-0e3c-4103-bfba-c7fe9866b485" xlink:to="loc_cvs_SeniorNotes4.75DueDecember2022Member_142d8a08-cbda-49de-aba4-06776d4816b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2e5feee9-ba47-4578-a0a7-3552d8d9b6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f0863845-f121-4605-9af4-77089a26cf26" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2e5feee9-ba47-4578-a0a7-3552d8d9b6f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_beb6b0ed-f75e-49bd-b389-ac8a65ea7af1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2e5feee9-ba47-4578-a0a7-3552d8d9b6f3" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_beb6b0ed-f75e-49bd-b389-ac8a65ea7af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_f4000f6f-27ca-4206-9b8c-23611af930c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_beb6b0ed-f75e-49bd-b389-ac8a65ea7af1" xlink:to="loc_us-gaap_SubsequentEventMember_f4000f6f-27ca-4206-9b8c-23611af930c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_21c5564b-503d-451a-b6f8-0573694746ad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f0863845-f121-4605-9af4-77089a26cf26" xlink:to="loc_srt_StatementScenarioAxis_21c5564b-503d-451a-b6f8-0573694746ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_9562228a-e9c4-47aa-996d-66b56c0d156d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_21c5564b-503d-451a-b6f8-0573694746ad" xlink:to="loc_srt_ScenarioUnspecifiedDomain_9562228a-e9c4-47aa-996d-66b56c0d156d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_176e2ead-2dbc-4a3e-87e4-5d66327d6674" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_9562228a-e9c4-47aa-996d-66b56c0d156d" xlink:to="loc_srt_ScenarioForecastMember_176e2ead-2dbc-4a3e-87e4-5d66327d6674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_041500dc-3b71-434b-a30c-837aa0aa0c11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f0863845-f121-4605-9af4-77089a26cf26" xlink:to="loc_us-gaap_DebtInstrumentLineItems_041500dc-3b71-434b-a30c-837aa0aa0c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f9dd5258-885f-4e65-886f-1e3f6d7acc0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_041500dc-3b71-434b-a30c-837aa0aa0c11" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f9dd5258-885f-4e65-886f-1e3f6d7acc0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_6ca78326-bb0d-4734-bd1d-6114db2e97c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_041500dc-3b71-434b-a30c-837aa0aa0c11" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_6ca78326-bb0d-4734-bd1d-6114db2e97c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="cvs-20220630.xsd#ShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_28f5b541-dfff-457b-8146-2e3e6feb33c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_8f2312ee-f90d-49e2-a094-3b78fb99452c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_28f5b541-dfff-457b-8146-2e3e6feb33c3" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_8f2312ee-f90d-49e2-a094-3b78fb99452c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityTables" xlink:type="simple" xlink:href="cvs-20220630.xsd#ShareholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_17f1096b-3715-4477-b589-aa343059a201" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_5d887e7e-70ac-44b3-8082-7aa1174f25f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_17f1096b-3715-4477-b589-aa343059a201" xlink:to="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_5d887e7e-70ac-44b3-8082-7aa1174f25f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#ShareholdersEquityShareRepurchasesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_d3e444c4-496f-493b-9516-0ce7df2708d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_cb8f6886-fbf7-4ca9-b901-38948b34b351" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d3e444c4-496f-493b-9516-0ce7df2708d6" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_cb8f6886-fbf7-4ca9-b901-38948b34b351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_5f83bbf2-3486-4e10-a9e5-f1ef682e97eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_cb8f6886-fbf7-4ca9-b901-38948b34b351" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_5f83bbf2-3486-4e10-a9e5-f1ef682e97eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_67ff3d5b-e437-4e40-888a-8003081b7914" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_5f83bbf2-3486-4e10-a9e5-f1ef682e97eb" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_67ff3d5b-e437-4e40-888a-8003081b7914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2021RepurchaseProgramMember_2072b1e2-1725-4075-bf09-e6e22a45076e" xlink:href="cvs-20220630.xsd#cvs_A2021RepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_67ff3d5b-e437-4e40-888a-8003081b7914" xlink:to="loc_cvs_A2021RepurchaseProgramMember_2072b1e2-1725-4075-bf09-e6e22a45076e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_90ed0f4b-feb4-4451-b1e5-4e1ed4271d62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_cb8f6886-fbf7-4ca9-b901-38948b34b351" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_90ed0f4b-feb4-4451-b1e5-4e1ed4271d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_92c957a8-e124-4b00-bab6-cfb2eadcfb9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_90ed0f4b-feb4-4451-b1e5-4e1ed4271d62" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_92c957a8-e124-4b00-bab6-cfb2eadcfb9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_1eade4c0-3e8b-4135-98c9-b1261ae433e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_90ed0f4b-feb4-4451-b1e5-4e1ed4271d62" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_1eade4c0-3e8b-4135-98c9-b1261ae433e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_2efca1ef-22fc-4d7e-b0a9-d478d56639c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_90ed0f4b-feb4-4451-b1e5-4e1ed4271d62" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_2efca1ef-22fc-4d7e-b0a9-d478d56639c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_ce814488-b61a-4470-a923-776c889f8f76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_90ed0f4b-feb4-4451-b1e5-4e1ed4271d62" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_ce814488-b61a-4470-a923-776c889f8f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#ShareholdersEquityAcceleratedShareRepurchasesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_b4810eee-892d-4acf-8034-8aae6459e31a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_171cc32a-915c-427f-854c-b6a7d1aedf61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b4810eee-892d-4acf-8034-8aae6459e31a" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_171cc32a-915c-427f-854c-b6a7d1aedf61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_62a86d4e-0f4b-4b61-9e02-31ae5a91e792" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_171cc32a-915c-427f-854c-b6a7d1aedf61" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_62a86d4e-0f4b-4b61-9e02-31ae5a91e792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_e47e1f00-4e4b-4607-a06a-59510ee39a47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_62a86d4e-0f4b-4b61-9e02-31ae5a91e792" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_e47e1f00-4e4b-4607-a06a-59510ee39a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2021AcceleratedRepurchaseProgramMember_a053dbc2-634d-4c20-bfe5-f3d5d5d41be6" xlink:href="cvs-20220630.xsd#cvs_A2021AcceleratedRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_e47e1f00-4e4b-4607-a06a-59510ee39a47" xlink:to="loc_cvs_A2021AcceleratedRepurchaseProgramMember_a053dbc2-634d-4c20-bfe5-f3d5d5d41be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_bdf4ebe1-bf71-42e3-bd8f-e8c591ccbdaf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_171cc32a-915c-427f-854c-b6a7d1aedf61" xlink:to="loc_srt_CounterpartyNameAxis_bdf4ebe1-bf71-42e3-bd8f-e8c591ccbdaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5e08c44e-7219-4592-897c-719159275976" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_bdf4ebe1-bf71-42e3-bd8f-e8c591ccbdaf" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5e08c44e-7219-4592-897c-719159275976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BarclaysBankMember_ab663ca8-a98e-4874-9a58-0cef419bbb18" xlink:href="cvs-20220630.xsd#cvs_BarclaysBankMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5e08c44e-7219-4592-897c-719159275976" xlink:to="loc_cvs_BarclaysBankMember_ab663ca8-a98e-4874-9a58-0cef419bbb18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_d25ee5f9-56d0-40a2-b549-d4291ff00aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_171cc32a-915c-427f-854c-b6a7d1aedf61" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_d25ee5f9-56d0-40a2-b549-d4291ff00aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a67ca9aa-0fa9-44b8-b590-3fab01c7d3c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d25ee5f9-56d0-40a2-b549-d4291ff00aa2" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a67ca9aa-0fa9-44b8-b590-3fab01c7d3c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_2e42b8f0-e934-4b7f-b52a-5b6e9b603f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a67ca9aa-0fa9-44b8-b590-3fab01c7d3c8" xlink:to="loc_us-gaap_ForwardContractsMember_2e42b8f0-e934-4b7f-b52a-5b6e9b603f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e0d2e52f-b914-44bb-b832-511d0f885293" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_171cc32a-915c-427f-854c-b6a7d1aedf61" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e0d2e52f-b914-44bb-b832-511d0f885293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesAgreementAmount_0c810142-77eb-4e14-bd43-9a2e176c9061" xlink:href="cvs-20220630.xsd#cvs_AcceleratedShareRepurchasesAgreementAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e0d2e52f-b914-44bb-b832-511d0f885293" xlink:to="loc_cvs_AcceleratedShareRepurchasesAgreementAmount_0c810142-77eb-4e14-bd43-9a2e176c9061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsForAcceleratedShareRepurchasesAmount_b8ecfd12-b204-4ea2-8083-50a1d7342812" xlink:href="cvs-20220630.xsd#cvs_PaymentsForAcceleratedShareRepurchasesAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e0d2e52f-b914-44bb-b832-511d0f885293" xlink:to="loc_cvs_PaymentsForAcceleratedShareRepurchasesAmount_b8ecfd12-b204-4ea2-8083-50a1d7342812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares_332da8ca-eb51-47b6-be89-e6b7f38338fc" xlink:href="cvs-20220630.xsd#cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e0d2e52f-b914-44bb-b832-511d0f885293" xlink:to="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares_332da8ca-eb51-47b6-be89-e6b7f38338fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased_393c5e8e-1ce7-46e3-a144-f1016763cd79" xlink:href="cvs-20220630.xsd#cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e0d2e52f-b914-44bb-b832-511d0f885293" xlink:to="loc_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased_393c5e8e-1ce7-46e3-a144-f1016763cd79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_d2e8baf9-b05f-43fc-8a6b-9aebee144a29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e0d2e52f-b914-44bb-b832-511d0f885293" xlink:to="loc_us-gaap_SharePrice_d2e8baf9-b05f-43fc-8a6b-9aebee144a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TransferOfSharesToTreasuryStockValue_faf66ae4-394c-4c9c-850b-405659cc38f2" xlink:href="cvs-20220630.xsd#cvs_TransferOfSharesToTreasuryStockValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e0d2e52f-b914-44bb-b832-511d0f885293" xlink:to="loc_cvs_TransferOfSharesToTreasuryStockValue_faf66ae4-394c-4c9c-850b-405659cc38f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_c61c8752-8eb4-4232-a112-9cb1ce337d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e0d2e52f-b914-44bb-b832-511d0f885293" xlink:to="loc_us-gaap_DerivativeNotionalAmount_c61c8752-8eb4-4232-a112-9cb1ce337d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram_4071f885-6879-49ef-a05e-d2434182ae4b" xlink:href="cvs-20220630.xsd#cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e0d2e52f-b914-44bb-b832-511d0f885293" xlink:to="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram_4071f885-6879-49ef-a05e-d2434182ae4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#ShareholdersEquityDividendsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e70b1549-3126-4bd0-a31a-280d34a92e39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_fa50a65b-bceb-4ccd-8643-80b0211f0392" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e70b1549-3126-4bd0-a31a-280d34a92e39" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_fa50a65b-bceb-4ccd-8643-80b0211f0392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncome" xlink:type="simple" xlink:href="cvs-20220630.xsd#OtherComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6dd0ddbe-a4e1-4762-8c1c-3b658d12d470" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_7c7dfc25-bfe1-4eb0-9b9e-7ee7ca882717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6dd0ddbe-a4e1-4762-8c1c-3b658d12d470" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_7c7dfc25-bfe1-4eb0-9b9e-7ee7ca882717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="cvs-20220630.xsd#OtherComprehensiveIncomeTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_33068537-df37-4b12-b5a1-04cc0faf23a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_dda7b003-2acb-45cc-bab9-3334afc0072a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_33068537-df37-4b12-b5a1-04cc0faf23a9" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_dda7b003-2acb-45cc-bab9-3334afc0072a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#OtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_bbe932d4-e90f-48c8-8309-354e47ae487c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_006c1a35-d288-4bb7-b149-7406af407940" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_bbe932d4-e90f-48c8-8309-354e47ae487c" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_006c1a35-d288-4bb7-b149-7406af407940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3920b785-87f6-43bf-ab8c-86b154ef971c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_006c1a35-d288-4bb7-b149-7406af407940" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3920b785-87f6-43bf-ab8c-86b154ef971c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0a0c93fe-6bdd-47d7-81f7-2d1152990558" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3920b785-87f6-43bf-ab8c-86b154ef971c" xlink:to="loc_us-gaap_EquityComponentDomain_0a0c93fe-6bdd-47d7-81f7-2d1152990558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_c4d0e31c-6aa2-4272-8ec1-9d699e5bfae9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0a0c93fe-6bdd-47d7-81f7-2d1152990558" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_c4d0e31c-6aa2-4272-8ec1-9d699e5bfae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_28760662-bd57-48e3-a699-f6766663e0fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0a0c93fe-6bdd-47d7-81f7-2d1152990558" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_28760662-bd57-48e3-a699-f6766663e0fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_3d228144-10a7-47fb-9784-54efd36d461c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0a0c93fe-6bdd-47d7-81f7-2d1152990558" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_3d228144-10a7-47fb-9784-54efd36d461c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_b5f8d5b3-1b24-46f8-8f0b-5e3872e59974" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0a0c93fe-6bdd-47d7-81f7-2d1152990558" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_b5f8d5b3-1b24-46f8-8f0b-5e3872e59974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_8db2a122-5193-465f-aafe-e597eb38dd86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0a0c93fe-6bdd-47d7-81f7-2d1152990558" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_8db2a122-5193-465f-aafe-e597eb38dd86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_7d9a9c35-7776-498c-93fe-67a2f0064799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_006c1a35-d288-4bb7-b149-7406af407940" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_7d9a9c35-7776-498c-93fe-67a2f0064799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_bd356bd4-6fad-4e26-81bf-11c291d23c50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_7d9a9c35-7776-498c-93fe-67a2f0064799" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_bd356bd4-6fad-4e26-81bf-11c291d23c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_51098d01-637e-4cb3-bbf0-c715cb852de1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_bd356bd4-6fad-4e26-81bf-11c291d23c50" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_51098d01-637e-4cb3-bbf0-c715cb852de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1b5a30a7-514e-4e2f-a6ed-5a8dbf62ed46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_bd356bd4-6fad-4e26-81bf-11c291d23c50" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1b5a30a7-514e-4e2f-a6ed-5a8dbf62ed46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_20be8523-ca9b-4d20-a306-e082e5800f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_bd356bd4-6fad-4e26-81bf-11c291d23c50" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_20be8523-ca9b-4d20-a306-e082e5800f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e85bc6b3-85fd-4711-8911-26b64d0c00b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_bd356bd4-6fad-4e26-81bf-11c291d23c50" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e85bc6b3-85fd-4711-8911-26b64d0c00b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4abddaa9-103c-4cc0-b7ab-3c0327511f46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_bd356bd4-6fad-4e26-81bf-11c291d23c50" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4abddaa9-103c-4cc0-b7ab-3c0327511f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_f62545ff-684b-4629-ad78-f07ec3178ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_7d9a9c35-7776-498c-93fe-67a2f0064799" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_f62545ff-684b-4629-ad78-f07ec3178ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_c58a2abe-bba9-4bb8-a8dc-c9ea4236aa36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_7d9a9c35-7776-498c-93fe-67a2f0064799" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_c58a2abe-bba9-4bb8-a8dc-c9ea4236aa36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_75a1d3eb-1752-45fe-b5c0-66253234b8ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_7d9a9c35-7776-498c-93fe-67a2f0064799" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_75a1d3eb-1752-45fe-b5c0-66253234b8ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShare" xlink:type="simple" xlink:href="cvs-20220630.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_925b8725-32a9-47af-b161-82548ea4e2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_ff031e17-56ee-4db5-9bef-3b70a2420e73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_925b8725-32a9-47af-b161-82548ea4e2ec" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_ff031e17-56ee-4db5-9bef-3b70a2420e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="cvs-20220630.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_740ce01a-aa0a-48e7-9f27-8d945bc47c98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_e7f0ea2f-4f05-4821-991d-6e42abb846f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_740ce01a-aa0a-48e7-9f27-8d945bc47c98" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_e7f0ea2f-4f05-4821-991d-6e42abb846f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#EarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e0897360-1c2d-4a80-bd20-c5c918dc0376" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_7ebb51d7-fc5e-47d6-8e4f-8661740325fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e0897360-1c2d-4a80-bd20-c5c918dc0376" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_7ebb51d7-fc5e-47d6-8e4f-8661740325fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5c5f976c-87f0-41f7-9bf2-f1ac0af9ddde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_7ebb51d7-fc5e-47d6-8e4f-8661740325fa" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5c5f976c-87f0-41f7-9bf2-f1ac0af9ddde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a861e0c2-9d0d-4028-9609-7da821269288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5c5f976c-87f0-41f7-9bf2-f1ac0af9ddde" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a861e0c2-9d0d-4028-9609-7da821269288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember_a0151c27-af1b-43eb-8b3c-399a2ac274d4" xlink:href="cvs-20220630.xsd#cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a861e0c2-9d0d-4028-9609-7da821269288" xlink:to="loc_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember_a0151c27-af1b-43eb-8b3c-399a2ac274d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StockOptionsAndStockAppreciationRightsMember_a4d2405b-1dd3-4f18-aa28-aa6f93e85508" xlink:href="cvs-20220630.xsd#cvs_StockOptionsAndStockAppreciationRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a861e0c2-9d0d-4028-9609-7da821269288" xlink:to="loc_cvs_StockOptionsAndStockAppreciationRightsMember_a4d2405b-1dd3-4f18-aa28-aa6f93e85508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b0900f95-6a20-4b15-a5f3-ff0eaba6bfc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_7ebb51d7-fc5e-47d6-8e4f-8661740325fa" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b0900f95-6a20-4b15-a5f3-ff0eaba6bfc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_12951df1-ebf5-4ede-8a71-55405ad8e10a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b0900f95-6a20-4b15-a5f3-ff0eaba6bfc2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_12951df1-ebf5-4ede-8a71-55405ad8e10a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_767b92dc-fc77-4f3b-bf2b-60efd710c390" xlink:href="cvs-20220630.xsd#cvs_NumeratorForEarningsPerShareCalculationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b0900f95-6a20-4b15-a5f3-ff0eaba6bfc2" xlink:to="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_767b92dc-fc77-4f3b-bf2b-60efd710c390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_a31725b4-c8bd-4413-a55e-550c99ae3c56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_767b92dc-fc77-4f3b-bf2b-60efd710c390" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_a31725b4-c8bd-4413-a55e-550c99ae3c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_86ba4103-59ff-432a-b46e-abc68a7d6ffe" xlink:href="cvs-20220630.xsd#cvs_DenominatorForEarningsPerShareCalculationAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b0900f95-6a20-4b15-a5f3-ff0eaba6bfc2" xlink:to="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_86ba4103-59ff-432a-b46e-abc68a7d6ffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c3e8aea8-86e5-4e47-a339-09bebb268ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_86ba4103-59ff-432a-b46e-abc68a7d6ffe" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c3e8aea8-86e5-4e47-a339-09bebb268ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_9df875a2-0e40-4a74-8d0b-b24ea90e9cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_86ba4103-59ff-432a-b46e-abc68a7d6ffe" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_9df875a2-0e40-4a74-8d0b-b24ea90e9cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fe508048-25d0-40c0-a536-8e19a7da0b91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_86ba4103-59ff-432a-b46e-abc68a7d6ffe" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fe508048-25d0-40c0-a536-8e19a7da0b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_f54a5bc1-618c-4ca1-bbdc-724a1351de53" xlink:href="cvs-20220630.xsd#cvs_EarningsPerShareBasicAndDilutedEPSAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b0900f95-6a20-4b15-a5f3-ff0eaba6bfc2" xlink:to="loc_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_f54a5bc1-618c-4ca1-bbdc-724a1351de53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_53183adb-0af7-4649-ae9a-1eb4cd66c53c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_f54a5bc1-618c-4ca1-bbdc-724a1351de53" xlink:to="loc_us-gaap_EarningsPerShareBasic_53183adb-0af7-4649-ae9a-1eb4cd66c53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_b83538db-24e7-4904-acd8-5a5f9d718264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_f54a5bc1-618c-4ca1-bbdc-724a1351de53" xlink:to="loc_us-gaap_EarningsPerShareDiluted_b83538db-24e7-4904-acd8-5a5f9d718264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="cvs-20220630.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d3b1e6f4-501e-4007-8750-526af8fdc4f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_a9ee2c57-6f1f-42d3-812b-c7613610db63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d3b1e6f4-501e-4007-8750-526af8fdc4f5" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_a9ee2c57-6f1f-42d3-812b-c7613610db63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bcdf3464-d1ca-46e5-b6a7-aca9552fa669" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_GuarantorObligationsNumberofLeases_33dadc0e-ed5d-4c6c-98f2-f2280ef9ea1a" xlink:href="cvs-20220630.xsd#cvs_GuarantorObligationsNumberofLeases"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bcdf3464-d1ca-46e5-b6a7-aca9552fa669" xlink:to="loc_cvs_GuarantorObligationsNumberofLeases_33dadc0e-ed5d-4c6c-98f2-f2280ef9ea1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LossContingencyAuditMethodologySampleSize_c1377eec-57c8-4022-a4ad-16b85579bebc" xlink:href="cvs-20220630.xsd#cvs_LossContingencyAuditMethodologySampleSize"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bcdf3464-d1ca-46e5-b6a7-aca9552fa669" xlink:to="loc_cvs_LossContingencyAuditMethodologySampleSize_c1377eec-57c8-4022-a4ad-16b85579bebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_73877f38-bf34-4313-94e1-24e1644418c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bcdf3464-d1ca-46e5-b6a7-aca9552fa669" xlink:to="loc_us-gaap_LossContingenciesTable_73877f38-bf34-4313-94e1-24e1644418c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_7fcd2194-d05c-4004-8d60-0fec3cc0bd04" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_73877f38-bf34-4313-94e1-24e1644418c6" xlink:to="loc_srt_LitigationCaseAxis_7fcd2194-d05c-4004-8d60-0fec3cc0bd04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_3bbd758d-1108-4697-bdcd-6c3cbd3f1232" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_7fcd2194-d05c-4004-8d60-0fec3cc0bd04" xlink:to="loc_srt_LitigationCaseTypeDomain_3bbd758d-1108-4697-bdcd-6c3cbd3f1232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StateOfFloridaSettlementMember_cf059e8e-1d67-4055-adf8-0fbcba648348" xlink:href="cvs-20220630.xsd#cvs_StateOfFloridaSettlementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_3bbd758d-1108-4697-bdcd-6c3cbd3f1232" xlink:to="loc_cvs_StateOfFloridaSettlementMember_cf059e8e-1d67-4055-adf8-0fbcba648348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember_7195c0df-843a-4304-bfe3-d4f2dadf9887" xlink:href="cvs-20220630.xsd#cvs_RadcliffeAndFlaimVAetnaIncEtAlMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_3bbd758d-1108-4697-bdcd-6c3cbd3f1232" xlink:to="loc_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember_7195c0df-843a-4304-bfe3-d4f2dadf9887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_ae61710a-7be8-4017-afdf-5b65709f0ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_73877f38-bf34-4313-94e1-24e1644418c6" xlink:to="loc_us-gaap_LitigationStatusAxis_ae61710a-7be8-4017-afdf-5b65709f0ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_4ab2688d-7048-4b65-8904-54a88fd2e8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_ae61710a-7be8-4017-afdf-5b65709f0ab8" xlink:to="loc_us-gaap_LitigationStatusDomain_4ab2688d-7048-4b65-8904-54a88fd2e8f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_301279af-75e1-4d39-9eb2-3557de51447f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_4ab2688d-7048-4b65-8904-54a88fd2e8f8" xlink:to="loc_us-gaap_PendingLitigationMember_301279af-75e1-4d39-9eb2-3557de51447f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_afd0e2a9-5dd6-44fa-9b7b-e353ce4cd167" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_73877f38-bf34-4313-94e1-24e1644418c6" xlink:to="loc_us-gaap_LossContingenciesLineItems_afd0e2a9-5dd6-44fa-9b7b-e353ce4cd167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_31ce6694-0612-4633-b948-35ade41e2262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_afd0e2a9-5dd6-44fa-9b7b-e353ce4cd167" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_31ce6694-0612-4633-b948-35ade41e2262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LegalSettlementPeriodOfPayment_dc9ea7c8-4fcb-4a70-8ede-3c405be4a01c" xlink:href="cvs-20220630.xsd#cvs_LegalSettlementPeriodOfPayment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_afd0e2a9-5dd6-44fa-9b7b-e353ce4cd167" xlink:to="loc_cvs_LegalSettlementPeriodOfPayment_dc9ea7c8-4fcb-4a70-8ede-3c405be4a01c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_e7ae0c45-f76c-4c64-bbdf-821c7cb0dd86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_afd0e2a9-5dd6-44fa-9b7b-e353ce4cd167" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_e7ae0c45-f76c-4c64-bbdf-821c7cb0dd86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_e1ba46c9-f678-4cec-89a7-268d9577a7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_afd0e2a9-5dd6-44fa-9b7b-e353ce4cd167" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_e1ba46c9-f678-4cec-89a7-268d9577a7e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReporting" xlink:type="simple" xlink:href="cvs-20220630.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_d62bcf70-fadd-40ff-b260-b0729a337c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_8b1240ef-c153-42db-87a6-ed335b235790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d62bcf70-fadd-40ff-b260-b0729a337c9d" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_8b1240ef-c153-42db-87a6-ed335b235790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="cvs-20220630.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3b44233c-753b-403f-881b-305f16e342a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b89fff0c-e213-4e97-ba25-26d126eda5a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3b44233c-753b-403f-881b-305f16e342a4" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b89fff0c-e213-4e97-ba25-26d126eda5a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ReconciliationOfOperatingIncomeToAdjustedOperatingIncomeTableTextBlock_5bd63118-2d88-45fe-8982-fa5202fb5f1c" xlink:href="cvs-20220630.xsd#cvs_ReconciliationOfOperatingIncomeToAdjustedOperatingIncomeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3b44233c-753b-403f-881b-305f16e342a4" xlink:to="loc_cvs_ReconciliationOfOperatingIncomeToAdjustedOperatingIncomeTableTextBlock_5bd63118-2d88-45fe-8982-fa5202fb5f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#SegmentReportingNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_6e3e3dca-d6cd-48c0-9c73-940911e42605" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_e061f1a6-9d19-49c3-9f67-438d8fd97371" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_6e3e3dca-d6cd-48c0-9c73-940911e42605" xlink:to="loc_us-gaap_NumberOfOperatingSegments_e061f1a6-9d19-49c3-9f67-438d8fd97371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_62724d16-ee15-4bd8-a0e3-062a4b64b046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_21549598-c795-4721-8ccf-23f9503653d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_62724d16-ee15-4bd8-a0e3-062a4b64b046" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_21549598-c795-4721-8ccf-23f9503653d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_1fa46c75-7eeb-4456-8546-ecb41e89fd91" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_21549598-c795-4721-8ccf-23f9503653d6" xlink:to="loc_srt_ConsolidationItemsAxis_1fa46c75-7eeb-4456-8546-ecb41e89fd91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_9761433e-7f1f-45d6-b2b5-ae39ae2e8c96" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_1fa46c75-7eeb-4456-8546-ecb41e89fd91" xlink:to="loc_srt_ConsolidationItemsDomain_9761433e-7f1f-45d6-b2b5-ae39ae2e8c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_f4889bc0-b61e-49bf-ad6d-cab9a1ba1e71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_9761433e-7f1f-45d6-b2b5-ae39ae2e8c96" xlink:to="loc_us-gaap_OperatingSegmentsMember_f4889bc0-b61e-49bf-ad6d-cab9a1ba1e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_844fc082-21d5-4af7-985f-d45fa9572138" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_9761433e-7f1f-45d6-b2b5-ae39ae2e8c96" xlink:to="loc_us-gaap_IntersegmentEliminationMember_844fc082-21d5-4af7-985f-d45fa9572138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_c11f483e-3ec2-453c-84f3-5d9bb02f2b30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_9761433e-7f1f-45d6-b2b5-ae39ae2e8c96" xlink:to="loc_us-gaap_CorporateNonSegmentMember_c11f483e-3ec2-453c-84f3-5d9bb02f2b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_806ce060-2e0c-4913-aae2-5d4e5e2d2ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_21549598-c795-4721-8ccf-23f9503653d6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_806ce060-2e0c-4913-aae2-5d4e5e2d2ad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_187623f2-196d-4219-95f2-9aa5b1cd60d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_806ce060-2e0c-4913-aae2-5d4e5e2d2ad2" xlink:to="loc_us-gaap_SegmentDomain_187623f2-196d-4219-95f2-9aa5b1cd60d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_b88847f6-7a5a-4007-9000-a4c5206f2eb8" xlink:href="cvs-20220630.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_187623f2-196d-4219-95f2-9aa5b1cd60d0" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_b88847f6-7a5a-4007-9000-a4c5206f2eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_fab3cc49-787e-4a6c-bb9e-e5d92ca959d7" xlink:href="cvs-20220630.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_187623f2-196d-4219-95f2-9aa5b1cd60d0" xlink:to="loc_cvs_PharmacyServicesSegmentMember_fab3cc49-787e-4a6c-bb9e-e5d92ca959d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_08798d33-478c-4e16-918c-bee1ce1afc87" xlink:href="cvs-20220630.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_187623f2-196d-4219-95f2-9aa5b1cd60d0" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_08798d33-478c-4e16-918c-bee1ce1afc87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_9205ad78-3652-481e-a4f6-cce1f79be373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_21549598-c795-4721-8ccf-23f9503653d6" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_9205ad78-3652-481e-a4f6-cce1f79be373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_2a74df8f-94fb-4948-87b1-8ec277a99bbd" xlink:href="cvs-20220630.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9205ad78-3652-481e-a4f6-cce1f79be373" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_2a74df8f-94fb-4948-87b1-8ec277a99bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b600dc4f-7d27-4866-a50b-aa103b302eba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9205ad78-3652-481e-a4f6-cce1f79be373" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b600dc4f-7d27-4866-a50b-aa103b302eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_797bd2f3-4c2a-438f-b4ba-41a896648ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9205ad78-3652-481e-a4f6-cce1f79be373" xlink:to="loc_us-gaap_NetInvestmentIncome_797bd2f3-4c2a-438f-b4ba-41a896648ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_f2153414-7eeb-4c8a-b8fc-1ad9d7253f25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9205ad78-3652-481e-a4f6-cce1f79be373" xlink:to="loc_us-gaap_Revenues_f2153414-7eeb-4c8a-b8fc-1ad9d7253f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_10766622-6121-40cd-a2bf-2f48316edb98" xlink:href="cvs-20220630.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9205ad78-3652-481e-a4f6-cce1f79be373" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_10766622-6121-40cd-a2bf-2f48316edb98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NetRevenuesRetailCoPayments_6a7003a7-1acd-486d-ab04-c8e7d9c00a31" xlink:href="cvs-20220630.xsd#cvs_NetRevenuesRetailCoPayments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9205ad78-3652-481e-a4f6-cce1f79be373" xlink:to="loc_cvs_NetRevenuesRetailCoPayments_6a7003a7-1acd-486d-ab04-c8e7d9c00a31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails" xlink:type="simple" xlink:href="cvs-20220630.xsd#SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_0f132f9d-62ed-490f-8a84-438e35f2dd17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_b7cc08e3-1052-466d-bd80-d9b77771266a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0f132f9d-62ed-490f-8a84-438e35f2dd17" xlink:to="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_b7cc08e3-1052-466d-bd80-d9b77771266a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_a706665e-30a3-4985-b06d-5c6efc063553" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_b7cc08e3-1052-466d-bd80-d9b77771266a" xlink:to="loc_srt_LitigationCaseAxis_a706665e-30a3-4985-b06d-5c6efc063553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_28d6e28e-550c-4e31-8833-b5e248ae8fc8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_a706665e-30a3-4985-b06d-5c6efc063553" xlink:to="loc_srt_LitigationCaseTypeDomain_28d6e28e-550c-4e31-8833-b5e248ae8fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StateOfFloridaSettlementMember_99246058-0198-4266-9b79-61230bf41653" xlink:href="cvs-20220630.xsd#cvs_StateOfFloridaSettlementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_28d6e28e-550c-4e31-8833-b5e248ae8fc8" xlink:to="loc_cvs_StateOfFloridaSettlementMember_99246058-0198-4266-9b79-61230bf41653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_2dfb0208-82e0-4e21-8c30-40828ed0a86b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_b7cc08e3-1052-466d-bd80-d9b77771266a" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_2dfb0208-82e0-4e21-8c30-40828ed0a86b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_838a7938-fbc1-4f12-9421-0049ced4d87f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_2dfb0208-82e0-4e21-8c30-40828ed0a86b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_838a7938-fbc1-4f12-9421-0049ced4d87f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_acfcf87b-f513-44c2-92d8-ef9f64b4f927" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_838a7938-fbc1-4f12-9421-0049ced4d87f" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_acfcf87b-f513-44c2-92d8-ef9f64b4f927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b9686a54-0e0b-47e6-a3d3-47cf3f9bcc62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_b7cc08e3-1052-466d-bd80-d9b77771266a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b9686a54-0e0b-47e6-a3d3-47cf3f9bcc62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e1984530-d9f2-48a1-a169-71a810610551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b9686a54-0e0b-47e6-a3d3-47cf3f9bcc62" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e1984530-d9f2-48a1-a169-71a810610551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PayflexMember_b7be983a-e4cb-433c-903d-8f8e544498af" xlink:href="cvs-20220630.xsd#cvs_PayflexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e1984530-d9f2-48a1-a169-71a810610551" xlink:to="loc_cvs_PayflexMember_b7be983a-e4cb-433c-903d-8f8e544498af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_72fda4ef-d7bc-4c50-98a0-d6440e7e6044" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_b7cc08e3-1052-466d-bd80-d9b77771266a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_72fda4ef-d7bc-4c50-98a0-d6440e7e6044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b6dbda47-d6da-4555-86d3-636641d7ec6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_72fda4ef-d7bc-4c50-98a0-d6440e7e6044" xlink:to="loc_us-gaap_SegmentDomain_b6dbda47-d6da-4555-86d3-636641d7ec6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_61a99c56-c385-420e-8869-c7d9ba17e4a2" xlink:href="cvs-20220630.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b6dbda47-d6da-4555-86d3-636641d7ec6e" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_61a99c56-c385-420e-8869-c7d9ba17e4a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_0cea689e-5e30-4495-95ab-92e96d371a47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_b7cc08e3-1052-466d-bd80-d9b77771266a" xlink:to="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_0cea689e-5e30-4495-95ab-92e96d371a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ee027389-2de9-4daa-8d9b-c2c38ffacba9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_0cea689e-5e30-4495-95ab-92e96d371a47" xlink:to="loc_us-gaap_OperatingIncomeLoss_ee027389-2de9-4daa-8d9b-c2c38ffacba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9ddce8e1-9a1b-4975-9975-7a7b678b8b05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_0cea689e-5e30-4495-95ab-92e96d371a47" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9ddce8e1-9a1b-4975-9975-7a7b678b8b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_536c4677-7996-43ba-aca4-977f816c736d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_0cea689e-5e30-4495-95ab-92e96d371a47" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_536c4677-7996-43ba-aca4-977f816c736d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_c615accd-93db-4cb9-99b7-606462224497" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_0cea689e-5e30-4495-95ab-92e96d371a47" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_c615accd-93db-4cb9-99b7-606462224497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_3f859a50-4cdd-4df9-ae84-815d2b5608a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_0cea689e-5e30-4495-95ab-92e96d371a47" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_3f859a50-4cdd-4df9-ae84-815d2b5608a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_a782cfcc-577f-4141-a69f-4e231d17be4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_0cea689e-5e30-4495-95ab-92e96d371a47" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_a782cfcc-577f-4141-a69f-4e231d17be4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_119a7cd5-0790-4551-af60-eb98156e9f65" xlink:href="cvs-20220630.xsd#cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_0cea689e-5e30-4495-95ab-92e96d371a47" xlink:to="loc_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_119a7cd5-0790-4551-af60-eb98156e9f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_769f840f-a3bc-456a-b747-97e6190142b1" xlink:href="cvs-20220630.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_0cea689e-5e30-4495-95ab-92e96d371a47" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_769f840f-a3bc-456a-b747-97e6190142b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_a2f18176-f958-4a02-bbd9-9d79f3f05dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_0cea689e-5e30-4495-95ab-92e96d371a47" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_a2f18176-f958-4a02-bbd9-9d79f3f05dbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LegalSettlementPeriodOfPayment_d1eb861d-2a0a-40d6-9a01-294bcaaa336a" xlink:href="cvs-20220630.xsd#cvs_LegalSettlementPeriodOfPayment"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_0cea689e-5e30-4495-95ab-92e96d371a47" xlink:to="loc_cvs_LegalSettlementPeriodOfPayment_d1eb861d-2a0a-40d6-9a01-294bcaaa336a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>cvs-20220630_g1.jpg
<DESCRIPTION>CVS HEALTH LOGO
<TEXT>
begin 644 cvs-20220630_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  < )T# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]#?\ @KK_
M ,%;8/V'M)B\%^#([/5OBEJT*S(LZ&6UT*W;($\PW+OD;!$<61T+MP%63YV_
M9&_X.-6T;X/>)K?XP:6VK>,-(M_/T&YTFV\F/Q 6X%M, "L$BLV[S0 AC!^4
M.H62S_P7L_X)B:[XL\2:I\>/!,$VKJUI$OBG3$3S)HXX8Q&MY".=R+&JK(O5
M0F\<;S7Y-(_G#<I#"0Y!SU^@^@S^=?#YIFF-PV+=](].Q_9OACX:\&<0\+4U
M;VE:ZE5E>TXRTO#RB]5YK7?;],OV0/\ @XC\:6WQV:/XR0:+-X%UZ;:TVF6#
M12^&G)PKCYV,T"CAP0TF/G5C@QM]T_\ !2[_ (*B:'^PA\$M%U;2[>U\5^)_
M&ZN/#EJEP?LDT:HK/=R.N<PH'C("\R%T52H9I$_%C]@3]@?Q;_P4!^,@\.:!
M')I^AZ:4DU[7)(]T.EPL> !T:9P&")GG#$X4,1[M_P %^OAM'\&OVC/AKX0T
ME;I/"_ACX<6.EZ2LSEMJPW-S$06/!(1+<L>ORCU%7A\SQD<#.M5?:S?JOP.?
MB/PYX/K\:X/*<&E%VE*K3@]+1C>-WT<NJ[:Z-W=X?\%H?VP+_P .R_$&'28E
M\$Q7&V6]B\&3/H$;>9Y90W63_'A/]=N#?+P>OHWCS_@X3^*&O?L\:#XF\)Z'
MX+TK7=+U'^QO%EK>V<]U;M+/"9;*XM=LT96*06]X&1B[1M&HW,"K-]V_LKKX
M ?\ X))>#U\3?8?^%=M\-H/[>.6$?V3^SE^V;S'\^[ EW[?GW!OXA7QOKOP5
M_9(_:8_9A^,7A7]FF&2;Q\OAH:SY44&K;Y$LYXYXHU^V#RP9''E?+A\3/CC=
M7;.ABZ</=KWYE?S[Z'S&%SWA3&XN5/%9(J<:-91YX)N"@Y<K]KYI:KSM\_J'
M]FO_ (*4WWQ)_P""5>M?'/Q%%HO_  DOA?3]5?4K*V#QVK7=J\H@B 9B1YJB
MW(&XG,U?%7PD_P"#A'XR1^!O&/B;Q9H?@C5+/28;;3=+M;&PGM/.U:[:1X3*
M[32?N([>UNW<#:S,D:@KO+#Y ^''[7-SX/\ ^"?7Q$^$$7$/C3Q-I6J1D [C
M;JI:Y8'D##V5@OJ1*W!"FOLK]G;_ ()=Z7\;?^".>DQZIXFT;P5XS\:>()/&
M>C3ZQ)';VTGEQ/:P02'&]H9+;]Z" 61K@-M8 JW)',,1B>14)VY8MN_5['T&
M*X#X<X=^LSSO#J4*^)C&EH[QI-*;:MK:S<7:]K'%G_@L#^V3J7P[N/BM;Z5I
MZ_#VVN_)FOH?"X.D1MY@3879S-M#D1E]^T-\N[=P/M_]B'_@HMX^_P""E7['
M7C"7X>3>!?!OQL\*SVEI,VKVMQ?:'&))$;[3Y,<BS>7+"ERJ(7)22/DLJ@M^
M:T7PL_:X_P"">/A2^UGP[>>)[/P+')---J/A_4(==\/2 <23F ^;&@R@#230
MH?D.=HXK]&_^")W_  4BUC]MWPAXK\.^+M+TFV\4>$8K:=K[38/L\6JVTWF(
M':,$A)4:(AMI"L'0J%^8+OE.,J/$*E7F^9K9K1^C/%\4N%\N>25<?D^$H.E3
MFDJE&34HIM+EG!K5]&[W3:T-W_@A)^UO\;OV^OV--/\ C)\6[_X=MIGCAI/^
M$>TWPWI5S9W&G"TO;VSNA<M--*LGF-!$Z;,;1O!SD;>&F_:I_:L'_!:Z']GL
M>(O@BW@63PU_PLX3?\([?_V@?#O]N&P_L[S/M.S[=Y()\[9Y>[G;CY3\[?\
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&-FB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863242836576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jul. 27, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-01011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CVS HEALTH CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">05-0494040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One CVS Drive,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Woonsocket,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">RI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(401)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">765-1500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CVS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,312,828,807<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000064803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863241863152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations (Unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">$ 21,260<span></span>
</td>
<td class="nump">$ 18,983<span></span>
</td>
<td class="nump">$ 42,891<span></span>
</td>
<td class="nump">$ 37,943<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">289<span></span>
</td>
<td class="nump">314<span></span>
</td>
<td class="nump">586<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">80,636<span></span>
</td>
<td class="nump">72,616<span></span>
</td>
<td class="nump">157,462<span></span>
</td>
<td class="nump">141,713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">49,290<span></span>
</td>
<td class="nump">43,520<span></span>
</td>
<td class="nump">94,799<span></span>
</td>
<td class="nump">84,414<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare', window );">Benefit costs</a></td>
<td class="nump">17,606<span></span>
</td>
<td class="nump">15,901<span></span>
</td>
<td class="nump">35,557<span></span>
</td>
<td class="nump">31,605<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="nump">9,171<span></span>
</td>
<td class="nump">8,869<span></span>
</td>
<td class="nump">19,047<span></span>
</td>
<td class="nump">17,791<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs</a></td>
<td class="nump">76,067<span></span>
</td>
<td class="nump">68,290<span></span>
</td>
<td class="nump">149,403<span></span>
</td>
<td class="nump">133,810<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">4,569<span></span>
</td>
<td class="nump">4,326<span></span>
</td>
<td class="nump">8,059<span></span>
</td>
<td class="nump">7,903<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">583<span></span>
</td>
<td class="nump">636<span></span>
</td>
<td class="nump">1,169<span></span>
</td>
<td class="nump">1,293<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income</a></td>
<td class="num">(43)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="num">(85)<span></span>
</td>
<td class="num">(95)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income tax provision</a></td>
<td class="nump">4,029<span></span>
</td>
<td class="nump">3,735<span></span>
</td>
<td class="nump">6,975<span></span>
</td>
<td class="nump">6,705<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">1,068<span></span>
</td>
<td class="nump">944<span></span>
</td>
<td class="nump">1,701<span></span>
</td>
<td class="nump">1,690<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">2,961<span></span>
</td>
<td class="nump">2,791<span></span>
</td>
<td class="nump">5,274<span></span>
</td>
<td class="nump">5,015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to CVS Health</a></td>
<td class="nump">$ 2,951<span></span>
</td>
<td class="nump">$ 2,783<span></span>
</td>
<td class="nump">$ 5,263<span></span>
</td>
<td class="nump">$ 5,006<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share attributable to CVS Health:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 2.25<span></span>
</td>
<td class="nump">$ 2.11<span></span>
</td>
<td class="nump">$ 4.01<span></span>
</td>
<td class="nump">$ 3.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 2.23<span></span>
</td>
<td class="nump">$ 2.10<span></span>
</td>
<td class="nump">$ 3.97<span></span>
</td>
<td class="nump">$ 3.78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">1,313<span></span>
</td>
<td class="nump">1,319<span></span>
</td>
<td class="nump">1,312<span></span>
</td>
<td class="nump">1,316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">1,321<span></span>
</td>
<td class="nump">1,327<span></span>
</td>
<td class="nump">1,325<span></span>
</td>
<td class="nump">1,325<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share (in dollars per share)</a></td>
<td class="nump">$ 0.55<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 1.10<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfCostGoodOrServiceExtensibleList', window );">Cost, Product and Service [Extensible List]</a></td>
<td class="text">Products<span></span>
</td>
<td class="text">Products<span></span>
</td>
<td class="text">Products<span></span>
</td>
<td class="text">Products<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 56,794<span></span>
</td>
<td class="nump">$ 50,525<span></span>
</td>
<td class="nump">$ 109,316<span></span>
</td>
<td class="nump">$ 97,912<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 2,436<span></span>
</td>
<td class="nump">$ 2,819<span></span>
</td>
<td class="nump">$ 4,941<span></span>
</td>
<td class="nump">$ 5,272<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsEarnedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsEarnedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfCostGoodOrServiceExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates type of cost from product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920602&amp;loc=SL49130690-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfCostGoodOrServiceExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863242789936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 2,961<span></span>
</td>
<td class="nump">$ 2,791<span></span>
</td>
<td class="nump">$ 5,274<span></span>
</td>
<td class="nump">$ 5,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Net unrealized investment gains (losses)</a></td>
<td class="num">(813)<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="num">(1,968)<span></span>
</td>
<td class="num">(237)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net cash flow hedges</a></td>
<td class="nump">15<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension and other postretirement benefits</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(798)<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td class="num">(1,953)<span></span>
</td>
<td class="num">(244)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">2,163<span></span>
</td>
<td class="nump">2,939<span></span>
</td>
<td class="nump">3,321<span></span>
</td>
<td class="nump">4,771<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Comprehensive income attributable to noncontrolling interests</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to CVS Health</a></td>
<td class="nump">$ 2,153<span></span>
</td>
<td class="nump">$ 2,931<span></span>
</td>
<td class="nump">$ 3,310<span></span>
</td>
<td class="nump">$ 4,762<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863242399152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 12,116<span></span>
</td>
<td class="nump">$ 9,408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Investments</a></td>
<td class="nump">2,877<span></span>
</td>
<td class="nump">3,117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">27,233<span></span>
</td>
<td class="nump">24,431<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">17,375<span></span>
</td>
<td class="nump">17,760<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">2,541<span></span>
</td>
<td class="nump">5,292<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">62,142<span></span>
</td>
<td class="nump">60,008<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">21,124<span></span>
</td>
<td class="nump">23,025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">12,764<span></span>
</td>
<td class="nump">12,896<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">18,562<span></span>
</td>
<td class="nump">19,122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">78,560<span></span>
</td>
<td class="nump">79,121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">28,135<span></span>
</td>
<td class="nump">29,026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">4,140<span></span>
</td>
<td class="nump">5,087<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">4,852<span></span>
</td>
<td class="nump">4,714<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">230,279<span></span>
</td>
<td class="nump">232,999<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable</a></td>
<td class="nump">13,238<span></span>
</td>
<td class="nump">12,544<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PharmacyClaimsandDiscountsPayableCurrent', window );">Pharmacy claims and discounts payable</a></td>
<td class="nump">18,393<span></span>
</td>
<td class="nump">17,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable</a></td>
<td class="nump">10,400<span></span>
</td>
<td class="nump">8,808<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherPolicyholderFunds', window );">Policyholders&#8217; funds</a></td>
<td class="nump">1,628<span></span>
</td>
<td class="nump">4,301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">17,728<span></span>
</td>
<td class="nump">17,670<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OtherInsuranceLiabilitiesCurrent', window );">Other insurance liabilities</a></td>
<td class="nump">1,197<span></span>
</td>
<td class="nump">1,303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">1,854<span></span>
</td>
<td class="nump">1,646<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">4,019<span></span>
</td>
<td class="nump">4,205<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">68,457<span></span>
</td>
<td class="nump">67,807<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">17,502<span></span>
</td>
<td class="nump">18,177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">50,797<span></span>
</td>
<td class="nump">51,971<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">5,450<span></span>
</td>
<td class="nump">6,270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountsLiability', window );">Separate accounts liabilities</a></td>
<td class="nump">4,140<span></span>
</td>
<td class="nump">5,087<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OtherInsuranceLiabilitiesNoncurrent', window );">Other long-term insurance liabilities</a></td>
<td class="nump">6,287<span></span>
</td>
<td class="nump">6,402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">2,140<span></span>
</td>
<td class="nump">1,904<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">154,773<span></span>
</td>
<td class="nump">157,618<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStocksIncludingAdditionalPaidInCapital', window );">Common stock, par value $0.01: 3,200 shares authorized; 1,755 shares issued and 1,312 shares outstanding at June&#160;30, 2022 and 1,744 shares issued and 1,322 shares outstanding at December&#160;31, 2021 and capital surplus</a></td>
<td class="nump">47,874<span></span>
</td>
<td class="nump">47,377<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost: 443 shares at June&#160;30, 2022 and 422 shares at December&#160;31, 2021</a></td>
<td class="num">(30,412)<span></span>
</td>
<td class="num">(28,173)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">58,710<span></span>
</td>
<td class="nump">54,906<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="num">(988)<span></span>
</td>
<td class="nump">965<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total CVS Health shareholders&#8217; equity</a></td>
<td class="nump">75,184<span></span>
</td>
<td class="nump">75,075<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">322<span></span>
</td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">75,506<span></span>
</td>
<td class="nump">75,381<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">$ 230,279<span></span>
</td>
<td class="nump">$ 232,999<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OtherInsuranceLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Insurance Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OtherInsuranceLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OtherInsuranceLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Insurance Liabilities, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OtherInsuranceLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PharmacyClaimsandDiscountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pharmacy Claims and Discounts Payable, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PharmacyClaimsandDiscountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStocksIncludingAdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of par value plus amounts in excess of par value or issuance value for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStocksIncludingAdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(13)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPolicyholderFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due to policyholders for funds held that are returnable under the terms of insurance contracts, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.14)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPolicyholderFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset at fair value held for benefit of separate account policyholder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=d3e19393-158473<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422397-158474<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for variable contract in which all or portion of contract holder's funds is allocated to specific separate account and supported by assets held in separate account.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422401-158474<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863242792688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">3,200,000,000<span></span>
</td>
<td class="nump">3,200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">1,755,000,000<span></span>
</td>
<td class="nump">1,744,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">1,312,000,000<span></span>
</td>
<td class="nump">1,322,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">443,000,000<span></span>
</td>
<td class="nump">422,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863242951040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromCustomers', window );">Cash receipts from customers</a></td>
<td class="nump">$ 151,769<span></span>
</td>
<td class="nump">$ 136,621<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies', window );">Cash paid for inventory and prescriptions dispensed by retail network pharmacies</a></td>
<td class="num">(90,887)<span></span>
</td>
<td class="num">(79,316)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PaymentsforInsuranceBenefits', window );">Insurance benefits paid</a></td>
<td class="num">(33,920)<span></span>
</td>
<td class="num">(31,245)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToSuppliersAndEmployees', window );">Cash paid to other suppliers and employees</a></td>
<td class="num">(15,119)<span></span>
</td>
<td class="num">(14,900)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromInterestAndDividendsReceived', window );">Interest and investment income received</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">394<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="num">(1,150)<span></span>
</td>
<td class="num">(1,263)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid</a></td>
<td class="num">(1,887)<span></span>
</td>
<td class="num">(1,552)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">9,006<span></span>
</td>
<td class="nump">8,739<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sales and maturities of investments</a></td>
<td class="nump">4,360<span></span>
</td>
<td class="nump">3,947<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments</a></td>
<td class="num">(5,010)<span></span>
</td>
<td class="num">(5,570)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(1,459)<span></span>
</td>
<td class="num">(1,315)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions (net of cash acquired)</a></td>
<td class="num">(125)<span></span>
</td>
<td class="num">(108)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Proceeds from sale of subsidiaries (net of cash and restricted cash sold of $2,807)</a></td>
<td class="num">(1,943)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="nump">54<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(4,123)<span></span>
</td>
<td class="num">(2,974)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="num">(1,529)<span></span>
</td>
<td class="num">(5,423)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="num">(2,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividends paid</a></td>
<td class="num">(1,462)<span></span>
</td>
<td class="num">(1,306)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">348<span></span>
</td>
<td class="nump">330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments for taxes related to net share settlement of equity awards</a></td>
<td class="num">(329)<span></span>
</td>
<td class="num">(159)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(139)<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(5,111)<span></span>
</td>
<td class="num">(6,512)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net decrease in cash, cash equivalents and restricted cash</a></td>
<td class="num">(228)<span></span>
</td>
<td class="num">(747)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the beginning of the period</a></td>
<td class="nump">12,691<span></span>
</td>
<td class="nump">11,043<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the end of the period</a></td>
<td class="nump">12,463<span></span>
</td>
<td class="nump">10,296<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Reconciliation of net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">5,274<span></span>
</td>
<td class="nump">5,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments required to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2,142<span></span>
</td>
<td class="nump">2,263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">236<span></span>
</td>
<td class="nump">232<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on sale of subsidiary</a></td>
<td class="num">(225)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_Deferredincometaxesandothernoncashitems', window );">Deferred income taxes and other noncash items</a></td>
<td class="num">(281)<span></span>
</td>
<td class="num">(370)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract', window );"><strong>Change in operating assets and liabilities, net of effects from acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="num">(2,687)<span></span>
</td>
<td class="num">(2,384)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="nump">469<span></span>
</td>
<td class="nump">1,517<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(325)<span></span>
</td>
<td class="num">(219)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable and pharmacy claims and discounts payable</a></td>
<td class="nump">2,033<span></span>
</td>
<td class="nump">1,702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInsuranceLiabilities', window );">Health care costs payable and other insurance liabilities</a></td>
<td class="nump">1,467<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="nump">903<span></span>
</td>
<td class="nump">879<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">$ 9,006<span></span>
</td>
<td class="nump">$ 8,739<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in operating assets and liabilities, net of effects from acquisitions: [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_Deferredincometaxesandothernoncashitems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits and amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_Deferredincometaxesandothernoncashitems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PaymentsforInsuranceBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Insurance Benefits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PaymentsforInsuranceBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Inventory and Prescriptions Dispensed by Retail Network Pharmacies</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInsuranceLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in insurance liability balances during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInsuranceLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToSuppliersAndEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash payments to suppliers for goods and services provided and to employees for services provided.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToSuppliersAndEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash receipts from customers during the current period which are usually for sales of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the cash inflow during the period from the sale of a component of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromInterestAndDividendsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received for dividends and interest on the entity's equity and debt investments during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3337-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromInterestAndDividendsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863237825824">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Total CVS Health Shareholders&#8217; Equity</div></th>
<th class="th"><div>Common Shares</div></th>
<th class="th" colspan="2"><div>Treasury Stock</div></th>
<th class="th" colspan="2"><div>Common Stock and Capital Surplus</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Noncontrolling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(423)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 69,701<span></span>
</td>
<td class="nump">$ 69,389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,178)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 46,513<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 49,640<span></span>
</td>
<td class="nump">$ 1,414<span></span>
</td>
<td class="nump">$ 312<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Shareholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,224<span></span>
</td>
<td class="nump">2,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(392)<span></span>
</td>
<td class="num">(392)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(392)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option activity, stock awards and other (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option activity, stock awards and other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">214<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">214<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">76<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 76<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common stock dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(660)<span></span>
</td>
<td class="num">(660)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(660)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease', window );">Other increases (decreases) in noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at end of period (in shares) at Mar. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury shares outstanding, balance at end of period (in shares) at Mar. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(422)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Mar. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">71,164<span></span>
</td>
<td class="nump">70,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,102)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">46,727<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">51,203<span></span>
</td>
<td class="nump">1,022<span></span>
</td>
<td class="nump">314<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(423)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">69,701<span></span>
</td>
<td class="nump">69,389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,178)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">46,513<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">49,640<span></span>
</td>
<td class="nump">1,414<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Shareholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(244)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at end of period (in shares) at Jun. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury shares outstanding, balance at end of period (in shares) at Jun. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(424)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Jun. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">73,565<span></span>
</td>
<td class="nump">73,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,252)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">46,995<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">53,331<span></span>
</td>
<td class="nump">1,170<span></span>
</td>
<td class="nump">321<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at beginning of period (in shares) at Mar. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury shares outstanding, balance at beginning of period (in shares) at Mar. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(422)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Mar. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">71,164<span></span>
</td>
<td class="nump">70,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,102)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">46,727<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">51,203<span></span>
</td>
<td class="nump">1,022<span></span>
</td>
<td class="nump">314<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Shareholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,791<span></span>
</td>
<td class="nump">2,783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">148<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option activity, stock awards and other (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option activity, stock awards and other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">268<span></span>
</td>
<td class="nump">268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">268<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance', window );">Purchases of treasury shares, net of ESPP issuances (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance', window );">Purchase of treasury shares, net of ESPP issuances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(150)<span></span>
</td>
<td class="num">(150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common stock dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(655)<span></span>
</td>
<td class="num">(655)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(655)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease', window );">Other increases (decreases) in noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at end of period (in shares) at Jun. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury shares outstanding, balance at end of period (in shares) at Jun. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(424)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Jun. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">73,565<span></span>
</td>
<td class="nump">73,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,252)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">46,995<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">53,331<span></span>
</td>
<td class="nump">1,170<span></span>
</td>
<td class="nump">321<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(422)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">75,381<span></span>
</td>
<td class="nump">75,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,173)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">47,377<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">54,906<span></span>
</td>
<td class="nump">965<span></span>
</td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Shareholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,313<span></span>
</td>
<td class="nump">2,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,155)<span></span>
</td>
<td class="num">(1,155)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,155)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option activity, stock awards and other (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option activity, stock awards and other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">300<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">300<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance', window );">Purchases of treasury shares, net of ESPP issuances (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance', window );">Purchase of treasury shares, net of ESPP issuances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,972)<span></span>
</td>
<td class="num">(1,972)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,972)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common stock dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(730)<span></span>
</td>
<td class="num">(730)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(730)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease', window );">Other increases (decreases) in noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at end of period (in shares) at Mar. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury shares outstanding, balance at end of period (in shares) at Mar. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(441)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Mar. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">74,140<span></span>
</td>
<td class="nump">73,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (30,145)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">47,677<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">56,488<span></span>
</td>
<td class="num">(190)<span></span>
</td>
<td class="nump">310<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(422)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">75,381<span></span>
</td>
<td class="nump">75,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,173)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">47,377<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">54,906<span></span>
</td>
<td class="nump">965<span></span>
</td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Shareholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,953)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at end of period (in shares) at Jun. 30, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury shares outstanding, balance at end of period (in shares) at Jun. 30, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(443)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Jun. 30, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">75,506<span></span>
</td>
<td class="nump">75,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (30,412)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">47,874<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">58,710<span></span>
</td>
<td class="num">(988)<span></span>
</td>
<td class="nump">322<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at beginning of period (in shares) at Mar. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury shares outstanding, balance at beginning of period (in shares) at Mar. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(441)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Mar. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">74,140<span></span>
</td>
<td class="nump">73,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (30,145)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">47,677<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">56,488<span></span>
</td>
<td class="num">(190)<span></span>
</td>
<td class="nump">310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Shareholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,961<span></span>
</td>
<td class="nump">2,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(798)<span></span>
</td>
<td class="num">(798)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(798)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option activity, stock awards and other (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option activity, stock awards and other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">197<span></span>
</td>
<td class="nump">197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">197<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance', window );">Purchases of treasury shares, net of ESPP issuances (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance', window );">Purchase of treasury shares, net of ESPP issuances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(267)<span></span>
</td>
<td class="num">(267)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (267)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common stock dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(729)<span></span>
</td>
<td class="num">(729)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(729)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease', window );">Other increases (decreases) in noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at end of period (in shares) at Jun. 30, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury shares outstanding, balance at end of period (in shares) at Jun. 30, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(443)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Jun. 30, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 75,506<span></span>
</td>
<td class="nump">$ 75,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (30,412)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">$ 47,874<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">$ 58,710<span></span>
</td>
<td class="num">$ (988)<span></span>
</td>
<td class="nump">$ 322<span></span>
</td>
</tr>
<tr><td colspan="11"></td></tr>
<tr><td colspan="11"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Treasury shares include 1 million shares held in trust and treasury stock includes $29 million related to shares held in trust as of June&#160;30, 2021, March 31, 2021 and December 31, 2020.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Common stock and capital surplus includes the par value of common stock of $17 million as of June&#160;30, 2021, March 31, 2021 and December 31, 2020.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Treasury shares include 1 million shares held in trust and treasury stock includes $29 million related to shares held in trust as of June&#160;30, 2022, March&#160;31, 2022 and December&#160;31, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Common stock and capital surplus includes the par value of common stock of $18 million as of June&#160;30, 2022 and $17 million as of March&#160;31, 2022 and December&#160;31, 2021.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ESPP Issuance, Net of Treasury Stock, Shares, Acquired, Cost Method</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ESPP Issuance, Net of Treasury Stock, Value, Acquired, Cost Method</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling interest, Other Period Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863242702112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Shareholders' Equity (Parenthetical) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockSharesHeldinTrust', window );">Treasury shares held in trust (in shares)</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockValueSharesHeldInTrust', window );">Treasury share held in trust</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockSharesHeldinTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Shares, Held in Trust</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockSharesHeldinTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockValueSharesHeldInTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Value, Shares Held In Trust</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockValueSharesHeldInTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863243763136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfCashFlowsAbstract', window );"><strong>Statement of Cash Flows [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashDivestedFromDeconsolidation', window );">Cash and restricted cash sold</a></td>
<td class="nump">$ 2,807<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashDivestedFromDeconsolidation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reduction in cash due to no longer including the former subsidiary's cash in the consolidated entity's cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashDivestedFromDeconsolidation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfCashFlowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfCashFlowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863243956224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">Significant Accounting Policies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business&#160; </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation, together with its subsidiaries (collectively, &#8220;CVS Health&#8221; or the &#8220;Company&#8221;), has more than 9,000 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with over 110 million plan members with expanding specialty pharmacy solutions and a dedicated senior pharmacy care business serving more than one million patients per year. The Company also serves an estimated 35 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#8220;PDP&#8221;). The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The coronavirus disease 2019 (&#8220;COVID-19&#8221;) and its emerging new variants continue to impact the economies of the U.S. and other countries around the world. The impact of COVID-19 on the Company&#8217;s businesses, operating results, cash flows and financial condition, as well as information regarding certain expected impacts of COVID-19 on the Company, is discussed throughout this Quarterly Report on Form 10-Q.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has four reportable segments: Health Care Benefits, Pharmacy Services, Retail/LTC and Corporate/Other, which are described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment operates as one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology products and services. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221; In addition, effective January 2022, the Company entered the individual public health insurance exchanges (&#8220;Public Exchanges&#8221;) in eight states through which it sells Insured plans directly to individual consumers. The Company has submitted regulatory filings to remain on the Public Exchanges in 2023 in each of those eight states, and has submitted regulatory filings to enter the Public Exchanges in four additional states effective January 2023. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Pharmacy Services Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment provides a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services and mail order pharmacy. In addition, through the Pharmacy Services segment, the Company provides specialty pharmacy and infusion services, clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#8220;Covered Entities&#8221;). The Company operates a group purchasing organization that negotiates pricing for the purchase of pharmaceuticals and rebates with pharmaceutical manufacturers on behalf of its participants. The Company also provides various administrative, management and reporting services to pharmaceutical manufacturers. The Pharmacy Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on Public Exchanges and private health insurance exchanges, other sponsors of health benefit plans throughout the United States and Covered Entities. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, COVID-19 and shingles and conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of June&#160;30, 2022, the Retail/LTC segment operated more than 9,000 retail </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">locations, more than 1,100 MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">locations as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate/Other Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) regarding interim financial reporting. In accordance with such rules and regulations, certain information and accompanying note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) have been omitted, although the Company believes the disclosures included herein are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2021 (the &#8220;2021 Form 10-K&#8221;).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Because of the influence of various factors on the Company&#8217;s operations, including business combinations, certain holidays and other seasonal influences, net income for any interim period may not be comparable to the same interim period in previous years or necessarily indicative of income for the full year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#8220;VIEs&#8221;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually evaluates its investments to determine if they represent variable interests in a VIE. If the Company determines that it has a variable interest in a VIE, the Company then evaluates if it is the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether the Company has the ability to direct the activities of a VIE that most significantly impact the entity&#8217;s economic performance. The Company consolidates a VIE if it is considered to be the primary beneficiary.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities of VIEs for which the Company is the primary beneficiary were not significant to the Company&#8217;s unaudited condensed consolidated financial statements. VIE creditors do not have recourse against the general credit of the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform with the current year presentation.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash included in other current assets on the unaudited condensed consolidated balance sheets represents funds held on behalf of members, including health savings account funds associated with high deductible health plans. Restricted cash included in other assets on the unaudited condensed consolidated balance sheets represents amounts held in a trust in one of the Company&#8217;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits and money market funds. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of cash and cash equivalents on the unaudited condensed consolidated balance sheets to total cash, cash equivalents and restricted cash on the unaudited condensed consolidated statements of cash flows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,116&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,119&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other assets)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash in the statements of cash flows</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,463&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,691&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,296&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in restricted cash included in other current assets as of June&#160;30, 2022 compared to December&#160;31, 2021 was primarily due to a decrease in health savings account funds held on behalf of customers as a result of the sale of PayFlex Holdings, Inc. (&#8220;PayFlex&#8221;). See Note 2 &#8216;&#8216;Divestitures and Asset Sales&#8217;&#8217; for additional information on the Company&#8217;s sale of PayFlex.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations. Accounts receivable, net is composed of the following:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,084&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor and manufacturer receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total accounts receivable, net </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,233&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,431&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s allowance for credit losses was $340 million and $339 million as of June&#160;30, 2022 and December&#160;31, 2021, respectively. When developing an estimate of the Company&#8217;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#8217;s accounts receivable are short duration in nature and typically settle in less than 30 days.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables disaggregate the Company&#8217;s revenue by major source in each segment for the three and six months ended June 30, 2022 and 2021:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,017&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,258)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,756&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,812&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,286&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,328)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,636&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,812&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,094)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,525&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,728&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,133)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,314&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,498)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,816&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,859&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,891&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,829&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,865&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,273&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,704&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,616)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,462&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,273&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021   </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,168)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,884&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,813&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,008&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,635&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,002&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,249)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,713&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,635&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS pharmacy retail store for the same price as mail order.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#8217;s retail pharmacies under the Maintenance Choice program.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily represent the Company&#8217;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about receivables and contract liabilities from contracts with customers:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables (included in accounts receivable, net)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,084&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities (included in accrued expenses)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2022 and 2021, the contract liabilities balance includes increases related to customers&#8217; earnings in ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rewards earnings and gift card issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and breakage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in SureScripts, LLC (&#8220;SureScripts&#8221;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $16 million and $10 million in the three months ended June&#160;30, 2022 and 2021, respectively, and expensed fees for the use of this network of approximately $31 million and $19 million in the six months ended June&#160;30, 2022 and 2021, respectively. The Company&#8217;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in Heartland Healthcare Services, LLC (&#8220;Heartland&#8221;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $23 million and $19 million for pharmaceutical inventory purchases during the three months ended June&#160;30, 2022 and 2021, respectively, and $44 million and $37 million for pharmaceutical inventory purchases during the six months ended June&#160;30, 2022 and 2021, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#8217;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Insurance Contracts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the Financial Accounting Standards Board issued Accounting Standards Update 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 944). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other comprehensive income. The rate used to discount the Company&#8217;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#8217;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#8217;s interim and annual financial statements. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company will adopt the new standard on January 1, 2023, using the modified retrospective transition method as of the earliest period presented for changes to the liability for future policy benefits and deferred acquisition costs. While the Company is still evaluating the impact of the new standard on its financial statements, the Company anticipates an increase to its liability for future policy benefits with a corresponding change in accumulated other comprehensive income as a result of updating the rate used to discount the liabilities to reflect the yield for an upper-medium grade fixed-income instrument compared to the Company&#8217;s expected investment yield under the existing guidance.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863352001360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Divestitures and Asset Sales<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Divestitures and Asset Sales</a></td>
<td class="text">Divestitures and Asset Sales<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestiture of PayFlex </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2022, the Company sold PayFlex for approximately $775&#160;million. PayFlex provides services to employers, their employees, and their former employees in the areas of tax-advantaged account reimbursement administration (flexible spending, health reimbursement, health savings, transit and parking), Consolidated Omnibus Budget Reconciliation Act (&#8220;COBRA&#8221;) administration and special-member billing administration. The results of this business have historically been reported within the Health Care Benefits segment. The Company recorded a pre-tax gain on the divestiture of $225&#160;million in the three and six months ended June&#160;30, 2022, which is reflected as a reduction in operating expenses in the Company&#8217;s unaudited condensed consolidated statements of operations within the Health Care Benefits segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestiture of Thailand Health Care Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the Company reached an agreement to sell its international health care business domiciled in Thailand (&#8220;Thailand business&#8221;), comprised of approximately 266,000 medical members, which was included in the Commercial Business reporting unit within the Health Care Benefits segment. At that time, a portion of the Commercial Business goodwill was specifically allocated to the Thailand business. The net assets of the Thailand business were accounted for as assets held for sale at March 31, 2022. The carrying value of the Thailand business was determined to be greater than its fair value and, accordingly, the Company recorded a $41&#160;million loss on assets held for sale within the Health Care Benefits segment during the first quarter of 2022. The sale closed in the second quarter of 2022, and the consideration received and ultimate loss on the sale were not material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International Health Care Benefits Renewal Rights Asset Sale</span></div>In May 2022, the Company sold the renewal rights of approximately 200,000 international medical members outside of the Americas, Thailand and India in connection with an Asset Purchase Agreement. As part of this agreement, the Company will introduce and help migrate these existing international medical members to the purchaser upon renewal. The Company expects the migration process to occur over a 16-month period between July 2022 and October 2023. The Company expects to cease writing any new or renewal business for international medical members outside of the Americas after October 31, 2022. The consideration received related to this agreement was not material.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863247533072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments</a></td>
<td class="text">Investments<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total investments at June&#160;30, 2022 and December&#160;31, 2021 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.106%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.384%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities available for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,775&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,976&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,751&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,231&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,877&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,124&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,001&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,117&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,025&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,142&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities available for sale at June&#160;30, 2022 and December&#160;31, 2021 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.133%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.133%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.265%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Allowance<br/>for Credit<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(740)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,857&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,201&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,515)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,751&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,174&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,174&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,240&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Investment risks associated with the Company&#8217;s experience-rated products generally do not impact the Company&#8217;s consolidated operating results. At June&#160;30, 2022, debt securities with a fair value of $658 million, gross unrealized capital gains of $5 million and gross unrealized capital losses of $39 million and at December&#160;31, 2021, debt securities with a fair value of $864 million, gross unrealized capital gains of $94 million and gross unrealized capital losses of $2 million were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income (loss).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net amortized cost and fair value of debt securities at June&#160;30, 2022 are shown below by contractual maturity.&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.690%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.692%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,031&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,201&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,751&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the debt securities the Company held at June&#160;30, 2022 and December&#160;31, 2021 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.244%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except number of securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,947&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,044&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,384&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,367&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,093&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,074&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,918&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,515&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,534&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,700&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,800&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,017&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,384&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviewed the securities in the table above and concluded that they are performing assets generating investment income to support the needs of the Company&#8217;s business.&#160;In performing this review, the Company considered factors such as the quality of the investment security based on research performed by the Company&#8217;s internal credit analysts and&#160;external rating agencies and the prospects of realizing the carrying value of the security based on the investment&#8217;s current prospects for recovery. Unrealized capital losses at June&#160;30, 2022 were generally caused by interest rate increases and not by unfavorable changes in the credit quality associated with these securities. As of June&#160;30, 2022, the Company did not intend to sell these securities, and did not believe it was more likely than not that it would be required to sell these securities prior to the anticipated recovery of their amortized cost basis.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity dates for debt securities in an unrealized capital loss position at June&#160;30, 2022 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.505%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.948%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting<br/>experience-rated products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting <br/>remaining products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,864&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,043&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,450&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,476&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,918&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,515&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mortgage Loans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s mortgage loans are collateralized by commercial real estate.&#160;During the three and six months ended June&#160;30, 2022 and 2021, the Company had the following activity in its mortgage loan portfolio:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.285%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New mortgage loans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans fully repaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans foreclosed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses mortgage loans on a regular basis for credit impairments, and assigns a credit quality indicator to each loan.&#160;The Company&#8217;s credit quality indicator is internally developed and categorizes each loan in its portfolio on a scale from 1 to 7.&#160;These indicators are based upon several factors, including current loan-to-value ratios, current and future property cash flow, property condition, market trends, creditworthiness of the borrower and deal structure. </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 1 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Represents loans of superior quality.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 2 to 4 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Represent loans where credit risk is minimal to acceptable; however, these loans may display some susceptibility to economic changes.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 5 and 6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represent loans where credit risk is not substantial, but these loans warrant management&#8217;s close attention.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represents loans where collections are potentially at risk; if necessary, an impairment is recorded.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the Company&#8217;s assessments at June&#160;30, 2022 and December&#160;31, 2021, the amortized cost basis of the Company's mortgage loans within each credit quality indicator by year of origination was as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost Basis by Year of Origination</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except credit quality indicator</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">861&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Income</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sources of net investment income for the three and six months ended June&#160;30, 2022 and 2021 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.625%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.283%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross investment income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (excluding net realized capital gains or losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital gains (losses) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net realized capital losses include yield-related impairment losses on debt securities of $30 million and are shown net of the reversal of previously recorded credit-related impairment losses on debt securities of $22 million in the three months ended June&#160;30, 2022. Net realized capital losses include credit-related and yield-related impairment losses on debt securities of $16 million and $48 million, respectively, in the six months ended June&#160;30, 2022. Net realized capital gains are net of yield-related impairment losses on debt securities of $2 million and $32 million, respectively, in the three and six months ended June&#160;30, 2021. There were no credit-related losses on debt securities in the three and six months ended June&#160;30, 2021.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net investment income includes $9 million and $18 million for the three and six months ended June&#160;30, 2022, respectively, and $10 million and $19 million for the three and six months ended June&#160;30, 2021, respectively, related to investments supporting experience-rated products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding amounts related to experience-rated products, proceeds from the sale of available-for-sale debt securities and the related gross realized capital gains and losses for the three and six months ended June&#160;30, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,052&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,963&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,267&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863243903744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value</a></td>
<td class="text">Fair Value<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company&#8217;s unaudited condensed consolidated financial statements in accordance with GAAP requires certain assets and liabilities to be reflected at their fair value and others to be reflected on another basis, such as an adjusted historical cost basis.&#160;The Company&#8217;s assets and liabilities carried at fair value have been classified within one of three levels of a hierarchy established by GAAP.&#160;The following are the levels of the hierarchy and a brief description of the type of valuation information (&#8220;valuation inputs&#8221;) that qualifies a financial asset or liability for each level:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; Unadjusted quoted prices for identical assets or liabilities in active markets.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; Valuation inputs other than Level 1 that are based on observable market data.&#160;&#160;These include: quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets, valuation inputs that are observable that are not prices (such as interest rates and credit risks) and valuation inputs that are derived from or corroborated by observable markets.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; Developed from unobservable data, reflecting the Company&#8217;s assumptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of the methods and assumptions that are used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument, see Note 4 &#8220;Fair Value&#8221; in the 2021 Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no financial liabilities measured at fair value on a recurring basis on the unaudited condensed consolidated balance sheets at June&#160;30, 2022 or December&#160;31, 2021. Financial assets measured at fair value on a recurring basis on the unaudited condensed consolidated balance sheets at June&#160;30, 2022 and December&#160;31, 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,781&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,045&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,668&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,751&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,501&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,449&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,056&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,954&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,086&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,697&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,372&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,812&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,440&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,266&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,817&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended June&#160;30, 2022 there were $26 million and $29 million of transfers out of Level 3. During the three and six months ended June&#160;30, 2021, there were no transfers into or out of Level 3.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the unaudited condensed consolidated balance sheets at adjusted cost or contract value at June&#160;30, 2022 and December&#160;31, 2021 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.284%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Estimated Fair Value</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,816&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,825&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,825&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets relate to the Company&#8217;s large case pensions products which represent funds maintained to meet specific objectives of contract holders.&#160;Since contract holders bear the investment risk of these assets, a corresponding Separate Accounts liability has been established equal to the assets.&#160;These assets and liabilities are carried at fair value.&#160;Separate Accounts financial assets as of June&#160;30, 2022 and December&#160;31, 2021 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.408%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.243%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,048&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common/collective trusts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,135&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,052&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,235&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,782&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,017&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $88 million and $70 million of other receivables at June&#160;30, 2022 and December&#160;31, 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863243820192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Health Care Costs Payable<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract', window );"><strong>Health Care and Other Insurance Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock', window );">Health Care Costs Payable</a></td>
<td class="text">Health Care Costs Payable<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in health care costs payable during the six months ended June&#160;30, 2022 and 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,808&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,936&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of the period, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Components of incurred health care costs</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(666)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(709)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred health care costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,474&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Claims paid</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total claims paid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,703&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Premium deficiency reserve</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of the period, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,396&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,396&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,414&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total incurred health care costs for the six months ended June&#160;30, 2022 and 2021 in the table above exclude (i) $5 million and $5 million, respectively, for premium deficiency reserves related to the Company&#8217;s Medicaid products, (ii) $37 million and $27 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the unaudited condensed consolidated balance sheets and (iii) $221 million and $99 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the unaudited condensed consolidated balance sheets. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimates of prior years&#8217; health care costs payable decreased by $666 million and $709 million, respectively, in the six months ended June&#160;30, 2022 and 2021, because claims were settled for amounts less than originally estimated (i.e., the amount of claims incurred was lower than originally estimated), primarily due to lower health care cost trends as well as the actual claim submission time being faster than originally assumed (i.e., the Company&#8217;s completion factors were higher than originally assumed) in estimating health care costs payable at the end of the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022, the Company&#8217;s liabilities for the ultimate cost of (i) services rendered to the Company&#8217;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid (collectively, &#8220;IBNR&#8221;) plus expected development on reported claims totaled approximately $8.0 billion. Substantially all of the Company&#8217;s liabilities for IBNR plus expected development on reported claims at June&#160;30, 2022 related to the current year.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Health Care and Other Insurance Liabilities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_HealthCareandOtherInsuranceLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for insurance products considered to be short-duration contracts because the contract provides insurance protection for a fixed period of short duration and enables the insurer to cancel the contract or to adjust the provisions of the contract at the end of any contract period, such as adjusting the amount of premiums charged or coverage provided, and on contracts on which amounts are paid but insurance risk is not transferred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -URI https://asc.fasb.org/topic&amp;trid=2303980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863243787488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Borrowings</a></td>
<td class="text">Borrowings<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s borrowings at June&#160;30, 2022 and December&#160;31, 2021: </span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.451%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5% senior notes due July 2022</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.75% senior notes due November 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.75% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.75% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8% senior notes due June 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4% senior notes due December 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.375% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.625% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5% senior notes due November 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5% senior notes due December 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1% senior notes due March 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.875% senior notes due July 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.875% senior notes due June 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3% senior notes due August 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.625% senior notes due April 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.25% senior notes due June 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3% senior notes due August 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3% senior notes due March 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.25% senior notes due August 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.75% senior notes due April 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.75% senior notes due August 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.875% senior notes due February 2031</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.125% senior notes due September 2031</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.875% senior notes due July 2035</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.625% senior notes due June 2036</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.75% senior notes due December 2037</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.78% senior notes due March 2038</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.125% senior notes due September 2039</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.125% senior notes due April 2040</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7% senior notes due August 2040</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.75% senior notes due May 2041</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5% senior notes due May 2042</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.125% senior notes due November 2042</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.3% senior notes due December 2043</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.75% senior notes due March 2044</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.125% senior notes due July 2045</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.875% senior notes due August 2047</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.05% senior notes due March 2048</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.25% senior notes due April 2050</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81Mi0wLTEtMS0xMzcyNzU_6dc679d2-e622-45de-819a-6f36bb88bc8b"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81Mi0wLTEtMS0xMzcyNzU_7cf3c139-629e-4185-b686-0b6e8760e74e">Finance lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt principal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,743&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt discounts and deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(740)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(786)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,816&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,176&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,019)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,205)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,797&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,971&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company exercised the par call option on its outstanding 3.5% senior notes due July 2022 and redeemed for cash on hand the entire $1.5&#160;billion aggregate principal amount. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 15, 2022, the Company announced that it will exercise the par call option on its outstanding 2.75% senior notes due November 2022 (issued by Aetna Inc.) and will redeem for cash on hand the entire $1.0&#160;billion aggregate principal amount. The redemption is expected to occur on or about August 15, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 2, 2022, the Company announced that it will exercise the par call options on its outstanding 2.75% senior notes due December 2022 and 4.75% senior notes due December 2022 (including the unexchanged notes issued by Omnicare, Inc.) and will redeem for cash on hand the entire $1.25&#160;billion and $399&#160;million aggregate principal amounts, respectively. The redemptions are expected to occur on or about September 1, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863243899024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholders' Equity</a></td>
<td class="text">Shareholders&#8217; Equity<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following share repurchase program has been authorized by CVS Health Corporation&#8217;s Board of Directors (the &#8220;Board&#8221;):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In billions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Authorization&#160;Date</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Authorized</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Remaining as of<br/>June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 9, 2021 (&#8220;2021 Repurchase Program&#8221;)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Repurchase Program permits the Company to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase (&#8220;ASR&#8221;) transactions, and/or other derivative transactions. The 2021 Repurchase Program can be modified or terminated by the Board at any time.</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2022, the Company repurchased approximately 19.1 million shares of common stock for approximately $2.0 billion pursuant to the 2021 Repurchase Program, including share repurchases under the ASR transaction described below. During the six months ended June&#160;30, 2021, the Company did not repurchase any shares of its common stock. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the authorization under the 2021 Repurchase Program, the Company entered into a $1.5&#160;billion fixed dollar ASR with Barclays Bank PLC (&#8220;Barclays&#8221;). Upon payment of the $1.5&#160;billion purchase price on January 4, 2022, the Company received a number of shares of CVS Health Corporation&#8217;s common stock equal to 80% of the $1.5&#160;billion notional amount of the ASR or approximately 11.6&#160;million shares at a price of $103.34 per share, which were placed into treasury stock in January 2022. The ASR was accounted for as an initial treasury stock transaction for $1.2&#160;billion and a forward contract for $0.3&#160;billion. The forward contract was classified as an equity instrument and was recorded within capital surplus. In February 2022, the Company received approximately 2.7&#160;million shares of CVS Health Corporation&#8217;s common stock, representing the remaining 20% of the $1.5&#160;billion notional amount of the ASR, thereby concluding the ASR. These shares were placed into treasury stock and the forward contract was reclassified from capital surplus to treasury stock in February 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the time they were received, the initial and final receipt of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted average common shares outstanding for basic and diluted earnings per share.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The quarterly cash dividend declared by the Board was $0.55 and $0.50 per share in the three months ended June&#160;30, 2022 and 2021, respectively. Cash dividends declared by the Board were $1.10 and $1.00 per share in the six months ended June&#160;30, 2022 and 2021, respectively. CVS Health Corporation has paid cash dividends every quarter since becoming a public company. Future dividend payments will depend on the Company&#8217;s earnings, capital requirements, financial condition and other factors considered relevant by the Board.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863243751536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Income<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Other Comprehensive Income</a></td>
<td class="text">Other Comprehensive Income<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders&#8217; equity included the following activity in accumulated other comprehensive income (loss) for the three and six months ended June&#160;30, 2022 and 2021:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net unrealized investment gains (losses):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(377)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$(1,105), $214, $(2,510), $(273) pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(868)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,098)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($77, $(18), $154, $(1) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(813)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,968)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,190)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,190)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($24, $0, $24, $0 pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(4), $(4), $(8), $(9) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension and other postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($1, $1, $1, $1 pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total beginning of period accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(190)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(798)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,953)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(244)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total end of period accumulated other comprehensive income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(988)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,170&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(988)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,170&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income (loss) for specifically identified debt securities are included in net investment income in the unaudited condensed consolidated statements of operations.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included in interest expense in the unaudited condensed consolidated statements of operations. The Company expects to reclassify approximately&#160;$11 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.</span></div>(3)Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the unaudited condensed consolidated statements of operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863244036320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">Earnings Per Share<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share is computed using the treasury stock method. Stock options and stock appreciation rights to purchase 4 million and 3 million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the three and six months ended June&#160;30, 2022, respectively, because their exercise prices were greater than the average market price of the common shares and, therefore, the effect would be antidilutive. For the same reason, stock options and stock appreciation rights to purchase 8 million and 9 million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the three and six months ended June&#160;30, 2021, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of basic and diluted earnings per share for the respective periods:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units and performance stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and stock appreciation rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,321&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,327&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863243884528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to evolve. The Company believes COVID-19&#8217;s impact on its businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic; the pandemic&#8217;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns; and the timing, scope and impact of stimulus legislation as well as other federal, state and local governmental responses to the pandemic. Those primary drivers are beyond the Company&#8217;s knowledge and control. As a result, the impact COVID-19 will have on the Company&#8217;s businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. COVID-19 also may result in legal and regulatory proceedings, investigations and claims against the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lease Guarantees</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between 1995 and 1997, the Company sold or spun off a number of subsidiaries, including Bob&#8217;s Stores and Linens &#8216;n Things, each of which subsequently filed for bankruptcy, and Marshalls. In many cases, when a former subsidiary leased a store, the Company provided a guarantee of the former subsidiary&#8217;s lease obligations for the initial lease term and any extension thereof pursuant to a renewal option provided for in the lease prior to the time of the disposition. When the subsidiaries were disposed of and accounted for as discontinued operations, the Company&#8217;s guarantees remained in place, although each initial purchaser agreed to indemnify the Company for any lease obligations the Company was required to satisfy. If any of the purchasers or any of the former subsidiaries fail to make the required payments under a store lease, the Company could be required to satisfy those obligations, and any significant adverse impact of COVID-19 on such purchasers and/or former subsidiaries increases the risk that the Company will be required to satisfy those obligations. As of June&#160;30, 2022, the Company guaranteed 68 such store leases (excluding the lease guarantees related to Linens &#8216;n Things, which have been recorded as a liability on the unaudited condensed consolidated balance sheets), with the maximum remaining lease term extending through 2030. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guaranty Fund Assessments, Market Stabilization and Other Non-Voluntary Risk Sharing Pools</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under guaranty fund laws existing in all states, insurers doing business in those states can be assessed (in most states up to prescribed limits) for certain obligations of insolvent insurance companies to policyholders and claimants. The life and health insurance guaranty associations in which the Company participates that operate under these laws respond to insolvencies of long-term care insurers and life insurers as well as health insurers. The Company&#8217;s assessments generally are based on a formula relating to the Company&#8217;s health care premiums in the state compared to the premiums of other insurers. Certain states allow assessments to be recovered over time as offsets to premium taxes. Some states have similar laws relating to HMOs and/or other payors such as not-for-profit consumer-governed health plans established under the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2009, the Pennsylvania Insurance Commissioner placed long-term care insurer Penn Treaty Network America Insurance Company and one of its subsidiaries (collectively, &#8220;Penn Treaty&#8221;) in rehabilitation, an intermediate action before insolvency, and subsequently petitioned a state court to convert the rehabilitation into a liquidation. Penn Treaty was placed in liquidation in March 2017. The Company has recorded a liability for its estimated share of future assessments by applicable life and health insurance guaranty associations. It is reasonably possible that in the future the Company may record a liability and expense relating to other insolvencies which could have a material adverse effect on the Company&#8217;s operating results, financial condition and cash flows, and the risk is heightened by any significant adverse impact of the COVID-19 pandemic on the solvency of other insurers, including long-term care and life insurers. While historically the Company has ultimately recovered more than half of guaranty fund assessments through statutorily permitted premium tax offsets, significant increases in assessments could lead to legislative and/or regulatory actions that limit future offsets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HMOs in certain states in which the Company does business are subject to assessments, including market stabilization and other risk-sharing pools, for which the Company is assessed charges based on incurred claims, demographic membership mix and other factors. The Company establishes liabilities for these assessments based on applicable laws and regulations. In certain states, the ultimate assessments the Company pays are dependent upon the Company&#8217;s experience relative to other entities subject to the assessment, and the ultimate liability is not known at the financial statement date. While the ultimate amount of the assessment is dependent upon the experience of all pool participants, the Company believes it has adequate reserves to cover such assessments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation and Regulatory Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been involved or is currently involved in numerous legal proceedings, including litigation, arbitration, government investigations, audits, reviews and claims. These include routine, regular and special investigations, audits and reviews by</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the U.S. Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;), state insurance and health and welfare departments, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the U.S. Department of Justice (the &#8220;DOJ&#8221;), </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">state attorneys general, the U.S. Drug Enforcement Administration (the &#8220;DEA&#8221;), the Federal Trade Commission (the &#8220;FTC&#8221;) and other governmental authorities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal proceedings, in general, and securities, class action and multi-district litigation, in particular, and governmental special investigations, audits and reviews can be expensive and disruptive. Some of the litigation matters may purport or be determined to be class actions and/or involve parties seeking large and/or indeterminate amounts, including punitive or exemplary damages, and may remain unresolved for several years. The Company also may be named from time to time in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> actions initiated by private third parties that could also be separately pursued by a governmental body. The results of legal proceedings, including government investigations, are often uncertain and difficult to predict, and the costs incurred in these matters can be substantial, regardless of the outcome.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred and the amount can be reasonably estimated. The Company evaluates, on a quarterly basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and reasonably estimable, the Company does not establish an accrued liability. None of the Company&#8217;s accruals for outstanding legal matters are material individually or in the aggregate to the Company&#8217;s financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise noted, the Company cannot predict with certainty the timing or outcome of the legal matters described below, and the Company is unable to reasonably estimate a possible loss or range of possible loss in excess of amounts already accrued for these matters. The Company believes that its defenses and assertions in pending legal proceedings have merit and does not believe that any of these pending matters, after consideration of applicable reserves and rights to indemnification, will </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have a material adverse effect on the Company&#8217;s financial position. Substantial unanticipated verdicts, fines and rulings, however, do sometimes occur, which could result in judgments against the Company, entry into settlements or a revision to its expectations regarding the outcome of certain matters, and such developments could have a material adverse effect on its results of operations.  In addition, as a result of governmental investigations or proceedings, the Company may be subject to damages, civil or criminal fines or penalties, or other sanctions including possible suspension or loss of licensure and/or exclusion from participating in government programs. The outcome of such governmental investigations of proceedings could be material to the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Usual and Customary Pricing Litigation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and certain current and former directors and officers are named as a defendant in a number of lawsuits that allege that the Company&#8217;s retail pharmacies overcharged for prescription drugs by not submitting the correct usual and customary price during the claims adjudication process. These actions are brought by a number of different types of plaintiffs, including plan members, private payors, government payors, and shareholders based on different legal theories. Some of these cases are brought as putative class actions, and in some instances, classes have been certified. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PBM Litigation and Investigations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its PBM practices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is facing multiple lawsuits, including by a State Attorney General, governmental subdivisions and several putative class actions, regarding drug pricing and its rebate arrangements with drug manufacturers.  These complaints, brought by a number of different types of plaintiffs under a variety of legal theories, generally allege that rebate agreements between the drug manufacturers and PBMs caused inflated prices for certain drug products. The Company is defending itself against these claims.  The Company has also received subpoenas, civil investigative demands (&#8220;CIDs&#8221;) and other requests for documents and information from, and is being investigated by, the FTC and Attorneys General of several states and the District of Columbia regarding its PBM practices, including pricing and rebates. The Company has been providing documents and information in response to these subpoenas, CIDs and requests for information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Behnke v. CVS Caremark Corporation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. (U.S. District Court for the Eastern District of Pennsylvania). In April 2018, the Court unsealed a complaint filed in February 2014. The government has declined to intervene in this case. The relator alleges that the Company submitted, or caused to be submitted, to Part D of the Medicare program Prescription Drug Event data and/or Direct and Indirect Remuneration reports that misrepresented true prices paid by the Company&#8217;s PBM to pharmacies for drugs dispensed to Part D beneficiaries with prescription benefits administered by the Company&#8217;s PBM. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Controlled Substances Litigation, Audits and Subpoenas</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, the U.S. Judicial Panel on Multidistrict Litigation consolidated numerous cases filed against various defendants by plaintiffs such as counties, cities, hospitals, Indian tribes and third-party payors, alleging claims generally concerning the impacts of widespread prescription opioid abuse. The consolidated multidistrict litigation captioned In re National Prescription Opiate Litigation (MDL No. 2804) is pending in the U.S. District Court for the Northern District of Ohio. This multidistrict litigation presumptively includes hundreds of relevant federal court cases that name the Company as a defendant. A significant number of similar cases that name the Company as a defendant in some capacity are pending in state courts. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company has been named as a defendant in similar cases brought by certain state Attorneys General. The Company is defending itself against all such claims. Additionally, the Company has received subpoenas, CIDs and/or other requests for information regarding opioids from state Attorneys General and insurance and other regulators of several U.S. jurisdictions. The Company has been cooperating with the government with respect to these subpoenas, CIDs and other requests for information.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the Company was among the chain pharmacies found liable by a jury in a trial in federal court in Ohio; the remedy pursuant to that verdict has not been determined and the Company plans to appeal.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, CVS Health Corporation and CVS Pharmacy, Inc. entered into a settlement agreement with the State of Florida to resolve claims related to opioid medications dating back more than a decade. Under the terms of the settlement agreement, CVS Health Corporation settled all opioid claims against it and its subsidiaries by the State of Florida for $484&#160;million, which is </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to be paid over a period of 18 years. During the three months ended March 31, 2022, the Company recorded a $484&#160;million liability associated with this legal settlement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the DOJ served the Company with a DEA administrative subpoena. The subpoena seeks documents relating to practices with respect to prescription opioids and other controlled substances at CVS pharmacy locations concerning potential violations of the federal Controlled Substances Act and the federal False Claims Act. In January 2022, the DOJ served the Company with a CID regarding similar subjects. The Company is providing documents and information in response to these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Prescription Processing Litigation and Investigations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its prescription processing practices, including the following:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ex rel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Bassan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> v. Omnicare, Inc. and CVS Health Corp. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. District Court for the Southern District of New York). In December 2019, the U.S. Attorney&#8217;s Office for the Southern District of New York (the &#8220;SDNY&#8221;) filed a complaint-in-intervention in this previously sealed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case. The complaint alleges that for certain non-skilled nursing facilities, Omnicare improperly filled prescriptions beyond one year where a valid prescription did not exist and that these dispensing events violated the federal False Claims Act. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. ex rel. Gill et al. v. CVS Health Corp. et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (U.S. District Court for the Northern District of Illinois).  In July 2022, the Delaware Attorney General&#8217;s Office moved for partial intervention as to allegations under the Delaware false claims act related to not escheating alleged overpayments in this previously sealed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case.  The federal government and the remaining states declined to intervene on other additional theories in the relator&#8217;s complaint.  The Company is defending itself against all of the claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2017, the Company also received a subpoena from the California Department of Insurance requesting documents concerning the Company&#8217;s Omnicare pharmacies&#8217; cycle fill process for assisted living facilities. The Company has been cooperating with the California Department of Insurance and providing documents and information in response to this subpoena.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2016, the Company received a CID from the U.S. Attorney&#8217;s Office for the Northern District of New York requesting documents and information in connection with a federal False Claims Act investigation concerning whether the Company&#8217;s retail pharmacies improperly submitted certain insulin claims to Part D of the Medicare program rather than Part B of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Provider Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in purported class actions and individual lawsuits arising out of its practices related to the payment of claims for services rendered to its members by providers with whom the Company has a contract and with whom the Company does not have a contract (&#8220;out-of-network providers&#8221;). Among other things, these lawsuits allege that the Company paid too little to its health plan members and/or providers for out-of-network services (including COVID-19 testing) and/or otherwise allege that the Company failed to timely or appropriately pay or administer out-of-network claims and benefits (including the Company&#8217;s post payment audit and collection practices and reductions in payments to providers due to sequestration). Other major health insurers are the subject of similar litigation or have settled similar litigation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has received subpoenas and/or requests for documents and other information from, and been investigated by, state Attorneys General and other state and/or federal regulators, legislators and agencies relating to, and the Company is involved in other litigation regarding, its out-of-network benefit payment and administration practices. It is reasonably possible that others could initiate additional litigation or additional regulatory action against the Company with respect to its out-of-network benefit payment and/or administration practices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CMS Actions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS regularly audits the Company&#8217;s performance to determine its compliance with CMS&#8217;s regulations and its contracts with CMS and to assess the quality of services it provides to Medicare beneficiaries. CMS uses various payment mechanisms to allocate and adjust premium payments to the Company&#8217;s and other companies&#8217; Medicare plans by considering the applicable </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">health status of Medicare members as supported by information prepared, maintained and provided by providers. The Company collects claim and encounter data from providers and generally relies on providers to appropriately code their submissions to the Company and document their medical records, including the diagnosis data submitted to the Company with claims. CMS pays increased premiums to Medicare Advantage plans and Medicare PDP plans for members who have certain medical conditions identified with specific diagnosis codes. Federal regulators review and audit the providers&#8217; medical records to determine whether those records support the related diagnosis codes that determine the members&#8217; health status and the resulting risk-adjusted premium payments to the Company. In that regard, CMS has instituted risk adjustment data validation (&#8220;RADV&#8221;) audits of various Medicare Advantage plans, including certain of the Company&#8217;s plans, to validate coding practices and supporting medical record documentation maintained by providers and the resulting risk-adjusted premium payments to the plans. CMS may require the Company to refund premium payments if the Company&#8217;s risk-adjusted premiums are not properly supported by medical record data. The Office of the Inspector General of the U.S. Department of Health and Human Services (&#8220;OIG&#8221;) also is auditing the Company&#8217;s risk adjustment-related data and that of other companies. The Company expects CMS and the OIG to continue these types of audits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2012, CMS revised its audit methodology for RADV audits to determine refunds payable by Medicare Advantage plans for contract year 2011 and forward. Under the revised methodology, among other things, CMS will extrapolate the error rate identified in the audit sample of approximately 200 members to all risk-adjusted premium payments made under the contract being audited. For contract years prior to 2011, CMS did not extrapolate sample error rates to the entire contract. As a result, the revised methodology may increase the Company&#8217;s exposure to premium refunds to CMS based on incomplete medical records maintained by providers. Since 2013, CMS has selected certain of the Company&#8217;s Medicare Advantage contracts for various contract years for RADV audit, and the number of RADV audits continues to increase. The Company is currently unable to predict which of its Medicare Advantage contracts will be selected for future audit, the amounts of any retroactive refunds of, or prospective adjustments to, Medicare Advantage premium payments made to the Company, the effect of any such refunds or adjustments on the actuarial soundness of the Company&#8217;s Medicare Advantage bids, or whether any RADV audit findings would require the Company to change its method of estimating future premium revenue in future bid submissions to CMS or compromise premium assumptions made in the Company&#8217;s bids for prior contract years, the current contract year or future contract years. Any premium or fee refunds or adjustments resulting from regulatory audits, whether as a result of RADV, Public Exchange related or other audits by CMS, the OIG or otherwise, including audits of the Company&#8217;s minimum medical loss ratio rebates, methodology and/or reports, could be material and could adversely affect the Company&#8217;s operating results, cash flows and/or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Medicare and Medicaid CIDs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has received CIDs from the Civil Division of the DOJ in connection with a current investigation of the Company&#8217;s patient chart review processes in connection with risk adjustment data submissions under Parts C and D of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to these CIDs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, the Company received a CID from the SDNY requesting documents and information concerning possible false claims submitted to Medicare in connection with reimbursements for prescription drugs under the Medicare Part D program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stockholder Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in February 2019, multiple class action complaints, as well as a derivative complaint, were filed by putative plaintiffs against the Company and certain current and former officers and directors. The plaintiffs in these cases assert a variety of causes of action under federal securities laws that are premised on allegations that the defendants made certain omissions and misrepresentations relating to the performance of the Company&#8217;s LTC business unit. The Company and its current and former officers and directors are defending themselves against these claims. Since filing, several of the cases have been consolidated, and the first-filed federal case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Miami Fire Fighters&#8217; and Police Officers&#8217; Retirement Trust, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anarkat</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), was dismissed with prejudice in February 2021. Plaintiffs have appealed that decision to the First Circuit after their motion for reconsideration was denied. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re CVS Health Corp. Securities Act Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Waterford</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re CVS Health Corp. Securities Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Warren</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Freundlich</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) have been stayed pending the outcome of the First Circuit appeal. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August and September 2020, two class actions under the Employee Retirement Income Security Act of 1974 (&#8220;ERISA&#8221;)</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">were filed in the U.S. District Court for the District of Connecticut against CVS Health, Aetna Inc. (&#8220;Aetna&#8221;), and several current and former executives, directors and/or members of Aetna&#8217;s Compensation and Talent Management Committee: </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Radcliffe v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flaim v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. The plaintiffs in these cases assert a variety of causes of action premised on allegations that the defendants breached fiduciary duties and engaged in prohibited transactions relating to participants in the Aetna 401(k) Plan&#8217;s investment in company stock between December 3, 2017 and February 20, 2019, claiming losses related to the performance of the Company&#8217;s LTC business unit. The district court consolidated the actions, and in October 2021, dismissed the consolidated action without prejudice. Plaintiffs filed an amended consolidated complaint, which the Company has moved to dismiss. The Company also received a related document request pursuant to ERISA &#167; 104(b), to which the Company has responded. The Company and its current and former officers and directors are defending themselves against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company received a demand for inspection of books and records pursuant to Delaware Corporation Law Section 220 (the &#8220;Demand&#8221;). The Demand purports to be related to potential breaches of fiduciary duties by the Board in relation to certain matters concerning opioids.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Legal and Regulatory Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also a party to other legal proceedings and is subject to government investigations, inquiries and audits and has received and is cooperating with the government in response to CIDs, subpoenas or similar process from various governmental agencies requesting information. These other legal proceedings and government actions include claims of or relating to bad faith, medical or professional malpractice, breach of fiduciary duty, claims processing, dispensing of medications, non-compliance with state and federal regulatory regimes, marketing misconduct, denial of or failure to timely or appropriately pay or administer claims and benefits, provider network structure (including the use of performance-based networks and termination of provider contracts), rescission of insurance coverage, improper disclosure or use of personal information, anticompetitive practices, general contractual matters, product liability, intellectual property litigation and employment litigation. Some of these other legal proceedings are or are purported to be class actions or derivative claims. The Company is defending itself against the claims brought in these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards to the Company and others of certain government contracts, particularly Medicaid contracts and other contracts with government customers in the Company&#8217;s Health Care Benefits segment, frequently are subject to protests by unsuccessful bidders. These protests may result in awards to the Company being reversed, delayed or modified. The loss or delay in implementation of any government contract could adversely affect the Company&#8217;s operating results. The Company will continue to defend contract awards it receives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There also continues to be a heightened level of review and/or audit by regulatory authorities and legislators of, and increased litigation regarding, the Company&#8217;s and the rest of the health care and related benefits industry&#8217;s business and reporting practices, including premium rate increases, utilization management, development and application of medical policies, complaint, grievance and appeal processing, information privacy, provider network structure (including provider network adequacy, the use of performance-based networks and termination of provider contracts), provider directory accuracy, calculation of minimum medical loss ratios and/or payment of related rebates, delegated arrangements, rescission of insurance coverage, limited benefit health products, student health products, pharmacy benefit management practices (including manufacturers&#8217; rebates, pricing, the use of narrow networks and the placement of drugs in formulary tiers), sales practices, customer service practices, vendor oversight and claim payment practices (including payments to out-of-network providers).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a leading national health solutions company, the Company regularly is the subject of government actions of the types described above. These government actions may prevent or delay the Company from implementing planned premium rate increases and may result, and have resulted, in restrictions on the Company&#8217;s businesses, changes to or clarifications of the Company&#8217;s business practices, retroactive adjustments to premiums, refunds or other payments to members, beneficiaries, states or the federal government, withholding of premium payments to the Company by government agencies,&#160;assessments of damages, civil or criminal fines or penalties, or other sanctions, including the possible suspension or loss of licensure and/or suspension or exclusion from participation in government programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company can give no assurance that its businesses, financial condition, operating results and/or cash flows will not be materially adversely affected, or that the Company will not be required to materially change its business practices, based on: (i)&#160;future enactment of new health care or other laws or regulations; (ii)&#160;the interpretation or application of existing laws or regulations as they may relate to one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iii)&#160;pending or future federal or state government investigations of one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iv)&#160;pending or future government audits, investigations or enforcement actions against the Company; (v)&#160;adverse developments in any pending </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit against the Company, whether sealed or unsealed, or in any future </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit that may be filed against the Company; or (vi)&#160;adverse developments in pending or future legal proceedings against the Company or affecting one or more of the industries in which the Company competes and/or the health care industry generally.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863243778816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text">Segment ReportingThe Company has three operating segments, Health Care Benefits, Pharmacy Services and Retail/LTC, as well as a Corporate/Other segment. The Company&#8217;s segments maintain separate financial information, and the Company&#8217;s chief operating decision maker (the &#8220;CODM&#8221;) evaluates the segments&#8217; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#8217;s segments based on adjusted operating income, which is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#8217;s business nor reflect the Company&#8217;s underlying business performance. See the reconciliations of consolidated operating income (GAAP measure) to consolidated adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#8217;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of financial measures of the Company&#8217;s segments to the consolidated totals:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.478%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,645&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,859&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,952&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,328)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,756&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,812&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,286&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,328)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,636&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,831&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,855&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(555)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,569&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,133)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,525&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,728&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,133)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,616)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,865&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,273&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,704&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,616)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(860)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(387)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,058&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,249)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,008&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,635&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,002&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,249)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,713&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,443&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(672)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(337)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total revenues of the Pharmacy Services segment include approximately $3.1 billion and $2.8 billion of retail co-payments for the three months ended  June&#160;30, 2022 and 2021, respectively, and $6.9 billion and $6.2 billion of retail co-payments for the six months ended June&#160;30, 2022 and 2021, respectively.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Pharmacy Services segment, and/or the Retail/LTC segment. Intersegment adjusted operating income eliminations occur when members of Pharmacy Services Segment clients (&#8220;PSS members&#8221;) enrolled in Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> elect to pick up maintenance prescriptions at one of the Company&#8217;s retail pharmacies instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail/LTC segments record the adjusted operating income on a stand-alone basis.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are reconciliations of consolidated operating income to adjusted operating income for the three and six months ended June&#160;30, 2022 and 2021:</span></div><div style="margin-bottom:0.3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,569&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,326&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,059&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,903&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on divestiture of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal settlement </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on assets held for sale </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition purchase price adjustment outside of measurement period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,810&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,887&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,293&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,092&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the unaudited condensed consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three and six months ended June&#160;30, 2022, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of PayFlex, which the Company sold on June 1, 2022, for approximately $775&#160;million. The gain on divestiture is reflected as a reduction in operating expenses in the Company&#8217;s unaudited condensed consolidated statements of operations within the Health Care Benefits segment.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the six months ended June&#160;30, 2022, the legal settlement relates to the agreement with the State of Florida, entered into in March 2022, to resolve claims dating back more than a decade related to opioid medications. Under this agreement, CVS Health Corporation settled all opioid claims against it and its subsidiaries by the State of Florida for $484&#160;million, inclusive of certain legal fees, to be paid over a period of 18 years. The legal settlement is reflected in the unaudited condensed consolidated statement of operations in operating expenses within the Corporate/Other segment.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the six months ended June&#160;30, 2022, the loss on assets held for sale relates to the Commercial Business reporting unit within the Health Care Benefits segment. In March 2022, the Company reached an agreement to sell its Thailand business, which was included in the Commercial Business reporting unit. At that time, a portion of the Commercial Business goodwill was specifically allocated to the Thailand business. The net assets of the Thailand business were accounted for as assets held for sale at March 31, 2022. The carrying value of the Thailand business was determined to be greater than its fair value and a loss on assets held for sale was recorded during the first quarter of 2022. The sale closed in the second quarter of 2022, and the ultimate loss on the sale was not material. The loss on assets held for sale is reflected in the unaudited condensed consolidated statement of operations in operating expenses within the Health Care Benefits segment.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three and six months ended June&#160;30, 2021, acquisition-related integration costs relate to the acquisition of Aetna. The acquisition-related integration costs are reflected in the unaudited condensed consolidated statements of operations in operating expenses within the Corporate/Other segment. </span></div>(6)In June 2021, the Company received $61 million related to a purchase price working capital adjustment for an acquisition completed during the first quarter of 2020. The resolution of this matter occurred subsequent to the acquisition accounting measurement period and is reflected in the Company&#8217;s unaudited condensed consolidated statements of operations for the three and six months ended June&#160;30, 2021 as a reduction of operating expenses within the Health Care Benefits segment.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863242409344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has four reportable segments: Health Care Benefits, Pharmacy Services, Retail/LTC and Corporate/Other, which are described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment operates as one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology products and services. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221; In addition, effective January 2022, the Company entered the individual public health insurance exchanges (&#8220;Public Exchanges&#8221;) in eight states through which it sells Insured plans directly to individual consumers. The Company has submitted regulatory filings to remain on the Public Exchanges in 2023 in each of those eight states, and has submitted regulatory filings to enter the Public Exchanges in four additional states effective January 2023. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Pharmacy Services Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment provides a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services and mail order pharmacy. In addition, through the Pharmacy Services segment, the Company provides specialty pharmacy and infusion services, clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#8220;Covered Entities&#8221;). The Company operates a group purchasing organization that negotiates pricing for the purchase of pharmaceuticals and rebates with pharmaceutical manufacturers on behalf of its participants. The Company also provides various administrative, management and reporting services to pharmaceutical manufacturers. The Pharmacy Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on Public Exchanges and private health insurance exchanges, other sponsors of health benefit plans throughout the United States and Covered Entities. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, COVID-19 and shingles and conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of June&#160;30, 2022, the Retail/LTC segment operated more than 9,000 retail </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">locations, more than 1,100 MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">locations as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate/Other Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) regarding interim financial reporting. In accordance with such rules and regulations, certain information and accompanying note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) have been omitted, although the Company believes the disclosures included herein are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2021 (the &#8220;2021 Form 10-K&#8221;).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Because of the influence of various factors on the Company&#8217;s operations, including business combinations, certain holidays and other seasonal influences, net income for any interim period may not be comparable to the same interim period in previous years or necessarily indicative of income for the full year.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#8220;VIEs&#8221;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually evaluates its investments to determine if they represent variable interests in a VIE. If the Company determines that it has a variable interest in a VIE, the Company then evaluates if it is the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether the Company has the ability to direct the activities of a VIE that most significantly impact the entity&#8217;s economic performance. The Company consolidates a VIE if it is considered to be the primary beneficiary.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities of VIEs for which the Company is the primary beneficiary were not significant to the Company&#8217;s unaudited condensed consolidated financial statements. VIE creditors do not have recourse against the general credit of the Company.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform with the current year presentation.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text">Restricted CashRestricted cash included in other current assets on the unaudited condensed consolidated balance sheets represents funds held on behalf of members, including health savings account funds associated with high deductible health plans. Restricted cash included in other assets on the unaudited condensed consolidated balance sheets represents amounts held in a trust in one of the Company&#8217;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits and money market funds.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text">Accounts ReceivableAccounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy', window );">Accounts Receivable, Allowance for Credit Losses</a></td>
<td class="text">When developing an estimate of the Company&#8217;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#8217;s accounts receivable are short duration in nature and typically settle in less than 30 days.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Contract Balances</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily represent the Company&#8217;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Related Party Transactions</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in SureScripts, LLC (&#8220;SureScripts&#8221;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $16 million and $10 million in the three months ended June&#160;30, 2022 and 2021, respectively, and expensed fees for the use of this network of approximately $31 million and $19 million in the six months ended June&#160;30, 2022 and 2021, respectively. The Company&#8217;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in Heartland Healthcare Services, LLC (&#8220;Heartland&#8221;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $23 million and $19 million for pharmaceutical inventory purchases during the three months ended June&#160;30, 2022 and 2021, respectively, and $44 million and $37 million for pharmaceutical inventory purchases during the six months ended June&#160;30, 2022 and 2021, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#8217;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements Not Yet Adopted</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Insurance Contracts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the Financial Accounting Standards Board issued Accounting Standards Update 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 944). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other comprehensive income. The rate used to discount the Company&#8217;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#8217;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#8217;s interim and annual financial statements. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company will adopt the new standard on January 1, 2023, using the modified retrospective transition method as of the earliest period presented for changes to the liability for future policy benefits and deferred acquisition costs. While the Company is still evaluating the impact of the new standard on its financial statements, the Company anticipates an increase to its liability for future policy benefits with a corresponding change in accumulated other comprehensive income as a result of updating the rate used to discount the liabilities to reflect the yield for an upper-medium grade fixed-income instrument compared to the Company&#8217;s expected investment yield under the existing guidance.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5144-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863245070096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Reconciliation of cash and cash equivalents</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of cash and cash equivalents on the unaudited condensed consolidated balance sheets to total cash, cash equivalents and restricted cash on the unaudited condensed consolidated statements of cash flows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,116&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,119&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other assets)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash in the statements of cash flows</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,463&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,691&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,296&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of accounts receivable, net</a></td>
<td class="text">Accounts receivable, net is composed of the following:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,084&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor and manufacturer receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total accounts receivable, net </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,233&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,431&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of revenue</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables disaggregate the Company&#8217;s revenue by major source in each segment for the three and six months ended June 30, 2022 and 2021:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,017&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,258)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,756&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,812&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,286&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,328)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,636&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,812&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,094)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,525&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,728&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,133)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,314&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,498)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,816&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,859&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,891&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,829&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,865&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,273&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,704&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,616)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,462&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,273&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021   </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,168)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,884&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,813&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,008&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,635&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,002&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,249)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,713&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,635&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS pharmacy retail store for the same price as mail order.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#8217;s retail pharmacies under the Maintenance Choice program.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of receivables and contract liabilities from contracts with customers</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about receivables and contract liabilities from contracts with customers:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables (included in accounts receivable, net)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,084&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities (included in accrued expenses)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2022 and 2021, the contract liabilities balance includes increases related to customers&#8217; earnings in ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rewards earnings and gift card issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and breakage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863248014752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsTableTextBlock', window );">Schedule of Total Investments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total investments at June&#160;30, 2022 and December&#160;31, 2021 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.106%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.384%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities available for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,775&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,976&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,751&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,231&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,877&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,124&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,001&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,117&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,025&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,142&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Debt Securities Available For Sale</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities available for sale at June&#160;30, 2022 and December&#160;31, 2021 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.133%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.133%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.265%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Allowance<br/>for Credit<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(740)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,857&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,201&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,515)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,751&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,174&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,174&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,240&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Investment risks associated with the Company&#8217;s experience-rated products generally do not impact the Company&#8217;s consolidated operating results. At June&#160;30, 2022, debt securities with a fair value of $658 million, gross unrealized capital gains of $5 million and gross unrealized capital losses of $39 million and at December&#160;31, 2021, debt securities with a fair value of $864 million, gross unrealized capital gains of $94 million and gross unrealized capital losses of $2 million were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income (loss).</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Schedule of Net Amortized Cost and Fair Value of Debt Securities by Contractual Maturity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net amortized cost and fair value of debt securities at June&#160;30, 2022 are shown below by contractual maturity.&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.690%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.692%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,031&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,201&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,751&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock', window );">Schedule of Debt Securities In An Unrealized Capital Loss Position</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the debt securities the Company held at June&#160;30, 2022 and December&#160;31, 2021 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.244%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except number of securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,947&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,044&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,384&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,367&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,093&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,074&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,918&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,515&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,534&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,700&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,800&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,017&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,384&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity dates for debt securities in an unrealized capital loss position at June&#160;30, 2022 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.505%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.948%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting<br/>experience-rated products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting <br/>remaining products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,864&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,043&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,450&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,476&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,918&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,515&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ActivityInMortgageLoanPortfolioTableTextBlock', window );">Schedule of Activity in Mortgage Loan Portfolio</a></td>
<td class="text">During the three and six months ended June&#160;30, 2022 and 2021, the Company had the following activity in its mortgage loan portfolio:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.285%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New mortgage loans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans fully repaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans foreclosed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock', window );">Schedule of Mortgage Loan Amortized Cost and Credit Quality Indicator</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the Company&#8217;s assessments at June&#160;30, 2022 and December&#160;31, 2021, the amortized cost basis of the Company's mortgage loans within each credit quality indicator by year of origination was as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost Basis by Year of Origination</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except credit quality indicator</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">861&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeTextBlock', window );">Schedule of Net Investment Income</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sources of net investment income for the three and six months ended June&#160;30, 2022 and 2021 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.625%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.283%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross investment income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (excluding net realized capital gains or losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital gains (losses) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net realized capital losses include yield-related impairment losses on debt securities of $30 million and are shown net of the reversal of previously recorded credit-related impairment losses on debt securities of $22 million in the three months ended June&#160;30, 2022. Net realized capital losses include credit-related and yield-related impairment losses on debt securities of $16 million and $48 million, respectively, in the six months ended June&#160;30, 2022. Net realized capital gains are net of yield-related impairment losses on debt securities of $2 million and $32 million, respectively, in the three and six months ended June&#160;30, 2021. There were no credit-related losses on debt securities in the three and six months ended June&#160;30, 2021.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net investment income includes $9 million and $18 million for the three and six months ended June&#160;30, 2022, respectively, and $10 million and $19 million for the three and six months ended June&#160;30, 2021, respectively, related to investments supporting experience-rated products.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock', window );">Schedule of Proceeds and Related Gross Realized Capital Gains and Losses From the Sale of Debt Securities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding amounts related to experience-rated products, proceeds from the sale of available-for-sale debt securities and the related gross realized capital gains and losses for the three and six months ended June&#160;30, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,052&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,963&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,267&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ActivityInMortgageLoanPortfolioTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Table representing activities in mortgage loan portfolio during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ActivityInMortgageLoanPortfolioTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item includes proceeds from the sale of debt securities and the related gross realized capital gains and losses, excluding amounts related to experience-rated and discontinued products.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule detailing credit quality information related to financing receivables by credit quality indicator and by class of financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item includes total investments, both current and long-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of unrealized gains and losses on investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863248245056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text">Financial assets measured at fair value on a recurring basis on the unaudited condensed consolidated balance sheets at June&#160;30, 2022 and December&#160;31, 2021 were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,781&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,045&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,668&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,751&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,501&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,449&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,056&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,954&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,086&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,697&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,372&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,812&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,440&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,266&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,817&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Fair Value, by Balance Sheet Grouping</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the unaudited condensed consolidated balance sheets at adjusted cost or contract value at June&#160;30, 2022 and December&#160;31, 2021 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.284%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Estimated Fair Value</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,816&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,825&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,825&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div>(1)It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock', window );">Schedule of Fair Value of Separate Accounts by Major Category of Investment</a></td>
<td class="text">Separate Accounts financial assets as of June&#160;30, 2022 and December&#160;31, 2021 were as follows:<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.408%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.243%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,048&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common/collective trusts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,135&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,052&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,235&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,782&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,017&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $88 million and $70 million of other receivables at June&#160;30, 2022 and December&#160;31, 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of asset supporting separate account.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=d3e19393-158473<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124504833&amp;loc=d3e7104-158389<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422397-158474<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863243787488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Health Care Costs Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract', window );"><strong>Health Care and Other Insurance Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense', window );">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in health care costs payable during the six months ended June&#160;30, 2022 and 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,808&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,936&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of the period, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Components of incurred health care costs</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(666)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(709)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred health care costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,474&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Claims paid</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total claims paid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,703&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Premium deficiency reserve</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of the period, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,396&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,396&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,414&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div>(1)Total incurred health care costs for the six months ended June&#160;30, 2022 and 2021 in the table above exclude (i) $5 million and $5 million, respectively, for premium deficiency reserves related to the Company&#8217;s Medicaid products, (ii) $37 million and $27 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the unaudited condensed consolidated balance sheets and (iii) $221 million and $99 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the unaudited condensed consolidated balance sheets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Health Care and Other Insurance Liabilities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_HealthCareandOtherInsuranceLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863243793296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Summary of Company's Borrowings</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s borrowings at June&#160;30, 2022 and December&#160;31, 2021: </span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.451%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5% senior notes due July 2022</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.75% senior notes due November 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.75% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.75% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8% senior notes due June 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4% senior notes due December 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.375% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.625% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5% senior notes due November 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5% senior notes due December 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1% senior notes due March 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.875% senior notes due July 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.875% senior notes due June 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3% senior notes due August 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.625% senior notes due April 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.25% senior notes due June 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3% senior notes due August 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3% senior notes due March 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.25% senior notes due August 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.75% senior notes due April 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.75% senior notes due August 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.875% senior notes due February 2031</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.125% senior notes due September 2031</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.875% senior notes due July 2035</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.625% senior notes due June 2036</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.75% senior notes due December 2037</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.78% senior notes due March 2038</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.125% senior notes due September 2039</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.125% senior notes due April 2040</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7% senior notes due August 2040</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.75% senior notes due May 2041</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5% senior notes due May 2042</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.125% senior notes due November 2042</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.3% senior notes due December 2043</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.75% senior notes due March 2044</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.125% senior notes due July 2045</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.875% senior notes due August 2047</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.05% senior notes due March 2048</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.25% senior notes due April 2050</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81Mi0wLTEtMS0xMzcyNzU_6dc679d2-e622-45de-819a-6f36bb88bc8b"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81Mi0wLTEtMS0xMzcyNzU_7cf3c139-629e-4185-b686-0b6e8760e74e">Finance lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt principal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,743&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt discounts and deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(740)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(786)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,816&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,176&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,019)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,205)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,797&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,971&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863243933520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock', window );">Share repurchase programs</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following share repurchase program has been authorized by CVS Health Corporation&#8217;s Board of Directors (the &#8220;Board&#8221;):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In billions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Authorization&#160;Date</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Authorized</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Remaining as of<br/>June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 9, 2021 (&#8220;2021 Repurchase Program&#8221;)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23309-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTreasuryStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863243933520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders&#8217; equity included the following activity in accumulated other comprehensive income (loss) for the three and six months ended June&#160;30, 2022 and 2021:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net unrealized investment gains (losses):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(377)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$(1,105), $214, $(2,510), $(273) pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(868)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,098)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($77, $(18), $154, $(1) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(813)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,968)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,190)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,190)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($24, $0, $24, $0 pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(4), $(4), $(8), $(9) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension and other postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($1, $1, $1, $1 pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total beginning of period accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(190)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(798)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,953)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(244)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total end of period accumulated other comprehensive income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(988)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,170&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(988)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,170&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income (loss) for specifically identified debt securities are included in net investment income in the unaudited condensed consolidated statements of operations.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included in interest expense in the unaudited condensed consolidated statements of operations. The Company expects to reclassify approximately&#160;$11 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.</span></div>(3)Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the unaudited condensed consolidated statements of operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863243763696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of basic and diluted earnings per share for the respective periods:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units and performance stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and stock appreciation rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,321&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,327&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863242923840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Summarized Financial Information Of Segments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of financial measures of the Company&#8217;s segments to the consolidated totals:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.478%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,645&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,859&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,952&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,328)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,756&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,812&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,286&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,328)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,636&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,831&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,855&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(555)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,569&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,133)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,525&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,728&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,133)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,616)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,865&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,273&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,704&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,616)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(860)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(387)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,058&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,249)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,008&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,635&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,002&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,249)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,713&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,443&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(672)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(337)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total revenues of the Pharmacy Services segment include approximately $3.1 billion and $2.8 billion of retail co-payments for the three months ended  June&#160;30, 2022 and 2021, respectively, and $6.9 billion and $6.2 billion of retail co-payments for the six months ended June&#160;30, 2022 and 2021, respectively.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Pharmacy Services segment, and/or the Retail/LTC segment. Intersegment adjusted operating income eliminations occur when members of Pharmacy Services Segment clients (&#8220;PSS members&#8221;) enrolled in Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> elect to pick up maintenance prescriptions at one of the Company&#8217;s retail pharmacies instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail/LTC segments record the adjusted operating income on a stand-alone basis.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ReconciliationOfOperatingIncomeToAdjustedOperatingIncomeTableTextBlock', window );">Reconciliation of Consolidated Operating Income to Adjusted Operating Income</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are reconciliations of consolidated operating income to adjusted operating income for the three and six months ended June&#160;30, 2022 and 2021:</span></div><div style="margin-bottom:0.3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,569&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,326&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,059&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,903&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on divestiture of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal settlement </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on assets held for sale </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition purchase price adjustment outside of measurement period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,810&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,887&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,293&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,092&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the unaudited condensed consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three and six months ended June&#160;30, 2022, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of PayFlex, which the Company sold on June 1, 2022, for approximately $775&#160;million. The gain on divestiture is reflected as a reduction in operating expenses in the Company&#8217;s unaudited condensed consolidated statements of operations within the Health Care Benefits segment.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the six months ended June&#160;30, 2022, the legal settlement relates to the agreement with the State of Florida, entered into in March 2022, to resolve claims dating back more than a decade related to opioid medications. Under this agreement, CVS Health Corporation settled all opioid claims against it and its subsidiaries by the State of Florida for $484&#160;million, inclusive of certain legal fees, to be paid over a period of 18 years. The legal settlement is reflected in the unaudited condensed consolidated statement of operations in operating expenses within the Corporate/Other segment.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the six months ended June&#160;30, 2022, the loss on assets held for sale relates to the Commercial Business reporting unit within the Health Care Benefits segment. In March 2022, the Company reached an agreement to sell its Thailand business, which was included in the Commercial Business reporting unit. At that time, a portion of the Commercial Business goodwill was specifically allocated to the Thailand business. The net assets of the Thailand business were accounted for as assets held for sale at March 31, 2022. The carrying value of the Thailand business was determined to be greater than its fair value and a loss on assets held for sale was recorded during the first quarter of 2022. The sale closed in the second quarter of 2022, and the ultimate loss on the sale was not material. The loss on assets held for sale is reflected in the unaudited condensed consolidated statement of operations in operating expenses within the Health Care Benefits segment.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three and six months ended June&#160;30, 2021, acquisition-related integration costs relate to the acquisition of Aetna. The acquisition-related integration costs are reflected in the unaudited condensed consolidated statements of operations in operating expenses within the Corporate/Other segment. </span></div>(6)In June 2021, the Company received $61 million related to a purchase price working capital adjustment for an acquisition completed during the first quarter of 2020. The resolution of this matter occurred subsequent to the acquisition accounting measurement period and is reflected in the Company&#8217;s unaudited condensed consolidated statements of operations for the three and six months ended June&#160;30, 2021 as a reduction of operating expenses within the Health Care Benefits segment.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ReconciliationOfOperatingIncomeToAdjustedOperatingIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reconciliation of Operating Income to Adjusted Operating Income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ReconciliationOfOperatingIncomeToAdjustedOperatingIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863242481184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Narrative (Details)<br> people in Millions, patient in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2023 </div>
<div>state</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>people </div>
<div>state </div>
<div>clinic </div>
<div>store </div>
<div>patient</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>people </div>
<div>state </div>
<div>clinic </div>
<div>Segment </div>
<div>store </div>
<div>patient</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberofPharmacyPlanMembers', window );">Number of pharmacy plan members | people</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberofPatientsServedperYear', window );">Number of patients served per year | patient</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Expenses from transactions with related party | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty', window );">Other revenues from transactions with related party | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvs_HeartlandHealthcareServicesMember', window );">Heartland Healthcare Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStatesInWhichEntityOperates', window );">Number of states in which entity operates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Number of retail locations (more than) | store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberofWalkInMedicalClinics', window );">Number of walk in medical clinics | clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberOfPeopleServed', window );">Number of people served | people</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates', window );">Number of states in which the Company has entered the individual public health insurance exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfAdditionalStates', window );">Additional number of states in which the Company has entered the individual public health insurance exchange</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfAdditionalStates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Individual Public Health Insurance Exchanges, Submitted Regulatory Filings, Number of Additional States</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfAdditionalStates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Individual Public Health Insurance Exchanges, Submitted Regulatory Filings, Number of States</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberOfPeopleServed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of People Served</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberOfPeopleServed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberofPatientsServedperYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Patients Served per Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberofPatientsServedperYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberofPharmacyPlanMembers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Pharmacy Plan Members</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberofPharmacyPlanMembers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberofWalkInMedicalClinics">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Walk In Medical Clinics</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberofWalkInMedicalClinics</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStatesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of states the entity operates in as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStatesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStores">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of stores.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStores</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the sum of all other revenue and income realized from sales and other transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvs_HeartlandHealthcareServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvs_HeartlandHealthcareServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863242466864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 12,116<span></span>
</td>
<td class="nump">$ 9,408<span></span>
</td>
<td class="nump">$ 7,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash (included in other current assets)</a></td>
<td class="nump">131<span></span>
</td>
<td class="nump">3,065<span></span>
</td>
<td class="nump">2,959<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash (included in other assets)</a></td>
<td class="nump">216<span></span>
</td>
<td class="nump">218<span></span>
</td>
<td class="nump">218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash in the statements of cash flows</a></td>
<td class="nump">$ 12,463<span></span>
</td>
<td class="nump">$ 12,691<span></span>
</td>
<td class="nump">$ 10,296<span></span>
</td>
<td class="nump">$ 11,043<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863242369792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Accounts Receivable (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Trade receivables</a></td>
<td class="nump">$ 9,084<span></span>
</td>
<td class="nump">$ 7,932<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_VendorandManufacturerReceivables', window );">Vendor and manufacturer receivables</a></td>
<td class="nump">12,242<span></span>
</td>
<td class="nump">10,573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsReceivableAtCarryingValue', window );">Premium receivables</a></td>
<td class="nump">3,399<span></span>
</td>
<td class="nump">2,537<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">2,508<span></span>
</td>
<td class="nump">3,389<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Total accounts receivable, net</a></td>
<td class="nump">27,233<span></span>
</td>
<td class="nump">24,431<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for credit losses</a></td>
<td class="nump">$ 340<span></span>
</td>
<td class="nump">$ 339<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_VendorandManufacturerReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Vendor and Manufacturer Receivables</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_VendorandManufacturerReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsReceivableAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date due the entity from (a) agents and insureds, (b) uncollected premiums and (c) others, net of the allowance for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),5)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsReceivableAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863237196848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 80,490<span></span>
</td>
<td class="nump">$ 72,327<span></span>
</td>
<td class="nump">$ 157,148<span></span>
</td>
<td class="nump">$ 141,127<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">289<span></span>
</td>
<td class="nump">314<span></span>
</td>
<td class="nump">586<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">80,636<span></span>
</td>
<td class="nump">72,616<span></span>
</td>
<td class="nump">157,462<span></span>
</td>
<td class="nump">141,713<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_PharmacyRevenueMember', window );">Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">51,326<span></span>
</td>
<td class="nump">45,932<span></span>
</td>
<td class="nump">98,816<span></span>
</td>
<td class="nump">88,884<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_FrontStoreRevenueMember', window );">Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">5,736<span></span>
</td>
<td class="nump">5,254<span></span>
</td>
<td class="nump">11,049<span></span>
</td>
<td class="nump">9,896<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_PremiumsMember', window );">Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">21,260<span></span>
</td>
<td class="nump">18,983<span></span>
</td>
<td class="nump">42,891<span></span>
</td>
<td class="nump">37,943<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">2,168<span></span>
</td>
<td class="nump">2,158<span></span>
</td>
<td class="nump">4,392<span></span>
</td>
<td class="nump">4,404<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">22,756<span></span>
</td>
<td class="nump">20,525<span></span>
</td>
<td class="nump">45,865<span></span>
</td>
<td class="nump">41,008<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember', window );">Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">42,812<span></span>
</td>
<td class="nump">38,314<span></span>
</td>
<td class="nump">82,273<span></span>
</td>
<td class="nump">74,635<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">26,286<span></span>
</td>
<td class="nump">24,728<span></span>
</td>
<td class="nump">51,704<span></span>
</td>
<td class="nump">48,002<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">22,645<span></span>
</td>
<td class="nump">20,367<span></span>
</td>
<td class="nump">45,642<span></span>
</td>
<td class="nump">40,682<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">137<span></span>
</td>
<td class="nump">177<span></span>
</td>
<td class="nump">285<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">22,756<span></span>
</td>
<td class="nump">20,525<span></span>
</td>
<td class="nump">45,865<span></span>
</td>
<td class="nump">41,008<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">21,245<span></span>
</td>
<td class="nump">18,968<span></span>
</td>
<td class="nump">42,859<span></span>
</td>
<td class="nump">37,910<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">1,423<span></span>
</td>
<td class="nump">1,420<span></span>
</td>
<td class="nump">2,829<span></span>
</td>
<td class="nump">2,813<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">39,859<span></span>
</td>
<td class="nump">35,745<span></span>
</td>
<td class="nump">76,055<span></span>
</td>
<td class="nump">69,058<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">42,812<span></span>
</td>
<td class="nump">38,314<span></span>
</td>
<td class="nump">82,273<span></span>
</td>
<td class="nump">74,635<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Pharmacy network</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">24,537<span></span>
</td>
<td class="nump">22,918<span></span>
</td>
<td class="nump">47,361<span></span>
</td>
<td class="nump">44,811<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Mail choice</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">18,030<span></span>
</td>
<td class="nump">15,235<span></span>
</td>
<td class="nump">34,404<span></span>
</td>
<td class="nump">29,483<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">245<span></span>
</td>
<td class="nump">161<span></span>
</td>
<td class="nump">508<span></span>
</td>
<td class="nump">341<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">42,567<span></span>
</td>
<td class="nump">38,153<span></span>
</td>
<td class="nump">81,765<span></span>
</td>
<td class="nump">74,294<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">245<span></span>
</td>
<td class="nump">161<span></span>
</td>
<td class="nump">508<span></span>
</td>
<td class="nump">341<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">17,952<span></span>
</td>
<td class="nump">16,185<span></span>
</td>
<td class="nump">35,386<span></span>
</td>
<td class="nump">31,325<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="num">(18)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">26,286<span></span>
</td>
<td class="nump">24,728<span></span>
</td>
<td class="nump">51,704<span></span>
</td>
<td class="nump">48,002<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">20,017<span></span>
</td>
<td class="nump">18,873<span></span>
</td>
<td class="nump">39,549<span></span>
</td>
<td class="nump">36,758<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">5,736<span></span>
</td>
<td class="nump">5,254<span></span>
</td>
<td class="nump">11,049<span></span>
</td>
<td class="nump">9,896<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">551<span></span>
</td>
<td class="nump">601<span></span>
</td>
<td class="nump">1,140<span></span>
</td>
<td class="nump">1,302<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="nump">171<span></span>
</td>
<td class="nump">255<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">110<span></span>
</td>
<td class="nump">182<span></span>
</td>
<td class="nump">236<span></span>
</td>
<td class="nump">317<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(11,328)<span></span>
</td>
<td class="num">(11,133)<span></span>
</td>
<td class="num">(22,616)<span></span>
</td>
<td class="num">(22,249)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="num">(11,258)<span></span>
</td>
<td class="num">(11,094)<span></span>
</td>
<td class="num">(22,498)<span></span>
</td>
<td class="num">(22,168)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="num">$ (70)<span></span>
</td>
<td class="num">$ (39)<span></span>
</td>
<td class="num">$ (118)<span></span>
</td>
<td class="num">$ (81)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_PharmacyRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_PharmacyRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_FrontStoreRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_FrontStoreRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_PremiumsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_PremiumsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=cvs_SalesChannelOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=cvs_SalesChannelOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863242407104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Receivables and Contracted Balances (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Trade receivables (included in accounts receivable, net)</a></td>
<td class="nump">$ 9,084<span></span>
</td>
<td class="nump">$ 7,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities (included in accrued expenses)</a></td>
<td class="nump">$ 80<span></span>
</td>
<td class="nump">$ 87<span></span>
</td>
<td class="nump">$ 79<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863245654592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Contract Balances (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ChangeinContractwithCustomerLiabilityRollForward', window );"><strong>Change in Contract with Customer, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities, beginning of the period</a></td>
<td class="nump">$ 87<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance', window );">Rewards earnings and gift card issuances</a></td>
<td class="nump">175<span></span>
</td>
<td class="nump">183<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ContractwithCustomerLiabilityRedemptionandBreakage', window );">Redemption and breakage</a></td>
<td class="num">(182)<span></span>
</td>
<td class="num">(175)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities, end of the period</a></td>
<td class="nump">$ 80<span></span>
</td>
<td class="nump">$ 79<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ChangeinContractwithCustomerLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in Contract with Customer, Liability [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ChangeinContractwithCustomerLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in contract liability recognized for loyalty program earnings and gift card issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ContractwithCustomerLiabilityRedemptionandBreakage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract with Customer Liability Redemption and Breakage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ContractwithCustomerLiabilityRedemptionandBreakage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863238100912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Divestitures and Asset Sales (Details)<br> member in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 01, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>member</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2022 </div>
<div>member</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (loss) on divestiture, pretax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 225<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Loss on assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | Payflex | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestiture of subsidiary</a></td>
<td class="nump">$ 775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (loss) on divestiture, pretax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | Thailand Business | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberOfMedicalMembers', window );">Number of medical members | member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Loss on assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | International Health Care Renewal Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold', window );">Number of international health care members, renewal rights sold | member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DisposalGroupNotDiscontinuedOperationMigrationPeriod', window );">Member migration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">16 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DisposalGroupNotDiscontinuedOperationMigrationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Not Discontinued Operation, Migration Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DisposalGroupNotDiscontinuedOperationMigrationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Not Discontinued Operation, Number of International Health Care Members, Renewal Rights Sold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberOfMedicalMembers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Medical Members</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberOfMedicalMembers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_PayflexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_PayflexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_ThailandBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_ThailandBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_InternationalHealthCareRenewalRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_InternationalHealthCareRenewalRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863237787632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Total Investment Schedule (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current</a></td>
<td class="nump">$ 2,877<span></span>
</td>
<td class="nump">$ 3,117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term</a></td>
<td class="nump">21,124<span></span>
</td>
<td class="nump">23,025<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Total</a></td>
<td class="nump">24,001<span></span>
</td>
<td class="nump">26,142<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsAxis=cvs_DebtAndEquitySecuritiesAvailableForSaleMember', window );">Debt securities available for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current</a></td>
<td class="nump">2,775<span></span>
</td>
<td class="nump">3,009<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term</a></td>
<td class="nump">17,976<span></span>
</td>
<td class="nump">20,231<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Total</a></td>
<td class="nump">20,751<span></span>
</td>
<td class="nump">23,240<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsAxis=cvs_MortgageLoansMember', window );">Mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term</a></td>
<td class="nump">905<span></span>
</td>
<td class="nump">844<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Total</a></td>
<td class="nump">993<span></span>
</td>
<td class="nump">902<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsAxis=us-gaap_OtherInvestmentsMember', window );">Other investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term</a></td>
<td class="nump">2,243<span></span>
</td>
<td class="nump">1,950<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Total</a></td>
<td class="nump">$ 2,257<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsAxis=cvs_DebtAndEquitySecuritiesAvailableForSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsAxis=cvs_DebtAndEquitySecuritiesAvailableForSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsAxis=cvs_MortgageLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsAxis=cvs_MortgageLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863241872992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Debt Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">$ 22,209<span></span>
</td>
<td class="nump">$ 22,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="num">(8)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">22,201<span></span>
</td>
<td class="nump">22,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">1,172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1,515)<span></span>
</td>
<td class="num">(106)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">20,751<span></span>
</td>
<td class="nump">23,240<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience-rated products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(39)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">658<span></span>
</td>
<td class="nump">864<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">2,194<span></span>
</td>
<td class="nump">2,349<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">2,194<span></span>
</td>
<td class="nump">2,349<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(118)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2,078<span></span>
</td>
<td class="nump">2,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, municipalities and political subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">2,472<span></span>
</td>
<td class="nump">2,947<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">2,472<span></span>
</td>
<td class="nump">2,947<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(110)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2,373<span></span>
</td>
<td class="nump">3,091<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">9,910<span></span>
</td>
<td class="nump">9,093<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">9,910<span></span>
</td>
<td class="nump">9,093<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">682<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(740)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">9,199<span></span>
</td>
<td class="nump">9,735<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember', window );">Foreign securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">2,857<span></span>
</td>
<td class="nump">2,821<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="num">(8)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">2,849<span></span>
</td>
<td class="nump">2,821<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">196<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(236)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2,631<span></span>
</td>
<td class="nump">2,993<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">808<span></span>
</td>
<td class="nump">870<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">808<span></span>
</td>
<td class="nump">870<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(61)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">747<span></span>
</td>
<td class="nump">875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">1,222<span></span>
</td>
<td class="nump">1,278<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">1,222<span></span>
</td>
<td class="nump">1,278<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(114)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">1,108<span></span>
</td>
<td class="nump">1,310<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">2,721<span></span>
</td>
<td class="nump">2,791<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">2,721<span></span>
</td>
<td class="nump">2,791<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(135)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2,591<span></span>
</td>
<td class="nump">2,792<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable preferred securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863237174400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Debt Securities by Maturity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Net Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Less than one year</a></td>
<td class="nump">$ 1,221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">One year through five years</a></td>
<td class="nump">6,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost', window );">After five years through ten years</a></td>
<td class="nump">5,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost', window );">Greater than ten years</a></td>
<td class="nump">4,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">22,201<span></span>
</td>
<td class="nump">$ 22,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Less than one year</a></td>
<td class="nump">1,221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">One year through five years</a></td>
<td class="nump">6,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">After five years through ten years</a></td>
<td class="nump">4,559<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Greater than ten years</a></td>
<td class="nump">4,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">20,751<span></span>
</td>
<td class="nump">23,240<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Net Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">808<span></span>
</td>
<td class="nump">870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">747<span></span>
</td>
<td class="nump">875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Net Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">1,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">1,222<span></span>
</td>
<td class="nump">1,278<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">1,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">1,108<span></span>
</td>
<td class="nump">1,310<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Net Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">2,721<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">2,721<span></span>
</td>
<td class="nump">2,791<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">2,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">$ 2,591<span></span>
</td>
<td class="nump">$ 2,792<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863245371360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Unrealized Loss Position (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>security</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>security</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">10,384<span></span>
</td>
<td class="nump">3,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">690<span></span>
</td>
<td class="nump">317<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">11,074<span></span>
</td>
<td class="nump">4,017<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 15,825<span></span>
</td>
<td class="nump">$ 6,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">1,093<span></span>
</td>
<td class="nump">584<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">16,918<span></span>
</td>
<td class="nump">7,384<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">1,367<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">148<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 1,515<span></span>
</td>
<td class="nump">$ 106<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">464<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">476<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 1,616<span></span>
</td>
<td class="nump">$ 242<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">1,674<span></span>
</td>
<td class="nump">282<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">115<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 118<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, municipalities and political subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">875<span></span>
</td>
<td class="nump">233<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">902<span></span>
</td>
<td class="nump">246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 1,372<span></span>
</td>
<td class="nump">$ 428<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">1,427<span></span>
</td>
<td class="nump">461<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 110<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">5,583<span></span>
</td>
<td class="nump">1,610<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">364<span></span>
</td>
<td class="nump">165<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">5,947<span></span>
</td>
<td class="nump">1,775<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 6,989<span></span>
</td>
<td class="nump">$ 2,296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">508<span></span>
</td>
<td class="nump">238<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">7,497<span></span>
</td>
<td class="nump">2,534<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">674<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 740<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember', window );">Foreign securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">1,304<span></span>
</td>
<td class="nump">449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">1,423<span></span>
</td>
<td class="nump">506<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 1,872<span></span>
</td>
<td class="nump">$ 747<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">172<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">2,044<span></span>
</td>
<td class="nump">838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 236<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">388<span></span>
</td>
<td class="nump">165<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">411<span></span>
</td>
<td class="nump">175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 644<span></span>
</td>
<td class="nump">$ 593<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">709<span></span>
</td>
<td class="nump">629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 61<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">436<span></span>
</td>
<td class="nump">188<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">489<span></span>
</td>
<td class="nump">223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 955<span></span>
</td>
<td class="nump">$ 462<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">118<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">1,073<span></span>
</td>
<td class="nump">574<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">91<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 114<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">1,324<span></span>
</td>
<td class="nump">1,011<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">91<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">1,415<span></span>
</td>
<td class="nump">1,037<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 2,358<span></span>
</td>
<td class="nump">$ 2,030<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">114<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">2,472<span></span>
</td>
<td class="nump">2,061<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">126<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 135<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable preferred securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863237863680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Unrealized Loss Position Maturities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear', window );">Less than one year</a></td>
<td class="nump">$ 445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears', window );">One year through five years</a></td>
<td class="nump">5,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears', window );">After five years through ten years</a></td>
<td class="nump">3,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears', window );">Greater than ten years</a></td>
<td class="nump">3,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">16,918<span></span>
</td>
<td class="nump">$ 7,384<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss', window );">Less than one year</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss', window );">One year through five years</a></td>
<td class="nump">322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss', window );">After five years through ten years</a></td>
<td class="nump">486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss', window );">Greater than ten years</a></td>
<td class="nump">392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">1,515<span></span>
</td>
<td class="nump">106<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">709<span></span>
</td>
<td class="nump">629<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">1,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">1,073<span></span>
</td>
<td class="nump">574<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">114<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">2,472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">2,472<span></span>
</td>
<td class="nump">2,061<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">135<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience-rated products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear', window );">Less than one year</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears', window );">One year through five years</a></td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears', window );">After five years through ten years</a></td>
<td class="nump">151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears', window );">Greater than ten years</a></td>
<td class="nump">196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss', window );">Less than one year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss', window );">One year through five years</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss', window );">After five years through ten years</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss', window );">Greater than ten years</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience-rated products | Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience-rated products | Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience-rated products | Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear', window );">Less than one year</a></td>
<td class="nump">438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears', window );">One year through five years</a></td>
<td class="nump">5,062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears', window );">After five years through ten years</a></td>
<td class="nump">3,713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears', window );">Greater than ten years</a></td>
<td class="nump">3,043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">16,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss', window );">Less than one year</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss', window );">One year through five years</a></td>
<td class="nump">320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss', window );">After five years through ten years</a></td>
<td class="nump">471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss', window );">Greater than ten years</a></td>
<td class="nump">374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">1,476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products | Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products | Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">1,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products | Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">2,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">$ 134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863244884080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Mortgage Loans (Details) - Commercial Real Estate - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans', window );">New mortgage loans</a></td>
<td class="nump">$ 121<span></span>
</td>
<td class="nump">$ 73<span></span>
</td>
<td class="nump">$ 180<span></span>
</td>
<td class="nump">$ 120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateLoansFullyRepaid', window );">Mortgage loans fully repaid</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="nump">172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstateForeclosures', window );">Mortgage loans foreclosed</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateLoansFullyRepaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pertains to amount of mortgage loans fully repaid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateLoansFullyRepaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoansOnRealEstateForeclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from foreclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 948<br> -SubTopic 310<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-29(Footnote 6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120402547&amp;loc=d3e617274-123014<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoansOnRealEstateForeclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from new investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 948<br> -SubTopic 310<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-29(Footnote 6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120402547&amp;loc=d3e617274-123014<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoansOnRealEstateNewMortgageLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863241918224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Mortgage Loans Credit Ratings Indicator (Details) - Commercial Real Estate - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">$ 993<span></span>
</td>
<td class="nump">$ 902<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">963<span></span>
</td>
<td class="nump">861<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2022 | 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2022 | 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2022 | 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2022 | 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">250<span></span>
</td>
<td class="nump">255<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2021 | 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2021 | 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">250<span></span>
</td>
<td class="nump">255<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2021 | 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2021 | 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2020 | 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2020 | 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2020 | 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2020 | 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2019 | 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2019 | 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2019 | 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2019 | 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2018 | 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2018 | 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2018 | 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2018 | 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">Prior</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">445<span></span>
</td>
<td class="nump">484<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">Prior | 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">Prior | 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">418<span></span>
</td>
<td class="nump">446<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">Prior | 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">Prior | 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoansOnRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 948<br> -SubTopic 310<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-29(Column G))<br> -URI https://asc.fasb.org/extlink&amp;oid=120402547&amp;loc=d3e617274-123014<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoansOnRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category2To4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category2To4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Categories5and6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Categories5and6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category7Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category7Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPriorToPeriodFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPriorToPeriodFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863237777168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Net Investment Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">$ 253<span></span>
</td>
<td class="nump">$ 285<span></span>
</td>
<td class="nump">$ 505<span></span>
</td>
<td class="nump">$ 543<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInvestmentExpense', window );">Investment expenses</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentIncomeExcludingCapitalGainsorLosses', window );">Net investment income (excluding net realized capital gains or losses)</a></td>
<td class="nump">244<span></span>
</td>
<td class="nump">276<span></span>
</td>
<td class="nump">487<span></span>
</td>
<td class="nump">526<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealizedInvestmentGainsLosses', window );">Net realized capital gains (losses)</a></td>
<td class="num">(98)<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="num">(173)<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Net investment income</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">289<span></span>
</td>
<td class="nump">314<span></span>
</td>
<td class="nump">586<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings', window );">Credit-related impairment loss</a></td>
<td class="num">(22)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings', window );">Yield-related impairment loss</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience-rated products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Net investment income</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember', window );">Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">172<span></span>
</td>
<td class="nump">160<span></span>
</td>
<td class="nump">336<span></span>
</td>
<td class="nump">317<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=cvs_MortgageLoansMember', window );">Mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember', window );">Other investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">$ 68<span></span>
</td>
<td class="nump">$ 112<span></span>
</td>
<td class="nump">$ 145<span></span>
</td>
<td class="nump">$ 198<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Credit-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_InvestmentIncomeExcludingCapitalGainsorLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment Income, Excluding Capital Gains or Losses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_InvestmentIncomeExcludingCapitalGainsorLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Yield-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInvestmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses related to the generation of investment income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInvestmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedInvestmentGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.3(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedInvestmentGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=cvs_MortgageLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=cvs_MortgageLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863239386064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Realized Gains (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Proceeds from sales</a></td>
<td class="nump">$ 1,052<span></span>
</td>
<td class="nump">$ 919<span></span>
</td>
<td class="nump">$ 2,963<span></span>
</td>
<td class="nump">$ 2,267<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain', window );">Gross realized capital gains</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss', window );">Gross realized capital losses</a></td>
<td class="nump">$ 72<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 107<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863236596064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Measurement on a Recurring Basis (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">$ 20,751<span></span>
</td>
<td class="nump">$ 23,240<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,078<span></span>
</td>
<td class="nump">2,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, municipalities and political subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,373<span></span>
</td>
<td class="nump">3,091<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">9,199<span></span>
</td>
<td class="nump">9,735<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember', window );">Foreign securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,631<span></span>
</td>
<td class="nump">2,993<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">747<span></span>
</td>
<td class="nump">875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,108<span></span>
</td>
<td class="nump">1,310<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,591<span></span>
</td>
<td class="nump">2,792<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable preferred securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">12,116<span></span>
</td>
<td class="nump">9,408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">20,751<span></span>
</td>
<td class="nump">23,240<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">189<span></span>
</td>
<td class="nump">169<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">33,056<span></span>
</td>
<td class="nump">32,817<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">7,335<span></span>
</td>
<td class="nump">4,954<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,045<span></span>
</td>
<td class="nump">2,372<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">121<span></span>
</td>
<td class="nump">114<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">9,501<span></span>
</td>
<td class="nump">7,440<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">4,781<span></span>
</td>
<td class="nump">4,454<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">18,668<span></span>
</td>
<td class="nump">20,812<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">23,449<span></span>
</td>
<td class="nump">25,266<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">106<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,078<span></span>
</td>
<td class="nump">2,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. government securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,045<span></span>
</td>
<td class="nump">2,372<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. government securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. government securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | States, municipalities and political subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,373<span></span>
</td>
<td class="nump">3,091<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | States, municipalities and political subdivisions | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | States, municipalities and political subdivisions | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,373<span></span>
</td>
<td class="nump">3,086<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | States, municipalities and political subdivisions | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">9,199<span></span>
</td>
<td class="nump">9,735<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. corporate securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. corporate securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">9,169<span></span>
</td>
<td class="nump">9,697<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. corporate securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Foreign securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,631<span></span>
</td>
<td class="nump">2,993<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Foreign securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Foreign securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,623<span></span>
</td>
<td class="nump">2,983<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Foreign securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">747<span></span>
</td>
<td class="nump">875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Residential mortgage-backed securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Residential mortgage-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">747<span></span>
</td>
<td class="nump">875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Residential mortgage-backed securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,108<span></span>
</td>
<td class="nump">1,310<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Commercial mortgage-backed securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Commercial mortgage-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,108<span></span>
</td>
<td class="nump">1,310<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Commercial mortgage-backed securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,591<span></span>
</td>
<td class="nump">2,792<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other asset-backed securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other asset-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,591<span></span>
</td>
<td class="nump">2,789<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other asset-backed securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Redeemable preferred securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Redeemable preferred securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Redeemable preferred securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Redeemable preferred securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863238129120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3', window );">Transfers out of Level 3</a></td>
<td class="nump">$ 26<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3', window );">Transfers into Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863237599760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Carrying Value and Fair Value Classified by Level (Details) - Nonrecurring - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">$ 993<span></span>
</td>
<td class="nump">$ 902<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity securities</a></td>
<td class="nump">183<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities with a fixed maturity</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities without a fixed maturity</a></td>
<td class="nump">333<span></span>
</td>
<td class="nump">336<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">54,816<span></span>
</td>
<td class="nump">56,176<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">940<span></span>
</td>
<td class="nump">907<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities with a fixed maturity</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities without a fixed maturity</a></td>
<td class="nump">317<span></span>
</td>
<td class="nump">373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">51,825<span></span>
</td>
<td class="nump">64,157<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Level 1 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities with a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities without a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">51,825<span></span>
</td>
<td class="nump">64,157<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Level 2 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities with a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities without a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Level 3 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">940<span></span>
</td>
<td class="nump">907<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities with a fixed maturity</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities without a fixed maturity</a></td>
<td class="nump">317<span></span>
</td>
<td class="nump">373<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment Contracts With Fixed Maturity, Fair Value Disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment Contracts Without A Fixed Maturity, Fair Value Disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of mortgage loans held-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgagesHeldForSaleFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863238176960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Separate Accounts Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">$ 4,140<span></span>
</td>
<td class="nump">$ 5,087<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">4,052<span></span>
</td>
<td class="nump">5,017<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other Receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">182<span></span>
</td>
<td class="nump">188<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">3,448<span></span>
</td>
<td class="nump">4,281<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Common/collective trusts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">421<span></span>
</td>
<td class="nump">547<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">917<span></span>
</td>
<td class="nump">1,235<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">913<span></span>
</td>
<td class="nump">1,233<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Common/collective trusts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">3,135<span></span>
</td>
<td class="nump">3,782<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">178<span></span>
</td>
<td class="nump">186<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">2,535<span></span>
</td>
<td class="nump">3,048<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Common/collective trusts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">421<span></span>
</td>
<td class="nump">547<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Common/collective trusts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset at fair value held for benefit of separate account policyholder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=d3e19393-158473<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422397-158474<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=cvs_OtherReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=cvs_OtherReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=cvs_CommonAndCollectiveTrustsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=cvs_CommonAndCollectiveTrustsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863237764096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract', window );"><strong>Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable, beginning of the period, net</a></td>
<td class="nump">$ 8,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable, end of the period, net</a></td>
<td class="nump">10,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts', window );">Benefit costs recorded in other insurance liabilities</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_CorporateOtherMember', window );">Corporate / Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts', window );">Benefit costs recorded in other insurance liabilities</a></td>
<td class="nump">221<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember', window );">Health Insurance Product Line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract', window );"><strong>Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Health care costs payable, beginning of the period</a></td>
<td class="nump">8,808<span></span>
</td>
<td class="nump">7,936<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Less: Reinsurance recoverables</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable, beginning of the period, net</a></td>
<td class="nump">8,800<span></span>
</td>
<td class="nump">7,926<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract', window );"><strong>Add: Components of incurred health care costs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense', window );">Current year</a></td>
<td class="nump">35,960<span></span>
</td>
<td class="nump">32,183<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Prior years</a></td>
<td class="num">(666)<span></span>
</td>
<td class="num">(709)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Total incurred health care costs</a></td>
<td class="nump">35,294<span></span>
</td>
<td class="nump">31,474<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1', window );">Current year</a></td>
<td class="nump">26,971<span></span>
</td>
<td class="nump">24,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1', window );">Prior years</a></td>
<td class="nump">6,732<span></span>
</td>
<td class="nump">6,409<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense', window );">Total claims paid</a></td>
<td class="nump">33,703<span></span>
</td>
<td class="nump">31,009<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumDeficiencyReserveLiability', window );">Add: Premium deficiency reserve</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable, end of the period, net</a></td>
<td class="nump">10,396<span></span>
</td>
<td class="nump">8,396<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Add: Reinsurance recoverables</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Health care costs payable, end of the period</a></td>
<td class="nump">10,400<span></span>
</td>
<td class="nump">8,414<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumDeficiencyReserveLiability', window );">Premium deficiency reserve</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PremiumDeficiencyReserveLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of reserves related to expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), in excess of existing reserves plus anticipated future premiums and reinsurance recoveries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PremiumDeficiencyReserveLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(13)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLossesAndLossAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21412-158489<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6824-158387<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_CorporateOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_CorporateOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863237574768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Health Care Costs Payable - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet', window );">Incurred but not reported (IBNR) claims liability, net</a></td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember', window );">Health Insurance Product Line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Decrease in prior years' healthcare costs payable</a></td>
<td class="nump">$ 666<span></span>
</td>
<td class="nump">$ 709<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of incurred-but-not-reported (IBNR) liabilities plus expected development on reported claims, for claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4E<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671321-158438<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671317-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863238912912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Borrowings - Schedule of Borrowings (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>May 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance lease liabilities</a></td>
<td class="nump">$ 1,407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LongtermDebtGrossAndLeaseObligation', window );">Total debt principal</a></td>
<td class="nump">55,346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,743<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premiums</a></td>
<td class="nump">210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet', window );">Debt discounts and deferred financing costs</a></td>
<td class="num">(740)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(786)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities', window );">Long-term debt and lease obligation</a></td>
<td class="nump">54,816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,176<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="num">(4,019)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,205)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">$ 50,797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,971<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Long-term debt<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Long-term debt<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.5% senior notes due July 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.75% senior notes due November 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.75% senior notes due December 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.75% senior notes due December 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">399<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.8% senior notes due June 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4% senior notes due December 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">414<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.375% senior notes due August 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.625% senior notes due August 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.5% senior notes due November 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5% senior notes due December 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">299<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.1% senior notes due March 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">950<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.875% senior notes due July 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 2,828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,828<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.875% senior notes due June 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3% senior notes due August 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.625% senior notes due April 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.25% senior notes due June 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">6.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">372<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.3% senior notes due August 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 2,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.3% senior notes due March 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.25% senior notes due August 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.75% senior notes due April 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.75% senior notes due August 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.875% senior notes due February 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">1.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.125% senior notes due September 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.875% senior notes due July 2035</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">652<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.625% senior notes due June 2036</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">6.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">771<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.75% senior notes due December 2037</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">6.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">533<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.78% senior notes due March 2038</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.78%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.125% senior notes due September 2039</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">6.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">447<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due April 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.7% senior notes due August 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.75% senior notes due May 2041</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.5% senior notes due May 2042</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due November 2042</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.3% senior notes due December 2043</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.75% senior notes due March 2044</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.125% senior notes due July 2045</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.875% senior notes due August 2047</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.05% senior notes due March 2048</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.05%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.25% senior notes due April 2050</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other Debt Obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 320<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Unamortized Discount and Debt Issuance Costs, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LongtermDebtGrossAndLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt, Gross And Lease Obligation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LongtermDebtGrossAndLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, including portion classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.5DueJuly2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.5DueJuly2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueNovember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueNovember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueDecember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueDecember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.75DueDecember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.75DueDecember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.8DueJune2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.8DueJune2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4DueDecember2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4DueDecember2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.375DueAugust2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.375DueAugust2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.625DueAugust2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.625DueAugust2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.5DueNovember2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.5DueNovember2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5DueDecember2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5DueDecember2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.1DueMarch2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.1DueMarch2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.875DueJuly2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.875DueJuly2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.875DueJune2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.875DueJune2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3DueAugust2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3DueAugust2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.625DueApril2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.625DueApril2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.25DueJune2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.25DueJune2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes13DueAugust2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes13DueAugust2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.3DueMarch2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.3DueMarch2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.25DueAugust2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.25DueAugust2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.75DueApril2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.75DueApril2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes175DueAugust2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes175DueAugust2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes1875DueFebruary2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes1875DueFebruary2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2125PercentDueSeptember2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2125PercentDueSeptember2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.875DueJuly2035Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.875DueJuly2035Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.625DueJune2036Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.625DueJune2036Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.75DueDecember2037Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.75DueDecember2037Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.78DueMarch2038Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.78DueMarch2038Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.125DueSeptember2039Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.125DueSeptember2039Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueApril2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueApril2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes27DueAugust2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes27DueAugust2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.75DueMay2041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.75DueMay2041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.5DueMay2042Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.5DueMay2042Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueNovember2042Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueNovember2042Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.3DueDecember2043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.3DueDecember2043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.75DueMarch2044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.75DueMarch2044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.125DueJuly2045Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.125DueJuly2045Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.875DueAugust2047Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.875DueAugust2047Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.05DueMarch2048Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.05DueMarch2048Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.25DueApril2050Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.25DueApril2050Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863237471104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 01, 2022</div></th>
<th class="th"><div>Aug. 15, 2022</div></th>
<th class="th"><div>May 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Redeemed principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,529<span></span>
</td>
<td class="nump">$ 5,423<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.5% senior notes due July 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Redeemed principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.75% senior notes due November 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.75% senior notes due November 2022 | Subsequent Event | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Redeemed principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.75% senior notes due December 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.75% senior notes due December 2022 | Subsequent Event | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Redeemed principal amount</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.75% senior notes due December 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.75% senior notes due December 2022 | Subsequent Event | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Redeemed principal amount</a></td>
<td class="nump">$ 399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.5DueJuly2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.5DueJuly2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueNovember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueNovember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueDecember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueDecember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.75DueDecember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.75DueDecember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863247702048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity - Share Repurchases (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 09, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock repurchased during period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2021RepurchaseProgramMember', window );">2021 Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock repurchase program, remaining authorized repurchase amount</a></td>
<td class="nump">$ 8,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock repurchased during period (in shares)</a></td>
<td class="nump">19,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Stock repurchased during period, value</a></td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2021RepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=cvs_A2021RepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863237752016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Shareholders' Equity - Accelerated Share Repurchases (Details) - 2021 ASR - Barclays Bank - USD ($)<br> $ / shares in Units, shares in Millions, $ in Billions</strong></div></th>
<th class="th"><div>Jan. 04, 2022</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AcceleratedShareRepurchasesAgreementAmount', window );">ASR agreement, amount</a></td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PaymentsForAcceleratedShareRepurchasesAmount', window );">Payments for ASR, amount</a></td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares', window );">ASR percent of notional amount received in shares</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased', window );">Shares repurchased under ASR agreement (in shares)</a></td>
<td class="nump">11.6<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share)</a></td>
<td class="nump">$ 103.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TransferOfSharesToTreasuryStockValue', window );">Transfer of shares to treasury stock value</a></td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram', window );">ASR, shares to be received at the end of program as a percent of notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2021AcceleratedRepurchaseProgramMember', window );">Forward contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Forward contract, notional amount</a></td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AcceleratedShareRepurchasesAgreementAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases Agreement, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AcceleratedShareRepurchasesAgreementAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases, Number of Shares Repurchased</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases, Percent of Notional Amount in Shares to be Received at End of Program</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases, Percent of Notional Amount Received in Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PaymentsForAcceleratedShareRepurchasesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Accelerated Share Repurchases, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PaymentsForAcceleratedShareRepurchasesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TransferOfSharesToTreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Transfer of Shares to Treasury Stock Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TransferOfSharesToTreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2021AcceleratedRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=cvs_A2021AcceleratedRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=cvs_BarclaysBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=cvs_BarclaysBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863242922032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity - Dividends (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share (in dollars per share)</a></td>
<td class="nump">$ 0.55<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 1.10<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863239723392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="nump">$ 74,140<span></span>
</td>
<td class="nump">$ 75,381<span></span>
</td>
<td class="nump">$ 71,164<span></span>
</td>
<td class="nump">$ 69,701<span></span>
</td>
<td class="nump">$ 75,381<span></span>
</td>
<td class="nump">$ 69,701<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(798)<span></span>
</td>
<td class="num">(1,155)<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td class="num">(392)<span></span>
</td>
<td class="num">(1,953)<span></span>
</td>
<td class="num">(244)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="nump">75,506<span></span>
</td>
<td class="nump">74,140<span></span>
</td>
<td class="nump">73,565<span></span>
</td>
<td class="nump">71,164<span></span>
</td>
<td class="nump">75,506<span></span>
</td>
<td class="nump">73,565<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Net unrealized investment gains (losses)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="num">(377)<span></span>
</td>
<td class="nump">778<span></span>
</td>
<td class="nump">828<span></span>
</td>
<td class="nump">1,214<span></span>
</td>
<td class="nump">778<span></span>
</td>
<td class="nump">1,214<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="num">(868)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,098)<span></span>
</td>
<td class="num">(236)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income, net of tax</a></td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(813)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,968)<span></span>
</td>
<td class="num">(237)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="num">(1,190)<span></span>
</td>
<td class="num">(377)<span></span>
</td>
<td class="nump">977<span></span>
</td>
<td class="nump">828<span></span>
</td>
<td class="num">(1,190)<span></span>
</td>
<td class="nump">977<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">OCI before reclassifications, pre-tax</a></td>
<td class="num">(1,105)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,510)<span></span>
</td>
<td class="num">(273)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified, pre-tax</a></td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember', window );">Net cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="nump">219<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="nump">244<span></span>
</td>
<td class="nump">248<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="nump">248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income, net of tax</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="nump">234<span></span>
</td>
<td class="nump">219<span></span>
</td>
<td class="nump">241<span></span>
</td>
<td class="nump">244<span></span>
</td>
<td class="nump">234<span></span>
</td>
<td class="nump">241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">OCI before reclassifications, pre-tax</a></td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified, pre-tax</a></td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Amount expected to be reclassified</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Pension and other postretirement benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="num">(35)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income, net of tax</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="num">(34)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="num">(54)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="num">(54)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified, pre-tax</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember', window );">AOCI Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="num">(190)<span></span>
</td>
<td class="nump">965<span></span>
</td>
<td class="nump">1,022<span></span>
</td>
<td class="nump">1,414<span></span>
</td>
<td class="nump">965<span></span>
</td>
<td class="nump">1,414<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="num">$ (988)<span></span>
</td>
<td class="num">$ (190)<span></span>
</td>
<td class="nump">$ 1,170<span></span>
</td>
<td class="nump">$ 1,022<span></span>
</td>
<td class="num">$ (988)<span></span>
</td>
<td class="nump">$ 1,170<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863245550352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumeratorForEarningsPerShareCalculationAbstract', window );"><strong>Numerator for earnings per share calculation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income attributable to CVS Health</a></td>
<td class="nump">$ 2,951<span></span>
</td>
<td class="nump">$ 2,783<span></span>
</td>
<td class="nump">$ 5,263<span></span>
</td>
<td class="nump">$ 5,006<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DenominatorForEarningsPerShareCalculationAbstract', window );"><strong>Denominator for earnings per share calculation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares, basic (in shares)</a></td>
<td class="nump">1,313<span></span>
</td>
<td class="nump">1,319<span></span>
</td>
<td class="nump">1,312<span></span>
</td>
<td class="nump">1,316<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average diluted shares outstanding (in shares)</a></td>
<td class="nump">1,321<span></span>
</td>
<td class="nump">1,327<span></span>
</td>
<td class="nump">1,325<span></span>
</td>
<td class="nump">1,325<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_EarningsPerShareBasicAndDilutedEPSAbstract', window );"><strong>Earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per share, basic (in dollars per share)</a></td>
<td class="nump">$ 2.25<span></span>
</td>
<td class="nump">$ 2.11<span></span>
</td>
<td class="nump">$ 4.01<span></span>
</td>
<td class="nump">$ 3.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per share, diluted (in dollars per share)</a></td>
<td class="nump">$ 2.23<span></span>
</td>
<td class="nump">$ 2.10<span></span>
</td>
<td class="nump">$ 3.97<span></span>
</td>
<td class="nump">$ 3.78<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember', window );">Restricted stock units and performance stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DenominatorForEarningsPerShareCalculationAbstract', window );"><strong>Denominator for earnings per share calculation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Effect of dilutive securities (in shares)</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cvs_StockOptionsAndStockAppreciationRightsMember', window );">Stock options and stock appreciation rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of EPS (in shares)</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DenominatorForEarningsPerShareCalculationAbstract', window );"><strong>Denominator for earnings per share calculation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Effect of dilutive securities (in shares)</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DenominatorForEarningsPerShareCalculationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Denominator For Earnings Per Share Calculation [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DenominatorForEarningsPerShareCalculationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_EarningsPerShareBasicAndDilutedEPSAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Earnings Per Share, Basic and Diluted EPS</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_EarningsPerShareBasicAndDilutedEPSAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumeratorForEarningsPerShareCalculationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Numerator For Earnings Per Share Calculation [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumeratorForEarningsPerShareCalculationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cvs_StockOptionsAndStockAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cvs_StockOptionsAndStockAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863244983616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>lease</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>lease</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2012 </div>
<div>member</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>claim</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_GuarantorObligationsNumberofLeases', window );">Guarantor obligations, number of leases | lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LossContingencyAuditMethodologySampleSize', window );">Sample size | member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Legal settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 484<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cvs_StateOfFloridaSettlementMember', window );">State of Florida Settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Legal settlement</a></td>
<td class="nump">$ 484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LegalSettlementPeriodOfPayment', window );">Legal settlement, period of payment</a></td>
<td class="text">18 years<span></span>
</td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Liability recorded in association with legal settlement</a></td>
<td class="nump">$ 484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cvs_RadcliffeAndFlaimVAetnaIncEtAlMember', window );">Radcliffe and Flaim v. Aetna Inc., et al | Pending Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of claims | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_GuarantorObligationsNumberofLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Guarantor Obligations, Number of Leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_GuarantorObligationsNumberofLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LegalSettlementPeriodOfPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Legal Settlement, Period of Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LegalSettlementPeriodOfPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LossContingencyAuditMethodologySampleSize">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Audit Methodology Sample Size</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LossContingencyAuditMethodologySampleSize</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14615-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cvs_StateOfFloridaSettlementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cvs_StateOfFloridaSettlementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cvs_RadcliffeAndFlaimVAetnaIncEtAlMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cvs_RadcliffeAndFlaimVAetnaIncEtAlMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863244026912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2022 </div>
<div>Segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863237296512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">$ 80,490<span></span>
</td>
<td class="nump">$ 72,327<span></span>
</td>
<td class="nump">$ 157,148<span></span>
</td>
<td class="nump">$ 141,127<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">289<span></span>
</td>
<td class="nump">314<span></span>
</td>
<td class="nump">586<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">80,636<span></span>
</td>
<td class="nump">72,616<span></span>
</td>
<td class="nump">157,462<span></span>
</td>
<td class="nump">141,713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">4,810<span></span>
</td>
<td class="nump">4,887<span></span>
</td>
<td class="nump">9,293<span></span>
</td>
<td class="nump">9,092<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">22,756<span></span>
</td>
<td class="nump">20,525<span></span>
</td>
<td class="nump">45,865<span></span>
</td>
<td class="nump">41,008<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember', window );">Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">42,812<span></span>
</td>
<td class="nump">38,314<span></span>
</td>
<td class="nump">82,273<span></span>
</td>
<td class="nump">74,635<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">26,286<span></span>
</td>
<td class="nump">24,728<span></span>
</td>
<td class="nump">51,704<span></span>
</td>
<td class="nump">48,002<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">22,645<span></span>
</td>
<td class="nump">20,367<span></span>
</td>
<td class="nump">45,642<span></span>
</td>
<td class="nump">40,682<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">137<span></span>
</td>
<td class="nump">177<span></span>
</td>
<td class="nump">285<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">22,756<span></span>
</td>
<td class="nump">20,525<span></span>
</td>
<td class="nump">45,865<span></span>
</td>
<td class="nump">41,008<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">1,831<span></span>
</td>
<td class="nump">1,614<span></span>
</td>
<td class="nump">3,582<span></span>
</td>
<td class="nump">3,396<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">39,859<span></span>
</td>
<td class="nump">35,745<span></span>
</td>
<td class="nump">76,055<span></span>
</td>
<td class="nump">69,058<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">42,812<span></span>
</td>
<td class="nump">38,314<span></span>
</td>
<td class="nump">82,273<span></span>
</td>
<td class="nump">74,635<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">1,855<span></span>
</td>
<td class="nump">1,755<span></span>
</td>
<td class="nump">3,491<span></span>
</td>
<td class="nump">3,262<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NetRevenuesRetailCoPayments', window );">Copayments</a></td>
<td class="nump">3,100<span></span>
</td>
<td class="nump">2,800<span></span>
</td>
<td class="nump">6,900<span></span>
</td>
<td class="nump">6,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">17,952<span></span>
</td>
<td class="nump">16,185<span></span>
</td>
<td class="nump">35,386<span></span>
</td>
<td class="nump">31,325<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="num">(18)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">26,286<span></span>
</td>
<td class="nump">24,728<span></span>
</td>
<td class="nump">51,704<span></span>
</td>
<td class="nump">48,002<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">1,862<span></span>
</td>
<td class="nump">2,049<span></span>
</td>
<td class="nump">3,467<span></span>
</td>
<td class="nump">3,443<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Intersegment revenues</a></td>
<td class="num">(11,328)<span></span>
</td>
<td class="num">(11,133)<span></span>
</td>
<td class="num">(22,616)<span></span>
</td>
<td class="num">(22,249)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(11,328)<span></span>
</td>
<td class="num">(11,133)<span></span>
</td>
<td class="num">(22,616)<span></span>
</td>
<td class="num">(22,249)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="num">(183)<span></span>
</td>
<td class="num">(162)<span></span>
</td>
<td class="num">(387)<span></span>
</td>
<td class="num">(337)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Intersegment revenues</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Intersegment revenues</a></td>
<td class="nump">2,953<span></span>
</td>
<td class="nump">2,569<span></span>
</td>
<td class="nump">6,218<span></span>
</td>
<td class="nump">5,577<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Intersegment revenues</a></td>
<td class="nump">8,352<span></span>
</td>
<td class="nump">8,543<span></span>
</td>
<td class="nump">16,352<span></span>
</td>
<td class="nump">16,631<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="nump">171<span></span>
</td>
<td class="nump">255<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">110<span></span>
</td>
<td class="nump">182<span></span>
</td>
<td class="nump">236<span></span>
</td>
<td class="nump">317<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="num">$ (555)<span></span>
</td>
<td class="num">$ (369)<span></span>
</td>
<td class="num">$ (860)<span></span>
</td>
<td class="num">$ (672)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AdjustedOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjusted Operating Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AdjustedOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NetRevenuesRetailCoPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Revenues, Retail CoPayments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NetRevenuesRetailCoPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139863242049936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Reconciliation of Consolidated Operating Income to Adjusted Operating Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 01, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (GAAP measure)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,569<span></span>
</td>
<td class="nump">$ 4,326<span></span>
</td>
<td class="nump">$ 8,059<span></span>
</td>
<td class="nump">$ 7,903<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">466<span></span>
</td>
<td class="nump">582<span></span>
</td>
<td class="nump">934<span></span>
</td>
<td class="nump">1,169<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on sale of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(225)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(225)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Legal settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">484<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Loss on assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Acquisition-related integration costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">81<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod', window );">Acquisition purchase price adjustment outside of measurement period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (61)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(61)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(61)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,810<span></span>
</td>
<td class="nump">$ 4,887<span></span>
</td>
<td class="nump">9,293<span></span>
</td>
<td class="nump">$ 9,092<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | Payflex | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on sale of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (225)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(225)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestiture of subsidiary</a></td>
<td class="nump">$ 775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cvs_StateOfFloridaSettlementMember', window );">State of Florida Settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Legal settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LegalSettlementPeriodOfPayment', window );">Legal settlement, period of payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AdjustedOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjusted Operating Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AdjustedOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Purchase Price Adjustment, Outside of Measurement Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LegalSettlementPeriodOfPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Legal Settlement, Period of Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LegalSettlementPeriodOfPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_PayflexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_PayflexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cvs_StateOfFloridaSettlementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cvs_StateOfFloridaSettlementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>cvs-20220630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cvs="http://www.cvshealth.com/20220630"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cvs-20220630.xsd" xlink:type="simple"/>
    <context id="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i19f7bb9164614f549fb4be76ce9dab1a_I20220727">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2022-07-27</instant>
        </period>
    </context>
    <context id="i735a87c60de044ac9f25eb3f0ab9e911_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia15d386324864519875ee9e5e2fd30c5_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ideaba68ef44648c6b282b6f6679adf93_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ifdc339e14e1d455eaa0c9a2b8396f603_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i434909542d34451ea488689d9cca7066_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i06f559cafd184fa0885076b8d71d4ab2_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2993c7eaedc041feab50da3fbcf43a01_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i363a5d855b604ba1a4087bcdf1601a77_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i497dd46327b4467f95cca59a81170078_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8af9eeada4aa4390a7aabb67f310e776_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id1b37908bcec4675b7dd487bd3f7f745_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9c91d440ca044d289daea52743e3cebd_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia48affe94b4f4604a40b1720a79d5db6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2c088d53680e46f6baea92de14e2e4bd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if58f043854c54a53a5f1e35f8cb23492_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5a1ac81823f94f75bab757497041c7f8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i86d57bb206de43c4896717f849b4338e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaba8a997161f4500808bdfdae2e0492b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5700fd54dde54828b88be719d7275959_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i683b5a41864d461590fab401c4e35230_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i42bd3a35f46d439da8e6e3e6a2da23e4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6ae3518ddcc841158d875c2d6c95917a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i079d98ea4b47435d8f5a9eb08672f5a0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iacd268c2c7e140009fb8bec3502a1e8c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4fe1e1bc63a6493a915ac4598cb1bf1e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1d0aa52dbadc483aad398f2459329f7b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iffa3d985891f4ee4956e9a77643827ed_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3b7f5b310ef64956895f542905a4622c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5f2fc9063f2c489db3055478a06e568b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4175aff97fca4747940e80338e1c6b6b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i47c09d87ce2542058a44638e0d3aee0e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1b872d657c42459e8731fba04a499743_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9df87f1b15834003ab59b7fdaccda9a7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i902a60f937e94b7db75169a88a51ae87_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3779b6c8ef834637b29b6a1763d82299_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i60699824f52b49fcb5663bfa26640e09_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4275461340524ac9a913007bb4256c99_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="idb80b8e269cf4f7cbdc40e28acc4636f_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9044e77680c543eab4fbb19765443084_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia4478efe64a3489c931acebf3d633806_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="idf70211547034c07b67bbb782ef034de_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i3c407840d1534bd3a85610f6bc0f2a82_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i65b5f26da4ed4d9f951f94da7cd00c3d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4ebe896f6f5249aebd3596e8ae9c06e3_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i91f59faea12744d3b7195336c1ca91cc_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3f6f61f23dd44e0f9334dc0bfb9b4810_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7d56c57b212d4a108b033b2948d0291b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic7e372c5939d46a59aed59e0c12a2a5a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia55d0b5fcc284c1bb1843f6b3df18f68_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic10a47a61fb346eca4da1c6b4eb8f3e0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i152dc72ae8c845738b9dc7cb8c6f3c9f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i40e08d0b5d454c76b137a0fcc9650921_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i49bd9c3e375d4c40a91fc221c0821506_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iad3da84ec0ac498db41f931fdcbc851b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i31664a1f007d452f8f852aa3e9e14177_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9917e617b6b24457b71193960c36094b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iee221d6eeb484991817f46c9fe0c087f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3fdbb1c5a52d4721a5d3e754c65f8bc3_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i561416f54ed14d4aa729dc31040c8e99_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i46f6d2a9429541919bc596eed6bc6437_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i772325f7509041e3ae0b28f2fede65ec_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if0eb4e5ad890414b9e6e3b2fbcd7a242_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia8357bbbf6fe4f958f2b67dcfcf2a97b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i24a096e6009a44be8a941b871322166f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if45457c84fd043c9b7d744c3fc83d3da_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ica2f5f3fd6224895b0ce4b545dcbd6be_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1320581fe0074807a2a6f1646978f417_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i98cd8c15279e490f8c5ece01fc0a2607_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9364eb9de5284648ba5dce23aaf45747_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic2b899747e3a4cae8ea6928b46d7a6ef_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia657fbce9b4e48baa94aeb01df078a63_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i959322b91e4a46abaae950c149d362c1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia4dd5a3fb4014191b1a23eef5aec7288_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i64c81a1cfe4e4ed3a4d01a9a55628941_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7e4dbea634eb411686fe24903cb97ba4_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i260f5a79243641bf898cd28e99b21a0f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i090190413d0546e98f4e006ce4c3c486_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if7c5ecaffa7d41eb8fdfaa819f432922_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idaa5b59feb95483188ced67d5fbf4950_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i48dfc02937744c869af28bd5454ce1e7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6ce9ce9b48d54a45a210fb81622aa4dc_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9a378f6ac4174a9c8b2c62fbb49af994_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i070d725cebd0413da9a910f72c7a5854_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1d834339a4a64e8ab4f3498ba15b93ea_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ibe740c19bbce491b8bf0931a8ba2c65c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i42940cbfec444379ba0dbd31dce09948_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3e0ead3c67874e9c96bf47478f6e8f41_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4313031902ce4be29cef2c3613a0b3a3_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i1c0bcd0eebfa40769648a67be75183aa_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i52b2448e457a41c18f816cae8ba1b237_D20230101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i211b727efe674251b7af74e7c727f2f6_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6ee2fa91c9e748c5bcd3a0dd4c42587d_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9ad952d467934022a4d99fb585b701e3_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i39657e3bd9404c6db2b0e8d4dfd62174_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia252187be8364a1dbaf93db9dc77a52d_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ieb6ae33774b44fb4995615218a58f912_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i925a067985ca40f48d352ec61580eefc_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i75f41b5ed07e47ae8a0cbb4ad812d296_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0248b692278b4870a7c3ba3d7f66b90f_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9d27d90709144b74bf478175cdb6010d_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0995d0ff3d504aba96c0fe94fe99a19d_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0c12809aa193462b8677fc041a26a3c0_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5f4852b5d8704ebdaab77950f88bb254_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i13c0259435fc49c299d3a7dee2d7874f_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if133058117fb48ffa3c1f39f82db08b3_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i600c45cedb7847fe8e7f77de34c118c8_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i71aab19dd48441a298119f6a243dc82c_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5d8c6ba01e94480ca8cf278d517a9619_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib5045314d03040549992e1b0d350c6f4_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i61b1e59accbc4a6b9fdbbf4dd1e166d8_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i054a08a597154e34b91b50e36527b86c_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i02a2e27009a64f7bb8e01545a97c8feb_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if1040a72d0304a058af732ed3761a15a_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0cb61ac775a7478680ac7295974da830_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia351ae656580421784396872e50f183f_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iba21d41e0574453f9043075ca63b9071_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1005878849c5409b8747da25c2c3aaaa_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if2a9323439d44a41bd807db01b403c2e_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id0b0ed60026f4fadb0d2eedd77fc61e3_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9705f2eab1364f59a4310ba9e64be4f7_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i66461e89f4cf4e2aa3f6185279aa73bb_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8548b563f1d944cca1d05b3dab4932ae_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia5f9bf2f84f5424a8f4403ced4cdf313_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if91a5b69cd074ce79d4d34e004ebe4a9_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5e8cf06c0bc54774a6be05b92ccb09f0_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id787a5341515453f9bca382ea7deede3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i76cc779209494399b277155e37005f03_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i69adb512452f407aa3bbe55a8fee69ec_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i92d89a578ea644c4b4cf67268c64ef50_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i435b5e917ab045a4a02bf177f2b0e8b9_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7efacb33d756442cbe220b672cf09431_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i36e853003adb424d944872c915ac6b0b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i03a49e5738514a6bb26ab374104cee06_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6859cf97c16a4a5ebd938b85cb35957b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9fab59a9eb31497ba179665fe456507e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i61167828fdf24a1dbd6b7d94ab77ec42_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibe16bcd19fa348eeb4e81dd6ad44410f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i507ba2e974e440f69b7567158be6571f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i438c350cb9734cbeb799f5b1892d664b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i623ff046ae5c485b878e5d00ab123314_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iac24217ba0c74626b4bf25cec318c623_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if86bb61e4141479b9697828b3dc20cc6_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic44e989a3ada405d8425fbe65629dc23_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3fa7e9e824974440a9373bee9896bb39_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4922155132bd45ada7189d0b3ef9fc3e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i81adcf0d41fd450681c65b683fb1aba1_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1728c43ce0c146c3837ea3dca24f858d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0723aca048c948b09c4e21b76e36afcb_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ief415c243f1342a49eed3ad3b8ccb6b3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0312c66cceb448a780815200255d58c0_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib88dd15d80484821a92bfc5cc6f71cec_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idf0d9424f03a41f0bea7d15520ac11ae_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i26d2adfcb7d047ac8b01711252305fdc_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib99bcbdff8fe401f90d46731f3dc1a6c_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6537cae612474b44bd681794d3356a66_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0782975245974b74b8eb5fc41883c74d_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i16bcbe7065de4f5399be949b1c27cc7d_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if2aff33ffc31447780863b02c8bd982b_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iaefa8d0706ce4702b6fcfb8adb353dfe_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1255b4ef9e894adaba3c64f6d2612e0b_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i52811493f7514547903b0812dc24ec85_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i85c678a2a2f645898239a8ad884b0cf9_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9dba48c9530b483c8e2a19d59638a1be_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id28fa46920ee4b9f8a0fc63559c2e476_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5d5d1a53ed80404d91555cf7ede4f1ac_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iddb342e81917421abee497b130cc5997_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6df2f846eb984710b6afeb4efcea88b1_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i74b2b424d482423984db3f523ee9fb5e_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i2c5104fe39a947b2bcd684db82b54e48_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie1416df2f1ea4d3694000029e33ace71_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i22caa8d1a08845c29d9104c92f002218_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i96ab3a063aca414ead5f29a63f96b5ae_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia17daf1ddb80489bbdce4d94932efa21_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib89fad02b4b74e5cbffe8ec18de4bc64_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i88782d759ab24dbd8db24d6e19ba64de_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8feac348d42b418da086e65a9b0801eb_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9b2e6ca6c94b4ad5afd1d4f01f87431e_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0b947bfa40dc4421923fa575beb49be8_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib1b6035f28cb43a18932f1ea69845c67_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib62a0f8998684d1d9ba32dd07b1f9ff9_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9c453fd49aa84dd8882ffc93c6c79248_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ibd9b5ab95c8b4a5685904bf985fd3749_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia84edce63c9740baa08e23d7f9537d75_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6303f55236d942fab6bbb1a2cba7ac53_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie437eecdbe674fc7ac7ace4c9417d023_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i450e973802ca4a89b066afe451cad627_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4e8e4ca7275c41668b2c0d85eeb02748_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i20c5541ab98a439d8cf5a822544191d2_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i80a33a8e6a7646c2bf5b7c8f67ed21e0_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6228c1327ede4b82b91ec1ba1d6893a7_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2e983c97388f434aa9ef46e937c90412_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i161127e00ea4498383d69d1be2d2c47a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1575b9d08b144d43981bd5eb802dd53f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4a3ca1a8f9864d8899757bcfaed24e58_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i30d7688d403b4e3ab22e76a11216efa3_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3b47e1b909d4426aafc04538f0b5b755_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie0048308c35140bb9969cdb4dd5440ee_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i79ef86c1028641728228a2602b0b7d4c_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i528af9caa41c45da877206ed8fc66f8d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia07a38bcea214ce6a38514324ed4c87c_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3ab215a9d2c44d37befa113efb740879_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i92d3e64078334a22bfdeba1976be9fcb_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie6a9e8a1a1b344cdb794e6a5f0c62ff6_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibcf5af83ee0148b4935c83147cd82d02_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i65583ca6502143fea8109266db45d395_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibfa2cea5de8e43f9ba651607d9a10c30_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia1d59b798de8427bb69d0f7d325309b7_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iec432ef32c864c91b9106f3307398132_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1bb38325fd294ffcb76280c930132208_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i78f790a00f154949a940714ab7c599ca_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i07c8c4b9dbbe4576a4bb2c9bf39072de_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1a7ca95dd5c9433bb8e72e9c147bb27f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i659e7d4e49dd4140b46f05ec617268b7_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic8e811dd702440d69beb3ddbac49f7c2_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i512aca10306b4c15a9e893f9f9a7fece_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6052c3c9f3814eb19317cbd04f0a8d6f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iedfe0ee1cea245499d6a17e933ed0082_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1cf77f9a3b234efcb511290bb7abcf0e_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i80f415ea92fb4d01a514f6f8865f49a7_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvs:HeartlandHealthcareServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id743f37942444621831b2935b6d1e18a_D20220601-20220601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:PayflexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-01</endDate>
        </period>
    </context>
    <context id="i9647c5ab754d4d37a49e9ee3963f2e2c_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:PayflexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id829479219c245759e9e3ab39d4a09b9_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:PayflexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i63fd0bfb9e4a43a58e4cfcab6009ac9e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:ThailandBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iac541484a57e442d8cefd6fa9441768c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:ThailandBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2a80d23584cd49d89a6bb9a7bff4bdd5_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:ThailandBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="icee03dec469e41edbf6c698fb0d48290_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:InternationalHealthCareRenewalRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="i437d75cbaaca4357be7aed594234e4e6_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i973f5697b1474af9a8c7a8e70194ec8a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icdbfd311e78b43f2b0104aa9cc8fb794_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i13669c8a36c24e5d8272623034c20f84_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibadb7cc69aae4c759a42a17ef71ff248_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="idd6de90b616a4a0989fc988def9d4af9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib04a3967c8004f97aa14f769721b3a73_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2e11998e647748a998ed3ae2000f65ec_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i1f3dc5b373774df58f1f755e836acc54_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i839c9086111641ffb78f678a49af4bfb_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7b1da324447946a5a60e70cf44b0c827_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i312562153ede48bfb0ae6742085c849a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iacd25bc0ddd1457bb0d369b53f596438_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i27a2d69d05ce407693c56825032df2c6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5f4295241da2454b9ca27744d8f494b2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic26d39b1909b4114abe91b81a22d3ca5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibf2696db609145edadde7083bbfb8eac_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i35a7089aaf074a29b807a8530fceab9c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4a4d5943f3344b028b2021d88fb2d40d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i57df9cc9e45b4dd8860db902aa9d7a4c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if33a8819dea14f63a14fc5b0024f0188_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if147f99b547041e7930b6068d7988826_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0aa8184ef83c4a40a3d80e580b517091_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i92bb3a9ebd6340bbafee19e1a0961497_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i565890e50f664de28c6c98865dd484ac_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="icc6cfcaae9cd409daffba0639d13efcd_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibfb24956f5d44b968d2715f9013c792b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9b35d26a394f498ead4b8911f6b783f3_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ice4289e5981f470c8348e6e0bd038770_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i81ecba3177494484943b0150ef662927_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia42bbf3cad014282b14444e67b52efed_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ieb0ab983715d47e4adbbebc254ffa1e4_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i371c0520998941618ef7aea89496ed34_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if373bf37aea3458b912ce5c9dedfd404_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4edd43c72fa24ecb8eb03fa5e6bd17c0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i33d8e2fa0f464eab934f3a3981276b03_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ief7e32fbdcdc4b1db1c33985f1a1bfca_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i46df26cf65e741a88308365f0fdce535_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3fd18a6eac95471682e4f96b85733eb0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia13fa065e11f43c99f24e914e7606b15_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic5eeda700ebc4f8eac3969546e289875_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia47b1c162c8a4dd19c3d46272804896b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i899578d869e54146a2dc8706728481b0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7b60a590a9d846f38abc0bedd2f2462b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4ec460be73364dbe9e6821a95e857a19_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3c0db9ae3a654d1abcb624237ab2b056_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6513ccc2104b42fc9d1803cfa7134a7a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib744f76b72ec42598309a6e5c4e51b42_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i456084319dfe4263a992c645b2d706b2_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i861b819f6b654647b93791e8fbac82b7_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic0fe0824d20a45ce92b02afde836c6e5_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7a9fd2dddbfe44ff88021ac1f64666f6_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i740f5a3a2f9a435891769f604897c8bb_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic0c41fd6ab6f49419e4feb0002f2d48f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ief32efb6abac44468898f50592a29547_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i850b791bc3e2407da5747eebb4ab8c3f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i38844338d2ce463798197e185e85f756_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if00cd26828534c21b6c33adb32cacfd7_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id743f9aa58344caf9f98f25c5d92b7de_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iea202e1537584a368ceecede86271423_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i62992d26f65645ff897bda2742cf86fb_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i11c72ce8b8dc4d21aae7ff8290b67bec_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i39b1269f49174087928bb212d8afc1d2_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4d994fd5d397459d8367d852e8f5452f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibb0affc8add2414ca8954a5991109f55_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4faa5bd0ec73475c94099ab518ccf4e3_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i26d61f9963ea4196b8ba2d07d228e5bd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifb3ebe7111bf41f584b98e07430377db_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i000af04ab3a34580abe06f0d79b475b9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i37656451d6e54a6f87723c3c55ee7693_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id04cb4912f0c4add911f641b85b28d8d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0a7a0277984b4d9292ccff484d447ce2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i27decdd521e9427eb51858ecd5161a1c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia0ab7e83123843f5995f6c913b85bc32_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib381c0925973492e9d3c59e35956766c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6f517e0f803f424d9f8a281c67637d41_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia5dabfedcb3446d79b9af20990e4475f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia44d0270c7fc4dab8d24ff7dd2185b17_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i787125a9fb1c4d2dae3f0091842a2905_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i533abaf939b14629802a0d1666202827_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0be6d49dea7a41c3b3be5025579b7f80_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic22d1b35d059439ba0cc5c6c6960921d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3530a0f47dac4ff1958936a41cb751d5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2ad0cb156fab4fb6afd4533b759fba57_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib317e948955944578ea101ab7b8681bc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id27b20e03a0a420eb7c6b974de8faa01_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i11c2cc84da31426aa9cf78264345c70d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i207775b0e52a46038a243f680c4bfe38_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic002c663bb55486dbea5fd9b8add8629_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i612e5e99ae014b8aab81d54d276d71a2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i93420b43b370461b8eefc357152611ba_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idde41fc6240949d2b00dd4bfaea668ce_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i53f958f5f6f642d2b0e5a8f47b9be63e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6a5ae34085d7468184ecc64dcf1815c3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib37a4b4576174adfbd328d6220e6446e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0218b9eeafa744cd976a2ee112999f4c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8b71fc37bdcc4544ba59a680d2a845ad_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6410396dd3b049fc94d73ed03406a6f0_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idb2b8ddb867c4af697afecf4d9a157e8_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i41d8c374cbf548e987ad1657cdc38098_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib36aad3ac1484f6bbdaa4f1c0fc5b0b0_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8e1b0b89b26a40c693ea4463c4d8593a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idfac0b03d2274f43871a43aeb40a5ec2_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i09b23468a180421fb01ec60b86dff5b1_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ifbcd8299564648c0b7ec0acfbd315e56_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6b5bf1c54d1e4c2e9d9b2486e17e7e6f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2fd8e5b0ac1842dca561465f4468b014_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic4c795e51e0c4660990629bf4fd31005_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iaf069440948942608f8ec319d2ecfe5c_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i05ef7a86b20148e5a32020bd5c7d5fd8_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8ca2c256a7cf4284bfbeea2216a84437_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ifdee0bd923464f248a69eb92727cbc33_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4e0d80e2d0a04bb8927a1bf01c58fd6a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i68271d4af0dd46f9a15ba39a24443504_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib17cda40f9cf4d1a8490ee4268351419_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2537a5824e5c47d28dc9352ea4fb9b9a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3b009077bf2641cfa4fee2b3ee3dc481_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ifc7e27d69ade4879bde348e70c0788ea_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic5106c4aa67f4d928a1bc9439a50bfb2_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2e7d19bf6cfd4b3b82ed5de057b0e6d8_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6777146f89994be2b6bcda5d10742ac8_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i08f072e891b342e49c41b996818d9499_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9a25737ed0924c969ac800d03eb71168_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9a1482c6ec9f4cc8b0730cd66f43a3cc_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i25ac6c0b47ec4e21b9505933348f0a1a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i56d79a48fdda41359c90f5247d0eaa51_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7fa48deca1e24bc0aec94bbb86efcea6_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i594d6d7e7e934f9cb1e27dbd9405aea9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ifcaa01a2d5a84178a364e0771d58f1d2_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i15029ba66bfc4f258fcf28f87b20183a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i906410efac8d4de18248e766580b4e35_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i835c385fd6b04a3eb891ef6fc524b805_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0aaf81e8b9884bad80414c289699a57f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i11805126295b4515b45903e544da225d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie9e16c082be94460bfbbd4e151ba7e34_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i336d2e637e8649208863699c4fda08c2_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i36599b795d654ff7b2fe314eced29657_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7e0a0f734ebb45bdbb6cf4e33bdc5fb0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8e86187a9ed44b89a6399da972fe5aa8_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i782d4ad0930949dea0a47084e41c4d26_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia7299fe8524a4d5e9629da62ce398ea5_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i75184f7f66bf420281dc428b61486c9c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4a23ab37e1624317a3210888b909e6ad_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i1b4261e4da4b4593bd9444e957605d51_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if5ac41f72364473b875a4f9f0cabfa01_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iebbf8ae6ec4b4ac7ba59ec1bf20f58c1_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iaebca4c2d3aa45788b5006d29248062c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i26cda38200ea4757af8c3ae23320d2dc_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8407bc5011ab4df18368ae6456978998_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i42bed7e3ca784f3ab32fc7ef56053fa3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i642c16a915674d7daa7f0a01f6634e62_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i04e6dfc862dc4741bba4eb830bd1fe1a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id2001a5cdcfe489587490f999c08e53d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibb4d21f9607446baa96c4753b5ae4a2d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib778b8c5692f4a2f9ce7ecd3827265b2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1b92e92046e3481c849127ba0d177b4f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1b390fc483eb4bf1bf3c1e193419740f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i80bffbb65d2b4070a225a033d6ea55b0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7bac9c5f699d457884697fc93aadabad_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iab74b3b8e454421c9d99fd0fea4f8b5d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i12831131b4b347d28cc365b3e2b5d442_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i04bb2995006a4a4f88bcd1f2ea901a73_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iea75515a7ca440c2b48524fcb1053c9f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie6de1349b73147148e1a6bc0dcb9232c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic4cf155fcd064bd8b37cde3d0bf8a683_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i52e238e983504ca6a0b5d0eca15be0f9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if2d9b47f36c344a89eccfc77028e066b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9026e142a9d243c79099838b180bad0f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i223e616c479846e7bcfb1b323650c580_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i001fe54ef077469e82d46f274819777f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2c084d4d05954ba4bad6546555d216b2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i904663f80f7d4ed8b9bdf80b571274b6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i29352f2ba2bb430fb7edf1a52db0a767_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i305ff43cd2da42f5837673228114f047_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i01d4fc3347b34e62bd298927db4d1507_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7455e34409e849e09720b15bdb39ef0b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i712137052e06498fbf764dbfba45c5cd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i82307e5c20bb45bdbfe5652fb891c9ec_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i09b4f7cbd578419a9e93e1f9baaea718_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i443a171c4d9046c6998ec0e711b34fb7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i84d6ff7bcaf644209c3df2eae876d580_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id8a0c11f7f38499ea3d96bb3423aa0f7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie480043139dd4ff799c6c90efb44c767_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1da882ac68a54dad9ccd7ec3d147e26a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib6f883902b9f4d569180bdd25d7ac485_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie30f666179e54a5cb8e16248e2aa4dc6_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i509def96f3774f389ccb60611ef5b220_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i057d1d2e7dcf476caee443d101525a56_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0e4863652a8d4786bda491af0f283e1f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="idf62033ec0a847bb91856b878b3b5184_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2abfa03cf0a34bb1a667090247c911ce_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0393895e099248fca624d76479d72f73_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icda51f2bbf534c3b99bd90ca2ff4fc4a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i950684090258490285b22303b8cbe92f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1998c1f186304330af3b39bac43d0a2f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="idc4896103e2847bfadabec9c0079aa36_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i09642d3a548b46338b4bb3f615251a26_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9170e75144bb41cd9ee98de35d2f8127_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i1401ca4c008547c2bac9543b488db12e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5ac71f0b9bb14e4092be832d41e515a8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic46902baf4774da0b1d69a2251e4c766_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibbbe45adfefe4948a1c89879ea88f003_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i65512635d3f94fc399a6c13c4e5ca1a1_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i251231de7362453a940ab517a85970ae_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i23f86f2cbd964ff2a810fd266595100f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i381f19e26d814d37904aee3ae800493b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i407ded4af3924d31952fb5d080084da1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id23c11799c424d598c0c1ae0ab2929ba_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5c8d2dc2b8704580a1a172c856d29530_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaf81bb9d192d4f34906afe0ca3308cca_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i934c58db24df4f5b8e2df9a748e0ce3a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie4c3e3b3b06443908af3ef65aa44ce1c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i18c1dbf858274c46886b39848454543e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3eeede4806c04b8ca1b1515f91d2454f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic3bcc189914f44dfbd6d8adba7da6648_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ida1294c97533481bbb71cc59e1332b94_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i61b3ccbd720b4118afa39412212dd864_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i74971ce242444f5b8eca08207bb3fd01_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifde0481021814f2a9b9298bd03a46270_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia7f7b435750440efa12f3876d71ad127_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if94bb34cac0e45b4b0a4cf53c05b0d13_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6df4f366580047d49b2e56046b8e7328_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3b49cf8f22064d1c891ff76da09969c1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie8a50f5f508f4a7b87e5542b0e6ffc42_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1f56b0ef04ec4465adcf279a0c980a91_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1a5e52e8002f439e863f471f508bd973_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i03d9d5c763344a06ad0ba56859f58bcc_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4b83284491314316be5282f5effb45cd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ica5caded5b9f40868f9db05f17444835_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8454af9021ca47c98336dfba07097dc4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i824fe68acd534f1cb26fac7871f45022_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i2c50d4663e7046e988ba0a3d936e983d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1581ff2350a744a6b1f3e0be5835a1dd_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i64773f23350843c69d9c79f2e715b95d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i856f8df36f55432cba11d2c1b2e7ba4e_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i633068dab92e4b98b0522d78e950565e_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:CorporateOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id563d585f536458ab16c7d10eb546a54_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:CorporateOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i701dfcde341042418a1230e58dfc107c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib7e9c49d1afb41528f0c6f58ad82f91c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i19ce665e627349488d7fdabbb5fd4f0c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if9e4fce0f5914bc194df0543a8fb78c7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4945c0919f8a4b6fa67244e6df69a8e3_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i79481fe5600c4d29829c7063ced8237b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i33b68889734a4fe89dcb2fdde065e999_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3a07ca981e96452699ccf6cc1296a094_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6f28d0a871b74ccabed8651290f5df32_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJune2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8b27b79528fa4d33895a9b7b0532c5a8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJune2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if5743e3b67ba46fa843ceef9c280ed2d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i699c54fc3b714c6282acce7eaaac6c49_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i29c21f5958d54c94a3300a81499e844e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.375DueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i89b3c50e60c94e5287f35e0966dd4a3c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.375DueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i34f2be9f895b466e96b08a69c1310ab7_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.625DueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i57483b066e9f454b8904cd684a7f0427_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.625DueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic48a061167f048b8902603753dfa8e1d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueNovember2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i51fd94c18b494791a8946f4cfd11cca6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueNovember2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id5da825f37b64596bcfb8830bb18cb6c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if4ce44f679934429824ee090659496ff_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idda7e364fedc4373a6c04d2aa621c990_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5c3bc22603f14476908cfe99fc1875c6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia9a0e60b49f44f1f9e50e8a2f21e126a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueJuly2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5609b04c209d4d23814975183321bf8d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueJuly2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i29521c68c83d45fbafda3ca446e28ad6_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.875DueJune2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i00f8ab37e94f47c5b959adc2fc05d1e4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.875DueJune2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i125e9ebb582747fc928d86e8183d5250_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3DueAugust2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if34ad8df01784ccd9c09e77e8c83abb0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3DueAugust2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0c9846afea30440f955cec9041311ebb_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.625DueApril2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic44e6bc4ca52465abc641a71fd0e3162_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.625DueApril2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2ef356dda5d1479b89006e9da3a6fafd_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.25DueJune2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if1bfd120dbe14e73916b7c46067dcc30_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.25DueJune2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i200e92b399884866831aa7f66216c0b6_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes13DueAugust2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i725dc7730e3249c58e3e72c65a8ed7bd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes13DueAugust2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iccf871c8fb35430d92796d1f0d0c146d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.3DueMarch2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="idf8670b729d642d49a6f047b3de3020e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.3DueMarch2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id7257e80fe294cf89f6d21eb9a5a160b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.25DueAugust2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3d68ec8cafb8440b922b87a639652d7d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.25DueAugust2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibd128b7c8158440a960fc33fff1e4942_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.75DueApril2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="icec9e0e991cc4516851d6f09627a471c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.75DueApril2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8d97a719154d42e589f04dcc38484757_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes175DueAugust2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7df071c343834f33b524951050d6f51a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes175DueAugust2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifdaae87a3e8b4e53973b84b8af214010_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1875DueFebruary2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9226a82fc64641d5afdd7ffa2c292e4c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1875DueFebruary2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie67b1016381d45dfb701cb39cb97655b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2125PercentDueSeptember2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if2abdfe43d904e9b927694acb3cd4cf8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2125PercentDueSeptember2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i944da40b07b447d0a332880d0b588a20_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.875DueJuly2035Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i914306c1134948118679d384eef61fbd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.875DueJuly2035Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i643fea13573a45d8afeeb8de059866ed_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.625DueJune2036Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie286fcf256214324826f57573776deaf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.625DueJune2036Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie598796a91a246aaa0c09f9f30782bd0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.75DueDecember2037Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i361edf6919cf4676b09461ea7e67b84c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.75DueDecember2037Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i65284b80f9764f99aa6e1e0c3d28922b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.78DueMarch2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i205b6c2b07564953a06f503cc5b37037_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.78DueMarch2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idf399710257743edb37384ff227cd40d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.125DueSeptember2039Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if5ed3b12e6eb4e059b0259b94de90f3d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.125DueSeptember2039Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id26f0bd9ad2d415ea77a3ab3ae626afc_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueApril2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i56de23d883344a9a927ab5a974600a0b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueApril2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i40305c3253a242ff97d2746b2a513a69_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes27DueAugust2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic138ff07b2f94c0cadf208f70bb6e79d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes27DueAugust2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icecf2da3a842413c965e457894528023_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.75DueMay2041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i166e8b849a1145b5905209025edd018e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.75DueMay2041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0a7c0b54785745fe9adc93c9cf289db1_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.5DueMay2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i764dca86272443deb0bce7cb4b41e0e9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.5DueMay2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ice00869200514840821cf7cc694e3133_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueNovember2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i614fbc67bf9144ee9a0deb06e9032f2e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueNovember2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifdf41bb2bcd94610b70c6a62ce138649_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.3DueDecember2043Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4cae7a6a82104f61a0553383911b0094_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.3DueDecember2043Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i28e511837f134fd4a0d69cfe195fae71_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueMarch2044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibae772bc2bae4e5ea9db4081c2e4001b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueMarch2044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie084c2a7344c420c92ae9437d7ab6be3_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.125DueJuly2045Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia31d9e274a59413bb7895e1b77158660_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.125DueJuly2045Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibd7eb609f3b14fac8983caa6c096c01d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueAugust2047Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3acd7c3b5f134957ac35694bfa158c39_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueAugust2047Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i43811273ae184613adc9bb723848272a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.05DueMarch2048Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i959c954325ef4865add18451ad9d7a29_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.05DueMarch2048Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie9bfff97b8b648908d79cc9a4159b298_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.25DueApril2050Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic19ab2f397f34a8585e736896e24aeed_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.25DueApril2050Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i015bc34a65a248e3a70847c5c7052cc6_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib4d2a19a3df4491a9d4ada04059faf42_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2b2cb684c3c54456b798887d44f26f18_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="if2a4890c67364387b34caac671f1ecb8_D20220501-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="if35632f79478444b837b68f876c276d3_I20220815">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-15</instant>
        </period>
    </context>
    <context id="i4f8c724d4dc244c0b8cca96a9f405f4d_D20220815-20220815">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-15</startDate>
            <endDate>2022-08-15</endDate>
        </period>
    </context>
    <context id="ide236c65d7b9413da75bda41de2407e0_I20220901">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-01</instant>
        </period>
    </context>
    <context id="ibd92c38e037f41c19fc207220bcc0c98_I20220901">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-01</instant>
        </period>
    </context>
    <context id="i5fbafbf9ebe841209a93040e930d5b09_D20220901-20220901">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-09-01</endDate>
        </period>
    </context>
    <context id="i6838b42fbf54414d9a3aa4b32a3784cc_D20220901-20220901">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-09-01</endDate>
        </period>
    </context>
    <context id="i2788e339558c49d4ad5e9a5ed3686ef7_I20211209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-09</instant>
        </period>
    </context>
    <context id="i973e6ae6f5664668812730f3574e2681_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibf2ba7a1f37c43a2a329487ba4c8244a_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6f0054d90f614171a2cdaff45560ffaa_I20220104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:BarclaysBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021AcceleratedRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-04</instant>
        </period>
    </context>
    <context id="id032d7a1b06a4edbb4e66d3c58ec984a_D20220104-20220104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:BarclaysBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021AcceleratedRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-04</startDate>
            <endDate>2022-01-04</endDate>
        </period>
    </context>
    <context id="id9b2681d79b94d2f9857c1c1e9cd12d4_I20220104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:BarclaysBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021AcceleratedRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-04</instant>
        </period>
    </context>
    <context id="i03eba332a9884f289cf2750b5c9cbf14_I20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:BarclaysBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021AcceleratedRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="i8f44bafd8b514e13885650b83df2cba5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i672c8f5d9c8f451eb39619a46f51f47f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2f9c15723eaf4a9eadcf03b852b70db2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i490d91efebc0468298a0da610cc516c9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7519dbaef94443449eecd8f162669ec1_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8ca72ce1ba034c0c9c20ad0f3602947d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib125e54cf2b14e81ac89b10807680e76_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i57a873f503fb43408df28140ea310d0d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i95c7b68f19d34e799c2a2da632fc1a25_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0186d665a01a437290bd18c75323ee1e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6d3ff99e11274317bfaa3db6aae0ba07_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibbf36ad6ce3b471588e3a05013e799fe_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="icef7877b29934f14b7831ab01b0e383a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib366b23034bd4459aada86fdb2dd3449_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i796acc4a7ae14fad88f553a72e53ed7b_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i882ca8d49b6a49d3b40dc01ce24b96ae_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0b5b675fa53d484099873bf8055a89db_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i249b23ce7c4a4a9181faba8d0c98b9da_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic4ad5ca1cf1345368ae93f7d409262d6_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i92bca9f2f539472898cf0d31e92244c6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if26019edad134ef49f67621aae7d0881_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9fb161b7e78242208da2fb60faed3211_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7ebfa804cc314a5cbaa6c16091e1300b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5002b5c4b193406a82d57085bca7379c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i17625cfa20f64405885913a70a548638_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9b668c841c514504b89920b0f42c84fc_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8384d5359f84472ca5781e3a2d42ea0a_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if039d6d6983848a48803a4bc6f9a0ed1_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6968e95408a14a959a6cf1b5595b1562_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i16a176b60bcf492c9d7596af5ec2d637_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie45bedb2b1594d3eb748dd76b2cab130_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i60f2853c6a3842dd843c429de5b2337d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie59f2df1b9114d43b76163c7a171e5a4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia6b9a02663b641188ebd9d833d0c8593_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2602b92305c04c68a196ab39ab51d7d1_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i44bba003a74946ed87d9d0b98b2c950d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i74776cd677844441a5cdd3bde68816e0_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4f24cf7d8a01489c8b678a8a8c86ef3f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib24237470dfb4b14bdc3819e68f90af7_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8898a5dbc52c442fad3cc1e0d98f102c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9a636d32fc2a454a89bd4991b0628853_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie7a27b274c3a4d16b682c158f10c219e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6688966640734a61a1a460ea4b661770_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id86c8e524f224b00811843646316152e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5185ac0c651b4a17bd97c114f383805d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2fdea86bdbcc429985d69c5258c861b8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6cb8479c571d4f03bbc71c0d8f664eca_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:StockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="icd272e9bdea14242a207e8aff8e2266e_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:StockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1ad6c128f57b4949a888c466705beca4_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:StockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i673355ef359540e592c71b0c9698de65_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:StockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id289f8fd821442c1a5d3cc80b9c40c2a_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia1edca8cccef478fbae52ae8fb77dfee_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i597a5458b92444dda6db7761d84ee082_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic81654dd29534869be7ad8d23a454adb_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i068019055ff349b0ba2c43c7bdcad5a5_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:StateOfFloridaSettlementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i201d84873cdc44b8a00591a48c940e6a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:StateOfFloridaSettlementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if80d8dd79ebc4415ad936ec2eebc9a64_D20120101-20121231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2012-01-01</startDate>
            <endDate>2012-12-31</endDate>
        </period>
    </context>
    <context id="ib401a332bf4543de8c13209d3b334652_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:RadcliffeAndFlaimVAetnaIncEtAlMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3962c203da554375b32683c47219d427_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie2694c12478b4def9c47ecb3ea71da60_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id75c1b3a512c4c79892d583882a1967c_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i44edbe7ef7ad43448a3b2d7631217636_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i3151b5f7456a43f18c1835c93c3d75af_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic9187390af124c90962d0c6a2b195568_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="icd5001431c3443ff88087eb017ad54d3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i21057757e50f4f2ea39ea7414498d440_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie4ddbdc32c264c4891a21d2f9fcead1d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i755c9c59fb084cf0998fe64e0d197ec9_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i991ced4046224c589a965f12944e86a9_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id55fb76a33f24129b20ebde108e75c89_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3bdb38f213f74f5ba49000631d9615b7_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i28d06c947ab54421a9e15efa5f456726_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="idf6b44713106481ab0b80236ef727531_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9ec2e1d871b94a40bc8202c2e78c4a16_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia0f6137335b9496e89f147de3d2c0b66_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i3203c39f39494e9b94ddb12984f8082f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4392ff7352894adabc22a650b7c08adb_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iea76a931684f4ae5b894d9b3eac6dabf_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i904838b1ae43477cbccf8a6438f44ca8_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3e5cd64cbc2d4ccabb220d0769a9469d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2e0586238be64c3f99884eb8d13d76cb_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:StateOfFloridaSettlementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8e046c9547cf4bf5b7545f9f74ee27f1_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:StateOfFloridaSettlementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if9b86cad51db4e70bd972f1f3cf0a9ea_D20210601-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="store">
        <measure>cvs:store</measure>
    </unit>
    <unit id="clinic">
        <measure>cvs:clinic</measure>
    </unit>
    <unit id="people">
        <measure>cvs:people</measure>
    </unit>
    <unit id="patient">
        <measure>cvs:patient</measure>
    </unit>
    <unit id="segment">
        <measure>cvs:Segment</measure>
    </unit>
    <unit id="state">
        <measure>cvs:state</measure>
    </unit>
    <unit id="member">
        <measure>cvs:member</measure>
    </unit>
    <unit id="security">
        <measure>cvs:security</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="lease">
        <measure>cvs:lease</measure>
    </unit>
    <unit id="claim">
        <measure>cvs:claim</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80L2ZyYWc6ZDRkYWNiN2NjN2UwNDU5MmFhZGQyZTU0MTE4ZTZlODEvdGFibGU6ZWY1MTE3MjgyMjUxNDcyMmJkODI4Y2JmZmUxZDQ5MjIvdGFibGVyYW5nZTplZjUxMTcyODIyNTE0NzIyYmQ4MjhjYmZmZTFkNDkyMl8zLTEtMS0xLTEyMTc5Nw_8c7a169b-ece2-4d35-b0b6-50e072c69515">0000064803</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80L2ZyYWc6ZDRkYWNiN2NjN2UwNDU5MmFhZGQyZTU0MTE4ZTZlODEvdGFibGU6ZWY1MTE3MjgyMjUxNDcyMmJkODI4Y2JmZmUxZDQ5MjIvdGFibGVyYW5nZTplZjUxMTcyODIyNTE0NzIyYmQ4MjhjYmZmZTFkNDkyMl80LTEtMS0xLTEyMTc5Nw_3360de2e-abff-40ff-b038-2237e9f87469">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80L2ZyYWc6ZDRkYWNiN2NjN2UwNDU5MmFhZGQyZTU0MTE4ZTZlODEvdGFibGU6ZWY1MTE3MjgyMjUxNDcyMmJkODI4Y2JmZmUxZDQ5MjIvdGFibGVyYW5nZTplZjUxMTcyODIyNTE0NzIyYmQ4MjhjYmZmZTFkNDkyMl81LTEtMS0xLTEyMTc5Nw_d7fae05c-5b2a-419e-a252-b98eae1db792">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80L2ZyYWc6ZDRkYWNiN2NjN2UwNDU5MmFhZGQyZTU0MTE4ZTZlODEvdGFibGU6ZWY1MTE3MjgyMjUxNDcyMmJkODI4Y2JmZmUxZDQ5MjIvdGFibGVyYW5nZTplZjUxMTcyODIyNTE0NzIyYmQ4MjhjYmZmZTFkNDkyMl82LTEtMS0xLTEyMTc5Nw_3676ec4a-781e-4582-a4d4-548c1d7d6696">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80L2ZyYWc6ZDRkYWNiN2NjN2UwNDU5MmFhZGQyZTU0MTE4ZTZlODEvdGFibGU6ZWY1MTE3MjgyMjUxNDcyMmJkODI4Y2JmZmUxZDQ5MjIvdGFibGVyYW5nZTplZjUxMTcyODIyNTE0NzIyYmQ4MjhjYmZmZTFkNDkyMl83LTEtMS0xLTEyMTc5Nw_d1d3eb0a-7765-4065-8d38-32a21add5ffe">false</dei:AmendmentFlag>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfOS0wLTEtMS0xMjE3OTc_160ea397-089c-4c69-9a75-1e41518644cc">http://fasb.org/us-gaap/2022#ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfOS0wLTEtMS0xMjE3OTc_20a62c90-3426-4729-933d-b5877901a94a">http://fasb.org/us-gaap/2022#ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfOS0wLTEtMS0xMjE3OTc_719a321b-4e2b-4d24-8046-f19cef0e0014">http://fasb.org/us-gaap/2022#ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfOS0wLTEtMS0xMjE3OTc_af9742cb-03e3-4e73-b493-02ef93572145">http://fasb.org/us-gaap/2022#ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81Mi0wLTEtMS0xMzcyNzU_6dc679d2-e622-45de-819a-6f36bb88bc8b">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations</us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81Mi0wLTEtMS0xMzcyNzU_7cf3c139-629e-4185-b686-0b6e8760e74e">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations</us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList>
    <dei:DocumentType
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGV4dHJlZ2lvbjo0M2E3NmE5ODFmMTA0Y2Q0YTZjY2MwNDU1NDU1NjBjMF84Ng_4d895fea-06ab-4a90-8439-b2fe63bb52b8">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGV4dHJlZ2lvbjo0M2E3NmE5ODFmMTA0Y2Q0YTZjY2MwNDU1NDU1NjBjMF8yMDI5_06fb7716-0c86-4945-8bee-b91c395a5db0">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGV4dHJlZ2lvbjo0M2E3NmE5ODFmMTA0Y2Q0YTZjY2MwNDU1NDU1NjBjMF8yMjQ_234c3b23-5126-4966-8bdd-d282662534a2">2022-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGV4dHJlZ2lvbjo0M2E3NmE5ODFmMTA0Y2Q0YTZjY2MwNDU1NDU1NjBjMF8yMDMy_d98ca8c8-7958-486d-b2f5-4b7efc20d79f">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGV4dHJlZ2lvbjo0M2E3NmE5ODFmMTA0Y2Q0YTZjY2MwNDU1NDU1NjBjMF8yMDMz_d1c87d39-e548-4f55-957c-e9f8817477ac">001-01011</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGV4dHJlZ2lvbjo0M2E3NmE5ODFmMTA0Y2Q0YTZjY2MwNDU1NDU1NjBjMF8yMDMw_680f66c8-5d65-41d4-8863-0696e319dc8c">CVS HEALTH CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGFibGU6MDUyNWUzMzVmMWU3NGU4NGFhZjc5YmVjY2FmNmQ2Y2UvdGFibGVyYW5nZTowNTI1ZTMzNWYxZTc0ZTg0YWFmNzliZWNjYWY2ZDZjZV8wLTAtMS0xLTEyMTc5Nw_1b9ca4d3-942d-4cb8-a708-8cbdd222b694">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGFibGU6MDUyNWUzMzVmMWU3NGU4NGFhZjc5YmVjY2FmNmQ2Y2UvdGFibGVyYW5nZTowNTI1ZTMzNWYxZTc0ZTg0YWFmNzliZWNjYWY2ZDZjZV8wLTItMS0xLTEyMTc5Nw_5df63beb-259d-4818-9fa0-e2fc9938a6ed">05-0494040</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGFibGU6ZmIzMDQ2ZmRmNjhmNDZlNTg3YjVmNGVkNjJhYjFjNmEvdGFibGVyYW5nZTpmYjMwNDZmZGY2OGY0NmU1ODdiNWY0ZWQ2MmFiMWM2YV8wLTEtMS0xLTEyMTc5Nw_6f5b9494-6480-4e02-9499-d9c46bc82fdd">One CVS Drive,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGFibGU6ZmIzMDQ2ZmRmNjhmNDZlNTg3YjVmNGVkNjJhYjFjNmEvdGFibGVyYW5nZTpmYjMwNDZmZGY2OGY0NmU1ODdiNWY0ZWQ2MmFiMWM2YV8wLTItMS0xLTEyMTc5Nw_1bef4c20-2695-43ba-a8e2-cce29c27c2fb">Woonsocket,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGFibGU6ZmIzMDQ2ZmRmNjhmNDZlNTg3YjVmNGVkNjJhYjFjNmEvdGFibGVyYW5nZTpmYjMwNDZmZGY2OGY0NmU1ODdiNWY0ZWQ2MmFiMWM2YV8wLTMtMS0xLTEyMTc5Nw_80667b9a-199a-414b-9355-6d02b0d193d7">RI</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGFibGU6ZmIzMDQ2ZmRmNjhmNDZlNTg3YjVmNGVkNjJhYjFjNmEvdGFibGVyYW5nZTpmYjMwNDZmZGY2OGY0NmU1ODdiNWY0ZWQ2MmFiMWM2YV8wLTUtMS0xLTEyMTc5Nw_f9a02857-042c-4ac1-8a0a-15bd529bf7f2">02895</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGFibGU6ZmIzMDQ2ZmRmNjhmNDZlNTg3YjVmNGVkNjJhYjFjNmEvdGFibGVyYW5nZTpmYjMwNDZmZGY2OGY0NmU1ODdiNWY0ZWQ2MmFiMWM2YV8zLTUtMS0xLTEyMTc5Nw_169e74e6-c974-4186-af60-7fd3dcb11558">(401)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGFibGU6ZmIzMDQ2ZmRmNjhmNDZlNTg3YjVmNGVkNjJhYjFjNmEvdGFibGVyYW5nZTpmYjMwNDZmZGY2OGY0NmU1ODdiNWY0ZWQ2MmFiMWM2YV8zLTYtMS0xLTEyMTc5Nw_16061125-f437-457d-955c-e5993cf95002">765-1500</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGFibGU6NTlhOWQxY2JkZmM5NGE3OGE0NmUxZmI3NDQ3MGQ1NjEvdGFibGVyYW5nZTo1OWE5ZDFjYmRmYzk0YTc4YTQ2ZTFmYjc0NDcwZDU2MV8xLTAtMS0xLTEyMTc5Nw_4f2aad97-cb1c-4bbf-a7d2-272c5f79aeb5">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGFibGU6NTlhOWQxY2JkZmM5NGE3OGE0NmUxZmI3NDQ3MGQ1NjEvdGFibGVyYW5nZTo1OWE5ZDFjYmRmYzk0YTc4YTQ2ZTFmYjc0NDcwZDU2MV8xLTEtMS0xLTEyMTc5Nw_2633d6cd-19e5-4315-b653-6af04dd27c28">CVS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGFibGU6NTlhOWQxY2JkZmM5NGE3OGE0NmUxZmI3NDQ3MGQ1NjEvdGFibGVyYW5nZTo1OWE5ZDFjYmRmYzk0YTc4YTQ2ZTFmYjc0NDcwZDU2MV8xLTItMS0xLTEyMTc5Nw_2b14e193-9832-4742-8439-38161f2e89fb">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGV4dHJlZ2lvbjo0M2E3NmE5ODFmMTA0Y2Q0YTZjY2MwNDU1NDU1NjBjMF8yMDI3_cef0a268-ddc4-478f-81dd-3ab6bfc28ad4">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGV4dHJlZ2lvbjo0M2E3NmE5ODFmMTA0Y2Q0YTZjY2MwNDU1NDU1NjBjMF8yMDI4_786f9a0c-c066-43ce-af68-b7e300d2390f">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGFibGU6ZTliMDQzNjE3MDQxNDI0NTllMzViYjA0ZDZkNjcyMGUvdGFibGVyYW5nZTplOWIwNDM2MTcwNDE0MjQ1OWUzNWJiMDRkNmQ2NzIwZV8wLTAtMS0xLTEyMTc5Nw_ea915210-3387-4b03-995f-16263e37ac7c">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGFibGU6ZTliMDQzNjE3MDQxNDI0NTllMzViYjA0ZDZkNjcyMGUvdGFibGVyYW5nZTplOWIwNDM2MTcwNDE0MjQ1OWUzNWJiMDRkNmQ2NzIwZV8xLTMtMS0xLTEyMTc5Nw_48789d26-472a-42ef-8d12-c3622ed0e42c">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGFibGU6ZTliMDQzNjE3MDQxNDI0NTllMzViYjA0ZDZkNjcyMGUvdGFibGVyYW5nZTplOWIwNDM2MTcwNDE0MjQ1OWUzNWJiMDRkNmQ2NzIwZV8yLTMtMS0xLTEyMTc5Nw_0d758d3d-2d6d-47f2-a868-6caec5a1d8e9">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGV4dHJlZ2lvbjo0M2E3NmE5ODFmMTA0Y2Q0YTZjY2MwNDU1NDU1NjBjMF8yMDMx_b8b0340c-7e4c-474b-88f3-1589a8ea2148">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i19f7bb9164614f549fb4be76ce9dab1a_I20220727"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xL2ZyYWc6NDNhNzZhOTgxZjEwNGNkNGE2Y2NjMDQ1NTQ1NTYwYzAvdGV4dHJlZ2lvbjo0M2E3NmE5ODFmMTA0Y2Q0YTZjY2MwNDU1NDU1NjBjMF8xOTc5_d2a84149-e93f-417e-9cfe-734b0356047f"
      unitRef="shares">1312828807</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i735a87c60de044ac9f25eb3f0ab9e911_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMy0xLTEtMS0xMjE3OTc_8005d24d-b9c7-4659-991e-162b01907614"
      unitRef="usd">56794000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia15d386324864519875ee9e5e2fd30c5_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMy0zLTEtMS0xMjE3OTc_1ec13d74-9ef2-445c-8e84-4071b321007c"
      unitRef="usd">50525000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ideaba68ef44648c6b282b6f6679adf93_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMy01LTEtMS0xMjE3OTc_116b1e04-5299-426b-86ff-cdbefd2e3e9e"
      unitRef="usd">109316000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifdc339e14e1d455eaa0c9a2b8396f603_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMy03LTEtMS0xMjE3OTc_7a63d5c8-ff32-42d9-8759-8ddac91c5d1a"
      unitRef="usd">97912000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:PremiumsEarnedNet
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNC0xLTEtMS0xMjE3OTc_17f68ac4-2cb7-47f1-a36f-1bab65edd180"
      unitRef="usd">21260000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNC0zLTEtMS0xMjE3OTc_c3dd59b8-af04-4779-b03a-cb43be2231de"
      unitRef="usd">18983000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNC01LTEtMS0xMjE3OTc_f2f91bbb-962b-4fc2-bc57-80d377dacfa0"
      unitRef="usd">42891000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNC03LTEtMS0xMjE3OTc_8b0e82b2-3c44-4ea4-ab11-4070db438966"
      unitRef="usd">37943000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i434909542d34451ea488689d9cca7066_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNS0xLTEtMS0xMjE3OTc_d5ca0b2f-51ca-47e0-87c3-5fc5527d6689"
      unitRef="usd">2436000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i06f559cafd184fa0885076b8d71d4ab2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNS0zLTEtMS0xMjE3OTc_493eeea9-1080-4fb3-9222-1d6d3d48cadd"
      unitRef="usd">2819000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2993c7eaedc041feab50da3fbcf43a01_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNS01LTEtMS0xMjE3OTc_75dfd8c4-2f67-4f49-9c5d-6e6712cf8344"
      unitRef="usd">4941000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i363a5d855b604ba1a4087bcdf1601a77_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNS03LTEtMS0xMjE3OTc_96b9bfd5-ea3c-441b-8aae-230e71f2999f"
      unitRef="usd">5272000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNi0xLTEtMS0xMjE3OTc_31718c78-1efd-4078-bf44-3e1b497a3267"
      unitRef="usd">146000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNi0zLTEtMS0xMjE3OTc_36502afb-f958-4701-9722-3f0b7416f66a"
      unitRef="usd">289000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNi01LTEtMS0xMjE3OTc_be07941a-c8de-473c-b4f0-27dbd4d791b3"
      unitRef="usd">314000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNi03LTEtMS0xMjE3OTc_124ab4da-081a-4c6d-accf-5c48be5d4eb1"
      unitRef="usd">586000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNy0xLTEtMS0xMjE3OTc_1b67120b-4080-4ebf-ad80-513e75000d88"
      unitRef="usd">80636000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNy0zLTEtMS0xMjE3OTc_62aba0a4-a333-449a-9db1-8986913e8847"
      unitRef="usd">72616000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNy01LTEtMS0xMjE3OTc_4be644f4-bc46-4ea7-96a6-96c77998e023"
      unitRef="usd">157462000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNy03LTEtMS0xMjE3OTc_7eff4f91-0b9f-498b-af76-fcc52e1dd88f"
      unitRef="usd">141713000000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfOS0xLTEtMS0xMjE3OTc_f254d1a4-2173-4972-8e38-afc0f97cb527"
      unitRef="usd">49290000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfOS0zLTEtMS0xMjE3OTc_5257a9da-0cba-43e0-8b93-654dcf013cc2"
      unitRef="usd">43520000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfOS01LTEtMS0xMjE3OTc_15cffdcc-0cba-430b-971f-95aac2bcc6a7"
      unitRef="usd">94799000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfOS03LTEtMS0xMjE3OTc_989c04f2-72fc-413f-b10d-047a96cebd15"
      unitRef="usd">84414000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTAtMS0xLTEtMTIxNzk3_1f8b073a-45e3-4a6b-92f6-e3b5caf8c17e"
      unitRef="usd">17606000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTAtMy0xLTEtMTIxNzk3_ac100ab0-aa51-42d8-9df5-baabeb507cfa"
      unitRef="usd">15901000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTAtNS0xLTEtMTIxNzk3_335d853b-bf48-42f6-8269-1fd0d8e7adb2"
      unitRef="usd">35557000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTAtNy0xLTEtMTIxNzk3_40ad683e-efd5-47d7-968e-3cfbb425731a"
      unitRef="usd">31605000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:OperatingExpenses
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTItMS0xLTEtMTIxNzk3_3b280f87-ca29-44f7-941b-3d0386267f90"
      unitRef="usd">9171000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTItMy0xLTEtMTIxNzk3_1e8a5040-7e9b-4040-87fb-118cb0e37766"
      unitRef="usd">8869000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTItNS0xLTEtMTIxNzk3_b25dc1ba-5d02-430c-a62e-8aedeb363446"
      unitRef="usd">19047000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTItNy0xLTEtMTIxNzk3_c4e70187-bfe4-4390-9e55-f2d32d461155"
      unitRef="usd">17791000000</us-gaap:OperatingExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTMtMS0xLTEtMTIxNzk3_8dfe6c20-d77f-44b2-8ba4-2354d76f1f70"
      unitRef="usd">76067000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTMtMy0xLTEtMTIxNzk3_cf20f4ee-91d0-4883-99ff-1be3c4f66d6a"
      unitRef="usd">68290000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTMtNS0xLTEtMTIxNzk3_5e41b749-7c7a-41a5-8a1a-113a866d9bb9"
      unitRef="usd">149403000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTMtNy0xLTEtMTIxNzk3_0e15d176-19f9-4542-8b6d-7a7a90332c5a"
      unitRef="usd">133810000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTQtMS0xLTEtMTIxNzk3_db38508a-2e3d-4819-8c0b-aa1df7a87cfc"
      unitRef="usd">4569000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTQtMy0xLTEtMTIxNzk3_b1820df7-684a-4403-aecd-78e7526ff1a7"
      unitRef="usd">4326000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTQtNS0xLTEtMTIxNzk3_59dc4fd5-97f8-4745-9928-30012ff95d5e"
      unitRef="usd">8059000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTQtNy0xLTEtMTIxNzk3_38d0b4b1-1370-4e0e-af64-5f9a3a25b5a9"
      unitRef="usd">7903000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTUtMS0xLTEtMTIxNzk3_2ad1f24e-e98d-482a-b815-62e7fe93779a"
      unitRef="usd">583000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTUtMy0xLTEtMTIxNzk3_835a43e7-6247-4a84-87a7-d124b2204ac7"
      unitRef="usd">636000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTUtNS0xLTEtMTIxNzk3_fcd0b1d1-3c12-4912-a1c3-acfc7f7b2709"
      unitRef="usd">1169000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTUtNy0xLTEtMTIxNzk3_10f48507-6ac8-4878-8767-f85abe8a1644"
      unitRef="usd">1293000000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTctMS0xLTEtMTIxNzk3_09c12506-ea7c-4bfe-86d4-95f45c378733"
      unitRef="usd">43000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTctMy0xLTEtMTIxNzk3_c31c73df-3b9e-4848-9204-b30d888a3ff5"
      unitRef="usd">45000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTctNS0xLTEtMTIxNzk3_1730b534-056a-4059-8973-74e682393cfb"
      unitRef="usd">85000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTctNy0xLTEtMTIxNzk3_4ce4d610-4f62-46af-91e0-e99d74008db4"
      unitRef="usd">95000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTgtMS0xLTEtMTIxNzk3_a05767b9-839e-48a1-8f64-e422b49aa77d"
      unitRef="usd">4029000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTgtMy0xLTEtMTIxNzk3_d9ddf656-8bc7-4944-b442-8cb3fb310f41"
      unitRef="usd">3735000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTgtNS0xLTEtMTIxNzk3_b63be615-45a1-4d8e-a9fd-a4606608c25c"
      unitRef="usd">6975000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTgtNy0xLTEtMTIxNzk3_6a90b9c5-204f-4d33-8aa9-f81cd28ccc35"
      unitRef="usd">6705000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTktMS0xLTEtMTIxNzk3_f8f04699-d7ae-44ea-a510-8f7867614406"
      unitRef="usd">1068000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTktMy0xLTEtMTIxNzk3_7402b16a-96a2-43bc-8fe8-638ad2a2f5bc"
      unitRef="usd">944000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTktNS0xLTEtMTIxNzk3_048b7ddb-c23d-4c65-bcab-3bd984d0ef42"
      unitRef="usd">1701000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMTktNy0xLTEtMTIxNzk3_c6e884a4-15fc-4886-9e8e-45fc66f4a8ef"
      unitRef="usd">1690000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjItMS0xLTEtMTIxNzk3_983be846-49f2-490f-98a1-b92cdc3102cc"
      unitRef="usd">2961000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjItMy0xLTEtMTIxNzk3_ac43508d-a865-4f75-bec0-ee030cbfb9d2"
      unitRef="usd">2791000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjItNS0xLTEtMTIxNzk3_af22c5b4-cc87-43fb-a555-be278fe41108"
      unitRef="usd">5274000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjItNy0xLTEtMTIxNzk3_d9234a80-69d4-4c73-8b81-8c5627ce30b4"
      unitRef="usd">5015000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjMtMS0xLTEtMTIxNzk3_277e9b9c-93ab-4946-beea-bae6b1c0a27c"
      unitRef="usd">10000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjMtMy0xLTEtMTIxNzk3_9deec45b-a6e8-43ee-897e-da209c8cc9b6"
      unitRef="usd">8000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjMtNS0xLTEtMTIxNzk3_18193c25-6910-4531-a4bb-1e50c4451eef"
      unitRef="usd">11000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjMtNy0xLTEtMTIxNzk3_903a8dfb-17fa-4a86-8160-95c18fac2ce5"
      unitRef="usd">9000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjQtMS0xLTEtMTIxNzk3_1aaabb70-bd86-44d7-a3e1-e218d993f612"
      unitRef="usd">2951000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjQtMy0xLTEtMTIxNzk3_f464f0a5-c106-439b-986e-e82fae9db659"
      unitRef="usd">2783000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjQtNS0xLTEtMTIxNzk3_d3186575-4aff-4b91-9f4a-1bf0cc273c41"
      unitRef="usd">5263000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjQtNy0xLTEtMTIxNzk3_3f81e086-2261-4679-921f-bb3dafa033b4"
      unitRef="usd">5006000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjctMS0xLTEtMTIxNzk3_d52eb521-4773-4a37-b6df-b48705e8bc49"
      unitRef="usdPerShare">2.25</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjctMy0xLTEtMTIxNzk3_da312616-83cc-429c-a550-ab0400a4a098"
      unitRef="usdPerShare">2.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjctNS0xLTEtMTIxNzk3_3d822908-2b1d-4a7c-849f-0d563281f381"
      unitRef="usdPerShare">4.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjctNy0xLTEtMTIxNzk3_670f11a0-b600-4143-b457-22526ade7c24"
      unitRef="usdPerShare">3.80</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjgtMS0xLTEtMTIxNzk3_3ded30a7-6d7b-4d90-9f1b-1a1982b26b50"
      unitRef="usdPerShare">2.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjgtMy0xLTEtMTIxNzk3_9ff4f381-5f9f-4f37-a1a0-95734c904417"
      unitRef="usdPerShare">2.10</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjgtNS0xLTEtMTIxNzk3_8571bce3-331b-4aa4-a140-4cafa3f2af29"
      unitRef="usdPerShare">3.97</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMjgtNy0xLTEtMTIxNzk3_6c45191f-02aa-4f8b-8df8-1f103d8976a7"
      unitRef="usdPerShare">3.78</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMzAtMS0xLTEtMTIxNzk3_aa7e5b7a-698f-41b7-8429-73ff3ac5f8ad"
      unitRef="shares">1313000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMzAtMy0xLTEtMTIxNzk3_a127c934-3b00-4ef7-ada4-75f14c09e95f"
      unitRef="shares">1319000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMzAtNS0xLTEtMTIxNzk3_a8b5b78b-1833-49c5-a187-93d477a77329"
      unitRef="shares">1312000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMzAtNy0xLTEtMTIxNzk3_32c654ca-f1ea-4573-aa98-fddc5982efd4"
      unitRef="shares">1316000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMzEtMS0xLTEtMTIxNzk3_7691591e-a7cf-4b8c-986d-adc2d670cbf9"
      unitRef="shares">1321000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMzEtMy0xLTEtMTIxNzk3_ff42000b-9383-4bb3-b247-1f884a4daa3b"
      unitRef="shares">1327000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMzEtNS0xLTEtMTIxNzk3_52c4c58b-be70-4edd-b85c-47edc82c2a0d"
      unitRef="shares">1325000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfMzEtNy0xLTEtMTIxNzk3_b64c4cf2-9ddd-44da-bda1-d1d20d12a4e3"
      unitRef="shares">1325000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNDItMS0xLTEtMTIxNzk3_f9759790-799b-491b-9959-2556e8b3ea33"
      unitRef="usdPerShare">0.55</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNDItMy0xLTEtMTIxNzk3_405efe83-2014-4203-81c8-41169ee11a3a"
      unitRef="usdPerShare">0.50</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNDItNS0xLTEtMTIxNzk3_43b10d4d-eb6a-44ca-b56d-c6f898290dbf"
      unitRef="usdPerShare">1.10</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xOS9mcmFnOjllYTM2OTg0YWZlYzRmNDdhNzU5YTMxYWU5NTg0YzI2L3RhYmxlOmM0OWRlYTY5MzdjZDRmMjlhZWMxNjBhZmI3NGE0NmY2L3RhYmxlcmFuZ2U6YzQ5ZGVhNjkzN2NkNGYyOWFlYzE2MGFmYjc0YTQ2ZjZfNDItNy0xLTEtMTIxNzk3_2c7a49e7-806c-46af-aa2e-21f1a21d6352"
      unitRef="usdPerShare">1.00</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:ProfitLoss
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfMi0xLTEtMS0xMjE3OTc_983be846-49f2-490f-98a1-b92cdc3102cc"
      unitRef="usd">2961000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfMi0zLTEtMS0xMjE3OTc_ac43508d-a865-4f75-bec0-ee030cbfb9d2"
      unitRef="usd">2791000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfMi01LTEtMS0xMjE3OTc_af22c5b4-cc87-43fb-a555-be278fe41108"
      unitRef="usd">5274000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfMi03LTEtMS0xMjE3OTc_d9234a80-69d4-4c73-8b81-8c5627ce30b4"
      unitRef="usd">5015000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNC0xLTEtMS0xMjE3OTc_90e17bbb-82e2-4072-b140-6ff7e446944d"
      unitRef="usd">-813000000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNC0zLTEtMS0xMjE3OTc_a2de8936-8ecc-4adf-a831-e2403a0425e7"
      unitRef="usd">149000000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNC01LTEtMS0xMjE3OTc_40746b58-b29f-47c0-88c9-750684580763"
      unitRef="usd">-1968000000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNC03LTEtMS0xMjE3OTc_2f4e15f6-c19d-4924-abc3-40fbffc9b329"
      unitRef="usd">-237000000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNS0xLTEtMS0xMjE3OTc_3a3fc48e-5b04-4ada-ba14-c4136903fc24"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNS0zLTEtMS0xMjE3OTc_4542449d-d901-4afa-a665-2494a1c04fce"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNS01LTEtMS0xMjE3OTc_a67bf679-7a14-4832-92da-d39f9f1bfc89"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNS03LTEtMS0xMjE3OTc_ebde053c-991c-4a85-9014-9dd8978b3352"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNi0xLTEtMS0xMjE3OTc_9eebd660-9164-4268-bf0b-85ee108ef34c"
      unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNi0zLTEtMS0xMjE3OTc_d3f30f22-3dcb-4c4b-9f8e-db5facb990a3"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNi01LTEtMS0xMjE3OTc_7197054b-9e23-4a75-859f-7a2918a4099a"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNi03LTEtMS0xMjE3OTc_6e2cd8ee-8498-49a6-92e8-b40ed7a14e1a"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNy0xLTEtMS0xMjE3OTc_a3783c1d-1c7d-4dd9-b104-339735cdec56"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNy0zLTEtMS0xMjE3OTc_74f43e28-b00b-4116-90a8-7678922a5cf9"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNy01LTEtMS0xMjE3OTc_45c9c89a-3584-4bb0-9a91-b5989c082cf8"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfNy03LTEtMS0xMjE3OTc_7cc2f951-6522-4982-b576-c046a6eabed1"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfOC0xLTEtMS0xMjE3OTc_aa440dec-1c5b-42ab-895f-0b8cc7126d5f"
      unitRef="usd">-798000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfOC0zLTEtMS0xMjE3OTc_6ce9934b-1102-4f49-be00-09275310fc34"
      unitRef="usd">148000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfOC01LTEtMS0xMjE3OTc_642c2039-3a27-4b6a-8d27-178e8e0b8867"
      unitRef="usd">-1953000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfOC03LTEtMS0xMjE3OTc_35971b4a-e8b7-4fa8-9268-2c35b87963db"
      unitRef="usd">-244000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfOS0xLTEtMS0xMjE3OTc_9e250154-3376-4ea9-8d23-978d4bee0bf6"
      unitRef="usd">2163000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfOS0zLTEtMS0xMjE3OTc_eea96009-37d9-45bd-9f72-92030bf34d6d"
      unitRef="usd">2939000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfOS01LTEtMS0xMjE3OTc_ed015c46-9a6c-4763-aad1-0f82a90b62ff"
      unitRef="usd">3321000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfOS03LTEtMS0xMjE3OTc_c0f8b71a-6f05-4fe0-9a27-fd5ef110f9ca"
      unitRef="usd">4771000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfMTAtMS0xLTEtMTIxNzk3_277e9b9c-93ab-4946-beea-bae6b1c0a27c"
      unitRef="usd">10000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfMTAtMy0xLTEtMTIxNzk3_01fd8de4-130d-4a9e-9b1b-e723b23c3d70"
      unitRef="usd">8000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfMTAtNS0xLTEtMTIxNzk3_18193c25-6910-4531-a4bb-1e50c4451eef"
      unitRef="usd">11000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfMTAtNy0xLTEtMTIxNzk3_903a8dfb-17fa-4a86-8160-95c18fac2ce5"
      unitRef="usd">9000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfMTEtMS0xLTEtMTIxNzk3_7fc49a1e-7f69-467f-b4dd-9beacf2eee06"
      unitRef="usd">2153000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfMTEtMy0xLTEtMTIxNzk3_d0c2b77b-b525-45fb-a1a8-9504dedf5fc4"
      unitRef="usd">2931000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfMTEtNS0xLTEtMTIxNzk3_03b97734-de05-40e4-9e98-0aa8c112ed2d"
      unitRef="usd">3310000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yMi9mcmFnOmIwNDAxOGNkYWEwNDRjY2NiZmI5NWMyMzkwM2ZlYmVmL3RhYmxlOmE4YzBjMDkxZTVkNDQ0Nzc4NDA3MWM0YmFiNDYwYTk4L3RhYmxlcmFuZ2U6YThjMGMwOTFlNWQ0NDQ3Nzg0MDcxYzRiYWI0NjBhOThfMTEtNy0xLTEtMTIxNzk3_30d6c5fe-2a31-4dfa-a3d4-f6e06b2d567d"
      unitRef="usd">4762000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMi0xLTEtMS0xMjE3OTc_bc70507c-f3d5-4616-80fa-3dd379c11c54"
      unitRef="usd">12116000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMi0zLTEtMS0xMjE3OTc_edb119ab-aa13-47e5-8aaf-c39508520fc0"
      unitRef="usd">9408000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMy0xLTEtMS0xMjE3OTc_21f1a6d8-fe04-41b7-a830-1e4057a6f1db"
      unitRef="usd">2877000000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMy0zLTEtMS0xMjE3OTc_42338b03-2498-4432-90e0-affd34ab9d8e"
      unitRef="usd">3117000000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNC0xLTEtMS0xMjE3OTc_9ef1e9f9-c970-4142-b31e-7dcde016dc3c"
      unitRef="usd">27233000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNC0zLTEtMS0xMjE3OTc_14f35731-29c5-4cd6-98c7-62805368272b"
      unitRef="usd">24431000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNS0xLTEtMS0xMjE3OTc_2b52b9a5-8661-4d41-8c0d-1a044d94d353"
      unitRef="usd">17375000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNS0zLTEtMS0xMjE3OTc_7f73cf11-6485-4ec2-9a02-d14f419b5d12"
      unitRef="usd">17760000000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNi0xLTEtMS0xMjE3OTc_83527418-3634-400c-b4b1-fae01717c787"
      unitRef="usd">2541000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNi0zLTEtMS0xMjE3OTc_7f91bec4-27af-4ca4-86c9-f5a04f12a2e7"
      unitRef="usd">5292000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNy0xLTEtMS0xMjE3OTc_de19ed7c-c89e-4eee-be90-b13fcb16c2c1"
      unitRef="usd">62142000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNy0zLTEtMS0xMjE3OTc_d14f32ab-de55-4e38-9211-2bb75cb560de"
      unitRef="usd">60008000000</us-gaap:AssetsCurrent>
    <us-gaap:LongTermInvestments
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfOC0xLTEtMS0xMjE3OTc_44f2585f-42c2-42fc-b985-f58f5d7e72dd"
      unitRef="usd">21124000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfOC0zLTEtMS0xMjE3OTc_ec0fc9d4-3831-4762-a7cd-ee353ec8e1ab"
      unitRef="usd">23025000000</us-gaap:LongTermInvestments>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfOS0xLTEtMS0xMjE3OTc_3fc70635-e9fe-488d-bb37-9f5dc3e31fc7"
      unitRef="usd">12764000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfOS0zLTEtMS0xMjE3OTc_29b0f59a-36b4-40b4-a926-5b08bf4c3543"
      unitRef="usd">12896000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTAtMS0xLTEtMTIxNzk3_8133ef92-c1e0-45ff-80fb-4d848732d02d"
      unitRef="usd">18562000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTAtMy0xLTEtMTIxNzk3_d7847448-2b3a-488a-a14b-13466713e558"
      unitRef="usd">19122000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTEtMS0xLTEtMTIxNzk3_7ea6d280-0c29-46e5-b0f0-9754054d65a9"
      unitRef="usd">78560000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTEtMy0xLTEtMTIxNzk3_8cb0cdf5-8ead-46ef-a229-40eb889d22ab"
      unitRef="usd">79121000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTItMS0xLTEtMTIxNzk3_eae2bbb9-6613-45a4-8c9d-af33f9287632"
      unitRef="usd">28135000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTItMy0xLTEtMTIxNzk3_03cfd3fe-c259-4579-9637-045adb60feb1"
      unitRef="usd">29026000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:SeparateAccountAssets
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTMtMS0xLTEtMTIxNzk3_79b5fd13-9219-4571-9858-fedcd3d0fa04"
      unitRef="usd">4140000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTMtMy0xLTEtMTIxNzk3_e017503b-6363-4fd0-86ec-2f356d8ba577"
      unitRef="usd">5087000000</us-gaap:SeparateAccountAssets>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTQtMS0xLTEtMTIxNzk3_2db7310a-b964-4f14-98ae-4a7ef9d1844d"
      unitRef="usd">4852000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTQtMy0xLTEtMTIxNzk3_29699511-a779-4751-a354-c3cff4820228"
      unitRef="usd">4714000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTUtMS0xLTEtMTIxNzk3_d1fcee79-4e1b-41f1-b0c4-53a0365d6636"
      unitRef="usd">230279000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTUtMy0xLTEtMTIxNzk3_1058ac0e-caac-4de3-b1fe-7057506baa5a"
      unitRef="usd">232999000000</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTgtMS0xLTEtMTIxNzk3_c7e5cfdb-8aba-41b4-9383-bfde15a379db"
      unitRef="usd">13238000000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTgtMy0xLTEtMTIxNzk3_79746230-03ad-46a4-94e1-88418179f58a"
      unitRef="usd">12544000000</us-gaap:AccountsPayableTradeCurrent>
    <cvs:PharmacyClaimsandDiscountsPayableCurrent
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTktMS0xLTEtMTIxNzk3_433105f4-3195-45ad-ba93-0514af1f9099"
      unitRef="usd">18393000000</cvs:PharmacyClaimsandDiscountsPayableCurrent>
    <cvs:PharmacyClaimsandDiscountsPayableCurrent
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMTktMy0xLTEtMTIxNzk3_2c150d6c-00e7-4290-bc6a-ff47dc59f10e"
      unitRef="usd">17330000000</cvs:PharmacyClaimsandDiscountsPayableCurrent>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjAtMS0xLTEtMTIxNzk3_66e5432b-8ae8-4d72-bad9-582af6b838c7"
      unitRef="usd">10400000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjAtMy0xLTEtMTIxNzk3_b7b22819-e99a-4d29-8309-afc9655b7f78"
      unitRef="usd">8808000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:OtherPolicyholderFunds
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjEtMS0xLTEtMTIxNzk3_74e93b2c-51bf-4d21-97bd-2f9861ce2994"
      unitRef="usd">1628000000</us-gaap:OtherPolicyholderFunds>
    <us-gaap:OtherPolicyholderFunds
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjEtMy0xLTEtMTIxNzk3_f370b173-9326-46b3-bd68-72961ffb7c6f"
      unitRef="usd">4301000000</us-gaap:OtherPolicyholderFunds>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjItMS0xLTEtMTIxNzk3_cc8d0760-e98f-4cbe-8923-69a4b89b79ef"
      unitRef="usd">17728000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjItMy0xLTEtMTIxNzk3_264c06a9-0143-47ca-bb00-9cce72325dfc"
      unitRef="usd">17670000000</us-gaap:AccruedLiabilitiesCurrent>
    <cvs:OtherInsuranceLiabilitiesCurrent
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjMtMS0xLTEtMTIxNzk3_cbe961b2-de8d-4e12-92bc-6ad259a61711"
      unitRef="usd">1197000000</cvs:OtherInsuranceLiabilitiesCurrent>
    <cvs:OtherInsuranceLiabilitiesCurrent
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjMtMy0xLTEtMTIxNzk3_014063a6-49b1-4fa3-9f74-056166542b09"
      unitRef="usd">1303000000</cvs:OtherInsuranceLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjQtMS0xLTEtMTIxNzk3_f941f9fb-d7d3-4096-8021-24a4feb13c81"
      unitRef="usd">1854000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjQtMy0xLTEtMTIxNzk3_19aeac77-36a8-437c-95fe-4858519f4b71"
      unitRef="usd">1646000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjYtMS0xLTEtMTIxNzk3_3dc82706-e66a-4fd1-b0b4-731787c89666"
      unitRef="usd">4019000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjYtMy0xLTEtMTIxNzk3_05cfee25-8f4a-4ea0-8bd1-4d68f86a832e"
      unitRef="usd">4205000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjctMS0xLTEtMTIxNzk3_d98da68c-d599-4555-94f7-23bc60286bd6"
      unitRef="usd">68457000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjctMy0xLTEtMTIxNzk3_d2cf1172-06cb-4ea6-8d61-692da507be84"
      unitRef="usd">67807000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjgtMS0xLTEtMTIxNzk3_41cdc8d5-d52e-4fba-84cf-cd3058292d95"
      unitRef="usd">17502000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjgtMy0xLTEtMTIxNzk3_a55fdd05-8b61-4a91-932a-f162e21488e7"
      unitRef="usd">18177000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjktMS0xLTEtMTIxNzk3_5ba32119-4680-43f2-b213-18f5ccc63162"
      unitRef="usd">50797000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMjktMy0xLTEtMTIxNzk3_79a24104-e0f7-40dc-96cf-55941d6761c5"
      unitRef="usd">51971000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzAtMS0xLTEtMTIxNzk3_1b4b549f-39bb-4444-a7bf-f1828c044a1d"
      unitRef="usd">5450000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzAtMy0xLTEtMTIxNzk3_5bd78e5a-0060-4acc-b741-034437e71345"
      unitRef="usd">6270000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:SeparateAccountsLiability
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzEtMS0xLTEtMTIxNzk3_99e333f3-e5f5-4fac-9483-a44b1b9b8b6e"
      unitRef="usd">4140000000</us-gaap:SeparateAccountsLiability>
    <us-gaap:SeparateAccountsLiability
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzEtMy0xLTEtMTIxNzk3_545b3dbc-c53f-49e4-95e8-77eecbdb11af"
      unitRef="usd">5087000000</us-gaap:SeparateAccountsLiability>
    <cvs:OtherInsuranceLiabilitiesNoncurrent
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzItMS0xLTEtMTIxNzk3_4f544bd5-cf9f-4953-b325-f39911b9e0fe"
      unitRef="usd">6287000000</cvs:OtherInsuranceLiabilitiesNoncurrent>
    <cvs:OtherInsuranceLiabilitiesNoncurrent
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzItMy0xLTEtMTIxNzk3_71c4363a-55b0-41ca-8312-6d0d8f2eacfb"
      unitRef="usd">6402000000</cvs:OtherInsuranceLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzMtMS0xLTEtMTIxNzk3_45e2fc9d-9c38-4b6d-988b-3710846da519"
      unitRef="usd">2140000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzMtMy0xLTEtMTIxNzk3_6993b0d5-cf2f-4644-b2ab-90f9f910b6d2"
      unitRef="usd">1904000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzQtMS0xLTEtMTIxNzk3_d5b607da-1a11-4764-b4cd-932bc1c73381"
      unitRef="usd">154773000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzQtMy0xLTEtMTIxNzk3_a2949ca3-bdb6-4630-aade-28b64acc5149"
      unitRef="usd">157618000000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzctMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MDVlNzJjZTgxNjJlNDA5N2E4Yjc5ZWVlZWQ3NjU4MmJfMzE_79616cf4-a2f8-4323-b8b4-0515e28f8baf"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzctMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MDVlNzJjZTgxNjJlNDA5N2E4Yjc5ZWVlZWQ3NjU4MmJfMzE_8130af97-a1df-4ae0-83e1-43a8f0599074"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzctMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MDVlNzJjZTgxNjJlNDA5N2E4Yjc5ZWVlZWQ3NjU4MmJfMzU_279874f7-adce-41ef-9543-76d739ff9076"
      unitRef="shares">100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzctMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MDVlNzJjZTgxNjJlNDA5N2E4Yjc5ZWVlZWQ3NjU4MmJfMzU_e5398018-2450-4b35-a866-7cd627c652ef"
      unitRef="shares">100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzctMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MDVlNzJjZTgxNjJlNDA5N2E4Yjc5ZWVlZWQ3NjU4MmJfNTc_13d79c1e-6519-453e-95da-c84481142782"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzctMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MDVlNzJjZTgxNjJlNDA5N2E4Yjc5ZWVlZWQ3NjU4MmJfNTc_34706be3-5ba7-4ea6-af21-4888235036d7"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzctMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MDVlNzJjZTgxNjJlNDA5N2E4Yjc5ZWVlZWQ3NjU4MmJfNTc_86208729-e4f6-457b-9045-a2beb39c48e6"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzctMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MDVlNzJjZTgxNjJlNDA5N2E4Yjc5ZWVlZWQ3NjU4MmJfNTc_cf1b947a-496e-4ace-b18d-b426ec99550c"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzctMS0xLTEtMTIxNzk3_2a79bfad-de6e-45ec-a889-45cdc1a942a2"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzctMy0xLTEtMTIxNzk3_0e492b28-9c21-4606-88a6-86a8aef30201"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzgtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MmU2NTNlNjQzOTEzNDA5YTg2NWQ5M2E3NzA5NzYxNzlfMjg_1114199c-90a6-4dea-aced-69bfc50c9df6"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzgtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MmU2NTNlNjQzOTEzNDA5YTg2NWQ5M2E3NzA5NzYxNzlfMjg_1c4bfc6c-a895-4e4e-9fe6-8673670d0140"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzgtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MmU2NTNlNjQzOTEzNDA5YTg2NWQ5M2E3NzA5NzYxNzlfMzI_551c7b51-09d6-429f-a1ee-010e47bcc925"
      unitRef="shares">3200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzgtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MmU2NTNlNjQzOTEzNDA5YTg2NWQ5M2E3NzA5NzYxNzlfMzI_b6b5535f-dbef-4532-bf45-98bcb170dc6a"
      unitRef="shares">3200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzgtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MmU2NTNlNjQzOTEzNDA5YTg2NWQ5M2E3NzA5NzYxNzlfNTQ_1e1c62c1-73d9-4bc7-ae39-59950e1a17c4"
      unitRef="shares">1755000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzgtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MmU2NTNlNjQzOTEzNDA5YTg2NWQ5M2E3NzA5NzYxNzlfNzU_4a2cb899-9d49-4d35-b3ca-faed0cf47ac9"
      unitRef="shares">1312000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzgtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MmU2NTNlNjQzOTEzNDA5YTg2NWQ5M2E3NzA5NzYxNzlfMTA3_ee2521b1-a9ea-4ec0-a4a1-efeb6d3caaf0"
      unitRef="shares">1744000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzgtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246MmU2NTNlNjQzOTEzNDA5YTg2NWQ5M2E3NzA5NzYxNzlfMTI4_11227be8-d86d-40fb-bfb0-e719f20a2e1c"
      unitRef="shares">1322000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStocksIncludingAdditionalPaidInCapital
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzgtMS0xLTEtMTIxNzk3_1ff8646f-8a4c-4113-a29c-2b89ae903ce2"
      unitRef="usd">47874000000</us-gaap:CommonStocksIncludingAdditionalPaidInCapital>
    <us-gaap:CommonStocksIncludingAdditionalPaidInCapital
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzgtMy0xLTEtMTIxNzk3_3abda348-bf3b-4538-8928-565c49d3b541"
      unitRef="usd">47377000000</us-gaap:CommonStocksIncludingAdditionalPaidInCapital>
    <us-gaap:TreasuryStockShares
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzktMC0xLTEtMTIxNzk3L3RleHRyZWdpb246NzQwMWEwYWIwNWViNDkwZGJhZmYxMjJlMmMyZmE3ZjFfMjk_996f00b3-8c7c-4abd-81e9-955e5bde7939"
      unitRef="shares">443000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzktMC0xLTEtMTIxNzk3L3RleHRyZWdpb246NzQwMWEwYWIwNWViNDkwZGJhZmYxMjJlMmMyZmE3ZjFfNDk_7e8819ca-4d4b-4309-9cd2-d8b8a02ac287"
      unitRef="shares">422000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzktMS0xLTEtMTIxNzk3_db25bf46-f5aa-43c4-843b-797a878a0ed2"
      unitRef="usd">30412000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfMzktMy0xLTEtMTIxNzk3_69ce047c-8b71-4fc1-8dc3-2c79a93240ae"
      unitRef="usd">28173000000</us-gaap:TreasuryStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNDAtMS0xLTEtMTIxNzk3_13bbd494-9fb4-4a3b-be24-b90ebcd2fc61"
      unitRef="usd">58710000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNDAtMy0xLTEtMTIxNzk3_c85cd752-1c59-435a-b914-d2acd2d4eeac"
      unitRef="usd">54906000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNDEtMS0xLTEtMTIxNzk3_0239cb9e-0a7d-451c-bded-9b231cc7d81d"
      unitRef="usd">-988000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNDEtMy0xLTEtMTIxNzk3_9de5066f-d8ae-40af-adf6-4c55151ea1a3"
      unitRef="usd">965000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNDItMS0xLTEtMTIxNzk3_2b56564e-f87d-438c-962b-0fb5bb510fd8"
      unitRef="usd">75184000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNDItMy0xLTEtMTIxNzk3_2f9af450-a712-4b4a-87f5-bcd63a904dab"
      unitRef="usd">75075000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNDMtMS0xLTEtMTIxNzk3_74a500be-124a-49ae-875d-a0b5794b6792"
      unitRef="usd">322000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNDMtMy0xLTEtMTIxNzk3_332ccf28-597f-49dc-8345-a2d4eb17cc74"
      unitRef="usd">306000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNDQtMS0xLTEtMTIxNzk3_afd3aafd-bcc1-4f31-b9ff-6ffcabedd81e"
      unitRef="usd">75506000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNDQtMy0xLTEtMTIxNzk3_dcbbd177-8554-4dbd-877b-1af3515e4876"
      unitRef="usd">75381000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNDUtMS0xLTEtMTIxNzk3_1bb4f8ec-8ad7-48ec-8fe3-dfffb021e8ba"
      unitRef="usd">230279000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yNS9mcmFnOjllYmM0MDBjYTBmMTQ1YmE4OWRmZDVkNzg5MTRmYjFjL3RhYmxlOmMzMWE4Nzc1MzY4YTQ0ODZiOTFmYTIzMGI0NGI4NWRiL3RhYmxlcmFuZ2U6YzMxYTg3NzUzNjhhNDQ4NmI5MWZhMjMwYjQ0Yjg1ZGJfNDUtMy0xLTEtMTIxNzk3_e340cc17-1a94-4350-a443-9071621cda64"
      unitRef="usd">232999000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProceedsFromCustomers
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMy0xLTEtMS0xMjE3OTc_cb1986a5-8b93-40b4-97a4-dd39cab2abc1"
      unitRef="usd">151769000000</us-gaap:ProceedsFromCustomers>
    <us-gaap:ProceedsFromCustomers
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMy0zLTEtMS0xMjE3OTc_f5b6bbad-1122-4fce-8e27-cf3ae8bca444"
      unitRef="usd">136621000000</us-gaap:ProceedsFromCustomers>
    <cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfNC0xLTEtMS0xMjE3OTc_45511d32-15a9-4608-ab99-0238fc4b44c1"
      unitRef="usd">90887000000</cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies>
    <cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfNC0zLTEtMS0xMjE3OTc_5ac509af-5f89-4fd0-9dca-290c6fa35e68"
      unitRef="usd">79316000000</cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies>
    <cvs:PaymentsforInsuranceBenefits
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfNS0xLTEtMS0xMjE3OTc_8f68cdf3-8e70-4424-925a-652bfc38afd5"
      unitRef="usd">33920000000</cvs:PaymentsforInsuranceBenefits>
    <cvs:PaymentsforInsuranceBenefits
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfNS0zLTEtMS0xMjE3OTc_524c483a-e329-45d5-9953-3c0532932a77"
      unitRef="usd">31245000000</cvs:PaymentsforInsuranceBenefits>
    <us-gaap:PaymentsToSuppliersAndEmployees
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfNi0xLTEtMS0xMjE3OTc_40b00c94-92bc-48c1-a0a2-83f8494950a7"
      unitRef="usd">15119000000</us-gaap:PaymentsToSuppliersAndEmployees>
    <us-gaap:PaymentsToSuppliersAndEmployees
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfNi0zLTEtMS0xMjE3OTc_79e14ef2-56e7-4ffc-8ebc-780f23109890"
      unitRef="usd">14900000000</us-gaap:PaymentsToSuppliersAndEmployees>
    <us-gaap:ProceedsFromInterestAndDividendsReceived
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfNy0xLTEtMS0xMjE3OTc_259548ca-77b6-4629-99ef-b65da8821a3d"
      unitRef="usd">200000000</us-gaap:ProceedsFromInterestAndDividendsReceived>
    <us-gaap:ProceedsFromInterestAndDividendsReceived
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfNy0zLTEtMS0xMjE3OTc_2e0d2566-a221-41aa-990c-16ee44c43397"
      unitRef="usd">394000000</us-gaap:ProceedsFromInterestAndDividendsReceived>
    <us-gaap:InterestPaidNet
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfOC0xLTEtMS0xMjE3OTc_d274f54b-e903-4577-9386-c11d5666dc1e"
      unitRef="usd">1150000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfOC0zLTEtMS0xMjE3OTc_3f824f54-c304-4066-8b56-954bf3813414"
      unitRef="usd">1263000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfOS0xLTEtMS0xMjE3OTc_8576b9a7-a27a-4a97-a3d7-c159f50ff50f"
      unitRef="usd">1887000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfOS0zLTEtMS0xMjE3OTc_f0a5d897-aec4-4b12-b925-2b39a99bf3d1"
      unitRef="usd">1552000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTAtMS0xLTEtMTIxNzk3_2300e934-f95c-45a0-8db7-fd7026af502f"
      unitRef="usd">9006000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTAtMy0xLTEtMTIxNzk3_c84eb4d5-b539-4459-a625-2ce835c706d2"
      unitRef="usd">8739000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTMtMS0xLTEtMTIxNzk3_7ed9cfcf-70fd-4fff-99a6-8da80a4fac73"
      unitRef="usd">4360000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTMtMy0xLTEtMTIxNzk3_d4b7aeb0-63a4-4129-86a0-eb7264a7bf05"
      unitRef="usd">3947000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTQtMS0xLTEtMTIxNzk3_b517f62b-28c8-4a88-8a73-980a26a00c25"
      unitRef="usd">5010000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTQtMy0xLTEtMTIxNzk3_a95a3738-104c-4c4f-8e5b-28d1cb220388"
      unitRef="usd">5570000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTUtMS0xLTEtMTIxNzk3_c511e387-3f60-4065-82a6-fddf94d29679"
      unitRef="usd">1459000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTUtMy0xLTEtMTIxNzk3_c97e6654-bf7b-4846-a782-94ac0fa726f0"
      unitRef="usd">1315000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTYtMS0xLTEtMTIxNzk3_63b54a27-0163-48e4-94e9-af56d5909845"
      unitRef="usd">125000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTYtMy0xLTEtMTIxNzk3_d064fd32-580c-4020-84ef-c3fc5ccf100d"
      unitRef="usd">108000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:CashDivestedFromDeconsolidation
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTctMC0xLTEtMTIxNzk3L3RleHRyZWdpb246NGViMjEyYmRhNjEzNDJkOWJlODlmODYyNWUzMjlkNTdfMzg0ODI5MDY5NzMxMg_b79e8bb4-f69e-48c7-9cb9-62660cb914d2"
      unitRef="usd">2807000000</us-gaap:CashDivestedFromDeconsolidation>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTctMS0xLTEtMTIxNzk3_a5f15d73-ddcb-4dae-bfa5-dabcb7a69e6a"
      unitRef="usd">-1943000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTctMy0xLTEtMTIxNzk3_153a5435-d7d5-4d6f-849d-66d4924e0112"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTgtMS0xLTEtMTIxNzk3_2bac8b76-e7a1-4dda-938a-06ecd909937c"
      unitRef="usd">-54000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTgtMy0xLTEtMTIxNzk3_76e8f612-34f1-4711-b09e-25614d295e51"
      unitRef="usd">-72000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTktMS0xLTEtMTIxNzk3_9b9c5050-6d1a-48f9-9645-a93fef2dcfe3"
      unitRef="usd">-4123000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMTktMy0xLTEtMTIxNzk3_23509902-8655-427f-9d34-7756dde8ed36"
      unitRef="usd">-2974000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMjQtMS0xLTEtMTIxNzk3_ebcdcd75-50c6-4b3a-bc5b-33e0c41d5edc"
      unitRef="usd">1529000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMjQtMy0xLTEtMTIxNzk3_246863d2-1f66-483e-bb51-6c7ed3ab2d36"
      unitRef="usd">5423000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMjUtMS0xLTEtMTIxNzk3_d0912635-174d-4d01-b460-eb452d3ae25e"
      unitRef="usd">2000000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMjUtMy0xLTEtMTIxNzk3_7fe1aee3-08c8-4a80-b8a2-1f440c13d463"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividends
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMjctMS0xLTEtMTIxNzk3_974a7172-937a-4efc-a85e-b0c71307529c"
      unitRef="usd">1462000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMjctMy0xLTEtMTIxNzk3_da1ae154-5f75-4761-a223-0c93b797ac78"
      unitRef="usd">1306000000</us-gaap:PaymentsOfDividends>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMjgtMS0xLTEtMTIxNzk3_c64a3e90-cb7a-43c8-a967-db68b8e63f1c"
      unitRef="usd">348000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMjgtMy0xLTEtMTIxNzk3_7cc05dd6-57fe-49dc-9d07-5c051e2bc393"
      unitRef="usd">330000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMjktMS0xLTEtMTIxNzk3_b765fa14-1d41-4d80-9d7d-bef55fb21d78"
      unitRef="usd">329000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMjktMy0xLTEtMTIxNzk3_ea998528-761b-46d4-b07b-282ef5d2f469"
      unitRef="usd">159000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMzAtMS0xLTEtMTIxNzk3_f750646f-23b2-49f1-b9ff-1b7c4a0182e9"
      unitRef="usd">-139000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMzAtMy0xLTEtMTIxNzk3_68f7596d-39b5-4253-8fe8-7d7b9973496a"
      unitRef="usd">46000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMzEtMS0xLTEtMTIxNzk3_4b60432e-2a5a-4219-a9ab-5e3252987881"
      unitRef="usd">-5111000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMzEtMy0xLTEtMTIxNzk3_53c2a35a-a522-4e1a-be59-b2dcd4fd9272"
      unitRef="usd">-6512000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMzItMS0xLTEtMTIxNzk3_02d098c7-5382-463f-a7b1-d82178dcfe1c"
      unitRef="usd">-228000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMzItMy0xLTEtMTIxNzk3_3b8240f3-1756-4a57-9908-6593d76ad29b"
      unitRef="usd">-747000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMzMtMS0xLTEtMTIxNzk3_30f1be7b-b5b5-421b-9b30-e1b190261cb9"
      unitRef="usd">12691000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id1b37908bcec4675b7dd487bd3f7f745_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMzMtMy0xLTEtMTIxNzk3_b1fd4d29-65d2-4839-a7de-2624e27d7b8b"
      unitRef="usd">11043000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMzQtMS0xLTEtMTIxNzk3_f8ee65da-cf86-4962-81b2-61f7f56d8de0"
      unitRef="usd">12463000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9c91d440ca044d289daea52743e3cebd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjM4ODM5YTk0ODY5MTRlMDc5MDRhN2UzOGRkZDI1YTdkL3RhYmxlcmFuZ2U6Mzg4MzlhOTQ4NjkxNGUwNzkwNGE3ZTM4ZGRkMjVhN2RfMzQtMy0xLTEtMTIxNzk3_9a5f87b3-3b9a-4838-b9a4-2754455bbdad"
      unitRef="usd">10296000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:ProfitLoss
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMy0xLTEtMS0xMjE3OTc_af22c5b4-cc87-43fb-a555-be278fe41108"
      unitRef="usd">5274000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMy0zLTEtMS0xMjE3OTc_d9234a80-69d4-4c73-8b81-8c5627ce30b4"
      unitRef="usd">5015000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfNS0xLTEtMS0xMjE3OTc_3a4c503c-a6e2-4639-9552-9aa8b6a9b8e3"
      unitRef="usd">2142000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfNS0zLTEtMS0xMjE3OTc_4681b732-2c74-412d-a89e-9f46c52ed89b"
      unitRef="usd">2263000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfNy0xLTEtMS0xMjE3OTc_0496fd8c-8a6f-4674-bea2-a699f8cc5c51"
      unitRef="usd">236000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfNy0zLTEtMS0xMjE3OTc_73e2da9d-7a6a-4881-a609-72a927bc7e33"
      unitRef="usd">232000000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfOC0xLTEtMS0xMjE3OTc_b0f97329-9a3f-4f07-94b5-92ceef770a86"
      unitRef="usd">225000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfOC0zLTEtMS0xMjE3OTc_ca6c3386-9274-4c6f-8471-8062e538ca24"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <cvs:Deferredincometaxesandothernoncashitems
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTAtMS0xLTEtMTIxNzk3_4ddf955c-b884-4b19-bd3f-b74d3a89512f"
      unitRef="usd">-281000000</cvs:Deferredincometaxesandothernoncashitems>
    <cvs:Deferredincometaxesandothernoncashitems
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTAtMy0xLTEtMTIxNzk3_8c9cf451-3c4a-45ba-89b9-2323f90a6f07"
      unitRef="usd">-370000000</cvs:Deferredincometaxesandothernoncashitems>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTItMS0xLTEtMTIxNzk3_b8ed8c81-7199-48ed-905a-4462017670fb"
      unitRef="usd">2687000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTItMy0xLTEtMTIxNzk3_d4279865-13b1-4964-872f-eddbfa1aca18"
      unitRef="usd">2384000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTMtMS0xLTEtMTIxNzk3_4b4f4563-d43f-4a7a-a27c-982003bd6a80"
      unitRef="usd">-469000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTMtMy0xLTEtMTIxNzk3_c511fb9b-d359-4c2f-8f8e-3abb0efa3e4b"
      unitRef="usd">-1517000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTQtMS0xLTEtMTIxNzk3_56cfd0ff-4e25-4180-ba56-f7e0acc56443"
      unitRef="usd">325000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTQtMy0xLTEtMTIxNzk3_7cf9865b-7e57-47a5-a3b2-dca7efa43098"
      unitRef="usd">219000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTUtMS0xLTEtMTIxNzk3_9a14867c-ea5d-499a-9a1d-94c0e0afde91"
      unitRef="usd">2033000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTUtMy0xLTEtMTIxNzk3_1778832a-a63c-43d0-b7d0-75543fa5fae2"
      unitRef="usd">1702000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTYtMS0xLTEtMTIxNzk3_45bfc26d-9bcb-4eba-ac9a-da7816d9508e"
      unitRef="usd">1467000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTYtMy0xLTEtMTIxNzk3_b6a430d8-f102-4644-adb2-39054417f48d"
      unitRef="usd">104000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTctMS0xLTEtMTIxNzk3_f57f0e9c-1fbb-4896-8aa9-d4fd4d2c3069"
      unitRef="usd">903000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTctMy0xLTEtMTIxNzk3_64846a31-6f9d-419f-a71d-198103339de0"
      unitRef="usd">879000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTgtMS0xLTEtMTIxNzk3_943e5d6c-6592-4fd0-9658-84fbe8cfdfcc"
      unitRef="usd">9006000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8yOC9mcmFnOjA5NGQwZmUyNWMyMjQ0YWQ5Y2UyNDdmMWVkYTU0OTk3L3RhYmxlOjRlMzdiNWM5MGNiYzQ4NjU4YmFmMDMyM2FiOTYzODM3L3RhYmxlcmFuZ2U6NGUzN2I1YzkwY2JjNDg2NThiYWYwMzIzYWI5NjM4MzdfMTgtMy0xLTEtMTIxNzk3_edbfd6c5-5a3e-4b27-869d-180c523103de"
      unitRef="usd">8739000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:SharesOutstanding
      contextRef="ia48affe94b4f4604a40b1720a79d5db6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNS0xLTEtMS0xMjE3OTc_c262cc0c-ceec-4c28-aecc-287c903a2dc6"
      unitRef="shares">1744000000</us-gaap:SharesOutstanding>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i2c088d53680e46f6baea92de14e2e4bd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNS0yLTEtMS0xMjE3OTc_e1e5fa5f-7a8b-44b1-b10e-e547456d4b5f"
      unitRef="shares">422000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if58f043854c54a53a5f1e35f8cb23492_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNS00LTEtMS0xMjE3OTc_ffce7b07-c2e2-4a8b-9241-b8361898f9d8"
      unitRef="usd">47377000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2c088d53680e46f6baea92de14e2e4bd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNS01LTEtMS0xMjE3OTc_3e47bdca-8b3c-4a9e-89e1-7a840174f8ce"
      unitRef="usd">-28173000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5a1ac81823f94f75bab757497041c7f8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNS02LTEtMS0xMjE3OTc_f256586f-8201-4308-8a93-12eda4870bcf"
      unitRef="usd">54906000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i86d57bb206de43c4896717f849b4338e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNS03LTEtMS0xMjE3OTc_8881103c-40e8-4f39-aced-5967ea6c4cd1"
      unitRef="usd">965000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaba8a997161f4500808bdfdae2e0492b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNS04LTEtMS0xMjE3OTc_684559cc-c9dd-4934-921a-679dec828288"
      unitRef="usd">75075000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5700fd54dde54828b88be719d7275959_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNS05LTEtMS0xMjE3OTc_7d77a9bb-dfed-4b1d-81a3-e80b5a2b94d9"
      unitRef="usd">306000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNS0xMC0xLTEtMTIxNzk3_ba1f5876-d388-433f-8dca-a2d318ae7750"
      unitRef="usd">75381000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i683b5a41864d461590fab401c4e35230_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNi02LTEtMS0xMjE3OTc_91aa2e1f-2954-4b89-86b1-0bb1c4ba71d0"
      unitRef="usd">2312000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i42bd3a35f46d439da8e6e3e6a2da23e4_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNi04LTEtMS0xMjE3OTc_8cf790dd-f704-4854-be23-4bcd5d87d7c6"
      unitRef="usd">2312000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6ae3518ddcc841158d875c2d6c95917a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNi05LTEtMS0xMjE3OTc_5719d1f4-97d4-4661-ad8c-fe631f9711cf"
      unitRef="usd">1000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i079d98ea4b47435d8f5a9eb08672f5a0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNi0xMC0xLTEtMTIxNzk3_1f685ee6-4f5e-45d0-bd45-3855e44a531f"
      unitRef="usd">2313000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iacd268c2c7e140009fb8bec3502a1e8c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNy03LTEtMS0xMjE3OTc_1b65f4c4-0ad2-4bf2-b086-e11a40edca80"
      unitRef="usd">-1155000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i42bd3a35f46d439da8e6e3e6a2da23e4_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNy04LTEtMS0xMjE3OTc_ca89e1ad-c844-4fdb-b05b-c8a4f0000e62"
      unitRef="usd">-1155000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i079d98ea4b47435d8f5a9eb08672f5a0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNy0xMC0xLTEtMTIxNzk3_525ca5fa-1e07-4d38-aa45-3456265b45dd"
      unitRef="usd">-1155000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i4fe1e1bc63a6493a915ac4598cb1bf1e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfOC0xLTEtMS0xMjE3OTc_a386e384-b46b-4ded-b630-5e8a4efe1341"
      unitRef="shares">3000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i1d0aa52dbadc483aad398f2459329f7b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfOC00LTEtMS0xMjE3OTc_c0b1eebe-cd0a-4caa-87f2-58695294064f"
      unitRef="usd">300000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i42bd3a35f46d439da8e6e3e6a2da23e4_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfOC04LTEtMS0xMjE3OTc_61559f25-638b-454f-940c-61bb9bf63ce8"
      unitRef="usd">300000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i079d98ea4b47435d8f5a9eb08672f5a0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfOC0xMC0xLTEtMTIxNzk3_b7fdfe0f-fe93-4dce-a858-a55efe5745a3"
      unitRef="usd">300000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance
      contextRef="iffa3d985891f4ee4956e9a77643827ed_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfOS0yLTEtMS0xMjE3OTc_ba77f96c-eade-451e-8d3a-2eb2bda33475"
      unitRef="shares">19000000</cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="iffa3d985891f4ee4956e9a77643827ed_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfOS01LTEtMS0xMjE3OTc_5f6533df-08ba-4e8e-8c9b-1267fa70c18f"
      unitRef="usd">1972000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i42bd3a35f46d439da8e6e3e6a2da23e4_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfOS04LTEtMS0xMjE3OTc_a13be57e-0152-4e64-a820-9c5b245c8f89"
      unitRef="usd">1972000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i079d98ea4b47435d8f5a9eb08672f5a0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfOS0xMC0xLTEtMTIxNzk3_26c89e57-557a-4966-bae7-7b5cd9d506a3"
      unitRef="usd">1972000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <us-gaap:DividendsCommonStock
      contextRef="i683b5a41864d461590fab401c4e35230_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTAtNi0xLTEtMTIxNzk3_01192483-7532-4c4f-a4a1-607224dac70d"
      unitRef="usd">730000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i42bd3a35f46d439da8e6e3e6a2da23e4_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTAtOC0xLTEtMTIxNzk3_91d60b07-e11c-43a5-827b-72f020f8ccec"
      unitRef="usd">730000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i079d98ea4b47435d8f5a9eb08672f5a0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTAtMTAtMS0xLTEyMTc5Nw_530cf02f-dc5f-4553-8a93-c71c349cadb5"
      unitRef="usd">730000000</us-gaap:DividendsCommonStock>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i6ae3518ddcc841158d875c2d6c95917a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTEtOS0xLTEtMTIxNzk3_805bd866-e7e4-4426-8e40-bfd25ce93cbc"
      unitRef="usd">3000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i079d98ea4b47435d8f5a9eb08672f5a0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTEtMTAtMS0xLTEyMTc5Nw_bb672445-c7a2-4241-b79e-b9ae24666f59"
      unitRef="usd">3000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <us-gaap:SharesOutstanding
      contextRef="i3b7f5b310ef64956895f542905a4622c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTItMS0xLTEtMTIxNzk3_2b50e3c8-daae-4eff-881d-8db8340feac8"
      unitRef="shares">1747000000</us-gaap:SharesOutstanding>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i5f2fc9063f2c489db3055478a06e568b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTItMi0xLTEtMTIxNzk3_1903b954-70cc-4787-accd-173691ab6baa"
      unitRef="shares">441000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4175aff97fca4747940e80338e1c6b6b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTItNC0xLTEtMTIxNzk3_dfa4649c-3f50-4e27-b8ac-8f10a789d3bb"
      unitRef="usd">47677000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5f2fc9063f2c489db3055478a06e568b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTItNS0xLTEtMTIxNzk3_686258d7-9a7b-45e9-9240-187605a59fdc"
      unitRef="usd">-30145000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i47c09d87ce2542058a44638e0d3aee0e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTItNi0xLTEtMTIxNzk3_cf987f91-b54d-4166-8748-d9c752dfcb21"
      unitRef="usd">56488000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1b872d657c42459e8731fba04a499743_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTItNy0xLTEtMTIxNzk3_03af1163-ecd2-483c-9942-43d25685f89e"
      unitRef="usd">-190000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9df87f1b15834003ab59b7fdaccda9a7_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTItOC0xLTEtMTIxNzk3_7d32c90c-b917-407d-9e22-92297168bb29"
      unitRef="usd">73830000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i902a60f937e94b7db75169a88a51ae87_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTItOS0xLTEtMTIxNzk3_aa34182c-45a8-41cc-b9e1-594c01d1f308"
      unitRef="usd">310000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3779b6c8ef834637b29b6a1763d82299_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTItMTAtMS0xLTEyMTc5Nw_f1e2957c-010b-4879-b319-46e62e5e4a80"
      unitRef="usd">74140000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i60699824f52b49fcb5663bfa26640e09_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTMtNi0xLTEtMTIxNzk3_690d9c7c-5133-4fc1-8b86-32d3f6a1798a"
      unitRef="usd">2951000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4275461340524ac9a913007bb4256c99_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTMtOC0xLTEtMTIxNzk3_7d1d6d71-ae30-4f83-8a05-be4fa292341c"
      unitRef="usd">2951000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="idb80b8e269cf4f7cbdc40e28acc4636f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTMtOS0xLTEtMTIxNzk3_49ac8c14-8f28-4a9a-83c8-72717dabd507"
      unitRef="usd">10000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTMtMTAtMS0xLTEyMTc5Nw_05f987a0-0b70-49f5-a0ce-0776d71fa68e"
      unitRef="usd">2961000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9044e77680c543eab4fbb19765443084_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTQtNy0xLTEtMTIxNzk3_a3f60fc5-0a8d-46f2-8936-75e4bddaa444"
      unitRef="usd">-798000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4275461340524ac9a913007bb4256c99_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTQtOC0xLTEtMTIxNzk3_18b9cdd9-af82-45d6-8312-b60a5cb5f488"
      unitRef="usd">-798000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTQtMTAtMS0xLTEyMTc5Nw_1fda5fa2-56c7-4351-9a54-8b640cc2de23"
      unitRef="usd">-798000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ia4478efe64a3489c931acebf3d633806_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTUtMS0xLTEtMTIxNzk3_3c819e17-4b2f-4c8b-8989-852d9485038f"
      unitRef="shares">8000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="idf70211547034c07b67bbb782ef034de_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTUtNC0xLTEtMTIxNzk3_6c2747e3-dede-457b-8fb6-f18a11dd3d80"
      unitRef="usd">197000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4275461340524ac9a913007bb4256c99_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTUtOC0xLTEtMTIxNzk3_dd9ad66e-a722-48ac-acdf-4edc9dae5bba"
      unitRef="usd">197000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTUtMTAtMS0xLTEyMTc5Nw_459737a9-e736-43e4-b58f-f895cf309a3a"
      unitRef="usd">197000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance
      contextRef="i3c407840d1534bd3a85610f6bc0f2a82_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTYtMi0xLTEtMTIxNzk3_154f1ad4-fca3-4f85-92d2-5a7635f0565d"
      unitRef="shares">2000000</cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i3c407840d1534bd3a85610f6bc0f2a82_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTYtNS0xLTEtMTIxNzk3_154e00c8-a541-4d98-accc-56eddbda1a6d"
      unitRef="usd">267000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i4275461340524ac9a913007bb4256c99_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTYtOC0xLTEtMTIxNzk3_3980c648-b7dc-4da2-8580-a2b0d6eab71f"
      unitRef="usd">267000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTYtMTAtMS0xLTEyMTc5Nw_f5e3ed1c-e688-4c63-918d-74dc53ba09ac"
      unitRef="usd">267000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <us-gaap:DividendsCommonStock
      contextRef="i60699824f52b49fcb5663bfa26640e09_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTctNi0xLTEtMTIxNzk3_0328278c-d48f-4faf-90f6-ff9d00853a07"
      unitRef="usd">729000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i4275461340524ac9a913007bb4256c99_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTctOC0xLTEtMTIxNzk3_967ed60d-080a-4cd9-80d5-003db4eda4eb"
      unitRef="usd">729000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTctMTAtMS0xLTEyMTc5Nw_eb93ce1f-431a-44e7-8e7a-b92748dd4e73"
      unitRef="usd">729000000</us-gaap:DividendsCommonStock>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="idb80b8e269cf4f7cbdc40e28acc4636f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTgtOS0xLTEtMTIxNzk3_c16b37f1-f7dc-418c-a395-5ffea7dc6413"
      unitRef="usd">2000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTgtMTAtMS0xLTEyMTc5Nw_1c8dcf77-6bf5-462c-9b67-c45a3a7e3251"
      unitRef="usd">2000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <us-gaap:SharesOutstanding
      contextRef="i65b5f26da4ed4d9f951f94da7cd00c3d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTktMS0xLTEtMTIxNzk3_5add3e46-74f9-4e2d-a5e7-32d8f2e8bc1d"
      unitRef="shares">1755000000</us-gaap:SharesOutstanding>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i4ebe896f6f5249aebd3596e8ae9c06e3_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTktMi0xLTEtMTIxNzk3_03bce8fe-e38d-4c1a-ba83-666579445e99"
      unitRef="shares">443000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i91f59faea12744d3b7195336c1ca91cc_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTktNC0xLTEtMTIxNzk3_987e90b2-e1f5-4dd2-b500-7e736e8766e7"
      unitRef="usd">47874000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4ebe896f6f5249aebd3596e8ae9c06e3_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTktNS0xLTEtMTIxNzk3_09c716ae-4201-4796-8206-a2ee1f58bb89"
      unitRef="usd">-30412000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3f6f61f23dd44e0f9334dc0bfb9b4810_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTktNi0xLTEtMTIxNzk3_a76f3777-8d7d-4f67-b8df-71b5cf509791"
      unitRef="usd">58710000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7d56c57b212d4a108b033b2948d0291b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTktNy0xLTEtMTIxNzk3_bb307c98-f314-4731-b086-226228a2c4c1"
      unitRef="usd">-988000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic7e372c5939d46a59aed59e0c12a2a5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTktOC0xLTEtMTIxNzk3_5e715efd-8165-4966-a0dc-7f811a4de7db"
      unitRef="usd">75184000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia55d0b5fcc284c1bb1843f6b3df18f68_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTktOS0xLTEtMTIxNzk3_499d9cf3-b2ff-4e4a-9cf4-08f54b9416b4"
      unitRef="usd">322000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTktMTAtMS0xLTEyMTc5Nw_cf917f62-f360-47b8-9123-abfb3d4bcd9a"
      unitRef="usd">75506000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="i3779b6c8ef834637b29b6a1763d82299_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMTcy_d00d5199-0aac-4e58-aeba-d5f762140f73"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMTcy_f2bba169-2673-477e-8c47-26b0ba6eae30"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMTcy_fbb06a2b-6db5-44d3-bc76-6f55a37286e7"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="i3779b6c8ef834637b29b6a1763d82299_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMjI0_be626d1b-cb08-4abb-a1c6-97ec4e5b604b"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMjI0_da30be1e-ad71-41a1-b56b-4cf6433518e4"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMjI0_ecbfc884-e47d-4eab-9a82-7d96df218bac"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <us-gaap:CommonStockValue
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMzY2_7ab51b95-5926-41b2-b5bf-1bc50e160f29"
      unitRef="usd">18000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMTA5OTUxMTYyOTAzMg_0931fc27-1fc5-423b-a3a4-85c5abf2f94f"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i3779b6c8ef834637b29b6a1763d82299_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMTA5OTUxMTYyOTAzMg_5b18a423-46a0-4b03-85bd-c0dd984f6915"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:SharesOutstanding
      contextRef="ic10a47a61fb346eca4da1c6b4eb8f3e0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNS0xLTEtMS0xMjcwMDM_0b480aa2-b1e1-4e32-9cd2-1c9e3748ec73"
      unitRef="shares">1733000000</us-gaap:SharesOutstanding>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i152dc72ae8c845738b9dc7cb8c6f3c9f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNS0yLTEtMS0xMjcwMDM_4b69fe63-e272-4068-992d-1a5b471b8279"
      unitRef="shares">423000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i40e08d0b5d454c76b137a0fcc9650921_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNS00LTEtMS0xMjcwMDM_54fa1447-121f-4df3-8c6b-e02c861e6ab3"
      unitRef="usd">46513000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i152dc72ae8c845738b9dc7cb8c6f3c9f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNS01LTEtMS0xMjcwMDM_797349a6-d7bb-4e80-99b7-d08c78b967a4"
      unitRef="usd">-28178000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i49bd9c3e375d4c40a91fc221c0821506_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNS02LTEtMS0xMjcwMDM_a8019749-4bab-4f5a-8aab-e30d4bce6342"
      unitRef="usd">49640000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iad3da84ec0ac498db41f931fdcbc851b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNS03LTEtMS0xMjcwMDM_8dc03ae3-708b-4528-8eda-53661e6acf25"
      unitRef="usd">1414000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i31664a1f007d452f8f852aa3e9e14177_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNS04LTEtMS0xMjcwMDM_e417b675-4d3f-4de4-8c04-6644ffbd48bb"
      unitRef="usd">69389000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9917e617b6b24457b71193960c36094b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNS05LTEtMS0xMjcwMDM_3601938e-fade-42f5-bd26-2c0e3aa08f1d"
      unitRef="usd">312000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id1b37908bcec4675b7dd487bd3f7f745_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNS0xMC0xLTEtMTI3MDAz_99ada50f-ec2a-41fb-8f19-f12130bf651f"
      unitRef="usd">69701000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="iee221d6eeb484991817f46c9fe0c087f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNi02LTEtMS0xMjcwMDM_9a4cbc09-8a61-41b7-a336-ac5ace52f6c4"
      unitRef="usd">2223000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3fdbb1c5a52d4721a5d3e754c65f8bc3_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNi04LTEtMS0xMjcwMDM_c9102396-e98d-4ac5-a974-67ba05a5b437"
      unitRef="usd">2223000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i561416f54ed14d4aa729dc31040c8e99_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNi05LTEtMS0xMjcwMDM_c7dbd971-c4bb-4f84-8bbb-636682e5fe87"
      unitRef="usd">1000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i46f6d2a9429541919bc596eed6bc6437_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNi0xMC0xLTEtMTI3MDAz_a555fbe7-814b-405a-b77e-b51d3eb97787"
      unitRef="usd">2224000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i772325f7509041e3ae0b28f2fede65ec_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNy03LTEtMS0xMjcwMDM_44ad32a0-9b6f-4c10-9ca6-caaecde350e8"
      unitRef="usd">-392000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3fdbb1c5a52d4721a5d3e754c65f8bc3_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNy04LTEtMS0xMjcwMDM_47a490b8-4876-44c2-837b-4ee2095a14cc"
      unitRef="usd">-392000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i46f6d2a9429541919bc596eed6bc6437_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNy0xMC0xLTEtMTI3MDAz_d88e8381-2607-4759-b346-9ec5b6a23b73"
      unitRef="usd">-392000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="if0eb4e5ad890414b9e6e3b2fbcd7a242_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfOC0xLTEtMS0xMjcwMDM_09d63b2e-caa0-49bb-aee8-2482d8f5dadf"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ia8357bbbf6fe4f958f2b67dcfcf2a97b_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfOC00LTEtMS0xMjcwMDM_8e4d2ad2-b399-4b6a-940c-a2e3e0d503e8"
      unitRef="usd">214000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i3fdbb1c5a52d4721a5d3e754c65f8bc3_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfOC04LTEtMS0xMjcwMDM_85a30975-8da6-4136-a273-5960954f5fe3"
      unitRef="usd">214000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i46f6d2a9429541919bc596eed6bc6437_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfOC0xMC0xLTEtMTI3MDAz_a61b1ffd-2925-4eb3-9bd2-551ce7b8c7b6"
      unitRef="usd">214000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod
      contextRef="i24a096e6009a44be8a941b871322166f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfOS0yLTEtMS0xMjcwMDM_e59e8c63-0c25-4211-a3f2-69398263ad87"
      unitRef="shares">1000000</cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="i24a096e6009a44be8a941b871322166f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfOS01LTEtMS0xMjcwMDM_9e0b0692-cefc-4172-8e83-11b20cc520d0"
      unitRef="usd">76000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="i3fdbb1c5a52d4721a5d3e754c65f8bc3_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfOS04LTEtMS0xMjcwMDM_7652c491-1d79-4ac8-9268-aebb58f918ac"
      unitRef="usd">76000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="i46f6d2a9429541919bc596eed6bc6437_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfOS0xMC0xLTEtMTI3MDAz_1d759c7c-a7bf-459c-a440-321e86d29cfd"
      unitRef="usd">76000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <us-gaap:DividendsCommonStock
      contextRef="iee221d6eeb484991817f46c9fe0c087f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTAtNi0xLTEtMTI3MDAz_f2e90576-2d68-46d5-818e-bad448e5fc9f"
      unitRef="usd">660000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i3fdbb1c5a52d4721a5d3e754c65f8bc3_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTAtOC0xLTEtMTI3MDAz_187e930c-e7c5-4b37-91dc-305d6f0b6351"
      unitRef="usd">660000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i46f6d2a9429541919bc596eed6bc6437_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTAtMTAtMS0xLTEyNzAwMw_a28f92b0-8a21-4c90-b4d3-3c9af591ccec"
      unitRef="usd">660000000</us-gaap:DividendsCommonStock>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i561416f54ed14d4aa729dc31040c8e99_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTEtOS0xLTEtMTI3MDAz_8b27b4d2-5841-418f-9c28-a8b41678186d"
      unitRef="usd">1000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i46f6d2a9429541919bc596eed6bc6437_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTEtMTAtMS0xLTEyNzAwMw_41d10884-e0f1-4a2e-a313-5a5b7e4b80ef"
      unitRef="usd">1000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <us-gaap:SharesOutstanding
      contextRef="if45457c84fd043c9b7d744c3fc83d3da_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTItMS0xLTEtMTI3MDAz_24fec2f4-42ce-4cd9-825a-1f7deb64787c"
      unitRef="shares">1735000000</us-gaap:SharesOutstanding>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ica2f5f3fd6224895b0ce4b545dcbd6be_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTItMi0xLTEtMTI3MDAz_911440fa-050b-488a-899d-429c516738f6"
      unitRef="shares">422000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1320581fe0074807a2a6f1646978f417_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTItNC0xLTEtMTI3MDAz_bb526491-7c2b-4a52-9a48-cbbdf1fff5eb"
      unitRef="usd">46727000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ica2f5f3fd6224895b0ce4b545dcbd6be_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTItNS0xLTEtMTI3MDAz_c33682a7-bcff-478e-bd70-3c9fde37f6fa"
      unitRef="usd">-28102000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i98cd8c15279e490f8c5ece01fc0a2607_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTItNi0xLTEtMTI3MDAz_53e159e9-3090-4322-a85e-02538a2f0db2"
      unitRef="usd">51203000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9364eb9de5284648ba5dce23aaf45747_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTItNy0xLTEtMTI3MDAz_918aebaa-e7f4-49a4-a7a8-bd63987e8a52"
      unitRef="usd">1022000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic2b899747e3a4cae8ea6928b46d7a6ef_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTItOC0xLTEtMTI3MDAz_f8cf8848-9ec6-4781-94a5-03bf372fd01e"
      unitRef="usd">70850000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia657fbce9b4e48baa94aeb01df078a63_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTItOS0xLTEtMTI3MDAz_f14c797f-28cb-45d5-9af7-ec2fb797722d"
      unitRef="usd">314000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i959322b91e4a46abaae950c149d362c1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTItMTAtMS0xLTEyNzAwMw_447a409c-3b58-4bcb-94b1-73b2c1ac4af9"
      unitRef="usd">71164000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="ia4dd5a3fb4014191b1a23eef5aec7288_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTMtNi0xLTEtMTI3MDAz_8fd738c0-18d6-4ea9-92f4-361af0593021"
      unitRef="usd">2783000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i64c81a1cfe4e4ed3a4d01a9a55628941_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTMtOC0xLTEtMTI3MDAz_55940efa-c7cc-421e-99e1-eb75f50e90f7"
      unitRef="usd">2783000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7e4dbea634eb411686fe24903cb97ba4_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTMtOS0xLTEtMTI3MDAz_2aa0278e-3302-4863-918b-7c2d6fab9740"
      unitRef="usd">8000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTMtMTAtMS0xLTEyNzAwMw_79d496fc-9708-48bf-a060-7a5e798397f5"
      unitRef="usd">2791000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i260f5a79243641bf898cd28e99b21a0f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTQtNy0xLTEtMTI3MDAz_b9a71718-e1f4-41ec-8361-a2bd40ee1ba6"
      unitRef="usd">148000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i64c81a1cfe4e4ed3a4d01a9a55628941_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTQtOC0xLTEtMTI3MDAz_b8e7f5ff-53fe-49c1-847a-d86678511c75"
      unitRef="usd">148000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTQtMTAtMS0xLTEyNzAwMw_3bb0d8ef-4973-432a-bc73-61618941dd4f"
      unitRef="usd">148000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i090190413d0546e98f4e006ce4c3c486_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTUtMS0xLTEtMTI3MDAz_730f2764-e71d-42f5-a819-6907a85875be"
      unitRef="shares">7000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="if7c5ecaffa7d41eb8fdfaa819f432922_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTUtNC0xLTEtMTI3MDAz_eeb6dd1a-454a-40c5-9b62-7871e942aac9"
      unitRef="usd">268000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i64c81a1cfe4e4ed3a4d01a9a55628941_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTUtOC0xLTEtMTI3MDAz_160e4d65-c45a-425d-8636-d90be1eed6dc"
      unitRef="usd">268000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTUtMTAtMS0xLTEyNzAwMw_6152fe27-3893-4c66-9a3b-7fb19410be06"
      unitRef="usd">268000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance
      contextRef="idaa5b59feb95483188ced67d5fbf4950_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTYtMi0xLTEtMTI3MDAz_9e1cc617-4617-4ca6-be10-e7d61fd3987b"
      unitRef="shares">2000000</cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="idaa5b59feb95483188ced67d5fbf4950_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTYtNS0xLTEtMTI3MDAz_691de804-9265-412f-bff6-1fbe6a8f3a9b"
      unitRef="usd">150000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i64c81a1cfe4e4ed3a4d01a9a55628941_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTYtOC0xLTEtMTI3MDAz_e6b1472a-f427-4d9c-9f30-1d822fc4108d"
      unitRef="usd">150000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTYtMTAtMS0xLTEyNzAwMw_8e531f18-1ef3-4568-8989-0d09680b19ae"
      unitRef="usd">150000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <us-gaap:DividendsCommonStock
      contextRef="ia4dd5a3fb4014191b1a23eef5aec7288_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTctNi0xLTEtMTI3MDAz_6579f989-c14f-46d2-9bb2-0229e912310f"
      unitRef="usd">655000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i64c81a1cfe4e4ed3a4d01a9a55628941_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTctOC0xLTEtMTI3MDAz_b9ba7b51-60c2-47b6-a6fa-180d4ea28d0e"
      unitRef="usd">655000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTctMTAtMS0xLTEyNzAwMw_6ffd9a2b-d350-4ae3-8cac-f9a8fc19dd25"
      unitRef="usd">655000000</us-gaap:DividendsCommonStock>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i7e4dbea634eb411686fe24903cb97ba4_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTgtOS0xLTEtMTI3MDAz_56554e8c-e8b8-4327-95e3-518c31862f3a"
      unitRef="usd">-1000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTgtMTAtMS0xLTEyNzAwMw_b1937e4b-0a1a-4744-8722-461637c183a8"
      unitRef="usd">-1000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <us-gaap:SharesOutstanding
      contextRef="i48dfc02937744c869af28bd5454ce1e7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTktMS0xLTEtMTI3MDAz_b9ead8e1-63b9-4492-9d0c-9c2874c7b972"
      unitRef="shares">1742000000</us-gaap:SharesOutstanding>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i6ce9ce9b48d54a45a210fb81622aa4dc_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTktMi0xLTEtMTI3MDAz_01df612b-9071-4ff9-8baf-73b2748bcc51"
      unitRef="shares">424000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9a378f6ac4174a9c8b2c62fbb49af994_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTktNC0xLTEtMTI3MDAz_da028d11-1181-47fb-8de2-1199b5addb2e"
      unitRef="usd">46995000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6ce9ce9b48d54a45a210fb81622aa4dc_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTktNS0xLTEtMTI3MDAz_b39331c3-41d8-444f-8ed9-c366fb0e90b8"
      unitRef="usd">-28252000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i070d725cebd0413da9a910f72c7a5854_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTktNi0xLTEtMTI3MDAz_03699afd-95ef-42eb-ba61-effbf37d5585"
      unitRef="usd">53331000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1d834339a4a64e8ab4f3498ba15b93ea_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTktNy0xLTEtMTI3MDAz_8aa50288-51d7-4e76-8f8f-698d6f11cbe1"
      unitRef="usd">1170000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibe740c19bbce491b8bf0931a8ba2c65c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTktOC0xLTEtMTI3MDAz_6d29af37-b808-423f-badc-3394f33c40c0"
      unitRef="usd">73244000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i42940cbfec444379ba0dbd31dce09948_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTktOS0xLTEtMTI3MDAz_1188f34f-86ae-4fa7-a432-ac334c729a51"
      unitRef="usd">321000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9c91d440ca044d289daea52743e3cebd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTktMTAtMS0xLTEyNzAwMw_b4f47d0d-1b70-4b97-ab01-77a35ef65ee3"
      unitRef="usd">73565000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="i9c91d440ca044d289daea52743e3cebd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMTA5OTUxMTYyODc1MQ_0f0054ab-8b30-42fa-ac96-62433e756172"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="id1b37908bcec4675b7dd487bd3f7f745_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMTA5OTUxMTYyODc1MQ_bc1717d8-9278-4399-ba60-8e301d24e74b"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="i959322b91e4a46abaae950c149d362c1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMTA5OTUxMTYyODc1MQ_bdd312b9-2a36-47fd-87e2-2efae22ffecc"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="i9c91d440ca044d289daea52743e3cebd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMTA5OTUxMTYyODc1Nw_0bd8908a-185f-49fd-a06a-8dfdc1f07bef"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="i959322b91e4a46abaae950c149d362c1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMTA5OTUxMTYyODc1Nw_778a89ff-0457-4645-aa69-5fb4626c1192"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="id1b37908bcec4675b7dd487bd3f7f745_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMTA5OTUxMTYyODc1Nw_c1e8a0c7-e4b5-4dee-ac29-f5504a484772"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <us-gaap:CommonStockValue
      contextRef="i959322b91e4a46abaae950c149d362c1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMTA5OTUxMTYyODc2Mg_16888582-ee38-4cca-8075-b7042ee0094d"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i9c91d440ca044d289daea52743e3cebd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMTA5OTUxMTYyODc2Mg_3c52963c-2574-47ac-a5a3-6a8a78dce6c0"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="id1b37908bcec4675b7dd487bd3f7f745_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMTA5OTUxMTYyODc2Mg_f5141bc7-c959-4445-afce-921a1ed44038"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTYxODI_222b3c15-a00e-4bed-95a5-1dd0a7b4492a">Significant Accounting Policies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Description of Business&#160; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CVS Health Corporation, together with its subsidiaries (collectively, &#x201c;CVS Health&#x201d; or the &#x201c;Company&#x201d;), has more than 9,000 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with over 110 million plan members with expanding specialty pharmacy solutions and a dedicated senior pharmacy care business serving more than one million patients per year. The Company also serves an estimated 35 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#x201c;PDP&#x201d;). The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The coronavirus disease 2019 (&#x201c;COVID-19&#x201d;) and its emerging new variants continue to impact the economies of the U.S. and other countries around the world. The impact of COVID-19 on the Company&#x2019;s businesses, operating results, cash flows and financial condition, as well as information regarding certain expected impacts of COVID-19 on the Company, is discussed throughout this Quarterly Report on Form 10-Q.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has four reportable segments: Health Care Benefits, Pharmacy Services, Retail/LTC and Corporate/Other, which are described below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Benefits Segment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Health Care Benefits segment operates as one of the nation&#x2019;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology products and services. The Health Care Benefits segment&#x2019;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#x201c;providers&#x201d;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#x201c;Insured&#x201d; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#x201c;ASC.&#x201d; In addition, effective January 2022, the Company entered the individual public health insurance exchanges (&#x201c;Public Exchanges&#x201d;) in eight states through which it sells Insured plans directly to individual consumers. The Company has submitted regulatory filings to remain on the Public Exchanges in 2023 in each of those eight states, and has submitted regulatory filings to enter the Public Exchanges in four additional states effective January 2023. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Pharmacy Services Segment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Pharmacy Services segment provides a full range of pharmacy benefit management (&#x201c;PBM&#x201d;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services and mail order pharmacy. In addition, through the Pharmacy Services segment, the Company provides specialty pharmacy and infusion services, clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#x201c;Covered Entities&#x201d;). The Company operates a group purchasing organization that negotiates pricing for the purchase of pharmaceuticals and rebates with pharmaceutical manufacturers on behalf of its participants. The Company also provides various administrative, management and reporting services to pharmaceutical manufacturers. The Pharmacy Services segment&#x2019;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on Public Exchanges and private health insurance exchanges, other sponsors of health benefit plans throughout the United States and Covered Entities. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Retail/LTC Segment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, COVID-19 and shingles and conducts long-term care pharmacy (&#x201c;LTC&#x201d;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of June&#160;30, 2022, the Retail/LTC segment operated more than 9,000 retail &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;locations, more than 1,100 MinuteClinic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;locations as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Corporate/Other Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Management and administrative expenses to support the Company&#x2019;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#x2019;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;) regarding interim financial reporting. In accordance with such rules and regulations, certain information and accompanying note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) have been omitted, although the Company believes the disclosures included herein are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2021 (the &#x201c;2021 Form 10-K&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Because of the influence of various factors on the Company&#x2019;s operations, including business combinations, certain holidays and other seasonal influences, net income for any interim period may not be comparable to the same interim period in previous years or necessarily indicative of income for the full year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#x201c;VIEs&#x201d;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continually evaluates its investments to determine if they represent variable interests in a VIE. If the Company determines that it has a variable interest in a VIE, the Company then evaluates if it is the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether the Company has the ability to direct the activities of a VIE that most significantly impact the entity&#x2019;s economic performance. The Company consolidates a VIE if it is considered to be the primary beneficiary.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities of VIEs for which the Company is the primary beneficiary were not significant to the Company&#x2019;s unaudited condensed consolidated financial statements. VIE creditors do not have recourse against the general credit of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior year amounts have been reclassified to conform with the current year presentation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash included in other current assets on the unaudited condensed consolidated balance sheets represents funds held on behalf of members, including health savings account funds associated with high deductible health plans. Restricted cash included in other assets on the unaudited condensed consolidated balance sheets represents amounts held in a trust in one of the Company&#x2019;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits and money market funds. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of cash and cash equivalents on the unaudited condensed consolidated balance sheets to total cash, cash equivalents and restricted cash on the unaudited condensed consolidated statements of cash flows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash (included in other current assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash (included in other assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash in the statements of cash flows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The decrease in restricted cash included in other current assets as of June&#160;30, 2022 compared to December&#160;31, 2021 was primarily due to a decrease in health savings account funds held on behalf of customers as a result of the sale of PayFlex Holdings, Inc. (&#x201c;PayFlex&#x201d;). See Note 2 &#x2018;&#x2018;Divestitures and Asset Sales&#x2019;&#x2019; for additional information on the Company&#x2019;s sale of PayFlex.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations. Accounts receivable, net is composed of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vendor and manufacturer receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total accounts receivable, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s allowance for credit losses was $340 million and $339 million as of June&#160;30, 2022 and December&#160;31, 2021, respectively. When developing an estimate of the Company&#x2019;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#x2019;s accounts receivable are short duration in nature and typically settle in less than 30 days.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables disaggregate the Company&#x2019;s revenue by major source in each segment for the three and six months ended June 30, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,328)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,094)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,616)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2021   &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#x2019;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS pharmacy retail store for the same price as mail order.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#x2019;s retail pharmacies under the Maintenance Choice program.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities primarily represent the Company&#x2019;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about receivables and contract liabilities from contracts with customers:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables (included in accounts receivable, net)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities (included in accrued expenses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the six months ended June&#160;30, 2022 and 2021, the contract liabilities balance includes increases related to customers&#x2019; earnings in ExtraBucks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rewards earnings and gift card issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redemption and breakage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Related Party Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in SureScripts, LLC (&#x201c;SureScripts&#x201d;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $16 million and $10 million in the three months ended June&#160;30, 2022 and 2021, respectively, and expensed fees for the use of this network of approximately $31 million and $19 million in the six months ended June&#160;30, 2022 and 2021, respectively. The Company&#x2019;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in Heartland Healthcare Services, LLC (&#x201c;Heartland&#x201d;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $23 million and $19 million for pharmaceutical inventory purchases during the three months ended June&#160;30, 2022 and 2021, respectively, and $44 million and $37 million for pharmaceutical inventory purchases during the six months ended June&#160;30, 2022 and 2021, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#x2019;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Insurance Contracts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the Financial Accounting Standards Board issued Accounting Standards Update 2018-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Topic 944). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other comprehensive income. The rate used to discount the Company&#x2019;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#x2019;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#x2019;s interim and annual financial statements. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company will adopt the new standard on January 1, 2023, using the modified retrospective transition method as of the earliest period presented for changes to the liability for future policy benefits and deferred acquisition costs. While the Company is still evaluating the impact of the new standard on its financial statements, the Company anticipates an increase to its liability for future policy benefits with a corresponding change in accumulated other comprehensive income as a result of updating the rate used to discount the liabilities to reflect the yield for an upper-medium grade fixed-income instrument compared to the Company&#x2019;s expected investment yield under the existing guidance.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:NumberOfStores
      contextRef="i3e0ead3c67874e9c96bf47478f6e8f41_I20220630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTgy_626e618e-4b09-4362-bd8d-6bcbe7b46fab"
      unitRef="store">9000</us-gaap:NumberOfStores>
    <cvs:NumberofWalkInMedicalClinics
      contextRef="i3e0ead3c67874e9c96bf47478f6e8f41_I20220630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMjEz_3546db12-4ca2-4a89-86f2-0d4deedbf09e"
      unitRef="clinic">1100</cvs:NumberofWalkInMedicalClinics>
    <cvs:NumberofPharmacyPlanMembers
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMjk2_8ff2831c-5f9a-46ac-a8b0-a80a24075b67"
      unitRef="people">110000000</cvs:NumberofPharmacyPlanMembers>
    <cvs:NumberofPatientsServedperYear
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfNDIw_76dd7f04-7080-459f-855c-272465d36875"
      unitRef="patient">1000000</cvs:NumberofPatientsServedperYear>
    <cvs:NumberOfPeopleServed
      contextRef="i4313031902ce4be29cef2c3613a0b3a3_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfNDc5_a660b6ec-64fc-406f-aa31-1a294c072425"
      unitRef="people">35000000</cvs:NumberOfPeopleServed>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTYyMDQ_cb27d99c-df5c-4768-b0f9-fb1ffa4c4828">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has four reportable segments: Health Care Benefits, Pharmacy Services, Retail/LTC and Corporate/Other, which are described below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Benefits Segment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Health Care Benefits segment operates as one of the nation&#x2019;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology products and services. The Health Care Benefits segment&#x2019;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#x201c;providers&#x201d;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#x201c;Insured&#x201d; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#x201c;ASC.&#x201d; In addition, effective January 2022, the Company entered the individual public health insurance exchanges (&#x201c;Public Exchanges&#x201d;) in eight states through which it sells Insured plans directly to individual consumers. The Company has submitted regulatory filings to remain on the Public Exchanges in 2023 in each of those eight states, and has submitted regulatory filings to enter the Public Exchanges in four additional states effective January 2023. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Pharmacy Services Segment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Pharmacy Services segment provides a full range of pharmacy benefit management (&#x201c;PBM&#x201d;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services and mail order pharmacy. In addition, through the Pharmacy Services segment, the Company provides specialty pharmacy and infusion services, clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#x201c;Covered Entities&#x201d;). The Company operates a group purchasing organization that negotiates pricing for the purchase of pharmaceuticals and rebates with pharmaceutical manufacturers on behalf of its participants. The Company also provides various administrative, management and reporting services to pharmaceutical manufacturers. The Pharmacy Services segment&#x2019;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on Public Exchanges and private health insurance exchanges, other sponsors of health benefit plans throughout the United States and Covered Entities. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Retail/LTC Segment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, COVID-19 and shingles and conducts long-term care pharmacy (&#x201c;LTC&#x201d;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of June&#160;30, 2022, the Retail/LTC segment operated more than 9,000 retail &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;locations, more than 1,100 MinuteClinic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;locations as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Corporate/Other Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Management and administrative expenses to support the Company&#x2019;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#x2019;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTI5Nw_409c8504-4ffb-4ce9-8506-357dea84e769"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <cvs:IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates
      contextRef="i1c0bcd0eebfa40769648a67be75183aa_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMjg0Mw_f908f3d9-3b04-43dc-aea5-9cb52d9a128c"
      unitRef="state">8</cvs:IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates>
    <cvs:IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates
      contextRef="i1c0bcd0eebfa40769648a67be75183aa_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMzg0ODI5MDcxNzQ4MQ_f908f3d9-3b04-43dc-aea5-9cb52d9a128c"
      unitRef="state">8</cvs:IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates>
    <cvs:IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfAdditionalStates
      contextRef="i52b2448e457a41c18f816cae8ba1b237_D20230101-20230131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMzg0ODI5MDcxNzE5NA_bf3db026-f55c-4da9-b4dd-a3475c36b469"
      unitRef="state">4</cvs:IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfAdditionalStates>
    <us-gaap:NumberOfStores
      contextRef="i3e0ead3c67874e9c96bf47478f6e8f41_I20220630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfNTAwNA_626e618e-4b09-4362-bd8d-6bcbe7b46fab"
      unitRef="store">9000</us-gaap:NumberOfStores>
    <cvs:NumberofWalkInMedicalClinics
      contextRef="i3e0ead3c67874e9c96bf47478f6e8f41_I20220630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfNTAzNQ_3546db12-4ca2-4a89-86f2-0d4deedbf09e"
      unitRef="clinic">1100</cvs:NumberofWalkInMedicalClinics>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTYxOTk_8959c64a-2091-4437-b8ed-be89769ae055">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;) regarding interim financial reporting. In accordance with such rules and regulations, certain information and accompanying note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) have been omitted, although the Company believes the disclosures included herein are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2021 (the &#x201c;2021 Form 10-K&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Because of the influence of various factors on the Company&#x2019;s operations, including business combinations, certain holidays and other seasonal influences, net income for any interim period may not be comparable to the same interim period in previous years or necessarily indicative of income for the full year.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTYxODU_22d02029-c745-4c5a-8ccf-e113567d7f2b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#x201c;VIEs&#x201d;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continually evaluates its investments to determine if they represent variable interests in a VIE. If the Company determines that it has a variable interest in a VIE, the Company then evaluates if it is the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether the Company has the ability to direct the activities of a VIE that most significantly impact the entity&#x2019;s economic performance. The Company consolidates a VIE if it is considered to be the primary beneficiary.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities of VIEs for which the Company is the primary beneficiary were not significant to the Company&#x2019;s unaudited condensed consolidated financial statements. VIE creditors do not have recourse against the general credit of the Company.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTYxNDc_81098d99-2334-4ccf-b285-a7d3b44f7ad0">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior year amounts have been reclassified to conform with the current year presentation.&lt;/span&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTYxOTE_bcbd4e27-74b6-4297-a4fc-dc74a624bbe2">Restricted CashRestricted cash included in other current assets on the unaudited condensed consolidated balance sheets represents funds held on behalf of members, including health savings account funds associated with high deductible health plans. Restricted cash included in other assets on the unaudited condensed consolidated balance sheets represents amounts held in a trust in one of the Company&#x2019;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits and money market funds.</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTYxODY_dda7a3b7-6967-44e0-b044-e589b4e5cd42">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of cash and cash equivalents on the unaudited condensed consolidated balance sheets to total cash, cash equivalents and restricted cash on the unaudited condensed consolidated statements of cash flows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash (included in other current assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash (included in other assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash in the statements of cash flows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjU5NDY5NjEwOTYzYTRiNGI4YWNiMGYzM2UxODIxNzFmL3RhYmxlcmFuZ2U6NTk0Njk2MTA5NjNhNGI0YjhhY2IwZjMzZTE4MjE3MWZfMS0xLTEtMS0xMjE3OTc_bc70507c-f3d5-4616-80fa-3dd379c11c54"
      unitRef="usd">12116000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjU5NDY5NjEwOTYzYTRiNGI4YWNiMGYzM2UxODIxNzFmL3RhYmxlcmFuZ2U6NTk0Njk2MTA5NjNhNGI0YjhhY2IwZjMzZTE4MjE3MWZfMS0zLTEtMS0xMjE3OTc_edb119ab-aa13-47e5-8aaf-c39508520fc0"
      unitRef="usd">9408000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9c91d440ca044d289daea52743e3cebd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjU5NDY5NjEwOTYzYTRiNGI4YWNiMGYzM2UxODIxNzFmL3RhYmxlcmFuZ2U6NTk0Njk2MTA5NjNhNGI0YjhhY2IwZjMzZTE4MjE3MWZfMS01LTEtMS0xMjE3OTc_6d864c8d-86bc-4ccf-9c11-c54e0ebbc9a0"
      unitRef="usd">7119000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjU5NDY5NjEwOTYzYTRiNGI4YWNiMGYzM2UxODIxNzFmL3RhYmxlcmFuZ2U6NTk0Njk2MTA5NjNhNGI0YjhhY2IwZjMzZTE4MjE3MWZfMi0xLTEtMS0xMjE3OTc_73953fe3-63e5-4884-bf5c-f5fa3e82ad6f"
      unitRef="usd">131000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjU5NDY5NjEwOTYzYTRiNGI4YWNiMGYzM2UxODIxNzFmL3RhYmxlcmFuZ2U6NTk0Njk2MTA5NjNhNGI0YjhhY2IwZjMzZTE4MjE3MWZfMi0zLTEtMS0xMjE3OTc_2399fab6-8462-4f35-a22d-c1f7f32d44c8"
      unitRef="usd">3065000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="i9c91d440ca044d289daea52743e3cebd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjU5NDY5NjEwOTYzYTRiNGI4YWNiMGYzM2UxODIxNzFmL3RhYmxlcmFuZ2U6NTk0Njk2MTA5NjNhNGI0YjhhY2IwZjMzZTE4MjE3MWZfMi01LTEtMS0xMjE3OTc_2970c51b-ce35-44a6-b1ad-fb6f8fdfa2cc"
      unitRef="usd">2959000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjU5NDY5NjEwOTYzYTRiNGI4YWNiMGYzM2UxODIxNzFmL3RhYmxlcmFuZ2U6NTk0Njk2MTA5NjNhNGI0YjhhY2IwZjMzZTE4MjE3MWZfMy0xLTEtMS0xMjE3OTc_976be642-6584-413a-be28-007523e78be9"
      unitRef="usd">216000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjU5NDY5NjEwOTYzYTRiNGI4YWNiMGYzM2UxODIxNzFmL3RhYmxlcmFuZ2U6NTk0Njk2MTA5NjNhNGI0YjhhY2IwZjMzZTE4MjE3MWZfMy0zLTEtMS0xMjE3OTc_1dc93548-9af9-4b00-b1f7-e399c5f542e9"
      unitRef="usd">218000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i9c91d440ca044d289daea52743e3cebd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjU5NDY5NjEwOTYzYTRiNGI4YWNiMGYzM2UxODIxNzFmL3RhYmxlcmFuZ2U6NTk0Njk2MTA5NjNhNGI0YjhhY2IwZjMzZTE4MjE3MWZfMy01LTEtMS0xMjE3OTc_7d4371ac-121a-4d7f-85a7-e1a01f08c13a"
      unitRef="usd">218000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjU5NDY5NjEwOTYzYTRiNGI4YWNiMGYzM2UxODIxNzFmL3RhYmxlcmFuZ2U6NTk0Njk2MTA5NjNhNGI0YjhhY2IwZjMzZTE4MjE3MWZfNC0xLTEtMS0xMjE3OTc_51e81291-7ef0-4ccc-bf41-30689547dadb"
      unitRef="usd">12463000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjU5NDY5NjEwOTYzYTRiNGI4YWNiMGYzM2UxODIxNzFmL3RhYmxlcmFuZ2U6NTk0Njk2MTA5NjNhNGI0YjhhY2IwZjMzZTE4MjE3MWZfNC0zLTEtMS0xMjE3OTc_741d167f-3c45-4b79-95ff-5059f1f8d901"
      unitRef="usd">12691000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9c91d440ca044d289daea52743e3cebd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjU5NDY5NjEwOTYzYTRiNGI4YWNiMGYzM2UxODIxNzFmL3RhYmxlcmFuZ2U6NTk0Njk2MTA5NjNhNGI0YjhhY2IwZjMzZTE4MjE3MWZfNC01LTEtMS0xMjE3OTc_5e48d43b-b104-4fa1-84ca-7d5e6a85fe3c"
      unitRef="usd">10296000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTYxNDg_bb9e1371-b659-4805-b1ab-2ac9e635d497">Accounts ReceivableAccounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTYxNTg_49d3ff2e-882a-4320-9e60-2d33e4392dd8">Accounts receivable, net is composed of the following:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vendor and manufacturer receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total accounts receivable, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjQzMjM2YTIyYzM4YjRmZTZhNGE3YzgwMTBkOGIxYjg5L3RhYmxlcmFuZ2U6NDMyMzZhMjJjMzhiNGZlNmE0YTdjODAxMGQ4YjFiODlfMS0xLTEtMS0xMjE3OTc_ba31fbd8-8535-402c-b785-bffb17c6da7e"
      unitRef="usd">9084000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjQzMjM2YTIyYzM4YjRmZTZhNGE3YzgwMTBkOGIxYjg5L3RhYmxlcmFuZ2U6NDMyMzZhMjJjMzhiNGZlNmE0YTdjODAxMGQ4YjFiODlfMS0zLTEtMS0xMjE3OTc_dc38c1fa-a272-4549-8ed3-de679298be34"
      unitRef="usd">7932000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <cvs:VendorandManufacturerReceivables
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjQzMjM2YTIyYzM4YjRmZTZhNGE3YzgwMTBkOGIxYjg5L3RhYmxlcmFuZ2U6NDMyMzZhMjJjMzhiNGZlNmE0YTdjODAxMGQ4YjFiODlfMi0xLTEtMS0xMjE3OTc_77a6cad7-3cb3-46ef-8801-9475352e5250"
      unitRef="usd">12242000000</cvs:VendorandManufacturerReceivables>
    <cvs:VendorandManufacturerReceivables
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjQzMjM2YTIyYzM4YjRmZTZhNGE3YzgwMTBkOGIxYjg5L3RhYmxlcmFuZ2U6NDMyMzZhMjJjMzhiNGZlNmE0YTdjODAxMGQ4YjFiODlfMi0zLTEtMS0xMjE3OTc_bbe47701-a684-44b4-917a-0084dfa828e3"
      unitRef="usd">10573000000</cvs:VendorandManufacturerReceivables>
    <us-gaap:PremiumsReceivableAtCarryingValue
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjQzMjM2YTIyYzM4YjRmZTZhNGE3YzgwMTBkOGIxYjg5L3RhYmxlcmFuZ2U6NDMyMzZhMjJjMzhiNGZlNmE0YTdjODAxMGQ4YjFiODlfMy0xLTEtMS0xMjE3OTc_1fe4b19f-def0-4973-af87-76a4efcd89d1"
      unitRef="usd">3399000000</us-gaap:PremiumsReceivableAtCarryingValue>
    <us-gaap:PremiumsReceivableAtCarryingValue
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjQzMjM2YTIyYzM4YjRmZTZhNGE3YzgwMTBkOGIxYjg5L3RhYmxlcmFuZ2U6NDMyMzZhMjJjMzhiNGZlNmE0YTdjODAxMGQ4YjFiODlfMy0zLTEtMS0xMjE3OTc_eed802a7-1f8e-4d0f-a0eb-a8eae4933fb4"
      unitRef="usd">2537000000</us-gaap:PremiumsReceivableAtCarryingValue>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjQzMjM2YTIyYzM4YjRmZTZhNGE3YzgwMTBkOGIxYjg5L3RhYmxlcmFuZ2U6NDMyMzZhMjJjMzhiNGZlNmE0YTdjODAxMGQ4YjFiODlfNC0xLTEtMS0xMjE3OTc_524592a3-7ed0-4c91-8191-b2e1dcb0a226"
      unitRef="usd">2508000000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjQzMjM2YTIyYzM4YjRmZTZhNGE3YzgwMTBkOGIxYjg5L3RhYmxlcmFuZ2U6NDMyMzZhMjJjMzhiNGZlNmE0YTdjODAxMGQ4YjFiODlfNC0zLTEtMS0xMjE3OTc_16f0f2c8-0561-41b8-ade6-2972771c7d44"
      unitRef="usd">3389000000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjQzMjM2YTIyYzM4YjRmZTZhNGE3YzgwMTBkOGIxYjg5L3RhYmxlcmFuZ2U6NDMyMzZhMjJjMzhiNGZlNmE0YTdjODAxMGQ4YjFiODlfNS0xLTEtMS0xMjE3OTc_94c2a9cd-3091-4454-9a2e-d69687550007"
      unitRef="usd">27233000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjQzMjM2YTIyYzM4YjRmZTZhNGE3YzgwMTBkOGIxYjg5L3RhYmxlcmFuZ2U6NDMyMzZhMjJjMzhiNGZlNmE0YTdjODAxMGQ4YjFiODlfNS0zLTEtMS0xMjE3OTc_805e0e64-56f9-473c-b6ee-bc2e9a4c13db"
      unitRef="usd">24431000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfOTcwOQ_85473069-d827-439a-9fbc-40b9f96d2d7f"
      unitRef="usd">340000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfOTcxNg_a1f493f2-b8e7-421b-a872-033c9c919cf0"
      unitRef="usd">339000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTYxNDI_2a4c4923-250e-4aa0-ab15-8e13d427bda5">When developing an estimate of the Company&#x2019;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#x2019;s accounts receivable are short duration in nature and typically settle in less than 30 days.</us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTYxOTU_2ba6b7ed-bd35-4019-ba9c-4c77bfe38308">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables disaggregate the Company&#x2019;s revenue by major source in each segment for the three and six months ended June 30, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,328)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,094)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,616)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2021   &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#x2019;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS pharmacy retail store for the same price as mail order.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#x2019;s retail pharmacies under the Maintenance Choice program.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i211b727efe674251b7af74e7c727f2f6_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMy0xLTEtMS0xMjE3OTc_86c113ae-7856-46a2-8eb0-673c801b0687"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6ee2fa91c9e748c5bcd3a0dd4c42587d_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMy0zLTEtMS0xMjE3OTc_dcf6ffa4-e9ff-427d-b2d6-e70fa7c37911"
      unitRef="usd">42567000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9ad952d467934022a4d99fb585b701e3_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMy01LTEtMS0xMjE3OTc_2600ee70-c0b9-4316-be77-013273cc21bf"
      unitRef="usd">20017000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i39657e3bd9404c6db2b0e8d4dfd62174_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMy03LTEtMS0xMjE3OTc_099360d2-4d9d-4c94-a478-7d3401f5ad68"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia252187be8364a1dbaf93db9dc77a52d_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMy05LTEtMS0xMjE3OTc_4f7080d7-ae2f-43dd-8ef9-b81cba9f04c2"
      unitRef="usd">-11258000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieb6ae33774b44fb4995615218a58f912_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMy0xMS0xLTEtMTIxNzk3_3a2506fc-8dd3-41c0-ac9c-ebb333aae915"
      unitRef="usd">51326000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i925a067985ca40f48d352ec61580eefc_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNC0xLTEtMS0xMjE3OTc_f88af3a7-9637-46be-95fb-00f9f1d49a86"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i75f41b5ed07e47ae8a0cbb4ad812d296_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNC0zLTEtMS0xMjE3OTc_9a63acb4-1115-4762-9416-22d8d4f9059d"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0248b692278b4870a7c3ba3d7f66b90f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNC01LTEtMS0xMjE3OTc_ba5964f5-21c1-4538-b429-ff529a059c74"
      unitRef="usd">5736000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d27d90709144b74bf478175cdb6010d_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNC03LTEtMS0xMjE3OTc_d6557057-055e-4ff8-b3ad-b9d6f419f0d7"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0995d0ff3d504aba96c0fe94fe99a19d_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNC05LTEtMS0xMjE3OTc_57dc1273-c554-42b9-b487-ecdaa771e383"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0c12809aa193462b8677fc041a26a3c0_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNC0xMS0xLTEtMTIxNzk3_c2844fea-3a3f-4acf-bc34-2b7ffe633586"
      unitRef="usd">5736000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5f4852b5d8704ebdaab77950f88bb254_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNS0xLTEtMS0xMjE3OTc_f09743d9-de3c-49bd-8256-078177cf236f"
      unitRef="usd">21245000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i13c0259435fc49c299d3a7dee2d7874f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNS0zLTEtMS0xMjE3OTc_11b54350-af62-47d7-82a5-27cd876813a9"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if133058117fb48ffa3c1f39f82db08b3_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNS01LTEtMS0xMjE3OTc_775575e2-89b0-4548-9267-3f824865819c"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i600c45cedb7847fe8e7f77de34c118c8_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNS03LTEtMS0xMjE3OTc_035ebf36-5f5e-4dd8-96e3-2b18c7816103"
      unitRef="usd">15000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i71aab19dd48441a298119f6a243dc82c_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNS05LTEtMS0xMjE3OTc_4c09df98-d65f-49bc-a623-90cf0f51a300"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5d8c6ba01e94480ca8cf278d517a9619_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNS0xMS0xLTEtMTIxNzk3_0a0cd2ce-d6d0-470d-97fe-74ac4766652d"
      unitRef="usd">21260000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="ib5045314d03040549992e1b0d350c6f4_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNi0xLTEtMS0xMjE3OTc_f18f10ed-9d0b-49a8-a7f1-05f22d3466a8"
      unitRef="usd">88000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i61b1e59accbc4a6b9fdbbf4dd1e166d8_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNi0zLTEtMS0xMjE3OTc_76f3fb83-1e6d-4889-9e52-d3894172ca7b"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i054a08a597154e34b91b50e36527b86c_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNi01LTEtMS0xMjE3OTc_be6be382-c22f-4905-9416-bfb7005a96a9"
      unitRef="usd">-18000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i02a2e27009a64f7bb8e01545a97c8feb_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNi03LTEtMS0xMjE3OTc_744c454b-f9c5-45a8-84ad-aad79f69f38f"
      unitRef="usd">76000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="if1040a72d0304a058af732ed3761a15a_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNi05LTEtMS0xMjE3OTc_e96d0d16-c015-49f9-9282-4a445144814d"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNi0xMS0xLTEtMTIxNzk3_50378b8c-d0b1-4d1b-af84-784a9b68617e"
      unitRef="usd">146000000</us-gaap:NetInvestmentIncome>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0cb61ac775a7478680ac7295974da830_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNy0xLTEtMS0xMjE3OTc_1a54ffd3-cfac-43e1-853d-5d3c84f3f1d2"
      unitRef="usd">1423000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia351ae656580421784396872e50f183f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNy0zLTEtMS0xMjE3OTc_cde3b659-0794-4bab-b95f-f9b409141b13"
      unitRef="usd">245000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iba21d41e0574453f9043075ca63b9071_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNy01LTEtMS0xMjE3OTc_3db7d23f-1ebe-42e7-8827-061ee5e6f78a"
      unitRef="usd">551000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1005878849c5409b8747da25c2c3aaaa_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNy03LTEtMS0xMjE3OTc_85780646-413d-43b1-8b2c-922311d8ec85"
      unitRef="usd">19000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if2a9323439d44a41bd807db01b403c2e_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNy05LTEtMS0xMjE3OTc_ef54f47b-1128-42d8-9c84-9cdd38607407"
      unitRef="usd">-70000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id0b0ed60026f4fadb0d2eedd77fc61e3_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfNy0xMS0xLTEtMTIxNzk3_4920e930-b272-42d3-9a86-0ed8c237d13c"
      unitRef="usd">2168000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="ib5045314d03040549992e1b0d350c6f4_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfOC0xLTEtMS0xMjE3OTc_e4743c15-23cd-4071-9a70-9597f339c7f0"
      unitRef="usd">22756000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i61b1e59accbc4a6b9fdbbf4dd1e166d8_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfOC0zLTEtMS0xMjE3OTc_a3a637b4-87eb-432d-8814-3192d80b6b8c"
      unitRef="usd">42812000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i054a08a597154e34b91b50e36527b86c_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfOC01LTEtMS0xMjE3OTc_3251c4b3-2ad6-47d8-88cb-4a591b42fdb5"
      unitRef="usd">26286000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i02a2e27009a64f7bb8e01545a97c8feb_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfOC03LTEtMS0xMjE3OTc_d5ced707-ad90-4563-a2f1-2d59fe3d5879"
      unitRef="usd">110000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if1040a72d0304a058af732ed3761a15a_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfOC05LTEtMS0xMjE3OTc_3f21011a-7144-4ad7-a035-631e4789642c"
      unitRef="usd">-11328000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfOC0xMS0xLTEtMTIxNzk3_55e7137f-6eaf-4627-89fc-4ac5da3f0060"
      unitRef="usd">80636000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9705f2eab1364f59a4310ba9e64be4f7_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTEtMy0xLTEtMTIxNzk3_a0f36f23-633d-4f83-bf67-b8301e198020"
      unitRef="usd">24537000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i66461e89f4cf4e2aa3f6185279aa73bb_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTItMy0xLTEtMTIxNzk3_432f368e-0cda-4e51-a4cf-fbd329629835"
      unitRef="usd">18030000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8548b563f1d944cca1d05b3dab4932ae_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTMtMy0xLTEtMTIxNzk3_6795570d-2b4b-496e-9476-ce9bca371e9a"
      unitRef="usd">245000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i61b1e59accbc4a6b9fdbbf4dd1e166d8_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTQtMy0xLTEtMTIxNzk3_5baca44a-be20-410a-9d99-6266c58ebe13"
      unitRef="usd">42812000000</us-gaap:Revenues>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia5f9bf2f84f5424a8f4403ced4cdf313_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTgtMS0xLTEtMTIxNzk3_348ceeb1-064d-4f78-9fd4-c4504272e4b2"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if91a5b69cd074ce79d4d34e004ebe4a9_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTgtMy0xLTEtMTIxNzk3_7e90391e-fd11-4b29-b711-5dae290906bf"
      unitRef="usd">38153000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e8cf06c0bc54774a6be05b92ccb09f0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTgtNS0xLTEtMTIxNzk3_dc8f926d-1ff0-4143-8710-85fed82d0659"
      unitRef="usd">18873000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id787a5341515453f9bca382ea7deede3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTgtNy0xLTEtMTIxNzk3_cb4901d0-2abd-4746-8740-54423bca52b9"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i76cc779209494399b277155e37005f03_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTgtOS0xLTEtMTIxNzk3_ad782389-119a-4df9-b6bc-7ef586b5eb85"
      unitRef="usd">-11094000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i69adb512452f407aa3bbe55a8fee69ec_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTgtMTEtMS0xLTEyMTc5Nw_d5b095cb-da1a-4367-bf91-60d61d65f438"
      unitRef="usd">45932000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i92d89a578ea644c4b4cf67268c64ef50_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTktMS0xLTEtMTIxNzk3_c890d9be-aa42-457a-8235-bb8f69541efc"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i435b5e917ab045a4a02bf177f2b0e8b9_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTktMy0xLTEtMTIxNzk3_f8882f5d-7b3a-4ce4-b7f5-72f8c64e8407"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7efacb33d756442cbe220b672cf09431_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTktNS0xLTEtMTIxNzk3_2e20d5e7-80bc-4a7a-bf87-9948ef080838"
      unitRef="usd">5254000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i36e853003adb424d944872c915ac6b0b_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTktNy0xLTEtMTIxNzk3_4f2c2b15-551c-4c0a-8fcb-b663517a17b4"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i03a49e5738514a6bb26ab374104cee06_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTktOS0xLTEtMTIxNzk3_3acedfcf-d914-41d3-b34b-19c5d5505b5b"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6859cf97c16a4a5ebd938b85cb35957b_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMTktMTEtMS0xLTEyMTc5Nw_1ce4d58d-6cf0-4018-80a7-5f8962e12e2e"
      unitRef="usd">5254000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9fab59a9eb31497ba179665fe456507e_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjAtMS0xLTEtMTIxNzk3_91ea05cc-bf74-4313-94bd-9cfa3400b100"
      unitRef="usd">18968000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61167828fdf24a1dbd6b7d94ab77ec42_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjAtMy0xLTEtMTIxNzk3_50f2b102-ba4c-41b4-b2e5-eeb45afff2d4"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe16bcd19fa348eeb4e81dd6ad44410f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjAtNS0xLTEtMTIxNzk3_f8f65a22-4f93-4877-a68b-347b5aa05491"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i507ba2e974e440f69b7567158be6571f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjAtNy0xLTEtMTIxNzk3_214f03ce-c9ab-4ac1-9af2-2c3699f5b920"
      unitRef="usd">15000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i438c350cb9734cbeb799f5b1892d664b_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjAtOS0xLTEtMTIxNzk3_e037ed85-07b6-425a-884e-2281329f31a5"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i623ff046ae5c485b878e5d00ab123314_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjAtMTEtMS0xLTEyMTc5Nw_40142651-8e61-4351-9e18-08d75bc42be8"
      unitRef="usd">18983000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="iac24217ba0c74626b4bf25cec318c623_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjEtMS0xLTEtMTIxNzk3_e14f0a89-c8ef-406f-8764-302d27316631"
      unitRef="usd">137000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="if86bb61e4141479b9697828b3dc20cc6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjEtMy0xLTEtMTIxNzk3_de653d12-cb14-4954-a5d9-ef47ff913c8e"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ic44e989a3ada405d8425fbe65629dc23_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjEtNS0xLTEtMTIxNzk3_9626702d-2eb6-4bfc-b87c-2df6b43ecd42"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i3fa7e9e824974440a9373bee9896bb39_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjEtNy0xLTEtMTIxNzk3_4f3b693f-d0a8-424b-b0f6-0960fc9f78f3"
      unitRef="usd">152000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i4922155132bd45ada7189d0b3ef9fc3e_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjEtOS0xLTEtMTIxNzk3_7743df0a-9576-4b4d-9f37-d4804bea7f81"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjEtMTEtMS0xLTEyMTc5Nw_f97c2c4e-1850-477d-b920-cb86616f56f3"
      unitRef="usd">289000000</us-gaap:NetInvestmentIncome>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i81adcf0d41fd450681c65b683fb1aba1_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjItMS0xLTEtMTIxNzk3_e056f634-84e7-4ef1-bc51-2be770bc74b4"
      unitRef="usd">1420000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1728c43ce0c146c3837ea3dca24f858d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjItMy0xLTEtMTIxNzk3_07a7a773-8b37-4258-a2ef-5b2cb885a949"
      unitRef="usd">161000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0723aca048c948b09c4e21b76e36afcb_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjItNS0xLTEtMTIxNzk3_86d5766a-74cf-43de-8e35-81c6351d7f31"
      unitRef="usd">601000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ief415c243f1342a49eed3ad3b8ccb6b3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjItNy0xLTEtMTIxNzk3_73418da3-6fd1-4bc0-953c-d8b77c9113d2"
      unitRef="usd">15000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0312c66cceb448a780815200255d58c0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjItOS0xLTEtMTIxNzk3_3fb16f10-11e0-4db2-99ed-6eaa1c2c7cb0"
      unitRef="usd">-39000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib88dd15d80484821a92bfc5cc6f71cec_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjItMTEtMS0xLTEyMTc5Nw_175ca155-ca75-4e75-8156-80f0da921001"
      unitRef="usd">2158000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="iac24217ba0c74626b4bf25cec318c623_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjMtMS0xLTEtMTIxNzk3_7bc5c2fe-a649-4dab-8757-bd1f99c63bf9"
      unitRef="usd">20525000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if86bb61e4141479b9697828b3dc20cc6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjMtMy0xLTEtMTIxNzk3_a8429618-62e6-4de2-b8f6-a820f22032e7"
      unitRef="usd">38314000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic44e989a3ada405d8425fbe65629dc23_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjMtNS0xLTEtMTIxNzk3_61c9dffd-c944-484c-b2c2-6b92ff8b5716"
      unitRef="usd">24728000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3fa7e9e824974440a9373bee9896bb39_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjMtNy0xLTEtMTIxNzk3_eede05f6-b7aa-4623-b4de-537f4338092e"
      unitRef="usd">182000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4922155132bd45ada7189d0b3ef9fc3e_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjMtOS0xLTEtMTIxNzk3_f8ade7e9-f012-4844-a36f-ebf2e11c4155"
      unitRef="usd">-11133000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjMtMTEtMS0xLTEyMTc5Nw_bd5434a5-704f-4749-99ce-afe078b10bf0"
      unitRef="usd">72616000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idf0d9424f03a41f0bea7d15520ac11ae_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjYtMy0xLTEtMTIxNzk3_05255fcd-5b59-49ec-8b46-e05468899557"
      unitRef="usd">22918000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i26d2adfcb7d047ac8b01711252305fdc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjctMy0xLTEtMTIxNzk3_757ad60d-3eec-46a1-83d3-a718daf9757a"
      unitRef="usd">15235000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib99bcbdff8fe401f90d46731f3dc1a6c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjgtMy0xLTEtMTIxNzk3_17485250-4501-4776-910a-76e2f15e8666"
      unitRef="usd">161000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if86bb61e4141479b9697828b3dc20cc6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmVlYzgyZjVmNWNjYTQ4YjE4ZWFhMWM4MmRhZWYxMDU5L3RhYmxlcmFuZ2U6ZWVjODJmNWY1Y2NhNDhiMThlYWExYzgyZGFlZjEwNTlfMjktMy0xLTEtMTIxNzk3_3bf14e46-a8a6-4e74-a078-a5a69cdc2697"
      unitRef="usd">38314000000</us-gaap:Revenues>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6537cae612474b44bd681794d3356a66_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMy0xLTEtMS0xMjc0MzE_b25fc545-cec1-4571-9f3a-f46fed196fb4"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0782975245974b74b8eb5fc41883c74d_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMy0zLTEtMS0xMjc0Mzk_ba816f37-07da-4406-b25b-d6afa62805fa"
      unitRef="usd">81765000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i16bcbe7065de4f5399be949b1c27cc7d_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMy01LTEtMS0xMjc0Mzk_392d701a-0087-468a-b11f-55cafa82db14"
      unitRef="usd">39549000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if2aff33ffc31447780863b02c8bd982b_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMy03LTEtMS0xMjc0NTA_18cb742e-9276-4164-8b7d-9864877e51e7"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaefa8d0706ce4702b6fcfb8adb353dfe_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMy05LTEtMS0xMjc0NTA_7513534e-4ebc-4c78-97ae-5ed98f5bb493"
      unitRef="usd">-22498000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1255b4ef9e894adaba3c64f6d2612e0b_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMy0xMS0xLTEtMTI3NDUw_4c557be2-8e64-4281-a8d9-45840db5734d"
      unitRef="usd">98816000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i52811493f7514547903b0812dc24ec85_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNC0xLTEtMS0xMjc0MzE_cf2f078d-0d71-4c41-976a-c9b8e7a41664"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i85c678a2a2f645898239a8ad884b0cf9_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNC0zLTEtMS0xMjc0Mzk_4d6039f0-73d1-4b28-8cc0-0ca31abddeac"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9dba48c9530b483c8e2a19d59638a1be_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNC01LTEtMS0xMjc0Mzk_da1f99c9-0e5a-4d86-b31e-e484ffce4b19"
      unitRef="usd">11049000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id28fa46920ee4b9f8a0fc63559c2e476_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNC03LTEtMS0xMjc0NTA_a89e18ca-775a-4b4a-b668-62449648b432"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5d5d1a53ed80404d91555cf7ede4f1ac_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNC05LTEtMS0xMjc0NTA_899bff1d-50cc-4db8-b651-9597ae4a40f4"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iddb342e81917421abee497b130cc5997_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNC0xMS0xLTEtMTI3NDUw_3cf62f82-631d-4572-b026-43ffde2025cd"
      unitRef="usd">11049000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6df2f846eb984710b6afeb4efcea88b1_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNS0xLTEtMS0xMjc0MzE_5d0c6f78-89ec-4b94-869c-3d8ed891b077"
      unitRef="usd">42859000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i74b2b424d482423984db3f523ee9fb5e_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNS0zLTEtMS0xMjc0Mzk_98406e4d-f908-4677-bdb4-40ef811e112e"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c5104fe39a947b2bcd684db82b54e48_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNS01LTEtMS0xMjc0Mzk_3db2292d-9a5b-4593-be98-1c1af50d201c"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie1416df2f1ea4d3694000029e33ace71_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNS03LTEtMS0xMjc0NTA_c7a74fef-ff3f-4663-879d-517a3e8c9629"
      unitRef="usd">32000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i22caa8d1a08845c29d9104c92f002218_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNS05LTEtMS0xMjc0NTA_fbc2363e-ba7c-443c-bb37-21423d1e92e5"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i96ab3a063aca414ead5f29a63f96b5ae_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNS0xMS0xLTEtMTI3NDUw_fbae69eb-679e-4589-97ea-940b9aec4b43"
      unitRef="usd">42891000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="ia17daf1ddb80489bbdce4d94932efa21_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNi0xLTEtMS0xMjc0MzE_a78df943-370d-43b8-8299-e304d5bf5dda"
      unitRef="usd">177000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ib89fad02b4b74e5cbffe8ec18de4bc64_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNi0zLTEtMS0xMjc0Mzk_068a07af-92ea-4118-bfec-c56805a153ce"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i88782d759ab24dbd8db24d6e19ba64de_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNi01LTEtMS0xMjc0Mzk_e12fe267-f62f-4024-8acb-f9083bad674b"
      unitRef="usd">-34000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i8feac348d42b418da086e65a9b0801eb_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNi03LTEtMS0xMjc0NTA_ee8763f1-6703-4364-a4ab-1ed6e19379db"
      unitRef="usd">171000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i9b2e6ca6c94b4ad5afd1d4f01f87431e_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNi05LTEtMS0xMjc0NTA_af2b02c7-0ac8-458d-a194-41d78a61fc2f"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNi0xMS0xLTEtMTI3NDUw_3a769233-6b6c-49d6-8671-909690afe89b"
      unitRef="usd">314000000</us-gaap:NetInvestmentIncome>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0b947bfa40dc4421923fa575beb49be8_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNy0xLTEtMS0xMjc0MzE_fe096c5d-562f-43bc-ad4f-1eb7113059b0"
      unitRef="usd">2829000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib1b6035f28cb43a18932f1ea69845c67_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNy0zLTEtMS0xMjc0Mzk_0de4d383-958b-470f-bcb1-ac878de906a6"
      unitRef="usd">508000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib62a0f8998684d1d9ba32dd07b1f9ff9_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNy01LTEtMS0xMjc0Mzk_e5a596a0-fd9a-4099-8e46-d7632333c19b"
      unitRef="usd">1140000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9c453fd49aa84dd8882ffc93c6c79248_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNy03LTEtMS0xMjc0NTA_b6e111e6-7573-4559-9e84-d4bec1833544"
      unitRef="usd">33000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibd9b5ab95c8b4a5685904bf985fd3749_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNy05LTEtMS0xMjc0NTA_1fcdcc15-7fdc-4e14-bc65-7e07210e7ebe"
      unitRef="usd">-118000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia84edce63c9740baa08e23d7f9537d75_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfNy0xMS0xLTEtMTI3NDUw_ae6fb3c8-1675-48d7-9137-ef39822a8e66"
      unitRef="usd">4392000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="ia17daf1ddb80489bbdce4d94932efa21_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfOC0xLTEtMS0xMjc0MzE_1262d4be-f5a5-46cc-acaa-79b423ba2530"
      unitRef="usd">45865000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib89fad02b4b74e5cbffe8ec18de4bc64_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfOC0zLTEtMS0xMjc0Mzk_056c5954-b195-4fff-9ac6-db6e0ac6ffc1"
      unitRef="usd">82273000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i88782d759ab24dbd8db24d6e19ba64de_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfOC01LTEtMS0xMjc0Mzk_aaba5640-f2df-4fcf-8468-33f38cb75b9a"
      unitRef="usd">51704000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8feac348d42b418da086e65a9b0801eb_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfOC03LTEtMS0xMjc0NTA_4fd04846-314c-41c7-9ade-80c43ff54f99"
      unitRef="usd">236000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9b2e6ca6c94b4ad5afd1d4f01f87431e_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfOC05LTEtMS0xMjc0NTA_8b3faef2-1ac0-47d2-95ac-744283bdf7bd"
      unitRef="usd">-22616000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfOC0xMS0xLTEtMTI3NDUw_e906a771-1f8b-4ea5-9454-441c895f63a5"
      unitRef="usd">157462000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6303f55236d942fab6bbb1a2cba7ac53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTEtMy0xLTEtMTI3NDU4_06e21abb-26e6-440f-983d-e77d0a7b1d73"
      unitRef="usd">47361000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie437eecdbe674fc7ac7ace4c9417d023_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTItMy0xLTEtMTI3NDU4_ba15b21f-8376-4d48-b7a0-661883225e80"
      unitRef="usd">34404000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i450e973802ca4a89b066afe451cad627_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTMtMy0xLTEtMTI3NDU4_da4f1ab4-b658-4aa8-89fa-835d0bd9aa5e"
      unitRef="usd">508000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib89fad02b4b74e5cbffe8ec18de4bc64_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTQtMy0xLTEtMTI3NDU4_1c60bc22-13ab-4c37-9004-3d3da54665ea"
      unitRef="usd">82273000000</us-gaap:Revenues>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e8e4ca7275c41668b2c0d85eeb02748_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTgtMS0xLTEtMTI3MzQ1_0cabae7b-b27e-4e76-a94d-45ff1ce4d4ec"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i20c5541ab98a439d8cf5a822544191d2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTgtMy0xLTEtMTI3MzQ1_c725a7dc-1c0e-413c-baaf-01f922c5f446"
      unitRef="usd">74294000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i80a33a8e6a7646c2bf5b7c8f67ed21e0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTgtNS0xLTEtMTI3MzQ1_9dc7f53d-9dab-4e5e-bbb9-9fecf94b9043"
      unitRef="usd">36758000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6228c1327ede4b82b91ec1ba1d6893a7_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTgtNy0xLTEtMTI3MzQ1_e7a963a9-1727-4fa7-a50f-56c76501b29d"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2e983c97388f434aa9ef46e937c90412_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTgtOS0xLTEtMTI3MzQ1_8d5b19e4-fd76-4490-9949-c3d7e8798199"
      unitRef="usd">-22168000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i161127e00ea4498383d69d1be2d2c47a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTgtMTEtMS0xLTEyNzM0NQ_5c4c8e64-2102-4277-93f9-71752a76b374"
      unitRef="usd">88884000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1575b9d08b144d43981bd5eb802dd53f_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTktMS0xLTEtMTI3MzQ1_40cba9ba-3eea-4bf4-9da6-a12524befae6"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a3ca1a8f9864d8899757bcfaed24e58_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTktMy0xLTEtMTI3MzQ1_1db65f0f-d6b0-4b0f-aab9-80d3ef3767fc"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i30d7688d403b4e3ab22e76a11216efa3_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTktNS0xLTEtMTI3MzQ1_de75788c-20e3-4d61-a47b-e411402b01cd"
      unitRef="usd">9896000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b47e1b909d4426aafc04538f0b5b755_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTktNy0xLTEtMTI3MzQ1_f2aefbd7-12c4-4749-a6b2-d5c7500db372"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie0048308c35140bb9969cdb4dd5440ee_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTktOS0xLTEtMTI3MzQ1_7138b0d9-023b-421d-8ac5-ac94d465d420"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i79ef86c1028641728228a2602b0b7d4c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMTktMTEtMS0xLTEyNzM0NQ_7f1dc46e-036f-42f9-b010-b3fb22404bd5"
      unitRef="usd">9896000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i528af9caa41c45da877206ed8fc66f8d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjAtMS0xLTEtMTI3MzQ1_6790e2b3-fde1-4fce-a979-4118debe3007"
      unitRef="usd">37910000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia07a38bcea214ce6a38514324ed4c87c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjAtMy0xLTEtMTI3MzQ1_7905a615-b5a6-45be-9d49-b6693d191a7c"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ab215a9d2c44d37befa113efb740879_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjAtNS0xLTEtMTI3MzQ1_17ec875c-0309-4a4e-bbea-3e96312fd43c"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i92d3e64078334a22bfdeba1976be9fcb_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjAtNy0xLTEtMTI3MzQ1_c7edfee0-8c6e-46e9-8675-be72a4026b41"
      unitRef="usd">33000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie6a9e8a1a1b344cdb794e6a5f0c62ff6_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjAtOS0xLTEtMTI3MzQ1_aba62c1e-d50d-4eed-91a5-1c0c76708328"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibcf5af83ee0148b4935c83147cd82d02_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjAtMTEtMS0xLTEyNzM0NQ_0876cf0c-0c99-459e-9a99-74b8f612053c"
      unitRef="usd">37943000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i65583ca6502143fea8109266db45d395_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjEtMS0xLTEtMTI3MzQ1_f439fc82-07c3-451f-86bc-3bab49c82b13"
      unitRef="usd">285000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ibfa2cea5de8e43f9ba651607d9a10c30_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjEtMy0xLTEtMTI3MzQ1_2bd9bca2-56e8-490d-b9af-c3ee7314ba51"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ia1d59b798de8427bb69d0f7d325309b7_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjEtNS0xLTEtMTI3MzQ1_2080805e-e48a-4343-bd74-e0da788dbb92"
      unitRef="usd">46000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="iec432ef32c864c91b9106f3307398132_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjEtNy0xLTEtMTI3MzQ1_00270083-6e25-45d0-9e0d-6303bb1c272c"
      unitRef="usd">255000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i1bb38325fd294ffcb76280c930132208_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjEtOS0xLTEtMTI3MzQ1_a37dd88e-5ac4-45cd-a06a-20415c701be2"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjEtMTEtMS0xLTEyNzM0NQ_0a18584d-576b-49e8-ae26-317aca08dcf0"
      unitRef="usd">586000000</us-gaap:NetInvestmentIncome>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i78f790a00f154949a940714ab7c599ca_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjItMS0xLTEtMTI3MzQ1_d21749d1-681e-4c2d-aaaf-f4ec06973aa3"
      unitRef="usd">2813000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i07c8c4b9dbbe4576a4bb2c9bf39072de_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjItMy0xLTEtMTI3MzQ1_0584150b-76fb-4d5b-9c43-be5b869a383e"
      unitRef="usd">341000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1a7ca95dd5c9433bb8e72e9c147bb27f_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjItNS0xLTEtMTI3MzQ1_5508e3c0-a2e8-44ae-8590-387d461534c2"
      unitRef="usd">1302000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i659e7d4e49dd4140b46f05ec617268b7_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjItNy0xLTEtMTI3MzQ1_6cb6dc15-5d3c-4957-9792-cf0d40d50515"
      unitRef="usd">29000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8e811dd702440d69beb3ddbac49f7c2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjItOS0xLTEtMTI3MzQ1_e7492005-86a6-4250-9379-1194f971ccb0"
      unitRef="usd">-81000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i512aca10306b4c15a9e893f9f9a7fece_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjItMTEtMS0xLTEyNzM0NQ_20cfbfcd-2033-4ae1-b1d2-2acf5a6c29c1"
      unitRef="usd">4404000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i65583ca6502143fea8109266db45d395_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjMtMS0xLTEtMTI3MzQ1_7944741c-080d-4c34-b07e-f2b4f2429388"
      unitRef="usd">41008000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibfa2cea5de8e43f9ba651607d9a10c30_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjMtMy0xLTEtMTI3MzQ1_766b8e8a-b405-44e6-8fe8-996fad03b203"
      unitRef="usd">74635000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia1d59b798de8427bb69d0f7d325309b7_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjMtNS0xLTEtMTI3MzQ1_83adccb0-ab9f-4899-81e2-bb38ff69be20"
      unitRef="usd">48002000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iec432ef32c864c91b9106f3307398132_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjMtNy0xLTEtMTI3MzQ1_fad3777b-fedf-44ae-8879-6fc0975eda4e"
      unitRef="usd">317000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1bb38325fd294ffcb76280c930132208_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjMtOS0xLTEtMTI3MzQ1_1d73ddca-4b0c-415b-85b8-22a248e15642"
      unitRef="usd">-22249000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjMtMTEtMS0xLTEyNzM0NQ_44603aad-a471-4286-addc-a90cb2e4636a"
      unitRef="usd">141713000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6052c3c9f3814eb19317cbd04f0a8d6f_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjYtMy0xLTEtMTI3MzQ4_888bd21e-cc1d-461f-ba2a-5bb72a48ebe5"
      unitRef="usd">44811000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iedfe0ee1cea245499d6a17e933ed0082_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjctMy0xLTEtMTI3MzQ4_db02dc8b-8e71-4073-bfce-0bbc501ef893"
      unitRef="usd">29483000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1cf77f9a3b234efcb511290bb7abcf0e_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjgtMy0xLTEtMTI3MzQ4_a90e4d1a-3bc9-43fa-bdbb-14803b3ed1eb"
      unitRef="usd">341000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibfa2cea5de8e43f9ba651607d9a10c30_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjIzYTU2MThjMzkwNzQ4ZGM5OTVkZjFkOWI1ZjZjNTVmL3RhYmxlcmFuZ2U6MjNhNTYxOGMzOTA3NDhkYzk5NWRmMWQ5YjVmNmM1NWZfMjktMy0xLTEtMTI3MzQ4_c0f589a2-e73d-4ca8-97d5-003ae30bd387"
      unitRef="usd">74635000000</us-gaap:Revenues>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTYxNTE_97c0cc43-f283-4ceb-8d42-a748d0878133">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities primarily represent the Company&#x2019;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTYxOTQ_22eafc1e-cbd8-4e9f-af97-04b21cc33acc">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about receivables and contract liabilities from contracts with customers:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables (included in accounts receivable, net)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities (included in accrued expenses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the six months ended June&#160;30, 2022 and 2021, the contract liabilities balance includes increases related to customers&#x2019; earnings in ExtraBucks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rewards earnings and gift card issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redemption and breakage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjFjYWZmMDMyMjViMzRjMmZhYzEwMDg3MzAwZjUyYjFkL3RhYmxlcmFuZ2U6MWNhZmYwMzIyNWIzNGMyZmFjMTAwODczMDBmNTJiMWRfMS0xLTEtMS0xMjE3OTc_ba31fbd8-8535-402c-b785-bffb17c6da7e"
      unitRef="usd">9084000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjFjYWZmMDMyMjViMzRjMmZhYzEwMDg3MzAwZjUyYjFkL3RhYmxlcmFuZ2U6MWNhZmYwMzIyNWIzNGMyZmFjMTAwODczMDBmNTJiMWRfMS0zLTEtMS0xMjE3OTc_a38bd33f-e133-496a-bd39-0334531e9bbd"
      unitRef="usd">7932000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjFjYWZmMDMyMjViMzRjMmZhYzEwMDg3MzAwZjUyYjFkL3RhYmxlcmFuZ2U6MWNhZmYwMzIyNWIzNGMyZmFjMTAwODczMDBmNTJiMWRfMi0xLTEtMS0xMjE3OTc_3dd7c5af-abd3-4baf-8318-6aea21d43bff"
      unitRef="usd">80000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOjFjYWZmMDMyMjViMzRjMmZhYzEwMDg3MzAwZjUyYjFkL3RhYmxlcmFuZ2U6MWNhZmYwMzIyNWIzNGMyZmFjMTAwODczMDBmNTJiMWRfMi0zLTEtMS0xMjE3OTc_5c6b828e-d22f-4322-abac-eeb86bae10bf"
      unitRef="usd">87000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmQ1YjY4NTI4Y2RkMTQ5NTk5ZjRlMmYyZWE5NzhmOWE3L3RhYmxlcmFuZ2U6ZDViNjg1MjhjZGQxNDk1OTlmNGUyZjJlYTk3OGY5YTdfMi0xLTEtMS0xMjE3OTc_5c6b828e-d22f-4322-abac-eeb86bae10bf"
      unitRef="usd">87000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="id1b37908bcec4675b7dd487bd3f7f745_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmQ1YjY4NTI4Y2RkMTQ5NTk5ZjRlMmYyZWE5NzhmOWE3L3RhYmxlcmFuZ2U6ZDViNjg1MjhjZGQxNDk1OTlmNGUyZjJlYTk3OGY5YTdfMi0zLTEtMS0xMjE3OTc_d9167c73-fb84-4c33-9f1c-37ac533ea676"
      unitRef="usd">71000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmQ1YjY4NTI4Y2RkMTQ5NTk5ZjRlMmYyZWE5NzhmOWE3L3RhYmxlcmFuZ2U6ZDViNjg1MjhjZGQxNDk1OTlmNGUyZjJlYTk3OGY5YTdfMy0xLTEtMS0xMjE3OTc_707aef21-6b5f-436e-98d0-52d68018f722"
      unitRef="usd">175000000</cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance>
    <cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmQ1YjY4NTI4Y2RkMTQ5NTk5ZjRlMmYyZWE5NzhmOWE3L3RhYmxlcmFuZ2U6ZDViNjg1MjhjZGQxNDk1OTlmNGUyZjJlYTk3OGY5YTdfMy0zLTEtMS0xMjE3OTc_1a9fd221-5c3b-489f-b821-48e3dee5bae7"
      unitRef="usd">183000000</cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance>
    <cvs:ContractwithCustomerLiabilityRedemptionandBreakage
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmQ1YjY4NTI4Y2RkMTQ5NTk5ZjRlMmYyZWE5NzhmOWE3L3RhYmxlcmFuZ2U6ZDViNjg1MjhjZGQxNDk1OTlmNGUyZjJlYTk3OGY5YTdfNC0xLTEtMS0xMjE3OTc_a0801a20-21b4-408c-8b2a-34cb45fa0278"
      unitRef="usd">182000000</cvs:ContractwithCustomerLiabilityRedemptionandBreakage>
    <cvs:ContractwithCustomerLiabilityRedemptionandBreakage
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmQ1YjY4NTI4Y2RkMTQ5NTk5ZjRlMmYyZWE5NzhmOWE3L3RhYmxlcmFuZ2U6ZDViNjg1MjhjZGQxNDk1OTlmNGUyZjJlYTk3OGY5YTdfNC0zLTEtMS0xMjE3OTc_5255a06e-de02-4a35-a81f-d5b7200372e2"
      unitRef="usd">175000000</cvs:ContractwithCustomerLiabilityRedemptionandBreakage>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmQ1YjY4NTI4Y2RkMTQ5NTk5ZjRlMmYyZWE5NzhmOWE3L3RhYmxlcmFuZ2U6ZDViNjg1MjhjZGQxNDk1OTlmNGUyZjJlYTk3OGY5YTdfNS0xLTEtMS0xMjE3OTc_3dd7c5af-abd3-4baf-8318-6aea21d43bff"
      unitRef="usd">80000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i9c91d440ca044d289daea52743e3cebd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RhYmxlOmQ1YjY4NTI4Y2RkMTQ5NTk5ZjRlMmYyZWE5NzhmOWE3L3RhYmxlcmFuZ2U6ZDViNjg1MjhjZGQxNDk1OTlmNGUyZjJlYTk3OGY5YTdfNS0zLTEtMS0xMjE3OTc_447476c6-8e90-4396-999a-4175e97473fb"
      unitRef="usd">79000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTYxMzc_3a5dcdca-1c54-48cd-a5d1-329b67ba6633">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Related Party Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in SureScripts, LLC (&#x201c;SureScripts&#x201d;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $16 million and $10 million in the three months ended June&#160;30, 2022 and 2021, respectively, and expensed fees for the use of this network of approximately $31 million and $19 million in the six months ended June&#160;30, 2022 and 2021, respectively. The Company&#x2019;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in Heartland Healthcare Services, LLC (&#x201c;Heartland&#x201d;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $23 million and $19 million for pharmaceutical inventory purchases during the three months ended June&#160;30, 2022 and 2021, respectively, and $44 million and $37 million for pharmaceutical inventory purchases during the six months ended June&#160;30, 2022 and 2021, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#x2019;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTI0OTI_716b7d01-ce61-43bf-82a1-355f5016b188"
      unitRef="usd">16000000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTI0OTk_1ae1e135-f136-42c8-9ffd-ce15a9f3c218"
      unitRef="usd">10000000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTA5OTUxMTY0NDA5NA_f6901326-1a3c-4456-80c3-9c36688fb568"
      unitRef="usd">31000000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTA5OTUxMTY0NDEwNg_91cebb7b-6a00-4300-885a-aac5bf4d4293"
      unitRef="usd">19000000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:NumberOfStatesInWhichEntityOperates
      contextRef="i80f415ea92fb4d01a514f6f8865f49a7_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTI4MDc_dd82318b-e444-4e6c-985e-b8e84b23bcb7"
      unitRef="state">4</us-gaap:NumberOfStatesInWhichEntityOperates>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTI4NDU_6be13586-67e7-4571-9c85-b2cc33afec13"
      unitRef="usd">23000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTI4NTI_9820ff1c-89e2-459b-bb3b-03e31501179e"
      unitRef="usd">19000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTA5OTUxMTY0NDMwMQ_51e99c7b-87a8-44b8-82e5-85250d7fd5e8"
      unitRef="usd">44000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTA5OTUxMTY0NDMwNw_fd77ebac-2172-4003-b169-a66bb0205fb3"
      unitRef="usd">37000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zNy9mcmFnOjZiNGUwZDI2ZGRkNjQ1ZjA5OTdjYmJhMjc2ODM5NWM3L3RleHRyZWdpb246NmI0ZTBkMjZkZGQ2NDVmMDk5N2NiYmEyNzY4Mzk1YzdfMTYxODk_2262c2c8-c9a0-41a4-9d87-180eff333b9c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Insurance Contracts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the Financial Accounting Standards Board issued Accounting Standards Update 2018-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Topic 944). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other comprehensive income. The rate used to discount the Company&#x2019;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#x2019;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#x2019;s interim and annual financial statements. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company will adopt the new standard on January 1, 2023, using the modified retrospective transition method as of the earliest period presented for changes to the liability for future policy benefits and deferred acquisition costs. While the Company is still evaluating the impact of the new standard on its financial statements, the Company anticipates an increase to its liability for future policy benefits with a corresponding change in accumulated other comprehensive income as a result of updating the rate used to discount the liabilities to reflect the yield for an upper-medium grade fixed-income instrument compared to the Company&#x2019;s expected investment yield under the existing guidance.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMTk0L2ZyYWc6OWYwZDg0MzYxYTY0NDA1M2IwZjU3NTliN2FhNWMyZmUvdGV4dHJlZ2lvbjo5ZjBkODQzNjFhNjQ0MDUzYjBmNTc1OWI3YWE1YzJmZV8zMjk4NTM0ODg2NjE4_0c2e0412-76de-499c-acec-064a0acc025a">Divestitures and Asset Sales&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Divestiture of PayFlex &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 1, 2022, the Company sold PayFlex for approximately $775&#160;million. PayFlex provides services to employers, their employees, and their former employees in the areas of tax-advantaged account reimbursement administration (flexible spending, health reimbursement, health savings, transit and parking), Consolidated Omnibus Budget Reconciliation Act (&#x201c;COBRA&#x201d;) administration and special-member billing administration. The results of this business have historically been reported within the Health Care Benefits segment. The Company recorded a pre-tax gain on the divestiture of $225&#160;million in the three and six months ended June&#160;30, 2022, which is reflected as a reduction in operating expenses in the Company&#x2019;s unaudited condensed consolidated statements of operations within the Health Care Benefits segment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Divestiture of Thailand Health Care Business&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2022, the Company reached an agreement to sell its international health care business domiciled in Thailand (&#x201c;Thailand business&#x201d;), comprised of approximately 266,000 medical members, which was included in the Commercial Business reporting unit within the Health Care Benefits segment. At that time, a portion of the Commercial Business goodwill was specifically allocated to the Thailand business. The net assets of the Thailand business were accounted for as assets held for sale at March 31, 2022. The carrying value of the Thailand business was determined to be greater than its fair value and, accordingly, the Company recorded a $41&#160;million loss on assets held for sale within the Health Care Benefits segment during the first quarter of 2022. The sale closed in the second quarter of 2022, and the consideration received and ultimate loss on the sale were not material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;International Health Care Benefits Renewal Rights Asset Sale&lt;/span&gt;&lt;/div&gt;In May 2022, the Company sold the renewal rights of approximately 200,000 international medical members outside of the Americas, Thailand and India in connection with an Asset Purchase Agreement. As part of this agreement, the Company will introduce and help migrate these existing international medical members to the purchaser upon renewal. The Company expects the migration process to occur over a 16-month period between July 2022 and October 2023. The Company expects to cease writing any new or renewal business for international medical members outside of the Americas after October 31, 2022. The consideration received related to this agreement was not material.</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="id743f37942444621831b2935b6d1e18a_D20220601-20220601"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMTk0L2ZyYWc6OWYwZDg0MzYxYTY0NDA1M2IwZjU3NTliN2FhNWMyZmUvdGV4dHJlZ2lvbjo5ZjBkODQzNjFhNjQ0MDUzYjBmNTc1OWI3YWE1YzJmZV8zODQ4MjkwNjk5Nzkz_08ace08c-0227-4f9e-a997-524b0c80c69b"
      unitRef="usd">775000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i9647c5ab754d4d37a49e9ee3963f2e2c_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMTk0L2ZyYWc6OWYwZDg0MzYxYTY0NDA1M2IwZjU3NTliN2FhNWMyZmUvdGV4dHJlZ2lvbjo5ZjBkODQzNjFhNjQ0MDUzYjBmNTc1OWI3YWE1YzJmZV8zODQ4MjkwNzAwOTMy_31481f9d-7958-4b99-b306-563c53c1b76b"
      unitRef="usd">225000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="id829479219c245759e9e3ab39d4a09b9_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMTk0L2ZyYWc6OWYwZDg0MzYxYTY0NDA1M2IwZjU3NTliN2FhNWMyZmUvdGV4dHJlZ2lvbjo5ZjBkODQzNjFhNjQ0MDUzYjBmNTc1OWI3YWE1YzJmZV8zODQ4MjkwNzAwOTMy_5230ca33-b040-4100-b796-e282185171ef"
      unitRef="usd">225000000</us-gaap:GainLossOnSaleOfBusiness>
    <cvs:NumberOfMedicalMembers
      contextRef="i63fd0bfb9e4a43a58e4cfcab6009ac9e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMTk0L2ZyYWc6OWYwZDg0MzYxYTY0NDA1M2IwZjU3NTliN2FhNWMyZmUvdGV4dHJlZ2lvbjo5ZjBkODQzNjFhNjQ0MDUzYjBmNTc1OWI3YWE1YzJmZV8zODQ4MjkwNzA3Njk3_00e6cfe1-8fcb-49ad-b1bb-a95bff557ce6"
      unitRef="member">266000</cvs:NumberOfMedicalMembers>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="iac541484a57e442d8cefd6fa9441768c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMTk0L2ZyYWc6OWYwZDg0MzYxYTY0NDA1M2IwZjU3NTliN2FhNWMyZmUvdGV4dHJlZ2lvbjo5ZjBkODQzNjFhNjQ0MDUzYjBmNTc1OWI3YWE1YzJmZV8zODQ4MjkwNzAwOTI0_391e178f-6bb2-4b7c-839a-455186066840"
      unitRef="usd">41000000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i2a80d23584cd49d89a6bb9a7bff4bdd5_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMTk0L2ZyYWc6OWYwZDg0MzYxYTY0NDA1M2IwZjU3NTliN2FhNWMyZmUvdGV4dHJlZ2lvbjo5ZjBkODQzNjFhNjQ0MDUzYjBmNTc1OWI3YWE1YzJmZV8zODQ4MjkwNzAwOTI0_5f600211-67ba-42fc-b37b-fddcecff0221"
      unitRef="usd">41000000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <cvs:DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold
      contextRef="icee03dec469e41edbf6c698fb0d48290_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMTk0L2ZyYWc6OWYwZDg0MzYxYTY0NDA1M2IwZjU3NTliN2FhNWMyZmUvdGV4dHJlZ2lvbjo5ZjBkODQzNjFhNjQ0MDUzYjBmNTc1OWI3YWE1YzJmZV8yNzQ4Nzc5MDc0ODUw_8952c114-4847-4b7c-bfd2-7a0d0bbb2c0d"
      unitRef="member">200000</cvs:DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold>
    <cvs:DisposalGroupNotDiscontinuedOperationMigrationPeriod
      contextRef="icee03dec469e41edbf6c698fb0d48290_I20220531"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMTk0L2ZyYWc6OWYwZDg0MzYxYTY0NDA1M2IwZjU3NTliN2FhNWMyZmUvdGV4dHJlZ2lvbjo5ZjBkODQzNjFhNjQ0MDUzYjBmNTc1OWI3YWE1YzJmZV8yNzQ4Nzc5MDc0ODY2_73cd93db-ccd3-40c9-84bd-091e7e719ede">P16M</cvs:DisposalGroupNotDiscontinuedOperationMigrationPeriod>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNTE1Mg_9456ae90-9043-4877-9d95-fc31adb23cc6">Investments&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total investments at June&#160;30, 2022 and December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.106%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities available for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt Securities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities available for sale at June&#160;30, 2022 and December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.265%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Allowance&lt;br/&gt;for Credit&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(740)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,515)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Investment risks associated with the Company&#x2019;s experience-rated products generally do not impact the Company&#x2019;s consolidated operating results. At June&#160;30, 2022, debt securities with a fair value of $658 million, gross unrealized capital gains of $5 million and gross unrealized capital losses of $39 million and at December&#160;31, 2021, debt securities with a fair value of $864 million, gross unrealized capital gains of $94 million and gross unrealized capital losses of $2 million were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net amortized cost and fair value of debt securities at June&#160;30, 2022 are shown below by contractual maturity.&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.690%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Summarized below are the debt securities the Company held at June&#160;30, 2022 and December&#160;31, 2021 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.244%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Greater than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except number of securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviewed the securities in the table above and concluded that they are performing assets generating investment income to support the needs of the Company&#x2019;s business.&#160;In performing this review, the Company considered factors such as the quality of the investment security based on research performed by the Company&#x2019;s internal credit analysts and&#160;external rating agencies and the prospects of realizing the carrying value of the security based on the investment&#x2019;s current prospects for recovery. Unrealized capital losses at June&#160;30, 2022 were generally caused by interest rate increases and not by unfavorable changes in the credit quality associated with these securities. As of June&#160;30, 2022, the Company did not intend to sell these securities, and did not believe it was more likely than not that it would be required to sell these securities prior to the anticipated recovery of their amortized cost basis.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The maturity dates for debt securities in an unrealized capital loss position at June&#160;30, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting&lt;br/&gt;experience-rated products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting &lt;br/&gt;remaining products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Mortgage Loans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s mortgage loans are collateralized by commercial real estate.&#160;During the three and six months ended June&#160;30, 2022 and 2021, the Company had the following activity in its mortgage loan portfolio:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans fully repaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans foreclosed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses mortgage loans on a regular basis for credit impairments, and assigns a credit quality indicator to each loan.&#160;The Company&#x2019;s credit quality indicator is internally developed and categorizes each loan in its portfolio on a scale from 1 to 7.&#160;These indicators are based upon several factors, including current loan-to-value ratios, current and future property cash flow, property condition, market trends, creditworthiness of the borrower and deal structure. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Category 1 - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Represents loans of superior quality.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Categories 2 to 4 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;- Represent loans where credit risk is minimal to acceptable; however, these loans may display some susceptibility to economic changes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Categories 5 and 6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Represent loans where credit risk is not substantial, but these loans warrant management&#x2019;s close attention.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Category 7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Represents loans where collections are potentially at risk; if necessary, an impairment is recorded.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on the Company&#x2019;s assessments at June&#160;30, 2022 and December&#160;31, 2021, the amortized cost basis of the Company's mortgage loans within each credit quality indicator by year of origination was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost Basis by Year of Origination&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except credit quality indicator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Prior&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Investment Income&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sources of net investment income for the three and six months ended June&#160;30, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (excluding net realized capital gains or losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized capital gains (losses) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Net realized capital losses include yield-related impairment losses on debt securities of $30 million and are shown net of the reversal of previously recorded credit-related impairment losses on debt securities of $22 million in the three months ended June&#160;30, 2022. Net realized capital losses include credit-related and yield-related impairment losses on debt securities of $16 million and $48 million, respectively, in the six months ended June&#160;30, 2022. Net realized capital gains are net of yield-related impairment losses on debt securities of $2 million and $32 million, respectively, in the three and six months ended June&#160;30, 2021. There were no credit-related losses on debt securities in the three and six months ended June&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Net investment income includes $9 million and $18 million for the three and six months ended June&#160;30, 2022, respectively, and $10 million and $19 million for the three and six months ended June&#160;30, 2021, respectively, related to investments supporting experience-rated products.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Excluding amounts related to experience-rated products, proceeds from the sale of available-for-sale debt securities and the related gross realized capital gains and losses for the three and six months ended June&#160;30, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <cvs:TotalInvestmentsTableTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNTA2OA_88b5272e-9039-4743-82ea-36d9cc15d305">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total investments at June&#160;30, 2022 and December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.106%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities available for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvs:TotalInvestmentsTableTextBlock>
    <us-gaap:ShortTermInvestments
      contextRef="i437d75cbaaca4357be7aed594234e4e6_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfMi0xLTEtMS0xMjE3OTc_fd437331-e39d-4a12-a51b-cd19dce1462b"
      unitRef="usd">2775000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i437d75cbaaca4357be7aed594234e4e6_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfMi0zLTEtMS0xMjE3OTc_fd95b780-186e-40ee-a870-633f9c1c4d88"
      unitRef="usd">17976000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i437d75cbaaca4357be7aed594234e4e6_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfMi01LTEtMS0xMjE3OTc_f5a74085-8625-44ab-b4ef-22694f33bff0"
      unitRef="usd">20751000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i973f5697b1474af9a8c7a8e70194ec8a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfMi03LTEtMS0xMjE3OTc_4d706f94-6d6a-428c-adf9-d62b3b123c3c"
      unitRef="usd">3009000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i973f5697b1474af9a8c7a8e70194ec8a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfMi05LTEtMS0xMjE3OTc_59748888-63bb-4186-894b-c2e98a7232b4"
      unitRef="usd">20231000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i973f5697b1474af9a8c7a8e70194ec8a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfMi0xMS0xLTEtMTIxNzk3_b26aab60-30cc-491d-b8c4-a9d092ed754e"
      unitRef="usd">23240000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="icdbfd311e78b43f2b0104aa9cc8fb794_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfMy0xLTEtMS0xMjE3OTc_40a9252c-14d5-4d9a-b3d0-ffbfe2ba82fc"
      unitRef="usd">88000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="icdbfd311e78b43f2b0104aa9cc8fb794_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfMy0zLTEtMS0xMjE3OTc_3c2fe39b-a438-43fb-8c4b-4aabd85f4bc8"
      unitRef="usd">905000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="icdbfd311e78b43f2b0104aa9cc8fb794_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfMy01LTEtMS0xMjE3OTc_8de585bb-8a75-4ba1-9877-9d2d27e3c2af"
      unitRef="usd">993000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i13669c8a36c24e5d8272623034c20f84_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfMy03LTEtMS0xMjE3OTc_9a353999-f1ae-4352-b021-e143cdb1f211"
      unitRef="usd">58000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i13669c8a36c24e5d8272623034c20f84_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfMy05LTEtMS0xMjE3OTc_5d3ec592-5f8d-4537-a307-b815f0f14a88"
      unitRef="usd">844000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i13669c8a36c24e5d8272623034c20f84_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfMy0xMS0xLTEtMTIxNzk3_a28a4a17-5b41-4a84-8024-8d5a5bbb5e64"
      unitRef="usd">902000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="ibadb7cc69aae4c759a42a17ef71ff248_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfNC0xLTEtMS0xMjE3OTc_a6f91ced-fa75-44bd-a2fe-704c7e03209f"
      unitRef="usd">14000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="ibadb7cc69aae4c759a42a17ef71ff248_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfNC0zLTEtMS0xMjE3OTc_248c993b-3b64-4005-bb52-81d63e2cc633"
      unitRef="usd">2243000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="ibadb7cc69aae4c759a42a17ef71ff248_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfNC01LTEtMS0xMjE3OTc_8744604f-25e5-4328-9984-9d1c88ae69cb"
      unitRef="usd">2257000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="idd6de90b616a4a0989fc988def9d4af9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfNC03LTEtMS0xMjE3OTc_30ece811-e409-43ae-afab-245c940718fa"
      unitRef="usd">50000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="idd6de90b616a4a0989fc988def9d4af9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfNC05LTEtMS0xMjE3OTc_1d51e974-234f-485f-bc69-d56f401ac663"
      unitRef="usd">1950000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="idd6de90b616a4a0989fc988def9d4af9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfNC0xMS0xLTEtMTIxNzk3_971d84fc-9bfa-4657-b0e9-ad88f859ec3f"
      unitRef="usd">2000000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfNS0xLTEtMS0xMjE3OTc_c5fa43a5-80be-4fc2-b102-c5cfe53e1c64"
      unitRef="usd">2877000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfNS0zLTEtMS0xMjE3OTc_6a1e4361-1770-4fe3-8304-71ea147cc290"
      unitRef="usd">21124000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfNS01LTEtMS0xMjE3OTc_8d0115b8-7377-476f-a181-dd13aaaea261"
      unitRef="usd">24001000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfNS03LTEtMS0xMjE3OTc_424085f6-7080-4617-95c3-9719f5fdd62d"
      unitRef="usd">3117000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfNS05LTEtMS0xMjE3OTc_6d4a0637-2d40-4cdc-90d2-87e0d6f281d1"
      unitRef="usd">23025000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEyOTdjMjI3NDI3YzQ2MDA4MWYyYTc3OWM1NTIyNjA4L3RhYmxlcmFuZ2U6MTI5N2MyMjc0MjdjNDYwMDgxZjJhNzc5YzU1MjI2MDhfNS0xMS0xLTEtMTIxNzk3_ac29da68-162c-484b-b134-a6d15e04666d"
      unitRef="usd">26142000000</us-gaap:Investments>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNTExMA_3ebe11f7-0caa-4806-8493-4ded51a7c1ae">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities available for sale at June&#160;30, 2022 and December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.265%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Allowance&lt;br/&gt;for Credit&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(740)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,515)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Investment risks associated with the Company&#x2019;s experience-rated products generally do not impact the Company&#x2019;s consolidated operating results. At June&#160;30, 2022, debt securities with a fair value of $658 million, gross unrealized capital gains of $5 million and gross unrealized capital losses of $39 million and at December&#160;31, 2021, debt securities with a fair value of $864 million, gross unrealized capital gains of $94 million and gross unrealized capital losses of $2 million were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMy0xLTEtMS0xMjE3OTc_da9721ab-7818-4db7-aeaa-b7c736f46ded"
      unitRef="usd">2194000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMy0zLTEtMS0xMjE3OTc_e9870ff3-5f38-4771-984a-8e0b3d58622e"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMy01LTEtMS0xMjE3OTc_97ab9024-9ea5-4147-ae76-218b5a5298f3"
      unitRef="usd">2194000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMy03LTEtMS0xMjE3OTc_569fd9f7-2c47-4f41-b4a1-6e7b8148718e"
      unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMy05LTEtMS0xMjE3OTc_a7b2864d-f2a9-4a68-9332-411d45ece77a"
      unitRef="usd">118000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMy0xMS0xLTEtMTIxNzk3_e4ec20b7-1394-451a-8e90-10e58c154cf6"
      unitRef="usd">2078000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib04a3967c8004f97aa14f769721b3a73_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNC0xLTEtMS0xMjE3OTc_8a50b9c4-1bfa-4d53-a4d1-9c52b851598f"
      unitRef="usd">2472000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ib04a3967c8004f97aa14f769721b3a73_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNC0zLTEtMS0xMjE3OTc_714289b8-2f5d-45e7-85c9-e0542c208ee2"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="ib04a3967c8004f97aa14f769721b3a73_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNC01LTEtMS0xMjE3OTc_4c1110ed-7101-4d21-917f-02bed687debe"
      unitRef="usd">2472000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib04a3967c8004f97aa14f769721b3a73_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNC03LTEtMS0xMjE3OTc_0d581751-e41b-425a-88c1-d8fbb5d2c34b"
      unitRef="usd">11000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib04a3967c8004f97aa14f769721b3a73_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNC05LTEtMS0xMjE3OTc_6d2eb6c1-663a-48e4-9b93-829e3afd96cd"
      unitRef="usd">110000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib04a3967c8004f97aa14f769721b3a73_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNC0xMS0xLTEtMTIxNzk3_96a32812-c733-4e35-9c26-42d9e21a5599"
      unitRef="usd">2373000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNS0xLTEtMS0xMjE3OTc_237e388c-9030-4f30-8008-14375c78a576"
      unitRef="usd">9910000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNS0zLTEtMS0xMjE3OTc_8480c7fe-1e5d-4177-bd74-177fdb08d342"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNS01LTEtMS0xMjE3OTc_9eee89e3-0ebf-4ff7-8c7f-cc82b137ec15"
      unitRef="usd">9910000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNS03LTEtMS0xMjE3OTc_8a893d90-225f-48c2-93a1-7bd09a36f410"
      unitRef="usd">29000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNS05LTEtMS0xMjE3OTc_c4bd422f-c16d-4513-af12-3af20397201b"
      unitRef="usd">740000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNS0xMS0xLTEtMTIxNzk3_b13dc98f-57a4-403d-8530-40fcec65806b"
      unitRef="usd">9199000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i2e11998e647748a998ed3ae2000f65ec_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNi0xLTEtMS0xMjE3OTc_e3850c99-bb4a-4dfe-abca-5d43a996e83a"
      unitRef="usd">2857000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i2e11998e647748a998ed3ae2000f65ec_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNi0zLTEtMS0xMjE3OTc_31b83536-1f60-45e3-af83-a393f5a5503b"
      unitRef="usd">8000000</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i2e11998e647748a998ed3ae2000f65ec_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNi01LTEtMS0xMjE3OTc_e28ffce8-8ef0-4767-8f0d-fb923cf2d83d"
      unitRef="usd">2849000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2e11998e647748a998ed3ae2000f65ec_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNi03LTEtMS0xMjE3OTc_f10659ca-d1a8-444c-8193-eadea536e83d"
      unitRef="usd">18000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2e11998e647748a998ed3ae2000f65ec_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNi05LTEtMS0xMjE3OTc_603a57e1-7052-42f4-911d-c5c187b3b93d"
      unitRef="usd">236000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2e11998e647748a998ed3ae2000f65ec_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNi0xMS0xLTEtMTIxNzk3_89313aa5-4260-413a-af21-9d45a7d739af"
      unitRef="usd">2631000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNy0xLTEtMS0xMjE3OTc_36ce35e7-4929-49e4-a349-c2c5808eba1d"
      unitRef="usd">808000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNy0zLTEtMS0xMjE3OTc_dc6ce1e3-451a-4612-b737-9c889629b11f"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNy01LTEtMS0xMjE3OTc_9dc47c04-b60a-4353-9ce0-e84d0e89923e"
      unitRef="usd">808000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNy03LTEtMS0xMjE3OTc_c6117a1d-04c6-49e1-9e8d-9777b4e623ee"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNy05LTEtMS0xMjE3OTc_03e9118a-d645-43ac-bec7-9dd633f6bdcb"
      unitRef="usd">61000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfNy0xMS0xLTEtMTIxNzk3_29869bf5-7f5d-4afc-a285-515f89d294f0"
      unitRef="usd">747000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfOC0xLTEtMS0xMjE3OTc_53945b29-61f1-45e0-ac32-381e39bb3312"
      unitRef="usd">1222000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfOC0zLTEtMS0xMjE3OTc_ff398509-cc86-41bd-b3e9-584f96df64dd"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfOC01LTEtMS0xMjE3OTc_a18eb7c1-cc42-4848-b95c-b0110e728f1b"
      unitRef="usd">1222000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfOC03LTEtMS0xMjE3OTc_fbf96f95-beaa-4326-acfc-2820a6a61034"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfOC05LTEtMS0xMjE3OTc_8c24ca2b-eeb6-4c62-b94e-6e17438b4bf1"
      unitRef="usd">114000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfOC0xMS0xLTEtMTIxNzk3_7e4308b0-83eb-4da2-98b8-2f896b9e2446"
      unitRef="usd">1108000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfOS0xLTEtMS0xMjE3OTc_9f0f2274-8086-4577-ac12-3f9d46c7b4e5"
      unitRef="usd">2721000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfOS0zLTEtMS0xMjE3OTc_07e79219-1971-4f84-ae6b-9b477a31283d"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfOS01LTEtMS0xMjE3OTc_20f9a2ae-872d-4b34-844d-29dde6219442"
      unitRef="usd">2721000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfOS03LTEtMS0xMjE3OTc_43ac9d13-6e0a-4df8-98c4-8ac0776b3e0b"
      unitRef="usd">5000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfOS05LTEtMS0xMjE3OTc_08f65fe2-7a20-49a7-a0fd-b33a302e1a5e"
      unitRef="usd">135000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfOS0xMS0xLTEtMTIxNzk3_ed5a70ca-e8a2-470e-ade9-ff7130fb6394"
      unitRef="usd">2591000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i7b1da324447946a5a60e70cf44b0c827_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTAtMS0xLTEtMTIxNzk3_d77b34d9-03b4-43c1-89b6-6fbbebccc9f4"
      unitRef="usd">25000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i7b1da324447946a5a60e70cf44b0c827_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTAtMy0xLTEtMTIxNzk3_2073cd0f-7c50-41e0-83f1-69630a64160f"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i7b1da324447946a5a60e70cf44b0c827_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTAtNS0xLTEtMTIxNzk3_a5e94bdc-67f2-4aed-8e1f-ce0adb4b2d3c"
      unitRef="usd">25000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7b1da324447946a5a60e70cf44b0c827_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTAtNy0xLTEtMTIxNzk3_7509c143-ca3e-4bb2-93c3-f5bdfbe6f36a"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7b1da324447946a5a60e70cf44b0c827_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTAtOS0xLTEtMTIxNzk3_3b22f17b-d9ed-4f5a-a429-bc7d704ab05a"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7b1da324447946a5a60e70cf44b0c827_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTAtMTEtMS0xLTEyMTc5Nw_e623d2ca-abf5-4b25-81d3-0110f04d3cc1"
      unitRef="usd">24000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTEtMS0xLTEtMTIxNzk3_1c8ea210-fb42-40e0-b96b-b702a15508a0"
      unitRef="usd">22209000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTEtMy0xLTEtMTIxNzk3_70b7f2ac-0fdb-4354-9803-fb6932d552a3"
      unitRef="usd">8000000</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTEtNS0xLTEtMTIxNzk3_61ab3b0a-e579-450a-803a-778245e6746a"
      unitRef="usd">22201000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTEtNy0xLTEtMTIxNzk3_aa76ac88-a220-4e20-85a9-aae9211503cf"
      unitRef="usd">65000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTEtOS0xLTEtMTIxNzk3_1ddd6d64-be9c-42a8-89ff-d6208e1b88f5"
      unitRef="usd">1515000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTEtMTEtMS0xLTEyMTc5Nw_a7dd3b8e-15da-497f-b592-79a269472038"
      unitRef="usd">20751000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTUtMS0xLTEtMTIxNzk3_68f2aa30-90d4-4bbc-8b2f-658e205b1a1b"
      unitRef="usd">2349000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTUtMy0xLTEtMTIxNzk3_b4acb7c9-037e-4055-9e3a-8177e93277d4"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTUtNS0xLTEtMTIxNzk3_6fbe3416-5296-46ae-80c4-73abe306439d"
      unitRef="usd">2349000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTUtNy0xLTEtMTIxNzk3_4e3f73f0-1e9e-40bf-a674-d454d534190b"
      unitRef="usd">70000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTUtOS0xLTEtMTIxNzk3_98ff59c3-866d-46df-81ea-24de3ab134b1"
      unitRef="usd">3000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTUtMTEtMS0xLTEyMTc5Nw_49e20397-fe7c-4e5e-8f36-6d5ab1fde6c4"
      unitRef="usd">2416000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i312562153ede48bfb0ae6742085c849a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTYtMS0xLTEtMTIxNzk3_d7c29457-7680-4823-81d6-4e74fd8aa518"
      unitRef="usd">2947000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i312562153ede48bfb0ae6742085c849a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTYtMy0xLTEtMTIxNzk3_dacf3a48-068b-4924-bb6f-ab873c1d466c"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i312562153ede48bfb0ae6742085c849a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTYtNS0xLTEtMTIxNzk3_8d0344e5-b8aa-40c9-9167-94f8e58ace32"
      unitRef="usd">2947000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i312562153ede48bfb0ae6742085c849a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTYtNy0xLTEtMTIxNzk3_38abfe1b-7829-47d8-b752-b5ef5f010761"
      unitRef="usd">148000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i312562153ede48bfb0ae6742085c849a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTYtOS0xLTEtMTIxNzk3_e9012b38-99b9-4fdc-9ab5-6da83446161b"
      unitRef="usd">4000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i312562153ede48bfb0ae6742085c849a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTYtMTEtMS0xLTEyMTc5Nw_ff8e18dc-fa42-419d-9e16-4912183c6516"
      unitRef="usd">3091000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="iacd25bc0ddd1457bb0d369b53f596438_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTctMS0xLTEtMTIxNzk3_a1656f5c-991e-4a50-b657-837607ab9e26"
      unitRef="usd">9093000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="iacd25bc0ddd1457bb0d369b53f596438_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTctMy0xLTEtMTIxNzk3_a9a65fb9-99e6-4d02-9030-644bf31cd9ed"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="iacd25bc0ddd1457bb0d369b53f596438_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTctNS0xLTEtMTIxNzk3_d795dafa-f7a1-4d86-af72-4e5e35ae6a08"
      unitRef="usd">9093000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iacd25bc0ddd1457bb0d369b53f596438_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTctNy0xLTEtMTIxNzk3_66957df9-ba5f-472d-8eff-47c083b7d175"
      unitRef="usd">682000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iacd25bc0ddd1457bb0d369b53f596438_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTctOS0xLTEtMTIxNzk3_5338fb06-c5e5-400f-a478-4262e72cacc4"
      unitRef="usd">40000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iacd25bc0ddd1457bb0d369b53f596438_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTctMTEtMS0xLTEyMTc5Nw_18d938b7-6e64-4d5d-9c80-a7c140daac30"
      unitRef="usd">9735000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i27a2d69d05ce407693c56825032df2c6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTgtMS0xLTEtMTIxNzk3_7698f536-eaea-46e8-bca5-4b2910772db5"
      unitRef="usd">2821000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i27a2d69d05ce407693c56825032df2c6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTgtMy0xLTEtMTIxNzk3_319a6529-59a6-4b9b-9710-60b522a5739d"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i27a2d69d05ce407693c56825032df2c6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTgtNS0xLTEtMTIxNzk3_2d3b5857-b49a-4068-a3ae-4dc87cb9216b"
      unitRef="usd">2821000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i27a2d69d05ce407693c56825032df2c6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTgtNy0xLTEtMTIxNzk3_88769638-1765-46f7-9c8b-b9fd37b72ec4"
      unitRef="usd">196000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i27a2d69d05ce407693c56825032df2c6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTgtOS0xLTEtMTIxNzk3_84d6fbb5-cce4-4b30-be9a-933e3ea73813"
      unitRef="usd">24000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i27a2d69d05ce407693c56825032df2c6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTgtMTEtMS0xLTEyMTc5Nw_3d5725de-0ae1-4d3b-8378-7e02784dd1f4"
      unitRef="usd">2993000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i5f4295241da2454b9ca27744d8f494b2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTktMS0xLTEtMTIxNzk3_b5d81be1-709e-4594-9adb-daee1e9dfedb"
      unitRef="usd">870000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i5f4295241da2454b9ca27744d8f494b2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTktMy0xLTEtMTIxNzk3_ffb8a81d-22c5-4a14-b2a1-5ab9996891b3"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i5f4295241da2454b9ca27744d8f494b2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTktNS0xLTEtMTIxNzk3_d1aafbbd-4e79-41c2-be95-dc4fd79c554d"
      unitRef="usd">870000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i5f4295241da2454b9ca27744d8f494b2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTktNy0xLTEtMTIxNzk3_cba46b30-ccc4-4c2f-8e4c-03f0a3e23d17"
      unitRef="usd">15000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i5f4295241da2454b9ca27744d8f494b2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTktOS0xLTEtMTIxNzk3_28f220a1-c46f-4312-9af9-ccf89e4ec13e"
      unitRef="usd">10000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5f4295241da2454b9ca27744d8f494b2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMTktMTEtMS0xLTEyMTc5Nw_578fb97b-529c-4de7-a021-86d2e056002c"
      unitRef="usd">875000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ic26d39b1909b4114abe91b81a22d3ca5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjAtMS0xLTEtMTIxNzk3_347fde55-610a-4cef-a5c8-3821dcf4bad3"
      unitRef="usd">1278000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ic26d39b1909b4114abe91b81a22d3ca5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjAtMy0xLTEtMTIxNzk3_04d25799-a66f-4907-9cb9-75882ccf98bb"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="ic26d39b1909b4114abe91b81a22d3ca5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjAtNS0xLTEtMTIxNzk3_bc2e9a43-d17c-489e-9375-c476dc78c3a8"
      unitRef="usd">1278000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic26d39b1909b4114abe91b81a22d3ca5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjAtNy0xLTEtMTIxNzk3_a282a6bb-19b1-44cd-9b97-ccece1bd8251"
      unitRef="usd">44000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic26d39b1909b4114abe91b81a22d3ca5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjAtOS0xLTEtMTIxNzk3_b623d09e-c027-4eb8-a3ed-8fbdca1289ce"
      unitRef="usd">12000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic26d39b1909b4114abe91b81a22d3ca5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjAtMTEtMS0xLTEyMTc5Nw_82818016-ade2-4200-b7cb-4e1bf082d1e3"
      unitRef="usd">1310000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ibf2696db609145edadde7083bbfb8eac_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjEtMS0xLTEtMTIxNzk3_7acb9652-a882-426b-b504-86f2859bbc61"
      unitRef="usd">2791000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ibf2696db609145edadde7083bbfb8eac_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjEtMy0xLTEtMTIxNzk3_76bb523a-d9e0-4b14-88eb-74af384a8dba"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="ibf2696db609145edadde7083bbfb8eac_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjEtNS0xLTEtMTIxNzk3_4aece58b-48d2-42e6-986c-1431167ef92d"
      unitRef="usd">2791000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ibf2696db609145edadde7083bbfb8eac_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjEtNy0xLTEtMTIxNzk3_b766961c-a6cd-4b0c-9abb-384eb4b7e9b5"
      unitRef="usd">14000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ibf2696db609145edadde7083bbfb8eac_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjEtOS0xLTEtMTIxNzk3_e4a96079-ae0d-49c4-a1f9-dcdded32bf00"
      unitRef="usd">13000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibf2696db609145edadde7083bbfb8eac_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjEtMTEtMS0xLTEyMTc5Nw_78c2c7b7-0660-428d-8b6e-fcef547f2bba"
      unitRef="usd">2792000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i35a7089aaf074a29b807a8530fceab9c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjItMS0xLTEtMTIxNzk3_21b0d449-5dd7-4b76-a38e-18ed6f0bd82d"
      unitRef="usd">25000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i35a7089aaf074a29b807a8530fceab9c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjItMy0xLTEtMTIxNzk3_e8bb30de-24f9-4b26-89a6-74626ddf09a5"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i35a7089aaf074a29b807a8530fceab9c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjItNS0xLTEtMTIxNzk3_ecbcd1b8-7b77-494e-b7de-2965860fcaec"
      unitRef="usd">25000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i35a7089aaf074a29b807a8530fceab9c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjItNy0xLTEtMTIxNzk3_b4653053-e28c-403e-a035-6e3e70c6fdef"
      unitRef="usd">3000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i35a7089aaf074a29b807a8530fceab9c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjItOS0xLTEtMTIxNzk3_fce2b872-bb00-40c2-8d30-5f3ec033fe7b"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i35a7089aaf074a29b807a8530fceab9c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjItMTEtMS0xLTEyMTc5Nw_fe63c404-9e61-45c4-82db-c8281c6e2d2d"
      unitRef="usd">28000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjMtMS0xLTEtMTIxNzk3_576de6e9-63b4-4275-990f-0e6b885f27ab"
      unitRef="usd">22174000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjMtMy0xLTEtMTIxNzk3_9e234471-e675-498a-9e89-187f1de58006"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjMtNS0xLTEtMTIxNzk3_4d6274c4-2e1f-4c2b-a5d9-2df8045a9e40"
      unitRef="usd">22174000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjMtNy0xLTEtMTIxNzk3_3c9dfcf4-5c44-49cb-b197-8f295cbfb841"
      unitRef="usd">1172000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjMtOS0xLTEtMTIxNzk3_44ef5297-a6d7-4689-b41e-51f028d9f85b"
      unitRef="usd">106000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjk0MDZkZGRlNTUyNzRlZGJiZTFlMGEzNmY2ODgxM2RmL3RhYmxlcmFuZ2U6OTQwNmRkZGU1NTI3NGVkYmJlMWUwYTM2ZjY4ODEzZGZfMjMtMTEtMS0xLTEyMTc5Nw_a891c2b0-8e1d-4656-bdf4-c81b7f5f1a80"
      unitRef="usd">23240000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4a4d5943f3344b028b2021d88fb2d40d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNjk0_269b1aa8-2135-49e4-ba97-8a9e6edcefe6"
      unitRef="usd">658000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i4a4d5943f3344b028b2021d88fb2d40d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNzMy_40203615-b610-4dc1-b325-ff945c979559"
      unitRef="usd">5000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i4a4d5943f3344b028b2021d88fb2d40d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNzc0_20e7bec7-f8dc-416e-88af-dc17037d7a9f"
      unitRef="usd">39000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i57df9cc9e45b4dd8860db902aa9d7a4c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfODI1_de21c2ec-2180-4956-903c-9472b6aa536b"
      unitRef="usd">864000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i57df9cc9e45b4dd8860db902aa9d7a4c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfODYz_7bbeffed-85bd-43ce-8f69-8717000915db"
      unitRef="usd">94000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i57df9cc9e45b4dd8860db902aa9d7a4c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfOTA1_c2426eaa-50d7-4d77-af66-ae8636c57195"
      unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNTA4NQ_81c87043-5db5-4667-b273-21ebdf03e46c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net amortized cost and fair value of debt securities at June&#160;30, 2022 are shown below by contractual maturity.&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.690%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfMi0xLTEtMS0xMjE3OTc_286c246e-756b-4e71-9e35-836b86483dee"
      unitRef="usd">1221000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfMi0zLTEtMS0xMjE3OTc_dd0d0a56-7038-4009-93bc-b9e95096825d"
      unitRef="usd">1221000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfMy0xLTEtMS0xMjE3OTc_a3f0bfc2-1ec1-4848-aec6-825bbd118f9c"
      unitRef="usd">6807000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfMy0zLTEtMS0xMjE3OTc_ba1abe61-b0db-4f9c-b02d-7efab1513c20"
      unitRef="usd">6503000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfNC0xLTEtMS0xMjE3OTc_4c372457-b595-42ff-ba5d-96667c901239"
      unitRef="usd">5031000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfNC0zLTEtMS0xMjE3OTc_b88df4bc-1ed0-40ae-b64c-47a53de2ea41"
      unitRef="usd">4559000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfNS0xLTEtMS0xMjE3OTc_4d8ddd92-4f8b-41ae-a5b7-00744c86b15b"
      unitRef="usd">4391000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfNS0zLTEtMS0xMjE3OTc_1884437e-c33e-4e05-a2b6-98e7e318d26a"
      unitRef="usd">4022000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
      contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfNi0xLTEtMS0xMjE3OTc_800dbf75-12d8-40ea-891b-25ec497c3791"
      unitRef="usd">808000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfNi0zLTEtMS0xMjE3OTc_cf2bc39e-2142-4f6f-9f1e-abe86b976c2f"
      unitRef="usd">747000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
      contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfNy0xLTEtMS0xMjE3OTc_e7bc43e4-c24c-4f70-9d28-79332b99c297"
      unitRef="usd">1222000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfNy0zLTEtMS0xMjE3OTc_d3ee445b-41e7-42e6-b0bc-d048b13f7bf7"
      unitRef="usd">1108000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
      contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfOC0xLTEtMS0xMjE3OTc_47739b50-8cbd-48f1-9ff4-958923717827"
      unitRef="usd">2721000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfOC0zLTEtMS0xMjE3OTc_6a913724-d75a-418e-8515-d9786a83f9da"
      unitRef="usd">2591000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfOS0xLTEtMS0xMjE3OTc_0d7a66ac-60ca-4bfc-a55e-5c71fa8e14fa"
      unitRef="usd">22201000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmI5MDUwYmM5NmZjNDQwMTZhYzU2MDI1MzYwMzQzOWIzL3RhYmxlcmFuZ2U6YjkwNTBiYzk2ZmM0NDAxNmFjNTYwMjUzNjAzNDM5YjNfOS0zLTEtMS0xMjE3OTc_efa74701-2141-4d43-a341-6d0079c7c3f4"
      unitRef="usd">20751000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNTE4Mg_944b28a5-a79b-4f7a-b41c-dcef42a32376">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Summarized below are the debt securities the Company held at June&#160;30, 2022 and December&#160;31, 2021 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.244%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Greater than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except number of securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The maturity dates for debt securities in an unrealized capital loss position at June&#160;30, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting&lt;br/&gt;experience-rated products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting &lt;br/&gt;remaining products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNC0xLTEtMS0xMjE3OTc_e24ce336-e539-4304-8ece-5ab97f048985"
      unitRef="security">464</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNC0zLTEtMS0xMjE3OTc_4e4de714-b255-4516-aacc-8dde00c6cbf7"
      unitRef="usd">1616000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNC01LTEtMS0xMjE3OTc_26df099f-fb68-4ba7-ac21-1299eac84faa"
      unitRef="usd">115000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNC03LTEtMS0xMjE3OTc_acd9cf28-4938-4923-98d6-40fdba18e6ce"
      unitRef="security">12</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNC05LTEtMS0xMjE3OTc_974583a7-dec9-4196-b1b0-cbf86be6ef22"
      unitRef="usd">58000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNC0xMS0xLTEtMTIxNzk3_0f15a7e4-6142-4a0d-b44a-814d4b91128f"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNC0xMy0xLTEtMTIxNzk3_629f810b-bcb2-4bec-ae5c-4e62c3399815"
      unitRef="security">476</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNC0xNS0xLTEtMTIxNzk3_68613ca8-83d5-4267-abea-4c28aedc4125"
      unitRef="usd">1674000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i3b2239b3d83a47dbaa7ed8135fce7670_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNC0xNy0xLTEtMTIxNzk3_70497229-fd70-4a62-bc9a-e0e99f8d0b63"
      unitRef="usd">118000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ib04a3967c8004f97aa14f769721b3a73_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNS0xLTEtMS0xMjE3OTc_8dd91f86-8656-4b9d-8aad-1f98ffe83037"
      unitRef="security">875</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ib04a3967c8004f97aa14f769721b3a73_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNS0zLTEtMS0xMjE3OTc_613c3f87-4d1a-4155-960a-f70d5dadfe9e"
      unitRef="usd">1372000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ib04a3967c8004f97aa14f769721b3a73_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNS01LTEtMS0xMjE3OTc_d0cd0f32-7f8e-47bb-9529-480f58d9bfb5"
      unitRef="usd">104000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ib04a3967c8004f97aa14f769721b3a73_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNS03LTEtMS0xMjE3OTc_1d7b6a4e-20be-42fa-b24b-53919f79ae06"
      unitRef="security">27</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ib04a3967c8004f97aa14f769721b3a73_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNS05LTEtMS0xMjE3OTc_ca0ad8e9-8e73-49c0-b0a0-3be1710d577e"
      unitRef="usd">55000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ib04a3967c8004f97aa14f769721b3a73_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNS0xMS0xLTEtMTIxNzk3_95a18e6e-5ea0-4e42-ba55-872b8827778e"
      unitRef="usd">6000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ib04a3967c8004f97aa14f769721b3a73_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNS0xMy0xLTEtMTIxNzk3_b876ae35-e892-4ffa-b891-5b296dc02c05"
      unitRef="security">902</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ib04a3967c8004f97aa14f769721b3a73_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNS0xNS0xLTEtMTIxNzk3_6cd4c4b5-8692-478d-8f10-53903c7e21ce"
      unitRef="usd">1427000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ib04a3967c8004f97aa14f769721b3a73_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNS0xNy0xLTEtMTIxNzk3_96acdbee-b7d1-40cd-afa1-08fc46476d89"
      unitRef="usd">110000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNi0xLTEtMS0xMjE3OTc_96dfe061-89c7-49ac-b42c-43204f0ee432"
      unitRef="security">5583</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNi0zLTEtMS0xMjE3OTc_20303117-c7f2-46ac-99c2-01488de3fba9"
      unitRef="usd">6989000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNi01LTEtMS0xMjE3OTc_a81ba555-3b54-4e91-a849-0109782a0ae0"
      unitRef="usd">674000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNi03LTEtMS0xMjE3OTc_fb8afcce-df54-4ab3-8cbd-510638e827c6"
      unitRef="security">364</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNi05LTEtMS0xMjE3OTc_06a975d2-4bd3-4103-bb90-fa014e928cc0"
      unitRef="usd">508000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNi0xMS0xLTEtMTIxNzk3_6728fe2a-94fc-4212-a242-a24974424f0c"
      unitRef="usd">66000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNi0xMy0xLTEtMTIxNzk3_c280b6b0-ab55-424e-80b4-9999cd5ff339"
      unitRef="security">5947</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNi0xNS0xLTEtMTIxNzk3_95d222c0-5167-474c-af4f-916abbf6dce8"
      unitRef="usd">7497000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i3061e87e34714ab9a7f5902e5cc9cf25_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNi0xNy0xLTEtMTIxNzk3_1e11ac6d-c43f-47ea-8d7b-31958966fa2d"
      unitRef="usd">740000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i2e11998e647748a998ed3ae2000f65ec_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNy0xLTEtMS0xMjE3OTc_300a4635-d60e-4f74-b7c8-53d684673fbc"
      unitRef="security">1304</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i2e11998e647748a998ed3ae2000f65ec_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNy0zLTEtMS0xMjE3OTc_5e5a462e-ecb8-43ae-898f-407a92fb20cd"
      unitRef="usd">1872000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i2e11998e647748a998ed3ae2000f65ec_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNy01LTEtMS0xMjE3OTc_18c8db1f-3057-463a-9270-71f8559b3d0a"
      unitRef="usd">206000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i2e11998e647748a998ed3ae2000f65ec_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNy03LTEtMS0xMjE3OTc_f2bf1be6-dd0a-414b-99cb-40c2d4e93d15"
      unitRef="security">119</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i2e11998e647748a998ed3ae2000f65ec_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNy05LTEtMS0xMjE3OTc_a8a0837d-5733-4d4f-828c-214845c798d3"
      unitRef="usd">172000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i2e11998e647748a998ed3ae2000f65ec_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNy0xMS0xLTEtMTIxNzk3_55dab8a2-9d69-4528-b7dc-8401459e0757"
      unitRef="usd">30000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i2e11998e647748a998ed3ae2000f65ec_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNy0xMy0xLTEtMTIxNzk3_17a720fe-1095-4f64-b588-cc5b44099eb9"
      unitRef="security">1423</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i2e11998e647748a998ed3ae2000f65ec_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNy0xNS0xLTEtMTIxNzk3_66b012b0-01de-4ed5-b058-058f95d04d41"
      unitRef="usd">2044000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i2e11998e647748a998ed3ae2000f65ec_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfNy0xNy0xLTEtMTIxNzk3_b5ad83a6-bcce-453b-ad08-a68d38422502"
      unitRef="usd">236000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOC0xLTEtMS0xMjE3OTc_2c9be325-2b25-431c-9426-08ebba312e6d"
      unitRef="security">388</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOC0zLTEtMS0xMjE3OTc_dccb406d-7909-4b70-9088-00f6f7122744"
      unitRef="usd">644000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOC01LTEtMS0xMjE3OTc_84e2c822-1f0b-48e4-b353-feca3ca87777"
      unitRef="usd">50000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOC03LTEtMS0xMjE3OTc_b05d4005-59cc-4bff-9d79-6d8be68b881f"
      unitRef="security">23</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOC05LTEtMS0xMjE3OTc_eca94e99-5d6e-4e8e-a9dd-cee4a6742cb3"
      unitRef="usd">65000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOC0xMS0xLTEtMTIxNzk3_1d46f84e-c9bb-4de1-b791-57e013da348f"
      unitRef="usd">11000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOC0xMy0xLTEtMTIxNzk3_d40b8e48-4441-4b0d-9213-5a1493fbb6bd"
      unitRef="security">411</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOC0xNS0xLTEtMTIxNzk3_7ef303b3-a57a-4f2c-9781-196784898574"
      unitRef="usd">709000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOC0xNy0xLTEtMTIxNzk3_59923759-5074-420b-b265-b662fa660bb3"
      unitRef="usd">61000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOS0xLTEtMS0xMjE3OTc_4eff5858-482c-4a13-97fe-33d0bcebbc2e"
      unitRef="security">436</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOS0zLTEtMS0xMjE3OTc_c42af3e1-8a4b-483a-8f83-d2c81ba01dd1"
      unitRef="usd">955000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOS01LTEtMS0xMjE3OTc_89de984f-c51b-428b-8fd6-3043a13799b9"
      unitRef="usd">91000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOS03LTEtMS0xMjE3OTc_d0badd97-bf06-4115-8982-1a55fad7ba81"
      unitRef="security">53</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOS05LTEtMS0xMjE3OTc_3434741a-ec0b-4260-8724-b2a44eb1cc3d"
      unitRef="usd">118000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOS0xMS0xLTEtMTIxNzk3_f3de2727-abff-44a6-aff0-0d2b8cf2347c"
      unitRef="usd">23000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOS0xMy0xLTEtMTIxNzk3_43d93b14-e04b-443c-8b53-6cc0f81fc043"
      unitRef="security">489</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOS0xNS0xLTEtMTIxNzk3_3a9a011c-5660-47f9-baad-e7b19a254708"
      unitRef="usd">1073000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfOS0xNy0xLTEtMTIxNzk3_a044158e-c72c-43e8-aa9d-18c44789a210"
      unitRef="usd">114000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTAtMS0xLTEtMTIxNzk3_46bd78f4-9434-4f47-97a5-ee8030b23bd6"
      unitRef="security">1324</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTAtMy0xLTEtMTIxNzk3_e911780f-8b06-48ae-90e7-3307ddeeba0c"
      unitRef="usd">2358000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTAtNS0xLTEtMTIxNzk3_8ab43055-4253-41e4-b16b-5a64da660818"
      unitRef="usd">126000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTAtNy0xLTEtMTIxNzk3_1106b5c9-5eef-4af9-8849-d5e1c827cb1d"
      unitRef="security">91</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTAtOS0xLTEtMTIxNzk3_bede8c1a-43e6-401c-b913-8dbd9909fd14"
      unitRef="usd">114000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTAtMTEtMS0xLTEyMTc5Nw_9525c9b1-324e-4220-b36d-b5a377fb115d"
      unitRef="usd">9000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTAtMTMtMS0xLTEyMTc5Nw_a8548c01-9612-42c3-9af3-f3f57c767be1"
      unitRef="security">1415</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTAtMTUtMS0xLTEyMTc5Nw_ce48515b-7540-475e-a68b-49c213abbfcb"
      unitRef="usd">2472000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTAtMTctMS0xLTEyMTc5Nw_902e664e-efd3-4eeb-aa8f-e4c1052520b6"
      unitRef="usd">135000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i7b1da324447946a5a60e70cf44b0c827_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTEtMS0xLTEtMTIxNzk3_ffb162b9-23a6-440d-80af-8873029d9488"
      unitRef="security">10</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i7b1da324447946a5a60e70cf44b0c827_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTEtMy0xLTEtMTIxNzk3_adb52224-e270-44b0-aca3-c4541f4c2e72"
      unitRef="usd">19000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i7b1da324447946a5a60e70cf44b0c827_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTEtNS0xLTEtMTIxNzk3_75e7eaf6-80ea-471c-8475-713d60686073"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i7b1da324447946a5a60e70cf44b0c827_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTEtNy0xLTEtMTIxNzk3_833c9f07-d843-43fc-9478-21166bacbeda"
      unitRef="security">1</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i7b1da324447946a5a60e70cf44b0c827_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTEtOS0xLTEtMTIxNzk3_2e3aaa56-11a9-4f15-bb89-6d01820ebf3f"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i7b1da324447946a5a60e70cf44b0c827_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTEtMTEtMS0xLTEyMTc5Nw_6c8de4ef-821e-4bb7-9ae7-80fa0f266855"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i7b1da324447946a5a60e70cf44b0c827_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTEtMTMtMS0xLTEyMTc5Nw_c2588a8f-28f3-42fe-92c6-11e7c9ac6296"
      unitRef="security">11</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i7b1da324447946a5a60e70cf44b0c827_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTEtMTUtMS0xLTEyMTc5Nw_381d1d93-ef76-415a-82dc-c1fe550cd73c"
      unitRef="usd">22000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i7b1da324447946a5a60e70cf44b0c827_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTEtMTctMS0xLTEyMTc5Nw_fdd9a978-913d-4490-aed8-a5bb1f164f51"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTItMS0xLTEtMTIxNzk3_a2ca64f2-5802-466f-aeab-f091075e5456"
      unitRef="security">10384</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTItMy0xLTEtMTIxNzk3_54103767-8923-4c1c-bcfa-f1d3c1f9c082"
      unitRef="usd">15825000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTItNS0xLTEtMTIxNzk3_cb98299f-dd52-473d-8392-3cbbc0430b89"
      unitRef="usd">1367000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTItNy0xLTEtMTIxNzk3_118ba0c8-455d-44c3-a162-7aa332361dc8"
      unitRef="security">690</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTItOS0xLTEtMTIxNzk3_fee6ab7c-a07d-4b7d-8661-c9796f472fff"
      unitRef="usd">1093000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTItMTEtMS0xLTEyMTc5Nw_fac09e69-25c0-4422-b977-37b599ea3ca5"
      unitRef="usd">148000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTItMTMtMS0xLTEyMTc5Nw_9aee9eca-cfa7-4285-9b2e-1705869f4b60"
      unitRef="security">11074</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTItMTUtMS0xLTEyMTc5Nw_8ea6c471-a536-4ff1-bcbc-309cd934a1a6"
      unitRef="usd">16918000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTItMTctMS0xLTEyMTc5Nw_b4599f36-7959-47ef-923e-e6b4d6f29c24"
      unitRef="usd">1515000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTYtMS0xLTEtMTIxNzk3_e46681f3-0a81-4fa9-a991-692b98ffae89"
      unitRef="security">43</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTYtMy0xLTEtMTIxNzk3_8181a012-10e6-47ef-b09f-43ca81c6362b"
      unitRef="usd">242000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTYtNS0xLTEtMTIxNzk3_e6056300-cacd-44f5-bc18-1b2ce1c30cb0"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTYtNy0xLTEtMTIxNzk3_85f86d40-814c-4470-9901-adcb778b582b"
      unitRef="security">10</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTYtOS0xLTEtMTIxNzk3_7d0cec8f-36f5-4703-aaac-bafcea6e6591"
      unitRef="usd">40000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTYtMTEtMS0xLTEyMTc5Nw_2f771f85-f116-41ef-87f8-9431f583a8e8"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTYtMTMtMS0xLTEyMTc5Nw_dff772bc-c034-489c-81c7-0469dd254b5f"
      unitRef="security">53</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTYtMTUtMS0xLTEyMTc5Nw_c05b8a38-c89f-4e6c-b44b-709be6845da5"
      unitRef="usd">282000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i9fe90b3704de4769a097c2d9fa16f7c9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTYtMTctMS0xLTEyMTc5Nw_8f52b691-81bd-4b27-bf21-43753f04dde3"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i312562153ede48bfb0ae6742085c849a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTctMS0xLTEtMTIxNzk3_b7c799ef-78a9-4351-bff9-13579b2a9e37"
      unitRef="security">233</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i312562153ede48bfb0ae6742085c849a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTctMy0xLTEtMTIxNzk3_ea39c89e-a988-4d36-956c-06962c4ca35e"
      unitRef="usd">428000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i312562153ede48bfb0ae6742085c849a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTctNS0xLTEtMTIxNzk3_d773f490-eb5e-4455-a2cd-5aa93a132cbb"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i312562153ede48bfb0ae6742085c849a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTctNy0xLTEtMTIxNzk3_b547a157-5408-4437-98ac-5b3fb88d5770"
      unitRef="security">13</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i312562153ede48bfb0ae6742085c849a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTctOS0xLTEtMTIxNzk3_7493af38-17fe-4049-9028-c75b53ef50a8"
      unitRef="usd">33000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i312562153ede48bfb0ae6742085c849a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTctMTEtMS0xLTEyMTc5Nw_bd10a4bb-6a12-46b7-9fd3-f190a56ceb1f"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i312562153ede48bfb0ae6742085c849a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTctMTMtMS0xLTEyMTc5Nw_66bef62f-b033-4567-a7fa-cdada019a701"
      unitRef="security">246</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i312562153ede48bfb0ae6742085c849a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTctMTUtMS0xLTEyMTc5Nw_4b5feaa8-7356-47e3-b82c-84deb2b50bf7"
      unitRef="usd">461000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i312562153ede48bfb0ae6742085c849a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTctMTctMS0xLTEyMTc5Nw_7f985562-0767-423c-9e91-f30d22c824dd"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="iacd25bc0ddd1457bb0d369b53f596438_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTgtMS0xLTEtMTIxNzk3_82770779-9f48-4f11-96fc-30e4e7629deb"
      unitRef="security">1610</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="iacd25bc0ddd1457bb0d369b53f596438_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTgtMy0xLTEtMTIxNzk3_a3363389-886f-4bac-a77a-8af0c7525288"
      unitRef="usd">2296000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="iacd25bc0ddd1457bb0d369b53f596438_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTgtNS0xLTEtMTIxNzk3_e7e1a418-e17c-43bc-854b-cc6c6e3085dd"
      unitRef="usd">31000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="iacd25bc0ddd1457bb0d369b53f596438_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTgtNy0xLTEtMTIxNzk3_a8e2463c-438a-48e0-bdd1-1071b2674a6e"
      unitRef="security">165</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="iacd25bc0ddd1457bb0d369b53f596438_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTgtOS0xLTEtMTIxNzk3_39e08299-0f55-4b6f-ac93-da0857c915ab"
      unitRef="usd">238000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="iacd25bc0ddd1457bb0d369b53f596438_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTgtMTEtMS0xLTEyMTc5Nw_10c04c1d-8e4a-4bb5-a537-b06ee4df84d2"
      unitRef="usd">9000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="iacd25bc0ddd1457bb0d369b53f596438_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTgtMTMtMS0xLTEyMTc5Nw_caa1ebae-37b0-4217-a96f-c331a9f2acc8"
      unitRef="security">1775</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="iacd25bc0ddd1457bb0d369b53f596438_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTgtMTUtMS0xLTEyMTc5Nw_04625ff8-013d-4b7f-8e2d-1c84ebade56b"
      unitRef="usd">2534000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="iacd25bc0ddd1457bb0d369b53f596438_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTgtMTctMS0xLTEyMTc5Nw_f03f9549-80ca-428e-a58e-c3dde4d38364"
      unitRef="usd">40000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i27a2d69d05ce407693c56825032df2c6_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTktMS0xLTEtMTIxNzk3_89b5823c-5b5c-43f8-9f50-aef79ac9eea3"
      unitRef="security">449</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i27a2d69d05ce407693c56825032df2c6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTktMy0xLTEtMTIxNzk3_a6ec1262-ad83-40b7-911b-d44c09fa066e"
      unitRef="usd">747000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i27a2d69d05ce407693c56825032df2c6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTktNS0xLTEtMTIxNzk3_6c947e79-d57e-4d35-a89d-36b337f890f1"
      unitRef="usd">20000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i27a2d69d05ce407693c56825032df2c6_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTktNy0xLTEtMTIxNzk3_ffcf3fb1-9b84-4ec4-afc0-0a61ebd35104"
      unitRef="security">57</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i27a2d69d05ce407693c56825032df2c6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTktOS0xLTEtMTIxNzk3_3c2a23b0-1683-43cf-b7e1-03741006101b"
      unitRef="usd">91000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i27a2d69d05ce407693c56825032df2c6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTktMTEtMS0xLTEyMTc5Nw_275ac835-4b3e-4b23-a710-e1ff97c22299"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i27a2d69d05ce407693c56825032df2c6_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTktMTMtMS0xLTEyMTc5Nw_c22fd5c2-cac9-47a9-9ee9-618d969c095a"
      unitRef="security">506</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i27a2d69d05ce407693c56825032df2c6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTktMTUtMS0xLTEyMTc5Nw_306bdae6-a565-4785-af77-0438f35d1fef"
      unitRef="usd">838000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i27a2d69d05ce407693c56825032df2c6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMTktMTctMS0xLTEyMTc5Nw_df84682f-ca7d-4a62-9a8a-c36cbc2fe22e"
      unitRef="usd">24000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i5f4295241da2454b9ca27744d8f494b2_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjAtMS0xLTEtMTIxNzk3_6450450a-94a8-4c65-9e17-a7e4ceccf8c9"
      unitRef="security">165</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i5f4295241da2454b9ca27744d8f494b2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjAtMy0xLTEtMTIxNzk3_da774992-1195-4076-810d-635e2eaba951"
      unitRef="usd">593000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i5f4295241da2454b9ca27744d8f494b2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjAtNS0xLTEtMTIxNzk3_b25df978-d4e2-4ce0-81ee-04e2ac1c3b91"
      unitRef="usd">9000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i5f4295241da2454b9ca27744d8f494b2_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjAtNy0xLTEtMTIxNzk3_52fe5541-36d5-4fe4-96e6-ad4d71a3caa7"
      unitRef="security">10</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i5f4295241da2454b9ca27744d8f494b2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjAtOS0xLTEtMTIxNzk3_ed7d0a06-5ba3-4565-aac2-1beab0317adc"
      unitRef="usd">36000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i5f4295241da2454b9ca27744d8f494b2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjAtMTEtMS0xLTEyMTc5Nw_e8dd4f07-810a-4fa0-957c-0926cb4ef912"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i5f4295241da2454b9ca27744d8f494b2_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjAtMTMtMS0xLTEyMTc5Nw_2d726668-fe44-45a7-9d81-2fef4bd24704"
      unitRef="security">175</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i5f4295241da2454b9ca27744d8f494b2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjAtMTUtMS0xLTEyMTc5Nw_3f72245a-8c9b-4465-be7b-67fcd01f9ea4"
      unitRef="usd">629000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i5f4295241da2454b9ca27744d8f494b2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjAtMTctMS0xLTEyMTc5Nw_cdacca2c-0a25-46f9-9673-7ce113f07155"
      unitRef="usd">10000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ic26d39b1909b4114abe91b81a22d3ca5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjEtMS0xLTEtMTIxNzk3_8d425258-a5e0-4a15-895b-4d57b9357249"
      unitRef="security">188</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ic26d39b1909b4114abe91b81a22d3ca5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjEtMy0xLTEtMTIxNzk3_fdd20a87-fd0e-4568-9201-771d9a20aa54"
      unitRef="usd">462000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ic26d39b1909b4114abe91b81a22d3ca5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjEtNS0xLTEtMTIxNzk3_4c786129-65a8-41f6-9045-7b7e640abe08"
      unitRef="usd">7000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ic26d39b1909b4114abe91b81a22d3ca5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjEtNy0xLTEtMTIxNzk3_14bc7c6f-e5bd-4860-9ccc-c7979d6e498c"
      unitRef="security">35</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ic26d39b1909b4114abe91b81a22d3ca5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjEtOS0xLTEtMTIxNzk3_e3230560-0646-4742-ad14-8aa0da5621d7"
      unitRef="usd">112000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ic26d39b1909b4114abe91b81a22d3ca5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjEtMTEtMS0xLTEyMTc5Nw_8d8897c0-31e1-4bfe-be28-988a68853fc4"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ic26d39b1909b4114abe91b81a22d3ca5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjEtMTMtMS0xLTEyMTc5Nw_6dd24b44-a0c8-4865-ad2c-d951bf6c8fbc"
      unitRef="security">223</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ic26d39b1909b4114abe91b81a22d3ca5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjEtMTUtMS0xLTEyMTc5Nw_23622b31-71ef-4d17-80c1-f0b826876c72"
      unitRef="usd">574000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ic26d39b1909b4114abe91b81a22d3ca5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjEtMTctMS0xLTEyMTc5Nw_284bb47c-84da-4912-b4d4-acda78de5881"
      unitRef="usd">12000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ibf2696db609145edadde7083bbfb8eac_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjItMS0xLTEtMTIxNzk3_6f2c44bb-3b40-4060-b984-8522ce66502a"
      unitRef="security">1011</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ibf2696db609145edadde7083bbfb8eac_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjItMy0xLTEtMTIxNzk3_f43cae44-949d-4aab-b21d-3d9c702d8c56"
      unitRef="usd">2030000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ibf2696db609145edadde7083bbfb8eac_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjItNS0xLTEtMTIxNzk3_a5d1f4db-aeb5-4c90-8572-1fbbe5e2cc90"
      unitRef="usd">12000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ibf2696db609145edadde7083bbfb8eac_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjItNy0xLTEtMTIxNzk3_dd4e620a-6d1e-4a96-9f96-c151e17a78f9"
      unitRef="security">26</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ibf2696db609145edadde7083bbfb8eac_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjItOS0xLTEtMTIxNzk3_b5cb2080-3b99-424b-932e-65a4fdce263b"
      unitRef="usd">31000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ibf2696db609145edadde7083bbfb8eac_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjItMTEtMS0xLTEyMTc5Nw_5ac92910-b75f-4a5c-b744-1e1ee66a8fbc"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ibf2696db609145edadde7083bbfb8eac_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjItMTMtMS0xLTEyMTc5Nw_0019e970-34b6-4978-b78e-bb638f47cb44"
      unitRef="security">1037</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ibf2696db609145edadde7083bbfb8eac_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjItMTUtMS0xLTEyMTc5Nw_ec9d766f-7de8-4cc4-972d-97c51004270d"
      unitRef="usd">2061000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ibf2696db609145edadde7083bbfb8eac_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjItMTctMS0xLTEyMTc5Nw_d55d42c6-3237-45b2-b0c2-b4e8ae74fe65"
      unitRef="usd">13000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i35a7089aaf074a29b807a8530fceab9c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjMtMS0xLTEtMTIxNzk3_37bad81a-ccd5-4118-a8a1-1c2a51b92f87"
      unitRef="security">1</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i35a7089aaf074a29b807a8530fceab9c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjMtMy0xLTEtMTIxNzk3_3f320457-7da2-42f3-82d9-1b162f471640"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i35a7089aaf074a29b807a8530fceab9c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjMtNS0xLTEtMTIxNzk3_d8ba1b77-83f9-4748-85f5-ba1c86795586"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i35a7089aaf074a29b807a8530fceab9c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjMtNy0xLTEtMTIxNzk3_a2797880-52ce-46c6-b507-190d40ce0bba"
      unitRef="security">1</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i35a7089aaf074a29b807a8530fceab9c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjMtOS0xLTEtMTIxNzk3_a23b49fb-9537-433b-86dc-6fce57e57822"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i35a7089aaf074a29b807a8530fceab9c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjMtMTEtMS0xLTEyMTc5Nw_23262f51-1bb3-45a8-b269-2b8c398d67df"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i35a7089aaf074a29b807a8530fceab9c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjMtMTMtMS0xLTEyMTc5Nw_78202113-2b93-496f-8cdb-ddfb83513f05"
      unitRef="security">2</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i35a7089aaf074a29b807a8530fceab9c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjMtMTUtMS0xLTEyMTc5Nw_84b691da-0d91-4f9a-953f-d8f1f3e4936d"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i35a7089aaf074a29b807a8530fceab9c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjMtMTctMS0xLTEyMTc5Nw_caeb2324-583d-421a-9f16-b2b227f00970"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjQtMS0xLTEtMTIxNzk3_0271636f-dea2-4219-8279-a11155298f7c"
      unitRef="security">3700</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjQtMy0xLTEtMTIxNzk3_e6b83c17-d806-44ea-b2ac-46a39fb1fc2a"
      unitRef="usd">6800000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjQtNS0xLTEtMTIxNzk3_8621fc7c-68c8-43f0-a07d-bf00926f7e1d"
      unitRef="usd">84000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjQtNy0xLTEtMTIxNzk3_a9e02040-66c4-4ac1-b73c-40bd817653c4"
      unitRef="security">317</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjQtOS0xLTEtMTIxNzk3_9ce1066f-12b8-4ad3-88ca-44253523aae2"
      unitRef="usd">584000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjQtMTEtMS0xLTEyMTc5Nw_6c2943c2-90fa-4c7e-986a-35660c24ceb5"
      unitRef="usd">22000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjQtMTMtMS0xLTEyMTc5Nw_1f18567b-975f-48f0-98d6-0a7383115f07"
      unitRef="security">4017</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjQtMTUtMS0xLTEyMTc5Nw_94ee6934-18e2-43cf-b5d0-292fb0ed0e59"
      unitRef="usd">7384000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmJiNmFkMmU3MTlhMTRjODZiNWQzNzYxMzMwZmM4YmM3L3RhYmxlcmFuZ2U6YmI2YWQyZTcxOWExNGM4NmI1ZDM3NjEzMzBmYzhiYzdfMjQtMTctMS0xLTEyMTc5Nw_5c3fb2c7-e907-4018-b0b8-a55301968904"
      unitRef="usd">106000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear
      contextRef="i4a4d5943f3344b028b2021d88fb2d40d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfMy0xLTEtMS0xMjE3OTc_b4384671-a0ec-47cc-908c-62b533c5edc5"
      unitRef="usd">7000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss
      contextRef="i4a4d5943f3344b028b2021d88fb2d40d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfMy0zLTEtMS0xMjE3OTc_67a8d715-4c20-4986-a4d2-f9a9d925be5a"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear
      contextRef="if33a8819dea14f63a14fc5b0024f0188_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfMy01LTEtMS0xMjE3OTc_6843d0aa-12e2-49b8-bd9e-87e99e4f7a7b"
      unitRef="usd">438000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss
      contextRef="if33a8819dea14f63a14fc5b0024f0188_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfMy03LTEtMS0xMjE3OTc_91de55c6-25bb-42e4-af6b-60d2a57b06f3"
      unitRef="usd">5000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfMy05LTEtMS0xMjE3OTc_b4b15cf0-6da0-459f-8618-682c09c60bc0"
      unitRef="usd">445000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfMy0xMS0xLTEtMTIxNzk3_8b97a0e1-9da7-4146-8be1-bc67f65e7a3d"
      unitRef="usd">5000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears
      contextRef="i4a4d5943f3344b028b2021d88fb2d40d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNC0xLTEtMS0xMjE3OTc_8abe90a8-5587-4cea-b6e0-d898a5c577ba"
      unitRef="usd">54000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss
      contextRef="i4a4d5943f3344b028b2021d88fb2d40d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNC0zLTEtMS0xMjE3OTc_7f0850d7-7c45-4b75-9baf-71c7546d4507"
      unitRef="usd">2000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears
      contextRef="if33a8819dea14f63a14fc5b0024f0188_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNC01LTEtMS0xMjE3OTc_ac5756c3-e816-4ca2-88a6-e813ccb7cb1e"
      unitRef="usd">5062000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss
      contextRef="if33a8819dea14f63a14fc5b0024f0188_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNC03LTEtMS0xMjE3OTc_62cb96da-8bcd-490b-8b50-9d0e954eec30"
      unitRef="usd">320000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNC05LTEtMS0xMjE3OTc_61f28c08-d716-48f6-8b62-9e4b229645e2"
      unitRef="usd">5116000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNC0xMS0xLTEtMTIxNzk3_d55c3ffc-074f-4469-bc59-5e55c0b67831"
      unitRef="usd">322000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears
      contextRef="i4a4d5943f3344b028b2021d88fb2d40d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNS0xLTEtMS0xMjE3OTc_f69f2159-86c3-4659-b847-c16cb52eb202"
      unitRef="usd">151000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss
      contextRef="i4a4d5943f3344b028b2021d88fb2d40d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNS0zLTEtMS0xMjE3OTc_091f1746-92d3-4d26-95c5-8c7df190016c"
      unitRef="usd">15000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears
      contextRef="if33a8819dea14f63a14fc5b0024f0188_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNS01LTEtMS0xMjE3OTc_c5aa8fbf-7df6-4e46-b0b9-351b4f97061e"
      unitRef="usd">3713000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss
      contextRef="if33a8819dea14f63a14fc5b0024f0188_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNS03LTEtMS0xMjE3OTc_df4048d3-050b-4b8c-b27b-3ac3bd3b8f2c"
      unitRef="usd">471000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNS05LTEtMS0xMjE3OTc_57870bfb-1eef-4520-9312-ad3438762777"
      unitRef="usd">3864000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNS0xMS0xLTEtMTIxNzk3_25bf65cf-920c-46c0-8ba4-6f6db992260a"
      unitRef="usd">486000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears
      contextRef="i4a4d5943f3344b028b2021d88fb2d40d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNi0xLTEtMS0xMjE3OTc_aa4a3399-71c3-43e4-ac4a-eb821d009a53"
      unitRef="usd">196000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss
      contextRef="i4a4d5943f3344b028b2021d88fb2d40d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNi0zLTEtMS0xMjE3OTc_efd75079-4a93-4759-9dac-c980f2d29908"
      unitRef="usd">18000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears
      contextRef="if33a8819dea14f63a14fc5b0024f0188_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNi01LTEtMS0xMjE3OTc_5a29a0a8-7739-470e-833e-69427194ea8f"
      unitRef="usd">3043000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss
      contextRef="if33a8819dea14f63a14fc5b0024f0188_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNi03LTEtMS0xMjE3OTc_fd9f6580-029b-400c-b64d-103aafd1855a"
      unitRef="usd">374000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNi05LTEtMS0xMjE3OTc_6dcb4301-abce-4af0-a162-105e3a84e6dc"
      unitRef="usd">3239000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNi0xMS0xLTEtMTIxNzk3_0c9522db-5b59-4e46-849f-07fe6e77a0fa"
      unitRef="usd">392000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="if147f99b547041e7930b6068d7988826_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNy0xLTEtMS0xMjE3OTc_29c960ff-21fd-45ce-8b2f-0905572ddd40"
      unitRef="usd">11000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="if147f99b547041e7930b6068d7988826_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNy0zLTEtMS0xMjE3OTc_88a5b015-f13b-42b8-ad88-84af86e7b129"
      unitRef="usd">1000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i0aa8184ef83c4a40a3d80e580b517091_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNy01LTEtMS0xMjE3OTc_f9538ef9-88af-49d1-8605-f56a5e7b5a0b"
      unitRef="usd">698000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i0aa8184ef83c4a40a3d80e580b517091_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNy03LTEtMS0xMjE3OTc_05d76dd0-64f2-48d0-87d5-fb9678260289"
      unitRef="usd">60000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNy05LTEtMS0xMjE3OTc_cfdb060b-a5f2-49b2-97b1-92732f30307b"
      unitRef="usd">709000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i1f3dc5b373774df58f1f755e836acc54_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfNy0xMS0xLTEtMTIxNzk3_cd0efcec-e2db-430e-94b5-d9d14109737f"
      unitRef="usd">61000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i92bb3a9ebd6340bbafee19e1a0961497_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfOC0xLTEtMS0xMjE3OTc_12dd0151-ee1a-46bd-8daf-1c90c1bacb73"
      unitRef="usd">33000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i92bb3a9ebd6340bbafee19e1a0961497_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfOC0zLTEtMS0xMjE3OTc_c017ea02-6b3e-4c00-9ed9-2fd85f2b1fa6"
      unitRef="usd">2000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i565890e50f664de28c6c98865dd484ac_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfOC01LTEtMS0xMjE3OTc_fcb7f717-59b3-4090-9b24-14b0abdf44f4"
      unitRef="usd">1040000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i565890e50f664de28c6c98865dd484ac_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfOC03LTEtMS0xMjE3OTc_548ff44a-bf1a-4a83-a04b-45ea1dfc94df"
      unitRef="usd">112000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfOC05LTEtMS0xMjE3OTc_ebc2fea8-eec1-4f2c-b9ea-bee0ea8a41e5"
      unitRef="usd">1073000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="ieb4aeee3ce4f4d89bec8dec0efb81f94_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfOC0xMS0xLTEtMTIxNzk3_213d1ef4-ce36-42fe-b0a1-6fab8e14060c"
      unitRef="usd">114000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="icc6cfcaae9cd409daffba0639d13efcd_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfOS0xLTEtMS0xMjE3OTc_361ea3d5-9107-4740-a694-a2f5742bfae4"
      unitRef="usd">16000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="icc6cfcaae9cd409daffba0639d13efcd_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfOS0zLTEtMS0xMjE3OTc_150dde76-1ef0-412c-b57c-3588db729533"
      unitRef="usd">1000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="ibfb24956f5d44b968d2715f9013c792b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfOS01LTEtMS0xMjE3OTc_8bb4dc47-392c-4efd-b8ea-a029110eadce"
      unitRef="usd">2456000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="ibfb24956f5d44b968d2715f9013c792b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfOS03LTEtMS0xMjE3OTc_b7b2b985-a3bb-4fef-b7c1-ea674ee45ad7"
      unitRef="usd">134000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfOS05LTEtMS0xMjE3OTc_e1f92f96-1f5e-4945-a073-994e1f97a7aa"
      unitRef="usd">2472000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i839c9086111641ffb78f678a49af4bfb_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfOS0xMS0xLTEtMTIxNzk3_2a8a230b-76d6-4f13-9935-6a1a9301fe78"
      unitRef="usd">135000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i4a4d5943f3344b028b2021d88fb2d40d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfMTAtMS0xLTEtMTIxNzk3_8d2372af-145b-4d19-bf47-4ff6b4603d4e"
      unitRef="usd">468000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i4a4d5943f3344b028b2021d88fb2d40d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfMTAtMy0xLTEtMTIxNzk3_5b124dd5-ca49-4094-9342-23264aeaf08c"
      unitRef="usd">39000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="if33a8819dea14f63a14fc5b0024f0188_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfMTAtNS0xLTEtMTIxNzk3_e973b4ce-6267-46c3-9637-a909e3343ef0"
      unitRef="usd">16450000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="if33a8819dea14f63a14fc5b0024f0188_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfMTAtNy0xLTEtMTIxNzk3_ef48a83d-e00a-4028-9446-6057966626ec"
      unitRef="usd">1476000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfMTAtOS0xLTEtMTIxNzk3_368dd331-baee-4359-b835-05aa981dbbd1"
      unitRef="usd">16918000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM3YmU0NDE1Y2JlYzQyNzFhNzIzODk5YzI5YzIwZWY0L3RhYmxlcmFuZ2U6YzdiZTQ0MTVjYmVjNDI3MWE3MjM4OTljMjljMjBlZjRfMTAtMTEtMS0xLTEyMTc5Nw_53d4385a-ea2d-4505-9986-b0af1953ec0f"
      unitRef="usd">1515000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <cvs:ActivityInMortgageLoanPortfolioTableTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNTE3Ng_fb1c942f-4609-45a7-9021-32a6a31b3755">During the three and six months ended June&#160;30, 2022 and 2021, the Company had the following activity in its mortgage loan portfolio:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans fully repaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans foreclosed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</cvs:ActivityInMortgageLoanPortfolioTableTextBlock>
    <us-gaap:MortgageLoansOnRealEstateNewMortgageLoans
      contextRef="i9b35d26a394f498ead4b8911f6b783f3_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEwZjNmZjVhMDI0YzQ2ODNhYjUyMjE5MTEzZjYzNGJkL3RhYmxlcmFuZ2U6MTBmM2ZmNWEwMjRjNDY4M2FiNTIyMTkxMTNmNjM0YmRfMi0xLTEtMS0xMjE3OTc_6a722aef-cc3d-45c6-953f-3439e8aff01e"
      unitRef="usd">121000000</us-gaap:MortgageLoansOnRealEstateNewMortgageLoans>
    <us-gaap:MortgageLoansOnRealEstateNewMortgageLoans
      contextRef="ice4289e5981f470c8348e6e0bd038770_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEwZjNmZjVhMDI0YzQ2ODNhYjUyMjE5MTEzZjYzNGJkL3RhYmxlcmFuZ2U6MTBmM2ZmNWEwMjRjNDY4M2FiNTIyMTkxMTNmNjM0YmRfMi0zLTEtMS0xMjE3OTc_c1028a98-97fc-4440-b36c-5d2b1d47dc5c"
      unitRef="usd">73000000</us-gaap:MortgageLoansOnRealEstateNewMortgageLoans>
    <us-gaap:MortgageLoansOnRealEstateNewMortgageLoans
      contextRef="i81ecba3177494484943b0150ef662927_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEwZjNmZjVhMDI0YzQ2ODNhYjUyMjE5MTEzZjYzNGJkL3RhYmxlcmFuZ2U6MTBmM2ZmNWEwMjRjNDY4M2FiNTIyMTkxMTNmNjM0YmRfMi01LTEtMS0xMjE3OTc_cb199bf4-d249-4b61-9aaf-4bdf318a3cc3"
      unitRef="usd">180000000</us-gaap:MortgageLoansOnRealEstateNewMortgageLoans>
    <us-gaap:MortgageLoansOnRealEstateNewMortgageLoans
      contextRef="ia42bbf3cad014282b14444e67b52efed_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEwZjNmZjVhMDI0YzQ2ODNhYjUyMjE5MTEzZjYzNGJkL3RhYmxlcmFuZ2U6MTBmM2ZmNWEwMjRjNDY4M2FiNTIyMTkxMTNmNjM0YmRfMi03LTEtMS0xMjE3OTc_99ef7ef3-5e46-4f18-8fbf-bc932be0f0ed"
      unitRef="usd">120000000</us-gaap:MortgageLoansOnRealEstateNewMortgageLoans>
    <cvs:MortgageLoansOnRealEstateLoansFullyRepaid
      contextRef="i9b35d26a394f498ead4b8911f6b783f3_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEwZjNmZjVhMDI0YzQ2ODNhYjUyMjE5MTEzZjYzNGJkL3RhYmxlcmFuZ2U6MTBmM2ZmNWEwMjRjNDY4M2FiNTIyMTkxMTNmNjM0YmRfMy0xLTEtMS0xMjE3OTc_ce3444da-ec0a-4230-8023-5961ddf99975"
      unitRef="usd">39000000</cvs:MortgageLoansOnRealEstateLoansFullyRepaid>
    <cvs:MortgageLoansOnRealEstateLoansFullyRepaid
      contextRef="ice4289e5981f470c8348e6e0bd038770_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEwZjNmZjVhMDI0YzQ2ODNhYjUyMjE5MTEzZjYzNGJkL3RhYmxlcmFuZ2U6MTBmM2ZmNWEwMjRjNDY4M2FiNTIyMTkxMTNmNjM0YmRfMy0zLTEtMS0xMjE3OTc_a1d7b057-8e44-4ead-9d01-429b9a7b7c30"
      unitRef="usd">82000000</cvs:MortgageLoansOnRealEstateLoansFullyRepaid>
    <cvs:MortgageLoansOnRealEstateLoansFullyRepaid
      contextRef="i81ecba3177494484943b0150ef662927_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEwZjNmZjVhMDI0YzQ2ODNhYjUyMjE5MTEzZjYzNGJkL3RhYmxlcmFuZ2U6MTBmM2ZmNWEwMjRjNDY4M2FiNTIyMTkxMTNmNjM0YmRfMy01LTEtMS0xMjE3OTc_6681b254-6d27-4de2-963b-2fc294a2e75b"
      unitRef="usd">74000000</cvs:MortgageLoansOnRealEstateLoansFullyRepaid>
    <cvs:MortgageLoansOnRealEstateLoansFullyRepaid
      contextRef="ia42bbf3cad014282b14444e67b52efed_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEwZjNmZjVhMDI0YzQ2ODNhYjUyMjE5MTEzZjYzNGJkL3RhYmxlcmFuZ2U6MTBmM2ZmNWEwMjRjNDY4M2FiNTIyMTkxMTNmNjM0YmRfMy03LTEtMS0xMjE3OTc_863d67dc-88fe-4394-b77b-04504f586a66"
      unitRef="usd">172000000</cvs:MortgageLoansOnRealEstateLoansFullyRepaid>
    <us-gaap:MortgageLoansOnRealEstateForeclosures
      contextRef="i9b35d26a394f498ead4b8911f6b783f3_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEwZjNmZjVhMDI0YzQ2ODNhYjUyMjE5MTEzZjYzNGJkL3RhYmxlcmFuZ2U6MTBmM2ZmNWEwMjRjNDY4M2FiNTIyMTkxMTNmNjM0YmRfNC0xLTEtMS0xMjE3OTc_c5b1a13e-28d1-4584-85b5-30197951b014"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstateForeclosures>
    <us-gaap:MortgageLoansOnRealEstateForeclosures
      contextRef="ice4289e5981f470c8348e6e0bd038770_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEwZjNmZjVhMDI0YzQ2ODNhYjUyMjE5MTEzZjYzNGJkL3RhYmxlcmFuZ2U6MTBmM2ZmNWEwMjRjNDY4M2FiNTIyMTkxMTNmNjM0YmRfNC0zLTEtMS0xMjE3OTc_9aa68a6a-9d61-47d2-bb72-6d71ee9de6eb"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstateForeclosures>
    <us-gaap:MortgageLoansOnRealEstateForeclosures
      contextRef="i81ecba3177494484943b0150ef662927_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEwZjNmZjVhMDI0YzQ2ODNhYjUyMjE5MTEzZjYzNGJkL3RhYmxlcmFuZ2U6MTBmM2ZmNWEwMjRjNDY4M2FiNTIyMTkxMTNmNjM0YmRfNC01LTEtMS0xMjE3OTc_450150d9-97cd-4ecd-9d56-a3833eb412f8"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstateForeclosures>
    <us-gaap:MortgageLoansOnRealEstateForeclosures
      contextRef="ia42bbf3cad014282b14444e67b52efed_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjEwZjNmZjVhMDI0YzQ2ODNhYjUyMjE5MTEzZjYzNGJkL3RhYmxlcmFuZ2U6MTBmM2ZmNWEwMjRjNDY4M2FiNTIyMTkxMTNmNjM0YmRfNC03LTEtMS0xMjE3OTc_e64059d4-7fe2-457a-ab41-5589449fd413"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstateForeclosures>
    <cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNTEwMg_c084d0f7-830b-42ef-95a0-a98430bd6ea2">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on the Company&#x2019;s assessments at June&#160;30, 2022 and December&#160;31, 2021, the amortized cost basis of the Company's mortgage loans within each credit quality indicator by year of origination was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost Basis by Year of Origination&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except credit quality indicator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Prior&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ieb0ab983715d47e4adbbebc254ffa1e4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMy0xLTEtMS0xMjE3OTc_956933cf-82d7-4e30-bedd-afb52b38f488"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i371c0520998941618ef7aea89496ed34_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMy0zLTEtMS0xMjE3OTc_58207aa7-593a-4448-843d-ef2620930484"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="if373bf37aea3458b912ce5c9dedfd404_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMy01LTEtMS0xMjE3OTc_218e7aa2-893f-4320-83d7-2592555dd42f"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i4edd43c72fa24ecb8eb03fa5e6bd17c0_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMy03LTEtMS0xMjE3OTc_0fc6b2c9-50d6-4146-91bd-e14162978f1d"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i33d8e2fa0f464eab934f3a3981276b03_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMy05LTEtMS0xMjE3OTc_0e54cb4e-42b8-44dc-a6ef-a51df7fe013b"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ief7e32fbdcdc4b1db1c33985f1a1bfca_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMy0xMS0xLTEtMTIxNzk3_ddcd1c30-67d8-4483-9226-17dd81ab7526"
      unitRef="usd">17000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i46df26cf65e741a88308365f0fdce535_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMy0xMy0xLTEtMTIxNzk3_526ebedd-ad95-45c3-acd5-4de8831bf0cf"
      unitRef="usd">17000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i3fd18a6eac95471682e4f96b85733eb0_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNC0xLTEtMS0xMjE3OTc_455ad2aa-6beb-46ac-9032-64831ec99237"
      unitRef="usd">162000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ia13fa065e11f43c99f24e914e7606b15_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNC0zLTEtMS0xMjE3OTc_4f18a87e-64be-45f5-80e1-48954c38ff9b"
      unitRef="usd">250000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ic5eeda700ebc4f8eac3969546e289875_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNC01LTEtMS0xMjE3OTc_8808b6ca-42fa-42ab-a517-33c304dc4319"
      unitRef="usd">48000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ia47b1c162c8a4dd19c3d46272804896b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNC03LTEtMS0xMjE3OTc_e779ff60-aac5-4326-99bd-880483e85ca2"
      unitRef="usd">20000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i899578d869e54146a2dc8706728481b0_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNC05LTEtMS0xMjE3OTc_1a4eafa9-5d7d-4036-996a-e2ddd450f6e0"
      unitRef="usd">65000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i7b60a590a9d846f38abc0bedd2f2462b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNC0xMS0xLTEtMTIxNzk3_14cf8f26-33a1-441e-bc63-8df458cd8efd"
      unitRef="usd">418000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i4ec460be73364dbe9e6821a95e857a19_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNC0xMy0xLTEtMTIxNzk3_14313cb4-df35-4dc0-a0ca-4c366c1de474"
      unitRef="usd">963000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i3c0db9ae3a654d1abcb624237ab2b056_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNS0xLTEtMS0xMjE3OTc_3f79fb5b-86b2-426d-b5bf-a03cda5c89a1"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i6513ccc2104b42fc9d1803cfa7134a7a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNS0zLTEtMS0xMjE3OTc_bf5baf67-8115-4cd5-aa2f-ad8e87769c5b"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ib744f76b72ec42598309a6e5c4e51b42_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNS01LTEtMS0xMjE3OTc_fd26441d-a7b2-4073-b84f-0c9b27fec1f1"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i456084319dfe4263a992c645b2d706b2_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNS03LTEtMS0xMjE3OTc_0550c337-4a15-4a9c-98e0-c927a7ef7a04"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i861b819f6b654647b93791e8fbac82b7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNS05LTEtMS0xMjE3OTc_f82cb4c9-e14c-413b-b8d6-a4995f1bbc62"
      unitRef="usd">3000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ic0fe0824d20a45ce92b02afde836c6e5_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNS0xMS0xLTEtMTIxNzk3_61bd2de1-e147-43aa-a60f-6c59a1e11bce"
      unitRef="usd">10000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i7a9fd2dddbfe44ff88021ac1f64666f6_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNS0xMy0xLTEtMTIxNzk3_6d83dfc6-5287-4271-9ecd-8a614623628a"
      unitRef="usd">13000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i740f5a3a2f9a435891769f604897c8bb_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNi0xLTEtMS0xMjE3OTc_4ddd858d-012c-4d98-9ba8-bf0ad23938ef"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ic0c41fd6ab6f49419e4feb0002f2d48f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNi0zLTEtMS0xMjE3OTc_58633822-4e6d-463b-9deb-0c33ec014006"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ief32efb6abac44468898f50592a29547_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNi01LTEtMS0xMjE3OTc_8f934eea-2f95-4feb-96aa-25cd4521e2c5"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i850b791bc3e2407da5747eebb4ab8c3f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNi03LTEtMS0xMjE3OTc_bae3e46b-9845-4c6a-af0d-e99e89fda6dd"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i38844338d2ce463798197e185e85f756_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNi05LTEtMS0xMjE3OTc_f8ea1f1f-6ca1-4c17-8f94-bee405ce7bd1"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="if00cd26828534c21b6c33adb32cacfd7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNi0xMS0xLTEtMTIxNzk3_e904b123-4a9e-434c-9687-329cc45d06df"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="id743f9aa58344caf9f98f25c5d92b7de_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNi0xMy0xLTEtMTIxNzk3_83fdcbfa-16d3-4429-b58e-6f311100f588"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="iea202e1537584a368ceecede86271423_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNy0xLTEtMS0xMjE3OTc_59bd1a5f-f78f-4754-9a0c-41db5f0b9199"
      unitRef="usd">162000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i62992d26f65645ff897bda2742cf86fb_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNy0zLTEtMS0xMjE3OTc_75378aae-b27c-4a2d-80b9-5e3a3bbb3da2"
      unitRef="usd">250000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i11c72ce8b8dc4d21aae7ff8290b67bec_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNy01LTEtMS0xMjE3OTc_e591e22d-b77b-428a-a5c3-85fd2f5610b9"
      unitRef="usd">48000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i39b1269f49174087928bb212d8afc1d2_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNy03LTEtMS0xMjE3OTc_e049d871-b605-4146-a3bd-3371a87264bf"
      unitRef="usd">20000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i4d994fd5d397459d8367d852e8f5452f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNy05LTEtMS0xMjE3OTc_89917e73-0d35-4586-b0ee-7865fa62364c"
      unitRef="usd">68000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ibb0affc8add2414ca8954a5991109f55_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNy0xMS0xLTEtMTIxNzk3_b637402b-2783-4263-b293-bcaeab23d879"
      unitRef="usd">445000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i4faa5bd0ec73475c94099ab518ccf4e3_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfNy0xMy0xLTEtMTIxNzk3_d414dab8-49e3-4e12-b0fa-2416bf7acd44"
      unitRef="usd">993000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i26d61f9963ea4196b8ba2d07d228e5bd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTAtMy0xLTEtMTIxNzk3_647831b3-05b9-43c0-a5eb-aab6f04e7295"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ifb3ebe7111bf41f584b98e07430377db_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTAtNS0xLTEtMTIxNzk3_c8b47685-317c-489c-8b92-c1dc0c495e3c"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i000af04ab3a34580abe06f0d79b475b9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTAtNy0xLTEtMTIxNzk3_333f83de-7ca1-4a1c-8b63-1e9c06da155a"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i37656451d6e54a6f87723c3c55ee7693_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTAtOS0xLTEtMTIxNzk3_bedef4b2-cf0e-4cc0-a7d7-99be10ec85f7"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="id04cb4912f0c4add911f641b85b28d8d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTAtMTEtMS0xLTEyMTc5Nw_8ce735aa-3086-4876-bfa1-257e7daad517"
      unitRef="usd">28000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i0a7a0277984b4d9292ccff484d447ce2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTAtMTMtMS0xLTEyMTc5Nw_b91c5254-d58b-41b2-be57-1a6ab55716d8"
      unitRef="usd">28000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i27decdd521e9427eb51858ecd5161a1c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTEtMy0xLTEtMTIxNzk3_3f7fa9d8-abdf-4c53-95c6-efab9547d296"
      unitRef="usd">255000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ia0ab7e83123843f5995f6c913b85bc32_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTEtNS0xLTEtMTIxNzk3_2500b290-85ee-4481-96c1-6935e855c006"
      unitRef="usd">48000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ib381c0925973492e9d3c59e35956766c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTEtNy0xLTEtMTIxNzk3_2ceee852-b38f-4e52-ada9-e0719c3387d0"
      unitRef="usd">40000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i6f517e0f803f424d9f8a281c67637d41_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTEtOS0xLTEtMTIxNzk3_95090e9a-e087-4320-ac34-f83f94dc3ca6"
      unitRef="usd">72000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ia5dabfedcb3446d79b9af20990e4475f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTEtMTEtMS0xLTEyMTc5Nw_b226582e-39c0-4431-a30b-68ac4956e8f6"
      unitRef="usd">446000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ia44d0270c7fc4dab8d24ff7dd2185b17_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTEtMTMtMS0xLTEyMTc5Nw_617e9a37-48c0-4bf0-91be-08be2d572882"
      unitRef="usd">861000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i787125a9fb1c4d2dae3f0091842a2905_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTItMy0xLTEtMTIxNzk3_c0d9f7d0-ccdb-4791-baa7-3e366d6e0563"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i533abaf939b14629802a0d1666202827_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTItNS0xLTEtMTIxNzk3_8da9c045-19f1-4307-b6b9-171f7de5a593"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i0be6d49dea7a41c3b3be5025579b7f80_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTItNy0xLTEtMTIxNzk3_065d384a-5718-4713-9852-2fd376daeedc"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ic22d1b35d059439ba0cc5c6c6960921d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTItOS0xLTEtMTIxNzk3_73aba20d-8456-407f-84a1-214909c2dd31"
      unitRef="usd">3000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i3530a0f47dac4ff1958936a41cb751d5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTItMTEtMS0xLTEyMTc5Nw_9ae44f95-cf6e-4b1d-8c83-798718b65d79"
      unitRef="usd">10000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i2ad0cb156fab4fb6afd4533b759fba57_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTItMTMtMS0xLTEyMTc5Nw_dd076a2d-f8c4-422b-986d-d3cdadff32a4"
      unitRef="usd">13000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ib317e948955944578ea101ab7b8681bc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTMtMy0xLTEtMTIxNzk3_b33a2148-d508-4891-9664-dda6fbd41d6c"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="id27b20e03a0a420eb7c6b974de8faa01_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTMtNS0xLTEtMTIxNzk3_0f106161-8df2-4dee-a8ae-5222c7fa4e2b"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i11c2cc84da31426aa9cf78264345c70d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTMtNy0xLTEtMTIxNzk3_a16e83b2-b7fa-4734-b4ec-c85c0fc7713f"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i207775b0e52a46038a243f680c4bfe38_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTMtOS0xLTEtMTIxNzk3_58a4aee0-6339-4656-9c20-885e07153621"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ic002c663bb55486dbea5fd9b8add8629_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTMtMTEtMS0xLTEyMTc5Nw_98b60afe-6906-447b-ab07-9491d5b26cbc"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i612e5e99ae014b8aab81d54d276d71a2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTMtMTMtMS0xLTEyMTc5Nw_e695165c-83f2-4859-9037-48ec48058ab6"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i93420b43b370461b8eefc357152611ba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTQtMy0xLTEtMTIxNzk3_d70a40e0-1d4b-470d-8f2c-eefe62bca640"
      unitRef="usd">255000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="idde41fc6240949d2b00dd4bfaea668ce_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTQtNS0xLTEtMTIxNzk3_c5e8d3bf-3054-49c1-b440-886a742ca1d7"
      unitRef="usd">48000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i53f958f5f6f642d2b0e5a8f47b9be63e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTQtNy0xLTEtMTIxNzk3_7fc0f370-e4dc-4752-a703-d6af80f94fee"
      unitRef="usd">40000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i6a5ae34085d7468184ecc64dcf1815c3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTQtOS0xLTEtMTIxNzk3_ef811277-d24f-4ac6-9753-8ccaa2ed37f6"
      unitRef="usd">75000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ib37a4b4576174adfbd328d6220e6446e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTQtMTEtMS0xLTEyMTc5Nw_e760f4b9-fc17-4e9c-b802-fdb1c37944b3"
      unitRef="usd">484000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i0218b9eeafa744cd976a2ee112999f4c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOmM4YThlNmI3YWI5ODRhZDc5NWRlOTI2ZTA3ZmNlN2NmL3RhYmxlcmFuZ2U6YzhhOGU2YjdhYjk4NGFkNzk1ZGU5MjZlMDdmY2U3Y2ZfMTQtMTMtMS0xLTEyMTc5Nw_61e516fa-210e-4fe0-933a-455a1cb1d625"
      unitRef="usd">902000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:InvestmentIncomeTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNTE1OA_ce9cf65a-b131-4088-9120-f4ff58a41f9a">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sources of net investment income for the three and six months ended June&#160;30, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (excluding net realized capital gains or losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized capital gains (losses) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Net realized capital losses include yield-related impairment losses on debt securities of $30 million and are shown net of the reversal of previously recorded credit-related impairment losses on debt securities of $22 million in the three months ended June&#160;30, 2022. Net realized capital losses include credit-related and yield-related impairment losses on debt securities of $16 million and $48 million, respectively, in the six months ended June&#160;30, 2022. Net realized capital gains are net of yield-related impairment losses on debt securities of $2 million and $32 million, respectively, in the three and six months ended June&#160;30, 2021. There were no credit-related losses on debt securities in the three and six months ended June&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Net investment income includes $9 million and $18 million for the three and six months ended June&#160;30, 2022, respectively, and $10 million and $19 million for the three and six months ended June&#160;30, 2021, respectively, related to investments supporting experience-rated products.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentIncomeTextBlock>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i8b71fc37bdcc4544ba59a680d2a845ad_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfMi0xLTEtMS0xMjE3OTc_285e85ad-c494-4c28-9495-21333fdb3705"
      unitRef="usd">172000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i6410396dd3b049fc94d73ed03406a6f0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfMi0zLTEtMS0xMjE3OTc_a0e3b76c-e9c4-443a-8f53-42804b5344f2"
      unitRef="usd">160000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="idb2b8ddb867c4af697afecf4d9a157e8_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfMi01LTEtMS0xMjE3OTc_f4b3c5c3-e793-4c9a-a631-5466e5691b1a"
      unitRef="usd">336000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i41d8c374cbf548e987ad1657cdc38098_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfMi03LTEtMS0xMjE3OTc_25003525-6890-42f9-acda-f1ad6a142a58"
      unitRef="usd">317000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ib36aad3ac1484f6bbdaa4f1c0fc5b0b0_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfMy0xLTEtMS0xMjE3OTc_8a7f5187-c8a4-40d9-a28e-74c91a7bf888"
      unitRef="usd">13000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i8e1b0b89b26a40c693ea4463c4d8593a_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfMy0zLTEtMS0xMjE3OTc_c7292402-06e3-426f-b568-78a7c14a3b93"
      unitRef="usd">13000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="idfac0b03d2274f43871a43aeb40a5ec2_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfMy01LTEtMS0xMjE3OTc_014ba98f-e884-4d57-8391-31002d7c9a2d"
      unitRef="usd">24000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i09b23468a180421fb01ec60b86dff5b1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfMy03LTEtMS0xMjE3OTc_ed6642f7-6a71-4866-9d18-49e5c16970a9"
      unitRef="usd">28000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ifbcd8299564648c0b7ec0acfbd315e56_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNC0xLTEtMS0xMjE3OTc_564c25e1-5b9d-4823-96ae-ae5bdcd9f06b"
      unitRef="usd">68000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i6b5bf1c54d1e4c2e9d9b2486e17e7e6f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNC0zLTEtMS0xMjE3OTc_cef880d8-1194-4e60-bd14-5d7b26a9c914"
      unitRef="usd">112000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i2fd8e5b0ac1842dca561465f4468b014_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNC01LTEtMS0xMjE3OTc_f5eaed79-dc3c-423c-9996-f24bd075b0e0"
      unitRef="usd">145000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ic4c795e51e0c4660990629bf4fd31005_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNC03LTEtMS0xMjE3OTc_347d6bb1-d387-473d-8d73-392626c446bd"
      unitRef="usd">198000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNS0xLTEtMS0xMjE3OTc_005ed880-50b4-4e4a-b414-7e5636a90a0f"
      unitRef="usd">253000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNS0zLTEtMS0xMjE3OTc_098c436f-e503-44df-9228-45a5639c7492"
      unitRef="usd">285000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNS01LTEtMS0xMjE3OTc_c95dba5b-02e6-4e7e-ac0d-308c554aa498"
      unitRef="usd">505000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNS03LTEtMS0xMjE3OTc_5a9298f1-10c2-41db-b4b3-38690e53cd21"
      unitRef="usd">543000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInvestmentExpense
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNi0xLTEtMS0xMjE3OTc_da894542-54ea-4c49-bc44-4b1e5becbe9e"
      unitRef="usd">9000000</us-gaap:InvestmentIncomeInvestmentExpense>
    <us-gaap:InvestmentIncomeInvestmentExpense
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNi0zLTEtMS0xMjE3OTc_14610c3f-b290-4afd-b846-891b2392f7b7"
      unitRef="usd">9000000</us-gaap:InvestmentIncomeInvestmentExpense>
    <us-gaap:InvestmentIncomeInvestmentExpense
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNi01LTEtMS0xMjE3OTc_56f32de6-c9ab-4ed0-852f-9f3132ecfc1b"
      unitRef="usd">18000000</us-gaap:InvestmentIncomeInvestmentExpense>
    <us-gaap:InvestmentIncomeInvestmentExpense
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNi03LTEtMS0xMjE3OTc_d8eb6293-bed6-44a1-933d-c16704767ed9"
      unitRef="usd">17000000</us-gaap:InvestmentIncomeInvestmentExpense>
    <cvs:InvestmentIncomeExcludingCapitalGainsorLosses
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNy0xLTEtMS0xMjE3OTc_d0e4fde3-0f28-4855-93b2-6885ce45e42f"
      unitRef="usd">244000000</cvs:InvestmentIncomeExcludingCapitalGainsorLosses>
    <cvs:InvestmentIncomeExcludingCapitalGainsorLosses
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNy0zLTEtMS0xMjE3OTc_6efd79f5-1e68-4cf2-bf06-52296148c922"
      unitRef="usd">276000000</cvs:InvestmentIncomeExcludingCapitalGainsorLosses>
    <cvs:InvestmentIncomeExcludingCapitalGainsorLosses
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNy01LTEtMS0xMjE3OTc_80233ed6-edcd-4a2e-a4f9-d1da1be4aebd"
      unitRef="usd">487000000</cvs:InvestmentIncomeExcludingCapitalGainsorLosses>
    <cvs:InvestmentIncomeExcludingCapitalGainsorLosses
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfNy03LTEtMS0xMjE3OTc_d3df2281-4f4c-44f0-8b4f-580c68d0e28e"
      unitRef="usd">526000000</cvs:InvestmentIncomeExcludingCapitalGainsorLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfOC0xLTEtMS0xMjE3OTc_2c52ae08-6790-4d3e-b9e3-e81258424c21"
      unitRef="usd">-98000000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfOC0zLTEtMS0xMjE3OTc_53dd0b77-c2ad-4b16-81a5-8e9336622fbe"
      unitRef="usd">13000000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfOC01LTEtMS0xMjE3OTc_25b76ecc-545d-4e22-8b26-26063938af9e"
      unitRef="usd">-173000000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfOC03LTEtMS0xMjE3OTc_d90b7667-b7d5-4ba2-a6ab-a0e95d36b0d9"
      unitRef="usd">60000000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:InvestmentIncomeNet
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfOS0xLTEtMS0xMjE3OTc_152c7406-f513-4d7d-a1d2-6cb1de2dd683"
      unitRef="usd">146000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfOS0zLTEtMS0xMjE3OTc_ffb0fe9a-a75f-4927-91a9-98b58bf0d3e6"
      unitRef="usd">289000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfOS01LTEtMS0xMjE3OTc_8a63140c-9eda-48d3-8e94-97ded7febcc7"
      unitRef="usd">314000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjIwNDRlOWZmYWI3YzQyNWJiN2I3MzM4ZTdjZTJjZjljL3RhYmxlcmFuZ2U6MjA0NGU5ZmZhYjdjNDI1YmI3YjczMzhlN2NlMmNmOWNfOS03LTEtMS0xMjE3OTc_c9856144-0778-4495-be20-171c7fbf19b8"
      unitRef="usd">586000000</us-gaap:InvestmentIncomeNet>
    <cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfMzg0ODI5MDcwNDMxMw_95ec9acd-19d1-459f-bc42-c5c6ea21d9e0"
      unitRef="usd">30000000</cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfMzg0ODI5MDcwNDUyMA_a0687a72-1e8d-40ca-b2a8-750f3ea2f665"
      unitRef="usd">-22000000</cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfMzg0ODI5MDcwNDUyOA_4214d3b5-99d4-4d46-96fb-25fa56ba0ee4"
      unitRef="usd">16000000</cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfMTA5OTUxMTYzMzcyNQ_7b19cc52-524e-448d-8df7-6cf2b98bf20f"
      unitRef="usd">48000000</cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNDU2Nw_7dfd3f33-1519-46bd-bdd5-40628ef27898"
      unitRef="usd">2000000</cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfMTY0OTI2NzQ0NzAwNA_404b3d3d-7185-46a6-ab95-a6a99147bfee"
      unitRef="usd">32000000</cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNDYxMQ_08988b42-607b-4af1-b96b-fe6fa83ab82d"
      unitRef="usd">0</cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNDYxMQ_487008bc-4fcf-4e05-ae3f-86c244157fe0"
      unitRef="usd">0</cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <us-gaap:InvestmentIncomeNet
      contextRef="iaf069440948942608f8ec319d2ecfe5c_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNDcyNg_1edf2451-9384-45ad-b3c8-d35be515625a"
      unitRef="usd">9000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i05ef7a86b20148e5a32020bd5c7d5fd8_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfMTY0OTI2NzQ0NzE1Mw_ab0fc8f0-8d9b-4af2-8537-cacdf389adb0"
      unitRef="usd">18000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i8ca2c256a7cf4284bfbeea2216a84437_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfMTY0OTI2NzQ0NzE2NA_2dd58999-8bdf-4fe6-a723-88773c5689b0"
      unitRef="usd">10000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="ifdee0bd923464f248a69eb92727cbc33_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfMTY0OTI2NzQ0NzE3Mw_5f0e18a7-fa2c-4e12-bc06-455e3af5a99d"
      unitRef="usd">19000000</us-gaap:InvestmentIncomeNet>
    <cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RleHRyZWdpb246MWQ3MTdhNWVjYTFlNGVkMWI1YjljNGE5NDM0NDMyN2FfNTA4Mg_4292183f-2b2f-4549-84fe-9d78c3f7e6cc">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Excluding amounts related to experience-rated products, proceeds from the sale of available-for-sale debt securities and the related gross realized capital gains and losses for the three and six months ended June&#160;30, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjc3ZjEwNjJkZjFiZDRhYzhiY2JhYmIyM2JiYjJkZGJhL3RhYmxlcmFuZ2U6NzdmMTA2MmRmMWJkNGFjOGJjYmFiYjIzYmJiMmRkYmFfMi0xLTEtMS0xMjE3OTc_ba6d2510-ca2d-4c52-b70f-397c8a50eb8c"
      unitRef="usd">1052000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjc3ZjEwNjJkZjFiZDRhYzhiY2JhYmIyM2JiYjJkZGJhL3RhYmxlcmFuZ2U6NzdmMTA2MmRmMWJkNGFjOGJjYmFiYjIzYmJiMmRkYmFfMi0zLTEtMS0xMjE3OTc_588aa7a1-e16f-4585-bf14-eece4ee6e9ff"
      unitRef="usd">919000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjc3ZjEwNjJkZjFiZDRhYzhiY2JhYmIyM2JiYjJkZGJhL3RhYmxlcmFuZ2U6NzdmMTA2MmRmMWJkNGFjOGJjYmFiYjIzYmJiMmRkYmFfMi01LTEtMS0xMjE3OTc_da490376-e147-494a-8132-29c14ff9b035"
      unitRef="usd">2963000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjc3ZjEwNjJkZjFiZDRhYzhiY2JhYmIyM2JiYjJkZGJhL3RhYmxlcmFuZ2U6NzdmMTA2MmRmMWJkNGFjOGJjYmFiYjIzYmJiMmRkYmFfMi03LTEtMS0xMjE3OTc_69c26597-40db-4f61-af77-6929a05c4c24"
      unitRef="usd">2267000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjc3ZjEwNjJkZjFiZDRhYzhiY2JhYmIyM2JiYjJkZGJhL3RhYmxlcmFuZ2U6NzdmMTA2MmRmMWJkNGFjOGJjYmFiYjIzYmJiMmRkYmFfMy0xLTEtMS0xMjE3OTc_06bf177b-7a74-443e-9183-818947a516cc"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjc3ZjEwNjJkZjFiZDRhYzhiY2JhYmIyM2JiYjJkZGJhL3RhYmxlcmFuZ2U6NzdmMTA2MmRmMWJkNGFjOGJjYmFiYjIzYmJiMmRkYmFfMy0zLTEtMS0xMjE3OTc_02f4dc98-19bd-4943-88ca-04628b7c3bb4"
      unitRef="usd">20000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjc3ZjEwNjJkZjFiZDRhYzhiY2JhYmIyM2JiYjJkZGJhL3RhYmxlcmFuZ2U6NzdmMTA2MmRmMWJkNGFjOGJjYmFiYjIzYmJiMmRkYmFfMy01LTEtMS0xMjE3OTc_dc7b2a03-0b98-4d2d-89f2-cf6b36cbe56e"
      unitRef="usd">17000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjc3ZjEwNjJkZjFiZDRhYzhiY2JhYmIyM2JiYjJkZGJhL3RhYmxlcmFuZ2U6NzdmMTA2MmRmMWJkNGFjOGJjYmFiYjIzYmJiMmRkYmFfMy03LTEtMS0xMjE3OTc_89e3c269-da63-4153-85ff-8764d7acb476"
      unitRef="usd">42000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjc3ZjEwNjJkZjFiZDRhYzhiY2JhYmIyM2JiYjJkZGJhL3RhYmxlcmFuZ2U6NzdmMTA2MmRmMWJkNGFjOGJjYmFiYjIzYmJiMmRkYmFfNC0xLTEtMS0xMjE3OTc_9fd2bdcb-bdd5-4f00-a57e-a940e3ecd2f9"
      unitRef="usd">72000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjc3ZjEwNjJkZjFiZDRhYzhiY2JhYmIyM2JiYjJkZGJhL3RhYmxlcmFuZ2U6NzdmMTA2MmRmMWJkNGFjOGJjYmFiYjIzYmJiMmRkYmFfNC0zLTEtMS0xMjE3OTc_261b9bd3-a472-4edd-bd16-0d51f6b86d5a"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjc3ZjEwNjJkZjFiZDRhYzhiY2JhYmIyM2JiYjJkZGJhL3RhYmxlcmFuZ2U6NzdmMTA2MmRmMWJkNGFjOGJjYmFiYjIzYmJiMmRkYmFfNC01LTEtMS0xMjE3OTc_cabffc6a-67e0-41e0-b21b-1b17b29aba41"
      unitRef="usd">107000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80MC9mcmFnOjFkNzE3YTVlY2ExZTRlZDFiNWI5YzRhOTQzNDQzMjdhL3RhYmxlOjc3ZjEwNjJkZjFiZDRhYzhiY2JhYmIyM2JiYjJkZGJhL3RhYmxlcmFuZ2U6NzdmMTA2MmRmMWJkNGFjOGJjYmFiYjIzYmJiMmRkYmFfNC03LTEtMS0xMjE3OTc_8f227899-c028-4f97-964f-ea7a56d52e9a"
      unitRef="usd">10000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RleHRyZWdpb246ODJhOGE1ZjBhNGQwNGFlZTg2Njc0MzRhZjFlMjBiNzVfMzEzNQ_fadea8c6-98c1-4f82-99be-5f62bbed4fcc">Fair Value&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the Company&#x2019;s unaudited condensed consolidated financial statements in accordance with GAAP requires certain assets and liabilities to be reflected at their fair value and others to be reflected on another basis, such as an adjusted historical cost basis.&#160;The Company&#x2019;s assets and liabilities carried at fair value have been classified within one of three levels of a hierarchy established by GAAP.&#160;The following are the levels of the hierarchy and a brief description of the type of valuation information (&#x201c;valuation inputs&#x201d;) that qualifies a financial asset or liability for each level:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 &#x2013; Unadjusted quoted prices for identical assets or liabilities in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 &#x2013; Valuation inputs other than Level 1 that are based on observable market data.&#160;&#160;These include: quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets, valuation inputs that are observable that are not prices (such as interest rates and credit risks) and valuation inputs that are derived from or corroborated by observable markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 &#x2013; Developed from unobservable data, reflecting the Company&#x2019;s assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For a description of the methods and assumptions that are used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument, see Note 4 &#x201c;Fair Value&#x201d; in the 2021 Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no financial liabilities measured at fair value on a recurring basis on the unaudited condensed consolidated balance sheets at June&#160;30, 2022 or December&#160;31, 2021. Financial assets measured at fair value on a recurring basis on the unaudited condensed consolidated balance sheets at June&#160;30, 2022 and December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and six months ended June&#160;30, 2022 there were $26 million and $29 million of transfers out of Level 3. During the three and six months ended June&#160;30, 2021, there were no transfers into or out of Level 3.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the unaudited condensed consolidated balance sheets at adjusted cost or contract value at June&#160;30, 2022 and December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Separate Accounts assets relate to the Company&#x2019;s large case pensions products which represent funds maintained to meet specific objectives of contract holders.&#160;Since contract holders bear the investment risk of these assets, a corresponding Separate Accounts liability has been established equal to the assets.&#160;These assets and liabilities are carried at fair value.&#160;Separate Accounts financial assets as of June&#160;30, 2022 and December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common/collective trusts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Excludes $88 million and $70 million of other receivables at June&#160;30, 2022 and December&#160;31, 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="i4e0d80e2d0a04bb8927a1bf01c58fd6a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RleHRyZWdpb246ODJhOGE1ZjBhNGQwNGFlZTg2Njc0MzRhZjFlMjBiNzVfMTQzMw_58c5c6fb-3e4f-48db-b2a8-7868d637290a"
      unitRef="usd">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="i68271d4af0dd46f9a15ba39a24443504_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RleHRyZWdpb246ODJhOGE1ZjBhNGQwNGFlZTg2Njc0MzRhZjFlMjBiNzVfMTQzMw_6be40818-600e-491f-a3a9-e6b2951050cc"
      unitRef="usd">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RleHRyZWdpb246ODJhOGE1ZjBhNGQwNGFlZTg2Njc0MzRhZjFlMjBiNzVfMzExMw_2b3981bb-0b7e-487a-95a0-feba1be2c28a">Financial assets measured at fair value on a recurring basis on the unaudited condensed consolidated balance sheets at June&#160;30, 2022 and December&#160;31, 2021 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ib17cda40f9cf4d1a8490ee4268351419_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMi0xLTEtMS0xMjE3OTc_8fccbef1-12a4-4d1a-b6af-7fa8885dc398"
      unitRef="usd">7335000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i2537a5824e5c47d28dc9352ea4fb9b9a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMi0zLTEtMS0xMjE3OTc_a143495a-0f53-40e4-b285-0ff99b7ec1fe"
      unitRef="usd">4781000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i3b009077bf2641cfa4fee2b3ee3dc481_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMi01LTEtMS0xMjE3OTc_44cc5d89-6163-44a3-9a7c-48e86f943de4"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i4e0d80e2d0a04bb8927a1bf01c58fd6a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMi03LTEtMS0xMjE3OTc_84d365ed-bf84-42b3-afb2-f205bf9a205d"
      unitRef="usd">12116000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifc7e27d69ade4879bde348e70c0788ea_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNC0xLTEtMS0xMjE3OTc_fbc35e2c-1048-49f6-8f52-87912a26db54"
      unitRef="usd">2045000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic5106c4aa67f4d928a1bc9439a50bfb2_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNC0zLTEtMS0xMjE3OTc_cb38db53-8a3f-40c5-95fd-d40608cbc700"
      unitRef="usd">33000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2e7d19bf6cfd4b3b82ed5de057b0e6d8_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNC01LTEtMS0xMjE3OTc_86623238-1783-42ec-bf83-bf9d82e37e10"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6777146f89994be2b6bcda5d10742ac8_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNC03LTEtMS0xMjE3OTc_7ac66591-9f0f-4f61-a279-f63b18072b16"
      unitRef="usd">2078000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i08f072e891b342e49c41b996818d9499_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNS0xLTEtMS0xMjE3OTc_7a454223-13d1-472e-b79c-c216fa72ffa2"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9a25737ed0924c969ac800d03eb71168_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNS0zLTEtMS0xMjE3OTc_3d470049-3b68-42c7-bc08-c18cfe1759dc"
      unitRef="usd">2373000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9a1482c6ec9f4cc8b0730cd66f43a3cc_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNS01LTEtMS0xMjE3OTc_9a87df1e-79d6-4c2a-97ec-326c79a697f6"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i25ac6c0b47ec4e21b9505933348f0a1a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNS03LTEtMS0xMjE3OTc_e8e744bb-bc0c-412a-a989-faaa02ceecf6"
      unitRef="usd">2373000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i56d79a48fdda41359c90f5247d0eaa51_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNi0xLTEtMS0xMjE3OTc_4b4211dd-168b-4f60-87ba-4ac319f503f2"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7fa48deca1e24bc0aec94bbb86efcea6_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNi0zLTEtMS0xMjE3OTc_f2c83ad3-9e5f-41f4-ac62-fa5310d5156f"
      unitRef="usd">9169000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i594d6d7e7e934f9cb1e27dbd9405aea9_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNi01LTEtMS0xMjE3OTc_8fd53ffb-4100-4aa7-896c-689f13d3b82c"
      unitRef="usd">30000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifcaa01a2d5a84178a364e0771d58f1d2_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNi03LTEtMS0xMjE3OTc_c44f6097-9da8-4e4e-8cd9-35e6558583ea"
      unitRef="usd">9199000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i15029ba66bfc4f258fcf28f87b20183a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNy0xLTEtMS0xMjE3OTc_46e36d40-4308-4b41-8680-c36226144eca"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i906410efac8d4de18248e766580b4e35_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNy0zLTEtMS0xMjE3OTc_e9b362ed-533b-4483-9612-989d6a235b18"
      unitRef="usd">2623000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i835c385fd6b04a3eb891ef6fc524b805_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNy01LTEtMS0xMjE3OTc_23b0df61-e048-4005-9f47-bf52b1d4dfb7"
      unitRef="usd">8000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0aaf81e8b9884bad80414c289699a57f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfNy03LTEtMS0xMjE3OTc_4f1edc90-a861-4915-80a6-9c6903126a3e"
      unitRef="usd">2631000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i11805126295b4515b45903e544da225d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfOC0xLTEtMS0xMjE3OTc_37055541-523a-431b-827b-b39a0c3d00bd"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie9e16c082be94460bfbbd4e151ba7e34_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfOC0zLTEtMS0xMjE3OTc_85da8a88-0f67-4851-ba69-39e309f8a235"
      unitRef="usd">747000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i336d2e637e8649208863699c4fda08c2_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfOC01LTEtMS0xMjE3OTc_462cef56-89f3-4706-aa24-72fc9de87949"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i36599b795d654ff7b2fe314eced29657_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfOC03LTEtMS0xMjE3OTc_3857febc-3489-4d43-b2bf-3127852fedee"
      unitRef="usd">747000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7e0a0f734ebb45bdbb6cf4e33bdc5fb0_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfOS0xLTEtMS0xMjE3OTc_2f1369a2-f2cc-4ce5-ba65-772fc32a7b7f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8e86187a9ed44b89a6399da972fe5aa8_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfOS0zLTEtMS0xMjE3OTc_88cd285c-78a4-4f82-8b75-f9dfdfaec977"
      unitRef="usd">1108000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i782d4ad0930949dea0a47084e41c4d26_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfOS01LTEtMS0xMjE3OTc_91e80580-1736-43a6-aca9-5365a6245847"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia7299fe8524a4d5e9629da62ce398ea5_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfOS03LTEtMS0xMjE3OTc_2fa019de-5b48-4e35-aafe-257af9b5637a"
      unitRef="usd">1108000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i75184f7f66bf420281dc428b61486c9c_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTAtMS0xLTEtMTIxNzk3_d900edd6-8986-413e-bb5d-2b5a8ba21eb2"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4a23ab37e1624317a3210888b909e6ad_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTAtMy0xLTEtMTIxNzk3_c486f9f5-f409-4b35-8b3d-39dc1793efc3"
      unitRef="usd">2591000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1b4261e4da4b4593bd9444e957605d51_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTAtNS0xLTEtMTIxNzk3_c7d513b7-01db-4b13-9317-bcf58bbe43d0"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if5ac41f72364473b875a4f9f0cabfa01_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTAtNy0xLTEtMTIxNzk3_fe7bf8f2-37ad-4216-8f8c-5157a9618217"
      unitRef="usd">2591000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iebbf8ae6ec4b4ac7ba59ec1bf20f58c1_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTEtMS0xLTEtMTIxNzk3_4c3a6899-f206-48be-9aea-5451fdf4ebcd"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iaebca4c2d3aa45788b5006d29248062c_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTEtMy0xLTEtMTIxNzk3_8b8d191d-38a5-4f81-b7de-3a87227679a2"
      unitRef="usd">24000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i26cda38200ea4757af8c3ae23320d2dc_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTEtNS0xLTEtMTIxNzk3_2599278e-bcfa-461b-9fb3-be5efdd107d4"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8407bc5011ab4df18368ae6456978998_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTEtNy0xLTEtMTIxNzk3_5a5f2d30-8f22-4e43-aea5-85d64e0efd12"
      unitRef="usd">24000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib17cda40f9cf4d1a8490ee4268351419_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTItMS0xLTEtMTIxNzk3_edd71221-7afb-4e39-b1bc-832abd8f5edc"
      unitRef="usd">2045000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2537a5824e5c47d28dc9352ea4fb9b9a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTItMy0xLTEtMTIxNzk3_653de171-d717-4f02-9299-601c4665f571"
      unitRef="usd">18668000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3b009077bf2641cfa4fee2b3ee3dc481_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTItNS0xLTEtMTIxNzk3_48fee770-4a70-4ab2-9ba4-2ce6a3f7d5ea"
      unitRef="usd">38000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4e0d80e2d0a04bb8927a1bf01c58fd6a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTItNy0xLTEtMTIxNzk3_4fdf5514-bd87-440f-b4c6-38efd10ceb88"
      unitRef="usd">20751000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ib17cda40f9cf4d1a8490ee4268351419_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTMtMS0xLTEtMTIxNzk3_30b7c73d-ac53-440b-8e15-a86aef219c85"
      unitRef="usd">121000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i2537a5824e5c47d28dc9352ea4fb9b9a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTMtMy0xLTEtMTIxNzk3_89e6b7e3-c1de-4af9-a63b-207f39db6df6"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i3b009077bf2641cfa4fee2b3ee3dc481_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTMtNS0xLTEtMTIxNzk3_8b77444e-6aba-4490-8b51-5515e97feed0"
      unitRef="usd">68000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i4e0d80e2d0a04bb8927a1bf01c58fd6a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTMtNy0xLTEtMTIxNzk3_c516f11d-745d-458d-ab02-994d92dda2a1"
      unitRef="usd">189000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib17cda40f9cf4d1a8490ee4268351419_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTQtMS0xLTEtMTIxNzk3_41530072-28cc-4571-9fe5-2dbb845bb264"
      unitRef="usd">9501000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2537a5824e5c47d28dc9352ea4fb9b9a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTQtMy0xLTEtMTIxNzk3_5cbc20b1-8b3e-44e0-9aa0-ebf4181ce440"
      unitRef="usd">23449000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i3b009077bf2641cfa4fee2b3ee3dc481_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTQtNS0xLTEtMTIxNzk3_5bf1a151-4f62-4765-9e44-348bf4b8c5c6"
      unitRef="usd">106000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i4e0d80e2d0a04bb8927a1bf01c58fd6a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTQtNy0xLTEtMTIxNzk3_761da240-0fdf-45b0-94eb-6acd8f4f4263"
      unitRef="usd">33056000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i42bed7e3ca784f3ab32fc7ef56053fa3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTctMS0xLTEtMTIxNzk3_d1609af7-4de3-421f-a9f4-05e13d482e60"
      unitRef="usd">4954000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i642c16a915674d7daa7f0a01f6634e62_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTctMy0xLTEtMTIxNzk3_3dcea918-c366-4b12-8a56-0a7f6497c1b7"
      unitRef="usd">4454000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i04e6dfc862dc4741bba4eb830bd1fe1a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTctNS0xLTEtMTIxNzk3_ff56a638-2341-4a22-9e3c-70079fe0a85d"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i68271d4af0dd46f9a15ba39a24443504_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTctNy0xLTEtMTIxNzk3_66dfc3b2-6e40-4e6d-a141-a972f2c368e6"
      unitRef="usd">9408000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id2001a5cdcfe489587490f999c08e53d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTktMS0xLTEtMTIxNzk3_70d7a567-563d-41d2-9cb5-315be498341e"
      unitRef="usd">2372000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibb4d21f9607446baa96c4753b5ae4a2d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTktMy0xLTEtMTIxNzk3_b5fae4f7-0b73-420a-bf5c-11c4350e30bb"
      unitRef="usd">44000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib778b8c5692f4a2f9ce7ecd3827265b2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTktNS0xLTEtMTIxNzk3_44a9a0ae-ae5c-46a1-9622-e846a7fd4aca"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1b92e92046e3481c849127ba0d177b4f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMTktNy0xLTEtMTIxNzk3_1dc659f9-8b65-4a1b-a509-60c296cfbedc"
      unitRef="usd">2416000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1b390fc483eb4bf1bf3c1e193419740f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjAtMS0xLTEtMTIxNzk3_a7fcaf29-501d-45ea-8a5a-edcdbe738aa4"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i80bffbb65d2b4070a225a033d6ea55b0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjAtMy0xLTEtMTIxNzk3_8d93df92-b791-441c-b10e-7d45d93011c5"
      unitRef="usd">3086000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7bac9c5f699d457884697fc93aadabad_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjAtNS0xLTEtMTIxNzk3_bb8233c5-d42c-43fd-9b17-0ac3b7896ed3"
      unitRef="usd">5000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iab74b3b8e454421c9d99fd0fea4f8b5d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjAtNy0xLTEtMTIxNzk3_14373c72-13fe-4d22-9935-644ddb224cd7"
      unitRef="usd">3091000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i12831131b4b347d28cc365b3e2b5d442_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjEtMS0xLTEtMTIxNzk3_75e60a9b-dd1e-4852-845c-8fb97d842045"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i04bb2995006a4a4f88bcd1f2ea901a73_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjEtMy0xLTEtMTIxNzk3_01f81033-2c40-4534-99c6-73c805e3800f"
      unitRef="usd">9697000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iea75515a7ca440c2b48524fcb1053c9f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjEtNS0xLTEtMTIxNzk3_270ddc5d-21de-4752-bd30-238165923142"
      unitRef="usd">38000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie6de1349b73147148e1a6bc0dcb9232c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjEtNy0xLTEtMTIxNzk3_a6ff44b7-ff8a-4185-acc1-23c84e981b07"
      unitRef="usd">9735000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic4cf155fcd064bd8b37cde3d0bf8a683_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjItMS0xLTEtMTIxNzk3_b474b947-ec0d-4984-8d9a-b9778e173f30"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i52e238e983504ca6a0b5d0eca15be0f9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjItMy0xLTEtMTIxNzk3_66e42b71-2fb5-4256-863a-3c648ddb337a"
      unitRef="usd">2983000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if2d9b47f36c344a89eccfc77028e066b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjItNS0xLTEtMTIxNzk3_b5df7378-15cc-4727-9632-b5a7b55210e9"
      unitRef="usd">10000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9026e142a9d243c79099838b180bad0f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjItNy0xLTEtMTIxNzk3_f2e6296c-74b4-4c67-ab5a-e39ff8a463a3"
      unitRef="usd">2993000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i223e616c479846e7bcfb1b323650c580_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjMtMS0xLTEtMTIxNzk3_44c2ee16-6aca-4046-845f-fafe39389645"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i001fe54ef077469e82d46f274819777f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjMtMy0xLTEtMTIxNzk3_3289ebf6-8a6a-44a8-8f93-b5f8122f13d1"
      unitRef="usd">875000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2c084d4d05954ba4bad6546555d216b2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjMtNS0xLTEtMTIxNzk3_f1bfb67c-4989-44ee-8b72-01f5ccfc7043"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i904663f80f7d4ed8b9bdf80b571274b6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjMtNy0xLTEtMTIxNzk3_3a0c4ca7-0692-447a-8724-1ca6954ae8c7"
      unitRef="usd">875000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i29352f2ba2bb430fb7edf1a52db0a767_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjQtMS0xLTEtMTIxNzk3_3b8f2f0a-6603-4bba-b28e-68d639ee98ef"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i305ff43cd2da42f5837673228114f047_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjQtMy0xLTEtMTIxNzk3_52eeba17-6327-4e27-a24e-007a9f4558be"
      unitRef="usd">1310000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i01d4fc3347b34e62bd298927db4d1507_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjQtNS0xLTEtMTIxNzk3_5a90fc18-75c1-4341-8ae0-c09b0baac740"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7455e34409e849e09720b15bdb39ef0b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjQtNy0xLTEtMTIxNzk3_8ac43f7c-d23f-4f0d-86af-c7db6220599e"
      unitRef="usd">1310000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i712137052e06498fbf764dbfba45c5cd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjUtMS0xLTEtMTIxNzk3_600c1662-4f43-40fb-889d-d3c941859f5d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i82307e5c20bb45bdbfe5652fb891c9ec_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjUtMy0xLTEtMTIxNzk3_2eb34626-7ba4-494f-88a8-406ef5e211ce"
      unitRef="usd">2789000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i09b4f7cbd578419a9e93e1f9baaea718_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjUtNS0xLTEtMTIxNzk3_4e88ad30-0979-4572-a526-9218a1309dd1"
      unitRef="usd">3000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i443a171c4d9046c6998ec0e711b34fb7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjUtNy0xLTEtMTIxNzk3_9cb79c12-1363-4e81-be80-07dcc6848081"
      unitRef="usd">2792000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i84d6ff7bcaf644209c3df2eae876d580_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjYtMS0xLTEtMTIxNzk3_497400b5-9099-4e20-81c9-b69ba57a7496"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id8a0c11f7f38499ea3d96bb3423aa0f7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjYtMy0xLTEtMTIxNzk3_3a3106fe-14b5-45cf-ab0b-e96871411ab1"
      unitRef="usd">28000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie480043139dd4ff799c6c90efb44c767_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjYtNS0xLTEtMTIxNzk3_ca63f165-b1a3-4481-8b23-b3d23611505a"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1da882ac68a54dad9ccd7ec3d147e26a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjYtNy0xLTEtMTIxNzk3_54342151-fca2-4c31-b556-11b3cf097dd6"
      unitRef="usd">28000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i42bed7e3ca784f3ab32fc7ef56053fa3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjctMS0xLTEtMTIxNzk3_bc06fe42-44ee-43f6-8e01-1700ba2d2f9f"
      unitRef="usd">2372000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i642c16a915674d7daa7f0a01f6634e62_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjctMy0xLTEtMTIxNzk3_1c5a8e61-5184-41d6-b14a-e71b3260ef3a"
      unitRef="usd">20812000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i04e6dfc862dc4741bba4eb830bd1fe1a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjctNS0xLTEtMTIxNzk3_9713f9d7-c156-4521-9a49-ae2b7cb80bd8"
      unitRef="usd">56000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i68271d4af0dd46f9a15ba39a24443504_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjctNy0xLTEtMTIxNzk3_2947d018-35bb-4b4a-8ce6-5af32984570a"
      unitRef="usd">23240000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i42bed7e3ca784f3ab32fc7ef56053fa3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjgtMS0xLTEtMTIxNzk3_6baddb2a-5fee-468e-b135-31af1bf5ed4b"
      unitRef="usd">114000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i642c16a915674d7daa7f0a01f6634e62_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjgtMy0xLTEtMTIxNzk3_1b738491-c15b-4060-b255-1c59c3d0454d"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i04e6dfc862dc4741bba4eb830bd1fe1a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjgtNS0xLTEtMTIxNzk3_1216b808-3f51-47c2-b6cf-b47703c5dd19"
      unitRef="usd">55000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i68271d4af0dd46f9a15ba39a24443504_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjgtNy0xLTEtMTIxNzk3_e2338377-2d0a-4f85-bed7-2cb5c91ba804"
      unitRef="usd">169000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i42bed7e3ca784f3ab32fc7ef56053fa3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjktMS0xLTEtMTIxNzk3_28486afb-e907-4521-876d-cef6901fa526"
      unitRef="usd">7440000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i642c16a915674d7daa7f0a01f6634e62_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjktMy0xLTEtMTIxNzk3_e6e2fdb4-b683-43d2-8b45-276f38d38fcd"
      unitRef="usd">25266000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i04e6dfc862dc4741bba4eb830bd1fe1a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjktNS0xLTEtMTIxNzk3_02f2c03e-04c1-45d7-ac6c-8728bc80ee1d"
      unitRef="usd">111000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i68271d4af0dd46f9a15ba39a24443504_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmE4ZjQ2ZjRiODQ3MTRlZWRhYTk4YjcyYjU3OWNiMDcyL3RhYmxlcmFuZ2U6YThmNDZmNGI4NDcxNGVlZGFhOThiNzJiNTc5Y2IwNzJfMjktNy0xLTEtMTIxNzk3_b207ed5e-bf68-47f4-ab41-d24c5da6a47e"
      unitRef="usd">32817000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RleHRyZWdpb246ODJhOGE1ZjBhNGQwNGFlZTg2Njc0MzRhZjFlMjBiNzVfMjAzNA_453a602e-09bd-4a39-bb11-08812125b21b"
      unitRef="usd">26000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RleHRyZWdpb246ODJhOGE1ZjBhNGQwNGFlZTg2Njc0MzRhZjFlMjBiNzVfMTY0OTI2NzQ0NDg0Mg_4aa4545a-9b82-4f84-bd88-ef36d3a528fa"
      unitRef="usd">29000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RleHRyZWdpb246ODJhOGE1ZjBhNGQwNGFlZTg2Njc0MzRhZjFlMjBiNzVfMjA5NQ_338d79b4-18dd-41d8-853e-a72244ef2d56"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RleHRyZWdpb246ODJhOGE1ZjBhNGQwNGFlZTg2Njc0MzRhZjFlMjBiNzVfMjA5NQ_a888e03a-8702-48ba-b4e4-fda9947fd8c5"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RleHRyZWdpb246ODJhOGE1ZjBhNGQwNGFlZTg2Njc0MzRhZjFlMjBiNzVfMjA5NQ_dadfd571-3b1a-428d-a975-ba538d3d95a0"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RleHRyZWdpb246ODJhOGE1ZjBhNGQwNGFlZTg2Njc0MzRhZjFlMjBiNzVfMjA5NQ_e4765e96-5920-48cf-bb92-0ba143609388"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RleHRyZWdpb246ODJhOGE1ZjBhNGQwNGFlZTg2Njc0MzRhZjFlMjBiNzVfMzExNA_d03355ee-3cb5-491d-941d-ee707a1d9db8">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the unaudited condensed consolidated balance sheets at adjusted cost or contract value at June&#160;30, 2022 and December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;(1)It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies.</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="ib6f883902b9f4d569180bdd25d7ac485_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfNC0xLTEtMS0xMjE3OTc_5d1404df-7c0d-4af8-9688-54a4108aff7f"
      unitRef="usd">993000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="ie30f666179e54a5cb8e16248e2aa4dc6_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfNC0zLTEtMS0xMjE3OTc_87434b32-ce01-47ea-993c-9c89a9708ad5"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i509def96f3774f389ccb60611ef5b220_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfNC01LTEtMS0xMjE3OTc_579e063f-fe92-4f2e-931a-d4d67729655a"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i057d1d2e7dcf476caee443d101525a56_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfNC03LTEtMS0xMjE3OTc_8fa34794-bb37-4113-9ccc-21d44a4d445f"
      unitRef="usd">940000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i0e4863652a8d4786bda491af0f283e1f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfNC05LTEtMS0xMjE3OTc_260355c0-2f34-4e30-b081-c84f42cad227"
      unitRef="usd">940000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="ib6f883902b9f4d569180bdd25d7ac485_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfNS0xLTEtMS0xMjE3OTc_e2b6dc50-e0c5-455c-813d-1e07ab301f3d"
      unitRef="usd">183000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="ib6f883902b9f4d569180bdd25d7ac485_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfOC0xLTEtMS0xMjE3OTc_e4f1bce2-d9a8-40b5-a74b-983f73dd29bb"
      unitRef="usd">4000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="ie30f666179e54a5cb8e16248e2aa4dc6_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfOC0zLTEtMS0xMjE3OTc_517299d4-ecdf-4712-931c-bb74929b4c57"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i509def96f3774f389ccb60611ef5b220_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfOC01LTEtMS0xMjE3OTc_37fc4485-a4b0-4443-87c5-e65fc74b1e92"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i057d1d2e7dcf476caee443d101525a56_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfOC03LTEtMS0xMjE3OTc_75712d46-d1e3-4c15-97fe-d5f7d993e327"
      unitRef="usd">4000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i0e4863652a8d4786bda491af0f283e1f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfOC05LTEtMS0xMjE3OTc_1abdf6b6-5429-4d88-b146-35417b94fd27"
      unitRef="usd">4000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="ib6f883902b9f4d569180bdd25d7ac485_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfOS0xLTEtMS0xMjE3OTc_9226aeb1-e778-494d-81d3-f97ea731fe56"
      unitRef="usd">333000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="ie30f666179e54a5cb8e16248e2aa4dc6_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfOS0zLTEtMS0xMjE3OTc_82859617-ca9e-4531-bd0a-4774925a2fb2"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i509def96f3774f389ccb60611ef5b220_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfOS01LTEtMS0xMjE3OTc_44bd8bf8-896a-4b3f-aa65-004b49303d03"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i057d1d2e7dcf476caee443d101525a56_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfOS03LTEtMS0xMjE3OTc_1a293e99-6ba1-4f2a-9309-977e1cf5d1c6"
      unitRef="usd">317000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i0e4863652a8d4786bda491af0f283e1f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfOS05LTEtMS0xMjE3OTc_0d3567ea-39c3-4633-baa4-027e6a18b18b"
      unitRef="usd">317000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ib6f883902b9f4d569180bdd25d7ac485_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTAtMS0xLTEtMTIxNzk3_8ddc252c-ff86-45f3-add4-98d8d2b07af5"
      unitRef="usd">54816000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ie30f666179e54a5cb8e16248e2aa4dc6_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTAtMy0xLTEtMTIxNzk3_3e290d1f-ce17-400f-9e0e-1553e181f84a"
      unitRef="usd">51825000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i509def96f3774f389ccb60611ef5b220_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTAtNS0xLTEtMTIxNzk3_91202d7e-27c2-470a-acb0-d8a2c0dce77e"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i057d1d2e7dcf476caee443d101525a56_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTAtNy0xLTEtMTIxNzk3_d0184478-31c2-46b2-919d-26262cf54b02"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i0e4863652a8d4786bda491af0f283e1f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTAtOS0xLTEtMTIxNzk3_9b6da564-09c5-4a0d-903d-fbd1c5bdbbc2"
      unitRef="usd">51825000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="idf62033ec0a847bb91856b878b3b5184_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTQtMS0xLTEtMTIxNzk3_773a5176-7882-4b8d-9a58-16eaa68341f8"
      unitRef="usd">902000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i2abfa03cf0a34bb1a667090247c911ce_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTQtMy0xLTEtMTIxNzk3_a04509b9-73ed-437b-b7b5-dbd26f9c1fda"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i0393895e099248fca624d76479d72f73_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTQtNS0xLTEtMTIxNzk3_5970624b-9590-4184-957e-425c38aa1627"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="icda51f2bbf534c3b99bd90ca2ff4fc4a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTQtNy0xLTEtMTIxNzk3_5f48130f-5ddd-424d-abf9-98840d9ec2a3"
      unitRef="usd">907000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i950684090258490285b22303b8cbe92f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTQtOS0xLTEtMTIxNzk3_fca90ea0-fcaf-4c09-bc3d-8a790d3bd783"
      unitRef="usd">907000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="idf62033ec0a847bb91856b878b3b5184_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTUtMS0xLTEtMTIxNzk3_c785377c-a9b0-41eb-b7be-d26f7f2fde90"
      unitRef="usd">126000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="idf62033ec0a847bb91856b878b3b5184_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTgtMS0xLTEtMTIxNzk3_805ba973-d19e-48d7-8445-301bca14759a"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i2abfa03cf0a34bb1a667090247c911ce_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTgtMy0xLTEtMTIxNzk3_4d5a109a-a625-46df-a457-a9f54e9372d5"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i0393895e099248fca624d76479d72f73_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTgtNS0xLTEtMTIxNzk3_5be9c48c-5d25-4080-a47e-9fd0dc5bd734"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="icda51f2bbf534c3b99bd90ca2ff4fc4a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTgtNy0xLTEtMTIxNzk3_0cde29c8-f620-44c0-9def-800bd26138ef"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i950684090258490285b22303b8cbe92f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTgtOS0xLTEtMTIxNzk3_2ccfe8c9-b217-4174-8cad-5603467c44e8"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="idf62033ec0a847bb91856b878b3b5184_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTktMS0xLTEtMTIxNzk3_5414c4ca-7863-4820-8cd4-563fd2fdb164"
      unitRef="usd">336000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i2abfa03cf0a34bb1a667090247c911ce_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTktMy0xLTEtMTIxNzk3_c010fe92-4d19-4d29-8a76-e1098b9ff9c3"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i0393895e099248fca624d76479d72f73_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTktNS0xLTEtMTIxNzk3_d435ef35-5ec8-417d-9358-9da473ec66ff"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="icda51f2bbf534c3b99bd90ca2ff4fc4a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTktNy0xLTEtMTIxNzk3_0500f4a7-9af9-4434-93f1-23551643c18d"
      unitRef="usd">373000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i950684090258490285b22303b8cbe92f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMTktOS0xLTEtMTIxNzk3_99946eea-7ca2-48c9-93ab-b405fc16d6c4"
      unitRef="usd">373000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <us-gaap:DebtInstrumentFairValue
      contextRef="idf62033ec0a847bb91856b878b3b5184_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMjAtMS0xLTEtMTIxNzk3_f001a729-0d8c-4e48-b66f-b0b57c61ed9b"
      unitRef="usd">56176000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i2abfa03cf0a34bb1a667090247c911ce_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMjAtMy0xLTEtMTIxNzk3_e9ab7d99-392c-4e2b-aaf4-cc556a212b74"
      unitRef="usd">64157000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i0393895e099248fca624d76479d72f73_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMjAtNS0xLTEtMTIxNzk3_15bbce61-f3f3-43b9-bbcd-f8c4c010725b"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="icda51f2bbf534c3b99bd90ca2ff4fc4a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMjAtNy0xLTEtMTIxNzk3_934c1714-96de-4c42-8184-71e8bf503e79"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i950684090258490285b22303b8cbe92f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOmQwNWYwOTk0MGZmNDQ3YmU4NmU1NDdjY2U3MTlmYjM2L3RhYmxlcmFuZ2U6ZDA1ZjA5OTQwZmY0NDdiZTg2ZTU0N2NjZTcxOWZiMzZfMjAtOS0xLTEtMTIxNzk3_0667078f-3947-4cef-85f3-4605ec03c632"
      unitRef="usd">64157000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RleHRyZWdpb246ODJhOGE1ZjBhNGQwNGFlZTg2Njc0MzRhZjFlMjBiNzVfMzExMQ_4d8ec71a-04a4-41db-a2e5-b1d44f5328ac">Separate Accounts financial assets as of June&#160;30, 2022 and December&#160;31, 2021 were as follows:&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common/collective trusts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Excludes $88 million and $70 million of other receivables at June&#160;30, 2022 and December&#160;31, 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock>
    <us-gaap:SeparateAccountAssets
      contextRef="i1998c1f186304330af3b39bac43d0a2f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMi0yLTEtMS0xMjE3OTc_f90a8eca-692f-45b3-ba9c-09c1b6bb78d7"
      unitRef="usd">4000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="idc4896103e2847bfadabec9c0079aa36_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMi00LTEtMS0xMjE3OTc_7daf18cd-0b59-42fa-8202-7ca92e28de2c"
      unitRef="usd">178000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i09642d3a548b46338b4bb3f615251a26_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMi02LTEtMS0xMjE3OTc_671fc745-52fb-4819-96f7-9767f1b72a50"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i9170e75144bb41cd9ee98de35d2f8127_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMi04LTEtMS0xMjE3OTc_48fd9d3d-b3e0-47d0-9c9f-e6ee7d23d301"
      unitRef="usd">182000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i1401ca4c008547c2bac9543b488db12e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMi0xMC0xLTEtMTIxNzk3_42d283ab-c6a0-4e3c-aea7-f9e33cd09643"
      unitRef="usd">2000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i5ac71f0b9bb14e4092be832d41e515a8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMi0xMi0xLTEtMTIxNzk3_39961993-0bd8-46e6-afc7-92d7a0e04413"
      unitRef="usd">186000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ic46902baf4774da0b1d69a2251e4c766_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMi0xNC0xLTEtMTIxNzk3_742b9bd5-8d76-4876-9d86-3c5e250f6618"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ibbbe45adfefe4948a1c89879ea88f003_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMi0xNi0xLTEtMTIxNzk3_431fe8f6-6841-40fb-84a4-36a41075e17c"
      unitRef="usd">188000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i65512635d3f94fc399a6c13c4e5ca1a1_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMy0yLTEtMS0xMjE3OTc_df625a54-9dd6-422f-bbbd-dea2cd62b5e6"
      unitRef="usd">913000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i251231de7362453a940ab517a85970ae_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMy00LTEtMS0xMjE3OTc_3ce17f78-89f4-4199-b851-6c77e42930e3"
      unitRef="usd">2535000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i23f86f2cbd964ff2a810fd266595100f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMy02LTEtMS0xMjE3OTc_248b3058-d703-481a-b03b-1982faf2bc42"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i381f19e26d814d37904aee3ae800493b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMy04LTEtMS0xMjE3OTc_831124ad-ca9b-4936-a85d-6acd95bd893e"
      unitRef="usd">3448000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i407ded4af3924d31952fb5d080084da1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMy0xMC0xLTEtMTIxNzk3_80282477-085e-4efa-8fd6-c18286436917"
      unitRef="usd">1233000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="id23c11799c424d598c0c1ae0ab2929ba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMy0xMi0xLTEtMTIxNzk3_bafe2a15-4e6f-4fe7-b089-203444290544"
      unitRef="usd">3048000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i5c8d2dc2b8704580a1a172c856d29530_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMy0xNC0xLTEtMTIxNzk3_575d3e18-0801-418c-b676-7c790dfa5d71"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="iaf81bb9d192d4f34906afe0ca3308cca_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfMy0xNi0xLTEtMTIxNzk3_7d8265a9-f176-48f7-af2b-e30ac92c0548"
      unitRef="usd">4281000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i934c58db24df4f5b8e2df9a748e0ce3a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNC0yLTEtMS0xMjE3OTc_072bdc9f-243e-4b9d-be2c-3c23b0f2a1ec"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ie4c3e3b3b06443908af3ef65aa44ce1c_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNC00LTEtMS0xMjE3OTc_787d20a2-a626-4cab-b1e3-99edd39b9a9f"
      unitRef="usd">1000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i18c1dbf858274c46886b39848454543e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNC02LTEtMS0xMjE3OTc_37e0eb09-f4de-4371-8af6-4fbb0952058d"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i3eeede4806c04b8ca1b1515f91d2454f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNC04LTEtMS0xMjE3OTc_948ca431-464f-4386-9f06-b3b947d0737b"
      unitRef="usd">1000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ic3bcc189914f44dfbd6d8adba7da6648_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNC0xMC0xLTEtMTIxNzk3_c7ac1d41-88b1-4471-9435-568b4aa19ce9"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ida1294c97533481bbb71cc59e1332b94_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNC0xMi0xLTEtMTIxNzk3_5a2fb73f-13f9-4977-8d54-67ccd767e270"
      unitRef="usd">1000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i61b3ccbd720b4118afa39412212dd864_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNC0xNC0xLTEtMTIxNzk3_ec78de4d-c6a6-4824-a1e3-ab9b50681c31"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i74971ce242444f5b8eca08207bb3fd01_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNC0xNi0xLTEtMTIxNzk3_e2d3d2f2-ce95-451c-bb54-c080ed0b2c26"
      unitRef="usd">1000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ifde0481021814f2a9b9298bd03a46270_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNS0yLTEtMS0xMjE3OTc_a82c1af3-4008-4f42-bf87-da5b1c473787"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ia7f7b435750440efa12f3876d71ad127_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNS00LTEtMS0xMjE3OTc_8b0fba2e-4a3f-49f2-b42a-05f683655599"
      unitRef="usd">421000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="if94bb34cac0e45b4b0a4cf53c05b0d13_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNS02LTEtMS0xMjE3OTc_7f69e674-ac74-4769-9342-e6e8d9e9fb61"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i6df4f366580047d49b2e56046b8e7328_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNS04LTEtMS0xMjE3OTc_9347f121-2cb5-4ba8-a2f3-e8dd3192ddd8"
      unitRef="usd">421000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i3b49cf8f22064d1c891ff76da09969c1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNS0xMC0xLTEtMTIxNzk3_b3756774-69ff-4d33-9d42-d70dfc9052b2"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ie8a50f5f508f4a7b87e5542b0e6ffc42_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNS0xMi0xLTEtMTIxNzk3_d406b7e2-1ec9-43f9-8a80-cc0de477e5d2"
      unitRef="usd">547000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i1f56b0ef04ec4465adcf279a0c980a91_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNS0xNC0xLTEtMTIxNzk3_135eaa0b-75ed-47f1-8e8c-27af063787fc"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i1a5e52e8002f439e863f471f508bd973_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNS0xNi0xLTEtMTIxNzk3_95469a78-735a-4a34-b6bd-b8673965dbff"
      unitRef="usd">547000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ib17cda40f9cf4d1a8490ee4268351419_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNi0yLTEtMS0xMjE3OTc_93d5b95e-b9cd-4db9-8854-db7168cf1dbb"
      unitRef="usd">917000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i2537a5824e5c47d28dc9352ea4fb9b9a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNi00LTEtMS0xMjE3OTc_35b20670-928e-4a4b-824d-c5fdd4e45f01"
      unitRef="usd">3135000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i3b009077bf2641cfa4fee2b3ee3dc481_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNi02LTEtMS0xMjE3OTc_f33d917f-4f3e-4114-9958-98cde90ecb70"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i4e0d80e2d0a04bb8927a1bf01c58fd6a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNi04LTEtMS0xMjE3OTc_00010b0a-e0ea-4f52-83bf-30aa4c1d26b4"
      unitRef="usd">4052000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i42bed7e3ca784f3ab32fc7ef56053fa3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNi0xMC0xLTEtMTIxNzk3_15c4d0f4-3d0b-4121-930a-77a45ffc8324"
      unitRef="usd">1235000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i642c16a915674d7daa7f0a01f6634e62_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNi0xMi0xLTEtMTIxNzk3_8920c5ce-1680-4bc0-b5d5-fc8ef1095868"
      unitRef="usd">3782000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i04e6dfc862dc4741bba4eb830bd1fe1a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNi0xNC0xLTEtMTIxNzk3_c5163da2-2d6c-4d6a-a15b-480fb03a1de9"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i68271d4af0dd46f9a15ba39a24443504_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RhYmxlOjg2ZjBmYmE5OTE4MTQyZWNiYzU2NTY0ZmQ0ZmMzYzM2L3RhYmxlcmFuZ2U6ODZmMGZiYTk5MTgxNDJlY2JjNTY1NjRmZDRmYzNjMzZfNi0xNi0xLTEtMTIxNzk3_fe9b8cef-eb98-457b-8201-167a3e35bfcd"
      unitRef="usd">5017000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i03d9d5c763344a06ad0ba56859f58bcc_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RleHRyZWdpb246ODJhOGE1ZjBhNGQwNGFlZTg2Njc0MzRhZjFlMjBiNzVfMzAzNw_a86b7302-1a77-4042-aa48-76f183b3f07c"
      unitRef="usd">88000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i4b83284491314316be5282f5effb45cd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80My9mcmFnOjgyYThhNWYwYTRkMDRhZWU4NjY3NDM0YWYxZTIwYjc1L3RleHRyZWdpb246ODJhOGE1ZjBhNGQwNGFlZTg2Njc0MzRhZjFlMjBiNzVfMzA0NA_15db98d4-35cf-42b9-8fcd-0f0faa43cb1c"
      unitRef="usd">70000000</us-gaap:SeparateAccountAssets>
    <us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RleHRyZWdpb246YTY2NzhjYjEwZjM3NDYwMzk4YmRkMmYwMjY1OTFkZjlfMjA4NA_bbaac4cf-f6f4-4a77-97a3-5135947fed89">Health Care Costs Payable&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of the change in health care costs payable during the six months ended June&#160;30, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of the period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Components of incurred health care costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(666)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(709)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total incurred health care costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Premium deficiency reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of the period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Total incurred health care costs for the six months ended June&#160;30, 2022 and 2021 in the table above exclude (i) $5 million and $5 million, respectively, for premium deficiency reserves related to the Company&#x2019;s Medicaid products, (ii) $37 million and $27 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the unaudited condensed consolidated balance sheets and (iii) $221 million and $99 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the unaudited condensed consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s estimates of prior years&#x2019; health care costs payable decreased by $666 million and $709 million, respectively, in the six months ended June&#160;30, 2022 and 2021, because claims were settled for amounts less than originally estimated (i.e., the amount of claims incurred was lower than originally estimated), primarily due to lower health care cost trends as well as the actual claim submission time being faster than originally assumed (i.e., the Company&#x2019;s completion factors were higher than originally assumed) in estimating health care costs payable at the end of the prior year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2022, the Company&#x2019;s liabilities for the ultimate cost of (i) services rendered to the Company&#x2019;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid (collectively, &#x201c;IBNR&#x201d;) plus expected development on reported claims totaled approximately $8.0 billion. Substantially all of the Company&#x2019;s liabilities for IBNR plus expected development on reported claims at June&#160;30, 2022 related to the current year.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock>
    <us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RleHRyZWdpb246YTY2NzhjYjEwZjM3NDYwMzk4YmRkMmYwMjY1OTFkZjlfMjA3NA_bebc7cd6-1a80-4552-80ed-9a5a2513ad5a">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of the change in health care costs payable during the six months ended June&#160;30, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of the period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Components of incurred health care costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(666)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(709)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total incurred health care costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Premium deficiency reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of the period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;(1)Total incurred health care costs for the six months ended June&#160;30, 2022 and 2021 in the table above exclude (i) $5 million and $5 million, respectively, for premium deficiency reserves related to the Company&#x2019;s Medicaid products, (ii) $37 million and $27 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the unaudited condensed consolidated balance sheets and (iii) $221 million and $99 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the unaudited condensed consolidated balance sheets.</us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ica5caded5b9f40868f9db05f17444835_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMi0xLTEtMS0xMjE3OTc_a033e72d-b4ec-49aa-83a0-f16d2443ea21"
      unitRef="usd">8808000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i8454af9021ca47c98336dfba07097dc4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMi0zLTEtMS0xMjE3OTc_a98b4417-347f-4e1e-9fc4-044bd2de11a3"
      unitRef="usd">7936000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="ica5caded5b9f40868f9db05f17444835_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMy0xLTEtMS0xMjE3OTc_3919a351-5eab-4f5f-87a1-e6152b15e3d8"
      unitRef="usd">8000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i8454af9021ca47c98336dfba07097dc4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMy0zLTEtMS0xMjE3OTc_b82605e8-0193-4d8c-86f4-da9f14294f0d"
      unitRef="usd">10000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="ica5caded5b9f40868f9db05f17444835_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfNC0xLTEtMS0xMjE3OTc_a4faf8a6-bd87-4226-ab40-1ac9b9173806"
      unitRef="usd">8800000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i8454af9021ca47c98336dfba07097dc4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfNC0zLTEtMS0xMjE3OTc_328c25fc-4c08-4253-8a9e-409c81a63661"
      unitRef="usd">7926000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i824fe68acd534f1cb26fac7871f45022_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfNy0xLTEtMS0xMjE3OTc_4745c6f9-1d4f-4e5f-a308-15bf96e22f4d"
      unitRef="usd">35960000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i2c50d4663e7046e988ba0a3d936e983d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfNy0zLTEtMS0xMjE3OTc_3176c0b2-8bf4-49ad-a066-808abf2e50c8"
      unitRef="usd">32183000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i824fe68acd534f1cb26fac7871f45022_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfOC0xLTEtMS0xMjE3OTc_4be84953-c128-4c69-b0d7-bcfc3ea417ce"
      unitRef="usd">-666000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i2c50d4663e7046e988ba0a3d936e983d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfOC0zLTEtMS0xMjE3OTc_7903e470-ba9d-4c7c-9975-ddf2c53e9448"
      unitRef="usd">-709000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i824fe68acd534f1cb26fac7871f45022_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfOS0xLTEtMS0xMjE3OTc_837449ad-a339-41f0-9896-e6cee2bec780"
      unitRef="usd">35294000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i2c50d4663e7046e988ba0a3d936e983d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfOS0zLTEtMS0xMjE3OTc_805859d4-ef09-43eb-ad45-c2a183f85ced"
      unitRef="usd">31474000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i824fe68acd534f1cb26fac7871f45022_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMTEtMS0xLTEtMTIxNzk3_dc1b5546-6c14-4fce-9a02-87e605f80afb"
      unitRef="usd">26971000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i2c50d4663e7046e988ba0a3d936e983d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMTEtMy0xLTEtMTIxNzk3_e9964b12-1b26-4ad7-8a42-1eebaaf57b5e"
      unitRef="usd">24600000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i824fe68acd534f1cb26fac7871f45022_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMTItMS0xLTEtMTIxNzk3_749d91a0-25d3-4a52-bfa0-822db2ad6945"
      unitRef="usd">6732000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i2c50d4663e7046e988ba0a3d936e983d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMTItMy0xLTEtMTIxNzk3_87cb0b6c-ead0-425a-8e08-02cb2516492a"
      unitRef="usd">6409000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i824fe68acd534f1cb26fac7871f45022_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMTMtMS0xLTEtMTIxNzk3_95b5785b-8abd-4872-9703-8e19b99eff7c"
      unitRef="usd">33703000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i2c50d4663e7046e988ba0a3d936e983d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMTMtMy0xLTEtMTIxNzk3_96f3b4ca-8c49-4ad4-ac95-487e75e2fbf3"
      unitRef="usd">31009000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="i1581ff2350a744a6b1f3e0be5835a1dd_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMTQtMS0xLTEtMTIxNzk3_c85de03c-ca5d-4019-a31b-b9d6c47303ec"
      unitRef="usd">5000000</cvs:PremiumDeficiencyReserveLiability>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="i64773f23350843c69d9c79f2e715b95d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMTQtMy0xLTEtMTIxNzk3_868e7180-67de-4246-a721-de11015e47de"
      unitRef="usd">5000000</cvs:PremiumDeficiencyReserveLiability>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i1581ff2350a744a6b1f3e0be5835a1dd_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMTYtMS0xLTEtMTIxNzk3_ee9a57a2-933a-4ecd-b03a-3ccb5bb6b23a"
      unitRef="usd">10396000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i64773f23350843c69d9c79f2e715b95d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMTYtMy0xLTEtMTIxNzk3_d8c10435-02a3-4cf2-b99b-7dba323df937"
      unitRef="usd">8396000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i1581ff2350a744a6b1f3e0be5835a1dd_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMTctMS0xLTEtMTIxNzk3_0479f9b9-c0ac-4492-bc8f-5172846667a6"
      unitRef="usd">4000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i64773f23350843c69d9c79f2e715b95d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMTctMy0xLTEtMTIxNzk3_720a1754-da3d-4ede-a2aa-31b4186f5f04"
      unitRef="usd">18000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i1581ff2350a744a6b1f3e0be5835a1dd_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMTgtMS0xLTEtMTIxNzk3_5062a5fd-a104-4ce0-8a8f-d951120e6709"
      unitRef="usd">10400000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i64773f23350843c69d9c79f2e715b95d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RhYmxlOmE5MTFiZmFmNGVkNTQxNjNiZWM2ZmQ0MzNhNTU0ZWFlL3RhYmxlcmFuZ2U6YTkxMWJmYWY0ZWQ1NDE2M2JlYzZmZDQzM2E1NTRlYWVfMTgtMy0xLTEtMTIxNzk3_049b8194-1b5d-432c-8de6-f333398154a8"
      unitRef="usd">8414000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="i1581ff2350a744a6b1f3e0be5835a1dd_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RleHRyZWdpb246YTY2NzhjYjEwZjM3NDYwMzk4YmRkMmYwMjY1OTFkZjlfMjc2_c85de03c-ca5d-4019-a31b-b9d6c47303ec"
      unitRef="usd">5000000</cvs:PremiumDeficiencyReserveLiability>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="i64773f23350843c69d9c79f2e715b95d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RleHRyZWdpb246YTY2NzhjYjEwZjM3NDYwMzk4YmRkMmYwMjY1OTFkZjlfMjgz_868e7180-67de-4246-a721-de11015e47de"
      unitRef="usd">5000000</cvs:PremiumDeficiencyReserveLiability>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="i1c0bcd0eebfa40769648a67be75183aa_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RleHRyZWdpb246YTY2NzhjYjEwZjM3NDYwMzk4YmRkMmYwMjY1OTFkZjlfMzgz_1bb19cb6-2117-453d-95a3-1e09020c6360"
      unitRef="usd">37000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="i856f8df36f55432cba11d2c1b2e7ba4e_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RleHRyZWdpb246YTY2NzhjYjEwZjM3NDYwMzk4YmRkMmYwMjY1OTFkZjlfMzkw_ba294fba-75d8-4a70-9efb-65526dbd4d08"
      unitRef="usd">27000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="i633068dab92e4b98b0522d78e950565e_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RleHRyZWdpb246YTY2NzhjYjEwZjM3NDYwMzk4YmRkMmYwMjY1OTFkZjlfNTg0_f1e63fef-9a62-4319-8b2c-5558185651a2"
      unitRef="usd">221000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="id563d585f536458ab16c7d10eb546a54_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RleHRyZWdpb246YTY2NzhjYjEwZjM3NDYwMzk4YmRkMmYwMjY1OTFkZjlfNTkx_3a54c37b-2a5e-4ce7-b007-7bf4ae450482"
      unitRef="usd">99000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i824fe68acd534f1cb26fac7871f45022_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RleHRyZWdpb246YTY2NzhjYjEwZjM3NDYwMzk4YmRkMmYwMjY1OTFkZjlfMTE1MQ_4be84953-c128-4c69-b0d7-bcfc3ea417ce"
      unitRef="usd">-666000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i2c50d4663e7046e988ba0a3d936e983d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RleHRyZWdpb246YTY2NzhjYjEwZjM3NDYwMzk4YmRkMmYwMjY1OTFkZjlfMTE1OA_7903e470-ba9d-4c7c-9975-ddf2c53e9448"
      unitRef="usd">-709000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80Ni9mcmFnOmE2Njc4Y2IxMGYzNzQ2MDM5OGJkZDJmMDI2NTkxZGY5L3RleHRyZWdpb246YTY2NzhjYjEwZjM3NDYwMzk4YmRkMmYwMjY1OTFkZjlfMTkzMQ_0f6c223c-7bd5-4df6-8c14-eb77f1e0b4d4"
      unitRef="usd">8000000000</us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGV4dHJlZ2lvbjoxZTY4Y2QxYjk0NTk0MzY2YmY1YTdiY2EwM2I5ODVlOF8zMjk4NTM0ODg3ODcx_33c8f423-6dc4-4322-a716-c5d7188ba974">Borrowings&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the Company&#x2019;s borrowings at June&#160;30, 2022 and December&#160;31, 2021: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5% senior notes due July 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.75% senior notes due November 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.75% senior notes due December 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.75% senior notes due December 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8% senior notes due June 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4% senior notes due December 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.375% senior notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.625% senior notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5% senior notes due November 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5% senior notes due December 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.1% senior notes due March 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.875% senior notes due July 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.875% senior notes due June 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3% senior notes due August 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.625% senior notes due April 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.25% senior notes due June 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3% senior notes due August 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.3% senior notes due March 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.25% senior notes due August 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.75% senior notes due April 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.75% senior notes due August 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.875% senior notes due February 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.125% senior notes due September 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.875% senior notes due July 2035&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.625% senior notes due June 2036&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.75% senior notes due December 2037&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.78% senior notes due March 2038&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.125% senior notes due September 2039&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due April 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.7% senior notes due August 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.75% senior notes due May 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.5% senior notes due May 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due November 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.3% senior notes due December 2043&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.75% senior notes due March 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.125% senior notes due July 2045&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.875% senior notes due August 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.05% senior notes due March 2048&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.25% senior notes due April 2050&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81Mi0wLTEtMS0xMzcyNzU_6dc679d2-e622-45de-819a-6f36bb88bc8b"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81Mi0wLTEtMS0xMzcyNzU_7cf3c139-629e-4185-b686-0b6e8760e74e"&gt;Finance lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total debt principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Debt premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Debt discounts and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(740)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(786)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-term Borrowings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2022, the Company exercised the par call option on its outstanding 3.5% senior notes due July 2022 and redeemed for cash on hand the entire $1.5&#160;billion aggregate principal amount. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 15, 2022, the Company announced that it will exercise the par call option on its outstanding 2.75% senior notes due November 2022 (issued by Aetna Inc.) and will redeem for cash on hand the entire $1.0&#160;billion aggregate principal amount. The redemption is expected to occur on or about August 15, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 2, 2022, the Company announced that it will exercise the par call options on its outstanding 2.75% senior notes due December 2022 and 4.75% senior notes due December 2022 (including the unexchanged notes issued by Omnicare, Inc.) and will redeem for cash on hand the entire $1.25&#160;billion and $399&#160;million aggregate principal amounts, respectively. The redemptions are expected to occur on or about September 1, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGV4dHJlZ2lvbjoxZTY4Y2QxYjk0NTk0MzY2YmY1YTdiY2EwM2I5ODVlOF8zMjk4NTM0ODg3ODcy_28a5d297-7cdf-4d4b-8931-488b0efdccff">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the Company&#x2019;s borrowings at June&#160;30, 2022 and December&#160;31, 2021: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5% senior notes due July 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.75% senior notes due November 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.75% senior notes due December 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.75% senior notes due December 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8% senior notes due June 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4% senior notes due December 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.375% senior notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.625% senior notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5% senior notes due November 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5% senior notes due December 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.1% senior notes due March 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.875% senior notes due July 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.875% senior notes due June 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3% senior notes due August 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.625% senior notes due April 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.25% senior notes due June 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3% senior notes due August 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.3% senior notes due March 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.25% senior notes due August 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.75% senior notes due April 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.75% senior notes due August 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.875% senior notes due February 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.125% senior notes due September 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.875% senior notes due July 2035&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.625% senior notes due June 2036&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.75% senior notes due December 2037&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.78% senior notes due March 2038&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.125% senior notes due September 2039&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due April 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.7% senior notes due August 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.75% senior notes due May 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.5% senior notes due May 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due November 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.3% senior notes due December 2043&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.75% senior notes due March 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.125% senior notes due July 2045&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.875% senior notes due August 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.05% senior notes due March 2048&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.25% senior notes due April 2050&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81Mi0wLTEtMS0xMzcyNzU_6dc679d2-e622-45de-819a-6f36bb88bc8b"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81Mi0wLTEtMS0xMzcyNzU_7cf3c139-629e-4185-b686-0b6e8760e74e"&gt;Finance lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total debt principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Debt premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Debt discounts and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(740)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(786)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i701dfcde341042418a1230e58dfc107c_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xMi0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjpmYWZjYzE0YmZiNzE0YTViOTY1ZjE1ZWNkMGNmZTM0NF8xMDk5NTExNjI3ODEw_516959f3-6ea7-4b2b-ad03-cb73f174c823"
      unitRef="number">0.035</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i701dfcde341042418a1230e58dfc107c_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xMi0xLTEtMS0xMzcyNzU_2c3563f8-599b-47f0-b873-d51d8b577a6b"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib7e9c49d1afb41528f0c6f58ad82f91c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xMi0zLTEtMS0xMzcyNzU_d32ac60c-42a9-4cc0-bc61-76f70d312552"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i19ce665e627349488d7fdabbb5fd4f0c_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xMy0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo0ZjAxNmNiM2UwOWE0NWVkOTAxNjhiMDg3ZDNlN2RiNF8xMDk5NTExNjI3ODIx_b14351f3-2aa2-4665-ba20-a1f5aa3b0c33"
      unitRef="number">0.0275</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i19ce665e627349488d7fdabbb5fd4f0c_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xMy0xLTEtMS0xMzcyNzU_45c7c7ee-8180-4f6c-bd0a-814ad8d6c9c7"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if9e4fce0f5914bc194df0543a8fb78c7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xMy0zLTEtMS0xMzcyNzU_5c553894-d754-4393-9cd6-63f4e122e473"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4945c0919f8a4b6fa67244e6df69a8e3_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xNC0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo1NjNkMmJhNjgyYzE0NTc3YmZkMmMzNzMxYWJlOWUxYl8xMDk5NTExNjI3ODIx_2eadc095-9dbe-412f-bca7-486aab93b69f"
      unitRef="number">0.0275</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i4945c0919f8a4b6fa67244e6df69a8e3_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xNC0xLTEtMS0xMzcyNzU_385d272a-db1e-4b68-9d0d-b48019e0e148"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i79481fe5600c4d29829c7063ced8237b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xNC0zLTEtMS0xMzcyNzU_3c2c9cb0-f591-48c6-a14f-a3d05fd2dc8d"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i33b68889734a4fe89dcb2fdde065e999_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xNS0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo0MDg3NTNkMmQ3YWI0YmYyYjU0YTQ5OGNjZWE4MzE2YV8xMDk5NTExNjI3ODIx_9a557561-60c8-416a-9bb6-f7534b70c6f9"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i33b68889734a4fe89dcb2fdde065e999_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xNS0xLTEtMS0xMzcyNzU_5561de0b-9a59-4303-a3a9-d19e5c1054a1"
      unitRef="usd">399000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3a07ca981e96452699ccf6cc1296a094_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xNS0zLTEtMS0xMzcyNzU_f4b69283-d375-441c-af06-b05a9c9ad14a"
      unitRef="usd">399000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6f28d0a871b74ccabed8651290f5df32_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xNy0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo2YjI2N2RmOTU4MWI0MmYyODM5MDliZjk1NmZlZmJhNV8xMDk5NTExNjI3ODE1_45d24637-dee2-4e6d-b2a9-5dfff0572124"
      unitRef="number">0.028</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6f28d0a871b74ccabed8651290f5df32_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xNy0xLTEtMS0xMzcyNzU_f95f0189-09e0-4aab-a3fc-b4b12b2fb628"
      unitRef="usd">1300000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8b27b79528fa4d33895a9b7b0532c5a8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xNy0zLTEtMS0xMzcyNzU_fb3edcf0-f90e-4cc7-9220-52af52191e04"
      unitRef="usd">1300000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if5743e3b67ba46fa843ceef9c280ed2d_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xOC0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjoxNWM3ZWM3Mzc2Y2M0ZTNhYTk3OGQ5ZmY1MWYwZmFhMl8xMDk5NTExNjI3ODE1_e3223a16-b592-4e4f-94fe-afdf23fe961e"
      unitRef="number">0.04</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if5743e3b67ba46fa843ceef9c280ed2d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xOC0xLTEtMS0xMzcyNzU_8239aadd-77a2-4c75-9cf7-a36bccf018f4"
      unitRef="usd">414000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i699c54fc3b714c6282acce7eaaac6c49_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xOC0zLTEtMS0xMzcyNzU_2c96c516-e205-40c5-9781-57b5f82c9ac4"
      unitRef="usd">414000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i29c21f5958d54c94a3300a81499e844e_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xOS0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo1OTI1ODZhMThkMjY0MjAwYmJhNTQyMjViOWMyZDI4YV8xMDk5NTExNjI3ODIx_14c7b651-41b7-4476-aa4b-d575b90e1cae"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i29c21f5958d54c94a3300a81499e844e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xOS0xLTEtMS0xMzcyNzU_540257fa-b88f-4878-a256-81d017114c27"
      unitRef="usd">650000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i89b3c50e60c94e5287f35e0966dd4a3c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8xOS0zLTEtMS0xMzcyNzU_5c16d1d1-bf05-41f2-8892-f640e714c090"
      unitRef="usd">650000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i34f2be9f895b466e96b08a69c1310ab7_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yMC0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjpjZmYxMzlhZThhZjU0NDIwOWM0ZDM3ZjE5MmE1NDMwYV8xMDk5NTExNjI3ODIx_4d3595fe-eff7-4c1e-ad8d-d45ecae8a6fa"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i34f2be9f895b466e96b08a69c1310ab7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yMC0xLTEtMS0xMzcyNzU_091e5313-1582-4f01-934c-ff9a17b0a6f9"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i57483b066e9f454b8904cd684a7f0427_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yMC0zLTEtMS0xMzcyNzU_8f5a8265-764b-414c-8747-70eae87e203b"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic48a061167f048b8902603753dfa8e1d_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yMS0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjoyNzNmN2NiMzA4MTY0NWI5OTA5NmZlNjZmZDFjMjJjYV8xMDk5NTExNjI3ODE5_f76ae7a1-b847-4afc-9b03-c4aac3708ed2"
      unitRef="number">0.035</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic48a061167f048b8902603753dfa8e1d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yMS0xLTEtMS0xMzcyNzU_ee17e182-c303-4abb-8b62-2ff44b799444"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i51fd94c18b494791a8946f4cfd11cca6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yMS0zLTEtMS0xMzcyNzU_46dad562-96c7-4c99-ad0e-51f002017e1e"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id5da825f37b64596bcfb8830bb18cb6c_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yMi0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjowYWZiY2FiMDJhYTA0N2M0Yjk5NmVkZDk4NzgwNDQ5N18xMDk5NTExNjI3ODE1_2e6abeb0-67b3-429a-ab84-63ef502401c5"
      unitRef="number">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id5da825f37b64596bcfb8830bb18cb6c_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yMi0xLTEtMS0xMzcyNzU_d4dc2494-3c5d-46ef-a94d-1e1a8b96bf80"
      unitRef="usd">299000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if4ce44f679934429824ee090659496ff_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yMi0zLTEtMS0xMzcyNzU_33f0c78a-64d2-4e29-890c-72edcafbfb01"
      unitRef="usd">299000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="idda7e364fedc4373a6c04d2aa621c990_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yMy0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjphNDIzNjFiYTc5MjI0MTk5YmM5YWJhZjFkODBmNDhkYV8xMDk5NTExNjI3ODE2_eab61242-1728-4a74-8a80-56cdd6018098"
      unitRef="number">0.041</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="idda7e364fedc4373a6c04d2aa621c990_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yMy0xLTEtMS0xMzcyNzU_b8bd04e5-8fe1-424c-9417-9b7d7912b885"
      unitRef="usd">950000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i5c3bc22603f14476908cfe99fc1875c6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yMy0zLTEtMS0xMzcyNzU_cd40934e-6159-4b2c-bab9-2d809794bf0b"
      unitRef="usd">950000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia9a0e60b49f44f1f9e50e8a2f21e126a_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yNC0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo2MzgyY2IyMWQ3MWM0NzFkOTY0OGQwZjdjMWZmNGFjNV8xMDk5NTExNjI3ODE5_a8fc5a21-94d3-4c74-99d7-0a706894e60d"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia9a0e60b49f44f1f9e50e8a2f21e126a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yNC0xLTEtMS0xMzcyNzU_b3ce6f3a-3b8e-4a2c-b4a5-0974c375df9c"
      unitRef="usd">2828000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i5609b04c209d4d23814975183321bf8d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yNC0zLTEtMS0xMzcyNzU_ee0e3f10-8c88-4198-aaf5-72c854d23e6f"
      unitRef="usd">2828000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i29521c68c83d45fbafda3ca446e28ad6_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yNS0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo1NGE0MjY3ZjU0NWI0ZDEwYjc5ZmMyOGQ4MjVhNzg1Yl8xMDk5NTExNjI3ODE5_ead422cb-60f6-4c2a-b958-3cdec3d91c8f"
      unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i29521c68c83d45fbafda3ca446e28ad6_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yNS0xLTEtMS0xMzcyNzU_39194eda-6f7e-4c6f-951d-09633dbd81a6"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i00f8ab37e94f47c5b959adc2fc05d1e4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yNS0zLTEtMS0xMzcyNzU_bd592f67-8872-4ec6-a2c8-375f757ed03f"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i125e9ebb582747fc928d86e8183d5250_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yNi0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjpmNDMxOWNjNWZjMDI0MTNkOWIxZmZkYzQ3MmMwZDIxOV8xMDk5NTExNjI3ODEz_044b7270-3f69-41b0-831e-9e704aa4711f"
      unitRef="number">0.03</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i125e9ebb582747fc928d86e8183d5250_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yNi0xLTEtMS0xMzcyNzU_b24b6fe2-b7d8-4ab2-a3a0-439ac967db1d"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if34ad8df01784ccd9c09e77e8c83abb0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yNi0zLTEtMS0xMzcyNzU_9ad09597-4b6f-498f-a426-c8b2b6ebd691"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0c9846afea30440f955cec9041311ebb_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yNy0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo3MGM4ZmE2MmIyNDQ0NjU2YjRiYWY1YmJhOWI0MWMxOV8xMDk5NTExNjI3ODIw_e40139cb-b37a-4573-bac4-bef63f5ca105"
      unitRef="number">0.03625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i0c9846afea30440f955cec9041311ebb_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yNy0xLTEtMS0xMzcyNzU_869ebeb5-c28b-4ebf-ae0b-c5808d3076a4"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic44e6bc4ca52465abc641a71fd0e3162_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yNy0zLTEtMS0xMzcyNzU_0b9ea5e9-eef7-47b9-b830-7ad3b77eafdb"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2ef356dda5d1479b89006e9da3a6fafd_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yOC0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo4Yjg0ZmRmMDE1Mjk0ZjM1YjhmOWRiZThkZjQ2YTQyOF8xMDk5NTExNjI3ODE3_94dd9854-f418-47a8-9a84-2a55043fca9f"
      unitRef="number">0.0625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2ef356dda5d1479b89006e9da3a6fafd_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yOC0xLTEtMS0xMzcyNzU_36c10a12-4744-4667-8b0f-e0942f6cfd14"
      unitRef="usd">372000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if1bfd120dbe14e73916b7c46067dcc30_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yOC0zLTEtMS0xMzcyNzU_7fb4fa3f-a186-43b6-b89e-cca1281cc8f6"
      unitRef="usd">372000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i200e92b399884866831aa7f66216c0b6_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yOS0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo2MzU0NGZjOTlhN2Y0YmViOGFhNGExNzRhOTU3Y2UwNl8xMDk5NTExNjI3ODE3_daecb0b0-3459-403a-be1c-c76f6bd6444b"
      unitRef="number">0.013</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i200e92b399884866831aa7f66216c0b6_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yOS0xLTEtMS0xMzcyNzU_8406ebdd-3e15-43b5-8514-03dba1669424"
      unitRef="usd">2250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i725dc7730e3249c58e3e72c65a8ed7bd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8yOS0zLTEtMS0xMzcyNzU_3e7324e9-5b5e-4076-b66b-e5824c310b99"
      unitRef="usd">2250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iccf871c8fb35430d92796d1f0d0c146d_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zMC0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjpjYmQwZTQ1MDFkNWU0MTdkYjQzMGFlOWEzZTZmN2FiNV8xMDk5NTExNjI3ODE2_1ee5703d-c154-4378-bceb-4d0a6e3c0a78"
      unitRef="number">0.043</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iccf871c8fb35430d92796d1f0d0c146d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zMC0xLTEtMS0xMzcyNzU_7a1c8203-23f1-48bd-bf6e-b52fccfa47b5"
      unitRef="usd">5000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="idf8670b729d642d49a6f047b3de3020e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zMC0zLTEtMS0xMzcyNzU_63616454-80c9-4fd1-b191-d622e2b62a05"
      unitRef="usd">5000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id7257e80fe294cf89f6d21eb9a5a160b_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zMS0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjowMTc1ODE4ZTQzNGE0YmRjYjU5YzU1NmJlYWI5YTQ4YV8xMDk5NTExNjI3ODE5_d15ce988-49ae-4860-92b9-6041db81a4cb"
      unitRef="number">0.0325</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id7257e80fe294cf89f6d21eb9a5a160b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zMS0xLTEtMS0xMzcyNzU_f2a93238-ebc8-486b-879c-9061bb147a78"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3d68ec8cafb8440b922b87a639652d7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zMS0zLTEtMS0xMzcyNzU_4e735268-03f1-43d9-a4b2-020073d93d10"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ibd128b7c8158440a960fc33fff1e4942_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zMi0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjoyMTI0NTRjMjM2MjM0ZDc4ODRjZWRlOGNkYTc5NTQwYl8xMDk5NTExNjI3ODE4_f6334bf7-0dbe-417e-ad84-fa8967da4ff5"
      unitRef="number">0.0375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ibd128b7c8158440a960fc33fff1e4942_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zMi0xLTEtMS0xMzcyNzU_c678b724-ba6e-41df-a92d-422cea7d0bb8"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="icec9e0e991cc4516851d6f09627a471c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zMi0zLTEtMS0xMzcyNzU_cce3145e-180d-497d-a1bf-7badbcab285a"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8d97a719154d42e589f04dcc38484757_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zMy0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjplOGYzNTRjMWIyNDM0NjdlYWU4MzgxZWYzMWU0NDA3Nl8xMDk5NTExNjI3ODE5_22dac1ea-a46b-4a46-ace8-6f636c5fd3ac"
      unitRef="number">0.0175</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8d97a719154d42e589f04dcc38484757_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zMy0xLTEtMS0xMzcyNzU_831f4d90-4a1d-4b3a-a86a-f6ed94ad76f8"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7df071c343834f33b524951050d6f51a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zMy0zLTEtMS0xMzcyNzU_b5005dd4-b5d7-4f52-81bf-adc2552503f7"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ifdaae87a3e8b4e53973b84b8af214010_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zNC0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo2NWY4YmVhNjgxNDQ0YzNlOGMzNmU1NDk0NjAxMzQ3NV8xMDk5NTExNjI3ODIz_453b38c2-2448-40f8-802c-4345e54b6e06"
      unitRef="number">0.01875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ifdaae87a3e8b4e53973b84b8af214010_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zNC0xLTEtMS0xMzcyNzU_7d6fe93f-e915-4724-a435-141c4690f2d8"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9226a82fc64641d5afdd7ffa2c292e4c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zNC0zLTEtMS0xMzcyNzU_098dbc82-a325-4c87-9cbe-370f87074ab5"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie67b1016381d45dfb701cb39cb97655b_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zNS0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjpkY2RhMjYxMjllOTQ0YzQxYjgzZWY2MjQ0YWZhYzlhOV8xMDk5NTExNjI3ODI0_15caaba2-af03-4801-830b-e6c8cebb7525"
      unitRef="number">0.02125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie67b1016381d45dfb701cb39cb97655b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zNS0xLTEtMS0xMzcyNzU_21769282-6cac-4701-ac71-9420fabd55a0"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if2abdfe43d904e9b927694acb3cd4cf8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zNS0zLTEtMS0xMzcyNzU_a49b608f-6b84-4ce4-8632-baa895c05cc0"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i944da40b07b447d0a332880d0b588a20_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zNi0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjpmODgyNDM3ZDAxNGU0YzMwOGZjMTFlNGFjZTI0MzZiOF8xMDk5NTExNjI3ODE5_f76a26de-b9ed-4c43-a76f-a6982f123051"
      unitRef="number">0.04875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i944da40b07b447d0a332880d0b588a20_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zNi0xLTEtMS0xMzcyNzU_6d736227-28ae-4afc-94ce-2f02c77e4c53"
      unitRef="usd">652000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i914306c1134948118679d384eef61fbd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zNi0zLTEtMS0xMzcyNzU_8d7eee0f-ddb3-4ff0-9ef0-5e57480423ae"
      unitRef="usd">652000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i643fea13573a45d8afeeb8de059866ed_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zNy0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjphZTI5ODRhY2M2Yzc0ZjI0YTAxMzJkY2ViNzQ2MDIxNF8xMDk5NTExNjI3ODE5_c1546dfd-44e5-4cab-a67f-43b0e2ecbd47"
      unitRef="number">0.06625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i643fea13573a45d8afeeb8de059866ed_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zNy0xLTEtMS0xMzcyNzU_8f8be4bf-8a74-47c8-b0e1-6b245b872ff2"
      unitRef="usd">771000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie286fcf256214324826f57573776deaf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zNy0zLTEtMS0xMzcyNzU_70c34dc0-0b97-4cea-af84-b044c13fb439"
      unitRef="usd">771000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie598796a91a246aaa0c09f9f30782bd0_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zOC0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo5NTg1ZjJkZDExNDc0M2JhYjBiMDNjNDEwYzY0NGNiNF8xMDk5NTExNjI3ODIx_79eed786-5e5c-4bf1-9401-71d6911d456f"
      unitRef="number">0.0675</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie598796a91a246aaa0c09f9f30782bd0_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zOC0xLTEtMS0xMzcyNzU_558afcdc-0877-4d18-89c7-c20dea107584"
      unitRef="usd">533000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i361edf6919cf4676b09461ea7e67b84c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zOC0zLTEtMS0xMzcyNzU_2e8da922-6303-4719-aff8-215f561b4747"
      unitRef="usd">533000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i65284b80f9764f99aa6e1e0c3d28922b_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zOS0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjozNmNkZDE2ODg3Mzg0OThhOWNlZTEwYzIxZWM2NWM4YV8xMDk5NTExNjI3ODE4_717f6949-d1bf-43c1-a967-02cb1ca84494"
      unitRef="number">0.0478</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i65284b80f9764f99aa6e1e0c3d28922b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zOS0xLTEtMS0xMzcyNzU_290c5322-cb35-4882-83b4-ad34c9008649"
      unitRef="usd">5000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i205b6c2b07564953a06f503cc5b37037_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV8zOS0zLTEtMS0xMzcyNzU_5c0ebd92-74f8-45c4-bfd0-4e421f8653ac"
      unitRef="usd">5000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="idf399710257743edb37384ff227cd40d_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80MC0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjpjZjQ5MTU2MjFiY2Q0YTJlYjQxMGVmZGNiOTNhNjk0ZF8xMDk5NTExNjI3ODI2_a36c62cb-35d4-4351-95e5-7e25b224cccb"
      unitRef="number">0.06125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="idf399710257743edb37384ff227cd40d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80MC0xLTEtMS0xMzcyNzU_9ef60489-f72a-465d-b14e-e5b954da81ed"
      unitRef="usd">447000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if5ed3b12e6eb4e059b0259b94de90f3d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80MC0zLTEtMS0xMzcyNzU_f30dfdea-ed9f-415b-8d51-6ebac1faebc7"
      unitRef="usd">447000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id26f0bd9ad2d415ea77a3ab3ae626afc_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80MS0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo2ODgwNTI5NzZkNDE0Mzk1OTViMzViMmZhYTRhZmRmMF8xMDk5NTExNjI3ODIw_a1003cbb-73bf-47fe-bec8-41146de5d792"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id26f0bd9ad2d415ea77a3ab3ae626afc_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80MS0xLTEtMS0xMzcyNzU_aa0f391f-e5bd-498d-b501-747db88778d3"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i56de23d883344a9a927ab5a974600a0b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80MS0zLTEtMS0xMzcyNzU_422c3b4a-de84-41f0-b1d4-c4fa75276993"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i40305c3253a242ff97d2746b2a513a69_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80Mi0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjpmMTk4MDhhNjRlNWQ0ZWNkYjg4M2FlYzU5OTQ4YzM4NF8xMDk5NTExNjI3ODE3_e8cdbaa8-1ae3-45c1-beca-6a36d89bea7d"
      unitRef="number">0.027</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i40305c3253a242ff97d2746b2a513a69_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80Mi0xLTEtMS0xMzcyNzU_845b0fd1-45d7-416f-a962-c591e17e57a6"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic138ff07b2f94c0cadf208f70bb6e79d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80Mi0zLTEtMS0xMzcyNzU_65fcfd06-8df8-4a5e-995e-e09d804ad8fd"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="icecf2da3a842413c965e457894528023_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80My0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjpkYTdiZTVjOTc2ZGY0ZDgxYjBmNjkyMzU1YmVhYmY4ZV8xMDk5NTExNjI3ODE2_f4ab8e01-1076-4264-902a-39bb8e49141a"
      unitRef="number">0.0575</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="icecf2da3a842413c965e457894528023_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80My0xLTEtMS0xMzcyNzU_e94e7fc0-c3c1-40fa-ba37-294f3a99abfb"
      unitRef="usd">133000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i166e8b849a1145b5905209025edd018e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80My0zLTEtMS0xMzcyNzU_5b381f6a-b856-4c8f-afd0-c4a62713d00c"
      unitRef="usd">133000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0a7c0b54785745fe9adc93c9cf289db1_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80NC0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjpiMzllYzc4ODZjNGY0ZjE3YTY1MzZmNDJmOTBiNWQ5YV8xMDk5NTExNjI3ODE0_7899f4ca-29cc-4ad2-9468-60ce25ea7566"
      unitRef="number">0.045</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i0a7c0b54785745fe9adc93c9cf289db1_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80NC0xLTEtMS0xMzcyNzU_b58dffb6-38a0-4c32-9c77-5ba1b9d38c2b"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i764dca86272443deb0bce7cb4b41e0e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80NC0zLTEtMS0xMzcyNzU_85256875-b850-410b-a7c7-b4d7d5eff19b"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ice00869200514840821cf7cc694e3133_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80NS0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjpmZDU0MWU1NWNiN2I0N2IyOWUzMTcxNzkxODM0NGQ2MF8xMDk5NTExNjI3ODIz_a14761be-4e8e-48c8-9c4b-96451bc284a7"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ice00869200514840821cf7cc694e3133_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80NS0xLTEtMS0xMzcyNzU_05076aa1-893f-43be-8a2b-4cfc2fb160f5"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i614fbc67bf9144ee9a0deb06e9032f2e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80NS0zLTEtMS0xMzcyNzU_ba17c043-8fb8-4fa4-a898-7b5948437b8e"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ifdf41bb2bcd94610b70c6a62ce138649_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80Ni0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjpiNTEzOWJhY2E3NTY0NzdmYmYwYThjNGVmMDFjM2ZkOV8xMDk5NTExNjI3ODE5_3bdb1adf-6125-46b3-a4f0-9ee1d6a963db"
      unitRef="number">0.053</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ifdf41bb2bcd94610b70c6a62ce138649_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80Ni0xLTEtMS0xMzcyNzU_315d046d-b40d-4213-b898-ce06285843d3"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i4cae7a6a82104f61a0553383911b0094_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80Ni0zLTEtMS0xMzcyNzU_49a46e59-5743-4a3d-9a20-7d99a57c96c1"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i28e511837f134fd4a0d69cfe195fae71_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80Ny0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo4NTU0OTkwZjFmOGY0YWVhOGQ5NTAzMTQzOGIwYjg5Nl8xMDk5NTExNjI3ODE4_986743f6-3aec-42f4-b988-1c0223c913ae"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i28e511837f134fd4a0d69cfe195fae71_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80Ny0xLTEtMS0xMzcyNzU_0399e343-5e11-4dcc-b167-2a09f5d18826"
      unitRef="usd">375000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ibae772bc2bae4e5ea9db4081c2e4001b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80Ny0zLTEtMS0xMzcyNzU_6359b51c-c56a-4108-ac6d-3f5cd555a7d4"
      unitRef="usd">375000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie084c2a7344c420c92ae9437d7ab6be3_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80OC0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo2YjBhOGU5MDUxMDU0M2VkODgxZGM4Y2JhZTFlYjM2Nl8xMDk5NTExNjI3ODE5_89022144-2efa-4009-ba7a-6d868e8fca28"
      unitRef="number">0.05125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie084c2a7344c420c92ae9437d7ab6be3_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80OC0xLTEtMS0xMzcyNzU_b2f906e2-54db-4602-b2d6-8a04c4a58c67"
      unitRef="usd">3500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia31d9e274a59413bb7895e1b77158660_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80OC0zLTEtMS0xMzcyNzU_ef2be768-0366-480a-a6b6-7c836b785552"
      unitRef="usd">3500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ibd7eb609f3b14fac8983caa6c096c01d_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80OS0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjpkMDQ0YWRhMDAzNGM0YzgyYWNkNDVhNTU4M2Y4ZmZhY18xMDk5NTExNjI3ODIx_6e7f9835-df44-462c-8f86-21196c77502b"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ibd7eb609f3b14fac8983caa6c096c01d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80OS0xLTEtMS0xMzcyNzU_35f9393a-abdc-4428-8ab9-a5dab35d92ea"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3acd7c3b5f134957ac35694bfa158c39_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV80OS0zLTEtMS0xMzcyNzU_37d7317a-6353-419c-934c-a94f353626b6"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i43811273ae184613adc9bb723848272a_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81MC0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjpjZmVmMjE2ZTc0MzA0N2U1YTNhYzI3NTJjNDgwMTA3Yl8xMDk5NTExNjI3ODE4_590efc8e-432f-40e3-8f0a-2de5cf661c56"
      unitRef="number">0.0505</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i43811273ae184613adc9bb723848272a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81MC0xLTEtMS0xMzcyNzU_093c717b-03b0-41ea-8409-e0e839e680b7"
      unitRef="usd">8000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i959c954325ef4865add18451ad9d7a29_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81MC0zLTEtMS0xMzcyNzU_636bd684-0293-4487-a92e-459a80ae2832"
      unitRef="usd">8000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie9bfff97b8b648908d79cc9a4159b298_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81MS0wLTEtMS0xMzcyNzUvdGV4dHJlZ2lvbjo1ZDY1MDQ1MjY0Nzc0NzAwOGE4YjRhODc0NzQxOTEyZF8xMDk5NTExNjI3ODE4_fde571b8-e48f-4ac0-94b6-6e9448ada834"
      unitRef="number">0.0425</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie9bfff97b8b648908d79cc9a4159b298_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81MS0xLTEtMS0xMzcyNzU_6a8895d1-af0a-4bf8-8dcc-799e1b799c9d"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic19ab2f397f34a8585e736896e24aeed_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81MS0zLTEtMS0xMzcyNzU_60bc1285-3331-4209-a323-4620e5e01513"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:FinanceLeaseLiability
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81Mi0xLTEtMS0xMzcyNzU_5071bf57-ab68-4c78-ad4e-0aac900332e3"
      unitRef="usd">1407000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81Mi0zLTEtMS0xMzcyNzU_7b9855be-2731-4b0a-95bf-017964778705"
      unitRef="usd">1300000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i015bc34a65a248e3a70847c5c7052cc6_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81My0xLTEtMS0xMzcyNzU_c8f30a83-d9a0-441c-8d46-a5401edfa48c"
      unitRef="usd">316000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib4d2a19a3df4491a9d4ada04059faf42_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81My0zLTEtMS0xMzcyNzU_6e1c29b2-596b-411c-9385-996d4cb31806"
      unitRef="usd">320000000</us-gaap:DebtInstrumentCarryingAmount>
    <cvs:LongtermDebtGrossAndLeaseObligation
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81NC0xLTEtMS0xMzcyNzU_87ef0334-d5f9-4b8a-90b2-b718eb2415a2"
      unitRef="usd">55346000000</cvs:LongtermDebtGrossAndLeaseObligation>
    <cvs:LongtermDebtGrossAndLeaseObligation
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81NC0zLTEtMS0xMzcyNzU_8be68c84-17c9-49ae-8aa4-eff172fc032e"
      unitRef="usd">56743000000</cvs:LongtermDebtGrossAndLeaseObligation>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81NS0xLTEtMS0xMzcyNzU_a0b1d525-fc1b-4406-8007-5407592c0c72"
      unitRef="usd">210000000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81NS0zLTEtMS0xMzcyNzU_67871774-150c-4391-880a-14f1188a441c"
      unitRef="usd">219000000</us-gaap:DebtInstrumentUnamortizedPremium>
    <cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81Ni0xLTEtMS0xMzcyNzU_cac1507e-9178-4565-a51f-68874f9a0592"
      unitRef="usd">740000000</cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet>
    <cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81Ni0zLTEtMS0xMzcyNzU_2e0c8615-1862-4b8b-898c-b85a7d90d461"
      unitRef="usd">786000000</cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81Ny0xLTEtMS0xMzcyNzU_e4af97f3-a2f3-474d-a3d1-69089dc4458b"
      unitRef="usd">54816000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV81Ny0zLTEtMS0xMzcyNzU_69a2a445-61a1-4644-a3eb-aa40c96a92a3"
      unitRef="usd">56176000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV82MC0xLTEtMS0xMzcyNzU_69b55644-ba50-4619-8222-50c0c30f609d"
      unitRef="usd">4019000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV82MC0zLTEtMS0xMzcyNzU_c6890c39-8662-4f67-8fe9-22da256fbe9a"
      unitRef="usd">4205000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV82MS0xLTEtMS0xMzcyNzU_d0782b20-83f9-4fba-a0c8-19b555b08932"
      unitRef="usd">50797000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i8af9eeada4aa4390a7aabb67f310e776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGFibGU6NTdiMWM3MTM4N2NlNDhiZTlkMDQ3YzljY2NlZWRlN2EvdGFibGVyYW5nZTo1N2IxYzcxMzg3Y2U0OGJlOWQwNDdjOWNjY2VlZGU3YV82MS0zLTEtMS0xMzcyNzU_4db575ba-083c-4712-aad2-745aea920635"
      unitRef="usd">51971000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2b2cb684c3c54456b798887d44f26f18_I20220531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGV4dHJlZ2lvbjoxZTY4Y2QxYjk0NTk0MzY2YmY1YTdiY2EwM2I5ODVlOF84MjQ2MzM3MjEzMTgw_2ee49ef1-6842-424f-b569-be872083c2be"
      unitRef="number">0.035</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="if2a4890c67364387b34caac671f1ecb8_D20220501-20220531"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGV4dHJlZ2lvbjoxZTY4Y2QxYjk0NTk0MzY2YmY1YTdiY2EwM2I5ODVlOF84MjQ2MzM3MjEzMjE4_a4df868e-f3b6-48e1-8757-3964198f11a7"
      unitRef="usd">1500000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if35632f79478444b837b68f876c276d3_I20220815"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGV4dHJlZ2lvbjoxZTY4Y2QxYjk0NTk0MzY2YmY1YTdiY2EwM2I5ODVlOF8zODQ4MjkwNzAzNTUz_8879be95-f4d9-4b1b-8b56-a8f9b3850a38"
      unitRef="number">0.0275</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i4f8c724d4dc244c0b8cca96a9f405f4d_D20220815-20220815"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGV4dHJlZ2lvbjoxZTY4Y2QxYjk0NTk0MzY2YmY1YTdiY2EwM2I5ODVlOF82NTk3MDY5NzcyOTYx_b16ec0d7-0705-44f7-8aac-52191642bcac"
      unitRef="usd">1000000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ide236c65d7b9413da75bda41de2407e0_I20220901"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGV4dHJlZ2lvbjoxZTY4Y2QxYjk0NTk0MzY2YmY1YTdiY2EwM2I5ODVlOF8zODQ4MjkwNzA0MzEw_7d781d65-f591-475d-b6af-b843dfad2968"
      unitRef="number">0.0275</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ibd92c38e037f41c19fc207220bcc0c98_I20220901"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGV4dHJlZ2lvbjoxZTY4Y2QxYjk0NTk0MzY2YmY1YTdiY2EwM2I5ODVlOF8zODQ4MjkwNzA0MzE3_03473677-755a-4d50-987e-140e42350315"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i5fbafbf9ebe841209a93040e930d5b09_D20220901-20220901"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGV4dHJlZ2lvbjoxZTY4Y2QxYjk0NTk0MzY2YmY1YTdiY2EwM2I5ODVlOF8zODQ4MjkwNzA0MzI0_276104c9-0a5e-4496-b5ff-7c7fe7919fae"
      unitRef="usd">1250000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i6838b42fbf54414d9a3aa4b32a3784cc_D20220901-20220901"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8xMjA0L2ZyYWc6MWU2OGNkMWI5NDU5NDM2NmJmNWE3YmNhMDNiOTg1ZTgvdGV4dHJlZ2lvbjoxZTY4Y2QxYjk0NTk0MzY2YmY1YTdiY2EwM2I5ODVlOF8zODQ4MjkwNzA0MzM5_edbfcea9-0dc5-448f-abc5-65e62af5969e"
      unitRef="usd">399000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMjQ5Ng_9776bdf5-6ff2-4ab0-ada5-0eac480e8a2f">Shareholders&#x2019; Equity&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share Repurchases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following share repurchase program has been authorized by CVS Health Corporation&#x2019;s Board of Directors (the &#x201c;Board&#x201d;):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In billions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Authorization&#160;Date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Authorized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Remaining as of&lt;br/&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 9, 2021 (&#x201c;2021 Repurchase Program&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2021 Repurchase Program permits the Company to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase (&#x201c;ASR&#x201d;) transactions, and/or other derivative transactions. The 2021 Repurchase Program can be modified or terminated by the Board at any time.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the six months ended June&#160;30, 2022, the Company repurchased approximately 19.1 million shares of common stock for approximately $2.0 billion pursuant to the 2021 Repurchase Program, including share repurchases under the ASR transaction described below. During the six months ended June&#160;30, 2021, the Company did not repurchase any shares of its common stock. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the authorization under the 2021 Repurchase Program, the Company entered into a $1.5&#160;billion fixed dollar ASR with Barclays Bank PLC (&#x201c;Barclays&#x201d;). Upon payment of the $1.5&#160;billion purchase price on January 4, 2022, the Company received a number of shares of CVS Health Corporation&#x2019;s common stock equal to 80% of the $1.5&#160;billion notional amount of the ASR or approximately 11.6&#160;million shares at a price of $103.34 per share, which were placed into treasury stock in January 2022. The ASR was accounted for as an initial treasury stock transaction for $1.2&#160;billion and a forward contract for $0.3&#160;billion. The forward contract was classified as an equity instrument and was recorded within capital surplus. In February 2022, the Company received approximately 2.7&#160;million shares of CVS Health Corporation&#x2019;s common stock, representing the remaining 20% of the $1.5&#160;billion notional amount of the ASR, thereby concluding the ASR. These shares were placed into treasury stock and the forward contract was reclassified from capital surplus to treasury stock in February 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At the time they were received, the initial and final receipt of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted average common shares outstanding for basic and diluted earnings per share.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The quarterly cash dividend declared by the Board was $0.55 and $0.50 per share in the three months ended June&#160;30, 2022 and 2021, respectively. Cash dividends declared by the Board were $1.10 and $1.00 per share in the six months ended June&#160;30, 2022 and 2021, respectively. CVS Health Corporation has paid cash dividends every quarter since becoming a public company. Future dividend payments will depend on the Company&#x2019;s earnings, capital requirements, financial condition and other factors considered relevant by the Board.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfTreasuryStockByClassTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMjQ4MA_5aaea866-7ade-4e4b-ad27-49b3835a6b7b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following share repurchase program has been authorized by CVS Health Corporation&#x2019;s Board of Directors (the &#x201c;Board&#x201d;):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In billions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Authorization&#160;Date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Authorized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Remaining as of&lt;br/&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 9, 2021 (&#x201c;2021 Repurchase Program&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfTreasuryStockByClassTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i2788e339558c49d4ad5e9a5ed3686ef7_I20211209"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RhYmxlOjFhYzQzMTIyYzYxMDQ2NjI4Y2RiNDEzZjEyMDkxNWIyL3RhYmxlcmFuZ2U6MWFjNDMxMjJjNjEwNDY2MjhjZGI0MTNmMTIwOTE1YjJfMS0xLTEtMS0xMjE3OTc_5e60e603-f162-4c2a-af89-da9ae9ca1e6f"
      unitRef="usd">10000000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i973e6ae6f5664668812730f3574e2681_I20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RhYmxlOjFhYzQzMTIyYzYxMDQ2NjI4Y2RiNDEzZjEyMDkxNWIyL3RhYmxlcmFuZ2U6MWFjNDMxMjJjNjEwNDY2MjhjZGI0MTNmMTIwOTE1YjJfMS0zLTEtMS0xMjE3OTc_b687dffe-66ee-4f12-a193-c00b4ea94808"
      unitRef="usd">8000000000.0</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ibf2ba7a1f37c43a2a329487ba4c8244a_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfNTkx_315fd505-248e-4535-97e2-f37cd37d7ae1"
      unitRef="shares">19100000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ibf2ba7a1f37c43a2a329487ba4c8244a_D20220101-20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfNjM1_fe743280-6b6d-4c21-a9e9-42428a6e9018"
      unitRef="usd">2000000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfNzk3_b07794c8-e40d-49ff-9bce-a6b82eade611"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <cvs:AcceleratedShareRepurchasesAgreementAmount
      contextRef="i6f0054d90f614171a2cdaff45560ffaa_I20220104"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfOTM4_7c362552-58d4-4fa1-a468-c9f401e452d9"
      unitRef="usd">1500000000</cvs:AcceleratedShareRepurchasesAgreementAmount>
    <cvs:PaymentsForAcceleratedShareRepurchasesAmount
      contextRef="id032d7a1b06a4edbb4e66d3c58ec984a_D20220104-20220104"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMTAxNQ_1adebeff-5656-4a03-8a05-b95be76e0721"
      unitRef="usd">1500000000</cvs:PaymentsForAcceleratedShareRepurchasesAmount>
    <cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares
      contextRef="i6f0054d90f614171a2cdaff45560ffaa_I20220104"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMTE0Mw_1869cf48-19fe-4fc4-958c-bdd3ed8fdef4"
      unitRef="number">0.80</cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares>
    <cvs:AcceleratedShareRepurchasesAgreementAmount
      contextRef="i6f0054d90f614171a2cdaff45560ffaa_I20220104"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMTE1Mw_ab98af33-9e05-4165-b921-963e9986f96f"
      unitRef="usd">1500000000</cvs:AcceleratedShareRepurchasesAgreementAmount>
    <cvs:AcceleratedShareRepurchasesNumberOfSharesRepurchased
      contextRef="i6f0054d90f614171a2cdaff45560ffaa_I20220104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMTIwMA_58635991-de45-4d79-9285-c81ceda1a261"
      unitRef="shares">11600000</cvs:AcceleratedShareRepurchasesNumberOfSharesRepurchased>
    <us-gaap:SharePrice
      contextRef="i6f0054d90f614171a2cdaff45560ffaa_I20220104"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMTIyNA_7c71a74a-327f-402d-8be7-8250adc18d94"
      unitRef="usdPerShare">103.34</us-gaap:SharePrice>
    <cvs:TransferOfSharesToTreasuryStockValue
      contextRef="i6f0054d90f614171a2cdaff45560ffaa_I20220104"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMTM2NA_f922dea8-e6d4-41d4-931d-49bdd19f8e6c"
      unitRef="usd">1200000000</cvs:TransferOfSharesToTreasuryStockValue>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id9b2681d79b94d2f9857c1c1e9cd12d4_I20220104"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMTM5NA_d9504c9b-5b98-4cf8-bff8-45e25e0c18ea"
      unitRef="usd">300000000</us-gaap:DerivativeNotionalAmount>
    <cvs:AcceleratedShareRepurchasesNumberOfSharesRepurchased
      contextRef="i03eba332a9884f289cf2750b5c9cbf14_I20220228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMTU1Mg_ec03059a-4fb6-4549-8917-e372effbf061"
      unitRef="shares">2700000</cvs:AcceleratedShareRepurchasesNumberOfSharesRepurchased>
    <cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram
      contextRef="i03eba332a9884f289cf2750b5c9cbf14_I20220228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMTYzMQ_2e8ad4e7-f778-45b1-8324-debf5347b07c"
      unitRef="number">0.20</cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram>
    <cvs:AcceleratedShareRepurchasesAgreementAmount
      contextRef="i03eba332a9884f289cf2750b5c9cbf14_I20220228"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMTY0MQ_ae20ceda-f882-4b25-90eb-6446dc8352b4"
      unitRef="usd">1500000000</cvs:AcceleratedShareRepurchasesAgreementAmount>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMjE1MQ_32566879-3cbe-4150-8a0f-6fc8abc0572e"
      unitRef="usdPerShare">0.55</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMjE1OA_12f996a0-f75d-412c-9b13-8bdb03d4ba95"
      unitRef="usdPerShare">0.50</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMTY0OTI2NzQ0NDM1NQ_61c3aafe-5814-43fb-a060-4f4b01d634bc"
      unitRef="usdPerShare">1.10</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV80OS9mcmFnOjMxNjdiNDhiZDBhYzRhYzE5ZGM0OWIwMTY2NjMwYTFiL3RleHRyZWdpb246MzE2N2I0OGJkMGFjNGFjMTlkYzQ5YjAxNjY2MzBhMWJfMTY0OTI2NzQ0NDM2Mg_aaa71b2c-267e-4f5f-8a6e-5b785881147e"
      unitRef="usdPerShare">1.00</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RleHRyZWdpb246MjkyZGE5MTM2NDRjNGU2MjkzMTkxY2VhZjJiNjk2OWNfNzk5_1ed7ca9e-6090-4a89-b844-10e565cc6521">Other Comprehensive Income&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shareholders&#x2019; equity included the following activity in accumulated other comprehensive income (loss) for the three and six months ended June&#160;30, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net unrealized investment gains (losses):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(377)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;$(1,105), $214, $(2,510), $(273) pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(868)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($77, $(18), $154, $(1) pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(813)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,968)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign currency translation adjustments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($24, $0, $24, $0 pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(4), $(4), $(8), $(9) pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension and other postretirement benefits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($1, $1, $1, $1 pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total beginning of period accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,953)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total end of period accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(988)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(988)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income (loss) for specifically identified debt securities are included in net investment income in the unaudited condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included in interest expense in the unaudited condensed consolidated statements of operations. The Company expects to reclassify approximately&#160;$11 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.&lt;/span&gt;&lt;/div&gt;(3)Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the unaudited condensed consolidated statements of operations.</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RleHRyZWdpb246MjkyZGE5MTM2NDRjNGU2MjkzMTkxY2VhZjJiNjk2OWNfNzg0_eae43be8-a5aa-4fc1-bdfa-343a133e3022">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shareholders&#x2019; equity included the following activity in accumulated other comprehensive income (loss) for the three and six months ended June&#160;30, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net unrealized investment gains (losses):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(377)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;$(1,105), $214, $(2,510), $(273) pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(868)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($77, $(18), $154, $(1) pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(813)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,968)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign currency translation adjustments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($24, $0, $24, $0 pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(4), $(4), $(8), $(9) pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension and other postretirement benefits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($1, $1, $1, $1 pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total beginning of period accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,953)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total end of period accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(988)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(988)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income (loss) for specifically identified debt securities are included in net investment income in the unaudited condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included in interest expense in the unaudited condensed consolidated statements of operations. The Company expects to reclassify approximately&#160;$11 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.&lt;/span&gt;&lt;/div&gt;(3)Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the unaudited condensed consolidated statements of operations.</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8f44bafd8b514e13885650b83df2cba5_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMy0xLTEtMS0xMjE3OTc_701921ea-5701-4901-8e41-f5a765ad24c2"
      unitRef="usd">-377000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i672c8f5d9c8f451eb39619a46f51f47f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMy0zLTEtMS0xMjE3OTc_e295de33-13de-49fb-a100-581d72a36ceb"
      unitRef="usd">828000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2f9c15723eaf4a9eadcf03b852b70db2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMy01LTEtMS0xMjE3OTc_5cae2ac6-be64-4edb-b49d-9c21413ad007"
      unitRef="usd">778000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i490d91efebc0468298a0da610cc516c9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMy03LTEtMS0xMjE3OTc_4f1d4f23-4e6b-49c0-8a6e-983100677a1e"
      unitRef="usd">1214000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i7519dbaef94443449eecd8f162669ec1_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNC0wLTEtMS0xMjE3OTcvdGV4dHJlZ2lvbjplNzQ3MGQ2ZWFlMzI0MTEzOWI5ZjlmZWJjMDFiY2JkMl81NQ_7a77edc5-b8ca-45e0-b011-887840f3e160"
      unitRef="usd">-1105000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i8ca72ce1ba034c0c9c20ad0f3602947d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNC0wLTEtMS0xMjE3OTcvdGV4dHJlZ2lvbjplNzQ3MGQ2ZWFlMzI0MTEzOWI5ZjlmZWJjMDFiY2JkMl82Mg_4048dfdc-4d2f-4d06-87a4-507a66d92556"
      unitRef="usd">214000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ib125e54cf2b14e81ac89b10807680e76_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNC0wLTEtMS0xMjE3OTcvdGV4dHJlZ2lvbjplNzQ3MGQ2ZWFlMzI0MTEzOWI5ZjlmZWJjMDFiY2JkMl8xMDk5NTExNjI3ODUw_ef59801f-298c-4c91-87ca-76c7b3cd0187"
      unitRef="usd">-2510000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i57a873f503fb43408df28140ea310d0d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNC0wLTEtMS0xMjE3OTcvdGV4dHJlZ2lvbjplNzQ3MGQ2ZWFlMzI0MTEzOWI5ZjlmZWJjMDFiY2JkMl8xMDk5NTExNjI3ODU5_1da0b7d0-fa04-4621-aa6a-e6074c29f6a6"
      unitRef="usd">-273000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i7519dbaef94443449eecd8f162669ec1_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNC0xLTEtMS0xMjE3OTc_57723e3e-abba-4fee-b9e2-b62307a69638"
      unitRef="usd">-868000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i8ca72ce1ba034c0c9c20ad0f3602947d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNC0zLTEtMS0xMjE3OTc_193605e9-a5c0-4d59-a902-e97f79489202"
      unitRef="usd">164000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ib125e54cf2b14e81ac89b10807680e76_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNC01LTEtMS0xMjE3OTc_ae5434b1-eb50-4b70-b5a5-a819eeba81a8"
      unitRef="usd">-2098000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i57a873f503fb43408df28140ea310d0d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNC03LTEtMS0xMjE3OTc_c1232ec0-401d-4651-8f18-ba26b25371c1"
      unitRef="usd">-236000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i7519dbaef94443449eecd8f162669ec1_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNS0wLTEtMS0xMjE3OTcvdGV4dHJlZ2lvbjo2NDJmNzU1ZTE2YWU0MWM4YTQ1NmQ4YWU2YzU0NDdlNl83MA_1d277bfb-96b2-41d8-ba2b-915998952e5a"
      unitRef="usd">77000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i8ca72ce1ba034c0c9c20ad0f3602947d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNS0wLTEtMS0xMjE3OTcvdGV4dHJlZ2lvbjo2NDJmNzU1ZTE2YWU0MWM4YTQ1NmQ4YWU2YzU0NDdlNl83Nw_ac4dd25b-580c-4d4f-9685-6e1fc375696d"
      unitRef="usd">-18000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ib125e54cf2b14e81ac89b10807680e76_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNS0wLTEtMS0xMjE3OTcvdGV4dHJlZ2lvbjo2NDJmNzU1ZTE2YWU0MWM4YTQ1NmQ4YWU2YzU0NDdlNl8xMDk5NTExNjI3ODc2_1e2c3601-4af7-4451-b1f0-76214806a37d"
      unitRef="usd">154000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i57a873f503fb43408df28140ea310d0d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNS0wLTEtMS0xMjE3OTcvdGV4dHJlZ2lvbjo2NDJmNzU1ZTE2YWU0MWM4YTQ1NmQ4YWU2YzU0NDdlNl8xMDk5NTExNjI3ODg1_5b478f02-2224-42eb-9fcb-b4d5fb5e12a2"
      unitRef="usd">-1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7519dbaef94443449eecd8f162669ec1_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNS0xLTEtMS0xMjE3OTc_20447903-374b-42be-a4b3-76abb92bef39"
      unitRef="usd">-55000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i8ca72ce1ba034c0c9c20ad0f3602947d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNS0zLTEtMS0xMjE3OTc_107832d4-8b0d-497d-baee-0fd2537f07ff"
      unitRef="usd">15000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ib125e54cf2b14e81ac89b10807680e76_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNS01LTEtMS0xMjE3OTc_8c65ad56-4c34-41f6-a28d-a12c6256b903"
      unitRef="usd">-130000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i57a873f503fb43408df28140ea310d0d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNS03LTEtMS0xMjE3OTc_3c6604c5-82bb-4542-8303-9990d27e457a"
      unitRef="usd">1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7519dbaef94443449eecd8f162669ec1_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNi0xLTEtMS0xMjE3OTc_b6e5c4b9-7f8c-467b-8113-9f36c158cf18"
      unitRef="usd">-813000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8ca72ce1ba034c0c9c20ad0f3602947d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNi0zLTEtMS0xMjE3OTc_7996b2ce-864d-4a85-8b34-914f21f5a033"
      unitRef="usd">149000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib125e54cf2b14e81ac89b10807680e76_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNi01LTEtMS0xMjE3OTc_2c91e421-6d38-4da0-ba5c-5cd085f358ca"
      unitRef="usd">-1968000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i57a873f503fb43408df28140ea310d0d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNi03LTEtMS0xMjE3OTc_861d7952-d0ea-41f1-b0c6-87c7a6b1f7bd"
      unitRef="usd">-237000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i95c7b68f19d34e799c2a2da632fc1a25_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNy0xLTEtMS0xMjE3OTc_fca2c61b-421b-4b0e-9585-02d4f47e2f92"
      unitRef="usd">-1190000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0186d665a01a437290bd18c75323ee1e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNy0zLTEtMS0xMjE3OTc_30101620-99ed-4b9e-909a-35f5ce11d4a5"
      unitRef="usd">977000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i95c7b68f19d34e799c2a2da632fc1a25_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNy01LTEtMS0xMjE3OTc_aa6bbbbb-a99b-4ba6-9c27-7788ca9cd468"
      unitRef="usd">-1190000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0186d665a01a437290bd18c75323ee1e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfNy03LTEtMS0xMjE3OTc_24001a38-69d9-4a85-8f9e-2acb988147dd"
      unitRef="usd">977000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6d3ff99e11274317bfaa3db6aae0ba07_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTAtMS0xLTEtMTIxNzk3_85c830ba-2f36-4eaf-8337-e44b1fb03a0a"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibbf36ad6ce3b471588e3a05013e799fe_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTAtMy0xLTEtMTIxNzk3_798d9d71-00ee-467c-9e12-b5c33ddd2be8"
      unitRef="usd">5000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icef7877b29934f14b7831ab01b0e383a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTAtNS0xLTEtMTIxNzk3_ac97c6f0-ecd6-42fb-88b5-e625864b3727"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib366b23034bd4459aada86fdb2dd3449_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTAtNy0xLTEtMTIxNzk3_57908c77-0c79-4fd4-823b-6bc9d2788ac4"
      unitRef="usd">7000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i796acc4a7ae14fad88f553a72e53ed7b_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTEtMS0xLTEtMTIxNzk3_46b2ba90-3dd4-4ad9-a33b-0027eb5b3fee"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i882ca8d49b6a49d3b40dc01ce24b96ae_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTEtMy0xLTEtMTIxNzk3_71ed74e9-1acf-41ec-88bb-0b24ac9845ec"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i0b5b675fa53d484099873bf8055a89db_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTEtNS0xLTEtMTIxNzk3_9cda4eaf-1c40-44a9-925f-e11fe267e605"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i249b23ce7c4a4a9181faba8d0c98b9da_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTEtNy0xLTEtMTIxNzk3_8448675a-b47d-4481-9265-2436aa372725"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i796acc4a7ae14fad88f553a72e53ed7b_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTMtMS0xLTEtMTIxNzk3_530eb94b-55bb-443e-97ad-2ae0b03e42cf"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i882ca8d49b6a49d3b40dc01ce24b96ae_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTMtMy0xLTEtMTIxNzk3_a9347e7d-f729-4768-8d28-530557a648ad"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0b5b675fa53d484099873bf8055a89db_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTMtNS0xLTEtMTIxNzk3_a53b2b3b-2155-4259-895b-92d46036e6e8"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i249b23ce7c4a4a9181faba8d0c98b9da_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTMtNy0xLTEtMTIxNzk3_f50a6c32-27ef-4677-a805-dc64da0d1ca7"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic4ad5ca1cf1345368ae93f7d409262d6_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTQtMS0xLTEtMTIxNzk3_f2215750-91eb-4149-b560-1224c6bbdf4f"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i92bca9f2f539472898cf0d31e92244c6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTQtMy0xLTEtMTIxNzk3_5b26f457-0266-4f29-a694-f0136ee4dbd0"
      unitRef="usd">6000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic4ad5ca1cf1345368ae93f7d409262d6_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTQtNS0xLTEtMTIxNzk3_5b7e187d-a39c-42a0-8c04-ee433846d070"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i92bca9f2f539472898cf0d31e92244c6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTQtNy0xLTEtMTIxNzk3_f0aa0b0d-4819-47b2-b357-695f48638bc9"
      unitRef="usd">6000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if26019edad134ef49f67621aae7d0881_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTctMS0xLTEtMTIxNzk3_6ff3712d-f88a-40ef-b391-0cbf26e8a20c"
      unitRef="usd">219000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9fb161b7e78242208da2fb60faed3211_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTctMy0xLTEtMTIxNzk3_a0288fba-a998-41a7-94fb-fab0fad08f4a"
      unitRef="usd">244000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7ebfa804cc314a5cbaa6c16091e1300b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTctNS0xLTEtMTIxNzk3_9eb31824-e939-4578-925b-78a7f884e54f"
      unitRef="usd">222000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5002b5c4b193406a82d57085bca7379c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTctNy0xLTEtMTIxNzk3_37cb3c1a-8a6f-4655-866b-01adc7653b5d"
      unitRef="usd">248000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i17625cfa20f64405885913a70a548638_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTgtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246OWFhNDEwODE2NzJmNGUxNzkwZDk4M2EwY2U0NGFiNDRfNjQ_d5723f60-14a0-46d5-b87d-6efa91b6203f"
      unitRef="usd">24000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i9b668c841c514504b89920b0f42c84fc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTgtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246OWFhNDEwODE2NzJmNGUxNzkwZDk4M2EwY2U0NGFiNDRfMTA5OTUxMTYyNzg3NQ_64ca949d-814c-4c6c-9fab-83f41959a01f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i8384d5359f84472ca5781e3a2d42ea0a_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTgtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246OWFhNDEwODE2NzJmNGUxNzkwZDk4M2EwY2U0NGFiNDRfNzE_1e2c74a5-2846-4062-b44b-a9af0f965bfa"
      unitRef="usd">24000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="if039d6d6983848a48803a4bc6f9a0ed1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTgtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246OWFhNDEwODE2NzJmNGUxNzkwZDk4M2EwY2U0NGFiNDRfMTA5OTUxMTYyNzg5MQ_41c23984-d344-4fd3-b6b6-a7fdd3b47d5c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i17625cfa20f64405885913a70a548638_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTgtMS0xLTEtMTIxNzk3_0d9c521d-d877-4fac-820a-7e7595e4024b"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i9b668c841c514504b89920b0f42c84fc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTgtMy0xLTEtMTIxNzk3_af48cb9a-b296-4bf9-bc7a-4324a315c9b8"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i8384d5359f84472ca5781e3a2d42ea0a_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTgtNS0xLTEtMTIxNzk3_a0477209-16fd-425e-aa89-ab14a22471e9"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="if039d6d6983848a48803a4bc6f9a0ed1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTgtNy0xLTEtMTIxNzk3_dc3f9e93-bf0b-4340-8544-4b7a1838ada7"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i17625cfa20f64405885913a70a548638_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTktMC0xLTEtMTIxNzk3L3RleHRyZWdpb246ZjllNTA5ODZmZjc1NDM4MGI3MWM5MzAwNmMzMzkwODRfNzA_3d28b86d-4897-4172-b915-187fd9e2eb94"
      unitRef="usd">-4000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i9b668c841c514504b89920b0f42c84fc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTktMC0xLTEtMTIxNzk3L3RleHRyZWdpb246ZjllNTA5ODZmZjc1NDM4MGI3MWM5MzAwNmMzMzkwODRfNzc_73fce5a3-4a98-4652-b0a1-74941d257907"
      unitRef="usd">-4000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i8384d5359f84472ca5781e3a2d42ea0a_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTktMC0xLTEtMTIxNzk3L3RleHRyZWdpb246ZjllNTA5ODZmZjc1NDM4MGI3MWM5MzAwNmMzMzkwODRfMTA5OTUxMTYyNzg3OA_d1df92e9-23a4-4220-a876-b04e4bf5e3b2"
      unitRef="usd">-8000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="if039d6d6983848a48803a4bc6f9a0ed1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTktMC0xLTEtMTIxNzk3L3RleHRyZWdpb246ZjllNTA5ODZmZjc1NDM4MGI3MWM5MzAwNmMzMzkwODRfMTA5OTUxMTYyNzg4Nw_05ae8785-2788-402f-8f04-827415d6b987"
      unitRef="usd">-9000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i17625cfa20f64405885913a70a548638_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTktMS0xLTEtMTIxNzk3_ff1904a8-5357-476b-98c5-27b95fb03a0e"
      unitRef="usd">3000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i9b668c841c514504b89920b0f42c84fc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTktMy0xLTEtMTIxNzk3_e5ae0ef7-7600-484a-b421-36ac2e829c88"
      unitRef="usd">3000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i8384d5359f84472ca5781e3a2d42ea0a_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTktNS0xLTEtMTIxNzk3_3f40786b-22f8-4e52-bd8a-0ec6232c605e"
      unitRef="usd">6000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="if039d6d6983848a48803a4bc6f9a0ed1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMTktNy0xLTEtMTIxNzk3_e6e73943-94ca-4b6e-8b06-bc9a3821f8ce"
      unitRef="usd">7000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i17625cfa20f64405885913a70a548638_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjAtMS0xLTEtMTIxNzk3_d2d0207e-2c7b-43fe-b4f2-26307ba43322"
      unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9b668c841c514504b89920b0f42c84fc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjAtMy0xLTEtMTIxNzk3_40005516-9258-42de-adc5-2e90d854104c"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8384d5359f84472ca5781e3a2d42ea0a_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjAtNS0xLTEtMTIxNzk3_92be235b-09f8-4850-838c-1514fa7fd5c7"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if039d6d6983848a48803a4bc6f9a0ed1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjAtNy0xLTEtMTIxNzk3_2cd9d02d-3ac2-43b9-9eea-e95baca02d6c"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6968e95408a14a959a6cf1b5595b1562_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjEtMS0xLTEtMTIxNzk3_e92e3b99-0cfb-447c-8856-c78042b7c961"
      unitRef="usd">234000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i16a176b60bcf492c9d7596af5ec2d637_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjEtMy0xLTEtMTIxNzk3_60fb6e05-2b9c-4e8d-a841-feb1615cf3cf"
      unitRef="usd">241000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6968e95408a14a959a6cf1b5595b1562_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjEtNS0xLTEtMTIxNzk3_20cb42cf-f33a-4fdb-8a4a-7598723e048b"
      unitRef="usd">234000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i16a176b60bcf492c9d7596af5ec2d637_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjEtNy0xLTEtMTIxNzk3_93488376-2975-4b04-bbf7-e83d1513f9cc"
      unitRef="usd">241000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie45bedb2b1594d3eb748dd76b2cab130_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjQtMS0xLTEtMTIxNzk3_8959ec1d-a263-44e9-b0a4-ee9de84f50bd"
      unitRef="usd">-35000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i60f2853c6a3842dd843c429de5b2337d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjQtMy0xLTEtMTIxNzk3_a3e62b7d-fe1f-475d-af7f-9bcd6583c47e"
      unitRef="usd">-55000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie59f2df1b9114d43b76163c7a171e5a4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjQtNS0xLTEtMTIxNzk3_0bde0971-9e09-4710-9066-2d1aa9610e5a"
      unitRef="usd">-35000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia6b9a02663b641188ebd9d833d0c8593_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjQtNy0xLTEtMTIxNzk3_03c15f34-5cd0-4bcd-bc62-83151df0b365"
      unitRef="usd">-55000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i2602b92305c04c68a196ab39ab51d7d1_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjYtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246YjEwNDllMDkxZTA0NGJhMWJjMWY3M2JhYmI3ZjJiOTJfNjg_e3b75a04-bd0e-4537-b348-03c9f838807b"
      unitRef="usd">1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i44bba003a74946ed87d9d0b98b2c950d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjYtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246YjEwNDllMDkxZTA0NGJhMWJjMWY3M2JhYmI3ZjJiOTJfNzI_ad4c8fc8-7adb-4aab-8288-900fe81ed6d2"
      unitRef="usd">1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i74776cd677844441a5cdd3bde68816e0_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjYtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246YjEwNDllMDkxZTA0NGJhMWJjMWY3M2JhYmI3ZjJiOTJfNzY_3783a296-9684-4ec8-bb70-a311934255d1"
      unitRef="usd">1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i4f24cf7d8a01489c8b678a8a8c86ef3f_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjYtMC0xLTEtMTIxNzk3L3RleHRyZWdpb246YjEwNDllMDkxZTA0NGJhMWJjMWY3M2JhYmI3ZjJiOTJfODM_e7ee39e4-1a6d-4734-be6e-0774b6a71d1c"
      unitRef="usd">1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i2602b92305c04c68a196ab39ab51d7d1_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjYtMS0xLTEtMTIxNzk3_1239e674-515a-458c-b422-4bb42d2da4f2"
      unitRef="usd">-1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i44bba003a74946ed87d9d0b98b2c950d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjYtMy0xLTEtMTIxNzk3_14ecde1b-0daf-4ec5-9eb2-6ce3965c2b96"
      unitRef="usd">-1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i74776cd677844441a5cdd3bde68816e0_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjYtNS0xLTEtMTIxNzk3_5b1c038c-f282-41b6-9baa-625ef22c8f26"
      unitRef="usd">-1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i4f24cf7d8a01489c8b678a8a8c86ef3f_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjYtNy0xLTEtMTIxNzk3_180b330b-7fee-4846-9008-345b52fae644"
      unitRef="usd">-1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2602b92305c04c68a196ab39ab51d7d1_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjctMS0xLTEtMTIxNzk3_fd26d51d-bba5-452e-844e-7cdd894c18e3"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i44bba003a74946ed87d9d0b98b2c950d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjctMy0xLTEtMTIxNzk3_de88e1ac-7ee2-41c2-8c7e-1a931a8d0ac9"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i74776cd677844441a5cdd3bde68816e0_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjctNS0xLTEtMTIxNzk3_6c704e3d-a0dd-4a53-a872-9432b212d216"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4f24cf7d8a01489c8b678a8a8c86ef3f_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjctNy0xLTEtMTIxNzk3_4673457f-9e45-4212-9da8-0d1e17639d4c"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib24237470dfb4b14bdc3819e68f90af7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjgtMS0xLTEtMTIxNzk3_1fa135c3-4687-466e-8539-e7a628030ce0"
      unitRef="usd">-34000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8898a5dbc52c442fad3cc1e0d98f102c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjgtMy0xLTEtMTIxNzk3_eec1af32-6231-40fa-97b2-85c4d787af30"
      unitRef="usd">-54000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib24237470dfb4b14bdc3819e68f90af7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjgtNS0xLTEtMTIxNzk3_cdd83e13-4b4c-4d6b-a0b8-428e633bf7dc"
      unitRef="usd">-34000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8898a5dbc52c442fad3cc1e0d98f102c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMjgtNy0xLTEtMTIxNzk3_638daa8b-3faa-4cea-8039-66974b1a5f59"
      unitRef="usd">-54000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9a636d32fc2a454a89bd4991b0628853_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMzAtMS0xLTEtMTIxNzk3_83fe55a7-6088-4ca3-85a8-01839c08212b"
      unitRef="usd">-190000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie7a27b274c3a4d16b682c158f10c219e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMzAtMy0xLTEtMTIxNzk3_8f6a2a66-80e8-4c65-9d6c-c368b0cee24b"
      unitRef="usd">1022000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6688966640734a61a1a460ea4b661770_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMzAtNS0xLTEtMTIxNzk3_73c0a6c6-fac9-4e8f-90c6-7c06824b426a"
      unitRef="usd">965000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id86c8e524f224b00811843646316152e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMzAtNy0xLTEtMTIxNzk3_23eacba8-900b-4a36-acf0-ddff89589197"
      unitRef="usd">1414000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMzEtMS0xLTEtMTIxNzk3_653898bc-44c6-49b9-b544-57a59aac62c1"
      unitRef="usd">-798000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMzEtMy0xLTEtMTIxNzk3_36f31643-8faf-4d15-8845-c9bddc1e056d"
      unitRef="usd">148000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMzEtNS0xLTEtMTIxNzk3_971d7cf3-4406-43de-ace7-59c67fa29f6a"
      unitRef="usd">-1953000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMzEtNy0xLTEtMTIxNzk3_9c7129de-c9d0-4af1-ab47-7eb7faaf932f"
      unitRef="usd">-244000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5185ac0c651b4a17bd97c114f383805d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMzItMS0xLTEtMTIxNzk3_3f065ddf-7466-4a31-bed8-728c497c9a09"
      unitRef="usd">-988000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2fdea86bdbcc429985d69c5258c861b8_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMzItMy0xLTEtMTIxNzk3_a8483bfb-822f-4d10-bda1-b4957b7d0cd9"
      unitRef="usd">1170000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5185ac0c651b4a17bd97c114f383805d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMzItNS0xLTEtMTIxNzk3_bbad81bf-5d67-4380-970f-a03b4cea6e39"
      unitRef="usd">-988000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2fdea86bdbcc429985d69c5258c861b8_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RhYmxlOmJlMWVjYWM1ZjdiNjQwM2Q4NjJkMzAzMDg4MDY4OTM2L3RhYmxlcmFuZ2U6YmUxZWNhYzVmN2I2NDAzZDg2MmQzMDMwODgwNjg5MzZfMzItNy0xLTEtMTIxNzk3_1dfd7dea-8f55-485d-b4ee-f2f00731d50d"
      unitRef="usd">1170000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
      contextRef="i6968e95408a14a959a6cf1b5595b1562_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81Mi9mcmFnOjI5MmRhOTEzNjQ0YzRlNjI5MzE5MWNlYWYyYjY5NjljL3RleHRyZWdpb246MjkyZGE5MTM2NDRjNGU2MjkzMTkxY2VhZjJiNjk2OWNfNjc2_8fc1fa79-2fe0-4ce4-8b08-d343cb69906c"
      unitRef="usd">11000000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RleHRyZWdpb246YjE0YWFhZTJmZDI3NDE3YWFlNjQ5NmFkZjFhZmJkM2ZfNTY4_95e2eb1f-4adf-4f7b-a40b-2ae022d765f1">Earnings Per Share&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings per share is computed using the treasury stock method. Stock options and stock appreciation rights to purchase 4 million and 3 million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the three and six months ended June&#160;30, 2022, respectively, because their exercise prices were greater than the average market price of the common shares and, therefore, the effect would be antidilutive. For the same reason, stock options and stock appreciation rights to purchase 8 million and 9 million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the three and six months ended June&#160;30, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of basic and diluted earnings per share for the respective periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator for earnings per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to CVS Health&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for earnings per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units and performance stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and stock appreciation rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i6cb8479c571d4f03bbc71c0d8f664eca_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RleHRyZWdpb246YjE0YWFhZTJmZDI3NDE3YWFlNjQ5NmFkZjFhZmJkM2ZfMTQ2_63edd667-f6bd-4cde-b017-746f5f53741f"
      unitRef="shares">4000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="icd272e9bdea14242a207e8aff8e2266e_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RleHRyZWdpb246YjE0YWFhZTJmZDI3NDE3YWFlNjQ5NmFkZjFhZmJkM2ZfMTA5OTUxMTYyODM5NA_793f9ce1-19b4-43f3-9c27-6e1e4a3196d5"
      unitRef="shares">3000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1ad6c128f57b4949a888c466705beca4_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RleHRyZWdpb246YjE0YWFhZTJmZDI3NDE3YWFlNjQ5NmFkZjFhZmJkM2ZfMTA5OTUxMTYyODgzOA_b832e5a0-47f9-4510-9b2a-d835e9dd22a5"
      unitRef="shares">8000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i673355ef359540e592c71b0c9698de65_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RleHRyZWdpb246YjE0YWFhZTJmZDI3NDE3YWFlNjQ5NmFkZjFhZmJkM2ZfMTA5OTUxMTYyODgwOQ_6c6a6514-f4c9-40ab-9e1f-ca4fe4d732dc"
      unitRef="shares">9000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RleHRyZWdpb246YjE0YWFhZTJmZDI3NDE3YWFlNjQ5NmFkZjFhZmJkM2ZfNTY5_5f2e75c6-0cc4-4834-bef9-06f26efc1f7e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of basic and diluted earnings per share for the respective periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator for earnings per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to CVS Health&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for earnings per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units and performance stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and stock appreciation rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfNi0xLTEtMS0xMjE3OTc_3bdc60ce-2cd1-42d6-99ff-bd3c49b15a02"
      unitRef="usd">2951000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfNi0zLTEtMS0xMjE3OTc_5e74afcc-0312-4940-9ed8-ffb823b26f00"
      unitRef="usd">2783000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfNi01LTEtMS0xMjE3OTc_d29ee9c8-8bfd-47ee-874b-1db5b3d13295"
      unitRef="usd">5263000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfNi03LTEtMS0xMjE3OTc_568cee06-eb5f-466a-9bd6-dcc6875379d4"
      unitRef="usd">5006000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfOS0xLTEtMS0xMjE3OTc_aa7e5b7a-698f-41b7-8429-73ff3ac5f8ad"
      unitRef="shares">1313000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfOS0zLTEtMS0xMjE3OTc_a127c934-3b00-4ef7-ada4-75f14c09e95f"
      unitRef="shares">1319000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfOS01LTEtMS0xMjE3OTc_a8b5b78b-1833-49c5-a187-93d477a77329"
      unitRef="shares">1312000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfOS03LTEtMS0xMjE3OTc_32c654ca-f1ea-4573-aa98-fddc5982efd4"
      unitRef="shares">1316000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="id289f8fd821442c1a5d3cc80b9c40c2a_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTAtMS0xLTEtMTIxNzk3_ffd22bd1-fdfb-4764-a796-5e2f92fb852e"
      unitRef="shares">4000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ia1edca8cccef478fbae52ae8fb77dfee_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTAtMy0xLTEtMTIxNzk3_fca4bb6d-d497-42f8-b297-f470126b6340"
      unitRef="shares">4000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i597a5458b92444dda6db7761d84ee082_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTAtNS0xLTEtMTI5NzY0_15bc5a9d-8372-45c4-b9a6-4865a67e84eb"
      unitRef="shares">8000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ic81654dd29534869be7ad8d23a454adb_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTAtNy0xLTEtMTI4MTA0_69e1eec2-a0e0-4685-a40f-3a302a6db10d"
      unitRef="shares">6000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i6cb8479c571d4f03bbc71c0d8f664eca_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTEtMS0xLTEtMTIxNzk3_e16c6d0a-6c46-4750-9863-3ac67f8fc006"
      unitRef="shares">4000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i1ad6c128f57b4949a888c466705beca4_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTEtMy0xLTEtMTIxNzk3_15e61d57-b7f2-455e-ae07-404267383524"
      unitRef="shares">4000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="icd272e9bdea14242a207e8aff8e2266e_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTEtNS0xLTEtMTI5NzY0_8b0b7a20-6211-462f-b4dc-1a647699d6e2"
      unitRef="shares">5000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i673355ef359540e592c71b0c9698de65_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTEtNy0xLTEtMTI4MTA0_0fdfd7d0-ccbd-41c4-a3b3-8fbd2c0ab1bb"
      unitRef="shares">3000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTItMS0xLTEtMTIxNzk3_7691591e-a7cf-4b8c-986d-adc2d670cbf9"
      unitRef="shares">1321000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTItMy0xLTEtMTIxNzk3_ff42000b-9383-4bb3-b247-1f884a4daa3b"
      unitRef="shares">1327000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTItNS0xLTEtMTIxNzk3_52c4c58b-be70-4edd-b85c-47edc82c2a0d"
      unitRef="shares">1325000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTItNy0xLTEtMTIxNzk3_b64c4cf2-9ddd-44da-bda1-d1d20d12a4e3"
      unitRef="shares">1325000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTUtMS0xLTEtMTIxNzk3_3f86a29a-7b50-4b94-aebf-c323f077c739"
      unitRef="usdPerShare">2.25</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTUtMy0xLTEtMTIxNzk3_d64ecfd8-e8fd-4d02-b036-43cb8e7cd4dc"
      unitRef="usdPerShare">2.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTUtNS0xLTEtMTIxNzk3_75f1b1ae-957c-40d5-b298-1b75038cec64"
      unitRef="usdPerShare">4.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTUtNy0xLTEtMTIxNzk3_a2bc2b45-c27d-4c43-9268-9953e86a0dd1"
      unitRef="usdPerShare">3.80</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTYtMS0xLTEtMTIxNzk3_aa04e6ef-b26f-489b-b71c-4a2e05acfb7f"
      unitRef="usdPerShare">2.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTYtMy0xLTEtMTIxNzk3_f33b3600-7a8f-49d6-ac62-af4f351645e0"
      unitRef="usdPerShare">2.10</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTYtNS0xLTEtMTIxNzk3_5fa4776b-f88d-4d65-9e1a-e7f1982c10d4"
      unitRef="usdPerShare">3.97</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81NS9mcmFnOmIxNGFhYWUyZmQyNzQxN2FhZTY0OTZhZGYxYWZiZDNmL3RhYmxlOjMxNjBhMWU0OWMzNDQxMDhiYjA3ODAwYjk1YTYwMjhlL3RhYmxlcmFuZ2U6MzE2MGExZTQ5YzM0NDEwOGJiMDc4MDBiOTVhNjAyOGVfMTYtNy0xLTEtMTIxNzk3_701b8a58-f96b-4a0f-bc69-c9a8592c7c20"
      unitRef="usdPerShare">3.78</us-gaap:EarningsPerShareDiluted>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81OC9mcmFnOmFlY2ZhYmMwMzg4ODRmNzQ4OThiZWY1OTM5NmY4Y2NmL3RleHRyZWdpb246YWVjZmFiYzAzODg4NGY3NDg5OGJlZjU5Mzk2ZjhjY2ZfMjg4NDU_56fb8bfa-fbba-4744-83f5-21bdb027b94e">Commitments and Contingencies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;COVID-19&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The COVID-19 pandemic continues to evolve. The Company believes COVID-19&#x2019;s impact on its businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic; the pandemic&#x2019;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns; and the timing, scope and impact of stimulus legislation as well as other federal, state and local governmental responses to the pandemic. Those primary drivers are beyond the Company&#x2019;s knowledge and control. As a result, the impact COVID-19 will have on the Company&#x2019;s businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. COVID-19 also may result in legal and regulatory proceedings, investigations and claims against the Company.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lease Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Between 1995 and 1997, the Company sold or spun off a number of subsidiaries, including Bob&#x2019;s Stores and Linens &#x2018;n Things, each of which subsequently filed for bankruptcy, and Marshalls. In many cases, when a former subsidiary leased a store, the Company provided a guarantee of the former subsidiary&#x2019;s lease obligations for the initial lease term and any extension thereof pursuant to a renewal option provided for in the lease prior to the time of the disposition. When the subsidiaries were disposed of and accounted for as discontinued operations, the Company&#x2019;s guarantees remained in place, although each initial purchaser agreed to indemnify the Company for any lease obligations the Company was required to satisfy. If any of the purchasers or any of the former subsidiaries fail to make the required payments under a store lease, the Company could be required to satisfy those obligations, and any significant adverse impact of COVID-19 on such purchasers and/or former subsidiaries increases the risk that the Company will be required to satisfy those obligations. As of June&#160;30, 2022, the Company guaranteed 68 such store leases (excluding the lease guarantees related to Linens &#x2018;n Things, which have been recorded as a liability on the unaudited condensed consolidated balance sheets), with the maximum remaining lease term extending through 2030. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Guaranty Fund Assessments, Market Stabilization and Other Non-Voluntary Risk Sharing Pools&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under guaranty fund laws existing in all states, insurers doing business in those states can be assessed (in most states up to prescribed limits) for certain obligations of insolvent insurance companies to policyholders and claimants. The life and health insurance guaranty associations in which the Company participates that operate under these laws respond to insolvencies of long-term care insurers and life insurers as well as health insurers. The Company&#x2019;s assessments generally are based on a formula relating to the Company&#x2019;s health care premiums in the state compared to the premiums of other insurers. Certain states allow assessments to be recovered over time as offsets to premium taxes. Some states have similar laws relating to HMOs and/or other payors such as not-for-profit consumer-governed health plans established under the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2009, the Pennsylvania Insurance Commissioner placed long-term care insurer Penn Treaty Network America Insurance Company and one of its subsidiaries (collectively, &#x201c;Penn Treaty&#x201d;) in rehabilitation, an intermediate action before insolvency, and subsequently petitioned a state court to convert the rehabilitation into a liquidation. Penn Treaty was placed in liquidation in March 2017. The Company has recorded a liability for its estimated share of future assessments by applicable life and health insurance guaranty associations. It is reasonably possible that in the future the Company may record a liability and expense relating to other insolvencies which could have a material adverse effect on the Company&#x2019;s operating results, financial condition and cash flows, and the risk is heightened by any significant adverse impact of the COVID-19 pandemic on the solvency of other insurers, including long-term care and life insurers. While historically the Company has ultimately recovered more than half of guaranty fund assessments through statutorily permitted premium tax offsets, significant increases in assessments could lead to legislative and/or regulatory actions that limit future offsets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;HMOs in certain states in which the Company does business are subject to assessments, including market stabilization and other risk-sharing pools, for which the Company is assessed charges based on incurred claims, demographic membership mix and other factors. The Company establishes liabilities for these assessments based on applicable laws and regulations. In certain states, the ultimate assessments the Company pays are dependent upon the Company&#x2019;s experience relative to other entities subject to the assessment, and the ultimate liability is not known at the financial statement date. While the ultimate amount of the assessment is dependent upon the experience of all pool participants, the Company believes it has adequate reserves to cover such assessments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Litigation and Regulatory Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has been involved or is currently involved in numerous legal proceedings, including litigation, arbitration, government investigations, audits, reviews and claims. These include routine, regular and special investigations, audits and reviews by&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the U.S. Centers for Medicare &amp;amp; Medicaid Services (&#x201c;CMS&#x201d;), state insurance and health and welfare departments, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the U.S. Department of Justice (the &#x201c;DOJ&#x201d;), &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;state attorneys general, the U.S. Drug Enforcement Administration (the &#x201c;DEA&#x201d;), the Federal Trade Commission (the &#x201c;FTC&#x201d;) and other governmental authorities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Legal proceedings, in general, and securities, class action and multi-district litigation, in particular, and governmental special investigations, audits and reviews can be expensive and disruptive. Some of the litigation matters may purport or be determined to be class actions and/or involve parties seeking large and/or indeterminate amounts, including punitive or exemplary damages, and may remain unresolved for several years. The Company also may be named from time to time in&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; actions initiated by private third parties that could also be separately pursued by a governmental body. The results of legal proceedings, including government investigations, are often uncertain and difficult to predict, and the costs incurred in these matters can be substantial, regardless of the outcome.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred and the amount can be reasonably estimated. The Company evaluates, on a quarterly basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and reasonably estimable, the Company does not establish an accrued liability. None of the Company&#x2019;s accruals for outstanding legal matters are material individually or in the aggregate to the Company&#x2019;s financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Except as otherwise noted, the Company cannot predict with certainty the timing or outcome of the legal matters described below, and the Company is unable to reasonably estimate a possible loss or range of possible loss in excess of amounts already accrued for these matters. The Company believes that its defenses and assertions in pending legal proceedings have merit and does not believe that any of these pending matters, after consideration of applicable reserves and rights to indemnification, will &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;have a material adverse effect on the Company&#x2019;s financial position. Substantial unanticipated verdicts, fines and rulings, however, do sometimes occur, which could result in judgments against the Company, entry into settlements or a revision to its expectations regarding the outcome of certain matters, and such developments could have a material adverse effect on its results of operations.  In addition, as a result of governmental investigations or proceedings, the Company may be subject to damages, civil or criminal fines or penalties, or other sanctions including possible suspension or loss of licensure and/or exclusion from participating in government programs. The outcome of such governmental investigations of proceedings could be material to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Usual and Customary Pricing Litigation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and certain current and former directors and officers are named as a defendant in a number of lawsuits that allege that the Company&#x2019;s retail pharmacies overcharged for prescription drugs by not submitting the correct usual and customary price during the claims adjudication process. These actions are brought by a number of different types of plaintiffs, including plan members, private payors, government payors, and shareholders based on different legal theories. Some of these cases are brought as putative class actions, and in some instances, classes have been certified. The Company is defending itself against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;PBM Litigation and Investigations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its PBM practices.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is facing multiple lawsuits, including by a State Attorney General, governmental subdivisions and several putative class actions, regarding drug pricing and its rebate arrangements with drug manufacturers.  These complaints, brought by a number of different types of plaintiffs under a variety of legal theories, generally allege that rebate agreements between the drug manufacturers and PBMs caused inflated prices for certain drug products. The Company is defending itself against these claims.  The Company has also received subpoenas, civil investigative demands (&#x201c;CIDs&#x201d;) and other requests for documents and information from, and is being investigated by, the FTC and Attorneys General of several states and the District of Columbia regarding its PBM practices, including pricing and rebates. The Company has been providing documents and information in response to these subpoenas, CIDs and requests for information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Behnke v. CVS Caremark Corporation, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al. (U.S. District Court for the Eastern District of Pennsylvania). In April 2018, the Court unsealed a complaint filed in February 2014. The government has declined to intervene in this case. The relator alleges that the Company submitted, or caused to be submitted, to Part D of the Medicare program Prescription Drug Event data and/or Direct and Indirect Remuneration reports that misrepresented true prices paid by the Company&#x2019;s PBM to pharmacies for drugs dispensed to Part D beneficiaries with prescription benefits administered by the Company&#x2019;s PBM. The Company is defending itself against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Controlled Substances Litigation, Audits and Subpoenas&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2017, the U.S. Judicial Panel on Multidistrict Litigation consolidated numerous cases filed against various defendants by plaintiffs such as counties, cities, hospitals, Indian tribes and third-party payors, alleging claims generally concerning the impacts of widespread prescription opioid abuse. The consolidated multidistrict litigation captioned In re National Prescription Opiate Litigation (MDL No. 2804) is pending in the U.S. District Court for the Northern District of Ohio. This multidistrict litigation presumptively includes hundreds of relevant federal court cases that name the Company as a defendant. A significant number of similar cases that name the Company as a defendant in some capacity are pending in state courts. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Company has been named as a defendant in similar cases brought by certain state Attorneys General. The Company is defending itself against all such claims. Additionally, the Company has received subpoenas, CIDs and/or other requests for information regarding opioids from state Attorneys General and insurance and other regulators of several U.S. jurisdictions. The Company has been cooperating with the government with respect to these subpoenas, CIDs and other requests for information.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, the Company was among the chain pharmacies found liable by a jury in a trial in federal court in Ohio; the remedy pursuant to that verdict has not been determined and the Company plans to appeal.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2022, CVS Health Corporation and CVS Pharmacy, Inc. entered into a settlement agreement with the State of Florida to resolve claims related to opioid medications dating back more than a decade. Under the terms of the settlement agreement, CVS Health Corporation settled all opioid claims against it and its subsidiaries by the State of Florida for $484&#160;million, which is &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to be paid over a period of 18 years. During the three months ended March 31, 2022, the Company recorded a $484&#160;million liability associated with this legal settlement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the DOJ served the Company with a DEA administrative subpoena. The subpoena seeks documents relating to practices with respect to prescription opioids and other controlled substances at CVS pharmacy locations concerning potential violations of the federal Controlled Substances Act and the federal False Claims Act. In January 2022, the DOJ served the Company with a CID regarding similar subjects. The Company is providing documents and information in response to these matters.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Prescription Processing Litigation and Investigations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its prescription processing practices, including the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;U.S. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ex rel.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Bassan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; v. Omnicare, Inc. and CVS Health Corp. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(U.S. District Court for the Southern District of New York). In December 2019, the U.S. Attorney&#x2019;s Office for the Southern District of New York (the &#x201c;SDNY&#x201d;) filed a complaint-in-intervention in this previously sealed &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; case. The complaint alleges that for certain non-skilled nursing facilities, Omnicare improperly filled prescriptions beyond one year where a valid prescription did not exist and that these dispensing events violated the federal False Claims Act. The Company is defending itself against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;U.S. ex rel. Gill et al. v. CVS Health Corp. et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (U.S. District Court for the Northern District of Illinois).  In July 2022, the Delaware Attorney General&#x2019;s Office moved for partial intervention as to allegations under the Delaware false claims act related to not escheating alleged overpayments in this previously sealed &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; case.  The federal government and the remaining states declined to intervene on other additional theories in the relator&#x2019;s complaint.  The Company is defending itself against all of the claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2017, the Company also received a subpoena from the California Department of Insurance requesting documents concerning the Company&#x2019;s Omnicare pharmacies&#x2019; cycle fill process for assisted living facilities. The Company has been cooperating with the California Department of Insurance and providing documents and information in response to this subpoena.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2016, the Company received a CID from the U.S. Attorney&#x2019;s Office for the Northern District of New York requesting documents and information in connection with a federal False Claims Act investigation concerning whether the Company&#x2019;s retail pharmacies improperly submitted certain insulin claims to Part D of the Medicare program rather than Part B of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to this CID.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Provider Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is named as a defendant in purported class actions and individual lawsuits arising out of its practices related to the payment of claims for services rendered to its members by providers with whom the Company has a contract and with whom the Company does not have a contract (&#x201c;out-of-network providers&#x201d;). Among other things, these lawsuits allege that the Company paid too little to its health plan members and/or providers for out-of-network services (including COVID-19 testing) and/or otherwise allege that the Company failed to timely or appropriately pay or administer out-of-network claims and benefits (including the Company&#x2019;s post payment audit and collection practices and reductions in payments to providers due to sequestration). Other major health insurers are the subject of similar litigation or have settled similar litigation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also has received subpoenas and/or requests for documents and other information from, and been investigated by, state Attorneys General and other state and/or federal regulators, legislators and agencies relating to, and the Company is involved in other litigation regarding, its out-of-network benefit payment and administration practices. It is reasonably possible that others could initiate additional litigation or additional regulatory action against the Company with respect to its out-of-network benefit payment and/or administration practices.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;CMS Actions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CMS regularly audits the Company&#x2019;s performance to determine its compliance with CMS&#x2019;s regulations and its contracts with CMS and to assess the quality of services it provides to Medicare beneficiaries. CMS uses various payment mechanisms to allocate and adjust premium payments to the Company&#x2019;s and other companies&#x2019; Medicare plans by considering the applicable &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;health status of Medicare members as supported by information prepared, maintained and provided by providers. The Company collects claim and encounter data from providers and generally relies on providers to appropriately code their submissions to the Company and document their medical records, including the diagnosis data submitted to the Company with claims. CMS pays increased premiums to Medicare Advantage plans and Medicare PDP plans for members who have certain medical conditions identified with specific diagnosis codes. Federal regulators review and audit the providers&#x2019; medical records to determine whether those records support the related diagnosis codes that determine the members&#x2019; health status and the resulting risk-adjusted premium payments to the Company. In that regard, CMS has instituted risk adjustment data validation (&#x201c;RADV&#x201d;) audits of various Medicare Advantage plans, including certain of the Company&#x2019;s plans, to validate coding practices and supporting medical record documentation maintained by providers and the resulting risk-adjusted premium payments to the plans. CMS may require the Company to refund premium payments if the Company&#x2019;s risk-adjusted premiums are not properly supported by medical record data. The Office of the Inspector General of the U.S. Department of Health and Human Services (&#x201c;OIG&#x201d;) also is auditing the Company&#x2019;s risk adjustment-related data and that of other companies. The Company expects CMS and the OIG to continue these types of audits.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2012, CMS revised its audit methodology for RADV audits to determine refunds payable by Medicare Advantage plans for contract year 2011 and forward. Under the revised methodology, among other things, CMS will extrapolate the error rate identified in the audit sample of approximately 200 members to all risk-adjusted premium payments made under the contract being audited. For contract years prior to 2011, CMS did not extrapolate sample error rates to the entire contract. As a result, the revised methodology may increase the Company&#x2019;s exposure to premium refunds to CMS based on incomplete medical records maintained by providers. Since 2013, CMS has selected certain of the Company&#x2019;s Medicare Advantage contracts for various contract years for RADV audit, and the number of RADV audits continues to increase. The Company is currently unable to predict which of its Medicare Advantage contracts will be selected for future audit, the amounts of any retroactive refunds of, or prospective adjustments to, Medicare Advantage premium payments made to the Company, the effect of any such refunds or adjustments on the actuarial soundness of the Company&#x2019;s Medicare Advantage bids, or whether any RADV audit findings would require the Company to change its method of estimating future premium revenue in future bid submissions to CMS or compromise premium assumptions made in the Company&#x2019;s bids for prior contract years, the current contract year or future contract years. Any premium or fee refunds or adjustments resulting from regulatory audits, whether as a result of RADV, Public Exchange related or other audits by CMS, the OIG or otherwise, including audits of the Company&#x2019;s minimum medical loss ratio rebates, methodology and/or reports, could be material and could adversely affect the Company&#x2019;s operating results, cash flows and/or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Medicare and Medicaid CIDs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has received CIDs from the Civil Division of the DOJ in connection with a current investigation of the Company&#x2019;s patient chart review processes in connection with risk adjustment data submissions under Parts C and D of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to these CIDs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2017, the Company received a CID from the SDNY requesting documents and information concerning possible false claims submitted to Medicare in connection with reimbursements for prescription drugs under the Medicare Part D program. The Company has been cooperating with the government and providing documents and information in response to this CID.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Stockholder Matters&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in February 2019, multiple class action complaints, as well as a derivative complaint, were filed by putative plaintiffs against the Company and certain current and former officers and directors. The plaintiffs in these cases assert a variety of causes of action under federal securities laws that are premised on allegations that the defendants made certain omissions and misrepresentations relating to the performance of the Company&#x2019;s LTC business unit. The Company and its current and former officers and directors are defending themselves against these claims. Since filing, several of the cases have been consolidated, and the first-filed federal case, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;City of Miami Fire Fighters&#x2019; and Police Officers&#x2019; Retirement Trust, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al. (formerly known as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Anarkat&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), was dismissed with prejudice in February 2021. Plaintiffs have appealed that decision to the First Circuit after their motion for reconsideration was denied. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In re CVS Health Corp. Securities Act Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (formerly known as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Waterford&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In re CVS Health Corp. Securities Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (formerly known as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;City of Warren&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Freundlich&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) have been stayed pending the outcome of the First Circuit appeal. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August and September 2020, two class actions under the Employee Retirement Income Security Act of 1974 (&#x201c;ERISA&#x201d;)&lt;/span&gt;&lt;span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;were filed in the U.S. District Court for the District of Connecticut against CVS Health, Aetna Inc. (&#x201c;Aetna&#x201d;), and several current and former executives, directors and/or members of Aetna&#x2019;s Compensation and Talent Management Committee: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Radcliffe v. Aetna Inc., &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Flaim v. Aetna Inc., &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al. The plaintiffs in these cases assert a variety of causes of action premised on allegations that the defendants breached fiduciary duties and engaged in prohibited transactions relating to participants in the Aetna 401(k) Plan&#x2019;s investment in company stock between December 3, 2017 and February 20, 2019, claiming losses related to the performance of the Company&#x2019;s LTC business unit. The district court consolidated the actions, and in October 2021, dismissed the consolidated action without prejudice. Plaintiffs filed an amended consolidated complaint, which the Company has moved to dismiss. The Company also received a related document request pursuant to ERISA &#xa7; 104(b), to which the Company has responded. The Company and its current and former officers and directors are defending themselves against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2021, the Company received a demand for inspection of books and records pursuant to Delaware Corporation Law Section 220 (the &#x201c;Demand&#x201d;). The Demand purports to be related to potential breaches of fiduciary duties by the Board in relation to certain matters concerning opioids.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other Legal and Regulatory Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is also a party to other legal proceedings and is subject to government investigations, inquiries and audits and has received and is cooperating with the government in response to CIDs, subpoenas or similar process from various governmental agencies requesting information. These other legal proceedings and government actions include claims of or relating to bad faith, medical or professional malpractice, breach of fiduciary duty, claims processing, dispensing of medications, non-compliance with state and federal regulatory regimes, marketing misconduct, denial of or failure to timely or appropriately pay or administer claims and benefits, provider network structure (including the use of performance-based networks and termination of provider contracts), rescission of insurance coverage, improper disclosure or use of personal information, anticompetitive practices, general contractual matters, product liability, intellectual property litigation and employment litigation. Some of these other legal proceedings are or are purported to be class actions or derivative claims. The Company is defending itself against the claims brought in these matters.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Awards to the Company and others of certain government contracts, particularly Medicaid contracts and other contracts with government customers in the Company&#x2019;s Health Care Benefits segment, frequently are subject to protests by unsuccessful bidders. These protests may result in awards to the Company being reversed, delayed or modified. The loss or delay in implementation of any government contract could adversely affect the Company&#x2019;s operating results. The Company will continue to defend contract awards it receives.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There also continues to be a heightened level of review and/or audit by regulatory authorities and legislators of, and increased litigation regarding, the Company&#x2019;s and the rest of the health care and related benefits industry&#x2019;s business and reporting practices, including premium rate increases, utilization management, development and application of medical policies, complaint, grievance and appeal processing, information privacy, provider network structure (including provider network adequacy, the use of performance-based networks and termination of provider contracts), provider directory accuracy, calculation of minimum medical loss ratios and/or payment of related rebates, delegated arrangements, rescission of insurance coverage, limited benefit health products, student health products, pharmacy benefit management practices (including manufacturers&#x2019; rebates, pricing, the use of narrow networks and the placement of drugs in formulary tiers), sales practices, customer service practices, vendor oversight and claim payment practices (including payments to out-of-network providers).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a leading national health solutions company, the Company regularly is the subject of government actions of the types described above. These government actions may prevent or delay the Company from implementing planned premium rate increases and may result, and have resulted, in restrictions on the Company&#x2019;s businesses, changes to or clarifications of the Company&#x2019;s business practices, retroactive adjustments to premiums, refunds or other payments to members, beneficiaries, states or the federal government, withholding of premium payments to the Company by government agencies,&#160;assessments of damages, civil or criminal fines or penalties, or other sanctions, including the possible suspension or loss of licensure and/or suspension or exclusion from participation in government programs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company can give no assurance that its businesses, financial condition, operating results and/or cash flows will not be materially adversely affected, or that the Company will not be required to materially change its business practices, based on: (i)&#160;future enactment of new health care or other laws or regulations; (ii)&#160;the interpretation or application of existing laws or regulations as they may relate to one or more of the Company&#x2019;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iii)&#160;pending or future federal or state government investigations of one or more of the Company&#x2019;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iv)&#160;pending or future government audits, investigations or enforcement actions against the Company; (v)&#160;adverse developments in any pending &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; lawsuit against the Company, whether sealed or unsealed, or in any future &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; lawsuit that may be filed against the Company; or (vi)&#160;adverse developments in pending or future legal proceedings against the Company or affecting one or more of the industries in which the Company competes and/or the health care industry generally.&lt;/span&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <cvs:GuarantorObligationsNumberofLeases
      contextRef="i497dd46327b4467f95cca59a81170078_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81OC9mcmFnOmFlY2ZhYmMwMzg4ODRmNzQ4OThiZWY1OTM5NmY4Y2NmL3RleHRyZWdpb246YWVjZmFiYzAzODg4NGY3NDg5OGJlZjU5Mzk2ZjhjY2ZfMjA1Mw_d8a803b8-162b-4e70-90b0-6cf1d10ac23f"
      unitRef="lease">68</cvs:GuarantorObligationsNumberofLeases>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i068019055ff349b0ba2c43c7bdcad5a5_D20220301-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81OC9mcmFnOmFlY2ZhYmMwMzg4ODRmNzQ4OThiZWY1OTM5NmY4Y2NmL3RleHRyZWdpb246YWVjZmFiYzAzODg4NGY3NDg5OGJlZjU5Mzk2ZjhjY2ZfMTI5NDQ_2efb6893-875b-4950-bf0f-424c6c396452"
      unitRef="usd">-484000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <cvs:LegalSettlementPeriodOfPayment
      contextRef="i201d84873cdc44b8a00591a48c940e6a_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81OC9mcmFnOmFlY2ZhYmMwMzg4ODRmNzQ4OThiZWY1OTM5NmY4Y2NmL3RleHRyZWdpb246YWVjZmFiYzAzODg4NGY3NDg5OGJlZjU5Mzk2ZjhjY2ZfMTI5ODU_c4682eff-ccd3-405c-9727-cf41f40d0309">P18Y</cvs:LegalSettlementPeriodOfPayment>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i201d84873cdc44b8a00591a48c940e6a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81OC9mcmFnOmFlY2ZhYmMwMzg4ODRmNzQ4OThiZWY1OTM5NmY4Y2NmL3RleHRyZWdpb246YWVjZmFiYzAzODg4NGY3NDg5OGJlZjU5Mzk2ZjhjY2ZfMTMwNTg_61d7309f-d148-4666-9357-ed1eec898c4e"
      unitRef="usd">484000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <cvs:LossContingencyAuditMethodologySampleSize
      contextRef="if80d8dd79ebc4415ad936ec2eebc9a64_D20120101-20121231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81OC9mcmFnOmFlY2ZhYmMwMzg4ODRmNzQ4OThiZWY1OTM5NmY4Y2NmL3RleHRyZWdpb246YWVjZmFiYzAzODg4NGY3NDg5OGJlZjU5Mzk2ZjhjY2ZfMTg4ODg_30497d15-108f-4529-b884-af0d0056c713"
      unitRef="member">200</cvs:LossContingencyAuditMethodologySampleSize>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ib401a332bf4543de8c13209d3b334652_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV81OC9mcmFnOmFlY2ZhYmMwMzg4ODRmNzQ4OThiZWY1OTM5NmY4Y2NmL3RleHRyZWdpb246YWVjZmFiYzAzODg4NGY3NDg5OGJlZjU5Mzk2ZjhjY2ZfMjI0NTA_7cf33a3a-4847-41da-bbc2-eb6d791c0b29"
      unitRef="claim">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RleHRyZWdpb246OTBlMDJkZDRiODFjNGNiOTk3NGM2ODBmMTUxYzMzMDFfNDQ0MQ_f68bbf80-2549-40f6-ad4c-93e289a5ed91">Segment ReportingThe Company has three operating segments, Health Care Benefits, Pharmacy Services and Retail/LTC, as well as a Corporate/Other segment. The Company&#x2019;s segments maintain separate financial information, and the Company&#x2019;s chief operating decision maker (the &#x201c;CODM&#x201d;) evaluates the segments&#x2019; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#x2019;s segments based on adjusted operating income, which is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#x2019;s business nor reflect the Company&#x2019;s underlying business performance. See the reconciliations of consolidated operating income (GAAP measure) to consolidated adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#x2019;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP. &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of financial measures of the Company&#x2019;s segments to the consolidated totals:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Services &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Eliminations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,328)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,328)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(555)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(183)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,616)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,616)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(860)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(672)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(337)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Total revenues of the Pharmacy Services segment include approximately $3.1 billion and $2.8 billion of retail co-payments for the three months ended  June&#160;30, 2022 and 2021, respectively, and $6.9 billion and $6.2 billion of retail co-payments for the six months ended June&#160;30, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Pharmacy Services segment, and/or the Retail/LTC segment. Intersegment adjusted operating income eliminations occur when members of Pharmacy Services Segment clients (&#x201c;PSS members&#x201d;) enrolled in Maintenance Choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; elect to pick up maintenance prescriptions at one of the Company&#x2019;s retail pharmacies instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail/LTC segments record the adjusted operating income on a stand-alone basis.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are reconciliations of consolidated operating income to adjusted operating income for the three and six months ended June&#160;30, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.3pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (GAAP measure)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on divestiture of subsidiary &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(225)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(225)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal settlement &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on assets held for sale &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related integration costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition purchase price adjustment outside of measurement period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company&#x2019;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the unaudited condensed consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#x2019;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#x2019;s insurance products, the services performed for the Company&#x2019;s customers or the sale of the Company&#x2019;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#x2019;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#x2019;s and investors&#x2019; ability to compare the Company&#x2019;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#x2019;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;During the three and six months ended June&#160;30, 2022, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of PayFlex, which the Company sold on June 1, 2022, for approximately $775&#160;million. The gain on divestiture is reflected as a reduction in operating expenses in the Company&#x2019;s unaudited condensed consolidated statements of operations within the Health Care Benefits segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;During the six months ended June&#160;30, 2022, the legal settlement relates to the agreement with the State of Florida, entered into in March 2022, to resolve claims dating back more than a decade related to opioid medications. Under this agreement, CVS Health Corporation settled all opioid claims against it and its subsidiaries by the State of Florida for $484&#160;million, inclusive of certain legal fees, to be paid over a period of 18 years. The legal settlement is reflected in the unaudited condensed consolidated statement of operations in operating expenses within the Corporate/Other segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;During the six months ended June&#160;30, 2022, the loss on assets held for sale relates to the Commercial Business reporting unit within the Health Care Benefits segment. In March 2022, the Company reached an agreement to sell its Thailand business, which was included in the Commercial Business reporting unit. At that time, a portion of the Commercial Business goodwill was specifically allocated to the Thailand business. The net assets of the Thailand business were accounted for as assets held for sale at March 31, 2022. The carrying value of the Thailand business was determined to be greater than its fair value and a loss on assets held for sale was recorded during the first quarter of 2022. The sale closed in the second quarter of 2022, and the ultimate loss on the sale was not material. The loss on assets held for sale is reflected in the unaudited condensed consolidated statement of operations in operating expenses within the Health Care Benefits segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;During the three and six months ended June&#160;30, 2021, acquisition-related integration costs relate to the acquisition of Aetna. The acquisition-related integration costs are reflected in the unaudited condensed consolidated statements of operations in operating expenses within the Corporate/Other segment. &lt;/span&gt;&lt;/div&gt;(6)In June 2021, the Company received $61 million related to a purchase price working capital adjustment for an acquisition completed during the first quarter of 2020. The resolution of this matter occurred subsequent to the acquisition accounting measurement period and is reflected in the Company&#x2019;s unaudited condensed consolidated statements of operations for the three and six months ended June&#160;30, 2021 as a reduction of operating expenses within the Health Care Benefits segment.</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RleHRyZWdpb246OTBlMDJkZDRiODFjNGNiOTk3NGM2ODBmMTUxYzMzMDFfNDE_49959d9f-3c39-47d0-83c3-1a3e248984f1"
      unitRef="segment">3</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RleHRyZWdpb246OTBlMDJkZDRiODFjNGNiOTk3NGM2ODBmMTUxYzMzMDFfNDQ0OA_22dfae15-cc71-4a52-9259-b77885ddfed5">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of financial measures of the Company&#x2019;s segments to the consolidated totals:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Services &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Eliminations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,328)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,328)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(555)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(183)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,616)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,616)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(860)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(672)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(337)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Total revenues of the Pharmacy Services segment include approximately $3.1 billion and $2.8 billion of retail co-payments for the three months ended  June&#160;30, 2022 and 2021, respectively, and $6.9 billion and $6.2 billion of retail co-payments for the six months ended June&#160;30, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Pharmacy Services segment, and/or the Retail/LTC segment. Intersegment adjusted operating income eliminations occur when members of Pharmacy Services Segment clients (&#x201c;PSS members&#x201d;) enrolled in Maintenance Choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; elect to pick up maintenance prescriptions at one of the Company&#x2019;s retail pharmacies instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail/LTC segments record the adjusted operating income on a stand-alone basis.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib5045314d03040549992e1b0d350c6f4_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMy0xLTEtMS0xMjE3OTc_97d3a4ce-8922-4f1d-b799-018aa8fb4355"
      unitRef="usd">22645000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61b1e59accbc4a6b9fdbbf4dd1e166d8_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMy0zLTEtMS0xMjE3OTc_95c8d151-68d4-4d4a-9741-c9c1c31d5767"
      unitRef="usd">39859000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i054a08a597154e34b91b50e36527b86c_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMy01LTEtMS0xMjE3OTc_e4d00986-ab96-4b1a-83f5-8a9bc75b5af2"
      unitRef="usd">17952000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i02a2e27009a64f7bb8e01545a97c8feb_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMy03LTEtMS0xMjE3OTc_6ea85cac-eedd-4725-8e01-3f97fc814e7f"
      unitRef="usd">34000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMy0xMS0xLTEtMTIxNzk3_42bd8c5a-7a3c-4b58-a651-5b760eb542c7"
      unitRef="usd">80490000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3962c203da554375b32683c47219d427_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNC0xLTEtMS0xMjE3OTc_2ade62fc-c5b6-4d42-8cd4-afd4e300c1d1"
      unitRef="usd">23000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie2694c12478b4def9c47ecb3ea71da60_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNC0zLTEtMS0xMjE3OTc_830a9ed6-99a8-44e8-a10b-9ef4775cc549"
      unitRef="usd">2953000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id75c1b3a512c4c79892d583882a1967c_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNC01LTEtMS0xMjE3OTc_ba5a9676-a1e8-4fac-874f-086ed409470a"
      unitRef="usd">8352000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if1040a72d0304a058af732ed3761a15a_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNC05LTEtMS0xMjE3OTc_5756750e-a66d-4039-bea4-b771b913e748"
      unitRef="usd">-11328000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="ib5045314d03040549992e1b0d350c6f4_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNS0xLTEtMS0xMjE3OTc_f18f10ed-9d0b-49a8-a7f1-05f22d3466a8"
      unitRef="usd">88000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i61b1e59accbc4a6b9fdbbf4dd1e166d8_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNS0zLTEtMS0xMjE3OTc_76f3fb83-1e6d-4889-9e52-d3894172ca7b"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i054a08a597154e34b91b50e36527b86c_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNS01LTEtMS0xMjE3OTc_be6be382-c22f-4905-9416-bfb7005a96a9"
      unitRef="usd">-18000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i02a2e27009a64f7bb8e01545a97c8feb_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNS03LTEtMS0xMjE3OTc_744c454b-f9c5-45a8-84ad-aad79f69f38f"
      unitRef="usd">76000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="if1040a72d0304a058af732ed3761a15a_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNS05LTEtMS0xMjE3OTc_e96d0d16-c015-49f9-9282-4a445144814d"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNS0xMS0xLTEtMTIxNzk3_50378b8c-d0b1-4d1b-af84-784a9b68617e"
      unitRef="usd">146000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="i44edbe7ef7ad43448a3b2d7631217636_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNi0xLTEtMS0xMjE3OTc_a1771858-7864-4f14-b849-65a10d466e78"
      unitRef="usd">22756000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3151b5f7456a43f18c1835c93c3d75af_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNi0zLTEtMS0xMjE3OTc_1fbd479c-31ec-41e0-a60f-051d5d2dec2f"
      unitRef="usd">42812000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic9187390af124c90962d0c6a2b195568_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNi01LTEtMS0xMjE3OTc_3e641451-6228-4709-b38c-f22a955f3f0d"
      unitRef="usd">26286000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i02a2e27009a64f7bb8e01545a97c8feb_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNi03LTEtMS0xMjE3OTc_b19c5dd5-228b-4d5f-9b7b-304ba0fae445"
      unitRef="usd">110000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if1040a72d0304a058af732ed3761a15a_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNi05LTEtMS0xMjE3OTc_43c9d347-37e2-4c74-9353-0c8770ebdbb6"
      unitRef="usd">-11328000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNi0xMS0xLTEtMTIxNzk3_c3cddfa9-d691-4281-a5c5-9c47d07a8187"
      unitRef="usd">80636000000</us-gaap:Revenues>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ib5045314d03040549992e1b0d350c6f4_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNy0xLTEtMS0xMjE3OTc_741a0a57-fe72-4c85-8ae5-ed1d9f15528d"
      unitRef="usd">1831000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i61b1e59accbc4a6b9fdbbf4dd1e166d8_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNy0zLTEtMS0xMjE3OTc_cbdd45a8-355d-42a6-9db6-5d2db3d6a17a"
      unitRef="usd">1855000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i054a08a597154e34b91b50e36527b86c_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNy01LTEtMS0xMjE3OTc_d82cf5cf-87de-423b-a374-1a12ada5abc2"
      unitRef="usd">1862000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i02a2e27009a64f7bb8e01545a97c8feb_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNy03LTEtMS0xMjE3OTc_33529953-adbd-43b2-af54-3f55b9fe8fb6"
      unitRef="usd">-555000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="if1040a72d0304a058af732ed3761a15a_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNy05LTEtMS0xMjE3OTc_48893e07-532f-4874-8b4f-e4b87cb7a1ed"
      unitRef="usd">-183000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfNy0xMS0xLTEtMTIxNzk3_4df2f5d1-bc02-4416-a8df-f5423a71ca92"
      unitRef="usd">4810000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iac24217ba0c74626b4bf25cec318c623_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTAtMS0xLTEtMTIxNzk3_b03fca31-871b-4e7c-a7eb-3d7bb6027800"
      unitRef="usd">20367000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if86bb61e4141479b9697828b3dc20cc6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTAtMy0xLTEtMTIxNzk3_facef4db-f85f-4a55-99b6-55e411141f81"
      unitRef="usd">35745000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic44e989a3ada405d8425fbe65629dc23_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTAtNS0xLTEtMTIxNzk3_69277aff-feb7-40db-9d77-512e8fc0945c"
      unitRef="usd">16185000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3fa7e9e824974440a9373bee9896bb39_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTAtNy0xLTEtMTIxNzk3_0dd8ad75-cafc-4156-bb17-a6effe6898a3"
      unitRef="usd">30000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTAtMTEtMS0xLTEyMTc5Nw_da40b270-7c26-4173-8dae-9353c51e901d"
      unitRef="usd">72327000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icd5001431c3443ff88087eb017ad54d3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTEtMS0xLTEtMTIxNzk3_6b11ecef-5475-4c96-a3e1-8424230515d5"
      unitRef="usd">21000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i21057757e50f4f2ea39ea7414498d440_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTEtMy0xLTEtMTIxNzk3_801ff96d-39cd-4bce-b70b-cd3054dcfc57"
      unitRef="usd">2569000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie4ddbdc32c264c4891a21d2f9fcead1d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTEtNS0xLTEtMTIxNzk3_81a60a9b-d5cd-4af8-894b-233776951801"
      unitRef="usd">8543000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4922155132bd45ada7189d0b3ef9fc3e_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTEtOS0xLTEtMTIxNzk3_bf27ca8a-fb68-4188-8bf6-884ecc2413d1"
      unitRef="usd">-11133000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="iac24217ba0c74626b4bf25cec318c623_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTItMS0xLTEtMTIxNzk3_e14f0a89-c8ef-406f-8764-302d27316631"
      unitRef="usd">137000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="if86bb61e4141479b9697828b3dc20cc6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTItMy0xLTEtMTIxNzk3_de653d12-cb14-4954-a5d9-ef47ff913c8e"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ic44e989a3ada405d8425fbe65629dc23_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTItNS0xLTEtMTIxNzk3_9626702d-2eb6-4bfc-b87c-2df6b43ecd42"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i3fa7e9e824974440a9373bee9896bb39_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTItNy0xLTEtMTIxNzk3_4f3b693f-d0a8-424b-b0f6-0960fc9f78f3"
      unitRef="usd">152000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i4922155132bd45ada7189d0b3ef9fc3e_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTItOS0xLTEtMTIxNzk3_7743df0a-9576-4b4d-9f37-d4804bea7f81"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTItMTEtMS0xLTEyMTc5Nw_36502afb-f958-4701-9722-3f0b7416f66a"
      unitRef="usd">289000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="i755c9c59fb084cf0998fe64e0d197ec9_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTMtMS0xLTEtMTIxNzk3_0bf01886-7861-4463-b217-1acbb0d51b16"
      unitRef="usd">20525000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i991ced4046224c589a965f12944e86a9_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTMtMy0xLTEtMTIxNzk3_1beb055b-23b6-4838-8a72-68cd422a3ed7"
      unitRef="usd">38314000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id55fb76a33f24129b20ebde108e75c89_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTMtNS0xLTEtMTIxNzk3_0cd65d73-a2e3-4707-97ee-9447a4d9ccf5"
      unitRef="usd">24728000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3fa7e9e824974440a9373bee9896bb39_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTMtNy0xLTEtMTIxNzk3_162163f6-a637-4015-b29e-eeddd21c901a"
      unitRef="usd">182000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4922155132bd45ada7189d0b3ef9fc3e_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTMtOS0xLTEtMTIxNzk3_aa7c92e4-851e-4e66-bb28-9e18d0f65884"
      unitRef="usd">-11133000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTMtMTEtMS0xLTEyMTc5Nw_065e31bf-fa6d-445b-93bd-5ecadfd05818"
      unitRef="usd">72616000000</us-gaap:Revenues>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="iac24217ba0c74626b4bf25cec318c623_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTQtMS0xLTEtMTIxNzk3_a0ffc4b1-85b8-45f3-8311-2f1deaaa3f77"
      unitRef="usd">1614000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="if86bb61e4141479b9697828b3dc20cc6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTQtMy0xLTEtMTIxNzk3_3596e494-d8fc-420c-9d12-7566f6b4583b"
      unitRef="usd">1755000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ic44e989a3ada405d8425fbe65629dc23_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTQtNS0xLTEtMTIxNzk3_0a0030a0-1e69-4516-90c6-f4b95e36670e"
      unitRef="usd">2049000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i3fa7e9e824974440a9373bee9896bb39_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTQtNy0xLTEtMTIxNzk3_1ec86406-22f7-4476-ba2d-1231edae716c"
      unitRef="usd">-369000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i4922155132bd45ada7189d0b3ef9fc3e_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTQtOS0xLTEtMTIxNzk3_7b14b470-264a-4a0e-85ac-81c05b1b8286"
      unitRef="usd">-162000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTQtMTEtMS0xLTEyMTc5Nw_5a131d51-d833-432a-8b21-ebe5de6abb14"
      unitRef="usd">4887000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia17daf1ddb80489bbdce4d94932efa21_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTgtMS0xLTEtMTIxNzk3_d668d659-f42d-4c56-908f-419852d847a7"
      unitRef="usd">45642000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib89fad02b4b74e5cbffe8ec18de4bc64_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTgtMy0xLTEtMTIxNzk3_b7fb0972-f462-4285-a271-661577183d89"
      unitRef="usd">76055000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i88782d759ab24dbd8db24d6e19ba64de_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTgtNS0xLTEtMTIxNzk3_8c3f79f0-1aef-44d5-9a4c-0b147d2fe501"
      unitRef="usd">35386000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8feac348d42b418da086e65a9b0801eb_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTgtNy0xLTEtMTIxNzk3_90b85ddf-242f-420f-881e-6cb5960d834e"
      unitRef="usd">65000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTgtMTEtMS0xLTEyMTc5Nw_acfe7a16-28a6-4b71-b884-c6e197bec38a"
      unitRef="usd">157148000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3bdb38f213f74f5ba49000631d9615b7_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTktMS0xLTEtMTIxNzk3_71eb2225-990c-45c7-8351-13aa720503ba"
      unitRef="usd">46000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i28d06c947ab54421a9e15efa5f456726_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTktMy0xLTEtMTIxNzk3_d3f9d30b-a5fe-4804-83c7-cf54754be0f1"
      unitRef="usd">6218000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idf6b44713106481ab0b80236ef727531_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTktNS0xLTEtMTIxNzk3_a6c84a67-bf09-485f-be57-e19c1a850fd8"
      unitRef="usd">16352000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9b2e6ca6c94b4ad5afd1d4f01f87431e_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMTktOS0xLTEtMTIxNzk3_f3c4d6d5-ec55-4275-8cb2-d9eb4accf003"
      unitRef="usd">-22616000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="ia17daf1ddb80489bbdce4d94932efa21_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjAtMS0xLTEtMTIxNzk3_350c86a6-ec38-4c36-bc2e-e3e7065a9dea"
      unitRef="usd">177000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ib89fad02b4b74e5cbffe8ec18de4bc64_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjAtMy0xLTEtMTIxNzk3_068a07af-92ea-4118-bfec-c56805a153ce"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i88782d759ab24dbd8db24d6e19ba64de_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjAtNS0xLTEtMTIxNzk3_6d12b180-0399-4c0f-ae58-73aea321ef0b"
      unitRef="usd">-34000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i8feac348d42b418da086e65a9b0801eb_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjAtNy0xLTEtMTIxNzk3_78897e49-3cc8-47f7-a36d-dd0b6ffe506a"
      unitRef="usd">171000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i9b2e6ca6c94b4ad5afd1d4f01f87431e_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjAtOS0xLTEtMTIxNzk3_af2b02c7-0ac8-458d-a194-41d78a61fc2f"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjAtMTEtMS0xLTEyMTc5Nw_be07941a-c8de-473c-b4f0-27dbd4d791b3"
      unitRef="usd">314000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="i1c0bcd0eebfa40769648a67be75183aa_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjEtMS0xLTEtMTIxNzk3_1fe2db1b-6714-4731-86bd-3a593513e214"
      unitRef="usd">45865000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9ec2e1d871b94a40bc8202c2e78c4a16_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjEtMy0xLTEtMTIxNzk3_86e7fa9b-5d14-406c-9a64-20dbf9e92fab"
      unitRef="usd">82273000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia0f6137335b9496e89f147de3d2c0b66_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjEtNS0xLTEtMTIxNzk3_4aa0ccd4-a2ee-4f0d-ba19-9478180721d2"
      unitRef="usd">51704000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8feac348d42b418da086e65a9b0801eb_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjEtNy0xLTEtMTIxNzk3_8317bfb2-82f0-409c-86c3-dd128ade6f57"
      unitRef="usd">236000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9b2e6ca6c94b4ad5afd1d4f01f87431e_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjEtOS0xLTEtMTIxNzk3_a24fbed6-3e52-4ce4-9fc1-5afd43764ca1"
      unitRef="usd">-22616000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjEtMTEtMS0xLTEyMTc5Nw_5c108b73-4c32-4ccd-8f7b-d763a64c422d"
      unitRef="usd">157462000000</us-gaap:Revenues>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ia17daf1ddb80489bbdce4d94932efa21_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjItMS0xLTEtMTIxNzk3_ed3ed027-23e3-411c-b49a-a0fd30ce2189"
      unitRef="usd">3582000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ib89fad02b4b74e5cbffe8ec18de4bc64_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjItMy0xLTEtMTIxNzk3_a8abaa5e-5ba9-4909-9589-03c9e0fec407"
      unitRef="usd">3491000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i88782d759ab24dbd8db24d6e19ba64de_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjItNS0xLTEtMTIxNzk3_b66729e7-330f-4876-b194-d68f91c4e547"
      unitRef="usd">3467000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i8feac348d42b418da086e65a9b0801eb_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjItNy0xLTEtMTIxNzk3_b133ac2a-ea60-4118-af80-bbce82561860"
      unitRef="usd">-860000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i9b2e6ca6c94b4ad5afd1d4f01f87431e_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjItOS0xLTEtMTIxNzk3_59531d42-8bbd-4867-bc1c-cf0587be1f7a"
      unitRef="usd">-387000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjItMTEtMS0xLTEyMTc5Nw_69e5f6c1-6f69-4fb1-a786-bf4d8e959631"
      unitRef="usd">9293000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i65583ca6502143fea8109266db45d395_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjUtMS0xLTEtMTIxNzk3_386a5810-853d-4d44-ab6d-494eb7726cff"
      unitRef="usd">40682000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibfa2cea5de8e43f9ba651607d9a10c30_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjUtMy0xLTEtMTIxNzk3_1c70ffab-8b31-4764-87a9-6acecc0470b4"
      unitRef="usd">69058000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia1d59b798de8427bb69d0f7d325309b7_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjUtNS0xLTEtMTIxNzk3_08530487-ae09-49f8-983c-9ae1e7c748ed"
      unitRef="usd">31325000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iec432ef32c864c91b9106f3307398132_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjUtNy0xLTEtMTIxNzk3_50ba7339-6fa1-4e70-a6b9-da28d8851ef0"
      unitRef="usd">62000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjUtMTEtMS0xLTEyMTc5Nw_ebcf58a7-9135-43eb-84d4-96604e32807f"
      unitRef="usd">141127000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3203c39f39494e9b94ddb12984f8082f_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjYtMS0xLTEtMTIxNzk3_f9fcc1f6-7942-48f8-8271-08bf051e2d89"
      unitRef="usd">41000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4392ff7352894adabc22a650b7c08adb_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjYtMy0xLTEtMTIxNzk3_e3b23a6c-7527-4b12-a520-f14f82bf622e"
      unitRef="usd">5577000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iea76a931684f4ae5b894d9b3eac6dabf_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjYtNS0xLTEtMTIxNzk3_87d62934-a267-40f4-a841-be648a69e3b5"
      unitRef="usd">16631000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1bb38325fd294ffcb76280c930132208_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjYtOS0xLTEtMTIxNzk3_a6e4345e-fbc2-4728-988b-1dfa947a153b"
      unitRef="usd">-22249000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i65583ca6502143fea8109266db45d395_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjctMS0xLTEtMTIxNzk3_26f647ae-9f32-41f3-8189-9d609ed58ec4"
      unitRef="usd">285000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ibfa2cea5de8e43f9ba651607d9a10c30_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjctMy0xLTEtMTIxNzk3_2bd9bca2-56e8-490d-b9af-c3ee7314ba51"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ia1d59b798de8427bb69d0f7d325309b7_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjctNS0xLTEtMTIxNzk3_2080805e-e48a-4343-bd74-e0da788dbb92"
      unitRef="usd">46000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="iec432ef32c864c91b9106f3307398132_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjctNy0xLTEtMTIxNzk3_00270083-6e25-45d0-9e0d-6303bb1c272c"
      unitRef="usd">255000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i1bb38325fd294ffcb76280c930132208_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjctOS0xLTEtMTIxNzk3_a37dd88e-5ac4-45cd-a06a-20415c701be2"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjctMTEtMS0xLTEyMTc5Nw_124ab4da-081a-4c6d-accf-5c48be5d4eb1"
      unitRef="usd">586000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="i856f8df36f55432cba11d2c1b2e7ba4e_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjgtMS0xLTEtMTIxNzk3_e7a5bccc-17c6-47ed-b9f8-63185cfeb09e"
      unitRef="usd">41008000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i904838b1ae43477cbccf8a6438f44ca8_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjgtMy0xLTEtMTIxNzk3_e7e23507-eebc-41c7-8a9b-094cd0494e9a"
      unitRef="usd">74635000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3e5cd64cbc2d4ccabb220d0769a9469d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjgtNS0xLTEtMTIxNzk3_bc366b1d-bef9-4297-b2e5-97052427a963"
      unitRef="usd">48002000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iec432ef32c864c91b9106f3307398132_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjgtNy0xLTEtMTIxNzk3_7b0389e7-d575-4ac0-a85f-fc5ea5818b1f"
      unitRef="usd">317000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1bb38325fd294ffcb76280c930132208_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjgtOS0xLTEtMTIxNzk3_5faf80c5-973c-4eef-84eb-cf54e4a7cbe6"
      unitRef="usd">-22249000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjgtMTEtMS0xLTEyMTc5Nw_d4eaa068-d583-4961-afaf-4399dc61859f"
      unitRef="usd">141713000000</us-gaap:Revenues>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i65583ca6502143fea8109266db45d395_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjktMS0xLTEtMTIxNzk3_c76716e4-b71a-4651-bf3b-b7735d653c52"
      unitRef="usd">3396000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ibfa2cea5de8e43f9ba651607d9a10c30_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjktMy0xLTEtMTIxNzk3_f72ab61b-afe5-47bb-aeb8-b773f9789a0c"
      unitRef="usd">3262000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ia1d59b798de8427bb69d0f7d325309b7_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjktNS0xLTEtMTIxNzk3_94c79ca9-9213-477e-9aec-2bf1c75dbcf0"
      unitRef="usd">3443000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="iec432ef32c864c91b9106f3307398132_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjktNy0xLTEtMTIxNzk3_c5bafb2a-f2d3-41c2-bb67-049a1bc6796e"
      unitRef="usd">-672000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i1bb38325fd294ffcb76280c930132208_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjktOS0xLTEtMTIxNzk3_c53b35f2-3bca-43db-ac93-b19938185245"
      unitRef="usd">-337000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI0YjIwMzVhYTA2ZjRjNzI5ZmNlNmY1OGRkZGQ5YjdkL3RhYmxlcmFuZ2U6MjRiMjAzNWFhMDZmNGM3MjlmY2U2ZjU4ZGRkZDliN2RfMjktMTEtMS0xLTEyMTc5Nw_c53f07af-94fa-4053-b7e2-fd302747acf8"
      unitRef="usd">9092000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:NetRevenuesRetailCoPayments
      contextRef="i61b1e59accbc4a6b9fdbbf4dd1e166d8_D20220401-20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RleHRyZWdpb246OTBlMDJkZDRiODFjNGNiOTk3NGM2ODBmMTUxYzMzMDFfMTczOA_b5135ee5-9ae7-40b9-82ac-1ea9941e60ed"
      unitRef="usd">3100000000</cvs:NetRevenuesRetailCoPayments>
    <cvs:NetRevenuesRetailCoPayments
      contextRef="if86bb61e4141479b9697828b3dc20cc6_D20210401-20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RleHRyZWdpb246OTBlMDJkZDRiODFjNGNiOTk3NGM2ODBmMTUxYzMzMDFfMTc0NQ_2a9e937b-a0e9-4192-b08b-5d56d67442f0"
      unitRef="usd">2800000000</cvs:NetRevenuesRetailCoPayments>
    <cvs:NetRevenuesRetailCoPayments
      contextRef="ib89fad02b4b74e5cbffe8ec18de4bc64_D20220101-20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RleHRyZWdpb246OTBlMDJkZDRiODFjNGNiOTk3NGM2ODBmMTUxYzMzMDFfMTA5OTUxMTYzMjMxMQ_fac203fe-ed4e-4cba-933f-7a29c195752c"
      unitRef="usd">6900000000</cvs:NetRevenuesRetailCoPayments>
    <cvs:NetRevenuesRetailCoPayments
      contextRef="ibfa2cea5de8e43f9ba651607d9a10c30_D20210101-20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RleHRyZWdpb246OTBlMDJkZDRiODFjNGNiOTk3NGM2ODBmMTUxYzMzMDFfMTA5OTUxMTYzMjMxOQ_befef6c1-dfb2-4d55-a79f-c42d60e23c5e"
      unitRef="usd">6200000000</cvs:NetRevenuesRetailCoPayments>
    <cvs:ReconciliationOfOperatingIncomeToAdjustedOperatingIncomeTableTextBlock
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RleHRyZWdpb246OTBlMDJkZDRiODFjNGNiOTk3NGM2ODBmMTUxYzMzMDFfNDQzOA_f3d4c572-0689-41a0-bca3-acc2303b9e04">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are reconciliations of consolidated operating income to adjusted operating income for the three and six months ended June&#160;30, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.3pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (GAAP measure)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on divestiture of subsidiary &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(225)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(225)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal settlement &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on assets held for sale &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related integration costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition purchase price adjustment outside of measurement period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company&#x2019;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the unaudited condensed consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#x2019;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#x2019;s insurance products, the services performed for the Company&#x2019;s customers or the sale of the Company&#x2019;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#x2019;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#x2019;s and investors&#x2019; ability to compare the Company&#x2019;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#x2019;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;During the three and six months ended June&#160;30, 2022, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of PayFlex, which the Company sold on June 1, 2022, for approximately $775&#160;million. The gain on divestiture is reflected as a reduction in operating expenses in the Company&#x2019;s unaudited condensed consolidated statements of operations within the Health Care Benefits segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;During the six months ended June&#160;30, 2022, the legal settlement relates to the agreement with the State of Florida, entered into in March 2022, to resolve claims dating back more than a decade related to opioid medications. Under this agreement, CVS Health Corporation settled all opioid claims against it and its subsidiaries by the State of Florida for $484&#160;million, inclusive of certain legal fees, to be paid over a period of 18 years. The legal settlement is reflected in the unaudited condensed consolidated statement of operations in operating expenses within the Corporate/Other segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;During the six months ended June&#160;30, 2022, the loss on assets held for sale relates to the Commercial Business reporting unit within the Health Care Benefits segment. In March 2022, the Company reached an agreement to sell its Thailand business, which was included in the Commercial Business reporting unit. At that time, a portion of the Commercial Business goodwill was specifically allocated to the Thailand business. The net assets of the Thailand business were accounted for as assets held for sale at March 31, 2022. The carrying value of the Thailand business was determined to be greater than its fair value and a loss on assets held for sale was recorded during the first quarter of 2022. The sale closed in the second quarter of 2022, and the ultimate loss on the sale was not material. The loss on assets held for sale is reflected in the unaudited condensed consolidated statement of operations in operating expenses within the Health Care Benefits segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;During the three and six months ended June&#160;30, 2021, acquisition-related integration costs relate to the acquisition of Aetna. The acquisition-related integration costs are reflected in the unaudited condensed consolidated statements of operations in operating expenses within the Corporate/Other segment. &lt;/span&gt;&lt;/div&gt;(6)In June 2021, the Company received $61 million related to a purchase price working capital adjustment for an acquisition completed during the first quarter of 2020. The resolution of this matter occurred subsequent to the acquisition accounting measurement period and is reflected in the Company&#x2019;s unaudited condensed consolidated statements of operations for the three and six months ended June&#160;30, 2021 as a reduction of operating expenses within the Health Care Benefits segment.</cvs:ReconciliationOfOperatingIncomeToAdjustedOperatingIncomeTableTextBlock>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfMi0xLTEtMS0xMjE3OTc_da982265-9d85-4055-9264-b61c44f6ccb9"
      unitRef="usd">4569000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfMi0zLTEtMS0xMjE3OTc_b1820df7-684a-4403-aecd-78e7526ff1a7"
      unitRef="usd">4326000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfMi01LTEtMS0xMjE3OTc_c0982b61-fc24-474a-987b-76846326d855"
      unitRef="usd">8059000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfMi03LTEtMS0xMjE3OTc_38d0b4b1-1370-4e0e-af64-5f9a3a25b5a9"
      unitRef="usd">7903000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfMy0xLTEtMS0xMjE3OTc_0abd2c70-8d42-4bbf-a6ba-92e855f20879"
      unitRef="usd">466000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfMy0zLTEtMS0xMjE3OTc_a59a8903-89d7-4c47-a414-a1ba52fe49af"
      unitRef="usd">582000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfMy01LTEtMS0xMjE3OTc_617d5f6a-8619-480a-9289-f6a27df91f24"
      unitRef="usd">934000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfMy03LTEtMS0xMjE3OTc_aa350532-c30a-4b5d-ae7c-92ce2bd940e3"
      unitRef="usd">1169000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNC0xLTEtMS0xMzY0NzU_4f1ac19a-b7dd-4e30-8556-688e5d32d96e"
      unitRef="usd">225000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNC0zLTEtMS0xMzY0Nzk_9e7999a2-e9d3-442d-88e8-9dacac6e2855"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNC01LTEtMS0xMzY0ODI_2c706547-7404-4716-b1c4-f767e991a455"
      unitRef="usd">225000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNC03LTEtMS0xMzY0ODY_37e40bcf-d605-4f44-bcd7-fe333bdd7bff"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNC0xLTEtMS0xMjE3OTc_55dfff34-800f-4a7f-b077-c8f722ea0e2b"
      unitRef="usd">0</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNC0zLTEtMS0xMjE3OTc_c05390b2-2a1f-4e6c-94ec-2c2b19f8d9ce"
      unitRef="usd">0</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNC01LTEtMS0xMjgyMDY_567a52e0-37b6-4ef4-a674-f683212ef4da"
      unitRef="usd">-484000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNC03LTEtMS0xMjk3Nzk_0c83104b-d79c-4b1f-9407-6601768ba42b"
      unitRef="usd">0</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNS0xLTEtMS0xMjE3OTc_916b7048-3757-4c6c-9238-48c5a412a36d"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNS0zLTEtMS0xMjE3OTc_c0766bae-0567-486f-91b2-0e071247dfe5"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNS01LTEtMS0xMjgyMDY_9241bbd9-df99-4f3f-9682-55a785b53786"
      unitRef="usd">41000000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNS03LTEtMS0xMjk3Nzk_4c79060b-0eda-4113-992d-360b0c074c84"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNi0xLTEtMS0xMjE3OTc_1e18ead1-f1cf-4b98-a18c-cb128803a652"
      unitRef="usd">0</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNi0zLTEtMS0xMjE3OTc_be8bd7e5-725e-4d92-87d9-54f4f90f2e25"
      unitRef="usd">40000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNi01LTEtMS0xMjE3OTc_664b6dac-3638-4d42-b934-a6f909ee14d2"
      unitRef="usd">0</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNi03LTEtMS0xMjE3OTc_049ac38d-b57b-427d-a44b-229a6cb97b45"
      unitRef="usd">81000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNy0xLTEtMS0xMjE3OTc_42d88774-9a14-4cad-af29-42d41bf26602"
      unitRef="usd">0</cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod>
    <cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNy0zLTEtMS0xMjE3OTc_9534771a-8267-48d9-812f-edeee25290d5"
      unitRef="usd">61000000</cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod>
    <cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNy01LTEtMS0xMjE3OTc_5efc79e1-b163-43bf-9b46-d99cc5dba4f4"
      unitRef="usd">0</cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod>
    <cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfNy03LTEtMS0xMjE3OTc_27280840-a340-48cc-a5a6-bef2ab529a68"
      unitRef="usd">61000000</cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfMTAtMS0xLTEtMTIxNzk3_4df2f5d1-bc02-4416-a8df-f5423a71ca92"
      unitRef="usd">4810000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="if84de8cb2b0148819ffc4e93b0d1cc43_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfMTAtMy0xLTEtMTIxNzk3_5a131d51-d833-432a-8b21-ebe5de6abb14"
      unitRef="usd">4887000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfMTAtNS0xLTEtMTIxNzk3_69e5f6c1-6f69-4fb1-a786-bf4d8e959631"
      unitRef="usd">9293000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RhYmxlOjI3OTBiMzljY2M5NTRkNzhiY2JiZjNlODI3NGRlYmViL3RhYmxlcmFuZ2U6Mjc5MGIzOWNjYzk1NGQ3OGJjYmJmM2U4Mjc0ZGViZWJfMTAtNy0xLTEtMTIxNzk3_c53f07af-94fa-4053-b7e2-fd302747acf8"
      unitRef="usd">9092000000</cvs:AdjustedOperatingIncomeLoss>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="id743f37942444621831b2935b6d1e18a_D20220601-20220601"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RleHRyZWdpb246OTBlMDJkZDRiODFjNGNiOTk3NGM2ODBmMTUxYzMzMDFfMzg0ODI5MDcwNDExMA_08ace08c-0227-4f9e-a997-524b0c80c69b"
      unitRef="usd">775000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i2e0586238be64c3f99884eb8d13d76cb_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RleHRyZWdpb246OTBlMDJkZDRiODFjNGNiOTk3NGM2ODBmMTUxYzMzMDFfMzg0ODI5MDcwNTAwMQ_bbf98490-c167-4415-bd08-5843de85cec0"
      unitRef="usd">-484000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <cvs:LegalSettlementPeriodOfPayment
      contextRef="i8e046c9547cf4bf5b7545f9f74ee27f1_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RleHRyZWdpb246OTBlMDJkZDRiODFjNGNiOTk3NGM2ODBmMTUxYzMzMDFfMzAyNw_9058d580-7a3e-44ca-97da-c7b9d0dde6cc">P18Y</cvs:LegalSettlementPeriodOfPayment>
    <cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod
      contextRef="if9b86cad51db4e70bd972f1f3cf0a9ea_D20210601-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV82MS9mcmFnOjkwZTAyZGQ0YjgxYzRjYjk5NzRjNjgwZjE1MWMzMzAxL3RleHRyZWdpb246OTBlMDJkZDRiODFjNGNiOTk3NGM2ODBmMTUxYzMzMDFfMzg0ODI5MDcwNDk4Mg_d5112f56-5e7a-4320-8d82-00f693d05cb5"
      unitRef="usd">61000000</cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfOS01LTEtMS0xMjE3OTc_5f6533df-08ba-4e8e-8c9b-1267fa70c18f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfOS01LTEtMS0xMjE3OTc_5f6533df-08ba-4e8e-8c9b-1267fa70c18f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTYtMi0xLTEtMTIxNzk3_154f1ad4-fca3-4f85-92d2-5a7635f0565d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTYtMi0xLTEtMTIxNzk3_154f1ad4-fca3-4f85-92d2-5a7635f0565d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTItNS0xLTEtMTIxNzk3_686258d7-9a7b-45e9-9240-187605a59fdc"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTItNS0xLTEtMTIxNzk3_686258d7-9a7b-45e9-9240-187605a59fdc"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTktMi0xLTEtMTIxNzk3_03bce8fe-e38d-4c1a-ba83-666579445e99"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTktMi0xLTEtMTIxNzk3_03bce8fe-e38d-4c1a-ba83-666579445e99"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTYtNS0xLTEtMTIxNzk3_154e00c8-a541-4d98-accc-56eddbda1a6d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTYtNS0xLTEtMTIxNzk3_154e00c8-a541-4d98-accc-56eddbda1a6d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTItMi0xLTEtMTIxNzk3_1903b954-70cc-4787-accd-173691ab6baa"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTItMi0xLTEtMTIxNzk3_1903b954-70cc-4787-accd-173691ab6baa"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfOS0yLTEtMS0xMjE3OTc_ba77f96c-eade-451e-8d3a-2eb2bda33475"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfOS0yLTEtMS0xMjE3OTc_ba77f96c-eade-451e-8d3a-2eb2bda33475"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTktNS0xLTEtMTIxNzk3_09c716ae-4201-4796-8206-a2ee1f58bb89"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTktNS0xLTEtMTIxNzk3_09c716ae-4201-4796-8206-a2ee1f58bb89"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNS0yLTEtMS0xMjE3OTc_e1e5fa5f-7a8b-44b1-b10e-e547456d4b5f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNS0yLTEtMS0xMjE3OTc_e1e5fa5f-7a8b-44b1-b10e-e547456d4b5f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNS01LTEtMS0xMjE3OTc_3e47bdca-8b3c-4a9e-89e1-7a840174f8ce"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNS01LTEtMS0xMjE3OTc_3e47bdca-8b3c-4a9e-89e1-7a840174f8ce"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfNDky_63589532-c838-4110-b767-3f81e3cda92d" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfNDky_63589532-c838-4110-b767-3f81e3cda92d" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Treasury shares include 1 million shares held in trust and treasury stock includes $29 million related to shares held in trust as of June&#160;30, 2022, March&#160;31, 2022 and December&#160;31, 2021.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfOS01LTEtMS0xMjE3OTc_5f6533df-08ba-4e8e-8c9b-1267fa70c18f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfNDky_63589532-c838-4110-b767-3f81e3cda92d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTYtMi0xLTEtMTIxNzk3_154f1ad4-fca3-4f85-92d2-5a7635f0565d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfNDky_63589532-c838-4110-b767-3f81e3cda92d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTItNS0xLTEtMTIxNzk3_686258d7-9a7b-45e9-9240-187605a59fdc"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfNDky_63589532-c838-4110-b767-3f81e3cda92d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTktMi0xLTEtMTIxNzk3_03bce8fe-e38d-4c1a-ba83-666579445e99"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfNDky_63589532-c838-4110-b767-3f81e3cda92d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTYtNS0xLTEtMTIxNzk3_154e00c8-a541-4d98-accc-56eddbda1a6d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfNDky_63589532-c838-4110-b767-3f81e3cda92d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTItMi0xLTEtMTIxNzk3_1903b954-70cc-4787-accd-173691ab6baa"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfNDky_63589532-c838-4110-b767-3f81e3cda92d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfOS0yLTEtMS0xMjE3OTc_ba77f96c-eade-451e-8d3a-2eb2bda33475"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfNDky_63589532-c838-4110-b767-3f81e3cda92d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTktNS0xLTEtMTIxNzk3_09c716ae-4201-4796-8206-a2ee1f58bb89"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfNDky_63589532-c838-4110-b767-3f81e3cda92d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNS0yLTEtMS0xMjE3OTc_e1e5fa5f-7a8b-44b1-b10e-e547456d4b5f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfNDky_63589532-c838-4110-b767-3f81e3cda92d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNS01LTEtMS0xMjE3OTc_3e47bdca-8b3c-4a9e-89e1-7a840174f8ce"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfNDky_63589532-c838-4110-b767-3f81e3cda92d"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTItNC0xLTEtMTI3MDAz_bb526491-7c2b-4a52-9a48-cbbdf1fff5eb"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTItNC0xLTEtMTI3MDAz_bb526491-7c2b-4a52-9a48-cbbdf1fff5eb"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNS00LTEtMS0xMjcwMDM_54fa1447-121f-4df3-8c6b-e02c861e6ab3"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNS00LTEtMS0xMjcwMDM_54fa1447-121f-4df3-8c6b-e02c861e6ab3"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTUtNC0xLTEtMTI3MDAz_eeb6dd1a-454a-40c5-9b62-7871e942aac9"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTUtNC0xLTEtMTI3MDAz_eeb6dd1a-454a-40c5-9b62-7871e942aac9"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfOC00LTEtMS0xMjcwMDM_8e4d2ad2-b399-4b6a-940c-a2e3e0d503e8"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfOC00LTEtMS0xMjcwMDM_8e4d2ad2-b399-4b6a-940c-a2e3e0d503e8"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTktNC0xLTEtMTI3MDAz_da028d11-1181-47fb-8de2-1199b5addb2e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTktNC0xLTEtMTI3MDAz_da028d11-1181-47fb-8de2-1199b5addb2e"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMzI5ODUzNDg4NDU2MQ_057b7f4e-b885-4b2e-9da9-bf48cbe75bc8" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMzI5ODUzNDg4NDU2MQ_057b7f4e-b885-4b2e-9da9-bf48cbe75bc8" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Common stock and capital surplus includes the par value of common stock of $17 million as of June&#160;30, 2021, March 31, 2021 and December 31, 2020.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTItNC0xLTEtMTI3MDAz_bb526491-7c2b-4a52-9a48-cbbdf1fff5eb"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMzI5ODUzNDg4NDU2MQ_057b7f4e-b885-4b2e-9da9-bf48cbe75bc8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNS00LTEtMS0xMjcwMDM_54fa1447-121f-4df3-8c6b-e02c861e6ab3"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMzI5ODUzNDg4NDU2MQ_057b7f4e-b885-4b2e-9da9-bf48cbe75bc8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTUtNC0xLTEtMTI3MDAz_eeb6dd1a-454a-40c5-9b62-7871e942aac9"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMzI5ODUzNDg4NDU2MQ_057b7f4e-b885-4b2e-9da9-bf48cbe75bc8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfOC00LTEtMS0xMjcwMDM_8e4d2ad2-b399-4b6a-940c-a2e3e0d503e8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMzI5ODUzNDg4NDU2MQ_057b7f4e-b885-4b2e-9da9-bf48cbe75bc8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTktNC0xLTEtMTI3MDAz_da028d11-1181-47fb-8de2-1199b5addb2e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMzI5ODUzNDg4NDU2MQ_057b7f4e-b885-4b2e-9da9-bf48cbe75bc8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTUtNC0xLTEtMTIxNzk3_6c2747e3-dede-457b-8fb6-f18a11dd3d80"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTUtNC0xLTEtMTIxNzk3_6c2747e3-dede-457b-8fb6-f18a11dd3d80"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfOC00LTEtMS0xMjE3OTc_c0b1eebe-cd0a-4caa-87f2-58695294064f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfOC00LTEtMS0xMjE3OTc_c0b1eebe-cd0a-4caa-87f2-58695294064f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNS00LTEtMS0xMjE3OTc_ffce7b07-c2e2-4a8b-9241-b8361898f9d8"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNS00LTEtMS0xMjE3OTc_ffce7b07-c2e2-4a8b-9241-b8361898f9d8"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTktNC0xLTEtMTIxNzk3_987e90b2-e1f5-4dd2-b500-7e736e8766e7"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTktNC0xLTEtMTIxNzk3_987e90b2-e1f5-4dd2-b500-7e736e8766e7"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTItNC0xLTEtMTIxNzk3_dfa4649c-3f50-4e27-b8ac-8f10a789d3bb"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTItNC0xLTEtMTIxNzk3_dfa4649c-3f50-4e27-b8ac-8f10a789d3bb"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfNDkw_1003b8e3-dae8-4a27-82a0-29bb92e78bc3" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfNDkw_1003b8e3-dae8-4a27-82a0-29bb92e78bc3" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Common stock and capital surplus includes the par value of common stock of $18 million as of June&#160;30, 2022 and $17 million as of March&#160;31, 2022 and December&#160;31, 2021.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTUtNC0xLTEtMTIxNzk3_6c2747e3-dede-457b-8fb6-f18a11dd3d80"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfNDkw_1003b8e3-dae8-4a27-82a0-29bb92e78bc3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfOC00LTEtMS0xMjE3OTc_c0b1eebe-cd0a-4caa-87f2-58695294064f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfNDkw_1003b8e3-dae8-4a27-82a0-29bb92e78bc3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfNS00LTEtMS0xMjE3OTc_ffce7b07-c2e2-4a8b-9241-b8361898f9d8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfNDkw_1003b8e3-dae8-4a27-82a0-29bb92e78bc3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTktNC0xLTEtMTIxNzk3_987e90b2-e1f5-4dd2-b500-7e736e8766e7"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfNDkw_1003b8e3-dae8-4a27-82a0-29bb92e78bc3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjM2Y2RmMDk4MmI4YTRiOWM4ZTk0OTAwOTZjOThmMzVhL3RhYmxlcmFuZ2U6MzZjZGYwOTgyYjhhNGI5YzhlOTQ5MDA5NmM5OGYzNWFfMTItNC0xLTEtMTIxNzk3_dfa4649c-3f50-4e27-b8ac-8f10a789d3bb"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfNDkw_1003b8e3-dae8-4a27-82a0-29bb92e78bc3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTItNS0xLTEtMTI3MDAz_c33682a7-bcff-478e-bd70-3c9fde37f6fa"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTItNS0xLTEtMTI3MDAz_c33682a7-bcff-478e-bd70-3c9fde37f6fa"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNS0yLTEtMS0xMjcwMDM_4b69fe63-e272-4068-992d-1a5b471b8279"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNS0yLTEtMS0xMjcwMDM_4b69fe63-e272-4068-992d-1a5b471b8279"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTktMi0xLTEtMTI3MDAz_01df612b-9071-4ff9-8baf-73b2748bcc51"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTktMi0xLTEtMTI3MDAz_01df612b-9071-4ff9-8baf-73b2748bcc51"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTItMi0xLTEtMTI3MDAz_911440fa-050b-488a-899d-429c516738f6"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTItMi0xLTEtMTI3MDAz_911440fa-050b-488a-899d-429c516738f6"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNS01LTEtMS0xMjcwMDM_797349a6-d7bb-4e80-99b7-d08c78b967a4"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNS01LTEtMS0xMjcwMDM_797349a6-d7bb-4e80-99b7-d08c78b967a4"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfOS01LTEtMS0xMjcwMDM_9e0b0692-cefc-4172-8e83-11b20cc520d0"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfOS01LTEtMS0xMjcwMDM_9e0b0692-cefc-4172-8e83-11b20cc520d0"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTYtNS0xLTEtMTI3MDAz_691de804-9265-412f-bff6-1fbe6a8f3a9b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTYtNS0xLTEtMTI3MDAz_691de804-9265-412f-bff6-1fbe6a8f3a9b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTktNS0xLTEtMTI3MDAz_b39331c3-41d8-444f-8ed9-c366fb0e90b8"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTktNS0xLTEtMTI3MDAz_b39331c3-41d8-444f-8ed9-c366fb0e90b8"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTYtMi0xLTEtMTI3MDAz_9e1cc617-4617-4ca6-be10-e7d61fd3987b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTYtMi0xLTEtMTI3MDAz_9e1cc617-4617-4ca6-be10-e7d61fd3987b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfOS0yLTEtMS0xMjcwMDM_e59e8c63-0c25-4211-a3f2-69398263ad87"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfOS0yLTEtMS0xMjcwMDM_e59e8c63-0c25-4211-a3f2-69398263ad87"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMzI5ODUzNDg4NDU2MA_e3676cc9-4075-4e41-88e3-205243fa39bd" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMzI5ODUzNDg4NDU2MA_e3676cc9-4075-4e41-88e3-205243fa39bd" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Treasury shares include 1 million shares held in trust and treasury stock includes $29 million related to shares held in trust as of June&#160;30, 2021, March 31, 2021 and December 31, 2020.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTItNS0xLTEtMTI3MDAz_c33682a7-bcff-478e-bd70-3c9fde37f6fa"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMzI5ODUzNDg4NDU2MA_e3676cc9-4075-4e41-88e3-205243fa39bd"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNS0yLTEtMS0xMjcwMDM_4b69fe63-e272-4068-992d-1a5b471b8279"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMzI5ODUzNDg4NDU2MA_e3676cc9-4075-4e41-88e3-205243fa39bd"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTktMi0xLTEtMTI3MDAz_01df612b-9071-4ff9-8baf-73b2748bcc51"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMzI5ODUzNDg4NDU2MA_e3676cc9-4075-4e41-88e3-205243fa39bd"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTItMi0xLTEtMTI3MDAz_911440fa-050b-488a-899d-429c516738f6"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMzI5ODUzNDg4NDU2MA_e3676cc9-4075-4e41-88e3-205243fa39bd"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfNS01LTEtMS0xMjcwMDM_797349a6-d7bb-4e80-99b7-d08c78b967a4"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMzI5ODUzNDg4NDU2MA_e3676cc9-4075-4e41-88e3-205243fa39bd"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfOS01LTEtMS0xMjcwMDM_9e0b0692-cefc-4172-8e83-11b20cc520d0"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMzI5ODUzNDg4NDU2MA_e3676cc9-4075-4e41-88e3-205243fa39bd"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTYtNS0xLTEtMTI3MDAz_691de804-9265-412f-bff6-1fbe6a8f3a9b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMzI5ODUzNDg4NDU2MA_e3676cc9-4075-4e41-88e3-205243fa39bd"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTktNS0xLTEtMTI3MDAz_b39331c3-41d8-444f-8ed9-c366fb0e90b8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMzI5ODUzNDg4NDU2MA_e3676cc9-4075-4e41-88e3-205243fa39bd"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfMTYtMi0xLTEtMTI3MDAz_9e1cc617-4617-4ca6-be10-e7d61fd3987b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMzI5ODUzNDg4NDU2MA_e3676cc9-4075-4e41-88e3-205243fa39bd"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RhYmxlOjg3ZTg2NWQ1NGJlNjRhZmE5MTBlZGIxYjFkZjQzNmFhL3RhYmxlcmFuZ2U6ODdlODY1ZDU0YmU2NGFmYTkxMGVkYjFiMWRmNDM2YWFfOS0yLTEtMS0xMjcwMDM_e59e8c63-0c25-4211-a3f2-69398263ad87"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjljZmMwNGM5NzVjYTRiM2Y4N2QyNTkyZjdkZWYwYzQxL3NlYzo5Y2ZjMDRjOTc1Y2E0YjNmODdkMjU5MmY3ZGVmMGM0MV8zMS9mcmFnOjVmZWQ3YzE0NDI5NDQ2Mjg4ZjhhODQ3OTFlMGJiN2Y0L3RleHRyZWdpb246NWZlZDdjMTQ0Mjk0NDYyODhmOGE4NDc5MWUwYmI3ZjRfMzI5ODUzNDg4NDU2MA_e3676cc9-4075-4e41-88e3-205243fa39bd"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>80
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MCG%\%^;I'GFZ1IZ_<Q%GLN<V$PHBZ&HW]2V7JA1UE$=<K*!"'84=SW:)PA.
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MC2!*7<;"*'57#$8-=8M.#Q.S'CZ=B":^P$8G)6IWA%&>RA=$J0+XOU!]OIT
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MBQ-65 #Y_S7GXOFDNL'Q8[_YOU!+ P04    " !X- -5WEZ_95@$  !J$0
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M /#]4@C]TB@&:#ZOC/X!4$L#!!0    ( '@T U59[*?>G <  )0A   8
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M].XG +L;H[;]*?JM,D95_>5&"@N^,[#?KY4R^YON8/[P0XS%OU!+ P04
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MRJI1=46T7%].KNCY=9S8&UJ+/Y1\:(X^$^O*JJZ_V2^_YI>3R"*2A<R,74+
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M;"]W;W)K<VAE971S+W-H965T,3 N>&ULO5P+;]M(DOXKC5RP< #:%O5V,A/
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M/2,[\29?TSV;.G,7_8*Y_9+2JT65JO20/0^*FBB.;2SL7.$>N\P>K=C=#EK
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M'0'!8&+'T&E59/(6;B%(Q5W73W8LF[V@=W[+%5E)T](3GF!7$9H/(LBASTD
M(DC$<W%L@L="@D"S)6@/4VB>V<YL'P*M'^=GI\?]J!H'5TQ%CV7PD^T2JO6<
M$,LMM ]1?&NEYS"1W#[Q9+*$PSUD A.G>BC>WPUI:'&I[.@2*1#&3J5C,&'"
M:I]![%RD%ED7!1][8.0( W@X1(_F<H?%&H?I61L.[M#'[OO1P8,-0%RF9VD0
M"17Y[=;O]B_?:7[P[<7SLQD066HPCZ$%5,='%WAH^OP4S1_1->GY-W<1C\FT
M! N@*"R \X5SL?M@!_W_ Y-_ 5!+ P04    " !X- -54PPZ*E$/  !%+P
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M@KPU\=08W1R@ K^"V6RD2*T \[V =A4DM*NI!AH@:T24F6DX\3:%8#,]&'&
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M+Z$AI)HGX)>GPI33H8@%'39JCT!!AP)N^0"!#=":#YD3J6S7[L9J7.AB>BJ
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M;=M&4ZWX1>E)U335DA\7.IWJF@;@]UF%0J)KT +#F_-O_@-02P,$%     @
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M1EL0#[(+W0A[^@LFG.SL$_;[?-X1J\40"57W/#D)2<D4RQV<U(+<&';I=F!
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MO*/8G,\BZ(T:\^A'P3G+DJWVCX(SPL;;O8>",P,,(GK.PX?#<C9NW@=+,AW
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MREI5N>9*< 0&FH#W2Z5LUZ$-^H]3EW\#4$L#!!0    ( '@T U5P\"Z.D04
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MY3+E#B^@^:4Q?OO""G97X?/_ %!+ P04    " !X- -5*2VQF9P%  "[$
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MY0U8GQGCNQ<VT%_T+_X'4$L#!!0    ( '@T U7[=W48#@4  &\.   9
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M75YQ8\1"Y-QZ@P/H!VS(PH3RLT^Z: RB8<+"@:?2\0!(J>6; 039)!L F\1
M'.&4Z" :3P9P5JM&6K.GG% NM*I?&*:@GZ9N49:YM5GB;6%[ZQ.=)/1(R(IQ
MZ.?/(P\R1AA8/"7^X7326DU^I-@]XF7GBVDX@&F:WJ.I2U,/EM0UM4:9WP(5
MKS05;[M_\4_31M0<CN$8$O#)'KV!])NB1M IQ;[4!7O<C\..8.)_+E5S;DI8
M4-%!B<42GX$4L2E$<0R1R_8X.V3-TVCZD8MUZ#+0$UW(6=;Y:X_\]H3K!['/
M[W;T^19,]S(MHM]X^Z,,#](O<3-+O "+//\3CAZ3JV+6/2^W1Q#7<5J#5XHV
M!K1"HV\1<Y2X$,\E5C"FF@@2-W34UWO)P2$?,5>%N]^=;QS$[?\!G^Q8GBBS
M<>RL=$-'72O+*\+[$.4+VX@O6C9T_7<Z28B*J46VVK] .G6-C5$FNW:1N 2@
M]-Y9A_?0O,PN:N#3+!OXILW2\,'\[Y?\^5K^7HW7[8]FA;DOR:JB';:@U&O5
M%3BW8)#ZGK "#="N?;=!TTXLJ6/L[6A;Q?3!;;B-Y$TAG!&YHJU2FI8RJA*%
MM\U8>OC&Z=Q*MP'=MH0C7X+?C.\0L/^WN0?(A+1(QRL+N%DYT[\#J&L2=Z<A
M+F^]UIQ8K+K#=PM\M=)J(^A&@&1NG['=T6+H/4WZJ B'.\>WYP<25;GP2Z^%
M+8&ZQ4-TA$9M@^5=XSBW@"1NK.M:[8'HZ+$SY&CO$E"C7OJK#JWBXM/>![JW
MW6WJK+U$W+&W5['W7"^=U14N2#0\2I,>Z/9ZTTZL6ODKQ5Q9NJ!XLJ0;(6K'
M0-\72MG=Q"W0W3%G_P%02P,$%     @ >#0#5?E9\R'_ P  .0H  !D   !X
M;"]W;W)K<VAE971S+W-H965T,3@N>&ULU59M;]LX#/XKA&^X3T'LV'EKE@3H
MRX;M@ U%<[=].-P'Q69BH;+DD^2F_?='RHZ78FG1?3P8D"R)?/B0HB@M#\;>
MNQ+1PV.EM%M%I??U(HY=7F(EW-#4J&EE9VPE/ WM/G:U15$$I4K%:9),XTI(
M':V78>[6KI>F\4IJO+7@FJH2]ND*E3FLHE%TG+B3^]+S1+Q>UF*/&_1_U;>6
M1G&/4L@*M9-&@\7=*KH<+:[&+!\$ODD\N)-_8$^VQMSSX'.QBA(FA ISSPB"
MN@>\1J48B&C\VV%&O4E6//T_HG\,OI,O6^'PVJCOLO#E*II'4.!.-,K?F<,G
M[/R9,%YNE LM'%K9+(D@;YPW5:=,#"JIVUX\=G$X49B_I)!V"FG@W1H*+&^$
M%^NE-0>P+$UH_!-<#=I$3FK>E(VWM"I)SZ\_"*NEWCNX10N;4EA<QIYP>37.
M.XRK%B-] 6,*7XSVI8,/NL#BN7Y,?'I2Z9'45?HJX!^-'D*6#"!-TO05O*QW
M,@MXV9N=A+\OM\Y;RHE_SOG;PHW/P_$Y6;A:Y+B*Z" XM \8K7__;31-WK]"
M=MR3';^&_L8=>17C/,,S4>BG:IIR84HZR$U5-QX+:!PM@B\1/!UXU]@GH(3,
M[Z%"7YIB")LP,C4?, ="%]VZJ,EL+D4X>)8/A@-OH&YL7M(1@C&ELE+A5)).
MUH\"!0=FQQPJG@AP!R1B5%&<)W&B-(!MX]M9?,Q50UD'.VNJ0#47*F]4:YJ
M"JF"+_BSJU326N=*B]BREX]0M;F,G,M F8A])@ZH"KD:0QU13T0"<]$XUD=I
MB0G:7-*PMC(G)P*]/<7-(YL1.M@2#VBIV-$1MO=4<H,LTPS,.Y_;(!"? 4]3
ME3(6PR_@;D?FJ= UJB#S).-E<) 8#>%CYX\3%0)OF-&#+H*_OD7S9UMT\?_8
MHM'S+1K"GR5C*+IZ.),IMP4)Y$;G4LG>/E5UF0?P-S#Y@<^+TA1N05:8W6D1
MA W1?#;Q61]#Z 8<$JS]";JH3*-I!SC-@B,G?U^;BG+&DWWF<(;:23@7\)6R
M2FK:&P+UWDK:!K%5R'M[_6T#GU H7\([2 <7DU'H9_.,^LD@G;8]7>=P@]K0
M;?-FJ]_#[4=N'O.[39-!%]O1(!MEH;T(;1K:*=PA%6&9LV*;1HV6OLU2,A2>
M')K.Q^G:F+XY3'^I]+#.A,K,BRR/^TZL*.#<SD([Z=J?Z^0"KH)G%, A"7 W
MXG".APEWV7">P$V'&F2R5B8)BQ>ST,WF<.["B$^N<]KZ?7BT<%FF%&EO]GZV
M?Q==ML^!'^+MH^J+L'M)\5&X(]5D.)M$;5". V_J\#C8&D]/C?!;TML.+0O0
M^LX8?QRP@?ZUN/X/4$L#!!0    ( '@T U7IRW5OZB4  )IY   9    >&PO
M=V]R:W-H965T<R]S:&5E=#$Y+GAM;,U]:W/;1K;M7T'YW)JRJRA94CQY.4F5
M;-F)4W&LLCR9FKIU/H! D^P8!#AH0#+/K[]K/_H%@K;LF7O.^9)8)-"]>_=^
MK/WHY@]W7?_>;8P9B@_;IG4_/M@,P^[[QX]=M3';TIUV.]/BFU77;\L!?_;K
MQV[7F[+FE[;-XXNSLZ\?;TO;/OCI!_[LNO_IAVX<&MN:Z[YPXW9;]OMGINGN
M?GQP_L!_\-:N-P-]\/BG'W;EVMR8X6^[ZQY_/0ZCU'9K6F>[MNC-ZL<'E^??
M/WM"S_,#?UASYY)_%[229=>]IS]>U3\^."."3&.J@48H\;];\]PT#0T$,OZI
M8SX(4]*+Z;_]Z"]Y[5C+LG3F>=?\W=;#YL<'WSXH:K,JQV9XV]W]8G0]?Z7Q
MJJYQ_-_B3I[]Z\6#HAK=T&WU95"PM:W\O_R@?$A>^/;LR L7^L(%TRT3,957
MY5#^]$/?W14]/8W1Z!^\5'X;Q-F6-N5FZ/&MQ7O#3\^[[=8.X/+@BK*MB^==
M.]AV;=K*&O?#XP%3T(./*QWNF0QW<62XKXO7&&#CBA=M;>K\_<<@+=!WX>E[
M=O'1 7\=V]/BJ[-%<7%V<?&1\;X*Z_V*Q_OJ2]9;7%E7-9T;>U/\W\NE&WH(
MS7_.<4$F>3(_"2G2]VY75N;'!] 49_I;\^"GO_S'^==G3S^RA"=A"4\^-OKG
M;]F_,%SQ_,T?KZY.SK\KWFU,_&.'!\W65D7%#X]X<.@*<]LUM^94'NVV>&A?
M+$UCS6TRT%_^X]N+\V^>NL+B@6HHH)D6,R]'![J<,VY1P.+T)=$ K7?0+GQ4
ME6Y3K&!!F,;'75^L;%N"Q+(A&FK+*K[K+2R+;?90HJ;!W$7=0^?;8KDO!A"U
M-MVZ+W<;6IA,;VI>,WWI0&9OASU_4(]$ 8;L5ORE7_#3[*^9M=#7?SN].>51
MUDVW!($&%'9;FI0^Q!^P@ ;&Q&S*6XNET*<;4S;#!NN$Z(V#;>Q_R?R[<AA,
MW[JG@<[!P@RL%X6KP"?^U,^^*AR^')O1%8U96]?($*4K[F#UZ/\=!@#K3 T&
M-QAB* <9HNDJ$+KNP(*61 %_@/<[D"I;FZZ:-KAS1KF]%Q[W6!Q(7YI]IW2J
M! 0>O6^[N\;4:^.Y,/1=<UI<XD7=YP6_IZL)LL9;"4X9S][IP/\6T;&N&-O*
M] /\V )##BDM53<V-8E36=-*907P")"7$DL(I):-Z_#Y7B<O;$L;@7GH^=ZL
M1^Q(!X[M^JXRI@:9H,^V4(_!KGFS5$2:TF[QSS6(<4.ZZ-/B-P,?5/P\EGW9
M#@:[\\P,=P8R?O[==W_EM_&/;Q;I2X7K0#X6[G8C2?0*'&_'[1*B0#(S+IVM
M+?3&,#55,Q)EQ;-N&5A\ [)5?'\#KT$F?_7UTQ:R(,LP9;6AX>XV%O^@0<T_
M1T@2E'%EL>\%  3\9_N^'W=#M5_P8*_+WFW*IG&GQ:L6G .MV"ZBXVZ#)97T
M$JE*H'$/AN(!:"V$%S3EZP1?;VW-WZX]@[P&'XP4%L<C%MVR"7M I/+VMQ .
M;)\\@>W>,M4TE?DP*#(AE3*89#?V;L24I"XDT:VYPZO=3BV34D9#6Y%C&15:
M1+-U7K<#P;6%_CF6SM/B[\0.ME+);D&M>_\<AL9[3%T%<6T'G0M*CP>\F:Z]
M@F"5BUEE6D?!Z@V!.KP#>G<-O!GV##:J&]<;V6W/'JR\VF MF&W=0ZYI-99L
M16M7^VR#F*)V/\/R]*F[DB;_YVA[&<OA&;>"[+]:\=O>)OMI7:'#'MEJ8M6J
MM V-M2W?&WXH3+ K]^+\1I#<>\$2$G/Q"F9@AC@\V.5+6@19<78-3MB*A,-;
MD&BS@_6 F+@1;$W6Y0W6S(*@J#V1**SKK7N/?Y1#SDCU@O>BETTQZ 'B,@%Q
MY0P(PE$77W\KQ";,<L5#\\%;CRC@F43!  H9Q\R(F \V]TNR:CV<9\\J37ZB
ML>42OA%.6GW!V):8C\8D4XX1Y5\P>+;FJ>!_8>NA-X20W2-,8.%FZ56 :#C+
MK8HYT9RH.:NW+J1GB;\X^^KLU-O=??$2T@*&8=6.I6=!MNP]@JB;@4E4]TTB
M\(:=[N]=>_)'UT SR8J]I?VZV6 K,<5U!Q!?_(W%;^TG6-$$30FO93Y8QRX-
M>@A;*5Z;334!54A)W=&WW@V*>:'-E0=A45OV74PL6/(0#VP[^!7]?MS1AA!0
MK7J[Q ,-$ 9XQ=JJ+C'350B))18#60U"!;.X8BFQ AAVV(%JOX'C43D6IX:E
M.0&(C5V9%/G$<0(+0'$'-RV3@@:1C<S@E_U@*[OC=;#XBWTSJLQX%GQ@+@J<
M4=LDQ#/ Q6*:KEV?\+8S_ I\96!$9,9/(I1*R<97&>H-UK2, @+PV1+J@C]D
MH,1>K/,^#LA M(-%KILUS2E$Q&YM[;AUWI<(DN,=4#UG"^F?PB(%^D5RG^O&
MJA" ,$0A*;T8@TU'1:"0:+TEAI*#(B"Y6CDC#^DDQ5!^,!CWIML&R6,U=I"F
MINS]+L0U_O+Z3;!P0AU,<0<NLV'!)&TWG( Y)W">*SL$X'PB,-4$T8%S@H
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M2DD]^)U08S#EL7@.+V<3V4DASUYX71MH?DV^;=P=T5DR#O !9)+$/D J@GW
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M2\L(+TF/%66^A(Z9HFB"&T,VS]<;%#9FK>"LZP7]P "\QOG9DX?+1YS@G2=
M;T*='I;]_^YI\^:;:0-]LF8YJJ@=^))XD*"#?MS#%[HE(Y1R(72@I0W=OY5W
M9"?YW[!-^<5-/$]L7GC';6P\MW9ZQ%M0@^3&]F#54E;R T75=O!G7=G7@FKU
M-GY*(.37'Z0@7SN9?3G^MW![_#UN(+-Z(K0LY Q3N.GM\-Z,PV[;CUSO8UM*
M@WCKDUSZE(69.N2G H$)P*< :I'4_:GE1=L&0IL914T^!Y??CQ6K[R&4RHYL
MO&/Y^Q@3TA ENXHA!%B4..\S@[HL:VH'(>?G4PB2(UL91L=\+4OCBRD+E9,#
M*=DO_!2Q97F1-J?BA>3XPX(;::>5Z_@+#@?M"J12:[K\8Z&7+G(EA^^"IR:1
M!2,R@;J4;BAMHPG:^S>XS'2T+$):M@B=.$,_\IGI:;?+Z.1VF>@'3B0+K&]J
M#4EO[%(;$(8/^<Y'= [=57K'FEQ.':ZD)MBQIN20MKGQ;?CZ$R]83"3!\<8E
MXD/> QM(.&.06\&2?G*M*P<BQG@7S\*?\X[G+!;<<,KEZU&$$!-"0YN\G=XP
MU&-A3'MF\@L4CDJS+(CCN]"F-G=C&G72)-'NS-GR3_0V^VWW1]BF-W<!05$!
M9K9LKOTGR1TPB0:&'5TD]]$U^YCHBBGNR4F/V)N1#L?W;-!T1U*FZ47/SWQ'
MEC-K.2&TZL-5QI.K37=TE[23?.0(6:M(>U=C0SG8T+? *5Q]+O])D'*6.U+<
MH61Q[RBXK&%Q]I(#W79U<KF%OYV)'Z#Q+%5+8CU6D^DS?/V7<I2YB'")(18&
M.Q68I,M0%FD'[R%D $I=DH_*RB%T.7UZ,7!#EP#)05'?1< =0IRC7^[S]'*X
M(I%E(FW0HN*% $#?/C'?<W6L74:+U^&*TO3^=<$@ @I",Y^%886Q._QE&GW<
ME]./W%R@Y0*Y!E-O^UUD/P:T#<%-=CV<^&7IT?$BX#T3W\,O9Z C,%W#F]^&
MMFJ)43,OE/?LP%;0D;_[&?:#I^3>U4HK/O\^FQ\^]("4+Q^#X:>IL/1*V[B8
M&T=3_K&9-/;?^HT-U0"HFI$^PO0JD_NX';YD.<I(Z&;5FT"H*7'D>VX/O@B'
MU/RK<?.31HV$\=GE)#Z%%):@%V-DF]!B-=W=A/,2Z>JMIW3;"N>%;>M_I@!L
MAK;UM ,.(;=+I=E;7-\ EWYW"_- ]1JR/9;O_6GU;&5@_>RRTO:08_W'C[1.
M3;=@TSNM/R'O^WRZ9O0GQY+J8PP]?$.A==,^UQF J.9 ^B#BQ7OELM,?/W-F
M[C6^VI2+@4,TWRD9#'2#,??W,[5)AT!N&R0)&US+0C'YK6^Y(2\B<)N#9:']
MTS^A)34XX3=#O#[<<7>TI!8,7;+A:3TY+QJ'_IM%6D\,/P$1'@LW4V7MD@M_
MH$>358=G@.1'7JA8H##Z$PU<Y%/2#=.P8I'=P4VJ\*]>\S9M"_S<N][RQX[?
M_":%E*,WOR6W3Q9KVIZ6&UG5>(4;&5.AF*E&SOS8FJ<SJ68R4)"3Z:%>2LAC
M@D'T\I?Y7S#2U]-?,4J&2LKQ<V+H^TJ^AU%YY"O=V*0J]&2U@!BI;P_[QE63
M>(,^[>!3C()AB$0^0[:C S6A6SIWP>%W>V;&X:-T&^-_VJ'1^T7Y2M->3K=_
M0M7DXMB#QQ6#V&-W]DL\8\)638&-QS"Q<Y:7C#7[G'?L%_":U_G.^:-)! XR
M_Y>N[79N::DYT Z&PQLB37(_>#@*=%@0Q"28PU];.;W6EX^^Z/S^@*.>E9F_
MCM-W4NBA2 IB]2:GA5Y;R\Y$UC$=4:XUD@LL\UMU,H(QSL-;>YSH0X;-!*0S
MI5%2$M9W?OF_8X=/YWYP]7'R>[F *VO^56"]+TA^.C=\6O@?'KZ4W]N-C\NO
M%K\N^S66B?6O\.K9Z3=_?2!WQ/H_AF['O[Z[[ 9@(_XG*(;BT /X?M4A2-0_
M:(+P<\P__3]02P,$%     @ >#0#5<EA!HMN#0  \2@  !D   !X;"]W;W)K
M<VAE971S+W-H965T,C N>&ULO5IK;]M&%OTK ]<H;("Q1%*DJ+P QWUET4=0
MI^V'Q6(Q(D?2;"B..C.TK/[Z/7>&I*B7K:1 \\$1*<Y]G/N^U.NUTI_,0@C+
M'I=E9=Y<+*Q=O1P,3+X02VYNU$I4^&:F]));7.KYP*RTX(4[M"P'T7"8#I9<
M5A=O7[M['_3;UZJVI:S$!\U,O5QRO7DG2K5^<Q%>M#=^E?.%I1N#MZ]7?"[N
MA?UM]4'C:M!1*>125$:JBFDQ>W-Q&[Y\-Z+GW0._2[$VO<^,-)DJ]8DNWA=O
M+H8DD"A%;HD"QW\/XDZ4)1&"&'\V-"\ZEG2P_[FE_IW3';I,N1%WJOQ#%G;Q
MYB*[8(68\;JTOZKU#Z+1)R%ZN2J-^\O6_MEH<L'RVEBU; Y#@J6L_/_\L<&A
M=R ;GC@0-0<B)[=GY*3\AEO^]K56:Z;I:5"C#TY5=QK"R8J,<F\UOI4X9]_>
MBSD@MNQ7L5+:RFK^>F!!EKX<Y V)=YY$=()$RGY2E5T8]FU5B&+W_ #B=#)%
MK4SOHB<)_JNN;E@\#%@TC*(GZ,6=CK&C%Y^K(_OW[=18#8_XSS%U/;71<6H4
M)2_-BN?BS07"P C]("[>?OU5F Y?/2'KJ)-U]!3U\^SQ)(GC A[0_;@0[$XM
M5[S:L 4WS"ZT$ S!KKF#R/@#)F _"%[:!;OC6K!WHA(S27<_+#B"(M^P>S"0
MN3",5P7(6R[+P8\?[P(&HFM$&_W/P4J#,;=B\(M="-V2OV$].;[^*HO"\2O3
M\6:454"PPIT5I]-L)BM>Y9*73%8^)2&V \?;'J&4+Z28];0J1"Y=/EGR3Y#B
MBL[0P]'PU=TOW_SD/H:OKIEXX&4-?L91;>5IR/;H 5^$OV&47W QKTONLH0T
MD,]Q*^BQ!9S *L;+4N6D!8ZI6CO0E@K?]YDX77"8&R.,Z9F"@:M3N<I%@QM$
MWA.U]PQ3LZ.8=(PHFQ5.].)_R#3TN5-,5KE:BH"M%S)?,*B#3 <_*\B:^T^Q
MJ^]O;S^PI>"FU@+@/>9E[?0F]A+<<TO"0%>XWE_.9'1-MJWF<EH*IVRCNG+^
M(:U8PLLD3E6; (2X9960[CLM2@(1@!)]I<$*]83E@-2<U'I: TL RBI%%&94
M%HX^6".+Z7)#XG=G=I"_1YS002UR!5<LI5/($&/<,*J4!3\&YCY,D'_G^9-6
M8%.JG0P2L%FM'00X:,6C)9?C>@LU@=; #SHSK9:'Q)Q?6J%13.CN2:X[H<EJ
M0\YZ4D)X!;("6VE<RQ6BL]&20#GBOOYY)JH%79FC=N!30&LW'B9\!6(K;FPO
M _0)KN$:J)=:'W""2_&*EYN_Q'.F]5D$% ISPWY6U0MGKRV_1J<=<5DA35XJ
MH!.@L4&H0+/SK(KG%ZHN"SBDA87=*0GYZ Q(H4!)6U/&4SJ D^,6"$A\L"HX
M)E1K5&(%!^%E7I=. LHE>8XPV0)%BGG[SA1RTMI)95P*Z_LT6>\(I^?R2A.8
M.S!897EI7K+W2+VR+%W ] O+83FY"J_;<M*K'B  -5N7^K:4T+B)OZOH&@_V
M>'YT):W?G#"T%J)K+4#^050U>+E(03P)#4]IVBYP89<LBH)TE.!#/ FR9((/
MX3B8)!'=&>&/TSYZA4_9,!A-AKORZ99!%+,(QV*6!3$.MZ>NPC"(H^RZN_$S
MVG!9/0ACW?DV<<#!S#7+LMY!'!JGW74X2ME'@KC',@K&2<I&49"%$8O2(,I2
M%H;#+5-(G,8INST9U0W?,,CBD/XF"?U-(W:5),DU"1%?LQ'H#W> #<\"=AC$
MZ9A@3(*Q0SA,@S!S4 ]W@!U'$'=\"M@0P";I!, FHW@'V#".GP,VC,?=$QV4
M/?M$V>0 UF&01 F+8<APQ*)1,(XR%F;1EB7D3<.S8$U!(825$N@P'$W859Q.
M"-8T<K!F8W8O'_^F X\2.#"YZS@-ADGB 8_A"I<L379P#I-Q$(ZR$T##P>!"
M849FVG'AR*E[I@N'XRW@5_&(;H3=#0)T#VU(GT',+ JB<<P2@#4$Z'#:CBU)
M/8)+/@MW'"2P4HP@#>DO?.\J2X> .\[&UVP21)/X\[UXA!#*"-UT G0S0I>"
MBX!-HUUT1W"/DVX\"ED2)  'Z*9QN(-N-)H\AVZ$N&F?@*&B9'N99 >9 9(,
MAQD;C\ J8:,,5P F'&^YD;#C,#X'U'B2XF^4.F@1@5?I.")08P?J<!*Q_W[.
M/Y?V]^1MZLUAB6AAA$S4\3"^6FGU*#$4B'+#+N.;D$U]L7&E_3*ZR;H;(*I=
M=4&=>K'B&U^ZJ,<B7GX:6OK($T<BC^B1DP34RZ^$VRV4&S^(7*8WDUW&Z4UT
M)F.#@/]LMC>N]AWS+";Z%7+;.,MCS\XQW#56=LL2::5K=M!ZJQR]%;H4NQ:B
M<H(>FPI;@P1/V\NA-&@4WDZ,VYEP1Y/33>>.;E["]0+B+<5R2N$)I ]E: ?A
MO)0.^*MF_/MP?]\>W$Z!E49[Y%NHGV@4%97KH>X6"K008N%X](H)/THHMI+Y
M)U:O_-3:/$H3>*[ER@M)2%8G1Y3&+59>9L)>5M"<%]YG<@&3^$Y_20ZJZOG"
MT0&_\H;]L7"6D0T4Z$>G&*5.6&)W5M^V;M3_:3]*G\;=#;L&LUOQ@I>DCQMX
M]_M)<HS/'I%H2#[)=S<X284SH^7EL5;PH+3V6U-WW!6![:=?GIGG4 U<)T+_
MQQ$56&16US*B8QPBF3X[_E+N&Z4IHT(UB:DW"$'O>UJ X$@A*>UC*&C&*HP(
MLI T^5+T(W<GU_VZT;OZ$5-B"2-;6PKG_%>]SJBK&]EH>P#)W9G9R[40&%,(
M?<,A[-7HR.%MR;K-_ZRED:3E"Y]P"I=NYMIKGBM#JO;$&PV[CUG8/\]6M<X7
MW% 84<!YUW :J-K2M$1 - 9H9TRI"A2A'A1IN'=QNJI=-MWL9=-^739]P>67
ME[)CDVU/PUZB7? 'T2R4?,IIEPSS2CZQ,J&@!3V:&]U\ZX.WQV(I[$*Y'$)C
M8%TYA?U>Q\V<F*D![Y)KB:))J4GS0N#R$U)(V^NXA0,M3,W V92"9"%7](1Z
MH%1GC9MCFV$=HRAJ@,@7E2K5'&41=?F!AEM6H830"P<7F[2Y<B;LIG$G-U2Y
M8=_0ODE:\:*$VQ?'%$<8-!LE,N6#UUQJ1D&R=&Y7&S&K2T84/$,Z8X6S/;DS
MK::D=H[C"@?504M9MY!N3>=*GQMEN=9N;> E7O)-.[63?<":0S"? )]?<DG3
M[I^V9JXK7A>2;@#H0E3&?]IF2J1;*WR.5MU"DS(5Y8;.C<7CBLX:-^7C&\%A
MY*ZLWJ)@NZ)Q*),SKYS6V[7:87':;1)HZVK/TK=0PCM' <OF%DZVN\!S7KO6
MTFEPHC2B$-:Z*:BJJ'/:0/NE:5/0FC5.8]BCJ^"N;6];+4IF)_BU7-SBI>$!
M (O"A10OJ=7;UW07BL84S&[0%M !-BM!T6]JN\VK;_G^:E9/U,Z<A.!(UD#C
M=^LV.SA6;H*=O=04W9$@O]_=QCYOKJ>7<FXW375(Z6X=?F13=Q339[9WU$">
MVN!17_ %2[SWSYBHORCUV=;7J^KD\@^/N)<J;L^%$_@@?2*J72=-U@"!)OZ.
MP;!'=QO8V[<8>[$&>M.-MYXQ"J?LT81(;W%\5A)?IMMS>,G]W?*9D$U%SFLC
M#OPO@"U+^4GLT&ET#X@;:<-G,Y\I 4$O[2GW8@ ^!6JY>^O2E'Z0=(6D.HQ/
MR($$8)JT[_>DSH:'!6,F/(=#(BY[/TA#-8KZKF]JW<;6N7VI#]3YLVW=GJOA
MXH7EC]W!?@[[P#??E>*Q?5_33P2H(2[5.!'"5@+*DGOC\GB<M VP+V7')-PI
M7MROC"E3.O\X6HI.A,&75[Q>;#TUA-ZX+K=GGG.,4NYWRMXMNYTVG\/$OF&0
MS7!U3W*2B-^52D/V@'*"6^/#=Y0?'='%MDR4>_E7HM7+2RZ7*(\>KRG'\(C@
M<%T'#5@%HJ;8Q@4.JI54LD!8N?:$L+AAOS4M'VWO6]D"=O?[?8=-LSHG WF]
M"GH/V1)KA.!D:Z1G:7V*)QA;1Z3>M,D_^[HZ-[JDR:%QG,#O8@P\Q@U[0KO7
MMQ[6F:"W)%!D2J]R9-.T\39R\7R8L8W@NIDE#XSQ]SJGSVF<O,>>>&5- ]#G
M^M53 ]6>CR%2T*:X#/JN+7"Z^^E"C:;X_!!XO^=]O;R@J3DD9ZAZ7@T1#+VS
M)R(?%UR6Y UMF6VSRYK>WE5-(=B&]S-"HU>Q34<MZ>T7[$[?^C;D%(FY4L4:
MKN5XTL)+SIINJGV77K2P'8CKG:BB*N91;_@</,C6@DJX'XZ:#I)2VS%;07P/
M:-RD4L]E;T XS8GOO*CSL0#TH8CV@4_(SU">&DIN:GG:?=;<;!N/8NN7,ZD1
MT7_6*)$@#I&VXKIS[K5E9T!#JYIB__%M3X*IU%6*3I:N_*R;OH.^U;!>$[Q/
MB?S/!O(S52+YDB(.Z_.S%AV[LTZ_B8<6M\)6O)D;SZ+FEVK_S/#X9 X\]E.G
M0>]G:(CDN?NQ'<V6""O_B[3N;O=[OEO_,[;MX_['@(BQ.0H22L ,1X<WX^2"
M:?\#.W]AU<K]J&VJ+*8Z]W$A4"\U/8#O9TK9]H(8=+]R?/M_4$L#!!0    (
M '@T U5X0>_VAA,  &4\   9    >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM
M;+5;:7/;.+;]*RA/:BI=)2^RG7VILIW,=/IU9EQQNKNF7KT/$ E)Z%"D&B"E
MJ'_]._=> "0E2L[2\R6Q*.+BKN<N@%ZN*_?)SXVIU>=%4?I71_.Z7CX_/?79
MW"RT/ZF6IL0WT\HM=(V/;G;JE\[HG!<MBM/SL[/'IPMMRZ/7+_G9K7O]LFKJ
MPI;FUBG?+!;:;:Y-4:U?'8V/XH,/=C:OZ<'IZY=+/3-WIOYE>>OPZ311R>W"
ME-Y6I7)F^NKH:OS\>GQ!"_B-7ZU9^\[?BD295-4G^O N?W5T1AR9PF0UD=#X
M;V5N3%$0)?#Q1R!ZE/:DA=V_(_5_L/ 09J*]N:F*WVQ>SU\=/3U2N9GJIJ@_
M5.L?31#H$='+JL+SOVHM[UX^.U)9X^MJ$1:#@X4MY7_].2BBL^#IV9X%YV'!
M.?,M&S&7;W2M7[]TU5HY>AO4Z \6E5>#.5N25>YJAV\MUM6O[^RLM%.;Z;)6
M5UE6-65MRYFZK0J;6>/5P_C7#R]/:^Q'JTZS0/M::)_OH?U8O:_*>N[5VS(W
M>7_]*?A,S)Y'9J_/#Q+\J2E/U,792)V?G9\?H'>1A+]@>A=[Z T)_+]7$U\[
M.,O_#0DL]"Z'Z5$$/?=+G9E71P@1;]S*'+W^^]_&C\]>'.#V,G%[>8CZZSLS
M0SC4ZH-95HZ8'F+P,(F/<Z-NJL52EQLUUUY-J\8AMHB>GA1&>=G"/U<_&EW4
M<W6CG5'7IC136_N1NIUK1$*V47>0S68&CSZ86MOB].>/-TJ7.:@[4-.U.?UW
M/3=NI-9SF\T5D<F-SYR=F%Q-" Q.!O=044IB=?"%P*,",-$^7D&.JC2JFBKL
MJ$I-T?[WOST]'S]YX54!I"+[YHA]Y^'IV'XN9#,B.XEDEZY:V1SOG-R_-:F.
M]K*EP"+#"X2'S:%0J$75%78IEFIA%A/0'.%5E56E!U;(ZVL+ZJ!A78\=<#$U
MGB!/%UBUT)^,6E0N;@7F<Y-9^AYR3X"RNS2^@/]J.@532JN)JS38UN5,].>@
MK)HW'ZE552 V@-0L&C._,.XXMPZ VFK1XCD(9,Q[WF381E11:'K+)T>Q958T
M; N( <#!%LO@3B-(A:T*7CDQ<[VR\*$B;K$L=$G*D&502HE\P8)D>JDGM@#/
MM,-[?@$"7^4KX!E>8H+I\5VS7!:R,)"\?7.;UMF^8W1VB3(PM21V:_K:9/.R
M*JK9IJ^#N.Y^BR1W%<0GXXBZC#*+95%MC%,S5S5+UB-\V>8-.PC@OS"0T]<-
MJ1!/EMK5QS42IW +?RPVG!G9#?L:W?(\\7_UD+@Y/WN1GO#G\8L?1FI6(8K*
MA1BK*1D3VF?'?@DO@;?F<8,"/AHY9W[,YZ6NG:6X%:U$-$(NIKT1-P,.]7 -
M*$$,U(AU\D+0*@H%RAIF^KURMM[$\'?6?P*LN>0MM&OP+I8SJWSM?R#0"&*^
MH_U,'H3D]W6.3&LI#5#)T-H?0<"I88<SVIE$5D$#_PT^K^YN3B*3[X WN83J
M2!E$,]<VZB==-A2PE!Y'O$U4+P@;LHN@5G0@M6PF2'N[H6P^9W,"A=89;N7-
MM_&+Z!,$;%SYP 49C>LYK#V;!]RW%#U%X570LCB&$A"!8[*]$SL19+9\@^#6
M-Y.%K0E1G)DUP)8*<DX1^N6,O<89*D$512-6;G-+7$(I%\RM!E]LA<J;'N\C
M"9DOV(W5N7<GSJK1/A K:&;03A<GNTFUEP-WOXTH'N*3<'S:P,\2C$=8C<FM
MBV7)GM?ODPD]D)Y8[8$TNS.HHSZ4?,&R;T<'^1\!(70$>=I]1E <U04M+Z6I
M"87VXNJ"WJX<\":M.>G[>?2L^I!6^FZ?5.272)MP\DW+$&T*%&^XOVC35 8C
M<T"VCW+K#0K_(=;;K(0=6(KT"M'O;G:*8*^H)MH++P0'+0S3^JG!GR!^<7EV
MK7+7P"P.92J9QU4SIQ<(F14'-G;D+)@,?!.^>!N^B-;NAU9;1 E* Q$</-G3
M%FCU=&G_##ENKFO8<%;5#-Z)#^*9T4_6=?W/P*F@F5@/3'@=USW]%TAIS12P
M"H!P5,MQ"5!,B1179LAHV S\UEO  .)5:^.5=K9J_)9Z1]LV<;%\;A6/B#[$
MTLGA0&R3=V$I!RM)IQ9=K@7$Q03.T14!-F,)N&I!&N70:_-H7&)2SN^G[:VJ
M1>3+0QJ75P1F.6[Q#52Z@U/LGLZN8)4#^#\*+AOR&I&,;T=PD:U"<(:*5/V"
MV@ ;WPGR26/0]\=[E-IZ9@"2@0A&J>2(Q?:K71!A%7<>(Y:7-%.@$.J\0?9
M*YCWGTL]2BJ9A_!,@,'%#&4!.$O9H*2INS!RTFV+NFC>>1P%E?Q(_2*ZHR63
MH4@/6$OC $/E!'PVU.[1 /3]&HM+- S]PG,&TQ!C2*5D1\*O41LGW:JO#8$
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M+KK%C!8'M<?5NJ3SBVZ"HW?(H=@Z;!%40KNCEU_?O6WGH\-EBA44E<(T#NK
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M239#SE\BM2XOV>U&4+&VY*09C-B40L%CE-8Z!)Y[".I-5+'83 >+.D/IDNI
M$D?+A&0^0^E2ZOO=]FYM0SL7I)A79H43KBU!]-NR_V.9#3QY$K.A/)E;T:W0
M\3?)XK1&NHX+5@W!SV+C&N-Z"6]0[=;U);N;1]D,FX!0AF"]D^\+P\R(@04
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ME2_TY5Q%$U70#?A]FN=5.Z -NE>6;_X#4$L#!!0    ( '@T U5SV^<!6 8
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M,(%"0+<W+NW JIF[Y1@I:U7ENE/!"Z%Q 3P?*V57 ]R@N_8Z_0]02P,$%
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MH'-SY8&JAT1M&%DZ84;2D,S=-J.YBLH&T'DJI=D9MD [J:?_ %!+ P04
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M85K0#P^-5Z#SM=9NM_ .]K_0^5]02P,$%     @ >#0#5742LY@%#   P2,
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M:6\C-HV3[MZ/$O:)(.ZI#+QQG+ H\%(_8$'B!6G"?'^T50J+DS!AM_G_X##
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M@MG#!8&ZDMEG5J_8LK>42&%6R94SDI!$.$\0J"8M5LYFPEZ6\)SG+F<R@9#
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MR.BT/Z3G=4C/K2']H,=VI2?A&.FK5"41UBO%._W!-"*].PPK[MC 0<)\2%@
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MA"F@WR\Y5\\WQD%]^'/^+U!+ P04    " !X- -5@R7&MA<#  "_"@  &0
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M3)JRN<^:AA;K^DJ8"VTNF/IU93X!0-H ,[X00N\:]I;I/BJR/U!+ P04
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MXHAKT=!BE1^8?!1:BR2_A,0:,6EN@-_G0NC7AG%0'32>_ ]02P,$%     @
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M"[4K4:[@RQW%C\4B>,V57E(7FP=*ME28 GU^Q[EZV3'KZOH[2O(?4$L#!!0
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M_Q6=U]NU=VELR1A#!MREY-IUMZRY9.U>"Q#@BVTQ24"SOWZ2<2P;"RWQ1-^
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M O4@%BS.W(4 %<0"51"K6&'+VE Q@ 7!R<+X*CS J<K/GRH521B11](%E 0
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M9(PJ-X,+2$L TA(\!33N-2!6,T&VK T5 \@ECDI[X^*?A@")G&W!>VAZ!@
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M@^KUFRPKGY_4IV,?CD-?_0]02P,$%     @ >#0#5>5\>GTP!0  PAX  !D
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M"61N\"CV#)RSL$CZ@> 6MWJC)WO0'#@'\B.^P'/I3^Z/GE0,L+III,RT;KY
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MDG]<4[*@(@O0OR\Y5R\7V>O>\O7^Y#]02P,$%     @ >#0#54KLMU#:!@
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MEL#SXT0?/ZXCZ*P?)T#U"%<_CG5FB-HJPD(SUPP22HSCQPE4186%9A8%%)7
M\^-$VVH[;3Q80\P4&]_(=K7BF.LQSCZ#\Y8-T2L2(*/$.%:<0-546&AF44!3
M"3PK3K1]MA:/;2%FBJ!PA*L5Q_H=X>RXSALU1/=(@(@2XUAQ E5*8:&9CUB
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M _7[FG-YO-$+5"=@BW\ 4$L#!!0    ( '@T U774E[&_0(  /$(   9
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MD[2-2J?1H53Z- MZ,FL '%< Q_]U X_[I-JG6="368/J:47U]* -#+E9E\=
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MXN9$DS218HND]39L=N"R[] F7Y3;>W*CI5FE!J?3FX)(* 3+0:KW:'%74_V
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MT3F).U6C@DD90L,D4W4"B2 SZG@7(M,((,18"?>J$8Y02N4T5<M4R$R[[_B
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M JJ(,N>T]R4R$LGN:@0%:A84JF<SB[C<6*M4--VPI5@3@*["+-7GJ&@^*EJ
MBA:BHD58:'*R-!H'?:-='A1UFP<JFH^*%J"BA:AH$1::G%V- D2Q=WM02(69
MJC,X8$2I.H<#1JZJYX!&JHC6A2YJ09(=V&@T]#MW>KQZ_4@!G4-],&/N7.^K
M3F>TU7"@2CD=AA@9.R4'K1%RJ%G(^=$/9*B^I>-*+:S,7>P=NG;& )4QA!C5
MG2V0S86*C38B"C7O;'G=XM\#1$,U(JBR!\"H1P15S(#&J$V"0*\N1:01'FAG
MX:%]^:_7\-1QU4@ 1NH]QH>,7*V^@HS4!_M=^A2UT,FN:^0'VB(_O/8)# 5*
M;\V-J.H"P*C='5#5A0Y#C(R=DG=5-^J"8U87>C]V<8":6HV%F;/W/NAVQ@"5
M,808U5LU9#.]$(U&6W"Z;)ZPV-<=6U1W99Z+"T:*#1@28+> *O:8B7N'!!,M
M0$4+.W@CPF*4P]QH(HY9$WDX'M:*LY>%URXO><%X4K!ZV^HCR]@J@1^NF;%[
MGUA %4I0T0)4M! 5+<)"DS/H[#3,6QV'P3T/@WL@!O=$#.Z1&-PS,3]"*'$:
MH<3!%DH<8%.(H]8<78Q\R$C=X!=T,0J[T$4M2+(#&Z'$Z;^9!;/F=@ M074V
MJEK23AB@$H;MA)'11 Y<(Y8X9K'D5?6VHU?^6C10!9!VP@"5,&PGC(PF<C0:
M]<,QJQ]]:FT'DB"TP@0RTF8@P$C=<Q6 1MH,U*%/40N=[+I&IG#,,D7_NDXO
M^;4D1CV(TDX8H!*&[821T42.1*-Z.&;5XZZ2/<0B+-TOJ]OH0U[46^CN."^2
MQSV/'U-6U7F_YV*:R7B1IVEE]B'C3(P)7J-A*@]S5#0?%2U 10M1T2(L-/G@
M<B/<N/;;5  NII0R1T7S4=$"5+00%2W"0I.SJQ&BW,Z;7+H>C(=.HV@G#@"K
MJ7K>V >,B*T^X@P@*U<[Q]:%,&J#DIW8R#RN6>;ILWPY0IT?S;^:3M1'H)"5
MYF0?L"+$4_5KR$KS<MBI7U$;X\&!P[,7T6Q9L:[?,52*U;98J1S>!'+Z]O0>
MH[OZ[3W*]_?D.B# ]R&YC@YO*6K@#R]-^A@7Z^HD>,I6@LI^[XE8%X?W$!T^
M\'Q7OP;G,><\W]9_;EB\9$5E('Y?Y3E_^5 1G-X&-?L_4$L#!!0    ( '@T
M U5-^G4= @4  .,:   9    >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;+59
M76^C.!3]*Q9;K5JI$P+DLYM$:@.CF=5V5#7JS,-J'UQP$JN L[9)NO]^;4,(
M$(>T4\]+&\RYQ_:]Q]>^>+(C](6M$>+@-8E3-K76G&]N;)N%:Y1 UB$;E(HW
M2T(3R,4C7=EL0Q&,E%$2VVZW.[ 3B%-K-E%M#W0V(1F/<8H>*&!9DD#ZWQV*
MR6YJ.=:^X1&OUEPVV+/)!J[0 O&GS0,53W;)$N$$I0R3%%"TG%JWSDW@C*2!
M0GS':,<JOX&<RC,A+_+A:S2UNG)$*$8AEQ10_-NB.8ICR23&\6]!:I5]2L/J
M[SW[9S5Y,9EGR-"<Q#]PQ-=3:V2!""UA%O-'LON"B@GU)5](8J;^@EV![5H@
MS!@G26$L1I#@-/\/7PM'5 P$C][ +0S<ID'OA(%7&'AO[:%7&/3>VD._,%!3
MM_.Y*\?YD,/9A)(=H!(MV.0/Y7UE+?R%4RF4!:?B+19V?!9 FN)TQ< #HF"Q
MAA2!2Q]QB&-V!3Z!IX4/+B^NP 6P 9-O&< I>$HQ9]>5AGL<QR+LHNVB^CBQ
MN1BB[,@.B^'<Y<-Q3PS' _<DY6L&@C1"D<;>;[<?M-C;PC6E?]R]?^[<5L(_
ML[0#O.XU<+NNJQG/_.WFCFXZ'^L]^.G>:\[P2K%XBL\[P?<M2Q"%G% @,A1
M>^ELA'24%D (XS"+H4P!-[K@Y_0]/;W,B3=L T,TM4328XAND37[_3=GT/U#
MYWF39+Y)LL 062U&O3)&O3;VV3>QN> T) D"D'.*GS,.GV,$. 'S[POP!<&8
MKW6QR6D'BE9N+]N9.^X+U6RK/M> AB.O#O*/07UWT  %&I#8VTI0;>[]<N[]
M5GWZ*"4B1WY$H7V3"C5)YILD"PR1U:(T**,T:%7H#[5YHPC K<@F*U3L(]=R
MP\<AN!0;2-YRI0M0SMVOZ,;QG(:XYEK0N"%3+<AMR%0+.B'38>F X?L<$.$X
MD\_%ABK.<XS#-!+2/>>-H69X;G/1:D'#AC>TH'[#&V= -6^,2F^,6A=M<+1(
MM0MS9')AFB3S39(%ALAJD1B7D1BWZO(X$M4U&9$XAK3R4BO(O(=A=8/H-&4T
MUX&<AFK]8U"OTVV @F.0UQGI]>AT#T?B[KO]L%^B;_=$T4G#%<U,I44U7:$!
M>9UQ8P4'6M3PE#<J!8+3ZHU'Q,0Q(E3YB9/P!63R] ]$?I(.4*5J&J+J.ZTW
M6CMY[_HURN8;90M,L=7#Y1["Y?[J,U#1@ZE8F63SC;(%IMCJL3J44TYK)3 +
MEDL4<D"6>7K!6[&,4)A1S+$X!IS9^@ONZF;<:R:7LQ!? QDU\\HQY,0!R#D4
M*4Y[E;)0V8)LI ;S7)+G#[@1C@ZQTB:@\IBDSR:M[.]6J$DVWRA;8(JM'J=#
M0>6T5U2W*<>E-A<';0:O89Q%8DM84I* .4DVHLQ401-BUGQ3^OLO00R^<I2P
M?[0!-5IW&67SC;(%IMCJ 3W47DY[\54+:"79H%I PT9 'Q9GL]%QH724C8XA
MHV8V.H8TOQMH(.,3V>A0CSG#7[YGMI9\[Q:P23;?*%M@BJT>JT.UZ+260!_<
M,T?G57H6XFL@S4)9 _$:*K4K'^T31%?JMH2)I9>E//\D6[:6-S*WZAZBT7[G
MW,P=3;LO;W#4)<&!/K_^N8=TA<6^&Z.EZ*K;&8IQTOQ&)7_@9*.N#)X)YR11
M/]<(1HA*@'B_)(3O'V0'Y;W6[']02P,$%     @ >#0#58!ZR]8/!0  !"8
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MJ3<B(.0B@BA[74"EY"'+LT=DP]22Q*<,3O8I@Y.Q.F</3I@T%Y7FH=)\5%J
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MN 0:@<@*Z-_GG*OWDRQ M?%K_!]02P,$%     @ >#0#5;\TN\\? @  I00
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MPHC9)KJHF$;$0J4N2GN61]2R$X!Q$A,&FQKO3(V]IKY9_E?W8#WPZ/RISOK
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M210EB1\!S.\@BC $GD8<P1R !PR)HNH]N/<^"IOW5+CYW]_X#U!+ P04
M" !X- -5EXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">
M, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]
M$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<
MUYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A
M(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X
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MN8)+!&BOI:FOO4A_=A] %&5:PEQNC3F'MJ\6$IIF_Y'B_@/+=_\!4$L#!!0
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M;%!+ 0(4 Q0    ( '@T U7B)%S_[@   "L"   1              "  :\
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M2P$"% ,4    " !X- -5WEZ_95@$  !J$0  &               @(&%%0
M>&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ >#0#55GLI]Z<
M!P  E"$  !@              ("!$QH  'AL+W=O<FMS:&5E=',O<VAE970T
M+GAM;%!+ 0(4 Q0    ( '@T U4?WZ=")0,  "0+   8              "
M@>4A  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4    " !X- -5
M_<BAV$((  #:)   &               @(% )0  >&PO=V]R:W-H965T<R]S
M:&5E=#8N>&UL4$L! A0#%     @ >#0#59:;8E+)$@  MMD  !@
M     ("!N"T  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    (
M '@T U60F7",\0(  "D+   8              " @;=   !X;"]W;W)K<VAE
M971S+W-H965T."YX;6Q02P$"% ,4    " !X- -5FE9S+4H"  #A!   &
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M970Q,RYX;6Q02P$"% ,4    " !X- -5</ NCI$%   6#P  &0
M    @(%<?P  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    (
M '@T U4I+;&9G 4  +L0   9              " @22%  !X;"]W;W)K<VAE
M971S+W-H965T,34N>&UL4$L! A0#%     @ >#0#52Y6H6! !@  ] \  !D
M             ("!]XH  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"
M% ,4    " !X- -5^W=U& X%  !O#@  &0              @(%ND0  >&PO
M=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( '@T U7Y6?,A_P,
M #D*   9              " @;.6  !X;"]W;W)K<VAE971S+W-H965T,3@N
M>&UL4$L! A0#%     @ >#0#5>G+=6_J)0  FGD  !D              ("!
MZ9H  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    " !X- -5
MR6$&BVX-  #Q*   &0              @($*P0  >&PO=V]R:W-H965T<R]S
M:&5E=#(P+GAM;%!+ 0(4 Q0    ( '@T U5X0>_VAA,  &4\   9
M      " @:_.  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%
M  @ >#0#5:=$D'7N"   *!H  !D              ("!;.(  'AL+W=O<FMS
M:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " !X- -5V>--:&4-  "^+
M&0              @(&1ZP  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+
M 0(4 Q0    ( '@T U5SV^<!6 8   (3   9              " @2WY  !X
M;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @ >#0#5;%)5*N%
M P  +P@  !D              ("!O/\  'AL+W=O<FMS:&5E=',O<VAE970R
M-2YX;6Q02P$"% ,4    " !X- -5'+R?":8$   Q#0  &0
M@(%X P$ >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( '@T
M U6T'K"IG (  +4%   9              " @54( 0!X;"]W;W)K<VAE971S
M+W-H965T,C<N>&UL4$L! A0#%     @ >#0#58J':7LA!0  =0X  !D
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M=#,R+GAM;%!+ 0(4 Q0    ( '@T U5H?H9EY (  & (   9
M  " @: I 0!X;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @
M>#0#5;VW>63Z#@  Y:,  !D              ("!NRP! 'AL+W=O<FMS:&5E
M=',O<VAE970S-"YX;6Q02P$"% ,4    " !X- -5+3OPB+@"  !J"   &0
M            @('L.P$ >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4
M Q0    ( '@T U5NT+L_]P(  /H'   9              " @=L^ 0!X;"]W
M;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ >#0#57WMLB*X!0
M="P  !D              ("!"4(! 'AL+W=O<FMS:&5E=',O<VAE970S-RYX
M;6Q02P$"% ,4    " !X- -5*]&&F*L#  !3$0  &0              @('X
M1P$ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( '@T U6X
M=CO06@@  #P[   9              " @=I+ 0!X;"]W;W)K<VAE971S+W-H
M965T,SDN>&UL4$L! A0#%     @ >#0#57_UNN?\!   \!X  !D
M     ("!:U0! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( '@T U7E?'I], 4  ,(>   9              "
M@>!Z 0!X;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @ >#0#
M5;M@A-#E @  DPD  !D              ("!1X ! 'AL+W=O<FMS:&5E=',O
M<VAE970T-BYX;6Q02P$"% ,4    " !X- -5(SC%'34-   BC@  &0
M        @(%C@P$ >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0
M   ( '@T U5WS9%"K (  /4(   9              " @<^0 0!X;"]W;W)K
M<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @ >#0#5>:@'($,!0  ZA\
M !D              ("!LI,! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q0
M2P$"% ,4    " !X- -52NRW4-H&  "S/@  &0              @('UF $
M>&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    ( '@T U55?)X*
M6 4   T;   9              " @0:@ 0!X;"]W;W)K<VAE971S+W-H965T
M-3$N>&UL4$L! A0#%     @ >#0#5==27L;] @  \0@  !D
M ("!E:4! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q02P$"% ,4    " !X
M- -5=&P,JT\1   5R0  &0              @(')J $ >&PO=V]R:W-H965T
M<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( '@T U7RB3,HI 4  $,W   9
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M970U."YX;6Q02P$"% ,4    " !X- -53?IU'0(%  #C&@  &0
M    @(&UTP$ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    (
M '@T U6 >LO6#P4   0F   9              " @>[8 0!X;"]W;W)K<VAE
M971S+W-H965T-C N>&UL4$L! A0#%     @ >#0#5;\TN\\? @  I00  !D
M             ("!--X! 'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6Q02P$"
M% ,4    " !X- -5# ?PSSL)  "$2   &0              @(&*X $ >&PO
M=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    ( '@T U7U&90K1P8
M "PL   9              " @?SI 0!X;"]W;W)K<VAE971S+W-H965T-C,N
M>&UL4$L! A0#%     @ >#0#5:(+H \_ P  "!0   T              ( !
M>O ! 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !X- -5EXJ[',     3 @
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8;6Q02P4&     $< 1P!H$P  ._X!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>650</ContextCount>
  <ElementCount>336</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>124</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>14</UnitCount>
  <MyReports>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1007007 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Shareholders' Equity (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1008008 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Shareholders' Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>1406401 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2110102 - Disclosure - Divestitures and Asset Sales</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/DivestituresandAssetSales</Role>
      <ShortName>Divestitures and Asset Sales</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2112103 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2123104 - Disclosure - Fair Value</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValue</Role>
      <ShortName>Fair Value</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2129105 - Disclosure - Health Care Costs Payable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayable</Role>
      <ShortName>Health Care Costs Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2133106 - Disclosure - Borrowings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/Borrowings</Role>
      <ShortName>Borrowings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2137107 - Disclosure - Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquity</Role>
      <ShortName>Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2142108 - Disclosure - Other Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherComprehensiveIncome</Role>
      <ShortName>Other Comprehensive Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2145109 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2148110 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2150111 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2313302 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/Investments</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2324303 - Disclosure - Fair Value (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueTables</Role>
      <ShortName>Fair Value (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/FairValue</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2330304 - Disclosure - Health Care Costs Payable (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayableTables</Role>
      <ShortName>Health Care Costs Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/HealthCareCostsPayable</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2334305 - Disclosure - Borrowings (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/BorrowingsTables</Role>
      <ShortName>Borrowings (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/Borrowings</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2338306 - Disclosure - Shareholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquityTables</Role>
      <ShortName>Shareholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/ShareholdersEquity</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2343307 - Disclosure - Other Comprehensive Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherComprehensiveIncomeTables</Role>
      <ShortName>Other Comprehensive Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/OtherComprehensiveIncome</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2346308 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/EarningsPerShare</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2351309 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/SegmentReporting</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2404402 - Disclosure - Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2405403 - Disclosure - Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails</Role>
      <ShortName>Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2406404 - Disclosure - Significant Accounting Policies - Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails</Role>
      <ShortName>Significant Accounting Policies - Accounts Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2407405 - Disclosure - Significant Accounting Policies - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails</Role>
      <ShortName>Significant Accounting Policies - Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2408406 - Disclosure - Significant Accounting Policies - Receivables and Contracted Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails</Role>
      <ShortName>Significant Accounting Policies - Receivables and Contracted Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2409407 - Disclosure - Significant Accounting Policies - Contract Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails</Role>
      <ShortName>Significant Accounting Policies - Contract Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2411408 - Disclosure - Divestitures and Asset Sales (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/DivestituresandAssetSalesDetails</Role>
      <ShortName>Divestitures and Asset Sales (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/DivestituresandAssetSales</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2414409 - Disclosure - Investments - Total Investment Schedule (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails</Role>
      <ShortName>Investments - Total Investment Schedule (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2415410 - Disclosure - Investments - Debt Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails</Role>
      <ShortName>Investments - Debt Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2416411 - Disclosure - Investments - Debt Securities by Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails</Role>
      <ShortName>Investments - Debt Securities by Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2417412 - Disclosure - Investments - Unrealized Loss Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails</Role>
      <ShortName>Investments - Unrealized Loss Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2418413 - Disclosure - Investments - Unrealized Loss Position Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails</Role>
      <ShortName>Investments - Unrealized Loss Position Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2419414 - Disclosure - Investments - Mortgage Loans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails</Role>
      <ShortName>Investments - Mortgage Loans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2420415 - Disclosure - Investments - Mortgage Loans Credit Ratings Indicator (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails</Role>
      <ShortName>Investments - Mortgage Loans Credit Ratings Indicator (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2421416 - Disclosure - Investments - Net Investment Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails</Role>
      <ShortName>Investments - Net Investment Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2422417 - Disclosure - Investments - Realized Gains (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails</Role>
      <ShortName>Investments - Realized Gains (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2425418 - Disclosure - Fair Value - Measurement on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails</Role>
      <ShortName>Fair Value - Measurement on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2426419 - Disclosure - Fair Value - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueNarrativeDetails</Role>
      <ShortName>Fair Value - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2427420 - Disclosure - Fair Value - Carrying Value and Fair Value Classified by Level (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails</Role>
      <ShortName>Fair Value - Carrying Value and Fair Value Classified by Level (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2428421 - Disclosure - Fair Value - Separate Accounts Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails</Role>
      <ShortName>Fair Value - Separate Accounts Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2431422 - Disclosure - Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails</Role>
      <ShortName>Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2432423 - Disclosure - Health Care Costs Payable - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails</Role>
      <ShortName>Health Care Costs Payable - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2435424 - Disclosure - Borrowings - Schedule of Borrowings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails</Role>
      <ShortName>Borrowings - Schedule of Borrowings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2436425 - Disclosure - Borrowings - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/BorrowingsNarrativeDetails</Role>
      <ShortName>Borrowings - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2439426 - Disclosure - Shareholders' Equity - Share Repurchases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails</Role>
      <ShortName>Shareholders' Equity - Share Repurchases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2440427 - Disclosure - Shareholders' Equity - Accelerated Share Repurchases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails</Role>
      <ShortName>Shareholders' Equity - Accelerated Share Repurchases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2441428 - Disclosure - Shareholders' Equity - Dividends (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails</Role>
      <ShortName>Shareholders' Equity - Dividends (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2444429 - Disclosure - Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails</Role>
      <ShortName>Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/OtherComprehensiveIncomeTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2447430 - Disclosure - Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/EarningsPerShareDetails</Role>
      <ShortName>Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/EarningsPerShareTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2449431 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/CommitmentsandContingencies</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2452432 - Disclosure - Segment Reporting - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingNarrativeDetails</Role>
      <ShortName>Segment Reporting - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2453433 - Disclosure - Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails</Role>
      <ShortName>Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="cvs-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2454434 - Disclosure - Segment Reporting - Reconciliation of Consolidated Operating Income to Adjusted Operating Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails</Role>
      <ShortName>Segment Reporting - Reconciliation of Consolidated Operating Income to Adjusted Operating Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="cvs-20220630.htm">cvs-20220630.htm</File>
    <File>a06302022ex101.htm</File>
    <File>a06302022ex102.htm</File>
    <File>a06302022ex103.htm</File>
    <File>a06302022ex151.htm</File>
    <File>a06302022ex311.htm</File>
    <File>a06302022ex312.htm</File>
    <File>a06302022ex321.htm</File>
    <File>a06302022ex322.htm</File>
    <File>cvs-20220630.xsd</File>
    <File>cvs-20220630_cal.xml</File>
    <File>cvs-20220630_def.xml</File>
    <File>cvs-20220630_lab.xml</File>
    <File>cvs-20220630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>cvs-20220630_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1567">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>85
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cvs-20220630.htm": {
   "axisCustom": 3,
   "axisStandard": 25,
   "contextCount": 650,
   "dts": {
    "calculationLink": {
     "local": [
      "cvs-20220630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cvs-20220630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "cvs-20220630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cvs-20220630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cvs-20220630_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cvs-20220630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 600,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 6,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 11
   },
   "keyCustom": 63,
   "keyStandard": 273,
   "memberCustom": 75,
   "memberStandard": 47,
   "nsprefix": "cvs",
   "nsuri": "http://www.cvshealth.com/20220630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.cvshealth.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Significant Accounting Policies",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110102 - Disclosure - Divestitures and Asset Sales",
     "role": "http://www.cvshealth.com/role/DivestituresandAssetSales",
     "shortName": "Divestitures and Asset Sales",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2112103 - Disclosure - Investments",
     "role": "http://www.cvshealth.com/role/Investments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2123104 - Disclosure - Fair Value",
     "role": "http://www.cvshealth.com/role/FairValue",
     "shortName": "Fair Value",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2129105 - Disclosure - Health Care Costs Payable",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayable",
     "shortName": "Health Care Costs Payable",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2133106 - Disclosure - Borrowings",
     "role": "http://www.cvshealth.com/role/Borrowings",
     "shortName": "Borrowings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2137107 - Disclosure - Shareholders' Equity",
     "role": "http://www.cvshealth.com/role/ShareholdersEquity",
     "shortName": "Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2142108 - Disclosure - Other Comprehensive Income",
     "role": "http://www.cvshealth.com/role/OtherComprehensiveIncome",
     "shortName": "Other Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2145109 - Disclosure - Earnings Per Share",
     "role": "http://www.cvshealth.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2148110 - Disclosure - Commitments and Contingencies",
     "role": "http://www.cvshealth.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PremiumsEarnedNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Statements of Operations (Unaudited)",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
     "shortName": "Condensed Consolidated Statements of Operations (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PremiumsEarnedNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2150111 - Disclosure - Segment Reporting",
     "role": "http://www.cvshealth.com/role/SegmentReporting",
     "shortName": "Segment Reporting",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Significant Accounting Policies (Policies)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - Significant Accounting Policies (Tables)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables",
     "shortName": "Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cvs:TotalInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2313302 - Disclosure - Investments (Tables)",
     "role": "http://www.cvshealth.com/role/InvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cvs:TotalInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2324303 - Disclosure - Fair Value (Tables)",
     "role": "http://www.cvshealth.com/role/FairValueTables",
     "shortName": "Fair Value (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2330304 - Disclosure - Health Care Costs Payable (Tables)",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayableTables",
     "shortName": "Health Care Costs Payable (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2334305 - Disclosure - Borrowings (Tables)",
     "role": "http://www.cvshealth.com/role/BorrowingsTables",
     "shortName": "Borrowings (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2338306 - Disclosure - Shareholders' Equity (Tables)",
     "role": "http://www.cvshealth.com/role/ShareholdersEquityTables",
     "shortName": "Shareholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2343307 - Disclosure - Other Comprehensive Income (Tables)",
     "role": "http://www.cvshealth.com/role/OtherComprehensiveIncomeTables",
     "shortName": "Other Comprehensive Income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2346308 - Disclosure - Earnings Per Share (Tables)",
     "role": "http://www.cvshealth.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2351309 - Disclosure - Segment Reporting (Tables)",
     "role": "http://www.cvshealth.com/role/SegmentReportingTables",
     "shortName": "Segment Reporting (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i497dd46327b4467f95cca59a81170078_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:NumberofPharmacyPlanMembers",
      "reportCount": 1,
      "unitRef": "people",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404402 - Disclosure - Significant Accounting Policies - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i497dd46327b4467f95cca59a81170078_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405403 - Disclosure - Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails",
     "shortName": "Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i9c91d440ca044d289daea52743e3cebd_I20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i497dd46327b4467f95cca59a81170078_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406404 - Disclosure - Significant Accounting Policies - Accounts Receivable (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails",
     "shortName": "Significant Accounting Policies - Accounts Receivable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i497dd46327b4467f95cca59a81170078_I20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:VendorandManufacturerReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407405 - Disclosure - Significant Accounting Policies - Disaggregation of Revenue (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
     "shortName": "Significant Accounting Policies - Disaggregation of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "ieb6ae33774b44fb4995615218a58f912_D20220401-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i497dd46327b4467f95cca59a81170078_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408406 - Disclosure - Significant Accounting Policies - Receivables and Contracted Balances (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails",
     "shortName": "Significant Accounting Policies - Receivables and Contracted Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i8af9eeada4aa4390a7aabb67f310e776_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409407 - Disclosure - Significant Accounting Policies - Contract Balances (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails",
     "shortName": "Significant Accounting Policies - Contract Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ReconciliationOfOperatingIncomeToAdjustedOperatingIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnSaleOfBusiness",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411408 - Disclosure - Divestitures and Asset Sales (Details)",
     "role": "http://www.cvshealth.com/role/DivestituresandAssetSalesDetails",
     "shortName": "Divestitures and Asset Sales (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i63fd0bfb9e4a43a58e4cfcab6009ac9e_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "cvs:NumberOfMedicalMembers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "member",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i497dd46327b4467f95cca59a81170078_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414409 - Disclosure - Investments - Total Investment Schedule (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails",
     "shortName": "Investments - Total Investment Schedule (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:TotalInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i497dd46327b4467f95cca59a81170078_I20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Investments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i497dd46327b4467f95cca59a81170078_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415410 - Disclosure - Investments - Debt Securities (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
     "shortName": "Investments - Debt Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i497dd46327b4467f95cca59a81170078_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i497dd46327b4467f95cca59a81170078_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Balance Sheets (Unaudited)",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i497dd46327b4467f95cca59a81170078_I20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:InventoryNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i497dd46327b4467f95cca59a81170078_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416411 - Disclosure - Investments - Debt Securities by Maturity (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
     "shortName": "Investments - Debt Securities by Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i497dd46327b4467f95cca59a81170078_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i497dd46327b4467f95cca59a81170078_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "security",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417412 - Disclosure - Investments - Unrealized Loss Position (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
     "shortName": "Investments - Unrealized Loss Position (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i497dd46327b4467f95cca59a81170078_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "security",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i497dd46327b4467f95cca59a81170078_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418413 - Disclosure - Investments - Unrealized Loss Position Maturities (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
     "shortName": "Investments - Unrealized Loss Position Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i497dd46327b4467f95cca59a81170078_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i9b35d26a394f498ead4b8911f6b783f3_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstateNewMortgageLoans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419414 - Disclosure - Investments - Mortgage Loans (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails",
     "shortName": "Investments - Mortgage Loans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i9b35d26a394f498ead4b8911f6b783f3_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstateNewMortgageLoans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i4faa5bd0ec73475c94099ab518ccf4e3_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420415 - Disclosure - Investments - Mortgage Loans Credit Ratings Indicator (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
     "shortName": "Investments - Mortgage Loans Credit Ratings Indicator (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i4faa5bd0ec73475c94099ab518ccf4e3_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentIncomeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterestAndDividend",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421416 - Disclosure - Investments - Net Investment Income (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
     "shortName": "Investments - Net Investment Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentIncomeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterestAndDividend",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422417 - Disclosure - Investments - Realized Gains (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails",
     "shortName": "Investments - Realized Gains (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i497dd46327b4467f95cca59a81170078_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425418 - Disclosure - Fair Value - Measurement on a Recurring Basis (Details)",
     "role": "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
     "shortName": "Fair Value - Measurement on a Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i4e0d80e2d0a04bb8927a1bf01c58fd6a_I20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FinancialLiabilitiesFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426419 - Disclosure - Fair Value - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/FairValueNarrativeDetails",
     "shortName": "Fair Value - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "ib6f883902b9f4d569180bdd25d7ac485_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgagesHeldForSaleFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427420 - Disclosure - Fair Value - Carrying Value and Fair Value Classified by Level (Details)",
     "role": "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
     "shortName": "Fair Value - Carrying Value and Fair Value Classified by Level (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "ib6f883902b9f4d569180bdd25d7ac485_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgagesHeldForSaleFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i497dd46327b4467f95cca59a81170078_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i497dd46327b4467f95cca59a81170078_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i497dd46327b4467f95cca59a81170078_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeparateAccountAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428421 - Disclosure - Fair Value - Separate Accounts Fair Value (Details)",
     "role": "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
     "shortName": "Fair Value - Separate Accounts Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i4e0d80e2d0a04bb8927a1bf01c58fd6a_I20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:SeparateAccountAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i8af9eeada4aa4390a7aabb67f310e776_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431422 - Disclosure - Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details)",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
     "shortName": "Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i1c0bcd0eebfa40769648a67be75183aa_D20220101-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i497dd46327b4467f95cca59a81170078_I20220630",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432423 - Disclosure - Health Care Costs Payable - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
     "shortName": "Health Care Costs Payable - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i497dd46327b4467f95cca59a81170078_I20220630",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i497dd46327b4467f95cca59a81170078_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435424 - Disclosure - Borrowings - Schedule of Borrowings (Details)",
     "role": "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails",
     "shortName": "Borrowings - Schedule of Borrowings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i497dd46327b4467f95cca59a81170078_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RepaymentsOfLongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436425 - Disclosure - Borrowings - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
     "shortName": "Borrowings - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "if2a4890c67364387b34caac671f1ecb8_D20220501-20220531",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:RepaymentsOfLongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchasedDuringPeriodShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439426 - Disclosure - Shareholders' Equity - Share Repurchases (Details)",
     "role": "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails",
     "shortName": "Shareholders' Equity - Share Repurchases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iec728b6b42c64aeba0f0e6ab1cec45f2_D20210101-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchasedDuringPeriodShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i6f0054d90f614171a2cdaff45560ffaa_I20220104",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "cvs:AcceleratedShareRepurchasesAgreementAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440427 - Disclosure - Shareholders' Equity - Accelerated Share Repurchases (Details)",
     "role": "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails",
     "shortName": "Shareholders' Equity - Accelerated Share Repurchases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i6f0054d90f614171a2cdaff45560ffaa_I20220104",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "cvs:AcceleratedShareRepurchasesAgreementAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441428 - Disclosure - Shareholders' Equity - Dividends (Details)",
     "role": "http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails",
     "shortName": "Shareholders' Equity - Dividends (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i3779b6c8ef834637b29b6a1763d82299_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444429 - Disclosure - Other Comprehensive Income (Details)",
     "role": "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails",
     "shortName": "Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i7519dbaef94443449eecd8f162669ec1_D20220401-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447430 - Disclosure - Earnings Per Share (Details)",
     "role": "http://www.cvshealth.com/role/EarningsPerShareDetails",
     "shortName": "Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i497dd46327b4467f95cca59a81170078_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cvs:GuarantorObligationsNumberofLeases",
      "reportCount": 1,
      "unitRef": "lease",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449431 - Disclosure - Commitments and Contingencies (Details)",
     "role": "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "if80d8dd79ebc4415ad936ec2eebc9a64_D20120101-20121231",
      "decimals": "-2",
      "lang": "en-US",
      "name": "cvs:LossContingencyAuditMethodologySampleSize",
      "reportCount": 1,
      "unique": true,
      "unitRef": "member",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452432 - Disclosure - Segment Reporting - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails",
     "shortName": "Segment Reporting - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453433 - Disclosure - Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)",
     "role": "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
     "shortName": "Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "ib5045314d03040549992e1b0d350c6f4_D20220401-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:AdjustedOperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454434 - Disclosure - Segment Reporting - Reconciliation of Consolidated Operating Income to Adjusted Operating Income (Details)",
     "role": "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails",
     "shortName": "Segment Reporting - Reconciliation of Consolidated Operating Income to Adjusted Operating Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ReconciliationOfOperatingIncomeToAdjustedOperatingIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "ic469e5969d2d48a3b0fb1b60ef493a3f_D20220401-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "ic10a47a61fb346eca4da1c6b4eb8f3e0_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007007 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Unaudited)",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
     "shortName": "Condensed Consolidated Statements of Shareholders' Equity (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i46f6d2a9429541919bc596eed6bc6437_D20210101-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "cvs:TreasuryStockSharesHeldinTrust",
       "link:footnote",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i497dd46327b4467f95cca59a81170078_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:TreasuryStockSharesHeldinTrust",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1008008 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Parenthetical)",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParenthetical",
     "shortName": "Condensed Consolidated Statements of Shareholders' Equity (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "cvs:TreasuryStockSharesHeldinTrust",
       "link:footnote",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "i497dd46327b4467f95cca59a81170078_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:TreasuryStockSharesHeldinTrust",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashDivestedFromDeconsolidation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1406401 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical)",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnauditedParenthetical",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20220630.htm",
      "contextRef": "iae100dd9bfc446dc8e8848db5148bc53_D20220101-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashDivestedFromDeconsolidation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 124,
   "tag": {
    "cvs_A2021AcceleratedRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Accelerated Repurchase Program",
        "label": "2021 Accelerated Repurchase Program [Member]",
        "terseLabel": "2021 ASR"
       }
      }
     },
     "localname": "A2021AcceleratedRepurchaseProgramMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_A2021RepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Repurchase Program",
        "label": "2021 Repurchase Program [Member]",
        "terseLabel": "2021 Repurchase Program"
       }
      }
     },
     "localname": "A2021RepurchaseProgramMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_AcceleratedShareRepurchasesAgreementAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases Agreement, Amount",
        "label": "Accelerated Share Repurchases Agreement, Amount",
        "terseLabel": "ASR agreement, amount"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesAgreementAmount",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases, Number of Shares Repurchased",
        "label": "Accelerated Share Repurchases, Number of Shares Repurchased",
        "terseLabel": "Shares repurchased under ASR agreement (in shares)"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesNumberOfSharesRepurchased",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases, Percent of Notional Amount in Shares to be Received at End of Program",
        "label": "Accelerated Share Repurchases, Percent of Notional Amount in Shares to be Received at End of Program",
        "terseLabel": "ASR, shares to be received at the end of program as a percent of notional amount"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases, Percent of Notional Amount Received in Shares",
        "label": "Accelerated Share Repurchases, Percent of Notional Amount Received in Shares",
        "terseLabel": "ASR percent of notional amount received in shares"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cvs_ActivityInMortgageLoanPortfolioTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table representing activities in mortgage loan portfolio during the period.",
        "label": "Activity in mortgage loan portfolio [Table Text Block]",
        "verboseLabel": "Schedule of Activity in Mortgage Loan Portfolio"
       }
      }
     },
     "localname": "ActivityInMortgageLoanPortfolioTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_AdjustedOperatingIncomeLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjusted Operating Income (Loss)",
        "label": "Adjusted Operating Income (Loss)",
        "terseLabel": "Adjusted operating income (loss)",
        "verboseLabel": "Adjusted operating income"
       }
      }
     },
     "localname": "AdjustedOperatingIncomeLoss",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_BarclaysBankMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Barclays Bank",
        "label": "Barclays Bank [Member]",
        "terseLabel": "Barclays Bank"
       }
      }
     },
     "localname": "BarclaysBankMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Purchase Price Adjustment, Outside of Measurement Period",
        "label": "Business Combination, Purchase Price Adjustment, Outside of Measurement Period",
        "negatedTerseLabel": "Acquisition purchase price adjustment outside of measurement period"
       }
      }
     },
     "localname": "BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_Categories5and6Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage loan credit quality indicator - Categories 5 and 6",
        "label": "Categories 5 and 6 [Member]",
        "terseLabel": "5 and 6"
       }
      }
     },
     "localname": "Categories5and6Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_Category1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loan Credit Quality Indicator - Category 1 [Member].",
        "label": "Category 1 [Member]",
        "terseLabel": "1"
       }
      }
     },
     "localname": "Category1Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_Category2To4Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loan Credit Quality Indicator - Category 2 to 4 [Member].",
        "label": "Category 2 to 4 [Member]",
        "terseLabel": "2 to 4"
       }
      }
     },
     "localname": "Category2To4Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_Category7Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage loan credit quality indicator - Category 7",
        "label": "Category 7 [Member]",
        "terseLabel": "7"
       }
      }
     },
     "localname": "Category7Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ChangeinContractwithCustomerLiabilityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in Contract with Customer, Liability [Roll Forward]",
        "label": "Change in Contract with Customer, Liability [Roll Forward]",
        "terseLabel": "Change in Contract with Customer, Liability [Roll Forward]"
       }
      }
     },
     "localname": "ChangeinContractwithCustomerLiabilityRollForward",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in operating assets and liabilities, net of effects from acquisitions: [Abstract]",
        "label": "Change in operating assets and liabilities, net of effects from acquisitions: [Abstract]",
        "terseLabel": "Change in operating assets and liabilities, net of effects from acquisitions:"
       }
      }
     },
     "localname": "ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_CommonAndCollectiveTrustsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of Common/Collective Trusts held by the company, primarily related to investment funds otherwise known as underlying funds.",
        "label": "Common and Collective Trusts [Member]",
        "terseLabel": "Common/collective trusts"
       }
      }
     },
     "localname": "CommonAndCollectiveTrustsMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in contract liability recognized for loyalty program earnings and gift card issuance.",
        "label": "Contract With Customer Liability Loyalty Program Earnings And Gift Card Issuance",
        "terseLabel": "Rewards earnings and gift card issuances"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_ContractwithCustomerLiabilityRedemptionandBreakage": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with Customer Liability Redemption and Breakage",
        "label": "Contract with Customer Liability Redemption and Breakage",
        "negatedTerseLabel": "Redemption and breakage"
       }
      }
     },
     "localname": "ContractwithCustomerLiabilityRedemptionandBreakage",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_CorporateOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate / Other [Member]",
        "label": "Corporate / Other [Member]",
        "terseLabel": "Corporate / Other"
       }
      }
     },
     "localname": "CorporateOtherMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings",
        "label": "Credit-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings",
        "terseLabel": "Credit-related impairment loss"
       }
      }
     },
     "localname": "CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtAndEquitySecuritiesAvailableForSaleMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in debt and equity securities which are categorized neither as trading securities nor held-to-maturity securities. Such securities are reported at fair value; unrealized gains and losses related to Available-for-sale securities are excluded from earnings and reported in a separate component of shareholders' equity (other comprehensive income)",
        "label": "Debt And Equity Securities Available For Sale [Member]",
        "terseLabel": "Debt securities available for sale"
       }
      }
     },
     "localname": "DebtAndEquitySecuritiesAvailableForSaleMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Unamortized Discount and Debt Issuance Costs, Net",
        "label": "Debt Instrument, Unamortized Discount and Debt Issuance Costs, Net",
        "negatedTerseLabel": "Debt discounts and deferred financing costs"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]",
        "label": "Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Amortized Cost",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Amortized Cost",
        "terseLabel": "Debt securities, maturity, without single maturity date, unrealized losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value",
        "terseLabel": "Debt securities, maturity, without single maturity date, fair value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_Deferredincometaxesandothernoncashitems": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits and amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Deferred income taxes and other noncash items",
        "terseLabel": "Deferred income taxes and other noncash items"
       }
      }
     },
     "localname": "Deferredincometaxesandothernoncashitems",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DenominatorForEarningsPerShareCalculationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Denominator For Earnings Per Share Calculation [Abstract]",
        "label": "Denominator For Earnings Per Share Calculation [Abstract]",
        "terseLabel": "Denominator for earnings per share calculation:"
       }
      }
     },
     "localname": "DenominatorForEarningsPerShareCalculationAbstract",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_DisposalGroupNotDiscontinuedOperationMigrationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Not Discontinued Operation, Migration Period",
        "label": "Disposal Group, Not Discontinued Operation, Migration Period",
        "terseLabel": "Member migration period"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationMigrationPeriod",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresandAssetSalesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Not Discontinued Operation, Number of International Health Care Members, Renewal Rights Sold",
        "label": "Disposal Group, Not Discontinued Operation, Number of International Health Care Members, Renewal Rights Sold",
        "terseLabel": "Number of international health care members, renewal rights sold"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresandAssetSalesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ESPP Issuance, Net of Treasury Stock, Shares, Acquired, Cost Method",
        "label": "ESPP Issuance, Net of Treasury Stock, Shares, Acquired, Cost Method",
        "terseLabel": "ESPP issuances, net of purchase of treasury shares (in shares)"
       }
      }
     },
     "localname": "ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ESPP Issuance, Net of Treasury Stock, Value, Acquired, Cost Method",
        "label": "ESPP Issuance, Net of Treasury Stock, Value, Acquired, Cost Method",
        "terseLabel": "ESPP issuances, net of purchase of treasury shares"
       }
      }
     },
     "localname": "ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_EarningsPerShareBasicAndDilutedEPSAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share, Basic and Diluted EPS",
        "label": "Earnings Per Share, Basic and Diluted EPS [Abstract]",
        "verboseLabel": "Earnings per share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedEPSAbstract",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_FrontStoreRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Front Store Revenue [Member]",
        "label": "Front Store Revenue [Member]",
        "terseLabel": "Front Store"
       }
      }
     },
     "localname": "FrontStoreRevenueMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_GuarantorObligationsNumberofLeases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantor Obligations, Number of Leases",
        "label": "Guarantor Obligations, Number of Leases",
        "terseLabel": "Guarantor obligations, number of leases"
       }
      }
     },
     "localname": "GuarantorObligationsNumberofLeases",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_HealthCareBenefitsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Benefits Segment [Member]",
        "label": "Health Care Benefits Segment [Member]",
        "terseLabel": "Health Care Benefits"
       }
      }
     },
     "localname": "HealthCareBenefitsSegmentMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresandAssetSalesDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_HealthCareandOtherInsuranceLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care and Other Insurance Liabilities [Abstract]",
        "label": "Health Care and Other Insurance Liabilities [Abstract]",
        "terseLabel": "Health Care and Other Insurance Liabilities [Abstract]"
       }
      }
     },
     "localname": "HealthCareandOtherInsuranceLiabilitiesAbstract",
     "nsuri": "http://www.cvshealth.com/20220630",
     "xbrltype": "stringItemType"
    },
    "cvs_HeartlandHealthcareServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Heartland Healthcare Services [Member]",
        "label": "Heartland Healthcare Services [Member]",
        "terseLabel": "Heartland Healthcare Services"
       }
      }
     },
     "localname": "HeartlandHealthcareServicesMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfAdditionalStates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Individual Public Health Insurance Exchanges, Submitted Regulatory Filings, Number of Additional States",
        "label": "Individual Public Health Insurance Exchanges, Submitted Regulatory Filings, Number of Additional States",
        "terseLabel": "Additional number of states in which the Company has entered the individual public health insurance exchange"
       }
      }
     },
     "localname": "IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfAdditionalStates",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Individual Public Health Insurance Exchanges, Submitted Regulatory Filings, Number of States",
        "label": "Individual Public Health Insurance Exchanges, Submitted Regulatory Filings, Number of States",
        "terseLabel": "Number of states in which the Company has entered the individual public health insurance exchange"
       }
      }
     },
     "localname": "IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_InternationalHealthCareRenewalRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Health Care Renewal Rights",
        "label": "International Health Care Renewal Rights [Member]",
        "terseLabel": "International Health Care Renewal Rights"
       }
      }
     },
     "localname": "InternationalHealthCareRenewalRightsMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresandAssetSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Contracts With Fixed Maturity, Fair Value Disclosure.",
        "label": "Investment Contracts With Fixed Maturity, Fair Value Disclosure",
        "terseLabel": "Investment contracts liabilities with a fixed maturity"
       }
      }
     },
     "localname": "InvestmentContractsWithFixedMaturityFairValueDisclosure",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Contracts Without A Fixed Maturity, Fair Value Disclosure.",
        "label": "Investment Contracts Without A Fixed Maturity, Fair Value Disclosure",
        "terseLabel": "Investment contracts liabilities without a fixed maturity"
       }
      }
     },
     "localname": "InvestmentContractsWithoutFixedMaturityFairValueDisclosure",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_InvestmentIncomeExcludingCapitalGainsorLosses": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InvestmentIncomeNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Income, Excluding Capital Gains or Losses",
        "label": "Investment Income, Excluding Capital Gains or Losses",
        "totalLabel": "Net investment income (excluding net realized capital gains or losses)"
       }
      }
     },
     "localname": "InvestmentIncomeExcludingCapitalGainsorLosses",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LegalSettlementPeriodOfPayment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal Settlement, Period of Payment",
        "label": "Legal Settlement, Period of Payment",
        "terseLabel": "Legal settlement, period of payment"
       }
      }
     },
     "localname": "LegalSettlementPeriodOfPayment",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs",
        "label": "Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs",
        "terseLabel": "Benefit costs recorded in other insurance liabilities"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LongtermDebtGrossAndLeaseObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Debt, Gross And Lease Obligation",
        "label": "Long-term Debt, Gross And Lease Obligation",
        "totalLabel": "Total debt principal"
       }
      }
     },
     "localname": "LongtermDebtGrossAndLeaseObligation",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LossContingencyAuditMethodologySampleSize": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Audit Methodology Sample Size",
        "label": "Loss Contingency, Audit Methodology Sample Size",
        "terseLabel": "Sample size"
       }
      }
     },
     "localname": "LossContingencyAuditMethodologySampleSize",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_MortgageLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents mortgage loans for the reporting period measured at carrying value. We carry the value of our mortgage loan investments on our balance sheet at the unpaid principal balance, net of impairment reserves.",
        "label": "Mortgage Loans [Member]",
        "terseLabel": "Mortgage loans"
       }
      }
     },
     "localname": "MortgageLoansMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans on Real Estate, Credit Quality Indicator [Axis].",
        "label": "Mortgage Loans on Real Estate, Credit Quality Indicator [Axis]",
        "terseLabel": "Mortgage Loans on Real Estate, Credit Quality Indicator [Axis]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCreditQualityIndicatorAxis",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans on Real Estate, Credit Quality Indicator [Domain].",
        "label": "Mortgage Loans on Real Estate, Credit Quality Indicator [Domain]",
        "terseLabel": "Mortgage Loans on Real Estate, Credit Quality Indicator [Domain]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCreditQualityIndicatorDomain",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_MortgageLoansOnRealEstateLoansFullyRepaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pertains to amount of mortgage loans fully repaid.",
        "label": "Mortgage Loans on Real Estate, Loans Fully Repaid",
        "terseLabel": "Mortgage loans fully repaid"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateLoansFullyRepaid",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_MortgageLoansOnRealEstateYearOfOriginationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans On Real Estate, Year Of Origination [Axis]",
        "label": "Mortgage Loans On Real Estate, Year Of Origination [Axis]",
        "terseLabel": "Mortgage Loans On Real Estate, Year Of Origination [Axis]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateYearOfOriginationAxis",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_MortgageLoansOnRealEstateYearOfOriginationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Mortgage Loans On Real Estate, Year Of Origination [Axis]",
        "label": "Mortgage Loans On Real Estate, Year Of Origination [Domain]",
        "terseLabel": "Mortgage Loans On Real Estate, Year Of Origination [Domain]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateYearOfOriginationDomain",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_NetRevenuesRetailCoPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Revenues, Retail CoPayments",
        "label": "Net Revenues, Retail CoPayments",
        "terseLabel": "Copayments"
       }
      }
     },
     "localname": "NetRevenuesRetailCoPayments",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling interest, Other Period Increase (Decrease)",
        "label": "Noncontrolling interest, Other Period Increase (Decrease)",
        "terseLabel": "Other increases (decreases) in noncontrolling interests"
       }
      }
     },
     "localname": "NoncontrollinginterestOtherPeriodIncreaseDecrease",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_NumberOfMedicalMembers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Medical Members",
        "label": "Number of Medical Members",
        "terseLabel": "Number of medical members"
       }
      }
     },
     "localname": "NumberOfMedicalMembers",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresandAssetSalesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberOfPeopleServed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of People Served",
        "label": "Number Of People Served",
        "terseLabel": "Number of people served"
       }
      }
     },
     "localname": "NumberOfPeopleServed",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberofPatientsServedperYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Patients Served per Year",
        "label": "Number of Patients Served per Year",
        "terseLabel": "Number of patients served per year"
       }
      }
     },
     "localname": "NumberofPatientsServedperYear",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberofPharmacyPlanMembers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Pharmacy Plan Members",
        "label": "Number of Pharmacy Plan Members",
        "terseLabel": "Number of pharmacy plan members"
       }
      }
     },
     "localname": "NumberofPharmacyPlanMembers",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberofWalkInMedicalClinics": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Walk In Medical Clinics",
        "label": "Number of Walk In Medical Clinics",
        "terseLabel": "Number of walk in medical clinics"
       }
      }
     },
     "localname": "NumberofWalkInMedicalClinics",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumeratorForEarningsPerShareCalculationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Numerator For Earnings Per Share Calculation [Abstract]",
        "label": "Numerator For Earnings Per Share Calculation [Abstract]",
        "terseLabel": "Numerator for earnings per share calculation:"
       }
      }
     },
     "localname": "NumeratorForEarningsPerShareCalculationAbstract",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_OtherAssetBackedSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by a variety of assets such as automobile loans, credit card receivables, home equity loans, etc.",
        "label": "Other Asset-Backed Securities [Member]",
        "terseLabel": "Other asset-backed securities"
       }
      }
     },
     "localname": "OtherAssetBackedSecuritiesMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_OtherInsuranceLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Insurance Liabilities, Current",
        "label": "Other Insurance Liabilities, Current",
        "terseLabel": "Other insurance liabilities"
       }
      }
     },
     "localname": "OtherInsuranceLiabilitiesCurrent",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OtherInsuranceLiabilitiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Insurance Liabilities, Noncurrent",
        "label": "Other Insurance Liabilities, Noncurrent",
        "terseLabel": "Other long-term insurance liabilities"
       }
      }
     },
     "localname": "OtherInsuranceLiabilitiesNoncurrent",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OtherReceivablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Receivables",
        "label": "Other Receivables [Member]",
        "terseLabel": "Other Receivables"
       }
      }
     },
     "localname": "OtherReceivablesMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_PayflexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payflex",
        "label": "Payflex [Member]",
        "terseLabel": "Payflex"
       }
      }
     },
     "localname": "PayflexMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresandAssetSalesDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_PaymentsForAcceleratedShareRepurchasesAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Accelerated Share Repurchases, Amount",
        "label": "Payments for Accelerated Share Repurchases, Amount",
        "terseLabel": "Payments for ASR, amount"
       }
      }
     },
     "localname": "PaymentsForAcceleratedShareRepurchasesAmount",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PaymentsforInsuranceBenefits": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Insurance Benefits",
        "label": "Payments for Insurance Benefits",
        "negatedTerseLabel": "Insurance benefits paid"
       }
      }
     },
     "localname": "PaymentsforInsuranceBenefits",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Inventory and Prescriptions Dispensed by Retail Network Pharmacies",
        "label": "Payments for Inventory and Prescriptions Dispensed by Retail Network Pharmacies",
        "negatedTerseLabel": "Cash paid for inventory and prescriptions dispensed by retail network pharmacies"
       }
      }
     },
     "localname": "PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PharmacyClaimsandDiscountsPayableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy Claims and Discounts Payable, Current",
        "label": "Pharmacy Claims and Discounts Payable, Current",
        "terseLabel": "Pharmacy claims and discounts payable"
       }
      }
     },
     "localname": "PharmacyClaimsandDiscountsPayableCurrent",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PharmacyRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy Revenue [Member]",
        "label": "Pharmacy Revenue [Member]",
        "terseLabel": "Pharmacy"
       }
      }
     },
     "localname": "PharmacyRevenueMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_PharmacyServicesSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy Services Segment [Member]",
        "label": "Pharmacy Services Segment [Member]",
        "terseLabel": "Pharmacy Services"
       }
      }
     },
     "localname": "PharmacyServicesSegmentMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_PremiumDeficiencyReserveLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of reserves related to expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), in excess of existing reserves plus anticipated future premiums and reinsurance recoveries.",
        "label": "Premium Deficiency Reserve Liability",
        "terseLabel": "Add: Premium deficiency reserve",
        "verboseLabel": "Premium deficiency reserve"
       }
      }
     },
     "localname": "PremiumDeficiencyReserveLiability",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax",
        "label": "Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax",
        "terseLabel": "Revenues",
        "verboseLabel": "Revenues from external customers"
       }
      }
     },
     "localname": "PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PremiumsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Premiums [Member]",
        "label": "Premiums [Member]",
        "terseLabel": "Premiums"
       }
      }
     },
     "localname": "PremiumsMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item includes proceeds from the sale of debt securities and the related gross realized capital gains and losses, excluding amounts related to experience-rated and discontinued products.",
        "label": "Proceeds And Related Gross Realized Capital Gains Losses From Sale Of Debt Securities [Table Text Block]",
        "verboseLabel": "Schedule of Proceeds and Related Gross Realized Capital Gains and Losses From the Sale of Debt Securities"
       }
      }
     },
     "localname": "ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_RadcliffeAndFlaimVAetnaIncEtAlMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Radcliffe and Flaim v. Aetna Inc., et al",
        "label": "Radcliffe and Flaim v. Aetna Inc., et al [Member]",
        "terseLabel": "Radcliffe and Flaim v. Aetna Inc., et al"
       }
      }
     },
     "localname": "RadcliffeAndFlaimVAetnaIncEtAlMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ReconciliationOfOperatingIncomeToAdjustedOperatingIncomeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reconciliation of Operating Income to Adjusted Operating Income",
        "label": "Reconciliation of Operating Income to Adjusted Operating Income [Table Text Block]",
        "terseLabel": "Reconciliation of Consolidated Operating Income to Adjusted Operating Income"
       }
      }
     },
     "localname": "ReconciliationOfOperatingIncomeToAdjustedOperatingIncomeTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Units (RSUs) and Performance Stock Units (PSUs)",
        "label": "Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) [Member]",
        "terseLabel": "Restricted stock units and performance stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_RetailLongTermCareSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retail Long-Term Care Segment [Member]",
        "label": "Retail Long-Term Care Segment [Member]",
        "terseLabel": "Retail/ LTC"
       }
      }
     },
     "localname": "RetailLongTermCareSegmentMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SalesChannelOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales Channel, Other [Member]",
        "label": "Sales Channel, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "SalesChannelOtherMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing credit quality information related to financing receivables by credit quality indicator and by class of financing receivable.",
        "label": "Schedule Of Mortgage Loan Internal Credit Ratings [Table Text Block]",
        "verboseLabel": "Schedule of Mortgage Loan Amortized Cost and Credit Quality Indicator"
       }
      }
     },
     "localname": "ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_SeniorNotes13DueAugust2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 1.3%, Due August 2027",
        "label": "Senior Notes, 1.3%, Due August 2027 [Member]",
        "terseLabel": "1.3% senior notes due August 2027"
       }
      }
     },
     "localname": "SeniorNotes13DueAugust2027Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes175DueAugust2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 1.75%, Due August 2030",
        "label": "Senior Notes, 1.75%, Due August 2030 [Member]",
        "terseLabel": "1.75% senior notes due August 2030"
       }
      }
     },
     "localname": "SeniorNotes175DueAugust2030Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes1875DueFebruary2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 1.875%, Due February 2031",
        "label": "Senior Notes, 1.875%, Due February 2031 [Member]",
        "terseLabel": "1.875% senior notes due February 2031"
       }
      }
     },
     "localname": "SeniorNotes1875DueFebruary2031Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.625DueAugust2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.625%, Due August 2024 [Member]",
        "label": "Senior Notes, 2.625%, Due August 2024 [Member]",
        "terseLabel": "2.625% senior notes due August 2024"
       }
      }
     },
     "localname": "SeniorNotes2.625DueAugust2024Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.75DueDecember2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.75%, Due December 2022 [Member]",
        "label": "Senior Notes, 2.75%, Due December 2022 [Member]",
        "terseLabel": "2.75% senior notes due December 2022"
       }
      }
     },
     "localname": "SeniorNotes2.75DueDecember2022Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.75DueNovember2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.75%, Due November 2022 [Member]",
        "label": "Senior Notes, 2.75%, Due November 2022 [Member]",
        "terseLabel": "2.75% senior notes due November 2022"
       }
      }
     },
     "localname": "SeniorNotes2.75DueNovember2022Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.875DueJune2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.875%, Due June 2026 [Member]",
        "label": "Senior Notes, 2.875%, Due June 2026 [Member]",
        "terseLabel": "2.875% senior notes due June 2026"
       }
      }
     },
     "localname": "SeniorNotes2.875DueJune2026Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.8DueJune2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.8%, Due June 2023 [Member]",
        "label": "Senior Notes, 2.8%, Due June 2023 [Member]",
        "terseLabel": "2.8% senior notes due June 2023"
       }
      }
     },
     "localname": "SeniorNotes2.8DueJune2023Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2125PercentDueSeptember2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.125 Percent, Due September 2031",
        "label": "Senior Notes, 2.125 Percent, Due September 2031 [Member]",
        "terseLabel": "2.125% senior notes due September 2031"
       }
      }
     },
     "localname": "SeniorNotes2125PercentDueSeptember2031Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes27DueAugust2040Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.7%, Due August 2040",
        "label": "Senior Notes, 2.7%, Due August 2040 [Member]",
        "terseLabel": "2.7% senior notes due August 2040"
       }
      }
     },
     "localname": "SeniorNotes27DueAugust2040Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.25DueAugust2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.25%, Due August 2029 [Member]",
        "label": "Senior Notes, 3.25%, Due August 2029 [Member]",
        "terseLabel": "3.25% senior notes due August 2029"
       }
      }
     },
     "localname": "SeniorNotes3.25DueAugust2029Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.375DueAugust2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.375%, Due August 2024 [Member]",
        "label": "Senior Notes, 3.375%, Due August 2024 [Member]",
        "terseLabel": "3.375% senior notes due August 2024"
       }
      }
     },
     "localname": "SeniorNotes3.375DueAugust2024Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.5DueJuly2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.5%, Due July 2022 [Member]",
        "label": "Senior Notes, 3.5%, Due July 2022 [Member]",
        "terseLabel": "3.5% senior notes due July 2022"
       }
      }
     },
     "localname": "SeniorNotes3.5DueJuly2022Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.5DueNovember2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.5%, Due November 2024 [Member]",
        "label": "Senior Notes, 3.5%, Due November 2024 [Member]",
        "terseLabel": "3.5% senior notes due November 2024"
       }
      }
     },
     "localname": "SeniorNotes3.5DueNovember2024Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.625DueApril2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.625%, Due April 2027 [Member]",
        "label": "Senior Notes, 3.625%, Due April 2027 [Member]",
        "terseLabel": "3.625% senior notes due April 2027"
       }
      }
     },
     "localname": "SeniorNotes3.625DueApril2027Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.75DueApril2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.75%, Due April 2030 [Member]",
        "label": "Senior Notes, 3.75%, Due April 2030 [Member]",
        "terseLabel": "3.75% senior notes due April 2030"
       }
      }
     },
     "localname": "SeniorNotes3.75DueApril2030Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.875DueAugust2047Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.875%, Due August 2047 [Member]",
        "label": "Senior Notes, 3.875%, Due August 2047 [Member]",
        "terseLabel": "3.875% senior notes due August 2047"
       }
      }
     },
     "localname": "SeniorNotes3.875DueAugust2047Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.875DueJuly2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.875%, Due July 2025 [Member]",
        "label": "Senior Notes, 3.875%, Due July 2025 [Member]",
        "terseLabel": "3.875% senior notes due July 2025"
       }
      }
     },
     "localname": "SeniorNotes3.875DueJuly2025Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3DueAugust2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3%, Due August 2026 [Member]",
        "label": "Senior Notes, 3%, Due August 2026 [Member]",
        "terseLabel": "3% senior notes due August 2026"
       }
      }
     },
     "localname": "SeniorNotes3DueAugust2026Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.125DueApril2040Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.125%, Due April 2040 [Member]",
        "label": "Senior Notes, 4.125%, Due April 2040 [Member]",
        "terseLabel": "4.125% senior notes due April 2040"
       }
      }
     },
     "localname": "SeniorNotes4.125DueApril2040Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.125DueNovember2042Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents senior notes due 2042 with a coupon rate of 4.125%.",
        "label": "Senior Notes, 4.125%, Due November 2042 [Member]",
        "terseLabel": "4.125% senior notes due November 2042"
       }
      }
     },
     "localname": "SeniorNotes4.125DueNovember2042Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.1DueMarch2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.1%, Due March 2025 [Member]",
        "label": "Senior Notes, 4.1%, Due March 2025 [Member]",
        "terseLabel": "4.1% senior notes due March 2025"
       }
      }
     },
     "localname": "SeniorNotes4.1DueMarch2025Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.25DueApril2050Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.25%, Due April 2050 [Member]",
        "label": "Senior Notes, 4.25%, Due April 2050 [Member]",
        "terseLabel": "4.25% senior notes due April 2050"
       }
      }
     },
     "localname": "SeniorNotes4.25DueApril2050Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.3DueMarch2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.3%, Due March 2028 [Member]",
        "label": "Senior Notes, 4.3%, Due March 2028 [Member]",
        "terseLabel": "4.3% senior notes due March 2028"
       }
      }
     },
     "localname": "SeniorNotes4.3DueMarch2028Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.5DueMay2042Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.5%, Due May 2042 [Member]",
        "label": "Senior Notes, 4.5%, Due May 2042 [Member]",
        "terseLabel": "4.5% senior notes due May 2042"
       }
      }
     },
     "localname": "SeniorNotes4.5DueMay2042Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.75DueDecember2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.75%, Due December 2022 [Member]",
        "label": "Senior Notes, 4.75%, Due December 2022 [Member]",
        "terseLabel": "4.75% senior notes due December 2022"
       }
      }
     },
     "localname": "SeniorNotes4.75DueDecember2022Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.75DueMarch2044Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.75%, Due March 2044 [Member]",
        "label": "Senior Notes, 4.75%, Due March 2044 [Member]",
        "terseLabel": "4.75% senior notes due March 2044"
       }
      }
     },
     "localname": "SeniorNotes4.75DueMarch2044Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.78DueMarch2038Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.78%, Due March 2038 [Member]",
        "label": "Senior Notes, 4.78%, Due March 2038 [Member]",
        "terseLabel": "4.78% senior notes due March 2038"
       }
      }
     },
     "localname": "SeniorNotes4.78DueMarch2038Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.875DueJuly2035Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.875%, Due July 2035 [Member]",
        "label": "Senior Notes, 4.875%, Due July 2035 [Member]",
        "terseLabel": "4.875% senior notes due July 2035"
       }
      }
     },
     "localname": "SeniorNotes4.875DueJuly2035Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4DueDecember2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4%, Due December 2023 [Member]",
        "label": "Senior Notes, 4%, Due December 2023 [Member]",
        "terseLabel": "4% senior notes due December 2023"
       }
      }
     },
     "localname": "SeniorNotes4DueDecember2023Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.05DueMarch2048Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5.05%, Due March 2048 [Member]",
        "label": "Senior Notes, 5.05%, Due March 2048 [Member]",
        "terseLabel": "5.05% senior notes due March 2048"
       }
      }
     },
     "localname": "SeniorNotes5.05DueMarch2048Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.125DueJuly2045Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5.125%, Due July 2045 [Member]",
        "label": "Senior Notes, 5.125%, Due July 2045 [Member]",
        "terseLabel": "5.125% senior notes due July 2045"
       }
      }
     },
     "localname": "SeniorNotes5.125DueJuly2045Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.3DueDecember2043Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5.3%, Due December 2043 [Member]",
        "label": "Senior Notes, 5.3%, Due December 2043 [Member]",
        "terseLabel": "5.3% senior notes due December 2043"
       }
      }
     },
     "localname": "SeniorNotes5.3DueDecember2043Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.75DueMay2041Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5.75%, Due May 2041 [Member]",
        "label": "Senior Notes, 5.75%, Due May 2041 [Member]",
        "terseLabel": "5.75% senior notes due May 2041"
       }
      }
     },
     "localname": "SeniorNotes5.75DueMay2041Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5DueDecember2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5%, Due December 2024 [Member]",
        "label": "Senior Notes, 5%, Due December 2024 [Member]",
        "terseLabel": "5% senior notes due December 2024"
       }
      }
     },
     "localname": "SeniorNotes5DueDecember2024Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes6.125DueSeptember2039Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 6.125%, Due September 2039 [Member]",
        "label": "Senior Notes, 6.125%, Due September 2039 [Member]",
        "terseLabel": "6.125% senior notes due September 2039"
       }
      }
     },
     "localname": "SeniorNotes6.125DueSeptember2039Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes6.25DueJune2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 6.25%, Due June 2027 [Member]",
        "label": "Senior Notes, 6.25%, Due June 2027 [Member]",
        "terseLabel": "6.25% senior notes due June 2027"
       }
      }
     },
     "localname": "SeniorNotes6.25DueJune2027Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes6.625DueJune2036Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 6.625%, Due June 2036 [Member]",
        "label": "Senior Notes, 6.625%, Due June 2036 [Member]",
        "terseLabel": "6.625% senior notes due June 2036"
       }
      }
     },
     "localname": "SeniorNotes6.625DueJune2036Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes6.75DueDecember2037Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 6.75%, Due December 2037 [Member]",
        "label": "Senior Notes, 6.75%, Due December 2037 [Member]",
        "terseLabel": "6.75% senior notes due December 2037"
       }
      }
     },
     "localname": "SeniorNotes6.75DueDecember2037Member",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_StateOfFloridaSettlementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "State of Florida Settlement",
        "label": "State of Florida Settlement [Member]",
        "terseLabel": "State of Florida Settlement"
       }
      }
     },
     "localname": "StateOfFloridaSettlementMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_StockOptionsAndStockAppreciationRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Options and Stock Appreciation Rights",
        "label": "Stock Options and Stock Appreciation Rights [Member]",
        "terseLabel": "Stock options and stock appreciation rights"
       }
      }
     },
     "localname": "StockOptionsAndStockAppreciationRightsMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SupportingExperienceRatedProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supporting discontinued and experience-rated products.",
        "label": "Supporting Experience Rated Products [Member]",
        "terseLabel": "Supporting experience-rated products"
       }
      }
     },
     "localname": "SupportingExperienceRatedProductsMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SupportingRemainingProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities in an unrealized capital loss position supporting remaining products.",
        "label": "Supporting Remaining Products [Member]",
        "terseLabel": "Supporting remaining products"
       }
      }
     },
     "localname": "SupportingRemainingProductsMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ThailandBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Thailand Business",
        "label": "Thailand Business [Member]",
        "terseLabel": "Thailand Business"
       }
      }
     },
     "localname": "ThailandBusinessMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresandAssetSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_TotalInvestmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Investments [Axis]",
        "terseLabel": "Total Investments [Axis]"
       }
      }
     },
     "localname": "TotalInvestmentsAxis",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_TotalInvestmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Investments [Domain]",
        "terseLabel": "Total Investments [Domain]"
       }
      }
     },
     "localname": "TotalInvestmentsDomain",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_TotalInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Investments [Line Items]",
        "terseLabel": "Total Investments [Line Items]"
       }
      }
     },
     "localname": "TotalInvestmentsLineItems",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_TotalInvestmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Investments [Table]",
        "terseLabel": "Total Investments [Table]"
       }
      }
     },
     "localname": "TotalInvestmentsTable",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_TotalInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item includes total investments, both current and long-term.",
        "label": "Total Investments [Table Text Block]",
        "verboseLabel": "Schedule of Total Investments"
       }
      }
     },
     "localname": "TotalInvestmentsTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_TransferOfSharesToTreasuryStockValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transfer of Shares to Treasury Stock Value",
        "label": "Transfer of Shares to Treasury Stock Value",
        "terseLabel": "Transfer of shares to treasury stock value"
       }
      }
     },
     "localname": "TransferOfSharesToTreasuryStockValue",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance",
        "label": "Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance",
        "negatedTerseLabel": "Purchases of treasury shares, net of ESPP issuances (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_TreasuryStockSharesHeldinTrust": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Shares, Held in Trust",
        "label": "Treasury Stock, Shares, Held in Trust",
        "terseLabel": "Treasury shares held in trust (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesHeldinTrust",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance",
        "label": "Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance",
        "negatedTerseLabel": "Purchase of treasury shares, net of ESPP issuances"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_TreasuryStockValueSharesHeldInTrust": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Value, Shares Held In Trust",
        "label": "Treasury Stock, Value, Shares Held In Trust",
        "terseLabel": "Treasury share held in trust"
       }
      }
     },
     "localname": "TreasuryStockValueSharesHeldInTrust",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_VendorandManufacturerReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vendor and Manufacturer Receivables",
        "label": "Vendor and Manufacturer Receivables",
        "terseLabel": "Vendor and manufacturer receivables"
       }
      }
     },
     "localname": "VendorandManufacturerReceivables",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_YearOfOriginationPeriodFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination, Period Five [Member]",
        "label": "Year Of Origination, Period Five [Member]",
        "terseLabel": "2018"
       }
      }
     },
     "localname": "YearOfOriginationPeriodFiveMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination, Period Four [Member]",
        "label": "Year Of Origination, Period Four [Member]",
        "terseLabel": "2019"
       }
      }
     },
     "localname": "YearOfOriginationPeriodFourMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination, Period One [Member]",
        "label": "Year Of Origination, Period One [Member]",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "YearOfOriginationPeriodOneMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination, Period Three [Member]",
        "label": "Year Of Origination, Period Three [Member]",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "YearOfOriginationPeriodThreeMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination, Period Two [Member]",
        "label": "Year Of Origination, Period Two [Member]",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "YearOfOriginationPeriodTwoMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPriorToPeriodFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination, Prior To Period Five [Member]",
        "label": "Year Of Origination, Prior To Period Five [Member]",
        "terseLabel": "Prior"
       }
      }
     },
     "localname": "YearOfOriginationPriorToPeriodFiveMember",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yield-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings",
        "label": "Yield-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings",
        "terseLabel": "Yield-related impairment loss"
       }
      }
     },
     "localname": "YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings",
     "nsuri": "http://www.cvshealth.com/20220630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r743"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r140",
      "r184",
      "r203",
      "r204",
      "r205",
      "r206",
      "r208",
      "r210",
      "r214",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r334",
      "r335",
      "r337",
      "r339",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r140",
      "r184",
      "r203",
      "r204",
      "r205",
      "r206",
      "r208",
      "r210",
      "r214",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r334",
      "r335",
      "r337",
      "r339",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r59",
      "r61",
      "r138",
      "r139",
      "r346",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis": {
     "auth_ref": [
      "r716",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Real Estate, Type of Property [Axis]",
        "terseLabel": "Real Estate, Type of Property [Axis]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MortgageLoansOnRealEstateLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]",
        "terseLabel": "Mortgage Loans on Real Estate [Line Items]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateLineItems",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MortgageLoansOnRealEstateNamePropertyTypeDomain": {
     "auth_ref": [
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Real Estate [Domain]",
        "terseLabel": "Real Estate [Domain]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateNamePropertyTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MortgageLoansOnRealEstateScheduleTable": {
     "auth_ref": [
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate Schedule [Table]",
        "terseLabel": "Mortgage Loans on Real Estate [Table]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateScheduleTable",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r217",
      "r321",
      "r322",
      "r416",
      "r418",
      "r591",
      "r676",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r217",
      "r321",
      "r322",
      "r416",
      "r418",
      "r591",
      "r676",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r60",
      "r61",
      "r138",
      "r139",
      "r346",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r154",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r154",
      "r159",
      "r317",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r154",
      "r159",
      "r317",
      "r436",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r25",
      "r48"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r222",
      "r223"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net",
        "totalLabel": "Total accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r68",
      "r73",
      "r80",
      "r81",
      "r82",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Pension and other postretirement benefits"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r63",
      "r73",
      "r80",
      "r81",
      "r82",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember": {
     "auth_ref": [
      "r73",
      "r80",
      "r81",
      "r82",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, including portion attributable to noncontrolling interest.",
        "label": "Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]",
        "terseLabel": "Net cash flow hedges"
       }
      }
     },
     "localname": "AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r65",
      "r66",
      "r67",
      "r73",
      "r80",
      "r81",
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), including portion attributable to noncontrolling interest.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Including Noncontrolling Interest [Member]",
        "terseLabel": "Net unrealized investment gains (losses)"
       }
      }
     },
     "localname": "AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r40",
      "r71",
      "r72",
      "r73",
      "r647",
      "r686",
      "r690"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r70",
      "r73",
      "r80",
      "r81",
      "r82",
      "r142",
      "r143",
      "r144",
      "r467",
      "r552",
      "r681",
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments required to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r44",
      "r225",
      "r268",
      "r270",
      "r271"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Allowance for credit losses"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r124",
      "r301",
      "r303"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of EPS (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r70",
      "r73",
      "r80",
      "r81",
      "r82",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r31",
      "r135",
      "r192",
      "r205",
      "r212",
      "r261",
      "r327",
      "r328",
      "r329",
      "r331",
      "r332",
      "r333",
      "r334",
      "r336",
      "r338",
      "r340",
      "r341",
      "r460",
      "r469",
      "r513",
      "r556",
      "r558",
      "r611",
      "r645"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r23",
      "r47",
      "r135",
      "r261",
      "r327",
      "r328",
      "r329",
      "r331",
      "r332",
      "r333",
      "r334",
      "r336",
      "r338",
      "r340",
      "r341",
      "r460",
      "r469",
      "r513",
      "r556",
      "r558"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r498"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r239"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r240"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r236",
      "r277"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "terseLabel": "Gross Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract]",
        "terseLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost": {
     "auth_ref": [
      "r245"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
     "auth_ref": [
      "r241",
      "r245",
      "r631"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": {
     "auth_ref": [
      "r244"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r241",
      "r244",
      "r630"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost": {
     "auth_ref": [
      "r246"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": {
     "auth_ref": [
      "r241",
      "r246",
      "r632"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract]",
        "terseLabel": "Net Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "auth_ref": [
      "r243"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r241",
      "r243",
      "r629"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost": {
     "auth_ref": [
      "r247"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.",
        "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost",
        "terseLabel": "Debt securities, maturity, without single maturity date"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": {
     "auth_ref": [
      "r247",
      "r633"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.",
        "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value",
        "terseLabel": "Debt securities, maturity, without single maturity date"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r233",
      "r237",
      "r277",
      "r618"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Fair Value",
        "totalLabel": "Total",
        "verboseLabel": "Debt securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Number of Positions [Abstract]",
        "terseLabel": "Number of Securities"
       }
      }
     },
     "localname": "AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r476",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "verboseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationIntegrationRelatedCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.",
        "label": "Business Combination, Integration Related Costs",
        "terseLabel": "Acquisition-related integration costs"
       }
      }
     },
     "localname": "BusinessCombinationIntegrationRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r511",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Carrying Value"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r20",
      "r27",
      "r126"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r127",
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r116",
      "r126",
      "r129"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at the end of the period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at the beginning of the period",
        "totalLabel": "Total cash, cash equivalents and restricted cash in the statements of cash flows"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r116",
      "r522"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net decrease in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashDivestedFromDeconsolidation": {
     "auth_ref": [
      "r104"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction in cash due to no longer including the former subsidiary's cash in the consolidated entity's cash.",
        "label": "Cash Divested from Deconsolidation",
        "terseLabel": "Cash and restricted cash sold"
       }
      }
     },
     "localname": "CashDivestedFromDeconsolidation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ChangeInContractWithCustomerLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Contract with Customer, Liability [Abstract]",
        "terseLabel": "Change in Contract with Customer, Liability [Abstract]"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r398",
      "r399",
      "r400",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialMortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r247",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by commercial real estate mortgage loans.",
        "label": "Commercial Mortgage-Backed Securities [Member]",
        "terseLabel": "Commercial mortgage-backed securities"
       }
      }
     },
     "localname": "CommercialMortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialRealEstateMember": {
     "auth_ref": [
      "r276",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property that is solely used for business purposes.",
        "label": "Commercial Real Estate [Member]",
        "terseLabel": "Commercial Real Estate"
       }
      }
     },
     "localname": "CommercialRealEstateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r313",
      "r314",
      "r315",
      "r323",
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared per share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock held by shareholders with par value plus amounts in excess of par value or issuance value (in cases of no-par value stock).",
        "label": "Common Stock Including Additional Paid in Capital [Member]",
        "terseLabel": "Common Stock and Capital Surplus"
       }
      }
     },
     "localname": "CommonStockIncludingAdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r142",
      "r143",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Shares"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r37",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r37",
      "r558"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStocksIncludingAdditionalPaidInCapital": {
     "auth_ref": [
      "r37",
      "r38",
      "r397"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of par value plus amounts in excess of par value or issuance value for common stock issued.",
        "label": "Common Stocks, Including Additional Paid in Capital",
        "terseLabel": "Common stock, par value $0.01: 3,200 shares authorized; 1,755 shares issued and 1,312 shares outstanding at June\u00a030, 2022 and 1,744 shares issued and 1,322 shares outstanding at December\u00a031, 2021 and capital surplus"
       }
      }
     },
     "localname": "CommonStocksIncludingAdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r76",
      "r78",
      "r79",
      "r90",
      "r624",
      "r660"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to CVS Health"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r76",
      "r78",
      "r89",
      "r458",
      "r473",
      "r623",
      "r659"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r88",
      "r97",
      "r622",
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Other Comprehensive Income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r130",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Schedule of receivables and contract liabilities from contracts with customers"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "auth_ref": [
      "r403",
      "r405",
      "r417"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "terseLabel": "Trade receivables",
        "verboseLabel": "Trade receivables (included in accounts receivable, net)"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r403",
      "r404",
      "r417"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "periodEndLabel": "Contract liabilities, end of the period",
        "periodStartLabel": "Contract liabilities, beginning of the period",
        "terseLabel": "Contract liabilities (included in accrued expenses)"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelAxis": {
     "auth_ref": [
      "r416",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by sales channel for delivery of good or service in contract with customer.",
        "label": "Contract with Customer, Sales Channel [Axis]",
        "terseLabel": "Contract with Customer, Sales Channel [Axis]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelDomain": {
     "auth_ref": [
      "r416",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales channel for delivery of good or service in contract with customer. Includes, but is not limited to, directly to consumer and through intermediary.",
        "label": "Contract with Customer, Sales Channel [Domain]",
        "terseLabel": "Contract with Customer, Sales Channel [Domain]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r203",
      "r204",
      "r205",
      "r206",
      "r208",
      "r214",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate/ Other"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r93",
      "r591"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating costs"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r132",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r359",
      "r366",
      "r367",
      "r369",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Borrowings"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/Borrowings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r32",
      "r34",
      "r35",
      "r134",
      "r140",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r349",
      "r355",
      "r356",
      "r357",
      "r358",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r371",
      "r372",
      "r373",
      "r374",
      "r537",
      "r612",
      "r613",
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r35",
      "r370",
      "r613",
      "r641"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails": {
       "order": 2.0,
       "parentTag": "cvs_LongtermDebtGrossAndLeaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r357",
      "r371",
      "r372",
      "r510"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r52",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r53",
      "r134",
      "r140",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r349",
      "r355",
      "r356",
      "r357",
      "r358",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r371",
      "r372",
      "r373",
      "r374",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r53",
      "r134",
      "r140",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r349",
      "r355",
      "r356",
      "r357",
      "r358",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r368",
      "r371",
      "r372",
      "r373",
      "r374",
      "r393",
      "r394",
      "r395",
      "r396",
      "r534",
      "r535",
      "r537",
      "r538",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedPremium": {
     "auth_ref": [
      "r355",
      "r534",
      "r538"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt premium.",
        "label": "Debt Instrument, Unamortized Premium",
        "terseLabel": "Debt premiums"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedPremium",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
     "auth_ref": [
      "r238",
      "r277",
      "r285",
      "r286"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Allowance for Credit Loss",
        "negatedTerseLabel": "Allowance for Credit Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss": {
     "auth_ref": [
      "r242"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, after Allowance for Credit Loss",
        "totalLabel": "Net Amortized Cost"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r254",
      "r283",
      "r288"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "terseLabel": "Fair Value, Greater than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "auth_ref": [
      "r254",
      "r283"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "terseLabel": "Unrealized Losses, Greater than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions": {
     "auth_ref": [
      "r281"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions",
        "terseLabel": "Number of Securities, Greater than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r254",
      "r283",
      "r288"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "verboseLabel": "Fair Value, Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r254",
      "r283"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "verboseLabel": "Unrealized Losses, Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions": {
     "auth_ref": [
      "r281"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions",
        "terseLabel": "Number of Securities, Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedGain": {
     "auth_ref": [
      "r255"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Realized Gain",
        "terseLabel": "Gross realized capital gains"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedGain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss": {
     "auth_ref": [
      "r255"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Realized Loss",
        "terseLabel": "Gross realized capital losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table Text Block]",
        "terseLabel": "Schedule of Debt Securities Available For Sale"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "auth_ref": [
      "r251",
      "r279",
      "r288"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position",
        "totalLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": {
     "auth_ref": [
      "r252",
      "r280"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss",
        "totalLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [
      "r253",
      "r281"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions",
        "totalLabel": "Number of Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesMember": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument issued by corporations, governments and governmental agencies, municipalities, and other institutions.",
        "label": "Debt Securities [Member]",
        "terseLabel": "Debt securities"
       }
      }
     },
     "localname": "DebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r444",
      "r445"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r124",
      "r187"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r61",
      "r477",
      "r478",
      "r480",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r474",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Forward contract, notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r416",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresandAssetSalesDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresandAssetSalesDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r305",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresandAssetSalesDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r19",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Divestitures and Asset Sales"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresandAssetSales"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r435",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresandAssetSalesDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStock": {
     "auth_ref": [
      "r397",
      "r636"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Dividends, Common Stock",
        "negatedTerseLabel": "Common stock dividends"
       }
      }
     },
     "localname": "DividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticCorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r235",
      "r426",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt security issued by corporation domiciled in United States of America (US).",
        "label": "Debt Security, Corporate, US [Member]",
        "terseLabel": "U.S. corporate securities"
       }
      }
     },
     "localname": "DomesticCorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income per share attributable to CVS Health:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r91",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r160",
      "r163",
      "r169",
      "r170",
      "r171",
      "r175",
      "r176",
      "r495",
      "r496",
      "r625",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Earnings per share, basic (in dollars per share)",
        "verboseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r91",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r163",
      "r169",
      "r170",
      "r171",
      "r175",
      "r176",
      "r495",
      "r496",
      "r625",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Earnings per share, diluted (in dollars per share)",
        "verboseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r172",
      "r173",
      "r174",
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r80",
      "r81",
      "r82",
      "r142",
      "r143",
      "r144",
      "r147",
      "r156",
      "r158",
      "r178",
      "r265",
      "r392",
      "r397",
      "r441",
      "r442",
      "r443",
      "r449",
      "r450",
      "r494",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r529",
      "r552",
      "r681",
      "r682",
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r115",
      "r260",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "Related Party Transactions"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r22",
      "r33",
      "r508"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r256",
      "r642",
      "r711",
      "r712",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r257"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r357",
      "r371",
      "r372",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r498",
      "r499",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r498",
      "r511",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r498",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r357",
      "r371",
      "r372",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r434",
      "r499",
      "r564",
      "r565",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r357",
      "r371",
      "r372",
      "r498",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r498",
      "r499",
      "r500",
      "r501",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r357",
      "r371",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r357",
      "r426",
      "r427",
      "r432",
      "r434",
      "r499",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r357",
      "r371",
      "r372",
      "r426",
      "r427",
      "r432",
      "r434",
      "r499",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r357",
      "r371",
      "r372",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r434",
      "r499",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3": {
     "auth_ref": [
      "r502"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3",
        "terseLabel": "Transfers into Level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3": {
     "auth_ref": [
      "r502"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3",
        "terseLabel": "Transfers out of Level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r357",
      "r371",
      "r372",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r434",
      "r564",
      "r565",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "auth_ref": [
      "r498",
      "r499",
      "r500",
      "r501",
      "r503",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.",
        "label": "Fair Value, Nonrecurring [Member]",
        "terseLabel": "Nonrecurring"
       }
      }
     },
     "localname": "FairValueMeasurementsNonrecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r504",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r544",
      "r546"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails": {
       "order": 1.0,
       "parentTag": "cvs_LongtermDebtGrossAndLeaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "verboseLabel": "Finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease liability.",
        "label": "Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r248",
      "r249",
      "r257",
      "r258",
      "r259",
      "r269",
      "r272",
      "r273",
      "r274",
      "r275",
      "r282",
      "r284",
      "r287",
      "r288",
      "r368",
      "r390",
      "r484",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.",
        "label": "Financial Liabilities Fair Value Disclosure",
        "terseLabel": "Financial liabilities measured at fair value on a recurring basis"
       }
      }
     },
     "localname": "FinancialLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r235",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt security issued by corporation not domiciled in United States of America (US).",
        "label": "Debt Security, Corporate, Non-US [Member]",
        "terseLabel": "Foreign securities"
       }
      }
     },
     "localname": "ForeignCorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForwardContractsMember": {
     "auth_ref": [
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts negotiated between two parties to purchase and sell a specific quantity of a financial instrument, foreign currency, or commodity at a price specified at origination of the contract, with delivery and settlement at a specified future date.",
        "label": "Forward Contracts [Member]",
        "terseLabel": "Forward contract"
       }
      }
     },
     "localname": "ForwardContractsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r124",
      "r468"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedLabel": "Gain on sale of subsidiary",
        "negatedTerseLabel": "Gain on sale of subsidiary",
        "terseLabel": "Gain (loss) on divestiture, pretax"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.cvshealth.com/role/DivestituresandAssetSalesDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r316"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "negatedLabel": "Legal settlement"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r29",
      "r289",
      "r290",
      "r297",
      "r299",
      "r558",
      "r610"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HealthInsuranceProductLineMember": {
     "auth_ref": [
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product line consisting of insurance against loss by illness or injury.",
        "label": "Health Insurance Product Line [Member]",
        "terseLabel": "Health Insurance Product Line"
       }
      }
     },
     "localname": "HealthInsuranceProductLineMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "auth_ref": [
      "r124",
      "r304"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.",
        "label": "Impairment of Long-Lived Assets to be Disposed of",
        "terseLabel": "Loss on assets held for sale",
        "verboseLabel": "Loss on assets held for sale"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresandAssetSalesDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r86",
      "r192",
      "r204",
      "r208",
      "r211",
      "r214",
      "r607",
      "r620",
      "r627",
      "r662"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income tax provision"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r435",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresandAssetSalesDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresandAssetSalesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r6",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r16",
      "r17",
      "r18",
      "r308",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresandAssetSalesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r136",
      "r157",
      "r158",
      "r190",
      "r446",
      "r451",
      "r452",
      "r663"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "verboseLabel": "Income tax provision"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "negatedTerseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable and pharmacy claims and discounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInsuranceLiabilities": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in insurance liability balances during the period.",
        "label": "Increase (Decrease) in Insurance Liabilities",
        "terseLabel": "Health care costs payable and other insurance liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInInsuranceLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedTerseLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Shareholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r164",
      "r165",
      "r166",
      "r171",
      "r438"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Effect of dilutive securities (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r300",
      "r302"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r84",
      "r186",
      "r533",
      "r536",
      "r626"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r113",
      "r120",
      "r128"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "negatedTerseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [
      "r483"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "terseLabel": "Amount expected to be reclassified"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r184",
      "r203",
      "r204",
      "r205",
      "r206",
      "r208",
      "r210",
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment Eliminations"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r21",
      "r45",
      "r558"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterestAndDividend": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 1.0,
       "parentTag": "cvs_InvestmentIncomeExcludingCapitalGainsorLosses",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Interest and Dividend",
        "terseLabel": "Gross investment income"
       }
      }
     },
     "localname": "InvestmentIncomeInterestAndDividend",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInvestmentExpense": {
     "auth_ref": [
      "r96",
      "r664"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 2.0,
       "parentTag": "cvs_InvestmentIncomeExcludingCapitalGainsorLosses",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses related to the generation of investment income.",
        "label": "Investment Income, Investment Expense",
        "negatedLabel": "Investment expenses"
       }
      }
     },
     "localname": "InvestmentIncomeInvestmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeNet": {
     "auth_ref": [
      "r94",
      "r95"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Net",
        "totalLabel": "Net investment income"
       }
      }
     },
     "localname": "InvestmentIncomeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeTextBlock": {
     "auth_ref": [
      "r94",
      "r95",
      "r96",
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.",
        "label": "Investment Income [Table Text Block]",
        "verboseLabel": "Schedule of Net Investment Income"
       }
      }
     },
     "localname": "InvestmentIncomeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r653"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Abstract]",
        "terseLabel": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "verboseLabel": "Schedule of Net Amortized Cost and Fair Value of Debt Securities by Contractual Maturity"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r256",
      "r608",
      "r634",
      "r714",
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r49",
      "r135",
      "r206",
      "r261",
      "r327",
      "r328",
      "r329",
      "r332",
      "r333",
      "r334",
      "r336",
      "r338",
      "r340",
      "r341",
      "r461",
      "r469",
      "r470",
      "r513",
      "r556",
      "r557"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r43",
      "r135",
      "r261",
      "r513",
      "r558",
      "r615",
      "r650"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r24",
      "r51",
      "r135",
      "r261",
      "r327",
      "r328",
      "r329",
      "r332",
      "r333",
      "r334",
      "r336",
      "r338",
      "r340",
      "r341",
      "r461",
      "r469",
      "r470",
      "r513",
      "r556",
      "r557",
      "r558"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r669",
      "r672"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.",
        "label": "Liability for Claims and Claims Adjustment Expense",
        "periodEndLabel": "Health care costs payable, end of the period",
        "periodStartLabel": "Health care costs payable, beginning of the period"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Liability for Claims and Claims Adjustment Expense [Line Items]",
        "terseLabel": "Liability for Claims and Claims Adjustment Expense [Line Items]"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the liability for claims and claims adjustment expense.",
        "label": "Liability for Claims and Claims Adjustment Expense [Table]",
        "terseLabel": "Liability for Claims and Claims Adjustment Expense [Table]"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]",
        "terseLabel": "Less: Claims paid"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": {
     "auth_ref": [
      "r671"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year",
        "terseLabel": "Current year"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": {
     "auth_ref": [
      "r671"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years",
        "terseLabel": "Prior years"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": {
     "auth_ref": [
      "r670"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims",
        "totalLabel": "Total incurred health care costs"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]",
        "terseLabel": "Add: Components of incurred health care costs"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet": {
     "auth_ref": [
      "r640",
      "r669",
      "r672"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Net",
        "periodEndLabel": "Health care costs payable, end of the period, net",
        "periodStartLabel": "Health care costs payable, beginning of the period, net",
        "terseLabel": "Health care costs payable"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]",
        "terseLabel": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-Term Debt and Lease Obligation",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails",
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-Term Debt and Lease Obligation, Current",
        "negatedTerseLabel": "Current portion of long-term debt",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails",
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, including portion classified as current.",
        "label": "Long-Term Debt and Lease Obligation, Including Current Maturities",
        "totalLabel": "Long-term debt and lease obligation"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermInvestments": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).",
        "label": "Long-Term Investments",
        "terseLabel": "Long-term",
        "verboseLabel": "Long-term investments"
       }
      }
     },
     "localname": "LongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r53",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r316",
      "r318",
      "r319",
      "r320",
      "r321",
      "r324",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r316",
      "r317"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Liability recorded in association with legal settlement"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r318",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Number of claims"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r58",
      "r135",
      "r261",
      "r327",
      "r332",
      "r333",
      "r334",
      "r340",
      "r341",
      "r513",
      "r614",
      "r649"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageLoansOnRealEstate": {
     "auth_ref": [
      "r715"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate",
        "terseLabel": "Mortgage loans"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageLoansOnRealEstateForeclosures": {
     "auth_ref": [
      "r717"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from foreclosure.",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Foreclosure",
        "terseLabel": "Mortgage loans foreclosed"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateForeclosures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageLoansOnRealEstateNewMortgageLoans": {
     "auth_ref": [
      "r717"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from new investment.",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, New Mortgage Loan",
        "terseLabel": "New mortgage loans"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateNewMortgageLoans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgagesHeldForSaleFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of mortgage loans held-for-sale.",
        "label": "Mortgages Held-for-sale, Fair Value Disclosure",
        "terseLabel": "Mortgage loans"
       }
      }
     },
     "localname": "MortgagesHeldForSaleFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r116",
      "r122",
      "r125"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r18",
      "r74",
      "r77",
      "r82",
      "r87",
      "r125",
      "r135",
      "r146",
      "r151",
      "r152",
      "r153",
      "r154",
      "r157",
      "r158",
      "r167",
      "r192",
      "r204",
      "r208",
      "r211",
      "r214",
      "r261",
      "r327",
      "r328",
      "r329",
      "r332",
      "r333",
      "r334",
      "r336",
      "r338",
      "r340",
      "r341",
      "r496",
      "r513",
      "r621",
      "r656"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income attributable to CVS Health"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r74",
      "r77",
      "r82",
      "r157",
      "r158",
      "r464",
      "r472"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      },
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Comprehensive income attributable to noncontrolling interests",
        "negatedTerseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r151",
      "r152",
      "r153",
      "r154",
      "r160",
      "r161",
      "r168",
      "r171",
      "r192",
      "r204",
      "r208",
      "r211",
      "r214"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Net income attributable to CVS Health"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentIncome": {
     "auth_ref": [
      "r658"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.",
        "label": "Net Investment Income",
        "terseLabel": "Net investment income (loss)",
        "verboseLabel": "Net investment income"
       }
      }
     },
     "localname": "NetInvestmentIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r153",
      "r159",
      "r175",
      "r231",
      "r232",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r441",
      "r442",
      "r443",
      "r447",
      "r448",
      "r449",
      "r450",
      "r453",
      "r454",
      "r455",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r531",
      "r532",
      "r539",
      "r540",
      "r541",
      "r542",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r592",
      "r593",
      "r594",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Pronouncements Not Yet Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r142",
      "r143",
      "r144",
      "r397",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfStatesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of states the entity operates in as of the balance sheet date.",
        "label": "Number of States in which Entity Operates",
        "terseLabel": "Number of states in which entity operates"
       }
      }
     },
     "localname": "NumberOfStatesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfStores": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of stores.",
        "label": "Number of Stores",
        "terseLabel": "Number of retail locations (more than)"
       }
      }
     },
     "localname": "NumberOfStores",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "verboseLabel": "Operating costs:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r192",
      "r204",
      "r208",
      "r211",
      "r214"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating income (GAAP measure)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r544"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r544"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r543"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r203",
      "r204",
      "r205",
      "r206",
      "r208",
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r46",
      "r558"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r458",
      "r459",
      "r466"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Net unrealized investment gains (losses)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": {
     "auth_ref": [
      "r73",
      "r80",
      "r81",
      "r523",
      "r525",
      "r529"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
        "terseLabel": "OCI before reclassifications, pre-tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r73",
      "r80",
      "r81",
      "r83",
      "r523",
      "r525",
      "r529"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "verboseLabel": "Other comprehensive income (loss) before reclassifications, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r64",
      "r71"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Net cash flow hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r75",
      "r78",
      "r80",
      "r81",
      "r83",
      "r88",
      "r392",
      "r523",
      "r528",
      "r529",
      "r622",
      "r657"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive loss",
        "totalLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r69",
      "r71"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Pension and other postretirement benefits"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherDebtSecuritiesMember": {
     "auth_ref": [
      "r250",
      "r278",
      "r426",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in debt securities classified as other.",
        "label": "Other Debt Obligations [Member]",
        "terseLabel": "Other Debt Obligations"
       }
      }
     },
     "localname": "OtherDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other investments.",
        "label": "Other Investments [Member]",
        "terseLabel": "Other investments"
       }
      }
     },
     "localname": "OtherInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other income"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPolicyholderFunds": {
     "auth_ref": [
      "r654"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due to policyholders for funds held that are returnable under the terms of insurance contracts, classified as other.",
        "label": "Other Policyholder Funds",
        "terseLabel": "Policyholders\u2019 funds"
       }
      }
     },
     "localname": "OtherPolicyholderFunds",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total CVS Health Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": {
     "auth_ref": [
      "r121",
      "r671"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid",
        "totalLabel": "Total claims paid"
       }
      }
     },
     "localname": "PaymentsForLossesAndLossAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r101",
      "r104"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedTerseLabel": "Payments for taxes related to net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Acquisitions (net of cash acquired)"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Purchases of investments"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToSuppliersAndEmployees": {
     "auth_ref": [
      "r111",
      "r112",
      "r119"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash payments to suppliers for goods and services provided and to employees for services provided.",
        "label": "Payments to Suppliers and Employees",
        "negatedTerseLabel": "Cash paid to other suppliers and employees"
       }
      }
     },
     "localname": "PaymentsToSuppliersAndEmployees",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare": {
     "auth_ref": [
      "r666"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.",
        "label": "Policyholder Benefits and Claims Incurred, Net, Health",
        "verboseLabel": "Benefit costs"
       }
      }
     },
     "localname": "PolicyholderBenefitsAndClaimsIncurredHealthCare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r36",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r36",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r36",
      "r558"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumsEarnedNet": {
     "auth_ref": [
      "r619",
      "r655",
      "r667",
      "r691"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.",
        "label": "Premiums Earned, Net",
        "terseLabel": "Premiums"
       }
      }
     },
     "localname": "PremiumsEarnedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumsReceivableAtCarryingValue": {
     "auth_ref": [
      "r652"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount as of the balance sheet date due the entity from (a) agents and insureds, (b) uncollected premiums and (c) others, net of the allowance for doubtful accounts.",
        "label": "Premiums Receivable, Net",
        "terseLabel": "Premium receivables"
       }
      }
     },
     "localname": "PremiumsReceivableAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromCustomers": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash receipts from customers during the current period which are usually for sales of goods and services.",
        "label": "Proceeds from Customers",
        "terseLabel": "Cash receipts from customers"
       }
      }
     },
     "localname": "ProceedsFromCustomers",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r100"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from divestiture of subsidiary"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresandAssetSalesDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity.",
        "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested",
        "terseLabel": "Proceeds from sale of subsidiaries (net of cash and restricted cash sold of $2,807)"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromInterestAndDividendsReceived": {
     "auth_ref": [
      "r110",
      "r118"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received for dividends and interest on the entity's equity and debt investments during the current period.",
        "label": "Proceeds from Interest and Dividends Received",
        "terseLabel": "Interest and investment income received"
       }
      }
     },
     "localname": "ProceedsFromInterestAndDividendsReceived",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r106",
      "r109"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from sales and maturities of investments"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r98",
      "r99",
      "r234"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale of Debt Securities, Available-for-Sale",
        "terseLabel": "Proceeds from sales"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r105",
      "r440"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other.",
        "label": "Product and Service, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProductAndServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Products"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r18",
      "r74",
      "r77",
      "r82",
      "r114",
      "r135",
      "r146",
      "r157",
      "r158",
      "r192",
      "r204",
      "r208",
      "r211",
      "r214",
      "r261",
      "r327",
      "r328",
      "r329",
      "r332",
      "r333",
      "r334",
      "r336",
      "r338",
      "r340",
      "r341",
      "r458",
      "r463",
      "r465",
      "r472",
      "r473",
      "r496",
      "r513",
      "r627"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r306",
      "r558",
      "r635",
      "r651"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RealizedInvestmentGainsLosses": {
     "auth_ref": [
      "r665"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InvestmentIncomeNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment.",
        "label": "Realized Investment Gains (Losses)",
        "terseLabel": "Net realized capital gains (losses)"
       }
      }
     },
     "localname": "RealizedInvestmentGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r224",
      "r228",
      "r229",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.",
        "label": "Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Losses"
       }
      }
     },
     "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]",
        "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": {
     "auth_ref": [
      "r73",
      "r80",
      "r81",
      "r523",
      "r527",
      "r529"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax",
        "terseLabel": "Amounts reclassified, pre-tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r73",
      "r80",
      "r81",
      "r83",
      "r523",
      "r527",
      "r529"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Amounts reclassified from accumulated other comprehensive income, net of tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]",
        "terseLabel": "Changes in Accumulated Other Comprehensive Income (Loss) by Component"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable": {
     "auth_ref": [
      "r206",
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification, description, and amounts of all significant reconciling items in the reconciliation of a significant segment item of information disclosed (for example, liabilities) other than profit (loss), revenues, or assets, between reportable segments in total and the entity's consolidated total for that significant segment item disclosed.",
        "label": "Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table]",
        "terseLabel": "Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemablePreferredStockMember": {
     "auth_ref": [
      "r26",
      "r135",
      "r261",
      "r327",
      "r332",
      "r333",
      "r334",
      "r340",
      "r341",
      "r376",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of type or class of redeemable preferred stock. For instance, cumulative preferred stock, noncumulative preferred stock, convertible or series.",
        "label": "Redeemable Preferred Stock [Member]",
        "terseLabel": "Redeemable preferred securities"
       }
      }
     },
     "localname": "RedeemablePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments": {
     "auth_ref": [
      "r638",
      "r668",
      "r669",
      "r672"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.",
        "label": "Reinsurance Recoverable for Unpaid Claims and Claims Adjustments",
        "periodEndLabel": "Add: Reinsurance recoverables",
        "periodStartLabel": "Less: Reinsurance recoverables"
       }
      }
     },
     "localname": "ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r433",
      "r553",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r553"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "terseLabel": "Expenses from transactions with related party"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the sum of all other revenue and income realized from sales and other transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party during the period.",
        "label": "Related Party Transaction, Other Revenues from Transactions with Related Party",
        "terseLabel": "Other revenues from transactions with related party"
       }
      }
     },
     "localname": "RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r433",
      "r553",
      "r555",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedTerseLabel": "Repayments of long-term debt",
        "terseLabel": "Redeemed principal amount"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResidentialMortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r235",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by residential real estate mortgage loans.",
        "label": "Residential Mortgage-Backed Securities [Member]",
        "terseLabel": "Residential mortgage-backed securities"
       }
      }
     },
     "localname": "ResidentialMortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r27",
      "r129"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "terseLabel": "Restricted cash (included in other current assets)"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r30",
      "r129",
      "r719"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash (included in other assets)"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r39",
      "r397",
      "r558",
      "r648",
      "r685",
      "r690"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r142",
      "r143",
      "r144",
      "r147",
      "r156",
      "r158",
      "r265",
      "r441",
      "r442",
      "r443",
      "r449",
      "r450",
      "r494",
      "r681",
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r183",
      "r184",
      "r203",
      "r209",
      "r210",
      "r217",
      "r218",
      "r220",
      "r415",
      "r416",
      "r591"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenues",
        "verboseLabel": "Intersegment revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r131",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Contract Balances"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r85",
      "r135",
      "r183",
      "r184",
      "r203",
      "r209",
      "r210",
      "r217",
      "r218",
      "r220",
      "r261",
      "r327",
      "r328",
      "r329",
      "r332",
      "r333",
      "r334",
      "r336",
      "r338",
      "r340",
      "r341",
      "r513",
      "r627"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Total revenues",
        "totalLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SalesChannelDirectlyToConsumerMember": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred directly to consumer.",
        "label": "Sales Channel, Directly to Consumer [Member]",
        "terseLabel": "Mail choice"
       }
      }
     },
     "localname": "SalesChannelDirectlyToConsumerMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesChannelThroughIntermediaryMember": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred through intermediary.",
        "label": "Sales Channel, Through Intermediary [Member]",
        "terseLabel": "Pharmacy network"
       }
      }
     },
     "localname": "SalesChannelThroughIntermediaryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of accounts receivable, net"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r73",
      "r528",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Reconciliation of cash and cash equivalents"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r53",
      "r140",
      "r371",
      "r373",
      "r393",
      "r394",
      "r395",
      "r396",
      "r534",
      "r535",
      "r538",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "terseLabel": "Summary of Company's Borrowings"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure about the extent of the entity's reliance on its major customers.",
        "label": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]",
        "terseLabel": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r498",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Separate Account Investment [Line Items]",
        "terseLabel": "Fair Value, Separate Account Investment [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable": {
     "auth_ref": [
      "r639",
      "r693",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about fair value of asset supporting separate account.",
        "label": "Fair Value, Separate Account Investment [Table]",
        "terseLabel": "Fair Value, Separate Account Investment [Table]"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock": {
     "auth_ref": [
      "r639",
      "r693",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of fair value of asset supporting separate account.",
        "label": "Fair Value, Separate Account Investment [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Separate Accounts by Major Category of Investment"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Net Investment Income [Line Items]",
        "terseLabel": "Schedule of Investment Income, Reported Amounts, by Category [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable": {
     "auth_ref": [
      "r94",
      "r95",
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.",
        "label": "Investment Income [Table]",
        "terseLabel": "Schedule of Investment Income, Reported Amounts, by Category [Table]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.",
        "label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]",
        "terseLabel": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense"
       }
      }
     },
     "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r192",
      "r195",
      "r207",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Summarized Financial Information Of Segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": {
     "auth_ref": [
      "r398",
      "r399",
      "r400",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table Text Block]",
        "terseLabel": "Share repurchase programs"
       }
      }
     },
     "localname": "ScheduleOfTreasuryStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r179",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r203",
      "r204",
      "r205",
      "r206",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r220",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r311",
      "r312",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresandAssetSalesDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r179",
      "r181",
      "r182",
      "r192",
      "r196",
      "r208",
      "r212",
      "r213",
      "r214",
      "r215",
      "r217",
      "r219",
      "r220",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReporting"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Other Significant Reconciling Item [Line Items]",
        "terseLabel": "Segment Reporting, Other Significant Reconciling Item [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingOtherSignificantReconcilingItemLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeparateAccountAssets": {
     "auth_ref": [
      "r644",
      "r692",
      "r693",
      "r696"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset at fair value held for benefit of separate account policyholder.",
        "label": "Separate Account Asset",
        "terseLabel": "Separate accounts assets"
       }
      }
     },
     "localname": "SeparateAccountAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeparateAccountsLiability": {
     "auth_ref": [
      "r646",
      "r692",
      "r694",
      "r695",
      "r697"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability for variable contract in which all or portion of contract holder's funds is allocated to specific separate account and supported by assets held in separate account.",
        "label": "Separate Account, Liability",
        "terseLabel": "Separate accounts liabilities"
       }
      }
     },
     "localname": "SeparateAccountsLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Services"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Share price (in dollars per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Shares outstanding, balance at end of period (in shares)",
        "periodStartLabel": "Shares outstanding, balance at beginning of period (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock": {
     "auth_ref": [
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for insurance products considered to be short-duration contracts because the contract provides insurance protection for a fixed period of short duration and enables the insurer to cancel the contract or to adjust the provisions of the contract at the end of any contract period, such as adjusting the amount of premiums charged or coverage provided, and on contracts on which amounts are paid but insurance risk is not transferred.",
        "label": "Short-Duration Insurance and Deposit Contracts [Text Block]",
        "terseLabel": "Health Care Costs Payable"
       }
      }
     },
     "localname": "ShortDurationInsuranceAndDepositContractsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r46",
      "r616",
      "r617",
      "r643"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-Term Investments",
        "terseLabel": "Investments",
        "verboseLabel": "Current"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet": {
     "auth_ref": [
      "r674",
      "r675"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted amount, after reinsurance, of incurred-but-not-reported (IBNR) liabilities plus expected development on reported claims, for claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.",
        "label": "Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net",
        "terseLabel": "Incurred but not reported (IBNR) claims liability, net"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r7",
      "r179",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r203",
      "r204",
      "r205",
      "r206",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r220",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r307",
      "r311",
      "r312",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresandAssetSalesDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r56",
      "r80",
      "r81",
      "r82",
      "r142",
      "r143",
      "r144",
      "r147",
      "r156",
      "r158",
      "r178",
      "r265",
      "r392",
      "r397",
      "r441",
      "r442",
      "r443",
      "r449",
      "r450",
      "r494",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r529",
      "r552",
      "r681",
      "r682",
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r142",
      "r143",
      "r144",
      "r178",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r36",
      "r37",
      "r392",
      "r397",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "terseLabel": "Stock option activity, stock awards and other (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r56",
      "r392",
      "r397"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Stock option activity, stock awards and other"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock repurchase program, remaining authorized repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r36",
      "r37",
      "r392",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "terseLabel": "Stock repurchased during period (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r36",
      "r37",
      "r392",
      "r397"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "terseLabel": "Stock repurchased during period, value"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r37",
      "r41",
      "r42",
      "r135",
      "r227",
      "r261",
      "r513",
      "r558"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total CVS Health shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r2",
      "r3",
      "r81",
      "r135",
      "r142",
      "r143",
      "r144",
      "r147",
      "r156",
      "r261",
      "r265",
      "r397",
      "r441",
      "r442",
      "r443",
      "r449",
      "r450",
      "r456",
      "r457",
      "r471",
      "r494",
      "r513",
      "r523",
      "r524",
      "r529",
      "r552",
      "r682",
      "r683"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r133",
      "r378",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r391",
      "r397",
      "r402",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Shareholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r530",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r530",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r530",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Reconciliation of net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r670"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.",
        "label": "Current Year Claims and Claims Adjustment Expense",
        "terseLabel": "Current year"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r670"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.",
        "label": "Prior Year Claims and Claims Adjustment Expense",
        "negatedLabel": "Decrease in prior years' healthcare costs payable",
        "terseLabel": "Prior years"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r248",
      "r249",
      "r257",
      "r258",
      "r259",
      "r368",
      "r390",
      "r484",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonMember": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockCommonMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "negatedPeriodEndLabel": "Treasury shares outstanding, balance at end of period (in shares)",
        "negatedPeriodStartLabel": "Treasury shares outstanding, balance at beginning of period (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r55",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r55",
      "r398",
      "r401"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock, at cost: 443 shares at June\u00a030, 2022 and 422 shares at December\u00a031, 2021"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfCostGoodOrServiceExtensibleList": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates type of cost from product sold and service rendered.",
        "label": "Cost, Product and Service [Extensible Enumeration]",
        "terseLabel": "Cost, Product and Service [Extensible List]"
       }
      }
     },
     "localname": "TypeOfCostGoodOrServiceExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r137",
      "r426",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "U.S. government securities"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USStatesAndPoliticalSubdivisionsMember": {
     "auth_ref": [
      "r426",
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bonds or similar securities issued by state, city, or local US governments or the agencies operated by state, city, or local governments. Debt securities issued by state governments may include bond issuances of US state authorities including, for example, but not limited to, housing authorities, dormitory authorities, and general obligations while debt securities issued by political subdivisions of US states would include, for example, debt issuances by county, borough, city, or municipal governments.",
        "label": "US States and Political Subdivisions Debt Securities [Member]",
        "terseLabel": "States, municipalities and political subdivisions"
       }
      }
     },
     "localname": "USStatesAndPoliticalSubdivisionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of unrealized gains and losses on investments.",
        "label": "Unrealized Gain (Loss) on Investments [Table Text Block]",
        "verboseLabel": "Schedule of Debt Securities In An Unrealized Capital Loss Position"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r162",
      "r171"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average diluted shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r160",
      "r171"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average shares, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 14
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3337-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=SL94080555-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/subtopic&trid=2122178"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5144-111524"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL6283291-111563"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(i)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2611-110228"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "https://asc.fasb.org/subtopic&trid=2176304"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(c))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(d)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/subtopic&trid=2209399"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99397103&loc=d3e6824-158387"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124504833&loc=d3e7104-158389"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(13)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(11))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),5)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.14)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.3(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.5)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99404803&loc=d3e21412-158489"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(cc)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671317-158438"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671321-158438"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=122147696&loc=SL65671395-207642"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(c)(3)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6484091&loc=d3e19268-158472"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=SL117422267-158473"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=SL117422267-158473"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124505678&loc=SL117422397-158474"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124505678&loc=SL117422401-158474"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "944",
   "URI": "https://asc.fasb.org/topic&trid=2303980"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "https://asc.fasb.org/subtopic&trid=2324412"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Column G))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 6))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29)",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r730": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r731": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r732": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r733": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r734": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r735": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r736": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r737": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r738": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r739": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r740": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r741": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r742": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403"
  },
  "r743": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3151-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>86
<FILENAME>0000064803-22-000029-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000064803-22-000029-xbrl.zip
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M2LL-/JH'&;+/:KXL?=Y,VV8OT9TP/.W%]LU2P3YZ<.T;2]HY\]ROCC %RY'
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MFMJ":8LUX-/Q,3F<]DR(*UYF#:V>YAW5_2QTDP3 =-$<.\\U<WU6\J>Y4[_
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M35N1IQS/_'+7>4YWL44%5O59OG1]D\67;A&R^U-RWWU%FTOF49_" FHI?.E
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MOA \%7=Q8Y ZF2A_BGMH)R]_0_? ]83"H?-MA0]%Y#?FD.+3O8!B/?HT&[:
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M2?*PDSS>-$D>SY_DL2+?.:^QQTD-OJ:]R#Z!TI*]9?W43.88%YYA9RJJ;?C
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M([SGNTHOACH:6<DB45^'94A90O!?XLD.DHUI<0=+1A/;U&SW1*6RCNI<_:Y
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M[C06>*'LMZK(4S397JL9GZM_H$\-%B42.X)&XJ[OZB<(K@!F3,GLXV.L%$8
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MBHO9LQ/IS%?P[ ^I%-L_CXY6!QZR3R^E<W7&/%NHF\@@8<=<H^!MAP\Z-6\
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M"JA:^YM4$;KB$#OF/1# 95MC#"]EOH-IKA.(<0=8:$YQ+Z*]>SH]PE6_1-%
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M'6JCQO;:VF<67;J((4T<5ZVE;?FV(B7#;J I^GNI!_7MB:G?9A1@\/U >B=
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M)Y@1J!0PZ")*4S%W)+FXI5.@?-P*;(0<9*'8F EB^)4=8CDFC7*W*"G7$_<
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MH2B]KHJCJ2IY(*SYMZDJ>0M%OXM\G=A$I4>W0<=75O+22H=RR* M+98(2%!
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M:1D+B\0TCKA\2LE:(_VJH- _^P33 0!=4^))$"P!NQ"03YH]2:YHP*VU=J9
MQI7EO<CJ#8T_BS^/J3N,B--*Q"+64..]%++2-/H-RUOK#DNMCON0 [Q4FK#$
M_B(5_\ :3S<(%&2_=XMP=I\>:Q@+=;0K<5>O;<U8@W5G8/QII1!5:W5O_&N@
MII)P(0Y#. 00CM:S'QUMU2"88J2VQ^LEL?%@I#=?ZMX0NI_8P12#[S72.,Z9
M <#1GOD4;!78UVDMV'*AWZC=9M4B,MTP)[JG(UK,96R9MHF!+P<N'09CA ;N
MME;%$+-I')1L,)C%'= I ,LI4J\J)B$F4_R]'1;LW*IIVA6>NNZ#DV#T,$2)
M%0X\Q\9VH0%FFJ '<Q]+]259W=RMTK H[N1^3  <J&MQ\)8Y1?F2,.]I/$!S
M$.:6CPW- '.==J:1WA$M+"R,FZM]I.SU)-*]KZT '>46 6\D#30Z/9H&G#FR
MXKH>'+9'"X"NK5KEKEC!!<'UU7*A6QL"B<R=%A-HL%8B2!DQ4=TI:;:*/4Z#
MG9?R1X_?0?JJ?"2/M5[&DW/I;+)2SA<4=EPKTQFJ ;1Q%02D(]K5YTN@5[?;
M.JJ%4C=L[O'>EN+0A+K4]C7TDO"*YADTJO +D?EK*MT%,>O#V,6F'QP'E'&@
MS*I[L8Q)\3Q3EK(#)&ZF5+JA0U*+QK6300TB@R5KKON8A32B27CI?"34O"'I
MVV)1M_RR7')OR(,U,08]5VC<-L)3(/Q<CNO=Z>FF<7F\ZIP3X'*28$H@9BUL
M_@MN':TLNL(QB]X'6^A@QYJD6+0%L11B(!&K:(D+BDMPZ<W&:2.8J/K3?=H)
MO/L0[VV:F?0H.5: H)BB][^]TK3(;J:I@':7D.&79D)2&OT6<2 .NS)L)FC]
MUN4FP3Q3_LT)E[^8..NAH.6#9IZ3WH:=N<DW6$% 106ZWM95>:S&.\MY/+#_
M!\I7?178?Z>UX9%4T 0,,]/VK6O)=0VUW,%>D*78TPL2SS2JD1/0D-5ASFY.
M@[94%165U?--3/7@S3% ?K0QG;&57'SWCU?)@JH57V6:S'21)50>3/9.;!EW
MNK</FG>QX1\"HP JH ;->NKZX"_Y8>7F'ZA ,"Q "(4[Y>?M_/R34W[^3Y6?
M'QW@#1)RF1_:"G2D[5%^CEYEZ"9&H]-L@Y$)ZM[#+7&LKK;LJKT35CGYG/!J
MR<<,P6F0-=D@JQY5FX,6,PU<+9I);D'1L&U 3.3JEM), F.9AZ2KS\]G>]75
MTQ-N>0"W' <Z@EN<"\2L03(7NX*XJE*3/ Y%J(U1*K$JW"%B[C:#QH@!:.PV
M +JYC-^ZO;=5J;4O1N7U7I7<-7[:]"D(<-K5-BY+B0'FC09D0.23LO04^5ZM
M@2>BTF%8#D6YCVUBBCSN]H)*0T#65=XP8-"%/ 3U@)V?D.GXA_< #F0$0Y/!
M9][LOFIINY GKM7R02..0A-SW>KV$,(]8.CT^T<036BZL2QC;GC(F"!DBEPO
MDYW'Z$X+I/0+$RO%N0=FFENK/W%@3O")L!+NO<4='+<&A\C"7L_[;0;WH=M2
M8\,Z?O</#D)8-2K&A HTM-)?9I"3:X0%'L'YR0ZA#(QD?%G(X?FXPT*3\S&M
M,=G+=NMAFQ@\<!ASQ5E('A Y-" 25C9*_:-:8!=)I>%9H4)NJQL+#--W9WD=
M601K07+')IJW&\*9V"E^SE9-+J=4T*&TME@'X1$(SSH]!,;LO=A8M?:^^6<-
M!5S:>FWN/,+-^\M9OY39PF6G3;L+&YL*.P P9MS+K]H@3 \*]':4"3)#,('\
M4S=_C(9F\#:Q+8#] _48TP,2>!+ '@&,QBV"70G<60I YK[,%AK[.7DQOG.2
MJ7;T^N9(H]TLZGQ.(2+I*7&N#/QY=0--%DJUNFCVJW_2:82-!L%5C$W-0Y8&
MJ=% >O,2D23;VDMS_?H0CS"<>>/4%$AVM%]500ECVH!]6Q[4^S@GD&BB]CN#
MBZ2YCA;0G6@#+2'4;[>IUGX5.E2MP/O'W89V&-3?A5,G9/,9E0"Z)H%J]S4/
M!8V_L5Y _<LF"E/[6QT^)@7,_ KH#H4SL7T3DC?VG8Y;\S\>K>;7ZKDKZXT/
MHOQLV7<[;1U&4&C?3?0"9R=G</PF/R%^8;>M,V7>^Z.*>GW&GW)YO&^8UFZA
MXATV1=KJF#[1*GW^K:#W5V?[II0<2LPA>G1J]<EHU>J]HXLZTQ%*SS2. W;2
MII^E31E.!IK0(EMVJ/8.)_.\;Y20K5;&-4/1:$X*PXF6@N*D QL(UBSK7^H+
MC-V_4[GP %VO0+O[7?J3SCCAX#X+!_>T,QTG'%SGL4>4NQU=>?AW_[#""Q:2
M/(SS[FGYT^], <#8SPTC,H.(SH7G,-AM%;LN,=8BEH)4;,*#V)8LZ*7%S H3
M8=LFJ[!7DP!3GSCLA$QV(G9*4\\&>53V_@TV>8@D2&IG;SBBTY.$5*_T][\\
M>?YCU?'\]2,T$XE?;A)(8)Z.DZTF* C1VGCE2$Y$Y524$I9BPS*[!2(![.+%
M I5ID<H<H0JD;-2W= -&R_NB;(P2+V$]D*R6."- SZ"O2+DYH$7?*SI!68'(
M#1&86*.%C%!DFJGFN$%!V9@.%L*+(!:9NG!ZG7BZ_K@%;M9TPZ7=RD_#_6*_
M>%>ZK=_F#?-^.>AH'@*J_UOL@VVNGG>;!!URG<NY,IWWNC$!2Y-]DMD?]V3M
MF[#3*CI'Z*DEJ[I&%6:12[V >^T5B_LND6E#L$7Z<)N4'YH!TM!AM,_2/%[#
M<4Z3'-7[3),!@R]SYV,O[ZP%F25V"-,B?! )C2Z!VUPQW(0:;*HFNZJS*S+
M^.3 YD=-.__#2@U;)?86/P5:]T5RB\_$2^ V=BX62G=P<I(&"W2PKIRJ?;:,
M#@H3QBDF(\!4<$I=</<<:Q,B#L*M2(>^ !1X("&OC0HNG1CG$HP!E:'\TDB-
M+/E*JR$(B-[F!=[2C'9ML*':?I<&R*BJ716-3+BAL:C=7I=,8,)A%RY&#+1P
MOLX*#&P3[8\HTTY.%/$IRW8#810AF#&-NW7 )&AN6%VW84B9\'.9.X9=>_'L
M?3<\8!AQ==$X98NZ](U"]^JEHZ5XE]U4!6*JV+[$^?6J3M\H64L0$T7"ICZ?
M>LO*(*<>CT])$[0^EKX)&"D$&BY!QW !%DB=C@JB[-N$&#%\O=OFB+&*:Z2R
M )T:#UC/[$-A!*6TV4%,FVF0U2NFFKMQ"@@VV!R%KABT#/@:A[Q.PR%[#AN_
MGSG<E>HF*4=0/E+6>)84:+#_T:97ADQR 2H4Z<ZJU3K#*.H?;9TW:<Z-B>;&
M=3"YC7B7(S!*KM1/FTV?^@HU8>_'&4&.C+JV@H:S!;Y7$L<KBMBD^W"$T3 #
M/HB<>62$>Q0B!*/?C-BZQJOV+T@]BU/A^IA@<9K75(^/?>NWB,2)16*H^YVR
M-6C69?\JP9U\FKJ,?&P*=.O\O]1(50O[+LM7\[9NB%3M-VLKN79&6B=H,? .
MZT+YD4T43Q<Y4'PP*P=B^RQ@2BFBW>L$<>WMC1OY;LH-$8"+&.-1MP+ LYG1
M,^RVOKD>/3-Z]&R_D5NH->ZR?L>N7)K4+@<$&V)<!9@XE0(1F<\V2S1LA59+
M4M+]TLA$$?% E:F.W1B>4>;?Y2'+4>GL+,U7' ]O!S, ]8,0[<H1IU27XTFI
M/IV=70AGU>Z-#AD.+QIH$-ECMSH\^$3HOG-[7UXF,/:]<36>O:%Q;";+,V[I
M/#^?7>P51@TL7OV%D>.>O!'@SECQ1BZ7-#/M534VDTV(AAWI^8HD7\D?8.3=
M66@7<1!#&OF$E+:1TL\ZTW%"2G<>^^4GS)X.%"#  ]&G[FG&0T*K6O<_"0 $
M/"I,O=?"UG(PXC+,I&& H1HP;%$5^J4FQ\,._^3O?SE_=O9C]__?(VO\4"NS
M]_^,+K$H",$<1VMXC8^+_(.3!Z)63K"_+*I/C+"KB51G73(GXO(7556GT, '
M.BYI-SN*H&O*I@!'7-T)PB+@<0-:2.U"YN6IHJR!3HAY<VUU@ON8W4'1+W1U
M1 B;6BN@\JF4ASSAODGCM&S^]]O7>R5 XCY274XJ:/\([8*R\B:O*VR  O#;
MIL(>E1"XN()BB1*G>]QSK+3#**9XH[1/9@I)3)Z <]_OVWF3I[DZ#;-F%D4?
M!O=-( NK=YM%:1NBFXX1P(:%$'Z'B0EE<(7@%"(_T=C7-KJ4X8YBE9O>MDS*
MF*C4'S4A6N!+V/T6%%B*DZS&'!.X;/0K\+;.D9KWK1[X*)8B+Z6BW^J&%_V^
MY@X8F=\ 59<,.5(51W.T /E7LM^TC6B?.^+1R>+&6H\FQCS!V#":E7&DYI3*
MV:#.J+*NFLI>-+^CC/KHA>'2(&S?H+T5,LWVJX@MIFTJ'#%#[HX>=G*G$91:
MC,N?[+]V@.6;2G2[@XN@B2&_\R")P\^E:AQ! C$>Z=Q 7G//B=4.7:6M<$QM
M')-( B8]Y_PA1ZL0[A44?E]BT2JPZG!UX:M19LOH;'9V]O1OU)^TI$Z72B%B
MPDE]=?XW>7QRQ;!]W<I4'XH(V]YYE-NW:)"2,[Q-=WF]B]ZW>[+E[4[;_+3-
M/Q.G68*5@!@LTRCXVYY9 04 QQ66V6/MVK^SNF)WA4R>S["2$B8*$ MXJQW!
M83PVI.L,0H>QKK2W@:QBNXDA!O]+717@[>H,$,>V$9Y*UPB<;01=+=!4:]1L
M8902$191Q'J)6ZU6Q&JP4@JBY9ZWK*Y0GX4Z@F",23K?!J(DO^3E1^[A"Q8V
M &&*C.LJ*C09VDU+#46H>?<\V]QF6=GU+H=#,-&$.ITL\/4,^>54K>HK'>WL
ML9A]6QE6T>E;(2UP@VZ""?Y( L]F8]_BQW:X,9WG:MYDG2-GEJ!JZ?82Z<I9
M]*WW#Q:CJ2UTD]&I;"S1-<CM9F.AW<>I"JV,W),]UV'>*^I^4.'>$?9-VQ*4
M0@6,G9@:8+;HT)S8#=(&M +%D4N6,:T?'55C3,2>9R'FJ:;B(3QZX&;4D <;
M,35JER]:/AW@UJ14\9-=!G"\<C>^'C,?#D,3C@"8T+1KZ"V69FXWX6;\D-!]
M-__SVRM_V_W]:(\)WL>S/:9QW?W]')M_?_>/M^]^>_'RY<_OX^CMY7^_>?GK
M!_6O%[_]^G]?OGO_^K=?U1^O?_WP\MW+]Q_BZ+]?O_SEYTC]X,/+%Q_4E]'E
MKS]'KUZ^?'\<V??'#[4+=EB=B]G%MM;L>6.PPVRGJX,<@DR& Q^@QH>V.&$=
M\6&81C3EV6#,=6 :G(:#?NT97# %$"^6^"R7T*W#Y+@/08'OER!6N4P+=,0"
M!6 Z$*&6"VM1TPQQ<+I<%8T\]NJ#2RRUTA![6&10+T" )72>R26=1;^7'!@9
ME!-T2?5="+K/W5E<#-0$O,"LR-;7$&*TR:YB@2_AK\AT52?7,J]7Y#PNDT]Q
ME*V2',"*\LOHML;9F5(0@CM*X*/0= =G=(6MAV_4#X4UJ/]MS.\#S8>L3FO&
MA0\52V@GV2WR>8'%53D^[Z>< B&QA#Z@&D:])3#T06A%5U9$/ROS/NX?,J:^
MFZ9=9=TIN$9NEY0Q\#R8W6:BXN)G=QSAUG2C-V4?[ @: M"? + V /;Y"0#[
MI0#8AX2['FIQ9NSGVY*PRHX=O:E/,CF-F+P#S[)!UJYNV\X( D1-1'?8PMVN
M='E,-9M%CC=IUZ*'4<6O"3,8/M ,2TY8=4.5;PV N(H[,^%Q, ,3X?52@O ;
MKV>H/2LFZ8K'?5-]YMGBSG6'Y <J\FN3!9 F-H,WQ!0&SCARV:^8* U2'8%W
MCB;NFR*G8)W=Y%7;8+.Z7->^HY$QA4/ZBG@\\2&:O(<$@])3:#:ET*!.I"2%
M:;>G)^?CN'_MU%5YX?W8^C4.;7 FL*"VAM^N<7++5AET_],J^Q#J'@/)9P.W
M0X/%Y [T2^+=#J@4]_%LWQ%\(NKS)ML2>IKK5UF*AOLKM,&CEY*+BMYA?KTK
M159]>=IFEJP@L1?*'O60PZOQ=S@0E%+\)I;NU.ZSO4>/K-!_SRU5HXN_S:)+
M0=+)&OC<&#KO)]U7E4+YHTW9EP'_%RM:&Y=$0[RLU\N IMVB]4+ZC55%[&B=
MIB*]07>URKQ"W@[1V3=N4VSR]$'),?J38P N0P=5YKHDXBE\B2H+SXPY9'/%
MU;'?V,$BFB/+:"-AML"A'$E=RN.'"B]\E<C86Y+\4S'*PV6)7B9&X]C%86AJ
M& J$V*$49]9P/KQY8]$.1E#(LIN^%QML>_X_F@#[&1T6T,W7M8M@T_/]*3JS
MY+:"2$V^S73IY=KJ)][LIC6YC8+3 4UL<+"_93*BGPTL!C[;UYD7U@R,B0;
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M9%YAA&-_H,D($,JYKME.O>._UU.7 YUTKY!?GX1L&]L)HU(UD.+)4[(IU\H
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M!/_Z)TNC5;CZ@&($8&C\3ZNV; 8( @P,'(M@[1SP%.972$T,13,M*!^JVJZ
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MD;5:1W95;OD?(>EC%8*%W,&JO]FG%:XM>MR< >=<5@6? 6FVV;!*Y309:'*
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MA"C32TW?C*-%-,:#M4F2@9<847:GM'@&A0K!E^@\C@OL5N>:#K.P43XG,E,
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M*PDK%OF*"9")"K98UJO&+1QCAAVX<[PP6I": ZM&&Z1([;Z,L4)_R3RX 9'
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M\-,WEZ<L3F&<\FR>C!7.LX<7WQ2G7#N$3([CKV !<'1JR@.;F%:",',&S.5
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M8!=S=OA0)(AJ? GF>J\C<!9*B>GQUX8]D)"K=W/N3;#XU6AL805M^%<QB2Y
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M[]N@91\39G">&-X@NOX0?))D'(6ZAY1&3.J?UBW FEY"B9<\N\Y9+61RZZ?
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MI8C%O.0H,:!\^:%F_4W#3^@5  3[P-W'Y*MY763-! UE=N@3OI\T:$0R>X3
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M@9)D'M7V::58G(FY/+)9';WYI?!<9KCZ:LZCL-V%IY\%^TCP'%I;X$+C&N4
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M8*&4O1@KU#%!Q)V5HRG*\WJ\343!>W*EI&>?33'? 6L. X!?7$9?8QT6E3^
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M(%IVW:O15,I#V F!L9K<IRX_KXS?^N:Z5J<MC:"3\TZ%/P2QFTF'5V0+8+8
M1UG*1)!R"_*U.03&[US:9:'V<^3M: J]ISJFO_8+N&>SR,'9'J$+S^]([4(
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MYFP:P6SB]>,QLG5K&BJFWC4VOMW .)O0YX9?2[4MQ6!M,4==H:S[CL>TI?C
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M)6F,K7J/L]&"3!JR'(DE7FU/%G%PNY&4W=? *P9MS&@HY9P!?YL]5/BV'(M
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MIU^? E_$$&R+)/DQTF%W#R],H3H4J0*!L/0)_@K:RAFG<N;7MG)FARMGRFS
MS3<O53S^Q?Z[#9.G*(%=U@"6P*X0_BLDMY*>Y=OJ*, D6R:S2]S-&()_N+#V
MC48[3O,=)&UY\]D#*[_%-FW-%QOV7:]FF<X5@<FC2+4K3'++$:G8J] GH-)4
MPI_9#9 KRFS;MX0WH0X;AAAU;9.$+*\Y(4,>:$$1D@6; V"BRG]1&C>:+D%B
M3)H1FS2I"3TI"!'M9\_X(>\>:#&<<U31>YI'P*5K>!HH)!GE.51P<[$W=E^(
M1O,LUQ <RP3T9\.G6L(*875T$RPH6$SI*'H1UQ4WKFEEZKW]=V^ULZD@VLTV
M!=&.1?&?A9PVS,_U4[U+-]U7!\(F@(Y;UC#*XIY!%^TN*K"'5-T[62H)%1%2
MN3T-I/218O\RAU<]EH/=Y'(PH+1CT,O56 %T)PB"#,F3H6 !YJ9LP!G6_61J
MB4L>P*M@DL=,-525AKZ1:\\0 %(MY;[/J08RPCX!<7HG"@K&QM-9HHB'VGJI
M-4(F0NV4D4[7*%BN,'@+6!!I=<*>67)J/7Q_!5LQ6,SO5;_2VTR,%;O(.%L,
MN5;<)Z"SV/"C.1L9Q5+AH9GXK9UO#JC#QE,@YK]8)+HR@+DR[YF<BL*OEMT9
M^GP[\=>9R%W23/Z27),,.C),XEQQ;S+#OWS*1*1"?8E%6]T;J6-MF6)Z4@PL
M1BKS/(N4#3#$]J[F=AB?+3>:5*V4Z$6@:2[.H&F;>U\*H@4K>?$KS0@]8K.O
MP!N18F:B5D AS_6E:18DF;22<CER8B-;8QO*+>918LO[WHHLL=;(ZHMYTP$-
MYJ"+8&.&R*IOD>24&\&8.ZC0H=QN][O;B%!3_93_VY_XW7L4ZHL/<>UAM=DA
M:H!ABM;!7T8U_W+Y.-$#_!03V]KX=FGAY4 P4P1]W<%J!XH>>?KCM*":(&F#
M2]W(#?'<Q(UU[_J1+&TTATULH9PUC3@O;M=;L:1=>N\\QFYOH,?+7H$I)KBS
M:3YK;UC'NF3SF-GYK<..#A$LO_$\TQ8'22'L.VAH1* ^! +#(,9+_.^$1-.U
MB1S$G^<$\RB<BHO6/E@CPA7:R6B%!@H?9/0MI3E#\1#TY"V0EZSKZ'J6JN3-
MEOG'2&B !4E%0* <J\KN*$N 2LLH._TK5>M:NR&QYSHV6K*VKYJ*HFXN0MWM
M!PVK6;(H="-#,X_JDTFL6+9AMBE H$H&+;+.4D$A-G",F-%-S*V H*'$K9O[
M7594]9KJ$8@.)2HL,NA:9QS%M+9P8$>Z/91L-+95"@;Y?/"K"H-9FT(%BHB2
MPH1\YYD.K98JN&H)]QBO%Z@]H()ZT#\3\-9CN,+$86%8P32.P;TJ^ K3FU2G
M]9>J*I#W_^U@9S+L=7L?2"D^DM9I*D9!(>0SY.:7NU84-QS(MN]-&G\B8!O)
M]P=L\'21,@%408:L5 %2Z28P(Q!/ECI1G@LX%F-II&6YUFIU,^*_"Z@G6"R_
M>0F,79D?968J9J*"/Q#<<WBJ3.$?-9\-N$TP$DJ7_22XD*BHA.D#W*8A[33D
MNS8-N<--2Y?)+M-7& _1'*+HULD"QFKI9.>01B.N]N@OA2.F2SK5EHE3-^LH
M1^:)J;4)2,0['2Q1SIO E:+QA*IF:$C,03-.63@4=-"D%;1%O5)QXF%H?TQ!
M,K,X 5'N"Z[;#.-C:/D#FCI"CTE:0?EUE(K_:C(]]9M$2..&6W_823;X-J"F
M\\5L/KIG L LN8W3$1+J2(77Z+CL.;_?A?/F38C1KMIB-HY9M?)F#I:]@PYN
M&/D+N<XQK#(%[BI?5NKZ%QWPBY>;N=CL2]UNV?U*9?.>EZ6VON[UJQWU@PXP
MV>.M\4'>(>)7&J()<IUE8\!Q*:=.I11XMXTY)1V/>3Z=76O<IQ=O-%&CWTCG
MT&QKJ"8GXGM A0FYZI$5\<'*!S"A2% L/0X=B_8 W]$)+('9PL)A'),SC\PG
M-[&VU*U @9PV:3Y!/)QZO,9HJN7QOXG&<MD25;C&SIR,OM><K#,E)*1>ZCV+
M<?I"]=M ?H* ^J"@K,)]C^P->I+HI=@&M1X&D8 Y#I)])FOR\%=,,!,C6X%=
M\='AA.F"NYI4[M<7G0?Y2$WPB*J)1@X.]G]]&IE7]7S7[#AXL__V]8K**3PF
M.>R$@O# />,_]'24>F>+.WXX@=MWI'^PUVJSF6CDK5*]R=PHDQU#@5^?9M@;
MA# CG/< Z4HR+5U,ATPK$P,)XUP);GI+$Z>1%T!LR/DE&*?@P%V32*]H=0[&
M'%<W0<\WY4JCI1@9"OJ@[]4\IS&XTQ":  ^=3%PICZ%E$OF/SDLC@V2>C1<C
MJID:X2A1KDXSQ&F!XDB=5PM,BV55_7O/&GET(\]4/);#"KIR6G2V;)3--&S'
ML:W-K2P,D-=I0$].DHVO%60(K:*@%)9>%G&0HSJVLW:I65+[[0C[A&8#@,/!
M(ZN>.CGH2?35A&*LZ,4T!AC:7KQ_O1\J6V1_-IXH*T1^1WTJ18K.QYO2"8VP
MDVK=337*(R -L^2^=O"$QK%'NKOU;9LL''HP-*=*.VVZ:V4I!(\1)NW>6E$L
MZAX1):&5O@N5RQFZ44I*:LG?2B^<@EUQJ&RXD(CMZ.L6*11(G\7\)LN5<8I1
M*L7=X/;)8>:Z1K+''=EQR&9XD ;(<.0&26UJ,O*G&#$3*J5GG+0IRTQK%U\@
M!QMN&U]'+@IXG'7M0 G4@E7P$L>5PAUR(U9]/X -1N6]V4A$"D,J74:5[-0O
M:.2IW+>"!JI 3,H9UMI+*U?#TZR$;0B!6R$%)?2:4>-0C'@\5/?!#G)J6/TB
M(3FVEIZG/-4U/+!BP#IIY##9W:NF+^C.1-<1=%ZP?UWAXR'\%+L<JI17+4]U
ME;XISP4B]73W6-3^I2GQ=XC *->40N>VV518)@P%^:63*%!<6#M9JBQXPQGK
M?$OWVG<C> :#D&^\!^45EI4SYA4H)/S<$5E6^-#0<L.+T[BM]'2BZ=#" )Q(
MLKVD]X[/D#LF+IT15_NSX40SX,XT ;4@(( ,/SB!^5SM1FNF\%3O,98F*$91
MFJJKSH_?!R30.YRAL+YH#\!]M/>L*"7+B.[$)"_0=7XJ$.P,<1YMW5@P@!P]
M<5R!LJRPL179C*9PA$QLU!R9+5=C<I:/9UFJB6D$IF59N#U1W/*!2L8:YU$V
MNV^&FJ%]Y[LRM#0ZTIT!62\E3A&>H609(7$TI&<("D0*@9#A'=*2S^[Y!BQ]
M:.LK6P7@7/*YGH);0WVYE"*!-[.A0V6J466I&89/(!I:@4B=U$79@J*=37N6
M\$">@N)+R7"1X$?$4#'#^B 8Y'X]Q8!/*>!GJ)?D?(6"8J29K5X0Q "RR)L/
MHX(YJD?3BJW5@D!_$LT5;U3\=0;DQPDK=C(S[NO'X[0UR+-1/ 9[0?4M&[>)
M3CO!^.OS-M&YP_665(.W)^:,:8U&?Z79';+;L-59>XS0K.037!%[T%9; 3#K
M/VV#I!SCQGQB"K[<7M3Q:'UK!X"Y"'WB>22<T:FVA&MOI?M JHB=T_[=(YD(
MP&>\5_&YVL>1J 8K15Y\+9^5<O]A1(+*&T]*825EMDT6.1HTM["HK&4XNSID
M8@Y*<U&Z8@6\Q$I:DVT3UGL]^H6E+)S.H!/9GKL:NL\X=%N#?#8E.!1NC=AE
M"OLRE38QH3SUOI H3A+Y+_P-9Y*7A)W84-:99=4\O>FV$UD #;">< LU?;;T
M9FS"A'D&%@1<$8H6J+( 1?HY#:V>WXDTA^2./G@=7 V. H#ZO?U-OO<;+!(5
M<^6D8MA+54/@R8%[R;]W)]'W1!7QWR71-XCGS[() 7,'-Q&6HDK1>DZTV]^
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MZ= [NFX!7X0$U]2,*<W29U):Q%'"]J-"QH)KLH+SL(78/2'$[M*KJ(T\3#4
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M5^*\NP=KW*2#Y52M%?%\GL0ZZH%H?"M:90>R_,B5C?TR4=HM"G5O]/BAAH?
M576:(]J84E_JO)SK]6^"TP*&D%"\P&.*+R*/)II65FBS,JB9HW:W044"^ABX
M%21L[^GMK9@/R/XRT?=0L3EN-^%*N-$ST<P9@IFYV7!2K+DS(S9./M/<N?GW
M9N<&'>C"Z[E=20G)78')WYU@"VX%K\3$EL+'%,AN78% 8$26OLZ47VKP32&G
MJ  >D8QJAFMRE93&(3@14R'H?&N)2J="KGL>@O;Q<>3(=I\M?V-OOG3[6>BL
M(I3/6/=TDXV=<(*.Z(Q-]Q.57L8\PG\6<A62>P<@5'?KBGQCY>BM9-VZ*$*
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M[G5+JU6A-!$ /KA8>G=A79/F*/;7^\]?5&EV!!,/L]NX\GBA>0R(:VV.;@N
MLL6IE&9FXP$3-[@F!8,;6ZL!8NE$^:,KM6W2 *DY,\KF6>'FX#+Z&FO#2OX
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M'KIRX\9?;\10S.N(/O7)9CP8R0?B3=1!8.Y9ZD2RX^DP&RO668BS _>"3J+
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M!Y=5H"*R'T-K^F4NBFO@&#J7"O@W764G6=@9K*,,UT86 V^R$&8>#KBVM+?
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M\*XW\5WID"D(9A/,)RS_X7RZN3R[0J]3^_2S.:$OO3:>4.FGOER#X_4EI[/
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M586?*I:!=C.6?M)5._9#X6$E8&RF]S%0ZD5+#M0\5!4>JEB^6;8'/? 1E>W
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M/#XYW#L^>6C-F=B__MG'0\Q1:N:_0Y42Z;UXUU>"?WW'![##[[GWR"=A_AS
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M1G)V!N+ND2L!JD>- U.49 L=7N7:O5]^/FZU=C]8+QS]VORPRMW;;I!?T!/
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ML0IC[I,/NYQLDV A=XY7RCT::4_6ZUP,O*&"OO;/@]G"C47J>.BU#TT455\
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MM96W]5%G)KV=M$W6VDYO2VY#&&U3EHO-HJ9>G*U'1:[VE-=AJK$?PL:1]W(
M.T%.>)AIV#"N5+W?$OO:)ZHWO1K)E-M#4RQ+@MZUGLLPY_:UK4T\"2?ITCH:
MB2=3)>NR/4U@E@]T!8)+O2,$N@G"[<V7*<KQ^*1$%=4VH,ON=QY%NU>:4Z!R
MEKVD]4\#PWGKL__KY\GZ*'SJ1PXB[B9IPG2:N&+>K 'A$IXMC--F)X9:@BMR
MJO;35:2MI+(Q KK*%"VUFVB:FLK>F,K2K2\/B>TUV>G.^4YWAV$@X>@#:^XV
M=W=:>QM?CE^?4,1N/5X>VW[=NHKM;3DE;2NV(41J:GR7@CAUHT6\[%#QU!&,
MY? &N]YI[^BRX1&U%D4'7["H87L54?I[^=U8-4I_T[A$NVQ+PRD5OEE9!_T5
MUF('\Z>LU]U2ZU:-Z3C:.:IUZVN3*EZFSLK4D0<+F>?=\UWQ$'@/.%%3J?E2
M=]Q %^)9,$)0I,,^6@#C&9]@4$M[1K-M\718;(0M,XI'S 6\.4OWIPOW2NKV
MHZ8> 2[W71X%:I(^K6N=3RVAL)7>4BM( '29Z?/"\:;F-OV(682M.IZ?WW1A
MTZ4W-_O%@GE.C?OD#I-/&LN1YZ=74&=[F:WS32,W,R>)O]"&3E7^SL]JYF,S
MN>K( [/@TH@$3IX=I ^,CLQA7H333W<$6%]4(SM=-:"1@E 91".8#[8%WA)8
MQ$:F41.RJMYT?PZ^D2 AZ9]A)#\< ;OB-3N<A)&@UR>XAN4F0$^-%09K/(1;
M8"@N,@W[G@)Y5 P+<:JS84A1$<JO/*R?1?]X'LFGX@X&"T[$9*R]P\Q6VO^5
MG%%KJ66#^;-"P93;J=;^SN$);D0FUP48]5X%\9A"O+HW*J8GV8YI(&(3]]C>
MEKN]M;=MCR\-\;#.-Y-^U=;JO7FRMT_--DW,>+M!07[-[X150I"C0\[]8L\_
MMAQ)QX>OH-S9._@'99 $:8OD)/OE(:"X\5BW0IH"5V'62M^^?QR$(9@6#>82
M8L CQ"70B?E-Q_G'-@]._YGPLM0[B^"O&FJ@@]+X!YW3DL )Q@$PJTSALAG
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MLH03]S_\\3'%<)NZ!3)G"Q*1 67ESYL(P;JMO@GE2.U)P30(Q&B1WI@:)9.
M:1[S< V9IQJZ/F-:C@"(MQU'0X.^4QED*/>2% C4:@'S DS?,$9UP:J2NX#9
M(&E:FM*ISY87E-3S 5ZA&YC",O^*E0R!V>SE&/&F47J]A2>^P!>PU(8VM^&1
M]@CHP.'XHF08@74UG 3K^E?LWIO2$=K@U/CZ*(*+H7[&I^WG82A,A05=7" [
MXZW ;';QSFWKZ@;(C2C$QK&KJRB 7N0/P2,.BC\.R-@DB9->:6RRX5+]/JH(
M-SBJX0:OZ*P'R\U01&D\<$4!')N"2SJ54PV=,(2-UEH43 ,_'(@T]XDL4GL'
M1^@Q<9>1C939B^!I:M\3#.BMS_$SC[F+ROR=)P;Z5%=R\JVEMG2EI9KS.]5J
M[1SA/I#M$@7.5VMBZ2,SV6U6GX1,9TSE4U@;&WM.JRP_/'-.NRW<"-Q\F^K1
ML&64P A -Q&F &(BNRT^%(K[D6G)J7/=TK39C3NJ53:M*6:I#)O8+%?KBDB*
M%Z0E*[=,MST4I#H="&_8V-=H*_,4^EAG2^[T8^]K(F_#[4:F=U]&Y,*@R,[C
MI/J.R23-O-3AX3!3=&&- !/KESL'6EY?<-"W>V&SG^$FNUIE3_:&A=Y@QHZF
M55L42PF*H#D&/E64SV2N3MG*08TI/[9U84\W55GD<YO"\IB[!8*_&'T/?]KJ
M8R0OC)(;EFDD:<:]!8,<Z_M1H(<9#QI>!WWX:G-[3H%-TT98#Y&4]LT'";8D
M^@'PM>37 TV*Q2EAQZB7)3)IXD0&L8!WIWOR DK?#DR70ZXH+Q_K@^EFRJ9>
MILYK-W6S*,-=";A*<L<4&(,Q7$M.D^R5,_$5C95XD$$<XH79,7Y)=,0D!AN;
MB7:FM\C47ZF=\F'&<PJ#=(#GJ;Q9FT838 AB44YRT*;Q*9AI+J?9%?BP\<8F
M;ADS;QLP,'/5]S-7AU:XEVWIVP!JH?S_@G M2$)&<;U,M31+SC].D#FZ6)P&
MEW28;,-UTY/VIDPT.3N?;%*!=7@#SYE*-PD?"JFA&AZ6LTXC13K^ MO'C</V
M1Q?Z)GZK[X3DE,=_E=[=BJ6ZK4)I*NA^TWG TZR:.Y,A(;TUER"[HB>'/#[8
MI$V7,WKJM?:M<-PVKF=$HBL\].KJ\,3SA"[3PM8(W?6Q$;[W-FXJ0W5!%"KM
M"2L//':=D@&.=XY6N6$;3ZB!Y_$WRH5_9I@!]5"YK&^S9_^[-(SL\<=![#$G
M5BI;_F>>=WWSB7E^)>?5'Q:J[9F6$ST>Q<K%(OX]$'ZZ3[WN3*&Q02"?+3 =
M5.@I^=4P=N6)>S!IAU13-?.EP,*J,)Q+D<Z,-4$&(->ACO\(JEJ8P U UP,Q
MI3Z\^VQXQ(15R;*$V]VFDU&GTP;3'$-_$A8_:QBMGI30LJ?2\QI0E#ED'?I+
M"F!2G I^X38CPD2S<8E7NFK(*>).5$)O81*--B8>W"*Q)%AHO$%X=8,O@UV#
M02?\8Q(\TW!('%[[%6=?O/"]2:!<OR6[*#!H'27[>ICL[<9@N=+"[CH0[^AI
M#))#S [VW%F%UB<QT56]EYV;OGG-3E'7V,KM<ZX\<G;#$_"EWIHJ<%[^($K#
M<IGD$U-N)XRR5_).C/Y:H U0ODB&%X[PX* ;[%(*9PAWJ#""VY>N''<=J$<^
MJ<)A%HF)4AVI <-.]9K@620%/::OV[#5!$TR[4.>_/)@GK#=RM?1A'NUN!<"
M<>8/NDU$.,8&!J9,HLW-4>EN9H8N5%4;3UPY5UEY2&J-;M8'];WZ%>D3ZY*I
MP ?Q<!J,2R3SUHA F\V=XQ4W\ZT!7%D UW$-X'H3B=%%MBA/1:M:9M2JK9A0
M>Q1F*E,1F9I6-Y16UR\K?P;A4&?E(X/F0M?:[4<P?1VMUCMELO=*S[Y'*V;?
M%*IC$JY<9G%!H?&D4MK\F-+/=3%E^QEUYS/>_WJ[EY.6C)TO:#&*#IEYF(HI
MA^\:;/6P5DRO:42-QEXP 4GWD3J21 @S+$]\B?M,V GVS03',,%&-H<+TRY,
MJ2!#.+_\W#S<_;"WM4=ACT[WHM=N)%UKL(X >34#I6./!%Z4_3@RV<YY<)EF
MIUXF]J(]L31J"HG;>#KQ'R38VB80>\D?2X0B\CR,&8<-IF(/X;I*W,>>!E%B
M0J^KDV!=<D^;GT'U8XM81PG\0Y+1A_C5OV+?,=^U+8^QS)0T -A,Z1"LTP?$
M-%;!*/;N*6:&G0 (>.KJ<L F,Z@XR:^15GPPX=!'/DGJHJ0;CJ\0.BO91%9!
MRWI\E+0RHKL/C(Q^>:P(9])Y=;ZS'@'>)$P'J6BH!$P6KR;)7[47_S/_#U>@
M1$)VQ3&3FII$-9(435W;1!=',64MX>?9+X54"F,HN$<50UP6\H&()K95=L58
M19HF4^7AE[ P!RX"(L*4C095P0'",C@,RJ(B7*YGE]+(]$[+=P>;BB<EW]!-
M88!D[P7QI,[&RA(Y!<<1+Y!TU HYB'Z3XH[%X3 %EC[ :S6,,A8^4)AI%X;T
M,/*I>]AV8RI594X3.9-6C&\@9"AR.56$(>PWIK0\R,#CN3#7M!3,9*OH4D-Z
MAC%VY1P"Z7M4KH"R6[!(EUT9[#/L!'X G*@9%!NC#X'^A<GM!0;3=0"*&3.T
MO=2RK+C@T8=M$[G[+C$0IL7-,T=&T(('@P!!)<HQ6YEGZR\E!?G U ]CA/ H
MV LME')0<8US2.E%4OYT/-(R58ZPX9N;3^2T*S:!;Z P<1_ ?J^/?%F_O)^.
M3JF\L"F5I4GW"8%W- C"-C.DA-#&5,\[,^V&P4Y,_S5IR^=ELT:3IKHS)0K"
MM)SE0V#K6OF!KW]!:\)4_+!C&9,5I*2I2 /&PT#7>L+<U(Q$=HU!@/P24;*D
MQLXELU&X%:&&.'FV!2)V&B10GRZRD&VT:.N)*,PY6G/&^4[%C"9[:=0P@77L
MY:8K(EL ]4+31L_V#&WK@BS-DZ-],L4XINE@\9DDA<SD,F"^T$R)8*($*BUC
MDB'(1J;?,F:RL67UTW%2JG+F%6EGZDK02GJ]*PW54!6M>$87DBIDA9?YAKT
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MMJ7/3*>[/O?HF^%0B.E];5#+*Q*76<9T1>@HV==G#)>9&-D%A:*%4E.-L7Z
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M)AK4U)VS)CHY]L_9UF;,4F9WF+6,#%PN#LA+M$[1+8+&Y+SL$+96*7AQ&"P
MSYA_B&#> _,%W<I7N 14-04U8FV="[-)TL_#S#/Y<UM714%\S]+2EE/NE5/9
M$@V#N/UTRSZ6#69X=Y3X'2V;JDIOI+P$8]98HQ*. 6@X\/P_$<(]D(_.I\/H
MAGN_:%#UF EIK6Z@4[X(*H/[@;#[<5BZ_#JA4DTUZ!5\:T>X92Q9W/Y$^-Y'
MCW&GGW]\^^EL=Q9T]TRI]]E%U>:H)#^*_S\8,\JUE! ^PPM:CO3 *]3\)9:!
MUYG$:XRNZQQ]6UD>W'=!^E@=C5WQ@[<WVJ"&L,[W_[!XG[71YUUAC+%,LEW@
MC;DM;0QAFWN:(Q21#++,EQ#'4_RJT1&@\<-%>8F=,V#D3*SYP4'8\V!09;C5
M4_"5>7_*Q<M6B/T_B^'^P0 \[6+B^-E1>D@<WZ> "@_K'%@L40,=1/5;D/+"
M+7+X(4NCGAY*H^Y3;P1$S.1U!F00'I*-0*G"?2]('>RR#.T _H#0+R=;+LV
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M,-L[E*L"V-!#7O6A1!0:%S%<?9#5@ZR&*:MMG5=M=#8_J-,[BNCI\4% [U%
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M621S!+]GZ\&'BS4AC$X5CI6.A%D2^3'KD$^ZH9F$,C\<"JI$-A_ %:D!(0P
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MHF7T5LSX3/P#75<PW!"F$(2-6;?%)5C# #B/,H&.CS$R!9[BKK^?G7W8>Y%
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M:EUH6=@DK^KM,3"-.LB+O)DG10 >C['E> _2%JZS1:9X%,1QF5TE6.<"PY;
M$4ZM\30Z:ZS-ZVQ;B0CY7?:MVJU0@]PAT3NK$DAL[$PP\&2[@)/DO_6F$+P4
MA-XYS.*&4%$6EI(A@;%[(K)!"P4X_<-1_&#)-BR4TJ,A74JKNA<=>!!<DUNJ
MMV#P3&()]J3@8:!73+53>9M""1;+O*8F!)G&;MMB+P'?M9'X7: ,JT@H*NZ4
M0GF@E>,X@\S1SH5[3SB\V/FE ' TJ3$N/EDY1I"$71CZ%3?85D(5)[(V"VTK
M/2KHK>5)\+ZN-2$:-%A.PD?J.$LY5]G(R>C-!73Y^J9#89<SZ-4$HC0729W2
M(0[EV1GJ>^5A<CM?+K?$+!/WP!/ [)+C>=QHGACSRIZ9O_[IY-GQ+PH=!7%%
MA1T!#B$T)M+-9DF3PRA918HA.FI2.Y%L0Z[=Z7JC1^#[=@24UM_I^$ )D68
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M#D)R+DR_ <?CD3*]PG4FQ@6.0YK7X@ I;H9#V^(+JG%=9_"P;RHS$N)\O:K
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M9,-B$;-UR=JQ<3 V26\8D340)'ZK6W- ^ 8$^ Q_P;2)_Q[JG,;JG  70A<
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M^7:K?\U@B@'89\ /6ZN'"T9+0RNH?]T3#B?O:<I'M*IJF=Z%B.B P)<9].Y
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M,8('L _D_:$%:]^UE-D"MD36/$W6#Q<H:K?UQO)D?*9@*JYS8FWIHRM(H>>
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M"%-\=]HMQ39ZO-5-L+>Z,K0RNS%I>*6Q,87$JG@J8NL(U1E(6/V]@U4L5!M
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M"@7Z=:W8)22N@4;C'QY!=$33C?7Y,XUQQN C$\21.=IXC/:T0 % H2.K./>
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MZ@MM.!'.-KF@ZTV700"H833(?A*0L?TMQB5I@X/]+2<C>JV+2."S;9UY?LW
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M'*HM!VTT]IE"XG\6@CDQ'X/V*+B6QHQ7J1B5&Q_PZ(Y^M&LXPD7W\(:TP,A
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M;!5FF&?T"GT,!+D&?8#&@C"0EPDXEVS_BQ]_^?_9>]?>MK$L;?2O$-/G;5@
M8\1)I9)" P.X$J=/9JJ2.DEJ^LQ'BJ1L=BA1S8L=]:]_UW5?R$U93EP6I7)A
M,!W;$B_[LO:Z/.MY"L;=R?S#TJMSMEH8R.*_8]8B3LH8WF!5\'I"8"0ZPHR-
MQ&HBESSA8WJ3&'[=8%6H!.N7*]TV1$7P;P.*0KM4U6TLF!6^L^41PY'0CX)Q
M*A.-MS )T6Y@A.&_A;PWA=2^9>,!J-2)<1P6@F%1;D'%)]6EB/T< QDYPQEI
ME0EXXTBDS.N@5<T3D^E"?1;U%H9FP+$"?$:;[^WM9-I^+-TEI)I" #5&R?A
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MNA0-Q,DY)P&4;A2\QZY>&6X0?F3L!#M[^;?&G 7\[.;7:;(NI-[&1AN+/E2
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M=P@_F;*,(6\2B!8K:3&;;]P3880R8OO^/U[O<3IP>>F!V;H5N_JZN$[*"5
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MFB,SA;46:@]JL+5YFD,VI6W*I)1ND__08LZ\@;4UJU';FJ2VS=F6!>(!](<
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MQ;53@'UR94S^0E:F'+"&E92^?T/D,AKU[WCY@2LGGMI*O&T*[XT'1H<8,OK
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M(RHDUMM11SS]RF)<[)_P,E\*ELGL-S $!I8$-7M(\M9AZ;G3\'@ON.AJ>K3
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ML0-RUF4Y\9=LK[EIUI 5K@6@Q@<)D^BUU26?-%2H=VRPP.N]6SIM3QC.X I
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MIV VI5/P+I&3>PRZ1Z!-#BU0"VWKZ1A[9V.,!?Q"1-/$X,;46P+71#MM JX
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MK-4=9-/?(PO%8&3V+O"XT\HKOGKK#NPC.+%:)QIX[CM=TK^B9/>C5=**+DL
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MZ)(8C!*;KG*RDK8Q)3M?A6#G=9]?- +R4A@[,",D32,;RYK837(\I+H7%.F
M<V._RJZG?M3:$QW-;B'I8#$7N9*W\+@%=(#.E(-1=\'JCZS?DCR(VB[,3S8.
MZ-8*>?Q)W";?J>04]?J3"O@WBE&O:_W;5E@+]6N4<@U/MX!&>VN%A0U,L:H;
M[4EERNPI4Z']CKYB<^HB>? MSA&WQTN]]O*!TF3L2V_9U,G2:$W'//."; *I
MY,C%+=T;CBWX))5@3)G'>$9'.;931FJ&..&+QU$N[@ 5_]Z@I8_WP2NH1 %/
M/;AN&HZI6H'0'Q%^2Y8$6W/%W_YZ].:7C=&P3Y3,X53;O-H:7&]AX;*I]G3"
MZ\.U:<;CWZ[4ARA,%AB0SN>BCCH_[ .% S_)83-U?JP?CP]?O-SO_# _9Z#5
MLO'O$=C3E[?9!./B"6JH_<,W;X\Z/_P^YEV8"ASV'5=;U?_W.,RS1/7WU$ET
M%B8KRL[!RY=K>ZVK*$6$R6_H=5\@Q>!$.Z37"!4L<ZODNOL2[_69M'1M=E[N
M'_34Z]?[NT>OJY6S77RK:VTPK/A6+U_NO_YF WN-.VN 1L32=VS[WS'NMCV0
MV!"7_M7+7\9WQ2T=-GM@3&WB7#"=(MAI\X>@:H2&3D/ I6FX1;;<-O@S0AE>
M[W<3RM 5P=O::5L#Z'L80-?93'W,IM-PL>C^">M;/8'J%YC@0FKC*ZR46" $
M 1?(?BXQ$]@C95I$"5$-'!S\8O9,!+\DU[H]U%5;3\_A7>,"/\6*.CQXM?OB
M]=&*5E27WO*I5M71R_VWWS&@L9%VUN(6GE[LS7A?/SM+2^U\FZ7%A*).<VM,
MHCKUA7*3I<1Y=00+]]7#C'$).J6(>H_:<UV9TBN0B!SN EKQQ9M?U-6"(LXW
MZO3THO-C/WK[5IU&7V$H"R1)A)4NNV]1U#N=*[!!#P\[/_#5;(E?RT)]W%/]
M1?P0WG;?FECQ_'SU\E5/O7GY9O?H\+#=7^_,6ZUX7AX>'*[P5AT^#[[]=+PI
MB[V09)1.QD*TX%,/QLW,A#07".G67;:A3EN14'<S*)O5;*]BP1 F@K-4..&(
MW8H*3?1HC9LY<3:2U5%Z](H__Q56;L)Y^+/Z'31/M"'+I'(NI9SR+'^6J_47
M2[\-+)+%_0;^P9_VJ8ORW_[Z\O4OEQ%B].3Q3S0+NR.M[Y#^#R:N/X/?CT.P
M7_;Z>T%;L[]-?,.W^_OJ\YZZSI$L[VH!+_=C^O^]WCLX6@DC4@OR+K+Y_[_[
M8N\-_OP.D__C,)&IPZ8 O/,6M^O<:^I]DF5+.%\[O/YGQP>[^X>O=O?A_UYN
MX@L<WX9Y F=?!)OS6!V^.3QZ0HBR.Z_1Y&FH?T9I&DT>U$E\<[-BH,Z>]NM'
MFX%)3F_S@T[KP]44W)O]W1=O7N^^?+._D8+A>VMKG<K7^R]W7QT>[1Z]VG]R
M0+4+4VE=)_4[[ZR]">XL<H=&V31$5^B[:/&&C-HF3-'R=@H(%R3P^)!(!KGG
M]:[Z=*5.LB0)\[7V5'A>)N9FFA(VRO=E$\???]?_:Z-^'87CWV_R##;#KC^6
MGS6R?^M_-G):I8#E+-MCW=OQ.=[X>0YG8BM\1L;=XR1B_BKXGG,V5P\I,POL
MG@[_M8EO>AE-19((#3+HGUY_4,?GEQ?GE_WKX?G9BMIS>6!L^1&^^4&W&L^/
MQ'V>UT&ZB2_"L9CS><1&V),1&EUXAP/U/HFBA?H</FSB\#]B,<EQ-A%%>M%_
MM7L$?N3^X>Z+)P#8N_,^5^,\3!=817X1[JF#-T=+$+A_2M3E@3\=G45==D>D
M_("54L]!:YF U1'"U-^^VGW[ZJ =5-7A%ZD$C=[L[^^^/CK:??/Z*?4WW7D=
M)W"S0#$;)S$6_3."<1&%L]*/X?SX$(YO_[UJP@=T9?J^(:BS#>3\F>W/9Q#'
M47]MCY9W(=*P*__?"6KSC5I;"7)T?'UY=3<UD+18B%&GW09UA0R(HX>G(LY^
MQ/]NI-B:B-4?"E@YJ,,_'IU:TTQPKU%BEA VB;"('J%CZ/#"_BD!0HO;9P)X
M>;&)+_ L 2]*_1.>KCZ$R,MYLXGO8V('"#@Y?'VT^^K@Q1,*'+KS(I78 8(^
M7A^\W3TZ/-A(.7-!'_#@O<G>+0O96B,&'<@8?1.4WN?DM)5AC)Y?>]Q :!21
MD ^I$R<3)+M2.]A,P]!!I>5LQ,,G5BA]54\5$>5'J6DZ_;YRA/\+TV.@L-(P
MSJ,?VPYZG11QHRY1Q!T\PA$W2*+Q(L_2>$QLH):6;*T]BM798Z1I4I4BJ5=J
M2XXM!BS!J/#&6IXTE.$R!W&\91ZTR+ZY=V\L$M5-YH7V[/W\XZF"]RO"&TW$
M1GRD:20\]2#A^-_WT:B(%Q%LA7F9%R76D<,XYWDVCB9ECJ\S1[(W?GY;40WL
MP[<_"J:X^3U!O<9:3C4NMZF V=9T>Z)K14"X;;V[*IM0 +/N%E:=GB/U8N_%
M6B<H%L9D3\1N0Z+89H+%5M9L$F5%C9Z0;SV<4S<4<(.)(9L(I;4<LS:C!\F+
M%\NT%SB:K>VZ\UI/C$"?U).X0!X,YDG'VG7:/U2-]#B!)=L,5O4N&5ZQBF:,
MMSIPJ0[DN<*6LE-#<J_G48Z]!$PUH2:E[COC,@ESLY)9=0F?K3'V*4W0@&W=
MB+9)']*ZCO-XA%W4=^(>:^"ZZ%?%V;:L]:WA6D=JWMGP'Z8M4D%N !'+O/ZE
M<,GQ0Z0:_SW-[I-H<L,T$MCJGGZ%A@=QO,/U\3PF+GBFG"^T58&W/-S_!?8S
MV#OFOCG#TZ()?7WP"TJ!N3*<U+^?ENE8- +,P!V\'&JI0,E](TT8RQ.C&U95
M!M[;;N5E6UF?(;I2-V_2L+IM \D:;'/=8#3-\AEH@9'NMG";E;;UE1&/H/H$
M_]X-G=,M(S\]4:RN;!ZE^&2XOWFB2'(*F[VY^P/A92O#P<V$[=?]+5;32=03
M7/IYI$OM[17VFOO%?*$W2L->$L_7W\L@_Q/1#A--UF>-T'$2ED4D] AQ3]-(
MZ]9JFJI^R1K$SOYB[X)[MCSHE=8OJ@=$]/@P@G:]_:<$H57"A5T!H6WX&;K6
MMF-/Y;P_YNZ>F%'BO=*MDV=OK4=.W[0GXN9L9"U*/U0GWA<\'NPCO?ZH8^"Y
M!+KC3^9T=)L[81OX8@=;4E4INFH!4]WHMG;/U=HI[:FKDOH?Z9\5($AP$8P%
M/)]P+LTM-Z&SR^%:8XU(D;%2@P/NC" !&4_^&GOJ1&ZG>+T6EE!-+3=9^&'Z
MV)?F[W+N;VW1I6ZE[AC;9J;H1CUHBQH3"]N4MMA^CYJJ-5NUW9+[(T;HL_5N
M=R9=.ID?2S5@8.H"K$_L<MNM/;C77%+YTS+?'P;JXK1__?[\\J,:7JF+R_/?
MAB>#$^V>]Z_@4^V5]\_<S_N_]8>G_7>G@SW]O<*[]7\=G%VKB_[E]7!PI7;@
MPI/!^^$9W/+=X/3\<T^=G*NS\VOUN7]YV8<KZ3?'QY\N^\=?U/FE.C[_>'$Z
MN!Z<#:ZNU/E[^O[=^>7E^>?!I?K8OQY<#ONG5W@E?J/Z)X-_?:*?\J7Z90(:
M[>#?%Y=PG],OZF1X=7S:'WY4I\/^N^'I\/J+@LM HP_@UI?PEF=XR_./PZNK
MX?G9E7I_>?ZQY=FP9&?G>OSTX/[9%_7/X=E)H!\8J"&\Q1!>&FYZ==V__G1]
M?OD%/CT[/OUT,CS[E7[BWN+CX/+X _PA@PO4^^$U30&.LL_S>?SIM'^I+CY=
M7IQ?#0(8Q-GN\.S])=QN\!$GG>=@>'E"EW]1E\-?/US35+V_' Q.X(7HK7X;
M7GZZ&M#GY_"&..4G UREP?$UC!S%X"-,JWKWA49I%_0+SM+Q^=D97(C(M\_#
MZP_^'-472*\'3-HPQ69]T9U5MNVQ,<E/3\DVO(RX4;+.M.W [DBX06;R$+AQ
MIVZ:3?Q.,OKUYMEIH_;89L$93F+=5[?2=2APK-_ L7U]Z(!TQ$.+/,F* @.8
MXR2,9_#O23@#;Q?^0S\BYDA+]!7.T2(R74)_CS$F<W\;T0W1 L_R12#MN<>V
MER-&2GLJS,$XPT.XK'7---%,"?LT)SCE&HSB%$X769.9^ B2EL=A0K<Q";W;
M/"MOV$#4QTC@3(.3<IC+U\3:YGUCD[BF,Q:-U-YZ*(&FY],^\"=ER;Y3^T#U
MF5IPLJE^7,Y*CE>!_@%[,'Y:9\$N+$L+B#(#'SM.RIR<U^AKE(\Q"8$N%*CG
M">C:!VI5S%_ # ;:S$7_2>^Z9D[.=H\9_YO: V,0'Z83]/:<-AQ<-\_C.W#X
M;S2-=;U[,1\7&14H1I03T.U231??---M8<F9@'%S^SCR\\'^-R\J>N?;!S,'
MSR I)Y&C !C@P;I /T?W$15U5'T^__#147!2E1LKRW4Q:E6ZDAU?<VUA:,"K
MS:U!;T9J;"6:%WL!@X(W*? 3=U96>)!I'#B",R2\?SX:ZR>U7?\N&NNJA'-$
MDK&7$6818?XD\('K]3G,L0;DV6BN/FSNO.$][\U[JADBW26,5]T"4KT 4CZ1
M#P/=D7*,:H5/;-,AV\%O6>" !(\H$X0V2BH1,?J"@DBL@PI:FDCO_'%)5^$0
MY*X/)@+A#_/Y[*2C#=I)%T)0#$LR$/N4K8 A7#-+&5)S:@W99QO5Z5J/80[=
M&.N<\$$%H0**##<4GD3@)< &QOPE-XA%$]M5$MQMP^YKWKUW&87O)9N) &+J
M=&M Q-B9,$OIMI-H@?D'2MO"/0IK='!S#G9=C*$0%XKU$-RVQM2#J"LTB2:!
M@LEFD,P#M\.-9R/0,]'R? +ZPZH_G8(@POMP,D1<Z3AW!TVZ1K0*QDK+Q6XV
MW9U3;RC07(5H1...P2R6V*A9(2JLS'-.-SLJSH3()^#")]F<%6CQD$XD2!LP
MU3?O+KFYUGQZLL*FGO>![GB/>('Y/#'=2V;9Q,EE9T&#O@P\A5[($&J#M_I9
M)V7PD>5L9B2$^K^C5Q@*T@T]T&@VY] #_7X$%II>;8I65TX8,7D9$K/R2V[S
MZ&X>_<6SRJ.O28U7]DV3-22R^I2-DVM3!G,BCN);:>>P!Z+W'*H_"W7G/,QJ
MFFL:2;IO$A>D+N5UINIJ'HUCVS8-].M(ZU=\&)_C#ZR&;K.D'2(K:H;<V,+H
M"W9D"W4;YC,"]A$LCO09ZC4R33&=J%'ZJ*'Q/-'C=:]T0V+D6&%W4?J+9AK.
MKCDGB0,^&8HRH</)/I/=])U,%@"6UMY#%AR$D5%%BSP>E0N:6ODJC6Y 2J.4
M&S3@)RM,A/BQ,@]T!IMD.4,_*8&.L05:5#[92!E.HX9 H//2MU&J)F74DT97
M B2%GS,V.<<3&%O>IZ;CO?ZNY8AJ,;GQ%*+4HJ_Z)=2\7(Y1^;.'4#G#EAQ9
M\CS\@80KY.FV&09[$GK%\0??8[,*TFUL-X Q+YR]8+<"L0JZMJX$=JO"#N)[
M$\9IL?#$F:7065YXZQ$(&+MH-B2L0\0F-&Q$(% RYX'Z3SFYD9.]*&/\%QDK
M@6.I-.U^$TK&L&VXP.C6_6VX*+((IWWG>RN;+$5MQOT9=V!W<23%/ !F)1N3
MV.#@*8]!L5U03_*KGO5D26,DB1;!^C+ RR_"WZ-4 E^P8A$M<( 83O,N#["M
MQQACSF&YV>3E(!@.Q3R7#$9:;BQ;$;OY/V4>%V#&<0W2(W>&-R]8U2X>EM[5
M7-4+_MC+ZB'5T3ELM+(VR25=#_MA"D.PLQ[!"MSCSFAYHE+A= H[B*-9I+#,
M/:2>HO#+%V3PT5=0F%J+^K^34P.F<$HM7+#1)^P;,M^S^U3/&R]4RAMH&N<S
M_-O(U?*%^.;UM4J6=T5D;Z5O@KL1%@IF?(9'S[QRCZ+W8Z0$_C&7L!6M%Z:^
M:KU>S_HLQF6IG)^\3"G<=!RQM@8YP?1,R*L62%PSPI2,.0\X",H*NE$?[^CD
MI4'BHI:JYB37!31HCLA(AK0EH"&9P74F)WM&I='F\8R8AOH[.<5 NL1<*%-9
M: D%\)G)XAGX^Y?#"(I0B+^S6IB%7^-9.5.Z514*"O*K(9*;\P!69#'@C66B
M*&S8LE=LOH?%K1@^XE^",9$_T'^$9+J0 NLZN*\3M%;=FIF?%\QLPSKZHB\R
M:BTY;6_BQC&&'ENDU@X#W<B(23;=&1(I)Z" _N--$5*U_B4Q5;\$HU@%_,"K
MP]Z$,68KSIK &W;Z/5MVA>LV+1,UBPM$"Y=C6,&;')[H^'$!7!Z69/V.P@DZ
M88M;8Y7P(H-#_$[N&JJ9P!P41E'&M]JB<<7%(JAK]SGN:0"&JJ="Z CNO/0<
MKK7"F=S"G1,SC<V3B))%$H5RM)"%P5U_AT#3&[%7<J[!C,3Y@(-RDD6,E,4H
M=T+I7J6A- [FQ3=I/<25$V!F2Y;1MR/"JE -DPETB@9Q_4+ZW ,(N8&*)>@!
M]0_0;]AX$$2XCSF]&VV /=+ADYP#$F3T#DQI,58WC]%$P'P!#*KG7R<G.Q=1
M%;3IR&U^!]?Y^]*)/^"[@ZF.KAQGT=-=4 51F(BES=XK.V!@]S)B8DS]%O%S
MUXSFW'ZHX>7%5O>N9B744ZR\.EXL'RE%XH5-_3* Q:3YM%5OOP2#3H?J3$PC
MG"%C96'"36WXBN<+\^X<HPP"F'S+FP(NH^PNJECY+"8$=4PS!^FH%W&[T1ZM
MS<B<8"'H7HH5FI@@P;OJT13M>7V[3<0)+G:EP+//9A0#QC7' > 7U^'7R(1%
MX0_4G$D<E<94H0OJ3EK%9^=(+F]Q&J;H][3IO3:@>3%*S,%^!W0S&A_@DMO*
M8H[:.W-,J]0ZR]W?G%LWN8-N<HQ2A_N<1E4LLFPB20LPL28VBB0!/J:[V KA
MMPGA.@N7NBR&)''=G)J.'A.3DD*KZ IN624\-,S+C4'#=,&%:86BOMH@*"H&
M-/ (.Y].L?9HT^# +42^W+60^>2L6V;.8B4UX MX**-G*/B)?V$@1O\;P1E3
M%VJ)X5<UB:?P(?OUT]C)QNK84&%)%[JMEU^L62T_'_#YZPW:\5?E&//FF8#-
M^D4!<[J%F'>!TJ=Y:=2O41KE"#Q8+U/Q]6-\)8;28A3SH4*D9%P((_5_J()'
M\#K3V(1%*\PX$A\E=#GA*C#H6O@3HT*9&9LUUX#IZ"LQ>1K?R^4 9?I<^JE7
MY^MK>LE):*<M;\E28: 'TRG,XA)GEA=0(^Z6E"XR7-TYI:0<4O["L7ZO<<J$
M(%T;\\OQC:-H-4H:RQ6$^%:]YAT_V'Z>1FX+#2#K'\:=[L,'F<5%/([G0H+W
MQ(F?V(G?SOM2/P_3G'%EZHF@DX*W)/@V759$XS+'"+V![14^719^E@L$K;(D
MT^V2K+@D.QJ-+BFN!6*<"=/O+$=N59LD>SWR+'.PI&7">="[+)[T*.!^*\A!
M_RPB_"[2MS$=?CP#EQ^K ,R=4$DO\A*^QM5&("4\6\ZKA[8\LG]4!8^>4^W'
M%%$[:*6 ^0 _ 6SJG>'%MHK@VX)BB._T9U5$(GGPH?;NFE2Y7V"ZZ9AVF<][
MG&^*;A@*'/VWC+G<P:NN)^P])B L\GZD\8%UVVF;T>T$<5??Z"2BF)9:E/6:
MW7U+<D%VH1NZ8!L1*\33B,M!\L@8> 4C"T#GJGF6:[""8S,2C:%C-#IY"&O4
M.[4,;;>SV >#;K!8!_<!7ND)_;16L#KX.L\*=!;PMP[PQG[.)C>]/Q??$BG_
MEGU[-<9#Y]0U9V'%[+%ES8C_HQCV(UT7']-1+<VP.J.C#C9)1WT$;Q*AXWU&
M$FQ, ,^/4^V_Z;9(]+LC$OM[KU_B1-0*DBH>#1>?+.(</9=9&!-]*.--]-?\
M U*J?DL&1X7WY1>YJWZ[H.(%MMH^!Q2>MQQR%E;*_I[+%*7ZN@O+^Q)-Q313
M,]E7,F,IIO!'YC2=\/D"0WZ^,O^N.S)_L/?B2&2>8,FXWAB]\YH3>+$I4.*(
MJ-WZ1ZN7>#QATTL5'_>XP  @DA3!=HUT45_AZ(0698/H<Q<:IR.4/U.%V,>"
MJ.14_E69B=8I:'LKH8E>8%4YPKVIAC#0<>$4'?S$>_51F$@]H&K !3_]7=L&
MYIAU3HFC59<[#LP\-*M&1.(4M[972C*BG,UMM8!3]5B]<5PX9%;+&.ME!4+-
MI\J=HT]@!)KC%VY%%9NV5FC)P )Y#1I/VRU[/AA$FB;!B?!_1P%L.OI_\(3H
M<^46J[3%\0-59"K)\*Q%25"#.Y&6DV@:ELEB$Y"<6WAA;6;>[AVL-7>(2KJ;
M,Z,/,9RA=7=EZ/X,W?:"[>Y:.D/Q6F6H^]T_<8[^L]XYPEZ?V5A(#[:821<S
M6>ETWV',Y$K.Z)I\3P*), 52G)94+>/7BQH,A* K"K5CC5J-N" [/&-V!H<H
MA$IYHF3"U$Y)^!!->M\>NNIZ,/.P.U[\X\',BSR39 *Z'5T(:2H"CVH:[Z9P
M.9%M(EU0-0 78M[6>1U-8*[I6UJC;T_)QS11SI '&7R+ZYA7W5\=[JHBJ>)"
M"I<5")CC0L$;W\:CF#,,XGART;]YV2=FH7SW_YA*F6-RN=[%$QUAP%9,6 L-
MCU<@52$XU47\!^IBN[ZI7VS2IK[$E#A:"L>BJ]>[H<\R<T"8/9SK(>KR46<G
M*R/Z'GK _&3T4(\\OMM&'I^"S,"P[H13BW\LL]CYF'H'\TB:CM@):AH[:^=;
M[:F&K25!M)VO")C9AL6>A^.^#8MMPV+;L-@V+-:-.>I26*P6PO"3D--:F@S!
MZ@^]INS9-P,9U$X3)P'S:2TJ5=#<=M8YV"-)[SKF  Q$\Z 8HT XZ-P1HS_G
M,K..HB2.[B@G'"YJ+WB?E<E$:,9U3L\\D:E5&=,]QEL*J7'A=,7I?EWE3ZH
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M*-(L=1JD>>A=.?O7^+):0[$5&QO<B)MVIR=0B%LF58J<;:$K3*>ZSV,"RS1
M>R:$W]&WKNG6JRB_<^9%S&N:=GEUS*O$A9V4&(-U4HKJX[2MAL=+FS1\%2%C
MAN/I^N>+:(FZA&AY!-!R&L,YI#,,B#_R9)@R$>OU"/L-$48AYG6]/= [42R)
MA1NJ&<A-]?4&\.>K;<AQI<*M[1QU-^ZX)5->P35/J\03.N%&?&%4&3N*HK11
MMS4UM*KD;I%^7&-IO?2<&!0<]4Q,*V3_YPV_1*. "*3,Z:_-#N/;,$P5C1.P
M*G06;V7%O8%ANK7+D;.8E@Z>:NJX(KQQ<=MDPQKZ]7A18)Q^!PA7Q>/[!N*&
MK-_.=+T-$9:$<)ZM7;S.*:_8Q4=[^X?+#6/#EPEZZF;=?)GM4&\UI_$IP]F.
M=;#1N,R1F]GFJ90+'$1(36.#P>::W8QO&%4Y&IS@@$L+1;>O#&K)C2CV^#Z"
MFY"_"E.$_0O#]'>'B IC&_#M"#^%(Q*?\A]XPV(2\\&.A EU O=N!8QU;F"M
M@6,*"&N:M<9%TN@NXKGPXC]"26(PSNXBVIHGYA1S24^=9SD/B[ADR7U 6%0H
M*+;DD%[MP)MG53O0F5/IICNGTBH-0W'SL$$'^\46Y[FL:K*=B#G(5N^NF3RR
MRML&J@$.&B[]<V.U3EA5,S3&4^_$\_GO%GYK!*-+\+4+3:%3X9-#BU=(!3O?
M*DD3L*VW49X*1QGF"IP:RF:I _,$H=X]#B:^V%<3T#[B*E:B\^U%O#7B2%,4
MGI/\<_>8PBE/=9)HB#-?X>G6@9%[POUJK\.DIY904 #)3!_B;T6O5+9VH\I[
M-0)6POD\ XM-#MI9)N2&&N\:XF.Q@0'<?]D*F+/XIUA!WRC574!*=#6>=PLB
M<K=>@HI :4MQ&L8)FNR5G),KKV9'6/ED^69,MG! V,UB.,UL$&SI.?;XWI)\
M(E6M,S4N;MRVI_!8"N_&@>WZ)Y4-NA4]NT8!>$SWI('F>7P7)]&-E*%/2JI(
M\6KEK35<0UD0KKW*BAKCSW1VD')YMO\/CE+FJT[:1*Y;FQHBF$."/E4\&\$Q
MQ][<N6.U^Z.3HAJG LR\/@<AF2G654GP,=$B]]]=VN)\K*)$(EGPSWY7#:RP
MW3]R=;SX<._MFDDTM!#7=X4CQ T;XA%IUA)5OZWQ4J?9,CFN<?A2B/CI EP]
M2-TXPG>0OKKPN0.KO\4FB>;AFNWY3_/,Y#+P&-#DR@UFBF.<-<@J<F@W'A_T
MMYA&L*+"NGS'> AFG[<$F2NK:3Z-%HQ<>.*IPD@+(LZF1$KU17G<I,Y58M7\
M6-1\:D,C&N+"\EPY$-CCP5IV;Q\U],B5$4AI%>T&#IF%>8YEEU*A2<SDX7B1
MY08BXAR+U=FH4NY059_>N@D!WLL9;\5*1/"1&[>T7*R\_7?O=[.NP,+M)@46
M3N+BOR5,&^6/AJF1TG7WG$!7$M%;RQK;.!PD9+;>AP7UNFE[)^=(HH.(*+U^
M#N3Q&]7^=8ZO>@*#7>=R"."Q9]&US;ELBI(R1!:#^Z-8%)B?4D 'P?1::&4;
M>$(QM$UN"C](4YH4&Y%+BIJ/EGI_VM0 [5!.4)W>QP4'J*+9/-%L(=MZGA7<
MR%A+RMBD$S1L-+9X %P0L#JI-WS[KJW@SQM8:]%B?J_[*MYE\413 DRR<B2U
MS%4B,H<5/5R(D5$L51Z&D=V1?+M!/0J-@C#IU+Y=*QSF3'P01AD.23EV9U E
MR8B^SN/<)T^4'\&:9,C,/XURS<$H3._PE&F<QOI'HMK:WDAO:\<4,Y-B81MP
MF.=9J&V $;6AM+>CF%6](9YN,\(O@LT]:09M>\^'6F!!/<J/WFA&F!%;N4)O
M!-3,5*^ 1D:;2]-,)1E823F,G"F$5A!#$+$*-3+<]R[.$F>-G/Y]MST\P3ST
M"PIF0.SJ#K-%O2&(O8,.IX"X/3S?;H"&GZ/^O\-IM8N+1B7))F[=K"Y[00MP
M2=,.5)=1SS\LGP2_LUP,<ZW#_KBVJ,2%*7J._:?1:D=:#=C]45IPS0K8X' V
M2K,H/YCMW+M])$N;,%&S32RW3$/)V[KU0*)IE]X[CZ@3$I[C=:_ @MWO7;K'
MUANV4:6XY$-NS/]=SX0(EM]XD1F+@[40]>2R-!=8OX#!,E3C-1YP1DJ9VCD)
M;"YRAB$47D7 UCY8(<(5N DZC58)GF3T+>4F(O6@!G +(A/J>V>]:%7V9NND
M0:PTMA $%X+P=C,A"-T*#*!3PG5/:&\U51IR,)[L(&L_F:]T>6^KCJ-VX]3#
MR=&(>G<5;=LK,(V$R%:?)V5A^L;9K:D_F4::P!LW,,><=)6DPP-:JZ&D?GFA
M,'O%"R?&;-EVV[;S<[9]VHV?;P!.Z-/'X9ENC>_0R6^,9I1(OSV3"T!WJM\P
M;8ZN>F%A>C,LNHG#I+!9A$5FHO6UHK56XC6!*"HM SI.C.T*$6(^P2ML:!^'
MI691A!Y[(5?85I F>[[4^D$3XG\]:GI&K44?%!@&8W!XTGBL0$N#(0;S#WNE
MN)7<B'MO-B*G,8H1O#_"H6=E*IQ7!?M&8%6 '9?@C&"* LPLV!>X+29@]V>Y
M,93:9J3Z+FCQX&)5^Z+@V+5%6R?C$O(M_ ?CQ1XUEZUUY%Z?2KJR$E=UW?7&
M"YE]*[9M5Y>MIVUM23=>8+#:>1JRN8(OFV.VBJFQP]\UG)0OZ34; %[YI*<P
MA"ZD54^RV'L- TGV;7Q(,]QA<2OVQ)38E&0&/"8R[(F).ZA]HWEA)]+),Y16
MF6(4[^IBWF44AB(#&T&U(3DF<#+D-V$:_\]PJNEODA@4OG1:<'-9^&L$S^;E
M?#%^$!ZX++F+TC'QJH 2Z'3X\T+>[])[\RZ$0A\3,1?.JKO)"A7'SD&/! :^
M@'6.<)4Y/M;XLJ#_#GOH?BX_^JFWDK[=LOO5JJ<KSHP6?=-:U?C#!STD#J=;
MTX,JFTA>:41J^2;+)@@AT;Z3CMR+M$TD\QM-9#X]J;5>RN$KP]=7[5ORSHHU
M%A4S*30"4F)8]= )K' ;Y@=]JBS=#CVG^IW>T8O?H"H7Y3")V&<F HS;R%@O
MCC\.TP9'"H:=N:5F1,=7'OV'V0R7+5&#!^K-R?A[S<DJ4\)*ZH6160J'%[J]
M 96I*VX[0;J*Y)Z*^,TD\4O)N>P\#!WN!0U2[$AG\N@KX1F)J&C=!?[W)"]9
M2A.)1GD][#W);NR"E=C,-P'>^IN?H_.:GN\;U >O]EX?/5) 0]LD1TDH&(HX
ML#;5P 2#GVVUTP_G\?J.+ #N6JTWX3N0)NT+X0=W@CFN7XE?@V.$O/D,S9#T
M FI7UFEI.1L)NTB$7'P+K;CY+:WO"A>@O^Q]B<8I&K4WK-(;.DNC,2=%+MAB
M2[L79"F&EIY9#2NEKVF$+@:Z:^BUL(D+^A@[U+!-[;TT$0GFV:0<<^G,F$9)
M>G66$1P*#X[4>S5E.]KJ(M '.9''M["GH@D,2_5A6DQ2:IS-#3K&LZWMK1RH
M386%VTQ.DDUN-#*'K")5B_XN\\)@5"=N<BRU2^J^'4.,R&Q 7"H&FYJG#@8]
M#;]:]]3QZ&81HKUVHKV;O4#;(GOSR51;(? ;_2FH%)/VMJAM V2#8]W/Z,$6
M ,,L>6@=/(->W)$^WX+/==8L/!D!TW0ZK;M)8"W235ZW<6\=SYZ)U<,D<+)D
M@78Y S]RP[DC^!:\< X 1(&VX0+F-^.?.]Q J'W*Q6V6:^.4XMRZA-_O(2$$
M9ITD$3MV8S/=\" M7N#8#QRY#%7L3PDP)="'GG729J(S'2F^)"HN$IOJ&5D6
M^#CGVBNM4 LY@I<XKASN $%L^KU" >,JSVP<AQJJ&2B34S0O:/4IR&W, ]58
M(>T,.TWI:W2]6MD&&,R*05%B'P8]#DV,)D/U'^P!E$;-+Q*P8^N<\S@$3!?"
M QL&; +I'J'9@^Z'0.Y,>!,B ;_[=8./1RA/:BJGTP"M=,5-YTU]+@@09YIU
MTNE?FY*JA,04Y9IQ.-$UFPK'A.' )SB),:F+;;+,39:]V=_,9%FW>GU9Y0@#
MQDTS%S/2,>=< 65@C<#';RNRFS<8Z]XV> 0_1I][IZ 3D;:$W[B7>-P.L" Q
M1&N!PK@$F_/1G!JUHQ**:FK7-RC%%N<9\#<O0^PPQD3<0;0G\X56<,Y,T4&Q
M(R@H58S#--5779R\5VPC]"01X/S0'8#_Z,JSPI2-;;Z3T,=@W_A93#!U#!T:
M@]D!<.04W*$5J!\_+BHFF_,4CHGCC=L;BS-DO9BZQJ\?E/$L1&^E?E[^I%#X
M$^T69YS'V?RA&Y8+RUW5.^:E,<F3#&F .3])P!I]/#*&RH"Q1FB3P+D2"# '
MG,/L06X@!QJ+OC9_$8@'SZW83"M81#Y9B:K,;."1I!H\8&J'4:4F#9S8MLF=
MDFXA:T&\13$:D):%U)<V"^*$/F+NBSE5=N$@]]H+YJL%\M5$\)+4:JQ!-&GF
M6BR$%4!=5)D/:]5)H)BGE3I9*64^"1>:D2KZ.D=:Y41L1;9<']K'XS5,R+-Q
M-$$35'>)TB61._%"$)KA^/<TNR<N$3'N6F]-UIN\58.+;XRC D'#GUTE70\E
M4]HN19=I)^Q52%1;!T A?S,+,A))G#0;G*VW,JW(_![IS67D"EVS!QT&:WT<
MBR]J;KCX!IZ52@M,PC7"C:>UZ(T^RJ9E3DK^#O6'[#Q)8HZD])ZS29P5>"2S
M[>2&6=\'[<Z%>6&0C]D<^S[M^*MANB=C;RM,&W,>04-FF#^B<"_3V0D;,=/O
MB_G8)('_HF\D8;LDNB/&@TG@ZI;073]/6"MVX$0A$>KZ;!EA[,*$50X=C&L2
M"D9ID+NF6)P%3MM9;/0.$GUPI#Y='2M$&;W^!=[[%94\Q@OM"U)T*6IH5/Y\
M\FD_J;[[N^33KJ+%;C9E3.#5;4B%E:!:+YCD^ ^ X[H>1>Y:(NTO?Q^FV$ B
M-K83IL MIC)'*]BI-JY"T+@:UD')Z>9&ME8@&X_+/"<.>JY>SK51(IU'M6.*
M]IIFICF)IB'6N6P"W?7;O8.UKNM?_JY!<-V?IS4S/\$<&9,.K=@D\LO1I(MS
MY/2=,?:J5Q?OXTIM9(3+<-K8F8P1*Q>P(V =#8(T&MO-YZ4M')5)U5,F HMW
M1=4V ALNI48P.DV8Q.*3!0;1,Z/SGG [92I_!#7KV!:T6R)$.P6@KRGFK@-&
MU>QV(%!-RN]RD0R=NTMN69FJI<W3'$P-J1I:3'1P*/?-0%]*E?.$V6AP/HX+
MQP!N>3F95;_2)_=F>Y'#L1*1)VFQ/X$:PZ?9) [!@<#58-\2[.<BDGB11Q=)
MR"'+1,S$"AD3@Q%$.:?8E2DU#-1_RLF-@8DN%B"4])?^9;VAD#]LC"]%24$P
MKGC&2C@GVMZL_;79U?@Y[UL\\86#1N ?DD,XE04U>; 0!H>A?$7AX.TMPLJ(
MAT!-88NA_9(36T:HFZT4TJ=$L<I9<E>!*UNM\<BU!$J+%O'"F62:F.73[)&;
M&&B:5XY<XS]1OC Z+^BN4U&.YEF4AH'T6:'6R,C:L?![>%5U*?=9-OXOO#G1
M?E>J:)<!+<3.H)LRBTA%3=J<$)/ZM$_M#Z=0V]@&?+RKF#L-U@@#+-XQ9G>4
MPY)F(H2&WZ5Y99ZOK=\YQ @8^U,W1"4!*\^PR4;,L46X5VXYLZ-MA[LL@1.=
MHK)QZORACQ&IC"=-JE,75?4;&.L$B2B(?D,CP:1TDNFK,JKLP+\)&J?+1MH)
MX+#@Z^M8^N#A[V#_*% 5(;Y8WEP#2^Z)0TMD*[Q&86+<$N2YTV-:.@:",,NL
M4<(;(\N3DOT>72KFO[ Q.ND:?E71N :J5BG/V59R5I/3!]OD]!]75^T[JRJ/
MXO,'2\_2*N$8PNDCG8_"VO];VH'S,A_?PC7UHG7.M\+O;P.)VME*2KL9S%B:
M",[JK?AT3BW.:[ON406#1$PF9F]Q(XB?)7 ^/XW?A_C7S,18'X=5$>M)TE5:
MQUJ@*2N%F>@J6QL9Y]]-HRE'IVGCJEVI=;D!P?IMHWC:THJ"Q*&RRK' H-AH
M14F_XTZ#QCM>(C^!=T7$/W(C%57N/NH+68QC"GP;T]OK4@ ?>C]AW@O=CFF9
M+-OOJ>2[UH_1$F+22Z*5H!'H0C^A P015G]1!,OW?$PVW3S5(3OQ-T)UK[CU
MC5B:'GM5YWZ[CR6/,9A%FA:-82=.;L*U90M;Y5YDU?5\9 I[VD(RC4ULT1#?
MDDK?J3R8+0<-@E^R+'%JR(3$N&@=)$)R72=+>B3)!$[+)*'^J6W-ZPT:L2Y\
MF3O$:J]FZ;SA*G+GMWZWS4W@'%DKJRZ==,;BMN$.(@LQYGL3#:TUR'O-'%3^
MJL'9AQ+Q(%#-RL&O*3$C.=NXE+HU+J5Q+97MZ#UQ3Y%X-E!);25BJ414JCO3
M8D$4%X2EX+ QJK!^S_/P='!D*6*B2NQ6@?L*-)J/  IH"_"W7HE3D4@W3 ,7
M(^5Q86+,1I6ZG8R1I(H31+X6;"LE[@66><1_&-J7,$T)XO]S.H9")YFEFW9H
M2@5GRMA/%J/8H7?7.*M*7,W&Z+ Z*C=]"ZOJ41>Q5EQA#+#5[-AV4[7" 4QW
MJ5($NKP31!MA"]+P_[Q65[58.-SHJAS!BU([>PWMW@GI,99.<[M]OVW[TD9]
M1J6^/ZO%Y K8A(.]PT>P"4/XSUD:+QZ>;6"R>R $SQ05YG%>AJF R:6]Q 5A
MJ8TS<RF%6_RQT4/6T3'DA@0VA?LR_G5]XBAXIZZ!PD3HZ>#D.5O[%!VLD<#E
M+W_OZ8PHVSJWV'"64U>UF5+@A,X(,HS&BB2_I2([H6QHP"E7^/<D1*@^_(=.
MS<>1!MJP) M)9H%]+WR[7<,\!48CR?:(&E2 (;\[S\:_1PM+9C:)"V,=T/FK
M:ZN1NFD'*TNBKYX9EB39.&0<*"-=R3--B02*?H6\E&C9(4(773M;1EV?%'0E
MJ?"<X>#W,(%<QT8- 1S,JHFD!;H<.KW!S#Z,Q3R8["BNQ+2Y?Z]KY@X;'4ZU
MBKV5O@E":&'86*N.EN.\<H^B!P;,\O'!!**7%(?)XF'IV,Q5O>!;YLQ.F1Y2
M:J.;$C8(D2J$ D_@G$N %IF[8 AV\="%O[_5?EF#Z'+"SLE[FUM( ^8*Y;CN
M?N(:X_[O)*!H@UQH)Q=<[W*?ZEGCQ=8%-C$7.!CA7+X,WRPC/V)US?=<B*2G
MLS[5/23BH36#QZ*0EL1T+1PS34LC'A &Q3'K7Z>1E>)4CY=;Q[HL0S5<XY7U
MU\@%-%.:RT(6D^/(:(O,X8I?</DL^WD@>%0R(45?"X=/09R&"NL%2T^<._A=
MOW^NUWM5(()%.9MY("VJP0H=FEHS.JGM]5C4VJ\V[T(1/3,O62Y]/&P;#SV:
MLK#-YK'"(YJ8NE:ZB]S&;DW<[Q'6=[ *8.8+W9 6[O0A_%^83[*R4!\-X2 Y
MG%A8I^?!-*O%J&:$A@YL)(9PX=^6P[_NI,E@C:\61X5AQAND=W&>D8\'@SW5
M4#%S$HDK>F\#PBO<G5SE^*XZ#S!RL^!T%.(!N)!UIVPR:"I3<YSKV47QY\PE
MAW:=AYJ"%@MM&X4%4Z9@U7^)/ !<183U2HLLK[#KP?]D7+<'C[B!54@D=ZQO
MU[(M8]O9=R&M?;^E'^C&D"H?[*\9W!I4"IBVR6\O^7VX37Y_C\IL\?D->RQG
ME+,6+1#86"I>\,U6?B5IIH]\C,^:P">.:%HF:A87H#XF):JS&]"G2%YP W/'
MQ7S3/"PG! (?A9JF4-MF3>-'SE4^6 S7K4(!L85Y+3W1E]WSN"?6BM155FGO
M.Z_L#M?:B8X#S2>/3"+16#SM#*5D'=%I8F* L%O(]X3Q>TX[2D5[O<.!.>C1
M?N]/$>I*M(R&D 2.L!&AOQ9LRC9:L@YTF@_?AHNJC&C-Y,:A^@?U:3V-0,K[
MW!A.^)<?::-=H02'/_"5QN$\'$O1,LIUKW(9"SW3+Q:2-R'"XJ"R=?W2RY!8
MD;DI5)JENZ MHC 1ET1CFM';?804<@N._(G@R.M*+7180<,C!%9G5DE>,LZ,
M>L6YMO"APGA$V7RN 5]&,,T"A[T5(^VU]C8G>?*S OTMV9,=%QO9C<"J1'M=
MA=<G^>A"C-.O="JP4S>%)S0Y%HOZ,G&MPG@L_@8-%6,ME"F)OUS:+2R9! -C
MTMSK%5^,'TB%$98HWR.".,TD@8NYZ=Q#]P5TA#F]C2XP$@@>YHU0AG%@HWI'
M ?[Y]R("?H)<LPE@[RI(9@KY+7DBV2X/O:;?VSH;TY5IXL' G>YE\A@)+^E[
M>\(US3F<(XV>X).TG&$<A*$F' EFJ!U(WZP-[R6AG<'7.;,"ZDX$A&")THP&
MVG)+9?E ^S<W.?5=JMUPQ[,D' /!MNSD2G1]TKCMW6OZ A]?D*&U160^6JW2
M,'W(&^>T:VG5:"V&X?.UQ,9=LL1,-GA9WS6-6=8X<(>X;&LAK8(O ?5T%TL!
ML\MGG]5UMYYK@WNJUJS@7XR@;^Z@I/=<6['P\]U8DRYM+*_^JX@6BR0R7BB!
MD)WH@1M8J$827'B7C9IM4#1[K=N/3G@,)#1G,L)N.B\79OV[X+2@(11K(ML)
MQWN(I8],*R?4U!ADRNET=W%#,1+O^\!YL?>,>&L. ;:_;#0TT%QQFTU=$JQU
M3W1SAG!F;M><]^KNS,1KIW'I[MS\9[US0PYT4>G%W$BN*-UBV=^=4FMFC:"D
M1(.&P!3$G=L ,A#0E;G.5IT9?$T!4U0@(T?&I9(MN2,.JS-B2$@%3/ZK1DK3
MH-<K'H+Q\6GD1,^>+7_CRGS9QNL1Y?"2:-G3;79L*@D3)DNU[3ITNH_BNO\M
M8162!P\#U';KAOQ/X^B=Y,FJ0$%$^7&QO)<Y,LW"^):KWLV\8NC&>PSY*8))
M)G>(%-H&+]IA#N&"8H#QU(.?M<F&B2@5E?9T.@R"7+<%)9D$FT=?2%ZBL+V$
M#$+1+UKQ_.W6G9>[CS.5WK(#1$YA$'=AG#RVCUB=8&!R$D^G<#^DM"%(+6="
M'9XZG"ULWNG=MYJZ-)6:]12.: +KW-#]*1Z7:%"0$?P94HOG]=VG XO2]3-S
M[H\@L\RB"!V-N*I*U/@KYPD!1V(QK!C3YN0:X[M(-[UONU6C^D>\XSR/9T)G
MS1!904A68)$^T)*:Z(K$M#[2#P8T8%UU!S\B8\>N=_#5CN&YA^<4M8.G*5[7
M"TS0MG+:$8@CRUUV&H)J<,9X];/0JXAKQ3Y0]/CXB4N@:QRJ-$Q&F3J5<@;7
M;;ZTT%M!9_L9:5/%MG7.5^Q15(7Q5;SS9AES3 1]^MOP2D!Y_1SQ%9%T&-'=
MC&FETD6."G.+:',1;2^VB+8_+LT2US-H$SE-[%%E@SI"ZB_=C1![U&A+,_<=
M=FU:<%^.0LBAV ?@/[UM4:;.N8?WOHV2":%R^1SGZ,T$9/D!22@-,SYIAV*!
M!@T=(T(\KY,[=*<LX0RHN9E0\-'=A$ZX\37T2!LL:ZPL>-K6?726G= I3Y2#
MPI(R%6R\8MXB3%QX>&/6PX-;,X0/"XT,?CO+!8>H3"]O3EN.L$VO].FVG2OL
M '%U)?!%0T/3T310<^"0X<2!BW&LZ[':\7K-L"<HTFS#D9>HQ\UOXJDLR<2:
M7RM*)MJ,4]<,9DB662O3!QXF"\[DZ=2SN.R\5!2_Q4;8"D53(68JP=I*Q03+
M[P<JGUPL9DP G'B>,Y=F[[M*L",@C7Q#6\/B<<.BH;R5K%-7W[8(\;094QF(
MTFY)YX!XZ"WM!,>=I?2ZMS4['TOBX6!QDK!K-[\:%U?+0AH2,J\(*^%/K.)9
MHA3;[OL=52'3132HZH<_H!"7NP[_Z^GBD()Y=<4O2Z<Q)C+CD%[((52HLK;H
M7&[1H GVGF]GZJA+25;*L384 _E=ZBML*+6.1RDU JMR.;=CHETHA!RT!JFM
M%4(UU\@13F8(FR-E"5%3YDZP$W]E8SSDM5(T@,%D7#P%=W4HQK7[@UTD<^H2
M)862@9J7H#>HVD^.(8J!8LV!G'&\076S#BF:JY0VKEK[)]$"H9BJ5"#R$*5I
M'=;($CM:4V&?BW38!BV7(:ZPC%?L Y)MALLKV)MRV%$KJF;;S1XJ+N('^WD3
M263#?JDJ/E_D'I<TT>:FP%'A _*)U/31>='D'$APLK'  <:W+*QCSL4]-:Q$
M,5'W>UT5==PAGF'C#9#LY*&Q>1=Y ZPY5B;);PA>A&!QYIKC@'<0-2$0#G^>
MC>5)]<>5@E$#=IG\I4%'2:^;7B8D$\KFV'V*7E0XQ<A4YK)2N;"W:J&T4A6%
M$JQ0"QVXE= FGZ.S($MJHU<M4M8EQTRE]^2RX^>+GIIVYV _VML_;#K9";,[
MRNZBQNU%YC$"FXTYNBDXQ2T<I#8S:W<B_8 #* 8_WM""=S+YZ&\N4'7+[^'D
MS#AIYH3@U'7X-3*&%?R!^C>)H]+X(73!H]%U6SE5\# U.4:S#]E];!6(S%$'
ML+X28O,2I:/(G>)V1WVKKK;JZEO1#*M&\X6PMBW0M97"K13^ ;PU"%PWYZ:;
MI\2D%';<NV?4&/7@X.=,\'=A'_T5V=DIF7D:WF_:$C2+V'6="$SG,IU.HPT%
M7X9,C'F6+(;FAB:)K!<.75BB:R:FQB[6\).H2E)M.:J3\-X\YVHAD5)\X2]9
M_GN[[/\I 1DO-P:0T85-T*Z'?A*YS'?10U=$!L"!B^>AA@;$@&@S,4Y\W]%,
M5%PD60'VE)@6823TI=3P!8.=$7)6YL[]-%[0:*DXI1YX8 HG!@]>IE$*3N\X
M\@!CG,)GQ:3[Y@4,H8TUW;'^F60VIXH5:#0+XY0[_9C4H#\2[0!JD _F/6;S
MD*E)=,B2+'.N S3/EV%+(M49.0]!PN<>Q>;23H#.&U%&J?I"!GM!<ZO\V=7$
M^!1__6:*G"Y(9[M^>+%!^F$(F^2&/]ZT!6A6#WT0W.CK;3R*%VWTI69G"UZ)
M]0.S09J O#0\];(*T6R43327+N8\D&[")+1P[XF3+*&Q4;2X1UQ%1F74$BNK
M6D-- ( *LD$K @;PS^$)$:$KX"T8;F(&4=1'47SO83RCG?IR@W;J->)_-#CH
M.,JIO^<P)>;>IV[?C<H@=:_-P:#>R<"@"?$<IZ41,(B'^S&4X6;5*#\ZB:;,
M.!<EV3VR.7T=1W,I\W&O%5S%)"[&"254B24Z:R3UXT_)TO&^E8R]2]V,JB"E
M[HN<G:4NTQG\8DP?<@T,=14+$:F"_Y[ <0Z7L<<G!6:V^.B.2AX: H<F6JB+
M1XB'0#?-D_<J&>A)S8PTO"6F64"K9UJ;6)6&"_R-Q6;9&6,W$GU*LIG@<;]'
MT;Q^G7N_+2_/4I1(O8V'VZ;0@)"F4J)/>*B,&G;4A1"!K? )NO2P8W!I4&#:
M%D88OOWR&"R#BPJ-EB C_*9,0JK*"LO%;983X*[,J9$@)\ HI>L9O!B(P%"W
M4ZC#B,QDNMMT0VGB&!*=%U&GA()P[!=%-HX-#\LP!7FF%R0V%H(7@NSWB%5*
M,/>A;OIF>#9)F>R(&F@"RH2EX JBKZ&A?1%:69Z*49C^KCL4APYDBF,NPA;>
M.%?2B(XJ"IR[$^-Y_7):#T0VP%K.\(=,C._6W453Q  )UAJ7UD^SV[[Q8N:P
M3:-+ZARM4"V,<OD:)^2NP+W(]#,=#GN:T+TN-7'>!+$IG!?53;A$LK![5Q:E
M(56C<=6;U$<2G*,H5EA4[-JV.>NZGN6ZZQF2>#I:&-'%=BI\?]=K*Z>N-2U'
M\QZ-7*\? ?^'O7TS<JBI],--HE?0;-G2.[*_0(ZRMN D9%KME& 827;NXIXQ
MP&DZ'%=#(,:5> %6I:-,\!8D SZ<1=Q2.=/8HZ[GW]1/M,M;*[AM:T7;9X]X
MG"]LJSTE'04%%VRLJ4=^X? PZY1I[@7-G42I)UY8'KND&P/J@RCGK:+I<;29
M9O93<1_.N;HJC^\8?.P W"KR7:E9HLXO=IPDH:Q7?T4(R]5M%"U<@U!K2%)8
M\)0)MKP=Z::-NNUX[)SUV((;S0?N6C2)D"J2D/#VIN[E&EX?$[2RY$Z6TEO9
M?0Z.,^Y9+=%:H>$#M7?BK]53HV8V[AR L7CP:O^74820FD*>C*7G!J?A-F3T
M@="AQ]3>]8VY38PW)L;7JJI(_SA29(^@FN=I=J[*B%)= X8\2[Z)?.&P(N(U
MJH86AG<8BG=OK]F,WSO(\5W14B*J=<_#&X6@%72?@R(K\[&WK[PQHUWQ>XH]
MJK1)4GW%4>0:'G17L5H(FUW9Y%+8 \J QM8P+FK*"ZJ ;0[6H.@ICQ^:#!6Y
MH#K/J%ZK'7C(T^7!3\.QQO=Y;6V-[0#K1-<??[H:7JBK*+]#]IUW8(>%I9Y[
MK9+;![>X]5KK!N"(8[-@1*J3:BMNV36:J%F68E-H*='EIZ;E;$35*U-9'=#.
M2"JS3<.Z:=BCC4G#=K@NGK?@-$9Q:PI=K[)M]I1;Q]%>FE4CJL4XG ["B7W@
M]-&KF&X<@G)"4B,N%:T6C\E>F82+D#I9ZT"<WK2%;&EYC]QD-Q(I$HW!2RP6
MT@NK]>J57K!-,SB_U9E7]S6"UH*MP#S"(:5]OD4/'>R*\9Z*<W(LQ-F@+M[K
M]@0[R>/J&"<=(')5LX@XI*G7LU5S>23-3.L$@'XW(L_H:?5 E_QFB6$Y*@OD
M5:.:"=</TP@%S_N4-D@KV;=^O,>W<Y=8L"94YD3)1@\20E[A79]1ZO4GH66_
M2^JU/T:'(HF86Z/8M$5HAW/: (]Y0UW#C?V*0*9OPT(H(#&6Q'%:32 G2<XT
MNLD6L?@+ME\M\TPZ'6OK2(Q P4F)=[R+\T49M5W$ "F)Q]_&<P?%T%Y)SVW$
MBJII0U6N9*6D$;P<\N3I*VSH1U]"FYLOPHXJV+@CB2BT&DJ(:K3(.#K&]F:6
MB[<X7N&UTDS]AYJ@(?$?:@*F?'7>SF4#,!^VM4]X1KKAU0;IAF/+QO,/)Z.X
M:8O1@K5T^DAJP)#@A>(\C^ZR,;,#EZ.9 [>B?O1%7,NQ<GQ*@[,%KHW"_3Z:
M8,<J\ VPBQXX]+K!.SD, IS0OPMP!R!1#7[X,4QA+RY"#,7?25:G*.-%8*@V
MI<6BQ,>Y$-[/ZOAUY]+9V;-"*ITNU*!__$&=OU?7'P;JHG]Y/1Q<J0^#R\'U
MN1I>7@Y^.S_NOSO]HC[WA[\-K@(%'^.5[S^=G@ZNKM7@W]>#LVMU,;C\.+R^
M'IRH=U_4:?]SH/IG7]3YNW\,CJ^'YV?J\X<A/&5XK3[VOZBS\\_J_)(>TG]_
M/8#_ZO\VT#<^[7\9GOVJ!_3;X.S3 /_ VUU]@GM<?1I>P]WIMH$Z/NT//\*_
MSC^=P8WH+[SUQ>7Y\6!P@C=Z=WG^Z=</UVIXQK_OX\67UW##$[HI_^;Z0__Z
M^S_C0_]*O1L,SMP+^F?PO\?G9_!F0YRY]^>7GSZ"\[Y$.G6VE>B"JHQA+C_8
M4X5%-\G4J09I_1@(Z35:P426#)8>2C<WC$0O7F,DP"K4NP,5^"AFY[V<(SAV
M\8R4^.L-4N(Z7 K"=,&I_$U;AR?K;W>':/B";H\!L^'TX(B='6,W2RTU/HWR
M7/.F;$!@X2?9&"T^,V9?(EL_3WEZ^&P:YS#AH'=H,>(D@'D%TU"\Z;F+=LJ8
MG8W+S% CH1Z*(Q,G#'18E'_H&/@3T_,6=DF.ZZZ1<YP]MJ0]=!3*NJ*3NAE+
MN];>SWLKGTKF!!+=@UC.*C(=*<+)?3+A;:8+Q-.CL#I+[U\Y1)8<<-ZF=9I+
M\H-U8\8R24#(=-;;K71AE [1;B_"WZ-4"(<2#:*G&A%D,"H(#*?'2 /#2\TW
MQC$DH.HS.O;>;-"Q=Y:I4R2KDG!^:M*&("97(#>;MBK-6_+,I36K%8-(L&V6
M30S15\#<63G#>^"R">=HO/)5IS"*<#RFCVAK-MPV-F>2*,;Y9'S<FCTL>U=Z
M%7A<8 KW'K/[:1ZV/_CH42X0,M$(A3GTJS%) V@O<\WR4*D9R_QZKB7QB#]E
MUO?5QF1]N["3V_7KVPW2KQ0 N"3'_'+8/T5'_Q^?+K\\#[7J!D&.+\&KOS:Q
M$ P4X,?OSB\OSS_##/SS[/PS>/VG7P+UV_GII[/K_N7P] M=-SS#:,CP_*Q_
M:D(F%%:X')+[S_$/'>[H^S.)T8'+P=7%X/A:1SQ.A]?#7_L408&'7%%@Y!-^
M&ZA/9R>X&I?XJ^/SLS,=:!E>?^ XRGG_3)V<'W_Z"".ZP@OQT^O+_MD5!S:N
M\&?7@X\7IWV,VUQC..;=ESWU_M,E_G?@OS1_JXX',"GO<5HH8G)V#B.^@$'#
M,V"8\%KPG/ZO&->0-VB<TP OPWC*U>"4)J+]0@RAF$<,3@(U^#?^<073"_<X
MQY%^'EX- AO!:5[%S^>?3D]@O-<!3AA>,/A-ADDA&SO3@;H:#/Z)PQJ<O3^_
M/(9)^S"\4E;\>2WA>UHT7L*+R_/?8'W.S_;\:>L?H[2<#DY^U5/6,#:2!XH3
M#<]./AWC8N##,3(& G7.S^__>CD8X%J"N*POE=N\>X8TUO[IL+_>!#>%,/5*
M7+$DP-1UU,F3'?L3SX$6+V_35'CK>7KXDXB=OLMY>A$N\CA;J#X8WF?47G#3
MUF%)F$ZL<IW5:T0=[$A5791,30V-1TYOS?N>)JC%/HQ37;1NFS!2W*_,$=UI
M0'-2%26.$3L5GZ[ZH'5!99]?T[SO7",_LAH.AQ0M+4=[ZG1/'>R_WCUZI7:H
M](&8>S)R5L['BVP$CSM\%:C#_?V#7D @^!D3<S T))XQU +^W5,[^,Q.HFX<
MX>L ZJ9'S'QQ82O9L!7<"*N" G6']]3M[Y TJ0'HHO&3OEP$ID>$O=YT<Z!D
M/U44(<N(C1W6LM+U6@UZ)A7S@N^<W7-H2B1>@,XMWFOAU.=1X%)&_E#S3^L]
M32+E+-HSTMF;1(1VEJGW\:0<4[>@D_*YL!#YZ!DGKML G:5P$85OS79YE%9<
M&2H?K*LM4UW.5+D_Q:0L&UJM8,L%CRV!OC@ -KH0/_L'85-.HW"B^CD,]X;0
M,_C-%2P%Z!E-^7.<P;;#:E*-?EE2W]&(K2&]0#79H4'L^8 ?FEG3QV5,G7 "
M#(G%,U.K8&C=[^,BXK#7U C>I&1DG@[*ZW6HOCCJI?5MKK46.OWE[TTKKK7S
MLC7G2]J7G"T5*0_&A="L#I9_AU<_AY5K[)5L*:7<?4.M(=S-\8Q4_"9QS%EX
MI*UX<&!1[\(XV1T2_J>OR<O>@^RDR!6 ! F+>$&0P6>2=&]H',0)B$J'(!WJ
MKU6+>QQI3@N+D#>EOLSGFF* H-DH<ZW1J#30K:!OP'H2M7Q<H7#360(-BTX?
M63V#H[+U]=Z;!4W%M/:I,58^%]&XS#%!K9$(MOX=?_DYCQ?1[@G6]HF,@:5+
MM'(7>.J9T]5A=+B,*$& U_0-$X+AKRX,ZRBY/+J3BS=#SL6<XQQ1K?'HX6]_
M/7KSRU-$=J-*6+K'NE2I3=1R^JA02!^IQX1"E\B[8DGM%$2L;;4ENT@BHO/P
M01<+Q O-%/+4O<.,0S#\9RM.':R((EU$RV(2FOJHZH]U1KPF$DBHJ3F"J,>Z
ME:L_IA!>=_M4VXF[LX)'>Z]>X$0@F0(RXPBQ*.)6Y/QD&Q_L0PP')(FG,/SE
MI*WW?!>M0ZMVN'?TAE=M;'4TKDF2,-)"$447?1C4S(.4D1<Y%WSI")/NZ<4U
MY_=(K87^HD;G+M>Z ;G(("J,<I+.B#B0;2MW'[SP>F/ "ZOLSC5MQE$>@T%)
M0JM-9K=;)C(M"'YVX<4RB'*"09@$[]-!EE!LZ)5WA7:[PS'RCS&FB-&"NL\3
M$5@P*Y%75,_@S[KR;"4K:N'"8CLGRY^QONV.PCUXNW?T0ALZ=V%N20DI NGU
M&'85[7)J-:5O\)V<L6<4L]DDWF]-(#RX'%[UU4<B>'Y2_&6CO(_N.;-NRA>Y
MA0Q]+@<<[BG60[P99B--L*#(I90<16/*QNG[^#R).IB!+=#'V5V4\OU,.?Z3
M;J<C,+4?C;&=>R%,ORTCF4H,>12ET33FEJV/4I$T!J,EYVUO&=YE,:?\L!PW
M*T<<9H)OZP^M)#HY\K50V)!^H9Q>W=,,4Y2$&);%D',3.]-L?;R?[..YF>*8
M\S\EQ6,D+3]/B%BOB!:%I.75#IY: EA&<@KAJ()_I$J$"<U>[+P\[.$7K -=
MDXL^)I'(U2S+06Q$BBX2Y+JH$@XY8S0-L2,,\C*Q,>Z!N::!%&<U:"#3D0()
MRIH;+B'I7!X(()M["Q>VN7!09=7A=(Q'R_-\Y;5# JO=VTIZ%RVGV9R[JKC=
MT%WINK@>%)91&OY2;U[NJH.7:B>48C![$]1K8SF\O6S8)$*3CGGDJ9-Z-(]H
MA=1_2U@]ZL4XS[-I1!S48<*;!@L-0M2MO8 >_/9H]]7^DYX;IW=9<L<%%IKK
M&GF]B908M@T6=@M?L7G(_N[!=WO&/,N07+R(8(M1R6WE60>[+]Y\X\.(NE2X
MN/"$@F^B@GLP3,&6*GI$\(H/>;6K#E_\H>7:O<V01;NV*+$+@%F/YEE1[_#)
M_6=1/-W1/,;/0\[BRG$9IE6A%=EBYG-]B/[+:(@+5T/T21@_LC ^<KHBA$+]
MQJ! 5F '+Y'-^YV,:95'<,\'O+$S:/!?I-&7"W1TWQ/V 47':@(?>>(NL!B1
M\^\CX&KGF&DW']UTZD=MNX9AJ0(>41AP7Q76690CD#O10\C L[AE0HV=FYY9
M2G\EV9,X,83((ZP/-4G2RH($;4^5ARHB%VI[4!Z9X4\V3=\]Z]#676<TWN'^
MWH%U#NK]9[B$DSSH!\GPL_^+YI6$6Z5_-39LR..%VZVK'8P:IY0Q0!8H8G #
M]]80!#N2N>6U_(E97(_!M4P3Q Y&,8D$4C*CK@.;#$TK++"7<RN>86,(." 2
MY.Z/QLQAH:]#YK."O/UZCPX'M(R,R^9OY$DS#+-A^A29;( N>Z.^6WG8@7<L
M3LN<I^&'A9?4,PDP;9-];K+OS68F^[K%3_T#8Y:MDBWAL=#!/3=18W.PK&I$
ML]<;V28:G;6RW"9=+=DJU'7YG8&%U_H"<8I3@&&-<]F4V R:X9KXX<3P29!J
M$!P_KZKP1O2>KUDP[I)9L,%LUS\K@]C:]\C+?NBNE)PIOK\%T[@L1+)AWQ%D
MW_^%A .*9YTDD9!)-X7)S5.L4Y9TL$BXP9G-&@UKT)TR@;JMJ#GM,)-C@DQ.
M5U2=I>X9/*T#"Y=J5)/&84KAT,T.Z7OZM]3;[N7;UT>V+RO(.D:E+B,P9TL\
MB"84I4<^7WP)L4GOJ9V:G*-2'LFUN:[.X;22?HZ2=),+[*G^HOHRQ,.TZCA[
ME</=H'56F6]X4'W&OOW VF[A;]_"%]>##NU<MU.2F]6JYCD$O28FU:>]JSUU
M@AD9T['Z-!Q1?6!A!=/^6L=DVNK"5Y7$5_N^W/T@1VK5F7Q[\,O5\->S_O6G
M2R0*1D*3<^;\A>]>M)^0?TJW\VV[V_G_C;+) _SK=C%+_O[_ %!+ P04
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MB)XBL:#^BHQOA/:R,/!Y'U3'1-D-U,1N:M%"+,+-3+TW%!P429_]\O/>\3M
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M0A&GQPB867GTZ3D,I3C&$IUC:^? H%)!- X<I!N#U)1$1^")I(RR*%8"4R&
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MPXH [DQPCYU^ZEW<:M;6VFOMMSZU;X^78\AE6HKE- 7+^>_#)]""C 3;/%Y
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MW;8_8P%'^'1Z<_U'I]O#9%,L 7/7Z79Z=PWV^:)SB9FG-W>=TVQ'O*41]KF
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M*NK#B[>,=$[_6/M@PYS&3!V;-9<6SA"#"[S\B>H:TL'8! )Q[%"A*SML)71
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M',R'%? XF@\LG-2.R46.29O"6+(-*B5/+M2 2[AO*Z[GE08F:)ZKFQ$";PL
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M$S[//A12"8VAX!Y5&G%9R <BFMCVVQ5#%6D:5Y4'7\+"_+@(@ C3.1I4/0<
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M0U5DL@-*!52U7:RVBQ5":5=[^&I K0&UC(!ZSAWMO#H7-3']3C_:2L/<-AY
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M;MQNA<X;"R.E@Y5T]IBUI9M7 %(HC#M6?:EKD296:S07]@.71L%P-[2/]-'
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M&CXNW'PUB.*F9;B[18,8#M& 8PM-!*KC864!T@ PT'D1S&16FB[4K#.W3 (
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M^UL:^%HWCK5?ZR$O#*-AK,@,E7K3R@*LJZP$O%+34]ZYF<WF2@O=6*=HFJY
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M)'.K.:179Y]B:W^[._OMI[V74O6NH4CEG0B@]F,9_O'A73#*8:>P#Z< ?3B
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M]*1P)=$H1SZ$+0(@E*U<1X:H"G;)A=H6%T@W:N&;YLE49W$ XIM^E0:2"'H
M;@Q<;N*:T#\UK3.2V1\)8I$% OS.Y< "3*]%"WJ9)GCWC>4IW(/H_.ME-@&M
MN%TKAQG,4-R!]S6;,ULTT@Y'@&T[S-\ R,SJK;F!-!*TR584M-,=2C(\-I*"
MH*_\,\]&#7-9K&JMYUN5;"J&I (#42Y,E$28G3HQ[,=*#34H\-TCVZ8K#GO*
M3\?/]MUCVG&AC$W!K#D,TW\#P1]#XL_T,6N4!Y/71%07PO A5W,OFGR58><C
M:LBT5(8 5&Y=I.;VB1)NZDY-6JM0R@9;SQC,958CBA7I49GHJRBQTU+K5_/L
M:N^351UU?OYU6=9-%0X\QS)5A;[-H0%3!PN'@FG%U?'2P_T&)EHV<JCEC<''
M<NHPN[<9<ILB_;I$>K.NP2N22J*JS-\43S8E4F!I<-B6F'^),PMNSC:DD*[B
M 0FU(?1X*&^JH5Y_Q"A]W$^M$<?.'HEE2IH""ZZ8WI6L<;H_#&>2I@44.5V6
M1:F&/^J\:>?]I%JJ.PQ^DBD",'@G^.%'X8==M.G<W'&#OO PO$D_ ##.6YK$
MHLK7EK2E3SX8[3"@12P59349IXDP)?Q>%C2<D&E''EO>TYUNWKZGQP/WN3H_
MG++Z@/202NIPTMZF 6FM'8H2/AX;5I9#C/ !Q/:CTF%I'5 T"'.(@/CGCCJK
M#'N#VF&^8"G?Q47^/P<1OD<1SM*0PMDW4#Z[NE!G>QPM\W0&?U[>+"&8H,GM
M:^C72NT3U&%? #LN(G"BA!"<W/D2J]7C*"VFS6)220"<PA+(T Y\$-8ER*PK
MGVN:4C[XOV1 MB\!=?O+Z$H9*F4EQ6>ES3;4:0EA=7Y@!EUU$2#*U_>*")G:
M=MLQ+&4&HHE9E,B?O^*PE#(M@<PYP?:]>IZ95 $6K\.'X<+_#><T&&I*U/9>
M&91)0,H "J#*_ H6CX]7JEM._%686.W6*7+^\2K<W-YAP2QGM]]9'#5++I!/
MORK%JU.8LS17*UM9;8=UCS:,\$?4(TXJVEQ'5#^BEFYR/\*"A[3.J7_C<A3'
MMW=K0]#C[M^]9]5[#ZWKL6DV%8NKMP]F)7?)TP7"A@.WWOU**KQ%]&E53K^$
M(Z+*R [+)'X8CO3!(9"\J:>JE0IP<K8K-T0I!W%M1&QGCH[[: @)?S=$34F%
M!"G$*%A6FL+I;:K4$-;I Q&;.KMNZE6Z\"=HN6(?7,QFJ1Q;,%!\^=I#F8I3
MIO+D4*9RSUHTP(X.[[D->'0V_7>3D<QN]ZA!K65.G,2,2]!AY^J3U8TF6*F%
M:)1[6&7*AR&BKXL,[6+.@FMV#J?A56:HM!*;.E5I#TBF,>TA\/9Q0SWL%E^U
M8KS(+'FI61+50*.CLMKHMSKP@3<WK2N; O*%2MBS&D-QRZJ<-5. 6Q4<6BG<
M7I=(+32R9H*B6+HE$H9NW*PC/#N;I63JT01!4O6(T(0P((>^3U!'0,Q=%@6;
M@W@9I(JIKUA_.Z*A=F"^9\,+63<SH;[6M83(08=TTB"PD&^0)E7Q"!+85A\O
MIC>O1QH,2;% =RHL-C7?F]JCU*TW>]^[*(NI.&)VE-'JXVB%1J']UU)=G18D
M$9;\.V,<C2B)BW<A,&4=_?GI\7%\3/_;?R-95-=,&0MU.%E+;\-B[+6%2X7:
M"")K"WF!A%Y ?I05L?DAXBK]5&("PU F55(@F%?'P&,)QB+/JZ@(O*UIB;H)
M;^\J^9(6R(,475^6>6IC*+#]3_<^ZHW5 S#=!45TW2T,OW8#9S@P"Q;AWOEL
MIHR&K%Y5:'M%9Q<8TS<0 2%BX@(V]?P4^/-)J[2>M#N;8H=M"7.,AF-*.&=[
M2V+;&Y9P/K*]Y&<:'H.8-Q3M#N,L_T9MX:N4CJ0:MS.>-<1M"*R';(-80R(%
MKORD0@!YT=')\5]&,E8@OH8,EC$P.GL71N30=+<)N/DBBX#;8OC.;]#(R5-T
ME8B8^T8=H-:&]T[$\#PHXX-;9(*Y45\FAJ[7>9\C,M@RFR,YS3/$$X+F&!DR
MU/:<U=')L7_.MC9CCC*[PZRE9. R<" KT#I%]Q6*EK.B0;I;K>#583 ''F3^
M(9* ]\P75#)?X1(0H@KP8ZLJ4V:3M+2'F>>&TJNJS'/J(2V6MDRY5TZE7!H&
M<?OIEAJ7#69X=Y3X'2V;LIS=B+P$8]8XHU*. 6@XB-!\(F9\:&@Z'?>S(N[]
MH@$B,E726MY %7T>5';W W'^X[ ,-#LA&*<>]!*^=3,1$O-7MS]1OO?18]SI
MYQ_??3K;G07=/5/JU_2B7&6H)#^J_Q^,&=6VE)!:PTMVCBV'EZCY"X2(5ZGP
M/$;758:^K4"'NRY(E\>C=M% >'NK1*J/(WW_#XM?TU7T>5<ZS3@FV2[TF[EM
MNQGB1/<43N@&--BYOH XGNZ?&QT!BS]<E!5850-&SLB9'QR$.P]6BXTVL@J^
MLN]/>0LID]C_LQCN'PSYTRXF^)\=S0X)_OL44.5AG4/W2]1 !U']%K;# QCE
MOF4UH"9"7@-4 K^0X(+V'UR'@6UNVQUQ=J >7LGTR99A&Q"X@\9Q )93]I&R
MHB"'2'V6?!6#!"R4K)E;5@B94(2',L6>J;>3LD3L!^Q>(_&B*KT >@FXBFH1
MZE&\R_4UKPZ:ZOXTU6]JM[\OH14/MFCY&%+WLSG'Q;0'JSR1J0"@NAE#IS]9
M2?@&RX]J>=<.+X#I4?-I6D&)\D?TE>$1"0&QN ,5=2VR.JBA L7.16%!V4(H
M?:')85U#A2\:4!'6; 49T/)LS0!G;<L\DM=EDW,WV>L,N-^(%XL"$_])*\D;
M'G"+-F[QZ9[B%K=PNAX4RGXI%$^;)?4/T"1HCRR;2NWWM-;<&4[)6&2:ZNXX
MAF;0: Q,K'&^7QO,X6?(YC^,$ U,4P@6=-M('H:&&<H;&R9&O<5(J*MTFBTS
MH6<%6"DC.6F78$?@"0*!2XH@-.:G!M3624<8(B)I5=W=0C$M:Y0M8/_-"%^G
M7JW)N<Z= :!P"_!K"9\J(C%)5]=@UZ,M8-Y"MNP?3975LXQ^BT_07KMZJM-1
MWMQ4#8#QS8@S:=WZ,B$@-5:.IK-8JD;AKQH\O03B> 0W,?POG?D!@#$F>=3U
M,XW&[7Q!+/QSZ4O;Y0K@"]("^ MF @'G=ZN4L!%_F<W)%PLN<$82XJX(8(3+
MG!IY8J2!VL?J!_(3I/S9N7JT.RKQCIXUSBL*;3#Z (XV>Y\TJZ9*@?QVL82^
MX$V%'\]XB0  19O.V9;IUVE&5 5+P<7BKX33HK:QXWEZA;E%>Z?8B@-5AK/_
M#6:='A>Y<H/CQK(DNRX[-D79  ,FF67FX%ACQM%#:.G$N'V,#ZD@P'(M5P+6
MN>390:<68'K^DTBK+$_(PI"%.$K&_0;G:'>(,A^/3?N>;8CZWFL633X6$J_W
M#B7 @*?TD*Q]*!&%JE7,1QQD]2"K8<KJJLK*570V/:C3.XKHZ?%!0.]10%_]
M/9SVJF!V"S3Z55HH(5U%?V\2Y3XJ/^!U62U94B+E ";*C:TOJ7)5&Z^?F@F1
MR)V!W_X9__KNGY'&2&LX/!$:H".21V?-ZK)$=Q91\MP%@R(:\Z9@AYP)F?9>
M("QH>C""X=!EP]_."2.?:C%!)+U5!IQ$W0* $2 5_F '27L4QZ=:/$ Z-,+^
MY%1B25C97B#;Q55:-,#C-./$KQ(/?!QC*;B,6.C6E=]&$M=J3,-IRSK[BM!2
M\.(62NJ259K?@ \]-8U8I/<0(F@P-YW"30&U#?6?</>LP%@/9Z*5"PAER?YB
M4)H\MZQ>S1N]_-E\KBY2@]A_$:=R_%"$&V$(P"PP:Y(\CN99M8AQ20LUT,ML
M"5R?BPPB;P(BID(L9(+[ [NX0P*\ <&8&BV)=*'E-.-_:&*"5:7622Y$IAQS
MMZ: @C&Z!6%\S WXNA[5Z89Q"J6&U>V$,!Z"?UBX1B$\^UUGS10DT012@!TT
MF>+E$$*5.C1.CEC$!4(K?O\@HR 3=(-#:.WH .=GZU1($):>H0*5G;'W>@_.
M2+5;/J9E=9$4V7\":^BW.WX)]Y8%__ERA+7%!Q_E7N5V!0FL@Z3>55*?;[=Y
MTMX+:)5-J7#D*LV#D5)G5-&[N/V!YY/N1_\TGT3\V3^)ML;^V3_?_8ALTZVI
M"F;AC:]YF;*GF189IC\Q<0^.1 G^)8"/@4\L8I[X-G9B<@.E $=?1]&GO_[I
M\8N?/T"5.GK)E^JAE%(]NAFUJ C@-Z?F1S^8%(0J!D*?<T=1P.+PMB0\VD04
M'EL_TC6RK4F+9J5Z>ZC\A<;* ZSEO;!,#\QS:Y?]D+#?9YWIV _8[\[IGWU5
M0%W]\^K5J_]G PWT*DE.?#JH2#.,-[5U4=$Q;]Z]HX;OZ?Z'"%K6WX\D2YN)
MTJE7E$HB?^TUN8T@>83K!Y6N?16N'O':Q%A2\N4UE];*UX!+YY&X?_Z@ A?J
MT?@MR]OUV#WN^7=:[RU1@OU:KB!K"C7FS",-#$!. LA]WSI=0=X(*FPGY55*
MS9"L'.SFN[M+5*GVMNQKV)[N%IYE\SG]QC 8P=I"=O@JR0%PJUNRJ8'&U*N;
M?'1<HBD6[+?>QE0-Z7:[DP1 O[J'5(Y#HRH!NC^1<.-OKI-J5DM1/_RZ4 LK
M*L8>SOYK@Y+1':'H@;#R<EN,9/_TMQV*J0,J[>3X@)S<VZH_I2B0'D3)XF=3
MNQ2*TJ#4M:ZH(B($(,C3@Z8R%XUD>OG\Z2"4R8$]'3\S<"@XX" HEWY-%\O5
M;6\;6S=]X6"LL)&(.>X2MVJ0G@:8N]V1\3L?2%CC%(QDN8TR3.L2:B6RNEE2
M<7*5 G9GB5\EV%)ED7T%**;4;$DO#WV%9D1$O)K^E[Z@O"ZHRA!;U1I*(GK\
MWLO!Y_-@1&#'SN'3QT?3PSE\C[+)?>& >>PU]D,)15(/MK-^.#)#3(G)%IC?
MJ7L#PB2!:THZ"4NQ/+/OEGG.35=AWT,G+^QLD<S*);G5%;2;L3IV\?5Y<AU'
M50/-9RK3-!!^K<X%@&UBHR[39(<KM?V785<IN931S.@-6S8!G#_9@CL'RK_!
MXEA6Z4H_G0T*TQD*FG'=$%/7 &A5J0]B.Z97A1'44$\P3>5]F;XPCBZ:#"J!
MJ=_7+*M "RE[Y4A0KDAH@ 83%^@S#Q[=2KW_2 ;D'\ZAS?T UU<,$^N$@=1$
M I0>@"FPW" X%-_ 7AF(*990[IMR-GOT5AG-7Z)_@5WR2<E;"M6#R%((U@H0
M7#<+S :5*SY>SJ8K;<FP$-0DPK4E#+4C#5PGHBO.09CZ6[29"._MG@%TD$U^
M06S<3-H.+P=@:;;%L<F+>M-TM<JE)SC]KDYSZ$2]R%:K%,GLX%*8QT_-$GI'
M8/G'4:=OA%5XGXC$CB)&9_]>H./Q26U'&BQT0%''G&QU.#[DJ@Q;F1<4Q@.X
M4.S4\-  ,;+)N@ A16H'X07JSVF>-$"3@Q3>/(&QCUP'VX]&:PXR5$=)-4-J
M+T&7@]I,BV2*[!JH$<D\I>6,L;%=60#;Y=Q4[#M%(%"S?Y$6T"4U=[P=-:XC
M ;93F4CE-'%7KIRY;I(B64C9J-T@*TU4*JVN=J-H2NW&+=>PU@N&&R.K';^1
MB$7H!^I)=;9J2)XXTEF#8N,J%JQ&P/YCI3P';'4@,-"$#M(2;Y4HQ8T5.*@[
M4)K:XS#!VU%,%J>.;'K>4OTSJ^1=0>.JPP(\#YC-65:K <&=?@!#[%#J_$VE
MS@='X7[ET]9BFO/D(*YWHIQ^L646=3A8#:97_1QR1GS U7+81E1OR8T=E:4!
M-L\\>DTGQ)EED"/TC0[E5JZK?=FA"[@#JWO>F8X#K&X+ZNPW0YH6CD)K=7=N
M=YEI9ZZAJ0V2TI5"$H<?@>-O&L'V:'&Z.SCVQKMQ@\6TC^M--O*^" BIM ]D
M&@<C%KYVQ_"/;)[!:#F>;T77-7I!EXO6FKS0,KK)_2PKZ ZL?CA-X6]<7P]'
M0G*AY229*;N_K$S72^[N#M\-/WC_A6:9)\!X>.@QL[,<<#^(C.(!<!#3@Y@&
M*Z;<OH8C1<$(*1A4-MI0=RZ$ Y4"K[BW/F/(B_RC-Q!P+!G"ER9*E!!)C'%(
M8",&4V_>ND'-7MAEHD[G%=^,PI03X".V/G)[+DGT.=9!-LY76(,[XW[4%Y"8
M$>K0I\=_D6&<75Q V'25=B^*M:T(LP C)_)1F.GN(\E7//^J?#/@B]W@>>X5
M^R_F]50-#WUEFM]@!'V'M#&5P3\>GQZ"@'N+VE,[!8(ZF+F3!-6!J1^+#:+S
M\[/(-S\1](+S>8R__R-ZJPZ/8IHE>?2N4-*W8C+L!+[SW6MW9/O.FGA595/N
M;' (;]_=-'YQH".Y7T&]*G/;N@*F^0 $%>W"L,Z,H1D+QJ,("Q%TJ!+9.(EW
MHES!@Z*[OVW+A7BA[%. /RE/K9I%.*[H0UF:EKS&FOH$(*NI>O8OO[P&<ZJV
MZ%CGNKCP[WDY0=-K.M:LQ0:,A0BR5;GW"YP0^W(* #WE^E;AE$JXE,31E(:'
M>+BT4N8PX,P(/Y51$EVXAQ%66UVD&D\K+[GWR0]K-4.CX+47$^-WNO0ERK-:
M0FCV8CT22 -\#TLY2Z&I#J4$\<HZ6B09PN$,2O,WS)S!S]\R0/*LKM-5#?C3
M557J*-_OXT_CZ$T*L#ON-$2]A 'YUK"8^7^&$$R#P>:7@#(;K/0%78+<GQ0H
M5%X?-!*G=EI1=[L)0CJR;S:EL>;T6AK^^&/4ZF@!"$9XE1%2E(MLBK!;?<K4
M,DZ"UP/5;;J8J"4 IBWN&A5KF#UV=$?\NN[)1HVPL%R^I#]9AE'H+C2"/8X,
MZ_KJ$BB:G9L^K.#OCO0%P"!]RPWP:7J9SAK8];\7R562Y<)%_N;^&:8WX9/>
MO3C(X_$+I5R/3@].PKYNF?/7T<=T65:K!^H9N\$&L3%AVCLY/3YY$9T518,U
MW#!@* QY"]4Q)\>/_A'[K_IWH_1O"M4#D;(DVE?]7\W=;WZGS)"LG*E#!H^+
M]TFE[(;')S$\_R7E#<&<>/'H'Q$@@H!_1?J^.E V<)F@6(8J1MS;X%V<G.LY
MEJ]!V/;-X8BX7WG_[>W'4 3]$#73#X=-\(EICGX#NPV^DXB$VH<?!6;@,=S>
MIC.H18*,3UI=<9V9,K=@:/]35E^H4LP*35B5FV6U]_TRL=O]&9(M!9(.ZJ3S
MWBA333FN6$$;X7A%SP("A3YY)VV5/Z""CJ/C\<GQ7Z*CD^/Q,9!- ;\(](NI
M]W]! 2J;Y.@ UP&QN:.+/:5!25V&K]TZ<J]3&^ZN"W<HKG"**UX<BBNVM,ET
MR#N8_64C]K \M[UWJ'>:TU_K3CVZ3*,KW9&+VF69OG&.K:L&\]<_/7G^,^<
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M_^(&>?$S?"97R=%O&;E\V?<:&=8]8A?2%'OBP"&5P415L#'4-U"\J_S$]"M
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M>!M"]JS+6D\8 %"^8$Y[LZM_GYS<9H-[0PQ]OKTA:O:J\\3PP\J=1"EF("!
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MJ VV,760 I"2FG&D^L8RR:5Z7%)(<V.UB.FZ1.[0.)C3I#.,R!D(]BZL5O:
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M=.P\RN_!6>\&]5+Z=9EQ"UQTG"D[;ZIFG&[MG0RU&#&=<XS.7*D3AB:_P)2
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M]A410+-N#:15R:;4:C7-R-CFJ%T%,X>/A+4S/)(].X[@C(5Z%N0(0"_7[&3
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MK/ (,8$C[1XZK#H;1GLK85*?^98T"*MI=TK8U#9ZO-5-<  TVH#&QYWIV%=
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M.K>JZV:!IZ[[X,0;P//Q0_ECO[&Q76B J6:KP>S#7'U)5C=W3S24@ANY'T<
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MODTUL^<T3:A0E^R=V#+N=*\9-.]B0\8#1@'4(@V:]=0"H;WDNY4>?Z!2/;\
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MWFG9+,F^G*7SM&#8KII=^&#6,&<B-#]JP-PDQ@# 2V-0(5LHSR]3;AQ$\G3
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M-6+MPOT< KD8Q^1.1OZ@*^0:DNFJJSHI=']T.NJ7":UR$W.6%,CH5.LBLQ:
MKIV*,BWNL>"( A_0:6-$SU<?1]'1XS6#$-HCH@JQ_ ^0N"(E3'+/&^(3I9M4
M:]O<1HNW,-<U=Y%8 T#TH*[QQUU9PI:$GD[1'$N(),M#@R3"6F_ZB,(27A!V
M[$%APX@LW%0?*+LUM SM7,A<*'%H7PHQ+U'K:X#8\*6:SH2-W[6X6^3M(>MV
MP_Z-GI*#25)\H;3&3%FLE9*K!GANRH(F#+ZF7E=%O4\TVX_'#]0IY+M@*5^7
MA=IP2"5 &_DWU"/O$^Q+M;<^2W@(R\_M?%@*X$:G^P[LRFZ63/U)B[B*N)AT
M45:IA^:(NM7;7$>PHR^R*\V8U(-D@.83='.OCVZXP-!1RI21<562JF>G2L*>
M^$I@YAQQ( OX6Z@6RN"M/U)KZ5',CO6-#(^U) '\:OW6Z6P<O0,B5H$+=#*+
MSDQ&&\YE:Z9P[FZ<&2Z4,'AFF7Q%<QOW(MV4NF]]-GK&!NM6E!%VR"4TXLFQ
MI'W/(+NM%W5U7?H7M>95W=JBZI@-1CK50=4.;E+(48CB5N4!)#$$DJ#":]'U
MS/'6$?"NK+%'@O1M H2B.'>/+C@L@C>%&=:4*.NU@FVS=;F$QE$KL!9USHPU
M2'I1JG_%/B5"?HHMS;,TAU9)GG:YH/[5K5<V*T#WALKPUG S=9.FETF<\-U$
M1@$.'\28,];YD-9,IM3D\*CUH$@_"OP-TH"$!*I*0 +-S*/0MA^AXT$! G2/
M>@;.'-.@F[]XWAYH)@R31.]1T0IPWE@1;8UZLV8[ZU3UBG;'EN]4"\:S*3DP
MTQBS6V6+"@9LPD4ATV*A\MM>19@@B6!0\VH%C*M-&$7OFD=2VB=I>=:2SO3C
MA)OC'CU:Y\QG"(%[L+22I'AD] ,XUN7+3=I51B#H!9NT$\7*8RCQ!C%6A5O/
ML0.4'5MM.TE:")KUE,2]F%2KPQ$_9&=U;%HC>@);Z8AI3(V7-:DX4P>#R=:U
MQRR>G(&LS ZHRM,MTP*"QN!>=+!H=;+H("0T S'B#WT+1UJ.: W X]+LV7\^
M.8[5"\#_(B)J2BCN=0%!MP5P7"]SU*I_/M$_-&%?@8-P]!0::%6(!$N(9-75
MCUW%UQ]+^R$1'"]_& 1',!&V #%>O[9<#:5@E0F $>JHU3"KQ1D:^TQ6]9_#
M0T[MLD'+YPQ0L8- .O#3=KH].KX;0NH/&]$]O'$B, :1M%EZ;+(:.K]BO*=\
MO OUJ"_')UOF4@F]IA!F:)N[;C=FZ')TW[&88;,C_!G*MLM85.Z")OHCA'[A
ME'.'DP&9-HDT'Q((&*7J:/GV1<,,<)&-DH,8 $9OG&.0W9V*@U%][3S0+U+&
ML7WP^?IP=)WU_J,-4SX4BK@R1&[V$W3\(6F4 :7>;(JH CC1LZ))T;9OA< E
MUM47!._<S!UIZV840LPARP(Q-<$-M3V,+K&0YV4_VT%1JVPTH=8G9M&9V@E[
MQ@-J(:V-6^HG."7(!\,?8 5PP05PZ!A%@H#")SG4%P=PZP-3\5@1-P/B1V&@
M,+!='P,5G5#M*)ZN36 =T2]ACZW;GCVH2^$O]%BWWDU^!-Q=9445EN3ECM2=
ML/A%;Z>C;,6?H2#6J[*<61'\SMMW2J@G.C;=Y@H+^VS9;JN)X(_>K7*NC/97
MR\U"TG*]SCJ?/+KYB=2;.T<1XASNO%#/0\&6]2S427@+E<U]P1&T(H =@P/?
M!,'QG >[$'LXW7(6IJP.N:H-@@\^^\33\0M4AK$/P @"\Z>':@& O%^7&;TU
MPV;:-GR[+FTX8.=4J@SV3]#-$\4SL$9=27E9;UQ0NWO,N(ONB^NC$&^OYJ.A
M['%Q$W?X.3C-P9O8'VP\9%;O! C:NR/J-+PCRB/+X#%,[+Z<L,?Z3RF?Z^Y6
MG1)8)P4PO86[=(D%\,92ZH.\PGH?)TH\H4LM?&BQV%@TESW\!"U&@EW, V^9
M23$Q["9[MQD?[^QF1.%&##1NI*.O#_0F =8MGCSU09NP,OYF%*EO_>PU-K(J
M,4AT..D)P^,+LF#E#[6=QG@+AH<<:\D/>?</P;8)DJA6=\A3#XS1<SU_Y1IU
MD2D3:S/(PV\6R1<>([RG-ZWJ&^8Z6C94T'FF1'._RI0>*-;T7<J4]-D+Y6DD
M^\P"C^?H'G/EA%:I-$C,+T#B]\FJJ;+5S5;[AT?G:ZATPK:+H'G,=M/YX9,$
M;W5V IT:D)MM9JW I.YR9255IQ-$4V MNP%]3Y)<G"T$/W;Y=MQ.4)#EQ./
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M9*,"5%F_S4#H_'0C%M*;59Y]31D 2XS"X'FC;>#J?5$>[<)\,KV%^?JW"S7
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M2)3I7/"?Z"XJAV(]+'F7$BKL-E/=59F5/8U9O CI2D6[H..N&2RJ2*]IXEC
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M*D=Q$\6U&M;9:E^ 7;: 7(;.&\:&^,N189JGQ, 5"_R4T:3!;]B^A8TJX#.
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M9!)=9NF:$2VGG*Z:A$GWYESR4>X AY(CMDO U*>\>>#92;\A)AESVWSVAZU
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MLDROBY@ZK(0VI I>%8MSPK;$M<\TJK:FU]H-$2>R]>Z![T0\QO])1R[J&;Q
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MCHH5Q#H=7!:HQ151,:SG<K8$&&<E;'/$4L9IQ=IHXHM-78^79^?L;,_RQF@
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M-B$@GC\E#"4*(S9&P-I158/?",\'GD.<J)$N6-KKN($08^&D;$)-U0X]Y/&
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M^U])-1&@J8D]%S*:$UJ4CC$!6V3HW\^=)@SVE%PMHE_MEUZ;+[6]^SB/4&Z
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M;ZLGAC8YK+Z=#JX.)#EQM30,FSY9LM3L&9F3C!]1!N%6%$^EO+"C6RE_,1P
MBZ:$$;T:9MDZ'AO\\J!LL%C7-T+<?U''>_63#VT5]+_&^6J#:-!+;4EK=_O#
M+D3KHTY32%@)=87_BXKSOV+Y_YS]HU+JC,%G>$T(3I7"X751E D"#PKA/'A=
M/-*]R>;D_%(9Y>3/GYVN.OFC"V]=6=)^JPUBZ)"TZTY]WEZ*OL5(L528F5LJ
M51V_?J17[RZH)*>P;@:MQSVE2^ZHA0\)#$N:] OPSU=IT51P[#%8YL&._/!K
M>#Q>)K=O3V,#/#!(#N?0QNC,:=P;X43YBDZ*T:KVI,Y2F-;2Z!,X&V^CT>0)
M7E@4W*:9 Y+')F=MGXM2A.UF5B)<'+)V==T)98U.?7'CJ))8[$MM\5YTV5+U
M9F4RB5'M4UK%L)@)>'.^1)(30>X)B3M]@Q3$0T_PF]U;IJXAC['G2D$%7V3Z
M(O+^*DX^POU'&8*I=8 Y5-%776J<WW,#0YTSWW@,.?QT>)8L(<Y =QB?X3K*
M<F:*@150*<6_\*%NL#-!KQ=R=H"8II#07$B00LIXT# DD1#SL)?NYEDI'TM/
MT_/$I#5C'UHXJ& ?P_G7O@9,N,X5RM*,G'N<6($QCH30!W]\FR8X^L%;>ML+
MDR_^A->FTD50XC\5I#C."M%7N,6V&WQB>$<PCBC<T^0I:Q[CR%%7#O)$I:LJ
M8C@@1V?^+#FZSC<1M;NX'!))NH"O6WE&9083LV+R=30UUU'>I"H2>2+I=LJ
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M(N,>6S]>)9UMN7/LS;NS6M\ZX]5%)Z X%\CQ0IA_9M8:N]FTX^CE*VSH^NG
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MFRK3@L*5V-:RQZ:FR7/3TSD]V@HOJ@%KM_Z-.$NID&WS(]!IWMICSZ[GSQR
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M^^KP:/?HU?Z3'=]=F$IK.JD_^&3M3?!DD3DTRJ8AFD+?18HW^!PW88J65SM
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MJ'B<N_1(RS#R@F_VQ</25LU3O>#/#59WJ8ZP8H66+Z]<(!=P'J;0!3OK$:S
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M;>L"U(TTZ:RQU>*H, 2.@_0NSC.R\:"SIQI&9FXB,47O;?QAA=;)5([OJO,
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M*,&?65N\/';&\=6W>BN92PM7$%]+6?Z<3T>'CL?+O?T7^F*Z"W/+VD8>(Z]
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MO0/'Z:3F8G>0;%MH\)#GP8V0[]@ML7S-=$EG1SM3U_Y/W?:0Z49DA]DT8[?
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M+8V+#'H9G$+_,1YA,:3H)#;I>JT@7(IE46 >$19$&S%(>$'#-4"-< K@H8-
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M2^V,<JS=K7TS>6*KF1W<)Q4< 64+M5GE%:_M2]?R<Y#Y,'7\-U!+ P04
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MO'?T]/#VT<UP^[MOQOONE9L_V?>#.$<WOS]\>/^[FT]O??^/A_>/OLRWOAB
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M?O?MZN,4,E"@ LDR#)WC/$A7D8Q4N85:]T+S7OYP3S3O:_B%VDLAY6X1H7-
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M\&E9QX)Z#_SC\=D8;\[.[CR_Q"5*^N3L^5!T^-7)\8.[?GKTZ8BBR]?,M_7
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M79)!L/EZW-_NQW_G\:,A&*9=[)\]G6[',$[^S<6&X.=O64H-HC3KI$H.93K
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MT,C-*!&#L*TSL2MU_O,.L92]QFD]'B%4;Z)=HN24:PE:< E3G]>R]^6J2]]
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MVQ]T/BQ%>>2 $82TFB4O00(-PJ805$J6>9;[A]?#;:@]'DK<)U8J1PF57-,
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MC]PH_L\1WG/M"_YU!6!^/&'>4%JF/K+I_-;WTI@;E?+>O*D+*LI(527M%8,
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MZ[E)U2E8#:4 )-F"".(*T!H]8V-" <QX0:7B.LEF6&^,QR]R@..&YR9@"-2
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MIX?/<K]P>+SPQURHSM7D^N JLA4_=4:9I,9M//+\U.3K1ZE)DA+-O@B3"<P
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M4IM@O+>*2-E4K52*J;8O9P""\)8XE@I!O<7((9)"*\\+D;P03 6)XEY89HO
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M:&55$2@#EQG4>K6P7,).@8V:SJ^:EA[U7U+3QMLO3X<O1?S)H[=/ RVXIZP
M@W]9ZGEA??(J*<<4R?4+B_3^F?]&B^=7BTN/VQLM?D@MOK2"D230@J EMEZC
MPZPT6F*IBJ2%=5%;*@&R%C,S3RYSTW1BOIM.S'6^8W.\'X<E%&Y4D-=_>]+B
MC#SN[4%_\&-BM@FJ?H7*_>7<!S'HB DBBVB5+\"E6&@9H# B@?!<:<5YWD/@
M$H__WJQ=K8/"EE])T2ALJ0I[:0T(IU[QD KN3$3?"W1AD% +QTG0&BDW)8$*
M>[G;5Z.PM5#8\LL>&H4M4V$OI3RHXL0)#@41TA9 A"FT4;Q0$*5FW.16?0O+
MNE'8FBIL^34*C<*6JK"7>FKZ"$%24D"2K !I4V%H)$4T)BC$ Y(M+"R;.5'8
MYU%LD '><C$-AG$6A+?&]CAO[_FE,\*Q;UI"S$MMPFG9U*OAH/<2[]7I'^'X
MS>JJ!OW17Q,A3L_;L<=QM'8\'EH40:=OAR?KX]@;(;?EIQP.NMT)NTU3NTU.
MMSS6^W0Y$6")4%(Y=$[X)*ZPM-"Y#BL"8PZ,M4J%7(]-6%DS,W-3B]FL*_W_
M['W[4U/)UO:_DN*\]=6<JBRG[Q?G%%6.Z!RF!G 4Q])?K+Y*-"2<)*CPUW_=
M.P$Q"0ID)^R$?M\Z#))DIV_/T\]:O7JMA@90%"Y9#RZ95E!>>Q\%%Y L4@E,
M,P:6Y7NJSM)H:3X^PEO;M"UI74G)"Y=L%)<L(<JC<,E:<,ELEDU!;1"8 ^-)
MDC"O A@=/1@FD!!(.<+=UK9H:UFXI'#):F)-"I>L!Y=,ZQ)A-++:\331+"8N
MH124,1JBPLX3Y9RC/'.)K*U82O/NFJQA[,5N70Z?]74XW[]/)_'8Q,,\J?I4
MN*H^KOHTZX^)*J(TDQJ\- $8"P8,QPA4E$I(@1E#.;MX&PG5H)S$Y?AH/;PJ
M<]!< 'L[P$Z+"\D0L5@8T,+D<@#6):P&!8(JXXDAD=MDJ&C6I$+O!:[KX;@H
MF^]2L3SC=$!IMJ3W%AS)":J<X&"=L4"MUXF0LY8B>?.5B]=(+FAN+IJ7Y#HH
M:%XNFF=")D5F8<, \^ARVFP!.J@DJM,_A8C,J! SFL7B6;-7%]C1O&L@Z_+.
M,K!-N0>TAJ%(^V%T$8!48HZ:X9]Z,>BG/;2D:JIU'_TXIP"M5M0&Q00P'?/E
M;11!YS@AJXGSCF)$7+)P25N+A55Q.8K;1.C7[LPJT%\2]*<EM$FSPY'R8%2R
MA5F4R2 .#D$(B")GHTULGJ%?0X6\ OU-A'[MCK$"_>5 ?\879B(ACEL&SBD)
MC$8+AO.,?R)5# QCI+:V>9O(A3W;!?J;"/W:O6@%^DN"_FP<+Z',* 3)6&/
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MLD_]X/ H[G4FOO!7Z.O>QV<T]>N]5M0&Q00P'4GZ@2)H93!839QW%"/B7&+
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M4D"_)-#/")/LRZ#$V#2@//LX:*X+C3$0:R5WE@OD0P(]:J/%8SC7K#[TNCA
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M"5W?8XP9UMHE0RM71_;!0)+('D3:VUV2QMK''YE<*SCC+:MH#5:18VFYB*P
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MST+QF*STC&I"6(?]5Q>3\:3GGUU,1>&LVCBK,\<=@BQ"+M<X(-8!4PZ#08:
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M4_;D<L8*F]5V3^_PR9P*C!2AH"F#G/H7&#<(TKQ*B%XB(DQ2)"1)$MU&I?9
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M'G.*HQ3_RZIOVH:O8> Z8U],Y81I]4^JK!\/S!G3F&3L>0X.QE/P;#(W)27
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M;!8^0G(KO6=*6D^CC)+Q"NNH8'V=L#XM<2R./J<#3YK&DYS]12<[R0<@@K!
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M5G9?H/!6I20J,D6],,P$+JV Z#H($[$GU%(K;"&,CQ<=YQ91BJB(B"D@3:1
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M!QS#B^F@J4+_C"U5!L:"/O- R_$)\,\V.*+)D=X"]+C&5\.O_<_YDC< I#,
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M.=2\+*!:;D70H'7(QD-FU\O[60K:4:&=R1[5]FRLD4I8Z4V4AK*XLU:=7/Y
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M7%H0,@>P@5L;A=,Q)1ZUT; &CLEJJ=P5].V[V)B7N-.4N*PX 1TU@MY)PG5
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M0B:@P1)K0R(N)ZJ-9]1GNK.G^:YB:E-4NFD@>#:1V:&6#8LM.T-DCC$N/;#
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MP+<!I,@1K',(_&B,X3D'*X(*VO)55=54;"^"[99/WZO$&$N*:*D% 2DML<D
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MZNZR]!$(6FEJ!#=5H#\"V/O2)"0;@>S/P'BP0@8C&.@0#8^T-@W9>.S?$'5
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MK0(F@Z:ER4S5C1\!C%/0W'CE@0<%+GE',TW*(8NC+):Y2MR5F+(WN,(=,])
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M2.8>,@=NA3'(PFR7TGM?'KHH.E:<D5%9KK+<0U=?5)9[$)9K]5Y2RIMD'/&
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M39>@=D[^?@NTWOQ>RP^V@,MOJ/E\F/*#[X"7%?N-*G-6YEPZ<]I@$7) @Z,
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M^NKY$3]X_P+>T< 3!<:)5C$1L#80%U(@5(&C* @HE^[Z]<I&" G)QR08!9G
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M%KTI$*M_!-G8@D)2LK8ZQG(S=/QV_'8!]M*R48-T=W R>RP)0BP$:(V#*#@
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MKP*8^O\KI$.$X*0 *Z)1BHR;]I[IBO\.[Y[U7UG4#[+^*NMHO'$0,33%O_5
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M:D4)*%O[&ND6)5_O?F[GW@?&O3<I]ULV^?9ROWGX=2 +0.1B5"54LDV&;WV
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M?W5/!WN'\.4#G+WWLSO<^K_QN/[<);]UYL6<(;KN9&&+ESJ011DH.DO5KL9
M0:/R=,9=]6<X/VDDD0D%1^.\((_*^2 ]L1).&&UJ . ^I83/-\37U$=<EYMS
MB"4AVIP\>X\^1R/1QV3TJZ=3=UT*"9_]]J]9[W,VY>3[?3HYV2M[G/_QX?OZ
M:QH W]'^-IVVW?[A:=W/NXT?=^OO_\?^4?KC@;'8SNX3W/GW*R^3=P(U5&-7
M(WYK'43E=/6F..8B-*--&Q.N5/^V(>?X'2^IVFR*F-TW/*4WNE %UAUT<CJU
MPU\[\[,>/UV6RYKRW<F;H_>'D\C[1^\G\<-T1YYOE<G!^5YY=/9C3[[ZVW;5
M _HPR7O5ASB>E..C@\M^N/VS&MO0NZ^9MOUDY)9KJX^T_L QY\W*U/O[C62/
M6QN\M[17_ZI^_47JKG+M*1_FDVHKZL7V]VL,<W[-#_5']MH_/OJ\ZBO3LP=T
M_+K21<L'FVDF=IJQ_DRHTRQY?:7[]/:$'U]\\5W>.WF[3Q\>[QU.7\STA[X[
MO]8Y"U^26YZ2[=G'GTGID3@CIO,*R?/??/[QH^E',UG_L\\</G+:7OFQ>"2O
M_.Q;EY7BD0U7?_RMRW[[,^W5W2SV>I?]FRK4VQ:;+A3YX0+XTPL^;J[*7OJ*
M"MQE59[3M59/].AX:J\>OSNLF_;L#./9X863=77KR&L]A#/GX)X?PS=N>F-K
MAT^G%OR3*GKZ79-&W^!.KVP.L*(/Y<?*_-/G\+^-_;]Z$/==AKV,4_:GU>)=
MT#X_OL8^^+L#U&^?CUYC]]R^ ?6B%KD*[^V20^X'UO?W7WQ279D:N-9@E"<?
MF([G:=6P;FJARVYQ;?0^&%S.:+5RL<9ZK@23$IE 7K;<F_.+.?/=_N2#_[IW
M^F;O\/DAOZR[[*N:HK7.<9TI@0Z>F>VGO[Q_>5#7=O#;[_7S]]N[O[UY^?$7
MM?WTF=S^^/+]]L=_?WS^Z[./LTJ@E[__\7YG]Q][+S_^H>K]U>CQR5\[!S_^
MOK-;?^;W7S[N_/ZD_KYM4]=>MO?.U94OQ%_;O_^@ZWV]4MZF&I@R.&/;U%4G
M(; VX+6-WJ+7F=L\Y4VEYIY\-+ZN2YV].GLMGKV:NSOU=#MS+9"Y/LXR5\XB
M"S(6G- >ZI8)$'1,$ ,'(X+URN3Q,==#FQQ][C=6+[+>U>LWD]).)-K?]+G1
MHV&O:=5V?5.[9^_HQ_J*&H^==#?L;LCLP] -(UU$+$F!Y"0!/7H@3A8JB<68
MI?0EI(TMN^F%&]$8G#[>:DV1WUV8NT#]P(6))"FVEIE1Y!I\58S7KU0&QX6B
M-%(G)1KJC9B[Q74??G5;^$XQ\H7?\LF5.>7#.3R9!]',=RE\UECLG-!V^;![
M,G?':3O?#ST93-HI- ZB"090E0*13(9@K74I"*ETTYEO"CVFL*RW\5Y3Y'=/
MYBY0/_1DO,\%8ZKQ2V[M^XDA6DR CHS.K)A:'Q3<-&98)-"3,?<$WY^.F9HO
M,SW1F\][Z='877%8=UGNEKQ>7.*R9)]S#JI&8+Z&8;*2%YDVDE@XQ.1M#<5B
M(R\=YG99>O*EP_U2N'<_Y2Z@/O!3I/>(VC$DK1F0A0%2T4+P[%A+GY6E!O7Z
MHD<$]05E7$;MG/S,)WNM^\1>DV97T_=Z6E51[ZR/&K\6>\FB<S)1.^T<YF)\
MD<49PUY;2LG@71QY'[T[?5&?Z#Y_6;0QX[ATPKH^85VBS_%"Y%A?)$B5VRDW
M$_@@(RC#J1JLI%VH@9478YJMU),IZXKM+[R4CNN;X'K@B*2B8M*!04EL@8<M
M$(JL@4?D&G $9Y,J&UL.YS[N'5^Z9-1NR/='!P=\G.[ "WD0,11')&;6B;'4
ML#I$3KXRDN 2O2QA:5Y(CZD61&67:%?8Q82:$9)J&=_B!(2L/+B@M8HA)!7<
MF1!O3#%53Y^L*_1[*N4N8#_4WVIF1-,2INP %5N((B;( GV4NK@:MDQ;W\\?
MF_14RLU$M],F('1RPJ<]@W*#%L<ZI""\E5):E*5$YXMUGC!0P5AB]UU6F\2>
M7Z96<4Z': 3XU%I,U<"ZAF$%(1@?E';2>55)3&VZ4141] 3+ND*_^RYW ?N!
M[V(IR"93@^P,50?&,W@C#>3@O"6O2\C48&_F/_'M^9>;CZM?XL"&-:OR[!,M
M[ORXOX_''!G?7Z+P$=F1M93 BE3Y/I8$9 R#24X6\BRQT'0ZIA*+DO@L?]A%
M'R?4R7?=R;?WYUX"O0[<:2[DT+6VGQ(E8$8-I.M7-M=W&9)+NF"E5['IS/K0
MZR6SA'HWW6]VTW4C[Z;[M]UQ9[KIAAAD3#JJ;"0:PF!30E6D0<\:2=UY-]VO
M6\HW-_+YX1<==A]X^]P?</OUJX 8E2<#Y$(KL774!D@F:*-R4)%6VMG!>PTZ
M.)(V$A,F(X,3V0O9)MXIC#F/I]WNBW<'!W0\[;-[UB"W-<QM_6AGV^M^V:/V
M#>_GJ_KM'N8K9G2THI'3BY[H]=]=U5!_<L%+FQ-Z_?J87T_;DL</TQ7L\^'K
MTS>M_>]I?0K3O]K[O%TG;^A/KO?!A]-NZ^WW?2*Y-6R5J]0CIV_7T_9;E[6/
M+/H[Z92+#WJM[I'2>D76NDK/=976VO= 7VO= WB]JUZSN?>5IW+2K&:[Y\]=
M8Z6:'-1__N8F;;[7[G%\577;G\BE9SP/O@_^YH3_2OSV='+XKOG>S46^AF3G
MBZSN+9MNW^?FF)W!>T4'_>D#F ;N1V7Z_UXL_$%<I[WYVCS0;W3?[X_P>H_P
M<YYE^B#_-9W0M=B!#NOSL#J .X#']@@[@#N .X!7^!'^/8#72QQW^5-H&?O)
M1;*^#Q+JB^R+[(M<YT6.BY2O/2:L/\XQ3ET;]6T__?K _G9C J];[].OT:_1
MKS'::ZP"7\UA]?H36W#,NBK]AW]Y].+1Y/517=)A$WSUACH#H?S%L/@9M;R.
M2ND0=?::T.5(Y#A[J4U)[*P3EZOEG^W\>+-:I>_/5)!'[TX^IUM:IN5_SE5X
M[6!_]PT=2K4]/<,^2Q0^+Q>?GWP2THO5%)N>"^G_N;=S\.,?VP>_Z.W=_3?;
MN_5W/OVM_DS]MQ]?_K7]<?M]73N^/-C6 R']P3/U\M=_?_AM-_WU_-<?_JKW
MASL'S^1O3[?USN\_?-S^^(^#EQ_?[+W\F"\=GL *$VMM@8T.@%H@>$X,AF)P
M1: /WFQLH<41==2XIS*C!U HM)ZE/K<CKYO66=Z4NQY"0="]\=B@( @9,SN)
M$)4Q@$9:($H)?,XL1++IO#>0E;8S66>RSF1S,-F3E-X=O-MO=19GA>2=NV["
M77(P$=WF(D(H4*+U@)$<4%(2I J!*7DL1)6[I%D_YNIAUQC#K@N@/S_^U]'A
M:S[N8=><D->#Z;LIAU1417MHH\2#TA!\MH"BU+<N/=O$%?)KV+ZT^RK=5[E#
M7V66NKIS<C.F,K-,%1R:^D9=BU0#H P6HHP":D#E;63+1:F-+3.FCJN=J3I3
MK1Y3]:AJOLSV]D47KMUG?^U\_$._$D6:^F81['3@!8D,$9' 2\P8@Y3*EXVM
M,<TY[T'5"@=5EZ.\ATYSX_K##*ZM"L5+$2&F6'$=.0&Q28!L5=(Z!"_;D97K
MB=[NDHR3J);EDEQ.4?U@:I%TM3/KAEAOI4[DP>ML )5U;>06 2;EB7-"J<ST
M9,KU,_9.6)VP_IZP>J0T)T7->E1.8'!*!2C9B1HI655]JT# @D/UM;*(5K<#
MJ#$E>18DT5\5)>.+T[K=3S8G!Q63:>]M7=&TRUYKG_?VJ'U3USDY>1?SWI][
M)RW.Z%-WOAD41H&D@W7)"X$E."*)Q=D* QDU.=T%CJM(;I<T8O<Y!UF\!6^-
MK=%BR."),L@2?"GLM=!N8\N[N0_7^[2=L4!^Z*W<#NU=$;A"P!].W*E1ER[>
M 6;9)NX8 \$*@N)$-IERX=".V#>UF_N4O4._0[]+Z.X1[ ,)718IBZ(5N.(9
MT,4(P=2 !KTHQK>6Y[$E6<3<*98.];% ?=R.?9?0+1CR PF=S"Y:0@8E8H6\
M*@2M63X8'60H+A +N[&E7$?\NB!^K,:]:\[F@_9 <Y9(4/8<P+/3@"$)B(($
MZ,C2R>J^.U===]-#]@[M+M):):0/15K!3-7N#(8KP)%10:0:JGNGHO?*.><K
MU.>6<G2DCP7IRW7;NTCKCG ]>Z08O;/$V@#[H !+\\Y]D&"B"C8GH9*H 7D0
M/?>V-LA>E@WOJJ:[Q_=0U90R)HS54-N&;^<S^")%B[Z%3HZ5G!:P;6(/P#O"
MNPQHE)B>M=G!4LJ1&:++$E"D#%1(@O EH45GLP]-!B1&A.B'V- L'1V_;<-]
MN/<SNW8-B+"2O6.-3B+%0*Z8ZGRR2:G589OQR'VNX[7TJ.0:#+<WU +5R*-P
MW0G@0W* @1)$5 E0JVJ]!'/]8F/+;!K?J\+6AA$NT2[?B@RZ&FB%H#]0 RFA
MA9;207*EQBO5TX$0D@(AT?O,ND2JOHW=##YTZ'?H=S70"H%]H 8B+]LA@@$=
M#0)RD$ >0P6[",XK$L2B@GT="ZX>*M3'[?=W-=""(3]0 Y7HJ=1]#;DTR%/4
MX%/,8&1]N9Z]<LEN;.EU[&/\4"$_5NO>Y4#S87L@!Q*6@C.Y]7K(&E *#3$&
M4;=;]=XY*)]2->=&C*D\L6/[06"[>^[S9>@&>B#KE"^L" *6!*BD E(X_2,X
M1(5%I.JZKV%OEX<*]>5Z[M<6!/6\_ )1/WORF)07T48!%%OW?H4,]2\00OTO
M95.*UJ$EY@/.K2;HP!\+\)=EX[M>Z.X1/M +A>J_*Y5$#<BM W28@ H6"-)2
MC,7FQ'YCRVU6*]\1WA'>]4(CQ/2LU98L)25;=S#J4C'-!#Z["%H&XX.UA52N
MF,:Y]4*];=!MH5D!4;\]G%<HM(9:QBO"#E7W= B>+3J'GMJ761.KNLIB#:<N
M%%H[:OLP% II(0BM-I"M8,#B$*)+'HS.UJ-UNL0T[1W2&PJL#R,,O97;D4$7
M"JT0] ="(<.F0E\Q<(H>L+YN\,%7]T8X"JI$)5)NT/>];5"'?A<*K138!T(A
MZ9//41;0PCBH%I\@*"? R>*-:>UM!6ULU=?<H;XN4!^WW]^%0@N&_% HI&*1
MD2WDBFU B;$)@6,K=U(9.>C<ID?4S= AORZ0'ZMU[T*A^; ]$ J1)^&URV"<
MUH 9"WCE$RB)'DURP>?6Q[Q[[AW;72BT4E ?"H6,R10]*0C9!D"C?"M;3N!1
M2#2!A3-N8TN/J5:Y0WV%/?<N%%H&Z@='CHZ<$H5!BF  BT6(QGM(R41$$0+'
M<-9V9.X*W@[\L0!_63:^"X7N'N'#QD(V"JFB "$S W(V$(7Q4/]7@LFB>O5R
M8TMM"NQ';QWA72@T1DP/F@$::G/B+,16H8=&1Z L/)"M ;E'I8Q0%=-Z3&GV
M!]98Z&<^V<M<8UK:GQP<'9^^IM<,[28Y]RY#UPU%9-&Y.J+:Z4I:N52+)8LS
MAKVV5#U4'(]XJ,<AUV:TY]\/]4$JA<A:&5"Q_H%:)@BH+ C/,9*6BFW>V-*^
M5R2N#>2'+LKMT'[WZJ#NK=P$VP,!4$XIHK 97! !,#H!0?@:@%3'LSBIE$/<
MV++SAQ\=VQW;7?YSCU ?R'\\LDI>*9!%1$#/"%$;#843M9'MKO[7&@MTI*\+
MTL?MN'?USX(1/U#_1&%RW3(&3$BI&O=2(&07P&8?V?KHO2PM$]$1ORZ('ZMM
M[^*?^: ]$/]4FQV00P"3;3LX\ P4<MW:S$C6H4I15[]][J%A'=H=VEW[<Y_9
MMX'V1V:TI3KOD$*L?GMF"=&UX4*.A=29-/K2-+P=ZNL"]>7Z[7UJV!T!>_:@
ML/KFL4;A'A!15O=<9 A*:C D,>@2HXUY8PL[LM<'V<LRXE>)>[IMOA&$!_H=
MQT4+'360<0185(+@O 09K//H@S<.-[:<Z&WV.X2[>F>,B)XURB8$I9VI@;5P
M"*A$A*BL@6BM*F2MB-/ >DPV^8%U^?G^Z." C],=:'?64&MX12C!$8F9=6(L
MF'V(G'RE)L$E>EE"U^ZL))^]&&IWL)*,\:;&&+Z-_J(:7@17&+3.(B:.,2FN
M,<:HQ(A=7KQ@!^5V:._:G7%A>Z#=2:BH:);@"=N!OB;PQ6O(*K610$+F+#>V
M@IG[$*!CNV.[:W?N$>I#[4[('#P62$96J"L?*]2S!2U05YON0FB5@&'NJ*0C
M?2Q('[?CWK4["T;\0+M3W?.ZFX.#6(0%E-*TSGP*)!E3*+M(OAIWTPM_UP;Q
M8[7M7;LS'[0'VAV-&AU*@OHJFS&W KQ3"%$1(D>9DFY--^7<]30=VQW;7;QS
MG^FW@7BGZ,S**0?4U+>(9(%*$2"RBCX559D@+4*"VZ$^%J@OUW'OXIT[ O;L
M.2'J''24""Q:\@UU A^-!IN2*/6-IAJ9;VRA[YTUUP;9RS+BO3//W>-[H.S1
M%$A(F<#8ZI^C*P$B409V4092!IWPK?>6<-UV=X1W;<\8,3UKLTD@2N,9DFN'
MX9H]$(4,TB=$YRNLI6B!]YAZ;3VPSCS/3]_P\81.3OBT-^2Y88CA=4A!>"NE
MM"A+B<X7ZSQAH(*QQ/&(>GK7T,6PW/;ND]-!R@%MS/7-(P34"-5L.0B.##![
MH454.F8['>>E>E./M:&$H>=R.S;HX[Q6"ONS'@X'*9T7!7QLIX:>&()@!UH+
MES-S)-'2C9O:]&9='?M=%+12:!_D*#Q%U,(80&4TH&P=?:2-8,AB;K4*7K8<
MA9I;W-NQ/A:LC]OU[[*@A6-^,!- "AM-"F#JW@:D$L![#) -R^252U'F12@!
M.^3' OFQFO>N"YH3V\]G[7GDS#Y):JG)ZKT+F2 &J<'GF$,0H62)"\E/=G!W
M<'=AT+U&ZN<:P(KW#]N[R>R\?Q6,JG8\2M *N;KP2D#4-D,TI)TK44K3+'G'
M^KI@?;F^>Q_IM138;\_"GKQ!GX2$8*6JL$\:ZHO64'0Q+CGK(LOI4"_9F_>M
M#?279>:[=.@^,/[++,83HS?21' &FWC(<)O^$P%#4E)3C"7%EH;'^8?S=HQW
MC'?QT%V@.@T<=J'8VNJK<\D:D#D"D2_ F*2HSKP2L1VLZS'9[0?6&^AGSLP'
M#1R3M\=<^/BX=P6Z?B3BHLQ4HU%$%]"2(2O8B500HVBYY?$(B'H8<@,R^V&H
M$:JV2%H5 Z@VJ!!19/"""GCOM% A!_3MY+#/$U\;R ^]D]NAO7<%&ANV!RKG
M'(U2"H&5J\%'?9M B30D--4)Q:38J8KM7IC4L=T%0"L%]6'[8<..J=AJO)D
MG4S@T1EP4F<KK+?"Z0KUCO1U0?JX'?<N_UDXXF>-N]<ZA2(<9(\:4)<VB]=Y
M4%):6R$0.5-'_!HA?JRVO:M_YH3V0/VC6!.1L2 E!< B#<3HV[0^(;T2'(LN
M&UN]VKA#>]G:GR]/#\O>7YSA(Q\?=0:X:>0^U 395EV.7, KR8 Q.@C$KOKW
MA411UGIC-BKBZ\?JN\X$Z\($RW7K>\^@N\+W0/R3E/&^G1DJ7ZK[K@I#4*F9
M?'8I4+(JV$7,\NO0'@NTEV7D^\2O!6%X(.[17F:9@P8NKG7F-52M=4Z09&%C
M1,I.MQK;N94]'<,=PUW9<Q>0'BA[2LZ!@O,0I,Z & 009P]D8I1%6BQ&CBNK
MMJ"V0*,6\^P>G=)^A4\\_4+",YFG"5 \.LY\#*=';Q^W!W]RM+^7)^U&UHJN
MKH@F,+B<T6KE(J)U)9B4R 3R4CHAG!^/NJ=7("R*[9X-I3^D$E5"4V"\4(#6
MELIU%*&(((4S;-"T$$1L:K^H.L/KP6[)LN4[Y([1,>M_W,T;O,&;&Q5A#OV[
MVW%E;YZT4LPX&/V*4FAG'?B@-&!JY=>I$!29=0WN0A*^":?,IE>+DGAW9NS,
M.(*[7GEF_.8152?*^8AR(#M+,7@50H&<374A78V9O0X*=(JQ];T7T8=IATGK
M'A)/]DATM2+1+E=;.%,,NU7YUG+2 QK3$FM) TFKP!%IK;25.?F-+1OF+C19
M)9[H_E3WIT;F3PW5?-V!6APM#J1^A=E2= E(N$J+L?[AK960@@NVH%.EE.EP
MD3"WW*\38R?&\=SURA-C/WR=,^DVU#P62B*P#:!,:O6*2D$,SH%VT83 I.MK
MKV2(B^I8OA)4V&/)<<62O7O:4LAB(* ,Q!PX$:1"#E!Y R$JAOJRC;>A8+33
M$4Z;PO73R^XZ==?I[ERGWEON/AAP(#_U3#:ADT!&6\!2),04$V@14@X:25+3
M;]C-,/\ ^<Z G0''<]<KPH#]+/)."7$@WHU8P\12N= %$P =%PA*,["-F&U1
M(:G6-7_3+*RA[MWRX;FT]V(5%Q P4[9;M)+_&M?XXFYUO:5\]*ZUU_OJ=N>Y
M?%]B7V)?8E_BVB]QO4HVW*4NVE-.W%)B$RTW)]7%DE=6:RPB-]JOT:_1KS':
M:ZS$></E$4!_9#=[9 MJ,SX2VW;Y;3_]NA#Q\:WVS +]CWZ-?HU^C>5<8U5Y
MNC^RNS=MWYC>L0(3-'YY].+1Y/517=+A 1^>SCL\8PWG_%PA1 F%@XC:"<R,
MS@82P2650R%IBTMA>N0@I=)RV>7U785R@R.'E\,*>D9KO2P:!'D)6"@ A2#!
M!A6#+X6XE3_AHJ2[*W3&^@!.4M?SO/1VY-5G@8R-J@;MPJ67)*0"*=I$\78V
M&D4H@#I5[DI66]4&$>(:CB'L7-6YJL\V61GJ&A29LQ7&:B$@46JEH\5 3-*#
MC"JQ3%JD*"IUK1]Q];AJC'%5+Q9?..('SHHIWF84X"6FBG@G( 0A@7**SOEH
M?'-6YA]*.#[(=U^E^RI]5LMXJ6I0P.VR2)Q\ 6VK7U*92@,1)8A4$I-E:X+<
MV,).59VJ.E7U>NLE9H2&]=:J.">+-U"D;/WKV[095SP$U+(8K\FS7T"SZ_%1
M5P^LEA%8]>DR=X7L07%T+A7:*B9(0B.@#ZF&4LF!0!MR5@:C*1M;IA],=:]D
MG$RU+*^D#\M9$"4-JI63,-&3]I!\.W9B6V,DQ A.A,C6H\FMN8OR:YC'[9S4
M.:D/_QD=10WJAWTQ*MH@JZ\46S,^Y2 6)0&U,[K4EYQ9+V#N[@():D%J^U61
M)+XXK=O]9'-R4#&9]M[6%4T' =%AGKP]:M_4=4Y.WL6\]^?>28LE;J54O.09
MK6G@IZ4R5DFCN?*7CR4*8NM0"6^2QT!=J;B2Y):&2L7HD@N!"SC?1HIK(RNU
ME0!2&Q>BHL#:5>]+]Z'B:X/YH;MR.[AW;=_8P#U[7,ZD0XVJ&"AX#YBUA6!J
M?"5LL"IA(FUX8PO5W%V@.K@[N+L8[CZQ/A##9>=T:6-).1H&1&. 5,I@B((F
MJ56*<0$Q2D?Z6) ^;M>]B^$6COA9ZQX-.I+&@4%1K3MJ!\%3 A-UB=YGXUQK
M=-LAOS:0'ZMQ[^JQ.;$]5(]A-=I%>Y"N5&LN,$ 0RD-R)M:778P@7ZUYQW;'
M=I=;K134+Y%;Q2P%88Q@2;9YV[$:\I(U%!D$U7B=HRP+D%MUK(\%Z\MUW;O<
MZJZ0/9!;61NY6-5*:K4&--8!N4*0,F42,I 3LA77VH[M=<'VLNQX%R@M",0#
M@5+31#*1!Z?-M$)>0_0J@<?,444C8G$;6VB[@>X@[HJ>46)ZH.AQ)7A37R@(
M9]N0*)T@<)!0M,A*):\PYXKI$2'Z(3892T?';X^.Z[[O/<:N&T-0RLK$)'+.
M$HV+461M0S2ZF&!1^_$H=_H8O$4QW.NAK,<KYX1S 4)!#UBDA&!+&P'%R,ZJ
M4%V7-O'$KF.M_$.EA*'7<CLVN'MA3Y]WM$#LSYX+DM96:Q_ >UL Z]8'<H[
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MIC<-T][:K7/<19/J67"E_@BQAB0M4RHI#CF!$GYC$UQ#Z?JB-("-(I'%E%R
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M#QJ3;#&.VP=N+\91BQX&[PJKJ<\,LK;,*2^8HNF7V28?9-[8E%?>3-2 N[K
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M@.TS"_[_ _]*HX/:B>Y$@"E22[\@C4+8K\68!^_#<#P;3*:#T61&OGMO=EK
M\68=^_1IUF.O9\=3^.MBTI[7.9M,_[N;L<9DEV&R,S;O9XY0,BK&2UU4=%H3
MDT7)C',Z(6@$65,*8%E["=M2PUHA?VD!@H;\:T9^+U!@L&3KBV8"#2$_%<EB
MX89I*;VAR4Q>UL0">^5":0WYZXC\I04:&O*O&?F]@(/C4JGJN&!.F4&0R (4
MS[+(042L/FBNAY%>N8180_XZ(G]I\8J&_&M&?C]NH7*1T@D&!1(#*)RY"(5I
MQY-QY M(AQN;6MX9G7_320;7><3F#^,;YX0O_G$4O!@<S\Y2VV<>Z@LT\/'^
M9#;L#JN:XBC,AY_P<9UTIAZ><9!A##-<'&?U#_$MY+(X[[2%AZ\AN#*C#M-O
MI^/$KX[DZ1L'=VS;N/;27/ORC*(+,FD9D#MF;%V(S0I9]*@8.B&U PFI)G2=
ML8VL+>NL+&YO,W6BH76):.U%0[3*F4=K69(AU_0FPYP(FCF:,F6,E"7B,FHA
M-LBNL*I=0DRCJ=KK!V\OH"%UM 938AHT@1>E)+=&&B8-39%7+I2:I2AL'[U-
MUZXL<&\S@Z+!=8EP[4<A/&E:8RR+-FO2M4&R0+/% D>OLS)D(OF-S:6=0'47
M4RAN-<[0SZ.X@Y$%>4YDX8(AJ\5,/%(D+WER$$?X-6QU;P_*6?X K8T"NO:=
M+03+IG8NHW;.J)XAM$P6N&%%"\4@V\R"R)*9%$5&F;-QM=P]+#GXO02@W/*Z
M6*/,1IFK'Q]KE'EERNQ%Q4HA38;U"$6K"P,O+?,B>.9=U"X6GA6:6GRDOYVH
M46:CS$:9*YIRU2AS:9393ZZJI\T"3\QC#HRF1]4U!&#>9LRV8$S)UO,9EYQ0
MW2BS46:CS)O?6]<H\]*4V8L')^]J27-@W%K' +QF$25GPHID2RS"QUKNRJV/
M8]Z%DW^9!WKI<7QR^1'?"\17Y4_'5]]=YG_?1V+IQW$?C\:25?)])-PQ(P_'
MF0#VB-5/ELTQ[@)C\EUBVHV__?%WH^(>FFX4SDP 7&3^U2C]Z"#CX'"(H\RZ
M>:2;AGO[83CMPOA']Q%79HPDT)@.IC3I]:,R^(_;VNGWIC;WU:*U+[XVMBZR
M/:56_OFUD4\^A>&H8N6WR?1/8MI7F";OQXOUN6=A.J:QFFT,RF2Z%^;4QK_F
MC\8'>RQ/YNSHS7>=H4?X7Z\.W[[.^U&"V7K]A]K:R;O;KVO[?AMM/__WQZW7
MQ+C4]NWGS_3VTRU._PZWY6]EZ\M[_O+I"[WU-!&[;_VU]?F=UYA\2)D)GP4#
M[4NMZ"-9TLE@D"+[>C"!ZB^^#4C.1U4\PC@/PA0'L]W)YW&WKY:$:+Z+))Y$
M%S,22_I[G_X83@YFHT/Z.%4^):F=8A[.5UT^3V5P5$']M6MXD]0;D]1_'6X]
M>1>X<398R02ZS,BE"BS*X)C5O"@2U6*,WMB4_;-OODKJ<-S)Y7QWBCC8(SG9
MG0UP7$7Q]X,Q+HP'Q1\,JB@\'%R$84^)<(7"]9/N4K=:-5F^<5E^^>0=2 %9
M1<V\S_7$5C#,FQ*9U"5H0VX)8CW(J6_A?L>ZMR8T35-?N\SL/-$O=_[UU];.
M&_*9TN'V'^]L%#XE+9F6@.06N7H023T[-!49O8M%UFK_T$\@/Y:9!T1GLWU,
MU:@?'3XXIL/9\*^?),/%?I.J^X^T_O5SWU(WF#<QOFXQ)KJ3VY_?V5RR*DHQ
MH85G]<0<%G/-]>)&.BS2NEK ^F\T]V79;JE[$IN87#_;O>$O=U[([2]_\.TO
M3SYODX;D$%56F5GA2%!,,"Q$KVMFH/<";"R(Y)><+S/GL-W"^*OR]&/>$P\'
M.[M(]/:Y_K@MEKI&"ZT,_\+,ON!T\E7T^#T3O>VG;_[:^N,=)P9R1!?,<!MK
MF4S!HC>1%30E.!6BD_GV=D4W$;@!$0!G.2=;F$%)A0%R(AM4A3F3)(#0MM1(
MR'C28YP^!9UR"\^W?GZ*E.Y@^%2N8OBTG]=\Y-;/+N=9%6X\ /?@/$C#77&8
ME/"YUNI$G9:3[-G,AK. 2X[1^W<"<Y&@:\U%!_4@)+(N57(L*QU1"VVD#F>5
M./YIZY)K+#8X$V55[ZB#HHGE,>MDLR[9+2?QHLWXCPS%9V+K\[L0>4FN5J[(
MOM/<DCFM+$LAY:*<#SGR,\OE?IU^&NA+L[ \;5Y>5H9<"C));8)-!:2#6")B
MD%*8X "474Z^8Y.A'\J0)&=#DC/JO/?,Q4RJGXP^%JQ4S#EK5=+&^4Z&?K (
M<JDX1D8DQO!2@0%B+Q>,Q^BEE3;%I-1R$A':]/]P^A51B";37+A@R?J09/ZA
MD"PF;DB5:%2A:/(XNR-^ETLAXC2%')N+\\D)TV0VF!WL[T^F\UJTMAXJ,QWB
M."&;=K?N3R?Y(,UGIVS"HW9N'^S1[>E$,L'F?\;I+YO?W_S=O4L(&G]S6_YG
M.DF(>?9D?!P^Z0[M/=Y->;*DTV(KY6_3R5YU6UZ6[]V:G>K2[%"S_CF:I(_W
M3&"W=Y[ UOMW(+T4COP1&25QE 9B*V(JYK-U216+)J6- 1*J]VGXY],#O*5]
M@YW%_[5NUR#L30ZJ&)^0[G/%^$']K1.902%16(2G21YJE#@<N[:,P,:Z3T][
M4Q5WBX7GQ:O>=T=$GQ>V'G]US'[* .CNJS!>1(="?<QH-/D\>W2N?[87IN^'
MXRZ/2'>N6)?Q\S4_:9%E1#,T"OLS?'3\R^,\G.V/PN&CX;@;Y^Y+CX^>=92T
M=$9N3N?Z+2X__CS,\]V:+?>0+S+FCK:N'KWYZ/+#[M*IK*G%-<T?*B/.O<P?
MGG_M[QXK^$/M]4\]]N^OD2/0&GN7&FNXO-!C?[#Q^H>U$7SOUC-R?Q/6 PUO
M)L?5GZ)3>V:*ZT['3%L+1GK6,5*GR2LM#8B1SBU4O_Y#\R=1]<F!.7]<+B@[
MMYH,_K7/W0,?57TU3#\<A45;<TVL"EWNY@&-Q'21F?EB?&REGG\6X8DT_4ND
MNJZV7%0=O:P.GXN9-1TXL0P^6=.Q:4*U%*&Z#\?!_L]WSDQU67H4_*/NWMM-
M3)?N_]KL45IZ\9!C,?P673F]3/PMTE+C+FL=-SS:W934VP_//F]_^/WCVP^_
M#=\^I<^_[ [?R-_I^HO#+?G[\$V]]OSWW=.[F[:_Y+VMG2=R:^_5WM;KWS]N
M/__MP\OGOW]XL_<;?>?%ES=[OP_IVD?ZNVR=<81N#"9++3A+068&-:$O6EZ8
M\C:YH#E&ES8VQ0.N^[DM/U?P:F5V?/Z@@%WCPL:%UUT5Y/)<V.CN,G37+Z3K
M7 @V"(;"U+"UTRP6 0PQ(2 :I"G=V/1G+*XTLFMD=Z_(;NGU/)KA=XM,V*L$
MD@-XKJPA)@3+P$-@3BC)I$\"2O&1J[I_[8$WRZHJWKBP<>$J=?PV"W4T+KQ%
M+NR5^# ^2:,]T2#/D4$Q@H5B+3->^L!U@B2A<J$T5SYT[J:X\#Z<JOW\;Q(J
MKG)6]GJ7HU]Z0.]'>SX6TU/SJAI178:HSC@/FQOR5JV-S 8+#$ A\\(ILMR<
M!QNTJ%E7FU<VV,[F@KMR^.5ZPW?I,:@&W^N";R_ZQ&6!G+QCPL=<?:Z:TYT"
MXV#(O+1)Q5CMC"L?+='PN[KX77I8I>'WNO#;CYDD&V7@BO%(( 8RH)CS1;)4
M3%0F1=2F.\FIX7=]\;OT4$##[W7AM^?G.X^*/'W/<C"*@="D?W4IS%D#V884
MP9J-3;CR2O<2\7L?$I/.\>,7VR%^RI&_%^?*W9(C7_=&-2:Z!!-MGW'\LB]9
MQISB4>&APCD+VB(+'C@J3%D6O[%IEY5SLT*K*PV_M^S)-_Q>'K\]3UX:$<F'
M5RR E0PPUQ)BPC">M2!GP)E<BSR(!M_UA>\M.?(-OI>';\^13R$2V9K C$5.
MC@#]B%)$)J(@#]^'&$#4"@O+6NYK %Y! -^2)]\ ?'D ]SWY(FN93L\2EX[L
M9V^9-U 8!ALT*5^)/IQ9(N66#VG^_E2-TX4QZM]51(?C@["HY?:WI3).[.4_
MP@#4G??](S.^;KC_?S:^^];1=GW^[2LASB:C@_GY7^EMZ[IYG,O%#JY3-49.
M_*S-[5#E4TD<DK<Z!8BJ.)NE]K+8C(4G$.] ;1Q_:7?Z;2OA>V1QBN$C"X5Z
M^"B,/H?#V<8OWU=/&([9R5$_/6#G3]O?%\J3]G2AO/K)M8]R;Y]<-\KPM9++
MS;_]^TIYPC]<%*FXGOHPQQ3^6QA._QU&!_AT.$NCR>Q@BK.5J?1R>,S5[P_?
M[.SN;M=G[;SZ2-_???OZ7[#]X8VJE5K>O'Y#_/WB\YL/29RN]/+RZ>^[+Y\_
M$V\__'-W^_D?U-;?1F]WWLOM#XEO$<\3CX^V/OQS2.TO6U^>?=G^XUT)&8-+
MAGF7!%&MD\S[B$P7(V/$#*56>CFB+<Q/:HX:)YB9X(7V- ,QR,"3*B((&1+Z
M'.%T99@Z[(-NW/N<>(KQ_K9RT$GR7$S6CUOR?<NU!OJ46V5UK%70HBE6%7+3
MD\]<A7*;56QV=K&>7+(?%MOJCP\V^76R1XTY_+__QTEA'\_(Y D'>5@KSE#7
MB$)FB]^Z'+.N$$T9CL,X#<.(.D ?+.HZ#<>#D.I1*'0)!Y^'\]W!\R=/_F<P
MQ?\]&!(*!HF46ZAWS68X/RI8,PQQ.%I4NYE/!K'6NBDC3-WA$_/:.)K64N?V
M4YW;[CL3^G3:O[TK6M9=&\0P&\X>#&8':;?6L:%Q#OG#P:S>M3N<S2?3JF*I
M1[/YXM:'"YV^<\90G-/6%*;3X:*-)UJW&SXA-0K'@S2B+PY+O:4.!'5Z,L;%
M<-?"%R/\A*.N5GR@%N$T3-/N(4ETU>W#V2Y]*QYV@W>B98MJ/%T%HBEVT_;M
M*?6O;\_I#K 91&I@(6MSEJ;#_9.S/3_<[YI2VWPDY^-%;FC]_1^UZY(_/GEU
M_^#_9^];F]NZD6W_"DMU/IQ3)3AX-%[.E*J<V,DX=R1/$F=2]I=4 VA8=/0:
MDG)B__K;("4_2-F6+$JF2$PFBB2*FWL#6*M7-QK=D_'TU^K;_^-+\$/_]Y0M
M>)W6*'IO,4P':W \>CM4KZ>EB AY'J8WNUA*Z%+:Y,/:0*8IE/>9W;C;J Q[
M28A-Q\E]>SM6[_/U817,K-Z_VO /U&"ZL-6W@]^.WD+BOZ?'LYI5PWQ6.VK8
M1G&*D;/E_]Z4GE7YQ6F5MP'/S)^T4*ZM3]WRITZ_G;K_S"%S1H@-ET>#\VF>
M@K3Q1.MH-^7&X\2W]&I:GVLV:0.F<CSCE[<L,WY;,_C^!>MB/.1'QM'YJEA8
M!MN764O#=M_S[YMGFW</\-Y]O_T=T_SY1_SO.<D/FRO!##IH%=AFA#VK6CT8
M#<=_CO]O^IN/?TSA^7K5+%NK;,"WS79L=)R.9^7<F(P7AJ^O^9M?\^;MFG_8
M?CX^.9^@TZ/WYJ.MX^US(=#LXT62AA??Z>'4#%XP<9\T0E]G7G[@-8@76>]#
MFNP?E]D"?^^AWJWDT_%94<+Q9,@V?285YB14(08+^Y\++[X3$><*)K]5BE,S
M/OUU^^F=U1\>C5F#-PW(DHO%S1Y3P  &9SKBG3 _4Q#G->*GI0;Y,0\'2HK_
M=T'!SX4XQN:&*M3'0Q6W'76XT$?ZK,\SYR/E4*WTNDKVJP"('<2(S9U*I6 J
M47YE'^D+.J0 R1(DZ2)10DHA:H\J5:FR#;4X_./QY;9P?CB'U;_>Z:T+0@JK
MW_/BMD,-3W]^TRH?A];GLR9A"&KK3I_.>BH&%XHS7D>)5PKQNZ"]*H!5E@*N
M1E0VH8FH <!8"=-Y54H;U>?U!N?5)0(95!!.2A(0515H, IR24>KI)7MV,JE
M>IF\,USONS2'A&W\YSWZ%E1H#5Y/V=UG93&-%K1?-@/VV2A)PH-I*(0=^FD,
M87)1U5VV\P\ITV&BT=DKZKQ7TPU'*G_-^U1.V\G1MPOQP52B/S@J[ZW2W;.1
M>7+TR_DX?->&8;5J6-]^9+,U&];)Q*!2$C)Y7I;!HX@6I:B4F/U)9QUPWO8Y
M,KGEZGC)I@^+1\N3QH8PFU"*<0LUKW_X,+SR%9=J4XX7K]4+2D9_)@@[YRN]
M*R%]H;[X[)C=H=+3X.YI%Y9?<UC=<RK>E0+)_69O\&:U66;IZ8TN'WRG:I*>
M!?^66^OV#H[ 92K:KO<(F T>@:?'3!)K7)KWXJ<^+Q _N&Q%YV74%5F1$;DX
MC^_B/*VE)D#VX>S#V8=S18=S$^H7?8_C_=E69_NFY=F\PH.6C'.=@Z;K5G3N
MHD=<FQ3TI'PN"++&7*$H#! E$6@7C%6@XF7W'=I*>G!4VG\>O5M&GXU0KVP=
MN2^+!\ZRT@\?P?.7/_.G_3)\\K#UM?OEX/GO_-K3/X'_[O6SE[^9)[_O#7<?
MYM?S6>G\68=[#Y\?[OWX&/8>YK_W?OS/P?,??]A_\G1_N/?FI^'>T\S/\?@O
M_O["8NJAYIRH*J$T@F@3*I+#*GS%$((MV<2PM>.WC;$K=,1\224B.DFM*4EI
M:SS:H(%L!E]T*#D:JPFAIICBI3='.TE]#9):.+J*"@Q$BT)6:P1( I%TL/QC
MC3%YRJK2U@YL^W#MXZN=I#I)W1))F21EE-ZGJAVH7)F<B'0R1*9D".J&2>J"
MO?[.3Y?BIX6SN0 YVQ*B<*H5Z0$T(J+/ @(%5R.80C#+?%3ZV\Y0G:'N"$,M
M*\>LRZBO05.+)Y"A&&>9]%,-[.NQJ1%8DQ952YMJ1/Y/V=I1>ELIMT(LM5Z[
M*1>#\N&'C=CO+R-.>Q>>>S6BTGW$^HCU$;N-S8VI ?#WO%WQ$?CMWJ_W!B^.
M^9:.VCF3]ZBY=VGX:'&X[$G[XB*RNQ-\3(4,>T!>9NE#H$NKQ4^WE7GW4Q>+
MRQ*+%Y5[K"D;2SH+)2$(B-6)4*T6/+%*HW8EV6F#&0EKN#'00?VV8JM5TF5
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M;]@^__?'AX<TRC?@[&]$?-*31%F] 4KLYZ>2DLL5R)A4LJU)=I&QBE1U05$
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MYV2UC0?Q#4;T>F^S6P3WO,.0I9*59:& HEJO9!U;GK\3I&0,*=8:<V]NM@D
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M<K"%I,DBHV5I(U44:%02*1:7P1MIB*6-79)'MC*J9HG!F@W&N /O#6.<01[
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MK)?.LWKU)-O8][K[]7UL9DMJP^>THXL\A.LJW"6<_ABMSP%5> PF&0,F>LG
M>"2)2YW*Z]I[(_GCC=XD#$;%.+;QTG\,1N'@>57L6;/_AOZ;=\\[.T$U=S[Q
MK?>M@^;.IFQM?,)_3=X:?ABV=MZ*SK"UW]QH];;:>ZS;WOLGOO\;XO]\&'3Y
MX!_?'YUUVQU4S]MGG?X!Q>>BS6F'=X8=UFG''C[#:9-ORJV-OP=;[\RTV3^
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M3[3UOHOC'NRW>(=VAG_WMMZ_VV^]1WXZ_;B_U?Y4[G/:6LR/%;O1I>"IIT1
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M\11\!%UZ1]RSZ]E%\PCQF':]/T.,YV'@JVWA4X-M,1,W&Y_ 9V*<!@(Z&(+
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M5;/D+'PP65!G!(FV%,\'%HA!^D><!,I2S Y,>/%:,%4A][V.M:TY#1HB=^C
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M-5R^<^DZO&I\.BH689['5P!6)&T5D8I4<*0FS%/E($6/7JU2401I4K#F"CD
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MG 7=PE%"X7Q*)5F64;KU-,T?2LG(KG[L0[,\=!UR[I#]%\43H( DS],"*X:
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M,!_ I?QU16]IGCF;Y[(D1<)!.M<R Y4=71,ISX1..$TIUE80R???R@]4%G^
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M,*PN NOVD.W5LJD!!),T%REH(:5VA"FNT=1@B#2:&E UM7(AT)+>5A6EZY3
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MAM?_-$6Z_S,#,%ZN\WWXZF5S_J@*8:,&I(-U^NH"99&:*V*6<I3PW:(<LE
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M64:RO<6/F5=2::J=9@5WDA$>C"]Y212 6;;)#A[)WJ_:9*4B0N@04/!&(%8
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M3$6!F"\\T@&<61Z4IIIPPS4XLZ*OBETU(^A>K[/-%Z[<&IRN*L\J4Y^TQ^J
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MM%PQ+Y;^C---2*5LL 6S2G#0 P9@7CC"%0G"^5!8AG\3Q5'[T.EX87R<>&3
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M J[6L,UYH4FK)9,6C3H>EI @)!7IIZ-G\0B%]6XV;A9TIC_77<+B_L8]@,<
MP"=Q@7-"#VHK<O'N1):E %Z*_$6@2Z4;,? '2YI6:1ZI[AM6/K&@&9JZM6$#
MIHM=VFIK:@0=F=]K<RI^UT!04_U?0W@3H=/#.6@#^?38+<*;&_9RJC_[81WG
M^PHZRJ^<Y0 %X4;)DFI> JNUITOO>!*0MQD;OI]\W_MQ'"L _U.?G;_L_1OH
M?]+[^]]_>;I+_F$TF4:-_4Y/)MJ>SF*-TCK$/\[<7L].8&\:55\;,#FB.X_H
MBIU$=&F.Z'8YHBN.7OT$5G0/%^@?O4])5\<H3$R/7A^W?1R;\6=0,CUR7(OL
M\I_OYL;2W'YZ6TWLK-9A4=N^CAH\6IRQKGJNMV(0NTFGP6^6XG8?%H&A[YJX
MPKNW";5?M\&"[=SHVPI,>?3HNQR]X]9L:O/9AQ SV!P\C,7/)S[5PLR/8UZJ
MNK\45^JW4:3%8/V&X,LQIL8^GG_5?/S5KWX"QFO["1B S8>S>< I>98ZG9\9
M3VHO^;1>09L=GO0:3S:5,$0O.G6/@(?@\[/Z.JIX1WTDUJD?G*=8CQ^=1TD>
M-B?'SW6T!J/AGQ+,]1N25YU. EJ XDDRSZ(].6Q.[L [7'62,M]?1^.!FT?!
MSL!M77K+UQ@E:$ZI7]1N2HQ!G,;CA?"K9CDV.3^C]' SJV$\TE4GPUMW([J_
MB],9J@_\ B;G5%>#7JJ_K(,BBU_@/NB#WE<]^(RJ87-D8]"SP!J5C>=.P7;6
MR5H]/]7C,VWC\>$FAUR[5PU/I)IXC(MY7< YN.@P7@P%U.GH:*W"NN)8J3 4
M%G6Q&'5!K+J"TM6'1V)HQX--.U[\,NW#O$ S'<&.]O]\1:.A7TP"%IQ,:L"B
M%,&YO%EZ,!FE$9(GLG3:D_+%$#6-IJ?C=$ ^MD!H3GKW>U]@TL-IC-[4H>_A
M)!:#H?HT^X(1UX^H-X[<H%E@?8J\.83@FD1^LU?OTD; XEZ[+^#0P(X#GP8?
M"R3:O6I)5'LJ@[@!\Z=^T>-I[VV*2-EQ=9Z VHUG)S5]6F#^Y>TOBP#N\@[-
MSXI7J?O!</0EF6N7>/)LY/R@%8*XD]9&R@"KIL#5M"99'T@Z2$)Z68CBE6_U
MX=NXF,'H:SJ'_R7%82^])A4#'D3D=54>PR+JE^R#IOAB\F)C;4:_]TO+ZA_G
MG/%K$N'O__ZI=O172A3;0N\XC$N$-C%*YF$W.[9A-ZO+*TM6/M:[UJWU7,T
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M3$@7#M1]BN-] W9^"#*=;Z]C$##,QCG^"G_Y"E_^&A<Y 2<[#E8W.IPLE?X
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M]I>FFQI[KR/TO/=@D\9KNIHM3ZL_QQNWN"FKCB''Y6Z?[%W-B:T<^;R4RV]
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M$IY;S7>=2N*N9Y0.7XZ?PS&DNH7*Z/)AI/N4(CRY4WJB[!?E'?,,G3F&N<,
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M(B[MXY(Y-HE+%><2Z;QZ\(FDJ29<HL3ORG.IP3JOCNQX66BJ3?-&R8:A&73
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M/K]?'\Y8!KX=6] J/@B$RR-X":;RY%@P1QXQSL*EL)RI []?^HX7,<=C$5!
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MEAOOT2E2B68ZU?+!@Y0\W I\Z(B[:Q7.D#L%"*73.ET%I&]8.0;P'H;Z3E/
MQD!,7<0I@"=M)CR(B%U^U\B^!*'[WZ4- GN]<1X=U>\>>P=ZQF6]5.N@]/ZO
M_EEG[^7:&3(P(MAZ\'_AB^4C2ZOPL<^I8>6$80P<=L"TF3H>0,CS89> ZBH"
M78*,5;^&/KIL]R9C,*,\:P[:[BM;\I6T-L"N %ZS7X]^)E]*; _L'NRP#1+Q
MGR#K<1@%JTP'ZIL=]=G7.]\?5B7M,U[&AXT7'*YC__=WSMB:6IV>-1[V+=Z;
M=*>CH6WVQ^9T:(MIQ^H9_QJ-OKNAQ7-IRNT$RB7E/LTY6-W6:B,<GY4!71&]
M=93M7T#ZI[[K^L]R)<>-/ OC!=HA?PJU5=N=7[)!6-L/L"F0.P_8($GM@5^!
MC.(6"*0EV>:$#P>%;9\,)$/)9=8#45R^#,5#^L.C[81+EZ\>'$].37[T"(.?
M 9@2840L;?DP9'_J\09F>D=!+0FX)3TGCW7Y:,NSHIZ9?7W4.?RXHQL'GQUK
M=JB/C-%)K1Y_UAWU:*PTU@N,U>QV::QM'VNOV'A>J"*3JG7/]\3Q@ "]>?DW
M7V!6B? -O7K.5TUC^[AE8O+DS[8<2P=2YM9U0EKC0FFG[^?<FXE<+.NU^!OO
MO%H+2GR9!T*PC_#>/&2_>#;L=^7. 1TJK-O1"N3>-I4TGYUO.<)<D"X'CXS5
M2ZQVP92G&?Y#NOF>0NFC*Y+8_2)EVD/>XX \2MR"VNVFN9SC%WV@^\BBQFH+
MRP_4<0$9BL2WOOOQ@Z=\PHDW.=28^&8)0,!2!,A>/A/A:S!8.P0A/LXUX2*)
M-$TB7!%MU5;:$*@(5.>ES1M"U E4^Y[@1'"Z%)S.="O<;8S+ER-5<L9_)'EH
M#T7P4N"T[^N =*4CR31(&B0-LN6#/%/)_9O?^5E0T7]*,KI?<[WJWN,;E9OI
M8=.G9#&)8?GC&[>8;\_4^OW>)6I&$#;JCHWN2.L8'<(&86-WOB-#&QHCP@9A
M8W>^PY[6&0X)&R=AH]04JXV#GM;OE3T(>\1.KD%EURH=5R[(),/43ZS<^DH>
MW6*R13R^I)0:K92&VJ!W8NU_4DI74TH=_<1;[&JOE,X4-ZB+9RD]P/*:",(^
M$[GR$#?[I^V>+E"@I59TZW9.\U:UG6[]?I_H=A+=+BNG-2N"5)!J=[W!3F7(
M4U:P6Y?L:BAWC+YN7)L_MS>M"!R%P-$ER:TN<SIZOWV">\YHNV'J9M4W15]R
M5;Y>X[,JG%U7&WNL9VHCHU &]26+@S>/KMV1UC4ND@C0;KJ.3,T<=HFN%P@R
M#KJG;6G/Z%NMS55^A4-VO3%=Q=E8]AJ&7L&+K6]O8!*TSA%7ZY+F:"Q[C8Y>
MP1M\;Z\YVG#,Y[T?RC*RZ[K>P$.[=0&[7D?K]T[+AFU[#*4[T,S!@$AWRK(Z
MTCI=0MU)I.MHP]&8(@ G; +-X0TO,"$F%=S*E36WFQ(.(( 4VY"9I1,=28JK
MOZUJBA2?*:A7Z9W3[^N[>?#V(2]\73"OEE98[\3\J3,&/VI)MV[OYD&C6M)M
MU+W(R;/&TVUPXE:IY0<5C#Z=):DVB[I=_38\NKV)10 I),.]$^-6),/78I%I
MM%:&6W8>;'?'A-??<?:]O,>P6%YD0UT%^FV\.;<7 7(E%:%91Q\3/@@?1_1'
MV3H/A(\VX8/TQPT"ZM1&#=IH5Z3"\2Q_(1B5^BSMXZVXTC.TT64.^! TZ@^-
M8><B9VD(&G6'1E?K=4Y+W21H-!X:1I_*?+:^HI[1*;MQI/C)M8/[^FWJL-9G
M;T\:J4$:R>R11JJX1AJ6]C8V12.U-J";.)8HG*OR8EN;^$WAF&+X*)OQ0OAH
M%SXH'83P0>L+A7.IC6J'<VWGZ39B\<[^=QQ&PF;^H>#N64<UT/L%AO6X]$,G
M<GS0(\*%03V)1RP-<]^57V_3D(<"&\"2Q9NRIY*@+?+,-#R,8&BC$VO3D].N
M\= 8$C0(&@?BTF.#H$'0V <-<W"1"M$M@$:#HD#P)T6!JLVB_JGE:%OCI""-
MU""-9)H4EZZX1AJV]C;<EL6E#SO'*$"=!!#*7L%* 81V!9@&A _"!P4@"1\G
MXN,V-8:;AP]JHUEMM.&\\1^)4<WN)BMF.V$4.),8P\+,FG//$^X/#SM'D,^Z
M?:4VJ UJHQYM7/N2'=MY2MM.FKC']Q\&TJUQ(XWY:<Z#!;=6S!/1LQ]\K6,2
MCUDVB:>H>5NY]>VTF.N1ZU8J;N&:/:U_8N7E%\PIPD;ML6%J8^.T*O"$C89C
MHS?4NH/3\G@(&TW'1D\;&82-,X?-]TVQVC@PM(%QF]J$Y,XM$3BG\VBDDUJC
MDTRMW[]-/5W221=,+VR*3KK!&;?J><P^<L=EUMQW+%$_7QF[ZQYPEIW*S]I<
M166<?N?Q!3S1]2)=7S.[%SDQU7C2=7M:KW.1^KB-)YTYUGJCRUY7V,QL8U,;
MCND"N8HSR1B5SH1M2DXX :20GU(;FV6='R3%UY;B06O/FK7L9,?OT5P$IR6/
M'8F55![@9N\TN_\"V8RUHIMQF?!CX^G6[UPDI-]XNG5[E\5;,UVYH]L<%B .
M%=<')AWX(8 <76AO$XTA%A7?R8Y;>TEH:ZI"KO/(+9<[BY M ]\282CLASIF
ME/?.&"2KY-D':H/:H#:N?E:H+LZN+UBBI'6^KOZHIY\6;VR[]Z$_@&T:4>ZD
M+&2C;Q#J3J1=9SS2R>]U@E??O%%>-?&HN$>W]%UF3=DT$SX*K;G=&WE&B4<E
MJA&-6BK#E"K>\.(*IS*U-M9E;SP^T;9L>^)N;S@^<4?3=LJ-1UV=DL5/HERW
MIY]6**3E"8SCTB8*)9E>W8J\31[P[:U(PD<A?(QNE(1,/"IQ:+CL9KTI,DQE
M]O*'ANNX"7S5H>$ZAQA&?8IKG48X4Q\3X4[+9R3*G4BY4S?/[792FS>ZDH58
M5()%;8TC$#Z*>0C*GO<G$281KNH&\/6AP-M,^V_"@P\MO'AB*;P0QLX"'@G*
M@*]B1B^U06U0&Y0!?U(&?#--E-&HM>?TR(8M!)#RU6X((*T"R)"2E@D@QP%"
M]W/6_RY):J/^]W-6,D[>BHSI9F:XP.ZAK&IO2HH+I4 5W#V4-0X)(*T"")5$
M)H"\L'MH:[7=JKB!J8UJMD%9MBW(LFVH3ZB]%VJ1T[ @0&Z3WD0 J0U !@00
M @@!A,(.U,8)88>W$9^X(K4[SY] 6<!N-D^VF_]5YK^\A7UH%V.,4HWF>+;P
MHH=[_,VYY7E4@":P+3!^N,A>IDCOCSFJC/2!I,)G(=A?_FMDFIW'SV*V /JP
M=QYW5Z$3RE\;CXQ/_"?!'(]%<R=D@5CZ0<2F?L X_,/R/<MQ'8ZL9OZ4K8,^
MGT7P!'NWD(5)L_Y2!/":-X.F+'\AV-W?WKW[Q!:"AW$@?F"1S[C][SB,A+WS
MKL:>YXXUQ\X#$4)K(0Q&L/?^ JBXPH$:PT<L5 VO.TONIJWBB-+^H4D8--#0
M$GH-D6-6#3D[X3T ARVF\*W->)C6#I\ZKHN_B(!W$6[IN0<+]5)8#G>C5?K+
MI6K+$:&&''=C[&XOBW<^D W^]N5]KHU)'#'Q+6WG(W>\2'C(>?9>>12X!2K)
MB58IL&#LJE\8Z[,#0/=D[XN,$\+BD9CYP4K?UQZ :^$ *D&-S1Q0OS!]1X+.
M!5XMQ&(B@A 1CN3 EIT VUZW@JBV F>)4H30!HT_FZO>_< 6 1#6!14:K!B*
M7022]_Z?G],9KZD81CY 'B43QQ[R!38L9QMFVJHC^+M5 W_6._4"[OD>G9CA
M[)2C_LP@4<$PS B)0J%J5SX. 0NHVCZO7WGO>YZPHHM0J:^;KUCP37UT;,$'
M2W[8>[P9=[_[<7W)@6-]!8;%2\6SO)X![@!KGP4(+P^WI'7#Z6+Z"FPYH21T
MGQX)_%G %W64T5[59/1#*DDP&F592#L M# 8+0A(-N[<VWRUK7U]R1SQG]AY
MXJZT7*:HDL%0ZNYY7V=?T"S*=!"(J0NRJ$P4$&\$AD)'N*WI$V%G? F,_^8L
M8(EQ5TEGD20/ML$7L &0PX"W[!@:A%& @HB72UAE<-\ F O@!S2AF(=&CIOK
MZ#"<%CR8.=Z]VN,^=-?@^?&OD^#MCZ4_N\#V6+;XX$2@.*P<$(9[80CRATS@
ML%3> V>0D!_AHWG(?O%P<?][[ GE/>AV-&9V3),] 0_A!X/M3/<H+:X_X_V"
M]X=X$EXLPBJIC)>]&W+H<H<QN(SV+S2$O.(P>KJ,=\GS(B#&BJXHI %L)P \
M;^ %-@%]#S*EH2EF&/KP>PWE[DT/%KKT&4O,1R7("X4_<0A_6?'%K\!F@Z97
M@@?X(X@:S)K9 :RH'INL,L-9;MW3\^2[,>Z59H'_'*$ED;$AUN^BN3P)\$_'
MF[IRWZ8QZ#^"]Z ??SH-183]@)*$'5B,^B6Q9:4MZ2Q "3T)%+)P5Z\4D)@7
M5$O"G1ZZ"79-BF?'CN:);RS[5:*).IM/^"0$<D2'/\GX_2R8C AN) 3]SE:D
M,//G/-@(\4S<3X#Q7^_Y% ;[P-UG6 2^>YO7RZ"4LP3<GOMA#E1.K?V^=@&(
M;W@"EQ3<^13<+FU3C778?9.:*F"X0R<ST#)X0IJK#3VW 7E.& 522M>M/L+&
M".P0*W$/R3<7/JB:/]4ODO<>Y9/U4*2P*W5XU%&0VR]M#V')5X'ONAH3BZ7K
MKT -3V"\4]RC8V>^9<7 #-2=?KA/D1&VSHFM]0)J&'VVR"R@W:[>_UZ[TGH)
M%G$4@/D<!S@\N1#"5MH3(0XQ$K- H5(BXEQ#TMFN64G8.A^V8#O.T?N&2S@L
MD7*OEC?? H&>-LE^942XTK8)05>@7H.=F:$;WTLX=/3Q]\AXP4&QR%U? H![
M"0#LQ_'M(SC 1G KH2'60'>I[DXRDVZ_ K\[Y(TG0)\+T =)G-.9G4Y.9_;E
MGN-L^NG+?-,;MGHP",.>I>]KCX956P+8D,2!->>R6 H&AOR%8^4<^IM)X>8B
M<"9QXD(+_$4R+NG?4&MTF)H@B21NN]8P+KK,]ND',^XEMH6<5[B9&7KO G'J
M1D<#0^;(T+.;J[= 6!^&&VQ;).OIH(/^/;2,_/@%NH[2*,:-5RH2Z[.)=<A6
M?HQ+D .='+6K-['+37AR'6L%1G%--A7._=BUU;J5NH^G8-_ZSU*N%AB3Y=)*
MEXTH<WOBQ\HIG8+GH1B+NP-B\8L^HCT*24R!^)'T(-\Y/RC!D_L6W.F (D!6
M*14#"N7.25_Q)_(5#P:[EG(4>7@C?47&"O$ED-5$+TG&!F("6R5H;2J4#D'M
M8SNAA0[C7(P<0_4"U%"BL8 F,;JFXT $<BOENR+D+D8IL>O=J$6J)'%R<P[=
M QM@).C=]H^L&3K[X"FE:\4N#S2I?P3JO"?E"\<H_6;W^=-'^-&&IH*5ZL7B
M,>K#[$3D]DTJ6'@]3-SYZ[&%,&0A0[@IJ<$^A)YG\#X*29*F\ +A$F+9.?4N
M8AG"RM-.3A !HAQIL#9^%='2A;>9O?(XKH )16= @,B'B<%RY<V@5SE!UUDX
M47Z&:SSQB8P,XK1@M<()8#0Y7((2\ .Y%%LJ3,[7V_-UP"D-RB>Y';:##0 Y
M8/%+\SI@QLG3$#C!;6V=\.'E*8[&=A+/@!4U@F;L'-V5#5&BI_3WJ.*@_?03
M"S?IT;,0"@UV$,^2M1A(!AR4BU:.!EGCXJ.P@3W _$\ -R4V/V^_#:L]ERA+
MIZB:7W+'7L?-9;>3U1J0R4*9*02'\H=:6*]IQ.#@_>YD 9PWA+#MH%\3>CN1
MR8LQ0T1%^#9AN]W/TLP0/PXVC:\=6S 3CGH.P9W %;X!* M'ZDO\:DL]9#2\
MKU[PGSV5<)!/U-F\B/DOV(_T"L:AC%&"("]$A/4205ID@#N,\/LGV"J@11.N
M!1OU)G=W9Y9Z "U4ABK@&69C[HG6@85";<+OT8"^5S^CN1R[41J*34:22&E*
M%CE<967#*ABA I6K1-9B@ME,8Q<[V<PA341*%[OI%E>3J NN@JFK=,L!(1>L
M];J8CI5D[9*FV'([.6T'<&BUI ']3*Q_ EO)K,>RA[ZA2[HG88 YTT_+= X&
MAYOZRM,5:X-#CF9EI,9AH5I Z\I5HC1U8<\ C<A-XJ'Q[(_[;7:Z[W__YX>?
M[XTQB+$%E@97^0X$W$L"-Y=Q>")F37UT7<QNP+D7NH#5O:E.V2P:0M6Y4/7+
MMVS^[$9=[)5F+5FL#ELJ&Y:BW_$X!%,3^ORNJ%K8U0=J1A.TSP7M P3&?21L
MS-'#$"F#%XCLK$7@9=_;+&U7[3BS&7H9Y1NDJ9[H\I9NGF@KSV[OZR_:RP)D
M*,9IR+1#V K+L)'4JXGG>Z-G(Q G6.L#/DMG!RWB:]DI@&4[5WOH%;H0&7^"
M104/!4D];0&MT8\!&EVF'8+80>=I.!UVPM+*3JP Z;*27F:4[<0_GN:S9SQ%
M5@PF]4+Z0RYE@Z\W *7,;(J^GM5<>5F6%%=FAR1UO9H \+%&\2L,%:Q@N_[\
M6$1+GH8X)/); SP4X^)KNQA;5 ET.='7E)<1I2I2\2$I<3#.%PSJ\T7RRJ[\
M>\ARG'M('&#:2$7+1^/2[#M+?+R]F8)&GA:MRQ0LD/+]V?E&"=^TLITKX7NH
M#_()WQW=3!*^1Z;>W4[X#@%]E.Y=,7FA3.*;97OV1KG,)=/(9GM>5%A.R:!Y
MW8#(A57]/,]./L\S83IE=U)VY\VR.TUSG-.10P#IF50DY78V);?SW"M3+304
MI:G4.W3>AZW2!6V]5P3.05_PKR#%1Z+F:'@$#N:DV;LN1@J<5P^VYPZ<7P&Q
M%#:O$*8N&#8?% R;MW*5?R%H?@N$4LRPPC'#87[O7BYB.-1[#8H8OG9W>,MX
M89&QGS5:6++2$44@]T8@S<,12!RN8__W=\[8FEJ=GC4>]BW>FW2GHZ%M]L?F
M=&B+:<?J&?\:&]\U,6QY-$CYA\R3>8N%*I,ZJQ59KH_R^TONF*'23V&\0%WW
M9U*<+#.Q8T<:4QMG(\FIOW7W4.*/?TUZ2N4%"R5B_6.7+T/QD/[PB.K&Y:L'
MQY,CEQ\]YN5\3[%A*4OJ\08^>D=!*+EU)>DY>:S+1UM5QM4S$S:Y1O_@XXYN
M''QVK%E8Y :]DUH]_JP[.JU5&BN-]?A8S6Z7QMKVL?;,0JV^<+]5JM8]'PO$
M'JN.3V]>_LT7F%7B+@-Z]9ROFL;FD@AE("4F#]YL ML)QV9H'QZ[%$YM):YS
MW\GX)2M9VE_OY='XW)TGK\7?>.?56E!B3^E:N3' ;3*#'7*!>V&:2IKM%,\+
MTB61+"QD7F>QV@53GF;XCR0S5CI<BEPZ]")EVD/>XX \2MR"VJWLC9Z7(<)!
MS_X^LJBQVL+R54+#@SS.HXK^?_"2LC8J[R74\+(.L8PR"5[A:S!8.P0A/LXU
MX2*W2C6)<$6T55MI0Z B4)V7-F\(42=0K<@UCJTD#,'I]7"Z]G7Q5PY$=;)G
MWAZ*X.70A,\&I$M>[$F#I$'2(&F0!?WONSU-Y7][+[L>ZL-^Q17]I^242.&[
MO?=,=^]%YI6;Z6'3Y]B][7NF.ZS'5>9F7^N;HY/6[ZU);PL@8:/VV.AJ@\Z8
ML$'8V)UOOZ,9W2YA@["Q.]_>0.MT"!NG8:/4%*N- T,;&V,54WK-+(WRJ#\G
MYDX5UKWXJQZ31KIQ$Q;=8JY%'+ZDDQJMDWI@MG1()U6;26/]-BRZO4XZ4]2@
M+GZE].SA:^('^PSDRB-\.!R<8\[G<)S6BFZ&9ABG>22(<H-.GRAWVC:F?]IN
MMBCECJWB>RA7DU7\KMOK_E!X!3^RD%W*R&H[>SKZ\-K\N;V%1> H*+LCDMWJ
MLL<8ZE?GS^UEMV51]W^(*+F30]ZLD=2$O'/],-SA_:GDJ(T5=F?L OZLKI2F
M$DX6?C!W7"E$NV++(('NM!#@1<G63+?G/A5'3NGJ< <+TER;0;<WN@@=A= Q
MNCHTB#ME]DM=?=P^V3UG.,DP=;/J.Z;\E4$7.9523WO,'&CFZ.8AIZ81M:<-
M3\R=)J(>3"PUM&&G1T0][W9LI'4ZA8Z=7]+16HRH-3$I#*W?'Y7,4BE%AQIY
MT!O%V('>K1A;;V]'$J9>1\TNK&EFQ5!%C#U''I<^K!A;;Z\LSAFE,ZH?I7OO
MA[(^__HF->"EW;KPG#$&>^@TL[WML1)CJ(W[IQGG;2===Z1U3\P';3WI>MIX
M?%F!;:8O&1-IR]IRY/"_^JFVVQP\O+WU1?@HMB'KFGT2XFHS::S?AD6W%V*Z
MBX'>K,6;;:AR^/OZ5G:\?MC#F\U;=UX1-PN7C1\UEW*C_I H=\I&JZ,9 P+=
M29:3-C(O&T-OYKD:HUO6XJ2C3]=.NM%/C+K7?E- ^"BTL^_>!A_$HN(LTGLM
M%>&6'6#<LW/B\#_V/<9+HV*YNLUT;1GM+7%$OL^" !D00 @@QP!2-O6( -(F
M@)B=UH9/;I@#0FW4H(UV12U4W9#7[+5J6K;VU&UT3<JL&]JPU[F$AXB@47]H
MC"]3)I.@47=H=#73O$@U2X)&_:%AC"X2-6P!-$I-L=HPN#.&)4IE4/3DVNP9
MZU<OJUN?+3UIH@9IHF[9)'Y21M?>:.@G'FNNO4)J;2@W*4-+@=RD6@2%Z2@*
M<YAFP]+I:H2/-N%C4'H!)7RT"Q^TOM0_X$AMU#^(:SM/MQ&+=_:_XS 2-O.W
M;?!47LXZJH'>+S"LQZ4?.I'C@QX1+@SJ23QB+:/[KOQZFX8\%-@ ^A8WKBM)
MT!8Y9AH>/3"TT65.:Q$TZ@X-4^OT*!Q-T-@;<^P-+G(\EJ#1 &CT*%.A]4&@
M.V-T]6LJ*0)4)AQM4#B:-%$+-)%YFV.KI(P*<ZAS:CGFVBNDEH6C#_O$*"Z=
MQ!T-BAM07.D@S4:E;[D@?+0)'P,Z74SX.+J^4-Y"_6.HU$;]X]*WD(@_$J.:
MW4U6;,'_[0=LYOMV^!;:>W(LP?"3\(>'JA1OI#:H#6KCAFVTS#WQ:<Z#!;=6
MKS&.:NKO/=7NK4E0TNQH'>.T@/4+A@=AH^[8,$;::'A:Q)JPT7!L=,=:_\0<
M*,)&T[$QT(;]T^Z1)VR4FF*U<6!H1J]LB/D\7C5R?)9PC%-@C712:W22J0W'
MMP$\Z:02P9BV'A(\D[.]+GZE7P-XA7V._$"T[PZROC;L#JH24:@9Y<P3[V9O
M.^4,XU)'EQI/NK$V&E]67)N9P]H;W::D$K&HQ,7$;:UZ1?@HZ,CIETVO)"&^
M^M).AP7:$8W_/9J+X!RNK%K97_V^496\Q5K1;= ANIT:O3CM.@JB7+=S6N64
M=KL][_J=XB>/R2E];>Z,RM0I;XI#FK!1K*;#P"31K3![3+W7/MEM63#I'R)B
MCO<DPF@AO"@]/WWG^F&XP_O&>ZOOC-%9)MTZ-_]?_FMD&N:.#X5H5P1TW5TM
M2X0K$B.AP-)Y5!RYHZO#G4Y'+[&?;8HOFM!1;#-]=6@0=\K<F-?5KWYGWNUE
M]TQQI.J78/\4B- *G"46/ _9U'%=8=>Q^KIYH/IZXUWL\%O](B=L&D^Y[KBG
MGY8[V';*#<=]HMQIE!N,+RRMS?3;#G0Z/E9Q%AFM/:I!^"ATWJI_(X 0CXJ;
M1*VMG=F:.[<^\X6 /O&<5<A=:-?QK$# 1HK=V4+]],-#'7> W=?L .M0:8K:
MH#:H#:K,=D"Q?\&B\"VK!3_2.RVU5\B>+;0G-5MKT!) BIUW)'P0/H[Y':D8
M?/T+EU,;E2T&7Q?K^E#=XT+ZK[[Y'^7K+S4E X3R@PH:V+>Y.I  4@^ C/01
MX8/P<00?5'"F_JY6:H/<U^<K -DR)_;X1KE-]5&![?9!@8U-40X"R!& &.2E
M)( <.\73:6/1@ZIX2JF-:K9Q@Y2_M.VDB7M\_V$@C?-;^;4SY[_8D^_&"U''
MY+\7CW\UTWO2+7UE"WE/VN1=,WKD?B6 '*%93^\3/@@?%/\E]SRU<0OW?/4/
M#/U->/"AQ6PG7 HOA+&S@$>B?IL$]KI=0GW=/Z-1Z56>?$!M\@^.^J4OC""
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M^E.DETKD9W?L/')JC&SD+SDQ<^1$\4Z][<?D-W@Q2C]_[=):0)*1ID(7V"+
MFV!<O@S%0_K#(^H7EZ\>'$_.7'[TF.]OS[4KLC_U>(-!O:-PF-PWF?2</-;E
MHZW[EM0S<Z!WQN;!QQVP[PX].];L4!\,#W]YK-7CS[JC7FW&VN\>[O/TL79&
MPYJ,=:"/>Z>UVAP,U&FL;<?K$%H=%6KUA9M]4[7N^7@WUK%[PNC-R[_Y K-*
MW.I&KY[S5=/87)>G#*3$Y,$['F%/XM@,[<MCUV$K<^LZ-S^.7S*UI?WU7M80
MR=W^^%K\C7=>K04E]MS_(C<6N"]FL"4N<$-F4TFS?>3A@G1)) NW*G46JUTP
MY6F&_TA.BD@/2Y'K5U^D3'O(>QR01XE;4+OM(0.Z4J],A(/>^WUD46.UL<R>
M]!@^R).4ZK[3#UX:N0[Q$CE++*-,PD7X&OC5#CP(C7--N,C5NDTB7!%%U5;:
M$*@(5.>ES1M"U E4*W*7?2L)0W!Z/9Q>,!\GW/HZ"WRPO.Z3X5F6$-/IL2E?
MSZY\.8;5R1[_?BB"ET,3/AN07J+H:]J@0=(@:9 TR(*N]]V>IO*_;>W.\.^A
M/NQ77-%_"L3"B1<AVU;T9>;;8758TW9LGU)3S$XMP%8K-3<CN9+A-5-,45MB
MJJ5$<JO+;;$FP!'@"' $N -SZYH$. +<-0'7)< 1X*XX-YG]:S[6'G6;;)ER
MNZ:]""0VW7J^17SII)D:K9GNC!]('U66.5V]<VWVW%X/G2D(4Q<WW6<1/#G6
MD2R=8]C>,_6:8-L8EUQFCW#Y4MJGJ+>ZH1PJZP<B#E5]'TL<NC*'3-)R%>=0
MCQA4;0:9 WUX$Q[=WA(F@) $-X!!1E<?M52"6Y9R\@\190KL;9>Q;(?39C@@
M-W^U.63TZQ]P;CJ+A@:QJ-HL,OOUSQ-J.(ONA@.*[E27._U.&\,[!(Y"X!CU
M2'2KRYVNJ8_;)[I7.AX7^<L;33=_E^9K(K*%3T@61_SMR&(8G=/\-V7.B184
M!T6%6WG?FL764=E],+&U!FPUNV4]4,36&K"U:YP8!B.V5IFM=T.SN"%)'*T#
M1[MCO83?Y=(\O?VV@0#U6E] B23MUJF(^K'3[)]3/]1<.9PI0EY=G\)[/Y37
MOBS5#?0ALLZ^?DS\AMO,LLZ#5[G+3M!2-_=EWHXW9?-RB#77V\:3V%26-\95
M<WR(-Z7DAEA36=;T]1LHM=O;N 2-LR=QD]22U%9M9UJW:/=/PA-3)X+)A=$-
MCA_?TGP[,?!91\=9W9C3O^IY'N)-J:7 +)N63<RY&G/&5SUK3+PIYP.]Z@DX
M8DXY3UNGM(5[!O;<WL(E;+PLN":9BA5F3E>_ 7MN+[B-#YK^OA1XS9TW8^+;
M4GCAB<G8-?6X],;D#JLL<_JE:_H0<ZZW(FC=WE5/#A-[2FU1^Q0XK2QS[KK]
M*QUI([Z4XLN@3+I@(T(OA(J7CX.,KEI^@42VE '?T:]ZQ415Y+;Q(=/-OM3U
MP]V;U<HX6YIU1*'?K]"1E\J=4:@E2WN=$B4.B*5U8"ENCTE.&\;48;]$J1AB
M:1U8:O2&Q-)FL;3;+U,QB X%$Z!>LKC'5#B@82P=CO02+MCFZXBKAKEMY^DV
M<WYG_SL.(V$S?[]SX:QC&NC] H-Z7/JA$SD^X$.X,*0G\8CXNN_*K[<+U/%0
M8 /YR^0D.=O@Z[OK]REN4DG&= ?7JM%(C"E7SV1PK;JWQ)ARD<8RQ:B(,5=T
M"(RN&P(FQA2OX7VM0LU5L<H)%D7D=43R6D7&F*.KU=ROBKS*7?3;B$]<D>[+
MSK_7+;"O-$_>5_ZKS'_Y'2C\D<XQX>(]N@ >C%&*4\>SA1<]W.-OSLVO40&:
MY+;-5^_],4>5D3Z05/@L!/O+?XU,L_/X6<SD75[O/.ZN0B>4OS8>&9_X3X(Y
M'HOF3L@"L?2#B$W]@''XA^5[EN,Z'%F-M<_>^P$\YY%X^WLT%P$+DT:W/!YW
M?WOW[A-;"![&@?B!13[C^WTC&GN>.]8<NPU$""V%, P!W2R ?BL<HC%\#-DR
M<& <2^ZF;>)8TKZA01@N4,\2^D',+'@P<[Q[58/_H;M&R(]_G01O?RS]V044
M@6SQP8E 9JP<MX=[L08DPMGS8,7NV9=Y (S^"!_-0_8+R('-_AY[0F4N=3L:
M,SNFR9Y"'7\PV,YTC]+B^C/>+UU_;%?SKX!>>%F/RZ%+61L\7D0Y%!I"7CL8
M/533&XJB? '2H5,FU;E B5V7.41=H*0T(YK,\T& O1GJ !_XY\"+J#,L2RSA
M1P\&;8' ^PL1@)"',7S-0^:". EFP7K \# 0*)60<<^6+=U'(EC LP"5$<@X
MRO-Z$(<%^Z9,+XG@BL(@?UD&LX45@)8%'?)F:#(8@PM\TI"[6 _Y>PW!\<8P
M.NDCM78 9J026B@E) XI(0OQ$\ S: 6_ NA!RRO!@PP*[0 L"H]-5H",9X"8
MM^\Z2C8-_ 5^](2(%?^)G6B5>2M%5OH]S,D%0H%9S)?(,3;C@+-S#7X7H+70
MJ2^%+*HE;G44KD,4!@RG4F:,!E>1)7PEC +AS> G#T<"5A2:70'(3-KSMNEU
M4#5/XA ($"HQPR]3O2&;VB^QM@BMP)G B*7567FA*6!Z?7:^D>%%:_#EUN"1
MD5N#L>9XL@:;W1V]$0(::[H"OV[HE5<E35A_FR%JA5;DT14DJP;K<<JOA*@]
M].[MNOZ>'3N:)R[+[%>)VZ2S^81/8+<81X<_R?AB+1BH"&YD3?8'6PDPF3]Q
MN([]W]\Y8VMJ=7K6>-BW>&_2G8Z&MMD?F].A+:8=JV?\:SS\+OUH'FQ$>";N
M)\":K_=\"C-\X.XS7X7?O<U[GASO/DOU;8(=5F^75W)'K:/?'%@';%P)$(CO
M$U7_APC].+#V&!$5T],'3#X>SMFOL)159?Q'P?LEXZ=9P!H;R766,Q?,"Q>5
MC+OF41A/IX[EH$Y +ZT+4V2._'DA4&7 (F[AW#TA[,U2/?>#2"HAG?W^!*L[
M_A(5$\/?:3D_$4P&\!YN6D)4I 8 :+_8BM"?BQWR;\X"9@G-@V:;^ZX-+0<"
M'H/EDTY#MC-U/%!Y#C1@^9XM-8ML=OW2U!7?G(GCX@S1?36-92?0'1@J,\>"
MB<!74GF!:9XE%S0(*T+LQR&H:AZ"]@R3P0=B%H.^\\'J3X<?H,D3"&GK:.S9
M#[ZB$D^?2I)IH&,GD3*$@/H!T$*Q(7VRX# TR0EK+NS8%=JZ 5DQ!Z:'0\]W
M!<AR8,&WV9*O_!A_L_0C>(0DD=1#ASJ(VURJ?^P\H4#6.)/N.FA5J>8M.DR$
MZXBG9.J;A5)R<(IRH.%JMQ"!9,.2PQOHK)L%'/@/ZPX,FTTYQ@XB1\#+/&3/
MPG7Q;VQ^,]QD8!,_"/QGZ ()"2LO#& +F]-8K6NA2+^!R6?-S'1=S/'V78AX
MWUVK\R"=<U@!ES!^0" @!%C_QC!U@TTV-D &N_ #<N.)NXH;6U_V]='Z0^A;
MN4Z?8>)SX=KINH]V@A<IBP$& +SP? _6_BAP++1-PG@2@H2"R2#V.#\KJG/0
MR #,>3.14DS;(9>D86:B\KD-(H#:HZ"=A4W(_312E:.'&O56^/!2& =#E/U\
M6'MM9,BPZL9PD:G80#N7+T/QD/[P:#OATN6K!\>3%) ?/>:#1'L"H+(_]7BS
MCNL=M98G:=%)S\EC73[:"FNK9_V>WNOW#S[NZ,;!9\>:->##_O"D9H\_ZXYZ
M[1[L2!^/:C36L5FHU1=2^E_,21GOO+HGZ41)YW4N4A^_9-U*<=UV]TD5C"J*
M@78JD%W55+J\EVJ_S*&/DF<[+CRYXOL!/%4AQPK[:TR%P&TMF"8B4"DN'SRU
M6"7N S /Q#>,B6*: K(-C>$B67@E#@-5&QFX8I]KP@>EIJ&$,\ZA49I(FS>$
MJ!.H=I,:/Y>9<,$$RG_@C@1W&+!#PRVSW']MMK/<@FVBW*%>[+#FWF3:RM%I
M1Y[.-_\7TVMO.O&QUNF4+65YN?.Z:U*<\Q@V0;D=4!YIP^Z)-X<0E G*59JX
M.1@V&\@W+HUQ4^9V]1/OGKHD<RMRNN?R-3*J88['F&:!T3P9CSINBE_^&-M-
M:7+7TPRS>Z6C;*<ILYN?,[PM@TQM/+S6V6!BT D,,C2C=ZT*(<2@$QC4'5VM
M\GV=5_0Z.]C2%3W)S7G]BOZJJ\QN"_>^9AA&Z?IO-=V>U)%! ZUOE"^Z2 RZ
M%H,,K=>YZ@7%Q*03G#2&7O;FDO/PJ(8K^Q&39J@/^S58Y-/3!.4R^\K:?(F+
M9U-O@=E^C(EYZ21;Z^$]/X&J+7!WIEF^\M+YJ'/C#2')"<E)T5K39:X8(#DA
M.6FGG/2-$V_[;8RLE'$R7EANJ@>/P;CT9J8*^*C(5NA 4<*J'^K<U/$H=\(J
M'?I.=;BM ^?M*X]SD /%C^<73MF\S+T*!<FY*18 HWMC#H;GK1>@#F.FG<AS
M;ID* K%(OXB<15(W8'T8LN19NC(E-0CWU\#]L=R("F'>R)^//6^-#(5PK$"*
MY?^2+K9/C>+A3_QE[$8H 7($W)6U0>>"N]$<_OF$1XJQ+"&LW)$\0YR<PX4F
M)V+.W2F^OBY5*+U;OO?OV%.]/CO1/-?P)[[ZU17?-#S B^>78;#^=!H"[W*E
M<C:'K^&;[8HXV!Z8$B'*M&_)@_6RD,Z>?O3#E6!("*\AA/O"F3<5PDUE*"P!
MU7^]$+X9Z/WM-K87HFWG[W'R;%<3E=THV0C$>IW",A3K,_NR%,+95J[]TKE;
M&*$XQ?;(82U,W,_K2AWLIW6%A:I/93_PWV_*37R2Y290E?X$N[+[>,G>JXH3
MOZXK3E2H*D):9,*&;9_G1VS.GP13M4:V"FA@*8\(IB7EZ4#A"IU]D$N4)S(K
ME"RN<K <1W2@',P;4^^DDJ^!*#^)>[D.QUXHK!@E:Y*0-Q!/OOLD"X#D2GNL
MTOK=XMO2"7"U\]A'OE(C-@9RQ'WMDETQPY"]0%^(AXOVI.8S5"IQI\9)4CP'
MR\ULBIDP'K$GT(5^'#*L/8/ES>%7J(AL@=5=0!5JJ(=086G8T][RY_$$9$0I
M2;4-2H-MLBA,CL%8N1D&RYG")9;V2LK._">&/D0 .C&=*)L*:6SD"YAT]$[W
M>PWKW?# =K&B&+P2A]#$"^548"3/^(?G9RF0!;4\)RVQG]AKVS-->;-#W:K4
M0"FIM'X5,&&0R/_!:FN_^3"DG[CW%6?_DP\FIU<1-?5N4V]FFS7,056Q$(L)
M*BCUZ*59L3M\*[EWX-?_^>VGGY++!GZ0"$J;4YHITS.LRO)7/"G=!%CV)[*@
MD[+W[2>L="?KB4_^#?H/7[!$(-^ ?;"SB!?HY42;(]@JSZ2$5I:8@I?6\,1:
M2X Q+%;VQ!U7UH!9V^)RY <5L2H^DR_],^ZNJV(7EY6<UD^FN#6(%[?B266;
M4I<:E/JF?04 AX<+ -Z@EM]1WMW>SOQM;<E7SLP\RN4/:FG?K0@FOJ$M);=9
MJEH7: K79?Y2W82BZM!E);>K][]GH? <6<H+5WIT8OP]=E>;FE6PJ E01[8T
M$J1*@X;FJ4L "Z*!1GBS3JM*-V5\-L/%.!*9>U#X AT:55D5C]+X=T^1P>CO
M*[W&/0]F8DE"<RPXJ,J_I?0O2GY3'^ZC_S_\)[5R21[<.6$8*_?5.Q%Y'$QI
M2_]!LD9VJOCS$G<ZA;DCUQQL=*'&#4LIUO2SDBVQ;X%!BIU@);X)S(:]BV=Q
M&*TI51?V)L,VS\3?L 2#?Q96AL'(K%Z1%^^ 4VYLI^X&6*._J<)U=O+)!BF_
M+SP'2^UJIZ'%W!9F>.--=SS.50DZ J(0+?$000,+K;O:QE0H]Q+'4?59+",U
M=Z-:N"JYR/R,^Y_W(-$>![I49 Y%M_\[6YQ#VT\GJ=BYV;#FL(P%2J5%+%W6
M:#6G;G' 1Z8R*C:1J=N94DWB!\1N_0MF^](KH00"'1/R$A]7!.M+O_9MU+*U
M2YV-*PWKUTMG/(=VG[U9P&UQJ))U,NUD0YLO/VK[T"8.*ZE#*AM83Q1AG]!!
MN2&CK3FA/1XH_Q^?3G&GD"\;"]3<T"93++9HO5 T_66D8+%T'5E]6[IAI J;
MRKXD?394KPA83Q&X/Q1_;NGSWDK,J+# %X+/GEKN$BZ(JD#ZRY.M\T^<F^DU
M?; 2??1]>_/Q!QE5 B1_%L&38R7K$[M+OLV]G&Z_I59(&U_ORK'MS[C.\L!6
MP_X+7RP?V2??#];=_;H6GJ2_D/WVV_MU=Y_E)Y_2CI0W[IA;<G>VG^X/3S8S
M[G>YUY)^E?: Q<[U_:^'W&A;Y 9K+!V\3%\ITODGN8]]$OM& 'L)53 ZM2H.
M*+RTY']>I:P++DLS"3;.\SVC2/I"Y1<ZMH#V-#03, - 7L<8S54%Y;V][]3<
MEG6AUVQ=RFO<1)@MU:P8Z,F4)<FJ"7>EN@OG0J#C$I[/'40A)B=ERTFG\2!5
M!5Z-;M.7X\D;&R/E)W&CN1_/\M?+P<J'!9+=K4K46RQ,G:&)/;;@Z["YO.5
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M,:#@F)#%:@07%=0*UMC(%!W"!R2VRK2'@B,;.SUT1H!.!N?'3-):VW>0QD=
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MJZIKAKRKMB-B@S3Z^=S=BB:7"*?7IGPHX?02[7U@U 2<-*)9 C;PBZM/ANS
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MK5<:5=.:2@>$$=WK>H^2;9WF1$9"/"J6H=!<OD2$MQG;?#%^AH1MQ[6G+T1
M$V1G'H-D>X24 0+N)1/XJQ^"BAY0P$,"E"$)R,MRTF8AH\ZRRO]1MRF/Z^G;
ME$L8Q88:&,5J<W.?-C=WQ+\U2N/>@DCRR7;-%\LCKLL'/ ;(17Y!+(21O!!$
M7T\>CH<(.W<BYCSH'Y('><"MS)#T<R=:_QA#Y2>H>[$13K['=^ (Y!S/9TAS
MFYHR2"7+E6<QR9]-=,N('+651_HB')*2 16/+D;:@*D'S[=&H^A&-H8>$19>
M<M- #B""!R2#ZM,Q20H*8(_',6IS!+MSS,H3P7XL:5\IWE[@CHD%F;_\W')-
MBB>X=PXV3[K172%<H[1GEB@/X?%-N2(1ZE/J]8G(ZH*AQ7VA\!1&9(F63FLI
MN!. EKP5KWG8$C,#]\1*G;QQ$C5#%B"]UE'JG56Y!S)P[NM*J]M:Z;'9WVF=
M?.CY2S565;3&\:XTMLV=U_JY&0IJ;$MIJ_D:NWHM<E*A$:G'NL.=CM):>.IF
M+ORH9\>J7]'0DT6Z0VO_OK(K,D$;ET=&[[DK!T]-7;Q!=XUQAC,0T0GZ3/SH
M3CK')610!PE\VB=Q]2@*(8E )")F!P]'Z+>)D"!*[D.+:FYFT>]94XN^T3TI
M5*#?HGO$=<]<I4=O]&'/MATX%&;0=P!:(ZX6;[JCN&N9>NW]&X5>&!&35,XQ
M+$:9_0FA<=*HT.\0*>-UU[H0^7=3#,@7,VG@GL!TRGO-I89E@8N9SU+V^5)O
M,#@MA>]9O&H20^%:(Z8&6Z#(D,;H4[G629VKC<6R$+$LQ+Y<% RC=2:[%154
MG>6M?=ZJO'"!TCB=X<&.!ROO%P9\BT+)+XP,Z[!PHLY:F&('M70Z\/?"QG&)
M\:LF<T&3N;)6>S[ E;7Z&-:J4^//QW^JUB[IE-Z%K$1.<?, >RXNA,_$]G*>
MJ'!/+69QMF^!B=L?8[5#9J><,Z+2MDK;]E';\COY#;CKO<CPP-[UG"/'#]>1
MW]E3HY-WY,N\[MD?^Y6OB]6L*ULZI3(.E7&HC,-F4AL;S%[D,0F4:!&'DC3>
M'L.9PA$G*<L/F6E=FU VO,8LYM)JMGS(V9*,F?QQJS74]51K-*MJC;VLUM@J
M;A,9J/S_GYL#'7%%GR8.(&78EN-&"B-VH8S@QK&+ N]JM#^58V";2P_L-7\0
M>] 'IO\616?:C0'U62\HE"AH:+5Z28:VM?30OA/-H$Q:^G&#B,9:@@A-*RR(
MD-?Q'O:/N-0 5/W$FX['NON6+K2M1QBQYIJ_AM:SY9]NO8$;+!)=;KR*MV_'
M"F,7- [SWF>16I;*A$&]HIA1'AM9R,B!%8B61W5IQP2^;XV@]L\#*"0_'Y*&
M$DB(ZNT-@EG2H1H?0 R\'^S@7X?X=-X+KMZ(Q(JH1'R4"5S7&0,7!3$.3."\
M-#*'N"Y@'PA@U^ E!'/K#W5;@/2*WB#P^]CR$<S#)/QY?NE; &8>(#T1U+"X
M#5]$%X0%C@J[BY0TDGSJZL'SX4'S\,"R+ *'(I8$P!UX./JC)G@(H&+7A1L!
MU.&9O_W%-:F0<#!U;<L;RB+)F0K> -T-@54(!5+GDID@D#'B&8O.639_PQ2E
MB)6<EI?>O01@R!6G[?:<4(I^WIQ??&./M^SBV^^77RX?'W(61&Z\_+';53HM
M;97JQX[2KG?77O76Z2KU;KXR/)&AG0ET-!)B<>F:M9UHXT.^^=F)08A:3]WF
MWL'>7$LTFC-IM9,J5ZIILG1F5N7:5M1$V48N36V4/-+-;J"(=/7ZL5:'HRKF
M+[6N*D-_#(6P/TWV'4"0SH![FB_RP:^C$R8\ (),Q6.LQQ*TX9EP2 F>/QX>
M4+@P L 'EZ*M-_C$-7V'L.>_Z/8/>&)OS#O9UVOL1NDIP/;#>@9?_N!C$$BU
M]\(;H20$UY5JOE,UTX\J5:I9!M5L2-5T/1_TQ#8H*';82MHJXO)E[D6MVUW)
M[7K["0%F53M;F=ERF%FM,K.E5C9MZV86[U6[E:+/WR.S%+:#TROCZ4E7;O/A
M)311*6OYUCZMY:],'Y@M7/.$3258&8'%6^,(IJJ5L$-72@4HH>!3/%VKB+5^
M<(9J&\YN 7C4]IU==@,3G%U++/>%EB W[85K<\?W#WT\.67?G2GW/%=7=TSO
M W_(R#20_%U_U=T8*\R4 #EUP;,@?%IO^C+ES])$?0QN$E/&GM]C$7><^>H1
M(7.&2NZ,>RJA=B:;1:VP/-PV>A/REC0/],//2%D"OR$),O(Z(S]T9=G78MDU
M=;^RN'MGUC55F/78](?5!"+1)_.#53:V #W9JY3J'NI)8Z&>S''E57JR]EBD
M,"W91F\>!/F:JK7J5?Q1B%UM5/%'N>UJHXH_RJ$G5?Q1;CVIXH\2>&RUOHP[
M21)!)?05-D*WE1TNM%MQGAQ):^=19A6U.I$$9@%YHR2G(_(<V-[SK%_S)#H!
MYA"CS*DX]'Z))WK9MR_W5R?LP#H4?'2)-"\1<A=GP&XEP;=7XS<N<R?0W;GF
MD%\'+O[2[CMC$Y^1_9 O^@@)L!^&INGC2W\N\U(@S?L*I'G\SF5N3&?.06$?
M_!2ME@GL5<AR%$:LHYZ//32</IUI-QS3D\?Q87M8\"1=0CY<)^[P<]W7^3-'
M9G#0'PH#8#R9K[]X>* ?2((,0U0C!,\(!CYXGU*YCK6ZCF;E.C;O.I81^LZX
MCC-D++\#QK-DY3]""]+'RZ!N,.)4B%STGXM(@*4?^8NNRN!?2W,@W"+;_='4
MH ,KHDB)/UP]3#4L<V@4Y2(63:K!2V01V_"<H-)3;4:J*Y:>'E?X%9MORP8+
M2<M2I?9P^=M-[_'I_F*^/"U'D6A!7VY::>]FZ"%%I6(0;<Y40P:5D+T^EJ"J
M7:U9$S>&U97<VAI3;M8Q_C.H3E6<M: "2(\//M1WVA@</IM#?320J02<D^("
M/"0XM?E-^+R0HG))\(8%7^X,YV+S6&G7VVLO.]0455M_,2-O;*>5CQEP7Z*]
M9!BO]83')>I\\OH"LP47O:O'W]G9[?W=[7WO\?+V9AD>K1)V=?/CG ,B[6/8
M.J7=7+^I:]:Y45J_K2O0@N;CPEU=LQ+A_[:G6GP):9[LYAY["J]>[%SI^WI6
MLK'Z\E; 2&T5CO.S]QD2K*\VNU;8;U-H6>(9^_WTZYMS=LL@EI9ZPE23I701
M\%;G0WA4Y$^K;[([U_0L [9.8&\F99>\FC,EB*;7UNE.KKS+3)\WGE%.7R7$
M_G]VC#?^8^B/1__]/U!+ P04    " !Y- -5IAUG-, 7   ?$P$ $    &-V
M<RTR,#(R,#8S,"YX<V3M75MOXSBR?I]?H9.7,P=8)[XHM\:D%\YM-HMTQR=)
MS^P^#6B)LGE:%CV4E,3[ZT^1DBS)$BG*L3O<M8$&.K9911:_8K%(%HN__/5M
MYELOF(6$!A<'O</N@84#A[HDF%P<?'N^[9P=_/7S3S_]\E^=SC\N'^^M:^K$
M,QQ$UA7#*,*N]4JBJ?6[B\/OEL?HS/J=LN_D!74ZGP71%9TO&)E,(ZO?[?=7
M?V6?NCV[ZZ+3DPX>#)R.?=[M=<[&@W'G&"&[;_=/T+B+_C+YA-'YJ>><'W?.
MNOVSCHUMW#E# ]3I>^?>R>EYKX>0(YB^A9]"9XIGR +!@O#36WAQ,(VB^:>C
MH]?7U\/7P2%EDZ-^M]L[^L>7^R=1]" MZY/@>ZGTVYCY6?G!$?]YC$*<%7=>
MRKSA\Q0C/YH>.G1VQ,7MG@RZ66G.BRBXDR",4. LN;L1ZT2+.0[K:>#G(_XS
MKZ?;@5[K]XHUN=&2K%C-\5'RXX&%HHB1<1SA6\IFU]A#L0\D<?!GC'SB$>R"
M'OB8(UTJ4/@Y0FR"HZ]HAL,Y<K!.5WS^R;(X0F0VIRRR@@JMA\*Q:&O((D%V
M8"5HWE,'14)%><DP$ZM2_@C[4<@_=?BGP[?0/3C2KS4..Q.$YJUJ+M(DM:??
MM&E!035[Y^?G1V]<U^I;4*L\HGR'_]GI]3N#7HMJ95JH7S=\ZF1TFVA#/L[:
MM2&C>V<;:D>63!>:*,7G4+,9]2-5LQ,R B[]<9L*0^P<3NC+D8N)CN*O%N=_
MU*@Z"@(:"7K^3?K=?$X"CR9?P%<<L$\9:H_8R^Q7Q0[7# WQWR?$'$;]AG%T
M-&=TCEE$<%BTX8+!E&'OX@#,52<S4G_X:'P(#<E*5/B7-8__? 0DV+_/!<EH
M.?@7!R'TOX^3KC%8[CG#;>4&DA!F" 'SO[OX#O+;B@\D3NS_1TCO8J^M]$!"
M K*&\)SZ&7ZWB'MQ<$7!^1RA"32.?__M\4[A2(AZ<XJ,;<8X;]'G+CAX\,_J
MY YKQQ*4%B?]Y6B58(55'&+W(?@L_E[5\I0X+:(@7-$/;;IRS]:2I5]F7:GL
MX,#% 1##'R'UB<N]]B>01CAW(?4>0$U$&\-O 8I=$G'G3AN+-9@K8.L)V/J
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MN=65_:%"_'($,H3.%,_0YY_^'U!+ P04    " !Y- -58*Q^%I$K  !0P@$
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M4!7:G*2VXEB!>5P1[0+K\ZJ[YSA9S"_?66ESI<D##.=<\;M+^@)"_<)+C*,
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M2QXHL),V)*8Y^540-3+A1! BZQ)C\[V][6ZJYS\6)7:4?;OVLS">UJ>_G7Z
M";XM+Y?S\10)#:=0/G,(3"2HO5,+F40?+0.G)7IE C:_$N@A+!OQXD=+$3=1
M3+MK@VC$=\[NO<?YHANG!>:+LWVWW[CQR7?8C6?Y_N)W4>OZ\]=T M-/^!X6
M^',IF!8C,"I$@XF5VJ%=@W-D1HMFF!/FB#YBZ>-LYN%&V-/FU[J]/\--<,J&
M>C^#83KYN@L8>3UF)S(J\E=XZ],*NU9M'K=R?\ <O[LX]*3^OO=FSX][WL;G
M5**!>LU*D@12F, BMY)%43>L94ZBM(Z&-T<WI.+%IT_/?=5_C-(!P\GM=N2&
M0ZY.6>#(/ ;+A!6@P;L,S8O==BT=..X&U=.GY[[J/\;JR;./1OA R[E IHNF
MA9W^9 [!!<>U=-CZ^-VNJ^=^58:OQZNO7RR[&[XPGE]%5>&<_Q[SR&DKE7.9
MI7IN7 >O6-298FD7C!;2)NUZN$]G:YQ#<GQZXMOW:A%[46?S\L2/LQ>)%JD.
M;_:IX :]*[%>&<!7)Y<%\UQ'9D0MN#7&NM3\KMSOX'D*)2_-F=1*/WT4M-ZD
M^45+SONCKU%Z=BXQ-,HQC1D8<"*XXY!4(J,CFC?6VA+B4SA[T1>O^M!B/[7W
MY#Z17_4/H(5TO/CVMOP#NG_AZKCP!TSUO96/;:*+W)%GC;;.""28W@O&:4IH
M2%9HUWH/:6N03Z DID][V%Z1_1G#!^_4&VD3L39J8J) 9-IH68\H:28C!.5#
M"%(T/_2Q,;HMRVE^J 6ML>[ZX]8:5_#B-WDD78Y":<-HX(:L>XXL**V95<5D
M8;A,J:\3(9O@>PI%-[WSJY7^!M=:8G3'D/?57(*><ZSV$G>'V&^#B779%JT=
M>.4LXSZX>E\C9P!9LEQ"+K)PA\TOC3_D.9WS%BOO8)QKWS-E54:/@:%R%-G&
M)&G>^<04-SJ8A#K)UGM<=R \U9,WV]!DS960.VNA%Q?^$A 9XZM#O><'-VA&
M%J^*EZDP4#(SG?6JW[M@UEMMN0R.ULT>/??O81O2ULB!N-.+VIH4L%_:X3+K
MKGHKPC2_(X2I&Y\?^7T]GI^M+$+\]IXBB_&$I/9EUOWKW0ETIY"J<"AHC=F*
MP)*HUPN Y2QXH1D'D7*6,0O4CYB\=FB>0@*B%<..I,->%K17R_EB=HH=>9:
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M LFM2./=T +/K<AZJ*!S4&1MK/B#;8K?+NU\-YN/SV]X;[ E_OVO;KTAOL5
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M%?6&SM3%^_6/2,'"7__P_P%02P,$%     @ >30#56-07AMK?   Y( % !0
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M>%F+J(M&%KVHTU<UR2#FG+H5Y%[_T .;IWVI8=I"AHU+=#]^AG&=2+=*Y;A
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M DZNOO^0/F,^.]EC8&3WSVY18;7C2M9*K2":0C9]@A)!U^(YLA,U3RJ;*#@
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MJP(:PP1)- @G0NQ]&/G>BWB*YNQQ:'SP+71;\V9MD2/!(^184[&3*4P'71B
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MK [+-BHAT13$VJ$#M"--=)X!!\=6@V-\#M&6UO': U#.Q9-K(>EQ%&"C]EV
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MU^12H\'[DB7ZYC5-8RK!(SD38^E 'RD/P/TFG'0#;MNFBPOI A3F#!US.JO
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MHX[T=P)\L%9[2*U;H>^!<8;Z<:RP!QFNNU+9Q461PB@M-'.(=,XE#RSZDIB
M'+*31A5IACDT1FQ5,?9)T$^LC5L!K+O;8O[PO3:O6NURVU?J0O#:%UQ*9H44
MM4-!9B!C8;)HKX3%'$.7</X#2YP1J2V%V7#"ZZHS&2ZWJO9I9=._FVW2T!87
M%ASG"ASI&B&BFX5@15X;A:'+(7$.2G3@^($ESHSC5L*\S[%I5X?]RW0Y6?[X
MCTG&#=:W/_X._SF;;XV,Q=L?U]+9NH#K,#>=1#J8X%ERP3#M2%=]2J2FJ@3#
M258J-Q_A>SSLL?)[!K\2QJ;P.:0%W40>2(PK$:XBK:+4C#9G-I>B-I9YHRW#
M%+5 'TKNULWHD=2!_:N?OE!Y)/YG37EHG%9R']$F$-L%4\-\HD,XQL\G:L'1
M@Y0?(>"QR _."JT4,E=$8=IDRZ*,A@&J "C1I]#IBGI6I#^04S06YWWD.D"0
MX=IHWIYFFP<2LH]]B(FS:.DFU:'.I\MD626( 40$@:YU5[L#4,9-2&G#T^[4
M^@9"'B" N1I8L3$E?KF<K)KVW3R1>:U+XEXR*3)=:+7C5?"FL*Q-@6#H@E/M
M6VL^ .@,]*"=P <X"=[-YF38P!+?UZJX+[>SXX2H[C(RA:D.XE:)>5T4,SG$
MR&614;6>97T0S!EH01M!#]%1;#NQ].W5@ORJQ6)[7*UN/L]M0FXYD\@3'5:U
MFSEME<!I-"BSA-RZ2O5!0*_-66C/TA JM,:R^4JZ@!DHK>T.D!./@CZ>J%T5
M.%K* ]P?=T$)[RQILV0BD$&CI0@L&/K' &"B2-GRW/K.&('RKB.?!V:\CW ;
MUR+\VRHCYUWM3K2>UK>X>X5%[[VN(ZT=&*AU%V3$<,X9Z&0DMT7B;AKSWLCV
M(\N<++K]% )FPTBO<1W"QZ\P_P;IQV><_SE)N .L0%0IZ<"<=^2I@$TLQE"'
MV>4@$UFG(7<I0'APD9=*:CO)-6^E55]*?I]-O_R!\V]5Z^Y"X]X%GY4B Z0V
MQ45A6:CM<2.B2"B@I&Y5)0\O\U)I;2F]@Y;6N"FDM[,-=UY+E[,#SZC#Y9$>
M@V:,9-)FTMK)*)7<@898N'-&.U$@69N]@"1TL*#RHQFEQP!KFU;Z8?D5YY\G
M7Z:3,DE0_V"#E)8E2^CF=8XG!.OIV#.H.-/D_-!'")$%B?15*B= M^[J]%2L
MS2*JM](0$+ETR@<F,P:F,P#SY-.S))/RA30@0NNTK6>9]S&(OAR,MCZ1@ $B
MK6^^U?W_SZ;/YV_3)4R_3.(EUFS#U<2;G-"C8#7J2YZ!H]W67QRX:)V//O+6
M"5X/(WHEFM*0E@$<ZFW7L@_3SU##35NG\L(HF[1UCKD0+-,J H,$F@7GBA<V
M.65;#U@[A.65*$H3*@8(MW5K;)>L,)!29D'EFN@8R0(.T3'+K;922I)%Z\OW
MF?87/*GRM"-I@%Y2OWW[#I-Y1?*A5)_G]\F?F-?GX!^SM_CS9/&]YB5]*!>J
M>!/ D!12)G\JESH$QVOFA<DR&LL]M)XVTQG<*]&H8<AJF/^Z!;H])]_-OL7-
M8V=] _TR7[<(7G\0[V8+NFS!>9E*2LS0T<FTT(*!#?1W*)7(PD74K<=9=4?W
M2O1J(+H:)MW6P,P>E!^OYNDK+/#C?))P[0&OOHZKY6*2Z;[>E%[>M 2]$'7<
M7\J&<1=(3,80_F(YPQCHV[ 8BMTQN??&OEI@.7/E.@EE]U7.#E6OX4CMO>:%
M@8J)8%E@T6E')B!:$;C0,G;)Y7_6]1J#*T@K =_GW1W=J6$^2XAY44L'?Y[4
M$K')DA3SQ@E .@UE$5XXRTHPGFG@LO:*)0LNNU!4X2;OE@L?W[7A<5AGKC=#
M$71?A_R0O;T%1F]%9A)X??++E@7@@LF@8P( I2QT.#Z>6V_OT4^0AF*^KP#A
M^%K.VR'\#^41<:QT^3IEZ&Z7B%4"470I<8^*"5ZK7:S-+&;/62:7D?X2TNYJ
M38.2T*9;.%7QT"A'TBGI?@[%17L:<H+CUEJ#3'%03 =O6.2T#Y,LED1GF=D=
M:?W">PZ?5 <>;E;<AXNQ>M9VP?1:FA7WXJ=+\]JG"'<LXJ7/%J6G<];4M#A4
M@GE?9Z\8E-H#^I(ZU1D\*\+[-2MNSG<?F8[;K#@$J2TG&YR+0(8X'5JU(7^H
M]?F*QZ*%W;T&7FZSXEXL=&]6W$>$ [QEKZ/+</FW^>SJ^[M+6"Q6%]I*OE69
M92Z12^Z9E\AK/+#FME<+BGN21>;@;6QLFCX"Z35; $.P-L!#Y@/PMA]3!X #
MU1(\"NXT]05-*>VN+D?P,4"2Q.- O?+@@O*LQ"3J[$G)@B:TG.N0,.OLFW=4
M/9'"/%*=<%I]Z4/#T'IR\T#Z]D=-Z'@_6])OI57[\:OK(#2=O]OQI:FDXEUD
MQ0BRSW2=EBJS9UA"L3KJ$F3K!(IC\(X?[6M,_T/*-21W@]18UW>,F\(@N%S-
M3?Z*JZZ7;W)>,0.7=0^7LU5_V+<_[FQX03]BW9MP_SY7WVX,UELPFG'DD6F'
MEH&JHW9=*JJ$F%+S$:+C[.POV^U9ZM  &4B] -\:8-T%]AB&87?(IS$7GZ,6
M/730#ZP"0]L8/> C^?':J'H8E-JZ# 0#80-S KS@EDX,T[K7RK/2W$?LUC-6
MW#[,-X[3?80?Y1+_M2T\=1&#5\!0U\'(2B46N,K,%X]&:QT\[#A)^^L[;__0
M$YNA0]$P:R'# 2S-AXO/G2P9-!:674VB288SPD,[MEIS)&7GNG76[K/LWO&<
M[+IVC V0NGNWB+8+F-?:R:,740_V=7B*E ?OY!%MCH3*$8H,->W2,&_I7K3*
M6BVRPV3QY5%^5">/=HSW$>[(G3RL@!"2L2PI;YB6')GW="DF1V<;"(<:9 >3
MX)EW\NA%0(].'GVDUWK U+U/;B4>Q/SM__Y22]$7M<;QE^G5MXTI]/NDECC<
M ;.OP+_'9UT77-Q\UW7I?B7[#;9P775_[) ^B&0.+">X>!,7J\$AC4^[?2L<
M.UEPT[7B9XS51WH'WR=+N/P=88$?XN7FM7K1>A_=%CW!6+F##-Z;%=A+;GV_
MV\UOUU\B_<3_]W_^%U!+ P04    " !Y- -51__R*<0.  !^#P  $P   &-V
M<RTR,#(R,#8S,%]G,2YJ<&>=EGLX5&O?QQ?&:9 F(:&)1#4..\="9E=;2-@1
M(2)2QFF29&28'"?&(><B3844)N=#"..X2YKP4#,T!J&#R<Q.8S&G=SS7\[[O
M/^\?[_-\U[VNM:[KOG]K_3[W]W>O=0L_"AG ]M.G'$X!8F)B@+_H (33P$E
M7$QLJ_U+$I(26Y*"0"0DI:6DI;=.&5DY61D9J(RT-%0!"I63%TE:=INB@ORV
MK?NMAVR%;T6)FKR,M(S\ORUA+P"3 32 ,@DQ;4 <)B8!$Q,. '  $),4^Z>
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MCO'EF*M]=/VN?0,E6$;M1;B.:ER-?<&E,98=E?QG8V-X4%8Z_E=(QN*@_]<
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M02OH_('*I#1:Q5US$:N0^E]02P,$%     @ >30#58IWU]3<) $ J0T, !0
M  !C=G,M,C R,C V,S!?;&%B+GAM;-2]>7/C.)8O^O]\"KR:US/5$486%W!!
MSW+#N?7D1%;:-YW5?>=5O%!@M3DEDVY2<J7GTU^ BR3+$@50(,V^,;?::9/
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MM*: [:H*LEK7"Z#,:5!(L"+?[;C>Z0=@QOR3C^<TZ\"^6LWX[2@&:LW ,]7
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M*LN]I\T@T81)/\4Q%#3$:I B K'2 ":11SP6,3_TO7:0NI(-KSQ$AXM43#1
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MHQ?_/(B$(_/V>=N3FJX'U=HW2P\_-#!".E]E/%NN=;;[[1;_PW>V7'/!]9F
MONI;-VO3E?Q 2IW@I[H694TRGS?5,$(9)EY0YTE&#"(_)9!&Q(<4>9Q11L.0
M6D6HN!)L;N;IKEZ[U70[S9H#MQW=]"+=::<O%YH5^HR"*,Z&W(RS7F,@1Z:[
M2<?0/EK:,>"N@J5=B35MK+1C,%^$2KMN_U66@29N<D$23&.?!M 380(1\K!:
M P2#21S&W$NIL@FMLAH[D6K6"T"U)0_QC#S8'GE<WPQW9W(SN).PO?V0_7U0
MO=I/UYK-AN6? ST/BF]E^GOB]^<P.B;WO<8G2(%TE7>I.'16CKW\.7Y,_)3%
M7&WS4P%12$-(*(HAQ0%-B*2I0%;NJ,XDFQO#*UGK3$>;U$?;;$@CYC[J'3M#
M\GZ-$1F9P*?+?:2'O<M^I"%YI?Q')N/R&OF/>N6:;_XC$SC/RG]DU,%P9]EM
MWVVH"XX9#SW!81K+.JH@U ZR#*)$,#]A,0DXMW6+W>]D;HQ<D\#6UK;W?GV!
MHAFAGHO-M-SH,+&E"0 .751?=#&Y,^HQ)0^YG1Y]=F!DT9I6XF]K[8KPJ/ZC
MDV-<?L^J!4:2B%37O.<\@@B'RE03H8"AEWHX]EG"A55BLR/]S&VN;\4$M9Q
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M7#UU"3Q\3!#B(20,8XA8G$",*((>QC)DJ4A\9!1*=[R+N9%2*R&H11R8L>,
MD&8L<QX\(S.*)3+65'%<>4>T<*"#22G@N(+[T[WGR8$I>L0#T1Y-EXQIAZ5J
M$P.PB -.D[2^$$J5 >)[(<2>"" 1S*<H93@.K?)S'>UI;A.]$Q205E*P;$6U
M+GIS'%VS:>\$L]%W@RU<K9 78".EP_0\IX!PE9[G:#_3IN<YI>Z+]#PG7QBC
M[N'V7PN*B P]%L#8$XHM&)$PY:F$0B8D4;9"X"=6@9&F'<^-/+91*2Z+%.X
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M2\ ,S@S.@F'LC7\K'&B@&) 0X  F%EOOL["9:/^\N>/[7) <-)LD\+_71)]
MJLTPSVH.!! < ]-1\<OC8/7M=5^^--V&]:C SW:=QY\:D(Q%Y%E1?BE6HHK>
MA._7HG-N#CP4=APG&*:>E\#4PQ0BDE"8QM*#(<(\H6$B*:+&.5A.]S<WTE-R
M_@%4M=P@UX(#KB]:6[F!%MPB'8@!WJ<ITC&*(W-F(RVHQ;T &LX+\'X?PB&I
M50RPM,BHXA;3J1*IN,'6+I>*.5)]*50,6IDN<XJY2L\2IEB\=A8WAV^"2#5_
MN;Y=5RL%)6X_;TI]/R%<P-C7V?1B%$.,< BIB"0*$2$L-HHF,NMN;LRLQ3Q
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M81 DJ1?3,"#:Y#//CK33MA6=3)#^Z)ON8WAL_BYJ9JPQ$(N1N>&S 0#64_^
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M4\D0C)'T A&@&'G&]2(.=S&WA:%)&[$CY@"GM"-@GJ;W\R$:F<0'H&-%$?T
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M6Y$+F>DT73Z+B90^C GW(1(QA50J:QI1G<N!8X]C:1%B?*H_HYDZ?8CQ1DY
M6T&!WN)8Y&/OP_BTS7PV9!-EL&_%K \#MIAUDCJ"RR)[O2/8IDI>/Q ^N\SU
M!ICT):[O>WVZO/4&2CQ+6V_R_# +5M<9*\6=R*OLL0U!^")65_(;^3[$8V0A
M]?]3O K3)!40>1Q!3#B&@D4LE3'B<2)MHLP<RV=EYTX06?9,O3:RS,YV=3V
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MCQ,>02R" "(/,TB2*(5,J$U PD,_87*AG4X*?K,BY6JN [@OXGC#V*6%)"M
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MJ4J4%%$$LY@EQF9#"E+"L=F,TE1J8[UE"OG8;)VC38V7'8K0]H#4S6X+!M3
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M,'3UIR6HY[/0B^6?X*?E\]K^\/,-: NCV(9K93W[OX1Q!GA.78<;P/5)HSD
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MY%BJ#'(:60L\HEHPJ13RJI-SE313X_;=6EA;F<'=<C$772=? \R3&YN/AO[
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M7 CA]>V>'6EJGW$K*%A82?V^X?-PNGW.04 :^LM^_Q9\$P]*/EOO0Q3#F-X
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MMVG<;2%OI:SJ0+'%MB])^>9EWR-E'E&G(I[Q8/TU-[L[0TZ4RQAJ&E.(>9)
M$F<1)$C;ZBF$*>U4"WA<L:=&=_N.7O#97 K^L()Z!GZ,-.ENW#F]J1S>E>\[
MB]Z4.RZH@6A[)*%'I?YQ)^)P^1AY]'Y+T.U2S#>C;%ICK5=S_ES%*7]?6A^D
MS8%?+A95[7K#M:I<;\K,(\89BZ#0L;1)Z@B2B.80LURS*":4Y,IG:;E.G*DM
M&;=?WGX$&W5 VT-N5R%;\VY?)=#JY+>L7#F1;LO%>-,S\#)PW<P,D(X?!ME
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MYPSB)$TACA""A"4)3%3.M!8XS@3UX8C>DDR-1FI%0+G1Q(\]^L^(&\&,@O/
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M-ZJ">Z-K"7Y:5.WN^I= #SW5;GN1:4S@P*NX+;)^T/K.J-?DJ]T I\9Y&R#
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M/U%/5/LZC+I1<O,8G7G&:[B,NM4YXS.Z<%._/=/O1=MTM"V8^:78=FL\;/K
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M]?"I+1YU?;9M6D$= =:$1?_[OY$XRO^KJNZU?O$,R]U%U,T:[HO3P%Q?BS7
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M*VLG$\HBK+@RO)+*"&*F<YNH'4&E2$152CFA3KOZTX^?FO&RE="ZN_T\=6<
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M1(<3<VJ6XE8^4&S:=I:5J+8)SY\/<_%0U1BW50M9\0(>6 F47>G-IVE_/]]
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M.X\Z8L8U?48HQC1%""(A%,0H-9#K*(:)TIDF(HVU#@H9]IMV:DJVVO1+OM9
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M*XVN(9.:0T9I9@Q-%95>)0*"9IV:'5<B [F%YN^6\>?XLH-K$.8&5@H.,VB
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M53 O)29B-.(PX1Q#3 K=EAD8D8A9&Y@H0[R"(7TGG)JNVV$N/O@%:O#C'2B
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M^!8O>)[?F>_KHO712Y%"7=1DFV5Q@B-K[\ T41'$6&:0$6J@,$H9PS+.L%<
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M:'&MJTI_!TXPC3 1$"N*($ZL9F!2:$B(5HI32BB/?32#_Y134Q*MH?1A[J4
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MB:F$6!H$.8\QC)&6,=.:<X5#K*&3LTQ-S^U! FE1NA1^E]!5)@ZMBN=65JU
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MGJ_4+%7:9!AK:#63JUZ#)+0:+(&))!S%1HHH]6]JU ' U#17^:4 3S5*\%S
M#"C0UF45+I]]#\WMP+KK=:&5&Q=>=Z;"R@W820&^CL%]0'&[@==@K.)T0ZQ%
M6#FY*XAL*P?79=CQRKE=(?2K<FS7C-/1-;I:/K@J[ZX2G/N*W?XYSV=&(68M
MVQ0FL4H@3AB"E&?(?CZ02;4F&6$XR,UY8I*I?1U>U[N_ 0XG^-TA#;1C3S+J
MZ8V\DJ>A/8NORMO[413N(&SAH"]GWZDIQG7<M0AYY(1KN[9K6_CBC/<K7V]>
MOML-=<YE43+JEY?F7XH'-XT9URK.(--"0LS3&'*3)E8?2,H3P>V6.*C4O?_4
M4U,0%3Y0 .RD&0)H]],7PY YL!8)XK%#)_%02GIK(.X]\<A]PT,).6X7'CQ"
M^ [WZR-?/W'Y4AX@\*4J;!]7,.HK?W'5HJKSA)G!*(H(C2!)*8=82^5\_0DD
M1C%DXD@H[.7K#YET:JJHQ@WD_EA/U=#!<XG=?V_ES?WEO>P0C ZLCW9D-LY(
M=ZA!!7MW'#H J_Z[U"'8'6EGVA/+07O14+I:]I_>0XVVYPP5KKG/#+ZW8X4^
M%\?S33]7^2A?URN[<WWZIEU5#5?P:[MY=#4<M-I?<_OD8*!9%J51EF0"LHAC
M5\$E@5S(# IA,L$$2@W+@FKX=88R-=U?2 +6.YC@N93EQOZND@;PG3C-"WDA
M4& EP.Y+Z&?"CK,P W]"RC79(P1?ZS79"0+VDC0OO&U?D_"*@U?3V5=-PNY
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M7:S6<\7O=Z7YZUZ'&+,(6[N>N9Q,K&()W<<;<HI2)!"+1"R\CZ5:IYK:-[E
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M-0'OZ>EXQ>8RI'9N9CQ04Q_F&05AHV'74@W>5)69P]%V7'_6;T<SJ>9/HWY
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M$W;Q6&!T9W.![7S$[0;LU3X4/V] H_E-@_+[JRB[]XLY Q:J8\Q>\+P]8\Z
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M\>F77%5_7S_I?_W\4_<=_1_#0_WS3W\!4$L#!!0    ( 'DT U7B[HT>0J\
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M#J!Q+H=SXDT6$HTCC[Y8VBE@. N(AF6,+D)"!\6T=CJN$S!.,Y/AH'&X='N
MQL4Q2S$#OJ0_KB:0HQ,<%85IM5XU ^$:N60\!A$0DN3IL1J>HYS22RK& 4E#
MYZ.1@#N R%O\@O,S7%VZYR!%C,5+EDKMS$"^>GT+9UBQ4BFO>(#P6$[D$(#<
MIJ$3W_1 G2X:"K@?@/Q"<GJVF&]8^.=T_?'9V6I-X=WRQ=<T.ZL7BT]6*Z3_
M\GOX.I&!6T",S&5-9M+5*B:C @O<D)E$J(^NA\'0/F2."[/C<'$_R 934@<X
M?+/$3].S3ZL7L)QC_@W7$RX\%*<50Y$+HV,\,B],83D')71*7,2=HN>]O.!;
M1(Q[DC7%T'$"[@ A1/++^1=<K:OQWF:?)I%0#JJV'7.U[9C4GL6B$G, PGNA
M4G*/%0L<@I%[R!BGI=L@*#E6R ?CY LNXZ*QTS,1$ISE*"C4@WJGZ1.+PG/F
MO'%).2\$#N7LC-/3;<C39S]Q'FXP%FN8-8'!^<W'_,.+KY_K%<F5-*0P-BO)
M&191W_2"9#&B9R2(Y%44*=K6"98'B>DD6&KC#;<1>1=&Y-EBM7Y=_KY8Y.LI
MAW>+69[$BGH?#5/"4%QILF8ADH2L@2)]IAT"C[5E.00^#U,SKIO;2.&+063?
M@=/R9C&;IF\?B7)</L4YENDF@_5L!M-/*SI?:X56_H_-G>XS$OB$@\&2E*;#
MM4BF15(,<M(L^VR!9YW=HV5-!SF]^Y$XKKT:!F]#:JD+8W9';!,/)H# 0F8]
MUTXFR3*?-3+,@,2>C^3S#7T$CNLW#P.EXR3=@<6JMK>"_Y+^&%(V#@+CKG;9
M\SRP*%UF+J:8=,@%RV.O.0X][:[3,*XS/=P9=["<>_*NMU'BJ\6*H)Y5KOU2
MF'<!Z7"6%&4X.J:+3=Y*\B*)M:&,RA49XYJ5H3SJ \7< 5(V;Z)QM3Y'^J9"
M2!9RW RQ7ELJT.GI2#I%0K 6#$^QM8]SBX1Q[4ECA!PCW@[.F]?KC[C\;3%?
MW 3Z!3>U=DQ%JY@,96-B#8M>*>93])!UD724MC8ICU(T3IOVH:Q+.^'O#Z6P
MA=(</]2:U??-$'5E*2\N3*;S,^+MJA+V*9;%$K<_]QZ^XNK%5SK027?3.2R_
M;<1*0DGUJF4QFVW$LMUC$VF=*-+2B1]S(L]?>A:2I/"3"Q[HK[SPK>LO!F1G
MG&;S@]G!/M3>Q8E[SN+Y1CZ/:2=6@3') N,%ZA0G$,P7 2P&K4G ',"T3EP]
M0,HX[>L'1=YQXNXB3?!FN2"Z-SZF1%\P$-DN%)*'E)J!+I8D([0FQ%LO!JA!
M/%]]G([U Z'C0*%V8$8VEX$71O7)>KV<QK-U+:IZOWC 3H;HB@:NF0";*^(E
M ZDYBRHKITR&:,L0]['[$#E.Q_N!P#6LBOKQZ6[P.:&X-TM//%@2#OFE$6H;
M=\Z\%"K)K%14C_62.!IF(_7'/P6&]I)M!S:JEK,0O%=O<+EIAG&9FT-GA$TN
ML! D4!A,!M='$A J)7U(Q(MOC9&':!FI8?Y <&DB\0X2#[?Y> JK:9H8H<G7
MK_>+P09BHLZ*4+7_KW4:A)89L;6+?"\AXU[KMM'Q=X"SO\"[<))OL_%\.CNC
MLVX2G.5>*\ML"(7VE.?$ _&%RD,4M<K&MW[H^@ IXU[1G@0[APB]"_3\$^MT
M=\Q/Z$/APWF7^=?E3B.G2ZD5J731&&J90WW$8"A^Y-K4[K)>$?= \41C6.U+
MXT@3/P8ZWP;54 ?GWJ[\;<US#)"=K4TJ'=3;:TOA0E::<<^S\#$";UXJMQ>!
MXYZ3PV+E0&#NK[A^47ENY^_VN0M>HY?<LUB;%&DZ/YC/M,,]Y\EC<$9#ZT3\
MGB2.>PKW@,PFRNL F]<:+CZ??IEFG.<K1P33C'[+$V^\R$*1_U'J%0%Y)2P@
M-TQ&9Z,2R5G1&I"[T#72,*:!SN;FFN@ 7>_IYUZ76@Y4"UXO&R.\J&UY5M,X
MPU?3U7JB9'!).V(*4MF.4H=D/4.10A8E\@*M,ZL[$3;2Q*>!\-5>%S]N:ZS:
MAGB)'ROC7\XO30?MD?7H>B=JEK4[SXVZ9ETN_KILEZMEQW>)N#JE0T[9<%?!
M'>L@B< @8*8OHPG>*9>'>]^_&XD-[R"MB$X60<Y!JO>G6L7JG%@FG;%>*:=R
M:%X,O]\=Y/ YVP%P\<@%Y3X2[^#HW)0OW2.6RLMO2+)[#U^WG2SI^TN$5742
M-K]?"LYQD>MK:,9S32!%*"PH;1F6 -XDDD94C3%V/-6=O!D[ 39/K.&.,?WD
M"TQG]6:W+)8KF.'YM+(IKI[D_WVV?;![*9$ZGXK <.,^^,U&N1/4!8 +S61(
MY![5.=A><\4LF!REB3+[4P&^$4LCOX [,4)WW"!CP*7CW;,I"UPL<?IAONV*
MGKZ]7\)\54=U$>?SO/EJMD7-'0%-"O%MDD$F2ZVX!U4GLSA@/'BO@JFUL*V3
M\,-P,O+KO3[WR@G!T?D6>0:KC[_,%G_\!^8/^'>8SC=E1846?UNS*ZO5M$P3
M7$B%>!<%/)=<,Q5T?0FI.9D''5C&$D5ML\?C8PW76V^,?>D?^05BO]MA4"!T
MO@G>U&]L&-O\U)L%R1K7T^7&YSVO[7TS(XMPCRT07J5-+\)8M&(Z@&'>",<H
M?)(.5!+*M<X"#\3*R&\N^]T:IX)'/\67NRAC4G(R5L>:"LVP38KZ.GI 58X]
M@!:[M31N'$B/^URK8Q@?I+@."C[O8>>"%?IJVP?OWH#F@7IH#A3""%#,6T-;
M,M?NL04$DTEIQ) $N-9UHHU9Z.2]\PFR06/JO@/H[U_LGTJQ)&S+%$;RRI(E
MXV$*9T5DFXLQ,39W1X9YCS'\!>()X#NL_H[U%X:VSI,8C>40.7,Y$#-H!?-!
M(./%@(W2T"DT0(7$0^1T\HY[7*NYETZ:6<"37&4_!?+!$[[[B+AN/]SI@4\?
M\)IZ%W[:7TK_,IW3JE.849@SW6R."T3Z4CQ/.3*N*-;71JHZG5BS1"<J*@3A
M7!SN)OI!NHXU8+6%\OJJPX]67L4"G)&/3/L.!3!0TC&!4,O9 UC1^CG(30JZ
MN89N@X3;MND(<7>01:I9LFJXZ;<7_W4V_0*S6D;R9/T,ELMO=([_)\S.D(+^
M0L&]\,P9[IG6,;$@=6&HA M<I>!XZS*&G0@;%UK':/[V ==<#1U@Z]U'"F3>
MX_+353_FU209!ZA+9%%5?] 7RR#F4CN[)Q.L(J::E__<0\>XMT@-D7.TD#L
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M+N\.(K=+ZK<2J<5<BWG=MD^^3LG)AQ2*DY;YZ(!I(3B+M; &LG \)!0:!QL
M?1]!G6#I $T_!)JCQ=X!AF[Q\)P"T^E\DH%;ZXAJ*<E)T&@BL5,[V$8G0X[&
M0/-2XGL)Z00SQRMZT5KJ'4!G&^G\BI\B+B=9<^=$[<[M>9TO)&JY2XS,H@!P
MH!/&UD?5]?7'!4H#==[I*G.@;#O Q;4F<^<,D/_OB@?!C*WO=^L$*J\T2:)
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M=(X\:B6.QMX#B^\&O1_Z8N0TBND@-+F<['Q]:GB!E(HW@G&N=:TQ1N:5C<Q
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M!RR':'$QE$A'Q,=JN;Z*&MXEG,-RNMCL%^,\9LG)^$:LTYR-94&HP*SC05(
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M?7OSQ=<T.\O3^8?:KH'^R^_AZT0)X^D05TP92RQ#$B1/[AD&I+]Q@6O<92I
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M(ZUT8.E>?OH,TV45\NM2QY"](@.^K;==O5\\Q:M;_@EWT@91.+,J96(,8GW
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M$2VO%\LOB_H0L/7$.68T*\J#K'U,5$$.3A@%G Z;=%::*&5C; [:V+0O-=U
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M?UU=S3Z'JX?3WW;3%C!+CIH!YT&1Z^T+>/0)2M9:$9'H;/.$^SWV-ZT#>RI
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M;#U39J-R:S$D<U'1;>QYC;_2Y1P"!VL=MT(RFT,:<*-M_WI_8#A$;HNF3.Q
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ML1NMZ L+3C*RP]=<TAR\-4AWJ92VJ"!4W/,Y<,=*PV!REJ'8%KSM!RGF)_%
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MX7, W_L#T.:N58RQ.JM V-IHG&X<\-&1^R@-YX%L?);LN.#IP8%J).3GH7,
MQR>$S6IY=7'WO/X^X3PL9XN;T\23UD9%T*RVI=>\MA H#IBVTGAEE0EY"&1H
MA0=PH9_NH;)S\9[LF\.OIC:\G1H<M_O^VWSU!=.LS##?GAFOC1!UMCWZ.MO>
MA@#>FPQDYVF36.;:- '(K@U,HTL:"771FL.=P.2WQ1)36&VT(+<&!89<1X&2
M1Q D^7@6%>AL:L43_=.JAACY?O4) =)&I%M <@1_.S!.=F6,,<5KDYH$,EK2
MKI(.4: +LL[T"V3"!99X:]OVF!+[$U7^M'XL.HS?W<'FV4+NXG/60CMP3M=W
M$J/I5V2%<93%9!M28O]38G\$& XOL=]',AU@[AU^"=\J4:LWY6&^](5)P3HI
M#,3(Z)JW4D&L;:;)K%<Y"O0V#;K2]D#8KKWT],C0!D]-N-YM7N_[3\383XM+
MDLOJU_^ZK@7NWVUY4#[OEH^TR>-]:7>-\G=O/GV7ORE<T5$K#KD6MBAM(SBN
M# B4: I&*5/K>.CW.S@ZX'*U2'__CFTUD'V?J?J!^/:*_H._7[@B)!>(4'S%
ML$<!@7E5SXDKT7NE16I,ZN#-37LU'8&))]&84<1Q1BIE;34>4BBP\U-CJ9=M
M.QU'R7!;.*N)>-)R#4I9"U'7\%Z02C)-9C1K[5\T5C+I$^;K2WQ3/BPQ$(Z_
MK7'^ZMOKR[!:W6-:9T?^GZT-N&H_+A4E..8$T,W+N55%Z-(\SCML:UTIF'WP
M\$3!C""*,U(OZ]\A,^UZF3Z%%:X.+TP:_NVQ%- @6L;12%FB4JJ&@#SY0,K+
M"%YS RRAS460;Y];5_2TU4AKM#\Z S<!BQ1=,>3:08G%UEYJ'J)G'*3SRD5R
M!Z1NK6QW;J8KK;./S!]KG3;L[L"O?G3FWBX7'Y?A\SJ KHN3,18!4A$Y"CF#
MX+$&OI HK#X>QM:7U\[=3(N<1N)^?'6UX7VW*+J-L1M;BLPZ BI)+$+%P#D7
MZ/IEDCD>K>>M(S3/[6?B-^]&,A\$I0,$,'%FW\\D2OZ$CLU,4V9%Y.07<BO(
M3&160RS, QH4(BC-K'G)R'EIC1[!<8@4%R.PM ,]<W.#;]/&]_%.SS"SHB(4
MC*I.^.% %.IZH# K87DVK:OA!FQKVMCP./=7:VET +#U[I^JY^NK3XME;:9V
MTU667WB1O+;! 7)!9$7&((9H()58WW_I7WZ4V.'+6^O!Q&X(B6WAQ,;RZ19V
M[[ J_MK+^(Z^^[^SH903.:@2 XDN@N)2@W>)3C$7A@>Z*R2VKM([?+?3:L%I
MP-E<BOWA-?]RO20"W^)RMLAK(Z9F_Y84R'(%(4H"E2U"9'2[9&5=UL9(GUHW
M,7AY5]/FV)\8?\=*I7.<_4>XO";[!1U7RKG:>2_4T'%UFH0$:TURSA=7;.O
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M+FAT;5!+ 0(4 Q0    ( 'DT U6A7/0C$;L! !J.#P 2              "
M 8:N 0!A,#8S,#(P,C)E>#$P,BYH=&U02P$"% ,4    " !Y- -5E.=)#W>]
M 0!=J@\ $@              @ '':0, 83 V,S R,#(R97@Q,#,N:'1M4$L!
M A0#%     @ >30#54<Z! I5 P  *PH  !(              ( !;B<% &$P
M-C,P,C R,F5X,34Q+FAT;5!+ 0(4 Q0    ( 'DT U7'HH!F$ @  *8E   2
M              "  ?,J!0!A,#8S,#(P,C)E>#,Q,2YH=&U02P$"% ,4
M" !Y- -59 ^\(1L(  #$)0  $@              @ $S,P4 83 V,S R,#(R
M97@S,3(N:'1M4$L! A0#%     @ >30#57UN#O;7!   \Q(  !(
M     ( !?CL% &$P-C,P,C R,F5X,S(Q+FAT;5!+ 0(4 Q0    ( 'DT U6P
MM.Z'X@0  %@3   2              "  85 !0!A,#8S,#(P,C)E>#,R,BYH
M=&U02P$"% ,4    " !Y- -5& *K.-2[ P )@S8 $               @ &7
M104 8W9S+3(P,C(P-C,P+FAT;5!+ 0(4 Q0    ( 'DT U6F'6<TP!<  !\3
M 0 0              "  9D!"0!C=G,M,C R,C V,S N>'-D4$L! A0#%
M  @ >30#56"L?A:1*P  4,(! !0              ( !AQD) &-V<RTR,#(R
M,#8S,%]C86PN>&UL4$L! A0#%     @ >30#56-07AMK?   Y( % !0
M         ( !2D4) &-V<RTR,#(R,#8S,%]D968N>&UL4$L! A0#%     @
M>30#54?_\BG$#@  ?@\  !,              ( !Y\$) &-V<RTR,#(R,#8S
M,%]G,2YJ<&=02P$"% ,4    " !Y- -5BG?7U-PD 0"I#0P %
M    @ '<T D 8W9S+3(P,C(P-C,P7VQA8BYX;6Q02P$"% ,4    " !Y- -5
MXNZ-'D*O  "^^ < %               @ 'J]0H 8W9S+3(P,C(P-C,P7W!R
;92YX;6Q02P4&      \ #P#% P  7J4+

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
